PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gordon, DR; Gantz, CA; Jerde, CL; Chadderton, WL; Keller, RP; Champion, PD				Gordon, Doria R.; Gantz, Crysta A.; Jerde, Christopher L.; Chadderton, W. Lindsay; Keller, Reuben P.; Champion, Paul D.			Weed Risk Assessment for Aquatic Plants: Modification of a New Zealand System for the United States	PLOS ONE			English	Article							INVASIONS	We tested the accuracy of an invasive aquatic plant risk assessment system in the United States that we modified from a system originally developed by New Zealand's Biosecurity Program. The US system is comprised of 38 questions that address biological, historical, and environmental tolerance traits. Values associated with each response are summed to produce a total score for each species that indicates its risk of invasion. To calibrate and test this risk assessment, we identified 39 aquatic plant species that are major invaders in the continental US, 31 species that have naturalized but have no documented impacts (minor invaders), and 60 that have been introduced but have not established. These species represent 55 families and span all aquatic plant growth forms. We found sufficient information to assess all but three of these species. When the results are compared to the known invasiveness of the species, major invaders are distinguished from minor and non-invaders with 91% accuracy. Using this approach, the US aquatic weed risk assessment correctly identifies major invaders 85%, and non-invaders 98%, of the time. Model validation using an additional 10 non-invaders and 10 invaders resulted in 100% accuracy for the former, and 80% accuracy for the latter group. Accuracy was further improved to an average of 91% for all groups when the 17% of species with scores of 31-39 required further evaluation prior to risk classification. The high accuracy with which we can distinguish non-invaders from harmful invaders suggests that this tool provides a feasible, pro-active system for pre-import screening of aquatic plants in the US, and may have additional utility for prioritizing management efforts of established species.	[Gordon, Doria R.] Univ Florida, Nat Conservancy, Gainesville, FL 32611 USA; [Chadderton, W. Lindsay] Univ Notre Dame, Environm Change Initiat, Nat Conservancy, Notre Dame, IN 46556 USA; [Gordon, Doria R.] Univ Florida, Dept Biol, Gainesville, FL USA; [Keller, Reuben P.] Loyola Univ, Dept Environm Sci, Chicago, IL 60611 USA; [Champion, Paul D.] Freshwater Biosecur Natl Inst Water & Atmospher R, Hamilton, New Zealand	Nature Conservancy; State University System of Florida; University of Florida; Nature Conservancy; University of Notre Dame; State University System of Florida; University of Florida; Loyola University Chicago	Gordon, DR (corresponding author), Univ Florida, Nat Conservancy, Gainesville, FL 32611 USA.	dgordon@tnc.org	Jerde, Christopher/AAJ-4385-2020; Jerde, Christopher/K-5111-2012	Jerde, Christopher/0000-0002-8074-3466; Jerde, Christopher/0000-0003-4448-3561	United States Army Corps of Engineers (USACE) [W912HZ-10-2-0014]; Florida Chapter of The Nature Conservancy; Nature Conservancy's Great Lakes Fund for Partnership in Conservation Science and Economics; National Oceanic and Atmospheric Administration CSCOR [NA09NOS4780192]; USACE [W912HZ-08-2-0014]; National Science Foundation [DEB 02-13698]; USFWS [30181AJ261]; David Lodge's laboratory facilities	United States Army Corps of Engineers (USACE); Florida Chapter of The Nature Conservancy; Nature Conservancy's Great Lakes Fund for Partnership in Conservation Science and Economics; National Oceanic and Atmospheric Administration CSCOR; USACE; National Science Foundation(National Science Foundation (NSF)); USFWS(US Fish & Wildlife Service); David Lodge's laboratory facilities	Research was funded by the United States Army Corps of Engineers (USACE) Cooperative Agreement No. W912HZ-10-2-0014 (DRG). DRG, CAG, and LWC were partially supported by the Florida Chapter of The Nature Conservancy and The Nature Conservancy's Great Lakes Fund for Partnership in Conservation Science and Economics. CAG, CLJ, and LWC were partially supported by the National Oceanic and Atmospheric Administration CSCOR (NA09NOS4780192) and CLJ was partially supported by USACE (W912HZ-08-2-0014) and National Science Foundation (DEB 02-13698). CAG, LWC, and RPK were partially supported by USFWS Award No. 30181AJ261. CAG and CLJ were also partially supported by David Lodge's laboratory facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and no official endorsement should be inferred.	Bisset P, 1905, BOOK WATER GARDENING; Caley P, 2006, AUSTRAL ECOL, V31, P647, DOI 10.1111/j.1442-9993.2006.01617.x; Champion P., 2008, RISK ASSESSMENT TRAD; Champion P. D., 2001, Weed risk assessment, P194; Champion PD, 2010, HYDROBIOLOGIA, V656, P167, DOI 10.1007/s10750-010-0446-x; Champion P. D., 2010, ASSESSING RISK POSED; Clayton J. S., 2006, HYDROBIOLOGIA, V570, P103; Clayton JS, 2000, SCI CONSERVATION, V141; Cook C. D. K., 1974, WATER PLANTS WORLD M; Crosson H, 2005, KEEPING AQUATIC PLAN; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; Environment Waikato, 2010, 5 4 21 WAT POPP HYDR; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Gordon DR, 2011, BIOL INVASIONS, V13, P1829, DOI 10.1007/s10530-011-0002-2; Gordon Doria R., 2010, Plant Protection Quarterly, V25, P56; Groves RH, 2006, EUPHYTICA, V148, P111, DOI 10.1007/s10681-006-5945-5; Haynes RR, 2000, FLORA N AM, V22; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kay SH, 2001, J AQUAT PLANT MANAGE, V39, P88; Keller R.P., 2009, BIOECONOMICS INVASIV, P44; Keller RP, 2007, BIOSCIENCE, V57, P428, DOI 10.1641/B570509; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Koop AL, 2012, BIOL INVASIONS, V14, P273, DOI 10.1007/s10530-011-0061-4; Koschnick T, 2007, MIDW AQ PLANT MAN SO, P4; Kunzer John M., 2008, Journal of the Botanical Research Institute of Texas, V2, P633; Les D. H., 1999, Biological Invasions, V1, P281, DOI 10.1023/A:1010086232220; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Maki K, 2004, BIOL CONSERV, V118, P389, DOI 10.1016/j.biocon.2003.09.015; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; NAPPFAST, 2007, N CAR STAT U AN PLAN; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Petroeschevsky A., 2008, Proceedings of the 16th Australian Weeds Conference, Cairns Convention Centre, North Queensland, Australia, 18-22 May, 2008, P399; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Reed RNR., 2009, 20091202 US GEOL SUR, DOI [10.3133/ofr20091202, DOI 10.3133/OFR20091202]; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; SCHMITZ DC, 1993, BIOLOGICAL POLLUTION: THE CONTROL AND IMPACT OF INVASIVE EXOTIC SPECIES, P173; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; Springborn M, 2011, ECOL ECON, V70, P2145, DOI 10.1016/j.ecolecon.2011.06.016; Stodola J, 1967, ENCY WATER PLANTS; TRICKER W, 1897, WATER GARDEN; Twongo T., 1996, LIMNOLOGY CLIMATOLOG, P633; Van TK, 1999, AQUAT BOT, V62, P225, DOI 10.1016/S0304-3770(98)00100-4; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769	49	54	57	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40031	10.1371/journal.pone.0040031	http://dx.doi.org/10.1371/journal.pone.0040031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808088	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700018
J	Plaza, JGR; Rojas, AV; Herrera, S; Garza-Ramos, G; Larios, AT; Amero, C; Granados, GZ; Aguilar, MG; Ortiz, MTL; Gonzalez, CP; Carvajal, SU; Coria, R; Diaz, AP; Bredesen, DE; Castro-Obregon, S; del Rio, G				Rodriguez Plaza, Jonathan G.; Villalon Rojas, Amanda; Herrera, Sur; Garza-Ramos, Georgina; Torres Larios, Alfredo; Amero, Carlos; Zarraga Granados, Gabriela; Gutierrez Aguilar, Manuel; Lara Ortiz, Maria Teresa; Polanco Gonzalez, Carlos; Uribe Carvajal, Salvador; Coria, Roberto; Pena Diaz, Antonio; Bredesen, Dale E.; Castro-Obregon, Susana; del Rio, Gabriel			Moonlighting Peptides with Emerging Function	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CEREVISIAE ALPHA-FACTOR; SACCHAROMYCES-CEREVISIAE; MATING FACTOR; CONFORMATIONAL-ANALYSIS; BIOLOGICAL-ACTIVITY; ANTICANCER ACTIVITY; SIGNALING PATHWAYS; CELL-DEATH; ANALOGS	Hunter-killer peptides combine two activities in a single polypeptide that work in an independent fashion like many other multi-functional, multi-domain proteins. We hypothesize that emergent functions may result from the combination of two or more activities in a single protein domain and that could be a mechanism selected in nature to form moonlighting proteins. We designed moonlighting peptides using the two mechanisms proposed to be involved in the evolution of such molecules (i.e., to mutate non-functional residues and the use of natively unfolded peptides). We observed that our moonlighting peptides exhibited two activities that together rendered a new function that induces cell death in yeast. Thus, we propose that moonlighting in proteins promotes emergent properties providing a further level of complexity in living organisms so far unappreciated.	[Rodriguez Plaza, Jonathan G.; Villalon Rojas, Amanda; Herrera, Sur; Torres Larios, Alfredo; Lara Ortiz, Maria Teresa; Polanco Gonzalez, Carlos; del Rio, Gabriel] Univ Nacl Autonoma Mexico, Biochem & Struct Biol Dept, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Garza-Ramos, Georgina] Univ Nacl Autonoma Mexico, Dept Biochem, Fac Med, Mexico City 04510, DF, Mexico; [Amero, Carlos] Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca, Morelos, Mexico; [Zarraga Granados, Gabriela; Castro-Obregon, Susana] Univ Nacl Autonoma Mexico, Dept Dev Genet & Mol Physiol, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Gutierrez Aguilar, Manuel; Uribe Carvajal, Salvador; Coria, Roberto; Pena Diaz, Antonio] Univ Nacl Autonoma Mexico, Dept Mol Genet, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Bredesen, Dale E.] Buck Inst Age Res, Novato, CA USA; [Bredesen, Dale E.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Plaza, JGR (corresponding author), Univ Nacl Autonoma Mexico, Biochem & Struct Biol Dept, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	gdelrio@ifc.unam.mx	Amero, Carlos/C-6952-2011; Castro-Obregon, Susana/AAE-5105-2020; Paredes, Sur Herrera/I-8617-2019; Amero, Carlos/AAE-7733-2020	Amero, Carlos/0000-0001-6300-0241; Paredes, Sur Herrera/0000-0001-9246-8337; Gutierrez-Aguilar, Manuel/0000-0002-8372-7410; Uribe-Carvajal, Salvador/0000-0002-7028-8121; Garza Ramos, Georgina/0000-0003-3496-9525; Polanco, Carlos/0000-0003-1673-2006; Torres-Larios, Alfredo/0000-0002-0702-350X; Castro-Obregon, Susana/0000-0003-0549-5690	PAPIIT [IN217708, IN205911, IN221909]; SEP-CoNaCyT [82308, 106598]; Academia Mexicana de Ciencias; CONACYT [C01-56431]; Consejo Nacional de Ciencia y Tecnologia grant [60127-Q]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; Universidad Nacional Autonoma de Mexico (PAPIIT) [IN202910]; Instituto de Ciencia y Tecnologia del Distrito Federal grant [PIFUTP09-279]	PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); SEP-CoNaCyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Academia Mexicana de Ciencias; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia grant; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal grant	GDR was supported by grants from PAPIIT (IN217708, IN205911) and from SEP-CoNaCyT (82308). SH was supported by a grant from the Academia Mexicana de Ciencias. SCO was supported by grants from PAPIIT (IN221909) and SEP-CoNaCyT (106598). CA was supported by a grant from CONACYT (C01-56431). ATL is supported by Consejo Nacional de Ciencia y Tecnologia grant 60127-Q, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) grant IN202910 and Instituto de Ciencia y Tecnologia del Distrito Federal grant PIFUTP09-279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MG, 1998, J PEPT RES, V52, P95; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Arap Wadih, 1998, Current Opinion in Oncology, V10, P560, DOI 10.1097/00001622-199811000-00014; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; del Rio G, 2001, FEBS LETT, V494, P213, DOI 10.1016/S0014-5793(01)02348-1; Ellerby HM, 2008, J MED CHEM, V51, P5887, DOI 10.1021/jm800495u; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GOUNARIDES JS, 1993, BIOCHEMISTRY-US, V32, P908, DOI 10.1021/bi00054a023; HARTWELL LH, 1980, J CELL BIOL, V85, P811, DOI 10.1083/jcb.85.3.811; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; KITADA K, 1988, CURR GENET, V13, P1, DOI 10.1007/BF00365748; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Lee BK, 2001, J BIOL CHEM, V276, P37950; LOW PS, 1993, J BIOL CHEM, V268, P14627; Muller H, 2008, EUKARYOT CELL, V7, P848, DOI 10.1128/EC.00456-07; Obeid M, 2009, MOL CANCER THER, V8, P2693, DOI 10.1158/1535-7163.MCT-09-0228; Rea AM, 2009, BIOCHEMISTRY-US, V48, P7556, DOI 10.1021/bi900805s; Rusten TE, 2007, NATURE, V445, P497, DOI 10.1038/445497a; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; SHENBAGAMURTHI P, 1985, BIOCHEMISTRY-US, V24, P7070, DOI 10.1021/bi00346a008; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; WAKAMATSU K, 1986, EUR J BIOCHEM, V154, P607, DOI 10.1111/j.1432-1033.1986.tb09442.x; WAKAMATSU K, 1987, EUR J BIOCHEM, V163, P331, DOI 10.1111/j.1432-1033.1987.tb10804.x; YANG W, 1995, BIOCHEMISTRY-US, V34, P1308, DOI 10.1021/bi00004a025; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177; Zhang YL, 1998, BIOCHEMISTRY-US, V37, P12465, DOI 10.1021/bi980787u	36	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40125	10.1371/journal.pone.0040125	http://dx.doi.org/10.1371/journal.pone.0040125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808104	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700022
J	Borner, K; Klavans, R; Patek, M; Zoss, AM; Biberstine, JR; Light, RP; Lariviere, V; Boyack, KW				Boerner, Katy; Klavans, Richard; Patek, Michael; Zoss, Angela M.; Biberstine, Joseph R.; Light, Robert P.; Lariviere, Vincent; Boyack, Kevin W.			Design and Update of a Classification System: The UCSD Map of Science	PLOS ONE			English	Article							TECHNOLOGY	Global maps of science can be used as a reference system to chart career trajectories, the location of emerging research frontiers, or the expertise profiles of institutes or nations. This paper details data preparation, analysis, and layout performed when designing and subsequently updating the UCSD map of science and classification system. The original classification and map use 7.2 million papers and their references from Elsevier's Scopus (about 15,000 source titles, 2001-2005) and Thomson Reuters' Web of Science (WoS) Science, Social Science, Arts & Humanities Citation Indexes (about 9,000 source titles, 2001-2004)-about 16,000 unique source titles. The updated map and classification adds six years (2005-2010) of WoS data and three years (2006-2008) from Scopus to the existing category structure-increasing the number of source titles to about 25,000. To our knowledge, this is the first time that a widely used map of science was updated. A comparison of the original 5-year and the new 10-year maps and classification system show (i) an increase in the total number of journals that can be mapped by 9,409 journals (social sciences had a 80% increase, humanities a 119% increase, medical (32%) and natural science (74%)), (ii) a simplification of the map by assigning all but five highly interdisciplinary journals to exactly one discipline, (iii) a more even distribution of journals over the 554 subdisciplines and 13 disciplines when calculating the coefficient of variation, and (iv) a better reflection of journal clusters when compared with paper-level citation data. When evaluating the map with a listing of desirable features for maps of science, the updated map is shown to have higher mapping accuracy, easier understandability as fewer journals are multiply classified, and higher usability for the generation of data overlays, among others.	[Boerner, Katy; Zoss, Angela M.; Biberstine, Joseph R.; Light, Robert P.; Lariviere, Vincent] Indiana Univ, Sch Lib & Informat Sci, Cyberinfrastruct Network Sci Ctr, Bloomington, IN 47401 USA; [Boerner, Katy] Royal Netherlands Acad Arts & Sci KNAW, Amsterdam, Netherlands; [Klavans, Richard; Patek, Michael] SciTech Strategies Inc, Berwyn, PA USA; [Lariviere, Vincent] Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ, Canada; [Lariviere, Vincent] Univ Quebec, CIRST, OST, Montreal, PQ H3C 3P8, Canada; [Boyack, Kevin W.] SciTech Strategies Inc, Albuquerque, NM USA	Indiana University System; Indiana University Bloomington; Universite de Montreal; University of Quebec; University of Quebec Montreal	Borner, K (corresponding author), Indiana Univ, Sch Lib & Informat Sci, Cyberinfrastruct Network Sci Ctr, Bloomington, IN 47401 USA.	katy@indiana.edu	Lariviere, Vincent/AAF-3179-2019; Zoss, Angela M./W-8726-2019	Zoss, Angela M./0000-0002-9647-597X; Light, Robert/0000-0001-7067-5562; Boyack, Kevin/0000-0001-7814-8951	James S. McDonnell Foundation; National Science Foundation [SBE-0738111]; National Institutes of Health [U24RR029822, U01GM098959]; University of California, San Diego (UCSD); NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR029822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098959] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego (UCSD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The generation of the 2010 UCSD map of science and classification system is funded in part by the James S. McDonnell Foundation, the National Science Foundation under award SBE-0738111, and the National Institutes of Health under awards U24RR029822 and U01GM098959. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The original 2005 UCSD map of science was created by SciTech Strategies as part of a research contract funded by the University of California, San Diego (UCSD). UCSD holds the copyright for both the original classification system and the map, and has given permission for them to be used in the instantiations mentioned in this work. We would like to thank Andrea Scharnhorst for detailed comments on an earlier version of this paper and Thomson Reuters and Elsevier for their permission to publish the journal name conversion tables.	[Anonymous], SCI METRIX SCI J ONT; [Anonymous], MACE BROWS CLASS; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Borner K, 2010, SCI TOOL TOOL SCI SC; Borner K, 2003, VISUAL INTERFACES DI; Bourke P, 1999, RES POLICY, V28, P489, DOI 10.1016/S0048-7333(99)00009-8; Boyack KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018029; Boyack KW, 2009, SCIENTOMETRICS, V79, P45, DOI 10.1007/s11192-009-0403-5; Boyack KW, 2009, SCIENTOMETRICS, V79, P27, DOI 10.1007/s11192-009-0402-6; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Boyack KW, 2003, J AM SOC INF SCI TEC, V54, P447, DOI 10.1002/asi.10230; Boyack KW, 2002, J AM SOC INF SCI TEC, V53, P764, DOI 10.1002/asi.10066; Bu┬rner K., 2010, ATLAS SCI VISUALIZIN; Crane D., 1972, INVISIBLE COLL DIFFU; de Nooy W., 2011, EXPLORATORY SOCIAL N, V2, DOI [10.1017/CBO9780511996368, DOI 10.1017/CBO9780511996368]; Irvine J., 1984, FORESIGHT SCI PICKIN; Jain A, 1998, SCIENTOMETRICS, V41, P357, DOI 10.1007/BF02459051; Klavans R, 2011, J AM SOC INF SCI TEC, V62, P1, DOI 10.1002/asi.21444; Klavans R, 2010, SCIENTOMETRICS, V82, P539, DOI 10.1007/s11192-010-0188-6; Klavans R, 2009, J AM SOC INF SCI TEC, V60, P455, DOI 10.1002/asi.20991; Kosecki S, 2011, SCIENTOMETRICS, V88, P707, DOI 10.1007/s11192-011-0359-0; Lewison G, 1998, SCIENTOMETRICS, V41, P17, DOI 10.1007/BF02457963; Lewison G, 1998, GUT, V43, P288, DOI 10.1136/gut.43.2.288; Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967; Polanco X, 2001, SCIENTOMETRICS, V51, P267, DOI 10.1023/A:1010537316758; Scharnhorst A, 2012, UNDERST COMPLEX SYST, P1, DOI [10.1007/978-3-642-23068-4, 10.1007/978-3-642-23068-4_1]; Schwechheimer H, 2001, SCIENTOMETRICS, V51, P311, DOI 10.1023/A:1010541418576; Schwechheimer H, 1999, SCIENTOMETRICS, V44, P547, DOI 10.1007/BF02458495; Shiffrin RM, 2004, P NATL ACAD SCI USA, V101, P5183, DOI 10.1073/pnas.0307852100; Shneiderman B, 1996, IEEE SYMPOSIUM ON VISUAL LANGUAGES, PROCEEDINGS, P336, DOI 10.1109/VL.1996.545307; Small H, 1999, J AM SOC INFORM SCI, V50, P799, DOI 10.1002/(SICI)1097-4571(1999)50:9<799::AID-ASI9>3.0.CO;2-G; Vargas-Quesada B., 2007, VISUALIZING STRUCTUR; VIVO, EN NAT SCI	33	124	127	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39464	10.1371/journal.pone.0039464	http://dx.doi.org/10.1371/journal.pone.0039464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973NH	22808037	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400009
J	Chiu, CL; Lujic, S; Thornton, C; O'Loughlin, A; Makris, A; Hennessy, A; Lind, JM				Chiu, Christine L.; Lujic, Sanja; Thornton, Charlene; O'Loughlin, Aiden; Makris, Angela; Hennessy, Annemarie; Lind, Joanne M.			Menopausal Hormone Therapy Is Associated with Having High Blood Pressure in Postmenopausal Women: Observational Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; REPLACEMENT THERAPY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; HOT FLUSHES; HYPERTENSION; ESTROGEN; HEALTH; PREVENTION; PREVALENCE	Background: The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remains controversial, with a number of studies advocating the use of MHT in reducing risk of cardiovascular diseases, while others have shown it to increase risk. The aim of this study was to determine the association between menopausal hormone therapy and high blood pressure. Methods and Findings: A total of 43,405 postmenopausal women were included in the study. Baseline data for these women were sourced from the 45 and Up Study, Australia, a large scale study of healthy ageing. These women reported being postmenopausal, having an intact uterus, and had not been diagnosed with high blood pressure prior to menopause. Odds ratios for the association between MHT use and having high blood pressure were estimated using logistic regression, stratified by age (<56 years, 56-61 years, 62-70 years and over 71 years) and adjusted for demographic and lifestyle factors. MHT use was associated with higher odds of having high blood pressure: past menopausal hormone therapy use:,56 years (adjusted odds ratio 1.59, 99% confidence interval 1.15 to 2.20); 56-61 years (1.58, 1.31 to 1.90); 62-70 years (1.26, 1.10 to 1.44). Increased duration of hormone use was associated with higher odds of having high blood pressure, with the effect of hormone therapy use diminishing with increasing age. Conclusions: Menopausal hormone therapy use is associated with significantly higher odds of having high blood pressure, and the odds increase with increased duration of use. High blood pressure should be conveyed as a health risk for people considering MHT use.	[Chiu, Christine L.; Lujic, Sanja; Thornton, Charlene; O'Loughlin, Aiden; Makris, Angela; Hennessy, Annemarie; Lind, Joanne M.] Univ Western Sydney, Sch Med, Penrith, NSW 1797, Australia; [Makris, Angela] Liverpool Hosp, Dept Renal Med, Sydney, NSW, Australia	Western Sydney University; Liverpool Hospital	Chiu, CL (corresponding author), Univ Western Sydney, Sch Med, Penrith, NSW 1797, Australia.	j.lind@uws.edu.au	Hennessy, Annemarie/HGB-5049-2022	Lujic, Sanja/0000-0002-9555-0261; Hennessy, Annemarie/0000-0002-5975-2843; Chiu, Christine L./0000-0002-6411-9719	National Health and Medical Research Council (NHMRC) (Australia)	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	Dr. Lind is supported by a National Health and Medical Research Council (NHMRC) Fellowship (Australia). www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Bauman A F, 2001, TRENDS POPULATION LE; Bechlioulis A, 2010, J CLIN ENDOCR METAB, V95, P1199, DOI 10.1210/jc.2009-2262; Food and Drug Administration DoHaHS, 2009, CONS INF AUD WOM MEN; FORD ES, 1991, HYPERTENSION, V18, P598, DOI 10.1161/01.HYP.18.5.598; Freeman EW, 2007, CLIMACTERIC, V10, P197, DOI 10.1080/13697130601181486; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Karalis I, 2005, BLOOD PRESSURE, V14, P38, DOI 10.1080/08037050510008788; Kaya C, 2006, CLIMACTERIC, V9, P437, DOI 10.1080/13697130601003094; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Miller VM, 2009, J CARDIOVASC TRANSL, V2, P228, DOI 10.1007/s12265-009-9104-y; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Perneger TV, 1999, BRIT MED J, V318, P1288; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sassarini J, 2011, CLIN ENDOCRINOL, V74, P97, DOI 10.1111/j.1365-2265.2010.03921.x; Trial TWGftP, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI DOI 10.1001/JAMA.1995.03520270033028; Tuomikoski P, 2010, ANN MED, V42, P334, DOI 10.3109/07853891003796760; van Ittersum FJ, 1998, AM J HYPERTENS, V11, P1147, DOI 10.1016/S0895-7061(98)00165-4; Wassertheil-Smoller S, 2000, HYPERTENSION, V36, P780, DOI 10.1161/01.HYP.36.5.780	24	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40260	10.1371/journal.pone.0040260	http://dx.doi.org/10.1371/journal.pone.0040260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808129	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400038
J	Schroeder, J; Nakagawa, S; Cleasby, IR; Burke, T				Schroeder, Julia; Nakagawa, Shinichi; Cleasby, Ian R.; Burke, Terry			Passerine Birds Breeding under Chronic Noise Experience Reduced Fitness	PLOS ONE			English	Article							HOUSE SPARROWS; ENVIRONMENTAL NOISE; RESPONSIVENESS; BLACKBIRD; SUCCESS; IMPACT; CALLS; SIZE; SEX	Background: Fitness in birds has been shown to be negatively associated with anthropogenic noise, but the underlying mechanisms remain obscure. It is however crucial to understand the mechanisms of how urban noise impinges on fitness to obtain a better understanding of the role of chronic noise in urban ecology. Here, we examine three hypotheses on how noise might reduce reproductive output in passerine birds: (H1) by impairing mate choice, (H2) by reducing territory quality and (H3) by impeding chick development. Methodology/Principal Findings: We used long-term data from an island population of house sparrows, Passer domesticus, in which we can precisely estimate fitness. We found that nests in an area affected by the noise from large generators produced fewer young, of lower body mass, and fewer recruits, even when we corrected statistically for parental genetic quality using a cross-fostering set-up, supporting H3. Also, individual females provided their young with food less often when they bred in the noisy area compared to breeding attempts by the same females elsewhere. Furthermore, we show that females reacted flexibly to increased noise levels by adjusting their provisioning rate in the short term, which suggests that noise may be a causal factor that reduces reproductive output. We rejected H1 and H2 because nestbox occupancy, parental body mass, age and reproductive investment did not differ significantly between noisy and quiet areas. Conclusions/Significance: Our results suggest a previously undescribed mechanism to explain how environmental noise can reduce fitness in passerine birds: by acoustically masking parent-offspring communication. More importantly, using a cross-fostering set-up, our results demonstrate that birds breeding in a noisy environment experience significant fitness costs. Chronic noise is omnipresent around human habitation and may produces similar fitness consequences in a wide range of urban bird species.	[Schroeder, Julia; Nakagawa, Shinichi; Cleasby, Ian R.; Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Nakagawa, Shinichi] Univ Otago, Dept Zool, Dunedin, New Zealand; [Nakagawa, Shinichi] Max Planck Inst Ornithol, Seewiesen, Germany	University of Sheffield; University of Otago; Max Planck Society	Schroeder, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	julia.schroeder@gmail.com	Burke, Terry/B-3196-2011; Schroeder, Julia/B-1436-2010; Nakagawa, Shinichi/B-5571-2011	Burke, Terry/0000-0003-3848-1244; Schroeder, Julia/0000-0002-4136-843X; Nakagawa, Shinichi/0000-0002-7765-5182	NERC(Natural Environment Research Council) [NE/F00607/1]; Humbolt Fellowship; Natural Environment Research Council [NE/F006071/1] Funding Source: researchfish; NERC [NE/F006071/1] Funding Source: UKRI	NERC(Natural Environment Research Council)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Humbolt Fellowship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the grant NE/F00607/1 from NERC(Natural Environment Research Council) to TB, and SN was supported by a Humbolt Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Burford JE, 1998, ANIM BEHAV, V56, P555, DOI 10.1006/anbe.1998.0830; Burke T., 1984, THESIS U NOTTINGHAM; Cleasby IR, 2010, BIOL J LINN SOC, V101, P680, DOI 10.1111/j.1095-8312.2010.01515.x; Cyr NE, 2007, GEN COMP ENDOCR, V154, P59, DOI 10.1016/j.ygcen.2007.06.016; Francis CD, 2011, P ROY SOC B-BIOL SCI, V278, P2025, DOI 10.1098/rspb.2010.1847; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gelman A., 2007, DATA ANAL USING REGR; Grodzinski U, 2007, P R SOC B, V274, P2449, DOI 10.1098/rspb.2007.0658; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Halfwerk W, 2011, P NATL ACAD SCI USA, V108, P14549, DOI 10.1073/pnas.1109091108; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Hole DG, 2002, NATURE, V418, P931, DOI 10.1038/418931a; Hu Y, 2010, ANIM BEHAV, V79, P863, DOI 10.1016/j.anbehav.2009.12.036; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Leonard ML, 2012, BIOL LETTERS, V8, P530, DOI 10.1098/rsbl.2012.0032; Leonard ML, 2005, P ROY SOC B-BIOL SCI, V272, P651, DOI 10.1098/rspb.2004.3021; Leonard ML, 2001, BEHAV ECOL SOCIOBIOL, V49, P170, DOI 10.1007/s002650000290; Nakagawa S, 2007, J EVOLUTION BIOL, V20, P1674, DOI 10.1111/j.1420-9101.2007.01403.x; Nakagawa S, 2008, J AVIAN BIOL, V39, P222, DOI 10.1111/j.2008.0908-8857.04171.x; Nakagawa S, 2007, BEHAV ECOL, V18, P831, DOI 10.1093/beheco/arm050; Ockendon N, 2009, BEHAV ECOL, V20, P305, DOI 10.1093/beheco/arp006; Peach WJ, 2008, ANIM CONSERV, V11, P493, DOI 10.1111/j.1469-1795.2008.00209.x; Price K, 1998, ANIM BEHAV, V56, P571, DOI 10.1006/anbe.1998.0832; Quinn JL, 2006, J AVIAN BIOL, V37, P601; Reijnen R, 1996, BIOL CONSERV, V75, P255, DOI 10.1016/0006-3207(95)00074-7; Rheindt FE, 2003, J ORNITHOL, V144, P295, DOI 10.1046/j.1439-0361.2003.03004.x; Schroeder J, 2012, J EVOLUTION BIOL, V25, P149, DOI 10.1111/j.1420-9101.2011.02412.x; Schroeder J, 2011, J AVIAN BIOL, V42, P271, DOI 10.1111/j.1600-048X.2010.05271.x; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Summers-Smith J.D., 1963, THE HOUSE SPARROW; Swaddle JP, 2007, ANIM BEHAV, V74, P363, DOI 10.1016/j.anbehav.2007.01.004; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006	36	110	110	3	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39200	10.1371/journal.pone.0039200	http://dx.doi.org/10.1371/journal.pone.0039200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808028	gold, Green Accepted, Green Published			2022-12-27	WOS:000306362400008
J	Yoshibori, M; Yorimitsu, T; Sato, K				Yoshibori, Mariko; Yorimitsu, Tomohiro; Sato, Ken			Involvement of the Penta-EF-Hand Protein Pef1p in the Ca2+-Dependent Regulation of COPII Subunit Assembly in Saccharomyces cerevisiae	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TRANSPORT VESICLES; ALG-2 INTERACTS; GTP HYDROLYSIS; COAT PROTEINS; ER; MEMBRANE; COMPLEX; VISUALIZATION; ORGANIZATION	Although it is well established that the coat protein complex II (COPII) mediates the transport of proteins and lipids from the endoplasmic reticulum (ER) to the Golgi apparatus, the regulation of the vesicular transport event and the mechanisms that act to counterbalance the vesicle flow between the ER and Golgi are poorly understood. In this study, we present data indicating that the penta-EF-hand Ca2+-binding protein Pef1p directly interacts with the COPII coat subunit Sec31p and regulates COPII assembly in Saccharomyces cerevisiae. ALG-2, a mammalian homolog of Pef1p, has been shown to interact with Sec31A in a Ca2+-dependent manner and to have a role in stabilizing the association of the Sec13/31 complex with the membrane. However, Pef1p displayed reversed Ca2+ dependence for Sec13/31p association; only the Ca2+-free form of Pef1p bound to the Sec13/31p complex. In addition, the influence on COPII coat assembly also appeared to be reversed; Pef1p binding acted as a kinetic inhibitor to delay Sec13/31p recruitment. Our results provide further evidence for a linkage between Ca2+-dependent signaling and ER-to-Golgi trafficking, but its mechanism of action in yeast seems to be different from the mechanism reported for its mammalian homolog ALG-2.	[Yoshibori, Mariko; Yorimitsu, Tomohiro; Sato, Ken] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Yoshibori, M (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	kensato@bio.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); MEXT:Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT); Grants-in-Aid for Scientific Research [20001009] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT:Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS) (TY and KS), and in part by the Targeted Proteins Research Program from MEXT:Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Kodera C, 2011, TRAFFIC, V12, P591, DOI 10.1111/j.1600-0854.2011.01173.x; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lee TH, 1999, MOL BIOL CELL, V10, P1445, DOI 10.1091/mbc.10.5.1445; Lu ZM, 2001, MOL BIOL CELL, V12, P795, DOI 10.1091/mbc.12.4.795; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Okamoto M, 2012, J CELL SCI IN PRESS; ORCI L, 1991, P NATL ACAD SCI USA, V88, P8611, DOI 10.1073/pnas.88.19.8611; Petersen OH, 2001, TRENDS NEUROSCI, V24, P271, DOI 10.1016/S0166-2236(00)01787-2; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Sato K, 2004, J BIOL CHEM, V279, P1330, DOI 10.1074/jbc.C300457200; Satoh H, 2002, BBA-PROTEINS PROTEOM, V1600, P61, DOI 10.1016/S1570-9639(02)00445-4; Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605; Tabata KV, 2009, EMBO J, V28, P3279, DOI 10.1038/emboj.2009.269; Vernarecci S, 2007, MOL MICROBIOL, V65, P1122, DOI 10.1111/j.1365-2958.2007.05852.x; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; WAHL M, 1992, J CELL PHYSIOL, V150, P593, DOI 10.1002/jcp.1041500321; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yorimitsu T, 2012, MOL BIOL CE IN PRESS, P23; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	42	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40765	10.1371/journal.pone.0040765	http://dx.doi.org/10.1371/journal.pone.0040765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792405	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400100
J	Hammond, M; Nong, RY; Ericsson, O; Pardali, K; Landegren, U				Hammond, Maria; Nong, Rachel Yuan; Ericsson, Olle; Pardali, Katerina; Landegren, Ulf			Profiling Cellular Protein Complexes by Proximity Ligation with Dual Tag Microarray Readout	PLOS ONE			English	Article							ENERGY-TRANSFER; IN-SITU; CANCER; ASSAYS	Patterns of protein interactions provide important insights in basic biology, and their analysis plays an increasing role in drug development and diagnostics of disease. We have established a scalable technique to compare two biological samples for the levels of all pairwise interactions among a set of targeted protein molecules. The technique is a combination of the proximity ligation assay with readout via dual tag microarrays. In the proximity ligation assay protein identities are encoded as DNA sequences by attaching DNA oligonucleotides to antibodies directed against the proteins of interest. Upon binding by pairs of antibodies to proteins present in the same molecular complexes, ligation reactions give rise to reporter DNA molecules that contain the combined sequence information from the two DNA strands. The ligation reactions also serve to incorporate a sample barcode in the reporter molecules to allow for direct comparison between pairs of samples. The samples are evaluated using a dual tag microarray where information is decoded, revealing which pairs of tags that have become joined. As a proof-of-concept we demonstrate that this approach can be used to detect a set of five proteins and their pairwise interactions both in cellular lysates and in fixed tissue culture cells. This paper provides a general strategy to analyze the extent of any pairwise interactions in large sets of molecules by decoding reporter DNA strands that identify the interacting molecules.	[Hammond, Maria; Nong, Rachel Yuan; Ericsson, Olle; Pardali, Katerina; Landegren, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Sci Life Lab, Uppsala, Sweden	Uppsala University	Hammond, M (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Sci Life Lab, Uppsala, Sweden.	Ulf.Landegren@igp.uu.se	Nong, Rachel Yuan/AAM-1591-2020; Landegren, Ulf D/A-8197-2019	Ericsson, Olle/0000-0003-0652-1969; Pardali, Katerina/0000-0002-4360-730X	National Institutes of Health/National Cancer Institute [1R21CA126727-01A1]; Knut and Alice Wallenberg Foundation; Swedish Research Council; Uppsala Berzelii Technology Centre for Neurodiagnostics; European Community; NATIONAL CANCER INSTITUTE [R21CA126727] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Berzelii Technology Centre for Neurodiagnostics; European Community(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute grant 1R21CA126727-01A1 and by funding from the Knut and Alice Wallenberg Foundation, as well as by the Swedish Research Council, Uppsala Berzelii Technology Centre for Neurodiagnostics, and the European Community's Sixth and Seventh Framework Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conze T, 2010, GLYCOBIOLOGY, V20, P199, DOI 10.1093/glycob/cwp161; Darmanis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025583; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; Ericsson O, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn106; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fredriksson S, 2008, CLIN CHEM, V54, P582, DOI 10.1373/clinchem.2007.093195; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101; Gustafsdottir SM, 2008, CLIN CHEM, V54, P1218, DOI 10.1373/clinchem.2007.099424; Gustafsdottir SM, 2007, P NATL ACAD SCI USA, V104, P3067, DOI 10.1073/pnas.0611229104; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Kamali-Moghaddam M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-124; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lundberg M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004978; McGregor LM, 2010, J AM CHEM SOC, V132, P15522, DOI 10.1021/ja107677q; Schallmeiner E, 2007, NAT METHODS, V4, P135, DOI 10.1038/nmeth974; Schroder C, 2010, MOL CELL PROTEOMICS, V9, P1271, DOI 10.1074/mcp.M900419-MCP200; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Weibrecht I, 2011, N BIOTECHNOL	24	17	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40405	10.1371/journal.pone.0040405	http://dx.doi.org/10.1371/journal.pone.0040405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808155	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500039
J	Polireddy, K; Khan, MMT; Chavan, H; Young, S; Ma, XC; Waller, A; Garcia, M; Perez, D; Chavez, S; Strouse, JJ; Haynes, MK; Bologa, CG; Oprea, TI; Tegos, GP; Sklar, LA; Krishnamurthy, P				Polireddy, Kishore; Khan, Mohiuddin Md Taimur; Chavan, Hemantkumar; Young, Susan; Ma, Xiaochao; Waller, Anna; Garcia, Matthew; Perez, Dominique; Chavez, Stephanie; Strouse, Jacob J.; Haynes, Mark K.; Bologa, Cristian G.; Oprea, Tudor I.; Tegos, George P.; Sklar, Larry A.; Krishnamurthy, Partha			A Novel Flow Cytometric HTS Assay Reveals Functional Modulators of ATP Binding Cassette Transporter ABCB6	PLOS ONE			English	Article							CANCER-CELLS; DRUG-BINDING; IDENTIFICATION; RESISTANCE; EXPRESSION; MECHANISM; PROTEINS; SURVIVAL; STRESS; GENES	ABCB6 is a member of the adenosine triphosphate (ATP)-binding cassette family of transporter proteins that is increasingly recognized as a relevant physiological and therapeutic target. Evaluation of modulators of ABCB6 activity would pave the way toward a more complete understanding of the significance of this transport process in tumor cell growth, proliferation and therapy-related drug resistance. In addition, this effort would improve our understanding of the function of ABCB6 in normal physiology with respect to heme biosynthesis, and cellular adaptation to metabolic demand and stress responses. To search for modulators of ABCB6, we developed a novel cell-based approach that, in combination with flow cytometric high-throughput screening (HTS), can be used to identify functional modulators of ABCB6. Accumulation of protoporphyrin, a fluorescent molecule, in wild-type ABCB6 expressing K562 cells, forms the basis of the HTS assay. Screening the Prestwick Chemical Library employing the HTS assay identified four compounds, benzethonium chloride, verteporfin, tomatine hydrochloride and piperlongumine, that reduced ABCB6 mediated cellular porphyrin levels. Validation of the identified compounds employing the hemin-agarose affinity chromatography and mitochondrial transport assays demonstrated that three out of the four compounds were capable of inhibiting ABCB6 mediated hemin transport into isolated mitochondria. However, only verteporfin and tomatine hydrochloride inhibited ABCB6's ability to compete with hemin as an ABCB6 substrate. This assay is therefore sensitive, robust, and suitable for automation in a high-throughput environment as demonstrated by our identification of selective functional modulators of ABCB6. Application of this assay to other libraries of synthetic compounds and natural products is expected to identify novel modulators of ABCB6 activity.	[Polireddy, Kishore; Chavan, Hemantkumar; Ma, Xiaochao; Krishnamurthy, Partha] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Khan, Mohiuddin Md Taimur; Young, Susan; Waller, Anna; Garcia, Matthew; Perez, Dominique; Chavez, Stephanie; Strouse, Jacob J.; Haynes, Mark K.; Bologa, Cristian G.; Oprea, Tudor I.; Tegos, George P.; Sklar, Larry A.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Khan, Mohiuddin Md Taimur; Tegos, George P.; Sklar, Larry A.] Univ New Mexico, Div Biocomp, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Khan, Mohiuddin Md Taimur; Tegos, George P.; Sklar, Larry A.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Tegos, George P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Tegos, George P.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	University of Kansas; University of Kansas Medical Center; University of New Mexico; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Polireddy, K (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	gtegos@salud.unm.edu; lsklar@salud.unm.edu; pkrishnamurthy@kumc.edu	Chavan, Hemantkumar/AAN-6756-2020; Oprea, Tudor I/A-5746-2011; Bologa, Cristian G/A-7952-2010; Chavan, Hemant/ABA-4925-2021	Chavan, Hemantkumar/0000-0002-9963-6230; Oprea, Tudor I/0000-0002-6195-6976; Bologa, Cristian G/0000-0003-2232-4244; Waller, Anna/0000-0003-3676-2501	National Institutes of Health (NIH) [5U54MH084690-02, R03MH093193]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH093193, U54MH084690] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for GPT and LAS was provided by the National Institutes of Health (NIH, 5U54MH084690-02, Center Driven Initiative 1) and PK by R03MH093193. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Annereau JP, 2004, MOL PHARMACOL, V66, P1397, DOI 10.1124/mol.104.005009; Bearden DT, 2008, J ANTIMICROB CHEMOTH, V62, P769, DOI 10.1093/jac/dkn272; Borel F., 2011, HEPATOLOGY; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Edwards BS, 2001, J BIOMOL SCREEN, V6, P83, DOI 10.1177/108705710100600204; Enomoto R, 2007, ANN NY ACAD SCI, V1095, P1, DOI 10.1196/annals.1397.001; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Furuya KN, 1997, CANCER RES, V57, P3708; Helmerl S, 2007, MELANOMA RES, V17, P265, DOI 10.1097/CMR.0b013e3282a7e0b9; Ivnitski-Steele I, 2008, ASSAY DRUG DEV TECHN, V6, P263, DOI 10.1089/adt.2007.107; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Krishnamurthy P, 2011, CURR PHARM BIOTECHNO, V12, P647, DOI 10.2174/138920111795163995; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kuckuck FW, 2001, CYTOMETRY, V44, P83, DOI 10.1002/1097-0320(20010501)44:1<83::AID-CYTO1085>3.3.CO;2-F; Li F, 2011, CHEM RES TOXICOL, V24, P744, DOI 10.1021/tx200033v; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; Marques JV, 2007, J NAT PROD, V70, P2036, DOI 10.1021/np070347g; Mayo GL, 2003, AM J OPHTHALMOL, V136, P1151, DOI 10.1016/S0002-9394(03)00675-5; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Polireddy K, 2011, MOL ONCOL, V5, P410, DOI 10.1016/j.molonc.2011.07.005; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramirez S, 2003, CYTOM PART A, V53A, P55, DOI 10.1002/cyto.a.10035; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simons V, 2006, ANTIMICROB AGENTS CH, V50, P2732, DOI 10.1128/AAC.00289-06; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; UniProt Consortium, 2011, NUCL ACIDS RES, P39; Virgili G, 2011, CURR DRUG TARGETS, V12, P212, DOI 10.2174/138945011794182665; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zhang HL, 2008, BIOORG MED CHEM LETT, V18, P3272, DOI 10.1016/j.bmcl.2008.04.052; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	42	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40005	10.1371/journal.pone.0040005	http://dx.doi.org/10.1371/journal.pone.0040005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808084	gold, Green Published			2022-12-27	WOS:000306355500020
J	Gao, C; Qiu, JH; Ma, CQ; Xu, P				Gao, Chao; Qiu, Jianhua; Ma, Cuiqing; Xu, Ping			Efficient Production of Pyruvate from DL-Lactate by the Lactate-Utilizing Strain Pseudomonas stutzeri SDM	PLOS ONE			English	Article							LACTIC-ACID; BIOTECHNOLOGICAL ROUTES; ESCHERICHIA-COLI; BIOCATALYST; MEMBRANE; OXIDASE; (R)-LACTATE; CATALYST; GLUCOSE; BIOMASS	Background: The platform chemical lactate is currently produced mainly through the fermentation of sugars presented in biomass. Besides the synthesis of biodegradable polylactate, lactate is also viewed as a feedstock for the green chemistry of the future. Pyruvate, another important platform chemical, can be produced from lactate through biocatalysis. Methodology/Principal Findings: It was established that whole cells of Pseudomonas stutzeri SDM catalyze lactate oxidation with lactate-induced NAD-independent lactate dehydrogenases (iLDHs) through the inherent electron transfer chain. Unlike the lactate oxidation processes observed in previous reports, the mechanism underlying lactate oxidation described in the present study excluded the costliness of the cofactor regeneration step and production of the byproduct hydrogen peroxide. Conclusions/Significance: Biocatalysis conditions were optimized by using the cheap DL-lactate as the substrate and whole cells of the lactate-utilizing P. stutzeri SDM as catalyst. Under optimal conditions, the biocatalytic process produced pyruvate at a high concentration (48.4 g l(-1)) and a high yield (98%). The bioconversion system provides a promising alternative for the green production of pyruvate.	[Gao, Chao; Qiu, Jianhua; Ma, Cuiqing; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University	Gao, C (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn		Ma, Cuiqing/0000-0002-7468-1027; Gao, Chao/0000-0002-5205-0670	National Natural Science Foundation of China [31000014, 31170052]; Research Fund for the Doctoral Program of Higher Education of China [20090131110036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The work was supported by the National Natural Science Foundation of China (31000014 and 31170052), and by the Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20090131110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 1997, APPL CATAL A-GEN, V150, P13, DOI 10.1016/S0926-860X(96)00295-5; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; BUTO S, 1994, BIOTECHNOL BIOENG, V44, P1288, DOI 10.1002/bit.260441104; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Cooper B, 1989, DE patent, Patent No. 3733157; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Distel KA, 2005, BIORESOURCE TECHNOL, V96, P617, DOI 10.1016/j.biortech.2004.06.005; DIXON NM, 1989, BIOELECTROCH BIOENER, V21, P245, DOI 10.1016/0302-4598(89)85004-4; Eisenberg A, 1997, J MOL CATAL B-ENZYM, V2, P223, DOI 10.1016/S1381-1177(96)00021-5; Gao C, 2009, BIORESOURCE TECHNOL, V100, P1878, DOI 10.1016/j.biortech.2008.09.053; Gao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036519; Gao C, 2012, J BACTERIOL, V194, P2687, DOI 10.1128/JB.06579-11; Gao C, 2011, BIOTECHNOL ADV, V29, P930, DOI 10.1016/j.biotechadv.2011.07.022; Gao CA, 2011, BIORESOURCE TECHNOL, V102, P4595, DOI 10.1016/j.biortech.2011.01.003; Gao C, 2010, PROCESS BIOCHEM, V45, P1912, DOI 10.1016/j.procbio.2010.05.029; Gao C, 2010, APPL ENVIRON MICROB, V76, P1679, DOI 10.1128/AEM.02470-09; Gu JS, 2002, J MOL CATAL B-ENZYM, V18, P299, DOI 10.1016/S1381-1177(02)00110-8; Hao JR, 2007, BIOTECHNOL LETT, V29, P105, DOI 10.1007/s10529-006-9204-6; Hekmat D, 1999, ENZYME MICROB TECH, V24, P471, DOI 10.1016/S0141-0229(98)00135-5; Jiang TY, 2012, J BACTERIOL, V194, P894, DOI 10.1128/JB.06478-11; John RP, 2007, APPL MICROBIOL BIOT, V74, P524, DOI 10.1007/s00253-006-0779-6; Li Y, 2002, APPL MICROBIOL BIOT, V60, P101, DOI [10.1007/s0253-002-1064-y, 10.1007/s00253-002-1064-y]; Li Y, 2001, APPL MICROBIOL BIOT, V57, P451, DOI 10.1007/s002530100804; Liu ZQ, 2010, PROCESS BIOCHEM, V45, P1632, DOI 10.1016/j.procbio.2010.06.012; Ma CQ, 2004, APPL MICROBIOL BIOT, V66, P34, DOI 10.1007/s00253-004-1646-y; Ma CQ, 2007, APPL MICROBIOL BIOT, V77, P91, DOI 10.1007/s00253-007-1132-4; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Miyazaki M, 2001, CHEM COMMUN, P1800, DOI 10.1039/b104873m; Ogawa J, 2001, J MOL CATAL B-ENZYM, V11, P355, DOI 10.1016/S1381-1177(00)00024-2; Qin JY, 2010, BIORESOURCE TECHNOL, V101, P7570, DOI 10.1016/j.biortech.2010.04.037; SCHINSCHEL C, 1993, J BIOTECHNOL, V31, P191, DOI 10.1016/0168-1656(93)90160-O; Stottmeister U, 2005, J IND MICROBIOL BIOT, V32, P651, DOI 10.1007/s10295-005-0254-x; van Maris AJA, 2004, APPL ENVIRON MICROB, V70, P159, DOI 10.1128/AEM.70.1.159-166.2004; Xu P, 2008, J BIOSCI BIOENG, V105, P169, DOI 10.1263/jbb.105.169; Zelic B, 2004, BIOTECHNOL BIOENG, V85, P638, DOI 10.1002/bit.10820	35	7	8	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40755	10.1371/journal.pone.0040755	http://dx.doi.org/10.1371/journal.pone.0040755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792404	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700066
J	Kim, SM; Kim, YG; Jeong, KH; Lee, SH; Lee, TW; Ihm, CG; Moon, JY				Kim, Su-Mi; Kim, Yang-Gyun; Jeong, Kyung-Hwan; Lee, Sang-Ho; Lee, Tae-Won; Ihm, Chun-Gyoo; Moon, Ju-Young			Angiotensin II-Induced Mitochondrial Nox4 Is a Major Endogenous Source of Oxidative Stress in Kidney Tubular Cells	PLOS ONE			English	Article							NAD(P)H OXIDASE; ENDOTHELIAL-CELLS; EXPRESSION; LOCALIZATION; DYSFUNCTION; APOPTOSIS; HYPERTENSION; ACTIVATION; DISEASE; RATS	Angiotensin II (Ang II)-induced activation of nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase leads to increased production of reactive oxygen species (ROS), an important intracellular second messenger in renal disease. Recent findings suggest that Ang II induces mitochondrial depolarization and further amplifies mitochondrial generation of ROS. We examined the hypothesis that ROS injury mediated by Ang II-induced mitochondrial Nox4 plays a pivotal role in mitochondrial dysfunction in tubular cells and is related to cell survival. In addition, we assessed whether angiotensin (1-7) peptide (Ang-(1-7)) was able to counteract Ang II-induced ROS-mediated cellular injury. Cultured NRK-52E cells were stimulated with 10(-6) M Ang II for 24 h with or without Ang-(1-7) or apocynin. Ang II simulated mitochondrial Nox4 and resulted in the abrupt production of mitochondrial superoxide (O-2(-)) and hydrogen peroxide (H2O2). Ang II also induced depolarization of the mitochondrial membrane potential, and cytosolic secretion of cytochrome C and apoptosis-inducing factor (AIF). Ang-(1-7) attenuated Ang II-induced mitochondrial Nox4 expression and apoptosis, and its effect was comparable to that of the NAD(P) H oxidase inhibitor. These findings suggest that Ang II-induced activation of mitochondrial Nox4 is an important endogenous source of ROS, and is related to cell survival. The ACE2-Ang-(1-7)-Mas receptor axis should be investigated further as a novel target of Ang II-mediated ROS injury.	[Kim, Su-Mi; Kim, Yang-Gyun; Lee, Sang-Ho; Moon, Ju-Young] Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp Gangdong, Dept Internal Med,Div Nephrol, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital	Kim, SM (corresponding author), Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp Gangdong, Dept Internal Med,Div Nephrol, Seoul, South Korea.	jymoon@khu.ac.kr	/W-5371-2019; KIM, YANG GYUN/AAI-9821-2020	KIM, YANG GYUN/0000-0002-3497-5514	Kyung Hee University [KHU-20100722]	Kyung Hee University	This work was supported by a grant from the Kyung Hee University in 2010 (KHU-20100722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Benter IF, 2008, AM J NEPHROL, V28, P25, DOI 10.1159/000108758; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Ferrario CM, 1997, HYPERTENSION, V30, P535, DOI 10.1161/01.HYP.30.3.535; Gallagher PE, 2008, AM J PHYSIOL-CELL PH, V295, pC1169, DOI 10.1152/ajpcell.00145.2008; Gava E, 2009, NEPHROL DIAL TRANSPL, V24, P1766, DOI 10.1093/ndt/gfn736; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Graham S, 2011, AM J PHYSIOL-CELL PH, V301, pC304, DOI 10.1152/ajpcell.00014.2011; Guzik TJ, 2006, ARTERIOSCL THROM VAS, V26, P333, DOI 10.1161/01.ATV.0000196651.64776.51; Gwathmey TM, 2010, HYPERTENSION, V55, P166, DOI 10.1161/HYPERTENSIONAHA.109.141622; Hampton MB, 1998, ANN NY ACAD SCI, V854, P328, DOI 10.1111/j.1749-6632.1998.tb09913.x; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Iyer SN, 2000, J CARDIOVASC PHARM, V36, P109, DOI 10.1097/00005344-200007000-00015; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Liao Xin-xue, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1345; Moon JY, 2011, AM J PHYSIOL-RENAL, V300, pF1271, DOI 10.1152/ajprenal.00065.2010; NAKAMOTO H, 1995, HYPERTENSION, V25, P796, DOI 10.1161/01.HYP.25.4.796; Nakamura S, 2003, AM J PHYSIOL-REG I, V284, pR164, DOI 10.1152/ajpregu.00210.2002; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Ruiz-Ortega M, 1998, NEPHROL DIAL TRANSPL, V13, P886, DOI 10.1093/ndt/13.4.886; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; SIMONS JM, 1990, FREE RADICAL BIO MED, V8, P251, DOI 10.1016/0891-5849(90)90070-Y; Stegbauer J, 2011, BRIT J PHARMACOL, V163, P974, DOI 10.1111/j.1476-5381.2011.01295.x; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	34	79	81	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39739	10.1371/journal.pone.0039739	http://dx.doi.org/10.1371/journal.pone.0039739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808054	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700018
J	Forbes, HJ; Doyle, AM; Maganja, K; Changalucha, J; Weiss, HA; Ross, DA; Hayes, RJ				Forbes, Harriet J.; Doyle, Aoife M.; Maganja, Kaballa; Changalucha, John; Weiss, Helen A.; Ross, David A.; Hayes, Richard J.			Rapid Increase in Prevalence of Male Circumcision in Rural Tanzania in the Absence of a Promotional Campaign	PLOS ONE			English	Article							SEXUAL HEALTH INTERVENTION; HIV PREVENTION; MWANZA REGION; INFECTION; MEN; RISK; TRIAL; DESIGN; KENYA	Objectives: To estimate the prevalence of circumcision among young men in rural Mwanza, North-Western Tanzania, and document trends in circumcision prevalence over time. To investigate associations of circumcision with socio-demographic characteristics, reported sexual behaviours and sexually transmitted infections (STIs). Design: A cross-sectional survey in communities which had previously participated in a cluster-randomized trial of an adolescent sexual health intervention that did not include male circumcision in 20 rural communities. Methods: In 2007/08, 7300 young men (age 16-23 years) were interviewed and examined by a clinician. The prevalence of circumcision by age was compared with data collected during the trial in 1998-2002. Odds ratios (OR) and 95% confidence intervals (CI) for the association of circumcision with socio-demographic characteristics, reported sexual behaviours and with HIV and other STIs were estimated using multivariable conditional logistic regression. Results: The prevalence of male circumcision was 40.6%, and age-specific prevalence had more than doubled since 2001/2002. Circumcised men reported less risky sexual behaviours, being more likely to report having ever used a condom (adjusted OR=2.62, 95% CI: 2.32-2.95). Men circumcised before sexual debut were at reduced risk of being HIV seropositive compared with non-circumcised men (adjusted OR=0.50, 95% CI: 0.25-0.97), and also had reduced risks of HSV-2 infection and genital ulcer syndrome in the past 12 months compared with non-circumcised men. Conclusions: There was a steep increase in circumcision prevalence between 2001/02 and 2007/08 in the absence of a promotional campaign. Circumcised men reported safer sexual practices than non-circumcised men and had lower prevalence of HIV and HSV-2 infection.	[Forbes, Harriet J.; Doyle, Aoife M.; Weiss, Helen A.; Ross, David A.; Hayes, Richard J.] London Sch Hyg & Trop Med, London WC1, England; [Maganja, Kaballa; Changalucha, John] Mwanza Ctr, Natl Inst Med Res, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Forbes, HJ (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	harriet.forbes@lshtm.ac.uk	Doyle, Aoife/AAX-3525-2020; weiss, helen/ABC-7823-2021	Doyle, Aoife/0000-0002-3305-7738; weiss, helen/0000-0003-3547-7936; Hayes, Richard/0000-0002-1729-9892; Forbes, Harriet/0000-0001-6888-2212	European Commission; UK Department for International Development, and Irish Aid; Medical Research Council of Great Britain; United Nations Joint Programme on HIV/AIDS (UNAIDS); Medical Research Council [G0700837, G0902121] Funding Source: researchfish; MRC [G0902121, G0700837] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department for International Development, and Irish Aid; Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Nations Joint Programme on HIV/AIDS (UNAIDS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MEMA kwa Vijana Trial was a collaboration between the London School of Hygiene & Tropical Medicine (LSHTM), the Tanzanian National Institute for Medical Research (NIMR), the African Medical and Research Foundation (AMREF), and the Ministries of Health and Social Welfare and of Education and Vocational Training of the Government of Tanzania. It was supported by grants from the European Commission, the UK Department for International Development, and Irish Aid, with additional funding support from the Medical Research Council of Great Britain and The United Nations Joint Programme on HIV/AIDS (UNAIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2012, 19 C RETR OPP INF CR; Bailey RC, 1999, J ACQ IMMUN DEF SYND, V22, P294; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; DFID Dfid, 2010, ROLL OUT AD MAL CIRC; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hayes RJ, 2005, CONTEMP CLIN TRIALS, V26, P430, DOI 10.1016/j.cct.2005.04.006; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Nnko S, 2001, SEX TRANSM DIS, V28, P214, DOI 10.1097/00007435-200104000-00005; Obasi AI, 2006, AIDS CARE, V18, P311, DOI 10.1080/09540120500161983; Rambura M, 2007, JAIDS-J ACQ IMM DEF, V46, P616, DOI 10.1097/QAI.0b013e31815a571a; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Sobngwi-Tambekou J, 2009, SEX TRANSM INFECT, V85, P116, DOI 10.1136/sti.2008.032334; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tanzania Commission for AIDS Dar es Salaam TaNBoSDeS Tanzania and ORC Macro Calverton Maryland USA, 2005, TANZ HIV AIDS IND SU; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; *UNAIDS WHO, 2007, NEW DAT MAL CIRC HIV; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; Wambura M, 2009, SITUATION ANAL MALE; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Weiss HA, 2008, TROP MED INT HEALTH, V13, P1054, DOI 10.1111/j.1365-3156.2008.02107.x; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40507	10.1371/journal.pone.0040507	http://dx.doi.org/10.1371/journal.pone.0040507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792359	gold, Green Published, Green Accepted			2022-12-27	WOS:000306461800100
J	Meng, S; Cao, JT; Wang, LS; Zhou, Q; Li, YG; Shen, CX; Zhang, XP; Wang, CQ				Meng, Shu; Cao, JiaTian; Wang, LianSheng; Zhou, Qing; Li, YiGang; Shen, ChengXing; Zhang, XiaoPing; Wang, ChangQian			MicroRNA 107 Partly Inhibits Endothelial Progenitor Cells Differentiation via HIF-1 beta	PLOS ONE			English	Article							GENE-EXPRESSION; HYPOXIA; ANGIOGENESIS; CANCER; NEOVASCULARIZATION; DEHYDROGENASE; INACTIVATION; SIGNATURE; SYNTHASE; PATHWAY	Endothelial progenitor cells (EPCs) play an important role in tissue repair after ischemic heart disease. In particular, the recovery of endothelial function is reliant on the ability and rate of EPCs differentiate into mature endothelial cells. The present study evaluated the effect of microRNA 107 (miR-107) on the mechanism of EPCs differentiation. EPCs were isolated from rats' bone marrow and miR-107 expression of EPCs in hypoxic and normoxic conditions were measured by real-time qualitative PCR. CD31 was analyzed by flow cytometry and eNOS was examined by real-time qualitative PCR and western blotting and these were used as markers of EPC differentiation. In order to reveal the mechanism, we used miR107 inhibitor and lentiviral vector expressing a short hairpin RNA (shRNA) that targets miR-107 and hypoxia-inducible factor-1 beta (HIF-1 beta) to alter miR107 and HIF-1 beta expression. MiR-107 expression were increased in EPCs under hypoxic conditions. Up-regulation of miR-107 partly suppressed the EPCs differentiation induced in hypoxia, while down-regulation of miR-107 promoted EPC differentiation. HIF-1 beta was the target. This study indicated that miR-107 was up-regulated in hypoxia to prevent EPCs differentiation via its target HIF-1 beta. The physiological mechanisms of miR-107 must be evaluated if it is to be used as a potential anti-ischemia therapeutic regime.	[Meng, Shu; Zhou, Qing; Li, YiGang; Shen, ChengXing] Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China; [Cao, JiaTian; Wang, ChangQian] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China; [Wang, LianSheng] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Lab Med, Shanghai 200030, Peoples R China; [Zhang, XiaoPing] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Nucl Med, Shangha, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Wang, CQ (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China.	changqianwang@163.com			National Natural Science Foundation of China [30971436]; Shanghai Committee of Science and Technology of China [09XD1403100, 09JC1410600, 10JC1408900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology of China	This project was supported by National Natural Science Foundation of China (Grant No. 30971436 URL: http://www.nsfc.gov.cn/Portal0/default152.htm), the Shanghai Committee of Science and Technology of China (Grant No. 09XD1403100, 09JC1410600 and 10JC1408900 URL: http://www.stcsm.gov.cn/structure/index.htmnd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen EY, 2001, CANCER RES, V61, P2429; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gou X, 2011, ASIAN J ANDROL, V13, P332, DOI 10.1038/aja.2010.116; Jiang M, 2006, J VASC RES, V43, P511, DOI 10.1159/000095964; Jiang Meng, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P565; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Ma FX, 2006, J LIPID RES, V47, P1227, DOI 10.1194/jlr.M500507-JLR200; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mole DR, 2008, PEDIATR NEPHROL, V23, P681, DOI 10.1007/s00467-007-0632-x; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weir L, 2011, BBA-MOL CELL RES, V1813, P60, DOI 10.1016/j.bbamcr.2010.11.014; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Zundel W, 2000, GENE DEV, V14, P391	29	42	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40323	10.1371/journal.pone.0040323	http://dx.doi.org/10.1371/journal.pone.0040323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792280	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800069
J	Zeck, A; Regula, JT; Larraillet, V; Mautz, B; Popp, O; Gopfert, U; Wiegeshoff, F; Vollertsen, UEE; Gorr, IH; Koll, H; Papadimitriou, A				Zeck, Anne; Regula, Joerg Thomas; Larraillet, Vincent; Mautz, Bjoern; Popp, Oliver; Goepfert, Ulrich; Wiegeshoff, Frank; Vollertsen, Ulrike E. E.; Gorr, Ingo H.; Koll, Hans; Papadimitriou, Apollon			Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; MISINCORPORATION; HETEROGENEITY; THERAPEUTICS	Sequence variants in recombinant biopharmaceuticals may have a relevant and unpredictable impact on clinical safety and efficacy. Hence, their sensitive analysis is important throughout bioprocess development. The two stage analytical approach presented here provides a quick multi clone comparison of candidate production cell lines as a first stage, followed by an in-depth analysis including identification and quantitation of aberrant sequence variants of selected clones as a second stage. We show that the differential analysis is a suitable tool for sensitive and fast batch to batch comparison of recombinant proteins. The optimized approach allows for detection of not only single amino acid substitutions in unmodified peptides, but also substitutions in posttranslational modified peptides such as glycopeptides, for detection of truncated or elongated sequence variants as well as double amino acid substitutions or substitution with amino acid structural isomers within one peptide. In two case studies we were able to detect sequence variants of different origin down to a sub percentage level. One of the sequence variants (Thr -> Asn) could be correlated to a cytosine to adenine substitution at DNA(desoxyribonucleic acid) level. In the second case we were able to correlate the sub percentage substitution (Phe -> Tyr) to amino acid limitation in the chemically defined fermentation medium.	[Zeck, Anne; Regula, Joerg Thomas; Larraillet, Vincent; Mautz, Bjoern; Popp, Oliver; Goepfert, Ulrich; Wiegeshoff, Frank; Vollertsen, Ulrike E. E.; Gorr, Ingo H.; Koll, Hans; Papadimitriou, Apollon] Roche Diagnost GmbH, Biol Res Pharma Res & Early Dev, Penzberg, Germany	Roche Holding	Zeck, A (corresponding author), Inst Univ Tuebingen, NMI Nat & Med Sci, Reutlingen, Germany.	anne.zeck@nmi.de		Regula, Joerg Thomas/0000-0002-7343-1077				Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; Dorai H, 2007, BIOPROCESS INT, P66; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Gineikiene E, 2009, EXPERT REV MOL DIAGN, V9, P817, DOI [10.1586/erm.09.66, 10.1586/ERM.09.66]; Guo DL, 2010, BIOTECHNOL BIOENG, V107, P163, DOI 10.1002/bit.22780; Gurer-Orhan H, 2006, BIOCHEM J, V395, P277, DOI 10.1042/BJ20051964; HARRIS RJ, 1993, BIO-TECHNOL, V11, P1293; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Khetan A, 2010, BIOTECHNOL BIOENG, V107, P116, DOI 10.1002/bit.22771; Klipcan L, 2009, P NATL ACAD SCI USA, V106, P11045, DOI 10.1073/pnas.0905212106; Kotia RB, 2010, ANAL BIOCHEM, V399, P190, DOI 10.1016/j.ab.2010.01.008; Listgarten J, 2005, MOL CELL PROTEOMICS, V4, P419, DOI 10.1074/mcp.R500005-MCP200; Omasa T, 2010, BIOPROC BIOSYST ENG, V33, P117, DOI 10.1007/s00449-009-0351-8; Que A, 2010, BIOPROCESS INT, V8, P52; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Ronaghi M, 2007, PHARMACOGENOMICS, V8, P1437, DOI 10.2217/14622416.8.10.1437; Samaranayake H, 2009, ANN MED, V41, P322, DOI 10.1080/07853890802698842; SCORER CA, 1991, NUCLEIC ACIDS RES, V19, P3511, DOI 10.1093/nar/19.13.3511; Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wen DY, 2009, J BIOL CHEM, V284, P32686, DOI 10.1074/jbc.M109.059360; Woodward C, 2010, HIGH SPEED AMINO ACI, p[1, 5]; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yang Y, 2010, MABS-AUSTIN, V2, P285, DOI 10.4161/mabs.2.3.11718; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h	27	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40328	10.1371/journal.pone.0040328	http://dx.doi.org/10.1371/journal.pone.0040328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792284	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800071
J	Inoue, M; Inoue, K; Akimoto, K				Inoue, Machiko; Inoue, Kazuo; Akimoto, Kimihiko			Effects of Age and Sex in the Diagnosis of Type 2 Diabetes Using Glycated Haemoglobin in Japan: The Yuport Medical Checkup Centre Study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; A1C-BASED DIAGNOSIS; CARDIOVASCULAR RISK; HBA(1C); INDIVIDUALS; PREVALENCE; CRITERIA; IMPACT; MELLITUS; HBA1C	Background: We examined how the prevalence of individuals diagnosed with diabetes differs by age and sex using the diagnostic criteria of fasting plasma glucose (FPG) and/or glycated haemoglobin (HbA1c) in a large Japanese population. Methods: We conducted a cross-sectional study using a dataset of 33,959 people (16,869 men and 17,090 women) without known diabetes who underwent health checkups from 1998 to 2006. We divided the age range of the participants into six groups of similar numbers. We compared the prevalence of diabetes using the criteria of FPG >= 7.0 mmol/l (126 mg/dl), HbA1c >= 48 mmol/mol (6.5%), or both, in men and women in each age group. Results: Men had higher prevalence of diabetes than women using the criterion of either FPG or HbA1c (7.5% men vs. 3.4% women, P<0.001), or both (4.3% men vs. 1.8% women, P<0.001). HbA1c increased steadily in women through the six age groups. In the oldest group (>= 66 years), the proportion of women among those diagnosed with diabetes was as high as 42.3% (215/508) using the criterion of either FPG or HbA1c, and 41.6% (116/279) using both criteria. Conclusions: Using either FPG or HbA1c, the prevalence of people diagnosed with diabetes would almost double compared to using the criterion of both scores, and this would include more elderly women than men. The impact of introducing HbA1c for diabetes diagnosis should be considered in terms of age and sex.	[Inoue, Machiko] Teikyo Univ, Sch Med, Dept Community Med, Tokyo 173, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Akimoto, Kimihiko] Akimoto Occupat Hlth Consultant Off, Tokyo, Japan	Teikyo University; Teikyo University	Inoue, M (corresponding author), Teikyo Univ, Sch Med, Dept Community Med, Tokyo 173, Japan.	machiko-inoue@umin.ac.jp	Inoue, Machiko/T-4884-2019	Inoue, Machiko/0000-0002-0799-5894				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Buell C, 2007, DIABETES CARE, V30, P2233, DOI 10.2337/dc07-0585; Carrera T, 1998, DIABETES CARE, V21, P2193, DOI 10.2337/diacare.21.12.2193; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Cohen RM, 2010, J CLIN ENDOCR METAB, V95, P5203, DOI 10.1210/jc.2010-2352; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; HASHIMOTO Y, 1995, DIABETES CARE, V18, P1337, DOI 10.2337/diacare.18.10.1337; Heianza Y, 2012, DIABETES RES CLIN PR, V95, P283, DOI 10.1016/j.diabres.2011.10.024; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hu YM, 2010, ACTA DIABETOL, V47, P231, DOI 10.1007/s00592-009-0143-2; Inoue K, 2012, DIABETIC MED, V29, pE75, DOI 10.1111/j.1464-5491.2011.03536.x; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Kim CH, 2011, DIABETES RES CLIN PR, V91, pE8, DOI 10.1016/j.diabres.2010.09.025; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Kuzuya T, 1999, J JPN DIAB SOC, V42, P385; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Mostafa SA, 2010, DIABETIC MED, V27, P762, DOI 10.1111/j.1464-5491.2010.03015.x; Motta M, 2006, ARCH GERONTOL GERIAT, V42, P101, DOI 10.1016/j.archger.2005.05.001; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Selvin E, 2006, DIABETES CARE, V29, P2415, DOI 10.2337/dc06-1058; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Yang YC, 1997, DIABETES CARE, V20, P988, DOI 10.2337/diacare.20.6.988; Yates AP, 2002, DIABETIC MED, V19, P254, DOI 10.1046/j.1464-5491.2002.00644.x	30	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40375	10.1371/journal.pone.0040375	http://dx.doi.org/10.1371/journal.pone.0040375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792294	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300060
J	Li, XY; Wang, X; Zhang, SP; Liu, DW; Duan, YX; Dong, W				Li, Xiaoyan; Wang, Xue; Zhang, Shaopeng; Liu, Dawei; Duan, Yuxi; Dong, Wei			Identification of Soybean MicroRNAs Involved in Soybean Cyst Nematode Infection by Deep Sequencing	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; MEDICAGO-TRUNCATULA; SMALL RNAS; REGULATED MICRORNAS; EXPRESSION ANALYSIS; NODULE DEVELOPMENT; RESPONSIVE MIRNAS; TARGET GENES; GENOME; RESISTANCE	Soybean cyst nematode (SCN), Heterodera glycines, is the most devastating pathogen of soybean worldwide. MicroRNAs (miRNAs) are a class of small, non-coding RNAs that are known to play important role in plant stress response. However, there are few reports profiling the miRNA expression patterns during pathogen stress. We sequenced four small RNA libraries from two soybean cultivar (Hairbin xiaoheidou, SCN race 3 resistant, Liaodou 10, SCN race 3 susceptible) that grown under un-inoculated and SCN-inoculated soil. Small RNAs were mapped to soybean genome sequence, 364 known soybean miRNA genes were identified in total. In addition, 21 potential miRNA candidates were identified. Comparative analysis of miRNA profiling indicated 101 miRNAs belong to 40 families were SCN-responsive. We also found 20 miRNAs with different express pattern even between two cultivars of the same species. These findings suggest that miRNA paly important role in soybean response to SCN and have important implications for further identification of miRNAs under pathogen stress.	[Li, Xiaoyan; Zhang, Shaopeng] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Li, Xiaoyan; Zhang, Shaopeng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Xue; Liu, Dawei; Duan, Yuxi] Shenyang Agr Univ, Nematol Inst No China, Shenyang, Peoples R China; [Dong, Wei] Beijing Genom Inst, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shenyang Agricultural University; Beijing Genomics Institute (BGI)	Li, XY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	duanyx6407@163.com; dongw@genomics.org.cn			National Natural Science Foundation of China [30392100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (grant numbers 30392100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P103, DOI 10.1007/978-94-007-0434-3_6; Alkharouf NW, 2006, PLANTA, V224, P838, DOI 10.1007/s00425-006-0270-8; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; [Anonymous], PHYSL PLANTARUM, V138, P226; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen L, 2011, PLANTA; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo N, 2011, GENOME, V54, P954, DOI [10.1139/g11-050, 10.1139/G11-050]; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Hewezi T, 2008, MOL PLANT MICROBE IN, V21, P1622, DOI 10.1094/MPMI-21-12-1622; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jones-Rhoades MW, 2011, PLANT MOL BIOL; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Klink VP, 2007, PLANTA, V226, P1389, DOI 10.1007/s00425-007-0581-4; Krol J, 2010, NATURE REV GENETICS; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li H, 2010, PLANT PHYSIOL, V153, P1759, DOI 10.1104/pp.110.156950; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li XY, 2011, CHINESE SCI BULL, V56, P1904, DOI 10.1007/s11434-011-4510-3; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramsay K, 2006, MOL PLANT PATHOL, V7, P429, DOI 10.1111/j.1364-3703.2006.00348.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simon SA, 2009, PLANT PHYSIOL, V151, P1002, DOI 10.1104/pp.109.144345; Sommer RJ, 2011, ANNU REV GENET, V45, P1, DOI 10.1146/annurev-genet-110410-132417; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Thiebaut F, 2011, PLANT CELL ENV; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang YW, 2009, BIOCHEM BIOPH RES CO, V378, P799, DOI 10.1016/j.bbrc.2008.11.140; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wrather J. A, 2009, EFFECTS DIS SOYBEAN; Zeng HQ, 2010, J PLANT PHYSIOL, V167, P1289, DOI 10.1016/j.jplph.2010.04.017; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	66	92	102	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39650	10.1371/journal.pone.0039650	http://dx.doi.org/10.1371/journal.pone.0039650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22802924	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800056
J	Maussion, G; Yang, J; Yerko, V; Barker, P; Mechawar, N; Ernst, C; Turecki, G				Maussion, Gilles; Yang, Jennie; Yerko, Volodymyr; Barker, Philip; Mechawar, Naguib; Ernst, Carl; Turecki, Gustavo			Regulation of a Truncated Form of Tropomyosin-Related Kinase B (TrkB) by Hsa-miR-185*in Frontal Cortex of Suicide Completers	PLOS ONE			English	Article							MICRORNA BIOGENESIS; PASSENGER STRAND; MENTAL-HEALTH; NEW-BRUNSWICK; EXPRESSION; RISK; MICROPROCESSOR; METHYLATION; DYSFUNCTION; DEPRESSION	Background: TrkB-T1 is a BDNF receptor lacking a tyrosine kinase domain that is highly expressed in astrocytes and regulates BDNF-evoked calcium transients. Previous studies indicate that downregulation of TrkB-T1 in frontal cortex may be involved in neurobiological processes underlying suicide. Methods: In a microarray screening study (N = 8), we interrogated all known microRNA in the frontal cortex of suicide completers with low expression of TrkB-T1 and normal controls. These findings were validated and followed up in a larger sample of cases and controls (N = 55). Functional analyses included microRNA silencing, microRNA overexpression and luciferase assays to investigate specificity and to validate interactions between differentially expressed microRNA and TrkB-T1. Results: MicroRNAs Hsa-miR-185* and Hsa-miR-491-3p were upregulated in suicide completers with low expression of TrkB.T1 (P-nominal: 9.10(-5) and 1.8.10(-4) respectively; FDR-corrected p = 0.031). Bioinformatic analyses revealed five putative binding sites for the DiGeorge syndrome linked microRNA Hsa-miR-185* in the 3'UTR of TrkB-T1, but none for Hsa-miR-491-3P. The increase of Hsa-miR-185* in frontal cortex of suicide completers was validated then confirmed in a larger, randomly selected group of suicide completers, where an inverse correlation between Hsa-miR-185* and TrkB-T1 expression was observed (R = -0.439; p = 0.001). Silencing and overexpression studies performed in human cell lines confirmed the inverse relationship between hsa-mir-185* and trkB-T1 expression. Luciferase assays demonstrated that Hsa-miR-185* binds to sequences in the 39UTR of TrkB-T1. Conclusion: These results suggest that an increase of Hsa-miR-185* expression levels regulates, at least in part, the TrkB-T1 decrease observed in the frontal cortex of suicide completers and further implicate the 22q11 region in psychopathology.	[Maussion, Gilles; Yang, Jennie; Yerko, Volodymyr; Mechawar, Naguib; Ernst, Carl; Turecki, Gustavo] McGill Univ, Douglas Hosp Res Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Barker, Philip] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University; McGill University	Maussion, G (corresponding author), McGill Univ, Douglas Hosp Res Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Maussion, Gilles/AAA-2027-2021; Turecki, Gustavo/K-5100-2015	Maussion, Gilles/0000-0001-5785-6238; Turecki, Gustavo/0000-0003-4075-2736	CIHR (Canadian Institutes of Health Research) [MOP 84291, MOP 93775]; AFSP (American Foundation for Suicide Prevention); FRSQ-INSERM (Institut national de la sante et de la recherche medicale, France)	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); AFSP (American Foundation for Suicide Prevention); FRSQ-INSERM (Institut national de la sante et de la recherche medicale, France)	This work was supported by CIHR (Canadian Institutes of Health Research) grants MOP 84291 and MOP 93775 and an AFSP Distinguished Scientist Award (American Foundation for Suicide Prevention) to GT. GM holds a fellowship from the FRSQ-INSERM program (Institut national de la sante et de la recherche medicale, France). CE is the Canada Research Chair in Psychiatric Genetics and is partially funded by a Young Investigator grant from the American Foundation of Suicide Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Beezhold KJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Boelle PY, 1999, LANCET, V353, P1364, DOI 10.1016/S0140-6736(05)74363-4; Cao Wen, 2005, Journal of Applied Genetics, V46, P217; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Christensen M, 2009, NEUROSCI LETT, V466, P55, DOI 10.1016/j.neulet.2009.04.043; Drury GL, 2010, J BIOL CHEM, V285, P31130, DOI 10.1074/jbc.M110.137919; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Duguay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026430; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; Dwivedi Y, 2010, ANN MED, V42, P87, DOI 10.3109/07853890903485730; Ernst C, 2009, MOL PSYCHIATR, V14, P830, DOI 10.1038/mp.2009.35; Ernst C, 2011, BIOL PSYCHIAT, V70, P312, DOI 10.1016/j.biopsych.2011.03.038; Ernst C, 2009, ARCH GEN PSYCHIAT, V66, P22, DOI 10.1001/archpsyc.66.1.22; George Ajish D, 2006, RNA Biol, V3, P57; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Horie T, 2010, CARDIOVASC RES, V87, P656, DOI 10.1093/cvr/cvq148; Hoven CW, 2010, EUR PSYCHIAT; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lesage A, 2008, CAN J PSYCHIAT, V53, P671, DOI 10.1177/070674370805301006; Mai JK, 2007, ATLAS HUMAN BRAIN, P280; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Mazan-Mamczarz Krystyna, 2007, Cancer Genomics & Proteomics, V4, P233; Miguel-Hidalgo JJ, 2010, J AFFECT DISORDERS, V127, P230, DOI 10.1016/j.jad.2010.06.003; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morton S, 2006, BIOCHEM J, V399, P265, DOI 10.1042/BJ20060681; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okasha A, 1999, CLIN PSYCHOL REV, V19, P917, DOI 10.1016/S0272-7358(99)00003-3; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Rossbach M, 2010, CURR MOL MED, V10, P361, DOI 10.2174/156652410791317048; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Seguin M, 2006, CAN J PSYCHIAT, V51, P581, DOI 10.1177/070674370605100906; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shenoy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006971; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Smirnov DA, 2008, AM J HUM GENET, V83, P243, DOI 10.1016/j.ajhg.2008.07.003; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Valentine GW, 2009, BIOCHEM PHARMACOL, V78, P431, DOI 10.1016/j.bcp.2009.04.008; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Weinberg MS, 2009, HUM MOL GENET, V18, pR27, DOI 10.1093/hmg/ddp070; World Health Organisation, 2009, COUNTR REP	68	56	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39301	10.1371/journal.pone.0039301	http://dx.doi.org/10.1371/journal.pone.0039301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22802923	Green Published, Green Submitted, gold			2022-12-27	WOS:000305781700027
J	Wolin, KY; Fagin, C; James, AS; Early, DS				Wolin, Kathleen Y.; Fagin, Casey; James, Aimee S.; Early, Dayna S.			Promoting Physical Activity in Patients with Colon Adenomas: A Randomized Pilot Intervention Trial	PLOS ONE			English	Article							1ST STEP PROGRAM; OUTCOME EVALUATION; CANCER PREVENTION; COLORECTAL-CANCER; WALKING; RISK; HEALTH; INDIVIDUALS; IMPACT; BREAST	Background: Physical activity decreases risk of colon polyps and colon cancer and might reduce risk of colon cancer recurrence. Focusing on recent calls for translation of epidemiologic evidence into clinical care, our pilot study delivered an evidence-based physical activity intervention in adults with polyps, who are thus at elevated risk of developing colon cancer. The objective was to evaluate change in physical activity, measured by steps per day and minutes of moderate/vigorous physical activity. Methods: Sixteen adults with adenomas detected and removed at screening colonoscopy were recruited to a 12-week physical activity intervention. Participants were randomized to receive a standard (30 minutes/day) or high (60 minutes/day) walking program. Physical activity was measured via blinded pedometer and accelerometer at baseline and follow-up. Intervention messages focused on self-monitoring using pedometers and overcoming barriers to engaging in physical activity. Results: Participants in both arms significantly increased objectively measured minutes of moderate/vigorous physical activity over the course of the intervention. Both arms exceeded the intervention goal, but there was not a significant difference between arms at follow-up. Results were similar for pedometer measured physical activity, with a significant overall increase in steps/day from baseline to follow-up, but no between arm difference in change. Conclusion: Simple interventions of minimal contact time focusing on walking can significantly increase physical activity in individuals at increased risk of developing colon cancer.	[Wolin, Kathleen Y.] Washington Univ, Sch Med, St Louis, MO 63130 USA; Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Siteman Cancer Center	Wolin, KY (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	wolink@wustl.edu	; Wolin, Kathleen/I-2154-2014	James, Aimee/0000-0002-1411-9307; Wolin, Kathleen/0000-0001-7950-9042	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR024992]; NIH Roadmap for Medical Research; Barnes Jewish Hospital Foundation; NCI Cancer Center Support Grant [P30 CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Hospital Foundation; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was made possible, in part, by Grant Number UL1 RR024992 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research and through support from the Barnes Jewish Hospital Foundation. The authors thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, for the use of the Tissue Procurement Core, which provided sample storage and processing. The Siteman Cancer Center is supported in part by NCI Cancer Center Support Grant #P30 CA91842. Study data were collected and managed using REDCap (Research Electronic Data Capture). The manuscript contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, J CLIN EPIDEMIOL, V46, P1403, DOI 10.1016/0895-4356(93)90140-V; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Basen-Engquist K, 2006, PATIENT EDUC COUNS, V64, P225, DOI 10.1016/j.pec.2006.02.006; Bennett GG, 2006, MED SCI SPORT EXER, V38, P768, DOI 10.1249/01.mss.0000210200.87328.3f; Brownson RC, 2000, AM J PUBLIC HEALTH, V90, P264, DOI 10.2105/AJPH.90.2.264; Chan CB, 2008, J PHYS ACT HEALTH, V5, P648, DOI 10.1123/jpah.5.5.648; Chan CB, 2004, PREV MED, V39, P1215, DOI 10.1016/j.ypmed.2004.04.053; Crespo CJ, 1996, ARCH INTERN MED, V156, P93, DOI 10.1001/archinte.156.1.93; Cronin KA, 2001, CANCER CAUSE CONTROL, V12, P305, DOI 10.1023/A:1011244700531; Croteau KA, 2004, AM J HEALTH PROMOT, V18, P217, DOI 10.4278/0890-1171-18.3.217; Culos-Reed SN, 2007, J SPORT EXERCISE PSY, V29, P118, DOI 10.1123/jsep.29.1.118; Demark-Wahnefried W, 2003, CONTROL CLIN TRIALS, V24, P206, DOI 10.1016/S0197-2456(02)00266-0; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hultquist CN, 2005, MED SCI SPORT EXER, V37, P676, DOI 10.1249/01.MSS.0000158993.39760.1B; International Agency for Research on Cancer, 2002, IARC HDB CANC PREVEN, V6; LEE IM, 1991, J NATL CANCER I, V83, P1324, DOI 10.1093/jnci/83.18.1324; LOMBARD DN, 1995, HEALTH PSYCHOL, V14, P164, DOI 10.1037/0278-6133.14.2.164; Masse LC, 1998, J WOMENS HEALTH, V7, P57, DOI 10.1089/jwh.1998.7.57; Matthews CE, 2007, SUPPORT CARE CANCER, V15, P203, DOI 10.1007/s00520-006-0122-x; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Moreau KL, 2001, MED SCI SPORT EXER, V33, P1825, DOI 10.1097/00005768-200111000-00005; National Academy of Sciences Institute of Medicine, 2002, DIET REF INT EN CARB; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Prochaska J., 2008, HLTH BEHAV HLTH ED; Rooney Brenda, 2003, WMJ, V102, P31; Satia JA, 2005, CANCER EPIDEM BIOMAR, V14, P718, DOI 10.1158/1055-9965.EPI-04-0132; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9; Silcott NA, 2011, MED SCI SPORT EXER, V43, P1791, DOI 10.1249/MSS.0b013e318212888c; Taylor CLC, 2006, PSYCHO-ONCOLOGY, V15, P847, DOI 10.1002/pon.1023; Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485; Tudor-Locke C., 2003, MANPO KEI ART SCI ST; Tudor-Locke C, 2000, CAN J DIABETES, V24, P54; Tudor-Locke C, 2003, MANPO KEI; Tudor-Locke C, 2009, AM J LIFESTYLE MED, V3, p50S, DOI 10.1177/1559827609331710; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P456, DOI 10.1123/jpah.6.4.456; Tudor-Locke CE, 2001, RES Q EXERCISE SPORT, V72, P1; Tudor-Locke CE, 2002, PATIENT EDUC COUNS, V47, P23, DOI 10.1016/S0738-3991(01)00169-0; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; Tudor-Locke CE, 2001, DIABETES EDUCATOR, V27, P85, DOI 10.1177/014572170102700110; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wilde BE, 2001, RES Q EXERCISE SPORT, V72, P411, DOI 10.1080/02701367.2001.10608977; Williams DM, 2008, MED SCI SPORT EXER, V40, pS567, DOI 10.1249/MSS.0b013e31817c7006; Wolin KY, 2011, BRIT J CANCER, V104, P882, DOI 10.1038/sj.bjc.6606045; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Wolin KY, 2007, INT J CANCER, V121, P2776, DOI 10.1002/ijc.23009; Wolin KY, 2010, ONCOLOGIST, V15, P556, DOI 10.1634/theoncologist.2009-0285; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39719	10.1371/journal.pone.0039719	http://dx.doi.org/10.1371/journal.pone.0039719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22808053	Green Published, gold			2022-12-27	WOS:000306406700012
J	Rose, MV; Kimaro, G; Nissen, TN; Kroidl, I; Hoelscher, M; Bygbjerg, IC; Mfinanga, SG; Ravn, P				Rose, Michala V.; Kimaro, Godfather; Nissen, Thomas N.; Kroidl, Inge; Hoelscher, Michael; Bygbjerg, Ib C.; Mfinanga, Sayoki G.; Ravn, Pernille			QuantiFERON (R)-TB Gold In-Tube Performance for Diagnosing Active Tuberculosis in Children and Adults in a High Burden Setting	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; SOUTH-AFRICAN CHILDREN; PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; INFECTION; MALNUTRITION; HIV; ANERGY; TESTS; AGE	Aim: To determine whether QuantiFERON (R)-TB Gold In-Tube (QFT) can contribute to the diagnosis of active tuberculosis (TB) in children in a high-burden setting and to assess the performance of QFT and tuberculin skin test (TST) in a prospective cohort of TB suspect children compared to adults with confirmed TB in Tanzania. Methods: Sensitivity and specificity of QFT and TST for diagnosing active TB as well as indeterminate QFT rates and IFN-gamma levels were assessed in 211 TB suspect children in a Tanzanian district hospital and contrasted in 90 adults with confirmed pulmonary TB. Results: Sensitivity of QFT and TST in children with confirmed TB was 19% (5/27) and 6% (2/31) respectively. In adults sensitivity of QFT and TST was 84% (73/87) and 85% (63/74). The QFT indeterminate rate in children and adults was 27% and 3%. Median levels of IFN-gamma were lower in children than adults, particularly children <2 years and HIV infected. An indeterminate result was associated with age <2 years but not malnutrition or HIV status. Overall childhood mortality was 19% and associated with an indeterminate QFT result at baseline. Conclusion: QFT and TST showed poor performance and a surprisingly low sensitivity in children. In contrast the performance in Tanzanian adults was good and comparable to performance in high-income countries. Indeterminate results in children were associated with young age and increased mortality. Neither test can be recommended for diagnosing active TB in children with immature or impaired immunity in a high-burden setting.	[Rose, Michala V.; Bygbjerg, Ib C.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Rose, Michala V.; Nissen, Thomas N.] Hvidovre Univ Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark; [Kimaro, Godfather; Mfinanga, Sayoki G.] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania; [Kroidl, Inge] NIMR Mbeya Med Res Programme, Mbeya, Tanzania; [Kroidl, Inge; Hoelscher, Michael] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany; [Ravn, Pernille] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; National Institute of Medical Research; University of Munich; University of Southern Denmark; Odense University Hospital	Rose, MV (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	michala.rose@gmail.com	Hoelscher, Michael/D-3436-2012	Nissen, Thomas Norrelykke/0000-0001-8565-9629; Bygbjerg, Ib/0000-0001-9100-2754	KNCV Tuberculosis Foundation; Reinholdt Jorck's Fund; Cluster in International Health; Justesen's Fund; Danish Research Council; Danish International Development Assistance [74-08-UHH DANIDA]	KNCV Tuberculosis Foundation; Reinholdt Jorck's Fund; Cluster in International Health; Justesen's Fund; Danish Research Council(Det Frie Forskningsrad (DFF)); Danish International Development Assistance	The study was financially supported by the KNCV Tuberculosis Foundation, Reinholdt Jorck's Fund, Cluster in International Health, Justesen's Fund, Danish Research Council and Danish International Development Assistance (74-08-UHH DANIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004220; [Anonymous], 2006, WHOHTMTB2006371; Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Bjerrum S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-6; Cattamanchi A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-75; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Du Toit G, 2002, INT J TUBERC LUNG D, V6, P814; European Centre for Disease Prevention and Control, 2011, US INT GAMM REL ASS; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Hamm DM, 2009, J INFECT DIS, V199, P1583, DOI 10.1086/598950; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Hoffmann M, 2010, EUR INFECT DIS, V4, P23; Jaspan HB, 2006, AIDS, V20, P483, DOI 10.1097/01.aids.0000210602.40267.60; Lewinsohn DA, 2010, CURR OPIN PEDIATR, V22, P71, DOI 10.1097/MOP.0b013e3283350301; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Lighter J, 2009, PEDIATRICS, V123, P30, DOI 10.1542/peds.2007-3618; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2010, INFECT DIS CLIN N AM, V24, P727, DOI 10.1016/j.idc.2010.04.004; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mbago F, 2010, ANN TB LEPROSY REPOR; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Muheza District Council, 2010, MUH DISTR COUNC REP; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2009, PEDIATRICS, V123, P38, DOI 10.1542/peds.2008-0611; Pai M, 2005, AM J RESP CRIT CARE, V172, P519, DOI 10.1164/rccm.2506003; Pelly TF, 2005, INT J TUBERC LUNG D, V9, P977; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Tatala S R, 2008, Tanzan J Health Res, V10, P189; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; van Rheenen P, 2002, TROP MED INT HEALTH, V7, P435, DOI 10.1046/j.1365-3156.2002.00882.x; World Health Organization, 2011, US TUB INT GAMM REL; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x	37	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e37851	10.1371/journal.pone.0037851	http://dx.doi.org/10.1371/journal.pone.0037851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808002	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400003
J	Capetti, A; Landonio, S; Meraviglia, P; Di Biagio, A; Lo Caputo, S; Sterrantino, G; Ammassari, A; Menzaghi, B; Franzetti, M; De Socio, GV; Pellicano, G; Mazzotta, E; Soria, A; Meschiari, M; Trezzi, M; Sasset, L; Celesia, BM; Zucchi, P; Melzi, S; Ricci, E; Rizzardini, G				Capetti, Amedeo; Landonio, Simona; Meraviglia, Paola; Di Biagio, Antonio; Lo Caputo, Sergio; Sterrantino, Gaetana; Ammassari, Adriana; Menzaghi, Barbara; Franzetti, Marco; De Socio, Giuseppe Vittorio; Pellicano, Giovanni; Mazzotta, Elena; Soria, Alessandro; Meschiari, Marianna; Trezzi, Michele; Sasset, Lolita; Celesia, Benedetto Maurizio; Zucchi, Patrizia; Melzi, Sara; Ricci, Elena; Rizzardini, Giuliano			96 Week Follow-Up of HIV-Infected Patients in Rescue with Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience	PLOS ONE			English	Article							LONG-TERM EFFICACY; HIV-1-INFECTED PATIENTS; PROTEASE INHIBITORS; BACKGROUND THERAPY; SAFETY; TRIAL; ETRAVIRINE; COHORT	Background: Long term efficacy of raltegravir (RAL)-including regimens in highly pre-treated HIV-1-infected patients has been demonstrated in registration trials. However, few studies have assessed durability in routine clinical settings. Methods: Antiretroviral treatment-experienced patients initiating a RAL-containing salvage regimen were enrolled. Routine clinical and laboratory follow-up was performed at baseline, week 4, 12, and every 12 weeks thereafter. Data were censored at week 96. Results: Out of 320 patients enrolled, 292 (91.25%) subjects maintained their initial regimen for 96 weeks; 28 discontinued prematurely for various reasons: death (11), viral failure (8), adverse events (5), loss to follow-up (3), consent withdrawal (1). Eight among these 28 subjects maintained RAL but changed the accompanying drugs. The mean CD4+ T-cell increase at week 96 was 227/mm(3); 273 out of 300 patients (91%), who were still receiving RAL at week 96, achieved viral suppression (HIV-1 RNA <50 copies/mL). When analyzing the immuno-virologic outcome according to the number of drugs used in the regimen, 2 (n = 45), 3 (n = 111), 4 (n = 124), or >4 (n = 40), CD4+ T-cell gain was similar across strata: +270, +214, +216, and +240 cells/mm(3), respectively, as was the proportion of subjects with undetectable viral load. Laboratory abnormalities (elevation of liver enzymes, total cholesterol and triglycerides) were rare, ranging from 0.9 to 3.1%. The mean 96-week total cholesterol increase was 23.6 mg/dL. Conclusions: In a routine clinical setting, a RAL-based regimen allowed most patients in salvage therapy to achieve optimal viral suppression for at least 96 weeks, with relevant immunologic gain and very few adverse events.	[Capetti, Amedeo; Landonio, Simona; Zucchi, Patrizia; Melzi, Sara; Ricci, Elena; Rizzardini, Giuliano] Luigi Sacco Hosp, Div Infect Dis 1, Milan, Italy; [Meraviglia, Paola] Luigi Sacco Hosp, Div Infect Dis 2, Milan, Italy; [Di Biagio, Antonio] San Martino Hosp, Infect Dis Clin, Genoa, Italy; [Lo Caputo, Sergio] Santa Maria Annunziata Hosp, Infect Dis Clin, Florence, Italy; [Sterrantino, Gaetana] Careggi Hosp, Div Infect Dis, Florence, Italy; [Ammassari, Adriana] Lazzaro Spallanzani Hosp, Div Infect Dis 3, Rome, Italy; [Menzaghi, Barbara] Osped Circolo, Div Infect Dis, Busto Arsizio, Italy; [Franzetti, Marco] Luigi Sacco Hosp, Div Infect Dis 3, Milan, Italy; [De Socio, Giuseppe Vittorio] Santa Maria della Misericordia Hosp, Div Infect Dis, Perugia, Italy; [Pellicano, Giovanni] Policlin G Martino, Div Infect Dis, Messina, Italy; [Mazzotta, Elena] Santo Spirito Hosp, Div Infect Dis, Pescara, Italy; [Soria, Alessandro] San Gerardo de Tintori Hosp, Infect Dis Clin, Monza, Italy; [Meschiari, Marianna] Azienda Osped Univ Policlin, Infect Dis Clin, Modena, Italy; [Trezzi, Michele] Santa Maria della Misericordia Hosp, Div Infect Dis, Grosseto, Italy; [Sasset, Lolita] Santa Maria della Misericordia Hosp, Div Infect Dis, Rovigo, Italy; [Celesia, Benedetto Maurizio] Univ Catania, ARNAS Azienda Osped Rilievo Nazl & Alta Specializ, Infect Dis Unit, Catania, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Genoa; IRCCS AOU San Martino IST; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Lazzaro Spallanzani; University of Milan; Luigi Sacco Hospital; Hospital Santa Maria della Misericordia; AOU Policlinico Gaetano Martino; University of Messina; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Hospital Santa Maria della Misericordia; Hospital Santa Maria della Misericordia; University of Catania	Capetti, A (corresponding author), Luigi Sacco Hosp, Div Infect Dis 1, Milan, Italy.	capetti.amedeo@hsacco.it	Meschiari, Marianna/AAC-1916-2022; Zucchi, Patrizia/AFQ-5312-2022; De Socio, Giuseppe Vittorio/H-6237-2012; Di Biagio, Antonio/J-4901-2019; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; celesia, benedetto maurizio/E-4562-2017	Meschiari, Marianna/0000-0002-1254-9995; De Socio, Giuseppe Vittorio/0000-0001-8774-4843; Di Biagio, Antonio/0000-0003-1436-5089; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; SORIA, Alessandro/0000-0002-4447-2574; Lo Caputo, Sergio/0000-0002-4729-7548; celesia, benedetto maurizio/0000-0002-6919-1955; Ricci, Elena/0000-0001-5279-0444; Ammassari, Adriana/0000-0002-0284-0340; meraviglia, paola/0000-0002-3356-7199				Caby F, 2010, SCAND J INFECT DIS, V42, P527, DOI 10.3109/00365541003621502; Capetti AF, 2009, JAIDS-J ACQ IMM DEF, V50, P233, DOI 10.1097/QAI.0b013e31818c7e8e; De Socio GVL, 2008, BIOMED PHARMACOTHER, V62, P16, DOI 10.1016/j.biopha.2007.07.012; Engsig Frederik N, 2010, Clin Epidemiol, V2, P145; Fagard C, 2012, JAIDS-J ACQ IMM DEF, V59, P489, DOI 10.1097/QAI.0b013e31824bb720; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Martinez E, 2010, AIDS, V24, P1697, DOI 10.1097/QAD.0b013e32833a608a; Masia M, 2010, J INFECTION, V61, P189, DOI 10.1016/j.jinf.2010.04.011; Nozza S, 2010, AIDS, V24, P924, DOI 10.1097/QAD.0b013e3283372d76; Reiss KA, 2010, AIDS, V24, P2757, DOI 10.1097/QAD.0b013e32833fca42; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; Teague A, 2010, JAIDS-J ACQ IMM DEF, V53, P666, DOI 10.1097/QAI.0b013e3181ba4845; Teppler H, 2011, CURR HIV RES, V9, P40, DOI 10.2174/157016211794582650; Vispo E, 2010, J ANTIMICROB CHEMOTH, V65, P543, DOI 10.1093/jac/dkp446; Wittkop L, 2009, J ANTIMICROB CHEMOTH, V63, P1251, DOI 10.1093/jac/dkp114; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210; Young B, 2010, HIV CLIN TRIALS, V11, P260, DOI 10.1310/hct1105-260	18	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39222	10.1371/journal.pone.0039222	http://dx.doi.org/10.1371/journal.pone.0039222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808029	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400009
J	de Viron, S; Van der Heyden, J; Ambrosino, E; Arbyn, M; Brand, A; Van Oyen, H				de Viron, Sylviane; Van der Heyden, Johan; Ambrosino, Elena; Arbyn, Marc; Brand, Angela; Van Oyen, Herman			Impact of Genetic Notification on Smoking Cessation: Systematic Review and Pooled-Analysis	PLOS ONE			English	Review							LUNG-CANCER RISK; NICOTINE REPLACEMENT THERAPY; AFRICAN-AMERICAN SMOKERS; SUSCEPTIBILITY; HEALTH; MOTIVATION; INFORMATION; FEEDBACK; GSTM1; POLYMORPHISMS	Objectives: This study aimed to evaluate the impact of genetic notification of smoking-related disease risk on smoking cessation in the general population. Secondary objectives were to assess the impact of genetic notification on intention-to-quit smoking and on emotional outcomes as well as the understanding and the recall of this notification. Methods: A systematic review of articles from inception to August 2011 without language restriction was realized using PubMed, Embase, Scopus, Web of Science, PsycINFO and Toxnet. Other publications were identified using hand search. The pooled-analysis included only randomized trials. Comparison groups were (i) high and low genetic risk versus control, and (ii) high versus low genetic risk. For the pooled-analysis random effect models were applied and sensitivity analyses were conducted. Results: Eight papers from seven different studies met the inclusion criteria of the review. High genetic risk notification was associated with short-term increased depression and anxiety. Four randomized studies were included in the pooled-analysis, which revealed a significant impact of genetic notification on smoking cessation in comparison to controls (clinical risk notification or no intervention) in short term follow-up less than 6 months (RR = 1.55, 95% CI 1.09-2.21). Conclusions: In short term follow-up, genetic notification increased smoking cessation in comparison to control interventions. However, there is no evidence of long term effect (up to 12 month) on smoking cessation. Further research is needed to assess more in depth how genetic notification of smoking-related disease could contribute to smoking cessation.	[de Viron, Sylviane; Van der Heyden, Johan; Arbyn, Marc; Van Oyen, Herman] Sci Inst Publ Hlth, Operat Direct Publ Hlth & Surveillance, Brussels, Belgium; [de Viron, Sylviane; Ambrosino, Elena; Brand, Angela] Maastricht Univ, IPHG, Maastricht, Netherlands; [de Viron, Sylviane; Ambrosino, Elena; Brand, Angela] Maastricht Univ, Res Inst CAPHRI, Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [de Viron, Sylviane; Brand, Angela] Maastricht Univ, Res Inst GROW, Sch Oncol & Dev Biol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	de Viron, S (corresponding author), Sci Inst Publ Hlth, Operat Direct Publ Hlth & Surveillance, Brussels, Belgium.	Sylviane.deviron@wiv-isp.be	Ambrosino, Elena/AAT-7930-2020	Ambrosino, Elena/0000-0001-6975-8213; Van der Heyden, Johan/0000-0002-6796-642X; Arbyn, Marc/0000-0001-8434-8263; Van Oyen, Herman/0000-0003-2119-4433	Belgian Federal Science Policy Office; European Commission PHGEN II (EU) [20081302]; Belgian Foundation Against Cancer	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Commission PHGEN II (EU); Belgian Foundation Against Cancer	This work is supported by a grant from the Belgian Federal Science Policy Office and the European Commission PHGEN II (Duration period: May, 2009 - June 2012 EU-Project No. 20081302). The work of M. Arbyn was supported by the "Belgian Foundation Against Cancer". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrie AK, 2004, CANCER EPIDEM BIOMAR, V13, P908; Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9; Carlsten C, 2011, ANN FAM MED, V9, P366, DOI 10.1370/afm.1244; Carpenter MJ, 2007, ANN BEHAV MED, V33, P22, DOI 10.1207/s15324796abm3301_3; Centers for Disease Control and Prevention (US) National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (US), 2010, TOB SMOK CAUS DIS BI; Christensen PM, 1997, EUR J CLIN PHARMACOL, V51, P389, DOI 10.1007/s002280050219; Conti DV, 2008, HUM MOL GENET, V17, P2834, DOI 10.1093/hmg/ddn181; Croyle R T, 1999, J Natl Cancer Inst Monogr, P59; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Haga Susanne B, 2009, J Diabetes Sci Technol, V3, P781; Hamajima Nobuyuki, 2004, Asian Pac J Cancer Prev, V5, P409; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hishida A, 2010, CANCER EPIDEMIOL, V34, P96, DOI 10.1016/j.canep.2009.11.008; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Ito H, 2006, PREV MED, V42, P102, DOI 10.1016/j.ypmed.2005.10.006; Kano Mayuko, 2007, Nagoya J Med Sci, V69, P149; Lerman C, 1997, HEALTH PSYCHOL, V16, P87, DOI 10.1037/0278-6133.16.1.87; Lerman C, 2004, PHARMACOGENOMICS J, V4, P184, DOI 10.1038/sj.tpj.6500238; Lerman C, 2006, NEUROPSYCHOPHARMACOL, V31, P231, DOI 10.1038/sj.npp.1300861; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lipkus IM, 2004, HEALTH PSYCHOL, V23, P178, DOI 10.1037/0278-6133.23.2.178; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; Manfredi C, 2007, HEALTH EDUC RES, V22, P747, DOI 10.1093/her/cyl155; McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521; McBride CM, 2010, ANNU REV PUBL HEALTH, V31, P89, DOI 10.1146/annurev.publhealth.012809.103532; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Sanderson SC, 2007, CLIN GENET, V71, P501, DOI 10.1111/j.1399-0004.2007.00810.x; Sanderson SC, 2008, J HEALTH PSYCHOL, V13, P481, DOI 10.1177/1359105308088519; Sanderson SC, 2008, J NUTRIGENET NUTRIGE, V1, P224, DOI 10.1159/000149826; Sanderson SC, 2009, CANCER EPIDEM BIOMAR, V18, P1953, DOI 10.1158/1055-9965.EPI-08-0620; Sanderson SC, 2005, HEALTH EDUC BEHAV, V32, P640, DOI 10.1177/1090198105278756; Shi XQ, 2008, LUNG CANCER, V59, P155, DOI 10.1016/j.lungcan.2007.08.004; Smerecnik C, 2012, TOB CONTROL, V21, P347, DOI 10.1136/tc.2011.042739; Sorensen K, 2011, PUBLIC HEALTH GENOM, V14, P195, DOI 10.1159/000324241; Sorensen M, 2004, INT J CANCER, V110, P219, DOI 10.1002/ijc.20075; Spinola M, 2007, LUNG CANCER, V55, P271, DOI 10.1016/j.lungcan.2006.10.023; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Trepanier Angela, 2004, J Genet Couns, V13, P83, DOI 10.1023/B:JOGC.0000018821.48330.77; Uhl G, 2009, PHARMACOGENOMICS J, V9, P111, DOI 10.1038/tpj.2008.10; Velicer WF, 2004, ADDICT BEHAV, V29, P51, DOI 10.1016/S0306-4603(03)00084-4; Westmaas JL, 2005, ADDICT BEHAV, V30, P1524, DOI 10.1016/j.addbeh.2005.03.002; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Wright AJ, 2008, CLIN GENET, V73, P306, DOI 10.1111/j.1399-0004.2008.00964.x; Wright AJ, 2003, TOB CONTROL, V12, P227, DOI 10.1136/tc.12.2.227; Wright AJ, 2007, ADDICTION, V102, P1657, DOI 10.1111/j.1360-0443.2007.01937.x; Wright AJ, 2006, HEALTH PSYCHOL, V25, P740, DOI 10.1037/0278-6133.25.6.740	49	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40230	10.1371/journal.pone.0040230	http://dx.doi.org/10.1371/journal.pone.0040230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22808123	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400035
J	van Vliet, MH; Horlings, HM; van de Vijver, MJ; Reinders, MJT; Wessels, LFA				van Vliet, Martin H.; Horlings, Hugo M.; van de Vijver, Marc J.; Reinders, Marcel J. T.; Wessels, Lodewyk F. A.			Integration of Clinical and Gene Expression Data Has a Synergetic Effect on Predicting Breast Cancer Outcome	PLOS ONE			English	Article							MICROARRAY DATA; PROGNOSTIC INDEX; IMMUNE-RESPONSE; SIGNATURE; CLASSIFICATION; SURVIVAL; PROLIFERATION; SERIES; GRADE	Breast cancer outcome can be predicted using models derived from gene expression data or clinical data. Only a few studies have created a single prediction model using both gene expression and clinical data. These studies often remain inconclusive regarding an obtained improvement in prediction performance. We rigorously compare three different integration strategies (early, intermediate, and late integration) as well as classifiers employing no integration (only one data type) using five classifiers of varying complexity. We perform our analysis on a set of 295 breast cancer samples, for which gene expression data and an extensive set of clinical parameters are available as well as four breast cancer datasets containing 521 samples that we used as independent validation. mOn the 295 samples, a nearest mean classifier employing a logical OR operation (late integration) on clinical and expression classifiers significantly outperforms all other classifiers. Moreover, regardless of the integration strategy, the nearest mean classifier achieves the best performance. All five classifiers achieve their best performance when integrating clinical and expression data. Repeating the experiments using the 521 samples from the four independent validation datasets also indicated a significant performance improvement when integrating clinical and gene expression data. Whether integration also improves performances on other datasets (e. g. other tumor types) has not been investigated, but seems worthwhile pursuing. Our work suggests that future models for predicting breast cancer outcome should exploit both data types by employing a late OR or intermediate integration strategy based on nearest mean classifiers.	[van Vliet, Martin H.; Reinders, Marcel J. T.; Wessels, Lodewyk F. A.] Delft Univ Technol, Delft Bioinformat Lab, Fac Elect Engn Math & Comp Sci, Delft, Netherlands; [Horlings, Hugo M.; van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van Vliet, Martin H.; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Biol, Bioinformat & Stat Grp, NL-1066 CX Amsterdam, Netherlands	Delft University of Technology; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute	van Vliet, MH (corresponding author), Erasmus MC, Skyline Diagnost BV, Fac Bldg, Rotterdam, Netherlands.	mhvvliet@gmail.com		van de Vijver, Marc/0000-0002-0385-4787	BSIK through Netherlands Genomics Initiative (NGI)	BSIK through Netherlands Genomics Initiative (NGI)	This work was part of the BioRange programme of the Netherlands Bioinformatics Centre (NBIC), which is supported by a BSIK grant through the Netherlands Genomics Initiative (NGI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Barnard MM, 1935, ANN EUGENIC, V6, P352, DOI 10.1111/j.1469-1809.1935.tb02117.x; Blamey RW, 2007, EUR J CANCER, V43, P1548, DOI 10.1016/j.ejca.2007.01.016; Boulesteix AL, 2008, BIOINFORMATICS, V24, P1698, DOI 10.1093/bioinformatics/btn262; Breiman L., 1984, CLASSIFICATION REGRE; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Daemen A, 2007, P ANN INT IEEE EMBS, P5411, DOI 10.1109/IEMBS.2007.4353566; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Domingos P., 1996, INDEPENDENCE CONDITI; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Haibe-Kains B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r18; Horlings H, 2012, MUTATIONAL ANA UNPUB; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pepe MS, 2004, STAT EVALUATION MED; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; Tibshirani R.J., 2002, STAT APPL GENET MOL, V10, P1; TODD JH, 1987, BRIT J CANCER, V56, P489, DOI 10.1038/bjc.1987.230; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik V., 1999, STAT LEARNING THEORY; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429	36	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40358	10.1371/journal.pone.0040358	http://dx.doi.org/10.1371/journal.pone.0040358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808140	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400044
J	Benz, J; Sendlmeier, C; Barends, TRM; Meinhart, A				Benz, Juliane; Sendlmeier, Christina; Barends, Thomas R. M.; Meinhart, Anton			Structural Insights into the Effector - Immunity System Tse1/Tsi1 from Pseudomonas aeruginosa	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; PROGRAMMED CELL-DEATH; VI SECRETION; ESCHERICHIA-COLI; BACTERIAL; PROTEIN; MECHANISM; FAMILY; CRYSTALLOGRAPHY; SUPERFAMILY	During an interbacterial battle, the type-6-secretion-system (T6SS) of the human pathogen Pseudomonas aeruginosa injects the peptidoglycan(PG)-hydrolase Tse1 into the periplasm of Gram-negative enemy cells and induces their lysis. However, for its own benefit, P. aeruginosa produces and transports the immunity-protein Tsi1 into its own periplasm where in prevents accidental exo- and endogenous intoxication. Here we present the high-resolution X-ray crystal structure of the lytic enzyme Tse1 and describe the mechanism by which Tse1 cleaves the gamma-D-glutamyl-L-meso-diaminopimelic acid amide bond of crosslinked PG. Tse1 belongs to the superfamily of N1pC/P60 peptidases but is unique among described members of this family of which the structure was described, since it is a single domain protein without any putative localization domain. Most importantly, we present the crystal structure of Tse1 bound to its immunity-protein Tsi1 as well and describe the mechanism of enzyme inhibition. Tsi1 occludes the active site of Tse1 and abolishes its enzyme activity by forming a hydrogen bond to a catalytically important histidine residue in Tse1. Based on our structural findings in combination with a bioinfomatic approach we also identified a related system in Burkholderia phytofirmans. Not only do our findings point to a common catalytic mechanism of the Tse1 PG-hydrolases, but we can also show that it is distinct from other members of this superfamily. Furthermore, we provide strong evidence that the mechanism of enzyme inhibition between Tsi1 orthologues is conserved. This work is the first structural description of an entire effector/immunity pair injected by the T6SS system. Moreover, it is also the first example of a member of the N1pC/P60 superfamily which becomes inhibited upon binding to its cognate immunity protein.	[Benz, Juliane; Sendlmeier, Christina; Barends, Thomas R. M.; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany	Max Planck Society	Benz, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany.	anton.meinhart@mpimf-heidelberg.mpg.de	Meinhart, Anton/M-9647-2014		Max Planck Society; Chica and Heinz Schaller Foundation	Max Planck Society(Max Planck Society); Chica and Heinz Schaller Foundation	This study was financially supported by the Max Planck Society and the Chica and Heinz Schaller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Cramer WA, 1999, NAT STRUCT BIOL, V6, P295, DOI 10.1038/7520; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Fu ZB, 2007, J BACTERIOL, V189, P8871, DOI 10.1128/JB.01272-07; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; HARTLEY RW, 1973, J BIOL CHEM, V248, P5624; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; James R, 2002, BIOCHIMIE, V84, P381, DOI 10.1016/S0300-9084(02)01450-5; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Meng W, 2010, J MED CHEM, V53, P5620, DOI 10.1021/jm100634a; Miranda JJL, 2003, PROTEIN SCI, V12, P73, DOI 10.1110/ps.0224203; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nakajima Y, 2008, J BACTERIOL, V190, P7819, DOI 10.1128/JB.02010-07; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Papadakos G, 2012, Q REV BIOPHYS, V45, P57, DOI 10.1017/S0033583511000114; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Sudmeier JL, 2003, J AM CHEM SOC, V125, P8430, DOI 10.1021/ja034072c; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Zou TT, 2012, J MOL BIOL, V417, P351, DOI 10.1016/j.jmb.2012.01.040	64	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40453	10.1371/journal.pone.0040453	http://dx.doi.org/10.1371/journal.pone.0040453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792331	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800088
J	Mpyet, C; Lass, BD; Yahaya, HB; Solomon, AW				Mpyet, Caleb; Lass, Barka David; Yahaya, Hadi B.; Solomon, Anthony W.			Prevalence of and Risk Factors for Trachoma in Kano State, Nigeria	PLOS ONE			English	Article							VISUAL IMPAIRMENT; MUSCA-SORBENS; VECTOR	Background: In northern Nigeria, trachoma is an important public health problem, but there are currently few population-based data on prevalence of disease and no formal trachoma control programs. Methodology / Principal Findings: In Kano state, Nigeria, we conducted a population-based cross-sectional survey using multistage cluster random sampling, combining examination for clinical signs of trachoma and application of questionnaires assessing potential household-level risk factors. A total of 4491 people were examined in 40 clusters, of whom 1572 were aged 1-9 years, and 2407 (53.6%) were female. In 1-9 year-olds, the prevalence of trachomatous inflammation-follicular (TF) was 17.5% (95% CI: 15.7-19.5%). In a multivariate model, independent risk factors for active trachoma were the presence of flies on the face (OR 1.98, 95% CI 1.30-3.02); a dirty face (OR 2.45, 95% CI 1.85-3.25) and presence of animal dung within the compound of residence (OR 3.46, 95% CI 1.62-7.41). The prevalence of trachomatous trichiasis in persons aged >= 15years was 10.9% (95% CI: 9.7-12.2%). Trichiasis was significantly more common in adult females than in adult males. Conclusion/Significance: There is an urgent need for a trachoma control program in Kano state, with emphasis given to provision of good quality trichiasis surgery. Particular effort will need to be made to identify women with trichiasis and engage them with appropriate services while also taking steps to secure azithromycin for mass treatment and ensuring personal and environmental hygiene.	[Mpyet, Caleb] Jos Univ Teaching Hosp, Dept Ophthalmol, Jos, Nigeria; [Lass, Barka David] Bingham Univ Teaching Hosp, Dept Ophthalmol, Jos, Nigeria; [Yahaya, Hadi B.] Murtala Mohammed Specialist Hosp, Dept Ophthalmol, Kano, Nigeria; [Solomon, Anthony W.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Mpyet, C (corresponding author), Jos Univ Teaching Hosp, Dept Ophthalmol, Jos, Nigeria.	mpyetc@yahoo.com		Solomon, Anthony/0000-0001-7101-6649	CBM Vision2020 Support Program, Jos, Nigeria; National Institute for Health Research [CL-2009-20-001] Funding Source: researchfish	CBM Vision2020 Support Program, Jos, Nigeria; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by CBM Vision2020 Support Program, Jos, Nigeria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu L, 2002, Niger J Med, V11, P108; Abdull MM, 2009, INVEST OPHTH VIS SCI, V50, P4114, DOI 10.1167/iovs.09-3507; Emerson PM, 2000, T ROY SOC TROP MED H, V94, P28, DOI 10.1016/S0035-9203(00)90427-9; Emerson PM, 2001, MED VET ENTOMOL, V15, P314, DOI 10.1046/j.0269-283x.2001.00318.x; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; Jip NF, 2008, OPHTHAL EPIDEMIOL, V15, P294, DOI 10.1080/09286580802256542; Kalua K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009067; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Miller K, 2004, BRIT J OPHTHALMOL, V88, P750, DOI 10.1136/bjo.2003.038661; Mpyet C, 2008, OPHTHAL EPIDEMIOL, V15, P303, DOI 10.1080/09286580802237633; Office S.I.N.S, 2009, REPORT 2009 POPULATI; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schemann JF, 2003, T ROY SOC TROP MED H, V97, P63, DOI 10.1016/S0035-9203(03)90025-3; Solomon AW, 2006, TRACHOMA CONTROL GUI; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; West S, 2004, BRIT J OPHTHALMOL, V88, P1368, DOI 10.1136/bjo.2004.041657; World Health Assembly, 1998, 51 WORLD HLTH ASS GE	17	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40421	10.1371/journal.pone.0040421	http://dx.doi.org/10.1371/journal.pone.0040421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792311	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000306461800080
J	Park, JH; Darvin, P; Lim, EJ; Joung, YH; Hong, DY; Park, EU; Park, SH; Choi, SK; Moon, ES; Cho, BW; Park, KD; Lee, HK; Kim, MJ; Park, DS; Chung, IM; Yang, YM				Park, Jin Hee; Darvin, Pramod; Lim, Eun Joung; Joung, Youn Hee; Hong, Dae Young; Park, Eui U.; Park, Seung Hwa; Choi, Soo Keun; Moon, Eon-Soo; Cho, Byung Wook; Park, Kyung Do; Lee, Hak Kyo; Kim, Myong-Jo; Park, Dong-Sik; Chung, Ill-Min; Yang, Young Mok			Hwanggeumchal sorghum Induces Cell Cycle Arrest, and Suppresses Tumor Growth and Metastasis through Jak2/STAT Pathways in Breast Cancer Xenografts	PLOS ONE			English	Article							FACTOR-I RECEPTOR; SIGNAL TRANSDUCER; IGF-1 EXPRESSION; KINASE-ACTIVITY; HYPOXIA; APOPTOSIS; STAT5B; ACTIVATOR; PROTEIN; PHASE	Background: Cancer is one of the highly virulent diseases known to humankind with a high mortality rate. Breast cancer is the most common cancer in women worldwide. Sorghum is a principal cereal food in many parts of the world, and is critical in folk medicine of Asia and Africa. In the present study, we analyzed the effects of HSE in metastatic breast cancer. Methodology/Principal Findings: Preliminary studies conducted on MDA-MB 231 and MCF-7 xenograft models showed tumor growth suppression by HSE. Western blotting studies conducted both in vivo and in vitro to check the effect of HSE in Jak/STAT pathways. Anti-metastatic effects of HSE were confirmed using both MDA-MB 231 and MCF-7 metastatic animal models. These studies showed that HSE can modulate Jak/STAT pathways, and it hindered the STAT5b/IGF-1R and STAT3/VEGF pathways not only by down-regulating the expression of these signal molecules and but also by preventing their phosphorylation. The expression of angiogenic factors like VEGF, VEGF-R2 and cell cycle regulators like cyclin D, cyclin E, and pRb were found down-regulated by HSE. In addition, it also targets Brk, p53, and HIF-1 alpha for anti-cancer effects. HSE induced G1 phase arrest and migration inhibition in MDA-MB 231 cells. The metastasis of breast cancer to the lungs also found blocked by HSE in the metastatic animal model. Conclusions/Significance: Usage of HS as a dietary supplement is an inexpensive natural cancer therapy, without any side effects. We strongly recommend the use of HS as an edible therapeutic agent as it possesses tumor suppression, migration inhibition, and anti-metastatic effects on breast cancer.	[Park, Jin Hee; Darvin, Pramod; Lim, Eun Joung; Joung, Youn Hee; Yang, Young Mok] Konkuk Univ, Sch Med, Dept Pathol, Seoul, South Korea; [Park, Jin Hee; Darvin, Pramod; Lim, Eun Joung; Joung, Youn Hee; Yang, Young Mok] Konkuk Univ, Inst Biomed Sci & Technol, Seoul, South Korea; [Hong, Dae Young] Konkuk Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Park, Eui U.] Konkuk Univ, Sch Med, Dept Forens Med, Seoul, South Korea; [Park, Seung Hwa] Konkuk Univ, Sch Med, Dept Anat, Seoul, South Korea; [Choi, Soo Keun] Kyung Hee Univ, Coll Hotel & Tourism Management, Dept Culinary & Serv Management, Seoul, South Korea; [Moon, Eon-Soo] Konkuk Univ, Sch Med, Dept Internal Med, Chungju, South Korea; [Cho, Byung Wook] Pusan Natl Univ, Coll Life Sci, Dept Anim Sci, Pusan 609735, South Korea; [Park, Kyung Do; Lee, Hak Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea; [Kim, Myong-Jo] Kangwon Natl Univ, Dept Appl Plant Sci, Chunchon, South Korea; [Park, Dong-Sik] Rural Dev Adm, Suwon, South Korea; [Chung, Ill-Min] Konkuk Univ, Dept Appl Life Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Kyung Hee University; Konkuk University; Konkuk University Medical Center; Pusan National University; Hankyong National University; Kangwon National University; Rural Development Administration (RDA); Konkuk University	Park, JH (corresponding author), Konkuk Univ, Sch Med, Dept Pathol, Glocal Campus, Seoul, South Korea.	ymyang@kku.ac.kr	Darvin, Pramod/M-1730-2019	Darvin, Pramod/0000-0003-3746-109X; Kim, Myong Jo/0000-0003-4378-4071	Next generation BioGreen 21 Programs [PJ0081062011]; Biogreen 21 programs, Rural Development Administration, South Korea [PJ006457]	Next generation BioGreen 21 Programs; Biogreen 21 programs, Rural Development Administration, South Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Next generation BioGreen 21 Programs (No. PJ0081062011), and partially supported by Biogreen 21 programs (No. PJ006457), Rural Development Administration, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awika JM, 2004, PHYTOCHEMISTRY, V65, P1199, DOI 10.1016/j.phytochem.2004.04.001; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; BARTKOVA J, 1994, J PATHOL, V172, P237, DOI 10.1002/path.1711720303; BASERGA R, 1994, CELL, V79, P927, DOI 10.1016/0092-8674(94)90023-X; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bernaciak TM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2341; Carr TP, 2005, J NUTR, V135, P2236, DOI 10.1093/jn/135.9.2236; Chen WJ, 2003, BIOCHEM PHARMACOL, V65, P1777, DOI 10.1016/S0006-2952(03)00156-4; Cho SH, 2000, FASEB J, V14, pA249; Chung IM, 2011, IMMUNOPHARM IMMUNOT, V33, P447, DOI 10.3109/08923973.2010.532804; Chung IM, 2004, KOREAN SOC CROP SCI, V8, P5; Dal Monte M, 2007, INVEST OPHTH VIS SCI, V48, P3480; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Friedman M, 2007, J AGR FOOD CHEM, V55, P243, DOI 10.1021/jf062276h; Funamoto M, 2000, J BIOL CHEM, V275, P10561, DOI 10.1074/jbc.275.14.10561; Girnita L, 2000, CANCER RES, V60, P5278; Gupta K, 2005, POSTGRAD MED J, V81, P236, DOI 10.1136/pgmj.2004.023309; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Himpe E, 2009, BIOFACTORS, V35, P76, DOI 10.1002/biof.20; Huang CS, 1998, CANCER RES, V58, P4102; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; Joung YH, 2005, EXP MOL MED, V37, P353, DOI 10.1038/emm.2005.45; Joung YH, 2008, INT J ONCOL, V33, P477, DOI 10.3892/ijo_00000030; Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kil HY, 2009, FOOD CHEM, V115, P1234, DOI 10.1016/j.foodchem.2009.01.032; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee MY, 2006, BREAST, V15, P187, DOI 10.1016/j.breast.2005.05.005; Lim EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033361; Lim EJ, 2010, INT J ONCOL, V36, P1243, DOI 10.3892/ijo_00000608; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Ludyga N, 2011, MOL BIOSYST, V7, P1603, DOI 10.1039/c0mb00286k; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mo HB, 1999, J NUTR, V129, P804, DOI 10.1093/jn/129.4.804; Morrissey PA, 1998, INT DAIRY J, V8, P463, DOI 10.1016/S0958-6946(98)00070-3; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Resnik JL, 1998, CANCER RES, V58, P1159; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Ryu HS, 2008, KOREAN J NUTR, V19, P176; SENGER DR, 1986, CANCER RES, V46, P5629; Takahashi H, 2000, BIOCHEM BIOPH RES CO, V267, P388, DOI 10.1006/bbrc.1999.1931; Terman BI, 2001, EINSTEIN Q J BIOL ME, V18, P59; Thomas R, 2009, PROSTATE, V69, P263, DOI 10.1002/pros.20885; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tweardy D, 2011, J CLIN ONCOL, V29, P2443, DOI 10.1200/JCO.2010.34.2014; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WARNER TF, 1988, MED HYPOTHESES, V26, P99, DOI 10.1016/0306-9877(88)90060-6; Werner H, 2006, TRENDS ENDOCRIN MET, V17, P236, DOI 10.1016/j.tem.2006.06.007; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yang LY, 2009, J AGR FOOD CHEM, V57, P1797, DOI 10.1021/jf8035066; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162	58	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40531	10.1371/journal.pone.0040531	http://dx.doi.org/10.1371/journal.pone.0040531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792362	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800103
J	Sivik, T; Gunnarsson, C; Fornander, T; Nordenskjold, B; Skoog, L; Stal, O; Jansson, A				Sivik, Tove; Gunnarsson, Cecilia; Fornander, Tommy; Nordenskjold, Bo; Skoog, Lambert; Stal, Olle; Jansson, Agneta			17 beta-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer	PLOS ONE			English	Article							ADJUVANT TAMOXIFEN; PROGNOSTIC MARKER; POSTMENOPAUSAL; DEHYDROGENASES; AMPLIFICATION; INHIBITORS; EXPRESSION; HSD17B1	Introduction: 17 beta-hydroxysteroid dehydrogenases (17 beta HSDs) are important enzymes regulating the pool of bioactive steroids in the breast. The current study was undertaken in order to evaluate implications of 17 beta HSD14 in breast cancer, measuring 17 beta HSD14 protein expression in breast tumours. Methods: An antibody targeting the 17 beta HSD14 antigen was generated and validated using HSD17B14-transfected cells and a peptide-neutralising assay. Tissue microarrays with tumours from 912 post-menopausal women diagnosed with lymph node-negative breast cancer, and randomised to adjuvant tamoxifen or no endocrine treatment, were analysed for 17 beta HSD14 protein expression with immunohistochemistry. Results: Results were obtained from 847 tumours. Patients with oestrogen positive tumours with high 17 beta HSD14 expression had fewer local recurrences when treated with tamoxifen (HR 0.38; 95% C.I. 0.19-0.77, p = 0.007) compared to patients with lower tumoural 17 beta HSD14 expression, for whom tamoxifen did not reduce the number of local recurrences (HR 1.19; 95% C.I. 0.54-2.59; p = 0.66). No prognostic importance of 17 beta HSD14 was seen for systemically untreated patients. Conclusions: Using a highly specific validated antibody for immunohistochemical analysis of a large number of breast tumours, we have shown that tumoural expression levels of 17 beta HSD14 can predict the outcome of adjuvant tamoxifen treatment in terms of local recurrence-free survival in patients with lymph node-negative ER+ breast cancer. The results need be verified to confirm any clinical relevance.	[Sivik, Tove; Nordenskjold, Bo; Stal, Olle; Jansson, Agneta] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Oncol, Linkoping, Sweden; [Gunnarsson, Cecilia] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Clin Genet, Linkoping, Sweden; [Gunnarsson, Cecilia; Nordenskjold, Bo; Stal, Olle] Cty Council Ostergotland, Linkoping, Sweden; [Fornander, Tommy; Skoog, Lambert] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Linkoping University; Linkoping University; City Council Ostergotland; Karolinska Institutet	Sivik, T (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Oncol, Linkoping, Sweden.	tove.sivik@liu.se	Gunnarsson, Cecilia/ABD-9170-2021		Swedish Cancer Society; Swedish Research Council [K2008-54X-20639-01-3]; Olle Engkvist Byggmastare Foundation; Cancer and Allergy Foundation; Percy Falk's Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Olle Engkvist Byggmastare Foundation; Cancer and Allergy Foundation; Percy Falk's Foundation	The study was supported by grants from the Swedish Cancer Society, Swedish Research Council (K2008-54X-20639-01-3), Olle Engkvist Byggmastare Foundation, The Cancer and Allergy Foundation and Percy Falk's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Gunnarsson C, 2003, ONCOGENE, V22, P34, DOI 10.1038/sj.onc.1206078; Gunnarsson C, 2001, CANCER RES, V61, P8448; Gunnarsson C, 2008, BREAST CANCER RES TR, V108, P35, DOI 10.1007/s10549-007-9579-7; IINO Y, 1991, BRIT J CANCER, V64, P1019, DOI 10.1038/bjc.1991.457; Jansson A, 2009, CLIN CANCER RES, V15, P3610, DOI 10.1158/1078-0432.CCR-08-2599; Jansson AK, 2006, CANCER RES, V66, P11471, DOI 10.1158/0008-5472.CAN-06-1448; Khoshnoud MR, 2011, BREAST CANC RES TREA; Labrie F, 1995, ANN NY ACAD SCI, V774, P16, DOI 10.1111/j.1749-6632.1995.tb17369.x; LONNING PE, 1990, J STEROID BIOCHEM, V35, P355, DOI 10.1016/0022-4731(90)90241-J; Lukacik P, 2007, BIOCHEM J, V402, P419, DOI 10.1042/BJ20061319; Oduwole OO, 2004, CANCER RES, V64, P7604, DOI 10.1158/0008-5472.CAN-04-0446; Pasqualini JR, 2009, MATURITAS, V62, P343, DOI 10.1016/j.maturitas.2008.12.008; Rutqvist LE, 2007, ACTA ONCOL, V46, P133, DOI 10.1080/02841860601034834; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900	18	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40568	10.1371/journal.pone.0040568	http://dx.doi.org/10.1371/journal.pone.0040568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792371	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800107
J	van der Heijden, K; Petersen, JM; Dubilier, N; Borowski, C				van der Heijden, Karina; Petersen, Jillian M.; Dubilier, Nicole; Borowski, Christian			Genetic Connectivity between North and South Mid-Atlantic Ridge Chemosynthetic Bivalves and Their Symbionts	PLOS ONE			English	Article							SEA HYDROTHERMAL VENT; SHRIMP RIMICARIS-EXOCULATA; EVOLUTIONARY RELATIONSHIPS; ENDOSYMBIOTIC BACTERIA; VESICOMYIDAE BIVALVIA; LARVAL DISPERSAL; MUSSELS BIVALVIA; DUAL SYMBIOSIS; FRACTURE-ZONE; HYBRID ZONE	Transform faults are geological structures that interrupt the continuity of mid-ocean ridges and can act as dispersal barriers for hydrothermal vent organisms. In the equatorial Atlantic Ocean, it has been hypothesized that long transform faults impede gene flow between the northern and the southern Mid-Atlantic Ridge (MAR) and disconnect a northern from a southern biogeographic province. To test if there is a barrier effect in the equatorial Atlantic, we examined phylogenetic relationships of chemosynthetic bivalves and their bacterial symbionts from the recently discovered southern MAR hydrothermal vents at 5 degrees S and 9 degrees S. We examined Bathymodiolus spp. mussels and Abyssogena southwardae clams using the mitochondrial cytochrome c oxidase subunit I (COI) gene as a phylogenetic marker for the hosts and the bacterial 16S rRNA gene as a marker for the symbionts. Bathymodiolus spp. from the two southern sites were genetically divergent from the northern MAR species B. azoricus and B. puteoserpentis but all four host lineages form a monophyletic group indicating that they radiated after divergence from their northern Atlantic sister group, the B. boomerang species complex. This suggests dispersal of Bathymodiolus species from north to south across the equatorial belt. 16S rRNA genealogies of chemoautotrophic and methanotrophic symbionts of Bathymodiolus spp. were inconsistent and did not match the host COI genealogy indicating disconnected biogeography patterns. The vesicomyid clam Abyssogena southwardae from 5 degrees S shared an identical COI haplotype with A. southwardae from the Logatchev vent field on the northern MAR and their symbionts shared identical 16S phylotypes, suggesting gene flow across the Equator. Our results indicate genetic connectivity between the northern and southern MAR and suggest that a strict dispersal barrier does not exist.	[van der Heijden, Karina; Petersen, Jillian M.; Dubilier, Nicole; Borowski, Christian] Max Planck Inst Marine Microbiol, Symbiosis Grp, Bremen, Germany	Max Planck Society	van der Heijden, K (corresponding author), Max Planck Inst Marine Microbiol, Symbiosis Grp, Bremen, Germany.	cborowsk@mpi-bremen.de	Petersen, Jillian/GVU-6351-2022; Petersen, Jillian/K-6066-2015; Dubilier, Nicole/I-8203-2018	Dubilier, Nicole/0000-0002-9394-825X; Petersen, Jillian/0000-0002-9852-3445	German Research Foundation (DFG) within the framework of the Program SPP 1144 "From Mantle to the Ocean: Energy-Material- and Life-Cycles at Spreading Axes'' [BO2500/2-1]; DFG Cluster of Excellence "The Ocean in the Earth System'' at MARUM, Bremen; Max Planck Society	German Research Foundation (DFG) within the framework of the Program SPP 1144 "From Mantle to the Ocean: Energy-Material- and Life-Cycles at Spreading Axes''(German Research Foundation (DFG)); DFG Cluster of Excellence "The Ocean in the Earth System'' at MARUM, Bremen; Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding was granted through the German Research Foundation (DFG, project no. BO2500/2-1) within the framework of the Program SPP 1144 "From Mantle to the Ocean: Energy-Material- and Life-Cycles at Spreading Axes'', the DFG Cluster of Excellence "The Ocean in the Earth System'' at MARUM, Bremen, and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano SM, 2009, BIOL BULL-US, V216, P149, DOI 10.1086/BBLv216n2p149; Bulgheresi S, 2011, ISME J, V5, P986, DOI 10.1038/ismej.2010.198; CANNAT M, 1991, J GEODYN, V13, P97, DOI 10.1016/0264-3707(91)90034-C; CARY SC, 1993, P NATL ACAD SCI USA, V90, P5695, DOI 10.1073/pnas.90.12.5695; DeChaine EG, 2006, ENVIRON MICROBIOL, V8, P1902, DOI 10.1111/j.1462-2920.2005.01113.x; Dekov V, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005526; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; ENDOW K, 1990, MAR ECOL PROG SER, V64, P309, DOI 10.3354/meps064309; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; German CR, 2008, EARTH PLANET SC LETT, V273, P332, DOI 10.1016/j.epsl.2008.06.048; Goffredi SK, 2003, MAR BIOL, V142, P311, DOI 10.1007/s00227-002-0941-3; Haase KM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001509; Haase KM, 2009, MAR GEOL, V266, P52, DOI 10.1016/j.margeo.2009.07.012; HEEZEN BC, 1964, DEEP-SEA RES, V11, P11, DOI 10.1016/0011-7471(64)91079-4; Hein J., 1999, EXPLOR MIN GEOL, V8, P299; Hurtado LA, 2003, APPL ENVIRON MICROB, V69, P2058, DOI 10.1128/AEM.69.4.2058-2064.2003; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; JOLLIVET D, 1995, HEREDITY, V74, P376, DOI 10.1038/hdy.1995.56; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Kojima S, 2004, MOL PHYLOGENET EVOL, V32, P396, DOI 10.1016/j.ympev.2004.02.016; Krylova EM, 2010, J MOLLUS STUD, V76, P107, DOI 10.1093/mollus/eyp052; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Le Pennec M, 1988, J SHELLFISH RES, V7, P483; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; LUTZ RA, 1984, SCIENCE, V226, P1451, DOI 10.1126/science.226.4681.1451; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Mercier H, 1998, J PHYS OCEANOGR, V28, P779, DOI 10.1175/1520-0485(1998)028<0779:TOBWIT>2.0.CO;2; Miyazaki JI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010363; Mullineaux LS, 2002, CAH BIOL MAR, V43, P281; MULLINEAUX LS, 1995, GEOPHYS MONOGR SER, V91, P408; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Peek AS, 2000, J MOL EVOL, V50, P141, DOI 10.1007/s002399910016; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Peek AS, 1998, MOL BIOL EVOL, V15, P1514, DOI 10.1093/oxfordjournals.molbev.a025879; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; Petersen JM, 2009, ENV MICROBIOL REP, V1, P319, DOI 10.1111/j.1758-2229.2009.00081.x; Plouviez S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-220; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; Shank T, 2004, OCEANUS, V42, P78; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Smith CR, 1998, CAH BIOL MAR, V39, P345; Stewart FJ, 2008, MOL BIOL EVOL, V25, P673, DOI 10.1093/molbev/msn010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Tyler PA, 2003, HYDROBIOLOGIA, V503, P9, DOI 10.1023/B:HYDR.0000008492.53394.6b; Tyler PA, 2002, OCEANOL ACTA, V25, P227, DOI 10.1016/S0399-1784(02)01202-1; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Won Y, 2003, MOL ECOL, V12, P3185, DOI 10.1046/j.1365-294X.2003.01974.x; Won Y, 2003, MOL ECOL, V12, P169, DOI 10.1046/j.1365-294X.2003.01726.x; Won YJ, 2002, CAH BIOL MAR, V43, P387; Won YJ, 2003, APPL ENVIRON MICROB, V69, P6785, DOI 10.1128/AEM.69.11.6785-6792.2003; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2	73	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39994	10.1371/journal.pone.0039994	http://dx.doi.org/10.1371/journal.pone.0039994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792208	gold, Green Submitted, Green Published			2022-12-27	WOS:000306461800030
J	Xiao, B; Huang, YS; Zhang, LZ; Lin, ZB; Wang, GF				Xiao, Bin; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu			Growth, Structure and Spectroscopic Characterization of Nd3+-Doped KBaGd(WO4)(3) Crystal with a Disordered Structure	PLOS ONE			English	Article							OPTICAL SPECTROSCOPY; ND-YAG; LASER; INTENSITIES; ABSORPTION	The undoped and the Nd3+:KBaGd(WO4)(3) crystals were grown by the top seeded solution growth (TSSG) method from a flux of K2W2O7. The structure of the pure crystal was determined by the single-crystal X-ray diffraction method. It crystallizes in the monoclinic symmetry with space group C2/c. In the structure, K+ and Ba2+ ions share the same 8f site with occupancy of 0.464 and 0.536, respectively. The investigation of spectral properties of Nd3+: KBaGd(WO4)(3) crystal indicates that it exhibits broad absorption and emission bands, which are attributed to locally disordered environments around the Nd3+ centers. The broad absorption band is suitable for diode laser pumping.	[Xiao, Bin; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu] Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China; [Xiao, Bin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiao, B (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China.	wgf@ms.fjirsm.ac.cn		Xiao, Bin/0000-0001-8512-0340	National Natural Science Foundation of China [61108054]; National Natural Science Foundation of Fujian Province [2011J01376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work is supported by the National Natural Science Foundation of China (No. 61108054) and the National Natural Science Foundation of Fujian Province (No. 2011J01376), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULL BF, 1982, IEEE J QUANTUM ELECT, V18, P925, DOI 10.1109/JQE.1982.1071611; BELRUSS V, 1971, MATER RES BULL, V6, P899, DOI 10.1016/0025-5408(71)90068-7; Cano-Torres JM, 2006, J OPT SOC AM B, V23, P2494, DOI 10.1364/JOSAB.23.002494; Cascales C, 2005, OPT MATER, V27, P1672, DOI 10.1016/j.optmat.2004.11.051; Cavalli E, 1999, J OPT SOC AM B, V16, P1958, DOI 10.1364/JOSAB.16.001958; Chen YJ, 2004, CHEM PHYS LETT, V397, P282, DOI 10.1016/j.cplett.2004.09.002; Garcia-Cortes A, 2008, APPL PHYS B-LASERS O, V91, P507, DOI 10.1007/s00340-008-3041-3; GIESEN A, 1994, APPL PHYS B-LASERS O, V58, P365, DOI 10.1007/BF01081875; Huang XY, 2009, J ALLOY COMPD, V468, P321, DOI 10.1016/j.jallcom.2007.12.091; JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750; Kaminsky W, 2007, J APPL CRYSTALLOGR, V40, P382, DOI 10.1107/S0021889807003986; Korotkov AS, 2010, J PHYS CHEM SOLIDS, V71, P958, DOI 10.1016/j.jpcs.2010.04.002; Li H, 2010, CRYSTENGCOMM, V12, P1307, DOI 10.1039/b914641e; Li H, 2009, J ALLOY COMPD, V478, P484, DOI 10.1016/j.jallcom.2008.11.079; Lu J, 2000, APPL PHYS B-LASERS O, V71, P469, DOI 10.1007/s003400000394; Meng XM, 2011, CRYSTENGCOMM, V13, P4069, DOI 10.1039/c0ce00922a; Minassian A, 2003, APPL PHYS B-LASERS O, V76, P341, DOI 10.1007/s00340-003-1095-9; OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366; Pujol MC, 1999, APPL PHYS B-LASERS O, V68, P187, DOI 10.1007/s003400050605; RAZEGHI M, 1994, NATURE, V369, P631, DOI 10.1038/369631a0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Song J, 1999, APPL OPTICS, V38, P5158, DOI 10.1364/AO.38.005158; Wang CQ, 2000, APPL PHYS B-LASERS O, V70, P769, DOI 10.1007/PL00021132; Zhou W.-L., 1997, OSA Trends in Optics and Photonics Series. Vol.10 Advanced Solid State Lasers. From the Topical Meeting, P451; Zhu HM, 2007, J OPT SOC AM B, V24, P2659, DOI 10.1364/JOSAB.24.002659	25	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40229	10.1371/journal.pone.0040229	http://dx.doi.org/10.1371/journal.pone.0040229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792248	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800053
J	Quesada, A; Vargas, F; Montoro-Molina, S; O'Valle, F; Rodriguez-Martinez, MD; Osuna, A; Prieto, I; Ramirez, M; Wangensteen, R				Quesada, Andres; Vargas, Felix; Montoro-Molina, Sebastian; O'Valle, Francisco; Dolores Rodriguez-Martinez, Maria; Osuna, Antonio; Prieto, Isabel; Ramirez, Manuel; Wangensteen, Rosemary			Urinary Aminopeptidase Activities as Early and Predictive Biomarkers of Renal Dysfunction in Cisplatin-Treated Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ALANINE AMINOPEPTIDASE; THYROID-DISORDERS; DIAGNOSTIC-VALUE; TUBULAR INJURY; NEPHROTOXICITY; ENZYMURIA; MARKER; MICROALBUMINURIA; GLUCOSAMINIDASE	This study analyzes the fluorimetric determination of alanyl- (Ala), glutamyl- (Glu), leucyl-cystinyl- (Cys) and aspartyl-aminopeptidase (AspAp) urinary enzymatic activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats. Male Wistar rats (n = 8 each group) received a single subcutaneous injection of either saline or cisplatin 3.5 or 7 mg/kg, and urine samples were taken at 0, 1, 2, 3 and 14 days after treatment. In urine samples we determined Ala, Glu, Cys and AspAp activities, proteinuria, N-acetyl-beta-D-glucosaminidase (NAG), albumin, and neutrophil gelatinase-associated lipocalin (NGAL). Plasma creatinine, creatinine clearance and renal morphological variables were measured at the end of the experiment. CysAp, NAG and albumin were increased 48 hours after treatment in the cisplatin 3.5 mg/kg treated group. At 24 hours, all urinary aminopeptidase activities and albuminuria were significantly increased in the cisplatin 7 mg/kg treated group. Aminopeptidase urinary activities correlated (p<0.011; r(2)>0.259) with plasma creatinine, creatinine clearance and/or kidney weight/body weight ratio at the end of the experiment and they could be considered as predictive biomarkers of renal injury severity. ROC-AUC analysis was made to study their sensitivity and specificity to distinguish between treated and untreated rats at day 1. All aminopeptidase activities showed an AUC>0.633. We conclude that Ala, Cys, Glu and AspAp enzymatic activities are early and predictive urinary biomarkers of the renal dysfunction induced by cisplatin. These determinations can be very useful in the prognostic and diagnostic of renal dysfunction in preclinical research and clinical practice.	[Quesada, Andres; Montoro-Molina, Sebastian; Prieto, Isabel; Ramirez, Manuel; Wangensteen, Rosemary] Univ Jaen, Dept Ciencias Salud, Area Fisiol, Jaen, Spain; [Vargas, Felix] Univ Granada, Fac Med, Dept Fisiol, Granada, Spain; [O'Valle, Francisco; Dolores Rodriguez-Martinez, Maria] Univ Granada, IBIMER Granada, Fac Med, Dept Anat Patol, E-18071 Granada, Spain; [Osuna, Antonio] Hosp Virgen de las Nieves, Serv Nefrol, Granada, Spain	Universidad de Jaen; University of Granada; University of Granada; Hospital Universitario Virgen de las Nieves	Quesada, A (corresponding author), Univ Jaen, Dept Ciencias Salud, Area Fisiol, Jaen, Spain.	rwangens@ujaen.es	OValle, Francisco/AAA-9151-2019; Prieto, Isabel/H-7463-2015; Osuna, Antonio/H-1896-2015; Wangensteen, Rosemary/M-9856-2015	Prieto, Isabel/0000-0003-0624-9504; Wangensteen, Rosemary/0000-0001-7161-9925; Quesada, Andres/0000-0002-9584-5756; Montoro-Molina, Sebastian/0000-0003-3683-3357	University of Jaen [R1/12/2010/66]; Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal) [REDinREN RD06/0016/0017, RD07/0016/2008]; "FEDER una manera de hacer Europa"	University of Jaen; Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal); "FEDER una manera de hacer Europa"	This study was supported by a grant (R1/12/2010/66) from the University of Jaen with the participation of Caja Rural of Jaen, and from the Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal, REDinREN RD06/0016/0017 and RD07/0016/2008), "FEDER una manera de hacer Europa." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiston AL, 2011, REGUL PEPTIDES, V166, P83, DOI 10.1016/j.regpep.2010.09.003; Bazzi C, 2002, NEPHROL DIAL TRANSPL, V17, P1890, DOI 10.1093/ndt/17.11.1890; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Eng J, 2006, ROC ANAL WEB BASED C; Glassock RJ, 2010, CURR HYPERTENS REP, V12, P364, DOI 10.1007/s11906-010-0133-3; Holdt B, 2008, CLIN CHEM LAB MED, V46, P537, DOI 10.1515/CCLM.2008.103; Inselmann G, 2003, MYCOSES, V46, P169, DOI 10.1046/j.1439-0507.2003.00856.x; Kawai Y, 2009, J PHARMACOL SCI, V111, P433, DOI 10.1254/jphs.09185FP; KENNY AJ, 1982, PHYSIOL REV, V62, P91, DOI 10.1152/physrev.1982.62.1.91; Kuzniar J, 2006, INT UROL NEPHROL, V38, P753, DOI 10.1007/s11255-006-0052-z; Lazarevic G, 2007, RENAL FAILURE, V29, P199, DOI 10.1080/08860220601098870; Lisowska-Myjak B, 2010, BLOOD PURIFICAT, V29, P357, DOI 10.1159/000309421; Marchewka Z, 2009, TRANSPL P, V41, P1660, DOI 10.1016/j.transproceed.2009.01.116; Masseroli M, 1998, LAB INVEST, V78, P511; Mitic B, 2008, RENAL FAILURE, V30, P896, DOI 10.1080/08860220802359048; Molitoris BA, 2007, J AM SOC NEPHROL, V18, P1992, DOI 10.1681/ASN.2007050567; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Naghibi B, 2007, J NEPHROL, V20, P482; Perez-Abud R, 2011, AM J PHYSIOL-ENDOC M, V301, pE281, DOI 10.1152/ajpendo.00690.2010; PETERS JE, 1972, CLIN CHIM ACTA, V37, P213, DOI 10.1016/0009-8981(72)90436-6; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; SAFIRSTEIN R, 1987, INT J ANDROL, V10, P325, DOI 10.1111/j.1365-2605.1987.tb00200.x; Segarra AB, 2006, HORM METAB RES, V38, P48, DOI 10.1055/s-2006-924978; SONG LJ, 1994, AM J PHYSIOL-RENAL, V267, pF546, DOI 10.1152/ajprenal.1994.267.4.F546; Spasovski D, 2011, CLIN LAB, V57, P305; SWEAT F, 1964, ARCH PATHOL, V78, P69; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; WINSTON JA, 1985, AM J PHYSIOL, V249, pF490, DOI 10.1152/ajprenal.1985.249.4.F490; Yang CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/759313; Yu Y, 2010, NAT BIOTECHNOL, V28, P470, DOI 10.1038/nbt.1624	33	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40402	10.1371/journal.pone.0040402	http://dx.doi.org/10.1371/journal.pone.0040402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792302	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300063
J	Takazawa, T; Croft, GF; Amoroso, MW; Studer, L; Wichterle, H; MacDermott, AB				Takazawa, Tomonori; Croft, Gist F.; Amoroso, Mackenzie W.; Studer, Lorenz; Wichterle, Hynek; MacDermott, Amy B.			Maturation of Spinal Motor Neurons Derived from Human Embryonic Stem Cells	PLOS ONE			English	Article							SPIKE-FREQUENCY ADAPTATION; IN-VITRO; DIRECTED DIFFERENTIATION; GENIOGLOSSAL MOTONEURONS; HORSERADISH-PEROXIDASE; QUANTITATIVE-ANALYSIS; PHRENIC MOTONEURONS; FIRING PROPERTIES; RAT; CORD	Our understanding of motor neuron biology in humans is derived mainly from investigation of human postmortem tissue and more indirectly from live animal models such as rodents. Thus generation of motor neurons from human embryonic stem cells and human induced pluripotent stem cells is an important new approach to model motor neuron function. To be useful models of human motor neuron function, cells generated in vitro should develop mature properties that are the hallmarks of motor neurons in vivo such as elaborated neuronal processes and mature electrophysiological characteristics. Here we have investigated changes in morphological and electrophysiological properties associated with maturation of neurons differentiated from human embryonic stem cells expressing GFP driven by a motor neuron specific reporter (Hb9::GFP) in culture. We observed maturation in cellular morphology seen as more complex neurite outgrowth and increased soma area over time. Electrophysiological changes included decreasing input resistance and increasing action potential firing frequency over 13 days in vitro. Furthermore, these human embryonic stem cell derived motor neurons acquired two physiological characteristics that are thought to underpin motor neuron integrated function in motor circuits; spike frequency adaptation and rebound action potential firing. These findings show that human embryonic stem cell derived motor neurons develop functional characteristics typical of spinal motor neurons in vivo and suggest that they are a relevant and useful platform for studying motor neuron development and function and for modeling motor neuron diseases.	[Takazawa, Tomonori; MacDermott, Amy B.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek; MacDermott, Amy B.] Columbia Univ, Dept Neurosci, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek] Columbia Univ, Dept Pathol, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek] Columbia Univ, Dept Neurol, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY USA; [Croft, Gist F.; Wichterle, Hynek] Columbia Univ, Columbia Stem Cell Initiat, New York, NY USA; [Takazawa, Tomonori; Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek; MacDermott, Amy B.] Jenifer Estess Lab Stem Cell Res, Project ALS, New York, NY USA; [Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center	Takazawa, T (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.	abm1@columbia.edu	Studer, Lorenz/ABH-1491-2021; Takazawa, Tomonori/H-9332-2019	Studer, Lorenz/0000-0003-0741-7987; Takazawa, Tomonori/0000-0002-0119-3532; Croft, Gist/0000-0002-9721-0148; Mathis, Mackenzie/0000-0001-7368-4456; Wichterle, Hynek/0000-0002-7817-0080	Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research; P2 ALS; NYSTEM [CO24415]; Dr. Leigh G. Cascarilla Post-Doctoral Fellowships in Stem Cell Research; National Institutes of Health [1RC2NS069395]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069395] Funding Source: NIH RePORTER	Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research; P2 ALS; NYSTEM; Dr. Leigh G. Cascarilla Post-Doctoral Fellowships in Stem Cell Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research; P2 ALS; NYSTEM grant CO24415; The Dr. Leigh G. Cascarilla Post-Doctoral Fellowships in Stem Cell Research; National Institutes of Health 1RC2NS069395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman J, 2001, DEV HUMAN SPINAL COR; Bertrand S, 1998, J NEUROPHYSIOL, V79, P342, DOI 10.1152/jn.1998.79.1.342; Brownstone RM, 2006, PROG NEUROBIOL, V78, P156, DOI 10.1016/j.pneurobio.2006.04.002; Brownstone RM, 2011, J NEUROPHYSIOL, V105, P1045, DOI 10.1152/jn.00411.2010; Burke RE, 1996, J COMP NEUROL, V372, P465; CAMERON WE, 1985, J COMP NEUROL, V231, P91, DOI 10.1002/cne.902310108; Carrascal L, 2005, BRAIN RES REV, V49, P377, DOI 10.1016/j.brainresrev.2005.02.003; CULLHEIM S, 1987, J COMP NEUROL, V255, P68, DOI 10.1002/cne.902550106; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Gao BX, 1998, J NEUROPHYSIOL, V80, P3047, DOI 10.1152/jn.1998.80.6.3047; Gorman RB, 2005, J COMP PHYSIOL A, V191, P583, DOI 10.1007/s00359-005-0612-1; GRANIT R, 1963, J PHYSIOL-LONDON, V168, P911, DOI 10.1113/jphysiol.1963.sp007230; Hinckley CA, 2005, J NEUROPHYSIOL, V93, P1439, DOI 10.1152/jn.00647.2004; Kuo JJ, 2004, J NEUROPHYSIOL, V91, P571, DOI 10.1152/jn.00665.2003; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li Y, 2005, J COMP NEUROL, V483, P304, DOI 10.1002/cne.20438; MACDERMOTT AB, 1986, DEV BIOL, V113, P317, DOI 10.1016/0012-1606(86)90167-3; Manuel M, 2009, J NEUROSCI, V29, P11246, DOI 10.1523/JNEUROSCI.3260-09.2009; Martin-Caraballo M, 2001, J NEUROBIOL, V46, P231, DOI 10.1002/1097-4695(200103)46:4<231::AID-NEU1005>3.0.CO;2-U; Martin-Caraballo M, 1999, J NEUROPHYSIOL, V81, P1365, DOI 10.1152/jn.1999.81.3.1365; Meehan CF, 2010, J NEUROPHYSIOL, V103, P2599, DOI 10.1152/jn.00668.2009; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Miles GB, 2005, J PHYSIOL-LONDON, V566, P519, DOI 10.1113/jphysiol.2005.086033; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; NUNEZABADES PA, 1995, J COMP NEUROL, V353, P129, DOI 10.1002/cne.903530112; NUNEZABADES PA, 1993, J NEUROPHYSIOL, V70, P1401, DOI 10.1152/jn.1993.70.4.1401; Patani R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1216; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Placantonakis Dimitris G, 2009, Clin Neurosurg, V56, P125; Powers RK, 1999, J PHYSIOL-PARIS, V93, P101, DOI 10.1016/S0928-4257(99)80141-7; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; ROBERTS A, 1990, EUR J NEUROSCI, V2, P11, DOI 10.1111/j.1460-9568.1990.tb00377.x; ROSE PK, 1985, J COMP NEUROL, V239, P89, DOI 10.1002/cne.902390108; SINGH RN, 2005, EXP NEUROL, V196, P224, DOI DOI 10.1016/J.EXPNEUROL.2005.06.021; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; STEIN RB, 1979, BRAIN RES, V175, P372, DOI 10.1016/0006-8993(79)91019-9; Takazawa T, 2004, J NEUROPHYSIOL, V92, P3106, DOI 10.1152/jn.00494.2004; VIANA F, 1994, NEUROSCIENCE, V59, P131, DOI 10.1016/0306-4522(94)90105-8; VIANA F, 1993, J NEUROPHYSIOL, V69, P2137, DOI 10.1152/jn.1993.69.6.2137; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; ZISKINDCONHAIM L, 1988, DEV BIOL, V128, P21, DOI 10.1016/0012-1606(88)90262-X	44	53	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40154	10.1371/journal.pone.0040154	http://dx.doi.org/10.1371/journal.pone.0040154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802953	Green Submitted, gold, Green Published			2022-12-27	WOS:000306186900027
J	Wu, KC; Cui, JY; Klaassen, CD				Wu, Kai Connie; Cui, Julia Yue; Klaassen, Curtis D.			Effect of Graded Nrf2 Activation on Phase-I and -II Drug Metabolizing Enzymes and Transporters in Mouse Liver	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; GLUTATHIONE-S-TRANSFERASE; XENOBIOTIC TRANSPORTERS; SUBSTRATE-SPECIFICITY; KEAP1-KNOCKDOWN MICE; ALDEHYDE REDUCTASE; BILIARY-EXCRETION; CELLULAR DEFENSE; MESSENGER-RNA; GENE BATTERY	Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that induces a battery of cytoprotective genes in response to oxidative/electrophilic stress. Kelch-like ECH associating protein 1 (Keap1) sequesters Nrf2 in the cytosol. The purpose of this study was to investigate the role of Nrf2 in regulating the mRNA of genes encoding drug metabolizing enzymes and xenobiotic transporters. Microarray analysis was performed in livers of Nrf2-null, wild-type, Keap1-knockdown mice with increased Nrf2 activation, and Keap1-hepatocyte knockout mice with maximum Nrf2 activation. In general, Nrf2 did not have a marked effect on uptake transporters, but the mRNAs of organic anion transporting polypeptide 1a1, sodium taurocholate cotransporting polypeptide, and organic anion transporter 2 were decreased with Nrf2 activation. The effect of Nrf2 on cytochrome P450 (Cyp) genes was minimal, with only Cyp2a5, Cyp2c50, Cyp2c54, and Cyp2g1 increased, and Cyp2u1 decreased with enhanced Nrf2 activation. However, Nrf2 increased mRNA of many other phase-I enzymes, such as aldo-keto reductases, carbonyl reductases, and aldehyde dehydrogenase 1. Many genes involved in phase-II drug metabolism were induced by Nrf2, including glutathione S-transferases, UDP-glucuronosyltransferases, and UDP-glucuronic acid synthesis enzymes. Efflux transporters, such as multidrug resistance-associated proteins, breast cancer resistant protein, as well as ATP-binding cassette g5 and g8 were induced by Nrf2. In conclusion, Nrf2 markedly alters hepatic mRNA of a large number of drug metabolizing enzymes and xenobiotic transporters, and thus Nrf2 plays a central role in xenobiotic metabolism and detoxification.	[Wu, Kai Connie; Cui, Julia Yue; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Wu, KC (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	cklaasse@kumc.edu	Wu, Kai/I-2202-2013		National Institutes of Health [DK-081461, ES-009716, RR-021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is supported by National Institutes of Health grants DK-081461, ES-009716, and RR-021940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Bakar A, 2007, DRUG METAB DISPOS, V35, P787, DOI 10.1124/dmd.106.014423; Alnouti Y, 2008, TOXICOL SCI, V101, P51, DOI 10.1093/toxsci/kfm280; Anwar-Mohamed A, 2011, TOXICOL IN VITRO, V25, P785, DOI 10.1016/j.tiv.2011.01.014; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cheng QQ, 2011, J BIOCHEM MOL TOXIC, V25, P320, DOI 10.1002/jbt.20392; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; Ebert B, 2010, BIOCHEMISTRY-US, V49, P8499, DOI 10.1021/bi100814d; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Gardner R, 2004, TOXICOL LETT, V148, P65, DOI 10.1016/j.toxlet.2003.12.056; Gu J, 1998, J PHARMACOL EXP THER, V285, P1287; Hinshelwood A, 2002, FEBS LETT, V523, P213, DOI 10.1016/S0014-5793(02)02982-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; Jansen PJ, 2006, BBA-MOL CELL BIOL L, V1761, P445, DOI 10.1016/j.bbalip.2006.03.015; Kassner N, 2008, DRUG METAB DISPOS, V36, P2113, DOI 10.1124/dmd.108.022251; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Klaassen CD, 2008, TOXICOL SCI, V101, P186, DOI 10.1093/toxsci/kfm214; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lamsa V, 2010, CHEM RES TOXICOL, V23, P977, DOI 10.1021/tx100084c; Lu H, 2010, TOXICOL SCI, V118, P380, DOI 10.1093/toxsci/kfq280; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Maher JM, 2007, HEPATOLOGY, V46, P1597, DOI 10.1002/hep.21831; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; MCLELLAN LI, 1994, BIOCHEM J, V300, P117, DOI 10.1042/bj3000117; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Nishinaka T, 2005, J PHARMACOL SCI, V97, P43, DOI 10.1254/jphs.FP0040404; Novak RF, 2000, ARCH PHARM RES, V23, P267, DOI 10.1007/BF02975435; Nunoya K, 1995, XENOBIOTICA, V25, P1283, DOI 10.3109/00498259509061917; Okada K, 2008, AM J PHYSIOL-GASTR L, V295, pG735, DOI 10.1152/ajpgi.90321.2008; Pilka ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007113; Reisman SA, 2009, TOXICOL SCI, V109, P24, DOI 10.1093/toxsci/kfp045; Reisman SA, 2009, TOXICOL SCI, V109, P31, DOI 10.1093/toxsci/kfp047; Reisman SA, 2009, BIOCHEM PHARMACOL, V77, P1273, DOI 10.1016/j.bcp.2008.12.028; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Short DM, 2006, TOXICOL APPL PHARM, V210, P163, DOI 10.1016/j.taap.2005.09.017; Singh S, 2010, INT J BIOCHEM CELL B, V42, P1105, DOI 10.1016/j.biocel.2010.01.022; Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Yokota SI, 2010, BIOCH PHARM; Zamek-Gliszczynski MJ, 2006, MOL PHARMACOL, V70, P2127, DOI 10.1124/mol.106.026955	49	99	102	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39006	10.1371/journal.pone.0039006	http://dx.doi.org/10.1371/journal.pone.0039006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808024	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400007
J	Comeros-Raynal, MT; Choat, JH; Polidoro, BA; Clements, KD; Abesamis, R; Craig, MT; Lazuardi, ME; McIlwain, J; Muljadi, A; Myers, RF; Nanola, CL; Pardede, S; Rocha, LA; Russell, B; Sanciangco, JC; Stockwell, B; Harwell, H; Carpenter, KE				Comeros-Raynal, Mia T.; Choat, John Howard; Polidoro, Beth A.; Clements, Kendall D.; Abesamis, Rene; Craig, Matthew T.; Lazuardi, Muhammad Erdi; McIlwain, Jennifer; Muljadi, Andreas; Myers, Robert F.; Nanola, Cleto L., Jr.; Pardede, Shinta; Rocha, Luiz A.; Russell, Barry; Sanciangco, Jonnell C.; Stockwell, Brian; Harwell, Heather; Carpenter, Kent E.			The Likelihood of Extinction of Iconic and Dominant Herbivores and Detritivores of Coral Reefs: The Parrotfishes and Surgeonfishes	PLOS ONE			English	Article							IUCN RED LIST; CLIMATE-CHANGE; PHASE-SHIFTS; HABITAT DEGRADATION; MARINE RESERVE; BOLBOMETOPON-MURICATUM; STOPLIGHT PARROTFISH; EVOLUTIONARY HISTORY; CHEILINUS-UNDULATUS; NUTRITIONAL ECOLOGY	Parrotfishes and surgeonfishes perform important functional roles in the dynamics of coral reef systems. This is a consequence of their varied feeding behaviors ranging from targeted consumption of living plant material (primarily surgeonfishes) to feeding on detrital aggregates that are either scraped from the reef surface or excavated from the deeper reef substratum (primarily parrotfishes). Increased fishing pressure and widespread habitat destruction have led to population declines for several species of these two groups. Species-specific data on global distribution, population status, life history characteristics, and major threats were compiled for each of the 179 known species of parrotfishes and surgeonfishes to determine the likelihood of extinction of each species under the Categories and Criteria of the IUCN Red List of Threatened Species. Due in part to the extensive distributions of most species and the life history traits exhibited in these two families, only three (1.7%) of the species are listed at an elevated risk of global extinction. The majority of the parrotfishes and surgeonfishes (86%) are listed as Least Concern, 10% are listed as Data Deficient and 1% are listed as Near Threatened. The risk of localized extinction, however, is higher in some areas, particularly in the Coral Triangle region. The relatively low proportion of species globally listed in threatened Categories is highly encouraging, and some conservation successes are attributed to concentrated conservation efforts. However, with the growing realization of man's profound impact on the planet, conservation actions such as improved marine reserve networks, more stringent fishing regulations, and continued monitoring of the population status at the species and community levels are imperative for the prevention of species loss in these groups of important and iconic coral reef fishes.	[Comeros-Raynal, Mia T.; Polidoro, Beth A.; Sanciangco, Jonnell C.; Harwell, Heather; Carpenter, Kent E.] Old Dominion Univ, IUCN Species Programme, SSC Marine Biodivers Unit Global Marine Species A, Norfolk, VA 23529 USA; [Choat, John Howard] James Cook Univ, Sch Marine Biol & Aquaculture, Townsville, Qld 4811, Australia; [Clements, Kendall D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Abesamis, Rene] Silliman Univ, Dumaguete, Negros Oriental, Philippines; [Craig, Matthew T.] Univ San Diego, Dept Marine Sci & Environm Studies, San Diego, CA 92110 USA; [Lazuardi, Muhammad Erdi] Conservat Int, Denpasar, Bali, Indonesia; [McIlwain, Jennifer] Curtin Univ Technol, Dept Environm & Agr, Perth, WA, Australia; [Muljadi, Andreas] Coral Triangle Ctr, Sanur, Bali, Indonesia; [Myers, Robert F.] Coral Graph, Wellington, FL USA; [Nanola, Cleto L., Jr.] Univ Philippines Mindanao, Coll Sci & Math, Davao, Philippines; [Pardede, Shinta] Wildlife Conservat Soc, Indonesia Marine Program, Bogor, Jawa Barat, Indonesia; [Rocha, Luiz A.] Calif Acad Sci, San Francisco, CA 94118 USA; [Russell, Barry] Charles Darwin Univ, Arafura Timor Res Facil C, Sch Environm & Life Sci, Brinkin, NT, Australia	Old Dominion University; James Cook University; University of Auckland; Silliman University; University of San Diego; Conservation International - Indonesia; Curtin University; University of the Philippines System; University of the Philippines Mindanao; Wildlife Conservation Society - Indonesia; California Academy of Sciences; Charles Darwin University	Comeros-Raynal, MT (corresponding author), Old Dominion Univ, IUCN Species Programme, SSC Marine Biodivers Unit Global Marine Species A, Norfolk, VA 23529 USA.	mcome003@odu.edu	Rocha, Luiz/T-6326-2019; Rocha, Luiz/C-5107-2011; Abesamis, Rene A./AAE-1917-2022; McIlwain, Jennifer L/J-9179-2012	Abesamis, Rene A./0000-0001-7456-1415; McIlwain, Jennifer L/0000-0002-7790-5081; Clements, Kendall/0000-0001-8512-5977; Lazuardi, Muhammad Erdi/0000-0001-8964-8898; Rocha, Luiz/0000-0003-4011-569X; Comeros-Raynal, Mia Theresa/0000-0002-5087-8984; Sanciangco, Jonnell Cueto/0000-0001-8268-3180	New Hampshire Charitable Foundation	New Hampshire Charitable Foundation	This research was supported by core funding from Tom Haas and the New Hampshire Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Allen GR, 2002, ENVIRON BIOL FISH, V65, P209, DOI 10.1023/A:1020093012502; [Anonymous], 2005, STATE CORAL REEF ECO; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Aswani S, 2004, ENVIRON CONSERV, V31, P1; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barber PH, 2006, EVOLUTION, V60, P1825; Bellwood DR, 2011, CORAL REEFS, V30, P549, DOI 10.1007/s00338-011-0738-2; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bernal MA, 2011, ZOOTAXA, P63; Breslauer G., 1991, DUAL CITY RESTRUCTUR, P3, DOI DOI 10.4095/134069; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Burke L., 2011, REEFS RISK REVISITED; Burkepile DE, 2011, CORAL REEFS, V30, P351, DOI 10.1007/s00338-011-0726-6; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burt J, 2008, MAR BIOL, V154, P27, DOI 10.1007/s00227-007-0892-9; BUTLER JN, 1993, ENVIRONMENT, V35, P6, DOI 10.1080/00139157.1993.9929067; Caicos GoTa, 2011, FISHERIES PROTECTION, P3; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Carpenter KE, 2010, J MAR BIOL, V2011, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cesar H., 2003, EC WORLDWIDE CORAL R; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Choat JH, 2006, MAR ECOL PROG SER, V318, P237, DOI 10.3354/meps318237; Choat J.H., 1991, P120; Choat JH, 2003, MAR ECOL PROG SER, V246, P265, DOI 10.3354/meps246265; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Choat JH, 2009, CHLORURUS BLEEKERI I; Claisse JT, 2009, MAR ECOL PROG SER, V389, P245, DOI 10.3354/meps08114; Clements KD, 2004, MOL PHYLOGENET EVOL, V32, P575, DOI 10.1016/j.ympev.2004.02.003; CLEMENTS KD, 1995, PHYSIOL ZOOL, V68, P355, DOI 10.1086/physzool.68.3.30163774; CLEMENTS KD, 1994, J COMP PHYSIOL B, V164, P372, DOI 10.1007/BF00302552; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Colin PL, 2012, REEF FISH SPAWNING A, P526; Council CFM, 2010, 2010 CAR ANN CAT 622; Crossman DJ, 2005, MAR ECOL PROG SER, V296, P129, DOI 10.3354/meps296129; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; Debrot D., 2008, P 60 GULF CAR FISH I, P335; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; Donaldson TJ, 2004, ENVIRON BIOL FISH, V70, P373, DOI 10.1023/B:EBFI.0000035509.89614.1e; Dulvy Nicholas K., 2009, P129; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Ferreira B, 2008, SCARUS TRISPINOSUS I; Ferreira CEL, 2006, J FISH BIOL, V69, P1533, DOI 10.1111/j.1095-8649.2006.01220.x; Ferreira CE, 2008, SCARUS GUACAMAIA IUC; Ferreira CEL, 2005, CORAL REEFS, V24, P128, DOI 10.1007/s00338-004-0459-x; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gillett R., 2006, SPEARFISHING PACIFIC; Gochfeld DJ, 2010, MAR ECOL PROG SER, V398, P137, DOI 10.3354/meps08302; Graham NAJ, 2005, CORAL REEFS, V24, P118, DOI 10.1007/s00338-004-0466-y; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Green A.L., 2009, MONITORING FUNCTIONA; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamilton R., 2003, PUTTING FISHERS KNOW, P68; Hamilton RJ, 2008, CORAL REEFS, V27, P153, DOI 10.1007/s00338-007-0304-0; Hamilton RJ, 2012, FISH FISHERIES SERIE, P490; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; IUCN, 2003, GUID APPL IUCN RED L; (IUCN) IUfCoN, 2012, CLASS SCHEM VERS 3 0; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 1999, CONSERV BIOL, V13, P1466, DOI 10.1046/j.1523-1739.1999.98324.x; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; Kronen M, 2012, OCEAN COAST MANAGE, V55, P63, DOI 10.1016/j.ocecoaman.2011.07.011; Lavides MN, 2009, ENVIRON CONSERV, V36, P235, DOI 10.1017/S0376892909990385; Lawson GL, 1999, ENVIRON BIOL FISH, V54, P19, DOI 10.1023/A:1007477527663; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCormick MI, 2010, CORAL REEFS, V29, P537, DOI 10.1007/s00338-010-0620-7; McManus JW, 2000, ICES J MAR SCI, V57, P572, DOI 10.1006/jmsc.2000.0720; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Montero R, 2009, FISHERIES NASSAU GRO; Mountfort DO, 2002, APPL ENVIRON MICROB, V68, P1374, DOI 10.1128/AEM.68.3.1374-1380.2002; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Mumby PJ, 2012, MARINE ECOLOGY PROGR, V445; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Nanola CL, 2011, ENVIRON BIOL FISH, V90, P405, DOI 10.1007/s10641-010-9750-6; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Parenti Paolo, 2011, Smithiana Bulletin, P29; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Polidoro BA, 2012, MAR ECOL PROG SER, V448, P93, DOI 10.3354/meps09545; Polidoro BA, 2011, J MARINE BIOL, V2011, P14; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2004, CORAL REEFS, V23, P352, DOI 10.1007/s00338-004-0394-x; Randall J.E., 2001, SURGEONFISHES HAWAII; Reeson PH, 1983, ICLARM STUD REV, P178; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; Rhodes KL, 2008, CORAL REEFS, V27, P443, DOI 10.1007/s00338-007-0331-x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; ROBERTSON DR, 1992, MAR BIOL, V114, P527, DOI 10.1007/BF00357250; ROBERTSON DR, 1988, MAR BIOL, V97, P495, DOI 10.1007/BF00391045; Rocha LA, 2012, ZOOTAXA, P61; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rotjan RD, 2005, MAR ECOL PROG SER, V305, P193, DOI 10.3354/meps305193; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Sabater MG, 2009, REV FISH SCI, V17, P318, DOI 10.1080/10641260802702872; Sabetian A., 2010, PARROTFISH FISHERIES; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; Sadovy Y, 2012, FISH FISHER IN PRESS; Sadovy Yvonne J., 2002, P391, DOI 10.1016/B978-012615185-5/50023-2; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stevenson TC, 2011, ICES J MAR SCI, V68, P813, DOI 10.1093/icesjms/fsr020; Stockwell B, 2009, MAR ECOL PROG SER, V389, P1, DOI 10.3354/meps08150; Streelman JT, 2002, EVOLUTION, V56, P961; Subcommittee ISaP, 2011, GUID US IUCN RED LIS; Tissot Brian N., 2004, Pacific Science, V58, P175, DOI 10.1353/psc.2004.0024; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; To AWL, 2009, FISH FISH, V10, P396, DOI 10.1111/j.1467-2979.2009.00326.x; Tolimieri N, 1998, B MAR SCI, V62, P253; UNEP/WCMC, 2010, GLOB DISTR COR REEFS; Vermeij GJ, 2000, PALEOBIOLOGY, V26, P419, DOI 10.1666/0094-8373(2000)026<0419:DHATAO>2.0.CO;2; Walsh W, 2010, REPORT FINDINGS RECO; (WDPA) WDoPA, 2010, PROT AR EXTR 2010 WO; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Wilkinson C, 2000, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CORAL REEFS W; WILKINSON C, 2002, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W; Wilkinson CR, 1998, STATUS CORAL REEFS W; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	159	46	50	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39825	10.1371/journal.pone.0039825	http://dx.doi.org/10.1371/journal.pone.0039825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808066	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000306362400022
J	Jamrozy, DM; Fielder, MD; Butaye, P; Coldham, NG				Jamrozy, Dorota M.; Fielder, Mark D.; Butaye, Patrick; Coldham, Nick G.			Comparative Genotypic and Phenotypic Characterisation of Methicillin-Resistant Staphylococcus aureus ST398 Isolated from Animals and Humans	PLOS ONE			English	Article							EVOLUTIONARY GENOMICS; MOLECULAR MECHANISM; GENETIC-VARIATION; CLONAL COMPLEXES; BETA-LYSIN; STRAINS; PIGS; INFECTIONS; POULTRY; PROTEIN	The high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) ST398 among pigs in certain European countries and North America and its occurrence in other animal species raises a question concerning the molecular mechanisms mediating the success of this lineage. In this study a panel of S. aureus strains belonging to sequence type (ST) 5 (n = 4), ST8 (n = 5), ST15 (n = 5), ST22 (n = 8), clonal complex (CC) 30 (n = 8), CC97 (n = 8), CC130 (n = 4), CC151 (n = 4) and ST398 (n = 18) were screened by DNA microarray and PCR for the carriage of virulence and antimicrobial resistance genes. Isolates belonging to the same sequence type/clonal complex (ST/CC) were found to share similar virulence gene profiles. The ST398 lineage displayed the lowest content of virulence genes, which consisted mainly of genes detected among the majority or all of the analysed lineages. All MRSA ST398 isolates lacked accessory virulence genes that were detected in other ST/CC. In contrast to virulence genotype, the antimicrobial resistance genes profiles varied between isolates belonging to the same ST/CC and profile similarities could be observed for isolates from different lineages. MRSA ST398 isolates in particular displayed significant diversity and high content of antimicrobial resistance genes. This was comparable with certain MRSA belonging to other sequence types particularly the equine MRSA ST8. The apparent lack of significant virulence genes among MRSA ST398 strains, demonstrates that the lineage features a unique genetic background but no ST398-specific virulence markers could be identified.	[Jamrozy, Dorota M.; Coldham, Nick G.] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, New Haw, England; [Jamrozy, Dorota M.; Fielder, Mark D.] Kingston Univ, Sch Life Sci, Fac Sci Engn & Comp, London, England; [Butaye, Patrick] Vet & Agrochem Res Ctr, Unit Gen Bacteriol, Brussels, Belgium; [Butaye, Patrick] Univ Ghent, Dept Pathol Bacteriol & Poultry Dis, B-9000 Ghent, Belgium	Kingston University; Ghent University	Jamrozy, DM (corresponding author), Anim Hlth & Vet Labs Agcy, Dept Bacteriol, New Haw, England.	d.jamrozy@vla.defra.gsi.gov.uk	Butaye, Patrick/AAJ-8240-2020; Coldham, Nick/F-6151-2010	Butaye, Patrick/0000-0003-0780-6384	Department for Environment, Food and Rural Affairs [SC1004]	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This study was supported by a PhD project grant SC1004 from the Department for Environment, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2009, J CLIN MICROBIOL, V47, P2097, DOI 10.1128/JCM.01486-08; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; CARROLL JD, 1993, FEMS MICROBIOL LETT, V106, P147; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; COLEMAN DC, 1986, MICROB PATHOGENESIS, V1, P549, DOI 10.1016/0882-4010(86)90040-9; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Delgado S, 2011, FEMS IMMUNOL MED MIC, V62, P225, DOI 10.1111/j.1574-695X.2011.00806.x; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Donker GA, 2009, CLIN MICROBIOL INFEC, V15, P137, DOI 10.1111/j.1469-0691.2008.02662.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fanoy E, 2009, EUROSURVEILLANCE, V14; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Harlizius J, 2008, PREVALENCE MRSA PIG; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Ikawaty R, 2009, VET MICROBIOL, V136, P277, DOI 10.1016/j.vetmic.2008.10.034; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Jorgensen HJ, 2005, APPL ENVIRON MICROB, V71, P8352, DOI 10.1128/AEM.71.12.8352-8361.2005; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Larsen AR, 2008, J ANTIMICROB CHEMOTH, V61, P589, DOI 10.1093/jac/dkm532; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Nashev D, 2004, FEMS MICROBIOL LETT, V233, P45, DOI 10.1016/j.femsle.2004.01.032; Nulens E, 2008, J CLIN MICROBIOL, V46, P2438, DOI 10.1128/JCM.00808-08; O'Neill E, 2009, J MED MICROBIOL, V58, P399, DOI 10.1099/jmm.0.005504-0; Otsuka T, 2006, BIOCHEM BIOPH RES CO, V346, P1234, DOI 10.1016/j.bbrc.2006.06.038; Persoons D, 2009, EMERG INFECT DIS, V15, P452, DOI 10.3201/eid1503.080696; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Shinji H, 2011, INFECT IMMUN, V79, P2215, DOI 10.1128/IAI.00133-11; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Smith EM, 2005, J CLIN MICROBIOL, V43, P4737, DOI 10.1128/JCM.43.9.4737-4743.2005; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000	51	42	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40458	10.1371/journal.pone.0040458	http://dx.doi.org/10.1371/journal.pone.0040458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792335	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400058
J	Kim, S; Parks, CG; Xu, ZL; Carswell, G; DeRoo, LA; Sandler, DP; Taylor, JA				Kim, Sangmi; Parks, Christine G.; Xu, Zongli; Carswell, Gleta; DeRoo, Lisa A.; Sandler, Dale P.; Taylor, Jack A.			Association between Genetic Variants in DNA and Histone Methylation and Telomere Length	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EPIGENETIC REGULATION; METHYLTRANSFERASE BHMT; BETAINE-HOMOCYSTEINE; OXIDATIVE STRESS; ARGININE; LOCUS; RISK; DISEASE; SNP	Telomere length, a biomarker of aging and age-related diseases, exhibits wide variation between individuals. Common genetic variation may explain some of the individual differences in telomere length. To date, however, only a few genetic variants have been identified in the previous genome-wide association studies. As emerging data suggest epigenetic regulation of telomere length, we investigated 72 single nucleotide polymorphisms (SNPs) in 46 genes that involve DNA and histone methylation as well as telomerase and telomere-binding proteins and DNA damage response. Genotyping and quantification of telomere length were performed in blood samples from 989 non-Hispanic white participants of the Sister Study, a prospective cohort of women aged 35-74 years. The association of each SNP with logarithmically-transformed relative telomere length was estimated using multivariate linear regression. Six SNPs were associated with relative telomere length in blood cells with p-values<0.05 (uncorrected for multiple comparisons). The minor alleles of BHMT rs3733890 G>A (p = 0.041), MTRR rs2966952 C>T (p = 0.002) and EHMT2 rs558702 G>A (p = 0.008) were associated with shorter telomeres, while minor alleles of ATM rs1801516 G>A (p = 0.031), MTR rs1805087 A>G (p = 0.038) and PRMT8 rs12299470 G>A (p = 0.019) were associated with longer telomeres. Five of these SNPs are located in genes coding for proteins involved in DNA and histone methylation. Our results are consistent with recent findings that chromatin structure is epigenetically regulated and may influence the genomic integrity of telomeric region and telomere length maintenance. Larger studies with greater coverage of the genes implicated in DNA methylation and histone modifications are warranted to replicate these findings.	[Kim, Sangmi] Georgia Hlth Sci Univ, Ctr Canc, Sect Hematol Oncol, Dept Med, Augusta, GA USA; [Kim, Sangmi; Parks, Christine G.; Xu, Zongli; DeRoo, Lisa A.; Sandler, Dale P.; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA; [Xu, Zongli; Carswell, Gleta; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC USA	University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kim, S (corresponding author), Georgia Hlth Sci Univ, Ctr Canc, Sect Hematol Oncol, Dept Med, Augusta, GA USA.	sankim@georgiahealth.edu; taylor@niehs.nih.gov	taylor, jack a/C-7154-2019	taylor, jack a/0000-0001-5303-6398; Sandler, Dale/0000-0002-6776-0018; xu, zongli/0000-0002-9034-8902; Parks, Christine/0000-0002-5734-3456	National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES044005, Z01 ES049033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044005, ZIAES049033, ZICES102546, ZIAES049032] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES044005 and Z01 ES049033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Boyles AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harmon DL, 1999, GENET EPIDEMIOL, V17, P298, DOI 10.1002/(SICI)1098-2272(199911)17:4<298::AID-GEPI5>3.0.CO;2-V; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Jin GF, 2010, CANCER-AM CANCER SOC, V116, P5700, DOI 10.1002/cncr.25301; Kim S, 2011, CANCER CAUSE CONTROL, V22, P1061, DOI 10.1007/s10552-011-9778-8; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li F, 2008, MOL GENET METAB, V94, P326, DOI 10.1016/j.ymgme.2008.03.013; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mirabello L, 2010, HUM MUTAT, V31, P1050, DOI 10.1002/humu.21314; Mitchell TRH, 2009, MOL CELL BIOL, V29, P4918, DOI 10.1128/MCB.00009-09; Mostowska A, 2010, EUR J ORAL SCI, V118, P325, DOI 10.1111/j.1600-0722.2010.00757.x; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Paul L, 2009, J NUTR; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; SELHUB J, 1992, AM J CLIN NUTR, V55, P131, DOI 10.1093/ajcn/55.1.131; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Simarro M, 2010, BIOCHEM BIOPH RES CO, V401, P440, DOI 10.1016/j.bbrc.2010.09.075; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stancheva I, 2005, BIOCHEM CELL BIOL, V83, P385, DOI 10.1139/o05-043; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Vera E, 2008, ONCOGENE, V27, P6817, DOI 10.1038/onc.2008.289; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Weinberg CR, 2007, AM J EPIDEMIOL, V166, P447, DOI 10.1093/aje/kwm097; Weisberg IS, 2003, ATHEROSCLEROSIS, V167, P205, DOI 10.1016/S0021-9150(03)00010-8; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	48	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40504	10.1371/journal.pone.0040504	http://dx.doi.org/10.1371/journal.pone.0040504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792358	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400065
J	Monttinen, HAM; Ravantti, JJ; Poranen, MM				Monttinen, Heli A. M.; Ravantti, Janne J.; Poranen, Minna M.			Evidence for a Non-Catalytic Ion-Binding Site in Multiple RNA-Dependent RNA Polymerases	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DE-NOVO INITIATION; GDD SEQUENCE MOTIF; DNA-POLYMERASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; REVERSE-TRANSCRIPTASE; ACID-RESIDUES	A high-affinity divalent cation-binding site located proximal to the catalytic center has been identified in several RNA-dependent RNA polymerases (RdRps), but the characteristics of such a site have not been systematically studied. Here, all available polymerase structures that follow the hand-like structural motif were screened for the presence of a divalent cation close to the catalytic site but distinct from catalytic metal ions. Such non-catalytic ions were found in all RNA virus families for which there were high-resolution RdRp structures available. Bound ions were always located in structurally similar locations at an approximate 6-angstrom distance from the catalytic site. Furthermore, the second aspartate residue in the highly conserved GDD sequence was found to be involved in the coordination of the bound ion in all viral RdRps studied. These results suggest that a non-catalytic ion-binding site is conserved across positive-sense, single-stranded, and double-stranded RNA viruses. Interestingly, a non-catalytic ion was also observed in a similar position in the reverse transcriptase of the human immunodeficiency virus. Moreover, two members of the DNA-dependent DNA polymerase B family displayed an ion at a comparable distance from the catalytic site, but the position was clearly distinct from the non-catalytic ion-binding sites of RdRps.	[Monttinen, Heli A. M.; Ravantti, Janne J.; Poranen, Minna M.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Ravantti, Janne J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; University of Helsinki	Monttinen, HAM (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	minna.poranen@helsinki.fi		Poranen, Minna/0000-0002-4775-3670; Monttinen, Heli/0000-0003-2461-0690; Ravantti, Janne/0000-0002-8578-7230	Academy of Finland [250113, 256069]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by grants from the Academy of Finland (grant number 250113 and 256069; www.aka.fi) and Sigrid Juselius Foundation (www.sigridjuselius.fi) to MMP. HAMM is a fellow of the Viikki Doctoral Programme in Molecular Biosciences (http://www.helsinki.fi/vgsb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui-Ismaili MH, 2000, J HUMAN VIROL, V3, P306; Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans RJ, 2008, P NATL ACAD SCI USA, V105, P20695, DOI 10.1073/pnas.0809989106; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JABLONSKI SA, 1995, J VIROL, V69, P1532, DOI 10.1128/JVI.69.3.1532-1539.1995; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurila MRL, 2005, J GEN VIROL, V86, P521, DOI 10.1099/vir.0.80492-0; LAZCANO A, 1988, J MOL EVOL, V27, P365, DOI 10.1007/BF02101199; Lee JH, 2011, J GEN VIROL, V92, P1607, DOI 10.1099/vir.0.031104-0; Leon PE, 1998, J MOL EVOL, V47, P122, DOI 10.1007/PL00006368; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Makeyev EV, 2000, EMBO J, V19, P124, DOI 10.1093/emboj/19.1.124; Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Poranen MM, 2008, NUCLEIC ACIDS RES, V36, P6633, DOI 10.1093/nar/gkn632; Ranjith-Kumar CT, 2003, VIROLOGY, V312, P270, DOI 10.1016/S0042-6822(03)00247-2; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Salgado PS, 2004, STRUCTURE, V12, P307, DOI 10.1016/j.str.2004.01.012; SANKAR S, 1992, J BIOL CHEM, V267, P10168; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Takeshita D, 2010, P NATL ACAD SCI USA, V107, P15733, DOI 10.1073/pnas.1006559107; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Valverde-Garduno V, 1998, J MOL EVOL, V47, P73, DOI 10.1007/PL00006364; Vazquez AL, 2000, J VIROL, V74, P3888, DOI 10.1128/JVI.74.8.3888-3891.2000; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wright S, 2012, J VIROL, V86, P2837, DOI 10.1128/JVI.05168-11; Yang HY, 2003, J VIROL, V77, P1195, DOI 10.1128/JVI.77.2.1195-1203.2003; Yang HY, 2001, J VIROL, V75, P11088, DOI 10.1128/JVI.75.22.11088-11095.2001; Yi GH, 2003, EUR J BIOCHEM, V270, P4952, DOI 10.1046/j.1432-1033.2003.03897.x; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	57	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40581	10.1371/journal.pone.0040581	http://dx.doi.org/10.1371/journal.pone.0040581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792374	gold, Green Published			2022-12-27	WOS:000306362400072
J	El-Keredy, A; Schleyer, M; Konig, C; Ekim, A; Gerber, B				El-Keredy, Amira; Schleyer, Michael; Koenig, Christian; Ekim, Aslihan; Gerber, Bertram			Behavioural Analyses of Quinine Processing in Choice, Feeding and Learning of Larval Drosophila	PLOS ONE			English	Article							BITTER TASTE; MELANOGASTER; RECEPTORS; REWARD; ORGANIZATION; ARCHITECTURE; PERCEPTION; SYSTEM; SMELL; MODEL	Gustatory stimuli can support both immediate reflexive behaviour, such as choice and feeding, and can drive internal reinforcement in associative learning. For larval Drosophila, we here provide a first systematic behavioural analysis of these functions with respect to quinine as a study case of a substance which humans report as "tasting bitter''. We describe the dose-effect functions for these different kinds of behaviour and find that a half-maximal effect of quinine to suppress feeding needs substantially higher quinine concentrations (2.0 mM) than is the case for internal reinforcement (0.6 mM). Interestingly, in previous studies (Niewalda et al. 2008, Schipanski et al 2008) we had found the reverse for sodium chloride and fructose/sucrose, such that dose-effect functions for those tastants were shifted towards lower concentrations for feeding as compared to reinforcement, arguing that the differences in dose-effect function between these behaviours do not reflect artefacts of the types of assay used. The current results regarding quinine thus provide a starting point to investigate how the gustatory system is organized on the cellular and/or molecular level to result in different behavioural tuning curves towards a bitter tastant.	[El-Keredy, Amira; Schleyer, Michael; Ekim, Aslihan; Gerber, Bertram] Univ Wurzburg, Wurzburg, Germany; [El-Keredy, Amira] Tanta Univ, Tanta, Egypt; [Schleyer, Michael; Koenig, Christian; Gerber, Bertram] Univ Leipzig, Leipzig, Germany; [Ekim, Aslihan] Bilkent Univ, Ankara, Turkey; [Gerber, Bertram] Leibniz Inst Neurobiol, Magdeburg, Germany; [Gerber, Bertram] Univ Magdeburg, D-39106 Magdeburg, Germany	University of Wurzburg; Egyptian Knowledge Bank (EKB); Tanta University; Leipzig University; Ihsan Dogramaci Bilkent University; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	El-Keredy, A (corresponding author), Univ Wurzburg, Wurzburg, Germany.	bertram.gerber@lin-magdeburg.de		Schleyer, Michael/0000-0001-8020-1483; Gerber, Bertram/0000-0003-3003-0051; Konig, Christian/0000-0001-6033-8255	PhD fellowship of the Studienstiftung des Deutschen Volkes; Channel System Program of the Egyptian Ministry of Higher Education; German Federal Ministry of Science and Technology (Bernstein Network Insect inspired robotics); Heisenberg Fellow of the Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft (SPP 1392 Integrative analyses of olfaction)	PhD fellowship of the Studienstiftung des Deutschen Volkes; Channel System Program of the Egyptian Ministry of Higher Education; German Federal Ministry of Science and Technology (Bernstein Network Insect inspired robotics); Heisenberg Fellow of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (SPP 1392 Integrative analyses of olfaction)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (SPP 1392 Integrative analyses of olfaction [to BG]), by a PhD fellowship of the Studienstiftung des Deutschen Volkes (to MS), by the Channel System Program of the Egyptian Ministry of Higher Education (to AEK), and by the German Federal Ministry of Science and Technology (Bernstein Network Insect inspired robotics [to BG]). BG is a Heisenberg Fellow of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cobb Matthew, 2009, SEB Experimental Biology Series, V63, P1; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Gerber B, 2009, RESULTS PROBL CELL D; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gerber B, 2006, P ROY SOC B-BIOL SCI, V273, P2965, DOI 10.1098/rspb.2006.3673; Hammer M, 1998, LEARN MEMORY, V5, P146; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Hendel T, 2005, J COMP PHYSIOL A, V191, P265, DOI 10.1007/s00359-004-0574-8; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kwon JY, 2011, J NEUROSCI, V31, P15300, DOI 10.1523/JNEUROSCI.3363-11.2011; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Menzel R, 1999, BEHAV NEUROSCI, V113, P744, DOI 10.1037/0735-7044.113.4.744; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Niewalda T, 2008, CHEM SENSES, V33, P685, DOI 10.1093/chemse/bjn037; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Russell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020100; Saumweber T, 2011, CHEM SENSES, V36, P223, DOI 10.1093/chemse/bjq128; Schipanski A, 2008, CHEM SENSES, V33, P563, DOI 10.1093/chemse/bjn024; Schleyer M, 2011, LEARN MEMORY, V18, P639, DOI 10.1101/lm.2163411; Stocker RF, 2008, ADV EXP MED BIOL, V628, P69, DOI 10.1007/978-0-387-78261-4_5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001	36	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40525	10.1371/journal.pone.0040525	http://dx.doi.org/10.1371/journal.pone.0040525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802964	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500052
J	Kreutz, M; Giquel, B; Hu, Q; Abuknesha, R; Uematsu, S; Akira, S; Nestle, FO; Diebold, SS				Kreutz, Martin; Giquel, Benoit; Hu, Qin; Abuknesha, Ram; Uematsu, Satoshi; Akira, Shizuo; Nestle, Frank O.; Diebold, Sandra S.			Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity	PLOS ONE			English	Article							AIDED CROSS-PRESENTATION; IN-VIVO; RECEPTOR DEC-205; MURINE DC; RESPONSES; CPG; IMMUNITY; DNA; INDUCTION; OLIGONUCLEOTIDES	Antibody-antigen conjugates, which promote antigen-presentation by dendritic cells (DC) by means of targeted delivery of antigen to particular DC subsets, represent a powerful vaccination approach. To ensure immunity rather than tolerance induction the co-administration of a suitable adjuvant is paramount. However, co-administration of unlinked adjuvant cannot ensure that all cells targeted by the antibody conjugates are appropriately activated. Furthermore, antigen-presenting cells (APC) that do not present the desired antigen are equally strongly activated and could prime undesired responses against self-antigens. We, therefore, were interested in exploring targeted co-delivery of antigen and adjuvant in cis in form of antibody-antigen-adjuvant conjugates for the induction of anti-tumour immunity. In this study, we report on the assembly and characterization of conjugates consisting of DEC205-specific antibody, the model antigen ovalbumin (OVA) and CpG oligodeoxynucleotides (ODN). We show that such conjugates are more potent at inducing cytotoxic T lymphocyte (CTL) responses than control conjugates mixed with soluble CpG. However, our study also reveals that the nucleic acid moiety of such antibody-antigen-adjuvant conjugates alters their binding and uptake and allows delivery of the antigen and the adjuvant to cells partially independently of DEC205. Nevertheless, antibody-antigen-adjuvant conjugates are superior to antibody-free antigen-adjuvant conjugates in priming CTL responses and efficiently induce anti-tumour immunity in the murine B16 pseudo-metastasis model. A better understanding of the role of the antibody moiety is required to inform future conjugate vaccination strategies for efficient induction of anti-tumour responses.	[Kreutz, Martin; Giquel, Benoit; Hu, Qin; Diebold, Sandra S.] Kings Coll London, Peter Gorer Dept Immunobiol, Guys Hosp, London WC2R 2LS, England; [Kreutz, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Abuknesha, Ram] Kings Coll London, Div Pharmaceut Sci, London WC2R 2LS, England; [Uematsu, Satoshi; Akira, Shizuo] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Nestle, Frank O.] Kings Coll London, Cutaneous Med & Immunotherapy Unit, Guys Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Radboud University Nijmegen; University of London; King's College London; Osaka University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Kreutz, M (corresponding author), Kings Coll London, Peter Gorer Dept Immunobiol, Guys Hosp, London WC2R 2LS, England.	sandra.diebold@kcl.ac.uk	Akira, Shizuo/C-3134-2009		Cancer Research UK Career Development Award; Cancer Research UK China Fellowship; Medical Research Council; King's College London; Medical Research Council [MR/J006742/1, G0600698B] Funding Source: researchfish	Cancer Research UK Career Development Award(Cancer Research UK); Cancer Research UK China Fellowship(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King's College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Cancer Research UK Career Development Award to Sandra Diebold, which also supported Benoit Giquel. Qin Hu received a Cancer Research UK China Fellowship and Martin Kreutz was jointly funded by a Ph.D. studentship from the Medical Research Council and King's College London. No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, CANC METASTASIS REV, V8, P82; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2010, EUR J IMMUNOL, V40, P36, DOI 10.1002/eji.200939748; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Caminschi I, 2009, EUR J IMMUNOL, V39, P931, DOI 10.1002/eji.200839035; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; Carter RW, 2006, CELL IMMUNOL, V239, P87, DOI 10.1016/j.cellimm.2006.05.001; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013; Demangel C, 2005, MOL IMMUNOL, V42, P979, DOI 10.1016/j.molimm.2004.09.034; Diebold SS, 2008, IMMUNOL CELL BIOL, V86, P389, DOI 10.1038/icb.2008.26; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Gurer C, 2008, BLOOD, V112, P1231, DOI 10.1182/blood-2008-03-148072; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Heit A, 2003, J IMMUNOL, V170, P2802, DOI 10.4049/jimmunol.170.6.2802; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Johnson TS, 2008, CLIN CANCER RES, V14, P8169, DOI 10.1158/1078-0432.CCR-08-1474; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; KIMURA Y, 1994, J BIOCHEM-TOKYO, V116, P991, DOI 10.1093/oxfordjournals.jbchem.a124658; Mahnke K, 2005, CANCER RES, V65, P7007, DOI 10.1158/0008-5472.CAN-05-0938; Maurer T, 2002, EUR J IMMUNOL, V32, P2356, DOI 10.1002/1521-4141(200208)32:8<2356::AID-IMMU2356>3.0.CO;2-Z; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Roberts TL, 2005, J IMMUNOL, V174, P605, DOI 10.4049/jimmunol.174.2.605; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Tacken PJ, 2011, BLOOD, V118, P6836, DOI 10.1182/blood-2011-07-367615; Tirapu I, 2009, INT IMMUNOL, V21, P871, DOI 10.1093/intimm/dxp053; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138; Waibler Z, 2008, EUR J IMMUNOL, V38, P3127, DOI 10.1002/eji.200838184; Wang B, 2009, ANN NY ACAD SCI, V1174, P6, DOI 10.1111/j.1749-6632.2009.04933.x; Wang H, 2000, P NATL ACAD SCI USA, V97, P847, DOI 10.1073/pnas.97.2.847; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Zhu FG, 2001, IMMUNOLOGY, V103, P226, DOI 10.1046/j.1365-2567.2001.01222.x	47	50	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40208	10.1371/journal.pone.0040208	http://dx.doi.org/10.1371/journal.pone.0040208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808118	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500031
J	Watson-Jones, D; Balira, R; Ross, DA; Weiss, HA; Mabey, D				Watson-Jones, Deborah; Balira, Rebecca; Ross, David A.; Weiss, Helen A.; Mabey, David			Missed Opportunities: Poor Linkage into Ongoing Care for HIV-Positive Pregnant Women in Mwanza, Tanzania	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; TREATMENT PROGRAMS; SERVICES; HEALTH; MOTHERS; ACCESS; INTEGRATION; MORTALITY	Background: Global coverage of prevention of mother-to-child (PMTCT) services reached 53% in 2009. However the number of pregnant women who test positive for HIV in antenatal clinics and who link into long-term HIV care is not known in many resource-poor countries. We measured the proportion of HIV-positive pregnant women in Mwanza city, Tanzania, who completed the cascade of care from antenatal HIV diagnosis to assessment and engagement in care in adult HIV clinics. Methods: Thirty antenatal and maternity ward health workers were interviewed about PMTCT activities. Nine antenatal HIV education sessions were observed. A prospective cohort of 403 HIV-positive women was enrolled by specially-trained clinicians and nurses on admission to delivery and followed for four months post-partum. Information was collected on referral and attendance at adult HIV clinics, eligibility for highly active antiretroviral therapy (HAART) and reasons for lack of attendance. Results: Overall, 70% of PMTCT health workers referred HIV-positive pregnant women to the HIV clinic for assessment and care. Antenatal HIV education sessions did not cover on-going care for HIV-infected women. Of 310 cohort participants tested in pregnancy, 51% had received an HIV clinic referral pre-delivery. Only 32% of 244 women followed to four months post-partum had attended an HIV clinic and been assessed for HAART eligibility. Non-attendance for HIV care was independently associated with fewer antenatal visits, poor PMTCT prophylaxis compliance, non-disclosure of HIV status, and non-Sukuma ethnicity. Conclusion: Most women identified as HIV-positive during pregnancy were not assessed for HAART eligibility during pregnancy or in the first four months post-partum. Initiating HAART at the antenatal clinic, improved counselling and linkages to care between PMTCT and adult HIV treatment services and reducing stigma surrounding disclosure of HIV results would benefit on-going care of HIV-positive pregnant women.	[Watson-Jones, Deborah; Mabey, David] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Watson-Jones, Deborah] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Balira, Rebecca] Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza, Tanzania; [Ross, David A.; Weiss, Helen A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, MRC Trop Epidemiol Grp, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine	Watson-Jones, D (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.	Deborah.Watson-Jones@lshtm.ac.uk	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Mabey, David/0000-0002-0031-8276	UK Department for International Development; Tanzanian National Institute for Medical Research; Wellcome Trust, UK; Commonwealth Scholarship [TZCA-2007-188]; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	UK Department for International Development; Tanzanian National Institute for Medical Research; Wellcome Trust, UK(Wellcome Trust); Commonwealth Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the UK Department for International Development through the Evidence for Action on HIV Treatment and Care Systems Research Programme, and the Tanzanian National Institute for Medical Research. Deborah Watson-Jones was supported by the Wellcome Trust, UK, and Rebecca Balira was supported by a Commonwealth Scholarship (TZCA-2007-188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, UN REP TANZ CENS 200; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Baek C., 2007, KEY FINDINGS EVALUAT; Baleta A, 2010, LANCET, V375, P1954, DOI 10.1016/S0140-6736(10)60909-9; Barasa S, 2008, 18 INT AIDS C MEX CI; Bassett IV, 2008, HIV MED, V9, P863, DOI 10.1111/j.1468-1293.2008.00635.x; Becquet R, 2010, AIDS, V24, P1239, DOI 10.1097/QAD.0b013e328338b791; Black V, 2008, JAIDS-J ACQ IMM DEF, V49, P276, DOI 10.1097/QAI.0b013e318189a769; Bolu OO, 2007, AM J OBSTET GYNECOL, V197, pS83, DOI 10.1016/j.ajog.2007.03.006; Buve A, 2001, TROP MED INT HEALTH, V6, P971, DOI 10.1046/j.1365-3156.2001.00809.x; Desgrees-du-Lou A, 2008, REPROD HEALTH MATTER, V16, P151, DOI 10.1016/S0968-8080(08)32407-0; Druce N, 2007, REPROD HEALTH MATTER, V15, P190, DOI 10.1016/S0968-8080(07)30337-6; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ferguson L, 2010, 18 INT AIDS C VIENN; Geissler Wenzel., 2009, AIDS RELIG PRACTICE; Government of Botswana, 2010, PROGR REP NAT RESP 2; Hargrove JW, 2010, AIDS, V24, pF11, DOI 10.1097/QAD.0b013e328335749d; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Hussain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027907; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Kairania RM, 2010, AIDS CARE, V22, P1041, DOI 10.1080/09540121003602226; Katz DA, 2009, INT J STD AIDS, V20, P765, DOI 10.1258/ijsa.2009.009139; KILLAM WP, 2010, 17 INT AIDS C MEX CI, V24, P85, DOI DOI 10.1097/QAD.0B013E32833298BE; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Levy JM, 2009, REPROD HEALTH MATTER, V17, P152, DOI 10.1016/S0968-8080(09)33436-9; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Marcellin F, 2009, AIDS, V23, P1015, DOI 10.1097/QAD.0b013e32832a5996; Martinson NA, 2007, JAIDS-J ACQ IMM DEF, V45, P206, DOI 10.1097/QAI.0b013e318050d652; Mavakala K, 2008, 17 INT AIDS C MEX CI; McColl K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1590; Moodley D, 2011, SAMJ S AFR MED J, V101, P122, DOI 10.7196/SAMJ.4330; Nacher M, 2011, AM J TROP MED HYG, V84, P806, DOI 10.4269/ajtmh.2011.10-0671; National Bureau of Statistics (NBS), 2010, TANZ DEM HLTH SURV 2; Oberlander L, 2000, B WORLD HEALTH ORGAN, V78, P1352; Okot-Chono R, 2009, INT J TUBERC LUNG D, V13, P955; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Piot M, 1967, SIMULATION MODEL CAS; Rosenfield A, 2001, AM J PUBLIC HEALTH, V91, P703, DOI 10.2105/AJPH.91.5.703; Rotheram-Borus MJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-2; Scott V, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-23; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tanzania Commission for AIDS, UNGASS COUNTR PROGR; Tanzanian Ministry of Health & Social Welfare, 2007, PREV MOTH TO CHILD T; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2011, UN REP TANZ; UNICEF, 2010, CHILDR AIDS 5 STOCKT; Weigel RH, 2008, 17 INT AIDS C MEX CI; World Bank. Tanzania, TAN SUBS AFR DEV ONL; World Health Organization, ANT DRUGS TREAT PREG; World Health Organization, 2021, ANT DRUGS TREAT PREG	53	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40091	10.1371/journal.pone.0040091	http://dx.doi.org/10.1371/journal.pone.0040091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973IV	22808096	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306354700025
J	Burd, BJ; Macdonald, TA; van Roodselaar, A				Burd, Brenda J.; Macdonald, Tara A.; van Roodselaar, Albert			Towards Predicting Basin-Wide Invertebrate Organic Biomass and Production in Marine Sediments from a Coastal Sea	PLOS ONE			English	Article							BENTHIC SECONDARY PRODUCTION; FREE DRY-WEIGHT; CONTINENTAL-SLOPE; BRITISH-COLUMBIA; ENERGY-TRANSFER; STANDING STOCK; WADDEN SEA; STRAIT; MEIOFAUNA; GEORGIA	Detailed knowledge of environmental conditions is required to understand faunal production in coastal seas with topographic and hydrographic complexity. We test the hypothesis that organic biomass and production of subtidal sediment invertebrates throughout the Strait of Georgia, west coast of Canada, can be predicted by depth, substrate type and organic flux modified to reflect lability and age of material. A basin-wide database of biological, geochemical and flux data was analysed using an empirical production/ biomass (P/B) model to test this hypothesis. This analysis is unique in the spatial extent and detail of P/B and concurrent environmental measurements over a temperate coastal region. Modified organic flux was the most important predictor of organic biomass and production. Depth and substrate type were secondary modifiers. Between 69-74% of variability in biomass and production could be explained by the combined environmental factors. Organisms <1 mm were important contributors to biomass and production primarily in shallow, sandy sediments, where high P/B values were found despite low organic flux. Low biomass, production, and P/B values were found in the deep, northern basin and mainland fjords, which had silty sediments, low organic flux, low biomass of organisms <1 mm, and dominance by large, slow-growing macrofauna. In the highest organic flux and biomass areas near the Fraser River discharge, production did not increase beyond moderate flux levels. Although highly productive, this area had low P/B. Clearly, food input is insufficient to explain the complex patterns in faunal production revealed here. Additional environmental factors (depth, substrate type and unmeasured factors) are important modifiers of these patterns. Potential reasons for the above patterns are explored, along with a discussion of unmeasured factors possibly responsible for unexplained (30%) variance in biomass and production. We now have the tools for basin-wide first-order estimates of sediment invertebrate production.	[Burd, Brenda J.; Macdonald, Tara A.] Fisheries Oceans Canada Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [van Roodselaar, Albert] Metro Vancouver, Kingsway Burnaby, BC, Canada	Fisheries & Oceans Canada	Burd, BJ (corresponding author), Fisheries Oceans Canada Inst Ocean Sci, Sidney, BC V8L 4B2, Canada.	burdb@dfo-mpo.gc.ca			Metro Vancouver	Metro Vancouver	This work is part of the Strait of Georgia Ambient Monitoring Program, which is a collaborative research program with two partners: Fisheries and Oceans Canada and Metro Vancouver (formerly the Greater Vancouver Regional District). Metro Vancouver supplied all the funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller JY, 2002, DEEP-SEA RES PT II, V49, P4599, DOI 10.1016/S0967-0645(02)00131-5; ALONGI D, 1998, COASTAL ECOSYSTEM PR; Altenbach AV, 2001, J FORAMIN RES, V31, P79, DOI 10.2113/0310079; ASMUS H, 1982, NETH J SEA RES, V16, P403, DOI 10.1016/0077-7579(82)90046-1; BANSE K, 1980, ECOL MONOGR, V50, P355, DOI 10.2307/2937256; Barrie J, 2008, GEORGIA BASIN GEOHAZ; Berkenbusch K, 2011, MAR ECOL PROG SER, V425, P79, DOI 10.3354/meps09014; Beukema J, 1983, INVERTEBRATES WADDEN, P134; BREY T, 1986, MEERESFORSCHUNG, V31, P52; Brey T, 1998, J EXP MAR BIOL ECOL, V231, P191, DOI 10.1016/S0022-0981(98)00060-4; BREY T, 2004, POPULATION DYNAMICS; Brey T., 2001, POPULATION DYNAMICS; Burd BJ, 2008, MAR ENVIRON RES, V66, pS3, DOI 10.1016/j.marenvres.2008.09.004; Burd BJ, 2008, MAR ENVIRON RES, V66, pS62, DOI 10.1016/j.marenvres.2008.08.009; Burd BJ, 2009, 2859 FISH AQ SCI, V2859; CARPENTER R, 1981, GEOCHIM COSMOCHIM AC, V45, P1155, DOI 10.1016/0016-7037(81)90139-3; Clarke A, 2008, MAR ECOL PROG SER, V369, P25, DOI 10.3354/meps07670; Coull BC, 1999, AUST J ECOL, V24, P327, DOI 10.1046/j.1442-9993.1999.00979.x; Cusson M, 2005, MAR ECOL PROG SER, V297, P1, DOI 10.3354/meps297001; Danovaro R, 2002, MAR ECOL PROG SER, V234, P95, DOI 10.3354/meps234095; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2007, MAR BIOL, V152, P339, DOI 10.1007/s00227-007-0696-y; Davenne E, 2001, WATER PROPERTIES STR; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; DEKKER R, 1989, NETH J SEA RES, V23, P57, DOI 10.1016/0077-7579(89)90043-4; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dinn P, 2011, THESIS U VICTORIA; Dolbeth M, 2005, J EXP MAR BIOL ECOL, V326, P115, DOI 10.1016/j.jembe.2005.05.010; ELLISON RL, 1984, HYDROBIOLOGIA, V109, P131, DOI 10.1007/BF00011572; EVANS S, 1983, MAR ECOL PROG SER, V10, P147, DOI 10.3354/meps010147; Galeron J, 2000, MAR ECOL PROG SER, V197, P121, DOI 10.3354/meps197121; GERLACH SA, 1971, OECOLOGIA, V6, P176, DOI 10.1007/BF00345719; GERLACH SA, 1978, OECOLOGIA, V33, P55, DOI 10.1007/BF00376996; Gobas F.A., 2001, PERSISTENT ORGANIC P, P145, DOI [10.1007/978-1-4615-1571-5_6, DOI 10.1007/978-1-4615-1571-5_6]; Gobas FAPC, 1998, ENVIRON SCI TECHNOL, V32, P2442, DOI 10.1021/es980022+; GORDON K, 1997, THESIS U BRIT COLUMB; GREBMEIER JM, 1988, MAR ECOL PROG SER, V48, P57, DOI 10.3354/meps048057; Heip C, 2003, MARINE SCIENCE FRONTIERS FOR EUROPE, P289; Hill PR, 2008, MAR ENVIRON RES, V66, pS39, DOI 10.1016/j.marenvres.2008.09.003; Hua Er, 2010, Journal of Ocean University of China, V9, P279, DOI 10.1007/s11802-010-1726-9; Isaaks EH, 1989, APPL GEOSTATISTICS; Johannessen SC, 2012, MAR POLLUT BULL, V64, P675, DOI 10.1016/j.marpolbul.2012.01.026; Johannessen SC, 2009, CLIM RES, V40, P1, DOI 10.3354/cr00819; Johannessen SC, 2008, MAR ENVIRON RES, V66, pS1, DOI 10.1016/j.marenvres.2008.10.001; Johannessen SC, 2005, ENVIRON SCI TECHNOL, V39, P4361, DOI 10.1021/es040535i; Johannessen SC, 2005, MAR GEOL, V216, P59, DOI 10.1016/j.margeo.2005.01.004; Johnson NA, 2007, DEEP-SEA RES PT I, V54, P1350, DOI 10.1016/j.dsr.2007.04.011; Jumars P.A., 1989, Elsevier Oceanography Series, V47, P349; LEUVEN RSEW, 1985, HYDROBIOLOGIA, V127, P151, DOI 10.1007/BF00004193; LEVINGS CD, 1983, CAN J FISH AQUAT SCI, V40, P1120, DOI 10.1139/f83-131; Li J, 1997, FUND APPL NEMATOL, V20, P487; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LLANSO RJ, 1998, PUBLICATION WASHINGT; Maar M, 2011, J MARINE SYST, V85, P57, DOI 10.1016/j.jmarsys.2010.11.006; Macdonald RW, 2008, MAR ENVIRON RES, V66, pS87, DOI 10.1016/j.marenvres.2008.08.001; Macdonald T, 2011, MARINE ECOLOGY PROGR, V445, P129; Macdonald TA, 2010, 2874 FISH AQ SCI, V2874; Manini E, 2002, CHEM ECOL, V18, P155, DOI 10.1080/02757540212682; Masson D, 2002, ESTUAR COAST SHELF S, V54, P115, DOI 10.1006/ecss.2001.0833; Nilsen M, 2006, MAR ECOL PROG SER, V321, P67, DOI 10.3354/meps321067; PROBERT PK, 1986, NEW ZEAL J MAR FRESH, V20, P407, DOI 10.1080/00288330.1986.9516160; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Ricciardi A, 1998, MAR ECOL PROG SER, V163, P245, DOI 10.3354/meps163245; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; SCHWINGHAMER P, 1986, MAR ECOL PROG SER, V31, P131, DOI 10.3354/meps031131; Seitz RD, 2009, J EXP MAR BIOL ECOL, V381, pS4, DOI 10.1016/j.jembe.2009.07.004; SHIRAYAMA Y, 1984, OCEANOL ACTA, V7, P113; Smith CR, 1997, DEEP-SEA RES PT II, V44, P2295, DOI 10.1016/S0967-0645(97)00022-2; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Soltwedel T, 1996, J MAR BIOL ASSOC UK, V76, P327, DOI 10.1017/S0025315400030587; Stucchi D, 2009, LONG TERM TRENDS DEE; Tagliapietra D, 2007, HYDROBIOLOGIA, V588, P205, DOI 10.1007/s10750-007-0663-0; Thatje S, 1999, POLAR BIOL, V22, P31; THOMSON RE, 1981, CANADIAN SPECIAL PUB, V56, P235; TUMBIOLO ML, 1994, MAR ECOL PROG SER, V114, P165, DOI 10.3354/meps114165; Vanaverbeke J, 1997, J SEA RES, V38, P93, DOI 10.1016/S1385-1101(97)00038-5; Vanden Berghe E, 2009, MAR ECOL PROG SER, V382, P225, DOI 10.3354/meps07826; Vandepitte L, 2010, HYDROBIOLOGIA, V644, P1, DOI 10.1007/s10750-010-0108-z; Vinogradov M, 1983, SEA, P123; VRANKEN G, 1986, HYDROBIOLOGIA, V135, P193, DOI 10.1007/BF00006530; VRANKEN G, 1986, OPHELIA, V26, P429, DOI 10.1080/00785326.1986.10422004; WARWICK RM, 1984, OECOLOGIA, V61, P32, DOI 10.1007/BF00379085; WESSA P, 2010, FREE STAT SOFTWARE; WIGLEY RL, 1964, LIMNOL OCEANOGR, V9, P485, DOI 10.4319/lo.1964.9.4.0485; WITTE JI, 1984, MAR ECOL PROG SER, V14, P129, DOI 10.3354/meps014129; WRIGHT CA, 2008, STRAIT GEORGIA AMBIE	89	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40295	10.1371/journal.pone.0040295	http://dx.doi.org/10.1371/journal.pone.0040295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792267	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800063
J	Crespo-Enriquez, I; Partanen, J; Martinez, S; Echevarria, D				Crespo-Enriquez, Ivan; Partanen, Juha; Martinez, Salvador; Echevarria, Diego			Fgf8-Related Secondary Organizers Exert Different Polarizing Planar Instructions along the Mouse Anterior Neural Tube	PLOS ONE			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; MORPHOGEN GRADIENT; ISTHMIC ORGANIZER; SIGNALING PATHWAYS; EXPRESSION DOMAINS; SPROUTY PROTEINS; FGF8; GENE; BRAIN; GBX2	Early brain patterning depends on proper arrangement of positional information. This information is given by gradients of secreted signaling molecules (morphogens) detected by individual cells within the responding tissue, leading to specific fate decisions. Here we report that the morphogen FGF8 exerts initially a differential signal activity along the E9.5 mouse neural tube. We demonstrate that this polarizing activity codes by RAS-regulated ERK1/2 signaling and depends on the topographical location of the secondary organizers: the isthmic organizer (IsO) and the anterior neural ridge (anr) but not on zona limitans intrathalamica (zli). Our results suggest that Sprouty2, a negative modulator of RAS/ERK pathway, is important for regulating Fgf8 morphogenetic signal activity by controlling Fgf8-induced signaling pathways and positional information during early brain development.	[Crespo-Enriquez, Ivan; Martinez, Salvador; Echevarria, Diego] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alicante, Spain; [Partanen, Juha] Univ Helsinki, Div Genet, Dept Biosci, Helsinki, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Helsinki	Crespo-Enriquez, I (corresponding author), Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alicante, Spain.	diegoaza@umh.es	Echevarria, Diego/E-6386-2016; Echevarria, Diego/P-7391-2019; Enriquez, Ivan Crespo/N-4949-2019; Mratinez, Salvador/L-4896-2014	Echevarria, Diego/0000-0002-0938-7470; Echevarria, Diego/0000-0002-0938-7470; Enriquez, Ivan Crespo/0000-0003-2967-4554; Mratinez, Salvador/0000-0002-9320-4103; Martinez, Salvador/0000-0002-2910-8926; Partanen, Juha/0000-0001-8850-4825	Spanish Government [BFU2008-00588, SAF 2008-01004]; Consolider-Ingenio [CSD2007-00023]; Spanish Government Fellowship [FPI-BES 2006-12420M]	Spanish Government(Spanish GovernmentEuropean Commission); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Government Fellowship	This work was supported by national grants from the Spanish Government BFU2008-00588, SAF 2008-01004 and Consolider-Ingenio CSD2007-00023. ICE was supported by a Spanish Government Fellowship FPI-BES 2006-12420M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon F, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-61; Aroca P, 2005, BRAIN RES REV, V49, P179, DOI 10.1016/j.brainresrev.2004.12.031; Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Blak AA, 2005, DEV DYNAM, V233, P1023, DOI 10.1002/dvdy.20386; Blak AA, 2007, DEV BIOL, V303, P231, DOI 10.1016/j.ydbio.2006.11.008; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; Christen B, 1999, DEVELOPMENT, V126, P119; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Echevarria D, 2005, DEV BIOL, V277, P114, DOI 10.1016/j.ydbio.2004.09.011; Echevarria D, 2001, INT J DEV BIOL, V45, P895; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gabay L, 1997, DEVELOPMENT, V124, P3535; Garda AL, 2001, MECH DEVELOP, V101, P111, DOI 10.1016/S0925-4773(00)00567-0; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Jukkola T, 2006, DEV BIOL, V297, P141, DOI 10.1016/j.ydbio.2006.05.002; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Lahti L, 2011, DEV BIOL, V349, P270, DOI 10.1016/j.ydbio.2010.11.008; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Lin W, 2005, GENESIS, V41, P110, DOI 10.1002/gene.20103; Lin W, 2002, MECH DEVELOP, V113, P163, DOI 10.1016/S0925-4773(02)00018-7; Liu AM, 1999, DEVELOPMENT, V126, P4827; Liu AM, 2003, DEVELOPMENT, V130, P6175, DOI 10.1242/dev.00845; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; MARIN F, 1994, DEV BIOL, V163, P19, DOI 10.1006/dbio.1994.1120; Martinez S, 2001, INT J DEV BIOL, V45, P367; Mason I, 2000, BIOCHEM CELL BIOL, V78, P577, DOI 10.1139/bcb-78-5-577; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; MEINHARDT H, 1984, Journal of Embryology and Experimental Morphology, V83, P289; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nakamura H, 2008, DEV GROWTH DIFFER, V50, pS113, DOI 10.1111/j.1440-169X.2008.00995.x; Nowak M, 2011, NAT CELL BIOL, V13, P153, DOI 10.1038/ncb2155; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Partanen J, 2007, J NEUROCHEM, V101, P1185, DOI 10.1111/j.1471-4159.2007.04463.x; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Raible F, 2004, TRENDS NEUROSCI, V27, P727, DOI 10.1016/j.tins.2004.10.003; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Sato T, 2004, DEV GROWTH DIFFER, V46, P487; Sato T, 2001, DEVELOPMENT, V128, P2461; Sato T, 2009, DEVELOPMENT, V136, P3617, DOI 10.1242/dev.041210; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shinya M, 2001, DEVELOPMENT, V128, P4153; Smith TG, 2006, FEBS LETT, V580, P4242, DOI 10.1016/j.febslet.2006.06.081; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Suzuki A, 2012, DEV GROWTH DIFFER, V54, P463, DOI 10.1111/j.1440-169X.2012.01332.x; Suzuki-Hirano A, 2010, DEV BIOL, V337, P284, DOI 10.1016/j.ydbio.2009.10.044; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Toyoda R, 2010, DEVELOPMENT, V137, P3439, DOI 10.1242/dev.055392; Trokovic R, 2005, DEV BIOL, V278, P428, DOI 10.1016/j.ydbio.2004.11.024; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Tsang Michael, 2004, Sci STKE, V2004, ppe17, DOI 10.1126/stke.2282004pe17; Vieira C, 2006, NEUROSCIENCE, V137, P7, DOI 10.1016/j.neuroscience.2005.09.017; Vieira C, 2010, INT J DEV BIOL, V54, P7, DOI 10.1387/ijdb.092853cv; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Wolpert L, 2011, J THEOR BIOL, V269, P359, DOI 10.1016/j.jtbi.2010.10.034; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Yu TA, 2011, DEVELOPMENT, V138, P2957, DOI 10.1242/dev.063784	79	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39977	10.1371/journal.pone.0039977	http://dx.doi.org/10.1371/journal.pone.0039977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792203	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800028
J	Frisch, D; Cottenie, K; Badosa, A; Green, AJ				Frisch, Dagmar; Cottenie, Karl; Badosa, Anna; Green, Andy J.			Strong Spatial Influence on Colonization Rates in a Pioneer Zooplankton Metacommunity	PLOS ONE			English	Article							HIGH DISPERSAL CAPACITY; AQUATIC INVERTEBRATES; TEMPORARY WETLANDS; COPEPODS; COMMUNITIES; PATTERNS; WIND; HYDROPERIOD; MECHANISMS; RICHNESS	The magnitude of community-wide dispersal is central to metacommunity models, yet dispersal is notoriously difficult to quantify in passive and cryptic dispersers such as many freshwater invertebrates. By overcoming the problem of quantifying dispersal rates, colonization rates into new habitats can provide a useful estimate of the magnitude of effective dispersal. Here we study the influence of spatial and local processes on colonization rates into new ponds that indicate differential dispersal limitation of major zooplankton taxa, with important implications for metacommunity dynamics. We identify regional and local factors that affect zooplankton colonization rates and spatial patterns in a large-scale experimental system. Our study differs from others in the unique setup of the experimental pond area by which we were able to test spatial and environmental variables at a large spatial scale. We quantified colonization rates separately for the Copepoda, Cladocera and Rotifera from samples collected over a period of 21 months in 48 newly constructed temporary ponds of 0.18-2.95 ha distributed in a restored wetland area of 2,700 ha in Donana National Park, Southern Spain. Species richness upon initial sampling of new ponds was about one third of that in reference ponds, although the rate of detection of new species from thereon were not significantly different, probably owing to high turnover in the dynamic, temporary reference ponds. Environmental heterogeneity had no detectable effect on colonization rates in new ponds. In contrast, connectivity, space (based on latitude and longitude) and surface area were key determinants of colonization rates for copepods and cladocerans. This suggests dispersal limitation in cladocerans and copepods, but not in rotifers, possibly due to differences in propagule size and abundance.	[Frisch, Dagmar] Univ Oklahoma, Biol Stn, Kingston, OK USA; [Cottenie, Karl] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Frisch, Dagmar; Badosa, Anna; Green, Andy J.] Donana Biol Stn EBD CSIC, Dept Wetland Ecol, Seville, Spain	University of Oklahoma System; University of Oklahoma - Norman; University of Guelph; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Frisch, D (corresponding author), Univ Oklahoma, Biol Stn, Kingston, OK USA.	dfrisch@sistern.net	Badosa, Anna/AAD-4016-2019; Frisch, Dagmar/F-6363-2012; Green, Andy J/A-5189-2008; Frisch, Dagmar/AAE-9499-2019	Green, Andy J/0000-0002-1268-4951; Frisch, Dagmar/0000-0001-9310-2230; Cottenie, Karl/0000-0001-9498-8483	Ministerio de Educacion y Ciencia; Spanish Ministerio de Medio Ambiente Donana restoration project; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [P06-RNM-02431]; European Science Foundation (Eurodiversity programme BIOPOOL project)	Ministerio de Educacion y Ciencia(Spanish Government); Spanish Ministerio de Medio Ambiente Donana restoration project; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); European Science Foundation (Eurodiversity programme BIOPOOL project)	The authors are grateful to Arantza Arechederra for her invaluable assistance with fieldwork and zooplankton analysis. Additional help in the field was provided by Ernesto Garcia, Ana Carvajal and Marta Sanchez. DF was supported partly via a postdoctoral fellowship from the Ministerio de Educacion y Ciencia. Additional funding was provided by the Spanish Ministerio de Medio Ambiente Donana 2005 restoration project, by the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (project P06-RNM-02431) and by the European Science Foundation (Eurodiversity programme BIOPOOL project).; DF was supported partly via a postdoctoral fellowship from the Ministerio de Educacion y Ciencia. Additional funding was provided by the Spanish Ministerio de Medio Ambiente Donana 2005 restoration project, by the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (project P06-RNM-02431) and by the European Science Foundation (Eurodiversity programme BIOPOOL project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2007, OECOLOGIA, V153, P135, DOI 10.1007/s00442-007-0704-4; Alonso M., 1996, FAUNA IBERICA; Badosa A, 2010, HYDROBIOLOGIA, V654, P67, DOI 10.1007/s10750-010-0370-0; Bartholme S, 2005, LIMNOL OCEANOGR, V50, P923, DOI 10.4319/lo.2005.50.3.0923; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brochet AL, 2010, HYDROBIOLOGIA, V637, P255, DOI 10.1007/s10750-009-9975-6; BUCKLEY RC, 1986, J BIOGEOGR, V13, P69, DOI 10.2307/2844850; Caceres CE, 2002, OECOLOGIA, V131, P402, DOI 10.1007/s00442-002-0897-5; Cadotte MW, 2006, AM NAT, V168, P704, DOI 10.1086/508296; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Cohen GM, 2003, OIKOS, V103, P603, DOI 10.1034/j.1600-0706.2003.12660.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Dussart B, 1969, COPEPODES EAUX CONTI, DOI DOI 10.1007/s00442-010-1847-2; Dussart B, 1967, COPEPODES EAUX CONTI; Einsle U, 1993, CRUSTACEA COPEPODA C, P208; Espinar JL, 2009, AQUAT ECOL, V43, P323, DOI 10.1007/s10452-007-9162-7; Fahd K, 2009, HYDROBIOLOGIA, V634, P219, DOI 10.1007/s10750-009-9889-3; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Frisch D, 2006, HYDROBIOLOGIA, V556, P327, DOI 10.1007/s10750-005-1305-z; Frisch D, 2005, FRESHWATER BIOL, V50, P323, DOI 10.1111/j.1365-2427.2004.01321.x; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Frisch D, 2007, FUND APPL LIMNOL, V168, P289, DOI 10.1127/1863-9135/2007/0168-0289; Frisch D, 2009, HYDROBIOLOGIA, V624, P115, DOI 10.1007/s10750-008-9672-x; Gray DK, 2011, ECOL APPL, V21, P1241, DOI 10.1890/10-0364.1; Guadagnin DL, 2007, BIODIVERS CONSERV, V16, P1231, DOI 10.1007/s10531-006-9127-5; Gyllstrom M, 2004, AQUAT SCI, V66, P274, DOI 10.1007/s00027-004-0712-y; Hovestadt T, 2005, DIVERS DISTRIB, V11, P333, DOI 10.1111/j.1366-9516.2005.00161.x; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jenkins DG, 2007, GLOBAL ECOL BIOGEOGR, V16, P415, DOI 10.1111/j.1466-8238.2007.00312.x; Jenkins DG, 1998, ECOL MONOGR, V68, P421, DOI 10.1890/0012-9615(1998)068[0421:DSCDIS]2.0.CO;2; Jenkins DG, 1998, HYDROBIOLOGIA, V387, P15, DOI 10.1023/A:1017080029317; Koste W, 1978, ROTATORIA RADERTIERE; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lindo Z, 2008, OIKOS, V117, P1856, DOI 10.1111/j.1600-0706.2008.16920.x; Louette G, 2005, ECOLOGY, V86, P353, DOI 10.1890/04-0403; Louette G, 2008, FRESHWATER BIOL, V53, P2309, DOI 10.1111/j.1365-2427.2008.02052.x; MAC ARTHUR ROBERT H., 1967; MCCORMICK PV, 1988, T AM MICROSC SOC, V107, P259, DOI 10.2307/3226502; Michels E, 2001, MOL ECOL, V10, P1929, DOI 10.1046/j.1365-294X.2001.01340.x; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Resetarits WJ, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P374; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Santamaria L, 2005, DONANA AGUA BIOSFERA, P313; Sarnelle O, 2004, LIMNOL OCEANOGR, V49, P1382, DOI 10.4319/lo.2004.49.4_part_2.1382; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Shurin JB, 2000, ECOLOGY, V81, P3074, DOI 10.2307/177402; Silver CA, 2012, ACTA OECOL, V39, P1, DOI 10.1016/j.actao.2011.10.001; Vanschoenwinkel B, 2008, FRESHWATER BIOL, V53, P2264, DOI 10.1111/j.1365-2427.2008.02071.x; Vanschoenwinkel B, 2008, ECOGRAPHY, V31, P567, DOI 10.1111/j.0906-7590.2008.05442.x; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Waterkeyn A, 2008, FRESHWATER BIOL, V53, P1808, DOI 10.1111/j.1365-2427.2008.02005.x; Waterkeyn A, 2010, AQUAT CONSERV, V20, P580, DOI 10.1002/aqc.1122	64	71	72	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40205	10.1371/journal.pone.0040205	http://dx.doi.org/10.1371/journal.pone.0040205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792241	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800049
J	Okada, K; Angkawidjaja, C; Koga, Y; Takano, K; Kanaya, S				Okada, Ken; Angkawidjaja, Clement; Koga, Yuichi; Takano, Kazufumi; Kanaya, Shigenori			Characteristic Features of Kynurenine Aminotransferase Allosterically Regulated by (Alpha)-Ketoglutarate in Cooperation with Kynurenine	PLOS ONE			English	Article							PYROCOCCUS-HORIKOSHII OT3; CRYSTAL-STRUCTURE; II HOMOLOG; ACID; SCHIZOPHRENIA	Kynurenine aminotransferase from Pyrococcus horikoshii OT3 (PhKAT), which is a homodimeric protein, catalyzes the conversion of kynurenine (KYN) to kynurenic acid (KYNA). We analyzed the transaminase reaction mechanisms of this protein with pyridoxal-5'-phosphate (PLP), KYN and alpha-ketoglutaric acid (2OG) or oxaloacetic acid (OXA). 2OG significantly inhibited KAT activities in kinetic analyses, suggesting that a KYNA biosynthesis is allosterically regulated by 2OG. Its inhibitions evidently were unlocked by KYN. 2OG and KYN functioned as an inhibitor and activator in response to changes in the concentrations of KYN and 2OG, respectively. The affinities of one subunit for PLP or 2OG were different from that of the other subunit, as confirmed by spectrophotometry and isothermal titration calorimetry, suggesting that the difference of affinities between subunits might play a role in regulations of the KAT reaction. Moreover, we identified two active and allosteric sites in the crystal structure of PhKAT-2OG complexes. The crystal structure of PhKAT in complex with four 2OGs demonstrates that two 2OGs in allosteric sites are effector molecules which inhibit the KYNA productions. Thus, the combined data lead to the conclusion that PhKAT probably is regulated by allosteric control machineries, with 2OG as the allosteric inhibitor.	[Okada, Ken; Angkawidjaja, Clement; Koga, Yuichi; Takano, Kazufumi; Kanaya, Shigenori] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Osaka, Japan; [Takano, Kazufumi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST)	Okada, K (corresponding author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Osaka, Japan.	okadak@mls.eng.osaka-u.ac.jp		Takano, Kazufumi/0000-0002-7548-7314; Angkawidjaja, Clement/0000-0002-5019-2536	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21380065]; Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan	This work was supported in part by a grant (21380065) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by an Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Chon H, 2005, PROTEINS, V61, P685, DOI 10.1002/prot.20614; Chon H, 2005, ACTA CRYSTALLOGR F, V61, P319, DOI 10.1107/S1744309105005269; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erhardt S, 2003, ADV EXP MED BIOL, V527, P155; Han Q, 2008, J BIOL CHEM, V283, P3567, DOI 10.1074/jbc.M708358200; Han Q, 2008, BIOCHEMISTRY-US, V47, P1622, DOI 10.1021/bi701800j; Han QA, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-19; Han Q, 2010, CELL MOL LIFE SCI, V67, P353, DOI 10.1007/s00018-009-0166-4; Hartai Z, 2007, NEUROCHEM INT, V50, P308, DOI 10.1016/j.neuint.2006.08.012; Kawarabayasi Y, 1998, DNA Res, V5, P147, DOI 10.1093/dnares/5.2.147; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Marciano D, 2009, MOL BIOCHEM PARASIT, V166, P172, DOI 10.1016/j.molbiopara.2009.04.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rossi F, 2004, J BIOL CHEM, V279, P50214, DOI 10.1074/jbc.M409291200; Rossi F, 2008, J BIOL CHEM, V283, P3559, DOI 10.1074/jbc.M707925200; Rossi F, 2008, CURR OPIN STRUC BIOL, V18, P748, DOI 10.1016/j.sbi.2008.09.009; TOBES MC, 1977, J BIOL CHEM, V252, P4591; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wogulis M, 2008, BIOCHEMISTRY-US, V47, P1608, DOI 10.1021/bi701172v; Wu HQ, 2010, J MOL NEUROSCI, V40, P204, DOI 10.1007/s12031-009-9235-2	22	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40307	10.1371/journal.pone.0040307	http://dx.doi.org/10.1371/journal.pone.0040307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792273	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800067
J	Hosp, J; Sagane, Y; Danks, G; Thompson, EM				Hosp, Julia; Sagane, Yoshimasa; Danks, Gemma; Thompson, Eric M.			The Evolving Proteome of a Complex Extracellular Matrix, the Oikopleura House	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CELLULOSE SYNTHASE; 3-DIMENSIONAL STRUCTURE; PHYLOGENETIC ANALYSIS; DIOICA; PREDICTION; SECRETION; PROTEINS; CHORDATE; APPENDICULARIAN	Extracellular matrices regulate biological processes at the level of cells, tissues, and in some cases, entire multicellular organisms. The subphylum Urochordata exemplifies the latter case, where animals are partially or completely enclosed in "houses" or "tunics". Despite this common strategy, we show that the house proteome of the appendicularian, Oikopleura, has very little in common with the proteome of the sister class, ascidian, Ciona. Of 80 identified house proteins (oikosins), similar to half lack domain modules or similarity to known proteins, suggesting de novo appearance in appendicularians. Gene duplication has been important in generating almost 1/3 of the current oikosin complement, with serial duplications up to 8 paralogs in one family. Expression pattern analyses revealed that individual oikosins are produced from specific fields of cells within the secretory epithelium, but in some cases, migrate up to at least 20 cell diameters in extracellular space to combine in defined house structures. Interestingly, peroxidasin and secretory phospholipase A(2) domains, implicated in innate immune defence are secreted from the anlage associated with the food-concentrating filter, suggesting that this extra-organismal structure may play, in part, such a role in Oikopleura. We also show that sulfation of proteoglycans is required for the hydration and inflation of pre-house rudiments into functional houses. Though correct proportioning in the production of oikosins would seem important in repetitive assembly of the complex house structure, the genomic organization of oikosin loci appears incompatible with common enhancers or locus control regions exerting such a coordinate regulatory role. Thus, though all tunicates employ extracellular matrices based on a cellulose scaffold as a defining feature of the subphylum, they have evolved radically different protein compositions associated with this common underlying structural theme.	[Hosp, Julia; Sagane, Yoshimasa; Danks, Gemma; Thompson, Eric M.] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Danks, Gemma] Univ Bergen, Computat Biol Unit, Bergen, Norway; [Thompson, Eric M.] Univ Bergen, Dept Biol, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Hosp, J (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway.	Eric.Thompson@sars.uib.no	Sagane, Yoshimasa/C-7635-2013; Sagane, Yoshimasa/AAG-5543-2019	Sagane, Yoshimasa/0000-0002-7815-3141; Danks, Gemma/0000-0001-7004-0065	Norwegian Research Council FUGE [17541/S10]	Norwegian Research Council FUGE(Research Council of Norway)	This work was supported by Norwegian Research Council FUGE grant 17541/S10. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DEIBEL D, 1985, MAR ECOL PROG SER, V27, P79, DOI 10.3354/meps027079; Denoeud F, 2010, SCIENCE, V330, P1381, DOI 10.1126/science.1194167; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong CH, 2011, FISH SHELLFISH IMMUN, V30, P1223, DOI 10.1016/j.fsi.2011.04.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FENAUX R, 1986, ZOOMORPHOLOGY, V106, P224, DOI 10.1007/BF00312043; Ganot P, 2002, DEV BIOL, V252, P59, DOI 10.1006/dbio.2002.0834; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Koehler CJ, 2009, J PROTEOME RES, V8, P4333, DOI 10.1021/pr900425n; Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579; Matthysse AG, 2004, P NATL ACAD SCI USA, V101, P986, DOI 10.1073/pnas.0303623101; Muller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robison BH, 2005, SCIENCE, V308, P1609, DOI 10.1126/science.1109104; Sagane Y, 2011, CELL MOL LIFE SCI, V68, P1611, DOI 10.1007/s00018-010-0547-8; Sagane Y, 2010, DEVELOPMENT, V137, P1483, DOI 10.1242/dev.044503; Schneppenheim R, 2011, J THROMB HAEMOST, V9, P209, DOI 10.1111/j.1538-7836.2011.04324.x; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Spada F, 2001, J BIOL CHEM, V276, P20624, DOI 10.1074/jbc.M100438200; Spada F, 2007, BIOL CELL, V99, P273, DOI 10.1042/BC20060124; Thompson EM, 2001, DEV BIOL, V238, P260, DOI 10.1006/dbio.2001.0414; Thompson EM, 2005, RESPONSE MARINE ECOS, P89; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troedsson C, 2009, J PLANKTON RES, V31, P1453, DOI 10.1093/plankt/fbp085; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	48	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40172	10.1371/journal.pone.0040172	http://dx.doi.org/10.1371/journal.pone.0040172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792236	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300034
J	Otero-Muras, I; Banga, JR; Alonso, AA				Otero-Muras, Irene; Banga, Julio R.; Alonso, Antonio A.			Characterizing Multistationarity Regimes in Biochemical Reaction Networks	PLOS ONE			English	Article							CHEMICAL-REACTION NETWORKS; MULTIPLE EQUILIBRIA; SYSTEMS BIOLOGY; OPTIMIZATION; BISTABILITY; BIFURCATION; KINETICS; SWITCH; MULTISTABILITY; HYSTERESIS	Switch like responses appear as common strategies in the regulation of cellular systems. Here we present a method to characterize bistable regimes in biochemical reaction networks that can be of use to both direct and reverse engineering of biological switches. In the design of a synthetic biological switch, it is important to study the capability for bistability of the underlying biochemical network structure. Chemical Reaction Network Theory (CRNT) may help at this level to decide whether a given network has the capacity for multiple positive equilibria, based on their structural properties. However, in order to build a working switch, we also need to ensure that the bistability property is robust, by studying the conditions leading to the existence of two different steady states. In the reverse engineering of biological switches, knowledge collected about the bistable regimes of the underlying potential model structures can contribute at the model identification stage to a drastic reduction of the feasible region in the parameter space of search. In this work, we make use and extend previous results of the CRNT, aiming not only to discriminate whether a biochemical reaction network can exhibit multiple steady states, but also to determine the regions within the whole space of parameters capable of producing multistationarity. To that purpose we present and justify a condition on the parameters of biochemical networks for the appearance of multistationarity, and propose an efficient and reliable computational method to check its satisfaction through the parameter space.	[Otero-Muras, Irene] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Zurich, Switzerland; [Banga, Julio R.; Alonso, Antonio A.] Spanish Natl Res Council, CSIC, Inst Invest Marinas, BioProc Engn Grp, Vigo, Spain	Swiss Federal Institutes of Technology Domain; ETH Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Otero-Muras, I (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Zurich, Switzerland.	antonio@iim.csic.es	Otero-Muras, Irene/K-3832-2014; Banga, Julio R./ABD-8629-2020; Banga, Julio R./A-8388-2008	Otero-Muras, Irene/0000-0003-2895-997X; Banga, Julio R./0000-0002-4245-0320; Banga, Julio R./0000-0002-4245-0320; Alonso, Antonio/0000-0001-8203-1799	Spanish government, Ministry of Science and Innovation [DPI2008-06880-C03-02, DPI2004-07444-C04-03]; Xunta de Galicia [PGIDIT02-PXIC40209PN]; Consejo Superior de Investigaciones CientA-ficas [PIE-201170E018]	Spanish government, Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Consejo Superior de Investigaciones CientA-ficas	Funding provided by Spanish government, Ministry of Science and Innovation project MultiSysBio (ref. DPI2008-06880-C03-02) and DPI2004-07444-C04-03, Xunta de Galicia (PGIDIT02-PXIC40209PN). Consejo Superior de Investigaciones CientA-ficas intramural project BioREDES (ref. PIE-201170E018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Angeli D, 2007, MATH BIOSCI, V210, P598, DOI 10.1016/j.mbs.2007.07.003; Bailey JE, 2001, NAT BIOTECHNOL, V19, P503, DOI 10.1038/89204; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Bishop LM, 2010, BIOPHYS J, V98, P1, DOI 10.1016/j.bpj.2009.09.055; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Chickarmane V, 2005, BIOINFORMATICS, V21, P3688, DOI 10.1093/bioinformatics/bti603; Conradi C, 2005, IEE P SYST BIOL, V152, P243, DOI 10.1049/ip-syb:20050045; Conradi C, 2007, P NATL ACAD SCI USA, V104, P19175, DOI 10.1073/pnas.0705731104; Craciun G, 2005, SIAM J APPL MATH, V65, P1526, DOI 10.1137/S0036139904440278; Craciun G, 2006, SIAM J APPL MATH, V66, P1321, DOI 10.1137/050634177; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Csendes T, 2008, OPTIM LETT, V2, P445, DOI 10.1007/s11590-007-0072-3; EDELSTEIN BB, 1970, J THEOR BIOL, V29, P57, DOI 10.1016/0022-5193(70)90118-9; Egea JA, 2007, J GLOBAL OPTIM, V37, P481, DOI 10.1007/s10898-006-9075-3; FEINBERG M, 1987, CHEM ENG SCI, V42, P2229, DOI 10.1016/0009-2509(87)80099-4; FEINBERG M, 1974, CHEM ENG SCI, V29, P775, DOI 10.1016/0009-2509(74)80195-8; FEINBERG M, 1977, ARCH RATION MECH AN, V66, P83, DOI 10.1007/BF00250853; Feinberg M., 1979, LECT CHEM REACTION N; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Govaerts W, 2003, P 2003 ACM S APPL CO, P161; Granvilliers L, 2006, ACM T MATH SOFTWARE, V32, P138, DOI 10.1145/1132973.1132980; HORN F, 1972, ARCH RATION MECH AN, V47, P81; HORN F, 1972, ARCH RATION MECH AN, V49, P172; HUANG S, 2005, COMPUTATIONAL SYSTEM; Jaulin L., 2001, APPL INTERVAL ANAL; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lu J, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-11; Moore RE., 1988, RELIABILITY COMPUTIN; Otero-Muras I, 2008, SYST CONTROL LETT, V57, P554, DOI 10.1016/j.sysconle.2007.12.003; Otero-Muras I, 2009, BIOTECHNOL PROGR, V25, P619, DOI 10.1002/btpr.112; Pal L, 2009, OPTIM METHOD SOFTW, V24, P749, DOI 10.1080/10556780902753395; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pedamallu CS, 2011, INT J MODEL IDENTIF, V14, P133, DOI 10.1504/IJMIC.2011.042347; Ross J, 1999, ANNU REV PHYS CHEM, V50, P51, DOI 10.1146/annurev.physchem.50.1.51; Rump S, 1999, DEV RELIABLE COMPUTI, P77, DOI DOI 10.1007/978-94-017-1247-7; Saez-Rodriguez J, 2008, IET SYST BIOL, V2, P80, DOI 10.1049/iet-syb:20070012; Schreiber I, 2003, J PHYS CHEM A, V107, P9846, DOI 10.1021/jp035310t; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Tyson JJ, 2008, J R SOC INTERFACE, V5, pS1, DOI 10.1098/rsif.2008.0179.focus; Vlad MO, 2006, DETERMINATION COMPLE; Wang YC, 2011, BMC SYST BIOL, V5, DOI [10.1186/1752-0509-5-S1-S6, 10.1186/1752-0509-5-S1-S1]; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19	46	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39194	10.1371/journal.pone.0039194	http://dx.doi.org/10.1371/journal.pone.0039194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802936	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900010
J	Li, YX; Wang, F; Zhang, XY; Qi, Z; Tang, MX; Szeto, C; Li, Y; Zhang, HY; Chen, XW				Li, Yingxin; Wang, Fang; Zhang, Xiaoying; Qi, Zhao; Tang, Mingxin; Szeto, Christopher; Li, Ying; Zhang, Hongyu; Chen, Xiongwen			beta-Adrenergic Stimulation Increases Cav3.1 Activity in Cardiac Myocytes through Protein Kinase A	PLOS ONE			English	Article							GATED CALCIUM-CHANNELS; SMOOTH-MUSCLE CELLS; CA2+ CHANNELS; VENTRICULAR MYOCYTES; ATRIAL CELLS; MODULATION; PHYSIOLOGY; NEURONS; MICE	The T-type Ca2+ channel (TTCC) plays important roles in cellular excitability and Ca2+ regulation. In the heart, TTCC is found in the sinoatrial nodal (SAN) and conduction cells. Cav3.1 encodes one of the three types of TTCCs. To date, there is no report regarding the regulation of Cav3.1 by beta-adrenergic agonists, which is the topic of this study. Ventricular myocytes (VMs) from Cav3.1 double transgenic (TG) mice and SAN cells from wild type, Cav3.1 knockout, or Cav3.2 knockout mice were used to study beta-adrenergic regulation of overexpressed or native Cav3.1-mediated T-type Ca2+ current (ICa-T(3.1)). ICa-T(3.1) was not found in control VMs but was robust in all examined TG-VMs. A b-adrenergic agonist (isoproterenol, ISO) and a cyclic AMP analog (dibutyryl-cAMP) significantly increased ICa-T(3.1) as well as ICa-L in TG-VMs at both physiological and room temperatures. The ISO effect on ICa-L and ICa-T in TG myocytes was blocked by H89, a PKA inhibitor. ICa-T was detected in control wildtype SAN cells but not in Cav3.1 knockout SAN cells, indicating the identity of ICa-T in normal SAN cells is mediated by Cav3.1. Real-time PCR confirmed the presence of Cav3.1 mRNA but not mRNAs of Cav3.2 and Cav3.3 in the SAN. ICa-T in SAN cells from wild type or Cav3.2 knockout mice was significantly increased by ISO, suggesting native Cav3.1 channels can be upregulated by the beta-adrenergic (beta-AR) system. In conclusion, b-adrenergic stimulation increases ICa-T(3.1) in cardiomyocytes, which is mediated by the cAMP/PKA pathway. The upregulation of ICa-T(3.1) by the b-adrenergic system could play important roles in cellular functions involving Cav3.1.	[Li, Yingxin; Wang, Fang; Zhang, Xiaoying; Qi, Zhao; Tang, Mingxin; Szeto, Christopher; Li, Ying; Zhang, Hongyu; Chen, Xiongwen] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA; [Li, Yingxin; Wang, Fang; Zhang, Xiaoying; Qi, Zhao; Tang, Mingxin; Szeto, Christopher; Li, Ying; Zhang, Hongyu; Chen, Xiongwen] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Li, Ying] Third Mil Med Univ, Inst Burn Res, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Army Medical University	Li, YX (corresponding author), Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA.	xchen001@temple.edu	Chen, Xiongwen/D-5988-2012	Chen, Xiongwen/0000-0002-3829-5815	National Institutes of Health [R01-HL088243]; American Heart Association [0730347N, 09PRE2260943]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (R01-HL088243 to X.C.) and American Heart Association (SDG Grant 0730347N to X.C. and Predoctoral Fellowship 09PRE2260943 to Y.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P. J., 2007, V45, P215; AKAIKE N, 1991, COMP BIOCHEM PHYS C, V98, P31; Alvarez JL, 1996, J PHYSIOL-LONDON, V491, P321, DOI 10.1113/jphysiol.1996.sp021218; ALVAREZ JL, 1992, J GEN PHYSIOL, V100, P519, DOI 10.1085/jgp.100.3.519; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; BENHAM CD, 1988, J PHYSIOL-LONDON, V404, P767, DOI 10.1113/jphysiol.1988.sp017318; Chemin J, 2007, J BIOL CHEM, V282, P32710, DOI 10.1074/jbc.M702746200; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chen XW, 2002, CIRC RES, V91, P517, DOI 10.1161/01.RES.0000033988.13062.7C; FISHER R, 1990, J NEUROPHYSIOL, V64, P1291, DOI 10.1152/jn.1990.64.4.1291; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Huc S, 2009, BBA-MOL CELL RES, V1793, P947, DOI 10.1016/j.bbamcr.2008.11.003; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Kim D, 2003, SCIENCE, V302, P117, DOI 10.1126/science.1088886; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011; Lenglet S, 2002, ENDOCR RES, V28, P651, DOI 10.1081/ERC-120016981; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Metrich M, 2009, PHARMACOL REP, V61, P146, DOI 10.1016/S1734-1140(09)70017-9; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Nilius B, 2006, CELL CALCIUM, V40, P81, DOI 10.1016/j.ceca.2006.04.011; NUSS HB, 1993, CIRC RES, V73, P777, DOI 10.1161/01.RES.73.4.777; Perez-Reyes E, 2006, CNS NEUROL DISORD-DR, V5, P605, DOI 10.2174/187152706779025508; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 2006, CELL CALCIUM, V40, P89, DOI 10.1016/j.ceca.2006.04.012; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Shuba YM, 2008, CHANNELS, V2, P299, DOI 10.4161/chan.2.4.6577; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995; Wu YJ, 2009, P NATL ACAD SCI USA, V106, P5972, DOI 10.1073/pnas.0806422106; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39965	10.1371/journal.pone.0039965	http://dx.doi.org/10.1371/journal.pone.0039965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808078	gold, Green Submitted, Green Published			2022-12-27	WOS:000306406700016
J	Avva, J; Weis, MC; Sramkoski, RM; Sreenath, N; Jacobberger, JW				Avva, Jayant; Weis, Michael C.; Sramkoski, R. Michael; Sreenath, N.; Jacobberger, James W.			Dynamic Expression Profiles from Static Cytometry Data: Component Fitting and Conversion to Relative, "Same Scale'' Values	PLOS ONE			English	Article							HUMAN CYCLIN B1; CELL-CYCLE; HISTONE H3; AURORA-B; GENE-EXPRESSION; FLOW-CYTOMETRY; PHOSPHORYLATION; LOCALIZATION; MODEL	Background: Cytometry of asynchronous proliferating cell populations produces data with an extractable time-based feature embedded in the frequency of clustered, correlated events. Here, we present a specific case of general methodology for calculating dynamic expression profiles of epitopes that oscillate during the cell cycle and conversion of these values to the same scale. Methods: Samples of K562 cells from one population were labeled by direct and indirect antibody methods for cyclins A2 and B1 and phospho-S10-histone H3. The same indirect antibody was used for both cyclins. Directly stained samples were counter-stained with 496-diamidino-2-phenylindole and indirectly stained samples with propidium to label DNA. The S phase cyclin expressions from indirect assays were used to scale the expression of the cyclins of the multi-variate direct assay. Boolean gating and two dimensional, sequential regions set on bivariate displays of the directly conjugated sample data were used to untangle and isolate unique, unambiguous expression values of the cyclins along the four-dimensional data path through the cell cycle. The median values of cyclins A2 and B1 from each region were correlated with the frequency of events within each region. Results: The sequential runs of data were plotted as continuous multi-line linear equations of the form y = [(y(i+1)-y(i))/(x(i+1)-x(i))]x+y(i)-[(y(i+1)-y(i))/(x(i+1)-x(i))]x(i) (line between points (x(i),y(i)) and (x(i+1), y(i+1))) to capture the dynamic expression profile of the two cyclins. Conclusions: This specific approach demonstrates the general methodology and provides a rule set from which the cell cycle expression of any other epitopes could be measured and calculated. These expression profiles are the "state variable'' outputs, useful for calibrating mathematical cell cycle models.	[Avva, Jayant; Weis, Michael C.; Sreenath, N.] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [Sramkoski, R. Michael; Jacobberger, James W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Avva, J (corresponding author), Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA.	jwj@case.edu	Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	National Cancer Institute [R01CA73413, P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA073413] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants (R01CA73413 to James W. Jacobberger) and (P30CA43703 to Stanton Gerson at Case Comprehensive Cancer Center Core Facility Support), both from the National Cancer Institute (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avva J, 2011, METHODS MOL BIOL, V717, P171, DOI 10.1007/978-1-61779-024-9_10; Bagwell CB, 1993, CLIN FLOW CYTOMETRY, P635; Bazile F, 2010, CELL CYCLE, V9, P3243, DOI 10.4161/cc.9.16.12620; Becker M, 2010, CELL CYCLE, V9, P1360, DOI 10.4161/cc.9.7.11177; Conradie R, 2010, FEBS J, V277, P357, DOI 10.1111/j.1742-4658.2009.07473.x; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Csikasz-Nagy A, 2009, BRIEF BIOINFORM, V10, P424, DOI 10.1093/bib/bbp005; Erlandsson F, 2000, EXP CELL RES, V259, P86, DOI 10.1006/excr.2000.4889; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; Frisa PS, 2000, CYTOMETRY, V39, P79, DOI 10.1002/(SICI)1097-0320(20000101)39:1<79::AID-CYTO11>3.0.CO;2-3; GONG JP, 1995, CELL GROWTH DIFFER, V6, P1485; Gray JW, 1990, FLOW CYTOMETRY CELL; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jacobberger JW, 2008, CYTOM PART A, V73A, P5, DOI 10.1002/cyto.a.20501; Jacobberger JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030870; Jacobberger JW, 2011, METHODS MOL BIOL, V699, P229, DOI 10.1007/978-1-61737-950-5_11; JACOBBERGER JW, 1986, CYTOMETRY, V7, P356, DOI 10.1002/cyto.990070410; Jacobberger JW, 2003, CYTOM PART A, V54A, P75, DOI 10.1002/cyto.a.10063; Jacobberger JW, 1999, CYTOMETRY, V35, P284, DOI 10.1002/(SICI)1097-0320(19990301)35:3<284::AID-CYTO12>3.0.CO;2-K; Juan G, 1999, EXP CELL RES, V246, P212, DOI 10.1006/excr.1998.4283; Koseoglu MM, 2010, CELL CYCLE, V9, P3857, DOI 10.4161/cc.9.19.13300; LOZZIO CB, 1973, J NATL CANCER I, V50, P535, DOI 10.1093/jnci/50.2.535; Monier K, 2007, J CELL SCI, V120, P101, DOI 10.1242/jcs.03326; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pines J, 2009, MOL CELL, V34, P135, DOI 10.1016/j.molcel.2009.04.006; Scrittori L, 2005, MOL BIOL CELL, V16, P292, DOI 10.1091/mbc.E04-06-0447; Singhania R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001077; Viallard JF, 1999, EXP CELL RES, V247, P208, DOI 10.1006/excr.1998.4352; Viallard JF, 2000, CYTOMETRY, V39, P117, DOI 10.1002/(SICI)1097-0320(20000201)39:2<117::AID-CYTO4>3.3.CO;2-R; WALKER PMB, 1954, J EXP BIOL, V31, P8; Weis MC, 2011, THESIS CASE W RESERV, P189	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e38275	10.1371/journal.pone.0038275	http://dx.doi.org/10.1371/journal.pone.0038275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808005	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400004
J	Chen, YY; Chang, JR; Huang, WF; Kuo, SC; Su, IJ; Sun, JR; Chiueh, TS; Huang, TS; Chen, YS; Dou, HY				Chen, Yih-Yuan; Chang, Jia-Ru; Huang, Wei-Feng; Kuo, Shu-Chen; Su, Ih-Jen; Sun, Jun-Ren; Chiueh, Tzong-Shi; Huang, Tsi-Shu; Chen, Yao-Shen; Dou, Horng-Yunn			Genetic Diversity of the Mycobacterium tuberculosis Beijing Family Based on SNP and VNTR Typing Profiles in Asian Countries	PLOS ONE			English	Article							POPULATION-STRUCTURE ANALYSIS; MOLECULAR EPIDEMIOLOGY; VARIABLE-NUMBER; EAST-ASIA; STRAINS; GENOTYPE; EVOLUTIONARY; SUBLINEAGES; RESISTANCE; RUSSIA	The Mycobacterium tuberculosis (MTB) Beijing strain is highly virulent, drug resistant, and endemic over Asia. To explore the genetic diversity of this family in several different regions of eastern Asia, 338 Beijing strains collected in Taiwan (Republic of China) were analyzed by mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing and compared with published MIRU-VNTR profiles and by the Hunter-Gaston diversity index (HGDI) of Beijing strains from Japan and South Korea. The results revealed that VNTR2163b (HGDI>0.6) and five other loci (VNTR424, VNTR4052, VNTR1955, VNTR4156 and VNTR 2996; HGDI>0.3) could be used to discriminate the Beijing strains in a given geographic region. Analysis based on the number of VNTR repeats showed three VNTRs (VNTR424, 3192, and 1955) to be phylogenetically informative loci. In addition, to determine the geographic variation of sequence types in MTB populations, we also compared sequence type (ST) data of our strains with published ST profiles of Beijing strains from Japan and Thailand. ST10, ST22, and ST19 were found to be prevalent in Taiwan (82%) and Thailand (92%). Furthermore, classification of Beijing sublineages as ancient or modern in Taiwan was found to depend on the repeat number of VNTR424. Finally, phylogenetic relationships of MTB isolates in Taiwan, South Korea, and Japan were revealed by a minimum spanning tree based on MIRU-VNTR genotyping. In this topology, the MIRU-VNTR genotypes of the respective clusters were tightly correlated to other genotypic characters. These results are consistent with the hypothesis that clonal evolution of these MTB lineages has occurred.	[Chen, Yih-Yuan; Chang, Jia-Ru; Huang, Wei-Feng; Kuo, Shu-Chen; Su, Ih-Jen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Sun, Jun-Ren; Chiueh, Tzong-Shi] Triserv Gen Hosp, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Sun, Jun-Ren; Chiueh, Tzong-Shi] Natl Def Med Ctr, Taipei, Taiwan; [Huang, Tsi-Shu; Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Microbiol, Kaohsiung, Taiwan; [Dou, Horng-Yunn] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	National Health Research Institutes - Taiwan; Tri-Service General Hospital; National Defense Medical Center; Kaohsiung Veterans General Hospital; Taipei Medical University	Chen, YY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Dou, horng-yunn/F-1966-2015; Su, Ih-Jen/B-2655-2010; Kuo, Shu-Chen/G-9108-2011; Dou, Horng-Yunn/B-2652-2010	Chen, Yih-Yuan/0000-0001-9507-291X; Sun, jun-ren/0000-0002-8769-9170	National Health Research Institutes; National Science Council, Taiwan [NSC 100-3111-B-400-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This project was supported by grants from the National Health Research Institutes and National Science Council (NSC 100-3111-B-400-001), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Chang JR, 2011, CLIN MICROBIOL INFEC, V17, P1391, DOI 10.1111/j.1469-0691.2010.03436.x; Dou HY, 2008, INFECT GENET EVOL, V8, P323, DOI 10.1016/j.meegid.2008.02.003; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Dou HY, 2011, INT J EVOL BIOL, V2011; Faksri K, 2011, INFECT GENET EVOL, V11, P1142, DOI 10.1016/j.meegid.2011.04.007; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Hanekom M, 2007, J CLIN MICROBIOL, V45, P2263, DOI 10.1128/JCM.02354-06; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Milan SJ, 2004, J CLIN MICROBIOL, V42, P1064, DOI 10.1128/JCM.42.3.1064-1068.2004; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2002, J CLIN MICROBIOL, V40, P1504, DOI 10.1128/JCM.40.4.1504-1507.2002; Mokrousov I, 2006, ANTIMICROB AGENTS CH, V50, P2820, DOI 10.1128/AAC.00324-06; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Schurch AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028365; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wada T, 2009, INFECT GENET EVOL, V9, P921, DOI 10.1016/j.meegid.2009.06.012; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007	33	29	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39792	10.1371/journal.pone.0039792	http://dx.doi.org/10.1371/journal.pone.0039792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808061	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400012
J	Nissen, TN; Rose, MV; Kimaro, G; Bygbjerg, IC; Mfinanga, SG; Ravn, P				Nissen, Thomas N.; Rose, Michala V.; Kimaro, Godfather; Bygbjerg, Ib C.; Mfinanga, Sayoki G.; Ravn, Pernille			Challenges of Loss to Follow-up in Tuberculosis Research	PLOS ONE			English	Article							GAMMA RELEASE ASSAY; ADHERENCE; CHILDREN; DIAGNOSIS; COHORT; STRATEGIES; MANAGEMENT; INFECTION; HIV	Background: In studies evaluating methods for diagnosing tuberculosis (TB), follow-up to verify the presence or absence of active TB is crucial and high dropout rates may significantly affect the validity of the results. In a study assessing the diagnostic performance of the QuantiFERON (R)-TB Gold In-Tube test in TB suspect children in Tanzania, factors influencing patient adherence to attend follow-up examinations and reasons for not attending were examined. Methods: In 160 children who attended and 102 children who did not attend scheduled 2-month follow-up baseline health characteristics, demographic data and risk factors for not attending follow-up were determined. Qualitative interviews were used to understand patient and caretakers reasons for not returning for scheduled follow-up. Results: Being treated for active TB in the DOTS program (OR: 4.14; 95% CI: 1.99-8.62; p-value < 0.001) and receiving money for the bus fare (OR: 129; 95% CI 16 > 100; P-value < 0.001) were positive predictors for attending follow-up at 2 months, and 21/85(25%) of children not attending scheduled follow-up had died. Interviews revealed that limited financial resources, i.e. lack of money for transportation and poor communication, were related to non-adherence. Conclusion: Patients lost to follow-up is a potential problem for TB research. Receiving money for transportation to the hospital and communication is crucial for adherence to follow-up conducted at a study facility. Strategies to ensure follow-up should be part of any study protocol.	[Nissen, Thomas N.; Rose, Michala V.; Ravn, Pernille] Univ Copenhagen, Hvidovre Hosp, Clin Res Unit, DK-2650 Hvidovre, Denmark; [Rose, Michala V.; Bygbjerg, Ib C.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Kimaro, Godfather; Mfinanga, Sayoki G.] Natl Inst Med Res Muhimbili Ctr, Dar Es Salaam, Tanzania; [Ravn, Pernille] Univ Hosp Hillerod, Dept Infect Dis, Hillerod, Denmark	University of Copenhagen; University of Copenhagen; Muhimbili University of Health & Allied Sciences; National Institute of Medical Research	Nissen, TN (corresponding author), Univ Copenhagen, Hvidovre Hosp, Clin Res Unit, DK-2650 Hvidovre, Denmark.	tnnissen@gmail.com		Nissen, Thomas Norrelykke/0000-0001-8565-9629; Bygbjerg, Ib/0000-0001-9100-2754	Cluster in International Health; Danish Research Council; Danida	Cluster in International Health; Danish Research Council(Det Frie Forskningsrad (DFF)); Danida	Thank you to Cluster in International Health, Danish Research Council, and Danida for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashaye AO, 2008, J GLAUCOMA, V17, P227, DOI 10.1097/IJG.0b013e31815768b3; Bailey A, 2008, AIDS CARE, V20, P1119, DOI 10.1080/09540120701842811; Bam TS, 2006, INT J TUBERC LUNG D, V10, P270; Bamford ARJ, 2010, ARCH DIS CHILD, V95, P180, DOI 10.1136/adc.2009.169805; Bianchi L, 2009, PEDIATR INFECT DIS J, V28, P510, DOI 10.1097/INF.0b013e31819abf6b; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cheng TL, 1997, PEDIATRICS, V100, P210, DOI 10.1542/peds.100.2.210; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Fraser HSF, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.4.e29; Giorgi A., 1985, SKETCH PSYCHOL PHENO, P8; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hunt JR, 1998, EPIDEMIOL REV, V20, P57, DOI 10.1093/oxfordjournals.epirev.a017972; Ickovics JR, 1997, J CLIN EPIDEMIOL, V50, P385, DOI 10.1016/S0895-4356(97)00041-3; Kampmann B, 2009, EUR RESPIR J, V33, P1374, DOI 10.1183/09031936.00153408; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Malterud K., 1996, KVALITATIVE METODER; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Morrow RHS, 1996, FIELD TRIALS HLTH IN; Mugusi F, 2002, J ACQ IMMUN DEF SYND, V30, P119, DOI 10.1097/00126334-200205010-00016; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Pace C, 2005, AM J PUBLIC HEALTH, V95, P1184, DOI 10.2105/AJPH.2004.053082; Pledger G W, 1988, Epilepsy Res Suppl, V1, P125; Robiner WN, 2005, CONTEMP CLIN TRIALS, V26, P59, DOI 10.1016/j.cct.2004.11.015; Robinson KA, 2007, J CLIN EPIDEMIOL, V60, P757, DOI 10.1016/j.jclinepi.2006.11.023; Rose MV, 2012, PLOS ONE IN PRESS; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Taylor S. J., 2015, INTRO QUALITATIVE RE, V4th; Wisniewski SR, 2006, BIOL PSYCHIAT, V59, P997, DOI 10.1016/j.biopsych.2006.01.017	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40183	10.1371/journal.pone.0040183	http://dx.doi.org/10.1371/journal.pone.0040183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808114	Green Published, gold			2022-12-27	WOS:000306366400016
J	Radicchi, F				Radicchi, Filippo			Universality, Limits and Predictability of Gold-Medal Performances at the Olympic Games	PLOS ONE			English	Article							RANDOM-WALK MODELS; RUNNING PERFORMANCE; WORLD; PROGRESSION; EVOLUTION	Inspired by the Games held in ancient Greece, modern Olympics represent the world's largest pageant of athletic skill and competitive spirit. Performances of athletes at the Olympic Games mirror, since 1896, human potentialities in sports, and thus provide an optimal source of information for studying the evolution of sport achievements and predicting the limits that athletes can reach. Unfortunately, the models introduced so far for the description of athlete performances at the Olympics are either sophisticated or unrealistic, and more importantly, do not provide a unified theory for sport performances. Here, we address this issue by showing that relative performance improvements of medal winners at the Olympics are normally distributed, implying that the evolution of performance values can be described in good approximation as an exponential approach to an a priori unknown limiting performance value. This law holds for all specialties in athletics-including running, jumping, and throwing-and swimming. We present a self-consistent method, based on normality hypothesis testing, able to predict limiting performance values in all specialties. We further quantify the most likely years in which athletes will breach challenging performance walls in running, jumping, throwing, and swimming events, as well as the probability that new world records will be established at the next edition of the Olympic Games.	Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain	Universitat Rovira i Virgili	Radicchi, F (corresponding author), Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain.	f.radicchi@gmail.com	Radicchi, Filippo/B-4407-2009	Radicchi, Filippo/0000-0002-8352-1287				ALT W, 1980, J MATH BIOL, V9, P147, DOI 10.1007/BF00275919; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Barney Robert, 1992, OLYMP REV, P627; Beirlant J., 2004, STAT EXTREMES THEORY; Ben-Naim E, 2007, J KOREAN PHYS SOC, V50, P124, DOI 10.3938/jkps.50.124; Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Denny MW, 2008, J EXP BIOL, V211, P3836, DOI 10.1242/jeb.024968; Desgorces FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003653; di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Grubb HJ, 1998, J ROY STAT SOC D-STA, V47, P509, DOI 10.1111/1467-9884.00151; Guillaume M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007573; GUTTMANN A, 1988, INT J, V43, P554, DOI 10.2307/40202563; Guttmann A, 2002, OLYMPICS HIST MODERN, P100; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; Holden C, 2004, SCIENCE, V305, P639, DOI 10.1126/science.305.5684.639; Katz J. Sylvan, 1999, Journal of Sports Sciences, V17, P467, DOI 10.1080/026404199365777; Mandell R.D., 1971, THE NAZI OLYMPICS; Nevill AM, 2007, INT J SPORTS MED, V28, P1012, DOI 10.1055/s-2007-965088; Nevill AM, 2005, MED SCI SPORT EXER, V37, P1785, DOI 10.1249/01.mss.0000181676.62054.79; PERONNET F, 1989, J APPL PHYSIOL, V67, P453, DOI 10.1152/jappl.1989.67.1.453; Peters EE., 1989, FINANCIAL ANAL J, V45, P32, DOI DOI 10.2469/FAJ.V45.N4.32; Petersen AM, 2011, EUR PHYS J B, V79, P67, DOI 10.1140/epjb/e2010-10647-1; Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108; Petersen AM, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50010; Preuss, 2004, EC STAGING OLYMPICS; Radicchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017249; Redner S, 2001, GUIDE FIRST PASSAGE; Reeve Simon, 2000, ONE DAY SEPTEMBER FU; Rice K, 2004, NATURE, V432, P147, DOI 10.1038/432147b; Saavedra S, 2010, PHYSICA A, V389, P1131, DOI 10.1016/j.physa.2009.10.038; Sabhapandit S, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/03/L03001; Savaglio S, 2000, NATURE, V404, P244, DOI 10.1038/35005165; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharp NCC, 2004, NATURE, V432, P147, DOI 10.1038/432147d; Sire C, 2008, EUR PHYS J B, V67, P5; SJODIN B, 1985, SPORTS MED, V2, P83; Sparling PB, 1998, MED SCI SPORT EXER, V30, P1725, DOI 10.1097/00005768-199812000-00011; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Stephens MA, 1986, GOODNESS OF FIT TECH; Swaddling J, 2000, ANCIENT OLYMPIC GAME; Tatem AJ, 2004, NATURE, V431, P525, DOI 10.1038/431525a; Tibshirani R, 1997, AM STAT, V51, P106, DOI 10.2307/2685397; Waitt G, 2003, ANN TOURISM RES, V30, P194, DOI 10.1016/S0160-7383(02)00050-6; Wergen G, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/30008; Wergen G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051109; WILK MB, 1968, BIOMETRIKA, V55, P1; Yaari G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024532	51	22	22	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40335	10.1371/journal.pone.0040335	http://dx.doi.org/10.1371/journal.pone.0040335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808137	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400019
J	Huang, XZ; Frye, JG; Chahine, MA; Glenn, LM; Ake, JA; Su, WW; Nikolich, MP; Lesho, EP				Huang, Xiao-Zhe; Frye, Jonathan G.; Chahine, Mohamad A.; Glenn, LaShanda M.; Ake, Julie A.; Su, Wanwen; Nikolich, Mikeljon P.; Lesho, Emil P.			Characteristics of Plasmids in Multi-Drug-Resistant Enterobacteriaceae Isolated during Prospective Surveillance of a Newly Opened Hospital in Iraq	PLOS ONE			English	Article							SALMONELLA-ENTERICA; GENES; MICROARRAY; INTEGRONS	Background: Gram-negative multidrug-resistant (MDR) bacteria are major causes of nosocomial infections, and antibiotic resistance in these organisms is often plasmid mediated. Data are scarce pertaining to molecular mechanisms of antibiotic resistance in resource constrained areas such as Iraq. Methodology/Principal Findings: In this study, all MDR Enterobacteriaceae (n = 38) and randomly selected non-MDR counterparts (n = 41) isolated from patients, healthcare workers and environmental surfaces in a newly opened hospital in Iraq were investigated to characterize plasmids found in these isolates and determine their contribution to antibiotic resistance. Our results demonstrated that MDR E. coli and K. pneumoniae isolates harbored significantly more (>= 3) plasmids compared to their non-MDR counterparts, which carried <= 2 plasmids (p<0.01). Various large plasmids (similar to 52 to 100 kb) from representative isolates were confirmed to contain multiple resistance genes by DNA microarray analysis. Aminoglycoside (acc, aadA, aph, strA/B, and ksgA), beta-lactam (bla(TEM1), bla(AMPC), bla(CTX-M-15), bla(OXA-1), bla(VIM-2) and bla(SHV)), sulfamethoxazole/trimethoprim (sul/dfr), tetracycline (tet) and chloramphenicol (cat) resistance genes were detected on these plasmids. Additionally, multiple plasmids carrying multiple antibiotic resistance genes were found in the same host strain. Genetic transfer-associated genes were identified on the plasmids from both MDR and non-MDR isolates. Seven plasmid replicon types (FII, FIA, FIB, B/O, K, I1 and N) were detected in the isolates, while globally disseminated IncA/C and IncHI1 plasmids were not detected in these isolates. Conclusions/Significance: This is the first report of the characteristics of the plasmids found in Enterobacteriaceae isolated following the opening of a new hospital in Iraq. The information provided here furthers our understanding of the mechanisms of drug resistance in this specific region and their evolutionary relationship with other parts of world. The large plasmids, carrying resistance genes and transfer-associated genes, may be potential factors for regional dissemination of antibiotic resistance.	[Huang, Xiao-Zhe; Chahine, Mohamad A.; Su, Wanwen; Nikolich, Mikeljon P.; Lesho, Emil P.] Walter Reed Army Inst Res, Bacterial Dis Branch, Silver Spring, MD USA; [Frye, Jonathan G.; Glenn, LaShanda M.] ARS, Bacterial Epidemiol & Antidrug Resistant Unit, USDA, Athens, GA USA; [Ake, Julie A.] Walter Reed Army Med Ctr, Infect Dis Serv, Washington, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Agriculture (USDA); United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Huang, XZ (corresponding author), Walter Reed Army Inst Res, Bacterial Dis Branch, Silver Spring, MD USA.	xiaozhe.huang1.ctr@us.army.mil	Frye, Jonathan G./I-6382-2013; Nikolich, Mikeljon P/ABC-9871-2021; Nikolich, Mikeljon/ABD-5270-2020	Frye, Jonathan G./0000-0002-8500-3395; Nikolich, Mikeljon P/0000-0001-5770-8980; 	Military Infectious Diseases Research Program (MIDRP); Global Emerging Infectious Diseases Surveillance and Response (GEIS), U.S. Department of Defense (DOD)	Military Infectious Diseases Research Program (MIDRP); Global Emerging Infectious Diseases Surveillance and Response (GEIS), U.S. Department of Defense (DOD)	This study was supported by the Military Infectious Diseases Research Program (MIDRP), and the Global Emerging Infectious Diseases Surveillance and Response (GEIS), U.S. Department of Defense (DOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ake J, 2011, INFECT CONT HOSP EP, V32, P545, DOI 10.1086/660015; Bouza Emilio, 2002, Semin Respir Infect, V17, P215, DOI 10.1053/srin.2002.34693; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2011, ANTIMICROB AGENTS CH; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; FRYE JG, 2009, MICROB DRUG RESIST; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Lesho E, 2011, MIL MED, V176, P763, DOI 10.7205/MILMED-D-10-00330; Lesho EP, 2011, MIL MED, V176, P1; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lindsey RL, 2011, APPL ENVIRON MICROB, V77, P6991, DOI 10.1128/AEM.00567-11; Lindsey RL, 2010, J MICROBIOL METH, V81, P96, DOI 10.1016/j.mimet.2010.01.024; Lindsey RL, 2009, APPL ENVIRON MICROB, V75, P1908, DOI 10.1128/AEM.02228-08; Magiorakos AP, 2011, CLIN MICROBIOL INFEC; Martinez JL, 2002, CLIN MICROBIOL REV, V15, P647, DOI 10.1128/CMR.15.4.647-679.2002; MAYER KH, 1986, AM J MED, V80, P56, DOI 10.1016/0002-9343(86)90480-8; Miro E, 2010, J ANTIMICROB CHEMOTH, V65, P661, DOI 10.1093/jac/dkp504; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128/AAC.00438-06; Novais A, 2006, ANTIMICROB AGENTS CH, V50, P2741, DOI 10.1128/AAC.00274-06; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; van Hal SJ, 2009, J CLIN MICROBIOL, V47, P2325, DOI 10.1128/JCM.02141-08; Whitman TJ, 2008, CLIN INFECT DIS, V47, P439, DOI 10.1086/589247; Zhao F, 2010, PLOS ONE, V5, DOI DOI 10.1371/journal.pone.0010141; Zou W, 2009, J APPL MICROBIOL, V107, P906, DOI 10.1111/j.1365-2672.2009.04270.x	30	24	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40360	10.1371/journal.pone.0040360	http://dx.doi.org/10.1371/journal.pone.0040360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808141	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400045
J	Shao, L; Zheng, H; Jia, FJ; Wang, HQ; Liu, L; Sun, Q; An, MY; Zhang, XH; Wen, H				Shao, Li; Zheng, Hong; Jia, Feng-Ju; Wang, Hui-Qin; Liu, Li; Sun, Qi; An, Meng-Ying; Zhang, Xiu-Hua; Wen, Hao			Methods of Patient Warming during Abdominal Surgery	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; NORMOTHERMIA; HYPOTHERMIA	Background: Keeping abdominal surgery patients warm is common and warming methods are needed in power outages during natural disasters. We aimed to evaluate the efficacy of low-cost, low-power warming methods for maintaining normothermia in abdominal surgery patients. Methods: Patients (n = 160) scheduled for elective abdominal surgery were included in this prospective clinical study. Five warming methods were applied: heated blood transfusion/fluid infusion vs. unheated; wrapping patients vs. not wrapping; applying moist dressings, heated or not; surgical field rinse heated or not; and applying heating blankets or not. Patients' nasopharyngeal and rectal temperatures were recorded to evaluate warming efficacy. Significant differences were found in mean temperatures of warmed patients compared to those not warmed. Results: When we compared temperatures of abdominal surgery patient groups receiving three specific warming methods with temperatures of control groups not receiving these methods, significant differences were revealed in temperatures maintained during the surgeries between the warmed groups and controls. Discussion: The value of maintaining normothermia in patients undergoing abdominal surgery under general anesthesia is accepted. Three effective economical and practically applicable warming methods are combined body wrapping and heating blanket; combined body wrapping, heated moist dressings, and heating blanket; combined body wrapping, heated moist dressings, and warmed surgical rinse fluid, with or without heating blanket. These methods are practically applicable when low-cost method is indeed needed.	[Shao, Li; Jia, Feng-Ju; Wang, Hui-Qin; Liu, Li; An, Meng-Ying; Zhang, Xiu-Hua] Xinjiang Med Univ, Teaching Hosp 1, Dept Operat Room, Urumqi, Xinjiang Uygur, Peoples R China; [Wen, Hao] Xinjiang Med Univ, Teaching Hosp 1, Dept Surg, Urumqi, Xinjiang Uygur, Peoples R China; [Zheng, Hong] Xinjiang Med Univ, Teaching Hosp 1, Dept Anesthesiol, Urumqi, Xinjiang Uygur, Peoples R China; [Sun, Qi] Xinjiang Med Univ, Teaching Hosp 1, Dept Stat Counseling, Urumqi, Xinjiang Uygur, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Shao, L (corresponding author), Xinjiang Med Univ, Teaching Hosp 1, Dept Operat Room, Urumqi, Xinjiang Uygur, Peoples R China.	dr.wenhao@163.com	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022					Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; FRANK SM, 1993, ANESTHESIOLOGY, V78, P468, DOI 10.1097/00000542-199303000-00010; HARLING DW, 1995, ANAESTHESIA, V50, P659; Hervey GR, 1988, TXB PHYSL, P510; Hirvonen EA, 2011, EUR J ANAESTH, V28, P376, DOI 10.1097/EJA.0b013e328340507d; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Liu XY, 2003, ANESTHESIOLOGY, V23, P712; Moran D S, 2001, Harefuah, V140, P1078; Park H, 2007, J KOREAN ACAD NURS, V37, P1061; Putzu Marta, 2007, Acta Biomed, V78, P163; Sessler DI, 1997, ANN NY ACAD SCI, V813, P757, DOI 10.1111/j.1749-6632.1997.tb51779.x; Sessler DI, 2001, ANESTHESIOLOGY, V95, P531, DOI 10.1097/00000542-200108000-00040; Sheng ZR, 1996, CLIN ANESTHESIOLOGY; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Wong PF, 2007, BRIT J SURG, V94, P421, DOI 10.1002/bjs.5631	15	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39622	10.1371/journal.pone.0039622	http://dx.doi.org/10.1371/journal.pone.0039622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808045	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400015
J	Adegoke, A; Utz, B; Msuya, SE; van den Broek, N				Adegoke, Adetoro; Utz, Bettina; Msuya, Sia E.; van den Broek, Nynke			Skilled Birth Attendants: Who is Who? A Descriptive Study of Definitions and Roles from Nine Sub Saharan African Countries	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; MATERNAL MORTALITY; AVAILABILITY	Background: Availability of a Skilled Birth Attendant (SBA) during childbirth is a key indicator for MDG5 and a strategy for reducing maternal and neonatal mortality in Africa. There is limited information on how SBAs and their functions are defined. The aim of this study was to map the cadres of health providers considered SBAs in Sub Saharan Africa (SSA); to describe which signal functions of Essential Obstetric Care (EmOC) they perform and assess whether they are legislated to perform these functions. Methods and Findings: Key personnel in the Ministries of Health, teaching institutions, referral, regional and district hospitals completed structured questionnaires in nine SSA countries in 2009-2011. A total of 21 different cadres of health care providers (HCP) were reported to be SBA. Type and number of EmOC signal functions reported to be provided, varied substantially between cadres and countries. Parenteral antibiotics, uterotonic drugs and anticonvulsants were provided by most SBAs. Removal of retained products of conception and assisted vaginal delivery were the least provided signal functions. Except for the cadres of obstetricians, medical doctors and registered nurse-midwives, there was lack of clarity regarding signal functions reported to be performed and whether they were legislated to perform these. This was particularly for manual removal of placenta, removal of retained products and assisted vaginal delivery. In some countries, cadres not considered SBA performed deliveries and provided EmOC signal functions. In other settings, cadres reported to be SBA were able to but not legislated to perform key EmOC signal functions. Conclusions: Comparison of cadres of HCPs reported to be SBA across countries is difficult because of lack of standardization in names, training, and functions performed. There is a need for countries to develop clear guidelines defining who is a SBA and which EmOC signal functions each cadre of HCP is expected to provide.	[Adegoke, Adetoro; Utz, Bettina; Msuya, Sia E.; van den Broek, Nynke] Univ Liverpool, Liverpool Sch Trop Med, Maternal & Newborn Hlth Unit, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Adegoke, A (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Maternal & Newborn Hlth Unit, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England.	s.e.msuya@liverpool.ac.uk		van den Broek, Nynke/0000-0001-8523-2684; Utz, Bettina/0000-0002-7263-3320	World Health Organization (WHO), Geneva; Department for International Development UK (DFID-UK AID)	World Health Organization (WHO), Geneva(World Health Organization); Department for International Development UK (DFID-UK AID)	The study was funded by the World Health Organization (WHO), Geneva and the Department for International Development UK (DFID-UK AID). The funders had no role in either the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Adegoke AA, 2011, MIDWIFERY, V27, P350, DOI 10.1016/j.midw.2011.03.006; Audo M O, 2005, East Afr Med J, V82, P547; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; Gao YQ, 2009, B WORLD HEALTH ORGAN, V87, P913, DOI 10.2471/BLT.08.060426; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Kongnyuy EJ, 2009, MATERN CHILD HLTH J, V13, P687, DOI 10.1007/s10995-008-0380-y; Kruk ME, 2009, HEALTH POLICY PLANN, V24, P279, DOI 10.1093/heapol/czp011; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lehmann U, 2008, MIDLEVEL HLTH WORKER, P42; Li J, 2007, BJOG-INT J OBSTET GY, V114, P865, DOI 10.1111/j.1471-0528.2007.01362.x; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; Scott S, 2009, TROP MED INT HEALTH, V14, P1523, DOI 10.1111/j.1365-3156.2009.02402.x; ten Hoope-Bender P, 2006, INT J GYNECOL OBSTET, V94, P226, DOI 10.1016/j.ijgo.2006.04.003; UNICEF WHO UNFPA & AMDD, 2009, MON EM OBST CAR HDB; USAID Measure DHS (Demographic and Health Surveys), 2011, USAID MEAS DHS DEM H; Van Lerberghe W, 2001, STUDIES HLTH SERVICE, V17, P7; WHO, 2008, PROP BIRTH ATT SKILL; WHO UNICEF UNFPA & Bank T. W, 2010, TRENDS MAT MORT 1990; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization and UNICEF, 2010, COUNTD 2015 DEC REP; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	26	83	83	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40220	10.1371/journal.pone.0040220	http://dx.doi.org/10.1371/journal.pone.0040220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808121	Green Accepted, Green Published, gold			2022-12-27	WOS:000306355500033
J	Saiz, H; Alados, CL				Saiz, Hugo; Alados, Concepcion L.			Changes in Semi-Arid Plant Species Associations along a Livestock Grazing Gradient	PLOS ONE			English	Article							POSITIVE INTERACTIONS; SPATIAL-PATTERNS; FACILITATION NETWORKS; COMPETITION; COMMUNITIES; VEGETATION; DESERT; DYNAMICS; SHRUB; ENVIRONMENTS	In semi-arid ecosystems, vegetation is heterogeneously distributed, with plant species often associating in patches. These associations between species are not constant, but depend on the particular response of each species to environmental factors. Here, we investigated how plant species associations change in response to livestock grazing in a semi-arid ecosystem, Cabo de Gata-Nijar Natural Park in South East Spain. We established linear point-intercept transects at four sites with different grazing intensity, and recorded all species at each point. We investigated plant associations by comparing the number of times that each pair of species occurred at the same spatial point (co-occurrences), with the expected number of times based on species abundances. We also assessed associations for each shrub and grass species by considering all their pairs of associations and for the whole plant community by considering all pairs of associations on each site. At all sites, the plant community had a negative pattern of association, with fewer co-occurrences than expected. Negative association in the plant community increased at maximum grazing intensity. Most species associated as expected, particularly grass species, and positive associations were most important at intermediate grazing intensities. No species changed its type of association along the grazing gradient. We conclude that in the present plant community, grazing-resistant species compete among themselves and segregate in space. Some shrub species act as refuges for grazing-sensitive species that benefit from being spatially associated with shrub species, particularly at intermediate grazing intensities where positive associations were highest. At high grazing intensity, these shrubs can no longer persist and positive associations decrease due to the disappearance of refuges. Spatial associations between plant species and their response to grazing help identify the factors that organize plant communities, and may contribute to improving management of semi-arid ecosystems.	[Saiz, Hugo; Alados, Concepcion L.] CSIC, Inst Pirenaico Ecol, Dept Biodiversidad & Restaurac, Grp Conservac Biodiversidad, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Saiz, H (corresponding author), CSIC, Inst Pirenaico Ecol, Dept Biodiversidad & Restaurac, Grp Conservac Biodiversidad, Zaragoza, Spain.	hsaiz@ipe.csic.es	Saiz, Hugo/K-8724-2014; Alados, Concepción L/K-8085-2014	Saiz, Hugo/0000-0002-7568-2996; Alados, Concepción L/0000-0002-6227-861X	Spanish Ministry of Science and Innovation [CGL2008-0065]; National Research Council of Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Research Council of Spain	The study was made possible by the financial support of CEBCE project Ref. CGL2008-0065 of the Spanish Ministry of Science and Innovation, and grant JAEPre from the National Research Council of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Alados CL, 2006, BIOL J LINN SOC, V87, P103, DOI 10.1111/j.1095-8312.2006.00559.x; Alados CL, 2003, ECOL MODEL, V163, P1, DOI 10.1016/S0304-3800(02)00294-6; Baraza E, 2006, OIKOS, V113, P148, DOI 10.1111/j.0030-1299.2006.14265.x; Barot S, 1999, ECOLOGY, V80, P1987, DOI 10.1890/0012-9658(1999)080[1987:DOASPT]2.0.CO;2; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bisigato AJ, 1997, J ARID ENVIRON, V36, P639, DOI 10.1006/jare.1996.0247; Brooker R, 2005, OIKOS, V109, P63, DOI 10.1111/j.0030-1299.2005.13557.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 1996, ECOLOGY, V77, P2130, DOI 10.2307/2265707; Casper BB, 1996, OECOLOGIA, V106, P144, DOI 10.1007/BF00328593; Cavieres L, 2002, J VEG SCI, V13, P547, DOI 10.1111/j.1654-1103.2002.tb02081.x; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Engel EC, 2008, PLANT ECOL, V195, P77, DOI 10.1007/s11258-007-9300-2; Escudero A, 2005, J VEG SCI, V16, P383, DOI 10.1111/j.1654-1103.2005.tb02377.x; FOWLER N, 1986, ANNU REV ECOL SYST, V17, P89, DOI 10.1146/annurev.es.17.110186.000513; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Holt AR, 2002, BASIC APPL ECOL, V3, P1, DOI 10.1078/1439-1791-00083; Maestre FT, 2005, PLANT ECOL, V179, P133, DOI 10.1007/s11258-004-4641-6; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; MCAULIFFE JR, 1988, AM NAT, V131, P459, DOI 10.1086/284802; MCNAUGHTON SJ, 1986, AM NAT, V128, P765, DOI 10.1086/284602; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Navarro T, 2009, CANDOLLEA, V64, P69; NIERING WA, 1963, SCIENCE, V142, P15, DOI 10.1126/science.142.3588.15; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Oyonarte C., 1999, CARTOGRAFIA DELIMITA; Passera C, 1999, THESIS U GRANADA GRA; Peinado M, 1992, FLORA VEGETATIO MUND; Pugnaire FI, 2011, J ARID ENVIRON, V75, P1310, DOI 10.1016/j.jaridenv.2011.01.016; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Rees M, 1996, AM NAT, V147, P1, DOI 10.1086/285837; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROBLES AB, 1995, J ARID ENVIRON, V30, P191, DOI 10.1016/S0140-1963(05)80070-9; Smit C, 2007, OECOLOGIA, V152, P265, DOI 10.1007/s00442-006-0650-6; Smit C, 2009, J ECOL, V97, P1215, DOI 10.1111/j.1365-2745.2009.01555.x; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tirado R, 2005, OIKOS, V111, P437, DOI 10.1111/j.1600-0706.2005.14094.x; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Verdu M, 2011, OIKOS, V120, P1351, DOI 10.1111/j.1600-0706.2011.19477.x	46	49	49	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40551	10.1371/journal.pone.0040551	http://dx.doi.org/10.1371/journal.pone.0040551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792367	Green Published, gold			2022-12-27	WOS:000306354700059
J	Bian, CJ; Wu, R; Cho, K; Yu, XC				Bian, Chunjing; Wu, Rong; Cho, Kathleen; Yu, Xiaochun			Loss of BRCA1-A Complex Function in RAP80 Null Tumor Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; HUMAN OVARIAN; CANCER SUSCEPTIBILITY; TARGETS BRCA1; BREAST; PROTEIN; MUTATIONS; BINDING; PALB2; BRIP1	Receptor Associated Protein 80 (RAP80) is a subunit of the BRCA1-A complex and targets BRCA1 to DNA damage sites in response to DNA double strand breaks. Since mutations of BRCA1 are associated with familial ovarian cancers, we screened 26 ovarian cancer-derived cell lines for RAP80 mutations and found that TOV-21G cells harbor a RAP80 mutation (c.1107G>A). This mutation generates a stop codon at Trp369, which deletes the partial AIR region and the C-terminal zinc fingers of RAP80. Interestingly, both the mutant and wild type alleles of RAP80 lose their expression due to promoter hypermethylation, suggesting that TOV-21G is a RAP80-null cell line. In these cells, not only is the BRCA1-A complex disrupted, but the relocation of the remaining subunits in the BRCA1-A complex including BRCA1, CCDC98, NBA1, BRCC36 and BRE is significantly suppressed. Moreover, TOV-21G cells are hypersensitive to ionizing radiation, which is due to the compromised DNA damage repair capacity in these cells. Reconstitution of TOV-21G cells with wild type RAP80 rescues these cellular defects in response to DNA damage. Thus, our results demonstrate that RAP80 is a scaffold protein in the BRCA1-A complex. Identification of TOV-21G as a RAP80 null tumor cell line will be very useful for the study of the molecular mechanism in DNA damage response.	[Bian, Chunjing; Cho, Kathleen; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Wu, Rong; Cho, Kathleen] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bian, CJ (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	kathcho@umich.edu; xiayu@umich.edu		Cho, Kathleen/0000-0003-0500-9998	American Cancer Society [RSG-08-125-01-CCG]; United States National Institutes of Health [CA132755, CA130899]; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society (RSG-08-125-01-CCG to X.Y.) and the United States National Institutes of Health (CA132755 and CA130899 to X.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Akbari MR, 2009, BREAST CANCER RES TR, V113, P377, DOI 10.1007/s10549-008-9938-z; American Cancer Society, 2007, GLOBAL CANC FACTS FI; BUICK RN, 1985, CANCER RES, V45, P3668; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Dansonka-Mieszkowska A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-20; De Nicolo A, 2008, CLIN CANCER RES, V14, P4672, DOI 10.1158/1078-0432.CCR-08-0087; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Kato M, 2000, J HUM GENET, V45, P133, DOI 10.1007/s100380050199; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Luo MP, 1997, GYNECOL ONCOL, V67, P277, DOI 10.1006/gyno.1997.4880; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Pylkas K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-146; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rauh-Adelmann C, 2000, MOL CARCINOGEN, V28, P236, DOI 10.1002/1098-2744(200008)28:4<236::AID-MC6>3.0.CO;2-H; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Velicescu M, 2003, CANCER RES, V63, P5813; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wong MW, 2011, BREAST CANCER RES TR, V127, P853, DOI 10.1007/s10549-011-1443-0; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	42	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40406	10.1371/journal.pone.0040406	http://dx.doi.org/10.1371/journal.pone.0040406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792303	Green Submitted, gold, Green Published			2022-12-27	WOS:000306461800077
J	Porter, NM; Bohannon, JH; Curran-Rauhut, M; Buechel, HM; Dowling, ALS; Brewer, LD; Popovic, J; Thibault, V; Kraner, SD; Chen, KC; Blalock, EM				Porter, Nada M.; Bohannon, Julia H.; Curran-Rauhut, Meredith; Buechel, Heather M.; Dowling, Amy L. S.; Brewer, Lawrence D.; Popovic, Jelena; Thibault, Veronique; Kraner, Susan D.; Chen, Kuey Chu; Blalock, Eric M.			Hippocampal CA1 Transcriptional Profile of Sleep Deprivation: Relation to Aging and Stress	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AGE-RELATED-CHANGES; SLOW-WAVE SLEEP; ALZHEIMERS-DISEASE; GENE-EXPRESSION; GLUCOSE-METABOLISM; MECHANISMS; HOMER1A; WAKE; BIOINFORMATICS	Background: Many aging changes seem similar to those elicited by sleep-deprivation and psychosocial stress. Further, sleep architecture changes with age suggest an age-related loss of sleep. Here, we hypothesized that sleep deprivation in young subjects would elicit both stress and aging-like transcriptional responses. Methodology/Principal Findings: F344 rats were divided into control and sleep deprivation groups. Body weight, adrenal weight, corticosterone level and hippocampal CA1 transcriptional profiles were measured. A second group of animals was exposed to novel environment stress (NES), and their hippocampal transcriptional profiles measured. A third cohort exposed to control or SD was used to validate transcriptional results with Western blots. Microarray results were statistically contrasted with prior transcriptional studies. Microarray results pointed to sleep pressure signaling and macromolecular synthesis disruptions in the hippocampal CA1 region. Animals exposed to NES recapitulated nearly one third of the SD transcriptional profile. However, the SD -aging relationship was more complex. Compared to aging, SD profiles influenced a significant subset of genes. mRNA associated with neurogenesis and energy pathways showed agreement between aging and SD, while immune, glial, and macromolecular synthesis pathways showed SD profiles that opposed those seen in aging. Conclusions/Significance: We conclude that although NES and SD exert similar transcriptional changes, selective presynaptic release machinery and Homer1 expression changes are seen in SD. Among other changes, the marked decrease in Homer1 expression with age may represent an important divergence between young and aged brain response to SD. Based on this, it seems reasonable to conclude that therapeutic strategies designed to promote sleep in young subjects may have off-target effects in the aged. Finally, this work identifies presynaptic vesicular release and intercellular adhesion molecular signatures as novel therapeutic targets to counter effects of SD in young subjects.	[Porter, Nada M.; Buechel, Heather M.; Brewer, Lawrence D.; Popovic, Jelena; Thibault, Veronique; Chen, Kuey Chu; Blalock, Eric M.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Bohannon, Julia H.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Curran-Rauhut, Meredith] Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA; [Dowling, Amy L. S.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Kraner, Susan D.] Wright State Univ, Dept Neurosci Cell Biol Physiol, Dayton, OH 45435 USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; Dickinson College; University of Kentucky; University System of Ohio; Wright State University Dayton	Porter, NM (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	emblal@uky.edu		Kraner, Susan/0000-0002-1062-4007	DARPA; NIH [NIA AG10836, NIA AG037868]; NATIONAL INSTITUTE ON AGING [P01AG010836, R01AG037868] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a DARPA sub-contract, and NIH grants NIA AG10836 and NIA AG037868. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, approval from DARPA was required to allow public access to microarray data.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Ancoli-Israel S, 2006, AM J GERIAT PSYCHIAT, V14, P95, DOI 10.1097/01.JGP.0000196627.12010.d1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avidan Alon Y, 2003, Clin Cornerstone, V5, P51, DOI 10.1016/S1098-3597(03)90035-4; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Benfenati F, 2004, J NEUROCHEM, V89, P1260, DOI 10.1111/j.1471-4159.2004.02419.x; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blalock EM, 2003, J NEUROSCI, V23, P3807; Blalock EM, 2011, J CHEM NEUROANATOMY; Blalock EM, 2012, J UROLOGY, V187, P725, DOI 10.1016/j.juro.2011.09.142; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Blalock EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010405; Blalock EM, 2010, J NEUROSCI, V30, P6058, DOI 10.1523/JNEUROSCI.3956-09.2010; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Born J, 2010, WORLD J BIOL PSYCHIA, V11, P16, DOI 10.3109/15622971003637637; BOWERSOX SS, 1984, SLEEP, V7, P380, DOI 10.1093/sleep/7.4.380; Boyle J, 2011, J PSYCHOPHARMACOLOGY; Buechel HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018387; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Cai AH, 1997, AM J PHYSIOL-REG I, V273, pR1764, DOI 10.1152/ajpregu.1997.273.5.R1764; Cho YW, 2011, SEIZURE-EUR J EPILEP, V20, P336, DOI 10.1016/j.seizure.2011.01.006; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; Christian LM, 2011, PSYCHONEUROENDOCRINO, V36, P1495, DOI 10.1016/j.psyneuen.2011.04.003; Cirelli C, 2006, J NEUROCHEM, V98, P1632, DOI 10.1111/j.1471-4159.2006.04058.x; Clement P, 2003, NEUROSCIENCE, V116, P863, DOI 10.1016/S0306-4522(02)00761-3; COENEN AML, 1985, PHYSIOL BEHAV, V35, P501, DOI 10.1016/0031-9384(85)90130-1; Conti B, 2007, MOL PSYCHIATR, V12, P167, DOI 10.1038/sj.mp.4001897; Diekelmann S, 2011, NAT NEUROSCI; ELDRIDGE JC, 1989, J NEUROSCI, V9, P3237; ELEFTHERIOU BE, 1975, GERONTOLOGY, V21, P21, DOI 10.1159/000212027; Espiritu JRD, 2008, CLIN GERIATR MED, V24, P1, DOI 10.1016/j.cger.2007.08.007; Florian C, 2011, J NEUROSCI, V31, P6956, DOI 10.1523/JNEUROSCI.5761-10.2011; Garrido P, 2011, AGING DIS, V2, P80; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hampson RE, 2009, PSYCHOPHARMACOLOGY, V202, P355, DOI 10.1007/s00213-008-1360-z; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Hughes Timothy R, 2009, J Biol, V8, P3, DOI 10.1186/jbiol104; Hursh SR, 2004, AVIAT SPACE ENVIR MD, V75, pA44; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kelly MJ, 2008, MOL CELL ENDOCRINOL, V290, P14, DOI 10.1016/j.mce.2008.04.014; Kitka T, 2009, BEHAV BRAIN RES, V205, P482, DOI 10.1016/j.bbr.2009.08.004; Kryger M, 2004, GERIATRICS-US, V59, P24; Landfield PW, 2007, CURR ALZHEIMER RES, V4, P205, DOI 10.2174/156720507780362083; Mackiewicz M, 2008, PHYSIOL GENOMICS, V33, P91, DOI 10.1152/physiolgenomics.00189.2007; Mackiewicz M, 2008, ANN NY ACAD SCI, V1129, P335, DOI 10.1196/annals.1417.030; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Mariani E, 2007, J ALZHEIMERS DIS, V12, P23; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Monjan Andrew A, 2010, Front Neurol, V1, P124, DOI 10.3389/fneur.2010.00124; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; Nelson SE, 2004, NEUROSCI LETT, V367, P105, DOI 10.1016/j.neulet.2004.05.089; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Snedecor GW, 1967, STATISTICAL METHODS, P199; Sohrabji F, 2006, ENDOCRINE, V29, P191, DOI 10.1385/ENDO:29:2:191; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Suchecki D, 2000, PHYSIOL BEHAV, V68, P309, DOI 10.1016/S0031-9384(99)00181-X; Takeuchi T, 2002, BEHAV BRAIN RES, V136, P193, DOI 10.1016/S0166-4328(02)00123-7; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Thompson CL, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00165; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tornatore Jane B, 2003, Am J Alzheimers Dis Other Demen, V18, P240, DOI 10.1177/153331750301800413; Tractenberg RE, 2005, J SLEEP RES, V14, P177, DOI 10.1111/j.1365-2869.2005.00445.x; Van Cauter E, 1998, HORM RES, V49, P147, DOI 10.1159/000023162; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Weinert D, 2000, CHRONOBIOL INT, V17, P261, DOI 10.1081/CBI-100101048; Youngblood BD, 1997, PHYSIOL BEHAV, V61, P249, DOI 10.1016/S0031-9384(96)00363-0; Zhdanova IV, 2011, J BIOL RHYTHM, V26, P149, DOI 10.1177/0748730410395849	86	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40128	10.1371/journal.pone.0040128	http://dx.doi.org/10.1371/journal.pone.0040128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792227	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300028
J	Tang, JS; Liao, YH; Zhou, B; Tan, CL; Liu, WQ; Wang, D; Liu, TQ; Hao, W; Tan, LW; Chen, XG				Tang, Jinsong; Liao, Yanhui; Zhou, Bing; Tan, Changliang; Liu, Weiqing; Wang, Dong; Liu, Tieqiao; Hao, Wei; Tan, Liwen; Chen, Xiaogang			Decrease in Temporal Gyrus Gray Matter Volume in First-Episode, Early Onset Schizophrenia: An MRI Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SYNDROME SCALE PANSS; BRAIN MORPHOLOGY; MACAQUE MONKEYS; 1ST EPISODE; PSYCHOSIS; DEFICITS; ADOLESCENTS; CHILDHOOD; DURATION	Background: Loss of gray matter has been previously found in early-onset schizophrenic patients. However, there are no consistent findings between studies due to different methods used to measure grey matter volume/density and influences of confounding factors. Methods: The volume of gray matter (GM) was measured in 29 first episode early-onset schizophrenia (EOS) and 34 well-matched healthy controls by using voxel-based morphometry (VBM). Psychotic symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS). The correlations between the GM volume and PANSS scores, age of psychosis onset, duration of psychosis, and chlorpromazine (CPZ) equivalent value were investigated. Results: Relative to healthy subjects, the patients with first episode EOS showed significantly lower GM volume in the left middle and superior temporal gyrus. The loss of GM volume negatively correlated with PANSS-positive symptoms (p = 0.002), but not with PANSS-negative symptoms, PANSS-general psychopathology, and PANSS-total score. No significant correlation was found between GM volume and age of psychosis onset, duration of psychosis, and CPZ equivalent value. Conclusion: Patients with first episode EOS have evidence of reduced GM in the left middle and superior temporal gyrus. Structural abnormalities in the left middle and superior temporal gyrus may contribute to the pathophysiology of schizophrenia.	[Tang, Jinsong; Liao, Yanhui; Liu, Weiqing; Wang, Dong; Liu, Tieqiao; Hao, Wei; Tan, Liwen; Chen, Xiaogang] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China; [Zhou, Bing; Tan, Changliang] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tang, JS (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China.	chenxghn@gmail.com	Liao, Yanhui/L-1590-2016; liu, tieqiao/GSE-2327-2022	Liao, Yanhui/0000-0003-4735-3252; 	Natural Science Foundation of China [30900486, 81100996, 81130020]; National Key Basic Research and Development Program (973) [2012CB517904, 2009CB522007]; National Key Technology R&D Program of China [2012BAI01B07]; Central Colleges Basic Scientific Research Operating Expenses [2011QNZT170]; Specialized Research Fund for the Doctoral Program of Higher Education [20110162120013]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); Central Colleges Basic Scientific Research Operating Expenses; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the Natural Science Foundation of China (Grant No. 30900486 to JT, 81100996 to YL, 81130020 to WH), the National Key Basic Research and Development Program (973) (Grant No. 2012CB517904 to XC, 2009CB522007 to WH), National Key Technology R&D Program in the 12th Five-Year Plan of China (2012BAI01B07 to WH), Central Colleges Basic Scientific Research Operating Expenses (2011QNZT170 to YL), and Specialized Research Fund for the Doctoral Program of Higher Education (20110162120013 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 2006, AM J MED GENET B, V141B, P513, DOI 10.1002/ajmg.b.30338; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; Arango C, 2012, ARCH GEN PSYCHIAT, V69, P16, DOI 10.1001/archgenpsychiatry.2011.150; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bangalore SS, 2009, NEUROREPORT, V20, P729, DOI 10.1097/WNR.0b013e32832ae501; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Emsley R, 2003, SCHIZOPHR RES, V61, P47, DOI 10.1016/S0920-9964(02)00302-X; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gogtay N, 2007, ARCH GEN PSYCHIAT, V64, P772, DOI 10.1001/archpsyc.64.7.772; Ho BC, 2003, AM J PSYCHIAT, V160, P142, DOI 10.1176/appi.ajp.160.1.142; Hoff AL, 2000, AM J PSYCHIAT, V157, P1824, DOI 10.1176/appi.ajp.157.11.1824; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honea RA, 2008, BIOL PSYCHIAT, V63, P465, DOI 10.1016/j.biopsych.2007.05.027; Janssen J, 2008, J AM ACAD CHILD PSY, V47, P1311, DOI 10.1097/CHI.0b013e318184ff48; Jung WH, 2010, J KOREAN MED SCI, V25, P1700, DOI 10.3346/jkms.2010.25.12.1700; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keshavan MS, 1998, J PSYCHIAT RES, V32, P161, DOI 10.1016/S0022-3956(97)00038-1; Kong XJ, 2011, J PSYCHIATR NEUROSCI, V36, P120, DOI 10.1503/jpn.100041; Konopaske GT, 2008, BIOL PSYCHIAT, V63, P759, DOI 10.1016/j.biopsych.2007.08.018; Konopaske GT, 2007, NEUROPSYCHOPHARMACOL, V32, P1216, DOI 10.1038/sj.npp.1301233; Kumra S, 2012, J AM ACAD CHILD PSY, V51, P171, DOI 10.1016/j.jaac.2011.11.001; Kyriakopoulos M, 2008, BIOL PSYCHIAT, V63, P519, DOI 10.1016/j.biopsych.2007.05.021; Pagsberg AK, 2007, J NEURAL TRANSM, V114, P489, DOI 10.1007/s00702-006-0573-8; Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; Schultz SK, 1999, LANCET, V353, P1425, DOI 10.1016/S0140-6736(98)07549-7; Schumacher A, 2006, CURR TOP MICROBIOL, V310, P81; Skelly LR, 2008, SCHIZOPHR RES, V98, P157, DOI 10.1016/j.schres.2007.10.009; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Tang JS, 2010, BRAIN RES, V1343, P199, DOI 10.1016/j.brainres.2010.04.083; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Tsuang Ming T, 2004, World Psychiatry, V3, P73; Velakoulis D, 2002, SCHIZOPHR RES, V57, P43, DOI 10.1016/S0920-9964(01)00307-3; Vidal CN, 2006, ARCH GEN PSYCHIAT, V63, P25, DOI 10.1001/archpsyc.63.1.25	36	34	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40247	10.1371/journal.pone.0040247	http://dx.doi.org/10.1371/journal.pone.0040247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802957	gold, Green Submitted, Green Published			2022-12-27	WOS:000306186900031
J	Xu, H; Yang, F; Sun, Y; Yuan, Y; Cheng, H; Wei, ZQ; Li, SY; Cheng, T; Brann, D; Wang, RM				Xu, Hong; Yang, Fang; Sun, Ying; Yuan, Yuan; Cheng, Hua; Wei, Zhongqiu; Li, Shuyu; Cheng, Tan; Brann, Darrell; Wang, Ruimin			A New Antifibrotic Target of Ac-SDKP: Inhibition of Myofibroblast Differentiation in Rat Lung with Silicosis	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ASPARTYL-LYSYL-PROLINE; RADIATION-INDUCED PNEUMONOPATHY; SERUM RESPONSE FACTOR; BETA TGF-BETA; PULMONARY-FIBROSIS; RECEPTOR BLOCKER; EXPRESSION; FIBROBLASTS; ACTIVATION	Background: Myofibroblast differentiation, characterized by alpha-smooth muscle actin (alpha-SMA) expression, is a key process in organ fibrosis, and is induced by TGF-beta. Here we examined whether an anti-fibrotic agent, N-acetyl-seryl-aspartyllysylproline (Ac-SDKP), can regulate induction of TGF-beta signaling and myofibroblast differentiation as a potential key component of its anti-fibrotic mechanism in vivo and in vitro. Methodology/Principal Findings: Rat pulmonary fibroblasts were cultured in vitro and divided to 4 groups 1) control; 2) TGF-beta 1; 3) TGF-beta 1+ LY364947; 4) TGF-beta 1+ Ac-SDKP. For in vivo studies, six groups of animals were utilized 1) control 4w; 2) silicotic 4w; 3) control 8w; 4) silicotic 8w; 5) Ac-SDKP post-treatment; 6) Ac-SDKP pre-treatment. SiO2 powders were douched in the trachea of rat to make the silicotic model. Myofibroblast differentiation was measured by examining expression of alpha-SMA, as well as expression of serum response factor (SRF), a key regulator of myofibroblast differentiation. The expressions of collagen, TGF-beta 1 and RAS signaling were also assessed. The results revealed that TGF-beta 1 strongly induced myofibroblast differentiation and collagen synthesis in vitro, and that pre-treatment with Ac-SDKP markedly attenuated myofibroblast activation, as well as induction of TGF-beta 1 and its receptor. Similar results were observed in vivo in the pathologically relevant rat model of silicosis. Ac-SDKP treatment in vivo strongly attenuated 1) silicosis-induced increased expressions of TGF-beta 1 and RAS signaling, 2) myofibroblast differentiation as indicated by a robust decrease of SRF and alpha-SMA-positive myofibroblast localization in siliconic nodules in the lung, 3) collagen deposition. Conclusion/Significance: The results of the present study suggest a novel mechanism of action for Ac-SDKP's beneficial effect in silicosis, which involves attenuation of TGF-beta 1 and its receptors, SRF and Ang II type 1 receptor (AT1) expression, collagen deposition and myofibroblast differentiation. The results further suggest that therapies targeting myofibroblast differentiation may have therapeutic efficacy in treatment of silicosis of the lung.	[Xu, Hong; Yang, Fang; Cheng, Tan] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China; [Yang, Fang; Sun, Ying; Yuan, Yuan; Cheng, Hua; Wei, Zhongqiu; Li, Shuyu; Wang, Ruimin] Hebei United Univ, Med Res Ctr, Tangshan, Peoples R China; [Brann, Darrell] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA	Hebei Medical University; North China University of Science & Technology; University System of Georgia; Augusta University	Xu, H (corresponding author), Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China.	fangyang02@sohu.com	Xu, Hong/ABC-2923-2021	Xu, Hong/0000-0002-3655-3833	National Natural Science Foundation of China [81072254]; Hebei Province Natural Science Foundation of China [C2011401024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Natural Science Foundation of China(Natural Science Foundation of Hebei Province)	This work was funded by the National Natural Science Foundation of China (No. 81072254) and Hebei Province Natural Science Foundation of China (No. C2011401024); http://159.226.244.22/portal/Proj_List.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkwright PD, 2000, THORAX, V55, P459, DOI 10.1136/thorax.55.6.459; Azizi M, 1996, J CLIN INVEST, V97, P839, DOI 10.1172/JCI118484; Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Chen W, 2001, OCCUP ENVIRON MED, V58, P31, DOI 10.1136/oem.58.1.31; Chou HC, 2012, J PHARMACOL EXP THER, V340, P169, DOI 10.1124/jpet.111.186288; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao XR, 2009, EUR J PHARMACOL, V606, P115, DOI 10.1016/j.ejphar.2008.12.049; Gauldie J, 1999, CURR TOPICS PATHOL, V93, P35; Health Mo, 2011, 2010 PREV WORK SIT O; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Horn A, 2012, ANN RHEUM DIS; Jagirdar J, 1996, AM J RESP CRIT CARE, V154, P1076, DOI 10.1164/ajrccm.154.4.8887610; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KUMAR CC, 1995, J BIOCHEM-TOKYO, V118, P1285, DOI 10.1093/oxfordjournals.jbchem.a125020; Martin MM, 2007, AM J PHYSIOL-LUNG C, V293, pL790, DOI 10.1152/ajplung.00099.2007; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Molteni A, 2007, CURR PHARM DESIGN, V13, P1307, DOI 10.2174/138161207780618777; Moltenti A, 2000, INT J RADIAT BIOL, V76, P523, DOI 10.1080/095530000138538; Omata M, 2006, J AM SOC NEPHROL, V17, P674, DOI 10.1681/ASN.2005040385; Pereira RM, 2009, WORLD J GASTROENTERO, V15, P2579, DOI 10.3748/wjg.15.2579; Perret-Guillaume C, 2009, J HYPERTENS, V27, pS3, DOI 10.1097/01.hjh.0000354511.14086.f1; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Sopel MJ, 2011, LAB INVEST, V91, P565, DOI 10.1038/labinvest.2010.190; Sun Y, 2010, LIFE SCI, V87, P232, DOI 10.1016/j.lfs.2010.06.016; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomas CR, 2010, ENVIRON HEALTH INSIG, V4, P21; Usuki J, 2012, J NIPPON MED SCH, V79, P46, DOI 10.1272/jnms.79.46; Xu Hong, 2009, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V25, P283; Yan Jing-Bo, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P401; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89; Yang F, 2011, XIAN DAI YU FANG YI, V38, P4930; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531	39	71	80	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40301	10.1371/journal.pone.0040301	http://dx.doi.org/10.1371/journal.pone.0040301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802960	Green Published, gold, Green Submitted			2022-12-27	WOS:000306186900034
J	Gabriel, MW; Woods, LW; Poppenga, R; Sweitzer, RA; Thompson, C; Matthews, SM; Higley, JM; Keller, SM; Purcell, K; Barrett, RH; Wengert, GM; Sacks, BN; Clifford, DL				Gabriel, Mourad W.; Woods, Leslie W.; Poppenga, Robert; Sweitzer, Rick A.; Thompson, Craig; Matthews, Sean M.; Higley, J. Mark; Keller, Stefan M.; Purcell, Kathryn; Barrett, Reginald H.; Wengert, Greta M.; Sacks, Benjamin N.; Clifford, Deana L.			Anticoagulant Rodenticides on our Public and Community Lands: Spatial Distribution of Exposure and Poisoning of a Rare Forest Carnivore	PLOS ONE			English	Article							STOATS MUSTELA ERMINEA; SEX-RATIO; NONTARGET WILDLIFE; INTOXICATION; BRODIFACOUM; ABUNDANCE; FISHERS; MAMMALS	Anticoagulant rodenticide (AR) poisoning has emerged as a significant concern for conservation and management of nontarget wildlife. The purpose for these toxicants is to suppress pest populations in agricultural or urban settings. The potential of direct and indirect exposures and illicit use of ARs on public and community forest lands have recently raised concern for fishers (Martes pennanti), a candidate for listing under the federal Endangered Species Act in the Pacific states. In an investigation of threats to fisher population persistence in the two isolated California populations, we investigate the magnitude of this previously undocumented threat to fishers, we tested 58 carcasses for the presence and quantification of ARs, conducted spatial analysis of exposed fishers in an effort to identify potential point sources of AR, and identified fishers that died directly due to AR poisoning. We found 46 of 58 (79%) fishers exposed to an AR with 96% of those individuals having been exposed to one or more second-generation AR compounds. No spatial clustering of AR exposure was detected and the spatial distribution of exposure suggests that AR contamination is widespread within the fisher's range in California, which encompasses mostly public forest and park lands Additionally, we diagnosed four fisher deaths, including a lactating female, that were directly attributed to AR toxicosis and documented the first neonatal or milk transfer of an AR to an altricial fisher kit. These ARs, which some are acutely toxic, pose both a direct mortality or fitness risk to fishers, and a significant indirect risk to these isolated populations. Future research should be directed towards investigating risks to prey populations fishers are dependent on, exposure in other rare forest carnivores, and potential AR point sources such as illegal marijuana cultivation in the range of fishers on California public lands.	[Gabriel, Mourad W.; Wengert, Greta M.] Integral Ecol Res Ctr, Blue Lake, CA USA; [Gabriel, Mourad W.; Sacks, Benjamin N.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Woods, Leslie W.; Poppenga, Robert] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab Syst, Davis, CA 95616 USA; [Sweitzer, Rick A.; Barrett, Reginald H.] Univ Calif Berkeley, Sierra Nevada Adapt Management Project, Berkeley, CA 94720 USA; [Thompson, Craig; Purcell, Kathryn] US Forest Serv, Pacific SW Res Stn, Sierra Nevada Res Ctr, Fresno, CA USA; [Matthews, Sean M.] Wildlife Conservat Soc, Hoopa, CA USA; [Higley, J. Mark] Hoopa Tribal Forestry, Dept Wildlife, Hoopa, CA USA; [Keller, Stefan M.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Clifford, Deana L.] Calif Dept Fish & Game, Wildlife Invest Lab, Rancho Cordova, CA 95670 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley; United States Department of Agriculture (USDA); United States Forest Service; Wildlife Conservation Society; University of California System; University of California Davis	Gabriel, MW (corresponding author), Integral Ecol Res Ctr, Blue Lake, CA USA.	mwgabriel@ucdavis.edu	Barrett, Reginald Haughton/AAC-2608-2020; Purcell, Kathryn L/S-2592-2016	Higley, Mark/0000-0002-7722-3785; Keller, Stefan/0000-0002-5428-2985				Alterio N, 1997, J ZOOL, V243, P863, DOI 10.1111/j.1469-7998.1997.tb01986.x; Alterio N, 1996, NEW ZEAL J ZOOL, V23, P331, DOI 10.1080/03014223.1996.9518092; Berny P, 2007, J VET PHARMACOL THER, V30, P93, DOI 10.1111/j.1365-2885.2007.00836.x; Bradbury, 2008, EPAHQOPP20060955 US; Brakes CR, 2005, J APPL ECOL, V42, P118, DOI 10.1111/j.1365-2664.2005.00997.x; Brown KP, 1998, WILDLIFE RES, V25, P419, DOI 10.1071/WR97069; Cervantes J, 2000, MARIJUANA OUTDOORS G; Coulter MW, 1967, THESIS SYRACUSE U; Dowdy S.M., 1991, STAT RES; Dubock AC, 1978, 8TH P VERT PEST C SA, P127; Eason C, 2000, ACS PUBL, V771, P157; Erickson W., 2004, POTENTIAL RISKS 9 RO; Eth W., 2008, PA STATE ENV LAW REV, P451; Fisher P, 2009, THESIS LINCON U; Fournier-Chambrillon C, 2004, J WILDLIFE DIS, V40, P688, DOI 10.7589/0090-3558-40.4.688; Gabriel MW, 2009, J WILDLIFE DIS, V45, P344, DOI 10.7589/0090-3558-45.2.344; GREAVES M, 1993, PHARMACOL THERAPEUT, V59, P311, DOI 10.1016/0163-7258(93)90073-M; HADLER M. R., 1992, P VERT PEST C, P149; Hoare JM, 2006, NEW ZEAL J ECOL, V30, P157; Hosea RC, 2000, PROC VERTEBR PEST C, P236; James AH, 2006, OBSTET GYNECOL SURV, V61, P59, DOI 10.1097/01.ogx.0000193878.57208.ad; JAQUES L B, 1959, Can Med Assoc J, V81, P848; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kaukeinen D., 1982, Proceedings of the Vertebrate Pest Conference, V10, P151; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; Kruger O, 2005, P ROY SOC B-BIOL SCI, V272, P375, DOI 10.1098/rspb.2004.2943; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Lofroth E.C., 2010, CONSERVATION FISHERS; Lund M, 1984, P VERTEBRATE PEST C, V11, P89; Mackintosh C. G., 1988, Proceedings. Thirteenth Vertebrate Pest Conference. Monterey, California, March 1,2 & 3, 1988., P86; Mallery M, 2011, BERKELEY UNDERGRADUA, V23, P1; Matthews SM, 2011, WILDLIFE SOC B, V35, P69, DOI 10.1002/wsb.19; Maxie M, 2007, JUBB KENNEDY PALMERS; McCarthy T., 2011, GROWING MARIJUANA PL; McEnry C, 2008, DRUG ENFORCEMENT AGE; McMillin SC, 2008, P 23 VERT PEST C, P163; Munday JS, 2003, VET PATHOL, V40, P216, DOI 10.1354/vp.40-2-216; Newton I., 1999, ADV VERTEBRATE PEST, P347; NORTH PM, 1985, ECOL MODEL, V30, P105, DOI 10.1016/0304-3800(85)90039-0; Ogilvie SC, 1997, NEW ZEAL J ECOL, V21, P195; Owner ST, 2010, MARIJUANA OUTDOOR GR; PAPWORTH DS, 1958, ROY SOC HEALTH J, V78, P52; Petterino C, 2001, VET HUM TOXICOL, V43, P353; Powell R.A., 1982, FISHER LIFE HIST ECO; Powell RA, 2000, METH C CONS, P65; Proulx G, 2011, P 9 PRAIR CONS END S, P128; Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Ruder MG, 2011, J WILDLIFE DIS, V47, P212, DOI 10.7589/0090-3558-47.1.212; SARELI P, 1989, AM J CARDIOL, V63, P1462, DOI 10.1016/0002-9149(89)90008-8; Shore RF, 1999, NEW ZEAL J ECOL, V23, P199; Spencer W. D., 2008, BASELINE EVALUATION; Spencer W, 2011, BIOL CONSERV, V144, P788, DOI 10.1016/j.biocon.2010.10.027; Stone WB, 1999, J WILDLIFE DIS, V35, P187, DOI 10.7589/0090-3558-35.2.187; Tosh DG, 2011, J ENVIRON MANAGE, V92, P1503, DOI 10.1016/j.jenvman.2010.12.014; United States Department of Agriculture, 2009, MAR CAL NAT FOR COMP; United States Fish and Wildlife Service, 2004, FED REGISTER, V69, P18770; Valchev I, 2008, TURK J VET ANIM SCI, V32, P237; Vandenbroucke V, 2008, J VET PHARMACOL THER, V31, P437, DOI 10.1111/j.1365-2885.2008.00979.x; Zar JH, 1999, BIOSTATISTICAL ANAL; Zielinski WJ, 2005, J BIOGEOGR, V32, P1385, DOI 10.1111/j.1365-2699.2005.01234.x; Zielinski WJ, 2004, J MAMMAL, V85, P649, DOI 10.1644/BOS-126	65	84	89	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40163	10.1371/journal.pone.0040163	http://dx.doi.org/10.1371/journal.pone.0040163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808110	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700023
J	Kobayashi, Y; Suzuki, Y				Kobayashi, Yuki; Suzuki, Yoshiyuki			Compensatory Evolution of Net-Charge in Influenza A Virus Hemagglutinin	PLOS ONE			English	Article							RECEPTOR-BINDING; LINKED GLYCOSYLATION; POSITIVE SELECTION; NEURAMINIDASE; SITES; OLIGOSACCHARIDES; IDENTIFICATION; GLYCOPROTEINS; GENERATION; MODEL	The propagation of influenza A virus depends on the balance between the activities of hemagglutinin (HA) for binding to host cells and neuraminidase (NA) for releasing from infected cells (HA-NA balance). Since the host cell membrane and the sialic acid receptor are negatively charged, the amino acid substitutions increasing (charge+) and decreasing (charge-) the positive charge of HA subunit 1 (HA1) enhance and reduce, respectively, the binding avidity and affinity. The positive charge of HA1 in human influenza A virus bearing subtype H3N2 (A/H3N2 virus) was observed to have increased during evolution, but the evolutionary mechanism for this observation was unclear because this may disrupt the HA-NA balance. Here we show, from the phylogenetic analysis of HA for human A/H3N2 and A/H1N1 viruses, that the relative frequencies of charge+ and charge- substitutions were elevated on the branches where the number of N-glycosylation sites (NGS) increased and decreased, respectively, compared to those where the number of NGS did not change. On the latter branches, the net-charge of HA1 appeared to have been largely maintained to preserve its structure and function. Since the charge+ and charge- substitutions in HA1 have opposite effects to the gain and loss of NGS on the binding and release of the virus, the net-charge of HA1 may have evolved to compensate for the effect of the gain and loss of NGS, probably through changing the avidity. Apparently, the relative frequency of charge- substitutions in HA1 of A/H3N2 virus was elevated after the introduction of oseltamivir, and that of charge+ substitutions in HA1 of A/H1N1 virus was elevated after the spread of oseltamivir resistance. These observations may also be explained by the compensatory effect of the net-charge in HA1 on the NA activity for keeping the HA-NA balance.	[Kobayashi, Yuki; Suzuki, Yoshiyuki] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi, Japan; [Kobayashi, Yuki] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Nagoya City University; University of Oxford	Kobayashi, Y (corresponding author), Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi, Japan.	yossuzuk@nsc.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors' study was supported by The Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists (http://www.jsps.go.jp/english/e-pd/index.html). The funders had no role in study design, data collection and analysis, decision to publish.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Arinaminpathy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015674; Bantia S, 1998, ANTIMICROB AGENTS CH, V42, P801, DOI 10.1128/AAC.42.4.801; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Cherry Joshua L, 2009, PLoS Curr, V1, pRRN1001; Cui JK, 2009, P NATL ACAD SCI USA, V106, P13421, DOI 10.1073/pnas.0905818106; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fukami-Kobayashi K, 2002, J MOL BIOL, V319, P729, DOI 10.1016/S0022-2836(02)00239-5; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; HARTIGAN JA, 1973, BIOMETRICS, V29, P53, DOI 10.2307/2529676; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Ilyushina NA, 2005, ARCH VIROL, V150, P1327, DOI 10.1007/s00705-005-0490-4; Karaivanova VK, 1998, BIOCHEM J, V329, P511; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KEMBLE GW, 1993, J CELL BIOL, V122, P1253, DOI 10.1083/jcb.122.6.1253; Kobayashi Y, 2012, J VIROL, V86, P3446, DOI 10.1128/JVI.06147-11; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RUDNEVA IA, 1993, ARCH VIROL, V133, P437, DOI 10.1007/BF01313781; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Spiro NJ, 2000, GLYCOBIOLOGY, V10, P1235, DOI 10.1093/glycob/10.11.1235; Suzuki Y, 2008, GENE, V427, P111, DOI 10.1016/j.gene.2008.09.012; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	42	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40422	10.1371/journal.pone.0040422	http://dx.doi.org/10.1371/journal.pone.0040422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808159	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400023
J	Qiu, XY				Qiu, Xiangyun			Heat Induced Capsid Disassembly and DNA Release of Bacteriophage lambda	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; VIRAL CAPSIDS; VIRUS MATURATION; PHAGE; INACTIVATION; TRANSITION; STABILITY; MECHANISM; DYNAMICS	Successive structural changes of bacteriophage lambda upon heating were characterized with quantitative experimental methods. In the commonly used Tris-Mg buffer, differential scanning calorimetry measurements first established that the protein capsid of l phage melts at 87 degrees C and its genomic DNA melts at 91 degrees C. Interestingly, prior to the capsid melting, lambda DNA was found to escape out of the capsid and subject to DNase digestion above similar to 68 degrees C, as concluded from light scattering, UV absorption, and electron microscopy studies. Further investigations indicated distinct temperature-dependent behaviors of the three phage proteins. Around 68 degrees C, disruption of the tail first occurs and leads to the escape of lambda DNA; above the capsid melting temperature of 87 degrees C, the auxiliary protein gpD of the phage head remains soluble in solution and resists centrifugal sedimentation, whereas the major capsid protein gpE is easily precipitated and likely exists as aggregates.	George Washington Univ, Dept Phys, Washington, DC 20052 USA	George Washington University	Qiu, XY (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.	xqiu@gwu.edu			George Washington University	George Washington University	This work is supported by the George Washington University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; BLAKE RD, 1979, BIOPOLYMERS, V18, P3089, DOI 10.1002/bip.1979.360181214; Blake RD, 1998, NUCLEIC ACIDS RES, V26, P3323, DOI 10.1093/nar/26.14.3323; BUCHWALD M, 1970, VIROLOGY, V42, P375, DOI 10.1016/0042-6822(70)90281-3; CASJENS SR, 1974, J MOL BIOL, V88, P535, DOI 10.1016/0022-2836(74)90500-2; Catalano C.E., 2005, VIRAL GENOME PACKAGI; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Cordova A, 2003, BIOPHYS J, V85, P70, DOI 10.1016/S0006-3495(03)74455-5; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; Duda RL, 2009, J MOL BIOL, V391, P471, DOI 10.1016/j.jmb.2009.06.035; Duguid JG, 1996, BIOPHYS J, V71, P3350, DOI 10.1016/S0006-3495(96)79528-0; DYSON RD, 1967, VIROLOGY, V33, P559, DOI 10.1016/0042-6822(67)90055-4; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fane BA, 2003, ADV PROTEIN CHEM, V64, P259; FEISS M, 1977, VIROLOGY, V77, P281, DOI 10.1016/0042-6822(77)90425-1; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Hendrix R, 1983, COLD SPRING HARBOR M; Hendrix RW, 2005, ADV VIRUS RES, V64, P1, DOI 10.1016/S0065-3527(05)64001-8; Hirneisen KA, 2010, COMPR REV FOOD SCI F, V9, P3, DOI 10.1111/j.1541-4337.2009.00092.x; Ivanovska I, 2007, P NATL ACAD SCI USA, V104, P9603, DOI 10.1073/pnas.0703166104; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kawai Y, 1999, J GEN APPL MICROBIOL, V45, P135, DOI 10.2323/jgam.45.135; Knobler CM, 2009, ANNU REV PHYS CHEM, V60, P367, DOI 10.1146/annurev.physchem.59.032607.093728; Los Marcin, 2004, Journal of Applied Genetics, V45, P111; Muller-Merbach M, 2005, J DAIRY RES, V72, P281, DOI 10.1017/S0022029905000725; Muller-Merbach M, 2005, INT DAIRY J; MURIALDO H, 1991, ANNU REV BIOCHEM, V60, P125; Odijk T, 2004, PHILOS T R SOC A, V362, P1497, DOI 10.1098/rsta.2004.1385; Panja D, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045006; Petrov AS, 2008, BIOPHYS J, V95, P497, DOI 10.1529/biophysj.108.131797; Purohit PK, 2003, P NATL ACAD SCI USA, V100, P3173, DOI 10.1073/pnas.0737893100; Qiu XY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028102; Reddy VS, 2005, ADV VIRUS RES, V64, P45, DOI 10.1016/S0065-3527(05)64003-1; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; STURTEVANT JM, 1987, ANNU REV PHYS CHEM, V38, P463, DOI 10.1146/annurev.pc.38.100187.002335; WIDOM J, 1983, J MOL BIOL, V171, P419, DOI 10.1016/0022-2836(83)90038-4; Zandi R, 2004, P NATL ACAD SCI USA, V101, P15556, DOI 10.1073/pnas.0405844101	40	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39793	10.1371/journal.pone.0039793	http://dx.doi.org/10.1371/journal.pone.0039793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808062	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400019
J	Wang, ZG; Zhang, ZQ; Jiao, Q; Liao, W; Chen, GH; Sun, KJ; Shen, LF; Wang, MX; Li, K; Liu, YJ; Lu, GM				Wang, Zhengge; Zhang, Zhiqiang; Jiao, Qing; Liao, Wei; Chen, Guanghui; Sun, Kangjian; Shen, Lianfang; Wang, Maoxue; Li, Kai; Liu, Yijun; Lu, Guangming			Impairments of Thalamic Nuclei in Idiopathic Generalized Epilepsy Revealed by a Study Combining Morphological and Functional Connectivity MRI	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; STRUCTURAL CONNECTIVITY; ABSENCE SEIZURES; BASAL GANGLIA; GLOBAL SIGNAL; STATE; NETWORKS; CORTEX; LOBE; EEG	Objective: Neuroimaging evidence suggested that the thalamic nuclei may play different roles in the progress of idiopathic generalized epilepsy (IGE). This study aimed to demonstrate the alterations in morphometry and functional connectivity in the thalamic nuclei in IGE. Methods: Fifty-two patients with IGE characterized by generalized tonic-clonic seizures and 67 healthy controls were involved in the study. The three-dimensional high-resolution T1-weighted MRI data were acquired for voxel-based morphometry (VBM) analysis, and resting-state blood-oxygenation level functional MRI data were acquired for functional connectivity analysis. The thalamic nuclei of bilateral medial dorsal nucleus (MDN) and pulvinar, as detected with decreased gray matter volumes in patients with IGE through VBM analysis, were selected as seed regions for functional connectivity analysis. Results: Different alteration patterns were found in functional connectivity of the thalamic nuclei with decreased gray matter volumes in IGE. Seeding at the MDN, decreased connectivity in the bilateral orbital frontal cortex, caudate nucleus, putamen and amygdala were found in the patients (P<0.05 with correction). However, seeding at the pulvinar, no significant alteration of functional connectivity was found in the patients (P<0.05 with correction). Conclusions: Some specific impairment of thalamic nuclei in IGE was identified using morphological and functional connectivity MRI approaches. These findings may strongly support the different involvement of the thalamocortical networks in IGE.	[Wang, Zhengge; Zhang, Zhiqiang; Jiao, Qing; Shen, Lianfang; Wang, Maoxue; Lu, Guangming] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China; [Chen, Guanghui] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Sun, Kangjian] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Li, Kai] Suzhou Univ, Dept Pharmacol, Suzhou 215006, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	Nanjing University; Nanjing University; Nanjing University; Hangzhou Normal University; Hangzhou Normal University; Soochow University - China; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wang, ZG (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China.	cjr.luguangming@vip.163.com			Natural Science Foundation of China [30800264, 30971019, 90820006, 81020108022, 61035006]; Key Program [10Z026, BWS11J063]; Grants for Young Scholars in Jinling Hospital [Q2008063, 2011060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program; Grants for Young Scholars in Jinling Hospital	This work was supported by Natural Science Foundation of China (Grant nos. 30800264, 30971019, 90820006, 81020108022 and 61035006); Key Program (Grant nos. 10Z026, BWS11J063); and Grants for Young Scholars in Jinling Hospital (Grant nos. Q2008063, 2011060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alelu-Paz R, 2008, J PSYCHIATR NEUROSCI, V33, P489; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bai XX, 2010, J NEUROSCI, V30, P5884, DOI 10.1523/JNEUROSCI.5101-09.2010; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bernhardt BC, 2009, NEUROIMAGE, V46, P373, DOI 10.1016/j.neuroimage.2009.01.055; Boyd JG, 2010, NEUROLOGY, V74, P1003, DOI 10.1212/WNL.0b013e3181d5dc4f; Ciumas C, 2006, NEUROLOGY, V67, P683, DOI 10.1212/01.wnl.0000230171.23913.cf; Deransart C, 2002, EPILEPTIC DISORD, V4, pS61; Deransart C, 1998, EPILEPSY RES, V32, P213, DOI 10.1016/S0920-1211(98)00053-9; Eckert U, 2011, HUM BRAIN MAPP; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Hodaie M, 2006, BRAIN RES, V1115, P1, DOI 10.1016/j.brainres.2006.07.085; Huang W, 2011, J NEURORADIOLOGY, V38, P298, DOI 10.1016/j.neurad.2010.12.007; Kato K, 2008, NEUROL MED-CHIR, V48, P285, DOI 10.2176/nmc.48.285; Lehericy S, 2002, EPILEPTIC DISORD, V4, pS23; Liao W., 2010, PLOS ONE, V5; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Luo C, 2011, HUM BRAIN MAPP; Luo C, 2011, EPILEPSIA, V52, P1092, DOI 10.1111/j.1528-1167.2011.03045.x; Mattson RH, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s.2.3.x; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; Moeller F, 2011, EPILEPSIA, V52, P515, DOI 10.1111/j.1528-1167.2010.02938.x; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Pulsipher DT, 2011, NEUROLOGY, V76, P28, DOI 10.1212/WNL.0b013e318203e8f3; Rosenberg DS, 2006, EPILEPSIA, V47, P98, DOI 10.1111/j.1528-1167.2006.00375.x; Song M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017294; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Strigaro G, 2012, EPILEPSIA; Tyvaert L, 2009, NEUROLOGY, V73, P2018, DOI 10.1212/WNL.0b013e3181c55d02; Wang ZG, 2011, BRAIN RES, V1374, P134, DOI 10.1016/j.brainres.2010.12.034; Yasuda CL, 2010, EXPERT REV NEUROTHER, V10, P975, DOI 10.1586/ERN.10.63; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zhang ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028817; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	44	51	54	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39701	10.1371/journal.pone.0039701	http://dx.doi.org/10.1371/journal.pone.0039701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808050	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400016
J	Zheng, YL; Huo, DZ; Zhang, J; Yoshimatsu, TF; Niu, Q; Olopade, OI				Zheng, Yonglan; Huo, Dezheng; Zhang, Jing; Yoshimatsu, Toshio F.; Niu, Qun; Olopade, Olufunmilayo I.			Microsatellites in the Estrogen Receptor (ESR1, ESR2) and Androgen Receptor (AR) Genes and Breast Cancer Risk in African American and Nigerian Women	PLOS ONE			English	Article							CAG REPEAT POLYMORPHISM; SUSCEPTIBILITY LOCI; BREAST/OVARIAN CANCER; MUTATION CARRIERS; NO ASSOCIATION; ALPHA GENE; LENGTH; POPULATION; EXON-1; BETA	Genetic variants in hormone receptor genes may be crucial predisposing factors for breast cancer, and microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes have been suggested to play a role. We studied 258 African-American (AA) women with breast cancer and 259 hospital-based controls, as well as 349 Nigerian (NG) female breast cancer patients and 296 community controls. Three microsatellites, ESR1_TA, ESR2_CA and AR_CAG, in the ESR1, ESR2 and AR genes, respectively, were genotyped. Their repeat lengths were then analyzed as continuous and dichotomous variables. Analyses of continuous variables showed no association with breast cancer risk in either AA or NG at ESR1_TA; AA cases had shorter repeats in the long allele of ESR2_CA than AA controls (Mann-Whitney P = 0.036; logistic regression P = 0.04, OR = 0.91, 95% CI 0.83-1.00), whereas NG patients had longer repeats in the short allele than NG controls (Mann-Whitney P = 0.0018; logistic regression P = 0.04, OR = 1.06, 95% CI 1.00-1.11); and AA cases carried longer repeats in the short allele of AR_CAG than AA controls (Mann-Whitney P = 0.038; logistic regression P = 0.03, OR = 1.08, 95% CI 1.01-1.15). When allele sizes were categorized as dichotomous variables, we discovered that women with two long alleles of ESR2_CA had increased risk of breast cancer (OR = 1.38, 95% CI 1.10-1.74; P = 0.006). This is the first study to investigate these three microsatellites in hormonal receptor genes in relation to breast cancer risk in an indigenous African population. After adjusting for multiple-testing, our findings suggest that ESR2_CA is associated with breast cancer risk in Nigerian women, whereas ESR1_TA and AR_CAG seem to have no association with the disease among African American or Nigerian women.	[Zheng, Yonglan; Zhang, Jing; Yoshimatsu, Toshio F.; Niu, Qun; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, Chicago, IL 60637 USA; [Huo, Dezheng] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Zheng, YL (corresponding author), Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, 5841 S Maryland Ave, Chicago, IL 60637 USA.	folopade@medicine.bsd.uchicago.edu	Yoshimatsu, Toshio F./HDN-6928-2022; Zheng, Yonglan/C-4236-2011; Zheng, Yonglan/O-4112-2019	Yoshimatsu, Toshio F./0000-0003-2674-8159; Zheng, Yonglan/0000-0001-6597-7072	National Cancer Institute at the National Institutes of Health [R01 CA142996-01, P50 CA125183]; Entertainment Industry Foundation; Falk Medical Research Trust; Susan G. Komen for the Cure; NATIONAL CANCER INSTITUTE [R01CA142996, P50CA125183] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Entertainment Industry Foundation; Falk Medical Research Trust; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute at the National Institutes of Health (R01 CA142996-01 and P50 CA125183), the Entertainment Industry Foundation, the Falk Medical Research Trust, and Susan G. Komen for the Cure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, INT J CANCER, V126, P2935, DOI 10.1002/ijc.24892; Anghel A, 2006, J CANCER RES CLIN, V132, P727, DOI 10.1007/s00432-006-0121-9; Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; BERNSTEIN L, 1993, EPIDEMIOL REV, V15, P48, DOI 10.1093/oxfordjournals.epirev.a036116; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Calvo RM, 2000, J CLIN ENDOCR METAB, V85, P1735, DOI 10.1210/jc.85.4.1735; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Chintamani, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-64; Cox DG, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1602; Dagan E, 2002, EUR J HUM GENET, V10, P724, DOI 10.1038/sj.ejhg.5200880; Dunning AM, 1999, CARCINOGENESIS, V20, P2131, DOI 10.1093/carcin/20.11.2131; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Elhaji YA, 2001, BREAST CANCER RES TR, V70, P109, DOI 10.1023/A:1012942910375; Forsti A, 2003, BREAST CANCER RES TR, V79, P409, DOI 10.1023/A:1024020609833; Fytili P, 2005, CLIN GENET, V68, P268, DOI 10.1111/j.1399-0004.2005.00495.x; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Giguere Y, 2001, CANCER RES, V61, P5869; Gilbert Samuel F, 2011, Breast Dis, V33, P17, DOI 10.3233/BD-2010-0323; Gilbert SF, 2011, BREAST CANCER RES TR, V129, P575, DOI 10.1007/s10549-011-1510-6; Given HF, 2000, EUR J CANCER, V36, P533, DOI 10.1016/S0959-8049(99)00310-X; Gonzalez A, 2007, EUR J CANCER, V43, P2373, DOI 10.1016/j.ejca.2007.07.001; Haiman CA, 2002, CANCER RES, V62, P1045; Hankinson Susan E., 2010, Hormones & Cancer, V1, P2, DOI 10.1007/s12672-009-0003-0; Hietala M, 2011, MOL GENET METAB, V102, P82, DOI 10.1016/j.ymgme.2010.09.006; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Iobagiu C, 2006, BREAST CANCER RES TR, V95, P153, DOI 10.1007/s10549-005-9060-4; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kadouri L, 2001, BRIT J CANCER, V85, P36, DOI 10.1054/bjoc.2001.1777; Kristiansen M, 2002, J MED GENET, V39, P30, DOI 10.1136/jmg.39.1.30; Lamp M, 2011, GYNECOL ENDOCRINOL, V27, P425, DOI 10.3109/09513590.2010.495434; Liede A, 2003, CANCER EPIDEM BIOMAR, V12, P848; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; MacLean HE, 2004, BREAST CANCER RES TR, V88, P239, DOI 10.1007/s10549-004-0781-6; Maggiolini M, 1999, CANCER RES, V59, P4864; Mehdipour P, 2011, BREAST J, V17, P39, DOI 10.1111/j.1524-4741.2010.01031.x; Menin C, 2001, CANCER LETT, V168, P31, DOI 10.1016/S0304-3835(01)00473-6; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Rajender S, 2011, BREAST CANCER RES TR, V127, P751, DOI 10.1007/s10549-010-1263-7; Rebbeck TR, 1999, AM J HUM GENET, V64, P1371, DOI 10.1086/302366; Russo J, 2004, TRENDS ENDOCRIN MET, V15, P211, DOI 10.1016/j.tem.2004.05.007; Sakoda LC, 2011, CANCER EPIDEMIOL, V35, P48, DOI 10.1016/j.canep.2010.08.005; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slattery ML, 2007, BREAST CANCER RES TR, V105, P327, DOI 10.1007/s10549-006-9453-z; Spurdle AB, 2005, BREAST CANCER RES, V7, pR176, DOI 10.1186/bcr971; Spurdle AB, 1999, JNCI-J NATL CANCER I, V91, P961, DOI 10.1093/jnci/91.11.961; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Suter NM, 2003, CANCER EPIDEM BIOMAR, V12, P127; Syrjakoski K, 2003, BREAST CANCER RES TR, V77, P167, DOI 10.1023/A:1021369508561; Tsezou A, 2008, BREAST, V17, P159, DOI 10.1016/j.breast.2007.08.007; Wang W, 2005, CANCER EPIDEM BIOMAR, V14, P2990, DOI 10.1158/1055-9965.EPI-05-0310; Wedren S, 2004, BREAST CANCER RES, V6, pR437, DOI 10.1186/bcr811; Wedren S, 2007, CANCER EPIDEM BIOMAR, V16, P1775, DOI 10.1158/1055-9965.EPI-06-1096; Wu MH, 2008, EUR J CANCER PREV, V17, P317, DOI 10.1097/CEJ.0b013e3282f75e7f; Young IE, 2000, J MED GENET, V37, P139, DOI 10.1136/jmg.37.2.139; Yu H, 2000, BREAST CANCER RES TR, V59, P153, DOI 10.1023/A:1006356502820; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	57	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40494	10.1371/journal.pone.0040494	http://dx.doi.org/10.1371/journal.pone.0040494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792352	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400063
J	Morales, J; Gunther, G; Zanocco, AL; Lemp, E				Morales, Javier; Guenther, German; Zanocco, Antonio L.; Lemp, Else			Singlet Oxygen Reactions with Flavonoids. A Theoretical - Experimental Study	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; CHEMICAL-REACTIVITY; QUENCHING REACTION; CHEMISTRY; FOOD	Detection of singlet oxygen emission, lambda(max) = 1270 nm, following laser excitation and steady-state methods were employed to measure the total reaction rate constant, k(T), and the reactive reaction rate constant, k(r), for the reaction between singlet oxygen and several flavonoids. Values of k(T) determined in deuterated water, ranging from 2.4x10(7) M(-1)s(-1) to 13.4x10(7) M(-1)s(-1), for rutin and morin, respectively, and the values measured for k(r), ranging from 2.8x10(5) M(-1)s(-1) to 65.7x10(5) M(-1)s(-1) for kaempferol and morin, respectively, being epicatechin and catechin chemically unreactive. These results indicate that all the studied flavonoids are good quenchers of singlet oxygen and could be valuable antioxidants in systems under oxidative stress, in particular if a flavonoid-rich diet was previously consumed. Analysis of the dependence of rate constant values with molecular structure in terms of global descriptors and condensed Fukui functions, resulting from electronic structure calculations, supports the formation of a charge transfer exciplex in all studied reactions. The fraction of exciplex giving reaction products evolves through a hydroperoxide and/or an endoperoxide intermediate produced by singlet oxygen attack on the double bond of the ring C of the flavonoid.	[Morales, Javier] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias & Tecnol Farmaceut, Santiago, Chile; [Guenther, German; Zanocco, Antonio L.; Lemp, Else] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fis Quim, Santiago, Chile	Universidad de Chile; Universidad de Chile	Morales, J (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias & Tecnol Farmaceut, Santiago, Chile.	elemp@ciq.uchile.cl	Gunther, German/I-1028-2013	Gunther, German/0000-0002-4733-8426; Morales Valenzuela, Javier Eduardo/0000-0002-9880-2567; ZANOCCO, ANTONIO/0000-0002-6521-5382	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090267]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico grant 1090267. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker EM, 2004, EUR FOOD RES TECHNOL, V219, P561, DOI 10.1007/s00217-004-1012-4; Bodamyali T, 2000, PROG INFLAM RES, P11; Briviba K, 1997, BIOL CHEM, V378, P1259; Briviba K, 2000, METHOD ENZYMOL, V319, P222; Castro-Olivares R, 2009, J PHOTOCH PHOTOBIO A, V207, P160, DOI 10.1016/j.jphotochem.2009.05.012; Chamorro E, 2005, J CHEM PHYS, V123; Contreras RR, 1999, CHEM PHYS LETT, V304, P405, DOI 10.1016/S0009-2614(99)00325-5; Cren-Olive C, 2002, J AM CHEM SOC, V124, P14027, DOI 10.1021/ja0262434; Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13&lt;1925::AID-JSFA714&gt;3.0.CO;2-4; Frisch G. W., 2013, GAUSSIAN 09; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; Galleano M, 2010, ARCH BIOCHEM BIOPHYS, V501, P23, DOI 10.1016/j.abb.2010.04.005; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; HALLIWELL B, 1995, BIOCHEM PHARMACOL, V49, P1341, DOI 10.1016/0006-2952(95)00088-H; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Hulten LM, 1999, FREE RADICAL BIO MED, V27, P1203; Kawanishi S, 2002, FREE RADICAL BIO MED, V32, P822, DOI 10.1016/S0891-5849(02)00779-7; Manach C, 1998, FEBS LETT, V426, P331, DOI 10.1016/S0014-5793(98)00367-6; MATSUURA T, 1970, TETRAHEDRON, V26, P435, DOI 10.1016/S0040-4020(01)97840-8; Mendoza-Wilson AM, 2006, J MOL STRUC-THEOCHEM, V761, P97, DOI 10.1016/j.theochem.2006.01.001; Mendoza-Wilson AM, 2005, J MOL STRUC-THEOCHEM, V716, P67, DOI 10.1016/j.theochem.2004.10.083; Mukai K, 2005, FREE RADICAL BIO MED, V39, P752, DOI 10.1016/j.freeradbiomed.2005.04.027; Nagai S, 2005, J PHYS CHEM B, V109, P4234, DOI 10.1021/jp0451389; Parr R. G., 1989, INT SERIES MONOGRAPH, V16; PARR RG, 1983, J AM CHEM SOC, V105, P7512, DOI 10.1021/ja00364a005; Payan-Gomez SA, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-12; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Roginsky V, 2005, FOOD CHEM, V92, P235, DOI 10.1016/j.foodchem.2004.08.004; Sachidanandam K, 2005, CARDIOVASC DRUG REV, V23, P115; Sies H, 2010, ARCH BIOCHEM BIOPHYS, V501, P2, DOI 10.1016/j.abb.2010.04.006; Stief TW, 2003, MED HYPOTHESES, V60, P567, DOI 10.1016/S0306-9877(03)00026-4; Tiznado W, 2005, J PHYS CHEM A, V109, P3220, DOI 10.1021/jp0450787; TOURNAIRE C, 1993, J PHOTOCH PHOTOBIO B, V19, P205, DOI 10.1016/1011-1344(93)87086-3	35	46	48	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40548	10.1371/journal.pone.0040548	http://dx.doi.org/10.1371/journal.pone.0040548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802966	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500054
J	Eriksson, K; Strimling, P				Eriksson, Kimmo; Strimling, Pontus			The Hard Problem of Cooperation	PLOS ONE			English	Article							PUBLIC-GOODS GAMES; SOCIAL DILEMMAS; PEOPLES REACTIONS; ALTRUISTIC PUNISHMENT; RATIONAL CHOICE; BEHAVIOR; SOCIETIES; TRUST; INSTITUTIONS; ORIENTATION	Based on individual variation in cooperative inclinations, we define the "hard problem of cooperation" as that of achieving high levels of cooperation in a group of non-cooperative types. Can the hard problem be solved by institutions with monitoring and sanctions? In a laboratory experiment we find that the answer is affirmative if the institution is imposed on the group but negative if development of the institution is left to the group to vote on. In the experiment, participants were divided into groups of either cooperative types or non-cooperative types depending on their behavior in a public goods game. In these homogeneous groups they repeatedly played a public goods game regulated by an institution that incorporated several of the key properties identified by Ostrom: operational rules, monitoring, rewards, punishments, and (in one condition) change of rules. When change of rules was not possible and punishments were set to be high, groups of both types generally abided by operational rules demanding high contributions to the common good, and thereby achieved high levels of payoffs. Under less severe rules, both types of groups did worse but non-cooperative types did worst. Thus, non-cooperative groups profited the most from being governed by an institution demanding high contributions and employing high punishments. Nevertheless, in a condition where change of rules through voting was made possible, development of the institution in this direction was more often voted down in groups of non-cooperative types. We discuss the relevance of the hard problem and fit our results into a bigger picture of institutional and individual determinants of cooperative behavior.	[Eriksson, Kimmo; Strimling, Pontus] Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden; [Eriksson, Kimmo] Malardalen Univ, Sch Educ Commun & Culture, Vasteras, Sweden	Stockholm University; Malardalen University	Eriksson, K (corresponding author), Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden.	kimmo.eriksson@mdh.se	Eriksson, Kimmo/F-6253-2013	Eriksson, Kimmo/0000-0002-7164-0924; Strimling, Pontus/0000-0002-9750-5835	Swedish Research Council [2009 2390, 2009 2678]; European Commission [FP6-2004-NEST-PATH-043434]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Swedish Research Council (grants 2009 2390 and 2009 2678) and the European Commission (contract number FP6-2004-NEST-PATH-043434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berggren N, 2006, KYKLOS, V59, P141, DOI 10.1111/j.1467-6435.2006.00324.x; Binmore K, 2005, NATURAL JUSTICE; Bogaert S, 2008, BRIT J SOC PSYCHOL, V47, P453, DOI 10.1348/014466607X244970; Brauer M, 2010, EUR J SOC PSYCHOL, V40, P490, DOI 10.1002/ejsp.640; Brekke KA, 2011, J PUBLIC ECON, V95, P1111, DOI 10.1016/j.jpubeco.2011.05.003; BURNS TR, 1992, INT SOCIOL, V7, P259, DOI 10.1177/026858092007003001; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Carneiro Robert L., 2003, EVOLUTIONISM CULTURA; Casari M, 2003, J ECON BEHAV ORGAN, V51, P217, DOI 10.1016/S0167-2681(02)00098-7; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Chaurand N, 2008, J APPL SOC PSYCHOL, V38, P1689, DOI 10.1111/j.1559-1816.2008.00365.x; Chekroun P, 2002, EUR J SOC PSYCHOL, V32, P853, DOI 10.1002/ejsp.126; Cinyabuguma M, 2005, J PUBLIC ECON, V89, P1421, DOI 10.1016/j.jpubeco.2004.05.011; Croson R, 2005, ECON LETT, V87, P95, DOI 10.1016/j.econlet.2004.10.007; Croson RTA, 2007, ECON INQ, V45, P199, DOI 10.1111/j.1465-7295.2006.00006.x; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Ertan A, 2009, EUR ECON REV, V53, P495, DOI 10.1016/j.euroecorev.2008.09.007; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Frank R. H., 1988, PASSIONS REASON; FRANK RH, 1987, AM ECON REV, V77, P593; Funder DC, 2006, J RES PERS, V40, P21, DOI 10.1016/j.jrp.2005.08.003; Gachter S, 2005, J EUR ECON ASSOC, V3, P303, DOI 10.1162/jeea.2005.3.2-3.303; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gunnthorsdottir A, 2007, J ECON BEHAV ORGAN, V62, P304, DOI 10.1016/j.jebo.2005.03.008; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hoff K, 2004, AM ECON REV, V94, P753, DOI 10.1257/0002828041464533; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kosfeld M, 2009, AM ECON REV, V99, P1335, DOI 10.1257/aer.99.4.1335; Kroll S, 2007, ECON INQ, V45, P557, DOI 10.1111/j.1465-7295.2007.00028.x; Lambsdorff JG, 2008, TRANSPARENCY INT GLO; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Lichbach MI, 1997, COOPERATORS DILEMMA; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Miller G, 2000, GOVERNANCE, V13, P535, DOI 10.1111/0952-1895.00145; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; North D. C., 1990, I I CHANGE EC PERFOR; North Douglass C, 1998, EC VALUES ORG; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E., 1994, RULES GAMES COMMON P; Ostrom Elinor, 2008, ALTERNATIVE I STRUCT; Palfrey TR, 2009, ANNU REV POLIT SCI, V12, P379, DOI 10.1146/annurev.polisci.12.091007.122139; Price ME, 2002, EVOL HUM BEHAV, V23, P203, DOI 10.1016/S1090-5138(01)00093-9; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rothstein B, 2000, J THEOR POLIT, V12, P477, DOI 10.1177/0951692800012004007; Rothstein Bo, 2005, SOCIAL TRAPS PROBLEM; Walker JM, 2000, ECON J, V110, P212, DOI 10.1111/1468-0297.00497; Wenzel M, 2002, J APPL PSYCHOL, V87, P629, DOI 10.1037//0021-9010.87.4.629; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; Young H. P, 2001, INDIVIDUAL STRATEGY	60	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40325	10.1371/journal.pone.0040325	http://dx.doi.org/10.1371/journal.pone.0040325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973IV	22792282	gold, Green Published			2022-12-27	WOS:000306354700036
J	Villeger, S; Miranda, JR; Hernandez, DF; Mouillot, D				Villeger, Sebastien; Ramos Miranda, Julia; Flores Hernandez, Domingo; Mouillot, David			Low Functional beta-Diversity Despite High Taxonomic beta-Diversity among Tropical Estuarine Fish Communities	PLOS ONE			English	Article							SPECIES RICHNESS; PHYLOGENETIC STRUCTURE; NULL MODELS; ASSEMBLAGES; CONGRUENCE; CHALLENGES; CALIFORNIA; GRADIENTS; TURNOVER; PATTERNS	The concept of beta-diversity, defined as dissimilarity among communities, has been widely used to investigate biodiversity patterns and community assembly rules. However, in ecosystems with high taxonomic beta-diversity, due to marked environmental gradients, the level of functional beta-diversity among communities is largely overlooked while it may reveal processes shaping community structure. Here, decomposing biodiversity indices into alpha (local) and gamma (regional) components, we estimated taxonomic and functional beta-diversity among tropical estuarine fish communities, through space and time. We found extremely low functional beta-diversity values among fish communities (<1.5%) despite high dissimilarity in species composition and species dominance. Additionally, in contrast to the high alpha and gamma taxonomic diversities, alpha and gamma functional diversities were very close to the minimal value. These patterns were caused by two dominant functional groups which maintained a similar functional structure over space and time, despite the strong dissimilarity in taxonomic structure along environmental gradients. Our findings suggest that taxonomic and functional beta-diversity deserve to be quantified simultaneously since these two facets can show contrasting patterns and the differences can in turn shed light on community assembly rules.	[Villeger, Sebastien] Univ Toulouse 3, Lab Evolut & Diversite Biol, F-31062 Toulouse, France; [Ramos Miranda, Julia; Flores Hernandez, Domingo] Univ Autonoma Campeche, Ctr Ecol Pesquerias & Oceanog Golfo Mexico, Campeche, Mexico; [Mouillot, David] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Mouillot, David] Univ Montpellier 2, Montpellier, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; James Cook University; Universite de Montpellier	Villeger, S (corresponding author), Univ Toulouse 3, Lab Evolut & Diversite Biol, F-31062 Toulouse, France.	sebastien.villeger@univ-tlse3.fr	Villéger, Sébastien/AAW-9949-2021; Villéger, Sébastien/C-6272-2011	Villéger, Sébastien/0000-0002-2362-7178; Villéger, Sébastien/0000-0002-2362-7178	PICS-CNRS program; ANR project "BIODIVNEK"; CONACYT grant; Marie Curie International Outgoing Fellowship (FISHECO) [IOF-GA-2009-236316]; EU project BIOFRESH [Nu226874]	PICS-CNRS program; ANR project "BIODIVNEK"(French National Research Agency (ANR)); CONACYT grant(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Marie Curie International Outgoing Fellowship (FISHECO)(European Commission); EU project BIOFRESH	This study was partially funded by a PICS-CNRS program and by the ANR project "BIODIVNEK". JRM and DFH benefited from a CONACYT grant. DM was supported by Marie Curie International Outgoing Fellowship (FISHECO) IOF-GA-2009-236316. SV was supported by the EU project BIOFRESH (7th Framework European program, Contract Nu226874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Blaber SJM, 2002, J FISH BIOL, V61, P1, DOI 10.1006/jfbi.2002.2063; Boyle KS, 2006, MAR ECOL PROG SER, V319, P65, DOI 10.3354/meps319065; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; David LT, 1998, CONT SHELF RES, V18, P1057, DOI 10.1016/S0278-4343(98)00033-8; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Dumay O, 2004, J FISH BIOL, V64, P970, DOI 10.1111/j.1095-8649.2004.00365.x; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Irz P, 2007, GLOBAL ECOL BIOGEOGR, V16, P350, DOI 10.1111/j.1466-8238.2006.00290.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Krasnov BR, 2010, INT J PARASITOL, V40, P807, DOI 10.1016/j.ijpara.2009.12.002; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mason NWH, 2007, OECOLOGIA, V153, P441, DOI 10.1007/s00442-007-0727-x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Munkemuller T, 2012, ECOGRAPHY IN PRESS; Pavoine S, 2009, ECOL LETT, V12, P898, DOI [10.1111/j.1461-0248.2009.01348.x, 10.1111/j.1461-0248.2009.01344.x]; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Qian H, 2009, ECOGRAPHY, V32, P553, DOI 10.1111/j.1600-0587.2008.05755.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricotta C, 2009, THEOR POPUL BIOL, V76, P299, DOI 10.1016/j.tpb.2009.10.001; Sokol ER, 2011, AM NAT, V177, P630, DOI 10.1086/659625; Sosa-Lopez A, 2007, MAR ECOL PROG SER, V342, P217, DOI 10.3354/meps342217; Sosa-Lopez A, 2007, J BIOGEOGR, V34, P52, DOI 10.1111/j.1365-2699.2006.01588.x; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; SWENSON NG, 2010, P BIOL SCI, V0278; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Villeger S, 2008, J ECOL, V96, P845, DOI 10.1111/j.1365-2745.2007.01351.x; Villeger S, 2008, MAR ECOL PROG SER, V364, P135, DOI 10.3354/meps07471; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046	47	99	103	7	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40679	10.1371/journal.pone.0040679	http://dx.doi.org/10.1371/journal.pone.0040679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792395	Green Published, Green Accepted, gold			2022-12-27	WOS:000306354700063
J	Loke, YK; Hinz, I; Wang, X; Rowlands, G; Scott, D; Salter, C				Loke, Yoon K.; Hinz, Ina; Wang, Xia; Rowlands, Gill; Scott, David; Salter, Charlotte			Impact of Health Literacy in Patients with Chronic Musculoskeletal Disease-Systematic Review	PLOS ONE			English	Review							OLDER-ADULTS; ARTHRITIS; COMMUNICATION; OUTCOMES	Objectives: To estimate the prevalence of low health literacy, and evaluate the impact of low health literacy on outcomes in patients with chronic musculoskeletal conditions. Data Sources: We searched Embase, Pubmed, PsycInfo, and CINAHL in January 2011 for relevant studies, restricted to English-language articles. Study Selection and Data Extraction: Studies were included if they measured health literacy and/or reported on the link between outcomes and health literacy levels in patients with osteoporosis, osteoarthritis, or rheumatoid arthritis. We assessed risk of bias from participant selection, methods of measuring health literacy and functional outcomes, missing data, and potential for confounding. Data Synthesis: We reviewed 1863 citations and judged 8 studies to be relevant. Most were cross-sectional in nature, and five were based in the United States. Diversity in measurements, participant characteristics, and settings meant that results had to be synthesized narratively. Prevalence of low health literacy varied from 7% to 42%. Of the five studies that reported on musculoskeletal outcomes, only one showed an association (unadjusted) between low health literacy and greater pain and limitations in physical functioning. However, other studies, including those with multivariate analyses, found no significant relationship between health literacy and measures of pain or disease specific questionnaires. One clinical trial found short-term improvements in the mental health of patients with musculoskeletal conditions after an intervention to improve health literacy. Limitations: Most of the studies were cross-sectional in nature, which precludes interpretation of a causal relationship. The sample sizes may not have been sufficiently large to enable detection of significant associations. Conclusions: The current evidence does not show a consistent association between low health literacy and poorer functional outcomes in patients with chronic musculoskeletal conditions. In the absence of a definite link, efforts to develop interventions to improve health literacy would not necessarily improve health service or patient-related outcomes.	[Loke, Yoon K.; Hinz, Ina; Wang, Xia; Scott, David; Salter, Charlotte] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Rowlands, Gill] London S Bank Univ, Inst Primary Care & Publ Hlth, London, England	University of East Anglia; London South Bank University	Loke, YK (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	y.loke@uea.ac.uk		Wang, Xia/0000-0001-6915-2588	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme [PB-PG-1207-15244]	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-1207-15244). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalraj S, 2009, ONCOLOGY-NY, V23, P369; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bhat AA, 2008, DISS ABSTR INT B, V69, P2262; Bhat AA, 2012, J HEALTH COMMUN, V17, P230, DOI 10.1080/10810730.2011.585688; Bhat AA, 2010, PATIENT EDUC COUNS, V81, P73, DOI 10.1016/j.pec.2009.12.004; Buchbinder R, 2006, J RHEUMATOL, V33, P879; Buchbinder R, 2011, J RHEUMATOL, V38, P1791, DOI 10.3899/jrheum.110406; Daniel D, 2010, FAM MED, V42, P7; Dennison CR, 2011, J CARDIOVASC NURS, V26, P359, DOI 10.1097/JCN.0b013e3181f16f88; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Eichler K, 2009, INT J PUBLIC HEALTH, V54, P313, DOI 10.1007/s00038-009-0058-2; Gordon MM, 2002, RHEUMATOLOGY, V41, P750, DOI 10.1093/rheumatology/41.7.750; Hirsh JM, 2011, JCR-J CLIN RHEUMATOL, V17, P236, DOI 10.1097/RHU.0b013e318226a01f; Hirsh JM, 2010, J RHEUMATOL, V37, P961, DOI 10.3899/jrheum.090964; Jordan JE, 2011, J CLIN EPIDEMIOL, V64, P366, DOI 10.1016/j.jclinepi.2010.04.005; Jordan JE, 2010, PATIENT EDUC COUNS, V79, P36, DOI 10.1016/j.pec.2009.10.001; Kim SH, 2009, J CLIN NURS, V18, P2337, DOI 10.1111/j.1365-2702.2008.02739.x; Morris Nancy S, 2006, BMC Fam Pract, V7, P21, DOI 10.1186/1471-2296-7-21; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Pleasant A, 2011, NURS OUTLOOK, V59, P95, DOI 10.1016/j.outlook.2010.12.006; Quinlan P, 2010, DISS ABSTR INT B, V71, P927; Rudd RE, 2009, PATIENT EDUC COUNS, V75, P334, DOI 10.1016/j.pec.2009.03.001; Swearingen CJ, 2010, JCR-J CLIN RHEUMATOL, V16, P359, DOI 10.1097/RHU.0b013e3181fe8ab1; Tsai TI, 2011, J HEALTH COMMUN, V16, P50, DOI 10.1080/10810730.2010.529488	29	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40210	10.1371/journal.pone.0040210	http://dx.doi.org/10.1371/journal.pone.0040210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792242	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800050
J	Menoret, A; Kumar, S; Vella, AT				Menoret, Antoine; Kumar, Sanjeev; Vella, Anthony T.			Cytochrome b5 and Cytokeratin 17 Are Biomarkers in Bronchoalveolar Fluid Signifying Onset of Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; STAPHYLOCOCCAL-ENTEROTOXIN-B; VON-WILLEBRAND-FACTOR; CLINICAL-OUTCOMES; T-CELLS; IN-VIVO; PLASMA; B(5); PROTEIN; MICE	Acute lung injury (ALI) is characterized by pulmonary edema and acute inflammation leading to pulmonary dysfunction and potentially death. Early medical intervention may ameliorate the severity of ALI, but unfortunately, there are no reliable biomarkers for early diagnosis. We screened for biomarkers in a mouse model of ALI. In this model, inhalation of S. aureus enterotoxin A causes increased capillary permeability, cell damage, and increase protein and cytokine concentration in the lungs. We set out to find predictive biomarkers of ALI in bronchoalveolar lavage (BAL) fluid before the onset of clinical manifestations. A cutting edge proteomic approach was used to compare BAL fluid harvested 16 h post S. aureus enterotoxin A inhalation versus BAL fluid from vehicle alone treated mice. The proteomic PF 2D platform permitted comparative analysis of proteomic maps and mass spectrometry identified cytochrome b5 and cytokeratin 17 in BAL fluid of mice challenged with S. aureus enterotoxin A. Validation of cytochrome b5 showed tropic expression in epithelial cells of the bronchioles. Importantly, S. aureus enterotoxin A inhalation significantly decreased cytochrome b5 during the onset of lung injury. Validation of cytokeratin 17 showed ubiquitous expression in lung tissue and increased presence in BAL fluid after S. aureus enterotoxin A inhalation. Therefore, these new biomarkers may be predictive of ALI onset in patients and could provide insight regarding the basis of lung injury and inflammation.	[Menoret, Antoine; Kumar, Sanjeev; Vella, Anthony T.] Univ Connecticut, Ctr Hlth, Farmington, CT USA	University of Connecticut	Menoret, A (corresponding author), Univ Connecticut, Ctr Hlth, Farmington, CT USA.	vella@uchc.edu		Kumar, Sanjeev/0000-0002-4454-9914	National Institutes of Health [PO1 AI056172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health PO1 AI056172 project 3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2007, Chem Immunol Allergy, V93, P214, DOI 10.1159/000100897; Bajaj MS, 1999, INTENS CARE MED, V25, P1259, DOI 10.1007/s001340050097; Barre O, 2006, PROTEOMICS, V6, P5096, DOI 10.1002/pmic.200600074; Beckhove P, 2010, J CLIN INVEST, V120, P2230, DOI 10.1172/JCI37646; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Calfee CS, 2011, CRIT CARE MED, V39, P711, DOI 10.1097/CCM.0b013e318207ec3c; Cheng IW, 2003, CRIT CARE MED, V31, P20, DOI 10.1097/00003246-200301000-00003; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Durr UHN, 2007, BBA-BIOMEMBRANES, V1768, P3235, DOI 10.1016/j.bbamem.2007.08.007; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Engstrom G, 2009, THORAX, V64, P211, DOI 10.1136/thx.2008.102079; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Gaggar A, 2006, CLIN CHIM ACTA, V372, P24, DOI 10.1016/j.cca.2006.04.019; GIORDANO SJ, 1993, BIOCHIM BIOPHYS ACTA, V1172, P95, DOI 10.1016/0167-4781(93)90274-H; Han SG, 2008, INHAL TOXICOL, V20, P391, DOI 10.1080/08958370801904014 ; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hung CH, 2004, J ALLERGY CLIN IMMUN, V114, P664, DOI 10.1016/j.jaci.2004.05.042; Iscimen R, 2008, CRIT CARE MED, V36, P1518, DOI 10.1097/CCM.0b013e31816fc2c0; Ishizaka A, 2004, AM J PHYSIOL-LUNG C, V286, pL1088, DOI 10.1152/ajplung.00420.2002; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim ST, 2011, AM J RHINOL ALLERGY, V25, P19, DOI 10.2500/ajra.2011.25.3564; Kropski JA, 2009, CHEST, V135, P1440, DOI 10.1378/chest.08-2465; Kuebler WM, 2011, CRIT CARE MED, V39, P207, DOI 10.1097/CCM.0b013e318202e669; LeClaire RD, 1996, TOXICOL PATHOL, V24, P619, DOI 10.1177/019262339602400513; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; Lee HJ, 2008, PROTEOMICS, V8, P3371, DOI 10.1002/pmic.200800111; Levitt Joseph E, 2009, J Intensive Care Med, V24, P151, DOI 10.1177/0885066609332603; Lombard N, 2002, ENDOCR RES, V28, P485, DOI 10.1081/ERC-120016827; Madan T, 2010, MOL IMMUNOL, V47, P1923, DOI 10.1016/j.molimm.2010.02.027; Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Menoret A, 2009, J IMMUNOL, V183, P7489, DOI 10.4049/jimmunol.0901414; Miyakawa H, 2002, EUR RESPIR J, V19, P447, DOI 10.1183/09031936.02.00265902; Muralimohan G, 2008, J IMMUNOL, V181, P3698, DOI 10.4049/jimmunol.181.5.3698; Nakanishi M, 2007, PROTEOM CLIN APPL, V1, P1660, DOI 10.1002/prca.200700545; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Rieder SA, 2011, INFECT IMMUN, V79, P3141, DOI 10.1128/IAI.00177-11; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; TENHOLDER MF, 1991, CHEST, V100, P1385, DOI 10.1378/chest.100.5.1385; Tesfaigzi Y, 2001, RESP PHYSIOL, V128, P79, DOI 10.1016/S0034-5687(01)00267-5; Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287; Thomas Damien, 2007, Chem Immunol Allergy, V93, P24, DOI 10.1159/000100856; Tripathi A, 2005, AM J RHINOL, V19, P327, DOI 10.1177/194589240501900401; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC	52	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40184	10.1371/journal.pone.0040184	http://dx.doi.org/10.1371/journal.pone.0040184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792238	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800047
J	Huang, GH; Garretson, TA; Cheng, XH; Holztrager, MS; Li, SJ; Wang, X; Cheng, XW				Huang, Guo-Hua; Garretson, Tyler A.; Cheng, Xin-Hua; Holztrager, Maria S.; Li, Shun-Ji; Wang, Xing; Cheng, Xiao-Wen			Phylogenetic Position and Replication Kinetics of Heliothis virescens Ascovirus 3h (HvAV-3h) Isolated from Spodoptera exigua	PLOS ONE			English	Article							DIADROMUS-PULCHELLUS ASCOVIRUS; DNA INSECT VIRUS; HOST-RANGE; FRUGIPERDA LEPIDOPTERA; APOPTOSIS; SEQUENCE; HISTOPATHOLOGY; ORGANIZATION; HYMENOPTERA; BACULOVIRUS	Insect-specific ascoviruses with a circular genome are distributed in the USA, France, Australia and Indonesia. Here, we report the first ascovirus isolation from Spodoptera exigua in Hunan, China. DNA-DNA hybridization to published ascoviruses demonstrated that the new China ascovirus isolate is a variant of Heliothis virescens ascovirus 3a (HvAV-3a), thus named HvAV-3h. We investigated the phylogenetic position, cell infection, vesicle production and viral DNA replication kinetics of HvAV-3h, as well as its host-ranges. The major capsid protein (MCP) gene and the delta DNA polymerase (DNA po1) gene of HvAV-3h were sequenced and compared with the available ascovirus isolates for phylogenetic analysis. This shows a close relationship with HvAV-3g, originally isolated from Indonesia, HvAV-3e from Australia and HvAV-3c from United States. HvAV-3h infection induced vesicle production in the SeE1 cells derived from S. exigua and Sf9 cells derived from S. frugiperda, resulting in more vesicles generated in Sf9 than SeE1. Viral DNA replication kinetics of HvAV-3h also demonstrated a difference between the two cell lines tested. HvAV-3h could readily infect three important insect pests Helicoverpa armigera (Hubner), Spodoptera exigua (Hubner) and Spodoptera litura (Fabricius) from two genera in different subfamilies with high mortalities.	[Huang, Guo-Hua; Li, Shun-Ji; Wang, Xing; Cheng, Xiao-Wen] Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Garretson, Tyler A.; Cheng, Xin-Hua; Holztrager, Maria S.; Cheng, Xiao-Wen] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	Hunan Agricultural University; University System of Ohio; Miami University	Huang, GH (corresponding author), Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.	chengx@muohio.edu		Garretson, Tyler/0000-0001-6799-0350	National Department Public Benefit Research Foundation [200903017]	National Department Public Benefit Research Foundation	This study was supported by National Department Public Benefit Research Foundation (no. 200903017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 2006, ARCH VIROL, V151, P1689, DOI 10.1007/s00705-006-0762-7; Asgari S, 2007, VIRUS RES, V128, P99, DOI 10.1016/j.virusres.2007.04.020; Asgari S, 2007, J GEN VIROL, V88, P1120, DOI 10.1099/vir.0.82651-0; Bideshi DK, 2006, J VIROL, V80, P11791, DOI 10.1128/JVI.01639-06; Bideshi DK, 2010, INSECT VIROLOGY, P3; Bideshi DK, 2005, GENE DEV, V19, P1416, DOI 10.1101/gad.1300205; Bigot Y, 1997, J GEN VIROL, V78, P1149, DOI 10.1099/0022-1317-78-5-1149; Bigot Y, 1997, J GEN VIROL, V78, P1139, DOI 10.1099/0022-1317-78-5-1139; Bigot Y., 2011, VIRAL TAXONOMY 9 REP, V3rd ed., P147, DOI [10.1016/B978-0-12-384684-6.00011-2, DOI 10.1016/B978-0-12-384684-6.00011-2]; Bigot Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006397; CARNER GR, 1983, J INVERTEBR PATHOL, V41, P238, DOI 10.1016/0022-2011(83)90224-0; Cheng XW, 1999, J GEN VIROL, V80, P1537, DOI 10.1099/0022-1317-80-6-1537; Cheng XW, 2005, J INVERTEBR PATHOL, V89, P193, DOI 10.1016/j.jip.2005.06.011; Cheng XW, 2003, BIOTECHNIQUES, V34, P1162, DOI 10.2144/03346bm08; Cheng XW, 2000, J GEN VIROL, V81, P3083, DOI 10.1099/0022-1317-81-12-3083; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DELIUS H, 1984, J VIROL, V49, P609, DOI 10.1128/JVI.49.2.609-614.1984; FEDERICI BA, 1990, J INVERTEBR PATHOL, V56, P300, DOI 10.1016/0022-2011(90)90116-N; FEDERICI BA, 1983, P NATL ACAD SCI-BIOL, V80, P7664, DOI 10.1073/pnas.80.24.7664; FEDERICI BA, 1982, J INVERTEBR PATHOL, V40, P41, DOI 10.1016/0022-2011(82)90035-0; Federici BA, 1999, VIRUS TAXONOMY; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goodman CL, 2001, IN VITRO CELL DEV-AN, V37, P367, DOI 10.1007/BF02577573; GOVINDARAJAN R, 1990, J INVERTEBR PATHOL, V56, P291, DOI 10.1016/0022-2011(90)90115-M; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; HAMM JJ, 1985, ENVIRON ENTOMOL, V14, P258, DOI 10.1093/ee/14.3.258; Hamm JJ, 1998, J INVERTEBR PATHOL, V72, P138, DOI 10.1006/jipa.1998.4763; HAMM JJ, 1986, FLA ENTOMOL, V69, P524, DOI 10.2307/3495385; HUDSON JS, 1981, P S E ELECT MICROSC, V4, P27; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Mitchell E.R., 1979, P386; Nei M., 2000, Molecular evolution and phylogenetics.; Newton IR, 2003, BIOL CHARACTERISATIO; Oppenheimer DI, 1997, ARCH VIROL, V142, P2107, DOI 10.1007/s007050050229; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Peterson MW, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-7; SKALITER R, 1994, P NATL ACAD SCI USA, V91, P10665, DOI 10.1073/pnas.91.22.10665; Stadelbacher EA, 1979, 37 ANN P EL MICR SOC, P52; Stasiak K, 2000, J GEN VIROL, V81, P3059, DOI 10.1099/0022-1317-81-12-3059; Stasiak K, 2005, J INSECT PHYSIOL, V51, P103, DOI 10.1016/j.jinsphys.2004.07.004; Stasiak K, 2003, J GEN VIROL, V84, P2999, DOI 10.1099/vir.0.19290-0; Swofford DL, 2002, PAUP PHYLEGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillman PG, 2004, ENVIRON ENTOMOL, V33, P633, DOI 10.1603/0046-225X-33.3.633; Wang LH, 2008, J GEN VIROL, V89, P1402, DOI 10.1099/vir.0.2008/000695-0; Wang LH, 2006, VIROLOGY, V354, P167, DOI 10.1016/j.virol.2006.06.029; Xue JL, 2011, J GEN VIROL, V92, P2797, DOI 10.1099/vir.0.035733-0	49	32	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40225	10.1371/journal.pone.0040225	http://dx.doi.org/10.1371/journal.pone.0040225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792245	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300038
J	Weigel, KJ; Rues, L; Doyle, EJ; Buchheit, CL; Wood, JG; Gallagher, RJ; Kelly, LE; Radel, JD; Bradley, KA; LeVine, SM				Weigel, Kelsey J.; Rues, Laura; Doyle, Edward J.; Buchheit, Cassandra L.; Wood, John G.; Gallagher, Ryan J.; Kelly, Laura E.; Radel, Jeffrey D.; Bradley, Kenneth A.; LeVine, Steven M.			Rapid Vascular Responses to Anthrax Lethal Toxin in Mice Containing a Segment of Chromosome 11 from the CAST/Ei Strain on a C57BL/6 Genetic Background	PLOS ONE			English	Article							MAP-KINASE-KINASE; TISSUE FACTOR; PROTECTIVE ANTIGEN; NEUTROPHIL RECRUITMENT; INTERFERON-GAMMA; FACTOR CLEAVES; STERNE STRAIN; IFN-GAMMA; CELLS; SUSCEPTIBILITY	Host allelic variation controls the response to B. anthracis and the disease course of anthrax. Mouse strains with macrophages that are responsive to anthrax lethal toxin (LT) show resistance to infection while mouse strains with LT non-responsive macrophages succumb more readily. B6.CAST.11M mice have a region of chromosome 11 from the CAST/Ei strain (a LT responsive strain) introgressed onto a LT non-responsive C57BL/6J genetic background. Previously, B6.CAST.11M mice were found to exhibit a rapid inflammatory reaction to LT termed the early response phenotype (ERP), and displayed greater resistance to B. anthracis infection compared to C57BL/6J mice. Several ERP features (e.g., bloat, hypothermia, labored breathing, dilated pinnae vessels) suggested vascular involvement. To test this, Evan's blue was used to assess vessel leakage and intravital microscopy was used to monitor microvascular blood flow. Increased vascular leakage was observed in lungs of B6.CAST.11M mice compared to C57BL/6J mice 1 hour after systemic administration of LT. Capillary blood flow was reduced in the small intestine mesentery without concomitant leukocyte emigration following systemic or topical application of LT, the latter suggesting a localized tissue mechanism in this response. Since LT activates the Nlrp1b inflammasome in B6.CAST.11M mice, the roles of inflammasome products, IL-1 beta and IL-18, were examined. Topical application to the mesentery of IL-1 beta but not IL-18 revealed pronounced slowing of blood flow in B6.CAST.11M mice that was not present in C57BL/6J mice. A neutralizing anti-IL-1 beta antibody suppressed the slowing of blood flow induced by LT, indicating a role for IL-1 beta in the response. Besides allelic differences controlling Nlrp1b inflammasome activation by LT observed previously, evidence presented here suggests that an additional genetic determinant(s) could regulate the vascular response to IL-1 beta. These results demonstrate that vessel leakage and alterations to blood flow are part of the rapid response in mice resistant to B. anthracis infection.	[Weigel, Kelsey J.; Rues, Laura; Doyle, Edward J.; Buchheit, Cassandra L.; Wood, John G.; Gallagher, Ryan J.; Kelly, Laura E.; LeVine, Steven M.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Weigel, Kelsey J.; Rues, Laura; Doyle, Edward J.; Buchheit, Cassandra L.; Kelly, Laura E.] Rockhurst Univ, Kansas City, MO USA; [Wood, John G.] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66103 USA; [Radel, Jeffrey D.] Univ Kansas, Med Ctr, Dept Occupat Therapy Educ, Kansas City, KS 66103 USA; [Bradley, Kenneth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of California System; University of California Los Angeles	Weigel, KJ (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	slevine@kumc.edu		Gorsuch, Cassandra/0000-0002-6993-6910	National Institutes of Health [AI077791]; NICHD Center Grant [HD 02528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077791, R01AI077791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD Center Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health Grant AI077791 (to KAB and SML) and a NICHD Center Grant (HD 02528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEALL FA, 1966, J INFECT DIS, V116, P377, DOI 10.1093/infdis/116.3.377; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2010, CELL HOST MICROBE, V8, P394, DOI 10.1016/j.chom.2010.10.011; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; BURKE JF, 1958, J PATHOL BACTERIOL, V76, P1, DOI 10.1002/path.1700760102; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; Dao T, 1998, J IMMUNOL, V161, P2217; Davis RC, 2007, GENOMICS, V90, P306, DOI 10.1016/j.ygeno.2007.05.009; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Dumas EK, 2011, TOXINS, V3, P1111, DOI 10.3390/toxins3091111; Elazar S, 2010, VET RES, V41, DOI 10.1051/vetres/2009058; EZZELL JW, 1992, J GEN MICROBIOL, V138, P543, DOI 10.1099/00221287-138-3-543; Fantuzzi G, 1998, BLOOD, V91, P2118, DOI 10.1182/blood.V91.6.2118.2118_2118_2125; Finigan JH, 2009, AM J PHYSIOL-LUNG C, V296, pL1002, DOI 10.1152/ajplung.90555.2008; FISH DC, 1968, J INFECT DIS, V118, P114, DOI 10.1093/infdis/118.1.114; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ganter CG, 2006, MINERVA ANESTESIOL, V72, P21; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Gozes Y, 2006, INFECT IMMUN, V74, P1266, DOI 10.1128/IAI.74.2.1266-1272.2006; Gray H., 1918, ANATOMY HUMAN BODY, V20th; Hack C E, 1994, Prog Clin Biol Res, V388, P335; Hack C Erik, 2003, Contrib Microbiol, V10, P18; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kalns J, 2002, BIOCHEM BIOPH RES CO, V292, P41, DOI 10.1006/bbrc.2002.6626; Kawa K, 2010, INT IMMUNOL, V22, P157, DOI 10.1093/intimm/dxp122; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; KLEIN F, 1962, SCIENCE, V138, P1331, DOI 10.1126/science.138.3547.1331; KLEIN F, 1967, P SOC EXP BIOL MED, V124, P678; KLEIN F, 1966, J INFECT DIS, V116, P123, DOI 10.1093/infdis/116.2.123; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.039; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Levi M, 2012, NETH J MED, V70, P114; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McAllister RD, 2003, AM J PATHOL, V163, P1735, DOI 10.1016/S0002-9440(10)63532-8; McColl SR, 1999, J IMMUNOL, V163, P2829; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Monroe DM, 1996, BLOOD COAGUL FIBRIN, V7, P459, DOI 10.1097/00001721-199606000-00005; Netea MG, 2000, J IMMUNOL, V164, P2644, DOI 10.4049/jimmunol.164.5.2644; Niatsetskaya Z, 2010, ANTIOXID REDOX SIGN, V12, P435, DOI 10.1089/ars.2009.2800; Norman KE, 2003, BLOOD, V101, P921, DOI 10.1182/blood-2001-12-0190; Ovanesov MV, 2005, J THROMB HAEMOST, V3, P321, DOI 10.1111/j.1538-7836.2005.01128.x; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Puhlmann M, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-37; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; Rao LVM, 2004, J THROMB HAEMOST, V2, P530, DOI 10.1111/j.1538-7933.2004.00629.x; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; SAKLATVALA J, 1993, FEBS LETT, V334, P189, DOI 10.1016/0014-5793(93)81709-9; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Shikama Y, 2011, INNATE IMMUN-LONDON, V17, P3, DOI 10.1177/1753425909347508; Singh Y, 1999, INFECT IMMUN, V67, P1853; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Steiner DRS, 2001, J APPL PHYSIOL, V91, P1160, DOI 10.1152/jappl.2001.91.3.1160; Stroher U, 2001, J VIROL, V75, P11025, DOI 10.1128/JVI.75.22.11025-11033.2001; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Sutherland AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7702; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takahashi H, 2006, J LEUKOCYTE BIOL, V79, P789, DOI 10.1189/jlb.0705372; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Terra J, 2010, THESIS U CALIFORNIA; Terra JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002469; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Vandenbroucke RE, 2011, EMBO MOL MED, V3, P367, DOI 10.1002/emmm.201100146; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; WELKOS SL, 1989, MICROB PATHOGENESIS, V7, P15, DOI 10.1016/0882-4010(89)90108-3; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; WILHELM DL, 1962, PHARMACOL REV, V14, P251; Wood JG, 2000, J APPL PHYSIOL, V89, P1561, DOI 10.1152/jappl.2000.89.4.1561; Xin LJ, 2007, INFECT IMMUN, V75, P5018, DOI 10.1128/IAI.00499-07; Zhu P, 1998, BIOCHEM J, V330, P975, DOI 10.1042/bj3300975; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	91	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40126	10.1371/journal.pone.0040126	http://dx.doi.org/10.1371/journal.pone.0040126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792226	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300027
J	Chiu, HW; Fang, WH; Chen, YL; Wu, MD; Yuan, GF; Ho, SY; Wang, YJ				Chiu, Hui-Wen; Fang, Wen-Hung; Chen, Yen-Lin; Wu, Ming-Der; Yuan, Gwo-Fang; Ho, Sheng-Yow; Wang, Ying-Jan			Monascuspiloin Enhances the Radiation Sensitivity of Human Prostate Cancer Cells by Stimulating Endoplasmic Reticulum Stress and Inducing Autophagy	PLOS ONE			English	Article							RED YEAST RICE; DNA-DAMAGE; COMBINATION TREATMENT; PANCREATIC-CANCER; ARSENIC TRIOXIDE; IN-VITRO; APOPTOSIS; RADIOTHERAPY; INHIBITION; INDUCTION	Prostate cancer is a very common cancer among males. Traditional treatments for prostate cancer have limited efficacy; therefore, new therapeutic strategies and/or new adjuvant drugs must be explored. Red yeast rice (RYR) is a traditional food spice made in Asia by fermenting white rice with Monascus purpureus Went yeast. Accumulating evidence indicates that RYR has antitumor activity. In this study, PC-3 cells (human prostate cancer cells) were used to investigate the anti-cancer effects of ionizing radiation (IR) combined with monascuspiloin (MP, a yellow pigment isolated from Monascus pilosus M93-fermented rice) and to determine the underlying mechanisms of these effects in vitro and in vivo. We found that IR combined with MP showed increased therapeutic efficacy when compared with either treatment alone in PC-3 cells. In addition, the combined treatment enhanced DNA damage and endoplasmic reticulum (ER) stress. The combined treatment induced primarily autophagy in PC-3 cells, and the cell death that was induced by the combined treatment was chiefly the result of inhibition of the Akt/mTOR signaling pathways. In an in vivo study, the combination treatment showed greater anti-tumor growth effects. These novel findings suggest that the combined treatment could be a potential therapeutic strategy for prostate cancer.	[Chiu, Hui-Wen; Fang, Wen-Hung; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Yen-Lin; Wu, Ming-Der; Yuan, Gwo-Fang] BCRC, Food Ind Res & Dev Inst, Hsinchu, Taiwan; [Ho, Sheng-Yow] Sinlau Christian Hosp, Dept Radiat Oncol, Tainan, Taiwan	National Cheng Kung University	Chiu, HW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	shengho@seed.net.tw; yjwang@mail.ncku.edu.tw			Food Industry Research and Development Institute; Ministry of Economic Affairs [101-EC-17-A-01-04-0525]; National Science Council, Taiwan [NSC 100-2314-B-006 -055]; Sinlau Christian Hospital, Tainan, Taiwan; Food and Drug Administration, Department, Executive Yuan [DOH101-FDA-41301]; Aim for the Top University Project	Food Industry Research and Development Institute; Ministry of Economic Affairs; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Sinlau Christian Hospital, Tainan, Taiwan; Food and Drug Administration, Department, Executive Yuan; Aim for the Top University Project	This study was supported by the Food Industry Research and Development Institute and the financial support (101-EC-17-A-01-04-0525) of the Ministry of Economic Affairs, the National Science Council, Taiwan (NSC 100-2314-B-006 -055), the Sinlau Christian Hospital, Tainan, Taiwan, Food and Drug Administration, Department, Executive Yuan (DOH101-FDA-41301) and Aim for the Top University Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Attard G, 2006, BRIT J CANCER, V95, P767, DOI 10.1038/sj.bjc.6603223; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burdak-Rothkamm S, 2009, EUR J PHARMACOL, V625, P151, DOI 10.1016/j.ejphar.2009.09.068; CHEN XP, 1987, J TRADIT MED, V5, P61; Cheng Yan, 2011, World J Biol Chem, V2, P226, DOI 10.4331/wjbc.v2.i10.226; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Dai Y, 2011, AM J CANCER RES, V1, P128; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; DiPaola RS, 2001, HEMATOL ONCOL CLIN N, V15, P509, DOI 10.1016/S0889-8588(05)70229-X; He L, 2009, FEBS LETT, V583, P903, DOI 10.1016/j.febslet.2009.02.002; Hong MY, 2008, J NUTR BIOCHEM, V19, P448, DOI 10.1016/j.jnutbio.2007.05.012; Hong MY, 2011, CANCER PREV RES, V4, P608, DOI 10.1158/1940-6207.CAPR-10-0219; Hong MY, 2008, J MED FOOD, V11, P657, DOI 10.1089/jmf.2007.0702; Hsu WH, 2012, APPL MICROBIOL BIOTE; Karnak D, 2010, CURR DRUG TARGETS, V11, P699, DOI 10.2174/138945010791170888; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee CL, 2008, APPL MICROBIOL BIOT, V79, P829, DOI 10.1007/s00253-008-1480-8; Li X, 2012, MOL CELL BIOCH; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; Martinkova L, 1999, FOOD ADDIT CONTAM, V16, P15, DOI 10.1080/026520399284280; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McArt DG, 2010, MUTAGENESIS, V25, P299, DOI 10.1093/mutage/geq006; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; Mukubou H, 2010, INT J ONCOL, V37, P821, DOI 10.3892/ijo_00000732; OSBORNE CK, 1987, EUR J CANCER CLIN ON, V23, P1189; Paglin S, 2001, CANCER RES, V61, P439; Palayoor ST, 1997, RADIAT RES, V148, P105, DOI 10.2307/3579566; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Sanchez C, 2009, PROSTATE, V69, P1448, DOI 10.1002/pros.20991; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Shin SW, 2012, BBA-MOL CELL RES, V1823, P451, DOI 10.1016/j.bbamcr.2011.10.014; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Viola G, 2012, BIOCHEM PHARMACOL, V83, P16, DOI 10.1016/j.bcp.2011.09.017; Wu CT, 2007, ENDOCR-RELAT CANCER, V14, P633, DOI 10.1677/ERC-07-0073; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663	41	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40462	10.1371/journal.pone.0040462	http://dx.doi.org/10.1371/journal.pone.0040462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802963	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900036
J	Caboux, E; Lallemand, C; Ferro, G; Hemon, B; Mendy, M; Biessy, C; Sims, M; Wareham, N; Britten, A; Boland, A; Hutchinson, A; Siddiq, A; Vineis, P; Riboli, E; Romieu, I; Rinaldi, S; Gunter, MJ; Peeters, PHM; van der Schouw, YT; Travis, R; Bueno-de-Mesquita, HB; Canzian, F; Sanchez, MJ; Skeie, G; Olsen, KS; Lund, E; Bilbao, R; Sala, N; Barricarte, A; Palli, D; Navarro, C; Panico, S; Redondo, ML; Polidoro, S; Dossus, L; Boutron-Ruault, MC; Clavel-Chapelon, F; Trichopoulou, A; Trichopoulos, D; Lagiou, P; Boeing, H; Fisher, E; Tumino, R; Agnoli, C; Hainaut, P				Caboux, Elodie; Lallemand, Christophe; Ferro, Gilles; Hemon, Bertrand; Mendy, Maimuna; Biessy, Carine; Sims, Matt; Wareham, Nick; Britten, Abigail; Boland, Anne; Hutchinson, Amy; Siddiq, Afshan; Vineis, Paolo; Riboli, Elio; Romieu, Isabelle; Rinaldi, Sabina; Gunter, Marc J.; Peeters, Petra H. M.; van der Schouw, Yvonne T.; Travis, Ruth; Bueno-de-Mesquita, H. Bas; Canzian, Federico; Sanchez, Maria-Jose; Skeie, Guri; Olsen, Karina Standahl; Lund, Eiliv; Bilbao, Roberto; Sala, Nuria; Barricarte, Aurelio; Palli, Domenico; Navarro, Carmen; Panico, Salvatore; Luisa Redondo, Maria; Polidoro, Silvia; Dossus, Laure; Boutron-Ruault, Marie Christine; Clavel-Chapelon, Francoise; Trichopoulou, Antonia; Trichopoulos, Dimitrios; Lagiou, Pagona; Boeing, Heiner; Fisher, Eva; Tumino, Rosario; Agnoli, Claudia; Hainaut, Pierre			Sources of Pre-Analytical Variations in Yield of DNA Extracted from Blood Samples: Analysis of 50,000 DNA Samples in EPIC	PLOS ONE			English	Article							GENOME WIDE; CELL COUNT; CANCER; RISK; SEX; AGE	The European Prospective Investigation into Cancer and nutrition (EPIC) is a long-term, multi-centric prospective study in Europe investigating the relationships between cancer and nutrition. This study has served as a basis for a number of Genome-Wide Association Studies (GWAS) and other types of genetic analyses. Over a period of 5 years, 52,256 EPIC DNA samples have been extracted using an automated DNA extraction platform. Here we have evaluated the pre-analytical factors affecting DNA yield, including anthropometric, epidemiological and technical factors such as center of subject recruitment, age, gender, body-mass index, disease case or control status, tobacco consumption, number of aliquots of buffy coat used for DNA extraction, extraction machine or procedure, DNA quantification method, degree of haemolysis and variations in the timing of sample processing. We show that the largest significant variations in DNA yield were observed with degree of haemolysis and with center of subject recruitment. Age, gender, body-mass index, cancer case or control status and tobacco consumption also significantly impacted DNA yield. Feedback from laboratories which have analyzed DNA with different SNP genotyping technologies demonstrate that the vast majority of samples (approximately 88%) performed adequately in different types of assays. To our knowledge this study is the largest to date to evaluate the sources of pre-analytical variations in DNA extracted from peripheral leucocytes. The results provide a strong evidence-based rationale for standardized recommendations on blood collection and processing protocols for large-scale genetic studies.	[Caboux, Elodie; Lallemand, Christophe; Ferro, Gilles; Hemon, Bertrand; Mendy, Maimuna; Biessy, Carine; Romieu, Isabelle; Rinaldi, Sabina] Int Agcy Res Canc, F-69372 Lyon, France; [Sims, Matt; Wareham, Nick; Britten, Abigail] Addenbrookes Hosp, Med Res Council MRC Epidemiol Unit, Cambridge, England; [Boland, Anne] Commissariat Energie Atom, Ctr Natl Genotypage, Inst Genom, Evry, France; [Hutchinson, Amy] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Siddiq, Afshan; Vineis, Paolo; Riboli, Elio; Gunter, Marc J.; Peeters, Petra H. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Peeters, Petra H. M.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Travis, Ruth] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez, Maria-Jose] CIBERESP, Granada, Spain; [Skeie, Guri; Olsen, Karina Standahl; Lund, Eiliv] Univ Tromso, Inst Community Med, Tromso, Norway; [Bilbao, Roberto] Fdn Vasca Innovac & Invest Sanitarias, Sondika, Bizkaia, Spain; [Sala, Nuria] Catalan Inst Oncol ICO IDIBELL, Unit Nutr Environm & Canc, Barcelona, Spain; [Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Barricarte, Aurelio; Navarro, Carmen] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, France; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Navarro, Carmen] Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Luisa Redondo, Maria] Publ Hlth Directorate, Asturias, Spain; [Polidoro, Silvia] HuGeF, Turin, Italy; [Dossus, Laure; Boutron-Ruault, Marie Christine; Clavel-Chapelon, Francoise] Paris S Univ, INSERM U1018, Inst Gustave Roussy, Villejuif, France; [Trichopoulou, Antonia; Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, World Hlth Org WHO Collaborating Ctr Food & Nutr, GR-11527 Athens, Greece; [Trichopoulou, Antonia; Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Trichopoulos, Dimitrios; Lagiou, Pagona] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, Dimitrios; Lagiou, Pagona] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Potsdam Rehbrucke Dept Epidemiol, Nuthetal, Germany; [Fisher, Eva] Commiss Genet Testing Robert Koch Inst, Adm Off, Berlin, Germany; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Histopathol Unit, Ragusa, Italy; [Agnoli, Claudia] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, Milan, Italy	World Health Organization; International Agency for Research on Cancer (IARC); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London; Utrecht University; Utrecht University Medical Center; University of Oxford; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Helmholtz Association; German Cancer Research Center (DKFZ); Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; UiT The Arctic University of Tromso; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Naples Federico II; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Robert Koch Institute; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan	Caboux, E (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	pierre.hainaut@i-pri.org	Sánchez, Maria-José/D-1087-2011; Boutron-Ruault, Marie-Christine/H-3936-2014; Polidoro, Silvia/GYJ-3517-2022; Dossus, Laure/B-2875-2013; Gunter, Marc/AAP-8621-2020; Caboux, Elodie/AAJ-3233-2020; Canzian, Federico/I-2804-2014; Clavel-Chapelon, Francoise/G-6733-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Hainaut, Pierre/B-6018-2012; Dossus, Laure/AAW-9097-2021; Mendy, Maimuna/ABD-5038-2021; Caboux, Elodie/AGW-7436-2022; van der Schouw, Yvonne T./F-8327-2014; Agnoli, Claudia/K-5916-2016; Sala, Nuria/G-8471-2015	Sánchez, Maria-José/0000-0003-4817-0757; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Dossus, Laure/0000-0003-2716-5748; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Hainaut, Pierre/0000-0002-1303-1610; Dossus, Laure/0000-0003-2716-5748; van der Schouw, Yvonne T./0000-0002-4605-435X; Agnoli, Claudia/0000-0003-4472-1179; Skeie, Guri/0000-0003-2476-4251; Gunter, Marc/0000-0001-5472-6761; Siddiq, Afshan/0000-0002-9110-1434; Riboli, Elio/0000-0001-6795-6080; Caboux, Elodie/0000-0001-8393-6979; Panico, Salvatore/0000-0002-5498-8312; Navarro, Carmen/0000-0001-8896-7483; PALLI, Domenico/0000-0002-5558-2437; Canzian, Federico/0000-0002-4261-4583; Sala, Nuria/0000-0003-3585-7613; Lund, Eiliv/0000-0002-8071-8711; tumino, rosario/0000-0003-2666-414X; Polidoro, Silvia/0000-0003-2968-0575	European Commission Research & Innovation DG project BBMRI (Biobanking and Biomolecular Resources Research Infrastructure) [212111]; Regular Budget of International Agency for Research on Cancer (IARC); Imperial College London (ICL); Medical Research Council UK (MRC UK); European Community INTERACT project through MRC Cambridge, UK; International Agency for Research on Cancer (IARC); EU FP6 Network of Excellence Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS); Cancer Research UK (CRCUK); Medical Research Council [MC_U106179471, G0801056B] Funding Source: researchfish	European Commission Research & Innovation DG project BBMRI (Biobanking and Biomolecular Resources Research Infrastructure); Regular Budget of International Agency for Research on Cancer (IARC); Imperial College London (ICL); Medical Research Council UK (MRC UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community INTERACT project through MRC Cambridge, UK; International Agency for Research on Cancer (IARC)(World Health Organization); EU FP6 Network of Excellence Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS); Cancer Research UK (CRCUK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by European Commission Research & Innovation DG project BBMRI (Biobanking and Biomolecular Resources Research Infrastructure, http://www.bbmri.eu), project number 212111 and by the Regular Budget of International Agency for Research on Cancer (IARC). DNA extraction data used in the study were generated as part of molecular epidemiological studies approved by the Steering Committee of the European Prospective Investigation into Cancer and Nutrition (EPIC, http://epic.iarc.fr). Detailed information about the funding of EPIC is available at http://epic.iarc.fr/funding.php. The funding agencies and organizations which provided funds for DNA extraction in specific EPIC studies were Imperial College London (ICL, BRCD study); Medical Research Council UK (MRC UK, EPHD study); European Community INTERACT project (through MRC Cambridge, UK, INT study, http://www.inter-act.eu); International Agency for Research on Cancer (IARC) and Imperial College London (ICL) (LUND study), EU FP6 Network of Excellence Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS, http://www.ecnis.org); and Cancer Research UK (CRCUK) (LYMD study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GA, 2005, MAYO CLIN PROC, V80, P1022, DOI 10.4065/80.8.1022; Al Safar HS, 2011, APPL MICROBIOL BIOT, V89, P807, DOI 10.1007/s00253-010-2926-3; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Beckmann L, 2011, J CLIN ENDOCR METAB, V96, pE360, DOI 10.1210/jc.2010-0912; Boffetta P, 2010, JNCI-J NATL CANCER I, V102, P529, DOI 10.1093/jnci/djq072; Carpi Francesco M, 2011, Recent Pat DNA Gene Seq, V5, P1; ERKELLERYUKSEL FM, 1992, J PEDIATR-US, V120, P216, DOI 10.1016/S0022-3476(05)80430-5; GenVault, 2011, DNA QUANT METH REC U; Hainaut P, 2011, METHODS MOL BIOL, V675, P179, DOI 10.1007/978-1-59745-423-0_7; Ivarsson M, 2011, METHODS MOL BIOL, V675, P261, DOI 10.1007/978-1-59745-423-0_14; Jee SH, 2005, AM J EPIDEMIOL, V162, P1062, DOI 10.1093/aje/kwi326; Laurson KR, 2011, J INVEST MED, V59, P27, DOI 10.231/JIM.0b013e318200151a; Nederhand RJ, 2003, J THROMB HAEMOST, V1, P987, DOI 10.1046/j.1538-7836.2003.00216.x; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Richardson AJ, 2006, J LAB CLIN MED, V147, P290, DOI 10.1016/j.lab.2006.01.005; Sale MM, 2009, METHODS MOL BIOL, V590, P403, DOI 10.1007/978-1-60327-378-7_25; Tao M, 2011, BREAST CANCER RES TR, V129, P247, DOI 10.1007/s10549-011-1512-4; Van Tiel ED, 2002, ANN EPIDEMIOL, V12, P378, DOI 10.1016/S1047-2797(01)00282-4; Visvikis S, 1998, CLIN CHEM LAB MED, V36, P551, DOI 10.1515/CCLM.1998.094	19	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39821	10.1371/journal.pone.0039821	http://dx.doi.org/10.1371/journal.pone.0039821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808065	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700014
J	Ahola, K; Siren, I; Kivimaki, M; Ripatti, S; Aromaa, A; Lonnqvist, J; Hovatta, I				Ahola, Kirsi; Siren, Ilari; Kivimaki, Mika; Ripatti, Samuli; Aromaa, Arpo; Lonnqvist, Jouko; Hovatta, Iiris			Work-Related Exhaustion and Telomere Length: A Population-Based Study	PLOS ONE			English	Article							INVENTORY-GENERAL SURVEY; FINNISH HEALTH 2000; BURNOUT; STRESS; DISORDERS; RESOURCES; VALIDITY; DISEASE; WOMEN	Background: Psychological stress is suggested to accelerate the rate of biological aging. We investigated whether work-related exhaustion, an indicator of prolonged work stress, is associated with accelerated biological aging, as indicated by shorter leukocyte telomeres, that is, the DNA-protein complexes that cap chromosomal ends in cells. Methods: We used data from a representative sample of the Finnish working-age population, the Health 2000 Study. Our sample consisted of 2911 men and women aged 30-64. Work-related exhaustion was assessed using the Maslach Burnout Inventory - General Survey. We determined relative leukocyte telomere length using a quantitative real-time polymerase chain reaction (PCR) -based method. Results: After adjustment for age and sex, individuals with severe exhaustion had leukocyte telomeres on average 0.043 relative units shorter (standard error of the mean 0.016) than those with no exhaustion (p = 0.009). The association between exhaustion and relative telomere length remained significant after additional adjustment for marital and socioeconomic status, smoking, body mass index, and morbidities (adjusted difference 0.044 relative units, standard error of the mean 0.017, p = 0.008). Conclusions: These data suggest that work-related exhaustion is related to the acceleration of the rate of biological aging. This hypothesis awaits confirmation in a prospective study measuring changes in relative telomere length over time.	[Ahola, Kirsi; Kivimaki, Mika] Work Org, Finnish Inst Occupat Hlth, Helsinki, Finland; [Siren, Ilari; Hovatta, Iiris] Univ Helsinki, Res Programs Unit Mol Neurol, Helsinki, Finland; [Siren, Ilari; Hovatta, Iiris] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kivimaki, Mika] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Ripatti, Samuli] Finland FIMM, Inst Mol Med, Helsinki, Finland; [Ripatti, Samuli] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Aromaa, Arpo] Publ Hlth Consulting, Helsinki, Finland; [Lonnqvist, Jouko; Hovatta, Iiris] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Lonnqvist, Jouko] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland; [Lonnqvist, Jouko] Univ Helsinki, Cent Hosp, Helsinki, Finland	Finnish Institute of Occupational Health; University of Helsinki; University of Helsinki; University of London; University College London; University of Helsinki; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Ahola, K (corresponding author), Work Org, Finnish Inst Occupat Hlth, Helsinki, Finland.	kirsi.ahola@ttl.fi	Kivimaki, Mika/B-3607-2012; Ripatti, Samuli/H-9446-2014; Hovatta, Iiris/D-6871-2012	Kivimaki, Mika/0000-0002-4699-5627; Ripatti, Samuli/0000-0002-0504-1202; Hovatta, Iiris/0000-0002-5990-7892	Academy of Finland [124940, 140747, 132944, 251217]; Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Peter and Patricia Gruber Foundation; EU; Medical Research Council, UK [G0902037]; Academy of Finland Center of Excellence in Complex Genetics [213506, 129680]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G8802774, G0902037, G19/35, G0100222] Funding Source: researchfish; MRC [G0902037] Funding Source: UKRI	Academy of Finland(Academy of Finland); Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Peter and Patricia Gruber Foundation; EU(European Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland Center of Excellence in Complex Genetics(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Academy of Finland (grant numbers 124940 and 140747 for IH, 132944 for MK, and 251217 for SR), Yrjo Jahnsson Foundation (IH), Signe and Ane Gyllenberg Foundation (IH), Rosalind Franklin Young Investigator Award from the Peter and Patricia Gruber Foundation (IH), EU New OSH ERA Research Programme (MK), the Medical Research Council, UK (G0902037 for MK), Academy of Finland Center of Excellence in Complex Genetics (grant numbers 213506 and 129680 for SR), the Finnish Foundation for Cardiovascular Research (SR), and the Sigrid Juselius Foundation (SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Ahola K, 2005, J AFFECT DISORDERS, V88, P55, DOI 10.1016/j.jad.2005.06.004; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 1999, HDB STAT FINL; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Eerola J, 2010, J GERONTOL A-BIOL, V65, P1181, DOI 10.1093/gerona/glq125; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; European Agency for Safety and Health at Work, 2009, OSH FIGURES STRESS W; European Social Dialogue, 2004, FRAM AGR WORK REL ST; Garcia-Bueno B, 2008, NEUROSCI BIOBEHAV R, V32, P1136, DOI 10.1016/j.neubiorev.2008.04.001; Heistaro S, 2008, PUBLICATIONS NATL PU; Honkonen T, 2007, SCAND J WORK ENV HEA, V33, P29, DOI 10.5271/sjweh.1061; Honkonen T, 2006, J PSYCHOSOM RES, V61, P59, DOI 10.1016/j.jpsychores.2005.10.002; Kalimo R, 2003, WORK STRESS, V17, P109, DOI 10.1080/0267837031000149919; Kalimo R., 2006, MASLACHIN YLEINEN TY; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; LEHTONEN R, 2003, RES REPORTS STAT FIN, V238, P91; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 2009, OXFORD HDB ORG WELL, P86, DOI [10.1093/oxfordhb/9780199211913.001.0001, DOI 10.1093/OXFORDHB/9780199211913.003.0005, 10.1093/oxfordhb/9780199211913.003.0005]; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd ed., P19; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Schutte N, 2000, J OCCUP ORGAN PSYCH, V73, P53, DOI 10.1348/096317900166877; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Taris TW, 1999, WORK STRESS, V13, P223, DOI 10.1080/026783799296039; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837	36	56	58	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40186	10.1371/journal.pone.0040186	http://dx.doi.org/10.1371/journal.pone.0040186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22808115	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400033
J	Richards, FM; Tape, CJ; Jodrell, DI; Murphy, G				Richards, Frances M.; Tape, Christopher J.; Jodrell, Duncan I.; Murphy, Gillian			Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; UP-REGULATED EXPRESSION; CONVERTING-ENZYME; BREAST-CANCER; PHASE-III; ALPHA INHIBITOR; FAMILY-MEMBERS; FACTOR TNF; ADAM17; ACTIVATION	ADAM 17 (TNF-alpha converting enzyme, TACE) is a potential target for cancer therapy, but the small molecule inhibitors reported to date are not specific to this ADAM family member. This membrane-bound metalloproteinase is responsible for ectodomain shedding of pathologically significant substrates including TNF-alpha and EGFR ligands. The aim of this study was to evaluate the pharmacokinetics, pharmacodynamics and anti-tumour efficacy of the first specific inhibitor, an anti-human ADAM17 IgG antibody, clone D1(A12). We used intraperitoneal xenografts of the human ovarian cancer cell line IGROV1-Luc in Balb/c nude mice, chosen because it was previously reported that growth of these xenografts is inhibited by knock-down of TNF-alpha. In vitro, 200 nM D1(A12) inhibited shedding of ADAM17 substrates TNF-alpha, TNFR1-alpha, TGF-alpha, amphiregulin (AREG), HB-EGF and IL-6R alpha, from IGROV1-Luc cells, (4.7 nM IC50 for TNF-alpha shedding). In IGROV1-Luc xenografts in vivo, D1(A12) IgG showed pharmacokinetic properties suitable for efficacy studies, with a single i.p. dose of 10 mg/kg D1(A12) sufficient to maintain IgG plasma and ascites fluid concentrations above 100 nM for more than 7 days. The plasma half life was 8.6 days. Next, an efficacy study was performed, dosing D1(A12) or anti-human TNF-alpha antibody infliximab at 10 mg/kg q7d, quantifying IGROV1-Luc tumour burden by bioluminescence. D1(A12) IgG showed a significant reduction in tumour growth (p = 0.005), 56% of vehicle control. Surprisingly, D1(A12) did not reduce the concentration of circulating human TNF-alpha, suggesting that another enzyme may compensate for inhibition of ADAM17 in vivo (but not in vitro). However, D1(A12) did show clear pharmacodynamic effects in the mice, with significant inhibition of shedding from tumour of ADAM17 substrates TNFR1-alpha, AREG, and TGF-alpha (4-15-fold reductions, p<0.0001 for all three). Thus, D1(A12) has anti-ADAM17 activity in vivo, inhibits shedding of EGFR ligands and has potential for use in EGF ligand-dependent tumours.	[Richards, Frances M.; Jodrell, Duncan I.] Univ Cambridge, Pharmacol & Drug Dev Grp, Canc Res UK Cambridge Res Inst, Cambridge, England; [Richards, Frances M.; Tape, Christopher J.; Jodrell, Duncan I.; Murphy, Gillian] Univ Cambridge, Dept Oncol, Cambridge, England; [Tape, Christopher J.; Murphy, Gillian] Univ Cambridge, Proteases & Tumour Microenvironm Grp, Canc Res UK Cambridge Res Inst, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Richards, FM (corresponding author), Univ Cambridge, Pharmacol & Drug Dev Grp, Canc Res UK Cambridge Res Inst, Cambridge, England.	frances.richards@cancer.org.uk		Tape, Christopher/0000-0003-4712-2737	Cancer Research UK [C96/A8333]; Hutchison-Whampoa Ltd.; Cancer Research UK [15678] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Hutchison-Whampoa Ltd.; Cancer Research UK(Cancer Research UK)	The research work in this study was funded by Cancer Research UK (www.cancerresearchuk.org), grant number C96/A8333. Prof. Murphy's Chair was funded by a charitable donation to the Univerity of Cambridge by Hutchison-Whampoa Ltd. She is not an employee of Hutchison Whampoa, and Hutchison Whampoa have no commercial interests in any of the authors' research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanious H, 2011, BLOOD, V117, P6237, DOI 10.1182/blood-2010-10-313940; Baumgart A, 2010, CANCER RES, V70, P5368, DOI 10.1158/0008-5472.CAN-09-3763; BENARD J, 1985, CANCER RES, V45, P4970; Bissett D, 2005, J CLIN ONCOL, V23, P842, DOI 10.1200/JCO.2005.03.170; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brown ER, 2008, ANN ONCOL, V19, P1340, DOI 10.1093/annonc/mdn054; Franovic A, 2006, CANCER RES, V66, P8083, DOI 10.1158/0008-5472.CAN-06-1595; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Georgopoulos S, 1996, J INFLAMM, V46, P86; Ghetie V, 2004, CANC DRUG DISC DEV, P475; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hassan MI, 1999, ANTICANCER RES, V19, P5657; Heath EI, 2001, CANCER CHEMOTH PHARM, V48, P269, DOI 10.1007/s002800100330; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Hirte H, 2006, GYNECOL ONCOL, V102, P300, DOI 10.1016/j.ygyno.2005.12.020; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; KENNEL SJ, 1991, CANCER RES, V51, P1529; Kornfeld JW, 2011, BRIT J CANCER, V104, P138, DOI 10.1038/sj.bjc.6606017; Kulbe H, 2011, CANC RES; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kyula JN, 2010, CLIN CANCER RES, V16, P3378, DOI 10.1158/1078-0432.CCR-10-0014; Lee MH, 2001, BIOCHEM BIOPH RES CO, V280, P945, DOI 10.1006/bbrc.2000.4192; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Lin P., 2011, MOL CELL BIOCH; Madhusudan S, 2005, J CLIN ONCOL, V23, P5950, DOI 10.1200/JCO.2005.04.127; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Mezyk-Kopec R, 2009, CYTOKINE, V46, P309, DOI 10.1016/j.cyto.2009.03.002; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Nakagawa M, 2009, CANCER SCI, V100, P654, DOI 10.1111/j.1349-7006.2009.01089.x; Narita D, 2012, ACTA HISTOCHEM, V114, P131, DOI 10.1016/j.acthis.2011.03.009; NAYLOR MS, 1993, J CLIN INVEST, V91, P2194, DOI 10.1172/JCI116446; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Qian MX, 2007, DRUG METAB DISPOS, V35, P1916, DOI 10.1124/dmd.107.015933; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Salako MA, 2011, MOL THER, V19, P490, DOI 10.1038/mt.2010.247; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Schmuck R, 2011, AM J PATHOL, V178, P1792, DOI 10.1016/j.ajpath.2010.12.043; Sinnathamby G, 2011, CLIN EXP IMMUNOL, V163, P324, DOI 10.1111/j.1365-2249.2010.04298.x; Sparano JA, 2004, J CLIN ONCOL, V22, P4683, DOI 10.1200/JCO.2004.08.054; Stokes A, 2010, CLIN CANCER RES, V16, P2022, DOI 10.1158/1078-0432.CCR-09-2525; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Thabet MM, 2006, CURR OPIN INVEST DR, V7, P1014; Van Schaeybroeck S, 2011, CANCER RES, V71, P1071, DOI 10.1158/0008-5472.CAN-10-0714; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zheng X, 2011, MOL CARCINOG; Zheng X, 2009, CANCER BIOL THER, V8, P1045, DOI 10.4161/cbt.8.11.8539; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	61	62	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40597	10.1371/journal.pone.0040597	http://dx.doi.org/10.1371/journal.pone.0040597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792380	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400078
J	Roux, S; Krupovic, M; Poulet, A; Debroas, D; Enault, F				Roux, Simon; Krupovic, Mart; Poulet, Axel; Debroas, Didier; Enault, Francois			Evolution and Diversity of the Microviridae Viral Family through a Collection of 81 New Complete Genomes Assembled from Virome Reads	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; STRUCTURAL-ANALYSIS; DNA; SEQUENCE; BACTERIOPHAGE; VIRUSES; ATTACHMENT; BACTERIAL; COMMUNITY; SERVER	Recent studies suggest that members of the Microviridae (a family of ssDNA bacteriophages) might play an important role in a broad spectrum of environments, as they were found in great number among the viral fraction from seawater and human gut samples. 24 completely sequenced Microviridae have been described so far, divided into three distinct groups named Microvirus, Gokushovirinae and Alpavirinae, this last group being only composed of prophages. In this study, we present the analysis of 81 new complete Microviridae genomes, assembled from viral metagenomes originating from various ecosystems. The phylogenetic analysis of the core genes highlights the existence of four groups, confirming the three subfamilies described so far and exhibiting a new group, named Pichovirinae. The genomic organizations of these viruses are strikingly coherent with their phylogeny, the Pichovirinae being the only group of this family with a different organization of the three core genes. Analysis of the structure of the major capsid protein reveals the presence of mushroom-like insertions conserved within all the groups except for the microviruses. In addition, a peptidase gene was found in 10 Microviridae and its analysis indicates a horizontal gene transfer that occurred several times between these viruses and their bacterial hosts. This is the first report of such gene transfer in Microviridae. Finally, searches against viral metagenomes revealed the presence of highly similar sequences in a variety of biomes indicating that Microviridae probably have both an important role in these ecosystems and an ancient origin.	[Roux, Simon; Poulet, Axel; Debroas, Didier; Enault, Francois] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Roux, Simon; Poulet, Axel; Debroas, Didier; Enault, Francois] Lab Microorganismes Genome & Environm, Aubiere, France; [Krupovic, Mart] Inst Pasteur, Unite Biol Mol Gene Chez Extremophiles, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Roux, S (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France.	francois.enault@univ-bpclermont.fr	Roux, Simon/ABE-6255-2020; Krupovic, Mart/I-4209-2012; Roux, Simon/B-3751-2013; Krupovic, Mart/ABD-6255-2021	Roux, Simon/0000-0002-5831-5895; Krupovic, Mart/0000-0001-5486-0098; Krupovic, Mart/0000-0001-5486-0098; Poulet, Axel/0000-0002-3415-8960	french defense procurement agency (DGA, Direction Generale de l'Armement); European Molecular Biology Organization [ALTF 347-2010]	french defense procurement agency (DGA, Direction Generale de l'Armement); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	SR was supported by a PhD grant from the french defense procurement agency (DGA, Direction Generale de l'Armement). MK was supported by the European Molecular Biology Organization (long term fellowship ALTF 347-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; AZUMA J, 1980, J BIOCHEM, V88, P525, DOI 10.1093/oxfordjournals.jbchem.a132999; Bennett A, 2008, COMPUT MATH METHOD M, V9, P183, DOI 10.1080/17486700802168247; Bernal RA, 2004, J MOL BIOL, V337, P1109, DOI 10.1016/j.jmb.2004.02.033; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; Bochtler M, 2004, PROTEIN SCI, V13, P854, DOI 10.1110/ps.03515704; Brentlinger KL, 2002, J BACTERIOL, V184, P1089, DOI 10.1128/jb.184.4.1089-1094.2002; Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x; Chapman MS, 2003, ADV PROTEIN CHEM, V64, P125; Cherwa J. E., 2011, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0000781.pub2, DOI 10.1002/9780470015902.A0000781.PUB2, 10.1002/9780470015902.A0000781.PUB2]; Cherwa JE, 2011, VIROLOGY, V411, P9, DOI 10.1016/j.virol.2010.12.026; Chipman PR, 1998, STRUCTURE, V6, P135, DOI 10.1016/S0969-2126(98)00016-1; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fane BA, 2011, BACTERIOPHAGES, P129; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11; Korndorfer IP, 2008, ACTA CRYSTALLOGR D, V64, P644, DOI 10.1107/S0907444908007890; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Krupovic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019893; Krupovic M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-112; Lee HS, 2011, WATER RES, V45, P3723, DOI 10.1016/j.watres.2011.04.024; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; Michel A, 2010, APPL ENVIRON MICROB, V76, P7310, DOI 10.1128/AEM.02721-09; Miller RV, 2001, ANTON LEEUW INT J G, V79, P141; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Morais MC, 2004, MOL CELL, V15, P991, DOI 10.1016/j.molcel.2004.08.023; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RENAUDIN J, 1987, J BACTERIOL, V169, P4950, DOI 10.1128/jb.169.11.4950-4961.1987; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Rosario K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/vir.0.012955-0; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033641; Ruboyianes MV, 2009, J VIROL, V83, P9952, DOI 10.1128/JVI.01077-09; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tucker KP, 2011, ISME J, V5, P822, DOI 10.1038/ismej.2010.188; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Young R, 2006, BACTERIOPHAGES, P104; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zsak L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-331	60	130	132	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40418	10.1371/journal.pone.0040418	http://dx.doi.org/10.1371/journal.pone.0040418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808158	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400053
J	Saderi, N; Salgado-Delgado, R; Avendano-Pradel, R; Basualdo, MD; Ferri, GL; Chavez-Macias, L; Roblera, JEO; Escobar, C; Buijs, RM				Saderi, Nadia; Salgado-Delgado, Roberto; Avendano-Pradel, Rafael; del Carmen Basualdo, Maria; Ferri, Gian-Luca; Chavez-Macias, Laura; Olvera Roblera, Juan E.; Escobar, Carolina; Buijs, Ruud M.			NPY and VGF Immunoreactivity Increased in the Arcuate Nucleus, but Decreased in the Nucleus of the Tractus Solitarius, of Type-II Diabetic Patients	PLOS ONE			English	Article							INTRACEREBROVENTRICULAR NEUROPEPTIDE-Y; IMMUNOCYTOCHEMICAL LOCALIZATION; GLUCOSE; NEURONS; PRECURSOR; HORMONE; STIMULATION; SUPPRESSION; INHIBITION; EXPRESSION	Ample animal studies demonstrate that neuropeptides NPY and alpha-MSH expressed in Arcuate Nucleus and Nucleus of the Tractus Solitarius, modulate glucose homeostasis and food intake. In contrast is the absence of data validating these observations for human disease. Here we compare the post mortem immunoreactivity of the metabolic neuropeptides NPY, alpha MSH and VGF in the infundibular nucleus, and brainstem of 11 type-2 diabetic and 11 non-diabetic individuals. alpha-MSH, NPY and tyrosine hydroxylase in human brain are localized in the same areas as in rodent brain. The similar distribution of NPY, alpha-MSH and VGF indicated that these neurons in the human brain may share similar functionality as in the rodent brain. The number of NPY and VGF immuno positive cells was increased in the infundibular nucleus of diabetic subjects in comparison to non-diabetic controls. In contrast, NPY and VGF were down regulated in the Nucleus of the Tractus Solitarius of diabetic patients. These results suggest an activation of NPY producing neurons in the arcuate nucleus, which, according to animal experimental studies, is related to a catabolic state and might be the basis for increased hepatic glucose production in type2 diabetes.	[Saderi, Nadia; Salgado-Delgado, Roberto; del Carmen Basualdo, Maria; Buijs, Ruud M.] Univ Nacl Autonoma Mexico, Dept Biol Celular & Fisiol, Inst Invest Biomed, Mexico City, DF, Mexico; [Saderi, Nadia; Ferri, Gian-Luca] Univ Cagliari, NEF Lab, Dept Cytomorphol, Monserrato, CA, Italy; [Salgado-Delgado, Roberto] UASLP, Fac Ciencias, San Luis Potosi, Mexico; [Avendano-Pradel, Rafael; Escobar, Carolina] Univ Nacl Autonoma Mexico, Dept Anat, Fac Med, Mexico City, DF, Mexico; [Chavez-Macias, Laura; Olvera Roblera, Juan E.] Hosp Gen Mexico City, Unidad Neuropatol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; University of Cagliari; Universidad Autonoma de San Luis Potosi; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico	Saderi, N (corresponding author), Univ Nacl Autonoma Mexico, Dept Biol Celular & Fisiol, Inst Invest Biomed, Mexico City, DF, Mexico.	ruudbuijs@gmail.com	Buijs, Rudolf/AAD-5707-2020; Escobar, Carolina/AAX-2354-2020; Ferri, Luca Angelo/AAC-5890-2022	Escobar, Carolina/0000-0002-2974-7875; Ferri, Luca Angelo/0000-0001-9031-6284; FERRI, Gian-Luca/0000-0003-2768-349X	Universidad National Autonoma de Mexico [PAPIIT] [IN 209711, IX 227504-1]; CONACYT, Mexico [79797]; Master and Back Program, Sardinia, Italy [TS 99]	Universidad National Autonoma de Mexico [PAPIIT]; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Master and Back Program, Sardinia, Italy	This study was supported by Universidad National Autonoma de Mexico [PAPIIT grants IN 209711 and IX 227504-1] and CONACYT [grant 79797], Mexico; and Master and Back Program [grant TS 99], Sardinia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABAYASHI A, 1993, BRAIN RES, V621, P343, DOI 10.1016/0006-8993(93)90125-7; ANAND BK, 1964, AM J PHYSIOL, V207, P1146, DOI 10.1152/ajplegacy.1964.207.5.1146; Balfour RH, 2006, J PHYSIOL-LONDON, V570, P469, DOI 10.1113/jphysiol.2005.098822; Basu R, 2004, DIABETES, V53, P2042, DOI 10.2337/diabetes.53.8.2042; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; Brancia C, 2005, J ENDOCRINOL, V186, P97, DOI 10.1677/joe.1.05992; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; BUIJS RM, 1989, BIOMED RES-TOKYO, V10, P213; CIOFI P, 1990, NEUROENDOCRINOLOGY, V51, P429, DOI 10.1159/000125370; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; DESY L, 1978, BRAIN RES, V154, P377, DOI 10.1016/0006-8993(78)90709-6; Dudas B, 2000, J COMP NEUROL, V427, P593, DOI 10.1002/1096-9861(20001127)427:4<593::AID-CNE7>3.0.CO;2-C; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Goldstone AP, 2002, J CLIN ENDOCR METAB, V87, P927, DOI 10.1210/jc.87.2.927; Goncharuk VD, 2007, J COMP NEUROL, V503, P148, DOI 10.1002/cne.21387; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Hahm S, 2002, J NEUROSCI, V22, P6929; HALLIDAY GM, 1988, NEUROSCIENCE, V26, P179, DOI 10.1016/0306-4522(88)90136-4; HALLIDAY GM, 1988, J COMP NEUROL, V273, P301, DOI 10.1002/cne.902730303; Kitahama K, 2009, J CHEM NEUROANAT, V38, P130, DOI 10.1016/j.jchemneu.2009.06.010; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Marks JL, 1996, J NEUROENDOCRINOL, V8, P507, DOI 10.1046/j.1365-2826.1996.04854.x; MENENDEZ JA, 1990, BRAIN RES, V516, P8, DOI 10.1016/0006-8993(90)90890-N; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; PEARSON J, 1983, NEUROSCIENCE, V8, P3, DOI 10.1016/0306-4522(83)90023-4; PELLETIER G, 1984, CELL TISSUE RES, V238, P203; PILCHER WH, 1988, J NEUROSURG, V68, P621, DOI 10.3171/jns.1988.68.4.0621; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; RITTER RC, 1981, SCIENCE, V213, P451, DOI 10.1126/science.6264602; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758; SUKHOV RR, 1995, J COMP NEUROL, V353, P604, DOI 10.1002/cne.903530410; Swaab DF, 2003, HDB CLIN NEUROLOGY 1, V79; van den Hoek AM, 2004, DIABETES, V53, P2529, DOI 10.2337/diabetes.53.10.2529; Wang R, 2004, DIABETES, V53, P1959, DOI 10.2337/diabetes.53.8.1959; Watson E, 2005, ENDOCRINOLOGY, V146, P5151, DOI 10.1210/en.2005-0588; WHITE J D, 1990, Molecular and Cellular Neuroscience, V1, P41	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40070	10.1371/journal.pone.0040070	http://dx.doi.org/10.1371/journal.pone.0040070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808091	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400029
J	Gill, RS; Lee, TF; Liu, JQ; Chaudhary, H; Brocks, DR; Bigam, DL; Cheung, PY				Gill, Richdeep S.; Lee, Tze-Fun; Liu, Jiang-Qin; Chaudhary, Hetal; Brocks, Dion R.; Bigam, David L.; Cheung, Po-Yin			Cyclosporine Treatment Reduces Oxygen Free Radical Generation and Oxidative Stress in the Brain of Hypoxia-Reoxygenated Newborn Piglets	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; N-ACETYLCYSTEINE IMPROVES; ISCHEMIC ENCEPHALOPATHY; DOSE-RESPONSE; CELL-DEATH; 100-PERCENT OXYGEN; CEREBRAL HYPOXIA; INJURY; NIM811; RATS	Oxygen free radicals have been implicated in the pathogenesis of hypoxic-ischemic encephalopathy. It has previously been shown in traumatic brain injury animal models that treatment with cyclosporine reduces brain injury. However, the potential neuroprotective effect of cyclosporine in asphyxiated neonates has yet to be fully studied. Using an acute newborn swine model of hypoxia-reoxygenation, we evaluated the effects of cyclosporine on the brain, focusing on hydrogen peroxide (H2O2) production and markers of oxidative stress. Piglets (1-4 d, 1.4-2.5 kg) were block-randomized into three hypoxia-reoxygenation experimental groups (2 h hypoxia followed by 4 h reoxygenation)(n = 8/group). At 5 min after reoxygenation, piglets were given either i.v. saline (placebo, controls) or cyclosporine (2.5 or 10 mg/kg i.v. bolus) in a blinded-randomized fashion. An additional sham-operated group (n = 4) underwent no hypoxia-reoxygenation. Systemic hemodynamics, carotid arterial blood flow (transit-time ultrasonic probe), cerebral cortical H2O2 production (electrochemical sensor), cerebral tissue glutathione (ELISA) and cytosolic cytochrome-c (western blot) levels were examined. Hypoxic piglets had cardiogenic shock (cardiac output 40-48% of baseline), hypotension (mean arterial pressure 27-31 mmHg) and acidosis (pH 7.04) at the end of 2 h of hypoxia. Post-resuscitation cyclosporine treatment, particularly the higher dose (10 mg/kg), significantly attenuated the increase in cortical H2O2 concentration during reoxygenation, and was associated with lower cerebral oxidized glutathione levels. Furthermore, cyclosporine treatment significantly attenuated the increase in cortical cytochrome-c and lactate levels. Carotid blood arterial flow was similar among groups during reoxygenation. Conclusively, post-resuscitation administration of cyclosporine significantly attenuates H2O2 production and minimizes oxidative stress in newborn piglets following hypoxia-reoxygenation.	[Gill, Richdeep S.; Bigam, David L.; Cheung, Po-Yin] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Lee, Tze-Fun; Liu, Jiang-Qin; Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Chaudhary, Hetal; Brocks, Dion R.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada	University of Alberta; University of Alberta; University of Alberta	Gill, RS (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	poyin@ualberta.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523	Canadian Institutes of Health Research [MOP53116]; Women and Children's Health Research Institute at the University of Alberta; Clinician Investigator Program of the Royal College of Physicians and Surgeons of Canada; Alberta Innovates Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute at the University of Alberta; Clinician Investigator Program of the Royal College of Physicians and Surgeons of Canada; Alberta Innovates Health Solutions	This work was supported by Canadian Institutes of Health Research, MOP53116, www.cihr-irsc.ca, the Women and Children's Health Research Institute at the University of Alberta, www.wchri.srv.ualberta.ca (operating funds), the Clinician Investigator Program of the Royal College of Physicians and Surgeons of Canada and the Alberta Innovates Health Solutions (salary awards to Dr. Richdeep S. Gill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri B, 1999, ACT NEUR S, V75, P21; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; dos Santos AB, 2009, TOXICON, V54, P16, DOI 10.1016/j.toxicon.2009.03.004; Frantseva MV, 2001, FREE RADICAL BIO MED, V31, P1216, DOI 10.1016/S0891-5849(01)00705-5; Gratton R, 1996, J SOC GYNECOL INVEST, V3, P60, DOI 10.1016/1071-5576(95)00047-X; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hwang JH, 2010, BRAIN RES, V1359, P208, DOI 10.1016/j.brainres.2010.08.047; Jacobs SE, 2010, J PAEDIATR CHILD H, V46, P568, DOI 10.1111/j.1440-1754.2010.01880.x; Jacobson J, 2002, J CELL SCI, V115, P1175; Johnson ST, 2007, SHOCK, V28, P484, DOI 10.1097/shk.0b013e31804f775d; Joynt C, 2009, SHOCK, V31, P292, DOI 10.1097/SHK.0b013e31817fd752; Kanduru SV, 2010, BIOMED CHROMATOGR, V24, P148, DOI 10.1002/bmc.1263; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kutzsche S, 1999, BIOL NEONATE, V76, P153, DOI 10.1159/000014155; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lee TF, 2008, INTENS CARE MED, V34, P190, DOI 10.1007/s00134-007-0880-z; Leger PL, 2011, EXP NEUROL, V230, P58, DOI 10.1016/j.expneurol.2010.06.009; Liu JQ, 2010, J NEUROTRAUM, V27, P1865, DOI 10.1089/neu.2010.1325; Martin LJ, 1997, J COMP NEUROL, V377, P262, DOI 10.1002/(SICI)1096-9861(19970113)377:2<262::AID-CNE8>3.0.CO;2-1; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Nakai A, 2004, PEDIATR NEUROL, V30, P247, DOI 10.1016/j.pediatrneurol.2003.09.006; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Pacheco-Lopez G, 2012, INT J NEUROPSYCHOPH, V5, P1; Piilgaard H, 2011, J CEREBR BLOOD F MET, V31, P1588, DOI 10.1038/jcbfm.2011.28; Puka-Sundvall M, 2001, DEV NEUROSCI-BASEL, V23, P192, DOI 10.1159/000046142; Richards JG, 2006, RESUSCITATION, V69, P319, DOI 10.1016/j.resuscitation.2005.08.012; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rodrigo J, 2005, FREE RADICAL BIO MED, V39, P26, DOI 10.1016/j.freeradbiomed.2005.02.010; Segawa D, 1998, J THORAC CARDIOV SUR, V115, P925, DOI 10.1016/S0022-5223(98)70375-7; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Vannucci RC, 2000, AM J PERINAT, V17, P113, DOI 10.1055/s-2000-9293; VANNUCCI RC, 1990, PEDIATRICS, V85, P961; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zuckerman SL, 1992, HEART CIRC PHYSL, V35, pH2198	40	10	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40471	10.1371/journal.pone.0040471	http://dx.doi.org/10.1371/journal.pone.0040471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792343	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700054
J	Lee, WT; Lin, MH; Lee, EJ; Hung, YC; Tai, SH; Chen, HY; Chen, TY; Wu, TS				Lee, Wei-Ting; Lin, Miao-Hui; Lee, E-Jian; Hung, Yu-Chang; Tai, Shih-Huang; Chen, Hung-Yi; Chen, Tsung-Ying; Wu, Tian-Shung			Magnolol Reduces Glutamate-Induced Neuronal Excitotoxicity and Protects against Permanent Focal Cerebral Ischemia Up to 4 Hours	PLOS ONE			English	Article							STROKE-INDUCED EPILEPSY; IN-VITRO MODEL; INDUCED EPILEPTOGENESIS; DOSE-RESPONSE; RATS; CALCIUM; INJURY; NEUROPROTECTION; NEUROTOXICITY; OFFICINALIS	Neuroprotective efficacy of magnolol, 5,5'-dially-2,2'-dihydroxydiphenyl, was investigated in a model of stroke and cultured neurons exposed to glutamate-induced excitotoxicity. Rats were subjected to permanent middle cerebral artery occlusion (pMCAO). Magnolol or vehicle was administered intraperitoneally, at 1 hr pre-insult or 1-6 hrs post-insult. Brain infarction was measured upon sacrifice. Relative to controls, animals pre-treated with magnolol (50-200 mg/kg) had significant infarct volume reductions by 30.9-37.8% and improved neurobehavioral outcomes (P<0.05, respectively). Delayed treatment with magnolol (100 mg/kg) also protected against ischemic brain damage and improved neurobehavioral scores, even when administered up to 4 hrs post-insult (P < 0.05, respectively). Additionally, magnolol (0.1 mu M) effectively attenuated the rises of intracellular Ca2+ levels, [Ca2+](i), in cultured neurons exposed to glutamate. Consequently, magnolol (0.1-1 mu M) significantly attenuated glutamate-induced cytotoxicity and cell swelling (P<0.05). Thus, magnolol offers neuroprotection against permanent focal cerebral ischemia with a therapeutic window of 4 hrs. This neuroprotection may be, partly, mediated by its ability to limit the glutamate-induced excitotoxicity.	[Lee, Wei-Ting; Lee, E-Jian; Hung, Yu-Chang; Tai, Shih-Huang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Neurophysiol Lab,Neurosurg Serv,Dept Surg, Tainan 70101, Taiwan; [Lee, Wei-Ting] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Lin, Miao-Hui] Natl Univ Tainan, Dept Early Childhood Educ, Tainan, Taiwan; [Chen, Hung-Yi] China Med Univ, Inst Pharm, Taichung, Taiwan; [Chen, Tsung-Ying] Buddhist Tzu Chi Gen Hosp, Hualien, Taiwan; [Chen, Tsung-Ying] Buddhist Tzu Chi Univ, Dept Anesthesiol, Hualien, Taiwan; [Wu, Tian-Shung] Natl Cheng Kung Univ, Inst Chem, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National University Tainan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; National Cheng Kung University	Lee, WT (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Neurophysiol Lab,Neurosurg Serv,Dept Surg, Tainan 70101, Taiwan.	ejian@mail.ncku.edu.tw		Chen, Tsung-Ying/0000-0002-2029-5550	National Cheng Kung University Hospital (NCKUH) [90-039]; National Science Council of Taiwan (NSC) [99-2314-B-006-022-MY3]	National Cheng Kung University Hospital (NCKUH); National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Cheng Kung University Hospital (NCKUH No. 90-039) and the National Science Council of Taiwan (NSC No. 99-2314-B-006-022-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CP, 2003, CLIN EXP PHARMACOL P, V30, P387, DOI 10.1046/j.1440-1681.2003.03847.x; Chen HY, 2009, PHYTOMEDICINE, V16, P976, DOI 10.1016/j.phymed.2009.03.001; Chen HY, 2009, J PINEAL RES, V47, P260, DOI 10.1111/j.1600-079X.2009.00709.x; Chen TY, 2012, CRIT CARE MED, V40, P532, DOI 10.1097/CCM.0b013e31822f0b08; Chen TY, 2011, CRIT CARE MED, V39, P1130, DOI 10.1097/CCM.0b013e31820a9442; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clemens JA, 2000, FREE RADICAL BIO MED, V28, P1526, DOI 10.1016/S0891-5849(00)00258-6; DeLorenzo RJ, 2007, INT REV NEUROBIOL, V81, P59, DOI 10.1016/S0074-7742(06)81005-6; Fan J, 2010, J NEUROCHEM, V115, P1045, DOI 10.1111/j.1471-4159.2010.06994.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HATFIELD RH, 1992, EUR J PHARMACOL, V216, P1, DOI 10.1016/0014-2999(92)90201-E; Hedrick MS, 2005, J EXP BIOL, V208, P681, DOI 10.1242/jeb.01436; Hsieh MT, 1998, CLIN EXP PHARMACOL P, V25, P813, DOI 10.1111/j.1440-1681.1998.tb02158.x; Lee EJ, 2009, EXP NEUROL, V217, P74, DOI 10.1016/j.expneurol.2009.01.019; Lee EJ, 2009, NEUROCHEM RES, V34, P1157, DOI 10.1007/s11064-008-9892-5; Lee EJ, 2005, FREE RADICAL BIO MED, V39, P495, DOI 10.1016/j.freeradbiomed.2005.04.004; Lee EJ, 2002, J NEUROSCI RES, V68, P636, DOI 10.1002/jnr.10251; Lee MM, 1998, NEUROREPORT, V9, P3451, DOI 10.1097/00001756-199810260-00021; Lin SP, 2011, PLANTA MED, V77, P1800, DOI 10.1055/s-0030-1271159; Lin YR, 2006, EUR J PHARMACOL, V537, P64, DOI 10.1016/j.ejphar.2006.03.035; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Ritz MF, 2008, BRAIN RES, V1239, P226, DOI 10.1016/j.brainres.2008.08.073; Sun DA, 2001, STROKE, V32, P2344, DOI 10.1161/hs1001.097242; Tai SH, 2011, J PINEAL RES, V50, P292, DOI 10.1111/j.1600-079X.2010.00839.x; Tai SH, 2010, J PINEAL RES, V49, P332, DOI 10.1111/j.1600-079X.2010.00797.x; TENG CM, 1990, LIFE SCI, V47, P1153, DOI 10.1016/0024-3205(90)90176-R; WATANABE K, 1983, PLANTA MED, V49, P103, DOI 10.1055/s-2007-969825; WILLIAMS DA, 1990, CELL CALCIUM, V11, P75, DOI 10.1016/0143-4160(90)90061-X; Yanamoto H, 2001, STROKE, V32, P232, DOI 10.1161/01.STR.32.1.232; Zhang M, 2010, NEUROSCIENCE, V166, P1083, DOI 10.1016/j.neuroscience.2010.01.030	32	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39952	10.1371/journal.pone.0039952	http://dx.doi.org/10.1371/journal.pone.0039952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808077	Green Submitted, gold, Green Published			2022-12-27	WOS:000306354700020
J	Xu, W; Lan, Q; Chen, MG; Chen, H; Zhu, N; Zhou, XH; Wang, J; Fan, HM; Yan, CS; Kuang, JL; Warburton, D; Togbe, D; Ryffel, B; Zheng, SG; Shi, W				Xu, Wei; Lan, Qin; Chen, Maogen; Chen, Hui; Zhu, Ning; Zhou, Xiaohui; Wang, Julie; Fan, Huimin; Yan, Chun-Song; Kuang, Jiu-Long; Warburton, David; Togbe, Dieudonnee; Ryffel, Bernhard; Zheng, Song-Guo; Shi, Wei			Adoptive Transfer of Induced-Treg Cells Effectively Attenuates Murine Airway Allergic Inflammation	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; CUTTING EDGE; EX-VIVO; ASTHMA; FOXP3; SUPPRESS; DISEASE; IL-2	Both nature and induced regulatory T (Treg) lymphocytes are potent regulators of autoimmune and allergic disorders. Defects in endogenous Treg cells have been reported in patients with allergic asthma, suggesting that disrupted Treg cell-mediated immunological regulation may play an important role in airway allergic inflammation. In order to determine whether adoptive transfer of induced Treg cells generated in vitro can be used as an effective therapeutic approach to suppress airway allergic inflammation, exogenously induced Treg cells were infused into ovalbumin-sensitized mice prior to or during intranasal ovalbumin challenge. The results showed that adoptive transfer of induced Treg cells prior to allergen challenge markedly reduced airway hyperresponsiveness, eosinophil recruitment, mucus hyper-production, airway remodeling, and IgE levels. This effect was associated with increase of Treg cells (CD4(+)FoxP3(+)) and decrease of dendritic cells in the draining lymph nodes, and with reduction of Th1, Th2, and Th17 cell response as compared to the controls. Moreover, adoptive transfer of induced Treg cells during allergen challenge also effectively attenuate airway inflammation and improve airway function, which are comparable to those by natural Treg cell infusion. Therefore, adoptive transfer of in vitro induced Treg cells may be a promising therapeutic approach to prevent and treat severe asthma.	[Xu, Wei; Chen, Hui; Warburton, David; Shi, Wei] Childrens Hosp Los Angeles, Dept Surg, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Lan, Qin; Chen, Maogen; Zhu, Ning; Zhou, Xiaohui; Wang, Julie; Zheng, Song-Guo] Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90033 USA; [Lan, Qin; Zhou, Xiaohui; Fan, Huimin] Tongji Univ, Inst Immunol, Shanghai E Hosp, Shanghai 200092, Peoples R China; [Xu, Wei; Yan, Chun-Song; Kuang, Jiu-Long] Nanchang Univ, Dept Resp Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Togbe, Dieudonnee; Ryffel, Bernhard] Univ Orleans, Orleans, France; [Togbe, Dieudonnee; Ryffel, Bernhard] CNRS, F-45071 Orleans, France	Children's Hospital Los Angeles; University of Southern California; Tongji University; Nanchang University; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS)	Xu, W (corresponding author), Childrens Hosp Los Angeles, Dept Surg, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.	szheng@usc.edu; wshi@chla.usc.edu	Warburton, David/AAD-5709-2020; Maogen, Chen/AAN-1551-2021; Togbe, Dieudonnee/AAE-1135-2020	Maogen, Chen/0000-0001-9319-5334; Togbe, Dieudonnee/0000-0001-6658-414X	National Institutes of Health (NIH) [HL109932, HL068597]; Webb Foundation [(WS)NIH AR059103]; American College of Rheumatology; Arthritis Foundation; California Institute of Regenerative Medicine Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109932, R01HL068597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Webb Foundation; American College of Rheumatology(General Electric); Arthritis Foundation; California Institute of Regenerative Medicine Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institutes of Health (NIH) HL109932 and HL068597, and Webb Foundation grant (WS)NIH AR059103, the American College of Rheumatology (Within Our Reach) and the Arthritis Foundation (SGZ). California Institute of Regenerative Medicine Training Grant (WX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2000, AM J RESP CRIT CARE, V162, P2295, DOI 10.1164/ajrccm.162.6.9912001; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Discombe G, 1946, LANCET, V1, P195; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fantini MC, 2006, GUT, V55, P671, DOI 10.1136/gut.2005.072801; Godebu E, 2008, J IMMUNOL, V181, P1798, DOI 10.4049/jimmunol.181.3.1798; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Larche M, 2007, CHEST, V132, P1007, DOI 10.1378/chest.06-2434; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Nguyen KD, 2009, J ALLERGY CLIN IMMUN, V123, P933, DOI 10.1016/j.jaci.2008.11.037; Richards IM, 1996, AM J PHYSIOL-LUNG C, V271, pL267, DOI 10.1152/ajplung.1996.271.2.L267; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; van Oosterhout AJM, 2005, EUR RESPIR J, V26, P918, DOI 10.1183/09031936.05.00011205; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Xue KY, 2007, J HUAZHONG U SCI-MED, V27, P31, DOI 10.1007/s11596-007-0109-y; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XH, 2010, J MOL CELL BIOL, V2, P164, DOI 10.1093/jmcb/mjq007	33	73	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40314	10.1371/journal.pone.0040314	http://dx.doi.org/10.1371/journal.pone.0040314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792275	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700035
J	Currylow, AF; MacGowan, BJ; Williams, RN				Currylow, Andrea F.; MacGowan, Brian J.; Williams, Rod N.			Short-Term Forest Management Effects on a Long-Lived Ectotherm	PLOS ONE			English	Article							TURTLES TERRAPENE-CAROLINA; AGED TIMBER HARVEST; BOX TURTLES; HOME-RANGE; AMPHIBIAN POPULATIONS; HABITAT FRAGMENTATION; MOVEMENT; REPTILES; THERMOREGULATION; TEMPERATURE	Timber harvesting has been shown to have both positive and negative effects on forest dwelling species. We examined the immediate effects of timber harvests (clearcuts and group selection openings) on ectotherm behavior, using the eastern box turtle as a model. We monitored the movement and thermal ecology of 50 adult box turtles using radiotelemetry from May-October for two years prior to, and two years following scheduled timber harvests in the Central Hardwoods Region of the U. S. Annual home ranges (7.45 ha, 100% MCP) did not differ in any year or in response to timber harvests, but were 33% larger than previous estimates (range 0.47-187.67 ha). Distance of daily movements decreased post-harvest (from 22 m +/- 1.2 m to 15 m +/- 0.9 m) whereas thermal optima increased (from 23 +/- 1 degrees C to 25 +/- 1 degrees C). Microclimatic conditions varied by habitat type, but monthly average temperatures were warmer in harvested areas by as much as 13 degrees C. Animals that used harvest openings were exposed to extreme monthly average temperatures (similar to 40 degrees C). As a result, the animals made shorter and more frequent movements in and out of the harvest areas while maintaining 9% higher body temperatures. This experimental design coupled with radiotelemetry and behavioral observation of a wild ectotherm population prior to and in response to anthropogenic habitat alteration is the first of its kind. Our results indicate that even in a relatively contiguous forested landscape with small-scale timber harvests, there are local effects on the thermal ecology of ectotherms. Ultimately, the results of this research can benefit the conservation and management of temperature-dependent species by informing effects of timber management across landscapes amid changing climates.	[Currylow, Andrea F.; MacGowan, Brian J.; Williams, Rod N.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Currylow, AF (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	a.currylow@gmail.com	Currylow, Andrea/J-5506-2014	Currylow, Andrea/0000-0003-1631-8964	Indiana Division of Forestry Grant [E-9-6-A558]; IDNR Division of Fish and Wildlife; Wildlife Diversity Section; State Wildlife Improvement Grant [E2-08-WDS15]	Indiana Division of Forestry Grant; IDNR Division of Fish and Wildlife; Wildlife Diversity Section; State Wildlife Improvement Grant	Funding for the project was provided by the Indiana Division of Forestry Grant #E-9-6-A558 and IDNR Division of Fish and Wildlife, Wildlife Diversity Section, State Wildlife Improvement Grant #E2-08-WDS15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Allard HA, 1935, SCI MON, V41, P325; ANDREN H, 1992, ECOLOGY, V73, P794, DOI 10.2307/1940158; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Bayless JW, 1984, HOME RANGE STUDIES E; Bernstein NP, 2005, AM MIDL NAT, V153, P370, DOI 10.1674/0003-0031(2005)153[0370:TEOOOB]2.0.CO;2; BLEM CR, 1986, COMP BIOCHEM PHYS A, V85, P563, DOI 10.1016/0300-9629(86)90447-0; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; BRATTSTROM BH, 1965, AM MIDL NAT, V73, P376, DOI 10.2307/2423461; Breshears DD, 1998, INT J PLANT SCI, V159, P1010, DOI 10.1086/314083; BROOKS RJ, 1991, CAN J ZOOL, V69, P1314, DOI 10.1139/z91-185; Cadenasso ML, 2001, CONSERV BIOL, V15, P91, DOI 10.1046/j.1523-1739.2001.99309.x; CAGLE FRED R., 1939, COPEIA, V1939, P170, DOI 10.2307/1436818; CONGDON JD, 1989, J HERPETOL, V23, P179, DOI 10.2307/1564027; Crawford JA, 2008, ANIM CONSERV, V11, P369, DOI 10.1111/j.1469-1795.2008.00191.x; Cunnington GM, 2008, ECOSCIENCE, V15, P472, DOI 10.2980/15-4-3140; Currylow AF, 2011, AM MIDL NAT, V165, P143, DOI 10.1674/0003-0031-165.1.143; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; do Amaral JPS, 2002, CAN J ZOOL, V80, P934, DOI 10.1139/Z02-070; DODD CK, 2001, N AM BOX TURTLES NAT; Dolbeer RA, 1969, ASB B, V16; Donaldson BM, 2005, J HERPETOL, V39, P278, DOI 10.1670/0022-1511(2005)039[0278:AHURTH]2.0.CO;2; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; ENGE KM, 1986, FOREST ECOL MANAG, V14, P177, DOI 10.1016/0378-1127(86)90116-7; ERNST C H, 1974, Transactions of the Kentucky Academy of Science, V35, P27; ESRI, 2009, ARCGIS DESKTOP 9; Ferner JW, 2007, REV MARKING INDIVIDU; Fox S.F., 2003, LIZARD SOCIAL BEHAV; Fredericksen TS, 2000, J FOREST, V98, P4; Garcia JDD, 2007, BIODIVERS CONSERV, V16, P2949, DOI 10.1007/s10531-007-9154-x; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gibbs JP, 2005, CONSERV BIOL, V19, P552, DOI 10.1111/j.1523-1739.2005.000155.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Gitzen RA, 2007, FOREST ECOL MANAG, V251, P142, DOI 10.1016/j.foreco.2007.05.028; Goldstein MI, 2005, J WILDLIFE MANAGE, V69, P525, DOI 10.2193/0022-541X(2005)069[0525:SRORAA]2.0.CO;2; GOULD E, 1957, BIOL BULL, V112, P336, DOI 10.2307/1539126; Gram WK, 2003, CONSERV BIOL, V17, P1324, DOI 10.1046/j.1523-1739.2003.02171.x; Hallgren-Scaffidi L, 1986, HABITAT HOME RANGE P; Hansbauer MM, 2008, J TROP ECOL, V24, P291, DOI 10.1017/S0266467408005002; Hocking DJ, 2008, J HERPETOL, V42, P689, DOI 10.1670/07-294R1.1; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; HUTCHISON VICTOR H., 1966, HERPETOLOGIA, V22, P32; Iglay RB, 2007, J HERPETOL, V41, P102, DOI 10.1670/0022-1511(2007)41[102:EBTTCC]2.0.CO;2; Kalb RA, NO FOREST E IN PRESS; Kipp RL, 2003, NESTING ECOLOGY E BO; Kroll JC, 1973, COMP PHYSL ECOLOGY E; MacGowan BJ, 2004, TURTLES INDIANA; MADDEN R. C., 1975, THESIS CITY U NEW YO; Marchand MN, 2004, CONSERV BIOL, V18, P758, DOI 10.1111/j.1523-1739.2004.00019.x; McLeod RF, 1998, AM MIDL NAT, V139, P164, DOI 10.1674/0003-0031(1998)139[0164:ROHCTF]2.0.CO;2; NICHOLS J. T., 1939, COPEIA, V1939, P125, DOI 10.2307/1436804; Nieuwolt PM, 1996, HERPETOLOGICA, V52, P487; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Penick DN, 2002, PHYSIOL BIOCHEM ZOOL, V75, P57, DOI 10.1086/339219; Perison D, 1997, FOREST ECOL MANAG, V90, P171, DOI 10.1016/S0378-1127(96)03896-0; Peterman WE, 2009, FOREST ECOL MANAG, V257, P8, DOI 10.1016/j.foreco.2008.08.011; PETERSON CC, 1987, J HERPETOL, V21, P16, DOI 10.2307/1564372; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; Quinn DP, 2008, RADIO TELEMETRIC STU; R Core Team, 2020, R LANG ENV STAT COMP; Renken RB, 2004, CONSERV BIOL, V18, P174, DOI 10.1111/j.1523-1739.2004.00312.x; Rittenhouse TAG, 2009, CAN J ZOOL, V87, P618, DOI 10.1139/Z09-049; Rittenhouse TAG, 2009, ECOLOGY, V90, P1620, DOI 10.1890/08-0326.1; Rodgers AR, 2005, HRE HOME RANGE EXTEN; ROSE F L, 1975, Herpetologica, V31, P448; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; SAS Institute Inc, 2008, JMP 8 0; SAS Institute Inc, 2007, SAS ONLINEDOC 9 2; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schwartz C.W., 1974, 3 TOED BOX TURTLE CE; Schwartz ER, 1984, 3 TOED BOX TURTLE 2; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Sepulveda M, 2008, J THERM BIOL, V33, P141, DOI 10.1016/j.jtherbio.2007.07.002; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Steen DA, 2006, ANIM CONSERV, V9, P269, DOI 10.1111/j.1469-1795.2006.00032.x; STICKEL LF, 1950, ECOL MONOGR, V20, P353, DOI 10.2307/1943570; STICKEL LF, 1989, J HERPETOL, V23, P40, DOI 10.2307/1564314; STRANG CA, 1983, J HERPETOL, V17, P43, DOI 10.2307/1563779; Summerville K, 2010, ECOLOGICAL APPL; Summerville KS, 2009, FOREST ECOL MANAG, V259, P8, DOI 10.1016/j.foreco.2009.09.033; Todd BD, 2008, CONSERV BIOL, V22, P753, DOI 10.1111/j.1523-1739.2008.00916.x; Tozetti AM, 2010, HERPETOL J, V20, P277; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Weiss JA, 2009, DEMOGRAPHICS ACTIVIT; WILLIAMS EC, 1987, HERPETOLOGICA, V43, P328; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	86	33	33	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40473	10.1371/journal.pone.0040473	http://dx.doi.org/10.1371/journal.pone.0040473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792344	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800093
J	Deleuze, V; El-Hajj, R; Chalhoub, E; Dohet, C; Pinet, V; Couttet, P; Mathieu, D				Deleuze, Virginie; El-Hajj, Rawan; Chalhoub, Elias; Dohet, Christiane; Pinet, Valerie; Couttet, Philippe; Mathieu, Daniele			Angiopoietin-2 Is a Direct Transcriptional Target of TAL1, LYL1 and LMO2 in Endothelial Cells	PLOS ONE			English	Article							ADULT HEMATOPOIETIC STEM; GENOME-WIDE ANALYSIS; LOOP-HELIX PROTEINS; VASCULAR DEVELOPMENT; DNA-BINDING; EXPRESSION; SCL; SCL/TAL-1; ANGIOGENESIS; LEUKEMIA	The two related basic helix-loop-helix, TAL1 and LYL1, and their cofactor LIM-only-2 protein (LMO2) are present in blood and endothelial cells. While their crucial role in early hematopoiesis is well established, their function in endothelial cells and especially in angiogenesis is less understood. Here, we identified ANGIOPOIETIN-2 (ANG-2), which encodes a major regulator of angiogenesis, as a direct transcriptional target of TAL1, LYL1 and LMO2. Knockdown of any of the three transcription factors in human blood and lymphatic endothelial cells caused ANG-2 mRNA and protein down-regulation. Transient transfections showed that the full activity of the ANG-2 promoter required the integrity of a highly conserved Ebox-GATA composite element. Accordingly, chromatin immunoprecipitation assays demonstrated that TAL1, LYL1, LMO2 and GATA2 occupied this region of ANG-2 promoter in human endothelial cells. Furthermore, we showed that LMO2 played a central role in assembling TAL1-E47, LYL1-LYL1 or/and LYL1-TAL1 dimers with GATA2. The resulting complexes were able to activate endogenous ANG-2 expression in endothelial cells as well as in non-endothelial cells. Finally, we showed that ANG-2 gene activation during angiogenesis concurred with the up-regulation of TAL1 and LMO2. Altogether, we identified ANG-2 as a bona fide target gene of LMO2-complexes with TAL1 and/or LYL1, highlighting a new function of the three hematopoietic factors in the endothelial lineage.	[Deleuze, Virginie; El-Hajj, Rawan; Chalhoub, Elias; Dohet, Christiane; Pinet, Valerie; Mathieu, Daniele] CNRS, Inst Genet Mol Montpellier, UMR 5535, Montpellier, France; [Deleuze, Virginie; El-Hajj, Rawan; Chalhoub, Elias; Dohet, Christiane; Pinet, Valerie; Mathieu, Daniele] Univ Montpellier 2, Montpellier, France; [Deleuze, Virginie; El-Hajj, Rawan; Chalhoub, Elias; Dohet, Christiane; Pinet, Valerie; Mathieu, Daniele] Univ Montpellier I, Montpellier, France; [Couttet, Philippe] Sanger Inst, Cambridge, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Wellcome Trust Sanger Institute	Deleuze, V (corresponding author), CNRS, Inst Genet Mol Montpellier, UMR 5535, Montpellier, France.	daniele.mathieu@igmm.cnrs.fr	PINET, Valérie/G-6085-2012; Couttet, Philippe/AAH-5489-2019; Mathieu, Daniele/G-6092-2012	PINET, Valérie/0000-0002-4044-6440; Couttet, Philippe/0000-0002-5255-6647; Deleuze-Marques, Virginie/0000-0001-9872-1946	"Ligue Regionale contre le Cancer" (Herault, France); "Conseil National de Recherche scientifique" (Libanon); "Association pour la Recherche sur le Cancer" (ARC, France); CNRS; INSERM; Association pour la Recherche sur le Cancer (ARC, FRANCE); Agence Nationale pour la Recherche (ANR-MNP, France); ROCHE-SAS (Neuilly-sur-Seine, FRANCE); ROCHE-SAS (France)	"Ligue Regionale contre le Cancer" (Herault, France); "Conseil National de Recherche scientifique" (Libanon); "Association pour la Recherche sur le Cancer" (ARC, France)(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer (ARC, FRANCE)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche (ANR-MNP, France)(French National Research Agency (ANR)); ROCHE-SAS (Neuilly-sur-Seine, FRANCE); ROCHE-SAS (France)	R.H. was successively supported by the "Ligue Regionale contre le Cancer" (Herault, France), the "Conseil National de Recherche scientifique" (Libanon), and the "Association pour la Recherche sur le Cancer" (ARC, France). V.D. and C.D. are supported by CNRS. D.M. and V.P. are supported by INSERM. This work was funded by grants from the Association pour la Recherche sur le Cancer (ARC, FRANCE) and Agence Nationale pour la Recherche (ANR-MNP, France), and an award from ROCHE-SAS (Neuilly-sur-Seine, FRANCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received awards from ROCHE-SAS (France) for this study. This does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bresnick EH, 2012, NUCL ACIDS RES; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chetty R, 1997, J PATHOL, V181, P311, DOI 10.1002/(SICI)1096-9896(199703)181:3<311::AID-PATH775>3.0.CO;2-B; Coffelt SB, 2010, CANC RES, V70; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gering M, 2003, DEVELOPMENT, V130, P6187, DOI 10.1242/dev.00875; Giroux S, 2007, GENE EXPR PATTERNS, V7, P215, DOI 10.1016/j.modgep.2006.10.004; Gratzinger D, 2009, AM J CLIN PATHOL, V131, P264, DOI 10.1309/AJCP5FP3NAXAXRJE; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jang C, 2009, ARTERIOSCL THROM VAS, V29, P401, DOI 10.1161/ATVBAHA.108.172676; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Kappel A, 2000, BLOOD, V96, P3078; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Lazrak M, 2004, J CELL SCI, V117, P1161, DOI 10.1242/jcs.00969; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lecuyer E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703939200; Lewis CE, 2011, CANCER CELL, V19, P431, DOI 10.1016/j.ccr.2011.03.016; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Miyamoto A, 1996, MOL CELL BIOL, V16, P2394; Patterson LJ, 2005, BLOOD, V105, P3502, DOI 10.1182/blood-2004-09-3547; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Pirot N, 2010, BLOOD, V115, P5270, DOI 10.1182/blood-2010-03-275651; Porcher C, 1999, DEVELOPMENT, V126, P4603; PULFORD K, 1995, BLOOD, V85, P675, DOI 10.1182/blood.V85.3.675.bloodjournal853675; Schlaeger TM, 2004, MOL CELL BIOL, V24, P7491, DOI 10.1128/MCB.24.17.7491-7502.2004; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Tang T, 2006, J PATHOL, V210, P121, DOI 10.1002/path.2028; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wozniak RJ, 2008, MOL CELL BIOL, V28, P6681, DOI 10.1128/MCB.01061-08; Yamada Y, 2002, ONCOGENE, V21, P1309, DOI 10.1038/sj.onc.1205285; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	55	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40484	10.1371/journal.pone.0040484	http://dx.doi.org/10.1371/journal.pone.0040484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792348	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800095
J	Gagnaire, J; Dauwalder, O; Boisset, S; Khau, D; Freydiere, AM; Ader, F; Bes, M; Lina, G; Tristan, A; Reverdy, ME; Marchand, A; Geissmann, T; Benito, Y; Durand, G; Charrier, JP; Etienne, J; Welker, M; Van Belkum, A; Vandenesch, F				Gagnaire, Julie; Dauwalder, Olivier; Boisset, Sandrine; Khau, David; Freydiere, Anne-Marie; Ader, Florence; Bes, Michele; Lina, Gerard; Tristan, Anne; Reverdy, Marie-Elisabeth; Marchand, Adrienne; Geissmann, Thomas; Benito, Yvonne; Durand, Geraldine; Charrier, Jean-Philippe; Etienne, Jerome; Welker, Martin; Van Belkum, Alex; Vandenesch, Francois			Detection of Staphylococcus aureus Delta-Toxin Production by Whole-Cell MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							GENE REGULATOR AGR; DESORPTION IONIZATION-TIME; QUORUM-SENSING SYSTEM; REDUCED SUSCEPTIBILITY; ROUTINE IDENTIFICATION; RESISTANT; VANCOMYCIN; STRAINS; VIRULENCE; DYSFUNCTION	The aim of the present study was to detect the Staphylococcus aureus delta-toxin using Whole-Cell (WC) Matrix Assisted Laser Desorption Ionization - Time-of-Flight (MALDI-TOF) mass spectrometry (MS), correlate delta-toxin expression with accessory gene regulator (agr) status, and assess the prevalence of agr deficiency in clinical isolates with and without resistance to methicillin and glycopeptides. The position of the delta-toxin peak in the mass spectrum was identified using purified delta-toxin and isogenic wild type and mutant strains for agr-rnaIII, which encodes delta-toxin. Correlation between delta-toxin production and agr RNAIII expression was assessed by northern blotting. A series of 168 consecutive clinical isolates and 23 unrelated glycopeptide-intermediate S. aureus strains (GISA/heterogeneous GISA) were then tested by WC-MALDI-TOF MS. The delta-toxin peak was detected at 3005 +/- 5 Thomson, as expected for the naturally formylated delta toxin, or at 3035 +/- 5 Thomson for its G10S variant. Multivariate analysis showed that chronicity of S. aureus infection and glycopeptide resistance were significantly associated with delta-toxin deficiency (p = 0.048; CI 95%: 1.01-10.24; p = 0.023; CI 95%: 1.20-12.76, respectively). In conclusion, the S. aureus delta-toxin was identified in the WC-MALDI-TOF MS spectrum generated during routine identification procedures. Consequently, agr status can potentially predict infectious complications and rationalise application of novel virulence factor-based therapies.	[Gagnaire, Julie; Dauwalder, Olivier; Boisset, Sandrine; Khau, David; Freydiere, Anne-Marie; Bes, Michele; Lina, Gerard; Tristan, Anne; Reverdy, Marie-Elisabeth; Benito, Yvonne; Etienne, Jerome; Vandenesch, Francois] Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Ctr Biol & Pathol E, Bron, France; [Dauwalder, Olivier; Boisset, Sandrine; Lina, Gerard; Tristan, Anne; Geissmann, Thomas; Benito, Yvonne; Etienne, Jerome; Vandenesch, Francois] Univ Lyon, Lyon, France; [Dauwalder, Olivier; Boisset, Sandrine; Ader, Florence; Bes, Michele; Lina, Gerard; Tristan, Anne; Geissmann, Thomas; Benito, Yvonne; Etienne, Jerome; Vandenesch, Francois] INSERM, Bacterial Pathogenesis & Innate Immun Lab, U851, F-69008 Lyon, France; [Ader, Florence] Hosp Civils Lyon, Serv Malad Infect, Lyon, France; [Marchand, Adrienne] Univ Poitiers, CNRS, IBMIG, Lab Chim & Microbiol Eau,UMR 6008,UFR Sci Fondame, Poitiers, France; [Durand, Geraldine; Welker, Martin; Van Belkum, Alex] bioMerieux SA, Microbiol Res & Dev Unit, La Balme Les Grottes, France; [Charrier, Jean-Philippe] bioMerieux SA, Technol Res Dept, Technol Platform, Marcy Letoile, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; bioMerieux	Gagnaire, J (corresponding author), Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Ctr Biol & Pathol E, Bron, France.	francois.vandenesch@univ-lyon1.fr	TRISTAN, Anne/GSN-8306-2022; Boisset, Sandrine SB/D-8144-2014; Lina, Gerard J/L-9352-2014; Vandenesch, Francois/C-7209-2014; ADER, Florence/M-7619-2014; Geissmann, Thomas/L-9432-2014; Tristan, Anne/L-9464-2014; Charrier, Jean-Philippe/E-3998-2013; DAUWALDER, Olivier/L-9619-2014	TRISTAN, Anne/0000-0001-9471-2655; Boisset, Sandrine SB/0000-0001-8717-8749; Vandenesch, Francois/0000-0001-9412-7106; Geissmann, Thomas/0000-0001-5734-5489; Welker, Martin/0000-0001-9819-6264; DAUWALDER, Olivier/0000-0003-1722-1582; ADER, Florence/0000-0002-4778-4338; Charrier, Jean-Philippe/0000-0001-5769-1189; Lina, Gerard/0000-0002-9236-7998				Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Benito Y, 1998, J BACTERIOL, V180, P5780, DOI 10.1128/JB.180.21.5780-5783.1998; Bergeron M, 2011, EUR J CLIN MICROBIOL, V30, P343, DOI 10.1007/s10096-010-1091-z; Bittar F, 2009, INT J ANTIMICROB AG, V34, P467, DOI 10.1016/j.ijantimicag.2009.03.017; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Cafiso V, 2012, J CLIN MICROBIOL, V50, P1742, DOI 10.1128/JCM.06307-11; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; Dauwalder O, 2010, INT J ANTIMICROB AG, V36, P193, DOI 10.1016/j.ijantimicag.2010.04.005; Dumitrescu O, 2011, ANTIMICROB AGENTS CH, V55, P3261, DOI 10.1128/AAC.01401-10; Fagerquist CK, 2009, APPL ENVIRON MICROB, V75, P4341, DOI 10.1128/AEM.00079-09; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Harigaya Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-287; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; JANZON L, 1989, MOL GEN GENET, V219, P480, DOI 10.1007/BF00259623; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LEVINE DP, 1991, ANN INTERN MED, V115, P674, DOI 10.7326/0003-4819-115-9-674; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Lipsky BA, 2004, CLIN INFECT DIS, V39, P885, DOI 10.1086/383271; Marchand A, 2011, PEPTIDES, V32, P845, DOI 10.1016/j.peptides.2011.01.025; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Otto M, 2000, BIOTECHNIQUES, V28, P1088, DOI 10.2144/00286bm07; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Tsuji BT, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-20; van Belkum A, 2012, J CLIN MICROBIOL, V50, P1513, DOI 10.1128/JCM.00420-12; Verdon J, 2009, PEPTIDES, V30, P817, DOI 10.1016/j.peptides.2008.12.017; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Walsh TR, 2001, J CLIN MICROBIOL, V39, P2439, DOI 10.1128/JCM.39.7.2439-2444.2001; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399	51	45	52	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40660	10.1371/journal.pone.0040660	http://dx.doi.org/10.1371/journal.pone.0040660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792394	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800115
J	Kazenwadel, J; Secker, GA; Betterman, KL; Harvey, NL				Kazenwadel, Jan; Secker, Genevieve A.; Betterman, Kelly L.; Harvey, Natasha L.			In Vitro Assays Using Primary Embryonic Mouse Lymphatic Endothelial Cells Uncover Key Roles for FGFR1 Signalling in Lymphangiogenesis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; THORACIC-DUCT; INTERSTITIAL FLOW; TISSUE-CULTURE; STEM-CELLS; EXPRESSION; DIFFERENTIATION; MORPHOGENESIS; BLOOD; LINE	Despite the importance of blood vessels and lymphatic vessels during development and disease, the signalling pathways underpinning vessel construction remain poorly characterised. Primary mouse endothelial cells have traditionally proven difficult to culture and as a consequence, few assays have been developed to dissect gene function and signal transduction pathways in these cells ex vivo. Having established methodology for the purification, short-term culture and transfection of primary blood (BEC) and lymphatic (LEC) vascular endothelial cells isolated from embryonic mouse skin, we sought to optimise robust assays able to measure embryonic LEC proliferation, migration and three-dimensional tube forming ability in vitro. In the course of developing these assays using the pro-lymphangiogenic growth factors FGF2 and VEGF-C, we identified previously unrecognised roles for FGFR1 signalling in lymphangiogenesis. The small molecule FGF receptor tyrosine kinase inhibitor SU5402, but not inhibitors of VEGFR-2 (SU5416) or VEGFR-3 (MAZ51), inhibited FGF2 mediated LEC proliferation, demonstrating that FGF2 promotes proliferation directly via FGF receptors and independently of VEGF receptors in primary embryonic LEC. Further investigation revealed that FGFR1 was by far the predominant FGF receptor expressed by primary embryonic LEC and correspondingly, siRNA-mediated FGFR1 knockdown abrogated FGF2 mediated LEC proliferation. While FGF2 potently promoted LEC proliferation and migration, three dimensional tube formation assays revealed that VEGF-C primarily promoted LEC sprouting and elongation, illustrating that FGF2 and VEGF-C play distinct, cooperative roles in lymphatic vascular morphogenesis. These assays therefore provide useful tools able to dissect gene function in cellular events important for lymphangiogenesis and implicate FGFR1 as a key player in developmental lymphangiogenesis in vivo.	[Kazenwadel, Jan; Secker, Genevieve A.; Betterman, Kelly L.; Harvey, Natasha L.] SA Pathol, Ctr Canc Biol, Div Haematol, Adelaide, SA, Australia; [Betterman, Kelly L.; Harvey, Natasha L.] Univ Adelaide, Sch Med, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide	Kazenwadel, J (corresponding author), SA Pathol, Ctr Canc Biol, Div Haematol, Adelaide, SA, Australia.	natasha.harvey@health.sa.gov.au	Kazenwadel, Jan/E-6620-2012	Kazenwadel, Jan/0000-0001-6216-3444; Harvey, Natasha/0000-0001-9839-8966; Secker, Genevieve/0000-0002-5109-3222	National Health and Medical Research Council of Australia [626959]; Cancer Council South Australia; MedVet Pty Ltd Research Fellowship; National Breast Cancer Foundation PhD Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council South Australia(Cancer Council South Australia); MedVet Pty Ltd Research Fellowship; National Breast Cancer Foundation PhD Scholarship	This work was supported by grants from the National Health and Medical Research Council of Australia (Project Grant 626959, NLH) and Cancer Council South Australia (NLH), a MedVet Pty Ltd Research Fellowship (NLH) and National Breast Cancer Foundation PhD Scholarship (KLB) (http://www.nhmrc.gov.au/, http://www.cancersa.org.au/aspx/home.aspx, http://www.nationalbreastcancer.org/, http://www.medvet.com.au/corporate/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; BORRON P, 1994, LYMPHOLOGY, V27, P6; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; BOWMAN CA, 1984, LYMPHOLOGY, V17, P15; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Clasper S, 2008, CANCER RES, V68, P7293, DOI 10.1158/0008-5472.CAN-07-6506; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; DJONEIDI M, 1991, MICROCIRC ENDOTH LYM, V7, P161; Fong TAT, 1999, CANCER RES, V59, P99; GNEPP DR, 1985, IN VITRO CELL DEV B, V21, P200, DOI 10.1007/BF02620930; Grand EK, 2004, LEUKEMIA, V18, P962, DOI 10.1038/sj.leu.2403347; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; JOHNSTON MG, 1984, IN VITRO CELL DEV B, V20, P566; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Kono T, 2006, ARTERIOSCL THROM VAS, V26, P2070, DOI 10.1161/01.ATV.0000225770.57219.b0; Kreuger J, 2006, ARTERIOSCL THROM VAS, V26, P1073, DOI 10.1161/01.ATV.0000217610.58032.b7; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kubo H, 2002, P NATL ACAD SCI USA, V99, P8868, DOI 10.1073/pnas.062040199; Liersch R, 2006, BLOOD, V107, P1214, DOI 10.1182/blood-2005-08-3400; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mancardi S, 1999, EXP CELL RES, V246, P368, DOI 10.1006/excr.1998.4270; Matsuo M, 2006, CELL TISSUE RES, V326, P749, DOI 10.1007/s00441-006-0229-x; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002; NICOSIA RF, 1987, IN VITRO CELL DEV B, V23, P167; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; PEPPER MS, 1994, EXP CELL RES, V210, P298, DOI 10.1006/excr.1994.1042; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Shayan R, 2007, GROWTH FACTORS, V25, P417, DOI 10.1080/08977190801932550; Shin JW, 2006, MOL BIOL CELL, V17, P576, DOI 10.1091/mbc.E05-04-0368; Sironi M, 2006, CELL TISSUE RES, V325, P91, DOI 10.1007/s00441-006-0171-y; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; WAY D, 1987, IN VITRO CELL DEV B, V23, P647, DOI 10.1007/BF02621074; Yamaguchi T, 2008, FEBS J, V275, P1988, DOI 10.1111/j.1742-4658.2008.06353.x; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	43	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40497	10.1371/journal.pone.0040497	http://dx.doi.org/10.1371/journal.pone.0040497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792354	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306461800098
J	Lin, YP; Yang, CY; Liao, CC; Yu, WC; Chi, CW; Lin, CH				Lin, Yao-Ping; Yang, Chih-Yu; Liao, Chen-Chung; Yu, Wen-Chung; Chi, Chin-Wen; Lin, Chao-Hsiung			Plasma Protein Characteristics of Long-Term Hemodialysis Survivors	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINS; CLUSTERIN/APOLIPOPROTEIN-J; PROTEOMIC ANALYSIS; GC-GLOBULIN; DIALYSIS; DISEASE; ACTIVATION; MECHANISMS; STRESS; ALPHA(1)-ANTITRYPSIN	Hemodialysis (HD) patients are under recurrent circulatory stress, and hemodialysis has a high mortality rate. The characteristics of plasma proteomes in patients surviving long-term HD remain obscure, as well as the potential biomarkers in predicting prognoses. This study reports the proteome analyses of patient plasma from non-diabetic long-term HD (LHD, dialysis vintage 14.9 +/- 4.1 years, n = 6) and the age/sex/uremic etiology-comparable short-term HD (SHD, dialysis vintage 5.3 +/- 2.9 years, n = 6) using 2-DE and mass spectrometry. In addition, a 4-year longitudinal follow-up of 60 non-diabetic HD patients was subsequently conducted to analyze the baseline plasma proteins by ELISA in predicting prognosis. Compared to the SHD, the LHD survivors had increased plasma vitamin D binding proteins (DBP) and decreased clusterin, apolipoprotein A-IV, haptoglobin, hemopexin, complement factors B and H, and altered isoforms of alpha 1-antitrypsin and fibrinogen gamma. During the 45.7 +/- 15 months for follow-up of the 60 HD patient cases, 16 patients died. Kaplan-Meier analysis demonstrated that HD patients with the lowest tertile of the baseline plasma DBP level have a significantly higher mortality rate. Multivariate Cox regression analysis further indicated that DBP is an independent predictor of mortality. In summary, the altered plasma proteins in LHD implicated accelerated atherosclerosis, defective antioxidative activity, increased inflammation/infection, and organ dysfunction. Furthermore, lower baseline plasma DBP in HD patients is related to mortality. The results suggest that the proteomic approach could help discover the potential biomarker in HD prognoses.	[Lin, Yao-Ping; Yang, Chih-Yu] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Lin, Yao-Ping; Yang, Chih-Yu; Yu, Wen-Chung] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Liao, Chen-Chung; Lin, Chao-Hsiung] Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan; [Chi, Chin-Wen; Lin, Chao-Hsiung] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genom Sci, Taipei 112, Taiwan; [Lin, Chao-Hsiung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Lin, YP (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.	chlin2@ym.edu.tw	Yang, Chih-Yu/AAR-6147-2020	Yang, Chih-Yu/0000-0001-9899-3159; LIN, CHAO-HSIUNG/0000-0001-6344-271X	National Science Council in Taiwan [NSC 93-2314-B-075-044, NSC96-2317-B-010-001, NSC98-2311-B-010-003-MY3]; Taipei Veterans General Hospital in Taiwan [VGH 95DHA0100584, VGH 95DHA0100695, VGHUST100-G7-5-1]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital in Taiwan	This work was supported in part by grants (NSC 93-2314-B-075-044, NSC96-2317-B-010-001, and NSC98-2311-B-010-003-MY3) from the National Science Council in Taiwan and grants (VGH 95DHA0100584, VGH 95DHA0100695, and VGHUST100-G7-5-1) from the Taipei Veterans General Hospital in Taiwan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borawski J, 2003, RENAL FAILURE, V25, P589, DOI 10.1081/JDI-120022550; Chu JG, 2001, CLIN CHIM ACTA, V311, P95, DOI 10.1016/S0009-8981(01)00585-X; Clark WR, 2002, J AM SOC NEPHROL, V13, pS41; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Daemen MARC, 2000, CIRCULATION, V102, P1420, DOI 10.1161/01.CIR.102.12.1420; Dahl B, 2003, CRIT CARE MED, V31, P152, DOI 10.1097/00003246-200301000-00024; Dihazi H, 2008, PROTEOM CLIN APPL, V2, P1167, DOI 10.1002/prca.200780143; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Gotch FA, 2000, BLOOD PURIFICAT, V18, P276, DOI 10.1159/000014449; Hallbauer J, 2010, PROTEOM CLIN APPL, V4, P953, DOI 10.1002/prca.201000051; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; Horl WH, 2002, J AM SOC NEPHROL, V13, pS62; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Jofre R, 2006, J AM SOC NEPHROL, V17, pS274, DOI 10.1681/ASN.2006080926; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kim CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009065; Kronenberg F, 2000, J AM COLL CARDIOL, V36, P751, DOI 10.1016/S0735-1097(00)00775-0; Langlois RG, 2004, AM J NEPHROL, V24, P268, DOI 10.1159/000077409; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lin YP, 2002, KIDNEY INT, V62, P1828, DOI 10.1046/j.1523-1755.2002.00610.x; Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138; Mateos-Caceres PJ, 2004, J AM COLL CARDIOL, V44, P1578, DOI 10.1016/j.jacc.2004.06.073; McIntyre CW, 2010, SEMIN DIALYSIS, V23, P449, DOI 10.1111/j.1525-139X.2010.00782.x; McVoy LA, 2005, J IMMUNOL, V175, P4754, DOI 10.4049/jimmunol.175.7.4754; Michelis R, 2003, NEPHROL DIAL TRANSPL, V18, P924, DOI 10.1093/ndt/gfg031; Mosesson MW, 2003, J THROMB HAEMOST, V1, P231, DOI 10.1046/j.1538-7836.2003.00063.x; Petropoulou C, 2001, FEBS LETT, V509, P287, DOI 10.1016/S0014-5793(01)03150-7; Pitteri SJ, 2010, CANCER RES, V70, P8598, DOI 10.1158/0008-5472.CAN-10-1676; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Schiodt FV, 1996, HEPATOLOGY, V23, P713, DOI 10.1002/hep.510230409; Silver J, 1999, KIDNEY INT, V56, pS2, DOI 10.1046/j.1523-1755.1999.07310.x; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Thongboonkerd V, 2009, CLIN SCI, V116, P721, DOI 10.1042/CS20080478; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Unruh ML, 2005, AM J KIDNEY DIS, V46, P1107, DOI 10.1053/j.ajkd.2005.09.002; Urbich C, 2000, CIRCULATION, V101, P352, DOI 10.1161/01.CIR.101.4.352; Weissinger EM, 2006, PROTEOMICS, V6, P993, DOI 10.1002/pmic.200500210; Witko-Sarsat W, 2003, KIDNEY INT, V64, P82, DOI 10.1046/j.1523-1755.2003.00044.x; Yamamoto N, 1996, J IMMUNOL, V157, P1744	41	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40232	10.1371/journal.pone.0040232	http://dx.doi.org/10.1371/journal.pone.0040232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792249	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800054
J	Saha, D; Fetzner, R; Burkhardt, B; Podlech, J; Metzler, M; Dang, H; Lawrence, C; Fischer, R				Saha, Debjani; Fetzner, Ramona; Burkhardt, Britta; Podlech, Joachim; Metzler, Manfred; Dang, Ha; Lawrence, Christopher; Fischer, Reinhard			Identification of a Polyketide Synthase Required for Alternariol (AOH) and Alternariol-9-Methyl Ether (AME) Formation in Alternaria alternata	PLOS ONE			English	Article							SECONDARY METABOLISM; MYCOTOXIN PRODUCTION; O-METHYLTRANSFERASE; GENE; BIOSYNTHESIS; TOXINS; PROTEINS; NITROGEN; ENCODES; BIOLOGY	Alternaria alternata produces more than 60 secondary metabolites, among which alternariol (AOH) and alternariol-9-methyl ether (AME) are important mycotoxins. Whereas the toxicology of these two polyketide-based compounds has been studied, nothing is known about the genetics of their biosynthesis. One of the postulated core enzymes in the biosynthesis of AOH and AME is polyketide synthase (PKS). In a draft genome sequence of A. alternata we identified 10 putative PKS-encoding genes. The timing of the expression of two PKS genes, pksJ and pksH, correlated with the production of AOH and AME. The PksJ and PksH proteins are predicted to be 2222 and 2821 amino acids in length, respectively. They are both iterative type I reducing polyketide synthases. PksJ harbors a peroxisomal targeting sequence at the C-terminus, suggesting that the biosynthesis occurs at least partly in these organelles. In the vicinity of pksJ we found a transcriptional regulator, altR, involved in pksJ induction and a putative methyl transferase, possibly responsible for AME formation. Downregulation of pksJ and altR caused a large decrease of alternariol formation, suggesting that PksJ is the polyketide synthase required for the postulated Claisen condensations during the biosynthesis. No other enzymes appeared to be required. PksH downregulation affected pksJ expression and thus caused an indirect effect on AOH production.	[Saha, Debjani; Fetzner, Ramona; Fischer, Reinhard] KIT, Inst Appl Biosci, Dept Microbiol, Karlsruhe, Germany; [Burkhardt, Britta; Metzler, Manfred] KIT, Inst Appl Biosci, Dept Food Chem, Karlsruhe, Germany; [Podlech, Joachim] KIT, Inst Organ Chem, Karlsruhe, Germany; [Dang, Ha; Lawrence, Christopher] Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Blacksburg, VA USA	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Virginia Polytechnic Institute & State University	Saha, D (corresponding author), KIT, Inst Appl Biosci, Dept Microbiol, South Campus, Karlsruhe, Germany.	reinhard.fischer@bio.uka.de	Fischer, Reinhard/I-1220-2016	Fischer, Reinhard/0000-0002-6704-2569	Humboldt Society; Baden Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Karlsruhe Institute of Technology (KIT); Direct For Biological Sciences [0918298] Funding Source: National Science Foundation	Humboldt Society(Alexander von Humboldt Foundation); Baden Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology (KIT); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Humboldt Society and the Baden Wurttemberg Stiftung. D.S. is a Humboldt fellow. The authors thank Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Karlsruhe Institute of Technology (KIT) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Y, 2011, J AGR FOOD CHEM, V59, P6360, DOI 10.1021/jf201516f; Akamatsu H, 1999, CURR GENET, V35, P647, DOI 10.1007/s002940050464; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Brase S, 2009, CHEM REV, V109, P3903, DOI 10.1021/cr050001f; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Brugger EM, 2006, TOXICOL LETT, V164, P221, DOI 10.1016/j.toxlet.2006.01.001; Brzonkalik K, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-28; Brzonkalik K, 2011, INT J FOOD MICROBIOL, V147, P120, DOI 10.1016/j.ijfoodmicro.2011.03.016; Burkhardt Britta, 2009, Mycotoxin Res, V25, P149, DOI 10.1007/s12550-009-0022-2; Cho YR, 2006, MOL PLANT MICROBE IN, V19, P7, DOI 10.1094/MPMI-19-0007; Covert SF, 2001, MYCOL RES, V105, P259, DOI 10.1017/S0953756201003872; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crawford JM, 2010, NAT REV MICROBIOL, V8, P879, DOI 10.1038/nrmicro2465; DASENBROCK J, 1987, J CHEM SOC CHEM COMM, P1235, DOI 10.1039/c39870001235; Fehr M, 2009, MOL NUTR FOOD RES, V53, P441, DOI 10.1002/mnfr.200700379; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; GATENBEC.S, 1965, ACTA CHEM SCAND, V19, P65, DOI 10.3891/acta.chem.scand.19-0065; Gulder TA, 2012, TOP CURR CHEM, P1, DOI DOI 10.1038/JA.2013.125; HARRIS TM, 1977, J AM CHEM SOC, V99, P1631, DOI 10.1021/ja00447a058; HILTUNEN M, 1992, EXP MYCOL, V16, P44, DOI 10.1016/0147-5975(92)90040-X; Imazaki A, 2010, EUKARYOT CELL, V9, P682, DOI 10.1128/EC.00369-09; Kelkar HS, 1996, APPL ENVIRON MICROB, V62, P4296, DOI 10.1128/AEM.62.11.4296-4298.1996; Kelkar HS, 1997, J BIOL CHEM, V272, P1589, DOI 10.1074/jbc.272.3.1589; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; KIMURA N, 1993, J BACTERIOL, V175, P4427, DOI 10.1128/JB.175.14.4427-4435.1993; Koch K, 2005, J ORG CHEM, V70, P3275, DOI 10.1021/jo050075r; LIU GT, 1992, CHINESE MED J-PEKING, V105, P394; Lo HC, 2012, J AM CHEM SOC, V134, P4709, DOI 10.1021/ja209809t; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Miyamoto Y, 2008, MOL PLANT MICROBE IN, V21, P1591, DOI 10.1094/MPMI-21-12-1591; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; NISHIMURA S, 1983, ANNU REV PHYTOPATHOL, V21, P87, DOI 10.1146/annurev.py.21.090183.000511; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; OTANI H, 1995, CAN J BOT, V73, pS453, DOI 10.1139/b95-282; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; PERO R W, 1973, Environmental Health Perspectives, V4, P87, DOI 10.2307/3428185; Pfeiffer E, 2007, MOL NUTR FOOD RES, V51, P307, DOI 10.1002/mnfr.200600237; Reyes-Dominguez Y, 2012, FUNGAL GENET BIOL, V49, P39, DOI 10.1016/j.fgb.2011.11.002; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Sambrook J., 1999, MOL CLONING LAB MANU; Schmidt-Heydt M, 2007, INT J FOOD MICROBIOL, V117, P131, DOI 10.1016/j.ijfoodmicro.2007.01.014; Scott PM, 2001, J AOAC INT, V84, P1809; SIMPSON TJ, 1987, NAT PROD REP, V4, P339, DOI 10.1039/np9870400339; Sprote P, 2009, EUKARYOT CELL, V8, P421, DOI 10.1128/EC.00374-08; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; THOMAS R, 1961, BIOCHEM J, V80, P234, DOI 10.1042/bj0800234; TRAIL F, 1995, MICROBIOL-UK, V141, P755, DOI 10.1099/13500872-141-4-755; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214	53	65	71	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40564	10.1371/journal.pone.0040564	http://dx.doi.org/10.1371/journal.pone.0040564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792370	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800106
J	Sakamoto, M; Ruta, M				Sakamoto, Manabu; Ruta, Marcello			Convergence and Divergence in the Evolution of Cat Skulls: Temporal and Spatial Patterns of Morphological Diversity	PLOS ONE			English	Article							LATE-MIOCENE; FELIDAE; CARNIVORA; PHYLOGENY; SIZE; MAMMALIA; PERFORMANCE; ALLOMETRY; RADIATION; REVISION	Background: Studies of biological shape evolution are greatly enhanced when framed in a phylogenetic perspective. Inclusion of fossils amplifies the scope of macroevolutionary research, offers a deep-time perspective on tempo and mode of radiations, and elucidates life-trait changes. We explore the evolution of skull shape in felids (cats) through morphometric analyses of linear variables, phylogenetic comparative methods, and a new cladistic study of saber-toothed cats. Methodology/Principal Findings: A new phylogenetic analysis supports the monophyly of saber-toothed cats (Machairodontinae) exclusive of Felinae and some basal felids, but does not support the monophyly of various saber-toothed tribes and genera. We quantified skull shape variation in 34 extant and 18 extinct species using size-adjusted linear variables. These distinguish taxonomic group membership with high accuracy. Patterns of morphospace occupation are consistent with previous analyses, for example, in showing a size gradient along the primary axis of shape variation and a separation between large and small-medium cats. By combining the new phylogeny with a molecular tree of extant Felinae, we built a chronophylomorphospace (a phylogeny superimposed onto a two-dimensional morphospace through time). The evolutionary history of cats was characterized by two major episodes of morphological divergence, one marking the separation between saber-toothed and modern cats, the other marking the split between large and small-medium cats. Conclusions/Significance: Ancestors of large cats in the `Panthera' lineage tend to occupy, at a much later stage, morphospace regions previously occupied by saber-toothed cats. The latter radiated out into new morphospace regions peripheral to those of extant large cats. The separation between large and small-medium cats was marked by considerable morphologically divergent trajectories early in feline evolution. A chronophylomorphospace has wider applications in reconstructing temporal transitions across two-dimensional trait spaces, can be used in ecophenotypical and functional diversity studies, and may reveal novel patterns of morphospace occupation.	[Sakamoto, Manabu; Ruta, Marcello] Univ Bristol, Sch Earth Sci, Bristol, Avon, England	University of Bristol	Sakamoto, M (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	m.sakamoto@bristol.ac.uk	; Sakamoto, Manabu/F-6690-2010	Ruta, Marcello/0000-0002-6151-0704; Sakamoto, Manabu/0000-0001-6447-406X	BBSRC [BB/H007954/1]; Biotechnology and Biological Sciences Research Council [BB/H007954/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC (http://www.bbsrc.ac.uk/) grant BB/H007954/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D., 2011, RGL 3D VISUALIZATION; Barnett R, 2005, CURR BIOL, V15, pR589, DOI 10.1016/j.cub.2005.07.052; Barnett R, 2009, MOL ECOL, V18, P1668, DOI 10.1111/j.1365-294X.2009.04134.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bookstein F. L., 1985, MORPHOMETRICS EVOLUT; Brusatte SL, 2012, J EVOLUTION BIOL, V25, P365, DOI 10.1111/j.1420-9101.2011.02427.x; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Burger J, 2004, MOL PHYLOGENET EVOL, V30, P841, DOI 10.1016/j.ympev.2003.07.020; Christiansen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002807; Christiansen P, 2008, CLADISTICS, V24, P977, DOI 10.1111/j.1096-0031.2008.00226.x; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Deng T, 2006, GEODIVERSITAS, V28, P499; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Geraads D, 2004, NEUES JAHRB GEOL P-M, P95; Goloboff P, 2008, CLADISTICS, V24, P91; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Leidy J, 1872, P ACAD NAT SCI PHILA, V24, P38; Liu Li-Ping, 2008, Vertebrata Palasiatica, V46, P124; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Meachen-Samuels J, 2009, BIOL J LINN SOC, V96, P784, DOI 10.1111/j.1095-8312.2008.01169.x; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Core Development Team, 2011, R LANG ENV STAT COMP; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; Rohlf F. James, 2002, VVolume 64, P175; Rothwell T, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)403<0001:PSONAP>2.0.CO;2; Roussiakis SJ, 2006, GEOBIOS-LYON, V39, P563, DOI 10.1016/j.geobios.2005.04.002; Sakamoto M, 2010, J EVOLUTION BIOL, V23, P463, DOI 10.1111/j.1420-9101.2009.01922.x; Sakamoto M, 2010, P ROY SOC B-BIOL SCI, V277, P3327, DOI 10.1098/rspb.2010.0794; Salesa MJ, 2012, J SYST PALAEONTOL, V10, P87, DOI 10.1080/14772019.2011.566584; Salesa MJ, 2010, PALAEONTOLOGY, V53, P1369, DOI 10.1111/j.1475-4983.2010.01013.x; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; SEYMOUR K, 1993, MORPHOLOGICAL CHANGE IN QUATERNARY MAMMALS OF NORTH AMERICA, P343, DOI 10.1017/CBO9780511565052.014; Sicuro FL, 2011, BIOL J LINN SOC, V103, P176, DOI 10.1111/j.1095-8312.2011.01636.x; Sicuro FL, 2011, ZOOL J LINN SOC-LOND, V161, P414, DOI 10.1111/j.1096-3642.2010.00636.x; Sidlauskas B, 2008, EVOLUTION, V62, P3135, DOI 10.1111/j.1558-5646.2008.00519.x; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Stayton CT, 2006, PALAEONTOLOGY, V49, P307, DOI 10.1111/j.1475-4983.2006.00523.x; Stone JR, 2003, ACTA ZOOL-STOCKHOLM, V84, P63, DOI 10.1046/j.1463-6395.2003.00131.x; Sunquist ME, 2002, WILD CATS WORLD; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Turner A., 1997, BIG CATS THEIR FOSSI; WERDELIN L, 1981, ANN ZOOL FENN, V18, P37; WERDELIN L, 1983, BIOL J LINN SOC, V19, P375, DOI 10.1111/j.1095-8312.1983.tb00793.x; Werdelin L, 2001, ZOOL J LINN SOC-LOND, V132, P147, DOI 10.1006/zjls.2000.0260; WERDELIN L, 1996, CARNIVORE BEHAV ECOL, V2, P582; Werdelin Lars, 2010, P59; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, P532	57	42	43	1	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39752	10.1371/journal.pone.0039752	http://dx.doi.org/10.1371/journal.pone.0039752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792186	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000306461800017
J	Kim, SJ; Nian, C; Karunakaran, S; Clee, SM; Isales, CM; McIntosh, CHS				Kim, Su-Jin; Nian, Cuilan; Karunakaran, Subashini; Clee, Susanne M.; Isales, Carlos M.; McIntosh, Christopher H. S.			GIP-Overexpressing Mice Demonstrate Reduced Diet-Induced Obesity and Steatosis, and Improved Glucose Homeostasis	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; GASTRIC-INHIBITORY POLYPEPTIDE; RECEPTOR KNOCKOUT MICE; HIGH-FAT DIET; MITOCHONDRIAL BIOGENESIS; SYNAPTIC PLASTICITY; ENERGY-EXPENDITURE; TRANSGENIC MICE; ADIPOSE-TISSUE; LIPOPROTEIN-LIPASE	Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone that potentiates glucose-stimulated insulin secretion during a meal. Since GIP has also been shown to exert beta-cell prosurvival and adipocyte lipogenic effects in rodents, both GIP receptor agonists and antagonists have been considered as potential therapeutics in type 2 diabetes (T2DM). In the present study, we tested the hypothesis that chronically elevating GIP levels in a transgenic (Tg) mouse model would increase adipose tissue expansion and exert beneficial effects on glucose homeostasis. In contrast, although GIP Tg mice demonstrated enhanced b-cell function, resulting in improved glucose tolerance and insulin sensitivity, they exhibited reduced diet-induced obesity. Adipose tissue macrophage infiltration and hepatic steatosis were both greatly reduced, and a number of genes involved in lipid metabolism/inflammatory signaling pathways were found to be down-regulated. Reduced adiposity in GIP Tg mice was associated with decreased energy intake, involving overexpression of hypothalamic GIP. Together, these studies suggest that, in the context of over-nutrition, transgenic GIP overexpression has the potential to improve hepatic and adipocyte function as well as glucose homeostasis.	[Kim, Su-Jin; Nian, Cuilan; Karunakaran, Subashini; Clee, Susanne M.; McIntosh, Christopher H. S.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Kim, Su-Jin; Nian, Cuilan; Karunakaran, Subashini; Clee, Susanne M.; McIntosh, Christopher H. S.] Univ British Columbia, Diabet Res Grp, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Isales, Carlos M.] Georgia Hlth Sci Univ, Dept Orthopaed Surg, Augusta, GA USA; [Isales, Carlos M.] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA USA	University of British Columbia; University of British Columbia; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kim, SJ (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada.	mcintoch@mail.ubc.ca	Clee, Susanne/AAC-4278-2020; Isales, Carlos/J-9902-2013; Clee, Susanne/F-7312-2010	Isales, Carlos/0000-0002-4480-3484; Clee, Susanne/0000-0001-7946-688X	Canadian Diabetes Association (CDA); Canadian Institutes of Health Research (CIHR)	Canadian Diabetes Association (CDA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	These studies were generously supported by funding to CHSM from the Canadian Diabetes Association (CDA) and the Canadian Institutes of Health Research (CIHR), and to SMC from the CDA. SMC holds a Canada Research Chair in the Genetics of Obesity and Diabetes and is a Michael Smith Foundation for Health Research (MSFHR) scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Andrews Zane B, 2010, Curr Aging Sci, V3, P102; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Ding KH, 2006, PEPTIDES, V27, P2750, DOI 10.1016/j.peptides.2006.05.011; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Faivre E, 2012, EUR J PHARMACOL, V674, P294, DOI 10.1016/j.ejphar.2011.11.007; Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Gault VA, 2011, J ENDOCRINOL, V208, P265, DOI 10.1530/JOE-10-0419; Getty-Kaushik L, 2006, OBESITY, V14, P1124, DOI 10.1038/oby.2006.129; Gniuli D, 2010, DIABETOLOGIA, V53, P2233, DOI 10.1007/s00125-010-1830-9; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Hawke Z, 2009, J NEUROSCI, V29, P14828, DOI 10.1523/JNEUROSCI.1526-09.2009; Hinke SA, 2002, DIABETES, V51, P652, DOI 10.2337/diabetes.51.3.652; Hinke SA, 2000, J ENDOCRINOL, V165, P281, DOI 10.1677/joe.0.1650281; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irwin N, 2006, PEPTIDES, V27, P893, DOI 10.1016/j.peptides.2005.08.003; Irwin N, 2009, DIABETOLOGIA, V52, P1724, DOI 10.1007/s00125-009-1422-8; Irwin N, 2010, EXPERT OPIN INV DRUG, V19, P1039, DOI 10.1517/13543784.2010.513381; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kerr BD, 2009, BIOCHEM PHARMACOL, V78, P1008, DOI 10.1016/j.bcp.2009.05.037; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim SJ, 2007, J BIOL CHEM, V282, P34139, DOI 10.1074/jbc.M704896200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Kim SJ, 2011, J LIPID RES, V52, P759, DOI 10.1194/jlr.M012203; Kim SJ, 2010, J LIPID RES, V51, P3145, DOI 10.1194/jlr.M006841; Kohlstedt K, 2011, BASIC RES CARDIOL, V106, P205, DOI 10.1007/s00395-010-0137-9; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; McIntosh CHS, 2010, VITAM HORM, V84, P21, DOI [10.1016/S0083-6729(10)84016-6, 10.1016/B978-0-12-381517-0.00002-3]; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; McIntosh CHS, 1999, ENDOCRINOLOGY, V140, P398, DOI 10.1210/en.140.1.398; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Mohammad S, 2011, J BIOL CHEM, V286, P43062, DOI 10.1074/jbc.M111.289009; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nyberg J, 2007, J NEUROSCI RES, V85, P2099, DOI 10.1002/jnr.21349; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; Porter DW, 2011, EUR J PHARMACOL, V650, P688, DOI 10.1016/j.ejphar.2010.10.059; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Widenmaier SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009590; Xie D, 2007, BONE, V40, P1352, DOI 10.1016/j.bone.2007.01.007; Ye JM, 2004, DIABETOLOGIA, V47, P1306, DOI 10.1007/s00125-004-1436-1	55	96	105	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40156	10.1371/journal.pone.0040156	http://dx.doi.org/10.1371/journal.pone.0040156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802954	Green Published, gold, Green Submitted			2022-12-27	WOS:000306186900028
J	Wu, CS; Yen, CJ; Chou, RH; Li, ST; Huang, WC; Ren, CT; Wu, CY; Yu, YL				Wu, Chen-Shiou; Yen, Chia-Jui; Chou, Ruey-Hwang; Li, Shiou-Ting; Huang, Wei-Chien; Ren, Chien-Tai; Wu, Chung-Yi; Yu, Yung-Luen			Cancer-Associated Carbohydrate Antigens as Potential Biomarkers for Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B VIRUS; LIVER-CANCER; ALTERED GLYCOSYLATION; ALPHA-FETOPROTEIN; CELL-MIGRATION; GLOBO-H; SERUM; ANTIBODIES; OLIGOSACCHARIDES; GLYCOPROTEINS	Hepatocellular carcinoma (HCC) is one of the most common human malignancies. Therefore, developing the early, high-sensitivity diagnostic biomarkers to prevent HCC is urgently needed. Serum a-fetoprotein (AFP), the clinical biomarker in current use, is elevated in only similar to 60% of patients with HCC; therefore, identification of additional biomarkers is expected to have a significant impact on public health. In this study, we used glycan microarray analysis to explore the potential diagnostic value of several cancer-associated carbohydrate antigens (CACAs) as biomarkers for HCC. We used glycan microarray analysis with 58 different glycan analogs for quantitative comparison of 593 human serum samples (293 HCC samples; 133 chronic hepatitis B virus (HBV) infection samples, 134 chronic hepatitis C virus (HCV) infection samples, and 33 healthy donor samples) to explore the diagnostic possibility of serum antibody changes as biomarkers for HCC. Serum concentrations of anti-disialosyl galactosyl globoside (DSGG), anti-fucosyl GM1 and anti-Gb2 were significantly higher in patients with HCC than in chronic HBV infection individuals not in chronic HCV infection patients. Overall, in our study population, the biomarker candidates DSGG, fucosyl GM1 and Gb2 of CACAs achieved better predictive sensitivity than AFP. We identified potential biomarkers suitable for early detection of HCC. Glycan microarray analysis provides a powerful tool for high-sensitivity and high-throughput detection of serum antibodies against CACAs, which may be valuable serum biomarkers for the early detection of persons at high risk for HCC.	[Wu, Chen-Shiou; Huang, Wei-Chien; Wu, Chung-Yi; Yu, Yung-Luen] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Yen, Chia-Jui] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan; [Yen, Chia-Jui] Natl Cheng Kung Univ Hosp, Div Hematol Oncol, Dept Internal Med, Tainan 70428, Taiwan; [Wu, Chen-Shiou; Li, Shiou-Ting; Ren, Chien-Tai; Wu, Chung-Yi] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chou, Ruey-Hwang; Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Academia Sinica - Taiwan; Asia University Taiwan	Wu, CS (corresponding author), China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan.	cyiwu@gate.sinica.edu.tw; ylyu@mail.cmu.edu.tw	Wu, Chung-Yi/K-8334-2018; Chou, Ruey-Hwang/K-8541-2013; Huang, Wei-Chien/H-3126-2019; Huang, Wei-Chien/D-1740-2012	Chou, Ruey-Hwang/0000-0002-2297-2180; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Wu, Chen-Shiou/0000-0003-0791-1483	National Science Council of Taiwan [NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC100-2321-B-039-004]; University of Texas MD Anderson-China Medical University; Hospital Sister Institution Fund [DMR-101-115]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); University of Texas MD Anderson-China Medical University(China Medical University); Hospital Sister Institution Fund	This work was supported by National Science Council of Taiwan grants NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC100-2321-B-039-004, and The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund DMR-101-115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Brandlein S, 2003, CANCER RES, V63, P7995; BREZICKA FT, 1989, CANCER RES, V49, P1300; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; CAPORASO N, 1991, J HEPATOL, V12, P367, DOI 10.1016/0168-8278(91)90841-X; Chandrasekaran EV, 2001, GLYCOBIOLOGY, V11, P353, DOI 10.1093/glycob/11.5.353; CHEN DS, 1984, GASTROENTEROLOGY, V86, P1404; Chen L, 2010, ANN SURG ONCOL, V17, P2518, DOI 10.1245/s10434-010-1038-8; de Leoz MLA, 2008, DIS MARKERS, V25, P243, DOI 10.1155/2008/515318; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; ElRefaie A, 1996, J HEPATOL, V24, P277, DOI 10.1016/S0168-8278(96)80005-5; Filmus Jorge, 2004, Mol Diagn, V8, P207, DOI 10.2165/00066982-200408040-00002; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Henry CJ, 2005, CLIN CANCER RES, V11, P751; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Lattova E, 2009, RAPID COMMUN MASS SP, V23, P2983, DOI 10.1002/rcm.4202; Liaw YF, 2005, SEMIN LIVER DIS, V25, P40, DOI 10.1055/s-2005-915649; Liaw YF, 2005, J CLIN VIROL, V34, pS143, DOI 10.1016/S1386-6532(05)80025-3; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Marrero J. A., 2005, CLIN LIVER DIS, V9, pvi; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Marrero Jorge A, 2005, Clin Liver Dis, V9, P235, DOI 10.1016/j.cld.2004.12.006; Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x; Nealen ML, 2001, CIRC RES, V88, P438; Ouerfelli O, 2005, EXPERT REV VACCINES, V4, P677, DOI 10.1586/14760584.4.5.677; Pang RWC, 2008, ANN SURG ONCOL, V15, P962, DOI 10.1245/s10434-007-9730-z; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Satoh M, 1996, CANCER RES, V56, P1932; Shriver Z, 2004, NAT REV DRUG DISCOV, V3, P863, DOI 10.1038/nrd1521; Stanley P, 2002, BBA-GEN SUBJECTS, V1573, P363, DOI 10.1016/S0304-4165(02)00404-X; Tseng SY, 2008, CHEM-ASIAN J, V3, P1395, DOI 10.1002/asia.200800154; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wands J, 2007, NEW ENGL J MED, V357, P1974, DOI 10.1056/NEJMcibr075652; Wang CC, 2008, P NATL ACAD SCI USA, V105, P11661, DOI 10.1073/pnas.0804923105; Wu CY, 2009, ORG BIOMOL CHEM, V7, P2247, DOI 10.1039/b902510n; Wu LH, 2010, GLYCOBIOLOGY, V20, P215, DOI 10.1093/glycob/cwp168; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	44	41	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39466	10.1371/journal.pone.0039466	http://dx.doi.org/10.1371/journal.pone.0039466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808038	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700009
J	Redondo, CM; Gago-Dominguez, M; Ponte, SM; Castelo, ME; Jiang, XJ; Garcia, AA; Fernandez, MP; Tome, MA; Fraga, M; Gude, F; Martinez, ME; Garzon, VM; Carracedo, A; Castelao, JE				Redondo, Carmen M.; Gago-Dominguez, Manuela; Miranda Ponte, Sara; Enguix Castelo, Manuel; Jiang, Xuejuan; Alonso Garcia, Ana; Pena Fernandez, Maite; Ausencia Tome, Maria; Fraga, Maximo; Gude, Francisco; Elena Martinez, Maria; Munoz Garzon, Victor; Carracedo, Angel; Esteban Castelao, J.			Breast Feeding, Parity and Breast Cancer Subtypes in a Spanish Cohort	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR STATUS; AFRICAN-AMERICAN WOMEN; HISPANIC WHITE WOMEN; SAN-LUIS VALLEY; RISK-FACTORS; ESTROGEN-RECEPTOR; MATERNAL RECALL; CLINICAL PRESENTATION; RACIAL/ETHNIC GROUPS; MOLECULAR ANALYSIS	Background: Differences in the incidence and outcome of breast cancer among Hispanic women compared with white women are well documented and are likely explained by ethnic differences in genetic composition, lifestyle, or environmental exposures. Methodolgy/Principal Findings: A population-based study was conducted in Galicia, Spain. A total of 510 women diagnosed with operable invasive breast cancer between 1997 and 2010 participated in the study. Data on demographics, breast cancer risk factors, and clinico-pathological characteristics were collected. The different breast cancer tumor subtypes were compared on their clinico-pathological characteristics and risk factor profiles, particularly reproductive variables and breastfeeding. Among the 501 breast cancer patients (with known ER and PR receptors), 85% were ER+/PR+ and 15% were ER-&PR-. Among the 405 breast cancer with known ER, PR and HER2 status, 71% were ER+/PR+/HER2- (luminal A), 14% were ER+/PR+/HER2+ (luminal B), 10% were ER-/PR-/HER2- (triple negative breast cancer, TNBC), and 5% were ER-/PR-/HER2+ (non-luminal). A lifetime breastfeeding period equal to or longer than 7 months was less frequent in case patients with TNBC (OR = 0.25, 95% CI = 0.08-0.68) compared to luminal A breast cancers. Both a low (2 or fewer pregnancies) and a high (3-4 pregnancies) number of pregnancies combined with a long breastfeeding period were associated with reduced odds of TNBC compared with luminal A breast cancer, although the association seemed to be slightly more pronounced among women with a low number of pregnancies (OR = 0.09, 95% CI = 0.005-0.54). Conclusions/Significance: In case-case analyses with the luminal A cases as the reference group, we observed a lower proportion of TNBC among women who breastfed 7 or more months. The combination of longer breastfeeding duration and lower parity seemed to further reduce the odds of having a TNBC compared to a luminal A breast cancer.	[Redondo, Carmen M.; Miranda Ponte, Sara; Esteban Castelao, J.] Complejo Hosp Univ Vigo, Genom Med Grp, Oncol & Genet Unit, Vigo, Spain; [Gago-Dominguez, Manuela; Carracedo, Angel] Complejo Hosp Univ Santiago, IDIS, Genom Med Grp, Galician Fdn Genom Med, Santiago De Compostela, Spain; [Enguix Castelo, Manuel; Munoz Garzon, Victor] Complejo Hosp Univ Vigo, Dept Radiotherapy, Vigo, Spain; [Jiang, Xuejuan] Univ So Calif, Ophtalmol & Prevent Med Dept, Los Angeles, CA USA; [Alonso Garcia, Ana] Hosp Univ Cent Asturias, Dept Radiotherapy, Oviedo, Spain; [Pena Fernandez, Maite] Complejo Hosp Univ Santiago, Ginecol Dept, Santiago De Compostela, Spain; [Ausencia Tome, Maria] Complejo Hosp Univ Santiago, Dept Endocrinol, Santiago De Compostela, Spain; [Fraga, Maximo] Complejo Hosp Univ Santiago, Dept Pathol, Santiago De Compostela, Spain; [Gude, Francisco] Complejo Hosp Univ Santiago, Clin Epidemiol Unit, Santiago De Compostela, Spain; [Elena Martinez, Maria] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Vigo; University of Southern California; Central University Hospital Asturias; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; University of California System; University of California San Diego	Redondo, CM (corresponding author), Complejo Hosp Univ Vigo, Genom Med Grp, Oncol & Genet Unit, Vigo, Spain.	carmen.redondo.marey@sergas.es	Fraga, Máximo/AAC-9417-2020; Carracedo, Angel/D-4257-2012; Gago-Dominguez, Manuela/AAP-6611-2021	Carracedo, Angel/0000-0003-1085-8986; Redondo, Carmen M./0000-0003-4971-2861; Castelao, Jose E/0000-0001-7110-1376; Fraga Rodriguez, Maximo/0000-0001-6185-9562; Gago, Manuela/0000-0001-6713-4351	Programa Grupos Emergentes EMERCIII, Instituto de Salud Carlos III, Cancer Genetics Unit Complejo Hospitalario Universitario de Vigo, Spain	Programa Grupos Emergentes EMERCIII, Instituto de Salud Carlos III, Cancer Genetics Unit Complejo Hospitalario Universitario de Vigo, Spain	Programa Grupos Emergentes EMERCIII, Instituto de Salud Carlos III, Cancer Genetics Unit Complejo Hospitalario Universitario de Vigo, Spain (IP: JEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Franco M, 2001, AM J HUM GENET, V69, P268; Chakraborty Bandana M., 1999, Ethnicity and Disease, V9, P278; Chu KC, 2002, BREAST CANCER RES TR, V74, P199, DOI 10.1023/A:1016361932220; Chu KC, 2001, CANCER, V92, P37, DOI 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Diez O, 1998, HUM GENET, V103, P707, DOI 10.1007/s004390050895; Diez O, 1999, BRIT J CANCER, V79, P1302, DOI 10.1038/sj.bjc.6690208; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; ELLIS IO, 2003, WHO CLASSIFICATION T, P9; FRIERSON HF, 1995, AM J CLIN PATHOL, V103, P195; Galicia Xd, 2001, XUNTA GALICIA, P456; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Hausauer AK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1839; Hines LM, 2008, CANCER EPIDEM BIOMAR, V17, P2700, DOI 10.1158/1055-9965.EPI-08-0504; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Lapham SJ, 1993, L136 CPH ETHN HISP B; LAUNER LJ, 1992, J EPIDEMIOL COMMUN H, V46, P203, DOI 10.1136/jech.46.3.203; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Ma HY, 2010, CANCER RES, V70, P575, DOI 10.1158/0008-5472.CAN-09-3460; Martinez ME, 2010, CANCER EPIDEM BIOMAR, V19, P2710, DOI 10.1158/1055-9965.EPI-10-0742; Martinez ME, 2010, HEALTH, V2, P1040, DOI DOI 10.4236/HEALTH.2010.29153; Mew NA, 2002, CLIN GENET, V62, P151, DOI 10.1034/j.1399-0004.2002.620208.x; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mullineaux LG, 2003, CANCER-AM CANCER SOC, V98, P597, DOI 10.1002/cncr.11533; Osorio A, 1998, CANCER LETT, V123, P153, DOI 10.1016/S0304-3835(97)00416-3; Osorio A, 2000, BRIT J CANCER, V82, P1266, DOI 10.1054/bjoc.1999.1089; Palmer JR, 2011, CANCER EPIDEM BIOMAR, V20, P1883, DOI 10.1158/1055-9965.EPI-11-0465; Patel TA, 2010, ONCOLOGIST, V15, P466, DOI 10.1634/theoncologist.2010-0004; Phipps AI, 2008, CANCER-AM CANCER SOC, V113, P1521, DOI 10.1002/cncr.23786; Phipps AI, 2011, JNCI-J NATL CANCER I, V103, P470, DOI 10.1093/jnci/djr030; Promislow JHE, 2005, AM J EPIDEMIOL, V161, P289, DOI 10.1093/aje/kwi044; Blesa JR, 2000, HUM MUTAT, V15, P381, DOI 10.1002/(SICI)1098-1004(200004)15:4<381::AID-HUMU14>3.0.CO;2-H; Sans M, 2000, HUM BIOL, V72, P155; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; Shetterly SM, 1998, AM J EPIDEMIOL, V147, P1019, DOI 10.1093/oxfordjournals.aje.a009395; Shinde SS, 2010, CANCER-AM CANCER SOC, V116, P4933, DOI 10.1002/cncr.25443; Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.1.01051; Trivers KF, 2009, CANCER CAUSE CONTROL, V20, P1071, DOI 10.1007/s10552-009-9331-1; Watlington AT, 2007, CANCER, V109, P2093, DOI 10.1002/cncr.22640; Vega A, 2002, ANN HUM GENET, V66, P29, DOI 10.1017/S0003480001001014; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Wojcik Barbara E, 2003, Breast J, V9, P175, DOI 10.1046/j.1524-4741.2003.09308.x; Xing P, 2010, MED ONCOL, V27, P926, DOI 10.1007/s12032-009-9308-7; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806	48	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40543	10.1371/journal.pone.0040543	http://dx.doi.org/10.1371/journal.pone.0040543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792365	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400068
J	von Glehn, F; Jarius, S; de Oliveira, ACP; Brandao, CO; Farias, AS; Damasceno, A; Casseb, J; Moraes, AS; Longhini, ALF; Wandinger, KP; Damasceno, BP; Wildemann, B; Santos, LMB				von Glehn, Felipe; Jarius, Sven; Penalva de Oliveira, Augusto C.; Brandao, Carlos Otavio; Farias, Alessandro S.; Damasceno, Alfredo; Casseb, Jorge; Moraes, Adriel S.; Longhini, Ana Leda F.; Wandinger, Klaus-Peter; Damasceno, Benito P.; Wildemann, Brigitte; Santos, Leonilda M. B.			Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy	PLOS ONE			English	Article							I-ASSOCIATED MYELOPATHY; VIRUS TYPE-I; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; 1-ASSOCIATED MYELOPATHY; BRAZILIAN PATIENTS; INFECTION; NEURITIS	Introduction: The seroprevalence of human T-cell leukemia virus type 1 (HTLV-1) is very high among Brazilians (similar to 1:200). HTLV-1 associated myelopathy or tropical spastic paraparesis (HAM/TSP) is the most common neurological complication of HTLV-1 infection. HAM/TSP can present with an acute/subacute form of longitudinally extensive myelitis, which can be confused with lesions seen in aquaporin-4 antibody (AQP4-Ab) positive neuromyelitis optica spectrum disorders (NMOSD) on MRI. Moreover, clinical attacks in patients with NMOSD have been shown to be preceded by viral infections in around 30% of cases. Objective: To evaluate the frequency of AQP4-Ab in patients with HAM/TSP. To evaluate the frequency of HTLV-1 infection in patients with NMOSD. Patients and Methods: 23 Brazilian patients with HAM/TSP, 20 asymptomatic HTLV-1+ serostatus patients, and 34 with NMOSD were tested for AQP4-Ab using a standardized recombinant cell based assay. In addition, all patients were tested for HTLV-1 by ELISA and Western blotting. Results: 20/34 NMOSD patients were positive for AQP4-Ab but none of the HAM/TSP patients and none of the asymptomatic HTLV-1 infected individuals. Conversely, all AQP4-Ab-positive NMOSD patients were negative for HTLV-1 antibodies. One patient with HAM/TSP developed optic neuritis in addition to subacute LETM; this patient was AQP4-Ab negative as well. Patients were found to be predominantly female and of African descent both in the NMOSD and in the HAM/TSP group; Osame scale and expanded disability status scale scores did not differ significantly between the two groups. Conclusions: Our results argue both against a role of antibodies to AQP4 in the pathogenesis of HAM/TSP and against an association between HTLV-1 infection and the development of AQP4-Ab. Moreover, the absence of HTLV-1 in all patients with NMOSD suggests that HTLV-1 is not a common trigger of acute attacks in patients with AQP4-Ab positive NMOSD in populations with high HTLV-1 seroprevalence.	[von Glehn, Felipe; Brandao, Carlos Otavio; Farias, Alessandro S.; Moraes, Adriel S.; Longhini, Ana Leda F.; Santos, Leonilda M. B.] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Neuroimmunol Unit, Campinas, SP, Brazil; [von Glehn, Felipe; Brandao, Carlos Otavio; Damasceno, Alfredo; Damasceno, Benito P.] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil; [Jarius, Sven; Wildemann, Brigitte] Heidelberg Univ, Div Mol Neuroimmunol, Dept Neurol, Heidelberg, Germany; [Penalva de Oliveira, Augusto C.] Univ Estadual Campinas, Dept Internal Med, Neuroinfect Dis Unit, Campinas, SP, Brazil; [Penalva de Oliveira, Augusto C.; Casseb, Jorge] Emilio Ribas Inst Infectol, Dept Neurol, Sao Paulo, Brazil; [Wandinger, Klaus-Peter] Euroimmun, Inst Expt Immunol, Lubeck, Germany	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Ruprecht Karls University Heidelberg; Universidade Estadual de Campinas; EUROIMMUN	von Glehn, F (corresponding author), Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Neuroimmunol Unit, Campinas, SP, Brazil.	fglehn@terra.com.br; leonilda@unicamp.br	Farias, Alessandro/C-6879-2012; Damasceno, Alfredo/D-8137-2016; Moraes, Adriel S/F-1259-2013; Farias, Alessandro/AAH-2228-2020; casseb, jorge/X-5219-2019; BRANDÃO, CARLOS OTÁVIO CO/M-3152-2014; von Glehn, Felipe/C-5970-2012	Farias, Alessandro/0000-0001-6759-1819; Moraes, Adriel S/0000-0002-9365-573X; Farias, Alessandro/0000-0001-6759-1819; casseb, jorge/0000-0002-4553-2559; BRANDÃO, CARLOS OTÁVIO CO/0000-0002-4898-5916; von Glehn, Felipe/0000-0002-1004-7641; Damasceno, Alfredo/0000-0002-7919-3989	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Bayer Schering Healthcare; Merck Serono; Abbott Bristol; Abbott GSK	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Bayer Schering Healthcare; Merck Serono(Merck & Company); Abbott Bristol; Abbott GSK	This study received financial support from the Brazilian government agencies FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -www.fapesp.br/en) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - www.capes.gov.br). The work of S.J. and B. W. was supported by research grants from Bayer Schering Healthcare and from Merck Serono. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of S.J. and B. W. was supported by research grants from Bayer Schering Healthcare and from Merck Serono. A.C.P.O. received consulting fees from - Abbott & Bristol and speaking fees from Abbott & GSK. K. P. W. is an employee of Euroimmun, Luebeck, Germany. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adoni T, 2010, MULT SCLER J, V16, P81, DOI 10.1177/1352458509353651; Bergamaschi R, 2004, MULT SCLER J, V10, P2, DOI 10.1191/1352458504ms988oa; Brito JCD, 2003, ARQ NEURO-PSIQUIAT, V61, P816, DOI 10.1590/S0004-282X2003000500021; Cabre P, 2001, NEUROLOGY, V56, P507, DOI 10.1212/WNL.56.4.507; Casseb J, 2008, J MED VIROL, V80, P392, DOI 10.1002/jmv.21111; GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x; Haines JL, 2002, HUM MOL GENET, V11, P2251; Jarius S, 2011, J NEUROL SCI, V306, P82, DOI 10.1016/j.jns.2011.03.038; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kanamori Y, 2011, NEUROLOGY, V77, P652, DOI 10.1212/WNL.0b013e318229e694; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kasahata N, 2003, ARCH NEUROL-CHICAGO, V60, P873, DOI 10.1001/archneur.60.6.873; Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Koga M, 2009, INTERNAL MED, V48, P1157, DOI 10.2169/internalmedicine.48.1989; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lana-Peixoto M A, 1992, Arq Neuropsiquiatr, V50, P419; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; MATSUMOTO M, 1990, AM J TROP MED HYG, V42, P365, DOI 10.4269/ajtmh.1990.42.365; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; MURPHY EL, 1989, ANN INTERN MED, V111, P555, DOI 10.7326/0003-4819-111-7-555; Olindo S, 2010, J CLIN NEUROSCI, V17, P1449, DOI 10.1016/j.jocn.2009.12.024; OSAME M, 1986, LANCET, V1, P1031; Papais-Alvarenga RM, 2002, J NEUROL NEUROSUR PS, V73, P429, DOI 10.1136/jnnp.73.4.429; Petzold A, 2010, J NEUROL NEUROSUR PS, V81, P109, DOI 10.1136/jnnp.2008.146894; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; WHO, 1989, SCI GROUP HTLV I INF, P4; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2007, NEUROLOGIST, V13, P2, DOI 10.1097/01.nrl.0000250927.21903.f8; Wingerchuk DM, 2009, J NEUROL SCI, V286, P18, DOI 10.1016/j.jns.2009.08.045; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Yoshida Y, 1998, OPHTHALMOLOGICA, V212, P73, DOI 10.1159/000027246	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39372	10.1371/journal.pone.0039372	http://dx.doi.org/10.1371/journal.pone.0039372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808032	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500009
J	Fusco, C; Micale, L; Egorov, M; Monti, M; D'Addetta, EV; Augello, B; Cozzolino, F; Calcagni, A; Fontana, A; Polishchuk, RS; Didelot, G; Reymond, A; Pucci, P; Merla, G				Fusco, Carmela; Micale, Lucia; Egorov, Mikhail; Monti, Maria; D'Addetta, Ester Valentina; Augello, Bartolomeo; Cozzolino, Flora; Calcagni, Alessia; Fontana, Andrea; Polishchuk, Roman S.; Didelot, Gerard; Reymond, Alexandre; Pucci, Piero; Merla, Giuseppe			The E3-Ubiquitin Ligase TRIM50 Interacts with HDAC6 and p62, and Promotes the Sequestration and Clearance of Ubiquitinated Proteins into the Aggresome	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; MASS-SPECTROMETRY; AUTOPHAGY; DEGRADATION; HUNTINGTIN; DISEASE; STRESS; CANCER; CELLS; MICE	In this study we report that, in response to proteasome inhibition, the E3-Ubiquitin ligase TRIM50 localizes to and promotes the recruitment and aggregation of polyubiquitinated proteins to the aggresome. Using Hdac6-deficient mouse embryo fibroblasts (MEF) we show that this localization is mediated by the histone deacetylase 6, HDAC6. Whereas Trim50-deficient MEFs allow pinpointing that the TRIM50 ubiquitin-ligase regulates the clearance of polyubiquitinated proteins localized to the aggresome. Finally we demonstrate that TRIM50 colocalizes, interacts with and increases the level of p62, a multifunctional adaptor protein implicated in various cellular processes including the autophagy clearance of polyubiquitinated protein aggregates. We speculate that when the proteasome activity is impaired, TRIM50 fails to drive its substrates to the proteasome-mediated degradation, and promotes their storage in the aggresome for successive clearance.	[Fusco, Carmela; Micale, Lucia; D'Addetta, Ester Valentina; Augello, Bartolomeo; Calcagni, Alessia; Merla, Giuseppe] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Egorov, Mikhail; Polishchuk, Roman S.] Telethon Inst Genet & Med, Naples, Italy; [Monti, Maria; Cozzolino, Flora; Pucci, Piero] Univ Naples Federico II, CEINGE Adv Biotechnol, Naples, Italy; [Monti, Maria; Cozzolino, Flora; Pucci, Piero] Univ Naples Federico II, Dept Organ Chem & Biochem, Naples, Italy; [Fontana, Andrea] IRCCS Casa Sollievo Sofferenza, Biostat Unit, San Giovanni Rotondo, Italy; [Didelot, Gerard; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	IRCCS Casa Sollievo Della Sofferenza; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; IRCCS Casa Sollievo Della Sofferenza; University of Lausanne	Fusco, C (corresponding author), IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy.	g.merla@operapadrepio.it	Kutalik, Zoltan/HHZ-5697-2022; Calcagni, Alessia/AAB-7918-2021; cozzolino, flora/AAA-3155-2022; Fusco, Carmela/H-2964-2016; Micale, Lucia/K-3909-2016; Fontana, Andrea/J-8584-2016; Augello, Bartolomeo/B-1927-2017; merla, giuseppe/K-4627-2012; MONTI, Maria/J-2816-2018	Kutalik, Zoltan/0000-0001-8285-7523; Calcagni, Alessia/0000-0002-1946-5815; Fusco, Carmela/0000-0001-7794-6046; Fontana, Andrea/0000-0002-6660-5315; Augello, Bartolomeo/0000-0001-7475-6976; merla, giuseppe/0000-0001-5078-928X; MONTI, Maria/0000-0002-7775-7154; Micale, Lucia/0000-0003-3604-194X; cozzolino, flora/0000-0002-4648-8107; Polishchuk, Roman/0000-0002-7698-1955; Reymond, Alexandre/0000-0003-1030-8327; PUCCI, Pietro/0000-0002-5885-1495	MIUR FIRB Project Italian Human ProteomeNet [RBRN07BMCT]; Jerome Lejeune Foundation; Ricerca Corrente; Italian Ministry of Health; "5x1000" voluntary contributions; Fondazione Banca del Monte di Foggia "Domenico Siniscalco Ceci"; Italian Telethon Foundation [GGP06122]; Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale; European Commission anEUploidy Integrated Project [037627]; Swiss National Science Foundation; Telethon Electron Microscopy Core Facility (Telethon Grant) [GFP08001]	MIUR FIRB Project Italian Human ProteomeNet; Jerome Lejeune Foundation; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Italian Ministry of Health(Ministry of Health, Italy); "5x1000" voluntary contributions; Fondazione Banca del Monte di Foggia "Domenico Siniscalco Ceci"; Italian Telethon Foundation(Fondazione Telethon); Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale(Ministry of Foreign Affairs and International Cooperation (Italy)); European Commission anEUploidy Integrated Project(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Telethon Electron Microscopy Core Facility (Telethon Grant)(Fondazione Telethon)	This work was in part supported by grants from the MIUR FIRB Project Italian Human ProteomeNet RBRN07BMCT to PP, Jerome Lejeune Foundation, the Ricerca Corrente 2010 funding granted by the Italian Ministry of Health, the "5x1000" voluntary contributions, the Fondazione Banca del Monte di Foggia "Domenico Siniscalco Ceci", the Italian Telethon Foundation (Grant #GGP06122) and with the contribution of Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale (2009-2010) to GM; the European Commission anEUploidy Integrated Project (grant 037627), the Jerome Lejeune Foundation, the Swiss National Science Foundation to AR. We acknowledge the Telethon Electron Microscopy Core Facility (Telethon Grant #GFP08001) for the help with the electron microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Chernorudskiy AL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-126; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Egorov MV, 2009, MOL BIOL CELL, V20, P2413, DOI 10.1091/mbc.E08-11-1136; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gozal YM, 2009, J PROTEOME RES, V8, P5069, DOI 10.1021/pr900474t; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Ichimura Y, 2010, SEMIN IMMUNOPATHOL, V32, P431, DOI 10.1007/s00281-010-0220-1; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luciani A, 2010, NAT CELL BIOL; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Merla G, 2010, HUM GENET; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Micale L, 2008, EUR J HUM GENET, V16, P1038, DOI 10.1038/ejhg.2008.68; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song CC, 2008, TOXICOL APPL PHARM, V228, P351, DOI 10.1016/j.taap.2007.12.026; Takashima A, 2001, Curr Protoc Cell Biol, VChapter 2, DOI 10.1002/0471143030.cb0201s00; Vasilescu J, 2005, J PROTEOME RES, V4, P2192, DOI 10.1021/pr050265i; Wilde IB, 2011, J PROTEOME RES, V10, P1062, DOI 10.1021/pr1008543; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	42	63	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40440	10.1371/journal.pone.0040440	http://dx.doi.org/10.1371/journal.pone.0040440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792322	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700049
J	Weber, KL; Doucet, M; Shaner, A; Hsu, N; Huang, D; Fogel, J; Kominsky, SL				Weber, Kristy L.; Doucet, Michele; Shaner, Adam; Hsu, Nigel; Huang, David; Fogel, Jenna; Kominsky, Scott L.			MIP-1 delta Activates NFATc1 and Enhances Osteoclastogenesis: Involvement of Both PLC gamma 2 and NF kappa B Signaling	PLOS ONE			English	Article							INFLAMMATORY PROTEIN 1-ALPHA; RECEPTOR ACTIVATOR; NUCLEAR-FACTOR; RHEUMATOID-ARTHRITIS; STIMULATING FACTOR; MYELOMA CELLS; EXPRESSION; DIFFERENTIATION; INHIBITION; CHEMOKINE	Pathological bone resorption is a source of significant morbidity in diseases affecting the skeleton such as rheumatoid arthritis, periodontitis, and cancer metastasis to bone. Evidence indicates that elevated levels of inflammatory mediators such as IL-1, IL-6, and TNF-alpha play a role in this process by promoting the formation of bone-resorbing osteoclasts. Additionally, current studies have identified inflammatory chemokines of the macrophage inflammatory protein (MIP) family as potential mediators of pathological bone resorption, where both MIP-1 alpha and -3 alpha have been shown to enhance osteoclast (OCL) development. In this study we provide evidence that MIP-1 delta, whose expression is associated with renal cell carcinoma bone metastasis and rheumatoid arthritis, enhances OCL formation in vitro via a direct effect on OCL precursors. Consistent with this ability, exposure of OCL precursors to MIP-1 delta resulted in the activation of PLC gamma 2 and NF-kappa B, two signaling pathways known to regulate OCL differentiation. Moreover, MIP-1 delta induced expression and nuclear translocation of NFATc1, a master regulator of osteoclastogenesis, which was dependent on activation of both the PLC gamma 2 and NF kappa B signaling pathways. Lastly, consistent with in vitro studies, in vivo administration of MIP-1 delta significantly increased OCL number and resorption area as determined using a murine calvarial bone resorption model. Taken together, these data highlight the potential of MIP-1 delta as a mediator of pathological bone resorption and provide insight into the molecular mechanism through which MIP-1 delta enhances osteoclastogenesis.	[Weber, Kristy L.; Doucet, Michele; Shaner, Adam; Hsu, Nigel; Huang, David; Fogel, Jenna; Kominsky, Scott L.] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Weber, KL (corresponding author), Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21218 USA.	kominsc@jhmi.edu	Doucet, Michele/A-8551-2013		National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR056373]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056373] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Award Number R21AR056373 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Arthritis and Musculoskeletal and Skin Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATAILLE R, 1992, INT J CLIN LAB RES, V21, P283, DOI 10.1007/BF02591662; Bendre MS, 2005, CANCER RES, V65, P11001, DOI 10.1158/0008-5472.CAN-05-2630; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Choi SJ, 2001, J CLIN INVEST, V108, P1833, DOI 10.1172/JCI13116; Choi SJ, 2000, BLOOD, V96, P671; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535; Gladue RP, 2010, CURR TOP MED CHEM, V10, P1268; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Hosokawa Y, 2007, CLIN EXP IMMUNOL, V149, P146, DOI 10.1111/j.1365-2249.2007.03398.x; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V142, P285, DOI 10.1111/j.1365-2249.2005.02912.x; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Lisignoli G, 2007, J CELL PHYSIOL, V210, P798, DOI 10.1002/jcp.20905; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Maruyama T, 2010, J BONE MINER RES, V25, P1058, DOI 10.1359/jbmr.091032; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; O'Brien CA, 2000, J CELL BIOCHEM, V79, P532, DOI 10.1002/1097-4644(20001215)79:4<532::AID-JCB20>3.0.CO;2-U; Sanda T, 2005, CLIN CANCER RES, V11, P1974, DOI 10.1158/1078-0432.CCR-04-1936; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; UY HL, 1995, J BONE MINER RES, V10, P295; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Victoriano AFB, 2006, ANTIMICROB AGENTS CH, V50, P547, DOI 10.1128/AAC.50.2.547-555.2006; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40799	10.1371/journal.pone.0040799	http://dx.doi.org/10.1371/journal.pone.0040799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792407	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700067
J	Loehr, J; Leinonen, T; Herczeg, G; O'Hara, RB; Merila, J				Loehr, John; Leinonen, Tuomas; Herczeg, Gabor; O'Hara, Robert B.; Merila, Juha			Heritability of Asymmetry and Lateral Plate Number in the Threespine Stickleback	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DEVELOPMENTAL STABILITY; DIRECTIONAL ASYMMETRY; DROSOPHILA-MELANOGASTER; MERISTIC CHARACTERS; SELECTION; EVOLUTION; POPULATIONS; GENETICS; FITNESS	The estimation of individual fitness and quality are important elements of evolutionary ecological research. Over the past six decades, there has been great interest in using fluctuating asymmetry (FA) to represent individual quality, yet, serious technical problems have hampered efforts to estimate the heritability of FA, which, in turn, has limited progress in the investigation of FA from an evolutionary perspective. Here we estimate the heritability of number of lateral plates, their FA and directional asymmetry (DA) in threespine stickleback, Gasterosteus aculeatus. By (i) using a meristic trait and (ii) basing our calculations on a large half-sib design experiment involving 2,079 offspring from 84 families, we overcame many of the difficulties faced by earlier FA studies. Both lateral plate number and FA in lateral plates were heritable (h(2)=0.46 and 0.21, respectively), even after controlling for marker genotypes linked to EDA (the major locus influencing plate number). Likewise, DA in lateral plates was heritable h(2)=0.23). The additive genetic component of FA in lateral plates makes it a prime candidate for further investigation into the evolutionary implications of FA and the genetic underpinnings of developmental instability. This discovery in an evolutionary model species holds the possibility to invigorate the study of FA from an evolutionary perspective.	[Loehr, John; Leinonen, Tuomas; Herczeg, Gabor; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Loehr, John] Univ Helsinki, Lammi Biol Stn, Lammi, Finland; [O'Hara, Robert B.] Univ Helsinki, Dept Math & Stat, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Loehr, J (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008; O'Hara, Bob/A-7499-2008; Herczeg, Gabor/AAZ-1661-2021; Herczeg, Gábor/AAF-9978-2020	Merila, Juha/0000-0001-9614-0072; O'Hara, Bob/0000-0001-9737-3724; Herczeg, Gabor/0000-0003-0441-342X; 	Academy of Finland [108601, 118673, 213491]; Ministry of Education; LOEWE program of Hesse's Ministry of Higher Education, Research and the Arts	Academy of Finland(Academy of Finland); Ministry of Education; LOEWE program of Hesse's Ministry of Higher Education, Research and the Arts	This work was supported by the Academy of Finland (www.aka.fi; grant nos. 108601, 118673 and 213491), the LUOVA graduate school funded by the Ministry of Education (TL), and the LOEWE program of Hesse's Ministry of Higher Education, Research and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Badyaev AV, 2000, ECOLOGY, V81, P336, DOI 10.1890/0012-9658(2000)081[0336:SADSVR]2.0.CO;2; BELL MA, 1981, EVOLUTION, V35, P67, DOI 10.1111/j.1558-5646.1981.tb04859.x; Bell MA, 2010, ENVIRON BIOL FISH, V89, P189, DOI 10.1007/s10641-010-9712-z; Bergstrom CA, 2003, EVOLUTION, V57, P2128; Bergstrom CA, 2000, BEHAVIOUR, V137, P1097, DOI 10.1163/156853900502457; Bjorklund M, 1997, ANN ZOOL FENN, V34, P133; BRADLEY BP, 1980, GENETICS, V95, P1033; Cano JM, 2006, MOL ECOL, V15, P4613, DOI 10.1111/j.1365-294X.2006.03099.x; Carter Ashley J R, 2009, Int J Evol Biol, V2010, P759159, DOI 10.4061/2009/759159; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; COYNE JA, 1987, J HERED, V78, P119, DOI 10.1093/oxfordjournals.jhered.a110329; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Duan W, 2001, J HERED, V92, P392, DOI 10.1093/jhered/92.5.392; Fuller Rebecca C., 2003, P157; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GIBSON JB, 1974, HEREDITY, V33, P293, DOI 10.1038/hdy.1974.95; HAGEN DW, 1973, HEREDITY, V30, P303, DOI 10.1038/hdy.1973.40; HAGEN DW, 1973, HEREDITY, V31, P75, DOI 10.1038/hdy.1973.59; Herczeg G, 2005, AMPHIBIA-REPTILIA, V26, P422, DOI 10.1163/156853805774408540; Hermida M, 2002, CAN J ZOOL, V80, P532, DOI 10.1139/Z02-022; Leamy L, 1997, J EVOLUTION BIOL, V10, P21; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Leamy LJ, 1997, EVOLUTION, V51, P957, DOI 10.2307/2411169; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Leung B, 1996, ECOSCIENCE, V3, P400, DOI 10.1080/11956860.1996.11682357; Lynch M., 1998, GENETICS ANAL QUANTI; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; MATHER K, 1953, HEREDITY, V7, P297, DOI 10.1038/hdy.1953.41; MERILA J, 1995, SYST BIOL, V44, P97, DOI 10.2307/2413486; Moller AP, 1997, J EVOLUTION BIOL, V10, P1, DOI 10.1007/s000360050001; Moller AP, 1997, ASYMMETRY DEV STABIL; MOODIE GEE, 1976, SYST ZOOL, V25, P49, DOI 10.2307/2412778; Nakagawa S, 2008, TRENDS ECOL EVOL, V23, P592, DOI 10.1016/j.tree.2008.06.014; Palmer AR, 1999, AM NAT, V154, P220, DOI 10.1086/303223; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Pelabon C, 2006, J EVOLUTION BIOL, V19, P764, DOI 10.1111/j.1420-9101.2005.01054.x; Pelabon C, 2010, EVOLUTION, V64, P1912, DOI 10.1111/j.1558-5646.2010.00979.x; Pritchard JR, 2001, EVOL ECOL RES, V3, P209; REEVE ECR, 1960, GENET RES, V1, P151, DOI 10.1017/S0016672300000148; Reimchen TE, 2001, BIOL J LINN SOC, V73, P51, DOI 10.1006/bijl.2001.0523; REIMCHEN TE, 1992, EVOLUTION, V46, P1224, DOI 10.1111/j.1558-5646.1992.tb00631.x; Reimchen TE, 2009, EVOLUTION, V63, P115, DOI 10.1111/j.1558-5646.2008.00520.x; SCHEINER SM, 1991, J EVOLUTION BIOL, V4, P51, DOI 10.1046/j.1420-9101.1991.4010051.x; SWAIN DP, 1987, AM NAT, V129, P761, DOI 10.1086/284671; Thornhill R, 1999, AM NAT, V154, P234, DOI 10.1086/303233; TUINSTRA EJ, 1990, P ROY SOC B-BIOL SCI, V241, P146, DOI 10.1098/rspb.1990.0078; Van Dongen S, 2007, EVOLUTION, V61, P1033, DOI 10.1111/j.1558-5646.2007.00096.x; VANVALEN L, 1962, EVOLUTION, V16, P125; Whitlock M, 1996, P ROY SOC B-BIOL SCI, V263, P849, DOI 10.1098/rspb.1996.0125	57	21	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39843	10.1371/journal.pone.0039843	http://dx.doi.org/10.1371/journal.pone.0039843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792190	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800021
J	Xu, BZ; Obata, Y; Cao, F; Taketo, T				Xu, Baozeng; Obata, Yayoi; Cao, Feng; Taketo, Teruko			The Presence of the Y-Chromosome, Not the Absence of the Second X-Chromosome, Alters the mRNA Levels Stored in the Fully Grown XY Mouse Oocyte	PLOS ONE			English	Article							OVARIAN FOLLICULAR DEVELOPMENT; RENIN-ANGIOTENSIN SYSTEM; GENE-EXPRESSION; EMBRYONIC-DEVELOPMENT; LINKED INHIBITOR; GERM-CELLS; SEX; TRANSLATION; FERTILIZATION; PROTEIN	The oocytes of B6.Y-TIR sex-reversed female mouse mature in culture but fail to develop after fertilization because of their cytoplasmic defects. To identify the defective components, we compared the gene expression profiles between the fully-grown oocytes of B6.Y-TIR (XY) females and those of their XX littermates by cDNA microarray. 173 genes were found to be higher and 485 genes were lower in XY oocytes than in XX oocytes by at least 2-fold. We compared the transcript levels of selected genes by RT-PCR in XY and XX oocytes, as well as in XO oocytes missing paternal X-chromosomes. All genes tested showed comparable transcript levels between XX and XO oocytes, indicating that mRNA accumulation is well adjusted in XO oocytes. By contrast, in addition to Y-encoded genes, many genes showed significantly different transcript levels in XY oocytes. We speculate that the presence of the Y-chromosome, rather than the absence of the second X-chromosome, caused dramatic changes in the gene expression profile in the XY fully-grown oocyte.	[Xu, Baozeng; Taketo, Teruko] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Xu, Baozeng; Taketo, Teruko] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Obata, Yayoi; Cao, Feng] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan	McGill University; McGill University; Tokyo University of Agriculture	Xu, BZ (corresponding author), McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada.	teruko.taketo@mcgill.ca		Taketo, Teruko/0000-0002-7077-3768	Canadian Institutes of Health Research fund [MOP 86567]	Canadian Institutes of Health Research fund(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research fund granted to TT (MOP 86567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; Alton M, 2008, REPRODUCTION, V135, P241, DOI 10.1530/REP-07-0383; Amleh A, 1996, DEV BIOL, V178, P263, DOI 10.1006/dbio.1996.0217; Amleh A, 2000, DEV BIOL, V219, P277, DOI 10.1006/dbio.1999.9600; Baarends WM, 1999, MOL CELL ENDOCRINOL, V151, P5, DOI 10.1016/S0303-7207(99)00060-X; Baumann C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001137; Bebington C, 2001, HUM REPROD UPDATE, V7, P102, DOI 10.1093/humupd/7.1.102; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; De La Fuente R, 2004, DEV BIOL, V272, P1, DOI 10.1016/j.ydbio.2003.12.012; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Ditton HJ, 2004, HUM MOL GENET, V13, P2333, DOI 10.1093/hmg/ddh240; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; KAPLAN G, 1982, J EXP ZOOL, V220, P361, DOI 10.1002/jez.1402200311; Kawamura K, 2003, DEV BIOL, V256, P331, DOI 10.1016/S0012-1606(02)00135-5; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KELLER SA, 1990, GENE DEV, V4, P1316, DOI 10.1101/gad.4.8.1316; Kim J, 2009, ENDOCRINOLOGY, V150, P3392, DOI 10.1210/en.2008-0948; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; LANE PW, 1990, J HERED, V81, P43, DOI 10.1093/oxfordjournals.jhered.a110923; Lee CH, 2001, GENESIS, V30, P7, DOI 10.1002/gene.1026; Lee J, 2004, MOL HUM REPROD, V10, P259, DOI 10.1093/molehr/gah037; Lee SH, 2010, FOOD CHEM TOXICOL, V48, P2633, DOI 10.1016/j.fct.2010.06.032; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; LIGHTMAN A, 1987, AM J OBSTET GYNECOL, V156, P808, DOI 10.1016/0002-9378(87)90336-X; Malapeira J, 2011, ONCOGENE, V30, P1912, DOI 10.1038/onc.2010.565; MANGIA F, 1975, DEV BIOL, V45, P211, DOI 10.1016/0012-1606(75)90061-5; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Morita Y, 2000, ANN NY ACAD SCI, V905, P209; NAGAMINE CM, 1990, GENE DEV, V4, P63, DOI 10.1101/gad.4.1.63; NAGAMINE CM, 1987, DIFFERENTIATION, V33, P223, DOI 10.1111/j.1432-0436.1987.tb01561.x; NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; Obata Y, 2008, P NATL ACAD SCI USA, V105, P13918, DOI 10.1073/pnas.0802680105; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Oh B, 2000, DEVELOPMENT, V127, P3795; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Pittois K, 1999, MAMM GENOME, V10, P54, DOI 10.1007/s003359900942; PLACHOT M, 1988, HUM REPROD, V3, P125, DOI 10.1093/oxfordjournals.humrep.a136644; Potireddy S, 2006, DEV BIOL, V298, P155, DOI 10.1016/j.ydbio.2006.06.024; ROLLER RJ, 1989, DEVELOPMENT, V106, P251; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Stutz A, 1998, GENE DEV, V12, P2535, DOI 10.1101/gad.12.16.2535; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; TAKETOHOSOTANI T, 1989, DEVELOPMENT, V107, P95; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Turner JMA, 2000, CHROMOSOMA, V109, P426, DOI 10.1007/s004120000097; Vanderhyden BC, 1997, BIOL REPROD, V57, P641, DOI 10.1095/biolreprod57.3.641; Villemure M, 2007, DEV BIOL, V301, P1, DOI 10.1016/j.ydbio.2006.10.034; Wang YF, 2002, ENDOCRINOLOGY, V143, P2732, DOI 10.1210/en.143.7.2732; Wong J, 2000, BIOL REPROD, V63, P756, DOI 10.1095/biolreprod63.3.756; Xiao CW, 2001, ENDOCRINOLOGY, V142, P557, DOI 10.1210/en.142.2.557; YOSHIMURA Y, 1994, J CLIN INVEST, V93, P180, DOI 10.1172/JCI116943; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218; ZWINGMAN T, 1993, P NATL ACAD SCI USA, V90, P814, DOI 10.1073/pnas.90.3.814	67	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40481	10.1371/journal.pone.0040481	http://dx.doi.org/10.1371/journal.pone.0040481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792347	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800094
J	Chiu, JKH; Chen, YPP				Chiu, Jimmy Ka Ho; Chen, Yi-Ping Phoebe			Conformational Features of Topologically Classified RNA Secondary Structures	PLOS ONE			English	Article							INCLUDING PSEUDOKNOTS; NONCODING RNAS; STRUCTURE PREDICTION; PARTITION-FUNCTION; RIBOSOMAL-RNA; ALGORITHM; THERMODYNAMICS; PROBABILITIES; INFORMATION	Background: Current RNA secondary structure prediction approaches predict prevalent pseudoknots such as the H-pseudoknot and kissing hairpin. The number of possible structures increases drastically when more complex pseudoknots are considered, thus leading to computational limitations. On the other hand, the enormous population of possible structures means not all of them appear in real RNA molecules. Therefore, it is of interest to understand how many of them really exist and the reasons for their preferred existence over the others, as any new findings revealed by this study might enhance the capability of future structure prediction algorithms for more accurate prediction of complex pseudoknots. Methodology/Principal Findings: A novel algorithm was devised to estimate the exact number of structural possibilities for a pseudoknot constructed with a specified number of base pair stems. Then, topological classification was applied to classify RNA pseudoknotted structures from data in the RNA STRAND database. By showing the vast possibilities and the real population, it is clear that most of these plausible complex pseudoknots are not observed. Moreover, from these classified motifs that exist in nature, some features were identified for further investigation. It was found that some features are related to helical stacking. Other features are still left open to discover underlying tertiary interactions. Conclusions: Results from topological classification suggest that complex pseudoknots are usually some well-known motifs that are themselves complex or the interaction results of some special motifs. Heuristics can be proposed to predict the essential parts of these complex motifs, even if the required thermodynamic parameters are currently unknown.	[Chiu, Jimmy Ka Ho; Chen, Yi-Ping Phoebe] La Trobe Univ, Dept Comp Sci & Comp Engn, Melbourne, Vic, Australia	La Trobe University	Chiu, JKH (corresponding author), La Trobe Univ, Dept Comp Sci & Comp Engn, Melbourne, Vic, Australia.	phoebe.chen@latrobe.edu.au	Chen, Yi-Ping Phoebe/B-8844-2008	Chen, Yi-Ping Phoebe/0000-0002-4122-3767				Akutsu T, 2000, DISCRETE APPL MATH, V104, P45, DOI 10.1016/S0166-218X(00)00186-4; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Andersen ES, 2006, NUCLEIC ACIDS RES, V34, pD163, DOI 10.1093/nar/gkj142; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bon M, 2008, J MOL BIOL, V379, P900, DOI 10.1016/j.jmb.2008.04.033; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Chen QF, 2011, IEEE T BIO-MED ENG, V58, P1528, DOI 10.1109/TBME.2010.2090043; Chen QF, 2009, IEEE T KNOWL DATA EN, V21, P974, DOI 10.1109/TKDE.2008.231; Chen WYC, 2007, T AM MATH SOC, V359, P1555; Chen WYC, 2009, P NATL ACAD SCI USA, V106, P22061, DOI 10.1073/pnas.0907269106; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Dirks RM, 2004, J COMPUT CHEM, V25, P1295, DOI 10.1002/jcc.20057; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Jiang MH, 2010, J COMPUT BIOL, V17, P915, DOI 10.1089/cmb.2009.0119; Lee KS, 1997, J MOL BIOL, V269, P732, DOI 10.1006/jmbi.1997.1092; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Reidys CM, 2011, BIOINFORMATICS, V27, P1076, DOI 10.1093/bioinformatics/btr090; Reiter NJ, 2011, CURR OPIN STRUC BIOL, V21, P319, DOI 10.1016/j.sbi.2011.03.003; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Rodland EA, 2006, J COMPUT BIOL, V13, P1197, DOI 10.1089/cmb.2006.13.1197; Sperschneider J, 2011, RNA, V17, P27, DOI 10.1261/rna.2394511; Steinberg SV, 2007, RNA, V13, P1036, DOI 10.1261/rna.495207; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Theis C, 2010, LECT N BIOINFORMAT, V6293, P52, DOI 10.1007/978-3-642-15294-8_5; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; van Batenburg FHD, 2001, NUCLEIC ACIDS RES, V29, P194, DOI 10.1093/nar/29.1.194; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	37	8	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39907	10.1371/journal.pone.0039907	http://dx.doi.org/10.1371/journal.pone.0039907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792195	Green Published, gold			2022-12-27	WOS:000306436300013
J	Gervan, P; Gombos, F; Kovacs, I				Gervan, Patricia; Gombos, Ferenc; Kovacs, Ilona			Perceptual Learning in Williams Syndrome: Looking Beyond Averages	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; OBSTRUCTIVE SLEEP-APNEA; DOWN-SYNDROME; HPC-1/SYNTAXIN 1A; VISUAL-CORTEX; RETT-SYNDROME; CHILDREN; NEUROANATOMY; ABNORMALITIES; INTEGRATION	Williams Syndrome is a genetically determined neurodevelopmental disorder characterized by an uneven cognitive profile and surprisingly large neurobehavioral differences among individuals. Previous studies have already shown different forms of memory deficiencies and learning difficulties in WS. Here we studied the capacity of WS subjects to improve their performance in a basic visual task. We employed a contour integration paradigm that addresses occipital visual function, and analyzed the initial (i.e. baseline) and after-learning performance of WS individuals. Instead of pooling the very inhomogeneous results of WS subjects together, we evaluated individual performance by expressing it in terms of the deviation from the average performance of the group of typically developing subjects of similar age. This approach helped us to reveal information about the possible origins of poor performance of WS subjects in contour integration. Although the majority of WS individuals showed both reduced baseline and reduced learning performance, individual analysis also revealed a dissociation between baseline and learning capacity in several WS subjects. In spite of impaired initial contour integration performance, some WS individuals presented learning capacity comparable to learning in the typically developing population, and vice versa, poor learning was also observed in subjects with high initial performance levels. These data indicate a dissociation between factors determining initial performance and perceptual learning.	[Gervan, Patricia; Gombos, Ferenc; Kovacs, Ilona] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary	Budapest University of Technology & Economics	Gervan, P (corresponding author), Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary.	pgervan@cogsci.bme.hu	Kovacs, Ilona/A-2372-2009	Kovacs, Ilona/0000-0002-1772-2697; Gervan, Patricia/0000-0001-5603-1912	OTKA (Hungarian Scientific Research Fund) [NF60806, TAMOP-4.2.2.B-10/1'2010-0009]	OTKA (Hungarian Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by OTKA (Hungarian Scientific Research Fund) NF60806 and TAMOP-4.2.2.B-10/1'2010-0009 (Social Renewal Operational Programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2002, J NEUROSCI, V22, P8633; Arens R, 1998, J PEDIATR-US, V133, P670, DOI 10.1016/S0022-3476(98)70110-6; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Ashkenas J, 1996, AM J HUM GENET, V59, P756; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bellugi U., 1988, LANGUAGE DEV EXCEPTI, P177; Bodizs R, 2012, RES DEV DISABIL, V33, P153, DOI 10.1016/j.ridd.2011.09.004; Botta A, 1999, J MED GENET, V36, P478; Botta A, 1999, GENOMICS, V62, P525, DOI 10.1006/geno.1999.5987; BURKHALTER A, 1993, CEREB CORTEX, V3, P476, DOI 10.1093/cercor/3.5.476; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Carter JC, 2008, AM J NEURORADIOL, V29, P436, DOI 10.3174/ajnr.A0857; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Chisum HJ, 2004, NEURAL NETWORKS, V17, P681, DOI 10.1016/j.neunet.2004.05.002; de Miguel-Diaz J, 2003, SLEEP, V26, P1006, DOI 10.1093/sleep/26.8.1006; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Didden R, 2001, RES DEV DISABIL, V22, P255, DOI 10.1016/S0891-4222(01)00071-3; Dyken ME, 2003, ARCH PEDIAT ADOL MED, V157, P655, DOI 10.1001/archpedi.157.7.655; Epstein CJ., 2001, METABOLIC MOL BASES, V8th ed, P1223; Ewen Joshua B, 2005, Semin Pediatr Neurol, V12, P229, DOI 10.1016/j.spen.2005.12.005; Facon B, 2011, RES DEV DISABIL, V32, P2134, DOI 10.1016/j.ridd.2011.07.029; Galaburda AM, 2000, J COGNITIVE NEUROSCI, V12, P74, DOI 10.1162/089892900561995; Galaburda AM, 2002, ARCH NEUROL-CHICAGO, V59, P1461, DOI 10.1001/archneur.59.9.1461; Gao MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010292; Gervan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025572; Gervan P, 2010, J VISION, V10, DOI 10.1167/10.6.24; Gombos F, 2011, J INTELL DISABIL RES, V55, P255, DOI 10.1111/j.1365-2788.2010.01354.x; Harvey MT, 2002, INT J DEV NEUROSCI, V20, P443, DOI 10.1016/S0736-5748(02)00008-4; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jarrold C, 2007, CORTEX, V43, P233, DOI 10.1016/S0010-9452(08)70478-7; JORGENSEN OS, 1990, J NEUROL SCI, V98, P63; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kovacs I, 1996, BEHAV BRAIN RES, V82, P1, DOI 10.1016/S0166-4328(97)81103-5; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Kozma P, 2002, 2 ANN M VIS SCI SOC; Kozma-Wiebe P, 2006, COMPUT HUM BEHAV, V22, P971, DOI 10.1016/j.chb.2004.03.017; Kronk R, 2010, SLEEP, V33, P679, DOI 10.1093/sleep/33.5.679; Mandolesi L, 2009, INT J DEV NEUROSCI, V27, P205, DOI 10.1016/j.ijdevneu.2009.01.004; MARCUS CL, 1991, PEDIATRICS, V88, P132; McKendrick AM, 2010, J VISION, V10, DOI 10.1167/10.2.1; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Nakayama T, 1998, CYTOGENET CELL GENET, V82, P49, DOI 10.1159/000015063; Pennington BF, 2001, DEV COGN NEUROSCI, P149; RAZ N, 1995, NEUROLOGY, V45, P356, DOI 10.1212/WNL.45.2.356; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; REISS AL, 1994, NEUROLOGY, V44, P1317, DOI 10.1212/WNL.44.7.1317; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; Roudaia E, 2008, VISION RES, V48, P2767, DOI 10.1016/j.visres.2008.07.026; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; SPITZ HH, 1982, MERRILL PALMER QUART, V28, P167; TAKASHIMA S, 1981, BRAIN RES, V225, P1, DOI 10.1016/0006-8993(81)90314-0; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; Temudo T, 2009, BRAIN DEV-JPN, V31, P46, DOI 10.1016/j.braindev.2008.05.003; Thompson PM, 2005, J NEUROSCI, V25, P4146, DOI 10.1523/JNEUROSCI.0165-05.2005; Vicari S, 1996, CORTEX, V32, P503, DOI 10.1016/S0010-9452(96)80007-4; Vicari S, 2003, DEV MED CHILD NEUROL, V45, P269, DOI 10.1017/S0012162203000513; WANG PP, 1994, J CLIN EXP NEUROPSYC, V16, P317, DOI 10.1080/01688639408402641; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; WEIS S, 1991, AM J NEURORADIOL, V12, P1207; Young D, 2007, BRAIN DEV-JPN, V29, P609, DOI 10.1016/j.braindev.2007.04.001	66	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40282	10.1371/journal.pone.0040282	http://dx.doi.org/10.1371/journal.pone.0040282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974LI	22792262	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300045
J	Griffin, MDW; Billakanti, JM; Wason, A; Keller, S; Mertens, HDT; Atkinson, SC; Dobson, RCJ; Perugini, MA; Gerrard, JA; Pearce, FG				Griffin, Michael D. W.; Billakanti, Jagan M.; Wason, Akshita; Keller, Sabrina; Mertens, Haydyn D. T.; Atkinson, Sarah C.; Dobson, Renwick C. J.; Perugini, Matthew A.; Gerrard, Juliet A.; Pearce, Frederick Grant			Characterisation of the First Enzymes Committed to Lysine Biosynthesis in Arabidopsis thaliana	PLOS ONE			English	Article							DIHYDRODIPICOLINATE SYNTHASE; ESCHERICHIA-COLI; BIOLOGICAL MACROMOLECULES; 3-DIMENSIONAL STRUCTURE; PARTIAL-PURIFICATION; QUATERNARY STRUCTURE; SOLUTION SCATTERING; AMINO-ACIDS; REDUCTASE; RESOLUTION	In plants, the lysine biosynthetic pathway is an attractive target for both the development of herbicides and increasing the nutritional value of crops given that lysine is a limiting amino acid in cereals. Dihydrodipicolinate synthase (DHDPS) and dihydrodipicolinate reductase (DHDPR) catalyse the first two committed steps of lysine biosynthesis. Here, we carry out for the first time a comprehensive characterisation of the structure and activity of both DHDPS and DHDPR from Arabidopsis thaliana. The A. thaliana DHDPS enzyme (At-DHDPS2) has similar activity to the bacterial form of the enzyme, but is more strongly allosterically inhibited by (S)-lysine. Structural studies of At-DHDPS2 show (S)-lysine bound at a cleft between two monomers, highlighting the allosteric site; however, unlike previous studies, binding is not accompanied by conformational changes, suggesting that binding may cause changes in protein dynamics rather than large conformation changes. DHDPR from A. thaliana (At-DHDPR2) has similar specificity for both NADH and NADPH during catalysis, and has tighter binding of substrate than has previously been reported. While all known bacterial DHDPR enzymes have a tetrameric structure, analytical ultracentrifugation, and scattering data unequivocally show that At-DHDPR2 exists as a dimer in solution. The exact arrangement of the dimeric protein is as yet unknown, but ab initio modelling of x-ray scattering data is consistent with an elongated structure in solution, which does not correspond to any of the possible dimeric pairings observed in the X-ray crystal structure of DHDPR from other organisms. This increased knowledge of the structure and function of plant lysine biosynthetic enzymes will aid future work aimed at improving primary production.	[Griffin, Michael D. W.; Atkinson, Sarah C.; Dobson, Renwick C. J.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Billakanti, Jagan M.; Wason, Akshita; Keller, Sabrina; Dobson, Renwick C. J.; Gerrard, Juliet A.; Pearce, Frederick Grant] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Billakanti, Jagan M.; Wason, Akshita; Keller, Sabrina; Dobson, Renwick C. J.; Gerrard, Juliet A.; Pearce, Frederick Grant] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Billakanti, Jagan M.; Gerrard, Juliet A.] Ind Res Ltd, Lower Hutt, New Zealand; [Mertens, Haydyn D. T.] Australian Synchrotron, Melbourne, Vic, Australia; [Atkinson, Sarah C.; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia	University of Melbourne; University of Canterbury; University of Canterbury; Callaghan Innovation; La Trobe University	Griffin, MDW (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia.	grant.pearce@canterbury.ac.nz	Dobson, Renwick/AAZ-7020-2021	Dobson, Renwick/0000-0002-5506-4939; Atkinson, Sarah/0000-0002-3518-9785; BILLAKANTI, JAGANMOHAN/0000-0002-8763-8036; Griffin, Michael/0000-0001-9845-7735; Pearce, Frederick/0000-0002-2683-0331; Mertens, Haydyn/0000-0002-5664-744X	Defense Threat Reduction Agency [W911NF-07-1-0073, AB07CBT004]; Foundation of Research, Science and Technology; New Zealand Synchrotron Group	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Foundation of Research, Science and Technology; New Zealand Synchrotron Group	This work was supported in part by the Defense Threat Reduction Agency (W911NF-07-1-0073 and AB07CBT004) and in part by the Foundation of Research, Science and Technology. Travel to the Australian Synchrotron was funded by the New Zealand Synchrotron Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SC, 2012, PLOS ONE UNPUB; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blickling S, 1997, J MOL BIOL, V274, P608, DOI 10.1006/jmbi.1997.1393; Blickling S, 1997, BIOL CHEM, V378, P207; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Cirilli M, 2003, BIOCHEMISTRY-US, V42, P10644, DOI 10.1021/bi030044v; Craciun A, 2000, FEBS LETT, V487, P234, DOI 10.1016/S0014-5793(00)02303-6; DEREPPE C, 1992, PLANT PHYSIOL, V98, P813, DOI 10.1104/pp.98.3.813; Devenish SRA, 2010, J MED CHEM, V53, P4808, DOI 10.1021/jm100349s; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, BIOCHEM J, V377, P757, DOI 10.1042/bj20031389; Dobson RCJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020439; Dommaraju S, 2010, ACTA CRYSTALLOGR F, V66, P57, DOI 10.1107/S1744309109047964; Dommaraju SR, 2011, ARCH BIOCHEM BIOPHYS, V512, P167, DOI 10.1016/j.abb.2011.06.006; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRISCH DA, 1991, PLANT PHYSIOL, V96, P444, DOI 10.1104/pp.96.2.444; Frizzi A, 2008, PLANT BIOTECHNOL J, V6, P13, DOI 10.1111/j.1467-7652.2007.00290.x; Galili G, 2002, ANNU REV PLANT BIOL, V53, P27, DOI 10.1146/annurev.arplant.53.091401.110929; GHISLAIN M, 1990, PLANTA, V180, P480, DOI 10.1007/BF02411444; Girish TS, 2011, FEBS LETT, V585, P2561, DOI 10.1016/j.febslet.2011.07.021; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Griffin MDW, 2011, ACTA CRYSTALLOGR F, V67, P1386, DOI 10.1107/S1744309111033276; Griffin MDW, 2010, ARCH BIOCHEM BIOPHYS, V494, P58, DOI 10.1016/j.abb.2009.11.014; Hudson AO, 2005, BBA-GEN SUBJECTS, V1721, P27, DOI 10.1016/j.bbagen.2004.09.008; Jander G, 2010, MOL PLANT, V3, P54, DOI 10.1093/mp/ssp104; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaur N, 2011, INT J BIOL MACROMOL, V48, P779, DOI 10.1016/j.ijbiomac.2011.03.002; Kiefer F, 2009, NUCL ACIDS RES, V37; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMPAISAL R, 1989, AGR BIOL CHEM TOKYO, V53, P355, DOI 10.1080/00021369.1989.10869297; KUMPAISAL R, 1987, PLANT PHYSIOL, V85, P145, DOI 10.1104/pp.85.1.145; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MATTHEWS BF, 1978, PLANTA, V141, P315, DOI 10.1007/BF00388350; Pearce FG, 2008, BIOCHEMISTRY-US, V47, P12108, DOI 10.1021/bi801094t; Pearce FG, 2008, J BIOCHEM, V143, P617, DOI 10.1093/jb/mvn012; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Pearce FG, 2011, BIOCH BIOPHYS ACTA; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Reddy S, 1996, BIOCHEMISTRY-US, V35, P13924; REDDY SG, 1995, BIOCHEMISTRY-US, V34, P3492, DOI 10.1021/bi00011a002; Rice EA, 2008, ARCH BIOCHEM BIOPHYS, V480, P111, DOI 10.1016/j.abb.2008.09.018; Roberts SJ, 2003, BIOORG MED CHEM LETT, V13, P265, DOI 10.1016/S0960-894X(02)00923-X; Sarrobert C, 2000, PLANT J, V24, P357, DOI 10.1046/j.1365-313x.2000.00884.x; SCAPIN G, 1995, BIOCHEMISTRY-US, V34, P3502, DOI 10.1021/bi00011a003; Scapin G, 1997, BIOCHEMISTRY-US, V36, P15081, DOI 10.1021/bi9719915; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Shimizu H, 2007, PLANT J, V52, P539, DOI 10.1111/j.1365-313X.2007.03256.x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TYAGI VVS, 1983, PLANT PHYSIOL, V73, P687, DOI 10.1104/pp.73.3.687; Ufaz S, 2008, PLANT PHYSIOL, V147, P954, DOI 10.1104/pp.108.118091; Vauterin M, 1999, PLANT MOL BIOL, V39, P695, DOI 10.1023/A:1006132428623; WALLSGROVE RM, 1981, PHYTOCHEMISTRY, V20, P2651, DOI 10.1016/0031-9422(81)85261-2	62	37	38	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40318	10.1371/journal.pone.0040318	http://dx.doi.org/10.1371/journal.pone.0040318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792278	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300053
J	Krueger, C; King, MR; Krueger, F; Branco, MR; Osborne, CS; Niakan, KK; Higgins, MJ; Reik, W				Krueger, Christel; King, Michelle R.; Krueger, Felix; Branco, Miguel R.; Osborne, Cameron S.; Niakan, Kathy K.; Higgins, Michael J.; Reik, Wolf			Pairing of Homologous Regions in the Mouse Genome Is Associated with Transcription but Not Imprinting Status	PLOS ONE			English	Article							REPRESSIVE HISTONE METHYLATION; ORDER CHROMATIN ARRANGEMENTS; STRAND BREAK REPAIR; HEAVY-CHAIN LOCUS; GENE-EXPRESSION; 3D STRUCTURE; RECOMBINATION; MAINTENANCE; DOMAIN; TRANS	Although somatic homologous pairing is common in Drosophila it is not generally observed in mammalian cells. However, a number of regions have recently been shown to come into close proximity with their homologous allele, and it has been proposed that pairing might be involved in the establishment or maintenance of monoallelic expression. Here, we investigate the pairing properties of various imprinted and non-imprinted regions in mouse tissues and ES cells. We find by allele-specific 4C-Seq and DNA FISH that the Kcnq1 imprinted region displays frequent pairing but that this is not dependent on monoallelic expression. We demonstrate that pairing involves larger chromosomal regions and that the two chromosome territories come close together. Frequent pairing is not associated with imprinted status or DNA repair, but is influenced by chromosomal location and transcription. We propose that homologous pairing is not exclusive to specialised regions or specific functional events, and speculate that it provides the cell with the opportunity of trans-allelic effects on gene regulation.	[Krueger, Christel; King, Michelle R.; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge, England; [Krueger, Felix] Babraham Inst, Bioinformat Grp, Cambridge, England; [Branco, Miguel R.] Imperial Coll Sch Med, Genome Funct Grp, MRC, Ctr Clin Sci, London, England; [Osborne, Cameron S.] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Niakan, Kathy K.; Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Niakan, Kathy K.] Univ Cambridge, Dept Physiol Dev & Neurosci, Anne McLaren Lab Regenerat Med, Cambridge, England; [Higgins, Michael J.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Cambridge; Roswell Park Cancer Institute	Krueger, C (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	christel.krueger@babraham.ac.uk; wolf.reik@bbsrc.ac.uk	Osborne, Cameron/N-1398-2017; Branco, Miguel/H-9509-2019; Reik, Wolf/I-6794-2012; Krueger, Felix/J-3340-2019	Osborne, Cameron/0000-0003-4126-2499; Branco, Miguel/0000-0001-9447-1548; Krueger, Felix/0000-0002-5513-3324; Reik, Wolf/0000-0003-0216-9881; Krueger, Christel/0000-0001-5601-598X; Niakan, Kathy/0000-0003-1646-4734	BBSRC [BB/H088071/1]; MRC [G0700760]; Wellcome Trust [095645/Z/11/Z]; EU through EpiGeneSys; EU through Blueprint; DFG [KR 3317/2-1]; CTR; NCI/NIH [2RO1 CA089426]; BBSRC [BB/H008071/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S119, BBS/E/B/0000C214, BB/H008071/1] Funding Source: researchfish; Medical Research Council [G0700760] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA089426] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EU through EpiGeneSys; EU through Blueprint; DFG(German Research Foundation (DFG)); CTR; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the BBSRC, grant BB/H088071/1 (www.bbsrc.ac.uk), MRC, grant G0700760 (www.mrc.ac.uk), Wellcome Trust, grant 095645/Z/11/Z (www.wellcome.ac.uk) and the EU through EpiGeneSys (www.epigenesys.eu) and Blueprint (www.blueprint-epigenome.eu). C. K. was funded by the DFG, personal fellowship KR 3317/2-1 (www.dfg.de) and CTR, personal short term fellowship (www.trophoblast.cam.ac.uk). M.J.H. received funding through grant NCI/NIH 2RO1 CA089426 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Anguera MC, 2006, COLD SPRING HARB SYM, V71, P429, DOI 10.1101/sqb.2006.71.012; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Brideau CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013784; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cope NF, 2009, COLD SPRING HARB PRO; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Duvillie B, 1998, GENOMICS, V47, P52, DOI 10.1006/geno.1997.5070; Fitzpatrick GV, 2007, MOL CELL BIOL, V27, P2636, DOI 10.1128/MCB.02036-06; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Heride C, 2010, J CELL SCI, V123, P4063, DOI 10.1242/jcs.066498; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hu JF, 1997, J BIOL CHEM, V272, P20715, DOI 10.1074/jbc.272.33.20715; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Koeman JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000176; Kozubek S, 2002, CHROMOSOMA, V111, P321, DOI 10.1007/s00412-002-0210-8; Landers M, 2005, NUCLEIC ACIDS RES, V33, P3976, DOI 10.1093/nar/gki705; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meguro-Horike M, 2011, HUM MOL GENET, V20, P3798, DOI 10.1093/hmg/ddr298; Moynahan ME, 1997, P NATL ACAD SCI USA, V94, P8988, DOI 10.1073/pnas.94.17.8988; Nagele RG, 2001, J CELL SCI, V114, P377; Nagy A., 2003, MANIPULATING MOUSE E; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Peltomaki P, 2012, EXP CELL RES, V318, P299, DOI 10.1016/j.yexcr.2011.12.001; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Stout K, 1999, CHROMOSOME RES, V7, P323, DOI 10.1023/A:1009287111661; Teller K, 2007, P NATL ACAD SCI USA, V104, P14970, DOI 10.1073/pnas.0704285104; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Thatcher KN, 2005, HUM MOL GENET, V14, P785, DOI 10.1093/hmg/ddi073; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Xu M, 2008, BBA-MOL CELL RES, V1783, P2155, DOI 10.1016/j.bbamcr.2008.07.013; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	53	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38983	10.1371/journal.pone.0038983	http://dx.doi.org/10.1371/journal.pone.0038983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802932	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900006
J	Yan, Z; Xiong, YM; Xu, WT; Gao, J; Cheng, Y; Wang, ZG; Chen, F; Zheng, GR				Yan, Zhi; Xiong, Yimin; Xu, Weitian; Gao, Juan; Cheng, Yi; Wang, Zhigang; Chen, Fang; Zheng, Guorong			Identification of hsa-miR-335 as a Prognostic Signature in Gastric Cancer	PLOS ONE			English	Article							CURATIVE RESECTION; EXPRESSION; RECURRENCE; MICRORNAS; SURGERY; METASTASIS; MICROARRAY; PREDICTION; PATTERNS; GENES	Background: Gastric cancer (GC) is one of the most common malignancy and primary cause of death in Chinese cancer patients. Recurrence is a major factor leading to treatment failure and low level of 5-year survival rate in GC patients following surgical resection. Therefore, identification of biomarkers with potential in predicting recurrence risk is the key problem of the prognosis in GC patients. Patients and Methods: A total of 74 GC patients were selected for systematic analysis, consisting of 31 patients with recurrence and 43 patients without recurrence. Firstly, miRNAs microarray and bioinformatics methods were used to characterize differential expressed miRNAs from primary tumor samples. Following, we used a ROC method to select signature with best sensitivity and specificity. Finally, we validated the signature in GC samples (frozen fresh and blood samples) using quantitative PCR. Results: We have identified 12 differential miRNAs including 7 up-regulated and 5 down-regulated miRNAs in recurrence group. Using ROC method, we further ascertained hsa-miR-335 as a signature to recognize recurrence and non-recurrence cases in the training samples. Moreover, we validated this signature using quantitative PCR method in 64 test samples with consistent result with training set. A high frequency recurrence and poor survival were observed in GC cases with high level of hsa-miR-335 (P<0.001). In addition, we evaluated that hsa-miR-335 were involved in regulating target genes in several oncogenic signal-pathways, such as p53, MAPK, TGF-beta, Wnt, ERbB, mTOR, Toll-like receptor and focal adhesion. Conclusion: Our results indicate that the hsa-miR-335 has the potential to recognize the recurrence risk and relate to the prognosis of GC patients.	[Yan, Zhi; Xiong, Yimin; Xu, Weitian; Gao, Juan; Cheng, Yi; Zheng, Guorong] Wuhan Gen Hosp Guangzhou Command, Dept Digest Dis, Wuhan, Hubei, Peoples R China; [Wang, Zhigang] Wuhan Gen Hosp Guangzhou Command, Dept Oncol, Wuhan, Hubei, Peoples R China; [Chen, Fang] Wuhan Gen Hosp Guangzhou Command, Dept Lab Med, Wuhan, Hubei, Peoples R China		Yan, Z (corresponding author), Wuhan Gen Hosp Guangzhou Command, Dept Digest Dis, Wuhan, Hubei, Peoples R China.	guorongzheng@sina.com						Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Inoue H, 2002, CLIN CANCER RES, V8, P3475; Lehnert T, 2002, EUR J SURG ONCOL, V28, P455, DOI 10.1053/ejso.2002.1260; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Liang RQ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Marrelli D, 2005, ANN SURG, V241, P247, DOI 10.1097/01.sla.0000152019.14741.97; Motoori M, 2005, INT J CANCER, V114, P963, DOI 10.1002/ijc.20808; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Pan JJ, 2009, J CLIN ONCOL, V27, P799, DOI 10.1200/JCO.2008.18.9670; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Roukos DH, 2001, ANN SURG ONCOL, V8, P620, DOI 10.1007/s10434-001-0620-5; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Shu MF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-59; Sim SH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-73; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340	33	78	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40037	10.1371/journal.pone.0040037	http://dx.doi.org/10.1371/journal.pone.0040037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802949	Green Published, gold, Green Submitted			2022-12-27	WOS:000306186900023
J	Shi, F; Wang, YC; Zhao, TZ; Zhang, S; Du, TY; Yang, CB; Li, YH; Sun, XQ				Shi, Fei; Wang, Yong-Chun; Zhao, Tian-Zhi; Zhang, Shu; Du, Ting-Yuan; Yang, Chang-Bin; Li, Ying-Hui; Sun, Xi-Qing			Effects of Simulated Microgravity on Human Umbilical Vein Endothelial Cell Angiogenesis and Role of the PI3K-Akt-eNOS Signal Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE AKT; GROWTH-FACTOR; STIMULATES ANGIOGENESIS; ACTIVATION; MIGRATION; CAVEOLIN; PHOSPHORYLATION; CLINOROTATION; CONSTITUENTS	Endothelial cells are very sensitive to microgravity and the morphological and functional changes in endothelial cells are believed to be at the basis of weightlessness-induced cardiovascular deconditioning. It has been shown that the proliferation, migration, and morphological differentiation of endothelial cells play critical roles in angiogenesis. However, the influence of microgravity on the ability of endothelial cells to foster angiogenesis remains to be explored in detail. In the present study, we used a clinostat to simulate microgravity, and we observed tube formation, migration, and expression of endothelial nitric oxide synthase (eNOS) in human umbilical vein endothelial cells (HUVEC-C). Specific inhibitors of eNOS and phosphoinositide 3-kinase (PI3K) were added to the culture medium and gravity-induced changes in the pathways that mediate angiogenesis were investigated. After 24 h of exposure to simulated microgravity, HUVEC-C tube formation and migration were significantly promoted. This was reversed by co-incubation with the specific inhibitor of N-nitro-L-arginine methyl ester hydrochloride (eNOS). Immunofluorescence assay, RT-PCR, and Western blot analysis demonstrated that eNOS expression in the HUVEC-C was significantly elevated after simulated microgravity exhibition. Ultrastructure observation via transmission electron microscope showed the number of caveolae organelles in the membrane of HUVEC-C to be significantly reduced. This was correlated with enhanced eNOS activity. Western blot analysis then showed that phosphorylation of eNOS and serine/threonine kinase (Akt) were both up-regulated after exposure to simulated microgravity. However, the specific inhibitor of PI3K not only significantly downregulated the expression of phosphorylated Akt, but also downregulated the phosphorylation of eNOS. This suggested that the PI3K-Akt signal pathway might participate in modulating the activity of eNOS. In conclusion, the present study indicates that 24 h of exposure to simulated microgravity promote angiogenesis among HUVEC-C and that this process is mediated through the PI3K-Akt-eNOS signal pathway.	[Shi, Fei; Wang, Yong-Chun; Zhao, Tian-Zhi; Zhang, Shu; Du, Ting-Yuan; Yang, Chang-Bin; Sun, Xi-Qing] Fourth Mil Med Univ, Dept Aerosp Biodynam, Xian 710032, Shaanxi, Peoples R China; [Li, Ying-Hui] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China	Air Force Military Medical University	Shi, F (corresponding author), Fourth Mil Med Univ, Dept Aerosp Biodynam, Xian 710032, Shaanxi, Peoples R China.	yinghuidd@vip.sina.com; sunxiqing@hotmail.com		Zhang, Shu/0000-0002-4380-1268	National Natural Science Foundation of China [30900279, 81171872]; Natural Science Foundation of Shaanxi Province [2010JQ4016]; opening foundation of the State Key Laboratory of Space Medicine Fundamentals and Application, Chinese Astronaut Research and Training Center [SMFA09K02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); opening foundation of the State Key Laboratory of Space Medicine Fundamentals and Application, Chinese Astronaut Research and Training Center	This work was supported by the National Natural Science Foundation of China (No. 30900279 and No. 81171872), the Natural Science Foundation of Shaanxi Province (No. 2010JQ4016), and the opening foundation of the State Key Laboratory of Space Medicine Fundamentals and Application, Chinese Astronaut Research and Training Center (No. SMFA09K02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barjaktarovic Z, 2007, J EXP BOT, V58, P4357, DOI 10.1093/jxb/erm302; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Bernatchez P, 2011, J CLIN INVEST, V121, P3747, DOI 10.1172/JCI44778; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Cines DB, 1998, BLOOD, V91, P3527; Convertino VA, 2009, RESP PHYSIOL NEUROBI, V169, pS34, DOI 10.1016/j.resp.2009.04.010; Coupe M, 2009, RESP PHYSIOL NEUROBI, V169, pS10, DOI 10.1016/j.resp.2009.04.009; Crawford-Young SJ, 2006, INT J DEV BIOL, V50, P183, DOI 10.1387/ijdb.052077sc; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dhillon B, 2003, MOL CELL BIOCHEM, V247, P101, DOI 10.1023/A:1024198518582; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dulak J, 2002, CARDIOVASC RES, V56, P487, DOI 10.1016/S0008-6363(02)00670-3; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Goetze S, 2002, HYPERTENSION, V40, P748, DOI 10.1161/01.HYP.0000035522.63647.D3; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; Grimm D, 2009, TISSUE ENG PT A, V15, P2267, DOI 10.1089/ten.tea.2008.0576; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; Kacena MA, 2002, CYTOTECHNOLOGY, V39, P147, DOI 10.1023/A:1023936503105; Kim I, 2001, CARDIOVASC RES, V49, P872, DOI 10.1016/S0008-6363(00)00295-9; Kraft TFB, 2000, PLANTA, V211, P415, DOI 10.1007/s004250000302; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Mariotti M, 2008, J CELL BIOCHEM, V104, P129, DOI 10.1002/jcb.21605; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Miura S, 2003, ARTERIOSCL THROM VAS, V23, P802, DOI 10.1161/01.ATV.0000066134.79956.58; Miura S, 2003, HYPERTENSION, V41, P1118, DOI 10.1161/01.HYP.0000064345.33807.57; Morbidelli L, 2005, BIOCHEM BIOPH RES CO, V334, P491, DOI 10.1016/j.bbrc.2005.06.124; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72; Namkoong S, 2008, METHOD ENZYMOL, V441, P393, DOI 10.1016/S0076-6879(08)01222-6; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Siamwala JH, 2010, FEBS LETT, V584, P3415, DOI 10.1016/j.febslet.2010.06.039; Siamwala JH, 2010, PROTOPLASMA, V242, P3, DOI 10.1007/s00709-010-0114-z; Spisni E, 2003, J CELL PHYSIOL, V197, P198, DOI 10.1002/jcp.10344; Spisni E, 2006, CELL BIOCHEM BIOPHYS, V46, P155, DOI 10.1385/CBB:46:2:155; Uruno A, 2004, HYPERTENS RES, V27, P887, DOI 10.1291/hypres.27.887; Wang YC, 2009, J CELL BIOCHEM, V107, P357, DOI 10.1002/jcb.22134; Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451	49	66	77	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40365	10.1371/journal.pone.0040365	http://dx.doi.org/10.1371/journal.pone.0040365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808143	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700025
J	Williams, PT				Williams, Paul T.			Non-Exchangeability of Running vs. Other Exercise in Their Association with Adiposity, and Its Implications for Public Health Recommendations	PLOS ONE			English	Article							OF-SPORTS-MEDICINE; PHYSICAL-ACTIVITY; WEIGHT-LOSS; ENERGY-EXPENDITURE; BODY FATNESS; OBESITY; ADULTS; AGE; PREVENTION; INTENSITY	Purpose: Current physical activity recommendations assume that different activities can be exchanged to produce the same weight-control benefits so long as total energy expended remains the same (exchangeability premise). To this end, they recommend calculating energy expenditure as the product of the time spent performing each activity and the activity's metabolic equivalents (MET), which may be summed to achieve target levels. The validity of the exchangeability premise was assessed using data from the National Runners' Health Study. Methods: Physical activity dose was compared to body mass index (BMI) and body circumferences in 33,374 runners who reported usual distance run and pace, and usual times spent running and other exercises per week. MET hours per day (METhr/d) from running was computed from: a) time and intensity, and b) reported distance run (1.02 MET.hours per km). Results: When computed from time and intensity, the declines (slope +/- SE) per METhr/d were significantly greater (P<10(-15)) for running than non-running exercise for BMI (slopes +/- SE, male: -0.12 +/- 0.00 vs. 0.00 +/- 0.00; female: -0.12 +/- 0.00 vs. -0.01 +/- 0.01 kg/m(2) per METhr/d) and waist circumference (male: 20.2860.01 vs. -0.07 +/- 0.01; female: -0.31 +/- 0.01 vs. -0.05 +/- 0.01 cm per METhr/d). Reported METhr/d of running was 38% to 43% greater when calculated from time and intensity than distance. Moreover, the declines per METhr/d run were significantly greater when estimated from reported distance for BMI (males: -0.29 +/- 0.01; females: -0.27 +/- 0.01 kg/m(2) per METhr/d) and waist circumference (males: -0.67 +/- 0.02; females: -0.69 +/- 0.02 cm per METhr/d) than when computed from time and intensity (cited above). Conclusion: The exchangeability premise was not supported for running vs. non-running exercise. Moreover, distance-based running prescriptions may provide better weight control than time-based prescriptions for running or other activities. Additional longitudinal studies and randomized clinical trials are required to verify these results prospectively.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung, and Blood Institute [HL094717]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grant HL094717 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Albarracin D, 2009, OBESITY, V17, P1451, DOI 10.1038/oby.2009.16; Andrade AM, 2010, PATIENT EDUC COUNS, V79, P320, DOI 10.1016/j.pec.2010.01.006; [Anonymous], 1998, OBES RES S, V2, p51s; Baker C. W., 2000, Physical activity and obesity, P311; Broom DR, 2009, AM J PHYSIOL-REG I, V296, pR29, DOI 10.1152/ajpregu.90706.2008; Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Goran MI, 2001, PEDIATR CLIN N AM, V48, P931, DOI 10.1016/S0031-3955(05)70349-7; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Institute of Medicine, 2005, DIET REF INT EN CARB, P880; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; King NA, 2008, INT J OBESITY, V32, P177, DOI 10.1038/sj.ijo.0803712; LENNON D, 1985, INT J OBESITY, V9, P39; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Martins C, 2008, INT J OBESITY, V32, P1337, DOI 10.1038/ijo.2008.98; Martins C, 2007, BRIT J NUTR, V98, P834, DOI 10.1017/S000711450774922X; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; O'Rahilly S, 2008, DIABETES, V57, P2905, DOI 10.2337/db08-0210; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pendleton VR, 2002, INT J EAT DISORDER, V31, P172, DOI 10.1002/eat.10010; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ratcliff L, 2011, INT J SPORT NUTR EXE, V21, P11, DOI 10.1123/ijsnem.21.1.11; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; The Centers for Disease Control and Prevention (CDC), 2010, MMWR-MORBID MORTAL W, V57, P1297; TREMBLAY A, 1990, AM J CLIN NUTR, V51, P153, DOI 10.1093/ajcn/51.2.153; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2010, AM J PREV MED, V39, pE13, DOI 10.1016/j.amepre.2010.05.017; U.S. Department of Health and Human Services, 2008, ODPHP PUBL; US Department of Health and Human Services, 1999, PHYS ACT HLTH REP SU; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams PT, 2008, OBESITY, V16, P102, DOI 10.1038/oby.2007.5; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2009, OBESITY, V17, P1428, DOI 10.1038/oby.2008.680; Williams PT, 2005, OBES RES, V13, P1370, DOI 10.1038/oby.2005.166; Williams PT, 2005, MED SCI SPORT EXER, V37, P1329, DOI 10.1249/01.mss.0000174894.05236.45; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2012, MED SCI SPO IN PRESS; Yoshioka M, 2001, INT J OBESITY, V25, P332, DOI 10.1038/sj.ijo.0801554	41	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e36360	10.1371/journal.pone.0036360	http://dx.doi.org/10.1371/journal.pone.0036360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808000	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700003
J	Myers, EM				Myers, Edith M.			G alpha(o) and G alpha(q) Regulate the Expression of daf-7, a TGF beta-like Gene, in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; SYNAPTIC-TRANSMISSION; LARVAL DEVELOPMENT; G-PROTEINS; PLC-BETA; SEROTONIN; BEHAVIOR; FOOD; PHEROMONE; G(Q)ALPHA	Caenorhabditis elegans enter an alternate developmental stage called dauer in unfavorable conditions such as starvation, overcrowding, or high temperature. Several evolutionarily conserved signaling pathways control dauer formation. DAF-7/TGF beta and serotonin, important ligands in these signaling pathways, affect not only dauer formation, but also the expression of one another. The heterotrimeric G proteins GOA-1 (G alpha(o)) and EGL-30 (G alpha(q)) mediate serotonin signaling as well as serotonin biosynthesis in C. elegans. It is not known whether GOA-1 or EGL-30 also affect dauer formation and/or daf-7 expression, which are both modulated in part by serotonin. The purpose of this study is to better understand the relationship between proteins important for neuronal signaling and developmental plasticity in both C. elegans and humans. Using promoter-GFP transgenic worms, it was determined that both goa-1 and egl-30 regulate daf-7 expression during larval development. In addition, the normal daf-7 response to high temperature or starvation was altered in goa-1 and egl-30 mutants. Despite the effect of goa-1 and egl-30 mutations on daf-7 expression in various environmental conditions, there was no effect of the mutations on dauer formation. This paper provides evidence that while goa-1 and egl-30 are important for normal daf-7 expression, mutations in these genes are not sufficient to disrupt dauer formation.	Fairleigh Dickinson Univ, Dept Biol & Allied Hlth Sci, Coll Florham, Madison, NJ USA	Fairleigh Dickinson University	Myers, EM (corresponding author), Fairleigh Dickinson Univ, Dept Biol & Allied Hlth Sci, Coll Florham, Madison, NJ USA.	emyers@fdu.edu			National Institutes of Health (NIH); Becton College (Fairleigh Dickinson University)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Becton College (Fairleigh Dickinson University)	Work was supported by an National Institutes of Health (NIH) Postdoctoral NRSA to EMM (while in the Koelle lab) as well as start up funds and a Becton College Grant in Aid (Fairleigh Dickinson University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 2000, GENETICS, V156, P1047; Ailion M, 2003, GENETICS, V165, P127; ALBERT PS, 1983, J COMP NEUROL, V219, P461, DOI 10.1002/cne.902190407; Bastiani CA, 2003, GENETICS, V165, P1805; BRENNER S, 1974, GENETICS, V77, P71; Burghoorn J, 2010, J CELL SCI, V123, P2076, DOI 10.1242/jcs.062885; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Dong MQ, 2000, GENE DEV, V14, P2003; Estevez M, 2004, J NEUROCHEM, V88, P102, DOI 10.1046/j.1471-4159.2003.02140.x; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Gallo M, 2009, J CHEM ECOL, V35, P272, DOI 10.1007/s10886-009-9599-3; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hawasli AH, 2004, GENETICS, V168, P831, DOI 10.1534/genetics.104.030502; Hofler C, 2011, J NEUROSCI, V31, P11553, DOI 10.1523/JNEUROSCI.2072-11.2011; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Koga M, 1999, DEVELOPMENT, V126, P5387; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Moussaif M, 2009, J NEUROSCI, V29, P4065, DOI 10.1523/JNEUROSCI.0044-09.2009; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shyn SI, 2003, CURR BIOL, V13, P1910, DOI 10.1016/j.cub.2003.10.025; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tanis JE, 2008, GENETICS, V178, P157, DOI 10.1534/genetics.107.079780; Zwaal RR, 1997, GENETICS, V145, P715	33	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							0040368	10.1371/journal.pone.0040368	http://dx.doi.org/10.1371/journal.pone.0040368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808145	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400046
J	Fang, XY; Lang, YJ; Wang, YX; Mo, W; Wei, HH; Xie, JH; Yu, M				Fang, Xiaoyun; Lang, Yongjiang; Wang, Yuxiong; Mo, Wei; Wei, Huanhuan; Xie, Jianhui; Yu, Min			Shp2 Activates Fyn and Ras to Regulate RBL-2H3 Mast Cell Activation following Fc epsilon RI Aggregation	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; AFFINITY IGE RECEPTOR; SIGNALING PATHWAY; NOONAN SYNDROME; NEGATIVE REGULATION; KINASE; GAB2; SYK; RELEASE; PTPN11	The protein-tyrosine phosphatase (PTP) Shp2 has been implicated in many immunoreceptor signaling pathways, but its role in immunoreceptor Fc epsilon RI signaling, which leads to the activation of mast cells and blood basophils, is still largely undefined. Using Shp2 knockdown RBL-2H3 (RBL) mast cells, we here reported that Shp2 is required for the activation of RBL cells induced by Fc epsilon RI. Fc epsilon RI-evoked degranulation, calcium mobilization, and synthesis of cytokine transcripts (IL-1 beta, IL-10, and monocyte chemoattractant protein 1 (MCP-1)) were reduced in Shp2 knockdown RBL cells. Signaling regulatory mechanism investigation using immunoblotting, immunoprecipitation, and GST pull-down assay reveals that the down-regulation of Shp2 expression in RBL cells leads to decreased activities of Fyn, PLC gamma, JNK, p38MAPK, and Ras/Erk1/2 after Fc epsilon RI aggregation. Further studies suggest that Paxillin phosphoryaltion was also impaired, but PAG phosphorylation was normal after Fc epsilon RI stimulation as a consequence of the inhibition of Shp2 expression in RBL cells. Collectively, our data strongly indicate that Shp2 is essential for the activation of RBL cells in response to Fc epsilon RI aggregation. Shp2 regulates this process through Fyn and Ras with no involvement of PAG. In addition, we identify Paxillin as an indirect substrate of Shp2 in Fc epsilon RI-initiated signaling of RBL cells.	[Fang, Xiaoyun; Lang, Yongjiang; Wang, Yuxiong; Mo, Wei; Wei, Huanhuan; Yu, Min] Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Mol Med, Shanghai 200433, Peoples R China; [Xie, Jianhui] Fudan Univ, Ctr Gene Res, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Fang, Xiaoyun; Lang, Yongjiang; Wang, Yuxiong; Mo, Wei; Wei, Huanhuan; Xie, Jianhui; Yu, Min] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Fang, XY (corresponding author), Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Mol Med, Shanghai 200433, Peoples R China.	jhxie@fudan.edu.cn; minyu@shmu.edu.cn			National Natural Science Foundation of China [30870565, 81171912]; The Key Program of New Drug Innovation; Ministry of Science and Technology of China [2009ZX09503-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Key Program of New Drug Innovation; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (No.30870565 and 81171912) and The Key Program of New Drug Innovation, Ministry of Science and Technology of China (2009ZX09503-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Araki T, 2009, P NATL ACAD SCI USA, V106, P4736, DOI 10.1073/pnas.0810053106; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Binder G, 2009, HORM RES, V71, P64, DOI 10.1159/000192439; Costello PS, 1996, ONCOGENE, V13, P2595; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; EISEMAN E, 1992, NATURE, V355, P78; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Furumoto Y, 2005, NOVART FDN SYMP, V271, P47; Furumoto Y, 2005, NOVART FDN SYMP, V271, P95; Furumoto Yasuko, 2005, Novartis Found Symp, V271, P39; Futami M, 2011, BLOOD, V118, P1077, DOI 10.1182/blood-2009-12-261636; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Hong H, 2007, BLOOD, V110, P2511, DOI 10.1182/blood-2007-01-066092; Hundley TR, 2004, BLOOD, V104, P2410, DOI 10.1182/blood-2004-02-0631; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kambayashi T, 2007, J ALLERGY CLIN IMMUN, V119, P544, DOI 10.1016/j.jaci.2007.01.017; Kambayashi T, 2009, IMMUNOL REV, V232, P99, DOI 10.1111/j.1600-065X.2009.00825.x; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kraft S, 2006, TRENDS IMMUNOL, V27, P88, DOI 10.1016/j.it.2005.11.008; Li L, 2011, BLOOD, V118, P1504, DOI 10.1182/blood-2010-06-288910; McPherson VA, 2009, J IMMUNOL, V183, P4940, DOI 10.4049/jimmunol.0900702; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naal RMZG, 2004, BIOSENS BIOELECTRON, V20, P791, DOI 10.1016/j.bios.2004.03.017; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nishida K, 2011, J IMMUNOL, V187, P932, DOI 10.4049/jimmunol.1100360; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Ohtake H, 2002, J IMMUNOL, V168, P2087, DOI 10.4049/jimmunol.168.5.2087; Pan Y, 2010, DEVELOPMENT, V137, P1085, DOI 10.1242/dev.042820; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Qiao HH, 2006, BLOOD, V107, P610, DOI 10.1182/blood-2005-06-2271; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Tang H, 1999, J BIOL CHEM, V274, P12401, DOI 10.1074/jbc.274.18.12401; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Xu RZ, 2005, BLOOD, V106, P3142, DOI 10.1182/blood-2004-10-4057; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang WJ, 2009, J BIOL CHEM, V284, P22353, DOI 10.1074/jbc.M109.020495	55	14	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40566	10.1371/journal.pone.0040566	http://dx.doi.org/10.1371/journal.pone.0040566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802969	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500059
J	Yamamoto, S; Miyazaki, M; Iwano, T; Kitazawa, S				Yamamoto, Shinya; Miyazaki, Makoto; Iwano, Takayuki; Kitazawa, Shigeru			Bayesian Calibration of Simultaneity in Audiovisual Temporal Order Judgments	PLOS ONE			English	Article							AUDITORY-VISUAL INTERACTION; SUPERIOR COLLICULUS; PERCEPTION; RECALIBRATION; CORTEX; ASYNCHRONY; STIMULI; INTEGRATION; NEURONS; VISION	After repeated exposures to two successive audiovisual stimuli presented in one frequent order, participants eventually perceive a pair separated by some lag time in the same order as occurring simultaneously (lag adaptation). In contrast, we previously found that perceptual changes occurred in the opposite direction in response to tactile stimuli, conforming to Bayesian integration theory (Bayesian calibration). We further showed, in theory, that the effect of Bayesian calibration cannot be observed when the lag adaptation was fully operational. This led to the hypothesis that Bayesian calibration affects judgments regarding the order of audiovisual stimuli, but that this effect is concealed behind the lag adaptation mechanism. In the present study, we showed that lag adaptation is pitch-insensitive using two sounds at 1046 and 1480 Hz. This enabled us to cancel lag adaptation by associating one pitch with sound-first stimuli and the other with light-first stimuli. When we presented each type of stimulus (high-or low-tone) in a different block, the point of simultaneity shifted to "sound-first" for the pitch associated with sound-first stimuli, and to "light-first" for the pitch associated with light-first stimuli. These results are consistent with lag adaptation. In contrast, when we delivered each type of stimulus in a randomized order, the point of simultaneity shifted to "light-first" for the pitch associated with sound-first stimuli, and to "sound-first" for the pitch associated with light-first stimuli. The results clearly show that Bayesian calibration is pitch-specific and is at work behind pitch-insensitive lag adaptation during temporal order judgment of audiovisual stimuli.	[Yamamoto, Shinya; Iwano, Takayuki; Kitazawa, Shigeru] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Miyazaki, Makoto] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan; [Iwano, Takayuki; Kitazawa, Shigeru] Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Dynam Brain Network Lab, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Ctr Informat & Neural Networks, Osaka, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Yamaguchi University; Juntendo University; Osaka University; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Yamamoto, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan.	yamamoto-s@aist.go.jp	Iwano, Takayuki/N-6112-2016; Yamamoto, Shinya/S-3134-2016	Iwano, Takayuki/0000-0001-8173-8901; Yamamoto, Shinya/0000-0002-0505-8848	Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18020037, 23680029]; MEXT [21670004, 18200024, 21240029]	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was partly supported by the Special Coordination Funds for Promoting Science and Technology, a Grant-in-Aid for Scientific Research on Priority Areas (System study on higher-order brain functions) (#18020037), and a Grant-in-Aid for Young Scientists (A) (#23680029) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to S.Y., a Grant-in-Aid for Young Scientists (S) (#21670004) from MEXT to M. M., and a Grant-in-Aid for Scientific Research (A) (#18200024, and #21240029) from MEXT to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; ALLON N, 1978, BRAIN RES, V159, P321, DOI 10.1016/0006-8993(78)90538-3; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bieser A, 1998, EXP BRAIN RES, V122, P139, DOI 10.1007/s002210050501; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Guo K, 2004, VISION RES, V44, P2349, DOI 10.1016/j.visres.2004.04.014; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Harrar V, 2005, EXP BRAIN RES, V166, P465, DOI 10.1007/s00221-005-2386-7; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Heron J, 2012, EXP BRAIN RES, V218, P477, DOI 10.1007/s00221-012-3038-3; Heron J, 2007, J VISION, V7, DOI 10.1167/7.13.5; HIRSCH JA, 1985, J NEUROPHYSIOL, V53, P726, DOI 10.1152/jn.1985.53.3.726; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Keetels M, 2008, NEUROSCI LETT, V430, P130, DOI 10.1016/j.neulet.2007.10.044; Keetels M, 2008, PERCEPT PSYCHOPHYS, V70, P765, DOI 10.3758/PP.70.5.765; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kersten D, 1997, PERCEPTION, V26, P171, DOI 10.1068/p260171; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LOE PR, 1969, ELECTROEN CLIN NEURO, V26, P395, DOI 10.1016/0013-4694(69)90089-3; Machulla TK, 2012, EXP BRAIN RES, V217, P89, DOI 10.1007/s00221-011-2976-5; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Navarra J, 2007, NEUROSCI LETT, V413, P72, DOI 10.1016/j.neulet.2006.11.027; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rao RPN, 1999, VISION RES, V39, P1963, DOI 10.1016/S0042-6989(98)00279-X; Roach NW, 2011, P ROY SOC B-BIOL SCI, V278, P1314, DOI 10.1098/rspb.2010.1737; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; Sato Y, 2009, ARTIF LIFE ROBOT, V14, P289, DOI 10.1007/s10015-009-0675-0; Sato Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019377; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Takahashi K, 2008, NEUROREPORT, V19, P319, DOI 10.1097/WNR.0b013e3282f4f039; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; WALKER JT, 1981, PERCEPT PSYCHOPHYS, V29, P475, DOI 10.3758/BF03207361; WALKER JT, 1979, PERCEPT PSYCHOPHYS, V26, P241, DOI 10.3758/BF03199875; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	42	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40379	10.1371/journal.pone.0040379	http://dx.doi.org/10.1371/journal.pone.0040379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792297	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700041
J	Giraudeau, B; Caille, A; Le Gouge, A; Ravaud, P				Giraudeau, Bruno; Caille, Agnes; Le Gouge, Amelie; Ravaud, Philippe			Participant Informed Consent in Cluster Randomized Trials: Review	PLOS ONE			English	Review							DESIGN; ISSUES; CONDUCT; RISK	Background: The Nuremberg code defines the general ethical framework of medical research with participant consent as its cornerstone. In cluster randomized trials (CRT), obtaining participant informed consent raises logistic and methodologic concerns. First, with randomization of large clusters such as geographical areas, obtaining individual informed consent may be impossible. Second, participants in randomized clusters cannot avoid certain interventions, which implies that participant informed consent refers only to data collection, not administration of an intervention. Third, complete participant information may be a source of selection bias, which then raises methodological concerns. We assessed whether participant informed consent was required in such trials, which type of consent was required, and whether the trial was at risk of selection bias because of the very nature of participant information. Methods and Findings: We systematically reviewed all reports of CRT published in MEDLINE in 2008 and surveyed corresponding authors regarding the nature of the informed consent and the process of participant inclusion. We identified 173 reports and obtained an answer from 113 authors (65.3%). In total, 23.7% of the reports lacked information on ethics committee approval or participant consent, 53.1% of authors declared that participant consent was for data collection only and 58.5% that the group allocation was not specified for participants. The process of recruitment (chronology of participant recruitment with regard to cluster randomization) was rarely reported, and we estimated that only 56.6% of the trials were free of potential selection bias. Conclusions: For CRTs, the reporting of ethics committee approval and participant informed consent is less than optimal. Reports should describe whether participants consented for administration of an intervention and/or data collection. Finally, the process of participant recruitment should be fully described (namely, whether participants were informed of the allocation group before being recruited) for a better appraisal of the risk of selection bias.	[Giraudeau, Bruno; Caille, Agnes; Ravaud, Philippe] INSERM, U738, Paris, France; [Giraudeau, Bruno; Caille, Agnes; Le Gouge, Amelie] INSERM, CIC 202, Tours, France; [Giraudeau, Bruno; Caille, Agnes] Univ Tours, Tours, France; [Giraudeau, Bruno; Caille, Agnes; Le Gouge, Amelie] CHRU Tours, Tours, France; [Ravaud, Philippe] Hop Hotel Dieu, Assistance Publ Hop Paris, Ctr Epidemiol Clin, F-75181 Paris, France; [Ravaud, Philippe] Univ Paris Descartes Sorbonne Paris Cite, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Giraudeau, B (corresponding author), INSERM, U738, Paris, France.	giraudeau@med.univ-tours.fr	ravaud, philippe/C-1694-2009; caille, agnes/L-9011-2015; Caille, Agnès/K-6628-2012; Giraudeau, Bruno/L-9003-2015	Giraudeau, Bruno/0000-0003-3031-8258; Caille, Agnes/0000-0003-4715-6144; Ravaud, Philippe/0000-0001-8264-9206	French Ministry of Health [PHRC 2008 10-03]	French Ministry of Health	This study was supported by a research grant (PHRC 2008 10-03) from the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland J Martin, 2004, BMC Med Res Methodol, V4, P21, DOI 10.1186/1471-2288-4-21; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutron I, 2006, PLOS MED, V3, P1931, DOI 10.1371/journal.pmed.0030425; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Edwards SJL, 1999, BMJ-BRIT MED J, V318, P1407, DOI 10.1136/bmj.318.7195.1407; Eldridge SM, 2005, CLIN TRIALS, V2, P91, DOI 10.1191/1740774505cn070oa; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2011, NEW ENGL J MED, V365, P1145, DOI 10.1056/NEJMsb1106942; Freemantle N, 2010, J CLIN EPIDEMIOL, V63, P1053, DOI 10.1016/j.jclinepi.2009.07.013; Giraudeau B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000065; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 2000, STAT METHODS MED RES, V9, P95, DOI 10.1191/096228000670953670; Hill CL, 2002, J CLIN EPIDEMIOL, V55, P783, DOI 10.1016/S0895-4356(02)00440-7; Hutton JL, 2001, STAT MED, V20, P473, DOI 10.1002/1097-0258(20010215)20:3<473::AID-SIM805>3.0.CO;2-D; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Klar N, 2007, WILEY ENCY CLIN TRIA; McRae AD, 2011, TRIALS, V12, DOI [10.1186/1745-6215-12-202, 10.1186/1745-6215-12-183]; Medical Research Council, 2002, CLUST RAND TRIALS ME; Osrin D, 2009, B WORLD HEALTH ORGAN, V87, P772, DOI 10.2471/BLT.08.051060; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Rhodes R, 2011, AM J BIOETHICS, V11, P1, DOI 10.1080/15265161.2011.615588; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Taljaard M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2496; Taljaard M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-61; Torgerson DJ, 2008, DESIGNING RANDOMISED TRIALS IN HEALTH, EDUCATION AND THE SOCIAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1057/9780230583993; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI [DOI 10.3310/HTA3050, DOI 10.3310/hta3050]; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; World Medical Association, DECL HELS ETH PRINC	30	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40436	10.1371/journal.pone.0040436	http://dx.doi.org/10.1371/journal.pone.0040436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792319	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800084
J	Grimley, R; Polyakova, O; Vamathevan, J; McKenary, J; Hayes, B; Patel, C; Smith, J; Bridges, A; Fosberry, A; Bhardwaja, A; Mouzon, B; Chung, CW; Barrett, N; Richmond, N; Modha, S; Solari, R				Grimley, Rachel; Polyakova, Oxana; Vamathevan, Jessica; McKenary, Joanne; Hayes, Brian; Patel, Champa; Smith, Janet; Bridges, Angela; Fosberry, Andrew; Bhardwaja, Anshu; Mouzon, Bernadette; Chung, Chun-Wa; Barrett, Nathalie; Richmond, Nicola; Modha, Sundip; Solari, Roberto			Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NF kappa B Responses	PLOS ONE			English	Article							PROTEIN DEACETYLASES; GENE-EXPRESSION; SIR2; CHROMATIN; SPECIFICITY; MECHANISM; SUBSTRATE; REPAIR; CELLS; ASSAY	SIRT6 is involved in inflammation, aging and metabolism potentially by modulating the functions of both NF kappa B and HIF1 alpha. Since it is possible to make small molecule activators and inhibitors of Sirtuins we wished to establish biochemical and cellular assays both to assist in drug discovery efforts and to validate whether SIRT6 represents a valid drug target for these indications. We confirmed in cellular assays that SIRT6 can deacetylate acetylated-histone H3 lysine 9 (H3K9Ac), however this deacetylase activity is unusually low in biochemical assays. In an effort to develop alternative assay formats we observed that SIRT6 overexpression had no influence on TNF alpha induced nuclear translocation of NFkB, nor did it have an effect on nuclear mobility of RelA/p65. In an effort to identify a gene expression profile that could be used to identify a SIRT6 readout we conducted genome-wide expression studies. We observed that overexpression of SIRT6 had little influence on NF kappa B-dependent genes, but overexpression of the catalytically inactive mutant affected gene expression in developmental pathways.	[Grimley, Rachel; Polyakova, Oxana; McKenary, Joanne; Patel, Champa; Bridges, Angela; Fosberry, Andrew; Bhardwaja, Anshu; Mouzon, Bernadette; Chung, Chun-Wa; Barrett, Nathalie; Richmond, Nicola; Modha, Sundip] GlaxoSmithKline, Platform Technol Sci, Stevenage, Herts, England; [Vamathevan, Jessica] GlaxoSmithKline, Computat Biol, Stevenage, Herts, England; [Vamathevan, Jessica; Hayes, Brian; Smith, Janet; Solari, Roberto] GlaxoSmithKline, Allerg Inflammat Discovery Performance Unit, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Grimley, R (corresponding author), GlaxoSmithKline, Platform Technol Sci, Gunnels Wood Rd, Stevenage, Herts, England.	roberto.2.solari@gsk.com		Vamathevan, Jessica/0000-0003-2016-9754				Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; French JB, 2008, BIOCHEMISTRY-US, V47, P10227, DOI 10.1021/bi800767t; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kawahara TLA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002153; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; MacNee W, 2009, BIOCHEM SOC T, V37, P819, DOI 10.1042/BST0370819; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Marcotte PA, 2004, ANAL BIOCHEM, V332, P90, DOI 10.1016/j.ab.2004.05.039; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; McDonagh T, 2005, METHODS, V36, P346, DOI 10.1016/j.ymeth.2005.03.005; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Schaaf MJM, 2006, J BIOL CHEM, V281, P22409, DOI 10.1074/jbc.M511086200; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	30	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39847	10.1371/journal.pone.0039847	http://dx.doi.org/10.1371/journal.pone.0039847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792191	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800022
J	Saulle, E; Guerriero, R; Petronelli, A; Coppotelli, E; Gabbianelli, M; Morsilli, O; Spinello, I; Pelosi, E; Castelli, G; Testa, U; Coppola, S				Saulle, Ernestina; Guerriero, Raffaella; Petronelli, Alessia; Coppotelli, Elena; Gabbianelli, Marco; Morsilli, Ornella; Spinello, Isabella; Pelosi, Elvira; Castelli, Germana; Testa, Ugo; Coppola, Simona			Autocrine Role of Angiopoietins during Megakaryocytic Differentiation	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; THROMBOPOIETIN; EXPRESSION; CELLS; RELEASE; BLOOD; IDENTIFICATION; PROLIFERATION; PROTEINS; LEUKEMIA	The tyrosine kinase Tie-2 and its ligands Angiopoietins (Angs) transduce critical signals for angiogenesis in endothelial cells. This receptor and Ang-1 are coexpressed in hematopoietic stem cells and in a subset of megakaryocytes, though a possible role of angiopoietins in megakaryocytic differentiation/proliferation remains to be demonstrated. To investigate a possible effect of Ang-1/Ang-2 on megakaryocytic proliferation/differentiation we have used both normal CD34(+) cells induced to megakaryocytic differentiation and the UT7 cells engineered to express the thrombopoietin receptor (TPOR, also known as c-mpl, UT7/mpl). Our results indicate that Ang-1/Ang-2 may have a role in megakaryopoiesis. Particularly, Ang-2 is predominantly produced and released by immature normal megakaryocytic cells and by undifferentiated UT7/mpl cells and slightly stimulated TPO-induced cell proliferation. Ang-1 production is markedly induced during megakaryocytic differentiation/maturation and potentiated TPO-driven megakaryocytic differentiation. Blocking endogenously released angiopoietins partially inhibited megakaryocytic differentiation, particularly for that concerns the process of polyploidization. According to these data it is suggested that an autocrine angiopoietin/Tie-2 loop controls megakaryocytic proliferation and differentiation.	[Saulle, Ernestina; Guerriero, Raffaella; Petronelli, Alessia; Coppotelli, Elena; Gabbianelli, Marco; Morsilli, Ornella; Spinello, Isabella; Pelosi, Elvira; Castelli, Germana; Testa, Ugo; Coppola, Simona] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Coppola, Simona] Ist Super Sanita, Natl Ctr Rare Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Saulle, E (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	ugo.testa@iss.it; simona.coppola@iss.it	Saulle, Ernestina/AAE-4654-2021; SAULLE, ERNESTINA/J-8834-2016; Gabbianelli, Marco/O-1210-2017; pelosi, elvira/J-7298-2016; Coppola, Simona/A-6638-2015; Testa, Ugo/J-6472-2016; SPINELLO, ISABELLA/J-8779-2016; Guerriero, Raffaella/O-1219-2017; castelli, germana/J-7244-2016	Gabbianelli, Marco/0000-0002-7824-780X; pelosi, elvira/0000-0002-3043-6249; Coppola, Simona/0000-0001-7851-9409; Testa, Ugo/0000-0001-7900-8942; castelli, germana/0000-0002-3593-1230; saulle, ernestina/0000-0001-6681-6887	FIRC (Federazione Italiana Ricerca sul Cancro, Milano, Italy) fellowship; Italian Health Ministery; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	FIRC (Federazione Italiana Ricerca sul Cancro, Milano, Italy) fellowship(Fondazione AIRC per la ricerca sul cancro); Italian Health Ministery; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Dr. Petronelli was supported by a FIRC (Federazione Italiana Ricerca sul Cancro, Milano, Italy) fellowship. This study was supported by a grant from the Italian Health Ministery to Dr. Testa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Batard P, 1996, BLOOD, V87, P2212, DOI 10.1182/blood.V87.6.2212.bloodjournal8762212; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bobik R, 1998, FEBS LETT, V423, P10, DOI 10.1016/S0014-5793(98)00056-8; Bornstein R, 2001, BRIT J HAEMATOL, V114, P458, DOI 10.1046/j.1365-2141.2001.02954.x; Brizzi MF, 1999, CIRC RES, V84, P785; Cardier JE, 1998, BLOOD, V91, P923, DOI 10.1182/blood.V91.3.923.923_923_929; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casella I, 2003, BLOOD, V101, P1316, DOI 10.1182/blood-2002-07-2184; Coppola S, 2006, CELL DEATH DIFFER, V13, P61, DOI 10.1038/sj.cdd.4401698; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DUMONT DJ, 1993, ONCOGENE, V8, P1293; Garcia J, 2001, MOL CELL BIOL, V21, P2659, DOI 10.1128/MCB.21.8.2659-2670.2001; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gomei Y, 2010, EXP HEMATOL, V38, P82, DOI 10.1016/j.exphem.2009.11.007; GUERRIERO R, 1995, BLOOD, V86, P3725, DOI 10.1182/blood.V86.10.3725.bloodjournal86103725; Guerriero R, 2006, J CELL SCI, V119, P744, DOI 10.1242/jcs.02784; Huang YQ, 2000, BLOOD, V95, P1993, DOI 10.1182/blood.V95.6.1993; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kanda S, 2005, CANCER RES, V65, P6820, DOI 10.1158/0008-5472.CAN-05-0522; Li JJ, 2001, THROMB HAEMOSTASIS, V85, P204, DOI 10.1055/s-0037-1615677; Mattia G, 2002, BLOOD, V99, P888, DOI 10.1182/blood.V99.3.888; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Neagoe PE, 2009, GROWTH FACTORS, V27, P335, DOI 10.3109/08977190903155043; Ohsaka A, 2009, BIOCHEM BIOPH RES CO, V390, P1171, DOI 10.1016/j.bbrc.2009.10.110; PARTANEN J, 1990, P NATL ACAD SCI USA, V87, P8913, DOI 10.1073/pnas.87.22.8913; Porteu F, 1996, MOL CELL BIOL, V16, P2473; Puri MC, 2003, P NATL ACAD SCI USA, V100, P12753, DOI 10.1073/pnas.2133552100; Riccioni R, 2007, STEM CELLS, V25, P1862, DOI 10.1634/stemcells.2006-0700; Rosa AI, 2010, J NEUROSCI, V30, P4573, DOI 10.1523/JNEUROSCI.5597-09.2010; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673; Schubert SY, 2011, ARTERIOSCLE IN PRESS; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Singh H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029319; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Yaun HT, 2009, MOL CELL BIOL, V29, P29011; Zetterberg E, 2003, BRIT J HAEMATOL, V121, P497, DOI 10.1046/j.1365-2141.2003.04289.x	44	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39796	10.1371/journal.pone.0039796	http://dx.doi.org/10.1371/journal.pone.0039796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792187	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800018
J	Song, NN; Zhang, GH; Geng, WY; Liu, ZB; Jin, WZ; Li, L; Cao, YX; Zhu, DN; Yu, J; Shen, LL				Song, Nana; Zhang, Guihong; Geng, Wenye; Liu, Zibing; Jin, Weizhong; Li, Li; Cao, Yinxiang; Zhu, Danian; Yu, Jerry; Shen, Linlin			Acid Sensing Ion Channel 1 in Lateral Hypothalamus Contributes to Breathing Control	PLOS ONE			English	Article							PROTON-GATED CHANNELS; OREXIN KNOCKOUT MICE; SENSORY NEURONS; HYPERCAPNIC CHEMOREFLEX; NERVOUS-SYSTEM; DIURNAL CYCLE; ACTIVE PERIOD; NA+ CHANNEL; RAT; WAKEFULNESS	Acid-sensing ion channels (ASICs) are present in neurons and may contribute to chemoreception. Among six subunits of ASICs, ASIC1 is mainly expressed in the central nervous system. Recently, multiple sites in the brain including the lateral hypothalamus (LH) have been found to be sensitive to extracellular acidification. Since LH contains orexin neurons and innervates the medulla respiratory center, we hypothesize that ASIC1 is expressed on the orexin neuron and contributes to acid-induced increase in respiratory drive. To test this hypothesis, we used double immunofluorescence to determine whether ASIC1 is expressed on orexin neurons in the LH, and assessed integrated phrenic nerve discharge (iPND) in intact rats in response to acidification of the LH. We found that ASIC1 was co-localized with orexinA in the LH. Microinjection of acidified artificial cerebrospinal fluid increased the amplitude of iPND by 70% (pH 7.4 v.s. pH 6.5:1.05 +/- 0.12 v.s. 1.70 +/- 0.10, n = 6, P<0.001) and increased the respiratory drive (peak amplitude of iPND/inspiratory time, PA/Ti) by 40% (1.10 +/- 0.23 v.s. 1.50 +/- 0.38, P<0.05). This stimulatory effect was abolished by blocking ASIC1 with a nonselective inhibitor (amiloride 10 mM), a selective inhibitor (PcTX1, 10 nM) or by damaging orexin neurons in the LH. Current results support our hypothesis that the orexin neuron in the LH can exert an excitation on respiration via ASIC1 during local acidosis. Since central acidification is involved in breathing dysfunction in a variety of pulmonary diseases, understanding its underlying mechanism may improve patient management.	[Song, Nana; Zhang, Guihong; Geng, Wenye; Liu, Zibing; Jin, Weizhong; Li, Li; Cao, Yinxiang; Zhu, Danian; Yu, Jerry; Shen, Linlin] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yu, Jerry] Univ Louisville, Dept Pulm Med, Louisville, KY 40292 USA	Fudan University; University of Louisville	Song, NN (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	llshen@shmu.edu.cn			National Natural Science Foundation of China [81070001, 30670771]; Science and Technology Commission of Shanghai Municipality [09JC1402100]; Shanghai Leading Academic Discipline Project [B112]; Shanghai MICCAI (Medical Image Computing and Computer Assisted Intervention) Key laboratory [06DZ22103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai MICCAI (Medical Image Computing and Computer Assisted Intervention) Key laboratory	This work was supported by National Natural Science Foundation of China (NO.81070001, NO.30670771) URL: http://www.nsfc.gov.cn; Science and Technology Commission of Shanghai Municipality (09JC1402100) URL: http://www.stcsm.gov.cn; Shanghai Leading Academic Discipline Project (B112) URL: http://www.shmec.gov.cn and Shanghai MICCAI (Medical Image Computing and Computer Assisted Intervention) Key laboratory (06DZ22103) URL: http://www.fudan.edu.cn/new_research/mainlab.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babinski K, 2000, J BIOL CHEM, V275, P28519, DOI 10.1074/jbc.M004114200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Berquin P, 2000, BRAIN RES, V857, P30, DOI 10.1016/S0006-8993(99)02304-5; [曹性玲 CAO Xing-ling], 2009, [四川大学学报. 医学版, Journal of Sichuan University. Medical Science Edition], V40, P662; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Dias MB, 2010, RESP PHYSIOL NEUROBI, V170, P96, DOI 10.1016/j.resp.2009.12.002; Dias MB, 2009, J PHYSIOL-LONDON, V587, P2059, DOI 10.1113/jphysiol.2008.168260; Dong X, 2011, ACTA PHYSIOL, V201, P97, DOI 10.1111/j.1748-1716.2010.02207.x; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Fung SJ, 2001, BRAIN RES, V903, P257, DOI 10.1016/S0006-8993(01)02318-6; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Guyenet PG, 2005, J NEUROSCI, V25, P8938, DOI 10.1523/JNEUROSCI.2415-05.2005; Han F, 2011, SLEEP BIOL RHYTHMS, V9, P44, DOI 10.1111/j.1479-8425.2010.00467.x; Hildebrand MS, 2004, HEARING RES, V190, P149, DOI 10.1016/S0378-5955(04)00015-2; Johnson PL, 2010, NAT MED, V16, P111, DOI 10.1038/nm.2075; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; Kc P, 2002, RESP PHYSIOL, V129, P289, DOI 10.1016/S0034-5687(01)00321-8; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Krout KE, 2005, BRAIN RES, V1050, P199, DOI 10.1016/j.brainres.2005.04.090; Kuwaki T, 2010, RESP PHYSIOL NEUROBI, V173, P223, DOI 10.1016/j.resp.2010.02.006; Li AH, 2010, J PHYSIOL-LONDON, V588, P2935, DOI 10.1113/jphysiol.2010.191288; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Liu ZB, 2010, CLIN EXP PHARMACOL P, V37, P963, DOI 10.1111/j.1440-1681.2010.05411.x; Meng QY, 2009, NEUROSCIENCE, V159, P1126, DOI 10.1016/j.neuroscience.2009.01.069; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Nakamura A, 2007, J APPL PHYSIOL, V102, P241, DOI 10.1152/japplphysiol.00679.2006; Peng BG, 2004, J NEUROSCI, V24, P10167, DOI 10.1523/JNEUROSCI.3196-04.2004; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; REDGATE ES, 1958, AM J PHYSIOL, V193, P189, DOI 10.1152/ajplegacy.1958.193.1.189; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sunanaga J, 2009, RESP PHYSIOL NEUROBI, V166, P184, DOI 10.1016/j.resp.2009.03.006; Tanaka M, 2008, AM J PHYSIOL-REG I, V294, pR477, DOI 10.1152/ajpregu.00633.2007; Ugawa S, 2003, J NEUROSCI, V23, P3616; von der Goltz C, 2011, HORM BEHAV, V60, P644, DOI 10.1016/j.yhbeh.2011.08.017; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang W, 2007, NEUROSCIENCE, V145, P631, DOI 10.1016/j.neuroscience.2006.12.009; Watson C, 2006, RAT BRAIN STEREOTAXI; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Young JK, 2005, J APPL PHYSIOL, V98, P1387, DOI 10.1152/japplphysiol.00914.2004; Yuan FL, 2010, MOL CELL BIOCHEM, V340, P153, DOI 10.1007/s11010-010-0412-y; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	54	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39982	10.1371/journal.pone.0039982	http://dx.doi.org/10.1371/journal.pone.0039982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792205	gold, Green Submitted, Green Published			2022-12-27	WOS:000306461800029
J	Zhou, X; Li, C; Xu, WT; Chen, JC				Zhou, Xiang; Li, Chao; Xu, Weiting; Chen, Jianchang			Trimetazidine Protects against Smoking-Induced Left Ventricular Remodeling via Attenuating Oxidative Stress, Apoptosis, and Inflammation	PLOS ONE			English	Article							HEART-FAILURE; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE; CARDIOMYOCYTE APOPTOSIS; DILATED CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CARDIAC FIBROBLASTS; TOBACCO-SMOKE; DYSFUNCTION	Trimetazidine, a piperazine derivative used as an anti-anginal agent, improves myocardial glucose utilization through inhibition of fatty acid metabolism. The present study was designed to investigate whether trimetazidine has the protective effects against smoking-induced left ventricular remodeling in rats. In this study, Wistar rats were randomly divided into 3 groups: smoking group (exposed to cigarette smoke), trimetazidine group (exposed to cigarette smoke and treated with trimetazidine), and control group. The echocardiographic and morphometric data indicated that trimetazidine has protective effects against smoking-induced left ventricular remodeling. Oxidative stress was evaluated by detecting malondialdehyde, superoxide dismutase, and glutathione peroxidase in the supernatant of left ventricular tissue. Cardiomyocyte apoptotic rate was determined by flow cytometry with Annexin V/PI staining. Gene expression and serum levels of inflammatory markers, including interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha, were deteced by quantitative real-time PCR and enzyme-linked immunosorbent assay. Our results suggested that trimetazidine could significantly reduce smoking-induced oxidative stress, apoptosis, and inflammation. In conclusion, our study demonstrates that trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation.	[Zhou, Xiang; Xu, Weiting; Chen, Jianchang] Soochow Univ, Affiliated Hosp 2, Dept Cardiol, Suzhou, Peoples R China; [Li, Chao] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China	Soochow University - China; University of Hong Kong	Zhou, X (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Cardiol, Suzhou, Peoples R China.	zhou-xiang@suda.edu.cn			academic research grants of the Second Affiliated Hospital of Soochow University	academic research grants of the Second Affiliated Hospital of Soochow University	This study was supported by the academic research grants of the Second Affiliated Hospital of Soochow University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2003, J AM COLL CARDIOL, V41, P753, DOI 10.1016/S0735-1097(02)02959-5; Abbate A, 2002, J CELL PHYSIOL, V193, P145, DOI 10.1002/jcp.10174; Bertomeu-Gonzalez V, 2006, AM J CARDIOL, V98, p19J, DOI 10.1016/j.amjcard.2006.07.005; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Castardeli E, 2007, EUR J HEART FAIL, V9, P1081, DOI 10.1016/j.ejheart.2007.09.004; Castardeli Édson, 2005, Arq. Bras. Cardiol., V84, P320, DOI 10.1590/S0066-782X2005000400009; Chandrashekhar Y, 2005, Curr Heart Fail Rep, V2, P18, DOI 10.1007/s11897-005-0003-5; Cheng TH, 2003, J AM COLL CARDIOL, V42, P1845, DOI 10.1016/j.jacc.2003.06.010; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Di Napoli P, 2005, HEART, V91, P161, DOI 10.1136/hrt.2003.031310; FANTINI E, 1994, J MOL CELL CARDIOL, V26, P949, DOI 10.1006/jmcc.1994.1116; Fragasso G, 2006, EUR HEART J, V27, P942, DOI 10.1093/eurheartj/ehi816; Fragasso G, 2006, J AM COLL CARDIOL, V48, P992, DOI 10.1016/j.jacc.2006.03.060; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gu LZ, 2008, EUR J HEART FAIL, V10, P1057, DOI 10.1016/j.ejheart.2008.08.009; Haustein KO, 1999, INT J CLIN PHARM TH, V37, P76; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Ibe W, 2007, EUR J HEART FAIL, V9, P160, DOI 10.1016/j.ejheart.2006.06.002; Kameda K, 2003, EUR HEART J, V24, P2180, DOI 10.1016/j.ehj.2003.09.022; Khan M, 2010, J PHARMACOL EXP THER, V333, P421, DOI 10.1124/jpet.109.165175; LAKIER JB, 1992, AM J MED, V93, pS8, DOI 10.1016/0002-9343(92)90620-Q; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord KC, 2010, CARDIOVASC RES, V87, P111, DOI 10.1093/cvr/cvq043; MARIDONNEAUPARINI I, 1985, BRIT J CLIN PHARMACO, V20, P148, DOI 10.1111/j.1365-2125.1985.tb05047.x; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Park KH, 2010, AM J CARDIOL, V105, P1723, DOI 10.1016/j.amjcard.2010.01.351; Rosen BD, 2006, J AM COLL CARDIOL, V47, P1150, DOI 10.1016/j.jacc.2005.08.078; Sabri A, 2003, ANTIOXID REDOX SIGN, V5, P731, DOI 10.1089/152308603770380034; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; SUN Y, 1988, CLIN CHEM, V34, P497; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thrainsdottir IS, 2004, J CARDIOVASC PHARM, V44, P101, DOI 10.1097/00005344-200407000-00014; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	43	38	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40424	10.1371/journal.pone.0040424	http://dx.doi.org/10.1371/journal.pone.0040424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792312	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800081
J	Cao, LY; Dai, C; Li, ZJ; Fan, Z; Song, Y; Wu, YL; Cao, ZJ; Li, WX				Cao, Luyang; Dai, Chao; Li, Zhongjie; Fan, Zheng; Song, Yu; Wu, Yingliang; Cao, Zhijian; Li, Wenxin			Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; FUNCTIONAL-CHARACTERIZATION; ANTIBIOTIC-RESISTANCE	BmKn2 is an antimicrobial peptide (AMP) characterized from the venom of scorpion Mesobuthus martensii Karsch by our group. In this study, Kn2-7 was derived from BmKn2 to improve the antibacterial activity and decrease hemolytic activity. Kn2-7 showed increased inhibitory activity against both Gram-positive bacteria and Gram-negative bacteria. Moreover, Kn2-7 exhibited higher antibacterial activity against clinical antibiotic-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA). In addition, the topical use of Kn2-7 effectively protected the skin of mice from infection in an S. aureus mouse skin infection model. Kn2-7 exerted its antibacterial activity via a bactericidal mechanism. Kn2-7 killed S. aureus and E. coli rapidly by binding to the lipoteichoic acid (LTA) in the S. aureus cell wall and the lipopolysaccharides (LPS) in the E. coli cell wall, respectively. Finally, the hemolytic activity of Kn2-7 was significantly decreased, compared to the wild-type peptide BmKn2. Taken together, the Kn2-7 peptide can be developed as a topical therapeutic agent for treating bacterial infections.	[Cao, Luyang; Dai, Chao; Li, Zhongjie; Fan, Zheng; Song, Yu; Wu, Yingliang; Cao, Zhijian; Li, Wenxin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Cao, LY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn; liwxlab@whu.edu.cn	Dai, Chao/I-6913-2012		Natural Science Foundation of China (NSFC) [31071942]; China Specific Project for Developing New Drugs [2009ZX09103-612, 2011ZX09102-001-32]; National Basic Research Program of China [2010CB529800, 2010CB530100]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Specific Project for Developing New Drugs; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from Natural Science Foundation of China (NSFC) (No. 31071942), the China Specific Project for Developing New Drugs (Nos. 2009ZX09103-612 and 2011ZX09102-001-32), and the National Basic Research Program of China (Nos. 2010CB529800 and 2010CB530100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; Chen YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034947; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; Fan SZ, 2010, CANCER LETT, V291, P158, DOI 10.1016/j.canlet.2009.10.011; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Godballe T, 2011, CHEM BIOL DRUG DES, V77, P107, DOI 10.1111/j.1747-0285.2010.01067.x; Hebert C, 2011, INFECT DIS CLIN N AM, V25, P181, DOI 10.1016/j.idc.2010.11.006; Hou Z, 2011, J INFECT DIS, V203, P273, DOI 10.1093/infdis/jiq029; Ippolito G, 2010, INT J INFECT DIS, V14, pS7, DOI 10.1016/j.ijid.2010.05.003; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kirillov L V, 1976, Dev Biol Stand, V32, P203; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Paulmann M, 2012, J BIOL CHEM     1224; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; Yuan WY, 2010, PEPTIDES, V31, P22, DOI 10.1016/j.peptides.2009.10.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zeng XC, 2004, PEPTIDES, V25, P143, DOI 10.1016/j.peptides.2003.12.003; Zhao ZH, 2009, ANTIMICROB AGENTS CH, V53, P3472, DOI 10.1128/AAC.01436-08	29	72	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40135	10.1371/journal.pone.0040135	http://dx.doi.org/10.1371/journal.pone.0040135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792229	Green Submitted, gold, Green Published			2022-12-27	WOS:000306436300030
J	Gehrau, RC; Archer, KJ; Mas, VR; Maluf, DG				Gehrau, Ricardo C.; Archer, Kellie J.; Mas, Valeria R.; Maluf, Daniel G.			Molecular Profiles of HCV Cirrhotic Tissues Derived in a Panel of Markers with Clinical Utility for Hepatocellular Carcinoma Surveillance	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DNA-DAMAGE; LIVER-TRANSPLANTATION; GROWTH ARREST; UNITED-STATES; REPAIR; CARCINOGENESIS; EPIDEMIOLOGY; INFECTION; GENES	Background: Early hepatocellular carcinoma (HCC) detection is difficult because low accuracy of surveillance tests. Genome-wide analyses were performed using HCV-cirrhosis with HCC to identify predictive signatures. Methodology/Principal Findings: Cirrhotic liver tissue was collected from 107 HCV-infected patients with diagnosis of HCC at pre-transplantation and confirmed in explanted livers. Study groups included: 1) microarray hybridization set (n = 80) including patients without (woHCC = 45) and with (wHCC = 24) HCC, and with incidental HCC (iHCC = 11); 2) independent validation set (n = 27; woHCC = 16, wHCC = 11). Pairwise comparisons were performed using moderated t-test. FDR < 1% was considered significant. L-1-penalized logistic regression model was fit for woHCC and wHCC microarrays, and tested against iHCC. Prediction model genes were validated in independent set by qPCR. The genomic profile was associated with genetic disorders and cancer focused on gene expression, cell cycle and cell death. Molecular profile analysis revealed cell cycle progression and arrest at G2/M, but progressing to mitosis; unregulated DNA damage check-points, and apoptosis. The prediction model included 17 molecules demonstrated 98.6% of accuracy and correctly classified 6 out of 11 undiagnosed iHCC cases. The best model performed even better in the additional independent set. Conclusions/Significances: The molecular analysis of HCV-cirrhotic tissue conducted to a prediction model with good performance and high potential for HCC surveillance.	[Gehrau, Ricardo C.; Mas, Valeria R.; Maluf, Daniel G.] Univ Virginia, Dept Surg, Transplant Div, Charlottesville, VA 22903 USA; [Archer, Kellie J.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Archer, Kellie J.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	University of Virginia; Virginia Commonwealth University; Virginia Commonwealth University	Gehrau, RC (corresponding author), Univ Virginia, Dept Surg, Transplant Div, Charlottesville, VA 22903 USA.	DGM9Y@hscmail.mcc.virginia.edu		Archer, Kellie/0000-0003-1555-5781	NIH-NCI [P30 CA016059]; NIH [N01-DK-7-0004/HHSN267200700004C]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part, by funding from NIH-NCI Cancer Center Support Grant P30 CA016059. Pathologic human livers were obtained through the Liver Tissue Cell Distribution System, which was funded by NIH Contract #N01-DK-7-0004/HHSN267200700004C. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; [Anonymous], 2011, SURV VIR HEP US; Archer KJ, 2010, BRIEF BIOINFORM, V11, P244, DOI 10.1093/bib/bbp055; Archer KJ, 2009, CANCER EPIDEM BIOMAR, V18, P2929, DOI 10.1158/1055-9965.EPI-09-0767; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruix J, 2006, ONCOGENE, V25, P3848, DOI 10.1038/sj.onc.1209548; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fartoux L, 2011, CLIN RES HEPATOL GAS, V35, pS21, DOI 10.1016/S2210-7401(11)70004-3; Fujita N, 2008, J VIRAL HEPATITIS, V15, P498, DOI 10.1111/j.1365-2893.2008.00972.x; Gehrau R, 2011, EXPERT REV GASTROENT, V5, P539, DOI [10.1586/egh.11.48, 10.1586/EGH.11.48]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Jakate S, 2010, AM J SURG PATHOL, V34, P935, DOI 10.1097/PAS.0b013e3181ddf52f; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Kershenobich D, 2011, LIVER INT, V31, P4, DOI 10.1111/j.1478-3231.2011.02535.x; Khalid SS, 2011, HEPATOL INT, V5, P782, DOI 10.1007/s12072-011-9252-4; Kim DY, 2011, ONCOLOGY-BASEL, V81, P56, DOI 10.1159/000333261; Kim TK, 2011, ABDOM IMAGING, V36, P244, DOI 10.1007/s00261-011-9686-0; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lee JM, 2011, ABDOM IMAGING, V36, P282, DOI 10.1007/s00261-011-9692-2; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Llovet JM, 2006, SEMIN LIVER DIS, V26, P248, DOI 10.1055/s-2006-947296; Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; Machida K, 2009, J VIROL, V83, P12590, DOI 10.1128/JVI.02643-08; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mas VR, 2004, LIVER TRANSPLANT, V10, P607, DOI 10.1002/lt.20118; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Mohd-Ismail NK, 2009, J VIROL, V83, P9993, DOI 10.1128/JVI.00509-09; Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x; Park M. Y., 2011, GLMPATH L1 REGULARIZ; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qiu WH, 2003, AM J PATHOL, V162, P1961, DOI 10.1016/S0002-9440(10)64329-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Utsunomiya T, 2010, J GASTROENTEROL, V45, P146, DOI 10.1007/s00535-009-0164-1; Washburn K, 2010, TRANSPLANT REV-ORLAN, V24, P11, DOI 10.1016/j.trre.2009.10.002; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yamashita T, 2011, J GASTROEN HEPATOL, V26, P960, DOI 10.1111/j.1440-1746.2011.06723.x; Zheng SY, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-62	44	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40275	10.1371/journal.pone.0040275	http://dx.doi.org/10.1371/journal.pone.0040275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792259	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300043
J	Ruwaard, J; Lange, A; Schrieken, B; Dolan, CV; Emmelkamp, P				Ruwaard, Jeroen; Lange, Alfred; Schrieken, Bart; Dolan, Conor V.; Emmelkamp, Paul			The Effectiveness of Online Cognitive Behavioral Treatment in Routine Clinical Practice	PLOS ONE			English	Article							INTERNET-BASED TREATMENT; PANIC DISORDER; PSYCHOLOGICAL TREATMENTS; POSTTRAUMATIC STRESS; ANXIETY DISORDER; DEPRESSION; THERAPY; INTERVENTIONS; PSYCHOTHERAPY; BENCHMARKS	Context: Randomized controlled trails have identified online cognitive behavioral therapy as an efficacious intervention in the management of common mental health disorders. Objective: To assess the effectiveness of online CBT for different mental disorders in routine clinical practice. Design: An uncontrolled before-after study, with measurements at baseline, posttest, 6-week follow-up, and 1-year follow-up. Participants & Setting: 1500 adult patients (female: 67%; mean age: 40 years) with a GP referral for psychotherapy were treated at a Dutch online mental health clinic for symptoms of depression (n = 413), panic disorder (n = 139), posttraumatic stress (n = 478), or burnout (n = 470). Interventions: Manualized, web-based, therapist-assisted CBT, odf which the efficacy was previously demonstrated in a series of controlled trials. Standardized duration of treatment varied from 5 weeks (online CBT for Posttraumatic stress) to 16 weeks (online CBT for Depression). Main Outcome Measures: Validated self-report questionnaires of specific and general psychopathology, including the Beck Depression Inventory, the Impact of Event Scale, the Panic Disorder Severity Scale-Self Report, the Oldenburg Burnout Inventory, and the Depression Anxiety Stress Scales. Results: Treatment adherence was 71% (n = 1071). Study attrition was 21% at posttest, 33% at 6-week FU and 65% at 1-year FU. Mixed-model repeated measures regression identified large short-term reductions in all measures of primary symptoms (d = 1.9 +/- 0.2 to d = 1.2 +/- 0.2; P<001), which sustained up to one year after treatment. At posttest, rates of reliable improvement and recovery were 71% and 52% in the completer sample (full sample: 55%/ 40%). Patient satisfaction was high. Conclusions: Results suggest that online therapist-assisted CBT may be as effective in routine practice as it is in clinical trials. Although pre-treatment withdrawal and long-term outcomes require further study, results warrant continued implementation of online CBT.	[Ruwaard, Jeroen; Lange, Alfred; Emmelkamp, Paul] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Ruwaard, Jeroen; Schrieken, Bart] Interapy PLC, Amsterdam, Netherlands; [Dolan, Conor V.] Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Ruwaard, J (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	jruwaard@interapy.nl	, paulemmelkamp/G-3274-2011	, paulemmelkamp/0000-0001-6066-5512	Interapy PLC	Interapy PLC	The study was partly funded by Interapy PLC (http://www.interapy.nl), in the form of logistic support and a study leave for JR. No additional external funding received for this study. JR conducted this study at the University of Amsterdam, in partial fullfillment of the requirements for a PhD-degree. At Interapy PLC, he is a member of the R&D department. BS is chef de clinique of Interapy PLC. BS is a lead developer of the treatment manuals and co-conceived this study. He, or any other employee of Interapy PLC, had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BS approved the manuscript without edits or comments.	Andersson G., 2009, E J APPL PSYCHOL, V5, P18, DOI DOI 10.7790/EJAP.V5I2.169; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bergstrom J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-54; Bergstrom J, 2009, NORD J PSYCHIAT, V63, P44, DOI 10.1080/08039480802191132; Bickel R., 2007, MULTILEVEL ANAL APPL; BOUMAN T, 1994, GEDRAGSTHERAPIE, V27, P69; Brom D, 1985, NEDERLANDS TIJDSCHRI, V40, P164; Cacciola JS, 1999, ASSESSMENT, V6, P235, DOI 10.1177/107319119900600304; Cahill J, 2010, BRIT J CLIN PSYCHOL, V49, P421, DOI 10.1348/014466509X470789; Childress CA, 2000, J MED INTERNET RES, V2, DOI 10.2196/jmir.2.1.e5; Christensen H, 2004, J MED INTERNET RES, V6, P13, DOI 10.2196/jmir.6.4.e46; Christensen H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1194; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; de Graaf LE, 2009, J AFFECT DISORDERS, V116, P227, DOI 10.1016/j.jad.2008.12.009; Demerouti E, 2003, EUR J PSYCHOL ASSESS, V19, P12, DOI 10.1027//1015-5759.19.1.12; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Donker T, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-59; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Farvolden Peter, 2005, J Med Internet Res, V7, pe7, DOI 10.2196/jmir.7.1.e7; Furukawa TA, 2009, DEPRESS ANXIETY, V26, P922, DOI 10.1002/da.20532; GGZ Nederland, 2010, ZORG WAARD GESCH UPD; Griffiths F, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e10; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Hunsley J, 2007, PROF PSYCHOL-RES PR, V38, P21, DOI 10.1037/0735-7028.38.1.21; Issakidis C, 2004, ACTA PSYCHIAT SCAND, V109, P426, DOI 10.1111/j.1600-0047.2004.00264.x; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kaldo-Sandstrom Viktor, 2004, Am J Audiol, V13, P185, DOI 10.1044/1059-0889(2004/023); Knaevelsrud C, 2009, COGN BEHAV THER; Knaevelsrud C, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-13; Lange A, 2003, J CONSULT CLIN PSYCH, V71, P901, DOI 10.1037/0022-006X.71.5.901; Lange A, 1998, COGNITIVE THER RES, V22, P225, DOI 10.1023/A:1018740725281; Lange A, 2001, J BEHAV THER EXP PSY, V32, P73, DOI 10.1016/S0005-7916(01)00023-4; Lange A, 2002, WRITING CURE EXPRESS; Lange A, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1455; Leonard K, 2006, SOC SCI MED, V63, P2330, DOI 10.1016/j.socscimed.2006.06.003; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; Marks IM, 2003, BRIT J PSYCHIAT, V183, P57, DOI 10.1192/bjp.183.1.57; Melville KM, 2010, BRIT J CLIN PSYCHOL, V49, P455, DOI 10.1348/014466509X472138; Minami T, 2007, J CONSULT CLIN PSYCH, V75, P232, DOI 10.1037/0022-006X.75.2.232; Nieuwenhuijsen K, 2003, OCCUP ENVIRON MED, V60, P77; Palmqvist Bjorn, 2007, Expert Rev Pharmacoecon Outcomes Res, V7, P291, DOI 10.1586/14737167.7.3.291; Postel M, 2009, MAANDBLAD GEESTELIJK, V64; R Core Team, 2021, R LANGUAGE ENV STAT; Riper H, 2009, ALCOHOL CLIN EXP RES; Ritterband LM, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1081; Ruwaard J, 2010, J ANXIETY DISORD, V24, P387, DOI 10.1016/j.janxdis.2010.01.010; Ruwaard Jeroen, 2009, Cognitive Behaviour Therapy, V38, P206, DOI 10.1080/16506070802408086; Ruwaard Jeroen, 2007, Cognitive Behaviour Therapy, V36, P179, DOI 10.1080/16506070701381863; Tate DF, 2009, ANN BEHAV MED, V38, P40, DOI 10.1007/s12160-009-9131-6; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010885; Wagner B, 2006, DEATH STUD, V30, P429, DOI 10.1080/07481180600614385; Wagner B, 2007, J TRAUMA STRESS, V20, P625, DOI 10.1002/jts.20230; Wampold BE, 2000, PSYCHOL METHODS, V5, P425, DOI 10.1037/1082-989X.5.4.425; Westen D, 2001, J CONSULT CLIN PSYCH, V69, P875, DOI 10.1037//0022-006X.69.6.875; Wilson GT, 1998, CLIN PSYCHOL-SCI PR, V5, P363, DOI 10.1111/j.1468-2850.1998.tb00156.x	61	95	100	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40089	10.1371/journal.pone.0040089	http://dx.doi.org/10.1371/journal.pone.0040089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974LI	22792217	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300023
J	Sabbir, MG; Prieditis, H; Ravinsky, E; Mowat, MRA				Sabbir, Mohammad Golam; Prieditis, Heather; Ravinsky, Esther; Mowat, Michael R. A.			The Role of Dlc1 Isoform 2 in K-Ras2(G12D) Induced Thymic Cancer	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; TUMOR-SUPPRESSOR GENE; CELL-CYCLE ARREST; HEPATOCELLULAR-CARCINOMA; SKIN CARCINOGENESIS; CPG ISLAND; K-RAS; RHO; EXPRESSION; MOUSE	The Deleted in liver cancer one (Dlc1) tumor suppressor gene encodes a RhoGTPase activating protein (RhoGAP). The Dlc1 gene has multiple transcriptional isoforms and we have previously established a mouse strain containing a gene trap (gt) insertion, which specifically reduces the expression of the 6.1 kb isoform (isoform 2). This gene trapped allele when homozygous results in embryonic lethality and the heterozygous gene trapped mice do not show an increased incidence of cancers, suggesting that cooperating oncogenic changes may be required for transformation. In the present work, we have studied the in vivo cooperation between oncogenic K-Ras2 and Dlc1 genes in tumourigenesis. We have observed an increase in invasive thymic cancers, including both thymomas and lymphomas, resulting in significantly shortened life spans in mice heterozygous for the gt Dlc1 allele and an inducible LSL-K-Ras2(G12D) allele compared with the LSL-K-Ras2(G12D) only mice. The heterozygous mice showed a high degree of metastasis in the lung. We have found tumour specific selective hypermethylation of the Dlc1 isoform 2 promoter and reduction of the corresponding protein expression in thymic lymphoma (TL) and thymic epithelial carcinoma (TEC) derived from the thymic tumours. The Dlc1 deficient thymic lymphoma cell lines exhibited increased trans-endothelial cell migration. TEC cell lines also exhibited increased stress fiber formation and Rho activity. Introduction of the three Dlc1 isoforms tagged with GFP into these cells resulted in different morphological changes. These results suggest that loss of expression of only isoform 2 may be sufficient for the development of thymic tumors and metastasis.	[Sabbir, Mohammad Golam; Prieditis, Heather; Mowat, Michael R. A.] CancerCare Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada; [Sabbir, Mohammad Golam; Mowat, Michael R. A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Ravinsky, Esther] Hlth Sci Ctr, Dept Pathol, Winnipeg, MB, Canada	CancerCare Manitoba Foundation; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Sabbir, MG (corresponding author), CancerCare Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada.	mmowat@cc.umanitoba.ca	Sabbir, Mohammad/AAG-6238-2019		Cancer Research Society Inc.; CancerCare Manitoba Foundation Inc.	Cancer Research Society Inc.; CancerCare Manitoba Foundation Inc.	This study was supported with grants from Cancer Research Society Inc. (http://www.src-crs.ca/en-CA) and CancerCare Manitoba Foundation Inc. (http://www.cancercarefdn.mb.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; BERNATZ PE, 1961, J THORAC CARDIOV SUR, V42, P424; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bryan JN, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-73; Costello PS, 2000, J EXP MED, V192, P77, DOI 10.1084/jem.192.1.77; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; DELLAGI K, 1987, CANCER RES, V47, P1170; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dooley J, 2007, DEV DYNAM, V236, P3459, DOI 10.1002/dvdy.21364; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Durkin ME, 2002, GENE, V288, P119, DOI 10.1016/S0378-1119(02)00462-6; Gomez J, 1997, EUR J IMMUNOL, V27, P2793, DOI 10.1002/eji.1830271108; HEATH JP, 1983, J CELL SCI, V60, P331; HICKS GG, 1991, MOL CELL BIOL, V11, P1344, DOI 10.1128/MCB.11.3.1344; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; HORII A, 1993, HUM MOL GENET, V2, P283, DOI 10.1093/hmg/2.3.283; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jackson RJ, 2003, CANCER RES, V63, P3021; Jackson RJ, 2002, ONCOGENE, V21, P8486, DOI 10.1038/sj.onc.1205946; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim TY, 2008, J BIOL CHEM, V283, P32762, DOI 10.1074/jbc.M800617200; KOHL NE, 1987, ONCOGENE, V2, P41; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Low JSW, 2011, ONCOGENE, V30, P1923, DOI 10.1038/onc.2010.576; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Ng IOL, 2000, CANCER RES, V60, P6581; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Opavsky R, 2007, PLOS GENET, V3, P1757, DOI 10.1371/journal.pgen.0030167; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Rohnelt RK, 1997, INT IMMUNOL, V9, P435, DOI 10.1093/intimm/9.3.435; Sabbir MG, 2006, INT J EXP PATHOL, V87, P151; Sabbir MG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-17; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Song Li-jie, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P428; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Vielkind S, 2005, J IMMUNOL, V175, P350, DOI 10.4049/jimmunol.175.1.350; Wang Y, 1996, P NATL ACAD SCI USA, V93, P3932, DOI 10.1073/pnas.93.9.3932; Weinberg WC, 1999, CANCER RES, V59, P2050; Wong CM, 2003, CANCER RES, V63, P7646; Woodside DG, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-2; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zheng SQL, 2003, MUTAT RES-FUND MOL M, V528, P45, DOI 10.1016/S0027-5107(03)00081-2	56	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40302	10.1371/journal.pone.0040302	http://dx.doi.org/10.1371/journal.pone.0040302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792269	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300050
J	Park-Windhol, C; Zhang, P; Zhu, M; Su, JL; Chaves, L; Maldonado, AE; King, ME; Rickey, L; Cullen, D; Mende, U				Park-Windhol, Cindy; Zhang, Peng; Zhu, Ming; Su, Jialin; Chaves, Leonard, Jr.; Maldonado, Angel E.; King, Michelle E.; Rickey, Lisa; Cullen, Darragh; Mende, Ulrike			Gq/11-Mediated Signaling and Hypertrophy in Mice with Cardiac-Specific Transgenic Expression of Regulator of G-Protein Signaling 2	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; PROGNOSTIC IMPLICATIONS; TRANSITION-STATE; C BETA; HEART; ACTIVATION; RGS2; KINASE; DYSFUNCTION; PALMITOYLATION	Cardiac hypertrophy is a well-established risk factor for cardiovascular morbidity and mortality. Activation of G(q/11)-mediated signaling is required for pressure overload-induced cardiomyocyte (CM) hypertrophy to develop. We previously showed that among Regulators of G protein Signaling, RGS2 selectively inhibits G(q/11) signaling and its hypertrophic effects in isolated CM. In this study, we generated transgenic mice with CM-specific, conditional RGS2 expression (dTG) to investigate whether RGS2 overexpression can be used to attenuate G(q/11)-mediated signaling and hypertrophy in vivo. Transverse aortic constriction (TAC) induced a comparable rise in ventricular mass and ANF expression and corresponding hemodynamic changes in dTG compared to wild types (WT), regardless of the TAC duration (1-8 wks) and timing of RGS2 expression (from birth or adulthood). Inhibition of endothelin-1-induced G(q/11)-mediated phospholipase C beta activity in ventricles and atrial appendages indicated functionality of transgenic RGS2. However, the inhibitory effect of transgenic RGS2 on G(q/11)mediated PLC beta activation differed between ventricles and atria: (i) in sham-operated dTG mice the magnitude of the inhibitory effect was less pronounced in ventricles than in atria, and (ii) after TAC, negative regulation of G(q/11) signaling was absent in ventricles but fully preserved in atria. Neither difference could be explained by differences in expression levels, including marked RGS2 downregulation after TAC in left ventricle and atrium. Counter-regulatory changes in other G(q/11)regulating RGS proteins (RGS4, RGS5, RGS6) and random insertion were also excluded as potential causes. Taken together, despite ample evidence for a role of RGS2 in negatively regulating G(q/11) signaling and hypertrophy in CM, CM-specific RGS2 overexpression in transgenic mice in vivo did not lead to attenuate ventricular G(q/11)-mediated signaling and hypertrophy in response to pressure overload. Furthermore, our study suggests chamber-specific differences in the regulation of RGS2 functionality and potential future utility of the new transgenic model in mitigating G(q/11) signaling in the atria in vivo.	[Park-Windhol, Cindy; Zhang, Peng; Zhu, Ming; Su, Jialin; Chaves, Leonard, Jr.; Maldonado, Angel E.; King, Michelle E.; Rickey, Lisa; Mende, Ulrike] Brown Univ, Rhode Isl Hosp, Div Cardiol, Cardiovasc Res Ctr, Providence, RI 02903 USA; [Park-Windhol, Cindy; Zhang, Peng; Zhu, Ming; Su, Jialin; Chaves, Leonard, Jr.; Maldonado, Angel E.; King, Michelle E.; Rickey, Lisa; Mende, Ulrike] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Park-Windhol, Cindy; Rickey, Lisa] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Cullen, Darragh] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cardiac Muscle Res Lab, Boston, MA 02115 USA; [Cullen, Darragh] Harvard Univ, Sch Med, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Park-Windhol, C (corresponding author), Brown Univ, Rhode Isl Hosp, Div Cardiol, Cardiovasc Res Ctr, Providence, RI 02903 USA.	ulrike_mende@brown.edu			National Heart Lung and Blood Institute [HL-80127]; American Heart Association (AHA) [0740098N, 09PRE2170075]; Brown University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080127] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); Brown University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart Lung and Blood Institute (HL-80127 to UM) and the American Heart Association (AHA) (0740098N to UM), an AHA predoctoral fellowship award [09PRE2170075 to CP] and an undergraduate teaching and research assistant award from Brown University (to LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Benjamin EJ, 1999, AM J MED SCI, V317, P168, DOI 10.1097/00000441-199903000-00006; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bootman MD, 2006, J CELL SCI, V119, P3915, DOI 10.1242/jcs.03223; Bowman JC, 1997, J CLIN INVEST, V100, P2189, DOI 10.1172/JCI119755; Chakir K, 2011, J MOL CELL CARDIOL, V50, P1000, DOI 10.1016/j.yjmcc.2011.01.015; Cingolani OH, 2011, AM J PHYSIOL-HEART C, V301, pH2198, DOI 10.1152/ajpheart.00781.2011; Cunningham ML, 2001, J BIOL CHEM, V276, P5438, DOI 10.1074/jbc.M007699200; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Genomics of Cardiovascular Development Adaptation and Remodeling, GEN CARD DEV AD REM; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Hill JA, 2002, J BIOL CHEM, V277, P10251, DOI 10.1074/jbc.M110722200; Hirose M, 2009, HEART RHYTHM, V6, P78, DOI 10.1016/j.hrthm.2008.10.018; Jones TLZ, 2004, METHOD ENZYMOL, V389, P33; Koitabashi N, 2012, NAT REV CARDIOL, V9, P147, DOI 10.1038/nrcardio.2011.172; Leenders JJ, 2011, J MOL CELL CARDIOL, V51, P156, DOI 10.1016/j.yjmcc.2011.04.017; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; McCloskey DT, 2005, PHYSIOL GENOMICS, V22, P118, DOI 10.1152/physiolgenomics.00016.2005; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Nattel S, 2009, HEART RHYTHM, V6, P85, DOI 10.1016/j.hrthm.2008.11.028; Ni JQ, 2006, INT J BIOCHEM CELL B, V38, P2209, DOI 10.1016/j.biocel.2006.06.015; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Rogers JH, 2001, J MOL CELL CARDIOL, V33, P209, DOI 10.1006/jmcc.2000.1307; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sheridan DJ, 2000, CARDIOVASC RES, V47, P133, DOI 10.1016/S0008-6363(00)00065-1; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Syed F, 2004, CIRC RES, V95, P1200, DOI 10.1161/01.RES.0000150366.08972.7f; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; Vinet L, 2008, AM J PHYSIOL-HEART C, V295, pH352, DOI 10.1152/ajpheart.01101.2007; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Woodcock EA, 2009, J MOL CELL CARDIOL, V47, P676, DOI 10.1016/j.yjmcc.2009.08.020; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zhang P, 2011, CIRC RES, V109, P320, DOI 10.1161/CIRCRESAHA.110.231423; Zhang W, 2006, J BIOL CHEM, V281, P5811, DOI 10.1074/jbc.M507871200; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002; Zou MX, 2006, CELL SIGNAL, V18, P1655, DOI 10.1016/j.cellsig.2006.01.012	56	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40048	10.1371/journal.pone.0040048	http://dx.doi.org/10.1371/journal.pone.0040048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802950	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900024
J	Dehmer, M; Tsoy, YR				Dehmer, Matthias; Tsoy, Yury Robertovich			The Quality of Zero Bounds for Complex Polynomials	PLOS ONE			English	Article								In this paper, we evaluate the quality of zero bounds on the moduli of univariate complex polynomials. We select classical and recently developed bounds and evaluate their quality by using several sets of complex polynomials. As the quality of priori bounds has not been investigated thoroughly, our results can be useful to find optimal bounds to locate the zeros of complex polynomials.	[Tsoy, Yury Robertovich] Tomsk Polytech Univ, Dept Comp Engn, Tomsk, Russia	Tomsk Polytechnic University		matthias.dehmer@umit.at						Dehmer M., 2006, J INEQUALITIES PURE, V7; Dehmer M., 2004, ANAL THEORIE POLYNOM; Dehmer M, 2011, APPL MATH COMPUT, V218, P4128, DOI 10.1016/j.amc.2011.09.043; DEUTSCH E, 1981, AM MATH MON, V88, P205, DOI 10.2307/2320474; Heitzinger W, 1985, PRAXIS NICHTLINEARER; Jain V. K., 1986, Journal of Mathematical and Physical Sciences, V20, P259; JOYAL A, 1967, CAN MATH BULLETIN, V10, P53, DOI 10.4153/CMB-1967-006-3; Kalantari B, 2005, MATH COMPUT, V74, P841; Kojima J, 1914, TOHOKU MATH J, V5, P54; Kuniyeda M, 1916, B AM MATH SOC, V8, P167; Marden M, 1966, MATH SURVEYS AM MATH, V3; McNamee JM, 2005, P 17 IMACS WORLD C P; Mignotte M., 1999, POLYNOMIALS ALGORITH; Milovanovic G.V., 1994, TOPICS POLYNOMIALS E; Obreschkoff N, 1963, HOCHSCHULBUCHER MATH, V55; Prasolov V. V, 2004, ALGORITHM COMP MATH; Rahman Q.I., 2002, ANAL THEORY POLYNOMI	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39537	10.1371/journal.pone.0039537	http://dx.doi.org/10.1371/journal.pone.0039537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808042	Green Published, gold			2022-12-27	WOS:000306366400010
J	Alvarado, A; Garcillan-Barcia, MP; de la Cruz, F				Alvarado, Andres; Pilar Garcillan-Barcia, M.; de la Cruz, Fernando			A Degenerate Primer MOB Typing (DPMT) Method to Classify Gamma-Proteobacterial Plasmids in Clinical and Environmental Settings	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; HYBRID OLIGONUCLEOTIDE PRIMERS; KLEBSIELLA-PNEUMONIAE STRAINS; PROTEIN SECONDARY STRUCTURE; HOST-RANGE PLASMIDS; ESCHERICHIA-COLI; INCX PLASMID; CONJUGATIVE RELAXASE; RESISTANCE PLASMIDS; NUCLEOTIDE-SEQUENCE	Transmissible plasmids are responsible for the spread of genetic determinants, such as antibiotic resistance or virulence traits, causing a large ecological and epidemiological impact. Transmissible plasmids, either conjugative or mobilizable, have in common the presence of a relaxase gene. Relaxases were previously classified in six protein families according to their phylogeny. Degenerate primers hybridizing to coding sequences of conserved amino acid motifs were designed to amplify related relaxase genes from gamma-Proteobacterial plasmids. Specificity and sensitivity of a selected set of 19 primer pairs were first tested using a collection of 33 reference relaxases, representing the diversity of gamma-Proteobacterial plasmids. The validated set was then applied to the analysis of two plasmid collections obtained from clinical isolates. The relaxase screening method, which we call "Degenerate Primer MOB Typing" or DPMT, detected not only most known Inc/Rep groups, but also a plethora of plasmids not previously assigned to any Inc group or Rep-type.	[Alvarado, Andres] Univ Cantabria, Dept Biol Mol, Consejo Super Invest Cient, SODERCAN, E-39005 Santander, Spain; Univ Cantabria, Inst Biomed & Biotecnol Cantabria, Consejo Super Invest Cient, SODERCAN, E-39005 Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Alvarado, A (corresponding author), Univ Cantabria, Dept Biol Mol, Consejo Super Invest Cient, SODERCAN, E-39005 Santander, Spain.	delacruz@unican.es	Garcillán-Barcia, María Pilar/G-5812-2016; de la Cruz, Fernando/L-2812-2014	Garcillán-Barcia, María Pilar/0000-0001-7058-5428; de la Cruz, Fernando/0000-0003-4758-6857	Spanish Ministry of Education [BFU2008-00995/BMC]; RETICS research network, Instituto de Salud Carlos III, Spanish Ministry of Health [RD06/0008/1012]; European VII Framework Program [248919/FP7-ICT-2009-4]; I Plan Regional de I+D+i de Cantabria [20-1-2007]; Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Education(Spanish Government); RETICS research network, Instituto de Salud Carlos III, Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European VII Framework Program; I Plan Regional de I+D+i de Cantabria; Consejo Superior de Investigaciones Cientificas	This work was supported by Spanish Ministry of Education (www.mec.es) (BFU2008-00995/BMC), RETICS research network, Instituto de Salud Carlos III, Spanish Ministry of Health (www.msps.es) (RD06/0008/1012) and grant no 248919/FP7-ICT-2009-4 from the European VII Framework Program (http://cordis.europa.eu/fp7/home_en.html). AA was partially funded by the I Plan Regional de I+D+i de Cantabria (Ref. 20-1-2007). MPGB was funded by a JAE-Doc_2009 postdoctoral contract from Consejo Superior de Investigaciones Cientificas (www.csic.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRES I, 1984, PLASMID, V11, P96, DOI 10.1016/0147-619X(84)90012-X; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; AUSTIN S, 1990, CELL, V60, P351, DOI 10.1016/0092-8674(90)90584-2; Bahl MI, 2009, PLASMID, V62, P134, DOI 10.1016/j.plasmid.2009.05.004; Bertini A, 2010, ANTIMICROB AGENTS CH, V54, P4168, DOI 10.1128/AAC.00542-10; Boer R, 2006, J MOL BIOL, V358, P857, DOI 10.1016/j.jmb.2006.02.018; BRADLEY DE, 1982, PLASMID, V7, P95, DOI 10.1016/0147-619X(82)90031-2; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; Camps Manel, 2010, Recent Pat DNA Gene Seq, V4, P58; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Coelho A, 2012, INT J ANTIMICROB AG, V39, P514, DOI 10.1016/j.ijantimicag.2012.01.006; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; DATTA N, 1971, NATURE, V234, P222, DOI 10.1038/234222a0; Datta S, 2003, STRUCTURE, V11, P1369, DOI 10.1016/j.str.2003.10.001; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Ejrnaes K, 2011, VIRULENCE, V2, P528, DOI 10.4161/viru.2.6.18189; Elhani D, 2010, CLIN MICROBIOL INFEC, V16, P157, DOI 10.1111/j.1469-0691.2009.03057.x; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Garcia-Fernandez A, 2010, J ANTIMICROB CHEMOTH, V65, P1155, DOI 10.1093/jac/dkq101; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gardner MN, 2004, MICROBIOL-SGM, V150, P1797, DOI 10.1099/mic.0.26951-0; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gotz A, 1996, APPL ENVIRON MICROB, V62, P2621; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Greated A, 1999, MICROBIOL-SGM, V145, P3003, DOI 10.1099/00221287-145-11-3003; Gstalder ME, 2003, RES MICROBIOL, V154, P499, DOI 10.1016/S0923-2508(03)00143-8; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; HEDGES RW, 1975, MOL GEN GENET, V140, P289, DOI 10.1007/BF00267320; Heuer H, 2009, ENV MICROBIOL, V11, P937; Heuer H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00002; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2009, METHODS MOL BIOL, V551, P27, DOI 10.1007/978-1-60327-999-4_3; JONES CS, 1993, J GEN MICROBIOL, V139, P735, DOI 10.1099/00221287-139-4-735; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Krasowiak R, 2002, FEMS MICROBIOL ECOL, V42, P217, DOI 10.1111/j.1574-6941.2002.tb01011.x; Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100; LOPEZ J, 1989, GENE, V78, P183, DOI 10.1016/0378-1119(89)90327-2; Mata C, 2012, J ANTIMICROB CHEMOTH, V67, P115, DOI 10.1093/jac/dkr412; Monzingo AF, 2007, J MOL BIOL, V366, P165, DOI 10.1016/j.jmb.2006.11.031; Morant Marc, 2002, BMC Plant Biol, V2, P7, DOI 10.1186/1471-2229-2-7; NIKOLETTI S, 1988, J BACTERIOL, V170, P1311, DOI 10.1128/jb.170.3.1311-1318.1988; Novais A, 2010, 20 EUR C CLIN MICR I; Novais A, 2007, ANTIMICROB AGENTS CH, V51, P796, DOI 10.1128/AAC.01070-06; Novais A, 2006, ANTIMICROB AGENTS CH, V50, P2741, DOI 10.1128/AAC.00274-06; Novais A, 2010, ANTIMICROB AGENTS CH, V54, P825, DOI 10.1128/AAC.00959-09; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; NUGENT ME, 1981, J GEN MICROBIOL, V126, P305; Nunez B, 2001, MOL MICROBIOL, V39, P1088, DOI 10.1046/j.1365-2958.2001.02308.x; Oliver A, 2005, ANTIMICROB AGENTS CH, V49, P1567, DOI 10.1128/AAC.49.4.1567-1571.2005; Pedrosa A, 2008, 18 EUR C CLIN MICR I; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Garcillan-Barcia MP, 2011, FEMS MICROBIOL REV, V35, P936, DOI 10.1111/j.1574-6976.2011.00291.x; PRASZKIER J, 1991, J BACTERIOL, V173, P2393, DOI 10.1128/JB.173.7.2393-2397.1991; Provencher C, 2003, APPL ENVIRON MICROB, V69, P3299, DOI 10.1128/AEM.69.6.3299-3307.2003; Rose TM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-20; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Schluter A, 2007, APPL ENVIRON MICROB, V73, P1952, DOI 10.1128/AEM.02159-06; Sekizuka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025334; Sesma A, 1998, APPL ENVIRON MICROB, V64, P3948; Sirichote P, 2010, J CLIN MICROBIOL, V48, P883, DOI 10.1128/JCM.01792-09; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Sobecky PA, 1997, APPL ENVIRON MICROB, V63, P888, DOI 10.1128/AEM.63.3.888-895.1997; Sobecky PA, 1998, APPL ENVIRON MICROB, V64, P2822; STALKER DM, 1985, PLASMID, V14, P245, DOI 10.1016/0147-619X(85)90008-3; Taylor DE, 2004, PLASMID BIOLOGY, P473; Tietze E, 1998, PLASMID, V39, P165, DOI 10.1006/plas.1998.1343; Toleman MA, 2011, FEMS MICROBIOL REV, V35, P912, DOI 10.1111/j.1574-6976.2011.00294.x; Valverde A, 2009, ANTIMICROB AGENTS CH, V53, P5204, DOI 10.1128/AAC.01706-08; van Elsas JD, 1998, APPL ENVIRON MICROB, V64, P880; Varsaki A, 2003, MOL MICROBIOL, V48, P481, DOI 10.1046/j.1365-2958.2003.03441.x; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Zong ZY, 2011, J MED MICROBIOL, V60, P435, DOI 10.1099/jmm.0.026997-0	83	57	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40438	10.1371/journal.pone.0040438	http://dx.doi.org/10.1371/journal.pone.0040438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792321	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400054
J	Kniffin, KM; Wansink, B				Kniffin, Kevin M.; Wansink, Brian			It's Not Just Lunch: Extra-Pair Commensality Can Trigger Sexual Jealousy	PLOS ONE			English	Article								Do people believe that sharing food might involve sharing more than just food? To investigate this, participants were asked to rate how jealous they (Study 1) - or their best friend (Study 2) - would be if their current romantic partner were contacted by an ex-romantic partner and subsequently engaged in an array of food- and drink-based activities. We consistently find - across both men and women - that meals elicit more jealousy than face-to-face interactions that do not involve eating, such as having coffee. These findings suggest that people generally presume that sharing a meal enhances cooperation. In the context of romantic pairs, we find that participants are attuned to relationship risks that extra-pair commensality can present. For romantic partners left out of a meal, we find a common view that lunch, for example, is not "just lunch."	[Kniffin, Kevin M.; Wansink, Brian] Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14853 USA	Cornell University	Kniffin, KM (corresponding author), Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14853 USA.	kmk276@cornell.edu						Amiraian D, 2009, APPETITE, V52, P226, DOI 10.1016/j.appet.2008.07.005; Amiraian DE, 2009, APPETITE, V53, P226, DOI 10.1016/j.appet.2009.06.012; Bove CF, 2003, APPETITE, V40, P25, DOI 10.1016/S0195-6663(02)00147-2; BUSS DM, 1992, PSYCHOL SCI, V3, P251, DOI 10.1111/j.1467-9280.1992.tb00038.x; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; DeScioli P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005802; DeSteno D, 2002, J PERS SOC PSYCHOL, V83, P1103, DOI 10.1037//0022-3514.83.5.1103; Frank R.H, 2013, FALLING RISING INEQU, DOI DOI 10.1525/9780520957435; Harris CR, 2000, J PERS SOC PSYCHOL, V78, P1082, DOI 10.1037//0022-3514.78.6.1082; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Kniffin Kevin M., 2009, Journal of Bioeconomics, V11, P23, DOI 10.1007/s10818-009-9056-y; Kniffin KM, 2010, GROUP ORGAN MANAGE, V35, P150, DOI 10.1177/1059601109360390; Kniffin KM, 2005, HUM NATURE-INT BIOS, V16, P278, DOI 10.1007/s12110-005-1011-6; Kniffin KM, 2004, EVOL HUM BEHAV, V25, P88, DOI 10.1016/S1090-5138(04)00006-6; O'Gorman R, 2009, P ROY SOC B-BIOL SCI, V276, P323, DOI 10.1098/rspb.2008.1082; Shackelford TK, 2007, CURR DIR PSYCHOL SCI, V16, P47, DOI 10.1111/j.1467-8721.2007.00473.x; Sobal J, 2003, APPETITE, V41, P181, DOI 10.1016/S0195-6663(03)00078-3; Solnick SJ, 2012, INJURY PREV, V18, P259, DOI 10.1136/injuryprev-2011-040117; Wang XT, 2010, PSYCHOL SCI, V21, P183, DOI 10.1177/0956797609358096; Wansink, 2006, MINDLESS EATING WHY; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wilson DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027826; Wrangham RW, 2009, CATCHING FIRE COOKIN; Young ME, 2009, APPETITE, V53, P268, DOI 10.1016/j.appet.2009.07.021	25	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40445	10.1371/journal.pone.0040445	http://dx.doi.org/10.1371/journal.pone.0040445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22792327	gold, Green Published			2022-12-27	WOS:000306362400055
J	Zhu, B; Peng, RH; Fu, XY; Jin, XF; Zhao, W; Xu, J; Han, HJ; Gao, JJ; Xu, ZS; Bian, L; Yao, QH				Zhu, Bo; Peng, Ri-He; Fu, Xiao-Yan; Jin, Xiao-Fen; Zhao, Wei; Xu, Jing; Han, Hong-Juan; Gao, Jian-Jie; Xu, Zhi-Sheng; Bian, Lin; Yao, Quan-Hong			Enhanced Transformation of TNT by Arabidopsis Plants Expressing an Old Yellow Enzyme	PLOS ONE			English	Article							2,4,6-TRINITROTOLUENE; PHYTOREMEDIATION; DETOXIFICATION; THALIANA; DROUGHT; WATER	2,4,6-Trinitrotoluene (TNT) is released in nature from manufacturing or demilitarization facilities, as well as after the firing or detonation of munitions or leakage from explosive remnants of war. Environmental contamination by TNT is associated with human health risks, necessitating the development of cost-effective remediation techniques. The lack of affordable and effective cleanup technologies for explosives contamination requires the development of better processes. In this study, we present a system for TNT phytoremediation by overexpressing the old yellow enzyme (OYE3) gene from Saccharomyces cerevisiae. The resulting transgenic Arabidopsis plants demonstrated significantly enhanced TNT tolerances and a strikingly higher capacity to remove TNT from their media. The current work indicates that S. cerevisiae OYE3 overexpression in Arabidopsis is an efficient method for the phytoremoval and degradation of TNT. Our findings have the potential to provide a suitable remediation strategy for sites contaminated by TNT.	[Zhu, Bo; Peng, Ri-He; Fu, Xiao-Yan; Jin, Xiao-Fen; Zhao, Wei; Xu, Jing; Han, Hong-Juan; Gao, Jian-Jie; Yao, Quan-Hong] Shanghai Acad Agr Sci, Agrobiotechnol Res Ctr, Shanghai, Peoples R China; [Xu, Zhi-Sheng] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Bian, Lin] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Peoples R China	Shanghai Academy of Agricultural Sciences; Nanjing Agricultural University; Yangzhou University	Zhu, B (corresponding author), Shanghai Acad Agr Sci, Agrobiotechnol Res Ctr, Shanghai, Peoples R China.	yaoquanhong_sh@yahoo.com.cn			Hi-tech Research and Development Program (863) of China [2008AA10Z401]; Shanghai Natural Science Foundation [11ZR1432600]; Development Fund of Shanghai Academy of Agricultural Sciences	Hi-tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Development Fund of Shanghai Academy of Agricultural Sciences	The research was supported by Hi-tech Research and Development Program (863) of China (2008AA10Z401) and Shanghai Natural Science Foundation (11ZR1432600) and the Development Fund of Shanghai Academy of Agricultural Sciences [Nongkefa 2011(11)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TA, 1994, ACS S SERIES, V63; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Begcy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023776; Beynon ER, 2009, PLANT PHYSIOL, V151, P253, DOI 10.1104/pp.109.141598; Bhadra R, 1999, ENVIRON SCI TECHNOL, V33, P446, DOI 10.1021/es980635m; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; CUNNINGHAM SD, 1995, TRENDS BIOTECHNOL, V13, P393, DOI 10.1016/S0167-7799(00)88987-8; CUNNINGHAM SD, 1993, IN VITRO CELL DEV-PL, V29P, P207, DOI 10.1007/BF02632036; ETNIER EL, 1989, REGUL TOXICOL PHARM, V9, P147, DOI 10.1016/0273-2300(89)90032-9; French CE, 1999, NAT BIOTECHNOL, V17, P491, DOI 10.1038/8673; Hannink NK, 2007, INT J PHYTOREMEDIAT, V9, P385, DOI 10.1080/15226510701603916; Koss G, 1989, BUNDESGESUNDHEITSBLA, V32; LEVSEN K, 1993, ACTA HYDROCH HYDROB, V21, P153, DOI 10.1002/aheh.19930210304; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Luo Zhi-yong, 2001, Hunan Yike Daxue Xuebao, V26, P178; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NIINO YS, 1995, J BIOL CHEM, V270, P1983, DOI 10.1074/jbc.270.5.1983; Pandey JS, 2000, MELB AUSTR P CSRA, P545; Pavlostathis SG, 1998, ENVIRON TOXICOL CHEM, V17, P2266, DOI [10.1002/etc.5620171117, 10.1897/1551-5028(1998)017&lt;2266:TOTBTA&gt;2.3.CO;2]; Peng R.H., 2001, ACTA PHYTOPHYSIOL SI, V27, P55; Pennington JC, 2002, THERMOCHIM ACTA, V384, P163, DOI 10.1016/S0040-6031(01)00801-2; Peuke AD, 2005, EMBO REP, V6, P497, DOI 10.1038/sj.embor.7400445; Spain JC, 2000, BIODEGRADATION OF NITROAROMATIC COMPOUNDS AND EXPLOSIVES, P1; Suresh B, 2004, CRIT REV BIOTECHNOL, V24, P97, DOI 10.1080/07388550490493627; Theorell H, 1935, BIOCHEM Z, V279, P463; Thompson PL, 1998, ENVIRON SCI TECHNOL, V32, P975, DOI 10.1021/es970799n; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Warburg O, 1932, NATURWISSENSCHAFTEN, V20, P980, DOI 10.1007/BF01504728; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; WON WD, 1976, APPL ENVIRON MICROB, V31, P576, DOI 10.1128/AEM.31.4.576-580.1976; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x	35	15	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39861	10.1371/journal.pone.0039861	http://dx.doi.org/10.1371/journal.pone.0039861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808068	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400023
J	Matisziw, TC; Grubesic, TH; Guo, JY				Matisziw, Timothy C.; Grubesic, Tony H.; Guo, Junyu			Robustness Elasticity in Complex Networks	PLOS ONE			English	Article							INFRASTRUCTURE; VULNERABILITY; EMERGENCE; DYNAMICS; SUPPORT; SCIENCE	Network robustness refers to a network's resilience to stress or damage. Given that most networks are inherently dynamic, with changing topology, loads, and operational states, their robustness is also likely subject to change. However, in most analyses of network structure, it is assumed that interaction among nodes has no effect on robustness. To investigate the hypothesis that network robustness is not sensitive or elastic to the level of interaction (or flow) among network nodes, this paper explores the impacts of network disruption, namely arc deletion, over a temporal sequence of observed nodal interactions for a large Internet backbone system. In particular, a mathematical programming approach is used to identify exact bounds on robustness to arc deletion for each epoch of nodal interaction. Elasticity of the identified bounds relative to the magnitude of arc deletion is assessed. Results indicate that system robustness can be highly elastic to spatial and temporal variations in nodal interactions within complex systems. Further, the presence of this elasticity provides evidence that a failure to account for nodal interaction can confound characterizations of complex networked systems.	[Matisziw, Timothy C.; Guo, Junyu] Univ Missouri, Dept Civil & Environm Engn, Columbia, MO 65211 USA; [Matisziw, Timothy C.] Univ Missouri, Dept Geog, Columbia, MO USA; [Matisziw, Timothy C.] Univ Missouri, Inst Informat, Columbia, MO USA; [Grubesic, Tony H.] Drexel Univ, Coll Informat Sci & Technol, Geog Informat Syst & Spatial Anal Lab, Philadelphia, PA 19104 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Drexel University	Matisziw, TC (corresponding author), Univ Missouri, Dept Civil & Environm Engn, Columbia, MO 65211 USA.	matisziwt@missouri.edu	Matisziw, Timothy/N-9105-2016	Matisziw, Timothy/0000-0003-2159-4904; Grubesic, Tony/0000-0003-4517-586X	National Science Foundation [0908030, 0718091]; National Academies Keck Futures Initiative [CS05]	National Science Foundation(National Science Foundation (NSF)); National Academies Keck Futures Initiative	This research is supported in part by the National Science Foundation (0908030 and 0718091). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. Portions of this work are also supported by the National Academies Keck Futures Initiative Complex Systems grant CS05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alderson DL, 2008, OPER RES, V56, P1047, DOI 10.1287/opre.1080.0606; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Caldarelli G., 2007, SCALE FREE NETWORKS; Church RL, 2004, ANN ASSOC AM GEOGR, V94, P491, DOI 10.1111/j.1467-8306.2004.00410.x; D'Souza RM, 2007, P NATL ACAD SCI USA, V104, P6112, DOI 10.1073/pnas.0606779104; de Menezes MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068701; Deville Yves, 2003, Briefings in Bioinformatics, V4, P246, DOI 10.1093/bib/4.3.246; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Fotheringham A.S., 1989, SPATIAL INTERACTION; Grubesic TH, 2008, INT REGIONAL SCI REV, V31, P88, DOI 10.1177/0160017607308679; Grubesic TH, 2011, J URBAN TECHNOL, V18, P51, DOI 10.1080/10630732.2011.578409; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kumar R, 2000, ANN IEEE SYMP FOUND, P57, DOI 10.1109/SFCS.2000.892065; Kurant M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036114; LAND AH, 1960, ECONOMETRICA, V28, P497, DOI 10.2307/1910129; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lerner AP, 1933, REV ECON STUD, V1, P226; Matisziw TC, 2009, COMPUT OPER RES, V36, P16, DOI 10.1016/j.cor.2007.09.004; Matisziw TC, 2009, ANN REGIONAL SCI, V43, P307, DOI 10.1007/s00168-008-0235-x; Matisziw TC, 2009, LANDSCAPE ECOL, V24, P89, DOI 10.1007/s10980-008-9282-z; Meloni S, 2009, P NATL ACAD SCI USA, V106, P16897, DOI 10.1073/pnas.0907121106; Murray AT, 2008, GROWTH CHANGE, V39, P573, DOI 10.1111/j.1468-2257.2008.00447.x; Myung YS, 2004, EUR J OPER RES, V156, P579, DOI 10.1016/S0377-2217(03)00135-8; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Rinaldi SA, 2001, IEEE CONTR SYST MAG, V21, P11, DOI 10.1109/37.969131; Saavedra S, 2008, P NATL ACAD SCI USA, V105, P16466, DOI 10.1073/pnas.0804740105; Shen S, 2011, NETWORKS, DOI 10-1002/net.20464; Snediker DE, 2008, DECIS SUPPORT SYST, V44, P954, DOI 10.1016/j.dss.2007.11.003; Snijders TAB, 2001, SOCIOL METHODOL, V31, P361, DOI 10.1111/0081-1750.00099; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Willinger W., 2009, NOT AM MATH SOC, V56, P586; WOLLMER R, 1964, OPER RES, V12, P934, DOI 10.1287/opre.12.6.934	40	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39788	10.1371/journal.pone.0039788	http://dx.doi.org/10.1371/journal.pone.0039788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973JD	22808060	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500014
J	Magre, S; Rebourcet, D; Ishaq, M; Wargnier, R; Debard, C; Meugnier, E; Vidal, H; Cohen-Tannoudji, J; Le Magueresse-Battistoni, B				Magre, Solange; Rebourcet, Diane; Ishaq, Muhammad; Wargnier, Richard; Debard, Cyrille; Meugnier, Emmanuelle; Vidal, Hubert; Cohen-Tannoudji, Joelle; Le Magueresse-Battistoni, Brigitte			Gender Differences in Transcriptional Signature of Developing Rat Testes and Ovaries following Embryonic Exposure to 2,3,7,8-TCDD	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; IN-UTERO; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; GENE-EXPRESSION; SEMINAL-VESICLE; GROWTH-FACTORS; NULL MUTATION; DIOXIN; IDENTIFICATION; SYNTHASE	Dioxins are persistent organic pollutants interfering with endocrine systems and causing reproductive and developmental disorders. The objective of our project was to determine the impact of an in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on reproductive function of male and female offspring in the rat with a special emphasis on the immature period. We used a low dose of TCDD (unique exposure by oral gavage of 200 ng/kg at 15.5 days of gestation) in order to mirror a response to an environmental dose of TCDD not altering fertility of the progeny. We choose a global gene expression approach using Affymetrix microarray analysis, and testes of 5 days and ovaries of 14 days of age. Less than 1% of the expressed genes in gonads were altered following embryonic TCDD exposure; specifically, 113 genes in ovaries and 56 in testes with 7 genes common to both sex gonads. It included the repressor of the aryl hydrocarbon receptor (Ahrr), the chemokines Ccl5 and Cxcl4 previously shown to be regulated by dioxin in testis, Pgds2/Hpgds and 3 others uncharacterized. To validate and extend the microarray data we realized real-time PCR on gonads at various developmental periods of interest (from 3 to 25 days for ovaries, from 5 to the adult age for testes). Overall, our results evidenced that both sex gonads responded differently to TCDD exposure. For example, we observed induction of the canonic battery of TCDD-induced genes coding enzymes of the detoxifying machinery in ovaries aged of 3-14 days of age (except Cyp1a1 induced at 3-10 days) but not in testes of 5 days (except Ahrr). We also illustrated that inflammatory pathway is one pathway activated by TCDD in gonads. Finally, we identified several new genes targeted by TCDD including Fgf13 in testis and one gene, Ptgds2/Hpgds regulated in the two sex gonads.	[Magre, Solange; Ishaq, Muhammad; Wargnier, Richard; Cohen-Tannoudji, Joelle] Univ Paris Diderot, EAC CNRS 4413, Paris, France; [Rebourcet, Diane; Debard, Cyrille; Meugnier, Emmanuelle; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte] Univ Lyon 1, CarMeN, Lab Lyonnais Rech Cardiovasc Metab Diabet & Nutr, INSERM,U1060,U1235,INRA, Oullins, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Magre, S (corresponding author), Univ Paris Diderot, EAC CNRS 4413, Paris, France.	brigitte.lemagueresse@inserm.fr	Vidal, Hubert/M-6674-2017; Le Magueresse-Battistoni, Brigitte/M-6927-2017; Le Magueresse-Battistoni, Brigitte/AAZ-5601-2021	Vidal, Hubert/0000-0002-9467-0317; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; meugnier, emmanuelle/0000-0002-2291-7691	Agence Nationale pour la Recherche [ANR-06-PNRA-006-01]; Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET) [EST-2006/1/33]; ANR [ANR-06-PNRA-006-01, ANR-CES-2008-011]; Schering-Plough (FARO) [0119-10/Organon]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); ANR(French National Research Agency (ANR)); Schering-Plough (FARO)	This research project was supported by Agence Nationale pour la Recherche (ANR-06-PNRA-006-01, Dhyoxhyme project) and by Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET, EST-2006/1/33). DR is the recipient of subsides from ANR (ANR-06-PNRA-006-01) and Schering-Plough (FARO-grant-0119-10/Organon). RW is the recipient of subsides from ANR (ANR-CES-2008-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128; Baba T, 2008, SEX DEV, V2, P1, DOI 10.1159/000117714; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bell DR, 2010, FOOD CHEM TOXICOL, V48, P1439, DOI 10.1016/j.fct.2010.04.005; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191; Cory AT, 2007, MOL REPROD DEV, V74, P1491, DOI 10.1002/mrd.20722; de Kretser DM, 1998, HUM REPROD, V13, P1; Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-365; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DOHLER KD, 1975, ENDOCRINOLOGY, V97, P898; Farhat A, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-3; Foster WG, 2010, ENVIRON HEALTH PERSP, V118, P458, DOI 10.1289/ehp.0901084; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Glowacki G, 2001, GENE, V275, P267, DOI 10.1016/S0378-1119(01)00608-4; GRAY LE, 1995, TOXICOL APPL PHARM, V133, P285, DOI 10.1006/taap.1995.1153; Greene JM, 1998, EUR J NEUROSCI, V10, P1911, DOI 10.1046/j.1460-9568.1998.00211.x; Haarmann-Stemmann T, 2009, BIOCHEM PHARMACOL, V77, P508, DOI 10.1016/j.bcp.2008.09.013; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hirst CE, 2001, MOL HUM REPROD, V7, P1133, DOI 10.1093/molehr/7.12.1133; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Huang GM, 2012, MOL PHARMACOL, V81, P338, DOI 10.1124/mol.111.075952; Huang P, 2002, NEUROTOXICOLOGY, V23, P783, DOI 10.1016/S0161-813X(02)00040-2; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Kobayashi S, 2008, RHEUMATOLOGY, V47, P1317, DOI 10.1093/rheumatology/ken259; Korkalainen M, 2004, BIOCHEM BIOPH RES CO, V315, P123, DOI 10.1016/j.bbrc.2004.01.028; Larsen JC, 2006, MOL NUTR FOOD RES, V50, P885, DOI 10.1002/mnfr.200500247; LI XL, 1995, FUND APPL TOXICOL, V27, P70, DOI 10.1006/faat.1995.1109; Lin TM, 2002, TOXICOL SCI, V68, P479, DOI 10.1093/toxsci/68.2.479; MEIJSROE.HM, 1973, J ENDOCRINOL, V59, P295, DOI 10.1677/joe.0.0590295; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mocarelli P, 2011, ENVIRON HEALTH PERSP, V119, P713, DOI 10.1289/ehp.1002134; Moniot B, 2011, DEV DYNAM, V240, P2335, DOI 10.1002/dvdy.22726; N'Diaye M, 2006, J BIOL CHEM, V281, P19906, DOI 10.1074/jbc.M601192200; Ohsako S, 2010, BIOL REPROD, V82, P636, DOI 10.1095/biolreprod.109.080812; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Rebourcet D, 2010, INT J ANDROL, V33, P413, DOI 10.1111/j.1365-2605.2009.01020.x; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Salisbury TB, 2002, BIOL REPROD, V66, P1621, DOI 10.1095/biolreprod66.6.1621; Sferruzzi-Perri AN, 2009, BIOL REPROD, V81, P207, DOI 10.1095/biolreprod.108.073312; SUTTER TR, 1991, SCIENCE, V254, P415, DOI 10.1126/science.1925598; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; Valdez KE, 2009, REPROD TOXICOL, V28, P32, DOI 10.1016/j.reprotox.2009.03.004; Vogel CFA, 2007, ARCH BIOCHEM BIOPHYS, V461, P169, DOI 10.1016/j.abb.2007.01.015; Wierinckx A, 2011, BRAIN PATHOL, V21, P533, DOI 10.1111/j.1750-3639.2011.00476.x; Yu J, 2008, HUM REPROD, V23, P1614, DOI 10.1093/humrep/den125; Zappa F, 2001, J HISTOCHEM CYTOCHEM, V49, P1187, DOI 10.1177/002215540104900913	47	16	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40306	10.1371/journal.pone.0040306	http://dx.doi.org/10.1371/journal.pone.0040306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808131	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700034
J	Michels, L; Luchinger, R; Koenig, T; Martin, E; Brandeis, D				Michels, Lars; Luechinger, Rafael; Koenig, Thomas; Martin, Ernst; Brandeis, Daniel			Developmental Changes of BOLD Signal Correlations with Global Human EEG Power and Synchronization during Working Memory	PLOS ONE			English	Article							SCHOOL-AGE CHILDREN; DEFAULT-MODE; PHASE SYNCHRONIZATION; ALPHA OSCILLATIONS; THETA-OSCILLATIONS; BRAIN ACTIVITY; HUMAN ELECTROENCEPHALOGRAM; NEURONAL SYNCHRONY; PARIETAL CORTEX; FREQUENCY BANDS	In humans, theta band (5-7 Hz) power typically increases when performing cognitively demanding working memory (WM) tasks, and simultaneous EEG-fMRI recordings have revealed an inverse relationship between theta power and the BOLD (blood oxygen level dependent) signal in the default mode network during WM. However, synchronization also plays a fundamental role in cognitive processing, and the level of theta and higher frequency band synchronization is modulated during WM. Yet, little is known about the link between BOLD, EEG power, and EEG synchronization during WM, and how these measures develop with human brain maturation or relate to behavioral changes. We examined EEG-BOLD signal correlations from 18 young adults and 15 school-aged children for age-dependent effects during a load-modulated Sternberg WM task. Frontal load (in-)dependent EEG theta power was significantly enhanced in children compared to adults, while adults showed stronger fMRI load effects. Children demonstrated a stronger negative correlation between global theta power and the BOLD signal in the default mode network relative to adults. Therefore, we conclude that theta power mediates the suppression of a task-irrelevant network. We further conclude that children suppress this network even more than adults, probably from an increased level of task-preparedness to compensate for not fully mature cognitive functions, reflected in lower response accuracy and increased reaction time. In contrast to power, correlations between instantaneous theta global field synchronization and the BOLD signal were exclusively positive in both age groups but only significant in adults in the frontal-parietal and posterior cingulate cortices. Furthermore, theta synchronization was weaker in children and was -in contrast to EEG power- positively correlated with response accuracy in both age groups. In summary we conclude that theta EEG-BOLD signal correlations differ between spectral power and synchronization and that these opposite correlations with different distributions undergo similar and significant neuronal developments with brain maturation.	[Michels, Lars; Martin, Ernst] Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland; [Michels, Lars] Univ Zurich Hosp, Inst Neuroradiol, CH-8091 Zurich, Switzerland; [Luechinger, Rafael; Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Koenig, Thomas] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland; [Martin, Ernst; Brandeis, Daniel] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Brandeis, Daniel] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Heidelberg, Germany	University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Bern; University Hospital of Bern; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Michels, L (corresponding author), Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland.	lars.michels@kispi.uzh.ch	Koenig, Thomas/F-6454-2010; Michels, Lars/X-6939-2018; Koenig, Thomas/ABD-2278-2020	Koenig, Thomas/0000-0002-1472-4638; Koenig, Thomas/0000-0002-1472-4638; Michels, Lars/0000-0003-3750-1100	University Research Priority Program "Integrative Human Physiology"	University Research Priority Program "Integrative Human Physiology"	This work was supported by the University Research Priority Program "Integrative Human Physiology" ("Linking the major system markers for typical and atypical brain development: a multimodal imaging and spectroscopy study" and "Thalamocortical interaction in brain state regulation during normal development and in epilepsy") at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P2252, DOI 10.1016/j.clinph.2004.05.004; Basar E, 1997, BIOL CYBERN, V76, P471, DOI 10.1007/s004220050360; Bell MA, 2002, PSYCHOPHYSIOLOGY, V39, P450, DOI 10.1017/S0048577201393174; Bell MA, 2007, DEV NEUROPSYCHOL, V31, P21, DOI 10.1207/s15326942dn3101_2; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Brem S, 2010, P NATL ACAD SCI USA, V107, P7939, DOI 10.1073/pnas.0904402107; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Campbell IG, 2011, SLEEP, V34, P83, DOI 10.1093/sleep/34.1.83; CASEY BJ, 1995, NEUROIMAGE, V2, P221, DOI 10.1006/nimg.1995.1029; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doesburg SM, 2010, EXP BRAIN RES, V201, P719, DOI 10.1007/s00221-009-2086-9; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Etherington SJ, 2011, J NEUROSCI, V31, P9526, DOI 10.1523/JNEUROSCI.0458-11.2011; Ewald A, 2012, NEUROIMAGE, V60, P476, DOI 10.1016/j.neuroimage.2011.11.084; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Feinberg I, 2011, SLEEP, V34, P325, DOI 10.1093/sleep/34.3.325; Feldman DE, 2000, NAT NEUROSCI, V3, P303, DOI 10.1038/73849; Fernandez T, 1998, NEUROREPORT, V9, P3681; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Finn AS, 2010, J NEUROSCI, V30, P11062, DOI 10.1523/JNEUROSCI.6266-09.2010; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Frei E, 2001, HUM BRAIN MAPP, V14, P152, DOI 10.1002/hbm.1049; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P100, DOI 10.1016/0013-4694(88)90205-2; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; Grieve PG, 2003, CLIN NEUROPHYSIOL, V114, P1594, DOI 10.1016/S1388-2457(03)00122-6; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hestrin S, 2005, NAT NEUROSCI, V8, P1283, DOI 10.1038/nn1005-1283; INGVAR DH, 1976, ELECTROEN CLIN NEURO, V41, P268, DOI 10.1016/0013-4694(76)90119-X; INGVAR DH, 1979, PHARMAKOPSYCH NEURO, V12, P200, DOI 10.1055/s-0028-1094611; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jensen O, 2006, NEUROSCIENCE, V139, P237, DOI 10.1016/j.neuroscience.2005.06.004; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 1998, J NEUROSCI, V18, P10688; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; Koenig T, 2001, NEUROIMAGE, V14, P383, DOI 10.1006/nimg.2001.0825; Koenig T, 2001, SCHIZOPHR RES, V50, P55, DOI 10.1016/S0920-9964(00)00154-7; Koenig T, 2009, ELECT NEUROIMAGING, P145, DOI DOI 10.1017/CBO9780511596889.009; Krause CM, 2007, NEUROREPORT, V18, P213, DOI 10.1097/WNR.0b013e3280148ea0; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luchinger R, 2011, NEUROIMAGE; Luchinger R, 2012, NEUROIMAGE, V60, P1426, DOI 10.1016/j.neuroimage.2012.01.031; MATOUSEK M, 1973, ELECTROEN CLIN NEURO, V35, P603, DOI 10.1016/0013-4694(73)90213-7; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meltzer JA, 2007, CLIN NEUROPHYSIOL, V118, P2419, DOI 10.1016/j.clinph.2007.07.023; Michels L, 2010, BRAIN TOPOGR; Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Muller V, 2009, DEVELOPMENTAL SCI, V12, P839, DOI 10.1111/j.1467-7687.2009.00834.x; NAGATA K, 1988, Brain Topography, V1, P97, DOI 10.1007/BF01129174; Nelson C.A., 2001, HDB DEV COGNITIVE NE; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; O'Hare ED, 2008, NEUROIMAGE, V42, P1678, DOI 10.1016/j.neuroimage.2008.05.057; Olesen PJ, 2007, CEREB CORTEX, V17, P1047, DOI 10.1093/cercor/bhl0l4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Pugnetti L, 2010, INT J NEUROSCI, V120, P88, DOI 10.3109/00207450903436346; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Sammer G, 2007, HUM BRAIN MAPP, V28, P793, DOI 10.1002/hbm.20309; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002; Sauseng P, 2002, NEUROSCI LETT, V324, P121, DOI 10.1016/S0304-3940(02)00225-2; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Scherf KS, 2006, J COGNITIVE NEUROSCI, V18, P1045, DOI 10.1162/jocn.2006.18.7.1045; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Supekar K, 2010, NEUROIMAGE; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wackermann J, 1998, ELECTROEN CLIN NEURO, V107, P415, DOI 10.1016/S0013-4694(98)00090-X; Wu X, 2007, NEUROIMAGE, V35, P1654, DOI 10.1016/j.neuroimage.2007.02.011; Yordanova J, 1996, NEUROREPORT, V8, P277, DOI 10.1097/00001756-199612200-00055; Yordanova J, 1997, INT J PSYCHOPHYSIOL, V26, P411, DOI 10.1016/S0167-8760(97)00779-4; Yordanova J, 1996, INT J NEUROSCI, V85, P155, DOI 10.3109/00207459608986360; Yordanova JY, 1996, ELECTROEN CLIN NEURO, V99, P527	115	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39447	10.1371/journal.pone.0039447	http://dx.doi.org/10.1371/journal.pone.0039447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792176	Green Accepted, Green Published, gold			2022-12-27	WOS:000306461800013
J	Pandelova, I; Figueroa, M; Wilhelm, LJ; Manning, VA; Mankaney, AN; Mockler, TC; Ciuffetti, LM				Pandelova, Iovanna; Figueroa, Melania; Wilhelm, Larry J.; Manning, Viola A.; Mankaney, Aakash N.; Mockler, Todd C.; Ciuffetti, Lynda M.			Host-Selective Toxins of Pyrenophora tritici-repentis Induce Common Responses Associated with Host Susceptibility	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TAN SPOT; PTR TOXA; GENE-EXPRESSION; MICROARRAY ANALYSIS; CHLOROSIS TOXIN; POWDERY MILDEW; JASMONIC ACID; CAUSAL AGENT; WHEAT	Pyrenophora tritici-repentis (Ptr), a necrotrophic fungus and the causal agent of tan spot of wheat, produces one or a combination of host-selective toxins (HSTs) necessary for disease development. The two most studied toxins produced by Ptr, Ptr ToxA (ToxA) and Ptr ToxB (ToxB), are proteins that cause necrotic or chlorotic symptoms respectively. Investigation of host responses induced by HSTs provides better insight into the nature of the host susceptibility. Microarray analysis of ToxA has provided evidence that it can elicit responses similar to those associated with defense. In order to evaluate whether there are consistent host responses associated with susceptibility, a similar analysis of ToxB-induced changes in the same sensitive cultivar was conducted. Comparative analysis of ToxA-and ToxB-induced transcriptional changes showed that similar groups of genes encoding WRKY transcription factors, RLKs, PRs, components of the phenylpropanoid and jasmonic acid pathways are activated. ROS accumulation and photosystem dysfunction proved to be common mechanism-of-action for these toxins. Despite similarities in defense responses, transcriptional and biochemical responses as well as symptom development occur more rapidly for ToxA compared to ToxB, which could be explained by differences in perception as well as by differences in activation of a specific process, for example, ethylene biosynthesis in ToxA treatment. Results of this study suggest that perception of HSTs will result in activation of defense responses as part of a susceptible interaction and further supports the hypothesis that necrotrophic fungi exploit defense responses in order to induce cell death.	[Pandelova, Iovanna; Figueroa, Melania; Wilhelm, Larry J.; Manning, Viola A.; Mankaney, Aakash N.; Mockler, Todd C.; Ciuffetti, Lynda M.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Pandelova, Iovanna; Figueroa, Melania; Wilhelm, Larry J.; Manning, Viola A.; Mankaney, Aakash N.; Mockler, Todd C.; Ciuffetti, Lynda M.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Figueroa, Melania] Oregon State Univ, USDA, ARS, Forage Seed & Cereal Res Unit, Corvallis, OR 97331 USA; [Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Oregon State University; Oregon State University; Oregon State University; United States Department of Agriculture (USDA); Donald Danforth Plant Science Center	Pandelova, I (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	ciuffetL@science.oregonstate.edu	Mockler, Todd C/L-2609-2013; Figueroa, Melania/AAI-8692-2021; Figueroa, Melania/R-7696-2017	Mockler, Todd C/0000-0002-0462-5775; Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X	National Research Initiative Microbial Biology: Microbial Associations with Plants Program of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES) [2006-55600-16619]; Agriculture and Food Research Initiative Competitive Grants Program [2010-65108-20548]; SIDA National Institute of Food and Agriculture	National Research Initiative Microbial Biology: Microbial Associations with Plants Program of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES); Agriculture and Food Research Initiative Competitive Grants Program; SIDA National Institute of Food and Agriculture	This project was supported by the National Research Initiative Microbial Biology: Microbial Associations with Plants Program of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES, grant#:2006-55600-16619) and in part by the Agriculture and Food Research Initiative Competitive Grants Program grant #:2010-65108-20548) from the SIDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari TB, 2009, MOL PLANT MICROBE IN, V22, P1056, DOI 10.1094/MPMI-22-9-1056; Anderson JA, 1999, PHYTOPATHOLOGY, V89, P293, DOI 10.1094/PHYTO.1999.89.4.293; Andrie RA, 2007, PHYTOPATHOLOGY, V97, P694, DOI 10.1094/PHYTO-97-6-0694; BALLANCE GM, 1989, PHYSIOL MOL PLANT P, V35, P203, DOI 10.1016/0885-5765(89)90051-9; Ballance GM, 1996, MOL PLANT PATHOL; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENNETT FGA, 1984, PLANT PATHOL, V33, P279, DOI 10.1111/j.1365-3059.1984.tb01324.x; Betts MF, 2011, PHYSIOL MOL PLANT P, V75, P138, DOI 10.1016/j.pmpp.2011.03.002; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Boddu J, 2007, MOL PLANT MICROBE IN, V20, P1364, DOI 10.1094/MPMI-20-11-1364; Boyle C, 2006, PLANT PATHOL, V55, P82, DOI 10.1111/j.1365-3059.2005.01281.x; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; Ciuffetti LM, 1998, CAN J PLANT PATHOL, V20, P421, DOI 10.1080/07060669809500415; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; Cosgrove DJ, 2001, CURR BIOL, V11, pR558, DOI 10.1016/S0960-9822(01)00342-6; De Wolf ED, 1998, CAN J PLANT PATHOL, V20, P349, DOI 10.1080/07060669809500404; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Faris JD, 1996, PHYTOPATHOLOGY, V86, P459, DOI 10.1094/Phyto-86-459; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Frick UB, 2002, PLANTA, V216, P83, DOI 10.1007/s00425-002-0887-1; Friesen TL, 2008, PLANT PHYSIOL, V146, P682, DOI 10.1104/pp.107.108761; Friesen TL, 2004, THEOR APPL GENET, V109, P464, DOI 10.1007/s00122-004-1678-9; Gamba FM, 1998, CAN J PLANT PATHOL, V20, P401, DOI 10.1080/07060669809500411; Gechev TS, 2004, CELL MOL LIFE SCI, V61, P1185, DOI 10.1007/s00018-004-4067-2; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; HAGBORG WAF, 1970, CAN J BOTANY, V48, P1135, DOI 10.1139/b70-165; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Kim YM, 2010, PROTEOMICS, V10, P2911, DOI 10.1002/pmic.200900670; Kwon CY, 1998, PHYSIOL MOL PLANT P, V52, P201, DOI 10.1006/pmpp.1998.0151; Lamari L, 2005, PHYTOPATHOLOGY, V95, P144, DOI 10.1094/PHYTO-95-0144; Lamari L, 2003, PHYTOPATHOLOGY, V93, P391, DOI 10.1094/PHYTO.2003.93.4.391; LAMARI L, 1991, PHYTOPATHOLOGY, V81, P1092, DOI 10.1094/Phyto-81-1092; Lamari L, 1995, CAN J PLANT PATHOL, V17, P312, DOI 10.1080/07060669509500668; Lamari L, 2010, CAN J PLANT PATHOL, V32, P4, DOI 10.1080/07060661003594117; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Mahalingam R, 1999, MOL PLANT MICROBE IN, V12, P490, DOI 10.1094/MPMI.1999.12.6.490; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Manning VA, 2004, MOL PLANT MICROBE IN, V17, P491, DOI 10.1094/MPMI.2004.17.5.491; Manning VA, 2008, MOL PLANT MICROBE IN, V21, P315, DOI 10.1094/MPMI-21-3-0315; Manning VA, 2009, MOL PLANT MICROBE IN, V22, P665, DOI 10.1094/MPMI-22-6-0665; Martinez JP, 2004, MOL PLANT MICROBE IN, V17, P467, DOI 10.1094/MPMI.2004.17.5.467; Martinez JP, 2001, MOL PLANT MICROBE IN, V14, P675, DOI 10.1094/MPMI.2001.14.5.675; MUELLER MJ, 1993, P NATL ACAD SCI USA, V90, P7490, DOI 10.1073/pnas.90.16.7490; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; OROLAZA NP, 1995, PHYTOPATHOLOGY, V85, P1282, DOI 10.1094/Phyto-85-1282; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Perello A, 2003, CROP PROT, V22, P157, DOI 10.1016/S0261-2194(02)00140-0; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; REINBOTHE S, 1994, P NATL ACAD SCI USA, V91, P7012, DOI 10.1073/pnas.91.15.7012; REINBOTHE S, 1993, EMBO J, V12, P1505, DOI 10.1002/j.1460-2075.1993.tb05794.x; REINBOTHE S, 1994, PLANT CELL, V6, P1197, DOI 10.1105/tpc.6.9.1197; Rickauer M, 1997, PLANTA, V202, P155, DOI 10.1007/s004250050114; Saad HA, 2008, CORNEA, V27, P818, DOI 10.1097/ICO.0b013e3181705ca2; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Sarma GN, 2005, PLANT CELL, V17, P3190, DOI 10.1105/tpc.105.034918; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stock WS, 1996, GENOME, V39, P598, DOI 10.1139/g96-075; Strelkov S, 1998, DEV PLANT PATHOL, V13, P137; Strelkov SE, 2005, PHYSIOL MOL PLANT P, V67, P164, DOI 10.1016/j.pmpp.2005.12.004; Strelkov SE, 2003, CAN J PLANT PATHOL, V25, P339; Strelkov SE, 1998, CAN J PLANT PATHOL, V20, P428, DOI 10.1080/07060669809500417; Strelkov SE, 1999, MOL PLANT MICROBE IN, V12, P728, DOI 10.1094/MPMI.1999.12.8.728; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; TOMAS A, 1990, MOL PLANT MICROBE IN, V3, P221, DOI 10.1094/MPMI-3-221; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; TUORI RP, 1995, MOL PLANT MICROBE IN, V8, P41, DOI 10.1094/MPMI-8-0041; Tuori RP, 2000, MOL PLANT MICROBE IN, V13, P456, DOI 10.1094/MPMI.2000.13.4.456; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Van Breusegem F, 2008, PLANT PHYSIOL, V147, P978, DOI 10.1104/pp.108.122325; VANWEES S, 2002, ARABIDOPSIS LAB MANU, P86; Vincent D, 2012, MOL PLANT PATHOL, V13, P467, DOI 10.1111/j.1364-3703.2011.00763.x; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Weise, 1987, COMPENDIUM WHEAT DIS, P42; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wi SJ, 2010, MOL CELLS, V30, P37, DOI 10.1007/s10059-010-0086-z; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z; Zhang HF, 1997, PHYTOPATHOLOGY, V87, P154, DOI 10.1094/PHYTO.1997.87.2.154; Zhang LR, 2008, PLANT CELL PHYSIOL, V49, P1092, DOI 10.1093/pcp/pcn086; Zhang SB, 2005, PLANT PHYSIOL, V139, P1107, DOI 10.1104/pp.105.069005; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	97	27	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40240	10.1371/journal.pone.0040240	http://dx.doi.org/10.1371/journal.pone.0040240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792250	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800055
J	Silva, LP; Vanzile, M; Bavari, S; Aman, JMJ; Schriemer, DC				Silva, Leslie P.; Vanzile, Michael; Bavari, Sina; Aman, J. M. Javad; Schriemer, David C.			Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails	PLOS ONE			English	Article							POSTEXPOSURE PROTECTION; NONHUMAN-PRIMATES; RNA; OLIGOMERIZATION; GLYCOPROTEIN; ASSOCIATION; PARTICLES; DISCOVERY; GENOME; TSG101	The matrix protein VP40 coordinates numerous functions in the viral life cycle of the Ebola virus. These range from the regulation of viral transcription to morphogenesis, packaging and budding of mature virions. Similar to the matrix proteins of other nonsegmented, negative-strand RNA viruses, VP40 proceeds through intermediate states of assembly (e.g. octamers) but it remains unclear how these intermediates are coordinated with the various stages of the life cycle. In this study, we investigate the molecular basis of synchronization as governed by VP40. Hydrogen/deuterium exchange mass spectrometry was used to follow induced structural and conformational changes in VP40. Together with computational modeling, we demonstrate that both extreme N and C terminal tail regions stabilize the monomeric state through a direct association. The tails appear to function as a latch, released upon a specific molecular trigger such as RNA ligation. We propose that triggered release of the tails permits the coordination of late-stage events in the viral life cycle, at the inner membrane of the host cell. Specifically, N-tail release exposes the L-domain motifs PTAP/PPEY to the transport and budding complexes, whereas triggered C-tail release could improve association with the site of budding.	[Silva, Leslie P.; Schriemer, David C.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Vanzile, Michael; Bavari, Sina; Aman, J. M. Javad] USA, Med Res Inst Infect Dis, Frederick, MD USA	University of Calgary	Silva, LP (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	dschriem@ucalgary.ca	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635	Alberta Innovates - Health Solutions; Defense Threat Reduction Agency [JSTO-CBD project] [44.10022-08-RD-B]; Defense Threat Reduction Agency TMTI (Transformational Medical Technologies Initiative) project [0048-09-RD-T]	Alberta Innovates - Health Solutions; Defense Threat Reduction Agency [JSTO-CBD project]; Defense Threat Reduction Agency TMTI (Transformational Medical Technologies Initiative) project	The work was supported in part by grants from Alberta Innovates - Health Solutions, the Defense Threat Reduction Agency [JSTO-CBD project 44.10022-08-RD-B and TMTI (Transformational Medical Technologies Initiative) project 0048-09-RD-T]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; Chalmers MJ, 2011, INT J MASS SPECTROM, V302, P59, DOI 10.1016/j.ijms.2010.08.002; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Halfmann P, 2008, P NATL ACAD SCI USA, V105, P1129, DOI 10.1073/pnas.0708057105; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; He J, 2009, VIRUSES-BASEL, V1, P441, DOI 10.3390/v1030441; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Hoenen T, 2012, EXPERT OPIN BIOL THE; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Johnson RF, 2006, J VIROL, V80, P5135, DOI 10.1128/JVI.01857-05; Kortepeter MG, 2008, EMERG INFECT DIS, V14, P881, DOI 10.3201/eid1406.071489; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Pigott DC, 2005, CRIT CARE CLIN, V21, P765, DOI 10.1016/j.ccc.2005.06.007; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Reynard O, 2011, J INFECT DIS, V204, pS884, DOI 10.1093/infdis/jir359; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Schmitt AP, 2004, CURR TOP MICROBIOL, V283, P145; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Slysz GW, 2008, ANAL CHEM, V80, P7004, DOI 10.1021/ac800897q; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; Timmins J, 2003, VIROLOGY, V312, P359, DOI 10.1016/S0042-6822(03)00260-5; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2005, EXPERT REV VACCINES, V4, P429, DOI 10.1586/14760584.4.3.429; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837	39	22	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39978	10.1371/journal.pone.0039978	http://dx.doi.org/10.1371/journal.pone.0039978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792204	Green Submitted, gold, Green Published			2022-12-27	WOS:000306436300018
J	Weinstein, SJ; Peters, U; Ahn, J; Friesen, MD; Riboli, E; Hayes, RB; Albanes, D				Weinstein, Stephanie J.; Peters, Ulrike; Ahn, Jiyoung; Friesen, Marlin D.; Riboli, Elio; Hayes, Richard B.; Albanes, Demetrius			Serum alpha-Tocopherol and gamma-Tocopherol Concentrations and Prostate Cancer Risk in the PLCO Screening Trial: A Nested Case-Control Study	PLOS ONE			English	Article							DIETARY VITAMIN-E; OMEGA-HYDROXYLASE PATHWAY; BETA-CAROTENE; SUPPLEMENTATION; RETINOL; ASSOCIATION; PREVENTION; SELENIUM; MICRONUTRIENTS; MEN	Background: Vitamin E compounds exhibit prostate cancer preventive properties experimentally, but serologic investigations of tocopherols, and randomized controlled trials of supplementation in particular, have been inconsistent. Many studies suggest protective effects among smokers and for aggressive prostate cancer, however. Methods: We conducted a nested case-control study of serum alpha-tocopherol and gamma-tocopherol and prostate cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, with 680 prostate cancer cases and 824 frequency-matched controls. Multivariate-adjusted, conditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CIs) for tocopherol quintiles. Results: Serum alpha-tocopherol and gamma-tocopherol were inversely correlated (r = -0.24, p < 0.0001). Higher serum alpha-tocopherol was associated with significantly lower prostate cancer risk (OR for the highest vs. lowest quintile = 0.63, 95% CI 0.44-0.92, p-trend 0.05). By contrast, risk was non-significantly elevated among men with higher gamma-tocopherol concentrations (OR for the highest vs. lowest quintile = 1.35, 95% CI 0.92-1.97, p-trend 0.41). The inverse association between prostate cancer and alpha-tocopherol was restricted to current and recently former smokers, but was only slightly stronger for aggressive disease. By contrast, the increased risk for higher gamma-tocopherol was more pronounced for less aggressive cancers. Conclusions: Our findings indicate higher alpha-tocopherol status is associated with decreased risk of developing prostate cancer, particularly among smokers. Although two recent controlled trials did not substantiate an earlier finding of lower prostate cancer incidence and mortality in response to supplementation with a relatively low dose of a-tocopherol, higher a-tocopherol status may be beneficial with respect to prostate cancer risk among smokers. Determining what stage of prostate cancer development is impacted by vitamin E, the underlying mechanisms, and how smoking modifies the association, is needed for a more complete understanding of the vitamin E-prostate cancer relation.	[Weinstein, Stephanie J.; Albanes, Demetrius] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Peters, Ulrike] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Ahn, Jiyoung; Hayes, Richard B.] NYU, Sch Med, Dept Populat Hlth, Div Epidemiol, New York, NY USA; [Friesen, Marlin D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol, London, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; New York University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Imperial College London	Weinstein, SJ (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	weinstes@mail.nih.gov; daa@nih.gov	Weinstein, Stephanie J/P-1627-2017; Albanes, Demetrius/B-9749-2015	Weinstein, Stephanie J/0000-0002-3834-1535; Riboli, Elio/0000-0001-6795-6080; Hayes, Richard/0000-0002-0918-661X; Ahn, Jiyoung/0000-0002-2900-2304	Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services (DHHS)	Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services (DHHS)	This research was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services (DHHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; [Anonymous], 1994, Ann Epidemiol, V4, P1, DOI 10.1016/1047-2797(94)90036-1; [Anonymous], 1997, AJCC CANC STAGING MA; Brigelius-Flohe R, 2002, AM J CLIN NUTR, V76, P703, DOI 10.1093/ajcn/76.4.703; Bruno RS, 2005, J NUTR, V135, P671, DOI 10.1093/jn/135.4.671; Bruno RS, 2005, AM J CLIN NUTR, V81, P95; Chan JM, 1999, CANCER EPIDEM BIOMAR, V8, P893; Cheng TYD, 2011, J NUTR, V141, P1731, DOI 10.3945/jn.111.141713; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Comstock GW, 2001, CANCER EPIDEM BIOMAR, V10, P65; Eichholzer M, 1996, INT J CANCER, V66, P145, DOI 10.1002/(SICI)1097-0215(19960410)66:2&lt;145::AID-IJC1&gt;3.0.CO;2-2; Fleshner NE, 2002, UROL CLIN N AM, V29, P107, DOI 10.1016/S0094-0143(02)00023-X; Ford ES, 2006, AM J CLIN NUTR, V84, P375; Gann PH, 2009, JAMA-J AM MED ASSOC, V301, P102, DOI 10.1001/jama.2008.863; Gann PH, 1999, CANCER RES, V59, P1225; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Gill JK, 2009, CANCER CAUSE CONTROL, V20, P1161, DOI 10.1007/s10552-009-9304-4; Goodman GE, 2003, CANCER EPIDEM BIOMAR, V12, P518; HANDELMAN GJ, 1985, J NUTR, V115, P807, DOI 10.1093/jn/115.6.807; Hartman TJ, 2001, PROSTATE, V46, P33, DOI 10.1002/1097-0045(200101)46:1&lt;33::AID-PROS1005&gt;3.0.CO;2-6; HAYES RB, 1988, CANCER-AM CANCER SOC, V62, P2021, DOI 10.1002/1097-0142(19881101)62:9<2021::AID-CNCR2820620925>3.0.CO;2-R; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Helzlsouer KJ, 2000, J NATL CANCER I, V92, P2018, DOI 10.1093/jnci/92.24.2018; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; Jiang Q, 2000, P NATL ACAD SCI USA, V97, P11494, DOI 10.1073/pnas.200357097; Key TJ, 2007, AM J CLIN NUTR, V86, P672, DOI 10.1093/ajcn/86.3.672; Kirsh VA, 2006, JNCI-J NATL CANCER I, V98, P245, DOI 10.1093/jnci/djj050; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; KNEKT P, 1988, AM J EPIDEMIOL, V127, P28, DOI 10.1093/oxfordjournals.aje.a114788; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Major JM, 2011, HUM MOL GENET; Meyer F, 2005, INT J CANCER, V116, P182, DOI 10.1002/ijc.21058; Mondu AM, 2011, J NUTR, V141, P2030, DOI 10.3945/jn.111.143669; Mondul AM, 2011, CANCER CAUSE CONTROL, V22, P827, DOI 10.1007/s10552-011-9753-4; Moyad M A, 1999, Semin Urol Oncol, V17, P85; Ni J, 2003, BIOCHEM BIOPH RES CO, V300, P357, DOI 10.1016/S0006-291X(02)02851-6; Nomura AMY, 1997, CANCER EPIDEM BIOMAR, V6, P487; Parker RS, 2004, ANN NY ACAD SCI, V1031, P13, DOI 10.1196/annals.1331.002; Peters U, 2008, CANCER CAUSE CONTROL, V19, P75, DOI 10.1007/s10552-007-9072-y; Peters U, 2007, CANCER EPIDEM BIOMAR, V16, P962, DOI 10.1158/1055-9965.EPI-06-0861; Ricciarelli R, 2001, FASEB J, V15, P2314, DOI 10.1096/fj.01-0258rev; Rodriguez C, 2004, CANCER EPIDEM BIOMAR, V13, P378; Rossini A, 2008, PHARMACOGENOMICS, V9, P1737, DOI 10.2217/14622416.9.11.1737; Rothman K., 1998, MODERN EPIDEMIOLOGY; Saldeen K, 2005, NUTR RES, V25, P877, DOI 10.1016/j.nutres.2005.09.019; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Steghens JP, 1997, J CHROMATOGR B, V694, P71, DOI 10.1016/S0378-4347(97)00140-0; Stram DO, 2006, CANCER CAUSE CONTROL, V17, P1193, DOI 10.1007/s10552-006-0064-0; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; Traber M.G., 1999, MODERN NUTR HLTH DIS, V9th, P347; Traber MG, 2010, MOL NUTR FOOD RES, V54, P661, DOI 10.1002/mnfr.200900440; Venkateswaran V, 2010, NAT REV UROL, V7, P442, DOI 10.1038/nrurol.2010.102; Wagner KH, 2004, ANN NUTR METAB, V48, P169, DOI 10.1159/000079555; Watters JL, 2009, CANCER RES, V69, P3833, DOI 10.1158/0008-5472.CAN-08-4640; Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045; Weinstein SJ, 2007, CANCER EPIDEM BIOMAR, V16, P1253, DOI 10.1158/1055-9965.EPI-06-1084; Woodson K, 2002, ANTICANCER RES, V22, P375; Wright ME, 2007, CANCER EPIDEM BIOMAR, V16, P1128, DOI 10.1158/1055-9965.EPI-06-1071; Zhang Y, 2002, P NATL ACAD SCI USA, V99, P7408, DOI 10.1073/pnas.102014399	63	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40204	10.1371/journal.pone.0040204	http://dx.doi.org/10.1371/journal.pone.0040204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792240	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300035
J	Roh, M; Zhang, Y; Murakami, Y; Thanos, A; Lee, SC; Vavvas, DG; Benowitz, LI; Miller, JW				Roh, Miin; Zhang, Yan; Murakami, Yusuke; Thanos, Aristomenis; Lee, Sung Chul; Vavvas, Demetrios G.; Benowitz, Larry I.; Miller, Joan W.			Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-alpha (TNF-alpha), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; MOUSE MODEL; FLUORESCEIN LEAKAGE; ACTIVATED MICROGLIA; ALZHEIMERS-DISEASE; NEURONAL DEATH; OPTIC DISC; EXPRESSION; ISCHEMIA	Background: Visual loss in glaucoma is associated with pathological changes in retinal ganglion cell (RGC) axons and a slow decline in the RGC population. Age and elevated intraocular pressure (IOP) are the main risk factors for glaucomatous loss of vision. Several studies have implicated the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) as a link between elevated IOP and RGC death, but the cellular source of TNF-alpha and its causative role in RGC death remain uncertain. Here, using a rat model of glaucoma, we investigated the source of elevated TNF-alpha and examined whether Etanercept, a TNF-alpha blocker that is in common clinical use for other indications, is protective against RGC death. Methodology/Principal Findings: Episcleral vein cauterization (EVC) caused intraocular pressure (IOP) to be elevated for at least 28 days. IOP elevation resulted in a dramatic increase in TNF-alpha levels within a few days, axonal degeneration, and a 38% loss of RGCs by 4 weeks. Immunostaining coupled with confocal microscopy showed that OHT induced robust induction of TNF-alpha in Iba-1-positive microglia around the optic nerve head (ONH). Despite persistent elevation of IOP, Etanercept reduced microglial activation, TNF-alpha levels, axon degeneration in the optic nerve, and the loss of RGCs. Conclusions/Significance: Ocular hypertension (OHT) triggers an inflammatory response characterized by the appearance of activated microglia around the ONH that express TNF-alpha. Blocking TNF-alpha activity with a clinically approved agent inhibits this microglial response and prevents axonal degeneration and loss of RGCs. These findings suggest a new treatment strategy for glaucoma using TNF-alpha antagonists or suppressors of inflammation.	[Roh, Miin; Zhang, Yan; Murakami, Yusuke; Thanos, Aristomenis; Vavvas, Demetrios G.; Miller, Joan W.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02215 USA; [Roh, Miin; Zhang, Yan; Murakami, Yusuke; Thanos, Aristomenis; Vavvas, Demetrios G.; Miller, Joan W.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Retina Serv,Dept Ophthalmol, Boston, MA USA; [Roh, Miin; Lee, Sung Chul] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seoul, South Korea; [Benowitz, Larry I.] Harvard Univ, Sch Med, Labs Neurosci Res Neurosurg, Boston, MA USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Dept Surg, FM Kirby Neurobiol Ctr,Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol, FM Kirby Neurobiol Ctr,Childrens Hosp, Boston, MA USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Yonsei University; Yonsei University Health System; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Roh, M (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02215 USA.	larry.benowitz@childrens.harvard.edu; joan_miller@meei.harvard.edu		Benowitz, Larry/0000-0002-0277-7222; Miller, Joan/0000-0003-2046-3996; Vavvas, Demetrios/0000-0002-8622-6478; Roh, Miin/0000-0003-3346-754X	Neovascular Research Fund; Bacardi Fund; Research to Prevent Blindness Foundation; Lions Eye Research Fund; Onassis Foundation; Fight For Sight; Harvard Ophthalmology Department; National Eye Institute [EY014104, EY05690]; NATIONAL EYE INSTITUTE [P30EY014104, R01EY005690] Funding Source: NIH RePORTER	Neovascular Research Fund; Bacardi Fund; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Lions Eye Research Fund; Onassis Foundation; Fight For Sight; Harvard Ophthalmology Department; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Neovascular Research Fund (JM, MR), the Bacardi Fund (DV), the Research to Prevent Blindness Foundation (DV), the Lions Eye Research Fund (DV), the Onassis Foundation (DV), a Fight For Sight Grant-in-Aid (DV), the Harvard Ophthalmology Department (DV), and National Eye Institute grants EY014104 (JM) and EY05690 (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend O, 2005, GRAEF ARCH CLIN EXP, V243, P659, DOI 10.1007/s00417-004-1092-7; Avunduk MC, 2004, EXP EYE RES, V79, P357, DOI 10.1016/j.exer.2004.06.001; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chen YN, 2007, BRAIN RES, V1148, P28, DOI 10.1016/j.brainres.2007.02.027; Chung HS, 1999, SURV OPHTHALMOL, V43, pS43, DOI 10.1016/S0039-6257(99)00050-8; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Fischer F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-120; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; Harms AS, 2012, GLIA, V60, P189, DOI 10.1002/glia.21254; Harms AS, 2011, MOL THER, V19, P46, DOI 10.1038/mt.2010.217; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hernandez M R, 1993, J Glaucoma, V2, P50; Sande PH, 2008, AM J PATHOL, V173, P1702, DOI 10.2353/ajpath.2008.080518; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Ju KR, 2006, BRAIN RES, V1122, P209, DOI 10.1016/j.brainres.2006.09.022; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kaur C, 2008, CLIN OPHTHALMOL, V2, P879, DOI 10.2147/opth.s3361; Kreutz MR, 2004, EUR J NEUROSCI, V19, P247, DOI 10.1111/j.1460-9568.2004.03087.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; Mangan BG, 2007, VET OPHTHALMOL, V10, P117, DOI 10.1111/j.1463-5224.2007.00585.x; Marina N, 2010, NAT PROTOC, V5, P1642, DOI 10.1038/nprot.2010.128; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Moreland LW, 2000, J RHEUMATOL, V27, P601; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nanda S, 2004, EXPERT OPIN PHARMACO, V5, P1175, DOI 10.1517/eoph.5.5.1175.31081; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Plange N, 2010, OPHTHAL PHYSL OPT, V30, P315, DOI 10.1111/j.1475-1313.2010.00717.x; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Ramiro S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008886.pub2; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; Schmidt KG, 2004, OPHTHALMOLOGE, V101, P1071, DOI 10.1007/s00347-004-1131-0; SHAREEF SR, 1995, EXP EYE RES, V61, P379, DOI 10.1016/S0014-4835(05)80131-9; Siu AW, 2002, EXP EYE RES, V75, P401, DOI 10.1006/exer.2002.2029; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P907, DOI 10.1167/iovs.09-4014; Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P705, DOI 10.1167/iovs.06-0810; Tochel C M, 2005, BMC Ophthalmol, V5, P22, DOI 10.1186/1471-2415-5-22; Trichonas G, 2010, INVEST OPHTH VIS SCI, V51, P1677, DOI 10.1167/iovs.09-4193; Uchihara T, 1997, STROKE, V28, P1948, DOI 10.1161/01.STR.28.10.1948; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666, DOI 10.1001/archopht.118.5.666; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	65	144	150	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40065	10.1371/journal.pone.0040065	http://dx.doi.org/10.1371/journal.pone.0040065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802951	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900025
J	Fang, CK; Chen, HW; Chiang, IT; Chen, CC; Liao, JF; Su, TP; Tung, CY; Uchitomi, Y; Hwang, JJ				Fang, Chun-Kai; Chen, Hong-Wen; Chiang, I-Tsang; Chen, Chia-Chieh; Liao, Jyh-Fei; Su, Ton-Ping; Tung, Chieh-Yin; Uchitomi, Yosuke; Hwang, Jeng-Jong			Mirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System	PLOS ONE			English	Article							TAIL SUSPENSION TEST; QUALITY-OF-LIFE; MAJOR DEPRESSION; CANCER-PATIENTS; HEALTHY-VOLUNTEERS; COLORECTAL-CANCER; COLON-CARCINOMA; ANTIDEPRESSANTS; MICE; INTERLEUKIN-12	To study the tumor inhibition effect of mirtazapine, a drug for patients with depression, CT26/luc colon carcinoma-bearing animal model was used. BALB/c mice were randomly divided into six groups: two groups without tumors, i.e. wild-type (no drug) and drug (mirtazapine), and four groups with tumors, i.e. never (no drug), always (pre-drug, i.e. drug treatment before tumor inoculation and throughout the experiment), concurrent (simultaneously tumor inoculation and drug treatment throughout the experiment), and after (post-drug, i.e. drug treatment after tumor inoculation and throughout the experiment). The "psychiatric" conditions of mice were observed from the immobility time with tail suspension and spontaneous motor activity post tumor inoculation. Significant increase of serum interlukin-12 (sIL-12) and the inhibition of tumor growth were found in mirtazapine-treated mice (always, concurrent, and after) as compared with that of never. In addition, interferon-gamma level and immunocompetent infiltrating CD4+/CD8+ T cells in the tumors of mirtazapine-treated, tumor-bearing mice were significantly higher as compared with that of never. Tumor necrosis factor-alpha (TNF-alpha) expressions, on the contrary, are decreased in the mirtazapine-treated, tumor-bearing mice as compared with that of never. Ex vivo autoradiography with [I-123] ADAM, a radiopharmaceutical for serotonin transporter, also confirms the similar results. Notably, better survival rates and intervals were also found in mirtazapine-treated mice. These findings, however, were not observed in the immunodeficient mice. Our results suggest that tumor growth inhibition by mirtazapine in CT26/luc colon carcinoma-bearing mice may be due to the alteration of the tumor microenvironment, which involves the activation of the immune response and the recovery of serotonin level.	[Fang, Chun-Kai; Chiang, I-Tsang; Tung, Chieh-Yin; Hwang, Jeng-Jong] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Fang, Chun-Kai] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Fang, Chun-Kai] Mackay Mem Hosp, Suicide Prevent Ctr, Taipei, Taiwan; [Chen, Hong-Wen] Mackay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, Hong-Wen] Mackay Mem Hosp, Hosp Palliat Care Ctr, Taipei, Taiwan; [Chen, Chia-Chieh] Inst Nucl Energy Res, Tao Yuan, Taiwan; [Liao, Jyh-Fei] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Su, Ton-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Uchitomi, Yosuke] Okayama Univ, Dept Neuropsychiat, Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Institute of Nuclear Energy Research - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Okayama University	Fang, CK (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	jjhwang@ym.edu.tw	Uchitomi, Yosuke/E-1463-2015		National Science Council, Taiwan [NSC100-2314-B-010-016]; University System of Taiwan [VGHUST98-P6-39]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); University System of Taiwan	This work was supported by grants from the National Science Council, Taiwan (NSC100-2314-B-010-016), and the University System of Taiwan (VGHUST98-P6-39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDUL N, 1995, J UROLOGY, V154, P247, DOI 10.1016/S0022-5347(01)67288-4; Anttila SAK, 2001, CNS DRUG REV, V7, P249; Arimochi H, 2006, EUR J PHARMACOL, V541, P17, DOI 10.1016/j.ejphar.2006.04.053; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Cankurtaran ES, 2008, SUPPORT CARE CANCER, V16, P1291, DOI 10.1007/s00520-008-0425-1; Chow TH, 2008, NUCL MED BIOL, V35, P623, DOI 10.1016/j.nucmedbio.2008.04.001; Chow TH, 2009, J NUCL MED, V50, P2073, DOI 10.2967/jnumed.109.063503; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dazzi L, 2002, SYNAPSE, V43, P70, DOI 10.1002/syn.10024; De Berardis D, 2010, INT J IMMUNOPATH PH, V23, P417, DOI 10.1177/039463201002300204; Frick LR, 2008, BIOCHEM PHARMACOL, V75, P1817, DOI 10.1016/j.bcp.2008.01.015; Gil-Ad I, 2008, INT J ONCOL, V33, P277, DOI 10.3892/ijo_00000007; Gu T, 2010, CANCER RES, V70, P129, DOI 10.1158/0008-5472.CAN-09-3170; Heyes MP, 1997, BIOCHEM J, V326, P351, DOI 10.1042/bj3260351; Kast RE, 2007, EUR J CANCER CARE, V16, P351, DOI 10.1111/j.1365-2354.2006.00760.x; Kast RE, 2001, SUPPORT CARE CANCER, V9, P469, DOI 10.1007/s005200000215; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; Kim SW, 2008, PSYCHIAT CLIN NEUROS, V62, P75, DOI 10.1111/j.1440-1819.2007.01778.x; Kim YK, 2002, MOL PSYCHIATR, V7, P1107, DOI 10.1038/sj.mp.4001084; Kraus T, 2002, PHARMACOPSYCHIATRY, V35, P220, DOI 10.1055/s-2002-36390; Kubera M, 2006, PHARMACOL BIOCHEM BE, V85, P813, DOI 10.1016/j.pbb.2006.11.017; Lee KM, 2006, INT IMMUNOPHARMACOL, V6, P1298, DOI 10.1016/j.intimp.2006.03.015; Lin KH, 2002, NUCL MED BIOL, V29, P643, DOI 10.1016/S0969-8051(02)00323-2; Lin KJ, 2004, J NUCL MED, V45, P673; Lopez MC, 2000, J GEN VIROL, V81, P1175, DOI 10.1099/0022-1317-81-5-1175; Lutgendorf SK, 2010, J CLIN ONCOL, V28, P4094, DOI 10.1200/JCO.2009.26.9357; Maes M, 1999, NEUROPSYCHOPHARMACOL, V20, P370, DOI 10.1016/S0893-133X(98)00088-8; Marek GJ, 2003, NEUROPSYCHOPHARMACOL, V28, P402, DOI 10.1038/sj.npp.1300057; Miovic M, 2007, CANCER-AM CANCER SOC, V110, P1665, DOI 10.1002/cncr.22980; Moreno-Smith M, 2011, CLIN CANCER RES, V17, P3649, DOI 10.1158/1078-0432.CCR-10-2441; Mortarini R, 2000, CANCER RES, V60, P3559; Muller N, 2007, NERVENARZT, V78, P1261, DOI 10.1007/s00115-007-2311-3; Pan CC, 2006, CHINESE J PHYSIOL, V49, P290; Qi H, 2009, J NEURO-ONCOL, V94, P367, DOI 10.1007/s11060-009-9887-3; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Rakhit A, 1999, CLIN PHARMACOL THER, V65, P615, DOI 10.1016/S0009-9236(99)90083-8; Reich M, 2008, CURR OPIN ONCOL, V20, P353, DOI 10.1097/CCO.0b013e3282fc734b; Riechelmann RP, 2010, AM J HOSP PALLIAT ME, V27, P106, DOI 10.1177/1049909109345685; Rogoz Z, 2005, J PHYSIOL PHARMACOL, V56, P661; Rosetti M, 2006, J Exp Ther Oncol, V6, P23; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stockler MR, 2007, LANCET ONCOL, V8, P603, DOI 10.1016/S1470-2045(07)70148-1; Sutcigil L, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/76396; Szuster-Ciesielska A, 2003, POL J PHARMACOL, V55, P353; Theobald DE, 2002, J PAIN SYMPTOM MANAG, V23, P442, DOI 10.1016/S0885-3924(02)00381-0; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsai HC, 2009, PROG NEURO-PSYCHOPH, V33, P711, DOI 10.1016/j.pnpbp.2009.03.018; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; Xu WN, 2006, LANCET ONCOL, V7, P301, DOI 10.1016/S1470-2045(06)70622-2	49	28	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e38886	10.1371/journal.pone.0038886	http://dx.doi.org/10.1371/journal.pone.0038886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808019	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700005
J	Hershey, T; Lugar, HM; Shimony, JS; Rutlin, J; Koller, JM; Perantie, DC; Paciorkowski, AR; Eisenstein, SA; Permutt, MA				Hershey, Tamara; Lugar, Heather M.; Shimony, Joshua S.; Rutlin, Jerrel; Koller, Jonathan M.; Perantie, Dana C.; Paciorkowski, Alex R.; Eisenstein, Sarah A.; Permutt, M. Alan		Washington Univ Wolfram Study Grp	Early Brain Vulnerability in Wolfram Syndrome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; VOXEL-BASED MORPHOMETRY; SYNDROME DIABETES-INSIPIDUS; SURFACE-BASED ANALYSIS; CEREBRAL WHITE-MATTER; BONE-MINERAL DENSITY; OPTIC ATROPHY; CHEMICAL CHAPERONES; INTRACRANIAL VOLUME; CORTICAL THICKNESS	Wolfram Syndrome (WFS) is a rare autosomal recessive disease characterized by insulin-dependent diabetes mellitus, optic nerve atrophy, diabetes insipidus, deafness, and neurological dysfunction leading to death in mid-adulthood. WFS is caused by mutations in the WFS1 gene, which lead to endoplasmic reticulum (ER) stress-mediated cell death. Case studies have found widespread brain atrophy in late stage WFS. However, it is not known when in the disease course these brain abnormalities arise, and whether there is differential vulnerability across brain regions and tissue classes. To address this limitation, we quantified regional brain abnormalities across multiple imaging modalities in a cohort of young patients in relatively early stages of WFS. Children and young adults with WFS were evaluated with neurological, cognitive and structural magnetic resonance imaging measures. Compared to normative data, the WFS group had intact cognition, significant anxiety and depression, and gait abnormalities. Compared to healthy and type 1 diabetic control groups, the WFS group had smaller intracranial volume and preferentially affected gray matter volume and white matter microstructural integrity in the brainstem, cerebellum and optic radiations. Abnormalities were detected in even the youngest patients with mildest symptoms, and some measures did not follow the typical age-dependent developmental trajectory. These results establish that WFS is associated with smaller intracranial volume with specific abnormalities in the brainstem and cerebellum, even at the earliest stage of clinical symptoms. This pattern of abnormalities suggests that WFS has a pronounced impact on early brain development in addition to later neurodegenerative effects, representing a significant new insight into the WFS disease process. Longitudinal studies will be critical for confirming and expanding our understanding of the impact of ER stress dysregulation on brain development.	[Hershey, Tamara; Lugar, Heather M.; Rutlin, Jerrel; Koller, Jonathan M.; Perantie, Dana C.; Eisenstein, Sarah A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Hershey, Tamara] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Hershey, Tamara; Shimony, Joshua S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Permutt, M. Alan] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Paciorkowski, Alex R.] Washington Univ, Dept Neurol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hershey, T (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	tammy@npg.wustl.edu		Hershey, Tamara/0000-0001-7549-0698	Washington University; American Diabetes Association; George Decker and Julio V. Santiago Pediatric Diabetes Research Fund; Mallinckrodt Institute of Radiology Pilot Fund; National Institutes of Health [DK016746-39, DK064832, NCRR 1S10RR022984-01A1, UL1 RR024992, MH064769]; National Headache Foundation; McDonnell Center for Systems Neuroscience Small Grants Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070855] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022984, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016746, R01DK064832, P30DK020579, R37DK016746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064769] Funding Source: NIH RePORTER	Washington University; American Diabetes Association(American Diabetes Association); George Decker and Julio V. Santiago Pediatric Diabetes Research Fund; Mallinckrodt Institute of Radiology Pilot Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Headache Foundation; McDonnell Center for Systems Neuroscience Small Grants Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Jack and J. T. Snow Fund at Washington University, the American Diabetes Association, the George Decker and Julio V. Santiago Pediatric Diabetes Research Fund, the Mallinckrodt Institute of Radiology Pilot Fund, and the National Institutes of Health [grant numbers DK016746-39 to MAP, DK064832, NCRR 1S10RR022984-01A1 and UL1 RR024992]. Drs. Deanna Barch, Joan Luby, Kelly Botteron, Tammie Benzinger and Soe Mar provided access to many of the control subject scans. These scans were supported by the National Headache Foundation, the McDonnell Center for Systems Neuroscience Small Grants Program, and the National Institutes of Health [grant number MH064769]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Akiyama M, 2009, DIABETOLOGIA, V52, P653, DOI 10.1007/s00125-009-1270-6; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Barkovich AJ, 2009, BRAIN, V132, P3199, DOI 10.1093/brain/awp247; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Barrett TG, 1997, EYE, V11, P882, DOI 10.1038/eye.1997.226; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bjorntorp P, 2000, MATTER WHITE MATTER, P325; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; CARSON MJ, 1977, AM J DIS CHILD, V131, P1382, DOI 10.1001/archpedi.1977.02120250064010; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; D'Annunzio G, 2008, DIABETES CARE, V31, P1743, DOI 10.2337/dc08-0178; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Ferguson SC, 2003, DIABETES, V52, P149, DOI 10.2337/diabetes.52.1.149; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Fridlund A., 1994, CALIFORNIA VERBAL LE; Galluzzi P, 1999, NEURORADIOLOGY, V41, P729, DOI 10.1007/s002340050832; Genis D, 1997, ACTA NEUROPATHOL, V93, P426, DOI 10.1007/s004010050635; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; GREGORIOS JB, 1989, J NEUROPATH EXP NEUR, V48, P308, DOI 10.1097/00005072-198905000-00028; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Hilson JB, 2009, ACTA NEUROPATHOL, V118, P415, DOI 10.1007/s00401-009-0546-8; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; JACKSON MJ, 1994, DIABETES CARE, V17, P728, DOI 10.2337/diacare.17.7.728; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; KEHL O, 1982, SCHWEIZ MED WSCHR, V112, P348; Kerbrat A, 2012, NEUROLOGY, V78, P194, DOI 10.1212/WNL.0b013e318240799a; KHARDORI R, 1983, DIABETES CARE, V6, P67, DOI 10.2337/diacare.6.1.67; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee NJ, 2009, BRAIN RES, V1276, P77, DOI 10.1016/j.brainres.2009.04.027; Limperopoulos C, 2006, CURR OPIN PEDIATR, V18, P621, DOI 10.1097/MOP.0b013e32801080e8; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Macey PM, 2011, CEREB CORTEX; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Meda SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031913; Moorhead TWJ, 2005, NEUROIMAGE, V28, P544, DOI 10.1016/j.neuroimage.2005.04.045; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Musen G, 2006, DIABETES, V55, P326, DOI 10.2337/diabetes.55.02.06.db05-0520; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nickl-Jockschat T, 2009, NEUROCASE, V15, P47, DOI 10.1080/13554790802613009; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Pakdemirli E, 2005, Australas Radiol, V49, P189, DOI 10.1111/j.1440-1673.2005.01420.x; Perantie DC, 2007, DIABETES CARE, V30, P2331, DOI 10.2337/dc07-0351; Perantie DC, 2011, DIABETES, V60, P3006, DOI 10.2337/db11-0589; Pereira JB, 2011, HUM BRAIN MAPP; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; RANDO TA, 1992, NEUROLOGY, V42, P1220, DOI 10.1212/WNL.42.6.1220; Raud S, 2009, NEUROSCI LETT, V460, P138, DOI 10.1016/j.neulet.2009.05.054; REUHL KR, 1991, NEUROTOXICOLOGY, V12, P341; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Rigoli L, 2011, CLIN GENET, V79, P103, DOI 10.1111/j.1399-0004.2010.01522.x; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Scheel C, 2011, NEUROIMAGE, V58, P391, DOI 10.1016/j.neuroimage.2011.06.040; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Scolding NJ, 1996, ANN NEUROL, V39, P352, DOI 10.1002/ana.410390312; Sgouros S, 1999, J NEUROSURG, V91, P610, DOI 10.3171/jns.1999.91.4.0610; Shannon P, 1999, ACTA NEUROPATHOL, V98, P304, DOI 10.1007/s004010051084; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Sierra C, 2002, J HYPERTENS, V20, P519, DOI 10.1097/00004872-200203000-00028; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sun SW, 2007, NEUROBIOL DIS, V28, P30, DOI 10.1016/j.nbd.2007.06.011; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Wessels AM, 2006, DIABETOLOGIA, V49, P2474, DOI 10.1007/s00125-006-0283-7; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Woods BT, 2005, SCHIZOPHR RES, V73, P221, DOI 10.1016/j.schres.2004.05.014; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamamoto H, 2006, EXP EYE RES, V83, P1303, DOI 10.1016/j.exer.2006.06.010	101	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40604	10.1371/journal.pone.0040604	http://dx.doi.org/10.1371/journal.pone.0040604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792385	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400082
J	Schmidt, F; van den Eijnden, M; Gobert, RP; Saborio, GP; Carboni, S; Alliod, C; Pouly, S; Staugaitis, SM; Dutta, R; Trapp, B; van Huijsduijnen, RH				Schmidt, Fanny; van den Eijnden, Monique; Gobert, Rosanna Pescini; Saborio, Gabriela P.; Carboni, Susanna; Alliod, Chantal; Pouly, Sandrine; Staugaitis, Susan M.; Dutta, Ranjan; Trapp, Bruce; van Huijsduijnen, Rob Hooft			Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GROWTH-FACTOR RECEPTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ELEMENT-BINDING PROTEIN; MULTIPLE-SCLEROSIS; PRECURSOR CELLS; CNS REMYELINATION; PROGENITOR CELLS; MYELIN FORMATION; SORTING NEXIN-6	Multiple sclerosis (MS) is a neuroinflammatory disease characterized by a progressive loss of myelin and a failure of oligodendrocyte (OL)-mediated remyelination, particularly in the progressive phases of the disease. An improved understanding of the signaling mechanisms that control differentiation of OL precursors may lead to the identification of new therapeutic targets for remyelination in MS. About 100 mammalian Protein Tyrosine Phosphatases (PTPs) are known, many of which are involved in signaling both in health and disease. We have undertaken a systematic genomic approach to evaluate PTP gene activity in multiple sclerosis autopsies and in related in vivo and in vitro models of the disease. This effort led to the identification of Dusp15/VHY, a PTP previously believed to be expressed only in testis, as being transcriptionally regulated during OL differentiation and in MS lesions. Subsequent RNA interference studies revealed that Dusp15/VHY is a key regulator of OL differentiation. Finally, we identified PDGFR-beta and SNX6 as novel and specific Dusp15 substrates, providing an indication as to how this PTP might exert control over OL differentiation.	[Schmidt, Fanny; van den Eijnden, Monique; Gobert, Rosanna Pescini; Saborio, Gabriela P.; Carboni, Susanna; Alliod, Chantal; Pouly, Sandrine; van Huijsduijnen, Rob Hooft] Merck Serono SA, Geneva, Switzerland; [Staugaitis, Susan M.; Dutta, Ranjan; Trapp, Bruce] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA	Merck KGaA; EMD Serono Inc.; Cleveland Clinic Foundation	Schmidt, F (corresponding author), Merck Serono SA, Geneva, Switzerland.	rob.hooft@merckgroup.com	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Pescini Gobert, Rosanna/0000-0002-2434-7530	European Union Research Training Network [MRTN-CT-2006-035830]; National Institute of Neurological Disorders and Stroke (NINDS) [NS38667, NS35058]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038667, R01NS035058, P50NS038667] Funding Source: NIH RePORTER	European Union Research Training Network(European Commission); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	FS, MvdE and RHvH received funding from the European Union Research Training Network MRTN-CT-2006-035830. The study is supported by the National Institute of Neurological Disorders and Stroke (NINDS). NS38667 and NS35058 (SMS, RD and BT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, J BIOL CHEM, V279, P32586, DOI 10.1074/jbc.M403442200; Appolloni I, 2009, INT J CANCER, V124, P2251, DOI 10.1002/ijc.24206; Arimura Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000966; Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Bourikas D, 2010, MOL CELL NEUROSCI, V45, P363, DOI 10.1016/j.mcn.2010.07.009; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cavet ME, 2008, FASEB J, V22, P3607, DOI 10.1096/fj.07-094086; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Christophi GP, 2009, LAB INVEST, V89, P742, DOI 10.1038/labinvest.2009.32; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Eng LF, 1996, NEUROCHEM RES, V21, P511, DOI 10.1007/BF02527717; Espejo C, 2005, NEUROSCIENCE, V132, P1135, DOI 10.1016/j.neuroscience.2005.01.057; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fyffe-Maricich SL, 2011, J NEUROSCI, V31, P843, DOI 10.1523/JNEUROSCI.3239-10.2011; Gobert RP, 2009, J BIOL CHEM, V284, P11385, DOI 10.1074/jbc.M807241200; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Haines JD, 2008, J MOL NEUROSCI, V35, P23, DOI 10.1007/s12031-007-9011-0; Hao XB, 2011, CELL SIGNAL, V23, P935, DOI 10.1016/j.cellsig.2011.01.022; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Hildreth KL, 2004, J BIOL CHEM, V279, P41775, DOI 10.1074/jbc.M403274200; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kim M, 2010, FEBS LETT, V584, P3923, DOI 10.1016/j.febslet.2010.08.034; Kippert A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-40; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Lafrenaye AD, 2010, J NEUROCHEM, V115, P269, DOI 10.1111/j.1471-4159.2010.06926.x; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; LUBETZKI C, 1993, P NATL ACAD SCI USA, V90, P6820, DOI 10.1073/pnas.90.14.6820; Massa PT, 2000, GLIA, V29, P376, DOI 10.1002/(SICI)1098-1136(20000215)29:4<376::AID-GLIA8>3.3.CO;2-J; Matesanz F, 2005, J NEUROL, V252, P994, DOI 10.1007/s00415-005-0795-y; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Morris PG, 2010, TARGET ONCOL, V5, P193, DOI 10.1007/s11523-010-0160-7; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; Oya T, 2002, GLIA, V38, P303, DOI 10.1002/glia.10074; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Pereira GB, 2011, J NEUROSCI RES, V89, P1070, DOI 10.1002/jnr.22625; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; Schwertassek U, 2010, FEBS J, V277, P2463, DOI 10.1111/j.1742-4658.2010.07661.x; Selvaraju R, 2004, MOL CELL NEUROSCI, V25, P707, DOI 10.1016/j.mcn.2003.12.014; Shiga H, 2005, NEUROSCI RES, V53, P436, DOI 10.1016/j.neures.2005.09.004; Shiga H, 2005, J NEUROSCI RES, V80, P767, DOI 10.1002/jnr.20513; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; SMITS A, 1993, EUR J NEUROSCI, V5, P986, DOI 10.1111/j.1460-9568.1993.tb00950.x; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Storch MK, 1996, NEUROSCIENCE, V71, P885, DOI 10.1016/0306-4522(95)00476-9; Syed YA, 2011, J NEUROSCI, V31, P3719, DOI 10.1523/JNEUROSCI.4930-10.2011; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Torisu R, 2011, BRAIN TUMOR PATHOL, V28, P33, DOI 10.1007/s10014-010-0006-0; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu JH, 2005, J BIOL CHEM, V280, P31027, DOI 10.1074/jbc.M501473200; Yamazaki T, 2009, J PERIPHER NERV SYST, V14, P165, DOI 10.1111/j.1529-8027.2009.00228.x	70	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40457	10.1371/journal.pone.0040457	http://dx.doi.org/10.1371/journal.pone.0040457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792334	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400057
J	Barisone, GA; Ngo, T; Tran, M; Cortes, D; Shahi, MH; Nguyen, TV; Perez-Lanza, D; Matayasuwan, W; Diaz, E				Barisone, Gustavo A.; Tin Ngo; Martin Tran; Cortes, Daniel; Shahi, Mehdi H.; Tuong-Vi Nguyen; Perez-Lanza, Daniel; Matayasuwan, Wanna; Diaz, Elva			Role of MXD3 in Proliferation of DAOY Human Medulloblastoma Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; PRECURSOR PROLIFERATION; INDUCED APOPTOSIS; GENE-EXPRESSION; SONIC HEDGEHOG; MAD FAMILY; IN-VIVO; MYC; DIFFERENTIATION; GROWTH	A subset of medulloblastomas, the most common brain tumor in children, is hypothesized to originate from granule neuron precursors (GNPs) in which the sonic hedgehog (SHH) pathway is over-activated. MXD3, a basic helix-look-helix zipper transcription factor of the MAD family, has been reported to be upregulated during postnatal cerebellar development and to promote GNP proliferation and MYCN expression. Mxd3 is upregulated in mouse models of medulloblastoma as well as in human medulloblastomas. Therefore, we hypothesize that MXD3 plays a role in the cellular events that lead to medulloblastoma biogenesis. In agreement with its proliferative role in GNPs, MXD3 knock-down in DAOY cells resulted in decreased proliferation. Sustained overexpression of MXD3 resulted in decreased cell numbers due to increased apoptosis and cell cycle arrest. Structure-function analysis revealed that the Sin3 interacting domain, the basic domain, and binding to E-boxes are essential for this activity. Microarray-based expression analysis indicated up-regulation of 84 genes and down-regulation of 47 genes. Potential direct MXD3 target genes were identified by ChIP-chip. Our results suggest that MXD3 is necessary for DAOY medulloblastoma cell proliferation. However, increased level and/or duration of MXD3 expression ultimately reduces cell numbers via increased cell death and cell cycle arrest.	[Barisone, Gustavo A.; Tin Ngo; Martin Tran; Cortes, Daniel; Shahi, Mehdi H.; Tuong-Vi Nguyen; Perez-Lanza, Daniel; Matayasuwan, Wanna; Diaz, Elva] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Barisone, GA (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.	ediaz@ucdavis.edu			James S. McDonnell Foundation [220020074.01]; National Institutes of Health [DP2 OD006479-01]; California Institute of Regenerative Medicine; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006479] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants to ED. from the James S. McDonnell Foundation (220020074.01) and the National Institutes of Health Director's New Innovator Award Program (DP2 OD006479-01) and by a postdoctoral fellowship to GAB from the California Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Amin MA, 2007, BIOCHEM BIOPH RES CO, V360, P320, DOI 10.1016/j.bbrc.2007.06.092; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Barisone GA, 2008, CELL CYCLE, V7, P423, DOI 10.4161/cc.7.4.5413; Barrio S, 2011, J CLIN PATHOL; Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Chen XR, 2010, WORLD J GASTROENTERO, V16, P1409, DOI 10.3748/wjg.v16.i11.1409; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; COLLINS VP, 1995, GLIA, V15, P289, DOI 10.1002/glia.440150309; CROUCH DH, 1993, ONCOGENE, V8, P1849; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; EISENMAN RE, 2006, MYC MAX MAD TRANSCRI; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FISHER F, 1993, EMBO J, V12, P5075, DOI 10.1002/j.1460-2075.1993.tb06201.x; Foley KP, 1998, EMBO J, V17, P774, DOI 10.1093/emboj/17.3.774; Fox EJ, 2001, BIOCHEM J, V359, P361, DOI 10.1042/0264-6021:3590361; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gore Y, 2010, MOL BIOL CELL, V21, P1864, DOI 10.1091/mbc.E09-09-0813; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Koh CM, 2011, AM J PATHOL, V178, P1824, DOI 10.1016/j.ajpath.2010.12.040; Komashko VM, 2008, GENOME RES, V18, P521, DOI 10.1101/gr.074609.107; Krieg AJ, 2006, MOL CELL BIOL, V26, P7030, DOI 10.1128/MCB.00322-06; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; McCabe MG, 2006, J NEUROPATH EXP NEUR, V65, P549, DOI 10.1097/00005072-200606000-00003; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Migheli A, 1999, AM J PATHOL, V155, P365, DOI 10.1016/S0002-9440(10)65133-4; Nair SK, 2006, CURR TOP MICROBIOL, V302, P123; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nasir A, 2011, PANCREAS, V40, P627, DOI 10.1097/MPA.0b013e3182152bda; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Piya S, 2011, MOL CANC RES; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Queva C, 1998, ONCOGENE, V16, P967, DOI 10.1038/sj.onc.1201611; Queva C, 2001, MOL CELL BIOL, V21, P703, DOI 10.1128/MCB.21.3.703-712.2001; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sibella-Arguelles C, 2001, CR ACAD SCI III-VIE, V324, P365, DOI 10.1016/S0764-4469(00)01300-7; Steiger D, 2008, NAT GENET, V40, P1084, DOI 10.1038/ng.178; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Yun JS, 2007, MOL CELL BIOL, V27, P8178, DOI 10.1128/MCB.00656-06	50	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38508	10.1371/journal.pone.0038508	http://dx.doi.org/10.1371/journal.pone.0038508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808009	Green Published, gold			2022-12-27	WOS:000306355500004
J	McCoy, CM; Nicholas, DQ; Masters, KS				McCoy, Chloe M.; Nicholas, Dylan Q.; Masters, Kristyn S.			Sex-Related Differences in Gene Expression by Porcine Aortic Valvular Interstitial Cells	PLOS ONE			English	Article							VALVE DISEASE; SEROTONIN MECHANISMS; STENOSIS; PROGRESSION; PATHOGENESIS; PATHWAY; HEART; CALCIFICATION; ANGIOGENESIS; RECEPTOR	While many large-scale risk factors for calcific aortic valve disease (CAVD) have been identified, the molecular etiology and subsequent pathogenesis of CAVD have yet to be fully understood. Specifically, it is unclear what biological phenomena underlie the significantly higher occurrence of CAVD in the male population. We hypothesized the existence of intrinsic, cellular-scale differences between male and female valvular interstitial cells (VICs) that contribute to male sex being a risk factor for CAVD. Differences in gene expression profiles between healthy male and female porcine VICs were investigated via microarray analysis. Mean expression values of each probe set in the male samples were compared to the female samples, and biological processes were analyzed for overrepresentation using Gene Ontology term enrichment analysis. There were 183 genes identified as significantly (fold change>2; P<0.05) different in male versus female aortic valve leaflets. Within this significant gene list there were 298 overrepresented biological processes, several of which are relevant to pathways identified in CAVD pathogenesis. In particular, pathway analysis indicated that cellular proliferation, apoptosis, migration, ossification, angiogenesis, inflammation, and extracellular matrix reorganization were all significantly represented in the data set. These gene expression findings also translated into functional differences in VIC behavior in the in vitro environment, as sex-related differences in proliferation and apoptosis were confirmed in VIC populations cultured in vitro. These data suggest that a sex-related propensity for CAVD exists on the cellular level in healthy subjects, a phenomenon that could have significant clinical implications. These findings also strongly support discontinuing the use of mixed-sex VIC cultures, thereby changing the current standard in the field.	[McCoy, Chloe M.; Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Nicholas, Dylan Q.] Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	McCoy, CM (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.	kmasters@wisc.edu			University of Wisconsin-Madison Biotechnology Training Program Grant [NIH 5 T32 GM08349]; University of Wisconsin-Madison Graduate Engineering Research Scholars Program; University of Wisconsin School of Medicine and Public Health Medical Scientist Training Program; National Institutes of Health/National Heart, Lung, and Blood Institute [R01 HL093281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349, T32GM008692] Funding Source: NIH RePORTER	University of Wisconsin-Madison Biotechnology Training Program Grant; University of Wisconsin-Madison Graduate Engineering Research Scholars Program; University of Wisconsin School of Medicine and Public Health Medical Scientist Training Program; National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding support for this work was provided by the University of Wisconsin-Madison Biotechnology Training Program Grant (NIH 5 T32 GM08349), University of Wisconsin-Madison Graduate Engineering Research Scholars Program, the University of Wisconsin School of Medicine and Public Health Medical Scientist Training Program, and the National Institutes of Health/National Heart, Lung, and Blood Institute (R01 HL093281). The sources of funding for this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger T, 2008, EXP MOL PATHOL, V85, P101, DOI 10.1016/j.yexmp.2008.06.002; [Anonymous], 2012, SEX SPECIFIC REPORTI; Aronow WS, 2001, AM J CARDIOL, V88, P693, DOI 10.1016/S0002-9149(01)01821-5; Bahler RC, 1999, AM J CARDIOL, V84, P1044, DOI 10.1016/S0002-9149(99)00496-8; Bosse Y, 2009, CIRC-CARDIOVASC GENE, V2, P489, DOI 10.1161/CIRCGENETICS.108.820795; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Elangbam CS, 2008, EXP TOXICOL PATHOL, V60, P253, DOI 10.1016/j.etp.2008.03.005; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffin M, 2000, MOL CELL BIOCHEM, V215, P21, DOI 10.1023/A:1026585420021; Gu XX, 2011, AM J PHYSIOL-HEART C, V300, pH448, DOI 10.1152/ajpheart.01178.2009; Gu XX, 2009, AM J PHYSIOL-HEART C, V296, pH1748, DOI 10.1152/ajpheart.00099.2009; Hakuno D, 2009, J MOL MED, V87, P17, DOI 10.1007/s00109-008-0400-9; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Jian B, 2002, AM J PATHOL, V161, P2111, DOI 10.1016/S0002-9440(10)64489-6; JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1; Kaden JJ, 2003, ATHEROSCLEROSIS, V170, P205, DOI 10.1016/S0021-9150(03)00284-3; Lee JH, 2011, J THORAC CARDIOV SUR, V141, P481, DOI 10.1016/j.jtcvs.2010.11.002; Lee SJ, 2005, PHYSIOL GENOMICS, V23, P62, DOI 10.1152/physiolgenomics.00251.2004; Li C, 2011, AM J PATHOL, V179, P1746, DOI 10.1016/j.ajpath.2011.06.007; Li C, 2011, CARDIOVASC PATHOL, V20, P183, DOI 10.1016/j.carpath.2010.09.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149; Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013; O'Brien KD, 2006, ARTERIOSCL THROM VAS, V26, P1721, DOI 10.1161/01.ATV.0000227513.13697.ac; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Owens DS, 2010, AM J CARDIOL, V105, P701, DOI 10.1016/j.amjcard.2009.10.071; Peltonen TO, 2007, CIRCULATION, V116, P1283, DOI 10.1161/CIRCULATIONAHA.106.685743; Pereira TMC, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-87; Rahimian R, 1998, BIOCHEM BIOPH RES CO, V248, P916, DOI 10.1006/bbrc.1998.9068; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosenhek Raphael, 2008, Expert Rev Cardiovasc Ther, V6, P385, DOI 10.1586/14779072.6.3.385; Rusanescu G, 2008, CURR CARDIOL REV, V4, P148, DOI 10.2174/157340308785160552; Shakya K, 2010, ADV EXP MED BIOL, V680, P139, DOI 10.1007/978-1-4419-5913-3_16; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soini Y, 2003, HUM PATHOL, V34, P756, DOI 10.1016/S0046-8177(03)00245-4; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Xu J, 2002, AM J PATHOL, V161, P2209, DOI 10.1016/S0002-9440(10)64497-5; Xu SY, 2010, CARDIOVASC PATHOL, V19, P236, DOI 10.1016/j.carpath.2009.09.007; Yip CYY, 2011, ARTERIOSCL THROM VAS, V31, P1881, DOI 10.1161/ATVBAHA.111.223974	45	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39980	10.1371/journal.pone.0039980	http://dx.doi.org/10.1371/journal.pone.0039980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808080	Green Submitted, Green Published, gold			2022-12-27	WOS:000306355500018
J	Peat, TS; Rhodes, DI; Vandegraaff, N; Le, G; Smith, JA; Clark, LJ; Jones, ED; Coates, JAV; Thienthong, N; Newman, J; Dolezal, O; Mulder, R; Ryan, JH; Savage, GP; Francis, CL; Deadman, JJ				Peat, Thomas S.; Rhodes, David I.; Vandegraaff, Nick; Le, Giang; Smith, Jessica A.; Clark, Lisa J.; Jones, Eric D.; Coates, Jonathan A. V.; Thienthong, Neeranat; Newman, Janet; Dolezal, Olan; Mulder, Roger; Ryan, John H.; Savage, G. Paul; Francis, Craig L.; Deadman, John J.			Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design	PLOS ONE			English	Article							HIV-1 INTEGRASE; CATALYTIC DOMAIN; BINDING DOMAIN; RALTEGRAVIR; MECHANISM; PROTEIN; MODEL; CORE	A fragment-based screen against human immunodeficiency virus type 1 (HIV) integrase led to a number of compounds that bound to the lens epithelium derived growth factor (LEDGF) binding site of the integrase catalytic core domain. We determined the crystallographic structures of complexes of the HIV integrase catalytic core domain for 10 of these compounds and quantitated the binding by surface plasmon resonance. We demonstrate that the compounds inhibit the interaction of LEDGF with HIV integrase in a proximity AlphaScreen assay, an assay for the LEDGF enhancement of HIV integrase strand transfer and in a cell based assay. The compounds identified represent a potential framework for the development of a new series of HIV integrase inhibitors that do not bind to the catalytic site of the enzyme.	[Peat, Thomas S.; Newman, Janet; Dolezal, Olan] CSIRO Mat Sci & Engn, Parkville, Vic, Australia; [Rhodes, David I.; Vandegraaff, Nick; Le, Giang; Smith, Jessica A.; Clark, Lisa J.; Jones, Eric D.; Coates, Jonathan A. V.; Thienthong, Neeranat; Deadman, John J.] Avexa Ltd, Melbourne, Vic, Australia; [Mulder, Roger; Ryan, John H.; Savage, G. Paul; Francis, Craig L.] CSIRO Mat Sci & Engn, Clayton, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Peat, TS (corresponding author), CSIRO Mat Sci & Engn, Parkville, Vic, Australia.	tom.peat@csiro.au	Francis, Craig L/D-6154-2015; Peat, Thomas S/F-9817-2010; Mulder, Roger J/F-4607-2011; Newman, Janet M/D-1857-2011; Ryan, John H/G-1343-2013; Savage, Gregory P/C-2443-2008; Le, Giang/I-3178-2016; Dolezal, Olan/E-1691-2015	Francis, Craig L/0000-0002-3814-8575; Peat, Thomas S/0000-0002-6488-0831; Mulder, Roger J/0000-0002-8740-802X; Newman, Janet M/0000-0003-2666-3219; Savage, Gregory P/0000-0001-7805-8630; Le, Giang/0000-0002-2591-9190; DOLEZAL, OLAN/0000-0002-5823-6978	Commonwealth of Australia, Department of Innovation, Industry, Science and Research [COMO4229]	Commonwealth of Australia, Department of Innovation, Industry, Science and Research(Australian Government)	The work was supported by a commercial ready grant COMO4229 from the Commonwealth of Australia, Department of Innovation, Industry, Science and Research to Avexa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldanti F, 2010, J MED VIROL, V82, P116, DOI 10.1002/jmv.21651; Ballana E, 2012, AIDS, V26, P527, DOI 10.1097/QAD.0b013e32834fa194; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Croxtall JD, 2010, DRUGS, V70, P631, DOI 10.2165/11204590-000000000-00000; De Luca L, 2011, ANTIVIR RES, V92, P102, DOI 10.1016/j.antiviral.2011.07.005; De Luca L, 2011, CHEMMEDCHEM, V6, P1184, DOI 10.1002/cmdc.201100071; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan X, 2011, BIOORGAN MED CHEM, V19, P4935, DOI 10.1016/j.bmc.2011.06.058; Fitzkee NC, 2011, PROTEIN SCI, V20, P500, DOI 10.1002/pro.582; Giannetti AM, 2008, J MED CHEM, V51, P574, DOI 10.1021/jm700952v; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; LESLIE AGW, 1992, NEWSLETTER PROTEIN C, V26; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Madlala P, 2011, AIDS, V25, P1711, DOI 10.1097/QAD.0b013e328349c693; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; McNeely M, 2011, J MOL BIOL, V410, P811, DOI 10.1016/j.jmb.2011.03.073; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Papalia G, 2010, ANAL BIOCHEM, V403, P30, DOI 10.1016/j.ab.2010.03.044; Papalia GA, 2008, ANAL BIOCHEM, V383, P255, DOI 10.1016/j.ab.2008.08.010; Rhodes DI, 2011, CHEMBIOCHEM, V12, P2311, DOI 10.1002/cbic.201100350; Rhodes David I., 2011, Antiviral Chemistry & Chemotherapy, V21, P155, DOI 10.3851/IMP1716; ROCANCOURT D, 1990, J VIROL, V64, P2660, DOI 10.1128/JVI.64.6.2660-2668.1990; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tsantrizos YS, 2007, International Patent Application, Patent No. [PCT/CA2007/000845, 2007000845]; Tsiang M, 2009, J BIOL CHEM, V284, P33580, DOI 10.1074/jbc.M109.040121; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wielens J, 2010, FEBS LETT, V584, P1455, DOI 10.1016/j.febslet.2010.03.016	49	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40147	10.1371/journal.pone.0040147	http://dx.doi.org/10.1371/journal.pone.0040147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808106	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500027
J	Tchinda, GG; Atashili, J; Achidi, EA; Kamga, HL; Njunda, AL; Ndumbe, PM				Tchinda, Gervais Gouana; Atashili, Julius; Achidi, Eric A.; Kamga, Henri L.; Njunda, Anna L.; Ndumbe, Peter M.			Impact of Malaria on Hematological Parameters in People Living with HIV/AIDS Attending the Laquintinie Hospital in Douala, Cameroon	PLOS ONE			English	Article							INFECTION; HIV	Background: People living with HIV/AIDS (PLWHA) frequently have abnormal blood counts including anemia, leucopenia and thrombocytopenia. The role of infection with plasmodia on these hematological parameters in PLWHA is not well known. In this study we compared selected hematological parameters between malaria positive and negative PLWHA. Methods: We conducted a cross-sectional study of PLWHA attending the Douala Laquintinie hospital. After obtaining consent, demographic and clinical data were obtained via a standardized questionnaire. Blood samples collected for hematological assays were run using an automated full blood counter. Malaria parasitaemia was determined by blood smear microscopy. Results: A total of 238 adult PLWHA were enrolled, 48.3% of who were on antiretroviral therapy and 24.8% of whom had malaria parasitaemia. The respective mean (+/- SD) of hemoglobin level, RBC count, WBC count, platelet count, lymphocyte count and CD4+ T cell counts in malaria co-infected patients versus non-infected patients were: 10.8(+/- 1.9) g/dl versus 11.4(+/- 2.0) g/dl; 3,745,254(+/- 793,353) cells/mu l versus 3,888,966(+/- 648,195) cells/mu l; 4,403(+/- 1,534) cells/mu l versus 4,920(+/- 1,922) cells/mu l; 216,051(+/- 93,884) cells/mu l versus 226,792(+/- 98,664) cells/mu l; 1,846(+/- 711) cells/mu l versus 2,052(+/- 845) cells/mu l and 245(+/- 195) cells/mu l versus 301(+/- 211) cells/mu l. All these means were not statistically significantly different from each other. Conclusion: There was no significant difference in studied hematological parameters between malaria positive and negative PLWHA. These data suggest little or no impact of malaria infection. Hematological anomalies in PLWHA in this area need not be necessarily attributed to malaria. These need to be further investigated to identify and treat other potential causes.	[Tchinda, Gervais Gouana; Achidi, Eric A.; Kamga, Henri L.; Njunda, Anna L.] Univ Buea, Fac Hlth Sci, Dept Med Lab Sci, Buea, Cameroon; [Atashili, Julius] Univ Buea, Fac Hlth Sci, Dept Publ Hlth & Hyg, Buea, Cameroon; [Ndumbe, Peter M.] Univ Buea, Fac Hlth Sci, Dept Biomed Sci, Buea, Cameroon		Tchinda, GG (corresponding author), Univ Buea, Fac Hlth Sci, Dept Med Lab Sci, Buea, Cameroon.	atashili@yahoo.ie			European and Developing Countries Trial Partnership (EDCTP)	European and Developing Countries Trial Partnership (EDCTP)	Dr. Atashili, Dr. Achidi and Dr. Ndumbe's work was partially supported by a grant from the European and Developing Countries Trial Partnership (EDCTP) to the Central African Network against Tuberculosis AIDS and Malaria (CANTAM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili Suresh Venkata Satya, 2008, Turk J Haematol, V25, P13; Audu R. A., 2005, Annals of African Medicine, V4, P10; Bashawri LAM, 2002, ANN SAUDI MED, V22, P372, DOI 10.5144/0256-4947.2002.372; Cheesbrougu M, 2006, DISTRICT LAB PRACTIC, V2nd, P319; Erhabor O, 2006, NIGERIAN J MED, V15; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Goselle ON, 2009, J VECTOR DIS, V46, P205; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; MULLER O, 1990, T ROY SOC TROP MED H, V84, P336, DOI 10.1016/0035-9203(90)90306-Y; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nkuo-Akenji T, 2008, AJAR-AFR J AIDS RES, V7, P229, DOI 10.2989/AJAR.2008.7.2.8.525; Richards MW, 1998, AM J TROP MED HYG, V59, P859, DOI 10.4269/ajtmh.1998.59.859; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Van Geertruyden JP, 2006, JAIDS-J ACQ IMM DEF, V43, P363; WHO, 2011, WORLD MALARIA REPORT 2011, P1	17	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40553	10.1371/journal.pone.0040553	http://dx.doi.org/10.1371/journal.pone.0040553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802967	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500055
J	Scartozzi, M; Loretelli, C; Galizia, E; Mandolesi, A; Pistelli, M; Bittoni, A; Giampieri, R; Faloppi, L; Bianconi, M; Del Prete, M; Bianchi, F; Belvederesi, L; Bearzi, I; Cascinu, S				Scartozzi, Mario; Loretelli, Cristian; Galizia, Eva; Mandolesi, Alessandra; Pistelli, Mirco; Bittoni, Alessandro; Giampieri, Riccardo; Faloppi, Luca; Bianconi, Maristella; Del Prete, Michela; Bianchi, Francesca; Belvederesi, Laura; Bearzi, Italo; Cascinu, Stefano			Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients	PLOS ONE			English	Article							PERITONEAL CARCINOMATOSIS; GENE; EXPRESSION; POLYMORPHISMS; ASSOCIATION; CELLS; ADENOCARCINOMA; ANGIOGENESIS; CHEMOTHERAPY; MECHANISMS	In radically resected gastric cancer the possibility to predict the site of relapse could be clinically relevant for the selection of post-surgical management. We previously showed that specific tumour integrins genotypes are independently associated with either peritoneal or hematogenous metastases (ITGA and ITGV). Recently VEGF and VEGF-R polymorphisms have been demonstrated to potentially affect tumour angiogenesis and the metastatic process in gastric cancer. We then investigated the role of VEGFs and VEGF-R genotyping in determining either peritoneal carcinosis or hematogenous metastases in radically resected gastric cancer patients. Tumour genotyping for integrins (ITGA and ITGV) was also performed according to our previous findings. Genotyping for VEGF-A, VEGF-C, VEGFR-1,2,3 and ITGA and ITGV was carried out on pT4a radically resected gastric tumours recurring with either peritoneal-only carcinosis or hematogenous metastases. 101 patients fulfilled the inclusion criteria: 57 with peritoneal carcinomatosis only and 44 with hematogenous spread only. At multivariate analysis, intestinal histology and the AC genotype of rs699947 (VEGFA) showed to independently correlate with hematogenous metastases (p = 0.0008 and 0.008 respectively), whereas diffuse histology and the AA genotype of rs2269772 (ITGA) independently correlated with peritoneal-only diffusion (p = <0.0001 and 0.03 respectively). Our results seem to indicate that combining information from genotyping of rs699947 (VEGFA, AC), rs2269772 (ITGA, AA) and tumour histology could allow clinicians to individuate gastric cancer at high risk for recurrence either with peritoneal or hematogenous metastases. The selection tool deriving from this analysis may allow an optimal use of the available treatment strategies in these patients.	[Scartozzi, Mario; Giampieri, Riccardo; Cascinu, Stefano] Univ Politecn Marche, Clin Oncol Med, AO Osped Riuniti, Ancona, Italy; [Loretelli, Cristian; Bianchi, Francesca; Belvederesi, Laura] Univ Politecn Marche, Ctr Regionale Genet Oncol, AO Osped Riuniti, Ancona, Italy; [Galizia, Eva] Osped Profili, Fabriano, Italy; [Pistelli, Mirco; Bittoni, Alessandro; Faloppi, Luca; Bianconi, Maristella; Del Prete, Michela] Univ Politecn Marche, Scuola Specializzaz Oncol, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Scartozzi, M (corresponding author), Univ Politecn Marche, Clin Oncol Med, AO Osped Riuniti, Ancona, Italy.	marioscartozzi@gmail.com	Cascinu, Stefano/G-2399-2017; Cascinu, Stefano/AAN-1923-2020; Loretelli, Cristian/AAO-7678-2020; Faloppi, Luca/K-1030-2016	Cascinu, Stefano/0000-0003-2215-0731; Faloppi, Luca/0000-0003-3689-3085; Loretelli, Cristian/0000-0002-7583-8540; SCARTOZZI, MARIO/0000-0001-5977-5546; Bianconi, Maristella/0000-0003-3475-2529; Pistelli, Mirco/0000-0002-9289-8537				Bando E, 1999, AM J SURG, V178, P256, DOI 10.1016/S0002-9610(99)00162-2; Bozzetti F, 2008, J SURG ONCOL, V98, P273, DOI 10.1002/jso.21052; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carter AM, 2002, THROMB HAEMOSTASIS, V87, P846, DOI 10.1055/s-0037-1613095; Ceelen WP, 2009, LANCET ONCOL, V10, P72, DOI 10.1016/S1470-2045(08)70335-8; Chen MH, 2011, PHARMACOGENOMICS J, V11, P227, DOI 10.1038/tpj.2010.48; Day DA, 1998, J ENDOCRINOL, V157, P361, DOI 10.1677/joe.0.1570361; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Formento JL, 2009, PHARMACOGENOMICS, V10, P1277, DOI [10.2217/pgs.09.54, 10.2217/PGS.09.54]; Fujiwara Y, 2007, GASTRIC CANCER, V10, P197, DOI 10.1007/s10120-007-0436-5; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Glehen O, 2004, LANCET ONCOL, V5, P219, DOI 10.1016/S1470-2045(04)01425-1; Hansen TF, 2011, PHARMACOGENOMICS J, V11, P53, DOI 10.1038/tpj.2010.4; Hansen TF, 2010, VIRCHOWS ARCH, V456, P251, DOI 10.1007/s00428-009-0878-8; Hesketh J, 2004, BIOCHEM SOC T, V32, P990, DOI 10.1042/BST0320990; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang JL, 2004, HUM MOL GENET, V13, P2691, DOI 10.1093/hmg/ddh279; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kim JG, 2007, ANN ONCOL, V18, P1030, DOI 10.1093/annonc/mdm085; Kitadai Y, 2010, J ONCOL, V2010, DOI 10.1155/2010/468725; Kodama M, 2008, CLIN CANCER RES, V14, P7205, DOI 10.1158/1078-0432.CCR-08-0818; Krippl P, 2003, INT J CANCER, V106, P468, DOI 10.1002/ijc.11238; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Scartozzi M, 2011, ANN ONCOL, V22, P897, DOI 10.1093/annonc/mdq542; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Smyth SS, 2002, J CELL BIOL, V158, P17, DOI 10.1083/jcb.200202100; Takahashi Y, 1996, CLIN CANCER RES, V2, P1679; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Yamamoto S, 1998, PATHOL INT, V48, P499, DOI 10.1111/j.1440-1827.1998.tb03940.x; Yan TD, 2007, ANN SURG ONCOL, V14, P2702, DOI 10.1245/s10434-007-9487-4; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhao R, 2010, CANCER LETT, V287, P150, DOI 10.1016/j.canlet.2009.06.006	35	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38192	10.1371/journal.pone.0038192	http://dx.doi.org/10.1371/journal.pone.0038192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808003	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700001
J	Chang, XL; Nick, P				Chang, Xiaoli; Nick, Peter			Defence Signalling Triggered by Flg22 and Harpin Is Integrated into a Different Stilbene Output in Vitis Cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; ACTIVATED PROTEIN-KINASE; DISEASE RESISTANCE; GENE-EXPRESSION; OXIDATIVE BURST; HYDROGEN-PEROXIDE; BOTRYTIS-CINEREA; HOST-DEFENSE; PLANT; ARABIDOPSIS	Plants can activate defence to pathogen attack by two layers of innate immunity: basal immunity triggered by pathogen-associated molecular pattern (PAMP) triggered immunity (PTI) and effector-triggered immunity (ETI) linked with programmed cell death. Flg22 and Harpin are evolutionary distinct bacterial PAMPs. We have previously shown that Harpin triggers hypersensitive cell death mimicking ETI in Vitis rupestris, but not in the Vitis vinifera cultivar 'Pinot Noir'. In contrast, the bacterial PAMP flg22 activating PTI does not trigger cell death. To get insight into the defence signalling triggered by flg22 and Harpin, we compared cellular responses upon flg22 and Harpin treatment in the two Vitis cell lines. We found that extracellular alkalinisation was blocked by inhibition of calcium influx, and modulated by pharmacological manipulation of the cytoskeleton and mitogen-activated protein kinase activity with quantitative differences between cell lines and type of PAMPs. In addition, an oxidative burst was detected that was much stronger and faster in response to Harpin as compared to flg22. In V. rupestris, both flg22 and Harpin induced transcripts of defence-related genes including stilbene synthase, microtubule disintegration and actin bundling in a similar way, whereas they differed in V. vinifera cv. 'Pinot Noir'. In contrast to Harpin, flg22 failed to trigger significant levels of the stilbene trans-resveratrol, and did not induce hypersensitive cell death even in the highly responsive V. rupestris. We discuss these data in a model, where flg22- and Harpin-triggered defence shares a part of early signal components, but differs in perception, oxidative burst, and integration into a qualitatively different stilbene output, such that for flg22 a basal PTI is elicited in both cell lines, while Harpin induces cell death mimicking an ETI-like pattern of defence.	[Chang, Xiaoli; Nick, Peter] Karlsruhe Inst Technol, Inst Bot 1, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Chang, XL (corresponding author), Karlsruhe Inst Technol, Inst Bot 1, Karlsruhe, Germany.	chang.xiaoli@bio.uni-karlsruhe.de						Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Adrian M, 1997, J CHEM ECOL, V23, P1689, DOI 10.1023/B:JOEC.0000006444.79951.75; Aslam SN, 2009, MOL PLANT PATHOL, V10, P375, DOI [10.1111/j.1364-3703.2009.00537.x, 10.1111/J.1364-3703.2009.00537.X]; Aziz A, 2004, PLANTA, V218, P767, DOI 10.1007/s00425-003-1153-x; BAKER CJ, 1993, PLANT PHYSIOL, V102, P1341, DOI 10.1104/pp.102.4.1341; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; Belhadj A, 2008, PLANT PHYSIOL BIOCH, V46, P493, DOI 10.1016/j.plaphy.2007.12.001; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bruno G, 2006, PHYSIOL MOL PLANT P, V69, P182, DOI 10.1016/j.pmpp.2007.04.006; Casagrande K, 2011, PLANTA, V234, P1097, DOI 10.1007/s00425-011-1461-5; Celimene CC, 2001, PHYTOCHEMISTRY, V56, P161, DOI 10.1016/S0031-9422(00)00384-8; Chang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026405; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; Desikan R, 1998, BIOCHEM J, V330, P115, DOI 10.1042/bj3300115; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Di Gaspero G, 2003, MOL GENET GENOMICS, V269, P612, DOI 10.1007/s00438-003-0884-5; DING JP, 1993, PLANT J, V3, P83, DOI 10.1111/j.1365-313X.1993.tb00013.x; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; Haapalainen M, 2011, MOL PLANT PATHOL, V12, P151, DOI 10.1111/j.1364-3703.2010.00655.x; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Hohenberger P, 2011, BBA-BIOMEMBRANES, V1808, P2304, DOI 10.1016/j.bbamem.2011.05.019; Holley SR, 2003, PLANT PHYSIOL, V132, P1728, DOI 10.1104/pp.103.024414; Ichinose Y, 2001, PLANT PHYSIOL BIOCH, V39, P771, DOI 10.1016/S0981-9428(01)01300-6; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Komis G, 2011, CURR OPIN PLANT BIOL, V14, P650, DOI 10.1016/j.pbi.2011.07.008; Kortekamp A, 2006, PLANT PHYSIOL BIOCH, V44, P58, DOI 10.1016/j.plaphy.2006.01.008; Lai ZB, 2011, PLANT J, V66, P953, DOI 10.1111/j.1365-313X.2011.04553.x; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LANGCAKE P, 1981, PHYSIOL PLANT PATHOL, V18, P213; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Maisch J, 2007, PLANT PHYSIOL, V143, P1695, DOI 10.1104/pp.106.094052; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nick P, 2011, SIGNAL COMMUN PLANTS, P53, DOI 10.1007/978-3-642-19091-9_3; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 1999, CELL MOL LIFE SCI, V55, P167, DOI 10.1007/s000180050283; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; Pezet R, 2004, PHYSIOL MOL PLANT P, V65, P297, DOI 10.1016/j.pmpp.2005.03.002; Pezet R, 2004, VITIS, V43, P145; Poinssot B, 2003, MOL PLANT MICROBE IN, V16, P553, DOI 10.1094/MPMI.2003.16.6.553; Qiao F, 2010, J EXP BOT, V61, P4021, DOI 10.1093/jxb/erq221; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Samuel MA, 2005, PLANT J, V42, P406, DOI 10.1111/j.1365-313X.2005.02382.x; Schmidt SM, 2007, PHYSIOL MOL PLANT P, V71, P135, DOI 10.1016/j.pmpp.2008.01.001; Tampakaki AP, 2010, ANNU REV PHYTOPATHOL, V48, P347, DOI 10.1146/annurev-phyto-073009-114407; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; TROPF S, 1994, J MOL EVOL, V38, P610; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Vandelle E, 2006, MOL PLANT MICROBE IN, V19, P429, DOI 10.1094/MPMI-19-0429; Wang SH, 2011, PLANT CELL, V23, P3412, DOI 10.1105/tpc.111.089920; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Yalamanchili RD, 2002, J BIOL CHEM, V277, P28424, DOI 10.1074/jbc.M203844200; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	81	46	47	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40446	10.1371/journal.pone.0040446	http://dx.doi.org/10.1371/journal.pone.0040446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792328	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800087
J	Kuo, YJ; Tsuang, FY; Sun, JS; Lin, CH; Chen, CH; Li, JY; Huang, YC; Chen, WY; Yeh, CB; Shyu, JF				Kuo, Yi-Jie; Tsuang, Fon-Yih; Sun, Jui-Sheng; Lin, Chi-Hung; Chen, Chia-Hsien; Li, Jia-Ying; Huang, Yi-Chian; Chen, Wei-Yu; Yeh, Chin-Bin; Shyu, Jia-Fwu			Calcitonin Inhibits SDCP-Induced Osteoclast Apoptosis and Increases Its Efficacy in a Rat Model of Osteoporosis	PLOS ONE			English	Article							SINTERED DICALCIUM PYROPHOSPHATE; MOLECULAR-MECHANISMS; OVARIECTOMIZED RATS; SALMON-CALCITONIN; BONE-FORMATION; IN-VITRO; BISPHOSPHONATES; METABOLISM; SURVIVAL; OSTEOBLASTS	Introduction: Treatment for osteoporosis commonly includes the use of bisphosphonates. Serious side effects of these drugs are caused by the inhibition of bone resorption as a result of osteoclast apoptosis. Treatment using calcitonin along with bisphosphonates overcomes these side-effects in some patients. Calcitonin is known to inhibit bone resorption without reducing the number of osteoclasts and is thought to prolong osteoclast survival through the inhibition of apoptosis. Further understanding of how calcitonin inhibits apoptosis could prove useful to the development of alternative treatment regimens for osteoporosis. This study aimed to analyze the mechanism by which calcitonin influences osteoclast apoptosis induced by a bisphosphate analog, sintered dicalcium pyrophosphate (SDCP), and to determine the effects of co-treatment with calcitonin and SDCP on apoptotic signaling in osteoclasts. Methods: Isolated osteoclasts were treated with CT, SDCP or both for 48 h. Osteoclast apoptosis assays, pit formation assays, and tartrate-resistant acid phosphatase (TRAP) staining were performed. Using an osteoporosis rat model, ovariectomized (OVX) rats received calcitonin, SDCP, or calcitonin + SDCP. The microarchitecture of the fifth lumbar trabecular bone was investigated, and histomorphometric and biochemical analyses were performed. Results: Calcitonin inhibited SDCP-induced apoptosis in primary osteoclast cultures, increased Bcl-2 and Erk activity, and decreased Mcl-1 activity. Calcitonin prevented decreased osteoclast survival but not resorption induced by SDCP. Histomorphometric analysis of the tibia revealed increased bone formation, and microcomputed tomography of the fifth lumbar vertebrate showed an additive effect of calcitonin and SDCP on bone volume. Finally, analysis of the serum bone markers CTX-I and P1NP suggests that the increased bone volume induced by co-treatment with calcitonin and SDCP may be due to decreased bone resorption and increased bone formation. Conclusions: Calcitonin reduces SDCP-induced osteoclast apoptosis and increases its efficacy in an in vivo model of osteoporosis.	[Kuo, Yi-Jie] Taipei Med Univ Hosp, Dept Orthopaed, Taipei, Taiwan; [Kuo, Yi-Jie] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Sun, Jui-Sheng] Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Hsinchu, Taiwan; [Sun, Jui-Sheng] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Chi-Hung; Chen, Chia-Hsien] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Li, Jia-Ying; Chen, Wei-Yu; Shyu, Jia-Fwu] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Huang, Yi-Chian] Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei 112, Taiwan; [Yeh, Chin-Bin; Shyu, Jia-Fwu] Triserv Gen Hosp, Dept Psychiat, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; National Yang Ming Chiao Tung University; National Defense Medical Center; National Yang Ming Chiao Tung University; Tri-Service General Hospital	Kuo, YJ (corresponding author), Taipei Med Univ Hosp, Dept Orthopaed, Taipei, Taiwan.	jiafwu.shyu@msa.hinet.net		Tsuang, Fon-Yih/0000-0001-5797-1885; SUN, JUI-SHENG/0000-0001-5142-8777	National Defense Medical Center of Medical Research Grants [DOD-100-C-11-02]; Tri-Service General Hospital of Medical Research Grants [TSGH-C99-011-12-S03]	National Defense Medical Center of Medical Research Grants; Tri-Service General Hospital of Medical Research Grants	This work was funded by National Defense Medical Center of Medical Research Grants (DOD-100-C-11-02) and Tri-Service General Hospital of Medical Research Grants (TSGH-C99-011-12-S03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; CHAMBERS TJ, 1984, J ENDOCRINOL, V102, P281, DOI 10.1677/joe.0.1020281; Davey RA, 2005, J BONE MINER METAB, V23, P359, DOI 10.1007/s00774-005-0613-8; Davey RA, 2008, J BONE MINER RES, V23, P1182, DOI 10.1359/JBMR.080310; de Paula FJA, 2010, HORM METAB RES, V42, P299, DOI 10.1055/s-0030-1248255; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Furuichi H, 2000, BIOL PHARM BULL, V23, P946; Gallagher JC, 2010, MATURITAS, V65, P301, DOI 10.1016/j.maturitas.2010.01.002; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hoff AO, 2002, J CLIN INVEST, V110, P1849, DOI 10.1172/JCI200214218; Horne WC, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P221, DOI 10.1016/B978-0-12-373884-4.00031-8; Huebner AK, 2008, ARCH BIOCHEM BIOPHYS, V473, P210, DOI 10.1016/j.abb.2008.02.013; Huebner AK, 2006, J BONE MINER RES, V21, P1924, DOI 10.1359/JBMR.060820; Iwamoto Jun, 2009, Ther Clin Risk Manag, V5, P499; Kanaoka K, 2000, ENDOCRINOLOGY, V141, P2995, DOI 10.1210/en.141.8.2995; Karsdal MA, 2008, BIODRUGS, V22, P137, DOI 10.2165/00063030-200822030-00001; Lin CL, 1996, GASTROENTEROLOGY, V111, P1263, DOI 10.1053/gast.1996.v111.pm8898640; LIN FH, 1995, BIOMATERIALS, V16, P793, DOI 10.1016/0142-9612(95)99642-Y; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Mochizuki K, 2000, J BONE MINER METAB, V18, P194, DOI 10.1007/s007740070020; Ogawa K, 2005, J BONE MINER METAB, V23, P351, DOI 10.1007/s00774-005-0612-9; Ozoran K., 2007, APLAR J RHEUMATOL, V10, P17; Penolazzi L, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-59; Rogers MJ, 2011, BONE, V49, P34, DOI 10.1016/j.bone.2010.11.008; Rogers MJ, 1999, BONE, V24, p73S, DOI 10.1016/S8756-3282(99)00070-8; Selander KS, 1996, MOL CELL ENDOCRINOL, V122, P119, DOI 10.1016/0303-7207(96)03870-1; Shyu JF, 2007, BONE, V40, P1329, DOI 10.1016/j.bone.2007.01.014; Stern PH, 2007, J CELL BIOCHEM, V101, P1087, DOI 10.1002/jcb.21311; Sun JS, 1999, ARTIF ORGANS, V23, P331, DOI 10.1046/j.1525-1594.1999.06235.x; Sun JS, 2003, J BIOMED MATER RES A, V64A, P616, DOI 10.1002/jbm.a.10439; Sun JS, 2002, J BIOMED MATER RES, V59, P246, DOI 10.1002/jbm.1238; Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N; Sutherland KA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2681; Tanaka S, 2010, ADV EXP MED BIOL, V658, P111, DOI 10.1007/978-1-4419-1050-9_12; Woodrow JP, 2006, ENDOCRINOLOGY, V147, P4010, DOI 10.1210/en.2005-1616; ZAIDI M, 1990, J ENDOCRINOL INVEST, V13, P119, DOI 10.1007/BF03349520	41	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40272	10.1371/journal.pone.0040272	http://dx.doi.org/10.1371/journal.pone.0040272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792258	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800059
J	Wang, L; Wang, GY; Lu, CQ; Feng, B; Kang, JH				Wang, Lin; Wang, Guiying; Lu, Chenqi; Feng, Bo; Kang, Jiuhong			Contribution of the -160C/A Polymorphism in the E-cadherin Promoter to Cancer Risk: A Meta-Analysis of 47 Case-Control Studies	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; CDH1 GENE PROMOTER; TRANSITIONAL-CELL CARCINOMA; CYCLIN D1 CCND1; PROSTATE-CANCER; GASTRIC-CANCER; COLORECTAL-CANCER; JAPANESE POPULATION; CLINICOPATHOLOGICAL DEVELOPMENT; CUMULATIVE EVIDENCE	Background: The -160C/A polymorphism (rs16260) of E-cadherin, a tumor repressor gene, has been shown to be a tumor susceptibility allele for various types of cancers. Because the significance of this polymorphism to cancer risk has been recognized, there are increasing studies investigating -160C/A in different types of cancers and ethnic populations. However, there is still uncertainty about the level of risk for a variety of cancers. Methods: To resolve the controversial question raised by these studies as of March 2012 and provide more statistical power for detecting the significance of -160C/A, we performed a meta-analysis of 47 case-control studies in 16 types of cancers (18,194 cases and 20,207 controls). A meta-regression model and subgroup analysis were employed to identify the source of heterogeneity. Publication bias was evaluated, and sensitivity analysis and cumulative evidence assessment were also performed. Results: Using fixed-and random-effects models, the -160AA homozygote was more susceptible to urothelial cancer compared with the -160CA heterozygote. Additionally, the -160A allele is an ethnicity-dependent risk factor for prostate and colorectal cancers. Carriers of the -160A allele in Asians and Europeans were more susceptible to prostate cancer, whereas their North American counterparts seemed tolerant. The -160AA homozygote plays a protective role for Europeans who develop colorectal cancer. The stability of these observations was confirmed by a one-way sensitivity analysis. However, the cumulative evidence for all cancer types was considered 'weak' using the Venice guidelines. Conclusions: A meta-analysis indicated that the -160A allele of E-cadherin provides a higher risk for the development of prostate and urothelial cancers and a protective role for colorectal cancer in an ethnicity-dependent manner.	[Wang, Lin; Wang, Guiying; Feng, Bo; Kang, Jiuhong] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Dept Endocrinol,Shanghai E Hosp, Shanghai 200092, Peoples R China; [Lu, Chenqi] Fudan Univ, Sch Life Sci, SKLGE, Inst Biostat,Lab Populat & Quantitat Genet, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Wang, L (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Dept Endocrinol,Shanghai E Hosp, Shanghai 200092, Peoples R China.	fengbo@medmail.com; jhkang@tongji.edu.cn			Ministry of Science and Technology [2011CB965100, 2011DFA30480, 2010CB945000, 2010CB944900, 2011CBA01100]; National Natural Science Foundation of China [90919028, 31101061, 31071306, 31000378, 31171432, 30971451]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 11XD1405300]; Ministry of Education, China [IRT1168, 20110072110039]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education, China(Ministry of Education, China)	This work was supported by grants from Ministry of Science and Technology (Grants 2011CB965100, 2011DFA30480, 2010CB945000, 2010CB944900, and 2011CBA01100), National Natural Science Foundation of China (Grants 90919028, 31101061, 31071306, 31000378, 31171432 and 30971451), Science and Technology Commission of Shanghai Municipality (Grants 11ZR1438500, 11XD1405300), IRT1168 and 20110072110039 from Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2008, CANCER RES, V68, P5096, DOI 10.1158/0008-5472.CAN-07-5619; Al-Moundhri MS, 2010, WORLD J GASTROENTERO, V16, P3432, DOI 10.3748/wjg.v16.i27.3432; Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Ben Nasr H, 2010, CLIN CHIM ACTA, V411, P1253, DOI 10.1016/j.cca.2010.05.001; Bonilla C, 2006, PROSTATE, V66, P546, DOI 10.1002/pros.20374; Cattaneo F, 2006, ANTICANCER RES, V26, P4627; Chien MH, 2012, HEAD NECK-J SCI SPEC, V34, P405, DOI 10.1002/hed.21746; Chien MH, 2011, J SURG ONCOL, V104, P299, DOI 10.1002/jso.21929; Corso G, 2009, EUR J CANCER PREV, V18, P46, DOI 10.1097/CEJ.0b013e32830c8d70; Cybulski C, 2007, UROL INT, V79, P44, DOI 10.1159/000102913; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fei Y, 2010, CANCER GENET CYTOGEN, V197, P25, DOI 10.1016/j.cancergencyto.2009.10.016; Goto T, 2007, UROLOGY, V70, P127, DOI 10.1016/j.urology.2007.03.036; Grunhage F, 2008, INT J COLORECTAL DIS, V23, P147, DOI 10.1007/s00384-007-0388-6; Hajdinjak T, 2004, INT J CANCER, V109, P480, DOI 10.1002/ijc.11705; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humar B, 2002, ONCOGENE, V21, P8192, DOI 10.1038/sj.onc.1205921; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Jacobs G, 2011, HAEMATOL-HEMATOL J, V96, P987, DOI 10.3324/haematol.2010.033126; Jenab M, 2008, EUR J CANCER, V44, P774, DOI 10.1016/j.ejca.2008.02.003; Jonsson BA, 2004, INT J CANCER, V109, P348, DOI 10.1002/ijc.11629; Kamoto T, 2005, JPN J CLIN ONCOL, V35, P158, DOI 10.1093/jjco/hyi040; Kiemeney LA, 2006, EUR J CANCER, V42, P3219, DOI 10.1016/j.ejca.2006.05.033; Koksal IT, 2007, ARCH ANDROLOGY, V53, P43, DOI 10.1080/01485010600822606; Kuraoka K, 2003, INT J ONCOL, V23, P421; Langevin SM, 2010, PHARMACOGENET GENOM, V20, P586, DOI 10.1097/FPC.0b013e32833c3892; Lei HX, 2002, INT J CANCER, V98, P199, DOI 10.1002/ijc.10176; Li LC, 2000, CANCER RES, V60, P873; Li Y, 2008, GYNECOL ONCOL, V108, P409, DOI 10.1016/j.ygyno.2007.10.024; Lindstrom S, 2005, HUM GENET, V118, P339, DOI 10.1007/s00439-005-0060-6; Lu Y, 2005, WORLD J GASTROENTERO, V11, P56, DOI 10.3748/wjg.v11.i1.56; Ma X, 2008, BJU INT, V102, P633, DOI 10.1111/j.1464-410X.2008.07634.x; Medina-Franco H, 2007, ANN SURG ONCOL, V14, P2246, DOI 10.1245/s10434-006-9054-4; Nakamura A, 2002, MUTAT RES-FUND MOL M, V502, P19, DOI 10.1016/S0027-5107(02)00024-6; Park WS, 2003, J KOREAN MED SCI, V18, P501, DOI 10.3346/jkms.2003.18.4.501; Pharoah PDP, 2002, INT J CANCER, V101, P196, DOI 10.1002/ijc.10590; Pittman AM, 2009, INT J CANCER, V125, P1622, DOI 10.1002/ijc.24542; Pookot D, 2006, J UROLOGY, V176, P793, DOI 10.1016/j.juro.2006.03.085; Porter TR, 2002, ONCOGENE, V21, P1928, DOI 10.1038/sj.onc.1205245; Ricketts C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006037; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Shin Y, 2004, CARCINOGENESIS, V25, P2173, DOI 10.1093/carcin/bgh223; Shin Y, 2004, CARCINOGENESIS, V25, P895, DOI 10.1093/carcin/bgh073; Song Chuan-gui, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P557; Tan XL, 2008, INT J CANCER, V122, P2573, DOI 10.1002/ijc.23363; Tobias A, 2000, STATA TECH B, V10, P15; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Tsukino H, 2004, UROL INT, V72, P203, DOI 10.1159/000077115; Tsukino H, 2003, CANCER LETT, V195, P53, DOI 10.1016/S0304-3835(03)00130-7; Verhage BAJ, 2002, INT J CANCER, V100, P683, DOI 10.1002/ijc.10541; Wang GY, 2008, AM J EPIDEMIOL, V167, P7, DOI 10.1093/aje/kwm264; Wang GY, 2008, LUNG CANCER, V62, P162, DOI 10.1016/j.lungcan.2008.03.023; Wang JH, 2007, EPIDEMIOLOGY; Wang YX, 2011, ENDOCRINE; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Wu MS, 2002, CANCER-AM CANCER SOC, V94, P1443, DOI 10.1002/cncr.10371; Yamada H, 2007, SCAND J GASTROENTERO, V42, P1479, DOI 10.1080/00365520701478436; Yu JC, 2006, J BIOMED SCI, V13, P419, DOI 10.1007/s11373-006-9069-7; Zhang BZ, 2008, CANCER EPIDEM BIOMAR, V17, P2402, DOI 10.1158/1055-9965.EPI-08-0315; Zhang X, 2003, J UROLOGY, V170, P1379, DOI 10.1097/01.ju.0000084297.43710.e9; Zhang Xiu-Feng, 2005, Ai Zheng, V24, P513	65	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40219	10.1371/journal.pone.0040219	http://dx.doi.org/10.1371/journal.pone.0040219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792244	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300037
J	Soares, MC; Bshary, R; Mendonca, R; Grutter, AS; Oliveira, RF				Soares, Marta C.; Bshary, Redouan; Mendonca, Rute; Grutter, Alexandra S.; Oliveira, Rui F.			Arginine Vasotocin Regulation of Interspecific Cooperative Behaviour in a Cleaner Fish	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SOCIAL-BEHAVIOR; LABROIDES-DIMIDIATUS; VASOPRESSIN; AGGRESSION; COURTSHIP; MODULATION; MECHANISMS; EVOLUTION; ISOTOCIN	In an interspecific cooperative context, individuals must be prepared to tolerate close interactive proximity to other species but also need to be able to respond to relevant social stimuli in the most appropriate manner. The neuropeptides vasopressin and oxytocin and their non-mammalian homologues have been implicated in the evolution of sociality and in the regulation of social behaviour across vertebrates. However, little is known about the underlying physiological mechanisms of interspecific cooperative interactions. In interspecific cleaning mutualisms, interactions functionally resemble most intraspecific social interactions. Here we provide the first empirical evidence that arginine vasotocin (AVT), a non-mammalian homologue of arginine vasopressin (AVP), plays a critical role as moderator of interspecific behaviour in the best studied and ubiquitous marine cleaning mutualism involving the Indo-Pacific bluestreak cleaner wrasse Labroides dimidiatus. Exogenous administration of AVT caused a substantial decrease of most interspecific cleaning activities, without similarly affecting the expression of conspecific directed behaviour, which suggests a differential effect of AVT on cleaning behaviour and not a general effect on social behaviour. Furthermore, the AVP-V1a receptor antagonist (manning compound) induced a higher likelihood for cleaners to engage in cleaning interactions and also to increase their levels of dishonesty towards clients. The present findings extend the knowledge of neuropeptide effects on social interactions beyond the study of their influence on conspecific social behaviour. Our evidence demonstrates that AVT pathways might play a pivotal role in the regulation of interspecific cooperative behaviour and conspecific social behaviour among stabilized pairs of cleaner fish. Moreover, our results suggest that the role of AVT as a neurochemical regulator of social behaviour may have been co-opted in the evolution of cooperative behaviour in an interspecific context, a hypothesis that is amenable to further testing on the potential direct central mechanism involved.	[Soares, Marta C.; Mendonca, Rute; Oliveira, Rui F.] ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal; [Soares, Marta C.; Bshary, Redouan] Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; [Grutter, Alexandra S.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Oliveira, Rui F.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	Instituto Superior Psicologia Aplicada (ISPA); University of Neuchatel; University of Queensland; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Soares, MC (corresponding author), ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal.	msoares@ispa.pt	Soares, Marta/GSM-7143-2022; Oliveira, Rui/A-3581-2013; Grutter, Alexandra S/J-2737-2013; Soares, Marta C/J-4448-2013; Soares, Marta/J-4448-2013	Soares, Marta/0000-0002-5213-2377; Oliveira, Rui/0000-0003-1528-618X; Grutter, Alexandra S/0000-0003-1688-2821; Soares, Marta C/0000-0002-5213-2377; Soares, Marta/0000-0001-5304-3424; Mendonca, Rute/0000-0001-7290-3901; Bshary, Redouan/0000-0001-7198-8472	Fundacao para a Ciencia e Tecnologia [PTDC/MAR/105276/2008]; Swiss Science Foundation	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Swiss Science Foundation(Swiss National Science Foundation (SNSF))	This study was financed by a grant provided by Fundacao para a Ciencia e Tecnologia (PTDC/MAR/105276/2008) (financing MCS and RM) and by the Swiss Science Foundation (grant to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Reagan E., 2005, HORMONES ANIMAL SOCI; Balment RJ, 2006, GEN COMP ENDOCR, V147, P9, DOI 10.1016/j.ygcen.2005.12.022; Bastian J, 2001, J EXP BIOL, V204, P1909; BERNSTEI.JJ, 1965, EXP NEUROL, V11, P464, DOI 10.1016/0014-4886(65)90060-9; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R., 2011, FISH COGNITION BEHAV, P277; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Bshary R, 2011, ETHOLOGY, V117, P246, DOI 10.1111/j.1439-0310.2010.01872.x; Bshary Redouan, 2008, P563; Bundgaard M, 2008, GLIA, V56, P699, DOI 10.1002/glia.20642; Burbach JPH, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3055; Carneiro LA, 2003, FISH PHYSIOL BIOCHEM, V28, P241, DOI 10.1023/B:FISH.0000030542.31395.8a; Cheney KL, 2008, BEHAV ECOL, V19, P1063, DOI 10.1093/beheco/arn067; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Cote IM, 1998, J FISH BIOL, V53, P256, DOI 10.1111/j.1095-8649.1998.tb01031.x; CUSHMAN JH, 1991, TRENDS ECOL EVOL, V6, P193, DOI 10.1016/0169-5347(91)90213-H; de Kloet ER, 2010, EUR J PHARMACOL, V626, P18, DOI 10.1016/j.ejphar.2009.10.017; Dewan AK, 2011, HORM BEHAV, V59, P56, DOI 10.1016/j.yhbeh.2010.10.002; DICKMAN CR, 1992, TRENDS ECOL EVOL, V7, P194, DOI 10.1016/0169-5347(92)90072-J; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; Feder HM, 1966, CLEANING SYMBIOSIS M; Feifel D, 2009, NEUROPSYCHOPHARMACOL, V34, P2011, DOI 10.1038/npp.2009.15; Goodson JL, 2010, CURR OPIN NEUROBIOL, V20, P784, DOI 10.1016/j.conb.2010.08.020; Goodson JL, 2008, PROG BRAIN RES, V170, P3, DOI 10.1016/S0079-6123(08)00401-9; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2004, CURR BIOL, V14, P1080, DOI 10.1016/j.cub.2004.05.048; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Grutter AS, 1997, COPEIA, P346, DOI 10.2307/1447754; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Lema SC, 2004, HORM BEHAV, V46, P628, DOI 10.1016/j.yhbeh.2004.07.003; Lema SC, 2010, MAR FRESHW BEHAV PHY, V43, P257, DOI 10.1080/10236244.2010.498632; Lema SC, 2010, MOL CELL ENDOCRINOL, V321, P215, DOI 10.1016/j.mce.2010.02.015; LENKE R, 1988, BEHAV BRAIN RES, V27, P73, DOI 10.1016/0166-4328(88)90110-6; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Manning M, 2008, PROGR BRAIN RES, V170; McEwen Barbara B, 2004, Adv Pharmacol, V50, P531; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Oldfield RG, 2011, PHYSIOL BEHAV, V102, P296, DOI 10.1016/j.physbeh.2010.11.022; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Robertson D.R., 1974, STUDY ETHOLOGY REPRO; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007; Santangelo N, 2006, P ROY SOC B-BIOL SCI, V273, P3085, DOI 10.1098/rspb.2006.3683; Santangelo N, 2010, BRAIN BEHAV EVOLUT, V75, P282, DOI 10.1159/000316867; Semsar K, 2004, HORM BEHAV, V45, P345, DOI 10.1016/j.yhbeh.2004.01.003; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Soares MC, 2008, ETHOLOGY, V114, P209, DOI 10.1111/j.1439-0310.2007.01471.x; Soares MC, 2010, PHILOS T R SOC B, V365, P2737, DOI 10.1098/rstb.2010.0151; Tebbich S, 2002, ANIM COGN, V5, P139, DOI 10.1007/s10071-002-0141-z; Thompson R, 2004, PSYCHONEUROENDOCRINO, V29, P35, DOI 10.1016/S0306-4530(02)00133-6; Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Young LJ, 2008, RES PERSPECT END INT, P57, DOI 10.1007/978-3-540-79288-8_5	61	36	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39583	10.1371/journal.pone.0039583	http://dx.doi.org/10.1371/journal.pone.0039583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802939	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900013
J	Kalema, N; Den Boon, S; Cattamanchi, A; Davis, JL; Andama, A; Katagira, W; Everett, C; Walter, N; Byanyima, P; Kaswabuli, S; Worodria, W; Huang, L				Kalema, Nelson; Den Boon, Saskia; Cattamanchi, Adithya; Davis, J. Lucian; Andama, Alfred; Katagira, Winceslaus; Everett, Charles; Walter, Nicholas; Byanyima, Patrick; Kaswabuli, Sylvia; Worodria, William; Huang, Laurence			Oral Antimicrobial Rinse to Reduce Mycobacterial Culture Contamination among Tuberculosis Suspects in Uganda: A Prospective Study	PLOS ONE			English	Article							SPUTUM COLLECTION; SYSTEMS	Rationale: Contamination by bacterial or fungal organisms reduces the effectiveness of mycobacterial culture for diagnosis of pulmonary tuberculosis (TB). We evaluated the effect of an anti-microbial and an anti-fungal oral rinse prior to expectoration on culture-contamination rates. Methods: We enrolled a consecutive random sample of adults with cough for >= 2 weeks and suspected TB admitted to Mulago Hospital (Kampala, Uganda) between October 2008 and June 2009. We randomly assigned patients to oral rinse (60 seconds with chlorhexidine followed by 60 seconds with nystatin) vs. no oral rinse prior to initial sputum collection. Uganda National Tuberculosis Reference Laboratory technicians blinded to the method of sputum collection (with or without oral rinse) processed all sputum specimens for smear microscopy (direct Ziehl-Neelsen) and mycobacterial culture (Lowenstein-Jensen media). Results: Of 220 patients enrolled, 177 (80%) were HIV-seropositive (median CD4-count 37 cells/uL, IQR 13-171 cells/uL). Baseline characteristics were similar between patients in the oral-rinse (N = 110) and no oral-rinse (N = 110) groups. The proportion of contaminated cultures was significantly lower in the oral-rinse group compared to the no oral-rinse group (4% vs. 15%, risk difference -11%, 95% Cl -18 to -3%, p = 0.005). Oral rinse significantly reduced the proportion of contaminated cultures among HIV-infected patients (3% vs. 18%, risk difference -14%, 95% Cl -23 to -6%, p = 0.002) but not HIV-uninfected (6% vs. 4%, risk difference 2%, 95% CI 212 to +15%, p = 0.81) patients. However, the proportion of smear-positive specimens (25% vs. 35%, p = 0.10) and culture-positive specimens (48% vs. 56%, p = 0.24) were lower in the oral-rinse compared to the no oral-rinse group, although the differences were not statistically significant. Conclusions: Oral rinse prior to sputum expectoration is a promising strategy to reduce mycobacterial culture contamination in areas with high HIV prevalence, if strategies can be devised to reduce the adverse impact of oral rinse on smear- and culture-positivity.	[Kalema, Nelson; Den Boon, Saskia; Cattamanchi, Adithya; Davis, J. Lucian; Andama, Alfred; Katagira, Winceslaus; Everett, Charles; Walter, Nicholas; Byanyima, Patrick; Kaswabuli, Sylvia; Worodria, William] Makerere Univ Univ Calif San Francisco MU UCSF Re, Kampala, Uganda; [Cattamanchi, Adithya; Davis, J. Lucian; Everett, Charles; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA; [Andama, Alfred; Worodria, William] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Walter, Nicholas] Univ Colorado, Div Pulm Sci & Crit Care Med, Denver, CO 80202 USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA	Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; University of Colorado System; University of Colorado Denver; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Kalema, N (corresponding author), Makerere Univ Univ Calif San Francisco MU UCSF Re, Kampala, Uganda.	kalemanelson@gmail.com	Huang, Laurence/AAZ-7120-2021; Kalema, Nelson/AAZ-5730-2020; Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; Kalema, Nelson/0000-0002-7118-704X; Davis, J. Lucian/0000-0002-8629-9992; Katagira, Winceslaus/0000-0003-4622-191X	National Institutes of Health [K24 HL087713, R01 HL090335, K23 AI080147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, K23HL094141, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K23AI080147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants K24 HL087713 (LH), R01 HL090335 (LH), and K23 AI080147 (JLD) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; FODOR T, 1980, ACTA MICROBIOL HUNG, V27, P343; Huang TS, 2001, ANN CLIN LAB SCI, V31, P279; Kent PT., 1985, PUBLIC HLTH MICROBIO; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Mataftsi M, 2011, ORAL DIS, V17, P13, DOI 10.1111/j.1601-0825.2010.01727.x; MITCHISON DA, 1972, J MED MICROBIOL, V5, P165, DOI 10.1099/00222615-5-2-165; Muyoyeta M, 2009, INT J TUBERC LUNG D, V13, P460; Muzanye G, 2009, AFR HEALTH SCI, V9, P200; Otu J, 2008, J INFECT DEV COUNTR, V2, P200; Peres RL, 2011, J CLIN MICROBIOL, V49, P3058, DOI 10.1128/JCM.00541-11; Russell AD, 1996, J APPL BACTERIOL, V81, pS87, DOI 10.1111/j.1365-2672.1996.tb04837.x; Verweij KE, 2010, INT J TUBERC LUNG D, V14, P1127; WHITTIER S, 1993, J CLIN MICROBIOL, V31, P861, DOI 10.1128/JCM.31.4.861-864.1993; Williams D., 2011, J ORAL MICROBIOL, P3; World Health Organization, GUID STAND OP PROC M	18	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e38888	10.1371/journal.pone.0038888	http://dx.doi.org/10.1371/journal.pone.0038888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808020	Green Published, gold			2022-12-27	WOS:000306366400005
J	Keogh, JS; Noble, DWA; Wilson, EE; Whiting, MJ				Keogh, J. Scott; Noble, Daniel W. A.; Wilson, Eleanor E.; Whiting, Martin J.			Activity Predicts Male Reproductive Success in a Polygynous Lizard	PLOS ONE			English	Article							SEXUAL SELECTION; MULTIPLE PATERNITY; BEHAVIOR	Activity patterns and social interactions play a key role in determining reproductive success, although this is poorly understood for species that lack overt social behaviour. We used genetic paternity analysis to quantify both multiple paternity and the relative roles of activity and social behaviour in determining reproductive success in a nondescript Australian lizard. During the breeding season we intensively followed and recorded the behaviour of a group of seven males and 13 females in a naturalistic outdoor enclosure to examine the relative roles of body size, activity and social interactions in determining male fertilization success. We found multiple paternity in 42% of clutches. No single behaviour was a significant predictor of male fertilization success in isolation, but male-female association, interactions and courtship explained 41% of the variation in male fertilization success. Males with the highest number of offspring sired invested heavily in interacting with females but spent very little time in interactions with males. These same males also sired offspring from more clutches. When taken collectively, an index of overall male activity, including locomotion and all social interactions, significantly explained 81% of the variation in the total number of offspring sired and 90% of the variation in the number of clutches in which males sired offspring. We suggest that the most successful male strategy is a form of endurance rivalry in which active mate searching and interactions with females have the greatest fitness benefits.	[Keogh, J. Scott; Wilson, Eleanor E.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Noble, Daniel W. A.; Whiting, Martin J.] Macquarie Univ, Div Brain Behav & Evolut, Dept Biol Sci, Sydney, NSW 2109, Australia	Australian National University; Macquarie University	Keogh, JS (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	scott.keogh@anu.edu.au	Keogh, Scott/C-8441-2009; Noble, Daniel/H-6214-2013; Whiting, Martin J./E-2999-2010	Keogh, Scott/0000-0002-1373-6186; Noble, Daniel/0000-0001-9460-8743; Whiting, Martin J./0000-0002-4662-0227	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council to JSK. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Baird TA, 2007, BEHAV ECOL, V18, P1146, DOI 10.1093/beheco/arm092; Borges-Landaez PA, 2003, J HERPETOL, V37, P592, DOI 10.1670/26-02N; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Head ML, 2005, ACTA ETHOL, V8, P79, DOI 10.1007/s10211-005-0003-1; Hoglund J, 1995, MONOGRAPHS BEHAV ECO; IMS RA, 1988, NATURE, V335, P541, DOI 10.1038/335541a0; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Lane JE, 2008, ANIM BEHAV, V75, P1927, DOI 10.1016/j.anbehav.2007.10.038; Lane JE, 2009, J ANIM ECOL, V78, P296, DOI 10.1111/j.1365-2656.2008.01502.x; Morrison SF, 2002, MOL ECOL, V11, P535, DOI 10.1046/j.0962-1083.2002.01450.x; Murphy CG, 1998, EVOLUTION, V52, P8, DOI 10.1111/j.1558-5646.1998.tb05133.x; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Olsson M, 2000, P ROY SOC B-BIOL SCI, V267, P2339, DOI 10.1098/rspb.2000.1289; Olsson M, 2011, EVOLUTION, V65, P3323, DOI 10.1111/j.1558-5646.2011.01387.x; Olsson M, 2011, EVOLUTION, V65, P574, DOI 10.1111/j.1558-5646.2010.01152.x; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; Salvador A, 2008, BEHAV ECOL, V19, P169, DOI 10.1093/beheco/arm118; Scott IAW, 2001, MOL ECOL NOTES, V1, P28, DOI 10.1046/j.1471-8278.2000.00011.x; Stapley J, 2005, BEHAV ECOL, V16, P514, DOI 10.1093/beheco/ari019; Stapley J, 2004, ANIM BEHAV, V68, P841, DOI 10.1016/j.anbehav.2004.02.008; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Whiting MJ, 2003, LIZARD SOCIAL BEHAVIOR, P47	26	27	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38856	10.1371/journal.pone.0038856	http://dx.doi.org/10.1371/journal.pone.0038856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808016	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400006
J	Ryan, MM; Ryan, B; Kyrke-Smith, M; Logan, B; Tate, WP; Abraham, WC; Williams, JM				Ryan, Margaret M.; Ryan, Brigid; Kyrke-Smith, Madeleine; Logan, Barbara; Tate, Warren P.; Abraham, Wickliffe C.; Williams, Joanna M.			Temporal Profiling of Gene Networks Associated with the Late Phase of Long-Term Potentiation In Vivo	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NF-KAPPA-B; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; DENTATE GYRUS; HISTONE MODIFICATIONS; GLUTAMATE-RECEPTOR; NEURITE OUTGROWTH; BEHAVING RATS; EXPRESSION	Long-term potentiation (LTP) is widely accepted as a cellular mechanism underlying memory processes. It is well established that LTP persistence is strongly dependent on activation of constitutive and inducible transcription factors, but there is limited information regarding the downstream gene networks and controlling elements that coalesce to stabilise LTP. To identify these gene networks, we used Affymetrix RAT230.2 microarrays to detect genes regulated 5 h and 24 h (n = 5) after LTP induction at perforant path synapses in the dentate gyrus of awake adult rats. The functional relationships of the differentially expressed genes were examined using DAVID and Ingenuity Pathway Analysis, and compared with our previous data derived 20 min post-LTP induction in vivo. This analysis showed that LTP-related genes are predominantly upregulated at 5 h but that there is pronounced downregulation of gene expression at 24 h after LTP induction. Analysis of the structure of the networks and canonical pathways predicted a regulation of calcium dynamics via G-protein coupled receptors, dendritogenesis and neurogenesis at the 5 h time-point. By 24 h neurotrophin-NFKB driven pathways of neuronal growth were identified. The temporal shift in gene expression appears to be mediated by regulation of protein synthesis, ubiquitination and time-dependent regulation of specific microRNA and histone deacetylase expression. Together this programme of genomic responses, marked by both homeostatic and growth pathways, is likely to be critical for the consolidation of LTP in vivo.	[Ryan, Margaret M.; Ryan, Brigid; Kyrke-Smith, Madeleine; Logan, Barbara; Tate, Warren P.; Abraham, Wickliffe C.; Williams, Joanna M.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Ryan, Margaret M.; Ryan, Brigid; Kyrke-Smith, Madeleine; Williams, Joanna M.] Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Ryan, Margaret M.; Tate, Warren P.] Otago Sch Med Sci, Dept Biochem, Dunedin, New Zealand; [Logan, Barbara; Abraham, Wickliffe C.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago	Ryan, MM (corresponding author), Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand.	joanna.williams@anatomy.otago.ac.nz		Tate, Warren/0000-0002-6971-7734	The Royal Society of New Zealand Marsden Fund [03-UOO-118]; University of Otago Grants Committee	The Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Otago Grants Committee	The Royal Society of New Zealand Marsden Fund; Grant number 03-UOO-118. University of Otago Grants Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2003, NEUROSCIENTIST, V9, P463, DOI 10.1177/1073858403259119; Abraham WC, 2002, J NEUROSCI, V22, P9626; Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Bramham CR, 1996, J COMP NEUROL, V368, P371; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Cheyne JE, 2008, MOL CELL NEUROSCI, V37, P432, DOI 10.1016/j.mcn.2007.10.015; Dong E, 2003, P NATL ACAD SCI USA, V100, P5479, DOI 10.1073/pnas.1031602100; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Errington ML, 2003, PHILOS T ROY SOC B, V358, P675, DOI 10.1098/rstb.2002.1251; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fujita S, 2001, BRIT J PHARMACOL, V132, P1417, DOI 10.1038/sj.bjp.0703970; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jurado S, 2010, EMBO J, V29, P2827, DOI 10.1038/emboj.2010.160; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Leone V, 2011, MOL ENDOCRINOL, V25, P1819, DOI 10.1210/me.2011-0014; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Lisman J., 2006, SCI STKE, V2006, pr; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; LYNCH MA, 1994, NEUROSCIENCE, V60, P1, DOI 10.1016/0306-4522(94)90197-X; Ma Q, 2008, CELL SIGNAL, V20, P1044, DOI 10.1016/j.cellsig.2008.01.015; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Mikl M, 2010, J COMP PHYSIOL A, V196, P321, DOI 10.1007/s00359-010-0520-x; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Moult PR, 2010, J NEUROSCI, V30, P4088, DOI 10.1523/JNEUROSCI.3614-09.2010; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nishimura H, 2003, J NEUROCHEM, V85, P1216, DOI 10.1046/j.1471-4159.2003.01760.x; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park CS, 2006, J BIOL CHEM, V281, P30195, DOI 10.1074/jbc.M605876200; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Pincheira R, 2009, EMBO J, V28, P261, DOI 10.1038/emboj.2008.274; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Ryan MM, 2011, HIPPOCAMPUS, V21, P541, DOI 10.1002/hipo.20770; Saba R., 2010, BRAIN RES; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SMIRNOVA T, 1993, SCIENCE, V262, P433, DOI 10.1126/science.8105538; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; Williams JM, 2007, J NEUROSCI, V27, P14171, DOI 10.1523/JNEUROSCI.2348-07.2007; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yellajoshyula D, 2011, P NATL ACAD SCI USA, V108, P3294, DOI 10.1073/pnas.1012053108; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	67	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40538	10.1371/journal.pone.0040538	http://dx.doi.org/10.1371/journal.pone.0040538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802965	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500053
J	Tolppanen, AM; Sayers, A; Fraser, WD; Lewis, G; Zammit, S; Lawlor, DA				Tolppanen, Anna-Maija; Sayers, Adrian; Fraser, William D.; Lewis, Glyn; Zammit, Stanley; Lawlor, Debbie A.			The Association of 25-Hydroxyvitamin D-3 and D-2 with Behavioural Problems in Childhood	PLOS ONE			English	Article							VITAMIN-D STATUS; DEPRESSION; CHILDREN; PERFORMANCE; PREGNANCY; SYMPTOMS; HEALTH; RISK	Background: Higher serum concentrations of 25-hydroxyvitamin D (25(OH)D), an indicator of vitamin D synthesis and intake, have been associated with better mental health and cognitive function. Concentrations of 1,25-dihydroxyvitamin D-3 (the active vitamin D-3 metabolite) have been associated with openness and extrovert behaviour, but 25(OH)D concentrations have not been associated with behavioural problems in humans. Methods: We investigated the prospective association between the different forms of 25(OH)D - 25(OH)D-3 and 25(OH)D-2- and childhood behavioural problems in Avon Longitudinal Study of Parents and Children (ALSPAC). Serum 25(OH)D-3 and 25(OH)D-2 concentrations were assessed at mean age 9.9 years. Incident behavioural problems were assessed with Strengths and Difficulties Questionnaire (SDQ; emotional symptoms, conduct problems, hyperactivity-inattention problems, peer relationship problems and pro-social behaviour subscales and total difficulties score) at mean age 11.7. Sample sizes varied between 2413-2666 depending on the outcome. Results: Higher 25(OH)D-3 concentrations were weakly associated with lower risk of prosocial problems (fully adjusted odds ratio: OR (95% confidence interval: CI) 0.85 (0.74, 0.98)). Serum 25(OH)D-3 or 25(OH)D-2 concentrations were not associated with other subscales of SDQ or total difficulties score after adjusting for concfounders and other measured analytes related to vitamin D. Conclusions: Our findings do not support the hypothesis that 25-hydroxyvitamin D status in childhood has important influences on behavioural traits in humans.	[Tolppanen, Anna-Maija; Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Fraser, William D.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Zammit, Stanley] Cardiff Univ, MRC, Ctr Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales	University of Bristol; University of East Anglia; Cardiff University	Tolppanen, AM (corresponding author), Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk	Lewis, Glyn/E-9944-2012; Sayers, Adrian/AAU-8134-2020	Lewis, Glyn/0000-0001-5205-8245; Sayers, Adrian/0000-0001-7452-5043; Lawlor, Debbie A/0000-0002-6793-2262; Zammit, Stanley/0000-0002-2647-9211	UK Medical Research Council (MRC) [G0701603]; Wellcome Trust [079960]; MRC [G0600705]; University of Bristol [G0600705]; MRC [G0701603] Funding Source: UKRI; Medical Research Council [G0600705, G0701603, G0801418B] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work on this study is funded by an UK Medical Research Council (MRC) Grant G0701603), which also pays AMT's salary. Salary support for AS is provided by Wellcome Trust grant ref 079960. MRC, the Wellcome Trust and the University of Bristol provide core funding support for ALSPAC. The MRC and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology (Grant G0600705). The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; Buell JS, 2009, J GERONTOL A-BIOL, V64, P888, DOI 10.1093/gerona/glp032; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Finch JL, 1999, J AM SOC NEPHROL, V10, P980; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Glendenning P, 2009, BONE, V45, P870, DOI 10.1016/j.bone.2009.07.015; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Lee DM, 2011, J PSYCHOPHARMACOL, V25, P1320, DOI 10.1177/0269881110379287; Lee DM, 2009, J NEUROL NEUROSUR PS, V80, P722, DOI 10.1136/jnnp.2008.165720; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; Llewellyn DJ, 2009, J GERIATR PSYCH NEUR, V22, P188, DOI 10.1177/0891988708327888; Mansbach JM, 2009, PEDIATRICS, V124, P1404, DOI 10.1542/peds.2008-2041; May HT, 2010, AM HEART J, V159, P1037, DOI 10.1016/j.ahj.2010.03.017; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; McGrath J, 2007, NEUROEPIDEMIOLOGY, V29, P49, DOI 10.1159/000108918; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Milaneschi Y, 2010, J CLIN ENDOCR METAB, V95, P3225, DOI 10.1210/jc.2010-0347; Partti K, 2010, PSYCHOSOM MED, V72, P933, DOI 10.1097/PSY.0b013e3181f7abd3; Seamans KM, 2009, AM J CLIN NUTR, V89, p1997S, DOI 10.3945/ajcn.2009.27230D; Slinin Y, 2010, NEUROLOGY, V74, P33, DOI 10.1212/WNL.0b013e3181c7197b; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tolppanen AM, 2012, J EPIDEMIOL COMMUNIT; Ubbenhorst A, 2011, PSYCHOPHARMACOLOGY, V215, P733, DOI 10.1007/s00213-011-2175-x; Whitehouse AJO, 2012, PEDIATRICS, V129, P485, DOI 10.1542/peds.2011-2644; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S; Zhao GX, 2010, BRIT J NUTR, V104, P1696, DOI 10.1017/S0007114510002588	34	26	26	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40097	10.1371/journal.pone.0040097	http://dx.doi.org/10.1371/journal.pone.0040097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808099	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000306355500025
J	Van der Burg, E; Olivers, CNL; Theeuwes, J				Van der Burg, Erik; Olivers, Christian N. L.; Theeuwes, Jan			The Attentional Window Modulates Capture by Audiovisual Events	PLOS ONE			English	Article							ABRUPT VISUAL ONSETS; SELECTIVE ATTENTION; SEARCH; COLOR; SOUND; ENHANCEMENT; INTEGRATION; SYNCHRONY; TACTILE; SIZE	Visual search is markedly improved when a target color change is synchronized with a spatially non-informative auditory signal. This "pip and pop" effect is an automatic process as even a distractor captures attention when accompanied by a tone. Previous studies investigating visual attention have indicated that automatic capture is susceptible to the size of the attentional window. The present study investigated whether the pip and pop effect is modulated by the extent to which participants divide their attention across the visual field We show that participants were better in detecting a synchronized audiovisual event when they divided their attention across the visual field relative to a condition in which they focused their attention. We argue that audiovisual capture is reduced under focused conditions relative to distributed settings.	[Van der Burg, Erik; Olivers, Christian N. L.; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Van der Burg, E (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	e.van.der.burg@psy.vu.nl	Theeuwes, Jan/ABF-3771-2020; Theeuwes, Jan/B-6862-2008	Theeuwes, Jan/0000-0002-5849-7721; Olivers, Christian/0000-0001-7470-5378	NWO-VIDI [452-06-007]	NWO-VIDI(Netherlands Organization for Scientific Research (NWO))	This research was supported by a NWO-VIDI grant (452-06-007) to CNLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Alsius A, 2007, EXP BRAIN RES, V183, P399, DOI 10.1007/s00221-007-1110-1; Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Belopolsky AV, 2010, NO CAPTURE OUTSIDE A; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; de Boer-Schellekens L, 2012, EXP BRAIN RES, V216, P243, DOI 10.1007/s00221-011-2926-2; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Hernandez M, 2010, ATTEN PERCEPT PSYCHO, V72, P963, DOI 10.3758/APP.72.4.963; Matusz PJ, 2011, PSYCHON B REV, V18, P904, DOI 10.3758/s13423-011-0131-8; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Ngo MK, 2010, ATTEN PERCEPT PSYCHO, V72, P1654, DOI 10.3758/APP.72.6.1654; Olivers CNL, 2008, BRAIN RES, V1242, P191, DOI 10.1016/j.brainres.2008.01.070; Perrott DR, 1996, HUM FACTORS, V38, P702, DOI 10.1518/001872096778827260; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Shams L, 2010, PHYS LIFE REV, V7, P269, DOI 10.1016/j.plrev.2010.04.006; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Spence C, 2007, ACOUST SCI TECHNOL, V28, P61, DOI 10.1250/ast.28.61; Staufenbiel SM, 2011, EXP BRAIN RES, V213, P457, DOI 10.1007/s00221-011-2797-6; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; THEEUWES J, 1994, PERCEPTION, V23, P429, DOI 10.1068/p230429; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; Van der Burg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010664; Van der Burg E, 2010, ACTA PSYCHOL, V134, P198, DOI 10.1016/j.actpsy.2010.01.010; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	41	20	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39137	10.1371/journal.pone.0039137	http://dx.doi.org/10.1371/journal.pone.0039137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973JD	22808027	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500007
J	Auliff, AM; Balu, B; Chen, NH; O'Neil, MT; Cheng, Q; Adams, JH				Auliff, Alyson M.; Balu, Bharath; Chen, Nanhua; O'Neil, Michael T.; Cheng, Qin; Adams, John H.			Functional Analysis of Plasmodium vivax Dihydrofolate Reductase-Thymidylate Synthase Genes through Stable Transformation of Plasmodium falciparum	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; SULFADOXINE-PYRIMETHAMINE; IN-VITRO; MALARIA PARASITE; ANTIFOLATE RESISTANCE; THERAPEUTIC RESPONSE; CHLOROQUINE; MUTATIONS; ANTIMALARIAL; TRANSFECTION	Mechanisms of drug resistance in Plasmodium vivax have been difficult to study partially because of the difficulties in culturing the parasite in vitro. This hampers monitoring drug resistance and research to develop or evaluate new drugs. There is an urgent need for a novel method to study mechanisms of P. vivax drug resistance. In this paper we report the development and application of the first Plasmodium falciparum expression system to stably express P. vivax dhfr-ts alleles. We used the piggyBac transposition system for the rapid integration of wild-type, single mutant (117N) and quadruple mutant (57L/58R/61M/117T) pvdhfr-ts alleles into the P. falciparum genome. The majority (81%) of the integrations occurred in non-coding regions of the genome; however, the levels of pvdhfr transcription driven by the P. falciparum dhfr promoter were not different between integrants of non-coding and coding regions. The integrated quadruple pvdhfr mutant allele was much less susceptible to antifolates than the wild-type and single mutant pvdhfr alleles. The resistance phenotype was stable without drug pressure. All the integrated clones were susceptible to the novel antifolate JPC-2067. Therefore, the piggyBac expression system provides a novel and important tool to investigate drug resistance mechanisms and gene functions in P. vivax.	[Auliff, Alyson M.; Chen, Nanhua; Cheng, Qin] Australian Army Malaria Inst, Drug Resistance & Diagnost Dept, Enoggera, Qld, Australia; [Auliff, Alyson M.; Cheng, Qin] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Balu, Bharath; Adams, John H.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [O'Neil, Michael T.] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD USA	QIMR Berghofer Medical Research Institute; University of Queensland; State University System of Florida; University of South Florida; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Auliff, AM (corresponding author), Australian Army Malaria Inst, Drug Resistance & Diagnost Dept, Enoggera, Qld, Australia.	qin.cheng@defence.gov.au; jadams3@health.usf.edu	Adams, John/G-1800-2015; Adams, John H./ABB-8458-2020; Cheng, Qin/AAO-2198-2020	Adams, John/0000-0003-3707-7979; Adams, John H./0000-0003-3707-7979; Cheng, Qin/0000-0001-7776-4437	National Institutes of Health [R21AI070888, R01AI033656]; Australian American Fulbright Scholarship; Chief of Army Scholarship; ARC/NHMRC Parasitology Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094973, R21AI070888, R01AI033656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian American Fulbright Scholarship; Chief of Army Scholarship; ARC/NHMRC Parasitology Network(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported in part by National Institutes of Health grants R21AI070888 and R01AI033656 (JHA). AMA received travel awards from the Australian American Fulbright Scholarship (2009), Chief of Army Scholarship (2009) and ARC/NHMRC Parasitology Network travel scholarship (2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additonal external funding received for this study.	Alam MT, 2007, ANTIMICROB AGENTS CH, V51, P857, DOI 10.1128/AAC.01200-06; Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67, DOI 10.1590/S0037-86821999000100013; Arnold C, 1991, PCR Methods Appl, V1, P39; Auliff A, 2006, AM J TROP MED HYG, V75, P617, DOI 10.4269/ajtmh.2006.75.617; Auliff AM, 2010, ANTIMICROB AGENTS CH, V54, P3927, DOI 10.1128/AAC.00628-10; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Balu B, 2007, INT J PARASITOL, V37, P1, DOI 10.1016/j.ijpara.2006.10.001; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bhattacharjee S, 2008, BLOOD, V111, P2418, DOI 10.1182/blood-2007-09-115279; CANFIELD CJ, 1993, AM J TROP MED HYG, V49, P121, DOI 10.4269/ajtmh.1993.49.121; Canfield CJ, 1986, WHO MONOGR SER, V99; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; COATNEY GR, 1963, AM J TROP MED HYG, V12, P121, DOI 10.4269/ajtmh.1963.12.121; DARLOW B, 1982, AM J TROP MED HYG, V31, P10, DOI 10.4269/ajtmh.1982.31.10; de Pecoulas PE, 1998, GENE, V211, P177, DOI 10.1016/S0378-1119(98)00118-8; de Pecoulas PE, 1998, MOL BIOCHEM PARASIT, V92, P265, DOI 10.1016/S0166-6851(97)00247-8; DOBERSTYN EB, 1979, T ROY SOC TROP MED H, V73, P15, DOI 10.1016/0035-9203(79)90121-4; Dua VK, 1996, TROP MED INT HEALTH, V1, P816; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; Edstein MD, 1997, ANTIMICROB AGENTS CH, V41, P2300, DOI 10.1128/AAC.41.10.2300; Edstein MD, 2007, J ANTIMICROB CHEMOTH, V60, P811, DOI 10.1093/jac/dkm280; Fryauff DJ, 1998, AM J TROP MED HYG, V59, P513, DOI 10.4269/ajtmh.1998.59.513; Goldberg DE, 2010, TRENDS PARASITOL; Hastings MD, 2005, ANTIMICROB AGENTS CH, V49, P733, DOI 10.1128/AAC.49.2.733-740.2005; Hastings MD, 2004, J INFECT DIS, V189, P744, DOI 10.1086/381397; Hastings MD, 2002, P NATL ACAD SCI USA, V99, P13137, DOI 10.1073/pnas.182295999; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Imwong M, 2003, ANTIMICROB AGENTS CH, V47, P1514, DOI 10.1128/AAC.47.5.1514-1521.2003; Imwong M, 2001, ANTIMICROB AGENTS CH, V45, P3122, DOI 10.1128/AAC.45.11.3122-3127.2001; Kurcer MA, 2004, ANN TROP MED PARASIT, V98, P447, DOI 10.1179/000349804225021343; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leartsakulpanich U, 2002, MOL BIOCHEM PARASIT, V119, P63, DOI 10.1016/S0166-6851(01)00402-9; Liu YG, 1998, PLANT MOL BIOL REP, V16, P175, DOI 10.1023/A:1007420918645; Maher SP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-222; MARLARTHAN, 1995, T ROY SOC TROP MED H, V89, P307, DOI 10.1016/0035-9203(95)90556-1; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Nirmalan N, 2004, MOL BIOCHEM PARASIT, V136, P63, DOI 10.1016/j.molbiopara.2004.02.013; Nirmalan N, 2002, MOL MICROBIOL, V46, P179, DOI 10.1046/j.1365-2958.2002.03148.x; O'Neil MT, 2007, J INFECT DIS, V196, P467, DOI 10.1086/519286; Peters W, 1998, ADV PARASIT, V41, P1, DOI 10.1016/S0065-308X(08)60421-2; Pfahler JM, 2006, MOL BIOCHEM PARASIT, V149, P99, DOI 10.1016/j.molbiopara.2006.03.018; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Phillips EJ, 1996, CLIN INFECT DIS, V23, P1171, DOI 10.1093/clinids/23.5.1171; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P1680, DOI 10.1128/AAC.44.6.1680-1685.2000; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Sa JM, 2006, MOL BIOCHEM PARASIT, V150, P219, DOI 10.1016/j.molbiopara.2006.08.006; Shearer TW, 2005, J MED CHEM, V48, P2805, DOI 10.1021/jm049683+; Somsak V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-291; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Tamez PA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000118; Tjitra E, 2002, ANTIMICROB AGENTS CH, V46, P3947, DOI 10.1128/AAC.46.12.3947-3953.2002; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; Young M. D., 1959, Bulletin of the World Health Organization, V20, P27; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	62	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40416	10.1371/journal.pone.0040416	http://dx.doi.org/10.1371/journal.pone.0040416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792308	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700044
J	Cento, V; Mirabelli, C; Salpini, R; Dimonte, S; Artese, A; Costa, G; Mercurio, F; Svicher, V; Parrotta, L; Bertoli, A; Ciotti, M; Di Paolo, D; Sarrecchia, C; Andreoni, M; Alcaro, S; Angelico, M; Perno, CF; Ceccherini-Silberstein, F				Cento, Valeria; Mirabelli, Carmen; Salpini, Romina; Dimonte, Salvatore; Artese, Anna; Costa, Giosue; Mercurio, Fabio; Svicher, Valentina; Parrotta, Lucia; Bertoli, Ada; Ciotti, Marco; Di Paolo, Daniele; Sarrecchia, Cesare; Andreoni, Massimo; Alcaro, Stefano; Angelico, Mario; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca			HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; DRUG-RESISTANCE; GENETIC BARRIER; NS3/4A PROTEASE; PEGINTERFERON ALPHA-2B; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; TELAPREVIR; REPLICATION; BOCEPREVIR	Background: Because of the extreme genetic variability of hepatitis C virus (HCV), we analyzed whether specific HCV-genotypes are differently prone to develop resistance to linear and macrocyclic protease-inhibitors (PIs). Methods: The study includes 1568 NS3-protease sequences, isolated from PI-naive patients infected with HCV-genotypes 1a (N=621), 1b (N=474), 2 (N=72), 3 (N=268), 4 (N=54)5 (N=6), and 6 (N=73). Genetic-barrier was calculated as the sum of nucleotide-transitions (score=1) and/or nucleotide-transversions (score=2.5) required for drug-resistance-mutations emergence. Forty-three mutations associated with PIs-resistance were analyzed (36A/M/L/G-41R-43S/V-54A/S/V-55A-Q80K/R/L/H/G-109K-138T-155K/Q/T/I/M/S/G/L-156T/V/G/S-158I-168A/H/T/V/E/I/G/N/Y-170A/T-175L). Structural analyses on NS3-protease and on putative RNA-models have been also performed. Results: Overall, NS3-protease was moderately conserved, with 85/181 (47.0%) amino-acids showing <1% variability. The catalytic-triad (H57-D81-S139) and 6/13 resistance-associated positions (Q41-F43-R109-R155-A156-V158) were fully conserved (variability <= 1%). Structural-analysis highlighted that most of the NS3-residues involved in drug-stabilization were highly conserved, while 7 PI-resistance residues, together with selected residues located in proximity of the PI-binding pocket, were highly variable among HCV-genotypes. Four resistance-mutations (80K/G-36L-175L)were found as natural polymorphisms in selected genotypes (80K present in 41.6% HCV-1a, 100% of HCV-5 and 20.6% HCV-6; 80G present in 94.4% HCV-2; 36L present in 100% HCV-3-5 and >94% HCV-2-4; 175L present in 100% HCV-1a-3-5 and >97% HCV-2-4). Furthermore, HCV-3 specifically showed non-conservative polymorphisms (R123T-D168Q) at two drug-interacting positions. Regardless of HCV-genotype, 13 PIs resistance-mutations were associated with low genetic-barrier, requiring only 1 nucleotide-substitution (41R-43S/V-54A-55A-80R-156V/T: score=1; 54S-138T-156S/G-168E/H: score=2.5). By contrast, by using HCV-1b as reference genotype, nucleotide-heterogeneity led to a lower genetic-barrier for the development of some drug-resistance-mutations in HCV-1a (36M-155G/I/K/M/S/T-170T), HCV-2 (36M-80K-155G/I/K/S/T-170T), HCV-3 (155G/I/K/M/S/T-170T), HCV-4-6 (155I/S/L), and HCV-5 (80G-155G/I/K/M/S/T). Conclusions: The high degree of HCV genetic variability makes HCV-genotypes, and even subtypes, differently prone to the development of PIs resistance-mutations. Overall, this can account for different responsiveness of HCV-genotypes to PIs, with important clinical implications in tailoring individualized and appropriate regimens.	[Cento, Valeria; Mirabelli, Carmen; Salpini, Romina; Dimonte, Salvatore; Mercurio, Fabio; Svicher, Valentina; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Artese, Anna; Costa, Giosue; Parrotta, Lucia; Alcaro, Stefano] Univ Catanzaro Magna Graecia, Dept Pharmacobiol Sci, Catanzaro, Italy; [Bertoli, Ada; Ciotti, Marco; Perno, Carlo Federico] Tor Vergata Univ Hosp, Complex Unit Mol Virol, Rome, Italy; [Di Paolo, Daniele; Angelico, Mario] Tor Vergata Univ Hosp, Dept Internal Med, Rome, Italy; [Sarrecchia, Cesare; Andreoni, Massimo] Tor Vergata Univ Hosp, Dept Publ Hlth, Rome, Italy	University of Rome Tor Vergata; Magna Graecia University of Catanzaro; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata	Cento, V (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy.	ceccherini@med.uniroma2.it	Cento, Valeria/AAF-2607-2020; Salpini, Romina/ABE-4828-2021; Andreoni, Masimo/AAL-2214-2020; Di Maio, Velia Chiara/AGH-2628-2022; perno, carlo federico/O-1544-2016; Salpini, Romina/K-2170-2016; Mirabelli, Carmen/D-9441-2018; Cento, Valeria/K-6636-2012; Costa, Giosuè/K-8461-2016; Ceccherini-Silberstein, Francesca/K-4762-2016	Salpini, Romina/0000-0002-2488-2082; Salpini, Romina/0000-0002-2488-2082; Mirabelli, Carmen/0000-0002-4785-5482; Cento, Valeria/0000-0002-3272-4252; Costa, Giosuè/0000-0003-0947-9479; BERTOLI, ADA/0000-0003-0663-2503; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; ANGELICO, Mario/0000-0003-2883-9206; Andreoni, Massimo/0000-0002-3205-9758; ALCARO, Stefano/0000-0002-0437-358X; PERNO, CARLO FEDERICO/0000-0002-0825-5388; SVICHER, VALENTINA/0000-0002-2377-504X	Merck Sharp; Dohme; Italian National Institute of Health; Italian Ministry of Instruction, University and Research (MIUR) (Accordi di Programma) [RBAP11YS7K_001]; Progetto FILAS; Aviralia Foundation	Merck Sharp; Dohme; Italian National Institute of Health; Italian Ministry of Instruction, University and Research (MIUR) (Accordi di Programma)(Ministry of Education, Universities and Research (MIUR)); Progetto FILAS; Aviralia Foundation	This work was supported by an unrestricted educational grant from Merck Sharp and Dohme and by grants from the Italian National Institute of Health, the Italian Ministry of Instruction, University and Research (MIUR) (Accordi di Programma 2011: RBAP11YS7K_001), by the "Progetto FILAS" and Aviralia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro S, 2010, CHEMMEDCHEM, V5, P575, DOI 10.1002/cmdc.200900541; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Butt AA, 2012, CLIN INFECT DIS, V54, P96, DOI 10.1093/cid/cir774; Chase R, 2009, ANTIVIR RES, V84, P178, DOI 10.1016/j.antiviral.2009.09.003; Colson P, 2012, J CLIN VIROL, V53, P178, DOI 10.1016/j.jcv.2011.10.005; Dimonte S, 2012, INTERVIROLOGY, V55, P385, DOI 10.1159/000334696; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Ferenci P, 2011, ANTIVIR THER, V16, P1187, DOI 10.3851/IMP1934; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Fried M W, 2001, Clin Liver Dis, V5, P1009, DOI 10.1016/S1089-3261(05)70206-3; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Herrmann E, 2000, ANTIVIR THER, V5, P85; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Imhof I, 2011, HEPATOLOGY, V53, P1090, DOI 10.1002/hep.24172; Irshad M, 2008, REV MED VIROL, V19, DOI [10.1002/rmv.603, DOI 10.1002/RMV.603]; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kim JJ, 2012, AM J HEALTH-SYST PH, V69, P19, DOI 10.2146/ajhp110123; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lemke CT, 2011, J BIOL CHEM, V286, P11434, DOI 10.1074/jbc.M110.211417; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Lopez-Labrador FX, 2008, ANTIVIR THER, V13, P481; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McCown MF, 2009, ANTIMICROB AGENTS CH, V53, P2129, DOI 10.1128/AAC.01598-08; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Ortuso F, 2006, BIOINFORMATICS, V22, P1449, DOI 10.1093/bioinformatics/btl115; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Prongay AJ, 2007, J MED CHEM, V50, P2310, DOI 10.1021/jm060173k; Qiu P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp251; Reiser M, 2005, HEPATOLOGY, V41, P832, DOI 10.1002/hep.20612; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Svicher V, 2011, DIGEST LIVER DIS, V43, P975, DOI 10.1016/j.dld.2011.07.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Trimoulet P, 2011, HIV MED, V12, P506, DOI 10.1111/j.1468-1293.2011.00913.x; Vallet S, 2011, ANTIVIR THER, V16, P1093, DOI 10.3851/IMP1900; van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4; Verbinnen T, 2010, J VIROL, V84, P11124, DOI 10.1128/JVI.01217-10; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; World Health Organization (WHO) HCV Fact Sheet, 2011, WHO HCV FACT SHEET; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	74	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39652	10.1371/journal.pone.0039652	http://dx.doi.org/10.1371/journal.pone.0039652			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792183	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800015
J	Lee, M; Jun, SY; Yoon, BY; Song, S; Lee, K; Ha, NC				Lee, Minho; Jun, So-Young; Yoon, Bo-Young; Song, Saemee; Lee, Kangseok; Ha, Nam-Chul			Membrane Fusion Proteins of Type I Secretion System and Tripartite Efflux Pumps Share a Binding Motif for TolC in Gram-Negative Bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MULTIDRUG EFFLUX; HEMOLYSIN TRANSLOCATOR; PERIPLASMIC COMPONENT; TIP REGION; HLYD; IDENTIFICATION; TRANSPORTER; HAIRPIN	The Hly translocator complex of Escherichia coli catalyzes type I secretion of the toxin hemolysin A (HlyA). In this complex, HlyB is an inner membrane ABC (ATP Binding Cassette)-type transporter, TolC is an outer membrane channel protein, and HlyD is a periplasmic adaptor anchored in the inner membrane that bridges HlyB to TolC. This tripartite organization is reminiscent of that of drug efflux systems such as AcrA-AcrB-TolC and MacA-MacB-TolC of E. coli. We have previously shown the crucial role of conserved residues located at the hairpin tip region of AcrA and MacA adaptors during assembly of their cognate systems. In this study, we investigated the role of the putative tip region of HlyD using HlyD mutants with single amino acid substitutions at the conserved positions. In vivo and in vitro data show that all mutations abolished HlyD binding to TolC and resulted in the absence of HlyA secretion. Together, our results suggest that, similarly to AcrA and MacA, HlyD interacts with TolC in a tip-to-tip manner. A general model in which these conserved interactions induce opening of TolC during drug efflux and type I secretion is discussed.	[Lee, Minho; Song, Saemee; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Jun, So-Young; Yoon, Bo-Young; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Coll Pharm, Dept Mfg Pharm, Pusan, South Korea	Chung Ang University; Pusan National University	Lee, M (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	kangseok@cau.ac.kr; hnc@pusan.ac.kr	Lee, Minho/AAK-4109-2021	Lee, Minho/0000-0002-8404-5702	National Research Foundation of Korea [2010-0015298]; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ009025]	National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea	This work was supported by grants 2010-0015298 from the National Research Foundation of Korea, and the Next-Generation BioGreen 21 Program (SSAC, grant#: PJ009025), Rural Development Administration, Republic of Korea. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; COHEN SN, 1977, J BACTERIOL, V132, P734, DOI 10.1128/JB.132.2.734-737.1977; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; HOLLAND IB, 1990, J BIOENERG BIOMEMBR, V22, P473, DOI 10.1007/BF00763178; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; KENNY B, 1992, MOL MICROBIOL, V6, P1477, DOI 10.1111/j.1365-2958.1992.tb00868.x; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lewis K, 2000, CURR BIOL, V10, pR678, DOI 10.1016/S0960-9822(00)00682-5; MACKMAN N, 1984, MOL GEN GENET, V196, P129, DOI 10.1007/BF00334104; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; Pimenta AL, 1999, MOL GEN GENET, V261, P122, DOI 10.1007/s004380050949; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; SCHULEIN R, 1992, MOL GEN GENET, V234, P155; SCHULEIN R, 1994, MOL GEN GENET, V245, P203; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2011, PROTEIN SCI, V20, P6, DOI 10.1002/pro.532; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; WANG RC, 1991, J MOL BIOL, V217, P441, DOI 10.1016/0022-2836(91)90748-U; WELCH RA, 1981, NATURE, V294, P665, DOI 10.1038/294665a0; Xu YB, 2012, J BIOL CHEM, V287, P11740, DOI 10.1074/jbc.M111.329375; Xu Y, 2011, J BIOL CHEM, V286, P17910, DOI 10.1074/jbc.M111.238535; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00189	33	38	37	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40460	10.1371/journal.pone.0040460	http://dx.doi.org/10.1371/journal.pone.0040460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792337	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800090
J	Liu, XY; Wang, YJ; Shih, CK; Ren, D; Yang, D				Liu, Xingyue; Wang, Yongjie; Shih, Chungkun; Ren, Dong; Yang, Ding			Early Evolution and Historical Biogeography of Fishflies (Megaloptera: Chauliodinae): Implications from a Phylogeny Combining Fossil and Extant Taxa	PLOS ONE			English	Article							WEELE MEGALOPTERA; NEUROPTERIDA INSECTA; NEOCHAULIODES-WEELE; CORYDALIDAE; GENUS; VICARIANCE; CHINA; SYSTEMATICS; HEMISPHERE; DISPERSAL	Fishflies (Corydalidae: Chauliodinae) are one of the main groups of the basal holometabolous insect order Megaloptera, with ca. 130 species distributed worldwide. A number of genera from the Southern Hemisphere show remarkably disjunctive distributions and are considered to be the austral remnants or "living fossils'' of Gondwana. Hitherto, the evolutionary history of fishflies remains largely unexplored due to limited fossil record and incomplete knowledge of phylogenetic relationships. Here we describe two significant fossil species of fishflies, namely Eochauliodes striolatus gen. et sp. nov. and Jurochauliodes ponomarenkoi Wang & Zhang, 2010 (original designation for fossil larvae only), from the Middle Jurassic of Inner Mongolia, China. These fossils represent the earliest fishfly adults. Furthermore, we reconstruct the first phylogenetic hypothesis including all fossil and extant genera worldwide. Three main clades within Chauliodinae are recognized, i.e. the Dysmicohermes clade, the Protochauliodes clade, and the Archichauliodes clade. The phylogenetic and dispersal-vicariance (DIVA) analyses suggest Pangaean origin and global distribution of fishflies before the Middle Jurassic. The generic diversification of fishflies might have happened before the initial split of Pangaea, while some Gondwanan-originated clades were likely to be affected by the sequential breakup of Pangaea. The modern fauna of Asian fishflies were probably derived from their Gondwanan ancestor but not the direct descendents of the Mesozoic genera in Asia.	[Liu, Xingyue; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Wang, Yongjie; Shih, Chungkun; Ren, Dong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	China Agricultural University; Capital Normal University	Liu, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	rendong@mail.cnu.edu.cn; dyangcau@yahoo.com.cn	Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659	National Natural Science Foundation of People's Republic of China [31000973]; Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China [201178]; Science Foundation of Doctor Subjects, State Education Ministry of People's Republic of China [20090008120019]	National Natural Science Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Science Foundation of Doctor Subjects, State Education Ministry of People's Republic of China	This research was supported by the National Natural Science Foundation of People's Republic of China (No. 31000973 to XL), the Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China (No. 201178 to XL), the Science Foundation of Doctor Subjects, State Education Ministry of People's Republic of China (No. 20090008120019 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS BA, 1988, J ULTRA MOL STRUCT R, V101, P185, DOI 10.1016/0889-1605(88)90008-0; Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Ansorge J, 2001, NEUES JAHRB GEOL P-M, P553; Ansorge J, 2005, ABSTR VORTR 2; Aspock Horst, 1998, Acta Zoologica Fennica, V209, P33; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; BRUNDIN L, 1967, ANNU REV ENTOMOL, V12, P149, DOI 10.1146/annurev.en.12.010167.001053; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Contreras-Ramos A, 1998, J N AM BENTHOL SOC, V17, P489, DOI 10.2307/1468368; Cox CB, 2000, MEM I OSWALDO CRUZ, V95, P509, DOI 10.1590/S0074-02762000000400012; Cranston PS, 2010, SYST ENTOMOL, V35, P636, DOI 10.1111/j.1365-3113.2010.00531.x; Engel MS, 2008, J KANSAS ENTOMOL SOC, V81, P188, DOI 10.2317/JKES-802.19.1; Esben-Petersen P., 1924, Annals of the South African Museum, V19, P151; Evans ED, 1972, THESIS OREGON STATES; FLINT O S JR, 1973, Revista Chilena de Entomologia, V7, P31; FLINT OLIVER S., 1965, PSYCHE J ENTOMOL [CAMBRIDGE MASSACHUSETTS], V72, P255; FLINT OS, 1983, ENTOMOL NEWS, V94, P15; Glasspool IJ, 2010, NAT GEOSCI, V3, P627, DOI 10.1038/NGEO923; Gould Katherine R., 1998, American Journal of Botany, V85, P133; Grimaldi David, 2005, pi; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; Hayashi F, 1995, THE NATURE INSECTS, V30, P15; Heilveil JS, 2006, MOL ECOL, V15, P1627, DOI 10.1111/j.1365-294X.2006.02876.x; Hennig W., 1953, Beitraege zur Entomologie Berlin, V3, P1; Kimmins D.E., 1954, Bulletin of the British Museum (Natural History) Entomology, V3, P417; Kukalova-Peck J., 1991, P141; Liu X.Y., 2010, FAUNA SINICA INSECTA, V51; Liu XY, 2006, ZOOL SCR, V35, P473, DOI 10.1111/j.1463-6409.2006.00240.x; Liu XY, 2008, SYST ENTOMOL, V33, P560, DOI 10.1111/j.1365-3113.2008.00429.x; Liu XY, 2007, ZOOTAXA, P29, DOI 10.11646/zootaxa.1511.1.3; Liu XY, 2006, SYST ENTOMOL, V31, P652, DOI 10.1111/j.1365-3113.2006.00346.x; Liu XY, 2011, ZOOTAXA, P23, DOI 10.11646/zootaxa.2981.1.2; Liu XY, 2011, ZOOTAXA, P1; Liu XY, 2010, ZOOTAXA, P33, DOI 10.11646/zootaxa.2692.1.2; Liu XY, 2010, EUR J ENTOMOL, V107, P425, DOI 10.14411/eje.2010.050; Liu XY, 2010, ANN ZOOL, V60, P109, DOI 10.3161/000345410X499597; Liu XY, 2006, ANN ZOOL, V56, P187; Liu XY, 2005, ENTOMOL SCI, V8, P293, DOI 10.1111/j.1479-8298.2005.00128.x; Liu XY, 2005, ZOOTAXA, P1; MADDISON DR, 2000, MACCLADE VERSION 4 0; New Timothy R., 1993, Handbuch der Zoologie (Berlin), V4, P1; PENNY ND, 1993, ENTOMOL NEWS, V104, P17; Penny ND, 1999, ENTOMOL NEWS, V110, P193; Pictet J.F., 1854, TRAITE PALEONTOLOGIE, V2, P301; PONOMARENKO A G, 1976, Entomologicheskoe Obozrenie, V55, P425; Ponomarenko A.G., 2002, HIST INSECTS, P176; Price BW, 2012, ZOOKEYS IN PRESS; Qian H, 1999, AM NAT, V154, P160, DOI 10.1086/303230; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; Ren D., 2010, SILENT STORIES INSEC; RIEK E F, 1974, Palaeontologia Africana, V17, P19; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; SCOTESE CR, 1991, PALAEOGEOGR PALAEOCL, V87, P493, DOI 10.1016/0031-0182(91)90145-H; STYS P, 1990, BIOL REV, V65, P401, DOI 10.1111/j.1469-185X.1990.tb01232.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tan Jing-Jing, 2002, Acta Zootaxonomica Sinica, V27, P428; Theischinger G, 2000, AUSTR ALDERFLY LARVA, V29; Theischinger Gunther, 1999, Stapfia, V60, P85; Thomas DC, 2012, J BIOGEOGR, V39, P98, DOI 10.1111/j.1365-2699.2011.02596.x; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; van der Weele H.W, 1910, COLLECTIONS ZOOLOGIQ, V5, P1; van dersWeele H.W., 1909, NOTES LEYDEN MUSEUM, V30, P249; VEEVERS JJ, 1991, AUST J EARTH SCI, V38, P373, DOI 10.1080/08120099108727979; Wang B, 2010, J PALEONTOL, V84, P774, DOI 10.1666/09-162.1; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wichard Wilfried, 2003, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V87, P147; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; WOOTTON RJ, 1979, SYST ENTOMOL, V4, P81, DOI 10.1111/j.1365-3113.1979.tb00614.x; Yu Y., 2011, RASP RECONSTRUCT ANC; [No title captured]	74	30	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40345	10.1371/journal.pone.0040345	http://dx.doi.org/10.1371/journal.pone.0040345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792287	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800072
J	Maezawa, Y; Binnie, M; Li, CJ; Thorner, P; Hui, CC; Alman, B; Taketo, MM; Quaggin, SE				Maezawa, Yoshiro; Binnie, Matthew; Li, Chengjin; Thorner, Paul; Hui, Chi-Chung; Alman, Benjamin; Taketo, Makoto Mark; Quaggin, Susan E.			A New Cre Driver Mouse Line, Tcf21/Pod1-Cre, Targets Metanephric Mesenchyme	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; BETA-CATENIN GENE; KIDNEY DEVELOPMENT; MAMMALIAN KIDNEY; TRANSGENIC MICE; HUMAN HOMOLOG; EXPRESSION; MUTATIONS; CELLS; POD1	Conditional gene targeting in mice has provided great insight into the role of gene function in kidney development and disease. Although a number of Cre-driver mouse strains already exist for the kidney, development of additional strains with unique expression patterns is needed. Here we report the generation and validation of a Tcf21/Pod1-Cre driver strain that expresses Cre recombinase throughout the condensing and stromal mesenchyme of developing kidneys and in their derivatives including epithelial components of the nephron and interstitial cells. To test the efficiency of this line, we crossed it to mice transgenic for either loss or gain of function beta-catenin conditional alleles. Mice with deletion of beta-catenin from Tcf21-expressing cells are born with hypoplastic kidneys, hydroureters and hydronephrosis. By contrast, Tcf21-Cre driven gain of function for beta-catenin in mice results in fused midline kidneys and hypoplastic kidneys. Finally, we report the first renal mesenchymal deletion of Patched1 (Ptch1), the receptor for sonic hedgehog (Shh), which results in renal cysts demonstrating a functional role of Shh signaling pathway in renal cystogensis. In summary, we report the generation and validation of a new Cre driver strain that provides robust excision in metanephric mesenchyme.	[Maezawa, Yoshiro; Li, Chengjin; Quaggin, Susan E.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Binnie, Matthew] Univ Toronto, St Michaels Hosp, Div Respirol, Toronto, ON M5B 1W8, Canada; [Thorner, Paul] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Hui, Chi-Chung; Alman, Benjamin] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Alman, Benjamin] Univ Toronto, Div Orthopaed Surg, Toronto, ON, Canada; [Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Quaggin, Susan E.] Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada; [Quaggin, Susan E.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Kyoto University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Maezawa, Y (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	quaggin@lunenfeld.ca		Maezawa, Yoshiro/0000-0001-5567-9901	Canadian Institutes of Health Research [MOP62931];  [016002]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); 	This work was funded by Canadian Institutes of Health Research grants MOP62931, Terry Fox grant 016002 to S.E.Q. who holds the Gabor-Zellerman Chair in Renal Research, University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Brault V, 2001, DEVELOPMENT, V128, P1253; Cain JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007313; Cui SY, 2005, J AM SOC NEPHROL, V16, P3247, DOI 10.1681/ASN.2005030278; Cui SY, 2003, DEV DYNAM, V226, P512, DOI 10.1002/dvdy.10244; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Li J, 2000, GENESIS, V26, P162, DOI 10.1002/(SICI)1526-968X(200002)26:2<162::AID-GENE21>3.0.CO;2-R; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; Maezawa Y, 2012, EMBRYOLOGY KIDNEY BR; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pietila I, DEV BIOL, V353, P50; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Robb L, 1998, DEV DYNAM, V213, P105, DOI 10.1002/(SICI)1097-0177(199809)213:1<105::AID-AJA10>3.0.CO;2-1; Robyn J, 2008, CURRENT TOPICS DEV B, V84, P250; Shan JD, 2010, DIFFERENTIATION, V79, P57, DOI 10.1016/j.diff.2009.08.006; Srinivas S, 1999, DEV GENET, V24, P241; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Tasouri E, 2011, CELL TISSUE RES, V345, P21, DOI 10.1007/s00441-011-1192-8; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Yu J, 2002, DEVELOPMENT, V129, P5301; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	36	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40547	10.1371/journal.pone.0040547	http://dx.doi.org/10.1371/journal.pone.0040547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792366	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800105
J	Padmanabhan, V; Khan, ZS; Solomon, DE; Armstrong, A; Rumbaugh, KP; Vanapalli, SA; Blawzdziewicz, J				Padmanabhan, Venkat; Khan, Zeina S.; Solomon, Deepak E.; Armstrong, Andrew; Rumbaugh, Kendra P.; Vanapalli, Siva A.; Blawzdziewicz, Jerzy			Locomotion of C. elegans: A Piecewise-Harmonic Curvature Representation of Nematode Behavior	PLOS ONE			English	Article							THERMAL-GRADIENT; CAENORHABDITIS; THERMOTAXIS; NEURONS; TOUCH	Caenorhabditis elegans, a free-living soil nematode, displays a rich variety of body shapes and trajectories during its undulatory locomotion in complex environments. Here we show that the individual body postures and entire trails of C. elegans have a simple analytical description in curvature representation. Our model is based on the assumption that the curvature wave is generated in the head segment of the worm body and propagates backwards. We have found that a simple harmonic function for the curvature can capture multiple worm shapes during the undulatory movement. The worm body trajectories can be well represented in terms of piecewise sinusoidal curvature with abrupt changes in amplitude, wavevector, and phase.	[Padmanabhan, Venkat] Texas Tech Univ, Venkat Padmanabhan Dept Mech Engn, Lubbock, TX 79409 USA; [Khan, Zeina S.] Texas Tech Univ, Zeina S Khan Dept Chem Engn, Lubbock, TX 79409 USA; [Solomon, Deepak E.] Texas Tech Univ, Deepak E Solomon Dept Chem Engn, Lubbock, TX 79409 USA; [Armstrong, Andrew] Texas Tech Univ, Hlth Sci Ctr, Andrew Armstrong Dept Surg, Lubbock, TX 79430 USA; [Rumbaugh, Kendra P.] Texas Tech Univ, Hlth Sci Ctr, Kendra P Rumbaugh Dept Surg, Lubbock, TX 79430 USA; [Vanapalli, Siva A.] Texas Tech Univ, Siva Vanapalli Dept Chem Engn, Lubbock, TX 79409 USA; [Blawzdziewicz, Jerzy] Texas Tech Univ, Jerzy Blawzdziewicz Dept Mech Engn, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Padmanabhan, V (corresponding author), Texas Tech Univ, Venkat Padmanabhan Dept Mech Engn, Lubbock, TX 79409 USA.	venkatram.padmanabhan@ttu.edu	Padmanabhan, Venkat/G-2798-2013		National Science Foundation (NSF) CAREER Award [1150836]; Howard Hughes Medical Institute (through the Undergraduate Science Education Program); NSF Grant [CBET 1059745]; Div Of Chem, Bioeng, Env, & Transp Sys [1059745] Funding Source: National Science Foundation	National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Howard Hughes Medical Institute (through the Undergraduate Science Education Program)(Howard Hughes Medical Institute); NSF Grant(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	SAV acknowledges National Science Foundation (NSF) CAREER Award Grant No.\ 1150836. KPR acknowledges the Howard Hughes Medical Institute (grant through the Undergraduate Science Education Program to Texas Tech University). This work was also supported by NSF Grant No.\ CBET 1059745 (JB,VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Berri S, 2009, HFSP J, V3, P186, DOI 10.2976/1.3082260; Boyle JH, 2008, LECT NOTES COMPUT SC, V4984, P37; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chen B, 1986, P NATL ACAD SCI USA, V103, P4723; Fang-Yen C, 2010, P NATL ACAD SCI USA, V107, P20323, DOI 10.1073/pnas.1003016107; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; GRAY J, 1964, J EXP BIOL, V41, P135; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hart A., 2006, WORMBOOK, DOI [10.1895/wormbook.1.87.1, DOI 10.1895/WORMBOOK.1.87.1, 10.1895/wormbook.1.87.1.]; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Jung S, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3359611; Kaplan F, 2009, J CHEM ECOL, V35, P878, DOI 10.1007/s10886-009-9670-0; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Kim D, 2011, J EXP BIOL, V214, P1554, DOI 10.1242/jeb.052092; Majmudar T, 2012, J R SOC INTERFACE; Matsuoka T, 2008, J THEOR BIOL, V250, P230, DOI 10.1016/j.jtbi.2007.10.002; Nakazato K, 2009, J THEOR BIOL, V260, P56, DOI 10.1016/j.jtbi.2009.05.027; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Pierce-Shimomura JT, 2005, J EXP BIOL, V208, P4727, DOI 10.1242/jeb.01933; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Ramot D, 2008, J NEUROSCI, V28, P12546, DOI 10.1523/JNEUROSCI.2857-08.2008; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shen XN, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.208101; Shenoy VB, 2007, P NATL ACAD SCI USA, V104, P8229, DOI 10.1073/pnas.0702454104; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stiernagle Theresa, 2006, WormBook, P1; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Sznitman J, 2010, EXP MECH, V50, P1303, DOI 10.1007/s11340-010-9339-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhao BB, 2003, J NEUROSCI, V23, P5319	36	17	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40121	10.1371/journal.pone.0040121	http://dx.doi.org/10.1371/journal.pone.0040121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792224	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800042
J	Sanchez-Guerrero, E; Chen, E; Kockx, M; An, SW; Chong, BH; Khachigian, LM				Sanchez-Guerrero, Estella; Chen, Elya; Kockx, Maaike; An, Si-Wei; Chong, Beng H.; Khachigian, Levon M.			IL-1beta Signals through the EGF Receptor and Activates Egr-1 through MMP-ADAM	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR RECEPTOR; NEOINTIMAL HYPERPLASIA; EPITHELIAL-CELLS; GENE-EXPRESSION; RESPONSE GENE-1; TRANSACTIVATION; TRANSCRIPTION; ATHEROSCLEROSIS; MIGRATION	The immediate-early gene Egr-1 controls the inducible expression of many genes implicated in the pathogenesis of a range of vascular disorders, yet our understanding of the mechanisms controlling the rapid expression of this prototypic zinc finger transcription factor is poor. Here we show that Egr-1 expression induced by IL-1beta is dependent on metalloproteinases (MMP) and a disintegrin and a metalloproteinase (ADAM). Pharmacologic MMP/ADAM inhibitors and siRNA knockdown prevent IL-1beta induction of Egr-1. Further, IL-1beta activates Egr-1 via the epidermal growth factor receptor (EGFR). This is blocked by EGFR tyrosine kinase inhibition and EGFR knockdown. IL-1beta induction of Egr-1 expression is reduced in murine embryonic fibroblasts (mEFs) deficient in ADAM17 despite unbiased expression of EGFR and IL-1RI in ADAM17-deficient and wild-type mEFs. Finally, we show that IL-1beta-inducible wound repair after mechanical injury requires both EGFR and MMP/ADAM. This study reports for the first time that Egr-1 induction by IL-1beta involves EGFR and MMP/ADAM-dependent EGFR phosphorylation.	[Sanchez-Guerrero, Estella; Chen, Elya; Kockx, Maaike; An, Si-Wei; Chong, Beng H.; Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia	University of New South Wales Sydney	Sanchez-Guerrero, E (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	L.Khachigian@unsw.edu.au	Khachigian, Levon/AAZ-7458-2020; Chong, Beng/AAE-2617-2019; Chong, Beng/AAM-9010-2021	Khachigian, Levon/0000-0003-3446-0323	National Health and Medical Research Council (NHMRC) of Australia; National Heart Foundation (NHF); Australian Research Council (ARC)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation (NHF)(National Heart Foundation of Australia); Australian Research Council (ARC)(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia, National Heart Foundation (NHF) and Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Bhindi R, 2011, J PATHOL IN PRESS; Bhindi R, 2007, AM J PATHOL, V171, P1079, DOI 10.2353/ajpath.2007.070120; Bos M, 1997, CLIN CANCER RES, V3, P2099; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; CAMPBELL GR, 1985, EXP MOL PATHOL, V42, P139, DOI 10.1016/0014-4800(85)90023-1; Chan HW, 2006, PULM PHARMACOL THER, V19, P74, DOI 10.1016/j.pupt.2005.04.005; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Day FL, 1999, J BIOL CHEM, V274, P23726, DOI 10.1074/jbc.274.34.23726; de Mestre AM, 2005, J BIOL CHEM, V280, P35136, DOI 10.1074/jbc.M503414200; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fuentes LQ, 2008, CELL SIGNAL, V20, P1642, DOI 10.1016/j.cellsig.2008.05.009; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Howe CL, 2006, NEUROBIOL DIS, V23, P731, DOI 10.1016/j.nbd.2006.06.012; Isoda K, 2003, CIRCULATION, V108, P516, DOI 10.1161/01.CIR.0000085567.18648.21; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, pE35, DOI 10.1161/ATVBAHA.111.225623; Johnson TW, 2005, ARTERIOSCL THROM VAS, V25, P754, DOI 10.1161/01.ATV.0000157582.33180.a9; Keates S, 2005, GUT, V54, P1363, DOI 10.1136/gut.2005.066977; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Khachigian LM, 1997, ARTERIOSCL THROM VAS, V17, P2280, DOI 10.1161/01.ATV.17.10.2280; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P1660; LEMIRE JM, 1994, AM J PATHOL, V144, P1068; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Lowe HC, 2002, THROMB HAEMOSTASIS, V87, P134, DOI 10.1055/s-0037-1612956; Lowe HC, 2001, CIRC RES, V89, P670, DOI 10.1161/hh2001.097867; Luo X, 2009, ARTERIOSCL THROM VAS, V29, P1836, DOI 10.1161/ATVBAHA.109.189753; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; Mifune M, 2005, J BIOL CHEM, V280, P26592, DOI 10.1074/jbc.M502906200; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Ohtani K, 2004, GENE THER, V11, P126, DOI 10.1038/sj.gt.3302153; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Poncet N, 2011, CELL SIGNAL, V23, P572, DOI 10.1016/j.cellsig.2010.11.009; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Reddy ABM, 2009, ENDOCRINOLOGY, V150, P63, DOI 10.1210/en.2008-0677; Saito S, 2002, BIOCHEM BIOPH RES CO, V294, P1023, DOI 10.1016/S0006-291X(02)00595-8; Sanchez-Guerrero E, 2008, NUCLEIC ACIDS RES, V36, P1941, DOI 10.1093/nar/gkm923; Santiago FS, 1999, NAT MED, V5, P1264, DOI 10.1038/15215; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Takaguri A, 2011, HYPERTENSION, V57, P841, DOI 10.1161/HYPERTENSIONAHA.110.166892; Wan YS, 2001, CELL SIGNAL, V13, P139, DOI 10.1016/S0898-6568(00)00146-7; Wang B, 2010, ARTERIOSCL THROM VAS, V30, P536, DOI 10.1161/ATVBAHA.109.193821; White KJ, 2011, J INVEST DERMATOL, V131, P435, DOI 10.1038/jid.2010.308; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298	51	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39811	10.1371/journal.pone.0039811	http://dx.doi.org/10.1371/journal.pone.0039811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792188	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800019
J	Sun, XM; Saito, M; Sato, Y; Chikata, T; Naruto, T; Ozawa, T; Kobayashi, E; Kishi, H; Muraguchi, A; Takiguchi, M				Sun, Xiaoming; Saito, Masumichi; Sato, Yoshinori; Chikata, Takayuki; Naruto, Takuya; Ozawa, Tatsuhiko; Kobayashi, Eiji; Kishi, Hiroyuki; Muraguchi, Atsushi; Takiguchi, Masafumi			Unbiased Analysis of TCR alpha/beta Chains at the Single-Cell Level in Human CD8(+) T-Cell Subsets	PLOS ONE			English	Article							ANTIGEN RECEPTOR GENES; V(D)J RECOMBINATION; GERMLINE TRANSCRIPTION; BETA-CHAINS; DIFFERENTIATION; REARRANGEMENT; RECOGNITION; PROMOTER; MEMORY; REPERTOIRE	T-cell receptor (TCR) alpha/beta chains are expressed on the surface of CD8(+) T-cells and have been implicated in antigen recognition, activation, and proliferation. However, the methods for characterization of human TCR alpha/beta chains have not been well established largely because of the complexity of their structures owing to the extensive genetic rearrangements that they undergo. Here we report the development of an integrated 5'-RACE and multiplex PCR method to amplify the full-length transcripts of TCRa/b at the single-cell level in human CD8+ subsets, including naive, central memory, early effector memory, late effector memory, and effector phenotypic cells. Using this method, with an approximately 47% and 62% of PCR success rate for TCR alpha and for TCR beta chains, respectively, we were able to analyze more than 1,000 reads of transcripts of each TCR chain. Our comprehensive analysis revealed the following: (1) chimeric rearrangements of TCR delta-alpha, (2) control of TCR alpha/beta transcription with multiple transcriptional initiation sites, (3) altered utilization of TCR alpha/beta chains in CD8(+) subsets, and (4) strong association between the clonal size of TCR alpha/beta chains and the effector phenotype of CD8(+) T-cells. Based on these findings, we conclude that our method is a useful tool to identify the dynamics of the TCR alpha/beta repertoire, and provides new insights into the study of human TCR alpha/beta chains.	[Sun, Xiaoming; Saito, Masumichi; Sato, Yoshinori; Chikata, Takayuki; Naruto, Takuya; Takiguchi, Masafumi] Kumamoto Univ, Ctr AIDS Res, Honjo, Kumamoto, Japan; [Ozawa, Tatsuhiko; Kobayashi, Eiji; Kishi, Hiroyuki; Muraguchi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 930, Japan	Kumamoto University; University of Toyama	Sun, XM (corresponding author), Kumamoto Univ, Ctr AIDS Res, Honjo, Kumamoto, Japan.	masafumi@kumamoto-u.ac.jp	Sun, Xiaoming/H-9656-2019; Sato, Yoshinori/J-2497-2015; Takiguchi, Masafumi/E-7468-2013	Sun, Xiaoming/0000-0001-6266-6869; Sato, Yoshinori/0000-0001-8250-6598; Kobayashi, Eiji/0000-0002-7303-2797; Ozawa, Tatsuhiko/0000-0002-3112-452X; Chikata, Takayuki/0000-0001-8907-1320	Global COE program "Global Education and Research Center Aiming at the control of AIDS" [F13]	Global COE program "Global Education and Research Center Aiming at the control of AIDS"	This research was supported by the Global COE program "Global Education and Research Center Aiming at the control of AIDS'' (No. F13), launched as a project commissioned by the Ministry of Education, Science, Sports, and Culture, Japan (http://www.jsps.go.jp/english/e-globalcoe/01_outline.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SJ, 1988, P NATL ACAD SCI USA, V85, P3551, DOI 10.1073/pnas.85.10.3551; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deng XZ, 1998, J BIOL CHEM, V273, P23709, DOI 10.1074/jbc.273.37.23709; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GELLERT M, 1992, ANNU REV GENET, V26, P425, DOI 10.1146/annurev.ge.26.120192.002233; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GORSKI J, 1994, J IMMUNOL, V152, P5109; Guidotti LG, 1996, CURR OPIN IMMUNOL, V8, P478, DOI 10.1016/S0952-7915(96)80034-3; Hamrouni A, 2003, J EXP MED, V197, P601, DOI 10.1084/jem.20021945; Inlay M, 2003, CLIN IMMUNOL, V109, P29, DOI 10.1016/S1521-6616(03)00199-2; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KOBAYASHI Y, 1991, J IMMUNOL, V147, P3201; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; MIOSSEC C, 1990, J EXP MED, V171, P1171, DOI 10.1084/jem.171.4.1171; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; PADOVAN E, 1995, ANN NY ACAD SCI, V756, P66, DOI 10.1111/j.1749-6632.1995.tb44482.x; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Sikes ML, 1998, J IMMUNOL, V161, P1399; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Ueno T, 2003, EUR J IMMUNOL, V33, P2910, DOI 10.1002/eji.200324148; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90	37	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40386	10.1371/journal.pone.0040386	http://dx.doi.org/10.1371/journal.pone.0040386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792299	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800075
J	Lee, RHC; Tseng, TY; Wu, CYC; Chen, PY; Chen, MF; Kuo, JS; Lee, TJF				Lee, Reggie Hui-Chao; Tseng, Ting-Yi; Wu, Celeste Yin-Chieh; Chen, Po-Yi; Chen, Mei-Fang; Kuo, Jon-Son; Lee, Tony Jer-Fu			Memantine Inhibits alpha 3 beta 2-nAChRs-Mediated Nitrergic Neurogenic Vasodilation in Porcine Basilar Arteries	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SUPERIOR CERVICAL-GANGLION; LARGE CEREBRAL-ARTERIES; OPEN-CHANNEL BLOCKERS; D-ASPARTATE RECEPTORS; ALZHEIMERS-DISEASE; ANTAGONIST MEMANTINE; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; BLOOD-FLOW	Memantine, an NMDA receptor antagonist used for treatment of Alzheimer's disease (AD), is known to block the nicotinic acetylcholine receptors (nAChRs) in the central nervous system (CNS). In the present study, we examined by wire myography if memantine inhibited alpha 3 beta 2-nAChRs located on cerebral perivascular sympathetic nerve terminals originating in the superior cervical ganglion (SCG), thus, leading to inhibition of nicotine-induced nitrergic neurogenic dilation of isolated porcine basilar arteries. Memantine concentration-dependently blocked nicotine-induced neurogenic dilation of endothelium-denuded basilar arteries without affecting that induced by transmural nerve stimulation, sodium nitroprusside, or isoproterenol. Furthermore, memantine significantly inhibited nicotine-elicited inward currents in Xenopous oocytes expressing alpha 3 beta 2-, alpha 7- or alpha 4 beta 2-nAChR, and nicotine-induced calcium influx in cultured rat SCG neurons. These results suggest that memantine is a non-specific antagonist for nAChR. By directly inhibiting alpha 4 beta 2-nAChRs located on the sympathetic nerve terminals, memantine blocks nicotine-induced neurogenic vasodilation of the porcine basilar arteries. This effect of memantine is expected to reduce the blood supply to the brain stem and possibly other brain regions, thus, decreasing its clinical efficacy in the treatment of Alzheimer's disease.	[Lee, Reggie Hui-Chao; Kuo, Jon-Son; Lee, Tony Jer-Fu] Tzu Chi Univ, Coll Med, Inst Med Sci, Hualien, Taiwan; [Tseng, Ting-Yi; Wu, Celeste Yin-Chieh; Chen, Po-Yi; Kuo, Jon-Son] Tzu Chi Univ, Coll Med, Inst Pharmacol & Toxicol, Hualien, Taiwan; [Lee, Tony Jer-Fu] Tzu Chi Univ, Coll Life Sci, Inst Life Sci, Hualien, Taiwan; [Lee, Reggie Hui-Chao; Tseng, Ting-Yi; Wu, Celeste Yin-Chieh; Chen, Po-Yi; Kuo, Jon-Son; Lee, Tony Jer-Fu] Tzu Chi Univ, Coll Life Sci, Ctr Vasc Med, Hualien, Taiwan; [Chen, Po-Yi; Chen, Mei-Fang] Buddhist Tzu Chi Gen Hosp, Dept Res, Hualien, Taiwan; [Lee, Tony Jer-Fu] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Tzu Chi University; Tzu Chi University; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Southern Illinois University System; Southern Illinois University	Lee, RHC (corresponding author), Tzu Chi Univ, Coll Med, Inst Med Sci, Hualien, Taiwan.	tlee@mail.tcu.edu.tw	Chen, Po-Yi/ABG-6350-2021	Lee, Reggie/0000-0001-6099-8333	Tzu Chi University [TCIRP 95005-01, TCIRP 95005-02, TCIRP 98005-01, TCIRP 98005-02, TCRPP99006]; National Science Council of Taiwan [NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC-99-2320-B-320-008, NSC-99-2120-M-259001, NSC 100-2320-B-320-007-MY2]; Tzu Chi Foundation	Tzu Chi University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi Foundation	This study was supported by Tzu Chi University (http://eng.tcu.edu.tw/) (Grants TCIRP 95005-01, TCIRP 95005-02, TCIRP 98005-01, TCIRP 98005-02, and TCRPP99006), National Science Council of Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp = 7) (NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC-99-2320-B-320-008, NSC-99-2120-M-259001, and NSC 100-2320-B-320-007-MY2), and Tzu Chi Foundation (http://tw.tzuchi.org/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Babic T, 1999, J NEUROL NEUROSUR PS, V67, P558, DOI 10.1136/jnnp.67.4.558; Brenner SR, 2008, NEUROLOGY, V70, P243, DOI 10.1212/01.wnl.0000299721.10189.fe; Brown DRP, 1996, J PSYCHIAT RES, V30, P109, DOI 10.1016/0022-3956(95)00032-1; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; Castellani RJ, 2006, ACTA NEUROPATHOL, V111, P503, DOI 10.1007/s00401-006-0071-y; CHEN FY, 1995, J PHARMACOL EXP THER, V273, P895; Chen MF, 2012, NEUROPHARMACOLOGY, V62, P1651, DOI 10.1016/j.neuropharm.2011.11.011; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Dogan A, 1999, ACTA NEUROCHIR, V141, P1107, DOI 10.1007/s007010050491; Doraiswamy P Murali, 2003, Psychopharmacol Bull, V37, P41; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; Erb C, 1999, BIOCHEM PHARMACOL, V57, P681, DOI 10.1016/S0006-2952(98)00338-4; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339; Gardoni F, 2006, EUR J PHARMACOL, V545, P2, DOI 10.1016/j.ejphar.2006.06.022; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hesselink MB, 1999, PHARMACEUT RES, V16, P637, DOI 10.1023/A:1018856020583; Hirsch C, 1997, DEMENT GERIATR COGN, V8, P98, DOI 10.1159/000106613; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jarvis B, 2003, DRUG AGING, V20, P465, DOI 10.2165/00002512-200320060-00005; KORNHUBER J, 1995, NEUROSCI LETT, V195, P137, DOI 10.1016/0304-3940(95)11785-U; Lee RHC, 2011, AM J PHYSIOL-HEART C, V301, pH344, DOI 10.1152/ajpheart.00172.2011; LEE TJF, 1976, CIRC RES, V39, P120, DOI 10.1161/01.RES.39.1.120; LEE TJF, 1981, CIRC RES, V49, P971, DOI 10.1161/01.RES.49.4.971; LEE TJF, 1982, J CEREBR BLOOD F MET, V2, P439, DOI 10.1038/jcbfm.1982.50; Lee TJF, 2000, AM J PHYSIOL-HEART C, V279, pH808, DOI 10.1152/ajpheart.2000.279.2.H808; Lin HW, 2008, P NATL ACAD SCI USA, V105, P19526, DOI 10.1073/pnas.0810262105; Long C, 2006, AM J PHYSIOL-HEART C, V291, pH202, DOI 10.1152/ajpheart.01192.2005; Maskell PD, 2003, BRIT J PHARMACOL, V140, P1313, DOI 10.1038/sj.bjp.0705559; MATHEW NT, 1974, STROKE, V5, P303, DOI 10.1161/01.STR.5.3.303; Mozayan M, 2006, J CEREBR BLOOD F MET, V26, P1562, DOI 10.1038/sj.jcbfm.9600310; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; RIVERA VM, 1974, J AM GERIATR SOC, V22, P397, DOI 10.1111/j.1532-5415.1974.tb05408.x; Rogawski MA, 2003, CNS DRUG REV, V9, P275, DOI 10.1111/j.1527-3458.2003.tb00254.x; Rogawski MA, 2000, AMINO ACIDS, V19, P133, DOI 10.1007/s007260070042; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Si ML, 2005, J CEREBR BLOOD F MET, V25, P1573, DOI 10.1038/sj.jcbfm.9600232; Si ML, 2002, CIRC RES, V91, P62, DOI 10.1161/01.RES.0000024417.79275.23; Si ML, 2001, J PHARMACOL EXP THER, V298, P122; WELCH MJ, 1976, J NEUROL NEUROSUR PS, V39, P367, DOI 10.1136/jnnp.39.4.367; Yeh JJ, 2001, J NEUROCHEM, V79, P258, DOI 10.1046/j.1471-4159.2001.00545.x; Zhang W, 1998, J PHARMACOL EXP THER, V284, P790; Zhou YF, 2001, J NEUROBIOL, V46, P178, DOI 10.1002/1097-4695(20010215)46:3<178::AID-NEU1001>3.0.CO;2-C; Zhou YF, 1998, J NEUROBIOL, V34, P164, DOI 10.1002/(SICI)1097-4695(19980205)34:2<164::AID-NEU6>3.0.CO;2-0	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40326	10.1371/journal.pone.0040326	http://dx.doi.org/10.1371/journal.pone.0040326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792283	gold, Green Submitted, Green Published			2022-12-27	WOS:000306436300055
J	Takamoto, M; Kaburaki, T; Mabuchi, A; Araie, M; Amano, S; Aihara, M; Tomidokoro, A; Iwase, A; Mabuchi, F; Kashiwagi, K; Shirato, S; Yasuda, N; Kawashima, H; Nakajima, F; Numaga, J; Kawamura, Y; Sasaki, T; Tokunaga, K				Takamoto, Mitsuko; Kaburaki, Toshikatsu; Mabuchi, Akihiko; Araie, Makoto; Amano, Shiro; Aihara, Makoto; Tomidokoro, Atsuo; Iwase, Aiko; Mabuchi, Fumihiko; Kashiwagi, Kenji; Shirato, Shiroaki; Yasuda, Noriko; Kawashima, Hidetoshi; Nakajima, Fumiko; Numaga, Jiro; Kawamura, Yoshiya; Sasaki, Tsukasa; Tokunaga, Katsushi			Common Variants on Chromosome 9p21 Are Associated with Normal Tension Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GENOME-WIDE ASSOCIATION; OPTIC-NERVE HEAD; NORMAL-PRESSURE GLAUCOMA; OCULAR HYPERTENSION; INTRAOCULAR-PRESSURE; GENETIC-VARIANTS; BLOOD-PRESSURE; TGF-BETA; JAPANESE POPULATION	Although intraocular pressure (IOP) is the most definitive cause of glaucoma, a subtype of open angle glaucoma (OAG) termed normal tension glaucoma (NTG), which occurs in spite of normal IOP, accounts for a large part of glaucoma cases, especially in Japan. To find common genetic variants contributing to NTG in Japanese patients, we conducted a genome-wide association study (GWAS). We performed the first screening for 531,009 autosomal SNPs with a discovery cohort of 286 cases and 557 controls, and then a second screening for the top 30 suggestive loci in an independent cohort of 183 cases and 514 controls. Our findings identified a significantly associated SNP; rs523096 [combined p-value = 7.40 x 10(-8), odds ratio (OR) = 2.00 with 95% confidence interval (CI) 1.55-2.58] located 10 kbp upstream of CDKN2B on chromosome 9p21. Moreover, analysis of another independent case- control set successfully replicated the results of the screening studies (combined values of all 3 stages p = 4.96 x 10(-11), OR = 2.13 with 95% CI 1.69-2.68). The SNPs near rs523096 were recently reported to be associated with OAG associated with elevated IOP in primary open-angle glaucoma (POAG), the predominant subtype of glaucoma in Caucasian populations. Our results revealed that the 9p21 locus is also associated with NTG in Japanese. In addition, we identified SNPs more strongly associated with NTG.	[Takamoto, Mitsuko; Kaburaki, Toshikatsu; Araie, Makoto; Amano, Shiro; Aihara, Makoto; Tomidokoro, Atsuo] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; [Mabuchi, Akihiko; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Iwase, Aiko] Tajimi Municipal Hosp, Dept Ophthalmol, Gifu, Japan; [Iwase, Aiko] Tajimi Iwase Eye Clin, Gifu, Japan; [Mabuchi, Fumihiko; Kashiwagi, Kenji] Univ Yamanashi, Dept Ophthalmol, Tamaho, Yamanashi, Japan; [Shirato, Shiroaki] Shirato Eye Clin, Tokyo, Japan; [Yasuda, Noriko] Tokyo Metropolitan Police Hosp, Dept Ophthalmol, Tokyo, Japan; [Kawashima, Hidetoshi; Nakajima, Fumiko] Saitama Red Cross Hosp, Dept Ophthalmol, Saitama, Japan; [Nakajima, Fumiko] Showa Gen Hosp, Dept Ophthalmol, Tokyo, Japan; [Numaga, Jiro] Tokyo Metropolitan Geriatr Hosp, Dept Ophthalmol, Tokyo 173, Japan; [Kawamura, Yoshiya] Yokohama Clin, Dept Psychiat, Yokohama, Kanagawa, Japan; [Sasaki, Tsukasa] Univ Tokyo, Dept Phys & Hlth Educ, Grad Sch Educ, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Yamanashi; Tokyo Metropolitan Institute of Gerontology; University of Tokyo	Takamoto, M (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	mwatanabe-tky@umin.ac.jp	Kaburaki, Toshikatsu/AAH-7091-2020		Ministry of Education, Culture, Sports, Science, and Technology [20592033]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This project was funded by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (20592033) to Dr. Kaburaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1981, ARCH OPHTHALMOL-CHIC, V99, P1795, DOI 10.1001/archopht.1981.03930020669009; Allingham RR, 2005, SHIELDS TXB GLAUCOMA, Vxiii; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; ANDERSON DR, 1999, AUTOMATED STATIC PER, pR14; Aung T, 2002, HUM GENET, V110, P513, DOI 10.1007/s00439-002-0711-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barry CJ, 1997, AUST NZ J OPHTHALMOL, V25, P137, DOI 10.1111/j.1442-9071.1997.tb01295.x; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burdon KP, 2011, NAT GENET       0527; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; CHIHARA E, 1992, GRAEF ARCH CLIN EXP, V230, P511, DOI 10.1007/BF00181770; COFFEY M, 1993, BRIT J OPHTHALMOL, V77, P17, DOI 10.1136/bjo.77.1.17; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Cursiefen C, 2000, AM J OPHTHALMOL, V129, P102, DOI 10.1016/S0002-9394(99)00289-5; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Dong J, 2001, BRIT J OPHTHALMOL, V85, P56, DOI 10.1136/bjo.85.1.56; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Duenker N, 2005, INT REV CYTOL, V245, P17, DOI 10.1016/S0074-7696(05)45002-0; Eid TE, 1997, AM J OPHTHALMOL, V124, P805, DOI 10.1016/S0002-9394(14)71698-8; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Fan BJ, 2005, MOL VIS, V11, P625; Fuchshofer R, 2011, EXP EYE RES, V93, P165, DOI 10.1016/j.exer.2010.07.014; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; GLOSTER J, 1981, BRIT J OPHTHALMOL, V65, P452, DOI 10.1136/bjo.65.7.452; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARRIS A, 1994, AM J OPHTHALMOL, V118, P642, DOI 10.1016/S0002-9394(14)76579-1; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Joachim SC, 2005, GRAEF ARCH CLIN EXP, V243, P817, DOI 10.1007/s00417-004-1094-5; Junemann AGM, 2000, GRAEF ARCH CLIN EXP, V238, P306, DOI 10.1007/s004170050357; KAISER HJ, 1993, GRAEF ARCH CLIN EXP, V231, P677, DOI 10.1007/BF00919280; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kawamura Y, 2011, J HUM GENET, V56, P852, DOI 10.1038/jhg.2011.117; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Kremmer S, 2001, CLIN EXP IMMUNOL, V125, P211, DOI 10.1046/j.1365-2249.2001.01578.x; Lam CY, 2006, J GLAUCOMA, V15, P218, DOI 10.1097/01.ijg.0000212217.19804.a7; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Mabuchi F, 2007, AM J OPHTHALMOL, V143, P125, DOI 10.1016/j.ajo.2006.09.028; Mabuchi F, 2011, INVEST OPHTH VIS SCI, V52, P4626, DOI 10.1167/iovs.11-7382; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Meyer JH, 1996, BRIT J OPHTHALMOL, V80, P864, DOI 10.1136/bjo.80.10.864; Morgan-Davies J, 2004, BRIT J OPHTHALMOL, V88, P1299, DOI 10.1136/bjo.2003.036020; Nakano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033389; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; Ohsaka Y, 2010, BIOCHEM GENET, V48, P970, DOI 10.1007/s10528-010-9379-3; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Pena JDO, 1999, BRIT J OPHTHALMOL, V83, P209, DOI 10.1136/bjo.83.2.209; PHELPS CD, 1985, INVEST OPHTH VIS SCI, V26, P1105; Pho L, 2006, CURR OPIN ONCOL, V18, P173, DOI 10.1097/01.cco.0000208791.22442.09; Powell B, 2003, MOL VIS, V9, P460; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Riccadonna M, 2003, J GLAUCOMA, V12, P156, DOI 10.1097/00061198-200304000-00011; ROJANAPONGPUN P, 1993, BRIT J OPHTHALMOL, V77, P25, DOI 10.1136/bjo.77.1.25; ROMANO C, 1995, INVEST OPHTH VIS SCI, V36, P1968; Rotchford AP, 2003, OPHTHALMOLOGY, V110, P376, DOI 10.1016/S0161-6420(02)01568-3; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Schwenn O, 2002, BRIT J OPHTHALMOL, V86, P981, DOI 10.1136/bjo.86.9.981; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Sripriya S, 2006, MOL VIS, V12, P816; Tezel G, 1996, OPHTHALMOLOGY, V103, P2105, DOI 10.1016/S0161-6420(96)30382-5; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Trivedi RH, 2011, J OCUL PHARMACOL TH, V27, P477, DOI 10.1089/jop.2010.0100; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vickers JC, 2002, MOL VIS, V8, P389; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640; Woo SJ, 2003, BRIT J OPHTHALMOL, V87, P695, DOI 10.1136/bjo.87.6.695; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Wu LL, 2000, JPN J OPHTHALMOL, V44, P643, DOI 10.1016/S0021-5155(00)00275-6; YAMAGAMI J, 1992, GRAEF ARCH CLIN EXP, V230, P446, DOI 10.1007/BF00175931; YAMAZAKI Y, 1991, GRAEF ARCH CLIN EXP, V229, P517, DOI 10.1007/BF00203313	93	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40107	10.1371/journal.pone.0040107	http://dx.doi.org/10.1371/journal.pone.0040107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792221	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300025
J	Vercelli, CA; Aisemberg, J; Cella, M; Salazar, AI; Wolfson, ML; Franchi, AM				Vercelli, Claudia A.; Aisemberg, Julieta; Cella, Maximiliano; Salazar, Ana Ines; Wolfson, Manuel L.; Franchi, Ana M.			Opposite Effects of Methanandamide on Lipopolysaccharide-Induced Prostaglandin E2 and F2 alpha Synthesis in Uterine Explants from Pregnant Mice	PLOS ONE			English	Article							MYOMETRIAL SMOOTH-MUSCLE; NITRIC-OXIDE SYNTHESIS; HUMAN DECIDUA VERA; ARACHIDONIC-ACID; ENDOCANNABINOID SYSTEM; ANANDAMIDE SYNTHESIS; FETAL MEMBRANES; DENDRITIC CELLS; RAT UTERUS; BIOSYNTHESIS	Prostaglandins (PG) are effective abortifacients and are important mediators of lipopolisaccharide (LPS)-induced embryonic resorption (ER). Besides, anandamide (AEA) has been described as one of the major endocannabinoids present in the uterus suggesting that it might play a role in reproduction. It has been reported that high levels of AEA are associated with pregnancy failure and that LPS increases AEA production. Also, it has been observed that AEA modulates PG production in different tissues. In this sense, we studied whether LPS-induced PG production is modulated by AEA and we also assessed the effect of this endocannabinoid on PG metabolism in an in vitro model. Uterine explants from BALB/c implantation sites were cultured in the presence of LPS plus cannabinoid receptor (CB) specific antagonists and PG production was assessed. Then, we studied the effect of exogenous AEA on different steps of PG metabolic pathway. We showed that AEA is involved in LPS-induced PG biosynthesis. Also, we observed that AEA exerts opposite effects on PGE(2) and PGF(2 alpha) biosynthesis, by inhibiting PGE(2) production and increasing PGF2a levels. We suggest that AEA could be involved in the mechanisms implicated in LPS-induced ER. A better understanding of how AEA could be affecting ER could help developing specific interventions to prevent this pathology.	[Vercelli, Claudia A.; Aisemberg, Julieta; Cella, Maximiliano; Salazar, Ana Ines; Wolfson, Manuel L.; Franchi, Ana M.] Univ Buenos Aires, Sch Med, Natl Res Council, Ctr Pharmacol & Bot Studies,Lab Physiopathol Preg, Buenos Aires, DF, Argentina	University of Buenos Aires	Vercelli, CA (corresponding author), Univ Buenos Aires, Sch Med, Natl Res Council, Ctr Pharmacol & Bot Studies,Lab Physiopathol Preg, Buenos Aires, DF, Argentina.	clauverce77@yahoo.com.ar		Wolfson, Manuel Luis/0000-0003-3433-1521	National Research Council [CONICET-PIP 2008-2204]; Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT - PICT 2006-2165]	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This study was supported by the National Research Council (CONICET-PIP 2008-2204) and by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT - PICT 2006-2165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; Cella M, 2008, PLACENTA, V29, P699, DOI 10.1016/j.placenta.2008.05.003; Chen P, 2005, MICROVASC RES, V69, P28, DOI 10.1016/j.mvr.2005.02.001; COX SM, 1988, AM J OBSTET GYNECOL, V159, P99, DOI 10.1016/0002-9378(88)90501-7; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; DIAZ S, 1994, J PHARMACOL EXP THER, V268, P1289; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Farina M, 2004, J STEROID BIOCHEM, V91, P211, DOI 10.1016/j.jsbmb.2004.05.001; Farina MG, 2006, PROSTAG OTH LIPID M, V79, P260, DOI 10.1016/j.prostaglandins.2006.02.004; GROSS TS, 1987, PROSTAG OTH LIPID M, V34, P903, DOI 10.1016/0090-6980(87)90070-0; GU W, 1990, PROSTAG LEUKOTR ESS, V40, P27, DOI 10.1016/0952-3278(90)90112-X; HANSEN HS, 1976, PROSTAGLANDINS, V12, P647, DOI 10.1016/0090-6980(76)90044-7; Hertelendy F, 2004, CURR PHARM DESIGN, V10, P2499, DOI 10.2174/1381612043383926; HORTA AEM, 1986, ANN RECH VET, V17, P395; Hunter SA, 1997, LIFE SCI, V60, P1563, DOI 10.1016/S0024-3205(97)00122-7; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kubota K, 2005, J ENDOCRINOL, V187, P339, DOI 10.1677/joe.1.06169; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; MICHALEK SM, 1980, J IMMUNOL, V125, P2220; Mitchell MD, 2008, AM J PHYSIOL-ENDOC M, V294, pE352, DOI 10.1152/ajpendo.00495.2007; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Navarrete CM, 2009, J NEUROCHEM, V109, P452, DOI 10.1111/j.1471-4159.2009.05966.x; NIESERT S, 1986, AM J OBSTET GYNECOL, V155, P1348, DOI 10.1016/0002-9378(86)90172-9; O'Banion MK, 2010, PROSTAG OTH LIPID M, V91, P113, DOI 10.1016/j.prostaglandins.2009.04.008; Paria BC, 2000, CHEM PHYS LIPIDS, V108, P211, DOI 10.1016/S0009-3084(00)00197-3; PARTHASARATHY S, 1989, P NATL ACAD SCI USA, V86, P1046, DOI 10.1073/pnas.86.3.1046; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHLEGEL W, 1984, FEBS LETT, V171, P141, DOI 10.1016/0014-5793(84)80475-5; SLAMA H, 1993, PROSTAGLANDINS, V45, P57, DOI 10.1016/0090-6980(93)90090-T; Slater DM, 2006, MOL HUM REPROD, V12, P89, DOI 10.1093/molehr/gal005; Someya A, 2002, EUR J PHARMACOL, V450, P131, DOI 10.1016/S0014-2999(02)02122-2; VANE JR, 1973, BRIT J PHARMACOL, V48, P629, DOI 10.1111/j.1476-5381.1973.tb08250.x; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Vercelli CA, 2009, PLACENTA, V30, P579, DOI 10.1016/j.placenta.2009.04.003; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Wang HB, 2007, PROSTAG OTH LIPID M, V83, P62, DOI 10.1016/j.prostaglandins.2006.09.009; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; WARTMANN M, 1995, FEBS LETT, V359, P133, DOI 10.1016/0014-5793(95)00027-7; Winchester SK, 2002, ENDOCRINOLOGY, V143, P2593, DOI 10.1210/en.143.7.2593; WIQVIST N, 1983, ACTA OBSTET GYN SCAN, P23; Zerani M, 2007, REPRODUCTION, V133, P1005, DOI 10.1530/REP-06-0107	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39532	10.1371/journal.pone.0039532	http://dx.doi.org/10.1371/journal.pone.0039532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792180	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300009
J	Vidal, A; Zhang, QH; Medigue, C; Fabre, S; Clement, F				Vidal, Alexandre; Zhang, Qinghua; Medigue, Claire; Fabre, Stephane; Clement, Frederique			DynPeak: An Algorithm for Pulse Detection and Frequency Analysis in Hormonal Time Series	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; SECRETORY EVENTS; APPRAISAL; INSIGHTS; SIGNAL; SURGE; FSH; EWE	The endocrine control of the reproductive function is often studied from the analysis of luteinizing hormone (LH) pulsatile secretion by the pituitary gland. Whereas measurements in the cavernous sinus cumulate anatomical and technical difficulties, LH levels can be easily assessed from jugular blood. However, plasma levels result from a convolution process due to clearance effects when LH enters the general circulation. Simultaneous measurements comparing LH levels in the cavernous sinus and jugular blood have revealed clear differences in the pulse shape, the amplitude and the baseline. Besides, experimental sampling occurs at a relatively low frequency (typically every 10 min) with respect to LH highest frequency release (one pulse per hour) and the resulting LH measurements are noised by both experimental and assay errors. As a result, the pattern of plasma LH may be not so clearly pulsatile. Yet, reliable information on the InterPulse Intervals (IPI) is a prerequisite to study precisely the steroid feedback exerted on the pituitary level. Hence, there is a real need for robust IPI detection algorithms. In this article, we present an algorithm for the monitoring of LH pulse frequency, basing ourselves both on the available endocrinological knowledge on LH pulse (shape and duration with respect to the frequency regime) and synthetic LH data generated by a simple model. We make use of synthetic data to make clear some basic notions underlying our algorithmic choices. We focus on explaining how the process of sampling affects drastically the original pattern of secretion, and especially the amplitude of the detectable pulses. We then describe the algorithm in details and perform it on different sets of both synthetic and experimental LH time series. We further comment on how to diagnose possible outliers from the series of IPIs which is the main output of the algorithm.	[Vidal, Alexandre] Univ Evry Val dEssonne, Lab Anal & Probabil EA 2172, Evry, France; [Zhang, Qinghua] INRIA Rennes Bretagne Atlantique Res Ctr, Project Team SISYPHE, Rennes, France; [Medigue, Claire; Clement, Frederique] INRIA Paris Rocquencourt Res Ctr, Project Team SISYPHE, Le Chesnay, France; [Fabre, Stephane] Univ Tours, IFCE, Lab Physiol Reprod & Comportements, INRA Tours Res Ctr,UMR INRA 85,UMR CNRS 6175, Nouzilly, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Vidal, A (corresponding author), Univ Evry Val dEssonne, Lab Anal & Probabil EA 2172, Evry, France.	alexandre.vidal@univ-evry.fr	FABRE, Stéphane/AAQ-8400-2020; Fabre, Stéphane/ABC-1483-2020	FABRE, Stéphane/0000-0001-7350-9500; 	French National Institute for Research in Computer Science and Control	French National Institute for Research in Computer Science and Control	Large Scale Initiative Action REGATE: academic funding supported by the French National Institute for Research in Computer Science and Control. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird D T, 1981, J Reprod Fertil Suppl, V30, P119; BAIRD DT, 1981, BIOL REPROD, V24, P1013, DOI 10.1095/biolreprod24.5.1013; Clarke I, 2002, ENDOCRINOLOGY, V143, P117, DOI 10.1210/en.143.1.117; Drouilhet L, 2010, BIOL REPROD, V82, P815, DOI 10.1095/biolreprod.109.082065; Keenan DM, 2000, SIAM J APPL MATH, V61, P934, DOI 10.1137/S0036139998334718; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; MOENTER SM, 1992, ENDOCRINOLOGY, V130, P2978, DOI 10.1210/en.130.5.2978; MOENTER SM, 1990, ENDOCRINOLOGY, V127, P1375, DOI 10.1210/endo-127-3-1375; SOLLENBERGER MJ, 1990, J NEUROENDOCRINOL, V2, P845, DOI 10.1111/j.1365-2826.1990.tb00650.x; URBAN RJ, 1988, ENDOCR REV, V9, P3, DOI 10.1210/edrv-9-1-3; VELDHUIS JD, 1990, J NEUROENDOCRINOL, V2, P755, DOI 10.1111/j.1365-2826.1990.tb00638.x; Vidal A, 2009, PHILOS T R SOC A, V367, P4759, DOI 10.1098/rsta.2009.0136	12	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39001	10.1371/journal.pone.0039001	http://dx.doi.org/10.1371/journal.pone.0039001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802933	Green Submitted, gold, Green Published			2022-12-27	WOS:000306186900007
J	Miernikiewicz, P; Owczarek, B; Piotrowicz, A; Boczkowska, B; Rzewucka, K; Figura, G; Letarov, A; Kulikov, E; Kopciuch, A; Switala-Jelen, K; Oslizlo, A; Hodyra, K; Gubernator, J; Dabrowska, K				Miernikiewicz, Paulina; Owczarek, Barbara; Piotrowicz, Agnieszka; Boczkowska, Barbara; Rzewucka, Kamila; Figura, Grzegorz; Letarov, Andrey; Kulikov, Eugene; Kopciuch, Agnieszka; Switala-Jelen, Kinga; Oslizlo, Anna; Hodyra, Katarzyna; Gubernator, Jerzy; Dabrowska, Krystyna			Recombinant Expression and Purification of T4 Phage Hoc, Soc, gp23, gp24 Proteins in Native Conformations with Stability Studies	PLOS ONE			English	Article							BACTERIOPHAGE THERAPY	Understanding the biological activity of bacteriophage particles is essential for rational design of bacteriophages with defined pharmacokinetic parameters and to identify the mechanisms of immunobiological activities demonstrated for some bacteriophages. This work requires highly purified preparations of the individual phage structural proteins, possessing native conformation that is essential for their reactivity, and free of incompatible biologically active substances such as bacterial lipopolysaccharide (LPS). In this study we describe expression in E. coli and purification of four proteins forming the surface of the bacteriophage T4 head: gp23, gp24, gphoc and gpsoc. We optimized protein expression using a set of chaperones for effective production of soluble proteins in their native conformations. The assistance of chaperones was critical for production of soluble gp23 (chaperone gp31 of T4 phage) and of gpsoc (chaperone TF of E. coli). Phage head proteins were purified in native conditions by affinity chromatography and size-exclusion chromatography. Two-step LPS removal allowed immunological purity grade with the average endotoxin activity less than 1 unit per ml of protein preparation. The secondary structure and stability of the proteins were studied using circular dichroism (CD) spectrometry, which confirmed that highly purified proteins preserve their native conformations. In increasing concentration of a denaturant (guanidine hydrochloride), protein stability was proved to increase as follows: gpsoc, gp23, gphoc. The denaturation profile of gp24 protein showed independent domain unfolding with the most stable larger domain. The native purified recombinant phage proteins obtained in this work were shown to be suitable for immunological experiments in vivo and in vitro.	[Miernikiewicz, Paulina; Owczarek, Barbara; Piotrowicz, Agnieszka; Boczkowska, Barbara; Rzewucka, Kamila; Figura, Grzegorz; Kopciuch, Agnieszka; Switala-Jelen, Kinga; Oslizlo, Anna; Hodyra, Katarzyna; Dabrowska, Krystyna] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Letarov, Andrey; Kulikov, Eugene] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow, Russia; [Gubernator, Jerzy] Univ Wroclaw, Dept Lipids & Liposomes, Fac Biotechnol, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences; University of Wroclaw	Miernikiewicz, P (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland.	dabrok@iitd.pan.wroc.pl	Dragos, Anna/C-4541-2019; Letarov, Andrey V./AAD-1731-2022; Dragos, Anna/X-2245-2019	Dragos, Anna/0000-0003-4136-986X; Dragos, Anna/0000-0003-4136-986X; Figura, Grzegorz/0000-0002-2663-8112; Miernikiewicz, Paulina/0000-0003-4592-3741; Maciejewska, Barbara/0000-0002-4876-8743; Dabrowska, Krystyna/0000-0002-1518-3183; Kulikov, Eugene/0000-0002-9101-1543; Owczarek, Barbara/0000-0001-5658-1455	EU Structural Funds; Polish Ministry of Science [N N401 417236, 13-0089-06/2010]	EU Structural Funds; Polish Ministry of Science(Ministry of Science and Higher Education, Poland)	This work was supported by EU Structural Funds (Operational Programme Innovative Economy "Optimization of characteristics and preparation of bacteriophage preparations for therapeutic purposes") and the Polish Ministry of Science (grant nos. N N401 417236 and 13-0089-06/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besley NA, 1999, J AM CHEM SOC, V121, P9636, DOI 10.1021/ja990627l; Besley NA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2426344; Black Lindsay W., 1994, P218; Buczek O, 2002, PROTEIN SCI, V11, P924, DOI 10.1110/ps.4460102; Calmat S, 2009, BIOCHEMISTRY-US, V48, P11692, DOI 10.1021/bi9013962; Carlson Karin, 1994, P427; Chan BK, 2012, ADV APPL MICROBIOL, V78, P1, DOI 10.1016/B978-0-12-394805-2.00001-4; Dabrowska K, 2005, J APPL MICROBIOL, V98, P7, DOI 10.1111/j.1365-2672.2004.02422.x; Dabrowska K, 2007, ARCH MICROBIOL, V187, P489, DOI 10.1007/s00203-007-0216-y; DeClue AE, 2012, VET J, V192, P455, DOI 10.1016/j.tvjl.2011.09.001; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Fokine A, 2011, J VIROL, V85, P8141, DOI 10.1128/JVI.00847-11; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Georgopoulos Costa P., 1994, P213; Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6; Gorski A, 2012, ADV VIRUS R IN PRESS; Hayashi Takaya, 2011, Nihon Rinsho Meneki Gakkai Kaishi, V34, P329; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Krisch HM, 2008, RES MICROBIOL, V159, P314, DOI 10.1016/j.resmic.2008.04.014; Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1; Letarov A, 2009, J APPL MICROBIOL, V107, P1, DOI 10.1111/j.1365-2672.2009.04143.x; Letarov AV, 2010, ACTA NATURAE, V2, P60, DOI 10.32607/20758251-2010-2-1-60-71; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Oslizlo A, 2011, BMC BIOTECHNOL, V31, P11; Ren ZJ, 1998, GENE, V215, P439, DOI 10.1016/S0378-1119(98)00298-4; Robertson K, 2012, BIOCHEM BIOPH RES CO, V418, P537, DOI 10.1016/j.bbrc.2012.01.061; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; Stone R, 2002, SCIENCE, V298, P728, DOI 10.1126/science.298.5594.728; Sulakvelidze A, 2005, DRUG DISCOV TODAY, V10, P807, DOI 10.1016/S1359-6446(05)03441-0	32	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e38902	10.1371/journal.pone.0038902	http://dx.doi.org/10.1371/journal.pone.0038902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808021	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700006
J	Jeong, HW; Cho, SY; Kim, S; Shin, ES; Kim, JM; Song, MJ; Park, PJ; Sohn, JH; Park, H; Seo, DB; Kim, WG; Lee, SJ				Jeong, Hyun Woo; Cho, Si Young; Kim, Shinae; Shin, Eui Seok; Kim, Jae Man; Song, Min Jeong; Park, Pil Joon; Sohn, Jong Hee; Park, Hyon; Seo, Dae-Bang; Kim, Wan Gi; Lee, Sang-Jun			Chitooligosaccharide Induces Mitochondrial Biogenesis and Increases Exercise Endurance through the Activation of Sirt1 and AMPK in Rats	PLOS ONE			English	Article							VITAMIN-C SUPPLEMENTATION; INDUCED MUSCULAR INJURY; SKELETAL-MUSCLE; INSULIN SENSITIVITY; LIPID CONCENTRATIONS; CALORIE RESTRICTION; METABOLIC SYNDROME; CELLULAR-ENERGY; PGC-1-ALPHA; CHITOSAN	By catabolizing glucose and lipids, mitochondria produce ATPs to meet energy demands. When the number and activity of mitochondria are not sufficient, the human body becomes easily fatigued due to the lack of ATP, thus the control of the quantity and function of mitochondria is important to optimize energy balance. By increasing mitochondrial capacity? it may be possible to enhance energy metabolism and improve exercise endurance. Here, through the screening of various functional food ingredients, we found that chitooligosaccharide (COS) is an effective inducer of mitochondrial biogenesis. In rodents, COS increased the mitochondrial content in skeletal muscle and enhanced exercise endurance. In cultured myocytes, the expression of major regulators of mitochondrial biogenesis and key components of mitochondrial electron transfer chain was increased upon COS treatment. COS-mediated induction of mitochondrial biogenesis was achieved in part by the activation of silent information regulator two ortholog 1 (Sirt1) and AMP-activated protein kinase (AMPK). Taken together, our data suggest that COS could act as an exercise mimetic by inducing mitochondrial biogenesis and enhancing exercise endurance through the activation of Sirt1 and AMPK.	[Jeong, Hyun Woo; Cho, Si Young; Shin, Eui Seok; Kim, Jae Man; Song, Min Jeong; Park, Pil Joon; Sohn, Jong Hee; Seo, Dae-Bang; Kim, Wan Gi; Lee, Sang-Jun] Amorepacific Corp Res & Dev Ctr, Yong In Si, Gyeonggi Do, South Korea; [Kim, Shinae; Park, Hyon] Kyung Hee Univ, Coll Phys Educ, Yong In City, Gyeonggi Do, South Korea	Kyung Hee University	Jeong, HW (corresponding author), Amorepacific Corp Res & Dev Ctr, Yong In Si, Gyeonggi Do, South Korea.	leesjun@amorepacific.com						Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Bartnik Ewa, 2001, Journal of Applied Genetics, V42, P65; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bertoni-Freddari C, 1997, Ann N Y Acad Sci, V826, P479, DOI 10.1111/j.1749-6632.1997.tb48508.x; Biskup S, 2006, BIOESSAYS, V28, P963, DOI 10.1002/bies.20471; BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009; Bryer SC, 2006, INT J SPORT NUTR EXE, V16, P270, DOI 10.1123/ijsnem.16.3.270; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Carter RA, 2010, AM J VET RES, V71, P314, DOI 10.2460/ajvr.71.3.314; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Cho SY, 2010, BIOL PHARM BULL, V33, P1128, DOI 10.1248/bpb.33.1128; Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cuero RG, 1999, EXS, V87, P315; Davy BM, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-3; Dowling MB, 2011, BIOMATERIALS, V32, P3351, DOI 10.1016/j.biomaterials.2010.12.033; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fernandes JC, 2008, FOOD MICROBIOL, V25, P922, DOI 10.1016/j.fm.2008.05.003; Gades MD, 2003, OBES RES, V11, P683, DOI 10.1038/oby.2003.97; Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5; Horowitz JF, 2007, EXERC SPORT SCI REV, V35, P192, DOI 10.1097/jes.0b013e318156e084; Huang R, 2006, LIFE SCI, V78, P2399, DOI 10.1016/j.lfs.2005.09.039; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jung WK, 2006, LIFE SCI, V78, P970, DOI 10.1016/j.lfs.2005.06.006; Karacabey K, 2009, J INT MED RES, V37, P1472, DOI 10.1177/147323000903700523; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kon M, 2007, EXERC IMMUNOL REV, V13, P76; Kraus WE, 2009, OBESITY, V17, pS21, DOI 10.1038/oby.2009.384; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LAMPMAN RM, 1985, METABOLISM, V34, P205, DOI 10.1016/0026-0495(85)90002-2; Liesa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003613; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakhostin-Roohi B, 2008, J SPORT MED PHYS FIT, V48, P217; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/00005373-200301000-00023; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; SHIMOMURA Y, 1991, BIOCHEM BIOPH RES CO, V176, P349, DOI 10.1016/0006-291X(91)90931-V; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stein E, 2007, METABOLISM, V56, P954, DOI 10.1016/j.metabol.2007.02.008; Sugiyama S, 1995, BIOCHEM MOL BIOL INT, V37, P1111; SUZUKI K, 1986, CARBOHYD RES, V151, P403, DOI 10.1016/S0008-6215(00)90359-8; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; Tsai GJ, 2000, J FOOD PROTECT, V63, P747, DOI 10.4315/0362-028X-63.6.747; Yang YM, 2009, CELL BIOL INT, V33, P352, DOI 10.1016/j.cellbi.2009.01.005; You Y, 2004, J MATER SCI-MATER M, V15, P297, DOI 10.1023/B:JMSM.0000015491.91918.64; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	58	15	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40073	10.1371/journal.pone.0040073	http://dx.doi.org/10.1371/journal.pone.0040073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808092	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400030
J	Ofek, M; Hadar, Y; Minz, D				Ofek, Maya; Hadar, Yitzhak; Minz, Dror			Ecology of Root Colonizing Massilia (Oxalobacteraceae)	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; MICROBIAL COMMUNITY; SOIL SUPPRESSIVENESS; CULTURABLE BACTERIA; METAM SODIUM; RHIZOSPHERE; DIVERSITY; IMPACT; GENES; IDENTIFICATION	Background: Ecologically meaningful classification of bacterial populations is essential for understanding the structure and function of bacterial communities. As in soils, the ecological strategy of the majority of root-colonizing bacteria is mostly unknown. Among those are Massilia (Oxalobacteraceae), a major group of rhizosphere and root colonizing bacteria of many plant species. Methodology/ Principal Findings: The ecology of Massilia was explored in cucumber root and seed, and compared to that of Agrobacterium population, using culture-independent tools, including DNA-based pyrosequencing, fluorescence in situ hybridization and quantitative real-time PCR. Seed-and root-colonizing Massilia were primarily affiliated with other members of the genus described in soil and rhizosphere. Massilia colonized and proliferated on the seed coat, radicle, roots, and also on hyphae of phytopathogenic Pythium aphanidermatum infecting seeds. High variation in Massilia abundance was found in relation to plant developmental stage, along with sensitivity to plant growth medium modification (amendment with organic matter) and potential competitors. Massilia absolute abundance and relative abundance (dominance) were positively related, and peaked (up to 85%) at early stages of succession of the root microbiome. In comparison, variation in abundance of Agrobacterium was moderate and their dominance increased at later stages of succession. Conclusions: In accordance with contemporary models for microbial ecology classification, copiotrophic and competition-sensitive root colonization by Massilia is suggested. These bacteria exploit, in a transient way, a window of opportunity within the succession of communities within this niche.	[Ofek, Maya; Minz, Dror] Agr Res Org, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel; [Ofek, Maya; Hadar, Yitzhak] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Ofek, M (corresponding author), Agr Res Org, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel.	Minz@agri.gov.il		Minz, Dror/0000-0001-6746-9151	US-Israel Binational Agricultural Research and Development Fund (BARD) [US-4264-09]; Israel Science Foundation (ISF) [1298/09]	US-Israel Binational Agricultural Research and Development Fund (BARD); Israel Science Foundation (ISF)(Israel Science Foundation)	This research was supported by research grant no. US-4264-09 from the US-Israel Binational Agricultural Research and Development Fund (BARD) and research grant no. 1298/09 from the Israel Science Foundation (ISF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shanab RAI, 2007, CHEMOSPHERE, V68, P360, DOI 10.1016/j.chemosphere.2006.12.051; Abou-Shanab RAI, 2010, WORLD J MICROB BIOT, V26, P101, DOI 10.1007/s11274-009-0148-6; Adrangi S, 2010, CARBOHYD RES, V345, P402, DOI 10.1016/j.carres.2009.11.015; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Bastian F, 2009, SOIL BIOL BIOCHEM, V41, P262, DOI 10.1016/j.soilbio.2008.10.024; Bernard L, 2007, ENVIRON MICROBIOL, V9, P752, DOI 10.1111/j.1462-2920.2006.01197.x; Blatny JM, 2011, AEROBIOLOGIA, V27, P147, DOI 10.1007/s10453-010-9184-9; Brooks DD, 2011, FEMS MICROBIOL ECOL, V76, P245, DOI 10.1111/j.1574-6941.2011.01060.x; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Cheng WX, 1996, SOIL BIOL BIOCHEM, V28, P1283, DOI 10.1016/S0038-0717(96)00138-1; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Danon M, 2007, SOIL BIOL BIOCHEM, V39, P1936, DOI 10.1016/j.soilbio.2007.02.012; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; De Weert S, 2006, PLANT-ASSOCIATED BACTERIA, P317; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dohrmann AB, 2005, APPL ENVIRON MICROB, V71, P7750, DOI 10.1128/AEM.71.12.7750-7758.2005; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Enya J, 2007, MICROB ECOL, V53, P524, DOI 10.1007/s00248-006-9085-1; Fahlgren C, 2011, AEROBIOLOGIA, V27, P107, DOI 10.1007/s10453-010-9181-z; Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2010, RES MICROBIOL, V161, P635, DOI [10.1016/J.resmic.2010.06.002, 10.1016/j.resmic.2010.06.002]; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Gallego V, 2006, INT J SYST EVOL MICR, V56, P2449, DOI 10.1099/ijs.0.64389-0; Graff A, 2005, FEMS MICROBIOL ECOL, V53, P401, DOI 10.1016/j.femsec.2005.01.009; Green SJ, 2007, ISME J, V1, P291, DOI 10.1038/ismej.2007.33; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gronemeyer JL, 2012, PLANT SOIL, V356, P67, DOI 10.1007/s11104-011-0798-7; Hoagland D.R., 1950, 347 U CAL CA AGR EXP, V347; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Hoitink HAJ, 1999, ANNU REV PHYTOPATHOL, V37, P427, DOI 10.1146/annurev.phyto.37.1.427; Hrynkiewicz K, 2010, J PLANT NUTR SOIL SC, V173, P747, DOI 10.1002/jpln.200900286; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; JANSSEN PHM, 1995, ECOL MODEL, V83, P55, DOI 10.1016/0304-3800(95)00084-9; Kampfer P., 2010, INT J SYST EVOL MICR, V61, P1528; Katan J., 2002, Plant roots: the hidden half, P949; Klein E, 2011, PLANT DIS, V95, P1116, DOI 10.1094/PDIS-01-11-0065; Kowalchuk GA, 2010, ENVIRONMENTAL MOLECULAR MICROBIOLOGY, P131; Kuffner M, 2010, J APPL MICROBIOL, V108, P1471, DOI 10.1111/j.1365-2672.2010.04670.x; La Scola B, 1998, J CLIN MICROBIOL, V36, P2847, DOI 10.1128/JCM.36.10.2847-2852.1998; Lindquist D, 2003, J CLIN MICROBIOL, V41, P192, DOI 10.1128/JCM.41.1.192-196.2003; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Nagy ML, 2005, FEMS MICROBIOL ECOL, V54, P233, DOI 10.1016/j.femsec.2005.03.011; Ofek M, 2011, ENVIRON MICROBIOL, V13, P2794, DOI 10.1111/j.1462-2920.2011.02551.x; Ofek M, 2009, APPL ENVIRON MICROB, V75, P6441, DOI 10.1128/AEM.00736-09; Pakarinen J, 2008, ENVIRON MICROBIOL, V10, P3317, DOI 10.1111/j.1462-2920.2008.01723.x; Pascault N, 2010, MICROB ECOL, V60, P816, DOI 10.1007/s00248-010-9705-7; Pisa G, 2011, BRAZ J MED BIOL RES, V44, P1215, DOI [10.1590/S0100-879X2011007500148, 10.1590/S0100-879X2011001200004]; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ruppel S, 2006, PLANT SOIL, V286, P21, DOI 10.1007/s11104-006-9023-5; Salomon PS, 2003, HARMFUL ALGAE, V2, P261, DOI 10.1016/S1568-9883(03)00045-3; Scheublin TR, 2010, ISME J, V4, P752, DOI 10.1038/ismej.2010.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Tani A, 2011, J BIOSCI BIOENG, V112, P32, DOI 10.1016/j.jbiosc.2011.03.012; Termorshuizen AJ, 2006, SOIL BIOL BIOCHEM, V38, P2461, DOI 10.1016/j.soilbio.2006.03.002; Triky-Dotan S, 2007, PLANT DIS, V91, P497, DOI 10.1094/PDIS-91-5-0497; Triky-Dotan S, 2010, PHYTOPATHOLOGY, V100, P367, DOI 10.1094/PHYTO-100-4-0367; Ulrich K, 2008, FEMS MICROBIOL ECOL, V63, P169, DOI 10.1111/j.1574-6941.2007.00419.x; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Vance C. P., 2002, Plant roots: the hidden half, P839; Weinert N, 2010, PLANT SOIL, V326, P437, DOI 10.1007/s11104-009-0024-z; Weisskopf L, 2011, APPL ENVIRON MICROB, V77, P7715, DOI 10.1128/AEM.05845-11; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; White C, 2011, APPL ENVIRON MICROB, V77, P5557, DOI 10.1128/AEM.02446-10; Zhou ZX, 2010, J MICROBIOL, V48, P139, DOI 10.1007/s12275-010-9185-y	70	173	184	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40117	10.1371/journal.pone.0040117	http://dx.doi.org/10.1371/journal.pone.0040117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808103	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400031
J	Lindegren, M; Dakos, V; Groger, JP; Gardmark, A; Kornilovs, G; Otto, SA; Mollmann, C				Lindegren, Martin; Dakos, Vasilis; Groeger, Joachim P.; Gardmark, Anna; Kornilovs, Georgs; Otto, Saskia A.; Moellmann, Christian			Early Detection of Ecosystem Regime Shifts: A Multiple Method Evaluation for Management Application	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; LEADING INDICATOR; MARINE ECOSYSTEM; SLOWING-DOWN; CLIMATE; DYNAMICS; TIME; REORGANIZATION; ZOOPLANKTON; VARIABILITY	Critical transitions between alternative stable states have been shown to occur across an array of complex systems. While our ability to identify abrupt regime shifts in natural ecosystems has improved, detection of potential early-warning signals previous to such shifts is still very limited. Using real monitoring data of a key ecosystem component, we here apply multiple early-warning indicators in order to assess their ability to forewarn a major ecosystem regime shift in the Central Baltic Sea. We show that some indicators and methods can result in clear early-warning signals, while other methods may have limited utility in ecosystem-based management as they show no or weak potential for early-warning. We therefore propose a multiple method approach for early detection of ecosystem regime shifts in monitoring data that may be useful in informing timely management actions in the face of ecosystem change.	[Lindegren, Martin] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Lindegren, Martin] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Dakos, Vasilis] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Groeger, Joachim P.] Fed Res Inst Rural Areas Forestry & Fisheries, Inst Sea Fisheries, von Thunen Inst, Hamburg, Germany; [Groeger, Joachim P.] Univ Rostock, Inst Biosci, Rostock, Germany; [Gardmark, Anna] Swedish Univ Agr Sci, Inst Coastal Res, Dept Aquat Resources, Oregrund, Sweden; [Kornilovs, Georgs] Inst Food Safety Anim Hlth & Environm, Dept Fish Resources Res, Riga, Latvia; [Otto, Saskia A.; Moellmann, Christian] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Hamburg, Germany	University of California System; University of California San Diego; Scripps Institution of Oceanography; Technical University of Denmark; Wageningen University & Research; Johann Heinrich von Thunen Institute; University of Rostock; Swedish University of Agricultural Sciences; Institute of Food Safety, Animal Health & Environment "BIOR"; University of Hamburg	Lindegren, M (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	mlindegren@ucsd.edu	Möllmann, Christian/M-8006-2019; Gårdmark, Anna/AAC-3909-2021; Möllmann, Christian/C-4788-2011	Möllmann, Christian/0000-0001-9161-6342; Dakos, Vasilis/0000-0001-8862-718X; Lindegren, Martin/0000-0002-9185-951X	European Research Council (ERC); BONUS-AMBER	European Research Council (ERC)(European Research Council (ERC)); BONUS-AMBER	VD was supported by an European Research Council (ERC) grant awarded to M. Scheffer and SAO by BONUS-AMBER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Carpenter SR, 2011, ECOLOGY, V92, P2196, DOI 10.1890/11-0716.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Donangelo R, 2010, INT J BIFURCAT CHAOS, V20, P315, DOI 10.1142/S0218127410025764; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Groger JP, 2011, ECOL INDIC, V11, P1084, DOI 10.1016/j.ecolind.2010.12.008; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Hansen FC, 2006, J PLANKTON RES, V28, P39, DOI 10.1093/plankt/fbi097; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Hewitt JE, 2010, MAR ECOL PROG SER, V413, P267, DOI 10.3354/meps08626; Hinrichsen HH, 2002, CAN J FISH AQUAT SCI, V59, P1858, DOI 10.1139/F02-149; Legendre P., 2012, NUMERICAL ECOLOGY; Link JS, 2009, PROG OCEANOGR, V81, P29, DOI 10.1016/j.pocean.2009.04.004; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2011, BIOL LETTERS, V7, P484, DOI 10.1098/rsbl.2010.1213; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Mollmann C, 2000, J PLANKTON RES, V22, P2015, DOI 10.1093/plankt/22.11.2015; Mollmann C, 2005, ICES J MAR SCI, V62, P1270, DOI 10.1016/j.icesjms.2005.04.021; Mollmann C, 2003, FISH OCEANOGR, V12, P360, DOI 10.1046/j.1365-2419.2003.00257.x; Renz J, 2006, MAR BIOL, V148, P567, DOI 10.1007/s00227-005-0103-5; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Trenkel VM, 2009, ECOL INDIC, V9, P732, DOI 10.1016/j.ecolind.2008.09.005; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Voss R, 2003, FISH RES, V63, P97, DOI 10.1016/S0165-7836(02)00282-5; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	37	65	66	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38410	10.1371/journal.pone.0038410	http://dx.doi.org/10.1371/journal.pone.0038410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808007	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000306355500002
J	Ruge, CA; Schaefer, UF; Herrmann, J; Kirch, J; Canadas, O; Echaide, M; Perez-Gil, J; Casals, C; Muller, R; Lehr, CM				Ruge, Christian A.; Schaefer, Ulrich F.; Herrmann, Jennifer; Kirch, Julian; Canadas, Olga; Echaide, Mercedes; Perez-Gil, Jesus; Casals, Cristina; Mueller, Rolf; Lehr, Claus-Michael			The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles	PLOS ONE			English	Article							PULMONARY SURFACTANT; PHYSICAL-PROPERTIES; TITANIUM-DIOXIDE; SP-A; AGGREGATION; COMPONENTS; OLIGOMERIZATION; PHOSPHOLIPIDS; RECOGNITION; ADSORPTION	The peripheral lungs are a potential entrance portal for nanoparticles into the human body due to their large surface area. The fact that nanoparticles can be deposited in the alveolar region of the lungs is of interest for pulmonary drug delivery strategies and is of equal importance for toxicological considerations. Therefore, a detailed understanding of nanoparticle interaction with the structures of this largest and most sensitive part of the lungs is important for both nanomedicine and nanotoxicology. Astonishingly, there is still little known about the bio-nano interactions that occur after nanoparticle deposition in the alveoli. In this study, we compared the effects of surfactant-associated protein A (SP-A) and D (SP-D) on the clearance of magnetite nanoparticles (mNP) with either more hydrophilic (starch) or hydrophobic (phosphatidylcholine) surface modification by an alveolar macrophage (AM) cell line (MH-S) using flow cytometry and confocal microscopy. Both proteins enhanced the AM uptake of mNP compared with pristine nanoparticles; for the hydrophilic ST-mNP, this effect was strongest with SP-D, whereas for the hydrophobic PL-mNP it was most pronounced with SP-A. Using gel electrophoretic and dynamic light scattering methods, we were able to demonstrate that the observed cellular effects were related to protein adsorption and to protein-mediated interference with the colloidal stability. Next, we investigated the influence of various surfactant lipids on nanoparticle uptake by AM because lipids are the major surfactant component. Synthetic surfactant lipid and isolated native surfactant preparations significantly modulated the effects exerted by SP-A and SP-D, respectively, resulting in comparable levels of macrophage interaction for both hydrophilic and hydrophobic nanoparticles. Our findings suggest that because of the interplay of both surfactant lipids and proteins, the AM clearance of nanoparticles is essentially the same, regardless of different intrinsic surface properties.	[Ruge, Christian A.; Schaefer, Ulrich F.; Kirch, Julian; Lehr, Claus-Michael] Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-6600 Saarbrucken, Germany; [Herrmann, Jennifer; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-6600 Saarbrucken, Germany; [Canadas, Olga; Echaide, Mercedes; Perez-Gil, Jesus; Casals, Cristina] Univ Complutense, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Canadas, Olga; Casals, Cristina] Univ Complutense, CIBER Enfermedades Resp, E-28040 Madrid, Spain; [Herrmann, Jennifer; Mueller, Rolf; Lehr, Claus-Michael] Univ Saarland, Helmholtz Inst Pharmaceut Res Saarland HIPS, D-6600 Saarbrucken, Germany	Saarland University; Saarland University; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid; Helmholtz Association; Saarland University	Ruge, CA (corresponding author), Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-6600 Saarbrucken, Germany.	lehr@mx.uni-saarland.de	Lehr, Claus-Michael/AAU-8117-2020; Cañadas, Olga/G-3547-2015; Perez-Gil, Jesus/H-3102-2019; ECHAIDE, MERCEDES/I-1649-2015; Casals, Cristina/H-4658-2015; Müller, Rolf/B-1559-2008	Lehr, Claus-Michael/0000-0002-5864-8462; Cañadas, Olga/0000-0002-1932-3796; Perez-Gil, Jesus/0000-0003-3587-7147; ECHAIDE, MERCEDES/0000-0002-0836-0858; Casals, Cristina/0000-0003-2696-0918; Müller, Rolf/0000-0002-1042-5665; Herrmann, Jennifer/0000-0003-3398-9938	German Research Foundation (DFG) [PAK 367]; Spanish Ministry of Economy and Competitivity [BIO2009-09694, CSD2007-00010, SAF2009-07810]; Community of Madrid [S2009MAT-1507]; Instituto de Salud Carlos III [CIBERES-CB06/06/0002]	German Research Foundation (DFG)(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitivity(Spanish Government); Community of Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the German Research Foundation (DFG, PAK 367). ME and JPG acknowledge funding from Spanish Ministry of Economy and Competitivity (BIO2009-09694, CSD2007-00010) and Community of Madrid (S2009MAT-1507). OC and CC acknowledge funding from Spanish Ministry of Economy and Competitivity (SAF2009-07810) and Instituto de Salud Carlos III (CIBERES-CB06/06/0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; Bernhard W, 2000, AM J RESP CRIT CARE, V162, P1524, DOI 10.1164/ajrccm.162.4.9908104; Blanco O, 2007, EUR J PHARMACOL, V568, P1, DOI 10.1016/j.ejphar.2007.04.035; CASALS C, 1994, BIOCHEM SOC T, V22, pS370, DOI 10.1042/bst022370s; Casals C, 2001, PEDIATR PATHOL MOL M, V20, P249, DOI 10.1080/152279501750412216; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Erpenbeck VJ, 2005, AM J PHYSIOL-LUNG C, V288, pL692, DOI 10.1152/ajplung.00362.2004; Geiser M, 2010, J AEROSOL MED PULM D, V23, P207, DOI 10.1089/jamp.2009.0797; Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Harishchandra RK, 2010, J R SOC INTERFACE, V7, pS15, DOI 10.1098/rsif.2009.0329.focus; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Jones BG, 2002, J PHARM PHARMACOL, V54, P1065, DOI 10.1211/002235702320266217; Kirch J, 2012, J CONTROL RELEASE, V159, P128, DOI 10.1016/j.jconrel.2011.12.015; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Muller RH, 1997, PHARMACEUT RES, V14, P18, DOI 10.1023/A:1012043131081; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Patton JS, 2007, NAT REV DRUG DISCOV, V6, P67, DOI 10.1038/nrd2153; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ruano MLF, 2000, BIOCHEMISTRY-US, V39, P6529, DOI 10.1021/bi000188z; Ruge CA, 2011, NANOMED-NANOTECHNOL, V7, P690, DOI 10.1016/j.nano.2011.07.009; Sachan AK, 2012, ACS NANO, V6, P1677, DOI 10.1021/nn204657n; Saenz A, 2007, BIOPHYS J, V92, P482, DOI 10.1529/biophysj.106.090217; Saenz A, 2006, FEBS J, V273, P2515, DOI 10.1111/j.1742-4658.2006.05258.x; Sanchez-Barbero F, 2005, J BIOL CHEM, V280, P7659, DOI 10.1074/jbc.M410266200; Sanchez-Barbero F, 2007, BIOCHEM J, V406, P479, DOI 10.1042/BJ20070275; Schleh C, 2011, EUR J PHARM BIOPHARM, V77, P350, DOI 10.1016/j.ejpb.2010.12.025; Schleh C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-90; Schulze C, 2011, EUR J PHARM BIOPHARM, V77, P376, DOI 10.1016/j.ejpb.2010.10.013; Seaton BA, 2010, INNATE IMMUN-LONDON, V16, P143, DOI 10.1177/1753425910368716; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Stensballe A, 2004, RAPID COMMUN MASS SP, V18, P1721, DOI 10.1002/rcm.1542; Stringer B, 1996, AM J RESP CELL MOL, V14, P155, DOI 10.1165/ajrcmb.14.2.8630265; Sung JC, 2007, TRENDS BIOTECHNOL, V25, P563, DOI 10.1016/j.tibtech.2007.09.005; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Tino MJ, 1998, BBA-MOL BASIS DIS, V1408, P241, DOI 10.1016/S0925-4439(98)00071-4; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931	41	118	118	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40775	10.1371/journal.pone.0040775	http://dx.doi.org/10.1371/journal.pone.0040775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802970	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500081
J	Chauhan, JS; Bhat, AH; Raghava, GPS; Rao, A				Chauhan, Jagat S.; Bhat, Adil H.; Raghava, Gajendra P. S.; Rao, Alka			GlycoPP: A Webserver for Prediction of N- and O-Glycosites in Prokaryotic Protein Sequences	PLOS ONE			English	Article							GLYCOSYLATION SITES; GLYCOPROTEINS; BACTERIA; OLIGOSACCHARYLTRANSFERASE; ACCESSIBILITY; BIOSYNTHESIS; DEFINITION; RESIDUES; EXTREME; ARCHAEA	Glycosylation is one of the most abundant post-translational modifications (PTMs) required for various structure/function modulations of proteins in a living cell. Although elucidated recently in prokaryotes, this type of PTM is present across all three domains of life. In prokaryotes, two types of protein glycan linkages are more widespread namely, N-linked, where a glycan moiety is attached to the amide group of Asn, and O- linked, where a glycan moiety is attached to the hydroxyl group of Ser/Thr/Tyr. For their biologically ubiquitous nature, significance, and technology applications, the study of prokaryotic glycoproteins is a fast emerging area of research. Here we describe new Support Vector Machine (SVM) based algorithms (models) developed for predicting glycosylated-residues (glycosites) with high accuracy in prokaryotic protein sequences. The models are based on binary profile of patterns, composition profile of patterns, and position-specific scoring matrix profile of patterns as training features. The study employ an extensive dataset of 107 N-linked and 116 O-linked glycosites extracted from 59 experimentally characterized glycoproteins of prokaryotes. This dataset includes validated N-glycosites from phyla Crenarchaeota, Euryarchaeota (domain Archaea), Proteobacteria (domain Bacteria) and validated O-glycosites from phyla Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria (domain Bacteria). In view of the current understanding that glycosylation occurs on folded proteins in bacteria, hybrid models have been developed using information on predicted secondary structures and accessible surface area in various combinations with training features. Using these models, N-glycosites and O-glycosites could be predicted with an accuracy of 82.71% (MCC 0.65) and 73.71% (MCC 0.48), respectively. An evaluation of the best performing models with 28 independent prokaryotic glycoproteins confirms the suitability of these models in predicting N- and O-glycosites in potential glycoproteins from aforementioned organisms, with reasonably high confidence. A web server GlycoPP, implementing these models is available freely at http:/www.imtech.res.in/raghava/glycopp/.	[Chauhan, Jagat S.; Raghava, Gajendra P. S.] CSIR, Bioinformat Ctr, Inst Microbial Technol, Chandigarh, India; [Bhat, Adil H.; Rao, Alka] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Chauhan, JS (corresponding author), CSIR, Bioinformat Ctr, Inst Microbial Technol, Chandigarh, India.	raghava@imtech.res.in; raoalka@imtech.res	Raghava, Gajendra P.S./AAA-2413-2022; Rao, Alka/F-9826-2010; Raghava, Gajendra/B-1717-2009	Raghava, Gajendra P.S./0000-0002-8902-2876; 	Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	AR and GPSR acknowledge the financial support from Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology (DBT), Government of India, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Abu-Qarn Mehtap, 2007, Archaea, V2, P73; Agarwal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024039; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Balonova L, 2010, J PROTEOME RES, V9, P1995, DOI 10.1021/pr9011602; Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Bhat AH, 2012, NUCLEIC ACIDS RES, V40, pD388, DOI 10.1093/nar/gkr911; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; Chauhan JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-301; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Dell A, 2010, INT J MICROBIOL, V2010, P148; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Faridmoayer A, 2008, J BIOL CHEM, V283, P34596, DOI 10.1074/jbc.M807113200; Fletcher CM, 2011, J BIOL CHEM, V286, P3219, DOI 10.1074/jbc.M110.194506; Garg A, 2005, PROTEINS, V61, P318, DOI 10.1002/prot.20630; Ghoshal A, 2009, GLYCOCONJUGATE J, V26, P675, DOI 10.1007/s10719-008-9223-8; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Hanna ES, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-11; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Herrmann JL, 2000, FEBS LETT, V473, P358, DOI 10.1016/S0014-5793(00)01553-2; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Jennings MP, 2011, CELL MICROBIOL, V13, P885, DOI 10.1111/j.1462-5822.2011.01586.x; Jervis AJ, 2010, J BACTERIOL, V192, P5228, DOI 10.1128/JB.00211-10; Joachims T, 1999, ADV KERNEL MODELS SU; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kalita MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002605; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Messner P, 2004, J BACTERIOL, V186, P2517, DOI 10.1128/JB.186.9.2517-2519.2004; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Rangarajan ES, 2007, PROTEIN SCI, V16, P990, DOI 10.1110/ps.062737507; Roy K, 2009, VACCINE, V27, P4601, DOI 10.1016/j.vaccine.2009.05.076; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97	43	52	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40155	10.1371/journal.pone.0040155	http://dx.doi.org/10.1371/journal.pone.0040155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808107	gold, Green Submitted, Green Published			2022-12-27	WOS:000306354700028
J	Jin, CN; Rajabi, H; Pitroda, S; Li, AL; Kharbanda, A; Weichselbaum, R; Kufe, D				Jin, Caining; Rajabi, Hasan; Pitroda, Sean; Li, Ailing; Kharbanda, Akriti; Weichselbaum, Ralph; Kufe, Donald			Cooperative Interaction between the MUC1-C Oncoprotein and the Rab31 GTPase in Estrogen Receptor-Positive Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MAMMARY-GLAND; LUNG-CANCER; PREDICT; DIFFERENTIATION; TUMORIGENESIS; TRAFFICKING; CARCINOMAS; ACTIVATION; SURVIVAL	Rab31 is a member of the Ras superfamily of small GTPases that has been linked to poor outcomes in patients with breast cancer. The MUC1-C oncoprotein is aberrantly overexpressed in most human breast cancers and also confers a poor prognosis. The present results demonstrate that MUC1-C induces Rab31 expression in estrogen receptor positive (ER+) breast cancer cells. We show that MUC1-C forms a complex with estrogen receptor alpha (ER alpha) on the Rab31 promoter and activates Rab31 gene transcription in an estrogen-dependent manner. In turn, Rab31 contributes to the upregulation of MUC1-C abundance in breast cancer cells by attenuating degradation of MUC1-C in lysosomes. Expression of an inactive Rab31(S20N) mutant in nonmalignant breast epithelial cells confirmed that Rab31 regulates MUC1-C expression. The functional significance of the MUC1-C/Rab31 interaction is supported by the demonstration that Rab31 confers the formation of mammospheres by a MUC1-C-dependent mechanism. Analysis of microarray databases further showed that (i) Rab31 is expressed at higher levels in breast cancers as compared to that in normal breast tissues, (ii) MUC1+ and ER+ breast cancers have increased levels of Rab31 expression, and (iii) patients with Rab31-positive breast tumors have a significantly decreased ten-year overall survival as compared to those with Rab31-negative tumors. These findings indicate that MUC1-C and Rab31 function in an autoinductive loop that contributes to overexpression of MUC1-C in breast cancer cells.	[Jin, Caining; Rajabi, Hasan; Kharbanda, Akriti; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Pitroda, Sean; Weichselbaum, Ralph] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Li, Ailing] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jin, CN (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu			National Cancer Institute [CA97098, CA42802, CA100707]; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA166480, R01CA097098, R01CA042802] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA97098, CA42802 and CA100707 awarded by the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Bao XK, 2002, EUR J BIOCHEM, V269, P259, DOI 10.1046/j.0014-2956.2001.02645.x; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Khodarev NN, 2009, CANCER RES, V69, P2833, DOI 10.1158/0008-5472.CAN-08-4513; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; Kotzsch M, 2008, BREAST CANCER RES TR, V111, P229, DOI 10.1007/s10549-007-9782-6; Kufe D, 2012, ONCOGENE IN PRESS; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Pitroda SP, 2009, P NATL ACAD SCI USA, V106, P5837, DOI 10.1073/pnas.0812029106; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Rodriguez-Gabin AG, 2010, J NEUROSCI RES, V88, P589, DOI 10.1002/jnr.22236; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030	30	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39432	10.1371/journal.pone.0039432	http://dx.doi.org/10.1371/journal.pone.0039432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792175	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700011
J	Liao, JH; Kuo, CI; Huang, YY; Lin, YC; Lin, YC; Yang, CY; Wu, WL; Chang, WH; Liaw, YC; Lin, LH; Chang, CI; Wu, SH				Liao, Jiahn-Haur; Kuo, Chiao-I; Huang, Ya-Yi; Lin, Yu-Ching; Lin, Yen-Chen; Yang, Chen-Yui; Wu, Wan-Ling; Chang, Wei-Hau; Liaw, Yen-Chywan; Lin, Li-Hua; Chang, Chung-I; Wu, Shih-Hsiung			A Lon-Like Protease with No ATP-Powered Unfolding Activity	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; LA; PROTEINS; SITES; PEPTIDES; CLEAVAGE; BINDING; AAA(+)	Lon proteases are a family of ATP-dependent proteases involved in protein quality control, with a unique proteolytic domain and an AAA(+) (ATPases associated with various cellular activities) module accommodated within a single polypeptide chain. They were classified into two types as either the ubiquitous soluble LonA or membrane-inserted archaeal LonB. In addition to the energy-dependent forms, a number of medically and ecologically important groups of bacteria encode a third type of Lon-like proteins in which the conserved proteolytic domain is fused to a large N-terminal fragment lacking canonical AAA(+) motifs. Here we showed that these Lon-like proteases formed a clade distinct from LonA and LonB. Characterization of one such Lon-like protease from Meiothermus taiwanensis indicated that it formed a hexameric assembly with a hollow chamber similar to LonA/B. The enzyme was devoid of ATPase activity but retained an ability to bind symmetrically six nucleotides per hexamer; accordingly, structure-based alignment suggested possible existence of a nonfunctional AAA-like domain. The enzyme degraded unstructured or unfolded protein and peptide substrates, but not well-folded proteins, in ATP-independent manner. These results highlight a new type of Lon proteases that may be involved in breakdown of excessive damage or unfolded proteins during stress conditions without consumption of energy.	[Liao, Jiahn-Haur; Kuo, Chiao-I; Lin, Yu-Ching; Lin, Li-Hua; Chang, Chung-I; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Huang, Ya-Yi] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Lin, Yen-Chen; Liaw, Yen-Chywan] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Yang, Chen-Yui; Wu, Wan-Ling; Chang, Chung-I; Wu, Shih-Hsiung] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Chang, Wei-Hau] Acad Sinica, Inst Chem, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Liao, JH (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	chungi@gate.sinica.edu.tw; shwu@gate.sinica.edu.tw	Chang, Wei-Hau/F-1965-2015	Chang, Wei-Hau/0000-0002-2612-850X; Chang, Chung-I/0000-0003-0989-1228	Academia Sinica and the National Science Council Taipei, Taiwan [NSC99-2320-B-001-MY2, NSC 100-2811-M-001-056]	Academia Sinica and the National Science Council Taipei, Taiwan	This work was supported by Academia Sinica and the National Science Council (NSC99-2320-B-001-MY2; NSC 100-2811-M-001-056), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERIK AY, 1991, FEBS LETT, V287, P211, DOI 10.1016/0014-5793(91)80053-6; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Botos I, 2005, J MOL BIOL, V351, P144, DOI 10.1016/j.jmb.2005.06.008; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Chen MY, 2002, INT J SYST EVOL MICR, V52, P1647, DOI 10.1099/00207713-52-5-1647; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Duman RE, 2010, J MOL BIOL, V401, P653, DOI 10.1016/j.jmb.2010.06.030; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fukui T, 2002, J BACTERIOL, V184, P3689, DOI 10.1128/JB.184.13.3689-3698.2002; Garcia-Nafria J, 2010, PROTEIN SCI, V19, P987, DOI 10.1002/pro.376; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; GOLDBERG AL, 1985, J BIOL CHEM, V260, P2029; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Im YJ, 2004, J BIOL CHEM, V279, P53451, DOI 10.1074/jbc.M410437200; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Lee AYL, 2004, EUR J BIOCHEM, V271, P834, DOI 10.1111/j.1432-1033.2004.03988.x; Liao JH, 2010, BIOPHYS J, V98, P129, DOI 10.1016/j.bpj.2009.09.052; Maehara T, 2008, EXTREMOPHILES, V12, P285, DOI 10.1007/s00792-007-0129-3; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Neuwald AF, 1999, GENOME RES, V9, P27; Nishii W, 2005, FEBS LETT, V579, P6846, DOI 10.1016/j.febslet.2005.11.026; Nishii W, 2002, EUR J BIOCHEM, V269, P451, DOI 10.1046/j.0014-2956.2001.02668.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Park SC, 2006, MOL CELLS, V21, P129; Rotanova TV, 2004, EUR J BIOCHEM, V271, P4865, DOI 10.1111/j.1432-1033.2004.04452.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shringarpure R, 2001, CELL MOL LIFE SCI, V58, P1442, DOI 10.1007/PL00000787; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR JS, 1991, P NATL ACAD SCI USA, V88, P6810, DOI 10.1073/pnas.88.15.6810; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; Ward Donald E., 2002, Archaea, V1, P63, DOI 10.1155/2002/503191; WAXMAN L, 1985, J BIOL CHEM, V260, P2022; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070	40	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40226	10.1371/journal.pone.0040226	http://dx.doi.org/10.1371/journal.pone.0040226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792246	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800051
J	Majumdar, R; Dighe, RR				Majumdar, Ritankar; Dighe, Rajan R.			The Hinge Region of Human Thyroid-Stimulating Hormone (TSH) Receptor Operates as a Tunable Switch between Hormone Binding and Receptor Activation	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; PROTEIN-COUPLED RECEPTORS; LEUCINE-RICH DOMAIN; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODIES; ALPHA-SUBUNIT; NEGATIVE COOPERATIVITY; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION	The mechanism by which the hinge regions of glycoprotein hormone receptors couple hormone binding to activation of downstream effecters is not clearly understood. In the present study, agonistic (311.62) and antagonistic (311.87) monoclonal antibodies (MAbs) directed against the TSH receptor extracellular domain were used to elucidate role of the hinge region in receptor activation. MAb 311.62 which identifies the LRR/Cb-2 junction (aa 265-275), increased the affinity of TSHR for the hormone while concomitantly decreasing its efficacy, whereas MAb 311.87 recognizing LRR 7-9 (aa 201-259) acted as a non-competitive inhibitor of Thyroid stimulating hormone (TSH) binding. Binding of MAbs was sensitive to the conformational changes caused by the activating and inactivating mutations and exhibited differential effects on hormone binding and response of these mutants. By studying the effects of these MAbs on truncation and chimeric mutants of thyroid stimulating hormone receptor (TSHR), this study confirms the tethered inverse agonistic role played by the hinge region and maps the interactions between TSHR hinge region and exoloops responsible for maintenance of the receptor in its basal state. Mechanistic studies on the antibody-receptor interactions suggest that MAb 311.87 is an allosteric insurmountable antagonist and inhibits initiation of the hormone induced conformational changes in the hinge region, whereas MAb 311.62 acts as a partial agonist that recognizes a conformational epitope critical for coupling of hormone binding to receptor activation. The hinge region, probably in close proximity with the alpha-subunit in the hormone-receptor complex, acts as a tunable switch between hormone binding and receptor activation.	[Majumdar, Ritankar; Dighe, Rajan R.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Majumdar, R (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rdighe@mrdg.iisc.ernet.in	Majumdar, Ritankar/AAE-7249-2022	Majumdar, Ritankar/0000-0001-6624-0187	India Institute of Science	India Institute of Science	This work was financially supported by a scholarship from the India Institute of Science to RM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Ando T, 2004, ENDOCRINOLOGY, V145, P5185, DOI 10.1210/en.2004-0789; Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Chen CR, 2008, ENDOCRINOLOGY, V149, P3427, DOI 10.1210/en.2008-0207; Chen CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031973; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2010, ENDOCRINOLOGY, V151, P1940, DOI 10.1210/en.2009-1430; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Costagliola S, 2004, MOL ENDOCRINOL, V18, P3020, DOI 10.1210/me.2004-0231; Costagliola S, 2002, BIOCHEM BIOPH RES CO, V299, P891, DOI 10.1016/S0006-291X(02)02762-6; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; Demarest JF, 2008, J CLIN PHARMACOL, V48, P1179, DOI 10.1177/0091270008322178; DIGHE RR, 1990, J IMMUNOL METHODS, V131, P229, DOI 10.1016/0022-1759(90)90194-Z; DIGHE RR, 1983, ARCH BIOCHEM BIOPHYS, V225, P490, DOI 10.1016/0003-9861(83)90058-9; DIGHE RR, 1990, MOL CELL ENDOCRINOL, V72, P63, DOI 10.1016/0303-7207(90)90240-9; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jeffreys J, 2002, THYROID, V12, P1051, DOI 10.1089/105072502321085144; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; KAUMANN AJ, 1982, N-S ARCH PHARMACOL, V318, P192, DOI 10.1007/BF00500480; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2011, J BIOL CHEM, V286, P22622, DOI 10.1074/jbc.M110.211193; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; Lin W, 2007, MOL CELL ENDOCRINOL, V260, P83, DOI 10.1016/j.mce.2006.06.012; Miguel RN, 2009, J MOL ENDOCRINOL, V42, P381, DOI 10.1677/JME-08-0152; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mizutori Y, 2009, J CLIN ENDOCR METAB, V94, P927, DOI 10.1210/jc.2008-2134; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1991, J CLIN INVEST, V88, P336, DOI 10.1172/JCI115297; NAGAYAMA Y, 1992, ENDOCRINOLOGY, V131, P548, DOI 10.1210/en.131.2.548; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; Nicholson LB, 1996, J MOL ENDOCRINOL, V16, P159, DOI 10.1677/jme.0.0160159; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; PANTEL J, 1993, BIOCHEM BIOPH RES CO, V195, P588, DOI 10.1006/bbrc.1993.2086; POWELLJONES CHJ, 1979, P NATL ACAD SCI USA, V76, P705, DOI 10.1073/pnas.76.2.705; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; RAPOPORT B, 1982, J CLIN ENDOCR METAB, V54, P1059, DOI 10.1210/jcem-54-5-1059; Roth KE, 1996, BIOCHEMISTRY-US, V35, P7928, DOI 10.1021/bi952566j; Saha S, 2010, METALLOMICS, V2, P754, DOI 10.1039/c0mt00028k; Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6; Sanders J, 1997, BAILLIERE CLIN ENDOC, V11, P451, DOI 10.1016/S0950-351X(97)80693-3; Sanders J, 2004, THYROID, V14, P560, DOI 10.1089/1050725041692918; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; Shepherd PS, 1999, MOL CELL ENDOCRINOL, V149, P197, DOI 10.1016/S0303-7207(98)00207-X; Smith BR, 2007, HOT THYROIDOLOGY; Strange PG, 2008, BRIT J PHARMACOL, V153, P1353, DOI 10.1038/sj.bjp.0707672; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WAYS JP, 1983, BIOCHEM J, V216, P423, DOI 10.1042/bj2160423; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797	66	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40291	10.1371/journal.pone.0040291	http://dx.doi.org/10.1371/journal.pone.0040291			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792265	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000306461800062
J	Yu, TW				Yu, Tianwei			ROCS: Receiver Operating Characteristic Surface for Class-Skewed High-Throughput Data	PLOS ONE			English	Article							PACKAGE	The receiver operating characteristic (ROC) curve is an important tool to gauge the performance of classifiers. In certain situations of high-throughput data analysis, the data is heavily class-skewed, i.e. most features tested belong to the true negative class. In such cases, only a small portion of the ROC curve is relevant in practical terms, rendering the ROC curve and its area under the curve (AUC) insufficient for the purpose of judging classifier performance. Here we define an ROC surface (ROCS) using true positive rate (TPR), false positive rate (FPR), and true discovery rate (TDR). The ROC surface, together with the associated quantities, volume under the surface (VUS) and FDR-controlled area under the ROC curve (FCAUC), provide a useful approach for gauging classifier performance on class-skewed high-throughput data. The implementation as an R package is available at http://userwww.service.emory.edu/similar to tyu8/ROCS/.	Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Yu, TW (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.	tianwei.yu@emory.edu		Yu, Tianwei/0000-0003-2502-1628	National Institutes of Health [5P01ES016731, 5U19AI057266, 1U19AI090023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, U19AI090023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was partially supported by National Institutes of Health grants 5P01ES016731, 5U19AI057266 and 1U19AI090023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adler D, 2003, P 3 INT WORKSH DISTR; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berrar D, 2012, BRIEF BIOINFORM, V13, P83, DOI 10.1093/bib/bbr008; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Soreide K, 2009, J CLIN PATHOL, V62, P1, DOI 10.1136/jcp.2008.061010; Swamidass SJ, 2010, BIOINFORMATICS, V26, P1348, DOI 10.1093/bioinformatics/btq140; Turro E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-439; Walter SD, 2005, STAT MED, V24, P2025, DOI 10.1002/sim.2103; Yu TW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-145	11	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40598	10.1371/journal.pone.0040598	http://dx.doi.org/10.1371/journal.pone.0040598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792381	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800109
J	Zhang, JD; Li, XB; Song, YY; Liu, J				Zhang, Jiedong; Li, Xiaobai; Song, Yiying; Liu, Jia			The Fusiform Face Area Is Engaged in Holistic, Not Parts-Based, Representation of Faces	PLOS ONE			English	Article							VOXEL PATTERN-ANALYSIS; SURFACE-BASED ANALYSIS; SPATIAL RELATIONS; CONFIGURAL INFORMATION; PERCEPTION; FEATURES; RECOGNITION; INVERSION; IDENTITY; WHOLES	Numerous studies with functional magnetic resonance imaging have shown that the fusiform face area (FFA) in the human brain plays a key role in face perception. Recent studies have found that both the featural information of faces (e.g., eyes, nose, and mouth) and the configural information of faces (i.e., spatial relation among features) are encoded in the FFA. However, little is known about whether the featural information is encoded independent of or combined with the configural information in the FFA. Here we used multi-voxel pattern analysis to examine holistic representation of faces in the FFA by correlating spatial patterns of activation with behavioral performance in discriminating face parts with face configurations either present or absent. Behaviorally, the absence of face configurations (versus presence) impaired discrimination of face parts, suggesting a holistic representation in the brain. Neurally, spatial patterns of activation in the FFA were more similar among correct than incorrect trials only when face parts were presented in a veridical face configuration. In contrast, spatial patterns of activation in the occipital face area, as well as the object-selective lateral occipital complex, were more similar among correct than incorrect trials regardless of the presence of veridical face configurations. This finding suggests that in the FFA faces are represented not on the basis of individual parts but in terms of the whole that emerges from the parts.	[Zhang, Jiedong; Li, Xiaobai; Song, Yiying; Liu, Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Jiedong; Li, Xiaobai; Song, Yiying; Liu, Jia] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Liu, Jia] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JD (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn		Liu, Jia/0000-0003-0383-0934	100 Talents Program of the Chinese Academy of Sciences; National Basic Research Program of China [2010CB833903, 2011CB505402]; Fundamental Research Funds for the Central Universities [2009SD-3]	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is funded by the 100 Talents Program of the Chinese Academy of Sciences, the National Basic Research Program of China (2010CB833903, 2011CB505402), and the Fundamental Research Funds for the Central Universities (2009SD-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Harris A, 2008, J COGNITIVE NEUROSCI, V20, P863, DOI 10.1162/jocn.2008.20509; Harris A, 2010, J NEUROPHYSIOL, V104, P336, DOI 10.1152/jn.00626.2009; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; HOSIE JA, 1988, PERCEPTION, V17, P461, DOI 10.1068/p170461; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; Liu J, 2010, J COGNITIVE NEUROSCI, V22, P203, DOI 10.1162/jocn.2009.21203; Maurer D, 2007, NEUROPSYCHOLOGIA, V45, P1438, DOI 10.1016/j.neuropsychologia.2006.11.016; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; McKone E, 2001, J EXP PSYCHOL HUMAN, V27, P573, DOI 10.1037/0096-1523.27.3.573; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Peelen MV, 2007, TRENDS COGN SCI, V11, P4, DOI 10.1016/j.tics.2006.10.009; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Raizada RDS, 2010, CEREB CORTEX, V20, P1, DOI 10.1093/cercor/bhp076; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; RHODES G, 1988, PERCEPTION, V17, P43, DOI 10.1068/p170043; Rhodes G, 2009, EUR J NEUROSCI, V30, P721, DOI 10.1111/j.1460-9568.2009.06861.x; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Rotshtein P, 2007, J COGNITIVE NEUROSCI, V19, P1435, DOI 10.1162/jocn.2007.19.9.1435; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Schiltz C, 2010, J VISION, V10, DOI 10.1167/10.2.25; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; SERGENT J, 1984, BRIT J PSYCHOL, V75, P221, DOI 10.1111/j.2044-8295.1984.tb01895.x; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Williams MA, 2007, NAT NEUROSCI, V10, P685, DOI 10.1038/nn1900; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Yovel G, 2008, PSYCHON B REV, V15, P933, DOI 10.3758/PBR.15.5.933; Zhu Q, 2011, J NEUROSCI, V31, P10323, DOI 10.1523/JNEUROSCI.0873-11.2011; Zhu Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006239	58	29	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40390	10.1371/journal.pone.0040390	http://dx.doi.org/10.1371/journal.pone.0040390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792301	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800076
J	Brown, MJ; Sinclair, M; Liddle, D; Hill, AJ; Madden, E; Stockdale, J				Brown, Mary Jane; Sinclair, Marlene; Liddle, Dianne; Hill, Alyson J.; Madden, Elaine; Stockdale, Janine			A Systematic Review Investigating Healthy Lifestyle Interventions Incorporating Goal Setting Strategies for Preventing Excess Gestational Weight Gain	PLOS ONE			English	Review							PHYSICAL-ACTIVITY PATTERNS; OBESE PREGNANT-WOMEN; DIETARY; OVERWEIGHT; BEHAVIOR; METAANALYSIS; PREDICTORS; MANAGEMENT; ATTRITION; PROGRAM	Background: Excess gestational weight gain (GWG) is an important risk factor for long term obesity in women. However, current interventions aimed at preventing excess GWG appear to have a limited effect. Several studies have highlighted the importance of linking theory with empirical evidence for producing effective interventions for behaviour change. Theorists have demonstrated that goals can be an important source of human motivation and goal setting has shown promise in promoting diet and physical activity behaviour change within non-pregnant individuals. The use of goal setting as a behaviour change strategy has been systematically evaluated within overweight and obese individuals, yet its use within pregnancy has not yet been systematically explored. Aim of review: To explore the use of goal setting within healthy lifestyle interventions for the prevention of excess GWG. Data collection and analysis: Searches were conducted in seven databases alongside hand searching of relevant journals and citation tracking. Studies were included if interventions used goal setting alongside modification of diet and/or physical activity with an aim to prevent excess GWG. The PRISMA guidelines were followed and a two-stage methodological approach was used. Stage one focused on systematically evaluating the methodological quality of included interventions. The second stage assessed intervention integrity and the implementation of key goal setting components. Findings: From a total of 839 citations, 54 full-text articles were assessed for eligibility and 5 studies met the inclusion criteria. Among interventions reporting positive results a combination of individualised diet and physical activity goals, self-monitoring and performance feedback indicators were described as active components. Conclusion: Interventions based on goal setting appear to be useful for helping women achieve optimal weight gain during pregnancy. However, overweight and obese women may require more theoretically-designed interventions. Further high quality, theoretically-designed interventions are required to determine the most effective and replicable components for optimal GWG.	[Brown, Mary Jane; Sinclair, Marlene] Univ Ulster, Inst Nursing Res, Newtownabbey, North Ireland; [Liddle, Dianne] Univ Ulster, Sch Hlth Sci, Newtownabbey, North Ireland; [Hill, Alyson J.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Madden, Elaine] S Eastern Hlth & Social Care Trust, Head Midwifery & Gynaecol, Belfast, Antrim, North Ireland; [Stockdale, Janine] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland	Ulster University; Ulster University; Ulster University; Trinity College Dublin	Brown, MJ (corresponding author), Univ Ulster, Inst Nursing Res, Newtownabbey, North Ireland.	brown-m7@email.ulster.ac.uk	; Liddle, Sarah Dianne/O-4686-2015	Hill, Alyson/0000-0003-3134-2794; Stockdale, Janine/0000-0003-0689-2719; Liddle, Sarah Dianne/0000-0001-8151-641X; Nao Hava, Dindainlez/0000-0003-4649-5312; sinclair, marlene/0000-0003-4444-1505	Department for Employment and Learning, Northern Ireland	Department for Employment and Learning, Northern Ireland	This PhD project was funded by the Department for Employment and Learning, Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, J AM DIET ASSOC, V109, P918, DOI 10.1016/j.jada.2009.03.020; [Anonymous], 2005, PER MORT 2005; Armstrong R, 2007, GUIDELINES SYSTEMATI; Asbee SM, 2009, OBSTET GYNECOL, V113, P305, DOI 10.1097/AOG.0b013e318195baef; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Birdsall KM, 2009, INT J CLIN PRACT, V63, P494, DOI 10.1111/j.1742-1241.2008.01910.x; Butland B, 2007, FORESIGHT TACKLING O; Campbell F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-491; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Central Office of Information, 2009, COMM BEH CHANG; Centre for Maternal Child Enquiries, 2010, MAT OB UK FIND NAT P; Claesson IM, 2008, MIDWIFERY, V24, P163, DOI 10.1016/j.midw.2006.10.007; Cochran W, 1996, STRIVING AND FEELING, P99; Cramp AG, 2009, RES Q EXERCISE SPORT, V80, P403; Cullen KW, 2001, J AM DIET ASSOC, V101, P562, DOI 10.1016/S0002-8223(01)00140-7; Dane AV, 1998, CLIN PSYCHOL REV, V18, P23, DOI 10.1016/S0272-7358(97)00043-3; Davidson I, 2002, PHYSIOTHERAPY, V88, P722; Davis MJ, 1999, ANN BEHAV MED, V21, P339, DOI 10.1007/BF02895967; Deeks J J, 2003, Health Technol Assess, V7, piii; Dobson D, 1980, EVAL PROGRAM PLANN, V3, P269, DOI DOI 10.1016/0149-7189(80)90042-7; Dodd JM, 2010, BJOG-INT J OBSTET GY, V117, P1316, DOI 10.1111/j.1471-0528.2010.02540.x; Dodd JM, 2008, ACTA OBSTET GYN SCAN, V87, P702, DOI 10.1080/00016340802061111; Downs DS, 2004, J MIDWIFERY WOM HEAL, V49, P138, DOI 10.1016/j.jmwh.2003.11.009; Effective Public Health Practice Project, 2009, EFF PUBL HLTH PRACT; Emmons RA, 1996, STRIVING AND FEELING, P79; Fraser A, 2011, AM J CLIN NUTR, V93, P1285, DOI 10.3945/ajcn.110.008326; Gardner B, 2011, OBES REV, V12, pE602, DOI 10.1111/j.1467-789X.2011.00884.x; GERONIMUS AT, 1993, AM J EPIDEMIOL, V137, P213, DOI 10.1093/oxfordjournals.aje.a116662; Gould Rothberg BE, 2010, AM J OBSTET GYNECOL, V204, P52; Green J, 2000, HEALTH EDUC RES, V15, P125, DOI 10.1093/her/15.2.125; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; Halloran D, 2011, J PERINATOLOGY; Hausenblas H, 2008, SOC SCI MED, V66, P2555, DOI 10.1016/j.socscimed.2008.02.002; Honas JJ, 2003, OBES RES, V11, P888, DOI 10.1038/oby.2003.122; Huang T, 2009, MIDWIFERY, V27, P257; Hui HL., 2006, CAN J DIABETES, V30, P169, DOI DOI 10.1016/S1499-2671(06)02010-7; Ineichen B, 1997, J ADOLESCENCE, V20, P505, DOI 10.1006/jado.1997.0105; Institute of Medicine, 1994, REDUCING RISKS MENTA, DOI DOI 10.17226/2139; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Institute of Medicine, 1990, NUTR PREGN; Keenan J, 2010, HEALTH RISK SOC, V12, P369, DOI 10.1080/13698571003792926; Kuhlmann AKS, 2008, AM J PREV MED, V34, P523, DOI 10.1016/j.amepre.2008.02.010; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Medical Research Council, 2009, DEV EV COMPL INT NEW; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Napolitano MA, 2011, J OBES, V2011, DOI 10.1155/2011/515803; National Health Service, PREGN CAR PLANN YOUR; National Institute for Health and Clinical Excellence, 2010, WEIGHT MAN PREGN; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Oakley A, 1999, M SCH PUBL POL U COL, P10; Olander EK, 2011, SEX REPROD HEALTHC, V2, P43, DOI 10.1016/j.srhc.2010.10.004; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Pearson ES, 2011, PATIENT ED IN PRESS; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Phelan S, 2010, AM J OBSTET GYNECOL, V202, DOI [10.1016/j.ajog.2009.06.008, 10.1016/j.ajog.2010.06.051]; Polley BA, 2002, INT J OBESITY, V26, P1494, DOI 10.1038/sj.ijo.0802130; Poudevigne MS, 2006, SPORTS MED, V36, P19, DOI 10.2165/00007256-200636010-00003; Ronnberg AK, 2010, BJOG-INT J OBSTET GY, V117, P1327, DOI 10.1111/j.1471-0528.2010.02619.x; Sansone C., 2000, INTRINSIC EXTRINSIC; Sansone C., 1991, ADV MOTIVATION ACHIE, V7, P21, DOI DOI 10.1037/0022-3514.65.5.904; Shilts MK, 2004, AM J HEALTH PROMOT, V19, P81, DOI 10.4278/0890-1171-19.2.81; Skouteris H, 2010, OBES REV, V11, P757, DOI 10.1111/j.1467-789X.2010.00806.x; Steckler A., 2002, PROCESS EVALUATION P; Streuling I, 2011, BJOG-INT J OBSTET GY, V118, P278, DOI 10.1111/j.1471-0528.2010.02801.x; Streuling I, 2011, J PERINAT MED, V39, P123, DOI [10.1515/JPM.2010.127, 10.1515/jpm.2010.127]; Streuling I, 2010, AM J CLIN NUTR, V92, P678, DOI 10.3945/ajcn.2010.29363; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Thomas BH, 2008, WHAT IS EFFECTIVENES; Tuffery O, 2005, J R SOC PROMO HEALTH, V125, P227, DOI 10.1177/146642400512500515; VISSER J, 1990, INSTR SCI, V19, P467, DOI 10.1007/BF00119391; Walker LO, 2007, JOGNN-J OBST GYN NEO, V36, P490, DOI 10.1111/J.1552-6909.2007.00179.x; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710	73	67	69	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39503	10.1371/journal.pone.0039503	http://dx.doi.org/10.1371/journal.pone.0039503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974LI	22792178	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300007
J	Kolar, F; Fer, T; Stech, M; Travnicek, P; Duskova, E; Schonswetter, P; Suda, J				Kolar, Filip; Fer, Tomas; Stech, Milan; Travnicek, Pavel; Duskova, Eva; Schoenswetter, Peter; Suda, Jan			Bringing Together Evolution on Serpentine and Polyploidy: Spatiotemporal History of the Diploid-Tetraploid Complex of Knautia arvensis (Dipsacaceae)	PLOS ONE			English	Article							DACTYLIS-GLOMERATA L; POPULATION-STRUCTURE; MULTIPLE ORIGINS; FLOW-CYTOMETRY; GENE FLOW; ASTERACEAE; DIFFERENTIATION; RANUNCULACEAE; CONSEQUENCES; DIVERGENCE	Polyploidization is one of the leading forces in the evolution of land plants, providing opportunities for instant speciation and rapid gain of evolutionary novelties. Highly selective conditions of serpentine environments act as an important evolutionary trigger that can be involved in various speciation processes. Whereas the significance of both edaphic speciation on serpentine and polyploidy is widely acknowledged in plant evolution, the links between polyploid evolution and serpentine differentiation have not yet been examined. To fill this gap, we investigated the evolutionary history of the perennial herb Knautia arvensis (Dipsacaceae), a diploid-tetraploid complex that exhibits an intriguing pattern of ecogeographic differentiation. Using plastid DNA sequencing and AFLP genotyping of 336 previously cytotyped individuals from 40 populations from central Europe, we unravelled the patterns of genetic variation among the cytotypes and the edaphic types. Diploids showed the highest levels of genetic differentiation, likely as a result of long term persistence of several lineages in ecologically distinct refugia and/or independent immigration. Recurrent polyploidization, recorded in one serpentine island, seems to have opened new possibilities for the local serpentine genotype. Unlike diploids, the serpentine tetraploids were able to escape from the serpentine refugium and spread further; this was also attributable to hybridization with the neighbouring non-serpentine tetraploid lineages. The spatiotemporal history of K. arvensis allows tracing the interplay of polyploid evolution and ecological divergence on serpentine, resulting in a complex evolutionary pattern. Isolated serpentine outcrops can act as evolutionary capacitors, preserving distinct karyological and genetic diversity. The serpentine lineages, however, may not represent evolutionary `dead-ends' but rather dynamic systems with a potential to further influence the surrounding populations, e.g., via independent polyplodization and hybridization. The complex eco-geographical pattern together with the incidence of both primary and secondary diploid-tetraploid contact zones makes K. arvensis a unique system for addressing general questions of polyploid research.	[Kolar, Filip; Fer, Tomas; Travnicek, Pavel; Duskova, Eva; Suda, Jan] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Kolar, Filip; Travnicek, Pavel; Suda, Jan] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Stech, Milan] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Schoenswetter, Peter] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Innsbruck	Kolar, F (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	filip.kolar@gmail.com	Fér, Tomáš/A-9991-2008; Schönswetter, Peter/T-8241-2017; Stech, Milan/C-9805-2009; kolar, filip/E-3826-2012; Suda, Jan/D-3369-2013; Travnicek, Pavel/G-9028-2012	Fér, Tomáš/0000-0002-0126-3684; Schönswetter, Peter/0000-0001-9225-4566; kolar, filip/0000-0002-8793-7992; Suda, Jan/0000-0001-8964-9153; Travnicek, Pavel/0000-0002-5806-1645; Stech, Milan/0000-0002-2987-6052	Grant Agency of the Academy of Sciences of the Czech Republic [KJB601110627]; Ministry of Education, Youth and Sports of the Czech Republic [MSM 0021620828, MSM6007665801]; Academy of Sciences of the Czech Republic [KJB600050812, AV0Z60050516]; Grant Agency of the Charles University [GAUK 261 211]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Charles University	This work was supported by the Grant Agency of the Academy of Sciences of the Czech Republic to JS and MS. (project number KJB601110627). Additional support was provided by the Ministry of Education, Youth and Sports of the Czech Republic (MSM 0021620828 and MSM6007665801), the Academy of Sciences of the Czech Republic (KJB600050812 and AV0Z60050516), and Grant Agency of the Charles University (GAUK 261 211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo N, 2010, NEW PHYTOL, V187, P1170, DOI 10.1111/j.1469-8137.2010.03328.x; Balao F, 2009, ANN BOT-LONDON, V104, P965, DOI 10.1093/aob/mcp182; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Breton Sintes S, 1974, ANN SCI NAT BOT BIOL, V12, P277; Breton Sintes S, 1975, ANNEE BIOL, V14, P45; BROCHMANN C, 1992, NORD J BOT, V12, P257, DOI 10.1111/j.1756-1051.1992.tb01303.x; Burnier J, 2009, MOL ECOL, V18, P3730, DOI 10.1111/j.1365-294X.2009.04281.x; Chessel D., 2004, R NEWS, V4, P5; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coulaud J, 1999, CAN J BOT, V77, P673, DOI 10.1139/b99-028; Duskova E, 2010, PRESLIA, V82, P127; DVORAKOVA M, 1988, Preslia (Prague), V60, P1; EHRENDORFER F., 1962, BER DEUTSCH BOT GESELL, V75, P137; EHRENDORFER F, 1981, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V102, P225; EHRENDORFER F., 1965, The genetics of colonizing species: Proc. 1st. Internat. Union biol. Sci., Asilomar, California., P331; Ehrendorfer F., 1980, Polyploidy. Biological relevance. Part I. Polyploidy and plant evolution., P45; Ehrendorfer F., 1976, FLORA EUROPAEA, V4, P60; Ehrendorfer F., 1962, OSTERR BOT Z, V109, P276; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FORDE MB, 1962, EVOLUTION, V16, P338, DOI 10.2307/2406283; HAHNE J, 1991, FLORA, V185, P17; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; JANKOVSKA V., 1980, PALAOGEOBOTANISCHE R; Kaplan Zdenek, 1998, Preslia (Prague), V70, P21; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kazakou E, 2008, BIOL REV, V83, P495, DOI 10.1111/j.1469-185X.2008.00051.x; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Krahulcova A, 1998, FOLIA GEOBOT, V33, P87, DOI 10.1007/BF02914931; Krahulec F, 2006, PRESLIA, V78, P503; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; KRUCKEBERG A R, 1991, Aliso, V13, P225; Kruckeberg A.R., 1984, CALIFORNIA SERPENTIN; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; KRUCKEBERG AR, 1967, BRITTONIA, V19, P133, DOI 10.2307/2805271; KRUCKEBERG AR, 1986, SYST BOT, V11, P455, DOI 10.2307/2419082; KRUCKEBERG AR, 1954, ECOLOGY, V35, P267, DOI 10.2307/1931126; Levin D. A, 2002, OX ECOL EV; Loureiro J, 2010, PRESLIA, V82, P3; Lozek V, 1973, PRIRODA CTVRTOHORACH; LUMARET R, 1987, OECOLOGIA, V73, P436, DOI 10.1007/BF00385262; Ma JX, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-100; MACEIRA NO, 1993, NEW PHYTOL, V124, P321, DOI 10.1111/j.1469-8137.1993.tb03822.x; Macnair MR, 1998, ENDLESS FORMS, P157; Mayer MS, 1999, SYST BOT, V24, P47, DOI 10.2307/2419385; MAYER MS, 1994, AM J BOT, V81, P1288, DOI 10.2307/2445405; MAYER MS, 1994, SYST BOT, V19, P557, DOI 10.2307/2419777; Moravec J., 2002, PREHLED VEGETACE CES; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; Novak F. A., 1960, PRESLIA, V32, P1; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Petit C, 1999, TRENDS ECOL EVOL, V14, P306, DOI 10.1016/S0169-5347(99)01608-0; Pritchard JK, 2000, GENETICS, V155, P945; Proctor J, 1999, TRENDS ECOL EVOL, V14, P334, DOI 10.1016/S0169-5347(99)01698-5; Rajakaruna N, 2004, INT GEOL REV, V46, P471, DOI 10.2747/0020-6814.46.5.471; Rajakaruna N, 2003, NEW PHYTOL, V157, P93, DOI 10.1046/j.1469-8137.2003.00648.x; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2007, HEREDITY, V98, P143, DOI 10.1038/sj.hdy.6800912; Rejzkova E, 2008, BOT J LINN SOC, V158, P115, DOI 10.1111/j.1095-8339.2008.00826.x; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Segraves KA, 1999, MOL ECOL, V8, P253, DOI 10.1046/j.1365-294X.1999.00562.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Slovak M, 2009, J BIOGEOGR, V36, P372, DOI 10.1111/j.1365-2699.2008.02005.x; SOJAK J., 1960, PRESLIA [PRAHA], V32, P369; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; STEPANEK J, 1982, Folia Geobotanica and Phytotaxonomica, V17, P359; STEPANEK J, 1983, Preslia (Prague), V55, P1; STEPANEK J, 1997, KVETENA CESKE REPUBL, V6, P543; Stepanek J, 1989, STUDIE CSAV, p[25, 25]; Stuessy TF, 2004, AM J BOT, V91, P889, DOI 10.3732/ajb.91.6.889; Tribsch A, 2002, AM J BOT, V89, P2024, DOI 10.3732/ajb.89.12.2024; Weiss H, 2002, NEW PHYTOL, V156, P85, DOI 10.1046/j.1469-8137.2002.00500.x; WESTERBERGH A, 1992, EVOLUTION, V46, P1537, DOI 10.1111/j.1558-5646.1992.tb01143.x	83	48	49	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39988	10.1371/journal.pone.0039988	http://dx.doi.org/10.1371/journal.pone.0039988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792207	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300020
J	Tilney, PM; van Wyk, AE; van der Merwe, CF				Tilney, Patricia M.; van Wyk, Abraham E.; van der Merwe, Chris F.			Structural Evidence in Plectroniella armata (Rubiaceae) for Possible Material Exchange between Domatia and Mites	PLOS ONE			English	Article							PLANT CUTICLES; LEAF DOMATIA; ULTRASTRUCTURE; MUTUALISM; BARRIER; ANATOMY	Domatia are small structures on the lower surface of a leaf, usually taking the form of cavities, pouches, domes with an opening, or hairs (or a combination of these), and located in the axils between the main veins. They are found in many dicotyledons including certain members of the Rubiaceae. As part of an ongoing study of selected southern African members of the tribe Vanguerieae of this family, their structure in transverse section was investigated. In some taxa, such as Plectroniella armata, light microscopic (LM) observations revealed large numbers of stomata in the domatia as well as a number of channel-like structures extending across the cuticle toward the cavity of the domatia. The cuticle of the epidermis lining the domatia also appeared thicker than in other parts of the leaves. The epidermis in P. armata was also examined using transmission electron microscopy (TEM). Domatia have been shown to house mainly mites, many of which are predatory or fungivorous, in a symbiotic (mutualistic) relationship with the plant. To date, much research has focussed on the role of domatia in providing shelter for various organisms, their eggs and their young. However, the TEM study revealed the apparent "channels" and thick cuticle seen under LM to be electron dense non-cellulosic branching fibrils within pronounced, often closely spaced cuticular folds. The functional significance of these fibrils and folds requires further investigation. Folding of cell walls and membranes at ultrastructural level is usually functionally associated with an increased surface area to facilitate active exchange of compounds/metabolites. This may indicate that translocation of substances and/or other forms of communication is possible between the domatium and its inhabitants. This therefore suggests a far more active role for the leaf in the symbiotic relationship than was previously thought. More work is required to test such a possibility.	[Tilney, Patricia M.] Univ Johannesburg, Dept Bot & Plant Biotechnol, Johannesburg, South Africa; [van Wyk, Abraham E.] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa; [van der Merwe, Chris F.] Univ Pretoria, Lab Microscopy & Microanal, ZA-0002 Pretoria, South Africa	University of Johannesburg; University of Pretoria; University of Pretoria	Tilney, PM (corresponding author), Univ Johannesburg, Dept Bot & Plant Biotechnol, Auckland Pk, Johannesburg, South Africa.	pmtilney@uj.ac.za	van Wyk, Abraham/A-2181-2008	van Wyk, Abraham/0000-0002-0437-3272	National Research Foundation grant [NRF 273030]; University of Pretoria	National Research Foundation grant(National Research Foundation of Korea); University of Pretoria	The work was funded by a National Research Foundation grant (NRF 273030) awarded to PMT. AEVW and CFVDM were funded by the University of Pretoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluska F, 2006, COMMUNICATION IN PLANTS: NEURONAL ASPECTS OF PLANT LIFE, P19; Cortesero AM, 2000, BIOL CONTROL, V17, P35, DOI 10.1006/bcon.1999.0777; Moraes TMD, 2009, BIOCELL, V33, P155; DICKE M, 1988, NETH J ZOOL, V38, P148, DOI 10.1163/156854288X00111; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; Hamilton AG, 1896, P LINNAEAN SOC NEW S, V21, P758; HESSEIN N A, 1986, International Journal of Acarology, V12, P215; HUXLEY CR, 1978, NEW PHYTOL, V80, P231, DOI 10.1111/j.1469-8137.1978.tb02285.x; JACOBS M, 1966, K NED AKAD VAN WET-P, V69, P275; Kerstiens G, 2006, J EXP BOT, V57, P2493, DOI 10.1093/jxb/erl017; Kirkwood RC, 1999, PESTIC SCI, V55, P69, DOI 10.1002/(SICI)1096-9063(199901)55:1&lt;69::AID-PS860&gt;3.0.CO;2-H; Lundstrom AN, 1887, NOVA ACTA REGIAE S 3, V13, P1; Matos CHC, 2006, ENTOMOL EXP APPL, V118, P185, DOI 10.1111/j.1570-7458.2006.00381.x; Nepi Massimo, 2007, P129, DOI 10.1007/978-1-4020-5937-7_3; Nishida S, 2006, ANN BOT-LONDON, V97, P601, DOI 10.1093/aob/mcl009; ODOWD DJ, 1991, TRENDS ECOL EVOL, V6, P179, DOI 10.1016/0169-5347(91)90209-G; ODOWD DJ, 1989, BIOL J LINN SOC, V37, P191, DOI 10.1111/j.1095-8312.1989.tb01901.x; Radice S, 2003, PLANT SYST EVOL, V238, P23, DOI 10.1007/s00606-002-0279-9; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Romero GQ, 2011, BIOTA NEOTROP, V11, P27, DOI 10.1590/S1676-06032011000100002; Schonherr J, 2006, J EXP BOT, V57, P2471, DOI 10.1093/jxb/erj217; Stace C.A., 1965, B BRIT MUS NAT HIST, V4, P1; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Wilkinson HP, 1979, ANATOMY DICOTYLEDONS, V1, P132	24	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39984	10.1371/journal.pone.0039984	http://dx.doi.org/10.1371/journal.pone.0039984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792206	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300019
J	Virtue, S; Masoodi, M; Velagapudi, V; Tan, CY; Dale, M; Suorti, T; Slawik, M; Blount, M; Burling, K; Campbell, M; Eguchi, N; Medina-Gomez, G; Sethi, JK; Oresic, M; Urade, Y; Griffin, JL; Vidal-Puig, A				Virtue, Sam; Masoodi, Mojgan; Velagapudi, Vidya; Tan, Chong Yew; Dale, Martin; Suorti, Tapani; Slawik, Marc; Blount, Margaret; Burling, Keith; Campbell, Mark; Eguchi, Naomi; Medina-Gomez, Gema; Sethi, Jaswinder K.; Oresic, Matej; Urade, Yoshihiro; Griffin, Julian L.; Vidal-Puig, Antonio			Lipocalin Prostaglandin D Synthase and PPAR gamma 2 Coordinate to Regulate Carbohydrate and Lipid Metabolism In Vivo	PLOS ONE			English	Article							ADIPOSE-TISSUE EXPANDABILITY; DEPOT-SPECIFIC DIFFERENCES; FATTY-ACID-METABOLISM; P465L PPAR-GAMMA; INSULIN SENSITIVITY; GENE-EXPRESSION; WEIGHT-LOSS; MICE; OBESITY; LIPOTOXICITY	Mice lacking Peroxisome Proliferator-Activated Receptor gamma 2 (PPAR gamma 2) have unexpectedly normal glucose tolerance and mild insulin resistance. Mice lacking PPAR gamma 2 were found to have elevated levels of Lipocalin prostaglandin D synthase (L-PGDS) expression in BAT and subcutaneous white adipose tissue (WAT). To determine if induction of L-PGDS was compensating for a lack of PPAR gamma 2, we crossed L-PGDS KO mice to PPAR gamma 2 KO mice to generate Double Knock Out mice (DKO). Using DKO mice we demonstrated a requirement of L-PGDS for maintenance of subcutaneous WAT (scWAT) function. In scWAT, DKO mice had reduced expression of thermogenic genes, the de novo lipogenic program and the lipases ATGL and HSL. Despite the reduction in markers of lipolysis in scWAT, DKO mice had a normal metabolic rate and elevated serum FFA levels compared to L-PGDS KO alone. Analysis of intra-abdominal white adipose tissue (epididymal WAT) showed elevated expression of mRNA and protein markers of lipolysis in DKO mice, suggesting that DKO mice may become more reliant on intra-abdominal WAT to supply lipid for oxidation. This switch in depot utilisation from subcutaneous to epididymal white adipose tissue was associated with a worsening of whole organism metabolic function, with DKO mice being glucose intolerant, and having elevated serum triglyceride levels compared to any other genotype. Overall, L-PGDS and PPAR gamma 2 coordinate to regulate carbohydrate and lipid metabolism.	[Virtue, Sam; Tan, Chong Yew; Dale, Martin; Blount, Margaret; Burling, Keith; Campbell, Mark; Sethi, Jaswinder K.; Vidal-Puig, Antonio] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Cambridge, England; [Masoodi, Mojgan] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Velagapudi, Vidya; Suorti, Tapani; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Slawik, Marc] Endocrinol Diabet Univ Hosp, Dept Med Innenstadt, Munich, Germany; [Eguchi, Naomi; Urade, Yoshihiro] Osaka Biosci Inst, Osaka, Japan; [Medina-Gomez, Gema] Univ Rey Juan Carlos, Dept Bioquim Fisiol & Genet Mol, Madrid, Spain; [Griffin, Julian L.] Med Res Council Human Nutr Res, Dept Biochem, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; VTT Technical Research Center Finland; Universidad Rey Juan Carlos; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Virtue, S (corresponding author), Univ Cambridge, Metab Res Labs, Inst Metab Sci, Cambridge, England.	sv234@medschl.cam.ac.uk; ajv22@medschl.cam.ac.uk	MASOODI, MOJGAN/P-1499-2019; Virtue, SAm/B-7578-2013; Oresic, Matej/K-7673-2016; Sethi, Jaswinder K./B-1413-2008; Medina-Gomez, Gema/CAF-4668-2022; Medina-Gomez, Gema/F-5667-2016; Medina-Gomez, Gema/CAI-1063-2022; Velagapudi, Vidya/L-7278-2015; Oresic, Matej/AAV-3978-2020	MASOODI, MOJGAN/0000-0001-9840-1731; Virtue, SAm/0000-0002-9545-5432; Oresic, Matej/0000-0002-2856-9165; Sethi, Jaswinder K./0000-0003-4157-0475; Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Velagapudi, Vidya/0000-0002-8261-7164; Vidal-Puig, Antonio/0000-0003-4220-9577	Diabetes UK; EU HEPADIP FP6 (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome); The Medical Research Council Centre for Obesity Related Disorders; Medical Research Council; BBSRC [BB/H013539/2, BB/H013539/1] Funding Source: UKRI; MRC [MC_UP_A090_1006, G0802051] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013539/1, BB/H013539/2, JF16994] Funding Source: researchfish; British Heart Foundation [PG/10/38/28359] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006, G0802051, G0600717B] Funding Source: researchfish	Diabetes UK(Diabetes UK); EU HEPADIP FP6 (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome); The Medical Research Council Centre for Obesity Related Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Diabetes UK (www.diabetes.org.uk), EU HEPADIP FP6 (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome) (www.hepadip.org), The Medical Research Council Centre for Obesity Related Disorders (www.mrc-cord.org), and the Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts P, 2006, CURR PROTOC NEUROSCI, V9; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Basu A, 2001, AM J PHYSIOL-ENDOC M, V280, pE1000, DOI 10.1152/ajpendo.2001.280.6.E1000; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Gray SL, 2006, ENDOCRINOLOGY, V147, P5708, DOI 10.1210/en.2006-0684; Gray SL, 2006, DIABETES, V55, P2669, DOI 10.2337/db06-0389; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Inoue T, 2008, ATHEROSCLEROSIS, V201, P385, DOI 10.1016/j.atherosclerosis.2008.03.010; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Laaksonen T, 2006, J AM CHEM SOC, V128, P14341, DOI 10.1021/ja064701t; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; Masoodi M, 2010, EXP DERMATOL, V19, P751, DOI 10.1111/j.1600-0625.2010.01098.x; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; O'Rourke RW, 2009, INT J OBESITY, V33, P978, DOI 10.1038/ijo.2009.133; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Quinkler M, 2006, GENE, V380, P137, DOI 10.1016/j.gene.2006.05.026; Ragolia L, 2005, J BIOL CHEM     1224; Rocha PM, 2008, METABOLISM, V57, P1315, DOI 10.1016/j.metabol.2008.01.003; Rodriguez-Cuenca S, 2012, FASEB J; Tan GD, 2008, J CLIN ENDOCR METAB, V93, P4462, DOI 10.1210/jc.2007-2356; Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	36	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39512	10.1371/journal.pone.0039512	http://dx.doi.org/10.1371/journal.pone.0039512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792179	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300008
J	Sato, JR; Kozasa, EH; Russell, TA; Radvany, J; Mello, LEAM; Lacerda, SS; Amaro, E				Sato, Joao R.; Kozasa, Elisa H.; Russell, Tamara A.; Radvany, Joao; Mello, Luiz E. A. M.; Lacerda, Shirley S.; Amaro, Edson, Jr.			Brain Imaging Analysis Can Identify Participants under Regular Mental Training	PLOS ONE			English	Article							CLASSIFICATION; MEDITATION; MINDFULNESS; INCREASES	Multivariate pattern recognition approaches have become a prominent tool in neuroimaging data analysis. These methods enable the classification of groups of participants (e. g. controls and patients) on the basis of subtly different patterns across the whole brain. This study demonstrates that these methods can be used, in combination with automated morphometric analysis of structural MRI, to determine with great accuracy whether a single subject has been engaged in regular mental training or not. The proposed approach allowed us to identify with 94.87% accuracy (p<0.001) if a given participant is a regular meditator (from a sample of 19 regular meditators and 20 non-meditators). Neuroimaging has been a relevant tool for diagnosing neurological and psychiatric impairments. This study may suggest a novel step forward: the emergence of a new field in brain imaging applications, in which participants could be identified based on their mental experience.	[Sato, Joao R.] Univ Fed ABC, Santo Andre, Brazil; [Kozasa, Elisa H.; Radvany, Joao; Lacerda, Shirley S.; Amaro, Edson, Jr.] Hosp Israelita Albert Einstein, Inst Cerebro, Sao Paulo, Brazil; [Kozasa, Elisa H.] UNIFESP Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Russell, Tamara A.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Mello, Luiz E. A. M.] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP); University of London; King's College London; Universidade Federal de Sao Paulo (UNIFESP)	Sato, JR (corresponding author), Univ Fed ABC, Santo Andre, Brazil.	edsonjr@einstein.br	Amaro, Edson/B-6653-2009; Kozasa, Elisa Harumi/F-9222-2010; amaro, edson/GLR-7735-2022; Lacerda, Shirley/H-4728-2012; Mello, Luiz E/B-4177-2009	Amaro, Edson/0000-0002-5889-1382; Kozasa, Elisa Harumi/0000-0003-4723-6099; amaro, edson/0000-0002-5889-1382; Lacerda, Shirley/0000-0002-2370-6693; Mello, Luiz E/0000-0002-6969-1108; Sato, Joao Ricardo/0000-0002-7503-9781; Russell, Tamara/0000-0003-2347-8157	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP Brazil [2010/01394-4]; Instituto Israelita de Ensino e Pesquisa Albert Einstein	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Israelita de Ensino e Pesquisa Albert Einstein	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP 2010/01394-4 Brazil and Instituto Israelita de Ensino e Pesquisa Albert Einstein. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1978, DEPRESSION INVENTORY; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Oliveira PPD, 2010, J ALZHEIMERS DIS, V19, P1263, DOI 10.3233/JAD-2010-1322; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033096; Kozasa EH, 2012, NEUROIMAGE, V59, P745, DOI 10.1016/j.neuroimage.2011.06.088; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lappe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021493; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lucignani G, 2006, FUNCT NEUROL, V21, P133; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Mobbs D, 2007, PLOS BIOL, V5, P693, DOI 10.1371/journal.pbio.0050103; Mourao-Miranda J, 2009, J COGNITIVE NEUROSCI, V21, P890, DOI 10.1162/jocn.2009.21078; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Rubia K, 2009, BIOL PSYCHOL, V82, P1, DOI 10.1016/j.biopsycho.2009.04.003; Sato JR, 2011, SOC NEUROSCI-UK, V6, P627, DOI 10.1080/17470919.2011.562687; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wei GX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309	27	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39832	10.1371/journal.pone.0039832	http://dx.doi.org/10.1371/journal.pone.0039832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802944	gold, Green Published, Green Submitted			2022-12-27	WOS:000306186900018
J	Isaakidis, P; Varghese, B; Mansoor, H; Cox, HS; Ladomirska, J; Saranchuk, P; Da Silva, E; Khan, S; Paryani, R; Udwadia, Z; Migliori, GB; Sotgiu, G; Reid, T				Isaakidis, Petros; Varghese, Bhanumati; Mansoor, Homa; Cox, Helen S.; Ladomirska, Joanna; Saranchuk, Peter; Da Silva, Esdras; Khan, Samsuddin; Paryani, Roma; Udwadia, Zarir; Migliori, Giovanni Battista; Sotgiu, Giovanni; Reid, Tony			Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; TREATMENT OUTCOMES; MDR-TB; HIV; METAANALYSIS; THERAPY	Background: Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings. Methods: Medecins Sans Frontieres (MSF) is supporting a community-based treatment program for drug-resistant tuberculosis in HIV-infected patients in a slum setting in Mumbai, India since 2007. Patients are being treated for both diseases and the management of AE is done on an outpatient basis whenever possible. Prospective data were analysed to determine the occurrence and nature of AE. Results: Between May 2007 and September 2011, 67 HIV/MDR-TB co-infected patients were being treated with anti-TB treatment and ART; 43.3% were female, median age was 35.5 years (Interquartile Range: 30.5-42) and the median duration of anti-TB treatment was 10 months (range 0.5-30). Overall, AE were common in this cohort: 71%, 63% and 40% of patients experienced one or more mild, moderate or severe AE, respectively. However, they were rarely life-threatening or debilitating. AE occurring most frequently included gastrointestinal symptoms (45% of patients), peripheral neuropathy (38%), hypothyroidism (32%), psychiatric symptoms (29%) and hypokalaemia (23%). Eleven patients were hospitalized for AE and one or more suspect drugs had to be permanently discontinued in 27 (40%). No AE led to indefinite suspension of an entire MDR-TB or ART regimen. Conclusions: AE occurred frequently in this Mumbai HIV/MDR-TB cohort but not more frequently than in non-HIV patients on similar anti-TB treatment. Most AE can be successfully managed on an outpatient basis through a community-based treatment program, even in a resource-limited setting. Concerns about severe AE in the management of co-infected patients are justified, however, they should not cause delays in the urgently needed rapid scale-up of antiretroviral therapy and second-line anti-TB treatment.	[Isaakidis, Petros; Varghese, Bhanumati; Mansoor, Homa; Ladomirska, Joanna; Da Silva, Esdras; Khan, Samsuddin; Paryani, Roma] Med Sans Frontieres, Mumbai, Maharashtra, India; [Cox, Helen S.; Saranchuk, Peter] Med Sans Frontieres, SAMU, Cape Town, South Africa; [Cox, Helen S.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Udwadia, Zarir] Parmanand Deepchand Hinduja Natl Hosp, Mumbai, Maharashtra, India; [Udwadia, Zarir] Med Res Ctr Hinduja, Mumbai, Maharashtra, India; [Migliori, Giovanni Battista] Fdn S Maugeri, World Hlth Org Collaborating Ctr TB & Lung Dis, Care & Res Inst, Tradate, Italy; [Sotgiu, Giovanni] Univ Sassari, Dept Biomed Sci, Epidemiol & Med Stat Unit, I-07100 Sassari, Italy; [Reid, Tony] Med Sans Frontieres, Opertat Res Unit, Brussels, Belgium	University of Cape Town; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; University of Sassari; Doctors Without Borders	Isaakidis, P (corresponding author), Med Sans Frontieres, Mumbai, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org	Sotgiu, Giovanni/N-1032-2017; Migliori, Giovanni Battista/AAB-8589-2020	Sotgiu, Giovanni/0000-0002-1600-4474; Migliori, Giovanni Battista/0000-0002-2597-574X; Isaakidis, Petros/0000-0002-7881-1554; Cox, Helen/0000-0002-6538-7192	Medecins Sans Frontieres	Medecins Sans Frontieres	Medecins Sans Frontieres private funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID PROGR MAN DRUG; Bhargava A, 2011, HYPOTHESIS, V9, pe7; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Duggal P, 2007, BMC EAR NOSE THROAT, V7, DOI 10.1186/1472-6815-7-5; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Joseph P, 2011, INDIAN J MED RES, V133, P529; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; NUNN P, 1991, LANCET, V337, P627; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Palacios E, 2012, INT J TUBERC LUNG D, V16, P348, DOI 10.5588/ijtld.11.0473; Ramma LD, 2012, INT J TUBERC LUNG D, V16, P283, DOI 10.5588/ijtld.11.0712; Satti H, 2012, INT J TUBERC LUNG DI; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; Torre P, 2006, INT J AUDIOL, V45, P559, DOI 10.1080/14992020600860935; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2009, MAN MDR TB FIELD GUI	26	65	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40781	10.1371/journal.pone.0040781	http://dx.doi.org/10.1371/journal.pone.0040781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792406	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400101
J	Makvandi-Nejad, S; Hoffman, GE; Allen, JJ; Chu, E; Gu, E; Chandler, AM; Loredo, AI; Bellone, RR; Mezey, JG; Brooks, SA; Sutter, NB				Makvandi-Nejad, Shokouh; Hoffman, Gabriel E.; Allen, Jeremy J.; Chu, Erin; Gu, Esther; Chandler, Alyssa M.; Loredo, Ariel I.; Bellone, Rebecca R.; Mezey, Jason G.; Brooks, Samantha A.; Sutter, Nathan B.			Four Loci Explain 83% of Size Variation in the Horse	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADULT HEIGHT; BIOLOGICAL PATHWAYS; POPULATION; VARIANTS; TRAITS; DOGS; DIFFERENTIATION; IDENTIFICATION; GENES	Horse body size varies greatly due to intense selection within each breed. American Miniatures are less than one meter tall at the withers while Shires and Percherons can exceed two meters. The genetic basis for this variation is not known. We hypothesize that the breed population structure of the horse should simplify efforts to identify genes controlling size. In support of this, here we show with genome-wide association scans (GWAS) that genetic variation at just four loci can explain the great majority of horse size variation. Unlike humans, which are naturally reproducing and possess many genetic variants with weak effects on size, we show that horses, like other domestic mammals, carry just a small number of size loci with alleles of large effect. Furthermore, three of our horse size loci contain the LCORL, HMGA2 and ZFAT genes that have previously been found to control human height. The LCORL/NCAPG locus is also implicated in cattle growth and HMGA2 is associated with dog size. Extreme size diversification is a hallmark of domestication. Our results in the horse, complemented by the prior work in cattle and dog, serve to pinpoint those very few genes that have played major roles in the rapid evolution of size during domestication.	[Makvandi-Nejad, Shokouh; Allen, Jeremy J.; Chu, Erin; Gu, Esther; Chandler, Alyssa M.; Loredo, Ariel I.; Sutter, Nathan B.] Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA; [Hoffman, Gabriel E.; Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Loredo, Ariel I.] La Sierra Univ, Dept Biol, Riverside, CA USA; [Bellone, Rebecca R.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Brooks, Samantha A.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; University of Tampa; Cornell University	Makvandi-Nejad, S (corresponding author), Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA.	nbs39@cornell.edu	Brooks, Samantha/ABD-5279-2020	Brooks, Samantha/0000-0002-4500-2689; Bellone, Rebecca/0000-0001-8838-7227; Allen, Jeremy/0000-0003-1224-4646	Cornell University Center for Vertebrate Genomics	Cornell University Center for Vertebrate Genomics	We thank the Cornell University Center for Vertebrate Genomics for grant support (NS and SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Brooks SA, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2010.02127.x; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Carty CL, 2011, HUM MOL GENET; Chase K, 2002, P NATL ACAD SCI USA, V99, P9930, DOI 10.1073/pnas.152333099; Cleynen I, 2008, INT J ONCOL, V32, P289; Clutton-Brock J, 1999, NATURAL HIST MUSEUM, pviii; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hermann-Kleiter N, 2009, INT J DEV BIOL, V53, P983, DOI 10.1387/ijdb.072435nh; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Loughran G, 2005, ONCOGENE, V24, P6185, DOI 10.1038/sj.onc.1208772; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Perola M, 2011, BEST PRACT RES CL EN, V25, P19, DOI 10.1016/j.beem.2010.10.013; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Takeuchi F, 2009, J HUM GENET, V54, P749, DOI 10.1038/jhg.2009.99; Tsunoda T, 2010, P NATL ACAD SCI USA, V107, P14199, DOI 10.1073/pnas.1002494107; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Zheng ZY, 2012, ONCOGENE; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	37	133	144	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39929	10.1371/journal.pone.0039929	http://dx.doi.org/10.1371/journal.pone.0039929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808074	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400026
J	Muhlemann, JK; Maeda, H; Chang, CY; Miguel, PS; Baxter, I; Cooper, B; Perera, MA; Nikolau, BJ; Vitek, O; Morgan, JA; Dudareva, N				Muhlemann, Joelle K.; Maeda, Hiroshi; Chang, Ching-Yun; Miguel, Phillip San; Baxter, Ivan; Cooper, Bruce; Perera, M. Ann; Nikolau, Basil J.; Vitek, Olga; Morgan, John A.; Dudareva, Natalia			Developmental Changes in the Metabolic Network of Snapdragon Flowers	PLOS ONE			English	Article							ANTIRRHINUM-MAJUS; BENZOIC-ACID; PETAL DEVELOPMENT; PETUNIA FLOWERS; FLORAL SCENT; FATTY-ACID; BIOSYNTHESIS; EMISSION; GENES; EXPRESSION	Evolutionary and reproductive success of angiosperms, the most diverse group of land plants, relies on visual and olfactory cues for pollinator attraction. Previous work has focused on elucidating the developmental regulation of pathways leading to the formation of pollinator-attracting secondary metabolites such as scent compounds and flower pigments. However, to date little is known about how flowers control their entire metabolic network to achieve the highly regulated production of metabolites attracting pollinators. Integrative analysis of transcripts and metabolites in snapdragon sepals and petals over flower development performed in this study revealed a profound developmental remodeling of gene expression and metabolite profiles in petals, but not in sepals. Genes up-regulated during petal development were enriched in functions related to secondary metabolism, fatty acid catabolism, and amino acid transport, whereas down-regulated genes were enriched in processes involved in cell growth, cell wall formation, and fatty acid biosynthesis. The levels of transcripts and metabolites in pathways leading to scent formation were coordinately up-regulated during petal development, implying transcriptional induction of metabolic pathways preceding scent formation. Developmental gene expression patterns in the pathways involved in scent production were different from those of glycolysis and the pentose phosphate pathway, highlighting distinct developmental regulation of secondary metabolism and primary metabolic pathways feeding into it.	[Muhlemann, Joelle K.; Maeda, Hiroshi; Miguel, Phillip San; Baxter, Ivan; Dudareva, Natalia] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Chang, Ching-Yun; Vitek, Olga] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Cooper, Bruce] Purdue Univ, Bindley Biosci Ctr, Metabolite Profiling Facil, W Lafayette, IN 47907 USA; [Perera, M. Ann; Nikolau, Basil J.] Iowa State Univ, WM Keck Metabol Res Lab, Ames, IA USA; [Nikolau, Basil J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Morgan, John A.] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; Iowa State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Muhlemann, JK (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	dudareva@purdue.edu	Morgan, John/B-8609-2018; Baxter, Ivan R/A-1052-2009; Dudareva, Natalia/S-8710-2017; SanMiguel, Phillip J/I-2196-2015	Morgan, John/0000-0002-5326-4988; Baxter, Ivan R/0000-0001-6680-1722; Dudareva, Natalia/0000-0003-0777-7763; SanMiguel, Phillip J/0000-0002-3742-9527; Muhlemann, Joelle/0000-0003-2431-4357	US National Science Foundation [MCB-0615700, DBI-1054826]	US National Science Foundation(National Science Foundation (NSF))	This work was supported by the grant MCB-0615700 from the US National Science Foundation to ND and JAM and by the US National Science Foundation CAREER grant DBI-1054826 to OV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bar-Akiva A, 2010, J EXP BOT, V61, P1393, DOI 10.1093/jxb/erq008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bey M, 2004, PLANT CELL, V16, P3197, DOI 10.1105/tpc.104.026724; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Delgado-Benarroch L, 2009, PLANTA, V229, P1219, DOI 10.1007/s00425-009-0910-x; Dixon RA, 2010, PLANT PHYSIOL, V154, P453, DOI 10.1104/pp.110.161430; Dudareva N, 2000, PLANT CELL, V12, P949, DOI 10.1105/tpc.12.6.949; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HO LC, 1975, ANN BOT-LONDON, V39, P439, DOI 10.1093/oxfordjournals.aob.a084958; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; Hudson A., 2008, CSH PROTOC; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; ITZHAKI H, 1990, PLANT PHYSIOL, V94, P1233, DOI 10.1104/pp.94.3.1233; JACKSON D, 1992, PLANT J, V2, P425, DOI 10.1111/j.1365-313X.1992.00425.x; Kolosova N, 2001, PLANT CELL, V13, P2333, DOI 10.1105/tpc.13.10.2333; Kolosova N, 2001, PLANT PHYSIOL, V126, P956, DOI 10.1104/pp.126.3.956; Muller GL, 2010, J EXP BOT, V61, P3675, DOI 10.1093/jxb/erq187; Long MC, 2009, PLANT J, V59, P256, DOI 10.1111/j.1365-313X.2009.03864.x; MATSUZAKI T, 1983, PLANT CELL PHYSIOL, V24, P199, DOI 10.1093/pcp/24.2.199; Moehs CP, 2001, PLANT MOL BIOL, V45, P281, DOI 10.1023/A:1006417009203; Nagegowda DA, 2008, PLANT J, V55, P224, DOI 10.1111/j.1365-313X.2008.03496.x; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Orlova I, 2006, PLANT CELL, V18, P3458, DOI 10.1105/tpc.106.046227; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Schwarz-Sommer Z, 2003, NAT REV GENET, V4, P657, DOI 10.1038/nrg1127; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; van Doorn WG, 2003, J EXP BOT, V54, P1801, DOI 10.1093/jxb/erg213; van Doorn WG, 2008, J EXP BOT, V59, P453, DOI 10.1093/jxb/erm356; Van Moerkercke A, 2011, PLANT J, V67, P917, DOI 10.1111/j.1365-313X.2011.04644.x; Verdonk JC, 2005, PLANT CELL, V17, P1612, DOI 10.1105/tpc.104.028837; Wagstaff C, 2009, PLANT J, V57, P690, DOI 10.1111/j.1365-313X.2008.03722.x; Whitehead MR, 2009, FUNCT ECOL, V23, P863, DOI 10.1111/j.1365-2435.2009.01620.x	43	55	59	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40381	10.1371/journal.pone.0040381	http://dx.doi.org/10.1371/journal.pone.0040381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808147	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400048
J	Yoshida, M; Takimoto, R; Murase, K; Sato, Y; Hirakawa, M; Tamura, F; Sato, T; Iyama, S; Osuga, T; Miyanishi, K; Takada, K; Hayashi, T; Kobune, M; Kato, J				Yoshida, Makoto; Takimoto, Rishu; Murase, Kazuyuki; Sato, Yasushi; Hirakawa, Masahiro; Tamura, Fumito; Sato, Tsutomu; Iyama, Satoshi; Osuga, Takahiro; Miyanishi, Koji; Takada, Kohichi; Hayashi, Tsuyoshi; Kobune, Masayoshi; Kato, Junji			Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach	PLOS ONE			English	Article							ALVEOLAR MACROPHAGE LECTIN; BINDING-SPECIFICITY; MONOCLONAL-ANTIBODY; ARMING ANTIBODIES; RAT-LIVER; PHASE-I; SERUM; LIPOSOMES; CARCINOMA; THERAPY	Owing to its aggressiveness and the lack of effective therapies, pancreatic ductal adenocarcinoma has a dismal prognosis. New strategies to improve treatment and survival are therefore urgently required. Numerous fucosylated antigens in sera serve as tumor markers for cancer detection and evaluation of treatment efficacy. Increased expression of fucosyltransferases has also been reported for pancreatic cancer. These enzymes accelerate malignant transformation through fucosylation of sialylated precursors, suggesting a crucial requirement for fucose by pancreatic cancer cells. With this in mind, we developed fucose-bound nanoparticles as vehicles for delivery of anticancer drugs specifically to cancer cells. L-fucose-bound liposomes containing Cy5.5 or Cisplatin were effectively delivered into CA19-9 expressing pancreatic cancer cells. Excess L-fucose decreased the efficiency of Cy5.5 introduction by L-fucose-bound liposomes, suggesting L-fucose-receptor-mediated delivery. Intravenously injected L-fucose-bound liposomes carrying Cisplatin were successfully delivered to pancreatic cancer cells, mediating efficient tumor growth inhibition as well as prolonging survival in mouse xenograft models. This modality represents a new strategy for pancreatic cancer cell-targeting therapy.	[Yoshida, Makoto; Takimoto, Rishu; Murase, Kazuyuki; Sato, Yasushi; Hirakawa, Masahiro; Tamura, Fumito; Sato, Tsutomu; Iyama, Satoshi; Osuga, Takahiro; Miyanishi, Koji; Takada, Kohichi; Hayashi, Tsuyoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido, Japan; [Yoshida, Makoto; Takimoto, Rishu; Hirakawa, Masahiro; Tamura, Fumito; Kato, Junji] Sapporo Med Univ, Grad Sch Med, Div Clin Oncol, Chuo Ku, Sapporo, Hokkaido, Japan; [Sato, Tsutomu; Kobune, Masayoshi] Sapporo Med Univ, Grad Sch Med, Div Mol Oncol, Chuo Ku, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Yoshida, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido, Japan.	jkato@sapmed.ac.jp	Iyama, Satoshi/AAA-6237-2019	Miyanishi, Koji/0000-0002-6466-3458; Sato, Yasushi/0000-0002-6776-4609	Ministry of Education, Science, Sports and Culture [21390231]; Grants-in-Aid for Scientific Research [24590985] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B), 21390231, 2009, to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALLEN TM, 1994, TRENDS PHARMACOL SCI, V15, P215, DOI 10.1016/0165-6147(94)90314-X; Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Aubert M, 2000, INT J CANCER, V88, P558, DOI 10.1002/1097-0215(20001115)88:4<558::AID-IJC7>3.0.CO;2-B; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Damascelli B, 2001, CANCER, V92, P2592, DOI 10.1002/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Deyasi S K, 1975, Indian J Pathol Bacteriol, V18, P16; GUNN FJ, 1994, MOL MICROBIOL, V12, P799, DOI 10.1111/j.1365-2958.1994.tb01066.x; HAKOMORI S, 1983, JNCI-J NATL CANCER I, V71, P231; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P5696; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P7433; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P7440; Hirai M, 2007, BIOCHEM BIOPH RES CO, V353, P553, DOI 10.1016/j.bbrc.2006.12.060; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kawakami S, 2000, BBA-GEN SUBJECTS, V1524, P258, DOI 10.1016/S0304-4165(00)00163-X; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; KOPROWSKI H, 1981, SCIENCE, V212, P53, DOI 10.1126/science.6163212; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7426; Lima CMSR, 2002, CURR OPIN ONCOL, V14, P424, DOI 10.1097/01.CCO.0000020621.28068.04; MAGNANI JL, 1982, METHOD ENZYMOL, V83, P235; Mas E, 1998, GLYCOBIOLOGY, V8, P605, DOI 10.1093/glycob/8.6.605; Miyanishi K, 2008, JPN J CLIN ONCOL, V38, P268, DOI 10.1093/jjco/hyn015; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Moghimi SM, 2006, J LIPOSOME RES, V16, P167, DOI 10.1080/08982100600848801; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakao A, 1998, SEMIN SURG ONCOL, V15, P15, DOI 10.1002/(SICI)1098-2388(199807/08)15:1<15::AID-SSU4>3.3.CO;2-G; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Sagawa T, 2008, HEPATOLOGY, V48, P828, DOI 10.1002/hep.22420; SAKAI T, 1990, CLIN CHEM, V36, P474; Sawke NG, 2010, INDIAN J CANCER, V47, P452, DOI 10.4103/0019-509X.73549; SENIOR JH, 1987, CRC CR REV THER DRUG, V3, P123; Shore S, 2003, ALIMENT PHARM THER, V18, P1049, DOI 10.1111/j.1365-2036.2003.01781.x; Sturgeon CM, 2010, CLIN CHEM, V56, pE1, DOI 10.1373/clinchem.2009.133124; SUGANO K, 1988, JPN J CANCER RES, V79, P618, DOI 10.1111/j.1349-7006.1988.tb00031.x; Symon Z, 1999, CANCER, V86, P72, DOI 10.1002/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.3.CO;2-T; Tajiri M, 2008, GLYCOBIOLOGY, V18, P2, DOI 10.1093/glycob/cwm117; Tawada K, 2009, PANCREAS, V38, P30, DOI 10.1097/MPA.0b013e318183ff73; Tonetti M, 1998, BIOCHIMIE, V80, P923, DOI 10.1016/S0300-9084(00)88889-6; Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1; Tsuchida A, 2003, J BIOL CHEM, V278, P22787, DOI 10.1074/jbc.M211034200; von Mehren M, 2003, ANNU REV MED, V54, P343, DOI 10.1146/annurev.med.54.101601.152442; Weiner LM, 2000, ONCOGENE, V19, P6144, DOI 10.1038/sj.onc.1204000; WIESE TJ, 1994, J BIOL CHEM, V269, P22705; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141	49	51	52	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39545	10.1371/journal.pone.0039545	http://dx.doi.org/10.1371/journal.pone.0039545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808043	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400014
J	Esposito, R; Mattei, PA; Briganti, C; Romani, GL; Tartaro, A; Caulo, M				Esposito, Roberto; Mattei, Peter A.; Briganti, Chiara; Romani, Gian Luca; Tartaro, Armando; Caulo, Massimo			Modifications of Default-Mode Network Connectivity in Patients with Cerebral Glioma	PLOS ONE			English	Article							INDEPENDENT COMPONENT MODEL; RESTING STATE NETWORKS; FUNCTIONAL CONNECTIVITY; PSYCHIATRIC-DISORDERS; BRAIN-FUNCTION; TEMPORAL-LOBE; DIFFUSION; FMRI; ORGANIZATION; TRACTOGRAPHY	Purpose: The aim of the study was to evaluate connectivity modifications in the Default Mode Network (DMN) in patients with cerebral glioma, and to correlate these modifications to tumor characteristics. Methods: Twenty-four patients with a left-hemisphere cerebral tumor (14 grade II and 10 grade IV gliomas) and 14 healthy age-matched right-hand volunteers were enrolled in the study. Subjects underwent fMRI while performing language tasks for presurgical mapping. Data was analyzed with independent component analysis in order to identify the DMN. DMN group maps were produced by random-effect analysis (p<0.001, FDR-corrected). An analysis of variance across the three groups (p<0.05) and post-hoc t-test contrasts between pairs of groups were calculated (p<0.05, FDR-corrected). Results: All three groups showed typical DMN areas. However, reduced DMN connectivity was detected in tumor patients with respect to controls. A significantly increased and reduced integration of DMN areas was observed in the hippocampal and prefrontal regions, respectively. Modifications were closely related to tumor grading. Moreover, the DMN lateralized to the hemisphere contralateral to tumor in the low-grade, but not in the high-grade tumor patients. Conclusion: Modifications of DMN connectivity were induced by gliomas and differed for high and low grade tumors.	[Esposito, Roberto; Mattei, Peter A.; Briganti, Chiara; Romani, Gian Luca; Tartaro, Armando; Caulo, Massimo] Univ G dAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Esposito, Roberto; Mattei, Peter A.; Briganti, Chiara; Romani, Gian Luca; Tartaro, Armando; Caulo, Massimo] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Esposito, R (corresponding author), Univ G dAnnunzio, Inst Adv Biomed Technol, Chieti, Italy.	massimo.caulo@itab.unich.it	Mattei, Peter/J-6661-2012; tartaro, armando at/K-2184-2016	tartaro, armando at/0000-0003-0095-2792; Mattei, Peter A./0000-0002-7343-5625; Esposito, Roberto/0000-0003-4708-6860				Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Bartolomei F, 2006, ANN NEUROL, V59, P128, DOI 10.1002/ana.20710; Bhardwaj RD, 2010, CHILD NERV SYST, V26, P185, DOI 10.1007/s00381-009-1017-1; Bizzi A, 2008, RADIOLOGY, V248, P579, DOI 10.1148/radiol.2482071214; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bunevicius A, 2008, CNS SPECTRUMS, V13, P950, DOI 10.1017/S1092852900014000; Calhoun VD, 2005, NEUROIMAGE, V25, P527, DOI 10.1016/j.neuroimage.2004.12.012; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Caulo M, 2011, AM J NEURORADIOL, V32, P1056, DOI 10.3174/ajnr.A2428; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Gomez C, 2009, IEEE T BIO-MED ENG, V56, P1683, DOI 10.1109/TBME.2009.2018454; Guggisberg AG, 2008, ANN NEUROL, V63, P193, DOI 10.1002/ana.21224; Harrison BJ, 2007, SCHIZOPHR RES, V91, P82, DOI 10.1016/j.schres.2006.12.027; He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kim LS, 2008, NEUROSCI LETT, V447, P1, DOI 10.1016/j.neulet.2008.09.077; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, RADIOLOGY, V253, P797, DOI 10.1148/radiol.2533090602; Martino J, 2011, ANN NEUROL, V69, P521, DOI 10.1002/ana.22167; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pravata E, 2011, AM J NEURORADIOL, V32, P532, DOI 10.3174/ajnr.A2311; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ronson A, 2004, CURR OPIN ONCOL, V16, P318, DOI 10.1097/01.cco.0000126917.74627.20; Seghier ML, 2008, MAGN RESON IMAGING, V26, P594, DOI 10.1016/j.mri.2007.10.010; Tieleman A, 2009, EUR RADIOL, V19, P2523, DOI 10.1007/s00330-009-1429-z; Warren JE, 2009, BRAIN, V132, P3428, DOI 10.1093/brain/awp270	40	59	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40231	10.1371/journal.pone.0040231	http://dx.doi.org/10.1371/journal.pone.0040231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808124	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700032
J	Lavoz, C; Rodrigues-Diez, R; Benito-Martin, A; Rayego-Mateos, S; Rodrigues-Diez, RR; Alique, M; Ortiz, A; Mezzano, S; Egido, J; Ruiz-Ortega, M				Lavoz, Carolina; Rodrigues-Diez, Raquel; Benito-Martin, Alberto; Rayego-Mateos, Sandra; Rodrigues-Diez, Raul R.; Alique, Matilde; Ortiz, Alberto; Mezzano, Sergio; Egido, Jesus; Ruiz-Ortega, Marta			Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; TGF-BETA; DIABETIC-NEPHROPATHY; FIBROTIC RESPONSE; KIDNEY FIBROSIS; CELL FATE; EXPRESSION; FIBROBLASTS; TRANSDIFFERENTIATION	Recent studies have described that the Notch signaling pathway is activated in a wide range of renal diseases. Angiotensin II (AngII) plays a key role in the progression of kidney diseases. AngII contributes to renal fibrosis by upregulation of profibrotic factors, induction of epithelial mesenchymal transition and accumulation of extracellular matrix proteins. In cultured human tubular epithelial cells the Notch activation by transforming growth factor-beta 1 (TGF-beta 1) has been involved in epithelial mesenchymal transition. AngII mimics many profibrotic actions of TGF-beta 1. For these reasons, our aim was to investigate whether AngII could regulate the Notch/Jagged system in the kidney, and its potential role in AngII-induced responses. In cultured human tubular epithelial cells, TGF-beta 1, but not AngII, increased the Notch pathway-related gene expression, Jagged-1 synthesis, and caused nuclear translocation of the activated Notch. In podocytes and renal fibroblasts, AngII did not modulate the Notch pathway. In tubular epithelial cells, pharmacological Notch inhibition did not modify AngII-induced changes in epithelial mesenchymal markers, profibrotic factors and extracellular matrix proteins. Systemic infusion of AngII into rats for 2 weeks caused tubulointerstitial fibrosis, but did not upregulate renal expression of activated Notch-1 or Jagged-1, as observed in spontaneously hypertensive rats. Moreover, the Notch/Jagged system was not modulated by AngII type I receptor blockade in the model of unilateral ureteral obstruction in mice. These data clearly indicate that AngII does not regulate the Notch/Jagged signaling system in the kidney, in vivo and in vitro. Our findings showing that the Notch pathway is not involved in AngII-induced fibrosis could provide important information to understand the complex role of Notch system in the regulation of renal regeneration vs damage progression.	[Lavoz, Carolina; Rodrigues-Diez, Raquel; Rayego-Mateos, Sandra; Rodrigues-Diez, Raul R.; Alique, Matilde; Ruiz-Ortega, Marta] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain; [Benito-Martin, Alberto; Ortiz, Alberto] Univ Autonoma Madrid, Dialysis Unit, Fdn Jimenez Diaz, IIS, Madrid, Spain; [Mezzano, Sergio] Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile	Autonomous University of Madrid; Autonomous University of Madrid; Fundacion Jimenez Diaz; Universidad Austral de Chile	Lavoz, C (corresponding author), Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain.	mruizo@fjd.es	Benito-Martin, Alberto/GLU-6164-2022; Alique, Matilde/I-1341-2016; Ortega, Marta Ruiz/AAN-2136-2020; Díez, Raquel Rodrigues/ABE-9703-2020; MATEOS, SANDRA RAYEGO/AAI-2123-2019; Ruiz-Ortega, Marta/D-3584-2012; ortiz, alberto/Y-7582-2018; Díez, Raúl R Rodrigues/G-8386-2017; ruiz-ortega, marta/D-3584-2012	Benito-Martin, Alberto/0000-0002-0700-3891; Alique, Matilde/0000-0002-7912-1133; Ortega, Marta Ruiz/0000-0002-1495-6535; Díez, Raquel Rodrigues/0000-0002-6348-1505; Ruiz-Ortega, Marta/0000-0002-1495-6535; ortiz, alberto/0000-0002-9805-9523; Rayego-Mateos, Sandra/0000-0001-6874-2359; Rodrigues Diez, Raul/0000-0002-2456-6709; ruiz-ortega, marta/0000-0002-1403-2690	Instituto de Salud Carlos III [PI081564, PI11/01854, PS09/00447, REDINREN ISCIII-RETIC RD06/0016/0004]; Sociedad Espanola de Nefrologia; Comunidad de Madrid [S2010/BMD-2321]; Agencia Espanola de Cooperacion Internacional [A/9571/07]; Fundacion Lilly; FONDECYT Chile [1080083, 1120480]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Sociedad Espanola de Nefrologia; Comunidad de Madrid(Comunidad de Madrid); Agencia Espanola de Cooperacion Internacional; Fundacion Lilly; FONDECYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grants from the Instituto de Salud Carlos III (PI081564, PI11/01854 and PS09/00447 and REDINREN ISCIII-RETIC RD06/0016/0004), Sociedad Espanola de Nefrologia, Comunidad de Madrid (S2010/BMD-2321), Agencia Espanola de Cooperacion Internacional (PCI Iberoamerica; A/9571/07), Fundacion Lilly, FONDECYT Chile 1080083 and 1120480. CL and RRD are fellows of ISCIII. Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boulos N, 2011, HYPERTENSION, V57, P1176, DOI 10.1161/HYPERTENSIONAHA.111.170746; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Challen GA, 2006, J AM SOC NEPHROL, V17, P1896, DOI 10.1681/ASN.2005111228; Chen L, 2006, ACTA PHARMACOL SIN, V27, P1029, DOI 10.1111/j.1745-7254.2006.00344.x; Daniel C, 2008, KIDNEY INT, V74, P551, DOI 10.1038/ki.2008.290; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Grego-Bessa J, 2004, CELL CYCLE, V3, P718; Gupta S, 2010, AM J PHYSIOL-RENAL, V298, pF209, DOI 10.1152/ajprenal.00451.2009; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kretzler M, 2008, NAT MED, V14, P246, DOI 10.1038/nm0308-246; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kwon SM, 2009, TRENDS CARDIOVAS MED, V19, P170, DOI 10.1016/j.tcm.2009.10.002; Lasagni L, 2010, STEM CELLS, V28, P1673, DOI 10.1002/stem.492; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lin CL, 2010, DIABETES, V59, P1915, DOI 10.2337/db09-0663; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; McCright B, 2001, DEVELOPMENT, V128, P491; McCright B, 2003, CURR OPIN NEPHROL HY, V12, P5, DOI 10.1097/00041552-200301000-00002; McLaughlin KA, 2000, DEV BIOL, V227, P567, DOI 10.1006/dbio.2000.9913; Morissey J, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017905.77985.4A; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Nyhan KC, 2010, BBA-MOL CELL RES, V1803, P1386, DOI 10.1016/j.bbamcr.2010.09.001; Ortiz A, 1997, J AM SOC NEPHROL, V8, P1845; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Diez RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014145; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Ruperez M, 2003, CIRCULATION, V108, P1499, DOI 10.1161/01.CIR.0000089129.51288.BA; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sanchez-Nino MD, 2012, LAB INVEST, V92, P32, DOI 10.1038/labinvest.2011.138; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Walsh DW, 2008, BBA-MOL BASIS DIS, V1782, P10, DOI 10.1016/j.bbadis.2007.09.005; Waters AM, 2008, J AM SOC NEPHROL, V19, P1139, DOI 10.1681/ASN.2007050596; Weisberg AD, 2005, ARTERIOSCL THROM VAS, V25, P365, DOI 10.1161/01.ATV.0000152356.85791.52; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2008, FRONT BIOSCI, V13, P6991; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616	55	30	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40490	10.1371/journal.pone.0040490	http://dx.doi.org/10.1371/journal.pone.0040490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792351	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700056
J	Chen, LF; Vicente-Manzanares, M; Potvin-Trottier, L; Wiseman, PW; Horwitz, AR				Chen, Lingfeng; Vicente-Manzanares, Miguel; Potvin-Trottier, Laurent; Wiseman, Paul W.; Horwitz, Alan Rick			The Integrin-Ligand Interaction Regulates Adhesion and Migration through a Molecular Clutch	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; NONMUSCLE MYOSIN-II; CELL-MIGRATION; FOCAL ADHESIONS; FIBROSARCOMA CELLS; ACTIN-FILAMENTS; ALPHA-ACTININ; GROWTH-FACTOR; U2OS CELLS; PROTEINS	Adhesive and migratory behavior can be cell type, integrin, and substrate dependent. We have compared integrin and substrate differences using three integrin receptors: alpha 5 beta 1, alpha 6 beta 1, and alpha L beta 2 expressed in a common cell type, CHO center dot B2 cells, which lack integrin alpha subunits, as well as in different cell types that express one or more of these integrins. We find that CHO center dot B2 cells expressing either alpha 6 beta 1 or alpha L beta 2 integrins migrate and protrude faster and are more directionally persistent on laminin or ICAM-1, respectively, than CHO center dot B2 cells expressing alpha 5 beta 1 on fibronectin. Despite rapid adhesion maturation and the presence of large adhesions in both the alpha 6 beta 1- and alpha L beta 2-expressing cells, they display robust tyrosine phosphorylation. In addition, whereas myosin II regulates adhesion maturation and turnover, protrusion rates, and polarity in cells migrating on fibronectin, surprisingly, it does not have comparable effects in cells expressing alpha 6 beta 1 or alpha L beta 2. This apparent difference in the integration of myosin II activity, adhesion, and migration arises from alterations in the ligand-integrin-actin linkage (molecular clutch). The elongated adhesions in the protrusions of the alpha 6 beta 1-expressing cells on laminin or the alpha L beta 2-expressing cells on ICAM-1 display a novel, rapid retrograde flux of integrin; this was largely absent in the large adhesions in protrusions of alpha 5 beta 1-expressing cells on fibronectin. Furthermore, the force these adhesions exert on the substrate in protrusive regions is reduced compared to similar regions in alpha 5-expressing cells, and the adhesion strength is reduced. This suggests that intracellular forces are not efficiently transferred from actomyosin to the substratum due to altered adhesion strength, that is, avidity, affinity, or the ligand-integrin-actin interaction. Finally, we show that the migration of fast migrating leukocytes on fibronectin or ICAM-1 is also largely independent of myosin II; however, their adhesions are small and do not show retrograde fluxing suggesting other intrinsic factors determine their migration differences.	[Chen, Lingfeng; Vicente-Manzanares, Miguel; Horwitz, Alan Rick] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA; [Vicente-Manzanares, Miguel] Univ Autonoma Madrid, Sch Med, Hosp Princesa, Madrid, Spain; [Potvin-Trottier, Laurent; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada	University of Virginia; Autonomous University of Madrid; McGill University; McGill University	Chen, LF (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA.	Horwitz@virginia.edu	Potvin-Trottier, Laurent/AAL-3122-2021; Bustelo, Xose R./A-9526-2010; Vicente-Manzanares, Miguel/H-1010-2018	Potvin-Trottier, Laurent/0000-0001-7876-2820; Bustelo, Xose R./0000-0001-9398-6072; Vicente-Manzanares, Miguel/0000-0001-5943-3220	National Institutes of Health grants [GM23244]; Cell Migration Consortium [U54 GM064346]; Ramon y Cajal program from the Spanish Ministerio de Economia y Competividad (MINECO) [RYC-2010-06094]; Natural Sciences and Engineering Council of Canada (NSERC); Canadian Institutes of Health Research; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); NSERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023244, R01GM023244, U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Migration Consortium; Ramon y Cajal program from the Spanish Ministerio de Economia y Competividad (MINECO); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ARH was supported by National Institutes of Health grants GM23244 and the Cell Migration Consortium (U54 GM064346). MVM is supported by the Ramon y Cajal program (RYC-2010-06094) from the Spanish Ministerio de Economia y Competividad (MINECO). PWW acknowledges funding support from the Natural Sciences and Engineering Council of Canada (NSERC) and the Canadian Institutes of Health Research. LPT acknowledges fellowship support from Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) and NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuta AKH, 2009, BIOTECHNOL PROGR, V25, P227, DOI 10.1002/btpr.58; Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1; Boudou T, 2009, BIORHEOLOGY, V46, P191, DOI 10.3233/BIR-2009-0540; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Chung J, 2004, MOL CELLS, V17, P203; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Damljanovic V, 2005, BIOTECHNIQUES, V39, P847, DOI 10.2144/000112026; De Ruijter JE, 2001, TISSUE ENG, V7, P279, DOI 10.1089/10763270152044143; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Eddy RJ, 2000, J CELL SCI, V113, P1287; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lein PJ, 2001, CELL BIOL, V153, P1427; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Millius A, 2009, METHODS MOL BIOL, V571, P167, DOI 10.1007/978-1-60761-198-1_11; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PETERSEN NO, 1993, BIOPHYS J, V65, P1135, DOI 10.1016/S0006-3495(93)81173-1; Pigott R, 1993, ADHESION MOL, P74; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; RAMOS DM, 1991, INVAS METAST, V11, P125; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; ter Brugge PJ, 2002, J BIOMED MATER RES, V61, P399, DOI 10.1002/jbm.10172; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Vicente-Manzanares M, 2010, BIOCHEM BIOPH RES CO, V402, P537, DOI 10.1016/j.bbrc.2010.10.071; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vicente-Manzanares M, 2009, J CELL SCI, V122, P1473, DOI 10.1242/jcs.052894; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Waterman-Storer C, 2002, CURR PROTOC CELL BIO; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Xue W, 1997, CANCER RES, V57, P1682; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235; Ziyyat A, 2006, J CELL SCI, V119, P416, DOI 10.1242/jcs.02730	73	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40202	10.1371/journal.pone.0040202	http://dx.doi.org/10.1371/journal.pone.0040202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792239	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800048
J	Liu, M; Wang, S; Sun, TG; Su, JG; Zhang, YX; Yue, JJ; Sun, ZW				Liu, Ming; Wang, Shuang; Sun, Tingguang; Su, Jiguo; Zhang, Yuanxing; Yue, Junjie; Sun, Zhiwei			Insight into the Structure, Dynamics and the Unfolding Property of Amylosucrases: Implications of Rational Engineering on Thermostability	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; NORMAL-MODE ANALYSIS; AMINO-ACID-SEQUENCE; MOLECULAR-DYNAMICS; NEISSERIA-POLYSACCHAREA; VIBRATIONAL DYNAMICS; SINGLE-PARAMETER; BINDING PROTEIN; MOTIONS; STABILITY	Amylosucrase (AS) is a kind of glucosyltransferases (E.C. 2.4.1.4) belonging to the Glycoside Hydrolase (GH) Family 13. In the presence of an activator polymer, in vitro, AS is able to catalyze the synthesis of an amylose-like polysaccharide composed of only alpha-1,4-linkages using sucrose as the only energy source. Unlike AS, other enzymes responsible for the synthesis of such amylose-like polymers require the addition of expensive nucleotide-activated sugars. These properties make AS an interesting enzyme for industrial applications. In this work, the structures and topology of the two AS were thoroughly investigated for the sake of explaining the reason why Deinococcus geothermalis amylosucrase (DgAS) is more stable than Neisseria polysaccharea amylosucrase (NpAS). Based on our results, there are two main factors that contribute to the superior thermostability of DgAS. On the one hand, DgAS holds some good structural features that may make positive contributions to the thermostability. On the other hand, the contacts among residues of DgAS are thought to be topologically more compact than those of NpAS. Furthermore, the dynamics and unfolding properties of the two AS were also explored by the gauss network model (GNM) and the anisotropic network model (ANM). According to the results of GNM and ANM, we have found that the two AS could exhibit a shear-like motion, which is probably associated with their functions. What is more, with the discovery of the unfolding pathway of the two AS, we can focus on the weak regions, and hence designing more appropriate mutations for the sake of thermostability engineering. Taking the results on structure, dynamics and unfolding properties of the two AS into consideration, we have predicted some novel mutants whose thermostability is possibly elevated, and hopefully these discoveries can be used as guides for our future work on rational design.	[Liu, Ming; Wang, Shuang; Yue, Junjie; Sun, Zhiwei] Beijing Inst Biotechnol, Beijing, Peoples R China; [Liu, Ming; Zhang, Yuanxing] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Liu, Ming] Genor Biopharma Co Ltd, Shanghai, Peoples R China; [Sun, Tingguang] Guangxi Univ Technol, Dept Biol & Chem Engn, Liuzhou, Peoples R China; [Su, Jiguo] Yanshan Univ, Coll Sci, Qinhuangdao, Peoples R China	East China University of Science & Technology; Guangxi University of Science & Technology; Yanshan University	Liu, M (corresponding author), Beijing Inst Biotechnol, Beijing, Peoples R China.	yxzhang@ecust.edu.cn; yue_junjie@126.com; szwyhhh@yahoo.com.cn		Yue, Junjie/0000-0002-2549-9261	National Natural Science Foundation of China [31170883]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by the National Natural Science Foundation of China 31170883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Albenne C, 2004, J BIOL CHEM, V279, P726, DOI 10.1074/jbc.M309891200; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bae E, 2008, P NATL ACAD SCI USA, V105, P9594, DOI 10.1073/pnas.0800938105; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 1997, J MOL BIOL, V266, P195, DOI 10.1006/jmbi.1996.0758; Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Chennubhotla C, 2005, PHYS BIOL, V2, pS173, DOI 10.1088/1478-3975/2/4/S12; Cortes J, 2004, J COMPUT CHEM, V25, P956, DOI 10.1002/jcc.20021; de Montalk GP, 2000, FEMS MICROBIOL LETT, V186, P103; de Montalk GP, 2000, FEBS LETT, V471, P219, DOI 10.1016/S0014-5793(00)01406-X; De Montalk GP, 1999, J BACTERIOL, V181, P375; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; Emond S, 2008, FEMS MICROBIOL LETT, V285, P25, DOI 10.1111/j.1574-6968.2008.01204.x; Emond S, 2008, PROTEIN SCI, V17, P967, DOI 10.1110/ps.083492608; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Guerin F, 2012, J BIOL CHEM, V287, P6642, DOI 10.1074/jbc.M111.322917; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ha SJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1505, DOI 10.1271/bbb.80891; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; HEHRE EJ, 1946, J BIOL CHEM, V166, P777; HEHRE EJ, 1949, J BIOL CHEM, V177, P267; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hinsen K, 1999, J CHEM PHYS, V111, P10766, DOI 10.1063/1.480441; Isin B, 2002, BIOPHYS J, V82, P569, DOI 10.1016/S0006-3495(02)75422-2; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Jernigan RL, 1999, INT J QUANTUM CHEM, V75, P301, DOI 10.1002/(SICI)1097-461X(1999)75:3<301::AID-QUA19>3.0.CO;2-0; Keskin O, 2002, BIOPHYS J, V83, P663, DOI 10.1016/S0006-3495(02)75199-0; Kundu S, 2002, BIOPHYS J, V83, P723, DOI 10.1016/S0006-3495(02)75203-X; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Li GH, 2002, BIOPHYS J, V83, P2457, DOI 10.1016/S0006-3495(02)75257-0; Liu M, 2008, BIOPHYS CHEM, V138, P42, DOI 10.1016/j.bpc.2008.09.001; Liu M, 2008, BIOPHYS CHEM, V135, P19, DOI 10.1016/j.bpc.2008.02.017; Liu M, 2009, BIOPOLYMERS, V91, P700, DOI 10.1002/bip.21211; Loris R, 1999, PROTEINS, V36, P117, DOI 10.1002/(SICI)1097-0134(19990701)36:1<117::AID-PROT10>3.0.CO;2-H; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; MACKENZIE CR, 1978, CAN J MICROBIOL, V24, P357, DOI 10.1139/m78-060; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Micheletti C, 2004, PROTEINS, V55, P635, DOI 10.1002/prot.20049; Ming D, 2002, P NATL ACAD SCI USA, V99, P8620, DOI 10.1073/pnas.082148899; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; MUNOZ V, 1994, PROTEINS, V20, P301, DOI 10.1002/prot.340200403; NEMETHY G, 1966, J PHYS CHEM-US, V70, P998, DOI 10.1021/j100876a008; Petukhov M, 1999, PROTEIN SCI, V8, P1982, DOI 10.1110/ps.8.10.1982; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pizzut-Serin S, 2005, FEBS LETT, V579, P1405, DOI 10.1016/j.febslet.2004.12.097; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; PREISS J, 1973, ANN NY ACAD SCI, V210, P265, DOI 10.1111/j.1749-6632.1973.tb47578.x; RIOU JY, 1983, ANN INST PASTEUR MIC, VB134, P257, DOI 10.1016/S0769-2609(83)80038-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; Skov LK, 2000, ACTA CRYSTALLOGR D, V56, P203, DOI 10.1107/S0907444999015887; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; Su JG, 2008, BIOPHYS J, V94, P4586, DOI 10.1529/biophysj.107.121665; Su JG, 2007, BIOPHYS J, V92, P1326, DOI 10.1529/biophysj.106.086512; Su JG, 2011, J BIOMOL STRUCT DYN, V29, P105, DOI 10.1080/07391102.2011.10507377; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Temiz NA, 2002, PROTEINS, V49, P61, DOI 10.1002/prot.10183; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; van der Veen BA, 2006, FEBS J, V273, P673, DOI 10.1111/j.1742-4658.2005.05076.x; Wang YM, 2004, J STRUCT BIOL, V147, P302, DOI 10.1016/j.jsb.2004.01.005; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Xu CY, 2003, J MOL BIOL, V333, P153, DOI 10.1016/j.jmb.2003.08.027; Xu XJ, 2011, J BIOMOL STRUCT DYN, V28, P717, DOI 10.1080/07391102.2011.10508601; Yennamalli RM, 2011, J BIOMOL STRUCT DYN, V29, P509, DOI 10.1080/07391102.2011.10507402	78	5	7	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40441	10.1371/journal.pone.0040441	http://dx.doi.org/10.1371/journal.pone.0040441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792323	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800085
J	Massimi, P; Zori, P; Roberts, S; Banks, L				Massimi, Paola; Zori, Patrizia; Roberts, Sally; Banks, Lawrence			Differential Regulation of Cell-Cell Contact, Invasion and Anoikis by hScrib and hDlg in Keratinocytes	PLOS ONE			English	Article							PAPILLOMAVIRUS E6 PROTEINS; LARGE TUMOR-SUPPRESSOR; DISCS LARGE; HUMAN HOMOLOG; POLARITY; EXPRESSION; TUMORIGENESIS; DEREGULATION; RECRUITMENT; MIGRATION	The components of the Scrib/Dlg tumour suppressor complex have complementary roles in Drosophila and loss of both proteins is a common event in many different human tumours. However no studies have directly addressed the respective contributions of loss of hScrib and hDlg in the same human cell background to cellular phenotypes associated with cell transformation. In human HaCaT keratinocytes we show that removal of hScrib greatly reduces cell-cell contact and cell-matrix interactions, and promotes an invasive phenotype. Conversely, in cells lacking hDlg1 cell-cell contacts are maintained and there are decreases in both cell growth and invasion. However, hDlg-depleted cells show increased resistance to a specialized form of apoptosis known as anoikis, to which cells lacking hScrib are highly susceptible. Thus whilst it has been widely assumed that hScrib and hDlg have complementary roles, these studies in fact demonstrate that hScrib and hDlg1 have distinct and opposing functions in human keratinocytes.	[Massimi, Paola; Zori, Patrizia; Banks, Lawrence] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Roberts, Sally] Univ Birmingham, Dept Canc Sci, Birmingham, W Midlands, England	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Birmingham	Massimi, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	banks@icgeb.org	Roberts, Sally/N-6143-2014	Roberts, Sally/0000-0003-4653-9442	Association for International Cancer Research; Wellcome Trust; Associazione italiana per la ricerca sul Cancro	Association for International Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Associazione italiana per la ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The work was supported by the Association for International Cancer Research, the Wellcome Trust and the Associazione italiana per la ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Cavatorta AL, 2004, INT J CANCER, V111, P373, DOI 10.1002/ijc.20275; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Lawrence DW, 2002, AM J PHYSIOL-CELL PH, V282, pC1235, DOI 10.1152/ajpcell.00288.2001; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Massimi P, 2008, EXP CELL RES, V314, P3306, DOI 10.1016/j.yexcr.2008.08.016; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Subbaiah VK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002543; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; Watson RA, 2002, CARCINOGENESIS, V23, P1791, DOI 10.1093/carcin/23.11.1791; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40279	10.1371/journal.pone.0040279	http://dx.doi.org/10.1371/journal.pone.0040279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792261	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800061
J	Stiubea-Cohen, R; David, R; Neumann, Y; Krief, G; Deutsch, O; Zacks, B; Aframian, DJ; Palmon, A				Stiubea-Cohen, Raluca; David, Ran; Neumann, Yoav; Krief, Guy; Deutsch, Omer; Zacks, Batia; Aframian, Doron J.; Palmon, Aaron			Effect of Irradiation on Cell Transcriptome and Proteome of Rat Submandibular Salivary Glands	PLOS ONE			English	Article							MASS-SPECTROMETRY; NECK-CANCER; RADIATION-THERAPY; ALPHA-AMYLASE; GRAFT CELLS; IDENTIFICATION; HEAD; RADIOSENSITIVITY; POLYMORPHISMS; RADIOTHERAPY	Salivary glands (SGs) are irreversibly damaged by irradiation (IR) treatment in head and neck cancer patients. Here, we used an animal irradiation model to investigate and define the molecular mechanisms affecting SGs following IR, focusing on saliva proteome and global transcription profile of submandibular salivary gland (SSG) tissue. We show that saliva secretion was gradually reduced to 50% of its initial level 12 weeks post-IR. Saliva protein composition was further examined by proteomic analysis following mass spectrometry (MS) analysis that revealed proteins with reduced expression originating from SSGs and proteins with increased expression derived from the serum, both indicating salivary tissue damage. To examine alterations in mRNA expression levels microarray analysis was performed. We found significant alterations in 95 genes, including cell-cycle arrest genes, SG functional genes and a DNA repair gene. Tissue damage was seen by confocal immunofluorescence of alpha-amylase and c-Kit that showed an increase and decrease, respectively, in protein expression. This was coherent with real-time PCR results. This data indicates that IR damages the SSG cells' ability to produce and secrete saliva and proteins, and maintain the physiological barrier between serum and saliva. The damage does not heal due to cell-cycle arrest, which prevents tissue regeneration. Taken together, our results reveal a new insight into IR pathobiology.	[Stiubea-Cohen, Raluca; David, Ran; Neumann, Yoav; Krief, Guy; Deutsch, Omer; Zacks, Batia; Palmon, Aaron] Hebrew Univ Jerusalem, Inst Dent Sci, Fac Dent Med, Jerusalem, Israel; [Aframian, Doron J.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Oral Med, Salivary Gland Clin, Jerusalem, Israel; [Aframian, Doron J.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Oral Med, Saliva Diagnost Lab, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Stiubea-Cohen, R (corresponding author), Hebrew Univ Jerusalem, Inst Dent Sci, Fac Dent Med, Jerusalem, Israel.	aharonp@ekmd.huji.ac.il			Tashtiot Foundation, Israeli Ministry of Science; Israel Science Foundation [1083/11]	Tashtiot Foundation, Israeli Ministry of Science; Israel Science Foundation(Israel Science Foundation)	This research was supported by the Tashtiot Foundation, Israeli Ministry of Science and by Israel Science Foundation grant no. 1083/11. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aframian DJ, 2004, TISSUE ENG, V10, P914, DOI 10.1089/1076327041348518; Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380; Azen EA, 1996, AM J HUM GENET, V58, P143; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan M, 2001, EUR J BIOCHEM, V268, P3423, DOI 10.1046/j.1432-1327.2001.02241.x; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Coppes RP, 2002, RADIOTHER ONCOL, V63, P321, DOI 10.1016/S0167-8140(02)00129-9; Cotrim AP, 2007, CLIN CANCER RES, V13, P4928, DOI 10.1158/1078-0432.CCR-07-0662; Cotroneo E, 2010, DIFFERENTIATION, V79, P120, DOI 10.1016/j.diff.2009.11.005; David R, 2008, TISSUE ENG PT A, V14, P331, DOI 10.1089/tea.2007.0122; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch O, 2008, ELECTROPHORESIS, V29, P4150, DOI 10.1002/elps.200800207; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P485, DOI 10.1177/154411130201300606; Eisbruch A, 2005, NAT CLIN PRACT ONCOL, V2, P34, DOI 10.1038/ncponc0058; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Hardt M, 2005, BIOCHEMISTRY-US, V44, P2885, DOI 10.1021/bi048176r; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hirtz C, 2005, PROTEOMICS, V5, P4597, DOI 10.1002/pmic.200401316; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; KASHIMA HK, 1965, AMER J ROENTGENOL RA, V94, P271; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Munter MW, 2007, INT J RADIAT ONCOL, V67, P651, DOI 10.1016/j.ijrobp.2006.09.035; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; O'Connell AC, 1999, RADIAT RES, V151, P150, DOI 10.2307/3579765; Palmon A, 2012, METHODS, V56, P305, DOI 10.1016/j.ymeth.2011.10.002; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Takagi K, 2003, RADIAT RES, V159, P351, DOI 10.1667/0033-7587(2003)159[0351:SOSIXI]2.0.CO;2; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Yaniv A, 2011, TISSUE ENG PART C-ME, V17, P69, DOI [10.1089/ten.tec.2010.0228, 10.1089/ten.TEC.2010.0228]; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200; Zeilstra LJW, 2000, INT J RADIAT BIOL, V76, P419, DOI 10.1080/095530000138763; Zhang ZD, 2010, DNA REPAIR, V9, P558, DOI 10.1016/j.dnarep.2010.02.006; Zheng CY, 2011, CLIN CANCER RES, V17, P2842, DOI 10.1158/1078-0432.CCR-10-2982; Zhou J, 2009, TUMOR BIOL, V30, P130, DOI 10.1159/000225242	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40636	10.1371/journal.pone.0040636	http://dx.doi.org/10.1371/journal.pone.0040636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792391	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800112
J	Malinowsky, K; Raychaudhuri, M; Buchner, T; Thulke, S; Wolff, C; Hofler, H; Becker, KF; Avril, S				Malinowsky, Katharina; Raychaudhuri, Mithu; Buchner, Theresa; Thulke, Sabrina; Wolff, Claudia; Hoefler, Heinz; Becker, Karl-Friedrich; Avril, Stefanie			Common Protein Biomarkers Assessed by Reverse Phase Protein Arrays Show Considerable Intratumoral Heterogeneity in Breast Cancer Tissues	PLOS ONE			English	Article							FORMALIN-FIXED TISSUES; PLASMINOGEN-ACTIVATOR; INHIBITOR PAI-1; MICROARRAYS; CARCINOMA; AMPLIFICATION; EVOLUTION; SPECIMENS; DIAGNOSIS	Proteins are used as prognostic and predictive biomarkers in breast cancer. However, the variability of protein expression within the same tumor is not well studied. The aim of this study was to assess intratumoral heterogeneity in protein expression levels by reverse-phase-protein-arrays (RPPA) (i) within primary breast cancers and (ii) between axillary lymph node metastases from the same patient. Protein was extracted from 106 paraffin-embedded samples from 15 large (>= 3 cm) primary invasive breast cancers, including different zones within the primary tumor (peripheral, intermediate, central) as well as 2-5 axillary lymph node metastases in 8 cases. Expression of 35 proteins including 15 phosphorylated proteins representing the HER2, EGFR, and uPA/PAI-1 signaling pathways was assessed using reverse-phase-protein-arrays. All 35 proteins showed considerable intratumoral heterogeneity within primary breast cancers with a mean coefficient of variation (CV) of 31% (range 22-43%). There were no significant differences between phosphorylated (CV 32%) and non-phosphorylated proteins (CV 31%) and in the extent of intratumoral heterogeneity within a defined tumor zone (CV 28%, range18-38%) or between different tumor zones (CV 24%, range 17-38%). Lymph node metastases from the same patient showed a similar heterogeneity in protein expression (CV 27%, range 18-34%). In comparison, the variation amongst different patients was higher in primary tumors (CV 51%, range 29-98%) and lymph node metastases (CV 65%, range 40-146%). Several proteins showed significant differential expression between different tumor stages, grades, histological subtypes and hormone receptor status. Commonly used protein biomarkers of breast cancer, including proteins from HER2, uPA/PAI-1 and EGFR signaling pathways showed higher than previously reported intratumoral heterogeneity of expression levels both within primary breast cancers and between lymph node metastases from the same patient. Assessment of proteins as diagnostic or prognostic markers may require tumor sampling in several distinct locations to avoid sampling bias.	[Malinowsky, Katharina; Raychaudhuri, Mithu; Buchner, Theresa; Thulke, Sabrina; Wolff, Claudia; Hoefler, Heinz; Becker, Karl-Friedrich; Avril, Stefanie] Tech Univ Munich, Dept Pathol, Munich, Germany	Technical University of Munich	Malinowsky, K (corresponding author), Tech Univ Munich, Dept Pathol, Munich, Germany.	stefanie.avril@lrz.tum.de	Avril, Stefanie/J-6668-2016; Becker, Karl-Friedrich/D-3636-2015	Avril, Stefanie/0000-0002-3394-8733; Becker, Karl-Friedrich/0000-0002-6801-4498	Deutsche Forschungsgemeinschaft (German Research Foundation, DFG) [SA1698/1-2]; NGFN (Nationales Genomforschungsnetz) Project of the BMBF (Bundesministerium fur Bildung und Forschung) [01GR0805]	Deutsche Forschungsgemeinschaft (German Research Foundation, DFG)(German Research Foundation (DFG)); NGFN (Nationales Genomforschungsnetz) Project of the BMBF (Bundesministerium fur Bildung und Forschung)	This study was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG;http://www.dfg.de/index.jsp) Grant No SA1698/1-2 and the NGFN (Nationales Genomforschungsnetz; http://www.ngfn.de) Project of the BMBF (Bundesministerium fur Bildung und Forschung) Grant No 01GR0805. Funding covered personnel costs (technicians) and consumables for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Berg D, 2011, APPL IMMUNOHISTO M M, V19, P300, DOI 10.1097/PAI.0b013e3182054f9f; Berg D, 2011, METHODS MOL BIOL, V785, P109, DOI 10.1007/978-1-61779-286-1_8; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Brunelli M, 2009, AM J CLIN PATHOL, V131, P678, DOI 10.1309/AJCP09VUTZWZXBMJ; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fujii H, 1996, CANCER RES, V56, P1493; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Glockner S, 2002, LAB INVEST, V82, P1419, DOI 10.1097/01.LAB.0000032371.16521.40; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Grubb RL, 2003, PROTEOMICS, V3, P2142, DOI 10.1002/pmic.200300598; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; LONN U, 1994, INT J CANCER, V58, P40, DOI 10.1002/ijc.2910580108; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; Murphy CG, 2009, BIOL-TARGETS THER, V3, P289; Nassar A, 2010, APPL IMMUNOHISTO M M, V18, P433, DOI 10.1097/PAI.0b013e3181dddb20; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Raychaudhuri M, 2012, J MOL DIAGN IN PRESS; Schmitt M, 2008, BREAST CARE, V3, P3, DOI 10.1159/000151737; Shen CY, 2000, CANCER RES, V60, P3884; Shin SJ, 2006, INT J SURG PATHOL, V14, P279, DOI 10.1177/1066896906293055; Wolff C, 2011, METHODS MOL BIOL, V785, P123, DOI 10.1007/978-1-61779-286-1_9; Wolff C, 2011, J PATHOL, V223, P54, DOI 10.1002/path.2791; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485	28	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40285	10.1371/journal.pone.0040285	http://dx.doi.org/10.1371/journal.pone.0040285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792263	Green Submitted, gold, Green Published			2022-12-27	WOS:000306436300046
J	Markowitz, VM; Chen, IMA; Chu, K; Szeto, E; Palaniappan, K; Jacob, B; Ratner, A; Liolios, K; Pagani, I; Huntemann, M; Mavromatis, K; Ivanova, NN; Kyrpides, NC				Markowitz, Victor M.; Chen, I-Min A.; Chu, Ken; Szeto, Ernest; Palaniappan, Krishna; Jacob, Biju; Ratner, Anna; Liolios, Konstantinos; Pagani, Ioanna; Huntemann, Marcel; Mavromatis, Konstantinos; Ivanova, Natalia N.; Kyrpides, Nikos C.			IMG/M-HMP: A Metagenome Comparative Analysis System for the Human Microbiome Project	PLOS ONE			English	Article							IDENTIFICATION; RECOGNITION; SEQUENCES; DATABASE; GENES	The Integrated Microbial Genomes and Metagenomes (IMG/M) resource is a data management system that supports the analysis of sequence data from microbial communities in the integrated context of all publicly available draft and complete genomes from the three domains of life as well as a large number of plasmids and viruses. IMG/M currently contains thousands of genomes and metagenome samples with billions of genes. IMG/M-HMP is an IMG/M data mart serving the US National Institutes of Health (NIH) Human Microbiome Project (HMP), focussed on HMP generated metagenome datasets, and is one of the central resources provided from the HMP Data Analysis and Coordination Center (DACC). IMG/M-HMP is available at http://www.hmpdacc-resources.org/imgm_hmp/.	[Markowitz, Victor M.; Chen, I-Min A.; Chu, Ken; Szeto, Ernest; Palaniappan, Krishna; Jacob, Biju; Ratner, Anna] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA; [Liolios, Konstantinos; Pagani, Ioanna; Huntemann, Marcel; Mavromatis, Konstantinos; Ivanova, Natalia N.; Kyrpides, Nikos C.] Dept Energy Joint Genome Inst, Microbial Genom & Metagen Program, Walnut Creek, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Markowitz, VM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA.	vmmarkowitz@lbl.gov; nckyrpides@lbl.gov	Huntemann, Marcel/HCH-8928-2022; Kyrpides, Nikos C./A-6305-2014; Pagani, Ioanna/E-7390-2012	Huntemann, Marcel/0000-0002-1284-3748; Kyrpides, Nikos C./0000-0002-6131-0462; Mavrommatis, Konstantinos/0000-0003-4549-385X; Palaniappan, Krishnaveni/0000-0003-4484-7505; Ivanova, Natalia/0000-0002-5802-9485	Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy [DE-AC02-05CH11231]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; U.S. National Institutes of Health Data Analysis and Coordination Center [U01-HG004866]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004866] Funding Source: NIH RePORTER	Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Institutes of Health Data Analysis and Coordination Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work presented in this paper was supported by the Director, Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The IMG/M-HMP system is supported by the U.S. National Institutes of Health Data Analysis and Coordination Center contract U01-HG004866. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Hunter S., 2005, NUCLEIC ACIDS RES, V37, pD211; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Markowitz VM, 2012, NUCL ACID RES; Markowitz VM, 2012, NUCL ACID R IN PRESS; Mavromatis K, 2011, SIGS UNPUB; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Pagani I, 2012, NUCL ACIDS RES; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; The Human Microbiome Consortium, 2012, NATURE UNPUB; The Human Microbiome Jumpstart Reference Strains Consortium, 2010, SCIENCE, V328, P994; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	21	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40151	10.1371/journal.pone.0040151	http://dx.doi.org/10.1371/journal.pone.0040151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792232	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300032
J	Stawski, C; Geiser, F				Stawski, Clare; Geiser, Fritz			Will Temperature Effects or Phenotypic Plasticity Determine the Thermal Response of a Heterothermic Tropical Bat to Climate Change?	PLOS ONE			English	Article							BODY-TEMPERATURE; TORPOR; HIBERNATION; ENERGETICS; PHYSIOLOGY; BIRDS; THERMOREGULATION; EVOLUTION; PATTERNS; MAMMALS	The proportion of organisms exposed to warm conditions is predicted to increase during global warming. To better understand how bats might respond to climate change, we aimed to obtain the first data on how use of torpor, a crucial survival strategy of small bats, is affected by temperature in the tropics. Over two mild winters, tropical free-ranging bats (Nyctophilus bifax, 10 g, n = 13) used torpor on 95% of study days and were torpid for 33.5+/-18.8% of 113 days measured. Torpor duration was temperature-dependent and an increase in ambient temperature by the predicted 2 degrees C for the 21st century would decrease the time in torpor to 21.8%. However, comparisons among Nyctophilus populations show that regional phenotypic plasticity attenuates temperature effects on torpor patterns. Our data suggest that heterothermy is important for energy budgeting of bats even under warm conditions and that flexible torpor use will enhance bats' chance of survival during climate change.	[Stawski, Clare; Geiser, Fritz] Univ New England, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia	University of New England	Stawski, C (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	clare.stawski@gmail.com	Geiser, Fritz/O-4175-2018; Stawski, Clare/E-2284-2011	Geiser, Fritz/0000-0001-7621-5049; Stawski, Clare/0000-0003-1714-0301	Australian Postgraduate Award; Bat Conservation International; Jagiellonian University; University of New England; Australian Research Council	Australian Postgraduate Award(Australian Government); Bat Conservation International; Jagiellonian University; University of New England; Australian Research Council(Australian Research Council)	Financial support was provided by an Australian Postgraduate Award, Bat Conservation International, Jagiellonian University and the University of New England to Clare Stawski and the Australian Research Council to Fritz Geiser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay RMR, 1996, J MAMMAL, V77, P1102, DOI 10.2307/1382791; Barclay RMR, 2001, CAN J ZOOL, V79, P1885, DOI 10.1139/cjz-79-10-1885; Bartels W, 1998, J COMP PHYSIOL B, V168, P233, DOI 10.1007/s003600050141; Bieber C, 2009, NATURWISSENSCHAFTEN, V96, P165, DOI 10.1007/s00114-008-0471-z; Boyer BB, 1999, BIOSCIENCE, V49, P713, DOI 10.2307/1313595; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Canale CI, 2010, CLIM RES, V43, P135, DOI 10.3354/cr00897; CARPENTER FL, 1988, CONDOR, V90, P373, DOI 10.2307/1368565; Churchill S, 2008, AUSTR BATS, V2nd; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; Dunbar MB, 2010, J COMP PHYSIOL B, V180, P885, DOI 10.1007/s00360-010-0457-y; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2001, J COMP PHYSIOL B, V171, P569; GEISER F, 1993, J COMP PHYSIOL B, V163, P133; Geiser Fritz, 2012, P109; Geiser F, 2011, INTEGR COMP BIOL, V51, P337, DOI 10.1093/icb/icr042; Geiser F, 2011, NATURWISSENSCHAFTEN, V98, P447, DOI 10.1007/s00114-011-0779-y; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; HEATH M, 1983, AM J PHYSIOL, V244, pR273, DOI 10.1152/ajpregu.1983.244.2.R273; Henshaw R.E., 1970, P188; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kelm DH, 2007, J COMP PHYSIOL B, V177, P667, DOI 10.1007/s00360-007-0164-5; Kortner G, 2000, OECOLOGIA, V123, P350, DOI 10.1007/s004420051021; Liow LH, 2009, AM NAT, V173, P264, DOI 10.1086/595756; Liu JN, 2011, J COMP PHYSIOL B, V181, P125, DOI 10.1007/s00360-010-0509-3; Lovegrove BG, 2008, J COMP PHYSIOL B, V178, P691, DOI 10.1007/s00360-008-0257-9; Maloney SK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P385, DOI 10.1086/316677; McKechnie AE, 2011, INTEGR COMP BIOL, V51, P349, DOI 10.1093/icb/icr035; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RICHARDS GC, 1989, AUST WILDLIFE RES, V16, P151; Riek A, 2012, J EXP BIOL, V215, P1552, DOI 10.1242/jeb.069559; Schmid J, 2009, NATURWISSENSCHAFTEN, V96, P609, DOI 10.1007/s00114-009-0515-z; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Speakman JR, 2003, BAT ECOLOGY, P430; Stawski Clare, 2012, P99; Stawski C, 2011, AM J PHYSIOL-REG I, V301, pR542, DOI 10.1152/ajpregu.00792.2010; Stawski C, 2010, NATURWISSENSCHAFTEN, V97, P29, DOI 10.1007/s00114-009-0606-x; Stawski C, 2009, J COMP PHYSIOL B, V179, P433, DOI 10.1007/s00360-008-0328-y; Toussaint DC, 2010, MAMM BIOL, V75, P466, DOI 10.1016/j.mambio.2009.06.001; Turbill C, 2003, PHYSIOL BIOCHEM ZOOL, V76, P868, DOI 10.1086/378915; Turbill C, 2008, J COMP PHYSIOL B, V178, P597, DOI 10.1007/s00360-007-0249-1; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; TWENTE JW, 1985, CAN J ZOOL, V63, P2955, DOI 10.1139/z85-443; Visser ME, 2012, NAT CLIM CHANGE, V2, P77, DOI 10.1038/nclimate1387; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Zervanos SM, 2010, PHYSIOL BIOCHEM ZOOL, V83, P135, DOI 10.1086/648736	50	25	25	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40278	10.1371/journal.pone.0040278	http://dx.doi.org/10.1371/journal.pone.0040278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802959	gold, Green Submitted, Green Published			2022-12-27	WOS:000306186900033
J	Dicks, MDJ; Spencer, AJ; Edwards, NJ; Wadell, G; Bojang, K; Gilbert, SC; Hill, AVS; Cottingham, MG				Dicks, Matthew D. J.; Spencer, Alexandra J.; Edwards, Nick J.; Wadell, Goran; Bojang, Kalifa; Gilbert, Sarah C.; Hill, Adrian V. S.; Cottingham, Matthew G.			A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; CIRCUMSPOROZOITE PROTEIN; HOMOLOGOUS RECOMBINATION; NEUTRALIZING ANTIBODIES; HIV-1 VACCINE; T-CELLS; ANTIGEN; IMMUNITY; DEPHOSPHORYLATION; GENERATION	Recombinant adenoviruses are among the most promising tools for vaccine antigen delivery. Recently, the development of new vectors has focused on serotypes to which the human population is less exposed in order to circumvent preexisting anti vector immunity. This study describes the derivation of a new vaccine vector based on a chimpanzee adenovirus, Y25, together with a comparative assessment of its potential to elicit transgene product specific immune responses in mice. The vector was constructed in a bacterial artificial chromosome to facilitate genetic manipulation of genomic clones. In order to conduct a fair head-to-head immunological comparison of multiple adenoviral vectors, we optimised a method for accurate determination of infectious titre, since this parameter exhibits profound natural variability and can confound immunogenicity studies when doses are based on viral particle estimation. Cellular immunogenicity of recombinant E1 E3-deleted vector ChAdY25 was comparable to that of other species E derived chimpanzee adenovirus vectors including ChAd63, the first simian adenovirus vector to enter clinical trials in humans. Furthermore, the prevalence of virus neutralizing antibodies (titre >1:200) against ChAdY25 in serum samples collected from two human populations in the UK and Gambia was particularly low compared to published data for other chimpanzee adenoviruses. These findings support the continued development of new chimpanzee adenovirus vectors, including ChAdY25, for clinical use.	[Dicks, Matthew D. J.; Spencer, Alexandra J.; Edwards, Nick J.; Gilbert, Sarah C.; Hill, Adrian V. S.; Cottingham, Matthew G.] Univ Oxford, Jenner Inst, Oxford, England; [Bojang, Kalifa] MRC Labs, Fajara, Gambia; [Wadell, Goran] Umea Univ, Dept Clin Microbiol, Umea, Sweden	University of Oxford; Jenner Institute; MRC Laboratory Molecular Biology; Umea University	Dicks, MDJ (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	matt.cottingham@ndm.ox.ac.uk	Gilbert, Sarah C./H-2857-2019; Spencer, Alexandra/AAE-6494-2019	Gilbert, Sarah C./0000-0002-6823-9750; Spencer, Alexandra/0000-0001-7958-6961; Bojang, Kalifa/0000-0001-7506-0938; Cottingham, Matthew/0000-0003-0766-6465; Dicks, Matthew/0000-0003-1909-7095; Edwards, Nick/0000-0002-7030-7839	Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative; Wellcome Trust; European Malaria Vaccine Development Association (EMVDA); Medical Research Council [MC_UP_A900_1118] Funding Source: researchfish; MRC [MC_UP_A900_1118] Funding Source: UKRI	Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); European Malaria Vaccine Development Association (EMVDA)(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been funded by grants from the Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative, with additional funding from the Wellcome Trust. MDJD received additional funding from the European Malaria Vaccine Development Association (EMVDA). MGC is a fellow of the Oxford Martin School Institute for Vaccine Design. SCG is a Jenner Investigator. AVSH is Director of the Jenner Institute and a Wellcome Trust Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Bewig B, 2000, BIOTECHNIQUES, V28, P870, DOI 10.2144/00285bm08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chen H, 2010, J VIROL, V84, P10522, DOI 10.1128/JVI.00450-10; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Cottingham MG, 2012, BIOTECHNOL BIOENG, V109, P719, DOI 10.1002/bit.24342; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043; Fan ZC, 2008, J VIROL METHODS, V149, P309, DOI 10.1016/j.jviromet.2008.01.011; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; Fitzgerald JC, 2003, J IMMUNOL, V170, P1416, DOI 10.4049/jimmunol.170.3.1416; Goodman AL, 2010, INFECT IMMUN, V78, P4601, DOI 10.1128/IAI.00315-10; Havenga M, 2006, J GEN VIROL, V87, P2135, DOI 10.1099/vir.0.81956-0; HILLIS WD, 1969, J IMMUNOL, V103, P1089; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Larsen KC, 2009, VACCINE, V27, P5589, DOI 10.1016/j.vaccine.2009.07.025; Lin JP, 2010, VACCINE, V28, P5669, DOI 10.1016/j.vaccine.2010.06.053; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mannervik M, 1999, VIROLOGY, V256, P313, DOI 10.1006/viro.1999.9663; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Pinto AR, 2003, J IMMUNOL, V171, P6774, DOI 10.4049/jimmunol.171.12.6774; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Roy S, 2004, VIROLOGY, V324, P361, DOI 10.1016/j.virol.2004.03.047; Roy S, 2004, HUM GENE THER, V15, P519, DOI 10.1089/10430340460745838; Roy S, 2011, J GENE MED, V13, P17, DOI 10.1002/jgm.1530; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Stanton RJ, 2008, BIOTECHNIQUES, V45, P659, DOI 10.2144/000112993; Tatsis N, 2006, GENE THER, V13, P421, DOI 10.1038/sj.gt.3302675; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Thomason LC, 2007, PLASMID, V58, P148, DOI 10.1016/j.plasmid.2007.03.001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WIGAND R, 1989, INTERVIROLOGY, V30, P1; Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809; Xiang ZQ, 2006, EMERG INFECT DIS, V12, P1596, DOI 10.3201/eid1210.060078; Yu D, 2011, J VIROL, V85, P13114, DOI 10.1128/JVI.05759-11; Zhou DM, 2010, NAT PROTOC, V5, P1775, DOI 10.1038/nprot.2010.134	51	214	226	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40385	10.1371/journal.pone.0040385	http://dx.doi.org/10.1371/journal.pone.0040385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808149	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700026
J	Jiang, YW; Soong, TD; Wang, L; Melnick, AM; Elemento, O				Jiang, Yanwen; Soong, T. David; Wang, Ling; Melnick, Ari M.; Elemento, Olivier			Genome-Wide Detection of Genes Targeted by Non-Ig Somatic Hypermutation in Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN GENES; CLASS SWITCH; EXPRESSION; AID; DIFFERENTIATION; DNA; MUTATIONS; MECHANISM	The processes of somatic hypermutation (SHM) and class switch recombination introduced by activation-induced cytosine deaminase (AICDA) at the Immunoglobulin (Ig) loci are key steps for creating a pool of diversified antibodies in germinal center B cells (GCBs). Unfortunately, AICDA can also accidentally introduce mutations at bystander loci, particularly within the 59 regulatory regions of proto-oncogenes relevant to diffuse large B cell lymphomas (DLBCL). Since current methods for genomewide sequencing such as Exon Capture and RNAseq only target mutations in coding regions, to date non-Ig promoter SHMs have been studied only in a handful genes. We designed a novel approach integrating bioinformatics tools with next generation sequencing technology to identify regulatory loci targeted by SHM genome-wide. We observed increased numbers of SHM associated sequence variant hotspots in lymphoma cells as compared to primary normal germinal center B cells. Many of these SHM hotspots map to genes that have not been reported before as mutated, including BACH2, BTG2, CXCR4, CIITA, EBF1, PIM2, and TCL1A, etc., all of which have potential roles in B cell survival, differentiation, and malignant transformation. In addition, using BCL6 and BACH2 as examples, we demonstrated that SHM sites identified in these 59 regulatory regions greatly altered their transcription activities in a reporter assay. Our approach provides a first cost-efficient, genome-wide method to identify regulatory mutations and non-Ig SHM hotspots.	[Jiang, Yanwen; Soong, T. David; Elemento, Olivier] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Jiang, Yanwen; Soong, T. David; Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Jiang, Yanwen; Wang, Ling; Melnick, Ari M.] Weill Cornell Med Coll, Dept Med, Div Hematol & Oncol, New York, NY USA	Cornell University; Cornell University; Cornell University	Jiang, YW (corresponding author), Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA.	amm2014@med.cornell.edu; ole2001@med.cornell.edu	Melnick, Ari/AAA-5763-2020		NATIONAL CANCER INSTITUTE [R01CA104348] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA104348] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Caron G, 2009, J IMMUNOL, V182, P7595, DOI 10.4049/jimmunol.0804272; Cattoretti G, 2009, CANCER RES, V69, P8686, DOI 10.1158/0008-5472.CAN-09-1110; Chen SX, 1997, STAT SINICA, V7, P875; Cycon KA, 2009, EXP HEMATOL, V37, P184, DOI 10.1016/j.exphem.2008.10.001; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; GOLDING GB, 1987, GENETICS, V115, P169; Gomez-Abad C, 2011, BLOOD, V118, P5517, DOI 10.1182/blood-2011-03-344374; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424; Hong JW, 2005, J BIOL CHEM, V280, P21256, DOI 10.1074/jbc.M500318200; Igarashi K, 2007, J BIOCHEM, V141, P783, DOI 10.1093/jb/mvm106; Kato L, 2012, P NATL ACAD SCI USA, V109, P2479, DOI 10.1073/pnas.1120791109; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lossos IS, 2004, LEUKEMIA, V18, P1775, DOI 10.1038/sj.leu.2403488; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2001, EMBO J, V20, P4570, DOI 10.1093/emboj/20.16.4570; Ramuz O, 2005, INT J ONCOL, V26, P151; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Smit LA, 2003, CANCER RES, V63, P3894; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; TWEEDDALE ME, 1987, BLOOD, V69, P1307; Yamane A, 2010, NAT IMMUNOL, V12, P62	44	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40332	10.1371/journal.pone.0040332	http://dx.doi.org/10.1371/journal.pone.0040332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808135	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400018
J	Bodalal, Z; Bendardaf, R; Ambarek, M				Bodalal, Zuhir; Bendardaf, Riyad; Ambarek, Mohammed			A Study of a Decade of Road Traffic Accidents in Benghazi-Libya: 2001 to 2010	PLOS ONE			English	Article								This paper aims to observe and to study the trends of road traffic accidents (RTA's) for the past ten years in Benghazi - Libya. A retrospective analysis was done using the patient records of Al-Jalaa hospital (the main trauma center in Benghazi) from over 21,753 RTA cases. The annual data were compared to each other and changes of trends were observed. RTA's represented an increasing percentage of Al-Jalaa's case load across the years. Around 41% of these cases needed to undergo surgery. The younger age group (20-29 years of age) formed the majority of cases while there was a trend towards an increasing average age of patients involved in an accident. Male patients were found to be younger than their female counterparts. Males comprised 81.5% while females formed 18.5% of RTA patients. In terms of inpatient duration, most patients stayed in the hospital for less than 1 week. Vehicle occupants (drivers and passengers) were admitted more often than pedestrians. There was a trend across the years towards an increased involvement of vehicle occupants and decrease in the proportion of pedestrians that had to be hospitalized. Additionally, there was a decrease in the fatalities of pedestrians. Overall, most RTA patients were discharged and made to follow-up in outpatient clinics however there was a startling trend towards increased LAMA and absconded patients. There were both encouraging findings as well as points that needed further emphasis and action. Public education, life support training and diversification of transport (apart from the use of the roads) should be looked into, as possible means of improving the current situation.	[Bodalal, Zuhir; Ambarek, Mohammed] Libyan Int Med Univ, Fac Med, Benghazi, Libya; [Bendardaf, Riyad] Benghazi Med Ctr, Dept Hematol & Oncol, Benghazi, Libya		Bodalal, Z (corresponding author), Libyan Int Med Univ, Fac Med, Benghazi, Libya.	zuhir.bodalal@limu.edu.ly		Bodalal, Zuhir/0000-0002-2617-8128				Ahmed Ali Abdulmajid, 2007, Libyan J Med, V2, P64, DOI 10.4176/070327; [Anonymous], 2009, ROAD TRAFF ACC STAT; [Anonymous], 2010, ANN STAT REP 2010; [Anonymous], 2008, ROAD TRAFF ACC STAT; Bener Abdulbari, 2005, Int J Inj Contr Saf Promot, V12, P45, DOI 10.1080/1745730051233142225; Downing A.J., 1991, PTRC 19 TRANSP HIGHW; Durak D, 2008, INJURY, V39, P547, DOI 10.1016/j.injury.2007.07.013; Eke N, 2000, A AGGRAWALS INT J FO, V2, P14; Hamza M, 2005, THESIS NEWCASTLE U; Haworth N, 2000, SERIOUS INJURY SINGL; James L, 2002, COMP INJURY RISK PAT; Jha N., 2004, INDIAN J COMMUNITY M, V29, P20, DOI [10.4103/0970-0218.62568, DOI 10.4103/0970-0218.62568]; Kazeem G, 1979, THESIS LIVERPOOL U L; Luby Stephen, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P395; MEKKY A, 1984, ACCIDENT ANAL PREV, V16, P263, DOI 10.1016/0001-4575(84)90021-6; Mekky A, 1982, INT J TRANSP ECON, V9, P125; Peden M., 2005, WORLD REPORT ROAD TR; Peden M., 2004, WORLD REPORT ROAD TR; Regional Office for the Eastern Mediterranean, 2006, GEND ROAD TRAFF INJ; ROBERTS I, 1994, SOC SCI MED, V38, P749, DOI 10.1016/0277-9536(94)90465-0; Roudsari BS, 2004, ACCIDENT ANAL PREV, V36, P391, DOI 10.1016/S0001-4575(03)00032-0; Salamat A, 2008, LIBYAN J MED, V3, P6, DOI 10.4176/080118; Shtewi M E, 1999, Community Eye Health, V12, P11; Smeed PJ, 1964, INT ROAD SAFETY TRAF, P4; World Health Organization, 2009, GLOB STAT REP ROAD S; Zahavi Y., 1976, TRAVEL CHARACTERISTI	26	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40454	10.1371/journal.pone.0040454	http://dx.doi.org/10.1371/journal.pone.0040454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792332	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400056
J	Kar, UK; Jiang, JN; Champion, CI; Salehi, S; Srivastava, M; Sharma, S; Rabizadeh, S; Niazi, K; Kickhoefer, V; Rome, LH; Kelly, KA				Kar, Upendra K.; Jiang, Janina; Champion, Cheryl I.; Salehi, Sahar; Srivastava, Minu; Sharma, Sherven; Rabizadeh, Shahrooz; Niazi, Kayvan; Kickhoefer, Valerie; Rome, Leonard H.; Kelly, Kathleen A.			Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice	PLOS ONE			English	Article							IN-VIVO; ANTIGEN PRESENTATION; CROSS-PRESENTATION; DELIVERY-SYSTEMS; DNA VACCINES; T-CELLS; PROTEIN; VIRUS; NANOPARTICLES; LOCALIZATION	Background: Modifications of adjuvants that induce cell-mediated over antibody-mediated immunity is desired for development of vaccines. Nanocapsules have been found to be viable adjuvants and are amenable to engineering for desired immune responses. We previously showed that natural nanocapsules called vaults can be genetically engineered to elicit Th1 immunity and protection from a mucosal bacterial infection. The purpose of our study was to characterize immunity produced in response to OVA within vault nanoparticles and compare it to another nanocarrier. Methodology and Principal Findings: We characterized immunity resulting from immunization with the model antigen, ovalbumin (OVA) encased in vault nanocapsules and liposomes. We measured OVA responsive CD8(+) and CD4(+) memory T cell responses, cytokine production and antibody titers in vitro and in vivo. We found that immunization with OVA contain in vaults induced a greater number of anti-OVA CD8(+) memory T cells and production of IFN gamma plus CD4(+) memory T cells. Also, modification of the vault body could change the immune response compared to OVA encased in liposomes. Conclusions/Significance: These experiments show that vault nanocapsules induced strong anti-OVA CD8(+) and CD4(+) T cell memory responses and modest antibody production, which markedly differed from the immune response induced by liposomes. We also found that the vault nanocapsule could be modified to change antibody isotypes in vivo. Thus it is possible to create a vault nanocapsule vaccine that can result in the unique combination of immunogen-responsive CD8(+) and CD4(+) T cell immunity coupled with an IgG1 response for future development of vault nanocapsule-based vaccines against antigens for human pathogens and cancer.	[Kar, Upendra K.; Kickhoefer, Valerie; Rome, Leonard H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Jiang, Janina; Champion, Cheryl I.; Salehi, Sahar; Kelly, Kathleen A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Srivastava, Minu; Sharma, Sherven] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Med Lab, Los Angeles, CA USA; [Rabizadeh, Shahrooz; Niazi, Kayvan] Univ Calif Los Angeles, Samueli Sch Engn, Dept Bioengn, Los Angeles, CA USA; [Rabizadeh, Shahrooz; Niazi, Kayvan; Kickhoefer, Valerie; Rome, Leonard H.; Kelly, Kathleen A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kar, UK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	kkelly@mednet.ucla.edu	Kar, Upendra K/H-5250-2012; Rome, Leonard H/E-8786-2016	Kar, Upendra K/0000-0003-4065-0860; Rome, Leonard H/0000-0002-1236-2063; Kickhoefer, Valerie/0000-0002-0048-0580	National Institutes of Health [AI026328]; Abraxis Bioscience, Inc [20090918]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026328, R21AI026328, R01AI079004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraxis Bioscience, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by the National Institutes of Health, AI026328 (Dr. Kelly), sponsored research award from Abraxis Bioscience, Inc (Dr. Kelly) and 20090918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 2010, TRENDS MOL MED, V16, P478, DOI 10.1016/j.molmed.2010.07.007; Andrews CD, 2012, MOL PHARMACEUTI 0406, P6; Assudani D, 2008, CANCER RES, V68, P9892, DOI 10.1158/0008-5472.CAN-08-3134; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; Bolhassani A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-3; Brave A, 2007, MOL PHARMACEUT, V4, P18, DOI 10.1021/mp060098+; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Carstens MG, 2011, VACCINE, V29, P4761, DOI 10.1016/j.vaccine.2011.04.081; Champion CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005409; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; FERRARI C, 1992, J VIROL, V66, P2536, DOI 10.1128/JVI.66.4.2536-2540.1992; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; Fritsche PJ, 2010, SWISS MED WKLY, V140, P238, DOI smw-12980; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Haglund K, 2002, J VIROL, V76, P7506, DOI 10.1128/JVI.76.15.7506-7517.2002; Han M, 2011, ACS NANO, V5, P6128, DOI 10.1021/nn2014613; Harnack U, 2010, ANTICANCER RES, V30, P3959; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Henriques AM, 2009, INT J PHARMACEUT, V377, P92, DOI 10.1016/j.ijpharm.2009.05.005; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Ingolotti M, 2010, EXPERT REV VACCINES, V9, P747, DOI 10.1586/ERV.10.57; Izquierdo MA, 1996, AM J PATHOL, V148, P877; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kar UK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018758; Kickhoefer VA, 2005, P NATL ACAD SCI USA, V102, P4348, DOI 10.1073/pnas.0500929102; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2009, ACS NANO, V3, P27, DOI 10.1021/nn800638x; Kim C, 2010, IMMUNOLOGY, V131, P310, DOI 10.1111/j.1365-2567.2010.03338.x; Langridge W, 2010, CURR OPIN INVEST DR, V11, P919; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; McNeela EA, 2001, ADV DRUG DELIVER REV, V51, P43, DOI 10.1016/S0169-409X(01)00169-7; Mikyas Y, 2004, J MOL BIOL, V344, P91, DOI 10.1016/j.jmb.2004.09.021; Mitchell DA, 1998, EUR J IMMUNOL, V28, P1923, DOI 10.1002/(SICI)1521-4141(199806)28:06<1923::AID-IMMU1923>3.0.CO;2-9; Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Moser M, 2001, IMMUNOBIOLOGY, V204, P551, DOI 10.1078/0171-2985-00092; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Ohlschlager P, 2011, INT J CANCER, V128, P473, DOI 10.1002/ijc.25344; Pathak Y., 2009, DRUG DELIVERY NANOPA, P1; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Poderycki MJ, 2006, BIOCHEMISTRY-US, V45, P12184, DOI 10.1021/bi0610552; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; Suprenant KA, 2002, BIOCHEMISTRY-US, V41, P14447, DOI 10.1021/bi026747e; Tiwari S, 2010, NANOMEDICINE-UK, V5, P1617, DOI [10.2217/nnm.10.128, 10.2217/NNM.10.128]; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Zhong ZH, 2010, INT J PHARMACEUT, V399, P156, DOI 10.1016/j.ijpharm.2010.07.053; Zhou F, 2010, INT REV IMMUNOL, V29, P56, DOI 10.3109/08830180903349644	53	31	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38553	10.1371/journal.pone.0038553	http://dx.doi.org/10.1371/journal.pone.0038553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808011	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400003
J	Mugusi, S; Ngaimisi, E; Janabi, M; Minzi, O; Bakari, M; Riedel, KD; Burhenne, J; Lindquist, L; Mugusi, F; Sandstrom, E; Aklillu, E				Mugusi, Sabina; Ngaimisi, Eliford; Janabi, Mohamed; Minzi, Omary; Bakari, Muhammad; Riedel, Klaus-Dieter; Burhenne, Juergen; Lindquist, Lars; Mugusi, Ferdinand; Sandstrom, Eric; Aklillu, Eleni			Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania	PLOS ONE			English	Article							DRUG-INDUCED HEPATOTOXICITY; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; DAR-ES-SALAAM; HEPATITIS-B; ANTITUBERCULOSIS TREATMENT; INFECTED PATIENTS; PLASMA EXPOSURE; VERBAL AUTOPSY; CYP2B6	Objectives: To investigate the timing, incidence, clinical presentation, pharmacokinetics and pharmacogenetic predictors for antiretroviral and anti-tuberculosis drug induced liver injury (DILI) in HIV patients with or without TB co-infection. Methods and Findings: A total of 473 treatment naive HIV patients (253 HIV only and 220 with HIV-TB co-infection) were enrolled prospectively. Plasma efavirenz concentration and CYP2B6*6, CYP3A5*3, *6 and *7, ABCB1 3435C/T and SLCO1B1 genotypes were determined. Demographic, clinical and laboratory data were collected at baseline and up to 48 weeks of antiretroviral therapy. DILI case definition was according to Council for International Organizations of Medical Sciences (CIOMS). Incidence of DILI and identification of predictors was evaluated using Cox Proportional Hazards Model. The overall incidence of DILI was 7.8% (8.3 per 1000 person-week), being non-significantly higher among patients receiving concomitant anti-TB and HAART (10.0%, 10.7per 1000 person-week) than those receiving HAART alone (5.9%, 6.3 per 1000 person-week). Frequency of CYP2B6* 6 allele (p = 0.03) and CYP2B6*6/*6 genotype (p = 0.06) was significantly higher in patients with DILI than those without. Multivariate cox regression model indicated that CYP2B6*6/*6 genotype and anti-HCV IgG antibody positive as significant predictors of DILI. Median time to DILI was 2 weeks after HAART initiation and no DILI onset was observed after 12 weeks. No severe DILI was seen and the gain in CD4 was similar in patients with or without DILI. Conclusions: Antiretroviral and anti-tuberculosis DILI does occur in our setting, presenting early following HAART initiation. DILI seen is mild, transient and may not require treatment interruption. There is good tolerance to HAART and anti-TB with similar immunological outcomes. Genetic make-up mainly CYP2B6 genotype influences the development of efavirenz based HAART liver injury in Tanzanians.	[Mugusi, Sabina; Sandstrom, Eric] Karolinska Inst, Infect Dis Unit, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Mugusi, Sabina] Muhimbili Natl Hosp, Dept Internal Med, Dar Es Salaam, Tanzania; [Ngaimisi, Eliford; Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Ngaimisi, Eliford; Minzi, Omary] Muhimbili Univ Hlth & Allied Sci, Unit Pharmacol & Therapeut, Sch Pharm, Dar Es Salaam, Tanzania; [Janabi, Mohamed; Bakari, Muhammad; Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Riedel, Klaus-Dieter; Burhenne, Juergen] Univ Heidelberg, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany; [Lindquist, Lars] Karolinska Inst, Div Infect Dis, Dept Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska University Hospital; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Ruprecht Karls University Heidelberg; Karolinska Institutet; Karolinska University Hospital	Mugusi, S (corresponding author), Karolinska Inst, Infect Dis Unit, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden.	Eleni.Aklillu@ki.se	Burhenne, Jürgen/AAU-2769-2021; Aklillu, Eleni/ABG-3461-2021	Burhenne, Jürgen/0000-0002-2190-1698; Aklillu, Eleni/0000-0002-9788-0790	EDCTP (European & Developing Countries Clinical Trials Partnership) [CT. 2005.32030.001]; SIDA/SAREC [HIV-2006-031, SWE 2007-270]	EDCTP (European & Developing Countries Clinical Trials Partnership); SIDA/SAREC	This study was supported by grants from EDCTP (European & Developing Countries Clinical Trials Partnership), CT. 2005.32030.001 and SIDA/SAREC HIV-2006-031, SWE 2007-270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia N, 2002, J ANTIMICROB CHEMOTH, V50, P763, DOI 10.1093/jac/dkf204; Aklillu E, 2007, PHARMACOGENOMICS ADM, P99; Aklillu E, 2011, EUR J CLIN PHARMACOL, V67, P1139, DOI 10.1007/s00228-011-1065-9; Anderson AM, 2010, WORLD J GASTROENTERO, V16, P4107, DOI 10.3748/wjg.v16.i32.4107; BENICHOU C, 1990, J HEPATOL, V11, P272; Figueroa SC, 2010, THER DRUG MONIT, V32, P579, DOI 10.1097/FTD.0b013e3181f0634c; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Desta Z, 2007, PHARMACOGENOMICS, V8, P547, DOI 10.2217/14622416.8.6.547; Dore GJ, 1999, J INFECT DIS, V180, P607, DOI 10.1086/314942; Fiegenbaum M, 2005, CLIN PHARMACOL THER, V78, P551, DOI 10.1016/j.clpt.2005.08.003; Gounden V, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-32; Habtewold A, 2011, J ANTIMICROB CHEMOTH, V66, P2350, DOI 10.1093/jac/dkr304; Hoffmann CJ, 2008, AIDS, V22, P67, DOI 10.1097/QAD.0b013e3282f2306e; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Kalyesubula R, 2011, AFR HEALTH SCI, V11, P16; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Lamar Zanetta S, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P183, DOI 10.1177/1545109711401411; Lopez-Lopez E, 2011, PEDIATR BLOOD CANCER, V57, P612, DOI 10.1002/pbc.23074; Lopman B, 2010, J EPIDEMIOL COMMUN H, V64, P330, DOI 10.1136/jech.2008.081554; Mankhatitham W, 2011, SE ASIAN J TROP MED, V42, P651; Matee MIN, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-21; Mirghani RA, 2006, PHARMACOGENET GENOM, V16, P637, DOI 10.1097/01.fpc.0000230411.89973.1b; Mugusi SF, 2012, ANTIVIR THER, V17, P265, DOI 10.3851/IMP1956; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Nelson M, 2003, AIDS, V17, pF7, DOI 10.1097/00002030-200301030-00002; Ngaimisi E, 2011, CLIN PHARMACOL THER, V90, P406, DOI 10.1038/clpt.2011.129; Ngaimisi E, 2010, CLIN PHARMACOL THER, V88, P676, DOI 10.1038/clpt.2010.172; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Ocama P, 2010, INT J STD AIDS, V21, P553, DOI 10.1258/ijsa.2010.010027; Patel A, 2004, JAIDS-J ACQ IMM DEF, V37, P1166, DOI 10.1097/01.qai.0000135956.96166.f0; Pukenyte E, 2007, INT J TUBERC LUNG D, V11, P78; Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Singla R, 2010, INDIAN J MED RES, V132, P81; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Stine JG, 2011, EXPERT OPIN DRUG MET, V7, P875, DOI 10.1517/17425255.2011.577415; Tostmann A, 2007, TROP MED INT HEALTH, V12, P852, DOI 10.1111/j.1365-3156.2007.01871.x; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Tostmann A, 2010, TROP MED INT HEALTH, V15, P268, DOI 10.1111/j.1365-3156.2009.02449.x; Turkova A, 2009, J ANTIMICROB CHEMOTH, V63, P623, DOI 10.1093/jac/dkn548; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Voora D, 2009, J AM COLL CARDIOL, V54, P1609, DOI 10.1016/j.jacc.2009.04.053; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; World Health Organization, WHOHTMTB2009420, V4th; Yimer G, 2012, PHARMACOGENOMICS J, V12, P499, DOI 10.1038/tpj.2011.34; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	52	43	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40180	10.1371/journal.pone.0040180	http://dx.doi.org/10.1371/journal.pone.0040180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808112	Green Published, gold			2022-12-27	WOS:000306362400032
J	Nishiumi, S; Kobayashi, T; Ikeda, A; Yoshie, T; Kibi, M; Izumi, Y; Okuno, T; Hayashi, N; Kawano, S; Takenawa, T; Azuma, T; Yoshida, M				Nishiumi, Shin; Kobayashi, Takashi; Ikeda, Atsuki; Yoshie, Tomoo; Kibi, Megumi; Izumi, Yoshihiro; Okuno, Tatsuya; Hayashi, Nobuhide; Kawano, Seiji; Takenawa, Tadaomi; Azuma, Takeshi; Yoshida, Masaru			A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer	PLOS ONE			English	Article							AMINO-ACID; MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; PLASMA; COLON; CARCINOMA; IDENTIFY; GC/MS	Background: To improve the quality of life of colorectal cancer patients, it is important to establish new screening methods for early diagnosis of colorectal cancer. Methodology/Principal Findings: We performed serum metabolome analysis using gas-chromatography/mass-spectrometry (GC/MS). First, the accuracy of our GC/MS-based serum metabolomic analytical method was evaluated by calculating the RSD% values of serum levels of various metabolites. Second, the intra-day (morning, daytime, and night) and inter-day (among 3 days) variances of serum metabolite levels were examined. Then, serum metabolite levels were compared between colorectal cancer patients (N = 60; N = 12 for each stage from 0 to 4) and age-and sex-matched healthy volunteers (N = 60) as a training set. The metabolites whose levels displayed significant changes were subjected to multiple logistic regression analysis using the stepwise variable selection method, and a colorectal cancer prediction model was established. The prediction model was composed of 2-hydroxybutyrate, aspartic acid, kynurenine, and cystamine, and its AUC, sensitivity, specificity, and accuracy were 0.9097, 85.0%, 85.0%, and 85.0%, respectively, according to the training set data. In contrast, the sensitivity, specificity, and accuracy of CEA were 35.0%, 96.7%, and 65.8%, respectively, and those of CA19-9 were 16.7%, 100%, and 58.3%, respectively. The validity of the prediction model was confirmed using colorectal cancer patients (N = 59) and healthy volunteers (N = 63) as a validation set. At the validation set, the sensitivity, specificity, and accuracy of the prediction model were 83.1%, 81.0%, and 82.0%, respectively, and these values were almost the same as those obtained with the training set. In addition, the model displayed high sensitivity for detecting stage 0-2 colorectal cancer (82.8%). Conclusions/Significance: Our prediction model established via GC/MS-based serum metabolomic analysis is valuable for early detection of colorectal cancer and has the potential to become a novel screening test for colorectal cancer.	[Nishiumi, Shin; Kobayashi, Takashi; Ikeda, Atsuki; Yoshie, Tomoo; Kibi, Megumi; Izumi, Yoshihiro; Okuno, Tatsuya; Azuma, Takeshi; Yoshida, Masaru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Hayashi, Nobuhide; Kawano, Seiji] Kobe Univ Hosp, Dept Clin Lab, Kobe, Hyogo, Japan; [Takenawa, Tadaomi; Yoshida, Masaru] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 657, Japan; [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Metabol Res, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University; Kobe University	Nishiumi, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan.	myoshida@med.kobe-u.ac.jp	Nishiumi, Shin/ABD-5775-2020; Okuno, Tatsuya/ABD-6927-2020; KOBAYASHI, Takashi/AAM-7549-2021	Nishiumi, Shin/0000-0003-2126-3013; KOBAYASHI, Takashi/0000-0002-9202-7643	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan; MEXT of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants for the Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (TK, TY, MK, TA, and MY); a Grant-in-Aid for Scientific Research on Innovative Areas from the MEXT of Japan (SN and TA); the Education Program for Specialized Clinicians in the Support Program for Improving Graduate School Education from the MEXT of Japan (AI); and Grants for project research (Development of fundamental technology for the analysis and evaluation of functional agricultural products and functional foods) from the Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan (MY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertini I, 2012, CANCER RES, V72, P356, DOI 10.1158/0008-5472.CAN-11-1543; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; DEMLING J, 1993, AMINO ACIDS, V5, P253, DOI 10.1007/BF00805988; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Herbst A, 2011, AM J GASTROENTEROL, V106, P1110, DOI 10.1038/ajg.2011.6; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; Iob V, 1963, J SURG RES, V3, P85; KIKUCHI Y, 1985, ACTA OBSTET GYN SCAN, V64, P553, DOI 10.3109/00016348509156361; Kimura T, 2009, CURR OPIN CLIN NUTR, V12, P49, DOI 10.1097/MCO.0b013e3283169242; Lavie Lena, 2004, J Circadian Rhythms, V2, P5, DOI 10.1186/1740-3391-2-5; Matsuda T, 2010, JPN J CLIN ONCOL, V40, P1192, DOI 10.1093/jjco/hyq109; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; Nishiumi S, 2010, METABOLOMICS, V6, P518, DOI 10.1007/s11306-010-0224-9; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162; Rainesalo S, 2004, NEUROCHEM RES, V29, P319, DOI 10.1023/B:NERE.0000010461.34920.0c; Ritchie SA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-13; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tagi T, 2010, J GASTROENTEROL, V45, P1201, DOI 10.1007/s00535-010-0279-4; Tsugawa H, 2011, J BIOSCI BIOENG, V112, P292, DOI 10.1016/j.jbiosc.2011.05.001; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Walczak K, 2011, SCAND J GASTROENTERO, V46, P903, DOI 10.3109/00365521.2011.579159; Yoshida M, 2012, J GASTROENTEROL, V47, P9, DOI 10.1007/s00535-011-0493-8	28	188	197	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40459	10.1371/journal.pone.0040459	http://dx.doi.org/10.1371/journal.pone.0040459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792336	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400059
J	Pang, S; Duan, LS; Liu, ZQ; Song, XY; Li, XF; Wang, CJ				Pang, Sen; Duan, Liusheng; Liu, Zhiqian; Song, Xiaoyu; Li, Xuefeng; Wang, Chengju			Co-Induction of a Glutathione-S-transferase, a Glutathione Transporter and an ABC Transporter in Maize by Xenobiotics	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; HERBICIDE RESISTANCE; DETOXIFICATION; DERIVATIVES; EXPRESSION; SAFENERS; ENZYMES; FAMILY; GENE	Glutathione conjugation reactions are one of the principal mechanisms that plants utilize to detoxify xenobiotics. The induction by four herbicides (2,4-D, atrazine, metolachlor and primisulfuron) and a herbicide safener (dichlormid) on the expression of three genes, ZmGST27, ZmGT1 and ZmMRP1, encoding respectively a glutathione-S-transferase, a glutathione transporter and an ATP-binding cassette (ABC) transporter was studied in maize. The results demonstrate that the inducing effect on gene expression varies with both chemicals and genes. The expression of ZmGST27 and ZmMRP1 was up-regulated by all five compounds, whereas that of ZmGT1 was increased by atrazine, metolachlor, primisulfuron and dichlormid, but not by 2,4-D. For all chemicals, the inducing effect was first detected on ZmGST27. The finding that ZmGT1 is activated alongside ZmGST27 and ZmMRP1 suggests that glutathione transporters are an important component in the xenobiotic detoxification system of plants.	[Pang, Sen; Duan, Liusheng] China Agr Univ, Engn Res Ctr Plant Growth Regulators, Minist Educ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Pang, Sen; Song, Xiaoyu; Li, Xuefeng; Wang, Chengju] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Liu, Zhiqian] Victorian AgriBiosci Ctr, Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia	China Agricultural University; China Agricultural University; Victorian Department of Environment & Primary Industries	Pang, S (corresponding author), China Agr Univ, Engn Res Ctr Plant Growth Regulators, Minist Educ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	lixuefeng2007@163.com; Wangchengju@cau.edu.cn	Duan, Liusheng/F-8954-2011	Duan, Liusheng/0000-0003-0323-9378	Chinese Universities Scientific Fund [2011JS001]	Chinese Universities Scientific Fund	This study was supported by Chinese Universities Scientific Fund (Project No. 2011JS001). The funders had no role in study design, data collection and analysis, decision to publish, or prepatation of the manuscript.	ALSCHER RG, 1989, PHYSIOL PLANTARUM, V77, P457, DOI 10.1111/j.1399-3054.1989.tb05667.x; ANDERSON MP, 1991, PLANT PHYSIOL, V96, P104, DOI 10.1104/pp.96.1.104; Basantani M, 2011, PESTIC BIOCHEM PHYS, V99, P111, DOI 10.1016/j.pestbp.2010.11.007; BRISTOL DW, 1977, J AGR FOOD CHEM, V25, P1308, DOI 10.1021/jf60214a008; Cagnac O, 2004, PLANT PHYSIOL, V135, P1378, DOI 10.1104/pp.104.039859; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; Del Buono D, 2006, PESTIC BIOCHEM PHYS, V85, P61, DOI 10.1016/j.pestbp.2005.09.006; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Edwards R, 1996, PESTIC BIOCHEM PHYS, V54, P96, DOI 10.1006/pest.1996.0013; GAILLARD C, 1994, FEBS LETT, V352, P219, DOI 10.1016/0014-5793(94)00961-9; Hatton PJ, 1996, PESTIC SCI, V46, P267, DOI 10.1002/(SICI)1096-9063(199603)46:3&lt;267::AID-PS347&gt;3.0.CO;2-N; Hatzios KK, 2004, WEED SCI, V52, P454, DOI 10.1614/P2002-168C; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; JEPSON I, 1994, PLANT MOL BIOL, V26, P1855, DOI 10.1007/BF00019498; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Letouze A, 2003, AGRONOMIE, V23, P601, DOI 10.1051/agro:2003036; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; MILLER KD, 1994, PESTIC BIOCHEM PHYS, V48, P123, DOI 10.1006/pest.1994.1013; Pang S, 2012, J FOOD AGRIC ENVIRON, V10, P621; Pang S, 2010, PROG BIOCHEM BIOPHYS, V37, P1120, DOI 10.3724/SP.J.1206.2010.00188; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; Scarponi L, 2005, J AGR FOOD CHEM, V53, P2483, DOI 10.1021/jf047948n; Swarbreck D, 2003, GENE, V315, P153, DOI 10.1016/S0378-1119(03)00734-0; Theodoulou FL, 2003, PEST MANAG SCI, V59, P202, DOI 10.1002/ps.576; TIMMERMAN KP, 1989, PHYSIOL PLANTARUM, V77, P465, DOI 10.1111/j.1399-3054.1989.tb05668.x; Yuan JS, 2007, TRENDS PLANT SCI, V12, P6, DOI 10.1016/j.tplants.2006.11.001; Zhang MY, 2004, PLANT PHYSIOL, V134, P482, DOI 10.1104/pp.103.030940	29	25	27	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40712	10.1371/journal.pone.0040712	http://dx.doi.org/10.1371/journal.pone.0040712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792398	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400094
J	Wiseman, R; Watt, C; ten Brinke, L; Porter, S; Couper, SL; Rankin, C				Wiseman, Richard; Watt, Caroline; ten Brinke, Leanne; Porter, Stephen; Couper, Sara-Louise; Rankin, Calum			The Eyes Don't Have It: Lie Detection and Neuro-Linguistic Programming	PLOS ONE			English	Article							MOVEMENT HYPOTHESIS	Proponents of Neuro-Linguistic Programming (NLP) claim that certain eye-movements are reliable indicators of lying. According to this notion, a person looking up to their right suggests a lie whereas looking up to their left is indicative of truth telling. Despite widespread belief in this claim, no previous research has examined its validity. In Study 1 the eye movements of participants who were lying or telling the truth were coded, but did not match the NLP patterning. In Study 2 one group of participants were told about the NLP eye-movement hypothesis whilst a second control group were not. Both groups then undertook a lie detection test. No significant differences emerged between the two groups. Study 3 involved coding the eye movements of both liars and truth tellers taking part in high profile press conferences. Once again, no significant differences were discovered. Taken together the results of the three studies fail to support the claims of NLP. The theoretical and practical implications of these findings are discussed.	[Wiseman, Richard] Univ Hertfordshire, Sch Psychol, Hatfield AL10 9AB, Herts, England; [Watt, Caroline; Couper, Sara-Louise; Rankin, Calum] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [ten Brinke, Leanne; Porter, Stephen] Univ British Columbia, Dept Psychol, Vancouver, BC V5Z 1M9, Canada	University of Hertfordshire; University of Edinburgh; University of British Columbia	Wiseman, R (corresponding author), Univ Hertfordshire, Sch Psychol, Hatfield AL10 9AB, Herts, England.	caroline.watt@ed.ac.uk						Bandler R., 1975, STRUCTURE MAGIC, V1; BECK CE, 1984, PERCEPT MOTOR SKILL, V58, P175, DOI 10.2466/PMS.58.1.175-176; CHAPMAN LJ, 1967, J ABNORM PSYCHOL, V72, P193, DOI 10.1037/h0024670; Ekman P., 2001, TELLING LIES CLUES D, V3rd; ELICH M, 1985, J COUNS PSYCHOL, V32, P622, DOI 10.1037/0022-0167.32.4.622; GRAY R, 1991, FED PROBAT, V55, P11; Heap M, 2008, SKEPTICAL INTELLIGEN, V11, P6; Macdonald S, LAW HUM BEH IN PRESS; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Porter S, 2010, LEGAL CRIMINOL PSYCH, V15, P57, DOI 10.1348/135532509X433151; Redelmeier DA, 1996, P NATL ACAD SCI USA, V93, P2895, DOI 10.1073/pnas.93.7.2895; Rhoads SA, 1987, POLICE CHIEF, V4, P39; SHARPLEY CF, 1984, J COUNS PSYCHOL, V31, P238, DOI 10.1037/0022-0167.31.2.238; SHARPLEY CF, 1987, J COUNS PSYCHOL, V34, P103, DOI 10.1037/0022-0167.34.1.103; THOMASON TC, 1980, PERCEPT MOTOR SKILL, V51, P230, DOI 10.2466/pms.1980.51.1.230; Vrij A., 2008, DETECTING LIES DECEI; Vrij A., 1997, J POLICE CRIMINAL PS, V12, P25	17	14	14	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40259	10.1371/journal.pone.0040259	http://dx.doi.org/10.1371/journal.pone.0040259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22808128	Green Published, gold			2022-12-27	WOS:000306362400037
J	Andres, NL; Tesse, A; Regnault, V; Louis, H; Cattan, V; Thornton, SN; Labat, C; Kakou, A; Tual-Chalot, S; Faure, S; Challande, P; Osborne-Pellegrin, M; Martinez, MC; Lacolley, P; Andriantsitohaina, R				Andres, Natalia Lopez; Tesse, Angela; Regnault, Veronique; Louis, Huguette; Cattan, Valerie; Thornton, Simon N.; Labat, Carlos; Kakou, Agustine; Tual-Chalot, Simon; Faure, Sebastien; Challande, Pascale; Osborne-Pellegrin, Mary; Martinez, M. Carmen; Lacolley, Patrick; Andriantsitohaina, Ramaroson			Increased Microparticle Production and Impaired Microvascular Endothelial Function in Aldosterone-Salt-Treated Rats: Protective Effects of Polyphenols	PLOS ONE			English	Article							RED WINE POLYPHENOLS; SHED MEMBRANE-PARTICLES; NITRIC-OXIDE; CIRCULATING MICROPARTICLES; BLOOD-PRESSURE; IN-VIVO; HYPERTENSIVE PATIENTS; VASCULAR FUNCTION; ANGIOTENSIN-II; CELL APOPTOSIS	We aimed to characterize circulating microparticles in association with arterial stiffness, inflammation and endothelial dysfunction in aldosterone-salt-induced hypertension in rats and to investigate the preventive effects of red wine polyphenols. Uninephrectomized male Sprague-Dawley rats were treated with aldosterone-salt (1 mu g.h(-1)), with or without administration of either red wine polyphenols, Provinols (TM) (20 mg.kg(-1).day(-1)), or spironolactone (30 mg.kg(-1).day(-1)) for 4 weeks. Microparticles, arterial stiffness, nitric oxide (NO) spin trapping, and mesenteric arterial function were measured. Aldosterone-salt rats showed increased microparticle levels, including those originating from platelets, endothelium and erythrocytes. Hypertension resulted in enhanced aortic stiffness accompanied by increased circulating and aortic NO levels and an upregulation of aortic inducible NO-synthase, NF kappa B, superoxide anions and nitrotyrosine. Flow-induced dilatation was reduced in mesenteric arteries. These effects were prevented by spironolactone. Provinols (TM) did not reduce arterial stiffness or systolic hypertension but had effects similar to those of spironolactone on endothelial function assessed by flow-mediated vasodilatation, microparticle generation, aortic NO levels and oxidative stress and apoptosis in the vessel wall. Neither the contractile response nor endothelium-dependent relaxation in mesenteric arteries differed between groups. The in vivo effects of Provinols (TM) were not mediated by mineralocorticoid receptors or changes in shear stress. In conclusion, vascular remodelling and endothelial dysfunction in aldosterone-salt-mediated hypertension are associated with increased circulating microparticles. Polyphenols prevent the enhanced release of microparticles, macrovascular inflammation and oxidative stress, and microvascular endothelial dysfunction independently of blood pressure, shear stress and mineralocorticoid receptor activation in a model of hyperaldosteronism.	[Andres, Natalia Lopez; Regnault, Veronique; Louis, Huguette; Cattan, Valerie; Thornton, Simon N.; Labat, Carlos; Kakou, Agustine; Lacolley, Patrick] Nancy Univ, INSERM, U961, Nancy, France; [Tesse, Angela; Tual-Chalot, Simon; Faure, Sebastien; Martinez, M. Carmen; Andriantsitohaina, Ramaroson] Univ Nantes Angers Le Mans, INSERM, U1063, Angers, France; [Challande, Pascale] Univ Paris 06, CNRS, UMR 7190, Paris, France; [Osborne-Pellegrin, Mary] Paris Diderot Univ, INSERM, U698, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Andres, NL (corresponding author), Nancy Univ, INSERM, U961, Nancy, France.	ramaroson.andriantsitohaina@univ-angers.fr	ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; Lacolley, Patrick/G-3118-2013; Clere, Nicolas/K-4414-2015; Lopez-Andres, Natalia/B-1276-2017; REGNAULT, Veronique/AAY-1711-2020; Tesse, Angela/D-4803-2015; Labat, Carlos/F-7492-2010; Regnault, Veronique/H-9138-2016	Lopez-Andres, Natalia/0000-0003-3728-2606; REGNAULT, Veronique/0000-0001-6418-5022; Tesse, Angela/0000-0002-2153-4357; Labat, Carlos/0000-0002-5275-3405; Faure, Sebastien/0000-0001-7524-8295; andriantsitohaina, ramaroson/0000-0002-4770-3585; Tual-Chalot, Simon/0000-0002-9307-7175	Fondation de France [2005005375]; Agence Nationale de la Recherche	Fondation de France(Fondation de France); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the "Fondation de France" (2005005375) and the "Agence Nationale de la Recherche". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Bernatova I, 2002, AM J PHYSIOL-HEART C, V282, pH942, DOI 10.1152/ajpheart.00724.2001; Boulanger CM, 2007, HYPERTENSION, V49, P902, DOI 10.1161/01.HYP.0000259667.22309.df; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; BRILLA CG, 1993, J MOL CELL CARDIOL, V25, P563, DOI 10.1006/jmcc.1993.1066; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Carlstrom M, 2007, HYPERTENSION, V49, P1342, DOI 10.1161/HYPERTENSIONAHA.107.087213; Chahed S, 2010, DIABETES, V59, P694, DOI 10.2337/db08-1524; Chalopin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008554; Di Zhang A, 2008, HYPERTENSION, V52, P1060, DOI 10.1161/HYPERTENSIONAHA.108.117531; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; GARWITZ ET, 1982, HYPERTENSION, V4, P374, DOI 10.1161/01.HYP.4.3.374; Huang W, 1998, CIRC RES, V82, P879; Jelic S, 2009, VASC HEALTH RISK MAN, V5, P909; Jeong Y, 2009, P NATL ACAD SCI USA, V106, P3782, DOI 10.1073/pnas.0804037106; Jimenez R, 2007, FREE RADICAL BIO MED, V43, P462, DOI 10.1016/j.freeradbiomed.2007.05.007; Kleschyov AL, 2007, J CHROMATOGR B, V851, P12, DOI 10.1016/j.jchromb.2006.10.006; Lacolley P, 2002, CIRCULATION, V106, P2848, DOI 10.1161/01.CIR.0000039328.33137.6C; Lijnen P, 1996, J CARDIOVASC PHARM, V27, P462, DOI 10.1097/00005344-199604000-00002; Lopez-Andres N, 2010, J HYPERTENS, V28, P1261, DOI 10.1097/HJH.0b013e328337fe42; Lopez-Sepulveda R, 2008, HYPERTENSION, V51, P1088, DOI 10.1161/HYPERTENSIONAHA.107.107672; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Martin S, 2003, BRIT J PHARMACOL, V139, P1095, DOI 10.1038/sj.bjp.0705347; Martinez MC, 2011, TRENDS PHARMACOL SCI, V32, P659, DOI 10.1016/j.tips.2011.06.005; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Membre A, 2008, HAEMATOLOGICA, V93, P566, DOI 10.3324/haematol.12364; Mercier N, 2006, CARDIOVASC RES, V72, P349, DOI 10.1016/j.cardiores.2006.08.008; Mesri C, 1998, J IMMUNOL, V161, P4382; Meziani F, 2006, AM J PATHOL, V169, P1473, DOI 10.2353/ajpath.2006.051304; MULSCH A, 1995, CIRCULATION, V92, P1876, DOI 10.1161/01.CIR.92.7.1876; Nakamura Y, 2006, AM J PATHOL, V169, P362, DOI 10.2353/ajpath.2006.051351; Ohlmann P, 2005, AM J PHYSIOL-HEART C, V289, pH2342, DOI 10.1152/ajpheart.00511.2004; Park JB, 2001, HYPERTENSION, V37, P1444, DOI 10.1161/01.HYP.37.6.1444; Pechanova O, 2004, J HYPERTENS, V22, P1551, DOI 10.1097/01.hjh.0000133734.32125.c7; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Priou P, 2010, AM J PATHOL, V177, P974, DOI 10.2353/ajpath.2010.091252; Savoia C, 2008, HYPERTENSION, V51, P432, DOI 10.1161/HYPERTENSIONAHA.107.103267; Schafer C, 2003, J MEMBRANE BIOL, V196, P157, DOI 10.1007/s00239-003-0634-7; Schiffrin EL, 2006, HYPERTENSION, V47, P312, DOI 10.1161/01.HYP.0000201443.63240.a7; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Sun Y, 1997, CARDIOVASC RES, V35, P138, DOI 10.1016/S0008-6363(97)00097-7; TARDY Y, 1991, CLIN PHYS PHYSIOL M, V12, P39, DOI 10.1088/0143-0815/12/1/003; Tual-Chalot S, 2010, AM J RESP CRIT CARE, V182, P261, DOI 10.1164/rccm.200909-1347OC; Wang JM, 2009, J HUM HYPERTENS, V23, P307, DOI 10.1038/jhh.2008.137; Williams TA, 2006, ENDOCRINOLOGY, V147, P2496, DOI 10.1210/en.2005-1318; Zhao WY, 2006, AM J PHYSIOL-HEART C, V291, pH336, DOI 10.1152/ajpheart.01307.2005; Zhou XS, 2008, AM J PHYSIOL-HEART C, V295, pH1008, DOI 10.1152/ajpheart.00114.2008	50	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39235	10.1371/journal.pone.0039235	http://dx.doi.org/10.1371/journal.pone.0039235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808030	gold, Green Published			2022-12-27	WOS:000306355500008
J	Srivastava, A; Sharma, KL; Srivastava, N; Misra, S; Mittal, B				Srivastava, Anshika; Sharma, Kiran Lata; Srivastava, Neena; Misra, Sanjeev; Mittal, Balraj			Significant Role of Estrogen and Progesterone Receptor Sequence Variants in Gallbladder Cancer Predisposition: A Multi-Analytical Strategy	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; ALPHA GENE POLYMORPHISMS; BONE-MINERAL DENSITY; BREAST-CANCER; RISK; ASSOCIATION; OVARIAN; CARCINOMA; GROWTH; REPLACEMENT	Background: Carcinoma of gallbladder (GBC) is an aggressive malignancy. The higher incidence of gallbladder cancer in women has been partly attributed to hormonal factors. Therefore the present study was designed to explore the role of genetic variants in estrogen (ESR1, ESR2) and progesterone (PGR) receptors in conferring risk of gallbladder cancer. Materials and Methods: The present case-control study recruited total of 860 subjects, including 410 GBC patients, 230 gallstone patients and 220 controls. We examined the associations of 6 selected polymorphisms in three genes: ESR1 (rs2234693, rs9340799, rs1801132), ESR2 (rs1271572, rs1256049) and PGR (rs1042838) with GBC risk. Genotyping for all the polymorphisms was done using PCR-RFLP. Multifactor dimensionality reduction and classification and regression tree approaches were combined with logistic regression to discover high-order gene-gene interactions in hormonal pathway. Results: On comparing the genotype frequency distribution in gallstone and GBC patients with that of healthy subjects, the homozygous variant genotypes of ESR1-397TT (rs2234693) polymorphism showed significant risk for developing gallstone [odds ratio: OR = 2.9] and GBC [OR = 1.8] respectively. Detailed haplotypes analysis suggested that ESR1 T (rs2234693)G C-rs9340799 (rs1801132) have significant association in conferring risk for both gallstones [OR = 2.2] and GBC [OR = 3.0]. However, the variant-containing genotypes (DI+II) of PGR (rs1042838) showed low risk in both GBC [OR = 0.4] and gallstone patients [OR = 0.4]. On performing the MDR analysis, ESR1 IVS1-397C>T, ESR1 IVS1-351A>G, and ESR2-789 A>C yielded the highest testing accuracy of 0.634. These results were further supported by the CART analysis which revealed that individuals with the combined genotypes of ESR1-397 CT or TT, ESR1-351 AG or GG and ESR2-789 AA had the highest risk for GBC [OR = 3.9]. Conclusion: Using multi-analytical approaches, our study showed important role of ESR1 IVS1-397C>T, ESR1 IVS1-351A>G, and ESR2-789 A>C variants in GBC susceptibility and the risk appears to be mediated through gallstone dependent pathway.	[Srivastava, Anshika; Sharma, Kiran Lata; Mittal, Balraj] Sanjay Gandhi Postgrad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India; [Srivastava, Neena] CSMMU, Dept Physiol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; King George's Medical University	Srivastava, A (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India.	balraj@sgpgi.ac.in	Sharma, Kiran/GZL-1834-2022; Sharma, Kiran Lata/F-7960-2017	Sharma, Kiran Lata/0000-0002-1988-389X	Indian Council of Medical Research (ICMR); Department of Biotechnology (DBT) Govt. of India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology (DBT) Govt. of India(Department of Biotechnology (DBT) India)	The study was supported by research and fellowship grants from Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT) Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, INT J CANCER, V126, P2935, DOI 10.1002/ijc.24892; Alvaro D, 2002, MOL CELL ENDOCRINOL, V193, P105, DOI 10.1016/S0303-7207(02)00103-X; Alvaro D, 2000, GASTROENTEROLOGY, V119, P1681, DOI 10.1053/gast.2000.20184; ANDERSEN TI, 1994, HUM GENET, V94, P665; Aruna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008712; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Eslick GD, 2010, GASTROENTEROL CLIN N, V39, P307, DOI 10.1016/j.gtc.2010.02.011; Fabjani G, 2002, BREAST CANCER RES TR, V72, P131, DOI 10.1023/A:1014813931765; Farquhar C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004143.pub3; Fumino S, 2005, J PEDIATR SURG, V40, P1716, DOI 10.1016/j.jpedsurg.2005.07.030; Gabbi C, 2010, P NATL ACAD SCI USA, V107, P14763, DOI 10.1073/pnas.1009483107; Gallus S, 2002, INT J CANCER, V99, P762, DOI 10.1002/ijc.10411; GOLDFINE ID, 1992, BREAST CANCER RES TR, V22, P69, DOI 10.1007/BF01833335; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hemminki K, 2003, GUT, V52, P592, DOI 10.1136/gut.52.4.592; HENSON DE, 1992, CANCER, V70, P1493, DOI 10.1002/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Hewitt SC, 2000, BREAST CANCER RES, V2, P345, DOI 10.1186/bcr79; Hsing AW, 2007, INT J CANCER, V121, P832, DOI 10.1002/ijc.22756; Hyder SM, 1997, CANCER RES, V57, P2547; Jackson HH, 2007, J AM COLL SURGEONS, V205, pS38, DOI 10.1016/j.jamcollsurg.2007.06.087; Joshi G, 2010, CEPHALALGIA, V30, P311, DOI 10.1111/j.1468-2982.2009.01967.x; Khan ZR, 1999, AM J GASTROENTEROL, V94, P149; Lai IC, 2002, NEUROPSYCHOBIOLOGY, V46, P173, DOI 10.1159/000067808; Langdahl BL, 2000, J BONE MINER RES, V15, P2222, DOI 10.1359/jbmr.2000.15.11.2222; Lattuada D, 2004, CLIN ENDOCRINOL, V61, P190, DOI 10.1111/j.1365-2265.2004.02076.x; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Liu HC, 1997, MOL HUM REPROD, V3, P21, DOI 10.1093/molehr/3.1.21; LOWENFELS AB, 1989, INT J EPIDEMIOL, V18, P50, DOI 10.1093/ije/18.1.50; Lurie G, 2011, PLOS ONE, V6; Lurie G, 2009, CANCER CAUSE CONTROL, V20, P47, DOI 10.1007/s10552-008-9216-8; Manolitsas TP, 1997, BRIT J CANCER, V75, P1398, DOI 10.1038/bjc.1997.238; MCKENNA NJ, 1995, BRIT J CANCER, V71, P451, DOI 10.1038/bjc.1995.92; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Misra S, 2003, LANCET ONCOL, V4, P167, DOI 10.1016/S1470-2045(03)01021-0; NAKAMURA S, 1989, JPN J SURG, V19, P189, DOI 10.1007/BF02471584; Park SK, 2009, CARCINOGENESIS, V30, P606, DOI 10.1093/carcin/bgp024; Pooley KA, 2006, CANCER EPIDEM BIOMAR, V15, P675, DOI 10.1158/1055-9965.EPI-05-0679; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; ROWE SM, 1995, CANCER RES, V55, P2743; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Schuit SCE, 2005, EUR J ENDOCRINOL, V153, P327, DOI 10.1530/eje.1.01973; Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969, DOI 10.1001/jama.291.24.2969; SINGLETARY BK, 1986, HEPATOLOGY, V6, P574, DOI 10.1002/hep.1840060405; SOBIN LH, 1988, CANCER, V61, P2310, DOI 10.1002/1097-0142(19880601)61:11<2310::AID-CNCR2820611127>3.0.CO;2-X; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Srivastava K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016449; SuvantoLuukkonen E, 1995, MATURITAS, V22, P255, DOI 10.1016/0378-5122(95)00935-E; Tong D, 2001, INT J CANCER, V95, P394, DOI 10.1002/1097-0215(20011120)95:6&lt;394::AID-IJC1070&gt;3.0.CO;2-X; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; Vares G, 2004, ONCOGENE, V23, P4603, DOI 10.1038/sj.onc.1207601; Vicent GP, 2006, ANN NY ACAD SCI, V1089, P59, DOI 10.1196/annals.1386.025; Wang HH, 2008, FRONT BIOSCI-LANDMRK, V13, P401, DOI 10.2741/2688; Wang HH, 2009, BBA-MOL CELL BIOL L, V1791, P1037, DOI 10.1016/j.bbalip.2009.06.006; Wang-Gohrke S, 2000, CANCER RES, V60, P2348; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zatonski WA, 1997, JNCI-J NATL CANCER I, V89, P1132, DOI 10.1093/jnci/89.15.1132	62	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40162	10.1371/journal.pone.0040162	http://dx.doi.org/10.1371/journal.pone.0040162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808109	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500028
J	Wang, Q; Dai, XQ; Li, Q; Wang, ZC; Cantero, MD; Li, S; Shen, J; Tu, JC; Cantiello, H; Chen, XZ				Wang, Qian; Dai, Xiao-Qing; Li, Qiang; Wang, Zuocheng; del Rocio Cantero, Maria; Li, Shu; Shen, Ji; Tu, Jian-Cheng; Cantiello, Horacio; Chen, Xing-Zhen			Structural Interaction and Functional Regulation of Polycystin-2 by Filamin	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; KIDNEY-DISEASE PROTEIN; ALPHA-ACTININ; CHANNEL ACTIVITY; INTRACELLULAR TRAFFICKING; HUMAN SYNCYTIOTROPHOBLAST; CD2-ASSOCIATED PROTEIN; SURFACE EXPRESSION; CATION CHANNEL; NMDA RECEPTOR	Filamins are important actin cross-linking proteins implicated in scaffolding, membrane stabilization and signal transduction, through interaction with ion channels, receptors and signaling proteins. Here we report the physical and functional interaction between filamins and polycystin-2, a TRP-type cation channel mutated in 10-15% patients with autosomal dominant polycystic kidney disease. Yeast two-hybrid and GST pull-down experiments demonstrated that the C-termini of filamin isoforms A, B and C directly bind to both the intracellular N- and C-termini of polycystin-2. Reciprocal co-immunoprecipitation experiments showed that endogenous polycystin-2 and filamins are in the same complexes in renal epithelial cells and human melanoma A7 cells. We then examined the effect of filamin on polycystin-2 channel function by electrophysiology studies with a lipid bilayer reconstitution system and found that filamin-A substantially inhibits polycystin-2 channel activity. Our study indicates that filamins are important regulators of polycystin-2 channel function, and further links actin cytoskeletal dynamics to the regulation of this channel protein.	[Wang, Qian; Dai, Xiao-Qing; Li, Qiang; Wang, Zuocheng; Li, Shu; Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB, Canada; [del Rocio Cantero, Maria; Cantiello, Horacio] Univ Buenos Aires, Fac Odontol, Catedra Biofis, Buenos Aires, DF, Argentina; [Shen, Ji; Tu, Jian-Cheng] Wuhan Univ, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China; [Cantiello, Horacio] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Charlestown, MA USA; [Cantiello, Horacio] Harvard Univ, Sch Med, Charlestown, MA USA	University of Alberta; University of Buenos Aires; Wuhan University; Harvard University; Massachusetts General Hospital; Harvard University	Wang, Q (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB, Canada.	cantiello@helix.mgh.harvard.edu; xzchen@ualberta.ca		Cantero, Maria del Rocio/0000-0002-9690-8413	Canadian Institutes of Health Research; Kidney Foundation of Canada; National Science Foundation of China [30770658]; National Institutes of Health ARRA [DK077079]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077079] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Canadian Institutes of Health Research and the Kidney Foundation of Canada (to XZC), and the National Science Foundation of China (to JCT, grant# 30770658). XZC is a Senior Scholar of the Alberta Heritage Foundation for Medical Research. MRC and HC are members of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) de Argentina. HC gratefully acknowledges partial support of this study by National Institutes of Health ARRA Award DK077079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar G, 2003, CANCER RES, V63, P2645; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Beekman JM, 2008, J IMMUNOL, V180, P3938, DOI 10.4049/jimmunol.180.6.3938; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chen XZ, 2008, FEBS J, V275, P4675, DOI 10.1111/j.1742-4658.2008.06616.x; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; de Wit MCY, 2009, J NEUROL NEUROSUR PS, V80, P426, DOI 10.1136/jnnp.2008.149419; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fiori JL, 2009, ENDOCRINOLOGY, V150, P2551, DOI 10.1210/en.2008-1344; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Harris PC, 2002, GENEREVIEWS; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Lehtonen S, 2000, J BIOL CHEM, V275, P32888, DOI 10.1074/jbc.M006624200; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2004, FEBS LETT, V576, P231, DOI 10.1016/j.febslet.2004.09.017; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Maruoka ND, 2000, FEBS LETT, V473, P188, DOI 10.1016/S0014-5793(00)01521-0; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montalbetti N, 2005, PFLUG ARCH EUR J PHY, V451, P294, DOI 10.1007/s00424-005-1458-7; Montalbetti N, 2005, J PHYSIOL-LONDON, V566, P309, DOI 10.1113/jphysiol.2005.087072; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Pirson Y, 2010, ADV CHRONIC KIDNEY D, V17, P173, DOI 10.1053/j.ackd.2010.01.003; Rycroft BK, 2004, J PHYSIOL-LONDON, V557, P795, DOI 10.1113/jphysiol.2003.059212; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0	45	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40448	10.1371/journal.pone.0040448	http://dx.doi.org/10.1371/journal.pone.0040448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802962	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500043
J	de Keijzer, J; van den Broek, LAM; Ketelaar, T; van Lammeren, AAM				de Keijzer, Jeroen; van den Broek, Lambertus A. M.; Ketelaar, Tijs; van Lammeren, Andre A. M.			Histological Examination of Horse Chestnut Infection by Pseudomonas syringae pv. aesculi and Non-Destructive Heat Treatment to Stop Disease Progression	PLOS ONE			English	Article							ALGINATE PRODUCTION; BACTERIAL POLYSACCHARIDES; SUBERIN DEPOSITION; ERWINIA-AMYLOVORA; BLEEDING CANKER; FIRE BLIGHT; TREE BARK; VIRULENCE; LIGNIN; LEAVES	Since its emergence in Northwest Europe as a pathogen that infects trunks and branches of Aesculus spp. (the horse chestnuts) approximately one decade ago, Pseudomonas syringae pv. aesculi has rapidly established itself as major threat to these trees. Infected trees exhibit extensive necrosis of phloem and cambium, which can ultimately lead to dieback. The events after host entry leading to extensive necrosis are not well documented. In this work, the histopathology of this interaction is investigated and heat-treatment is explored as method to eradicate bacteria associated with established infections. The early wound-repair responses of A. hippocastanum, both in absence and presence of P. s. pv. aesculi, included cell wall lignification by a distinct layer of phloem and cortex parenchyma cells. The same cells also deposited suberin lamellae later on, suggesting this layer functions in compartmentalizing healthy from disrupted tissues. However, monitoring bacterial ingress, its construction appeared inadequate to constrain pathogen spread. Microscopic evaluation of bacterial dispersal in situ using immunolabelling and GFP-tagging of P. s. pv. aesculi, revealed two discriminative types of bacterial colonization. The forefront of lesions was found to contain densely packed bacteria, while necrotic areas housed bacterial aggregates with scattered individuals embedded in an extracellular matrix of bacterial origin containing alginate. The endophytic localization and ability of P. s. pv aesculi to create a protective matrix render it poorly accessible for control agents. To circumvent this, a method based on selective bacterial lethality at 39 degrees C was conceived and successfully tested on A. hippocastanum saplings, providing proof of concept for controlling this disease by heat-treatment. This may be applicable for curing other tree cankers, caused by related phytopathogens.	[de Keijzer, Jeroen; Ketelaar, Tijs; van Lammeren, Andre A. M.] Univ Wageningen & Res Ctr, Cell Biol Lab, Wageningen, Netherlands; [van den Broek, Lambertus A. M.] Wageningen UR, Food & Biobased Res, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	de Keijzer, J (corresponding author), Univ Wageningen & Res Ctr, Cell Biol Lab, Wageningen, Netherlands.	andre.vanlammeren@wur.nl	van den Broek, Lambertus/K-4930-2012; van den Broek, Lambertus/O-1253-2019	van den Broek, Lambertus/0000-0002-4374-5753; van den Broek, Lambertus/0000-0002-4374-5753; de Keijzer, Jeroen/0000-0002-5175-9178	working group 'Aesculaap's; Dutch Ministry of Agriculture, Nature and Food Quality	working group 'Aesculaap's; Dutch Ministry of Agriculture, Nature and Food Quality	A. A. M. van Lammeren was supported by the working group 'Aesculaap's, financed by the Dutch Ministry of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Bassett CL, 2003, BIOTECHNOL LETT, V25, P199, DOI 10.1023/A:1022394716305; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BIGGS AR, 1986, J AM SOC HORTIC SCI, V111, P757; BIGGS AR, 1985, PHYTOPATHOLOGY, V75, P1191, DOI 10.1094/Phyto-75-1191; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BRASIER C M, 1976, European Journal of Forest Pathology, V6, P129; Bultreys A., 2008, PSEUDOMONAS SYRINGAE, P283; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; CHITNIS CE, 1993, MOL MICROBIOL, V8, P583, DOI 10.1111/j.1365-2958.1993.tb01602.x; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Dijkshoorn-Dekker M.W.C., 2005, EINDRAPPORT ONDERZOE; Dijkshoorn-Dekker MWC, 2008, EINDRAPPORT ONDERZ 2; Dijkshoorn-Dekker MWC, 2009, EINDRAPPORT ONDERZ 3; Dulla G, 2008, P NATL ACAD SCI USA, V105, P3082, DOI 10.1073/pnas.0711723105; Durgapal J. C., 1980, Indian Phytopathology, V33, P533; Elasri M, 2001, APPL ENVIRON MICROB, V67, P1198, DOI 10.1128/AEM.67.3.1198-1209.2001; FETT WF, 1986, APPL ENVIRON MICROB, V52, P466, DOI 10.1128/AEM.52.3.466-473.1986; FETT WF, 1989, PLANT PHYSIOL, V89, P5, DOI 10.1104/pp.89.1.5; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GARROD B, 1982, NEW PHYTOL, V90, P99, DOI 10.1111/j.1469-8137.1982.tb03245.x; Green S, 2009, PLANT PATHOL, V58, P731, DOI 10.1111/j.1365-3059.2009.02065.x; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harnik TY, 2004, HORTSCIENCE, V39, P1677, DOI 10.21273/HORTSCI.39.7.1677; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; KECK M, 1995, PLANT PATHOL, V44, P124, DOI 10.1111/j.1365-3059.1995.tb02724.x; Keith LMW, 1999, J BACTERIOL, V181, P7176, DOI 10.1128/JB.181.23.7176-7184.1999; Kennelly MM, 2007, PLANT DIS, V91, P4, DOI 10.1094/PD-91-0004; Laue H, 2006, MICROBIOL-SGM, V152, P2909, DOI 10.1099/mic.0.28875-0; MACKAY JM, 1983, PLANT PATHOL, V32, P385, DOI 10.1111/j.1365-3059.1983.tb02852.x; Mullick D.B., 1977, Recent Advances in Phytochemistry, V11, P395; OSMAN SF, 1986, J BACTERIOL, V166, P66, DOI 10.1128/jb.166.1.66-71.1986; Penaloza-Vazquez A, 2004, MICROBIOL-SGM, V150, P2727, DOI 10.1099/mic.0.27199-0; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; RIDE JP, 1975, PHYSIOL PLANT PATHOL, V5, P125, DOI 10.1016/0048-4059(75)90016-8; RITTINGER PA, 1987, CAN J BOT, V65, P1886, DOI 10.1139/b87-258; Rodriguez-Moreno L, 2009, MICROB BIOTECHNOL, V2, P476, DOI 10.1111/j.1751-7915.2009.00101.x; RUDOLPH KWE, 1994, MOL MECH BACTERIAL V, P357; Schmidt O, 2008, FOREST PATHOL, V38, P124, DOI 10.1111/j.1439-0329.2007.00539.x; SCHOUTEN HJ, 1989, NETH J PLANT PATHOL, V95, P169, DOI 10.1007/BF01974296; SCHULTE R, 1992, PLANT CELL, V4, P79, DOI 10.1105/tpc.4.1.79; SHIGO AL, 1984, ANNU REV PHYTOPATHOL, V22, P189, DOI 10.1146/annurev.py.22.090184.001201; Simard M, 2001, PHYTOPATHOLOGY, V91, P1128, DOI 10.1094/PHYTO.2001.91.12.1128; Steele H, 2010, PLANT PATHOL, V59, P1005, DOI 10.1111/j.1365-3059.2010.02354.x; Stuurman N, 2000, MOL PLANT MICROBE IN, V13, P1163, DOI 10.1094/MPMI.2000.13.11.1163; Webber JF, 2008, PLANT PATHOL, V57, P368, DOI 10.1111/j.1365-3059.2007.01754.x; Woodward S, 1996, EUR J FOREST PATHOL, V26, P97; Yu J, 1999, MOL MICROBIOL, V33, P712, DOI 10.1046/j.1365-2958.1999.01516.x; Zamski E, 2006, ISR J PLANT SCI, V54, P301, DOI 10.1560/IJPS_54_4_301	52	11	12	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39604	10.1371/journal.pone.0039604	http://dx.doi.org/10.1371/journal.pone.0039604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808044	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700014
J	Koberle, M; Goppel, D; Grandl, T; Gaentzsch, P; Manncke, B; Berchtold, S; Muller, S; Luscher, B; Asselin-Labat, ML; Pallardy, M; Sorg, I; Langer, S; Barth, H; Zumbihl, R; Autenrieth, IB; Bohn, E				Koeberle, Martin; Goeppel, David; Grandl, Tanja; Gaentzsch, Peer; Manncke, Birgit; Berchtold, Susanne; Mueller, Steffen; Luescher, Bernhard; Asselin-Labat, Marie-Liesse; Pallardy, Marc; Sorg, Isabel; Langer, Simon; Barth, Holger; Zumbihl, Robert; Autenrieth, Ingo B.; Bohn, Erwin			Yersinia enterocolitica YopT and Clostridium difficile Toxin B Induce Expression of GILZ in Epithelial Cells	PLOS ONE			English	Article							INDUCED LEUCINE-ZIPPER; NF-KAPPA-B; PROTECTS T-LYMPHOCYTES; GENE-PRODUCT RHOB; DENDRITIC CELLS; THYMOCYTE APOPTOSIS; VIRULENCE PLASMID; SIGNALING PATHWAY; BINDING PROTEINS; INVASIN PROTEIN	Glucocorticoid induced-leucine zipper (GILZ) has been shown to be induced in cells by different stimuli such as glucocorticoids, IL-10 or deprivation of IL-2. GILZ has anti-inflammatory properties and may be involved in signalling modulating apoptosis. Herein we demonstrate that wildtype Yersinia enterocolitica which carry the pYV plasmid upregulated GILZ mRNA levels and protein expression in epithelial cells. Infection of HeLa cells with different Yersinia mutant strains revealed that the protease activity of YopT, which cleaves the membrane-bound form of Rho GTPases was sufficient to induce GILZ expression. Similarly, Clostridium difficile toxin B, another bacterial inhibitor of Rho GTPases induced GILZ expression. YopT and toxin B both increased transcriptional activity of the GILZ promoter in HeLa cells. GILZ expression could not be linked to the inactivation of an individual Rho GTPase by these toxins. However, forced expression of RhoA and RhoB decreased basal GILZ promoter activity. Furthermore, MAPK activation proved necessary for profound GILZ induction by toxin B. Promoter studies and gel shift analyses defined binding of upstream stimulatory factor (USF) 1 and 2 to a canonical c-Myc binding site (E-box) in the GILZ promoter as a crucial step of its trans-activation. In addition we could show that USF-1 and USF-2 are essential for basal as well as toxin B induced GILZ expression. These findings define a novel way of GILZ promoter trans-activation mediated by bacterial toxins and differentiate it from those mediated by dexamethasone or deprivation of IL-2.	[Koeberle, Martin; Goeppel, David; Grandl, Tanja; Gaentzsch, Peer; Manncke, Birgit; Berchtold, Susanne; Mueller, Steffen; Autenrieth, Ingo B.; Bohn, Erwin] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Luescher, Bernhard] Univ Klinikum RWTH Aachen, Inst Biochem & Mol Biol, Aachen, Germany; [Asselin-Labat, Marie-Liesse; Pallardy, Marc] Universud, INSERM, UMR S 996, Fac Pharm Paris Sud, Chatenay Malabry, France; [Asselin-Labat, Marie-Liesse] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Sorg, Isabel] Univ Basel, Biozentrum, Basel, Switzerland; [Langer, Simon; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Ulm, Germany; [Zumbihl, Robert] INRA, UMR1333, Lab Diversite Genomes & Interact Microorganismes, F-34060 Montpellier, France; [Zumbihl, Robert] Univ Montpellier 2, Montpellier, France	Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Walter & Eliza Hall Institute; University of Basel; Ulm University; INRAE; Universite de Montpellier; Universite de Montpellier	Koberle, M (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	erwin.bohn@med.uni-tuebingen.de	Köberle, Martin/HCI-8264-2022; Barth, Holger/E-7920-2013; Luscher, Bernhard/A-7330-2011	Köberle, Martin/0000-0001-6825-2667; Langer, Simon/0000-0002-9660-8058; Luscher, Bernhard/0000-0002-9622-8709	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins I, 2008, MICROBES INFECT, V10, P798, DOI 10.1016/j.micinf.2008.04.014; Adkins I, 2007, INT J MED MICROBIOL, V297, P235, DOI 10.1016/j.ijmm.2007.02.005; Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200; Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Ausiello CM, 2006, MICROBES INFECT, V8, P2640, DOI 10.1016/j.micinf.2006.07.009; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bohn E, 2004, CELL MICROBIOL, V6, P129, DOI 10.1046/j.1462-5822.2003.00346.x; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Castagliuolo I, 2001, AM J PHYSIOL-GASTR L, V280, pG539, DOI 10.1152/ajpgi.2001.280.4.G539; Chen L, 2006, J BIOL CHEM, V281, P10849, DOI 10.1074/jbc.M511237200; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Dach K, 2009, INFECT IMMUN, V77, P5583, DOI 10.1128/IAI.00121-09; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Desbarats L, 1996, GENE DEV, V10, P447, DOI 10.1101/gad.10.4.447; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Gerhard R, 2005, J BIOL CHEM, V280, P1499, DOI 10.1074/jbc.M406014200; Ghashghaeinia M, 2011, CELL PHYSIOL BIOCHEM, V27, P45, DOI 10.1159/000325204; Godot V, 2006, ALLERGY, V61, P886, DOI 10.1111/j.1398-9995.2006.01065.x; Grassl GA, 2003, CELL MICROBIOL, V5, P957, DOI 10.1046/j.1462-5822.2003.00339.x; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; Jacobi CA, 1998, MOL MICROBIOL, V30, P865, DOI 10.1046/j.1365-2958.1998.01128.x; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Koberle M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000551; Koornhof HJ, 1999, EUR J CLIN MICROBIOL, V18, P87, DOI 10.1007/s100960050237; Lee JY, 2009, J MOL MED, V87, P169, DOI 10.1007/s00109-008-0415-2; Matte I, 2009, INFECT IMMUN, V77, P5400, DOI 10.1128/IAI.00485-09; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Mohammadi S, 2009, INFECT IMMUN, V77, P4771, DOI 10.1128/IAI.00850-09; Na X, 2005, GASTROENTEROLOGY, V128, P1002, DOI 10.1053/j.gastro.2005.01.053; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Schmid Y, 2004, INFECT IMMUN, V72, P6780, DOI 10.1128/IAI.72.12.6780-6789.2004; Schulte R, 1998, MED MICROBIOL IMMUN, V187, P53, DOI 10.1007/s004300050074; Schulte R, 1996, INFECT IMMUN, V64, P2106, DOI 10.1128/IAI.64.6.2106-2113.1996; Schulte R, 2000, FASEB J, V14, P1471, DOI 10.1096/fj.14.11.1471; Schulte R, 1998, INFECT IMMUN, V66, P1216, DOI 10.1128/IAI.66.3.1216-1224.1998; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219; Sorg I, 2003, INFECT IMMUN, V71, P4623, DOI 10.1128/IAI.71.8.4623-4632.2003; Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Suarez PE, 2012, MOL ENDOCRINOLOGY; Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2006, CELL MICROBIOL, V8, P1504, DOI 10.1111/j.1462-5822.2006.00729.x; Vohra P, 2012, FEMS IMMUNOL MED MIC, V65, P96, DOI 10.1111/j.1574-695X.2012.00952.x; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wiedmaier N, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.06.001; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Wu FQ, 2011, MED MICROBIOL IMMUN, V200, P203, DOI 10.1007/s00430-011-0196-z; Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289	74	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40730	10.1371/journal.pone.0040730	http://dx.doi.org/10.1371/journal.pone.0040730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792400	Green Published, gold			2022-12-27	WOS:000306354700065
J	Nikerel, E; Berkhout, J; Hu, FY; Teusink, B; Reinders, MJT; de Ridder, D				Nikerel, Emrah; Berkhout, Jan; Hu, Fengyuan; Teusink, Bas; Reinders, Marcel J. T.; de Ridder, Dick			Understanding Regulation of Metabolism through Feasibility Analysis	PLOS ONE			English	Article							YEAST GLYCOLYSIS; GENE-EXPRESSION; MODELS; ROBUSTNESS; PATHWAYS; DESIGN; ENZYME; CONSTRAINTS; PRINCIPLES; EVOLUTION	Understanding cellular regulation of metabolism is a major challenge in systems biology. Thus far, the main assumption was that enzyme levels are key regulators in metabolic networks. However, regulation analysis recently showed that metabolism is rarely controlled via enzyme levels only, but through non-obvious combinations of hierarchical (gene and enzyme levels) and metabolic regulation (mass action and allosteric interaction). Quantitative analyses relating changes in metabolic fluxes to changes in transcript or protein levels have revealed a remarkable lack of understanding of the regulation of these networks. We study metabolic regulation via feasibility analysis (FA). Inspired by the constraint-based approach of Flux Balance Analysis, FA incorporates a model describing kinetic interactions between molecules. We enlarge the portfolio of objectives for the cell by defining three main physiologically relevant objectives for the cell: function, robustness and temporal responsiveness. We postulate that the cell assumes one or a combination of these objectives and search for enzyme levels necessary to achieve this. We call the subspace of feasible enzyme levels the feasible enzyme space. Once this space is constructed, we can study how different objectives may (if possible) be combined, or evaluate the conditions at which the cells are faced with a trade-off among those. We apply FA to the experimental scenario of long-term carbon limited chemostat cultivation of yeast cells, studying how metabolism evolves optimally. Cells employ a mixed strategy composed of increasing enzyme levels for glucose uptake and hexokinase and decreasing levels of the remaining enzymes. This tradeoff renders the cells specialized in this low-carbon flux state to compete for the available glucose and get rid of over-overcapacity. Overall, we show that FA is a powerful tool for systems biologists to study regulation of metabolism, interpret experimental data and evaluate hypotheses.	[Nikerel, Emrah; Hu, Fengyuan; Reinders, Marcel J. T.; de Ridder, Dick] Delft Univ Technol, Delft Bioinformat Lab, Dept Intelligent Syst, Delft, Netherlands; [Berkhout, Jan; Teusink, Bas] Vrije Univ Amsterdam, Fac Earth & Life Sci, Syst Bioinformat IBIVU, Amsterdam, Netherlands; [Nikerel, Emrah; Berkhout, Jan; Teusink, Bas; Reinders, Marcel J. T.; de Ridder, Dick] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Nikerel, Emrah; Berkhout, Jan; Teusink, Bas; Reinders, Marcel J. T.; de Ridder, Dick] NCSB, Amsterdam, Netherlands; [Berkhout, Jan; Teusink, Bas] NISB, Amsterdam, Netherlands	Delft University of Technology; Vrije Universiteit Amsterdam	Nikerel, E (corresponding author), Delft Univ Technol, Delft Bioinformat Lab, Dept Intelligent Syst, Delft, Netherlands.	i.e.nikerel@tudelft.nl	Nikerel, Emrah/T-8664-2018; de Ridder, Dick/F-3169-2010	de Ridder, Dick/0000-0002-4944-4310; Nikerel, Emrah/0000-0002-9157-8662; Teusink, Bas/0000-0003-3929-0423	Netherlands Organization for Scientific Research (NWO-CLS); Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative	Netherlands Organization for Scientific Research (NWO-CLS)(Netherlands Organization for Scientific Research (NWO)); Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative	This work is supported by the Computational Life Science programme of the Netherlands Organization for Scientific Research (NWO-CLS), as well as by the Kluyver Centre for Genomics of Industrial Fermentation, part of the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barnes CP, 2011, P NATL ACAD SCI USA, V108, P15190, DOI 10.1073/pnas.1017972108; Beardmore RE, 2011, NATURE, V472, P342, DOI 10.1038/nature09905; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Del Moral P, 2006, J R STAT SOC B, V68, P411, DOI 10.1111/j.1467-9868.2006.00553.x; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Guillen-Gosalbez G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-386; Hafner M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000534; Haunschild MD, 2005, BIOINFORMATICS, V21, P1617, DOI 10.1093/bioinformatics/bti225; Heijnen JJ, 2005, BIOTECHNOL BIOENG, V91, P534, DOI 10.1002/bit.20558; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Heinrich R., 1996, REGULATION CELLULAR; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hofmeyr JHS, 1996, J THEOR BIOL, V182, P371, DOI 10.1006/jtbi.1996.0176; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Ingalls BP, 2004, J PHYS CHEM B, V108, P1143, DOI 10.1021/jp036567u; INGALLS BP, 2006, SYSTEM MODELING CELL; Jansen MLA, 2005, MICROBIOL-SGM, V151, P1657, DOI 10.1099/mic.0.27577-0; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kim PJ, 2007, P NATL ACAD SCI USA, V104, P13638, DOI 10.1073/pnas.0703262104; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Machado D, 2012, METAB ENG, V14, P112, DOI 10.1016/j.ymben.2012.01.003; Mashego MR, 2005, FEMS YEAST RES, V5, P419, DOI 10.1016/j.femsyr.2004.11.008; Miskovic L, 2011, BIOTECHNOL BIOENG, V108, P413, DOI 10.1002/bit.22932; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Nikerel IE, 2011, MATH COMP MODEL DYN, V17, P243, DOI 10.1080/13873954.2010.548167; Nikerel IE, 2009, THESIS DELFT U TECHN; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; POSTMA E, 1990, YEAST, V6, P149, DOI 10.1002/yea.320060209; Rossell S, 2005, FEMS YEAST RES, V5, P611, DOI 10.1016/j.femsyr.2004.11.003; Salvado B, 2011, MATH BIOSCI, V231, P3, DOI 10.1016/j.mbs.2011.02.005; Savageau M, 1976, BIOCH SYSTEMS ANAL S, V56; Savageau MA, 2009, FEBS LETT, V583, P3914, DOI 10.1016/j.febslet.2009.10.073; Savageau MA, 2009, P NATL ACAD SCI USA, V106, P6435, DOI 10.1073/pnas.0809869106; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Snoep JL, 2006, BIOSYSTEMS, V83, P207, DOI 10.1016/j.biosystems.2005.07.006; Sorribas A, 2010, J BIOTECHNOL, V149, P141, DOI 10.1016/j.jbiotec.2010.01.026; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Steuer R, 2007, BIOINFORMATICS, V23, P1378, DOI 10.1093/bioinformatics/btm065; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; Tran LM, 2008, BIOPHYS J, V95, P5606, DOI 10.1529/biophysj.108.135442; VANGULIK WM, 1995, BIOTECHNOL BIOENG, V48, P681, DOI 10.1002/bit.260480617; Vilaprinyo E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-184; Visser D, 2004, METAB ENG, V6, P378, DOI 10.1016/j.ymben.2004.07.001; Visser D, 2003, METAB ENG, V5, P164, DOI 10.1016/S1096-7176(03)00025-9; Voit E, 2006, P NATL ACAD SCI USA, V103, P9452, DOI 10.1073/pnas.0603337103; Voit E. O., 2000, COMPUTATIONAL ANAL B; Wang LQ, 2006, METAB ENG, V8, P133, DOI 10.1016/j.ymben.2005.11.003; Wilhelm T., 2004, Systems Biology, V1, P114, DOI 10.1049/sb:20045004; Wu L, 2006, METAB ENG, V8, P160, DOI 10.1016/j.ymben.2005.09.005; Zamora-Sillero E, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-142	67	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39396	10.1371/journal.pone.0039396	http://dx.doi.org/10.1371/journal.pone.0039396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808034	Green Published, gold			2022-12-27	WOS:000306354700010
J	Curjuric, I; Imboden, M; Nadif, R; Kumar, A; Schindler, C; Haun, M; Kronenberg, F; Kunzli, N; Phuleria, H; Postma, DS; Russi, EW; Rochat, T; Demenais, F; Probst-Hensch, NM				Curjuric, Ivan; Imboden, Medea; Nadif, Rachel; Kumar, Ashish; Schindler, Christian; Haun, Margot; Kronenberg, Florian; Kuenzli, Nino; Phuleria, Harish; Postma, Dirkje S.; Russi, Erich W.; Rochat, Thierry; Demenais, Florence; Probst-Hensch, Nicole M.			Different Genes Interact with Particulate Matter and Tobacco Smoke Exposure in Affecting Lung Function Decline in the General Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OXIDATIVE STRESS; CIGARETTE-SMOKE; AIR-POLLUTION; FOLLOW-UP; MITOCHONDRIAL LOCALIZATION; PULMONARY-FUNCTION; DUST EXPOSURE; SWISS COHORT; LARGE-SCALE	Background: Oxidative stress related genes modify the effects of ambient air pollution or tobacco smoking on lung function decline. The impact of interactions might be substantial, but previous studies mostly focused on main effects of single genes. Objectives: We studied the interaction of both exposures with a broad set of oxidative-stress related candidate genes and pathways on lung function decline and contrasted interactions between exposures. Methods: For 12679 single nucleotide polymorphisms (SNP5), change in forced expiratory volume in one second (FEV1), FEV1 over forced vital capacity (FEV1/FVC), and mean forced expiratory flow between 25 and 75% of the FVC (FEF25-75) was regressed on interval exposure to particulate matter < 10 mu m in diameter (PM10) or packyears smoked (a), additive SNP effects (b), and interaction terms between (a) and (b) in 669 adults with GWAS data. Interaction p-values for 152 genes and 14 pathways were calculated by the adaptive rank truncation product (ARTP) method, and compared between exposures. Interaction effect sizes were contrasted for the strongest SNPs of nominally significant genes (p(interaction) < 0.05). Replication was attempted for SNPs with MAF > 10% in 3320 SAPALDIA participants without GWAS. Results: On the SNP-level, rs2035268 in gene SNCA accelerated FEV1/FVC decline by 3.8% (p(interaction) = 2.5 x 10(-6)), and rs12190800 in PARK2 attenuated FEV1 decline by 95.1 ml p(interaction) = 9.7 x 10(-8)) over 11 years, while interacting with PM10. Genes and pathways nominally interacting with PM10 and packyears exposure differed substantially. Gene CRISP2 presented a significant interaction with PM10 (p(interaction) = 3.0 x 10(-4)) on FEV1/FVC decline. Pathway interactions were weak. Replications for the strongest SNPs in PARK2 and CRISP2 were not successful. Conclusions: Consistent with a stratified response to increasing oxidative stress, different genes and pathways potentially mediate PM10 and tobacco smoke effects on lung function decline. Ignoring environmental exposures would miss these patterns, but achieving sufficient sample size and comparability across study samples is challenging.	[Curjuric, Ivan; Imboden, Medea; Kumar, Ashish; Schindler, Christian; Kuenzli, Nino; Phuleria, Harish; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst SwissTPH, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Curjuric, Ivan; Imboden, Medea; Kumar, Ashish; Schindler, Christian; Kuenzli, Nino; Phuleria, Harish; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Nadif, Rachel] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Resp & Environm Epidemiol Team, Villejuif, France; [Nadif, Rachel] Univ Paris 11, UMRS 1018, Villejuif, France; [Kumar, Ashish] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Haun, Margot; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, Groningen, Netherlands; [Russi, Erich W.] Univ Zurich Hosp, Div Pulm Med, CH-8091 Zurich, Switzerland; [Rochat, Thierry] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Demenais, Florence] INSERM, U946, Genet Variat & Human Dis Unit, Paris, France; [Demenais, Florence] Fdn Jean Dausset, CEPH, Paris, France; [Demenais, Florence] Univ Paris Diderot, Inst Univ Hematol, Paris, France	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Wellcome Centre for Human Genetics; Medical University of Innsbruck; University of Groningen; University of Zurich; University Zurich Hospital; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; Universite Paris Cite	Curjuric, I (corresponding author), Swiss Trop & Publ Hlth Inst SwissTPH, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	Nicole.Probst@unibas.ch	Kuenzli, Nino/F-7195-2014; Nadif, Rachel/R-2876-2016; Schindler, Christian/D-3472-2015; Russi, Erich/AGN-8387-2022; Demenais, Florence/G-3298-2013; Kronenberg, Florian/B-1736-2008	Kuenzli, Nino/0000-0001-8360-080X; Nadif, Rachel/0000-0003-4938-9339; Demenais, Florence/0000-0001-8361-0936; Kronenberg, Florian/0000-0003-2229-1120; Kumar, Ashish/0000-0002-7075-5930	Swiss National Science Foundation [33CS30_134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, 3233-054996, PDFMP3-123171]; Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton government of Aargau; canton government of Basel-Stadt; canton government of Basel-Land; canton government of Geneva; canton government of Luzern; canton government of Ticino; canton government of Valais; canton government of Zurich; Swiss Lung League; canton Lung League of Basel Stadt; canton Lung League of Basel Landschaft; canton Lung League of Geneva; canton Lung League of Ticino; canton Lung League of Valais; canton Lung League of Zurich; Schweizerische Unfallversicherungsanstalt (SUVA); Freiwillige Akademische Gesellschaft; UBS Wealth Foundation; Talecris Biotherapeutics GmbH; Abbott Diagnostics; European Commission [018996]; Wellcome Trust [WT 084703MA]; French National Research Agency (Bio2nea project) [ANR-CES 2009]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton government of Aargau; canton government of Basel-Stadt; canton government of Basel-Land; canton government of Geneva; canton government of Luzern; canton government of Ticino; canton government of Valais; canton government of Zurich; Swiss Lung League; canton Lung League of Basel Stadt; canton Lung League of Basel Landschaft; canton Lung League of Geneva; canton Lung League of Ticino; canton Lung League of Valais; canton Lung League of Zurich; Schweizerische Unfallversicherungsanstalt (SUVA); Freiwillige Akademische Gesellschaft; UBS Wealth Foundation; Talecris Biotherapeutics GmbH; Abbott Diagnostics(Abbott Laboratories); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); French National Research Agency (Bio2nea project)(French National Research Agency (ANR))	The Swiss Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) was supported by the Swiss National Science Foundation (grants no 33CS30_134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, 3233-054996, PDFMP3-123171), the Federal Office for Forest, Environment and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, Valais and Zurich, Schweizerische Unfallversicherungsanstalt (SUVA), Freiwillige Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH, and Abbott Diagnostics. Genotyping in the GABRIEL framework was supported by grants European Commission 018996 and Wellcome Trust WT 084703MA. Identification of pathways was supported by the French National Research Agency (Bio2nea project ANR-CES 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts: The SAPALDIA study was supported by the UBS Wealth Foundation, Talecris Biotherapeutics GmbH, and Abbott Diagnostics in terms of unrestricted grants for personnel and genotyping. The support of these institutions did not influence the scientific work regarding study design, data collection, data analysis, interpretation of results, decision to publish, or preparation of the manuscript in any way. Also, this does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Ahsan MK, 2005, FREE RADICAL BIO MED, V39, P1549, DOI 10.1016/j.freeradbiomed.2005.07.016; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL1392, DOI 10.1152/ajplung.2001.281.6.L1392; Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Carta P, 1996, OCCUP ENVIRON MED, V53, P312, DOI 10.1136/oem.53.5.312; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Comandini A, 2010, PULM PHARMACOL THER, V23, P482, DOI 10.1016/j.pupt.2010.05.006; Curjuric I, 2010, EUR RESPIR J, V35, P505, DOI 10.1183/09031936.00044309; DAVIS GS, 1978, AM REV RESPIR DIS, V118, P7; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Eisner MD, 2007, ANN EPIDEMIOL, V17, P364, DOI 10.1016/j.annepidem.2006.10.008; Elliott NA, 2004, MOL CELL BIOL, V24, P3180, DOI 10.1128/MCB.24.8.3180-3187.2004; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hall IP, 2010, THORAX, V65, P760, DOI 10.1136/thx.2010.147173; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; He JQ, 2004, AM J RESP CRIT CARE, V170, P388, DOI 10.1164/rccm.200312-1763OC; Johnsen HL, 2010, AM J RESP CRIT CARE, V181, P1234, DOI 10.1164/rccm.200809-1381OC; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; KAUFFMANN F, 1982, BRIT J IND MED, V39, P221; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; KUNZLI N, 1995, EUR RESPIR J, V8, P371, DOI 10.1183/09031936.95.08030371; Kunzli N, 2005, SWISS MED WKLY, V135, P503; LANGE P, 1990, J CLIN EPIDEMIOL, V43, P867, DOI 10.1016/0895-4356(90)90070-6; Le Marchand L, 2008, CANCER EPIDEM BIOMAR, V17, P263, DOI 10.1158/1055-9965.EPI-07-0402; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Li N, 2002, INHAL TOXICOL, V14, P459, DOI 10.1080/089583701753678571; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nickel C, 2005, BIOL CHEM, V386, P1129, DOI 10.1515/BC.2005.129; Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Siedlinski M, 2008, AM J RESP CRIT CARE, V178, P13, DOI 10.1164/rccm.200711-1749OC; Silverman Edwin K, 2009, Proc Am Thorac Soc, V6, P539, DOI 10.1513/pats.200904-021DS; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Stavem K, 2005, EUR RESPIR J, V25, P618, DOI 10.1183/09031936.05.00008504; Sunyer J, 2005, AM J RESP CRIT CARE, V172, P1139, DOI 10.1164/rccm.200504-648OC; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Tomita M, 2006, INT J MOL MED, V17, P37; Tseng CF, 2004, PROTEIN EXPRES PURIF, V33, P265, DOI 10.1016/j.pep.2003.09.006; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; van Durme YMTA, 2010, EUR RESPIR J, V36, P89, DOI 10.1183/09031936.00129509; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yang IA, 2008, THORAX, V63, P555, DOI 10.1136/thx.2007.079426; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	64	33	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40175	10.1371/journal.pone.0040175	http://dx.doi.org/10.1371/journal.pone.0040175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792237	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800046
J	Lam, CY; Yip, CW; Poon, TCW; Cheng, CKC; Ng, EWY; Wong, NCL; Cheung, PFY; Lai, PBS; Ng, IOL; Fan, ST; Cheung, ST				Lam, Ching Yan; Yip, Chi Wai; Poon, Terence C. W.; Cheng, Christine K. C.; Ng, Eddy W. Y.; Wong, Nicholas C. L.; Cheung, Phyllis F. Y.; Lai, Paul B. S.; Ng, Irene O. L.; Fan, Sheung Tat; Cheung, Siu Tim			Identification and Characterization of Tropomyosin 3 Associated with Granulin-Epithelin Precursor in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; DOMINANT NEMALINE MYOPATHY; MESSENGER-RNA; GROWTH-FACTOR; TPM3; ISOFORMS; MUTATION; CANCER; TISSUE; CELLS	Background and Aim: Granulin-epithelin precursor (GEP) has previously been reported to control cancer growth, invasion, chemo-resistance, and served as novel therapeutic target for cancer treatment. However, the nature and characteristics of GEP interacting partner remain unclear. The present study aims to identify and characterize the novel predominant interacting partner of GEP using co-immunoprecipitation and mass spectrometry. Methods and Results: Specific anti-GEP monoclonal antibody was used to capture GEP and its interacting partner from the protein extract of the liver cancer cells Hep3B. The precipitated proteins were analyzed by SDS-PAGE, followed by mass spectrometry and the protein identity was demonstrated to be tropomyosin 3 (TPM3). The interaction has been validated in additional cell models using anti-TPM3 antibody and immunoblot to confirm GEP as the interacting partner. GEP and TPM3 expressions were then examined by real-time quantitative RT-PCR in clinical samples, and their transcript levels were significantly correlated. Elevated TPM3 levels were observed in liver cancer compared with the adjacent non-tumorous liver, and patients with elevated TPM3 levels were shown to have poor recurrence-free survival. Protein expression of GEP and TPM3 was observed only in the cytoplasm of liver cancer cells by immunohistochemical staining. Conclusions: TPM3 is an interacting partner of GEP and may play an important role in hepatocarcinogenesis.	[Lam, Ching Yan; Yip, Chi Wai; Cheng, Christine K. C.; Wong, Nicholas C. L.; Cheung, Phyllis F. Y.; Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Cheung, Phyllis F. Y.; Ng, Irene O. L.; Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene O. L.; Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Poon, Terence C. W.; Ng, Eddy W. Y.] Chinese Univ Hong Kong, Dept Paediat, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Lai, Paul B. S.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene O. L.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Lam, CY (corresponding author), Govt Hong Kong SAR, Dept Hlth, Hong Kong, Hong Kong, Peoples R China.	stcheung@hku.hk	Cheung, Siu-Tim/C-4238-2009; Lai, Paul BS/K-8556-2015	Cheung, Siu-Tim/0000-0003-2147-315X; Lai, Paul BS/0000-0002-9469-6728; Ng, Irene Oi-lin/0000-0001-7532-2029	Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery, Hong Kong Research Grants Council (RGC) [GRF 764111, HKU7/CRG/09]; University of Hong Kong	Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery, Hong Kong Research Grants Council (RGC); University of Hong Kong(University of Hong Kong)	This study was supported in part by Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery, Hong Kong Research Grants Council (RGC GRF 764111 and HKU7/CRG/09), Seed Funding Program for Basic Research and Small Project Funding of the University of Hong Kong. The sponsors had no role in study design as well as in data collection, analysis and interpretation.	Alaiya AA, 1997, INT J CANCER, V73, P678, DOI 10.1002/(SICI)1097-0215(19971127)73:5<678::AID-IJC11>3.0.CO;2-2; Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Cheung ST, 2002, CANCER RES, V62, P4711; Choi HS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-122; Clarke NF, 2008, ANN NEUROL, V63, P329, DOI 10.1002/ana.21308; Cooley BC, 2001, ARCH BIOCHEM BIOPHYS, V390, P71, DOI 10.1006/abbi.2001.2347; CULOUSCOU JM, 1993, J BIOL CHEM, V268, P10458; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Franzen B, 1996, BRIT J CANCER, V73, P909, DOI 10.1038/bjc.1996.162; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Hoque M, 2005, J BIOL CHEM, V280, P13648, DOI 10.1074/jbc.M409575200; Jung MH, 2000, GENOMICS, V69, P281, DOI 10.1006/geno.2000.6338; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lamant L, 1999, BLOOD, V93, P3088; Lehtokari VL, 2008, EUR J HUM GENET, V16, P1055, DOI 10.1038/ejhg.2008.60; LIN CS, 1988, MOL CELL BIOL, V8, P160, DOI 10.1128/MCB.8.1.160; MACLEOD AR, 1986, NUCLEIC ACIDS RES, V14, P8413, DOI 10.1093/nar/14.21.8413; Ng PC, 2010, J CLIN INVEST, V120, P2989, DOI 10.1172/JCI40196; Pawlak G, 2004, INT J CANCER, V110, P368, DOI 10.1002/ijc.20151; Pelham RJ, 1996, J CELL SCI, V109, P981; Penisson-Besnier I, 2007, NEUROMUSCULAR DISORD, V17, P330, DOI 10.1016/j.nmd.2007.01.017; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; PITTENGER MF, 1994, CURR OPIN CELL BIOL, V6, P96, DOI 10.1016/0955-0674(94)90122-8; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wang FL, 1996, CANCER RES, V56, P3634; WARREN KS, 1995, J CELL BIOL, V129, P697, DOI 10.1083/jcb.129.3.697; Wysocki PJ, 2010, EXPERT OPIN INV DRUG, V19, P265, DOI 10.1517/13543780903514110; Xia XM, 1998, BIOCHEM BIOPH RES CO, V245, P539, DOI 10.1006/bbrc.1998.8498; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200	37	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40324	10.1371/journal.pone.0040324	http://dx.doi.org/10.1371/journal.pone.0040324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792281	Green Published, gold			2022-12-27	WOS:000306461800070
J	Yoshida, T; Ozawa, K; Tanaka, S				Yoshida, Takamasa; Ozawa, Katsuya; Tanaka, Shigeru			Sensitivity Profile for Orientation Selectivity in the Visual Cortex of Goggle-Reared Mice	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; IN-VIVO; MONOCULAR DEPRIVATION; SINGLE ORIENTATION; RECEPTIVE-FIELDS; CRITICAL PERIOD; ADULT MICE; SELF-ORGANIZATION; CORTICAL-NEURONS	It has been widely accepted that ocular dominance in the responses of visual cortical neurons can change depending on visual experience in a postnatal period. However, experience-dependent plasticity for orientation selectivity, which is another important response property of visual cortical neurons, is not yet fully understood. To address this issue, using intrinsic signal imaging and two-photon calcium imaging we attempted to observe the alteration of orientation selectivity in the visual cortex of juvenile and adult mice reared with head-mounted goggles, through which animals can experience only the vertical orientation. After one week of goggle rearing, the density of neurons optimally responding to the exposed orientation increased, while that responding to unexposed orientations decreased. These changes can be interpreted as a reallocation of preferred orientations among visually responsive neurons. Our obtained sensitivity profile for orientation selectivity showed a marked peak at 5 weeks and sustained elevation at 12 weeks and later. These features indicate the existence of a critical period between 4 and 7 weeks and residual orientation plasticity in adult mice. The presence of a dip in the sensitivity profile at 10 weeks suggests that different mechanisms are involved in orientation plasticity in childhood and adulthood.	[Yoshida, Takamasa; Ozawa, Katsuya; Tanaka, Shigeru] RIKEN Brain Sci Inst, Lab Visual Neurocomp, Wako, Saitama, Japan	RIKEN	Yoshida, T (corresponding author), RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama, Japan.	shigeru@uec.ac.jp		Yoshida, Takamasa/0000-0002-5508-418X	Naito Foundation [2007-140]	Naito Foundation(Naito Memorial Foundation)	The Naito Foundation (2007-140); http://www.naito-f.or.jp/index.php?lang=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BLASDEL GG, 1977, J PHYSIOL-LONDON, V265, P615, DOI 10.1113/jphysiol.1977.sp011734; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; CARLSON M, 1986, DEV BRAIN RES, V25, P71, DOI 10.1016/0165-3806(86)90153-7; Chapman B, 1999, J NEUROBIOL, V41, P18, DOI 10.1002/(SICI)1097-4695(199910)41:1<18::AID-NEU4>3.0.CO;2-V; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Gordon JA, 1996, J NEUROSCI, V16, P3274; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kreile AK, 2011, J NEUROSCI, V31, P13911, DOI 10.1523/JNEUROSCI.2143-11.2011; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; MAFFEI L, 1992, J NEUROSCI, V12, P4651; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; MILLER KD, 1994, J NEUROSCI, V14, P409; MIYASHITA M, 1992, NEUROREPORT, V3, P69, DOI 10.1097/00001756-199201000-00018; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; O'Hasi K, 2007, NEUROSCI RES, V58, P86, DOI 10.1016/j.neures.2007.01.005; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Ranson A, 2012, P NATL ACAD SCI US; RAUSCHECKER JP, 1981, J PHYSIOL-LONDON, V310, P215, DOI 10.1113/jphysiol.1981.sp013545; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Smith SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009925; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tanaka S, 2006, NEUROIMAGE, V30, P462, DOI 10.1016/j.neuroimage.2005.09.056; Tanaka S, 2004, NEURAL NETWORKS, V17, P1363, DOI 10.1016/j.neunet.2004.06.014; Tanaka S, 2007, J NEUROSCI METH, V160, P206, DOI 10.1016/j.jneumeth.2006.09.004; Tanaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005380; Trevino M, 2011, CEREB CORTE IN PRESS, P1; Tropea D, 2009, PHILOS T R SOC B, V364, P341, DOI 10.1098/rstb.2008.0269; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yoshida T., 2009, DEV LEARN IEEE INT C, P1	58	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40630	10.1371/journal.pone.0040630	http://dx.doi.org/10.1371/journal.pone.0040630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792390	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800111
J	Andrews-Zwilling, Y; Gillespie, AK; Kravitz, AV; Nelson, AB; Devidze, N; Lo, I; Yoon, SY; Bien-Ly, N; Ring, K; Zwilling, D; Potter, GB; Rubenstein, JLR; Kreitzer, AC; Huang, YD				Andrews-Zwilling, Yaisa; Gillespie, Anna K.; Kravitz, Alexxai V.; Nelson, Alexandra B.; Devidze, Nino; Lo, Iris; Yoon, Seo Yeon; Bien-Ly, Nga; Ring, Karen; Zwilling, Daniel; Potter, Gregory B.; Rubenstein, John L. R.; Kreitzer, Anatol C.; Huang, Yadong			Hilar GABAergic Interneuron Activity Controls Spatial Learning and Memory Retrieval	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; HIPPOCAMPAL-NEOCORTICAL INTERACTIONS; SOMATOSTATIN-LIKE IMMUNOREACTIVITY; LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; RETROGRADE-AMNESIA; COGNITIVE NEUROSCIENCE; HOMOVANILLIC-ACID; SENILE-DEMENTIA; DENTATE GYRUS	Background: Although extensive research has demonstrated the importance of excitatory granule neurons in the dentate gyrus of the hippocampus in normal learning and memory and in the pathogenesis of amnesia in Alzheimer's disease (AD), the role of hilar GABAergic inhibitory interneurons, which control the granule neuron activity, remains unclear. Methodology and Principal Findings: We explored the function of hilar GABAergic interneurons in spatial learning and memory by inhibiting their activity through Cre-dependent viral expression of enhanced halorhodopsin (eNpHR3.0)-a light-driven chloride pump. Hilar GABAergic interneuron-specific expression of eNpHR3.0 was achieved by bilaterally injecting adeno-associated virus containing a double-floxed inverted open-reading frame encoding eNpHR3.0 into the hilus of the dentate gyrus of mice expressing Cre recombinase under the control of an enhancer specific for GABAergic interneurons. In vitro and in vivo illumination with a yellow laser elicited inhibition of hilar GABAergic interneurons and consequent activation of dentate granule neurons, without affecting pyramidal neurons in the CA3 and CA1 regions of the hippocampus. We found that optogenetic inhibition of hilar GABAergic interneuron activity impaired spatial learning and memory retrieval, without affecting memory retention, as determined in the Morris water maze test. Importantly, optogenetic inhibition of hilar GABAergic interneuron activity did not alter short-term working memory, motor coordination, or exploratory activity. Conclusions and Significance: Our findings establish a critical role for hilar GABAergic interneuron activity in controlling spatial learning and memory retrieval and provide evidence for the potential contribution of GABAergic interneuron impairment to the pathogenesis of amnesia in AD.	[Andrews-Zwilling, Yaisa; Gillespie, Anna K.; Kravitz, Alexxai V.; Nelson, Alexandra B.; Devidze, Nino; Lo, Iris; Yoon, Seo Yeon; Bien-Ly, Nga; Ring, Karen; Zwilling, Daniel; Kreitzer, Anatol C.; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Gillespie, Anna K.; Bien-Ly, Nga; Ring, Karen; Rubenstein, John L. R.; Kreitzer, Anatol C.; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Andrews-Zwilling, Yaisa; Nelson, Alexandra B.; Zwilling, Daniel; Kreitzer, Anatol C.; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Potter, Gregory B.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Andrews-Zwilling, Y (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	yhuang@gladstone.ucsf.edu	Core, Vector/CAF-4832-2022	Kravitz, Alexxai/0000-0001-5983-0218; Potter, Gregory/0000-0002-0585-6575	J. David Gladstone Institutes; National Institutes of Health [P01 AG022074, P30 NS065780, C06RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the J. David Gladstone Institutes and National Institutes of Health Grants P01 AG022074, P30 NS065780, and C06RR18928, and a gift from the S. D. Bechtel, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; BAREGGI SR, 1982, ARCH NEUROL-CHICAGO, V39, P709, DOI 10.1001/archneur.1982.00510230035010; Bast T, 2011, CURR OPIN NEUROBIOL, V21, P492, DOI 10.1016/j.conb.2011.01.003; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Cipolotti L, 2006, CURR OPIN NEUROL, V19, P593, DOI 10.1097/01.wco.0000247608.42320.f9; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Grouselle D, 1998, NEUROSCI LETT, V255, P21, DOI 10.1016/S0304-3940(98)00698-3; HARDY J, 1987, NEUROSCI LETT, V73, P192, DOI 10.1016/0304-3940(87)90016-4; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hu JH, 2004, NEUROREPORT, V15, P9, DOI 10.1097/00001756-200401190-00003; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Lopez J, 2011, HIPPOCAMPUS, V22, P827; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; Noulhiane M, 2007, BRAIN, V130, P3184, DOI 10.1093/brain/awm258; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Sachidhanandam S, 2009, J NEUROSCI, V29, P5000, DOI 10.1523/JNEUROSCI.5807-08.2009; Seidl R, 2001, N-S ARCH PHARMACOL, V363, P139, DOI 10.1007/s002100000346; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Winocur G, 2009, LEARN MEMORY, V16, P722, DOI 10.1101/lm.1447209; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; ZIMMER R, 1984, ARCH NEUROL-CHICAGO, V41, P602, DOI 10.1001/archneur.1984.04210080010005	49	65	66	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40555	10.1371/journal.pone.0040555	http://dx.doi.org/10.1371/journal.pone.0040555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792368	Green Published, gold			2022-12-27	WOS:000306436300071
J	Goulden, EF; Hall, MR; Pereg, LL; Hoj, L				Goulden, Evan F.; Hall, Michael R.; Pereg, Lily L.; Hoj, Lone			Identification of an Antagonistic Probiotic Combination Protecting Ornate Spiny Lobster (Panulirus ornatus) Larvae against Vibrio owensii Infection	PLOS ONE			English	Article							TROPICAL ROCK LOBSTER; BIOFILM FORMATION; MARINE BACTERIUM; ANTIBACTERIAL COMPOUNDS; TURBOT LARVAE; ANGUILLARUM; AQUACULTURE; ALTERNATIVES; ANTIBIOTICS; STRAINS	Vibrio owensii DY05 is a serious pathogen causing epizootics in the larviculture of ornate spiny lobster Panulirus ornatus. In the present study a multi-tiered probiotic screening strategy was used to identify a probiotic combination capable of protecting P. ornatus larvae (phyllosomas) from experimental V. owensii DY05 infection. From a pool of more than 500 marine bacterial isolates, 91 showed definitive in vitro antagonistic activity towards the pathogen. Antagonistic candidates were shortlisted based on phylogeny, strength of antagonistic activity, and isolate origin. Miniaturized assays used a green fluorescent protein labelled transconjugant of V. owensii DY05 to assess pathogen growth and biofilm formation in the presence of shortlisted candidates. This approach enabled rapid processing and selection of candidates to be tested in a phyllosoma infection model. When used in combination, strains Vibrio sp. PP05 and Pseudoalteromonas sp. PP107 significantly and reproducibly protected P. ornatus phyllosomas during vectored challenge with V. owensii DY05, with survival not differing significantly from unchallenged controls. The present study has shown the value of multispecies probiotic treatment and demonstrated that natural microbial communities associated with wild phyllosomas and zooplankton prey support antagonistic bacteria capable of in vivo suppression of a pathogen causing epizootics in phyllosoma culture systems.	[Goulden, Evan F.; Hall, Michael R.; Hoj, Lone] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Goulden, Evan F.; Pereg, Lily L.] Univ New England, Sch Sci & Technol, Res Ctr Mol Biol, Armidale, NSW, Australia	Australian Institute of Marine Science; University of New England	Goulden, EF (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	l.hoj@aims.gov.au	Hoj, Lone/A-1307-2008; Goulden, Evan/H-9691-2014	Hoj, Lone/0000-0002-7781-8754; Goulden, Evan/0000-0003-3991-5403	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	EFG was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN B, 1995, J FISH DIS, V18, P93, DOI 10.1111/j.1365-2761.1995.tb01271.x; Bourne D, 2007, AQUACULTURE, V268, P274, DOI 10.1016/j.aquaculture.2007.04.067; Bourne DG, 2006, AQUACULTURE, V260, P27, DOI 10.1016/j.aquaculture.2006.06.023; Bourne DG, 2004, AQUACULTURE, V242, P31, DOI 10.1016/j.aquaculture.2004.08.047; Brewster JD, 2003, J MICROBIOL METH, V53, P77, DOI 10.1016/S0167-7012(02)00226-9; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Cano-Gomez A, 2010, FEMS MICROBIOL LETT, V302, P175, DOI 10.1111/j.1574-6968.2009.01850.x; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Davies J, 2007, EMBO REP, V8, P616, DOI 10.1038/sj.embor.7401022; Defoirdt T, 2007, TRENDS BIOTECHNOL, V25, P472, DOI 10.1016/j.tibtech.2007.08.001; Defoirdt T, 2011, CURR OPIN MICROBIOL, V14, P251, DOI 10.1016/j.mib.2011.03.004; Dheilly A, 2010, APPL ENVIRON MICROB, V76, P3452, DOI 10.1128/AEM.02632-09; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Fjellheim AJ, 2007, AQUACULTURE, V269, P98, DOI 10.1016/j.aquaculture.2007.04.021; Gatesoupe FJ, 1997, AQUAT LIVING RESOUR, V10, P239, DOI 10.1051/alr:1997026; Gillis RJ, 2005, ANTIMICROB AGENTS CH, V49, P3858, DOI 10.1128/AAC.49.9.3858-3867.2005; Goulden EF, 2012, APPL ENVIRON MICROB, V78, P2841, DOI 10.1128/AEM.07274-11; Gram L, 1999, APPL ENVIRON MICROB, V65, P969; Gram L, 2010, MAR BIOTECHNOL, V12, P439, DOI 10.1007/s10126-009-9233-y; Hazen TH, 2010, FEMS MICROBIOL ECOL, V74, P485, DOI 10.1111/j.1574-6941.2010.00937.x; Hjelm M, 2004, SYST APPL MICROBIOL, V27, P360, DOI 10.1078/0723-2020-00256; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Holmstrom C, 2002, FEMS MICROBIOL ECOL, V41, P47, DOI 10.1111/j.1574-6941.2002.tb00965.x; Isnansetyo A, 2009, WORLD J MICROB BIOT, V25, P1103, DOI 10.1007/s11274-009-9992-7; Jayaprakash NS, 2005, DIS AQUAT ORGAN, V68, P39, DOI 10.3354/dao068039; Jorquera M. A., 1999, Aquaculture International, V7, P433, DOI 10.1023/A:1009246007208; Karunasagar I, 1996, AQUACULTURE, V140, P241, DOI 10.1016/0044-8486(95)01180-3; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Kittaka J., 2000, SPINY LOBSTER FISHER, P465; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Longeon A, 2004, MAR BIOTECHNOL, V6, P633, DOI 10.1007/s10126-004-3009-1; Balcazar JL, 2007, J INVERTEBR PATHOL, V96, P147, DOI 10.1016/j.jip.2007.04.008; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Makridis P, 2005, AQUAC RES, V36, P1619, DOI 10.1111/j.1365-2109.2005.01388.x; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pasmore M, 2003, J IND MICROBIOL BIOT, V30, P407, DOI 10.1007/s10295-003-0069-6; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; Riquelme C, 1997, AQUACULTURE, V154, P17, DOI 10.1016/S0044-8486(97)00043-4; Sabatini P, 2010, GLOBEFISH COMMODITY; Smith G, 2009, AQUACULTURE, V295, P76, DOI 10.1016/j.aquaculture.2009.06.030; Suzuki N, 2008, MAR BIOTECHNOL, V10, P49, DOI 10.1007/s10126-007-9038-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Timmerman HM, 2004, INT J FOOD MICROBIOL, V96, P219, DOI 10.1016/j.ijfoodmicro.2004.05.012; Vaseeharan B, 2003, LETT APPL MICROBIOL, V36, P83, DOI 10.1046/j.1472-765X.2003.01255.x; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Vesterlund S, 2005, J MICROBIOL METH, V60, P225, DOI 10.1016/j.mimet.2004.09.013; Vine NG, 2006, FEMS MICROBIOL REV, V30, P404, DOI 10.1111/j.1574-6976.2006.00017.x; Webster NS, 2006, AQUACULTURE, V255, P173, DOI 10.1016/j.aquaculture.2006.01.019; Wietz M, 2010, MAR DRUGS, V8, P2946, DOI 10.3390/md8122946	53	27	27	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39667	10.1371/journal.pone.0039667	http://dx.doi.org/10.1371/journal.pone.0039667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792184	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300010
J	Matsumura, N; Kamei, M; Tsujikawa, M; Suzuki, M; Xie, P; Nishida, K				Matsumura, Nagakazu; Kamei, Motohiro; Tsujikawa, Motokazu; Suzuki, Mihoko; Xie, Ping; Nishida, Kohji			Low-Dose Lipopolysaccharide Pretreatment Suppresses Choroidal Neovascularization via IL-10 Induction	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CHLAMYDIA-PNEUMONIAE; MOLECULAR MIMICRY; MURINE MODEL; INFECTION; INFLAMMATION; ENDOTOXIN; THERAPY; TRANSLOCATION	Recent studies have suggested that some kinds of microbial infection may have a crucial role in the development of many diseases such as autoimmune diseases and certain types of cancer. It has been reported that some chronic infections, such as Chlamydia pneumoniae, and immunological dysfunctions are associated with age-related macular degeneration (AMD), a leading cause of blindness. To evaluate the association between systemic low-level inflammation induced by infection and AMD pathogenesis, we investigated whether intraperitoneal injection of lipopolysaccharide (LPS) can modulate the development of laser-induced choroidal neovascularization (CNV), a key feature of AMD. Contrary to our expectations, the sizes of CNV in mice with LPS pretreatment were approximately 65% smaller than those of the control mice. After LPS pretreatment, serum IL-10 concentration and IL-10 gene expression in peritoneal macrophages and in the posterior part of the eye increased. Peritoneal injection of anti-IL10 antibody reduced CNV suppression by LPS pretreatment. Moreover, adoptive transfer of the resident peritoneal macrophages from LPS-treated mice into control littermates resulted in an approximately 26% reduction in the size of CNV compared with PBS-treated mice. We concluded that CNV formation was suppressed by low-dose LPS pretreatment via IL-10 production by macrophages.	[Matsumura, Nagakazu; Kamei, Motohiro; Tsujikawa, Motokazu; Suzuki, Mihoko; Xie, Ping; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Osaka, Japan	Osaka University	Matsumura, N (corresponding author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Osaka, Japan.	mkamei@ophthal.med.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610; Xie, Ping/0000-0003-4257-8970	Japan Society for the Promotion of Science [KAKENHI 21592231, 21592229]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (KAKENHI 21592231, 21592229). http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Antoszyk AN, 2008, AM J OPHTHALMOL, V145, P862, DOI 10.1016/j.ajo.2007.12.029; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Epstein SE, 2000, ARTERIOSCL THROM VAS, V20, P1417, DOI 10.1161/01.ATV.20.6.1417; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Folk JC, 2010, NEW ENGL J MED, V363, P1648, DOI 10.1056/NEJMct1000495; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hasegawa E, 2012, J LEUKOCYTE BIOL, V91, P267, DOI 10.1189/jlb.1110603; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Kaiser PK, 2006, GRAEF ARCH CLIN EXP, V244, P1132, DOI 10.1007/s00417-005-0199-9; Kalayoglu MV, 2005, GRAEF ARCH CLIN EXP, V243, P1080, DOI 10.1007/s00417-005-1169-y; Kalayoglu MV, 2003, ARCH OPHTHALMOL-CHIC, V121, P478, DOI 10.1001/archopht.121.4.478; Kamei M, 2004, AM J OPHTHALMOL, V138, P574, DOI 10.1016/j.ajo.2004.05.029; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Machemer R, 1998, AM J OPHTHALMOL, V125, P698, DOI 10.1016/S0002-9394(98)00020-8; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; Miller DM, 2004, AM J OPHTHALMOL, V138, P323, DOI 10.1016/j.ajo.2004.03.018; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang JH, 2003, J IMMUNOL, V170, P14, DOI 10.4049/jimmunol.170.1.14	30	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39890	10.1371/journal.pone.0039890	http://dx.doi.org/10.1371/journal.pone.0039890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802947	Green Submitted, Green Published, gold			2022-12-27	WOS:000306186900021
J	Ha, YP; Hurt, LS; Tawiah-Agyemang, C; Kirkwood, BR; Edmond, KM				Ha, Yoonhee P.; Hurt, Lisa S.; Tawiah-Agyemang, Charlotte; Kirkwood, Betty R.; Edmond, Karen M.			Effect of Socioeconomic Deprivation and Health Service Utilisation on Antepartum and Intrapartum Stillbirth: Population Cohort Study from Rural Ghana	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MATERNAL SURVIVAL; SYSTEMATIC ANALYSIS; INFANT-MORTALITY; NEONATAL DEATHS; OBSTETRIC CARE; RISK-FACTORS; DISPARITIES; RATES	Background: No studies have examined the effect of socioeconomic deprivation on antepartum and intrapartum stillbirths in the poorest women in low income countries. Methodology/Principal Findings: This study used data from a prospective population based surveillance system involving all women of childbearing age and their babies in rural Ghana. The primary objective was to evaluate associations between household wealth and risk of antepartum and intrapartum stillbirth. The secondary objective was to assess whether any differences in risk were mediated by utilisation of health services during pregnancy. Data were analysed using multivariable logistic regression. Random effect models adjusted for clustering of women who delivered more than one infant. There were 80267 babies delivered from 1 July 2003 to 30 September 2008: 77666 live births and 2601 stillbirths. Of the stillbirths 1367 (52.6%) were antepartum, 989 (38.0%) were intrapartum and 245 (9.4%) had no data on the timing of death. 94.8% of the babies born in the study (76129/80267) had complete data on all covariates and outcomes. 36 878 (48.4%) of babies were born to women in the two poorest quintiles and 3697 (4.9%) had no pregnancy care. There was no association between wealth and antepartum stillbirths. There was a marked 'dose response' of increasing risk of intrapartum stillbirth with increasing levels of socioeconomic deprivation (adjOR 1.09 [1.03-1.16] p value 0.002). Women in the poorest two quintiles had greater risk of intrapartum stillbirth (adjOR 1.19 [1.02-1.38] p value 0.023) compared to the richest women. Adjusting for heath service utilisation and other variables did not alter results. Conclusions/Significance: Poor women had a high risk of intrapartum stillbirth and this risk was not influenced by health service utilisation. Health system strengthening is required to meet the needs of poor women in our study population.	[Ha, Yoonhee P.; Hurt, Lisa S.; Kirkwood, Betty R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Tawiah-Agyemang, Charlotte] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo, Ghana; [Edmond, Karen M.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia	University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre; University of Western Australia	Ha, YP (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	Karen.Edmond@uwa.edu.au	Hurt, Lisa/GZG-4796-2022	Hurt, Lisa/0000-0002-2741-5383; Kirkwood, Betty/0000-0001-5274-6072	United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); Marshall Aid Commemoration Commission; Wellcome Trust; University of London Central Research Fund	United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Marshall Aid Commemoration Commission; Wellcome Trust(Wellcome TrustEuropean Commission); University of London Central Research Fund	This document is an output from a project supported by the United Kingdom Department for International Development (DFID) for the benefit of developing countries; the views expressed are not necessarily those of DFID. In addition, the United States Agency for International Development (USAID) contributed funding to the initial stages of the project. YPH was funded by a Marshall Scholarship from the Marshall Aid Commemoration Commission, a Dr. Gordon Smith Travelling Scholarship from the Wellcome Trust, and a grant from the University of London Central Research Fund. The researchers are fully independent from the funders. The study funders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; nor in the decision to submit the article for publication.	[Anonymous], 2010, SOCIOECONOMIC DIFFER; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF Macro, 2009, GHAN DEM HLTH SURV; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; Guildea ZES, 2001, ARCH DIS CHILD, V84, P307, DOI 10.1136/adc.84.4.307; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; McClure EM, 2006, INT J GYNECOL OBSTET, V94, P82, DOI 10.1016/j.ijgo.2006.03.023; McClure EM, 2009, J MATERN-FETAL NEO M, V22, P183, DOI 10.1080/14767050802559129; McClure EM, 2011, ACTA OBSTET GYNECOL; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Spong CY, 2011, LANCET, V377, P1635, DOI 10.1016/S0140-6736(11)60025-1; Spong CY, 2011, OBSTET GYNECOL, V117, P948, DOI 10.1097/AOG.0b013e318211726f; Stephansson O, 2001, INT J EPIDEMIOL, V30, P1296, DOI 10.1093/ije/30.6.1296; Sutan R, 2010, J PERINATOL, V30, P311, DOI 10.1038/jp.2009.158	24	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39050	10.1371/journal.pone.0039050	http://dx.doi.org/10.1371/journal.pone.0039050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808025	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000306406700007
J	Sato, A; Ikegami, M				Sato, Atsuyasu; Ikegami, Machiko			SP-B and SP-C Containing New Synthetic Surfactant for Treatment of Extremely Immature Lamb Lung	PLOS ONE			English	Article							NATURAL SURFACTANT; PREMATURE LAMBS; PROTEIN; VENTILATION; PHOSPHATIDYLCHOLINE; EXPRESSION; ANALOGS	Although superiority of synthetic surfactant over animal-driven surfactant has been known, there is no synthetic surfactant commercially available at present. Many trials have been made to develop synthetic surfactant comparable in function to animal-driven surfactant. The efficacy of treatment with a new synthetic surfactant (CHF5633) containing dipalmitoylphosphatidylcholine, phosphatidylglycerol, SP-B analog, and SP-C analog was evaluated using immature newborn lamb model and compared with animal lung tissue-based surfactant Survanta. Lambs were treated with a clinical dose of 200 mg/kg CHF5633, 100 mg/kg Survanta, or air after 15 min initial ventilation. All the lambs treated with air died of respiratory distress within 90 min of age. During a 5 h study period, Pco(2) was maintained at 55 mmHg with 24 cmH(2)O peak inspiratory pressure for both groups. The preterm newborn lamb lung functions were dramatically improved by CHF5633 treatment. Slight, but significant superiority of CHF5633 over Survanta was demonstrated in tidal volume at 20 min and dynamic lung compliance at 20 and 300 min. The ultrastructure of CHF5633 was large with uniquely aggregated lipid particles. Increased uptake of CHF5633 by alveolar monocytes for catabolism was demonstrated by microphotograph, which might be associated with the higher treatment dose of CHF5633. The higher catabolism of CHF5633 was also suggested by the similar amount of surfactant lipid in bronchoalveolar lavage fluid (BALF) between CHF5633 and Survanta groups, despite the 2-fold higher treatment dose of CHF5633. Under the present ventilation protocol, lung inflammation was minimal for both groups, evaluated by inflammatory cell numbers in BALF and expression of IL-1 beta, IL-6, IL-8, and TNF alpha mRNA in the lung tissue. In conclusion, the new synthetic surfactant CHF5633 was effective in treating extremely immature newborn lambs with surfactant deficiency during the 5 h study period.	[Sato, Atsuyasu; Ikegami, Machiko] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Sato, A (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA.	machiko.ikegami@cchmc.org	Sato, Atsuyasu/H-9690-2016	Sato, Atsuyasu/0000-0001-8068-9984	Chiesi Farmaceutici S.p.A.	Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc)	The study was supported by Chiesi Farmaceutici S.p.A. The surfactant CHF5633 was supplied by Chiesi Farmaceutici S.p.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS FH, 1978, PEDIATR RES, V12, P841, DOI 10.1203/00006450-197808000-00008; Akei H, 2006, AM J PHYSIOL-LUNG C, V291, pL572, DOI 10.1152/ajplung.00060.2006; Almlen A, 2010, NEONATOLOGY, V98, P91, DOI 10.1159/000276980; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHU J, 1967, PEDIATRICS, V40, P709; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Ding JQ, 2001, BIOPHYS J, V80, P2262, DOI 10.1016/S0006-3495(01)76198-X; DURAND DJ, 1985, J PEDIATR-US, V107, P775, DOI 10.1016/S0022-3476(85)80416-9; ENHORNING G, 1972, PEDIATRICS, V50, P58; Epaud R, 2003, AM J RESP CELL MOL, V28, P373, DOI 10.1165/rcmb.2002-0071OC; FUJIWARA T, 1980, LANCET, V1, P55; GROSS NJ, 1989, J APPL PHYSIOL, V66, P342, DOI 10.1152/jappl.1989.66.1.342; IKEGAMI M, 1983, J PEDIATR-US, V102, P443, DOI 10.1016/S0022-3476(83)80673-8; IKEGAMI M, 1981, J APPL PHYSIOL, V51, P306, DOI 10.1152/jappl.1981.51.2.306; IKEGAMI M, 1979, PEDIATR RES, V13, P777, DOI 10.1203/00006450-197906000-00012; Ikegami M, 2006, AM J RESP CRIT CARE, V173, P1342, DOI 10.1164/rccm.200509-1485OC; IKEGAMI M, 1993, AM REV RESPIR DIS, V148, P837, DOI 10.1164/ajrccm/148.4_Pt_1.837; Ikegami M, 1998, AM J RESP CRIT CARE, V157, P638, DOI 10.1164/ajrccm.157.2.9704006; Ikegami M, 2002, J APPL PHYSIOL, V92, P519, DOI 10.1152/japplphysiol.00459.2001; Ikegami M, 2005, AM J PHYSIOL-LUNG C, V289, pL962, DOI 10.1152/ajplung.00214.2005; Ikegami M, 2009, J APPL PHYSIOL, V106, P1545, DOI 10.1152/japplphysiol.91567.2008; JOBE A, 1978, AM J OBSTET GYNECOL, V132, P53, DOI 10.1016/0002-9378(78)90798-6; JOBE A, 1983, J APPL PHYSIOL, V55, P169, DOI 10.1152/jappl.1983.55.1.169; JOBE A, 1984, J CLIN INVEST, V73, P848, DOI 10.1172/JCI111280; Jobe AH, 1996, GENE THER, V3, P775; KING RJ, 1972, AM J PHYSIOL, V223, P707, DOI 10.1152/ajplegacy.1972.223.3.707; Kramer BW, 2000, AM J PHYSIOL-LUNG C, V279, pL842, DOI 10.1152/ajplung.2000.279.5.L842; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASON RJ, 1976, J LIPID RES, V17, P281; Michna J, 1999, AM J RESP CRIT CARE, V160, P634, DOI 10.1164/ajrccm.160.2.9902016; Morris RE, 1997, J ELECTRON MICROSC, V46, P315, DOI 10.1093/oxfordjournals.jmicro.a023525; Naik AS, 2001, AM J RESP CRIT CARE, V164, P494, DOI 10.1164/ajrccm.164.3.2010127; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P10965, DOI 10.1021/bi00109a022; POULAIN FR, 1992, AM J PHYSIOL, V262, pL730, DOI 10.1152/ajplung.1992.262.6.L730; Poulain FR, 1999, AM J RESP CELL MOL, V20, P1049, DOI 10.1165/ajrcmb.20.5.3497; Ramanathan R, 2009, J PERINATOL, V29, pS38, DOI 10.1038/jp.2009.31; RICE WR, 1989, BIOCHIM BIOPHYS ACTA, V1006, P237, DOI 10.1016/0005-2760(89)90202-6; ROBILLARD E, 1964, CAN MED ASSOC J, V90, P55; Rodriguez-Capote K, 2001, AM J PHYSIOL-LUNG C, V281, pL231, DOI 10.1152/ajplung.2001.281.1.L231; Sato Atsuyasu, 2010, Am J Respir Crit Care Med, V181, P1098, DOI 10.1164/rccm.200912-1818OC; UEDA T, 1994, J APPL PHYSIOL, V76, P45, DOI 10.1152/jappl.1994.76.1.45; VORBROKER DK, 1995, AM J PHYSIOL-LUNG C, V268, pL647, DOI 10.1152/ajplung.1995.268.4.L647; Wada K, 1997, J APPL PHYSIOL, V83, P1054, DOI 10.1152/jappl.1997.83.4.1054; Walther FJ, 2002, BIOL NEONATE, V82, P181, DOI 10.1159/000063607	47	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39392	10.1371/journal.pone.0039392	http://dx.doi.org/10.1371/journal.pone.0039392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808033	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700008
J	Zhou, JC; Zheng, SW; Yu, YX; Rouleau, K; Jiang, WL; Jin, CW; Zhou, DY; Pan, KH; Yu, YS				Zhou, Jian-Cang; Zheng, San-Wei; Yu, Yun-Xian; Rouleau, Keith; Jiang, Wei-Liang; Jin, Chong-Wu; Zhou, Dao-Yang; Pan, Kong-Han; Yu, Yun-Song			Trends in Computed Tomography Utilization and Association with Hospital Outcomes in a Chinese Emergency Department	PLOS ONE			English	Article							CT; INJURY; PHYSICIAN; MEDICINE; PATIENT	Background: Excessive use of computed tomography (CT) in emergency departments (EDs) has become a concern due to its expense and the potential risks associated with radiation exposure. Although studies have shown a steady increase in the number of CT scans requested by ED physicians in developed countries like the United States and Australia, few empirical data are available regarding China. Methods and Findings: We retrospectively analyzed a database of ED visits to a tertiary Chinese hospital to examine trends in CT utilization and their association with ED outcomes between 2005 and 2008. A total of 197,512 ED visits were included in this study. CT utilization increased from 9.8% in 2005 to 13.9% in 2008 (P<.001 for trend). The ED length of stay for visits with CT utilization was 0.6 hour longer than those in which CT was not obtained. CT utilization increased the ED cost by an average $48.2. After adjustment for patients' demographics, arrival hours and clinical condition, CT utilization during ED visits was significantly associated with high ED cost (Odds Ratio [OR]: 21.70; 95% confidence interval [CI], 17.00-27.71), long ED length of stay (OR: 1.22; 95% CI, 1.12-1.34), and more likely to receive emergency operations (OR: 2.31; 95% CI, 1.94-2.76). However, there was no significant correlation between CT use and the possibility to be admitted to inpatient wards (OR: 0.82; 95% CI, 0.65-1.04). With respect to the time-related trends, CT utilization during ED visits in all study years was significantly associated with high ED cost and more likely to receive emergency operations. Conclusion: CT utilization was associated with higher ED cost, longer ED length of stay and more likely to receive emergency operations, but did not correlate with a significant change in the admission rate.	[Zhou, Jian-Cang; Jiang, Wei-Liang; Zhou, Dao-Yang; Pan, Kong-Han] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Crit Care Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, San-Wei] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Biomed Informat, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Yun-Xian] Zhejiang Univ, Coll Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Chong-Wu] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Yun-Song] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zhou, JC (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Crit Care Med, Hangzhou 310003, Zhejiang, Peoples R China.	yvys119@163.com			Medical Scientific Research Foundation of Zhejiang province, China [2010KYA109]	Medical Scientific Research Foundation of Zhejiang province, China	This study was partially supported by the Medical Scientific Research Foundation of Zhejiang province, China (No. 2010KYA109). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2010, LANCET, V376, P657, DOI 10.1016/S0140-6736(10)61315-3; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Clem KJ, 1998, ANN EMERG MED, V32, P86, DOI 10.1016/S0196-0644(98)70103-9; Gottlieb RH, 2002, RADIOLOGY, V225, P441, DOI 10.1148/radiol.2252020101; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Kirsch TD, 2011, J EMERG MED, V41, P302, DOI 10.1016/j.jemermed.2010.06.030; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Kovacs G, 1999, ACAD EMERG MED, V6, P947, DOI 10.1111/j.1553-2712.1999.tb01246.x; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Pines JM, 2009, MED CARE, V47, P782, DOI 10.1097/MLR.0b013e31819748e9; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Shiralkar S, 2003, BRIT MED J, V327, P371, DOI 10.1136/bmj.327.7411.371; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Street M, 2009, INTERN MED J, V39, P713, DOI 10.1111/j.1445-5994.2009.01956.x; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Zhou JC, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.030	20	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40403	10.1371/journal.pone.0040403	http://dx.doi.org/10.1371/journal.pone.0040403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808154	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400022
J	Gerovasileiou, V; Voultsiadou, E				Gerovasileiou, Vasilis; Voultsiadou, Eleni			Marine Caves of the Mediterranean Sea: A Sponge Biodiversity Reservoir within a Biodiversity Hotspot	PLOS ONE			English	Article							MASS-MORTALITY; SUBMARINE CAVES; DIVERSITY; DEMOSPONGIAE; PORIFERA; AFFINITIES; BIOGEOGRAPHY; HOMOSCLEROMORPHA; INVERTEBRATES; ASSEMBLAGES	Marine caves are widely acknowledged for their unique biodiversity and constitute a typical feature of the Mediterranean coastline. Herein an attempt was made to evaluate the ecological significance of this particular ecosystem in the Mediterranean Sea, which is considered a biodiversity hotspot. This was accomplished by using Porifera, which dominate the rocky sublittoral substrata, as a reference group in a meta-analytical approach, combining primary research data from the Aegean Sea (eastern Mediterranean) with data derived from the literature. In total 311 species from all poriferan classes were recorded, representing 45.7% of the Mediterranean Porifera. Demospongiae and Homoscleromorpha are highly represented in marine caves at the family (88%), generic (70%), and species level (47.5%), the latter being the most favored group along with Dictyoceratida and Lithistida. Several rare and cave-exclusive species were reported from only one or few caves, indicating the fragmentation and peculiarity of this unique ecosystem. Species richness and phylogenetic diversity varied among Mediterranean areas; the former was positively correlated with research effort, being higher in the northern Mediterranean, while the latter was generally higher in caves than in the overall sponge assemblages of each area. Resemblance analysis among areas revealed that cavernicolous sponge assemblages followed a pattern quite similar to that of the overall Mediterranean assemblages. The same pattern was exhibited by the zoogeographic affinities of cave sponges: species with Atlanto-Mediterranean distribution and Mediterranean endemics prevailed (more than 40% each), 70% of them having warm-water affinities, since most caves were studied in shallow waters. According to our findings, Mediterranean marine caves appear to be important sponge biodiversity reservoirs of high representativeness and great scientific interest, deserving further detailed study and protection.	[Gerovasileiou, Vasilis; Voultsiadou, Eleni] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki	Gerovasileiou, V (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, GR-54006 Thessaloniki, Greece.	vgerovas@bio.auth.gr	Voultsiadou, Eleni/P-9890-2017; Gerovasileiou, Vasilis/H-6376-2019	Voultsiadou, Eleni/0000-0003-3429-6754; Gerovasileiou, Vasilis/0000-0002-9143-7480	European Union; National Strategic Reference Framework - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund; Alexander S. Onassis Public Benefit Foundation	European Union(European Commission); National Strategic Reference Framework - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund; Alexander S. Onassis Public Benefit Foundation	This research has been co-financed (01/2011 up to date) by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. VG also benefited from "Alexander S. Onassis Public Benefit Foundation" fellowship for postgraduate studies (10/2009-12/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A., 2008, STATUS MARINE PROTEC; Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Aguilar Ricardo, 2011, Zootaxa, V2925, P33; Appeltans W, 2011, WORLD REGISTER MARIN; Bakran-Petricioli T, 2007, MAR ECOL-EVOL PERSP, V28, P10, DOI 10.1111/j.1439-0485.2007.00179.x; Bakran-Petricioli T, 2012, ZOOTAXA, P20, DOI 10.11646/zootaxa.3172.1.2; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2003, J MAR BIOL ASSOC UK, V83, P1199, DOI 10.1017/S002531540300849X; Bell JJ, 2000, HYDROBIOLOGIA, V440, P55, DOI 10.1023/A:1004145011422; Bell JJ, 2002, MAR ECOL-P S Z N I, V23, P297, DOI 10.1046/j.1439-0485.2002.02784.x; BenedettiCecchi L, 1997, J EXP MAR BIOL ECOL, V208, P153, DOI 10.1016/S0022-0981(96)02650-0; Bianchi Carlo Nike, 2010, Travaux Scientifiques du Parc National de Port-Cros, V24, P39; BIBILONI MA, 1989, MAR ECOL-P S Z N I, V10, P317, DOI 10.1111/j.1439-0485.1989.tb00076.x; Blanquer A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-13; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Boury-Esnault N., 2004, B MUS I BIOL U GEN, V68, P3; BOURYESNAULT N, 1971, VIE MILIEU B OCEANOG, V22, P159; BOURYESNAULT N, 1994, SPONGES IN TIME AND SPACE, P407; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Bussotti S, 2006, MAR ECOL PROG SER, V325, P109, DOI 10.3354/meps325109; Calcinai B, 2011, J MAR BIOL ASSOC UK, V91, P339, DOI 10.1017/S0025315410001050; Carballo JL, 1997, J BIOGEOGR, V24, P223, DOI 10.1046/j.1365-2699.1997.00082.x; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; Cicogna F., 2003, GROTTE MARINE CINQUA; Clarke K. R., 2001, CHANGES MARINE COMMU; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Corriero G, 2000, MAR ECOL-P S Z N I, V21, P85, DOI 10.1046/j.1439-0485.2000.00655.x; Dailianis T, 2011, MOL ECOL, V20, P3757, DOI 10.1111/j.1365-294X.2011.05222.x; Denitto F, 2007, MAR ECOL-EVOL PERSP, V28, P35, DOI 10.1111/j.1439-0485.2007.00172.x; Di Franco A, 2009, ENVIRON CONSERV, V36, P32, DOI 10.1017/S0376892909005426; Dov Por Francis, 2009, BioRisk, V3, P5; DRACH P, 1948, CR HEBD ACAD SCI, V227, P1176; Ereskovsky AV, 2011, ZOOTAXA, P5, DOI 10.11646/zootaxa.2768.1.2; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Gorley C.K., 2006, GETTING STARTED PRIM; Harmelin JG, 1997, VIE MILIEU, V47, P351; Harmelin Jean-Georges, 2003, Travaux Scientifiques du Parc National de Port-Cros, V19, P117; Harmelin JG, 1997, MAR ECOL PROG SER, V153, P139, DOI 10.3354/meps153139; HARMELIN JG, 1985, TETHYS, V11, P214; Hiscock K., 2007, MARINE BIODIVERSITY; HOBBS HH, 1994, HYDROBIOLOGIA, V287, P95, DOI 10.1007/BF00006899; Hooper J.N.A., 2002, SYSTEMA PORIFERA GUI, V1 & 2, DOI [10.1002/aqc.593, DOI 10.1002/AQC.593]; Hooper JNA, 2002, BIODIVERS CONSERV, V11, P851, DOI 10.1023/A:1015370312077; Hunter RL, 2008, J BIOGEOGR, V35, P65, DOI 10.1111/j.1365-2699.2007.01767.x; Iliffe Thomas M., 2009, Smithsonian Contributions to the Marine Sciences, P269; ILIFFE TM, 1983, NATURE, V302, P141, DOI 10.1038/302141a0; Labate M., 1965, Bollettino di Zoologia, V32, P541; Laborel J., 1958, Bulletin de l'Institut Oceanographique Monaco, V1120, P1; Lejeusne C, 2006, MOL ECOL, V15, P4123, DOI 10.1111/j.1365-294X.2006.03101.x; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; MALDONADO M, 1995, J BIOGEOGR, V22, P89, DOI 10.2307/2846075; Maldonado M, 1999, NATURE, V398, P476, DOI 10.1038/19007; Manconi R, 2009, ITAL J ZOOL, V76, P306, DOI 10.1080/11250000802629471; Manconi R, 2006, J MAR BIOL ASSOC UK, V86, P691, DOI 10.1017/S0025315406013580; Manconi R, 2008, ZOOKEYS, P71, DOI 10.3897/zookeys.4.39; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; Marti R, 2004, J MAR BIOL ASSOC UK, V84, P557, DOI 10.1017/S0025315404009567h; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Muricy G, 1996, MAR ECOL PROG SER, V138, P181, DOI 10.3354/meps138181; Olson DB, 2007, J PHYS OCEANOGR, V37, P1898, DOI 10.1175/JPO3028.1; Pansini M., 1983, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V50, P287; Pansini Maurizio, 2003, Biogeographia, V24, P59; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Peres J. M., 1949, Compte Rendu de la Societe de Biogeographie Paris, VNo. 227, P42; Peres J. M., 1958, Ann Inst Oceanogr Paris NS, V34, P213; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; PERES JM, 1966, EXPERIENTIA, V22, P417, DOI 10.1007/BF01900958; Perez T, 2004, J MAR BIOL ASSOC UK, V84, P15, DOI 10.1017/S0025315404008859h; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Perez T, 2011, MAR ECOL-EVOL PERSP, V32, P174, DOI 10.1111/j.1439-0485.2011.00435.x; Pisera A, 2011, SCI MAR, V75, P17, DOI 10.3989/scsimar.2011.75n1017; POULIQUE.L, 1969, CR ACAD SCI D NAT, V268, P1324; Pouliquen L., 1972, Tethys, V3, P717; Price ARG, 2002, MAR ECOL PROG SER, V241, P23, DOI 10.3354/meps241023; RIEDL R, 1966, BIOL MEERESHOHLEN; Roberts CM, 2003, ECOL APPL, V13, pS199; Russ K., 1959, Pubblicazioni della Stazione Zoologica di Napoli Suppl, V30, P756; Rutzler, 1965, ZOOL ANZ, V176, P303; Samaai Toufiek, 2006, Zootaxa, V1358, P1; Sara M., 1962, Archivio Zoologico Italiano, V46, P1; Sara M., 1959, Archivio Zoologico Italiano Napoli, V43, P203; Sara M, 1973, SPONGIAIRES ANATOMIE, V3, P462; Sara M., 1968, RAPP COMM INT MER ME, V19, P83; Stewart I. S, 2009, PHYS GEOGRAPHY MEDIT, P385; STOCK JH, 1986, STYGOLOGIA, V2, P90; STOCK JH, 1994, HYDROBIOLOGIA, V287, P105, DOI 10.1007/BF00006900; Terlizzi A, 2002, MAR POLLUT BULL, V44, P544, DOI 10.1016/S0025-326X(01)00282-X; Tunesi L., 1993, International Journal of Environmental Studies, V43, P253, DOI 10.1080/00207239308710832; URIZ MJ, 1992, PSZNI MAR ECOL, V13, P101; Vacelet J., 1969, Memoires du Museum Nationale d'Histoire Naturelle Paris (Ser A), V59, P145; Vacelet J., 1965, Recueil des Travaux de la Station Marine de l'Endoume Fasc Hors Ser Suppl, V4, P71; VACELET J, 1958, CR HEBD ACAD SCI, V246, P318; VACELET J, 1994, DEEP-SEA RES PT I, V41, P965, DOI 10.1016/0967-0637(94)90013-2; Vacelet J, 2007, J MAR BIOL ASSOC UK, V87, P1539, DOI 10.1017/S0025315407060687; Vacelet J, 2008, MAR ECOL-EVOL PERSP, V29, P237, DOI 10.1111/j.1439-0485.2007.00218.x; Vacelet Jean, 1998, Zoosystema, V20, P5; Vacelet Jean, 1996, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V66, P109; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; van Soest RWM, 2011, HYDROBIOLOGIA; van Soest RWM, 2012, WORLD PORIFERA DATAB; VANSOEST RWM, 1994, SPONGES IN TIME AND SPACE, P213; VanStraalen NM, 2012, Introduction to Ecological Genomics, 2nd Edition, P1; Vishnyakov AE, 2009, MAR BIOL, V156, P1625, DOI 10.1007/s00227-009-1198-x; Voultsiadou E, 2005, HELGOLAND MAR RES, V59, P237, DOI 10.1007/s10152-005-0224-8; Voultsiadou E, 2005, ITAL J ZOOL, V72, P53, DOI 10.1080/11250000509356653; Voultsiadou E, 2011, REV FISH SCI, V19, P34, DOI 10.1080/10641262.2010.531794; Voultsiadou E, 2010, ESTUAR COAST SHELF S, V86, P598, DOI 10.1016/j.ecss.2009.11.035; Voultsiadou E, 2009, HYDROBIOLOGIA, V628, P1, DOI 10.1007/s10750-009-9725-9; Woodward J.C., 2009, PHYS GEOGRAPHY MEDIT, P287, DOI [10.1093/oso/9780199268030.003.0022, DOI 10.1093/OSO/9780199268030.003.0022]; ZERVAKIS V, 2005, STATE HELLENIC MARIN, P104; [No title captured]	118	94	95	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39873	10.1371/journal.pone.0039873	http://dx.doi.org/10.1371/journal.pone.0039873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808070	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400025
J	Pollack, JB; Cleveland, A; Palmer, TA; Reisinger, AS; Montagna, PA				Pollack, Jennifer Beseres; Cleveland, Andrew; Palmer, Terence A.; Reisinger, Anthony S.; Montagna, Paul A.			A Restoration Suitability Index Model for the Eastern Oyster (Crassostrea virginica) in the Mission-Aransas Estuary, TX, USA	PLOS ONE			English	Article							PERKINSUS-MARINUS; AMERICAN OYSTER; REEFS; POPULATIONS; CONSERVATION; HYPOXIA; GMELIN	Oyster reefs are one of the most threatened marine habitats on earth, with habitat loss resulting from water quality degradation, coastal development, destructive fishing practices, overfishing, and storm impacts. For successful and sustainable oyster reef restoration efforts, it is necessary to choose sites that support long-term growth and survival of oysters. Selection of suitable sites is critically important as it can greatly influence mortality factors and may largely determine the ultimate success of the restoration project. The application of Geographic Information Systems (GIS) provides an effective methodology for identifying suitable sites for oyster reef restoration and removes much of the uncertainty involved in the sometimes trial and error selection process. This approach also provides an objective and quantitative tool for planning future oyster reef restoration efforts. The aim of this study was to develop a restoration suitability index model and reef quality index model to characterize locations based on their potential for successful reef restoration within the Mission-Aransas Estuary, Texas, USA. The restoration suitability index model focuses on salinity, temperature, turbidity, dissolved oxygen, and depth, while the reef quality index model focuses on abundance of live oysters, dead shell, and spat. Size-specific Perkinsus marinus infection levels were mapped to illustrate general disease trends. This application was effective in identifying suitable sites for oyster reef restoration, is flexible in its use, and provides a mechanism for considering alternative approaches. The end product is a practical decision-support tool that can be used by coastal resource managers to improve oyster restoration efforts. As oyster reef restoration activities continue at small and large-scales, site selection criteria are critical for assisting stakeholders and managers and for maximizing long-term sustainability of oyster resources.	[Pollack, Jennifer Beseres] Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA; [Cleveland, Andrew; Palmer, Terence A.; Reisinger, Anthony S.; Montagna, Paul A.] Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX USA; [Reisinger, Anthony S.] Texas A&M Univ, Dept Phys & Environm Sci, Corpus Christi, TX USA	Texas A&M University System; Texas A&M University System; Texas A&M University System	Pollack, JB (corresponding author), Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA.	jennifer.pollack@tamucc.edu	Palmer, Terence Aaron/J-3427-2019; Montagna, Paul A./J-8208-2017	Montagna, Paul A./0000-0003-4199-3312; Palmer, Terence/0000-0001-6602-9760	National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program [NA09NMF4720179]; Texas General Land Office Coastal Management Program [11-011-000-4309]; Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi	National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program; Texas General Land Office Coastal Management Program; Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi	This study was supported by grant number NA09NMF4720179 from the National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program, and grant number 11-011-000-4309 from the Texas General Land Office Coastal Management Program. Partial support was also provided by the Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN R L, 1989, Journal of Shellfish Research, V8, P95; Allen YC, 2005, ESTUARIES, V28, P435, DOI 10.1007/BF02693925; Andrews JD, 1988, AM FISH SOC SPEC PUB, V18, P257; Barnes TK, 2007, J SHELLFISH RES, V26, P949, DOI 10.2983/0730-8000(2007)26[949:AHSIMF]2.0.CO;2; Battista TA, 1999, THESIS U MARYLAND, P111; Beck M. W., 2009, SHELLFISH REEFS RISK; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Breitburg DL, 2000, J SHELLFISH RES, V19, P371; Brown Stephen K., 2000, North American Journal of Fisheries Management, V20, P408, DOI 10.1577/1548-8675(2000)020<0408:HSIMFE>2.3.CO;2; Brumbaugh RD, 2006, PRACTITIONERS GUIDE, P32; Buczkowski B.J., 2006, US GEOL SURV DATA SE; Cake EW, 1983, FWSOBS82105737 US DE; Carlsson J, 2008, J SHELLFISH RES, V27, P1117, DOI 10.2983/0730-8000-27.5.1117; Carnegie RB, 2011, MAR ECOL PROG SER, V432, P1, DOI 10.3354/meps09221; Chu FLE, 1996, J SHELLFISH RES, V15, P57; CRAIG A, 1989, ESTUARIES, V12, P82, DOI 10.2307/1351499; Curnutt JL, 2000, ECOL APPL, V10, P1849, DOI 10.1890/1051-0761(2000)010[1849:LBSESI]2.0.CO;2; de Zwaan A., 1983, P137; Dellapenna TM, 2007, 11 TEX GEN LAND OFF; DORAN E, 1965, GEOGR REV, V55, P223, DOI 10.2307/212711; Economio VG, 2005, J SHELLFISH RES, V24, P143; Ford SE, 1996, E OYSTER CRASSOSTREA; Gribov A, 2011, STOCH ENV RES RISK A, V25, P1057, DOI 10.1007/s00477-011-0488-2; Grizzle RE, 2005, AM FISH S S, V41, P153; Haby MG, 2009, TAMUSG09201 COLL STA; Hargis W. J, 1999, OYSTER REEF HABITAT; Kennedy RJ, 1999, BIOL ENVIRON, V99B, P79; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; Levinton J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018849; Livingston RJ, 1997, ECOL APPL, V7, P277, DOI 10.1890/1051-0761(1997)007[0277:FITAGE]2.0.CO;2; Loosanoff V.L., 1953, P NATL SHELLFISH ASS, V43, P135; Loosanoff V.L., 1948, P NATL SHELLFISH ASS, V1947, P40; MACKENZIE CL, 1977, MAR FISH REV, V39, P1; MACKIN JOHN G., 1961, PUBL INST MAR SCI [PORT ARANSAS TEXAS], V7, P132; McKinley JCJ, 2009, TOUGH SEASON MAY FOR; Menzel R. W, 1958, P NATL SHELLFISH ASS, V48, P66; NOAA, 1990, EST US VIT STAT NAT; Orlando S.P., 1993, CHARACTERISTICS GULF; POWELL EN, 1995, FISH RES, V24, P199, DOI 10.1016/0165-7836(95)00370-P; Powell EN, 2007, N AM J FISH MANAGE, V27, P492, DOI 10.1577/M04-205.1; Ray S.M., 1966, P NATL SHELLFISH ASS, P55; Schoenbaechler C., 2011, COASTAL HYDROLOGY MI, P15; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Shumway S.E., 1996, E OYSTER CRASSOSTREA; Smith RW, 2001, ECOL APPL, V11, P1073, DOI 10.1890/1051-0761(2001)011[1073:BRIFAI]2.0.CO;2; Soniat TM, 1998, J SHELLFISH RES, V17, P1149; SONIAT TM, 1988, ESTUARIES, V11, P87, DOI 10.2307/1351995; Starke A, 2011, J SHELLFISH RES, V30, P671, DOI 10.2983/035.030.0309; Upton HF, 2011, R41640 CONGR RES SER; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; WIDDOWS J, 1989, BIOL BULL, V177, P154, DOI 10.2307/1541843; Williams N, 2010, CURR BIOL, V20, pR613, DOI 10.1016/j.cub.2010.07.019	52	46	47	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40839	10.1371/journal.pone.0040839	http://dx.doi.org/10.1371/journal.pone.0040839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792410	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400104
J	Widaa, A; Claro, T; Foster, TJ; O'Brien, FJ; Kerrigan, SW				Widaa, Amro; Claro, Tania; Foster, Timothy J.; O'Brien, Fergal J.; Kerrigan, Steven W.			Staphylococcus aureus Protein A Plays a Critical Role in Mediating Bone Destruction and Bone Loss in Osteomyelitis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FIBRONECTIN-BINDING PROTEINS; EXPERIMENTAL-MODEL; JOINT DESTRUCTION; EPITHELIAL-CELLS; OSTEOBLASTS; APOPTOSIS; MATRIX; INTERNALIZATION; MINERALIZATION	Staphylococcus aureus is the most frequent causative organism of osteomyelitis. It is characterised by widespread bone loss and bone destruction. Previously we demonstrated that S. aureus protein A (SpA) is capable of binding to tumour necrosis factor receptor-1 expressed on pre-osteoblastic cells, which results in signal generation that leads to cell apoptosis resulting in bone loss. In the current report we demonstrate that upon S. aureus binding to osteoblasts it also inhibits de novo bone formation by preventing expression of key markers of osteoblast growth and division such as alkaline phosphatase, collagen type I, osteocalcin, osteopontin and osteocalcin. In addition, S. aureus induces secretion of soluble RANKL from osteoblasts which in turn recruits and activates the bone resorbing cells, osteoclasts. A strain of S. aureus defective in SpA failed to affect osteoblast growth or proliferation and most importantly failed to recruit or activate osteoclasts. These results suggest that S. aureus SpA binding to osteoblasts provides multiple coordinated signals that accounts for bone loss and bone destruction seen in osteomyelitis cases. A better understanding of the mechanisms through which S. aureus leads to bone infection may improve treatment or lead to the development of better therapeutic agents to treat this notoriously difficult disease.	[Widaa, Amro; Claro, Tania; Kerrigan, Steven W.] Royal Coll Surgeons Ireland, Microbial Infect Grp, Dublin 2, Ireland; [Widaa, Amro; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland; [Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland; [O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Kerrigan, Steven W.] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Widaa, A (corresponding author), Royal Coll Surgeons Ireland, Microbial Infect Grp, Dublin 2, Ireland.	skerrigan@rcsi.ie	O'Brien, Fergal/F-9485-2011	O'Brien, Fergal/0000-0003-2030-8005	Science Foundation of Ireland [BMT/2008/1709]	Science Foundation of Ireland(Science Foundation Ireland)	Science Foundation of Ireland Research Frontiers Programme awarded to SWK (no. BMT/2008/1709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Berendt T, 2004, CLIN MED, V4, P510, DOI 10.7861/clinmedicine.4-6-510; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Bu RF, 2003, BONE, V33, P760, DOI 10.1016/j.bone.2003.07.006; CEDERGREN L, 1993, PROTEIN ENG, V6, P441, DOI 10.1093/protein/6.4.441; Claro T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018748; Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Evans CAW, 1998, J INFECT DIS, V177, P1582, DOI 10.1086/515313; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Garcia-Alvarez F, 2009, BIOGERONTOLOGY, V10, P649, DOI 10.1007/s10522-008-9211-1; Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1016/S0378-1097(99)00079-8; Klosterhalfen B, 1996, J TRAUMA, V40, P372, DOI 10.1097/00005373-199603000-00008; Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; LI NG, 1991, BIOCHEM BIOPH RES CO, V179, P236, DOI 10.1016/0006-291X(91)91360-O; Menzies BE, 1998, INFECT IMMUN, V66, P5994, DOI 10.1128/IAI.66.12.5994-5998.1998; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; O'Seaghdha M, 2006, FEBS J, V273, P4831, DOI 10.1111/j.1742-4658.2006.05482.x; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PIVIROTTO LA, 1995, MOL CELL ENDOCRINOL, V111, P67, DOI 10.1016/0303-7207(95)03549-M; Rao NL, 2011, PLAST RECONSTR SURG, V127, p177S, DOI 10.1097/PRS.0b013e3182001f0f; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Redlich K, 2002, ARTHRITIS RHEUM, V46, P785, DOI 10.1002/art.10097; ROACH HI, 1994, CELL BIOL INT, V18, P617, DOI 10.1006/cbir.1994.1088; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Rosenquist JB, 1996, INFLAMM RES, V45, P457, DOI 10.1007/BF02252317; TAICHMAN RS, 1992, INFLAMMATION, V16, P587, DOI 10.1007/BF00919342; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tucker KA, 2000, FEMS MICROBIOL LETT, V186, P151, DOI 10.1016/S0378-1097(00)00125-7; UHLEN M, 1984, J BACTERIOL, V159, P713; Wesson CA, 2000, INFECT IMMUN, V68, P2998, DOI 10.1128/IAI.68.5.2998-3001.2000; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003; Yoshii T, 2002, CYTOKINE, V19, P59, DOI 10.1006/cyto.2002.1039	45	103	107	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40586	10.1371/journal.pone.0040586	http://dx.doi.org/10.1371/journal.pone.0040586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792377	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400075
J	Palha, T; Gusmao, L; Ribeiro-Rodrigues, E; Guerreiro, JF; Ribeiro-dos-Santos, A; Santos, S				Palha, Teresinha; Gusmao, Leonor; Ribeiro-Rodrigues, Elzemar; Guerreiro, Joao Farias; Ribeiro-dos-Santos, Andrea; Santos, Sidney			Disclosing the Genetic Structure of Brazil through Analysis of Male Lineages with Highly Discriminating Haplotypes	PLOS ONE			English	Article							Y-CHROMOSOME; POPULATION; DIVERSITY; STRS; AMERICANS; AMAZON; LOCI	In a large variety of genetic studies, probabilistic inferences are made based on information available in population databases. The accuracy of the estimates based on population samples are highly dependent on the number of chromosomes being analyzed as well as the correct representation of the reference population. For frequency calculations the size of a database is especially critical for haploid markers, and for countries with complex admixture histories it is important to assess possible substructure effects that can influence the coverage of the database. Aiming to establish a representative Brazilian population database for haplotypes based on 23 Y chromosome STRs, more than 2,500 Y chromosomes belonging to Brazilian, European and African populations were analyzed. No matter the differences in the colonization history of the five geopolitical regions that currently exist in Brazil, for the Y chromosome haplotypes of the 23 studied Y-STRs, a lack of genetic heterogeneity was found, together with a predominance of European male lineages in all regions of the country. Therefore, if we do not consider the diverse Native American or Afro-descendent isolates, which are spread through the country, a single Y chromosome haplotype frequency database will adequately represent the urban populations in Brazil. In comparison to the most commonly studied group of 17 Y-STRs, the 23 markers included in this work allowed a high discrimination capacity between haplotypes from non-related individuals within a population and also increased the capacity to discriminate between paternal relatives. Nevertheless, the expected haplotype mutation rate is still not enough to distinguish the Y chromosome profiles of paternally related individuals. Indeed, even for rapidly mutating Y-STRs, a very large number of markers will be necessary to differentiate male lineages from paternal relatives.	[Palha, Teresinha; Gusmao, Leonor; Ribeiro-Rodrigues, Elzemar; Guerreiro, Joao Farias; Ribeiro-dos-Santos, Andrea; Santos, Sidney] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Gusmao, Leonor] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4100 Oporto, Portugal	Universidade Federal do Para; Universidade do Porto	Palha, T (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	tecaufpa@yahoo.com.br	Gusmao, Leonor/B-3122-2013; Santos, Ândrea Ribeiro dos/B-6061-2013; Gusmão, Leonor/L-8931-2019; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019	Gusmao, Leonor/0000-0003-0432-6481; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Gusmão, Leonor/0000-0003-0432-6481; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483	Brazilian science foundation Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Pro-Reitoria de Pesquisa da Universidade Federal do Para (PROPESP/UFPA); Fundacao de Amparo e Desenvolvimento da Pesquisa (FADESP); CAPES/Brasil	Brazilian science foundation Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Pro-Reitoria de Pesquisa da Universidade Federal do Para (PROPESP/UFPA); Fundacao de Amparo e Desenvolvimento da Pesquisa (FADESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Brazilian science foundation Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), Pro-Reitoria de Pesquisa da Universidade Federal do Para (PROPESP/UFPA), Fundacao de Amparo e Desenvolvimento da Pesquisa (FADESP). LG is supported by a grant from CAPES/Brasil. The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Ballantyne KN, 2011, FORENSIC SCI IN 0523; Palha TDBF, 2011, AM J PHYS ANTHROPOL, V144, P471, DOI 10.1002/ajpa.21436; Brenner CH, 2010, FORENSIC SCI INT-GEN, V4, P281, DOI 10.1016/j.fsigen.2009.10.013; Buckleton JS, 2011, FORENSIC SCI INT-GEN, V5, P78, DOI 10.1016/j.fsigen.2011.01.010; Carvalho-Silva DR, 2006, GENETICA, V126, P251, DOI 10.1007/s10709-005-1454-z; Curtin PD, 1969, ATLANTIC SLAVE TRACE; Domingues PM, 2007, INT J LEGAL MED, V121, P238, DOI 10.1007/s00414-007-0154-x; Dos Santos SEB, 2009, HUM BIOL, V81, P71, DOI 10.3378/027.081.0106; Egeland T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003988; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fausto B., 2006, HIST CONCISA BRASIL; Palha TDJBF, 2007, FORENSIC SCI INT, V166, P233, DOI 10.1016/j.forsciint.2005.12.012; Goes ACD, 2005, INT J LEGAL MED, V119, P70, DOI 10.1007/s00414-004-0504-x; Gois CC, 2008, FORENSIC SCI INT, V174, P80, DOI 10.1016/j.forsciint.2006.12.018; GOMES Flvio S., 1996, LIBERDADE FIO HIST Q; Grattapaglia D, 2005, FORENSIC SCI INT, V149, P99, DOI 10.1016/j.forsciint.2004.06.003; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; Hanson EK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000688; IBGE, 2012, BRAS 500 AN POV; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; NEVES WA, 1991, J HUM EVOL, V21, P261, DOI 10.1016/0047-2484(91)90107-7; Nunes ACS, 2011, LEGAL MED-TOKYO, V13, P161, DOI 10.1016/j.legalmed.2010.12.007; PALACIN L, 1994, HIST GOIAS; Palha T, 2011, FOR SCI INT GEN 0808; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pereira RW, 2007, FORENSIC SCI INT, V171, P226, DOI 10.1016/j.forsciint.2006.06.008; Quintana-Murci L, 2001, FORENSIC SCI INT, V118, P169, DOI 10.1016/S0379-0738(01)00387-5; Redd AJ, 2006, J FORENSIC SCI, V51, P580, DOI 10.1111/j.1556-4029.2006.00113.x; Roewer L, 2009, FORENSIC SCI MED PAT, V5, P77, DOI 10.1007/s12024-009-9089-5; Sambrook J., 1989, MOL CLONING, P916; Schwengber SP, 2009, FORENSIC SCI INT-GEN, V4, pE31, DOI 10.1016/j.fsigen.2009.02.001; Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358; Willuweit S, 2011, FORENSIC SCI INT-GEN, V5, P84, DOI 10.1016/j.fsigen.2010.10.014; Wolfgramm ED, 2011, FORENSIC SCI INT-GEN, V5, pE41, DOI 10.1016/j.fsigen.2010.05.001	35	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40007	10.1371/journal.pone.0040007	http://dx.doi.org/10.1371/journal.pone.0040007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808085	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500021
J	Anand, V; Dogra, N; Singh, S; Kumar, SN; Jena, MK; Malakar, D; Dang, AK; Mishra, BP; Mukhopadhyay, TK; Kaushik, JK; Mohanty, AK				Anand, Vijay; Dogra, Nilambra; Singh, Surender; Kumar, Sudarshan N.; Jena, Manoj K.; Malakar, Dhruba; Dang, Ajay K.; Mishra, Bishnu P.; Mukhopadhyay, Tapas K.; Kaushik, Jai K.; Mohanty, Ashok K.			Establishment and Characterization of a Buffalo (Bubalus bubalis) Mammary Epithelial Cell Line	PLOS ONE			English	Article							GENE-EXPRESSION; MAC-T; BOVINE; CULTURE; DIFFERENTIATION; GLAND; MODEL; MORPHOGENESIS; SECRETION; PROTEIN	Background: The objective of this study was to establish the buffalo mammary epithelial cell line (BuMEC) and characterize its mammary specific functions. Methodology: Buffalo mammary tissue collected from the slaughter house was processed enzymatically to obtain a heterogenous population of cells containing both epithelial and fibroblasts cells. Epithelial cells were purified by selective trypsinization and were grown in a plastic substratum. The purified mammary epithelial cells (MECs) after several passages were characterized for mammary specific functions by immunocytochemistry, RT-PCR and western blot. Principal Findings: The established buffalo mammary epithelial cell line (BuMEC) exhibited epithelial cell characteristics by immunostaining positively with cytokeratin 18 and negatively with vimentin. The BuMEC maintained the characteristics of its functional differentiation by expression of beta-casein, kappa-casein, butyrophilin and lactoferrin. BuMEC had normal growth properties and maintained diploid chromosome number (2n = 50) before and after cryopreservation. A spontaneously immortalized buffalo mammary epithelial cell line was established after 20 passages and was continuously subcultured for more than 60 passages without senescence. Conclusions: We have established a buffalo mammary epithelial cell line that can be used as a model system for studying mammary gland functions.	[Anand, Vijay; Singh, Surender; Kumar, Sudarshan N.; Jena, Manoj K.; Malakar, Dhruba; Dang, Ajay K.; Kaushik, Jai K.; Mohanty, Ashok K.] NDRI, Karnal, Haryana, India; [Dogra, Nilambra; Mukhopadhyay, Tapas K.] Punjab Univ, NCHGSR, Chandigarh 160014, India; [Mishra, Bishnu P.] IVRI, Izatnagar, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Panjab University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Anand, V (corresponding author), NDRI, Karnal, Haryana, India.	ashokmohanty1@gmail.com	Jena, M/AGM-1989-2022; Anand, Vijay/GLT-5411-2022; Dang, Ajay Kumar/AAB-4090-2019	Dang, Ajay Kumar/0000-0002-7306-5302; Anand, Vijay/0000-0002-4061-9946; Kaushik, Jai/0000-0002-8872-0066; Jena, Manoj/0000-0003-3847-8539; Kumar, Sudarshan/0000-0002-9816-4307	"National Agriculture Innovation Project (NAIP)", Indian Council of Agricultural Research, Government of India; "Department of Biotechnology (DBT)", Ministry of Science and Technology, Government of India	"National Agriculture Innovation Project (NAIP)", Indian Council of Agricultural Research, Government of India; "Department of Biotechnology (DBT)", Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The research was supported jointly by "National Agriculture Innovation Project (NAIP)", Indian Council of Agricultural Research, Government of India and "Department of Biotechnology (DBT)", Ministry of Science and Technology, Government of India. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript".	AHN JY, 1995, BIOSCI BIOTECH BIOCH, V59, P59, DOI 10.1271/bbb.59.59; Aoki N, 2006, BIOSCI BIOTECH BIOCH, V70, P2019, DOI 10.1271/bbb.60142; BARTEK J, 1985, J CELL SCI, V75, P17; BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557; BERDICHEVSKY F, 1992, J CELL SCI, V102, P437; CIFRIAN E, 1994, J DAIRY SCI, V77, P970, DOI 10.3168/jds.S0022-0302(94)77033-8; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duchler M, 1998, BIOL CELL, V90, P199, DOI 10.1016/S0248-4900(98)80340-7; FRANKE WW, 1981, J CELL BIOL, V89, P485, DOI 10.1083/jcb.89.3.485; GIBSON CA, 1991, IN VITRO CELL DEV B, V27, P585, DOI 10.1007/BF02631290; Gordon KE, 2000, BREAST CANCER RES, V2, P222, DOI 10.1186/bcr57; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; HURLEY WL, 1989, J DAIRY SCI, V72, P1637, DOI 10.3168/jds.S0022-0302(89)79276-6; HUYNH H, 1995, IN VITRO CELL DEV-AN, V31, P25, DOI 10.1007/BF02631334; HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q; IANNUZZI L, 1994, CYTOGENET CELL GENET, V67, P102; Ilan N, 1998, IN VITRO CELL DEV-AN, V34, P326; Kim H, 2002, BIOCHEM J, V365, P765, DOI 10.1042/BJ20011848; KNIGHT CH, 1984, Q J EXP PHYSIOL CMS, V69, P331, DOI 10.1113/expphysiol.1984.sp002809; Kumura H, 2001, BIOSCI BIOTECH BIOCH, V65, P2098, DOI 10.1271/bbb.65.2098; Larson B. L., 1985, Lactation, P129; LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419; LEVINE JF, 1984, EXP CELL RES, V151, P112, DOI 10.1016/0014-4827(84)90361-6; Martinet J., 1999, BIOL LACTATION; MATHER IH, 1993, J DAIRY SCI, V76, P3832, DOI 10.3168/jds.S0022-0302(93)77726-7; MORK C, 1990, DIFFERENTIATION, V43, P146; Ouyang WQ, 1999, CHIN J VET SCI, V19, P561; Pantschenko AG, 2000, IN VITRO CELL DEV-AN, V36, P26, DOI 10.1290/1071-2690(2000)036<0026:EACOAC>2.0.CO;2; PARRY G, 1987, J CELL BIOL, V105, P2043, DOI 10.1083/jcb.105.5.2043; PETRITESMURPHY MB, 1992, VET PATHOL, V29, P552, DOI 10.1177/030098589202900614; PICKETT PB, 1975, J CELL BIOL, V66, P316, DOI 10.1083/jcb.66.2.316; Riley LG, 2010, ANIM GENET, V41, P55, DOI 10.1111/j.1365-2052.2009.01964.x; Rosen J. M., 1985, UCLA Symposia on Molecular and Cellular Biology, V23, P385; SCHMID E, 1983, J CELL BIOL, V96, P37, DOI 10.1083/jcb.96.1.37; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; STRANGE R, 1991, CELL GROWTH DIFFER, V2, P549; Sun YL, 2006, CELL BIOL INT, V30, P970, DOI 10.1016/j.cellbi.2006.06.023; TALHOUK RS, 1990, TISSUE CELL, V22, P583, DOI 10.1016/0040-8166(90)90057-G; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Tong HL, 2012, IN VITRO CELL DEV-AN, V48, P149, DOI 10.1007/s11626-012-9481-4; United Nations Food and Agriculture Organization, 2000, WAT BUFF ASS UND; WARBURTON MJ, 1981, EXP CELL RES, V132, P57, DOI 10.1016/0014-4827(81)90082-3; Wheeler TT, 2001, MOL CELL ENDOCRINOL, V176, P39, DOI 10.1016/S0303-7207(01)00481-6; Wilde CJ, 1999, J MAMMARY GLAND BIOL, V4, P129, DOI 10.1023/A:1018717006152; ZAVIZION B, 1992, J DAIRY SCI, V75, P3381, DOI 10.3168/jds.S0022-0302(92)78114-4; Zavizion B, 1996, IN VITRO CELL DEV-AN, V32, P138, DOI 10.1007/BF02723679; ZAVIZION B, 1995, J DAIRY SCI, V78, P515, DOI 10.3168/jds.S0022-0302(95)76662-0; Zavizion B., 1995, Methods in Cell Science, V17, P271, DOI 10.1007/BF00986233; Zhang K, 1998, SHENG WU GONG CHENG, V13, P271; Zhao CF, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-82; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023; Zheng YM, 2010, RES VET SCI, V89, P383, DOI 10.1016/j.rvsc.2010.03.023; Zucchi I, 2002, J MAMMARY GLAND BIOL, V7, P373, DOI 10.1023/A:1024081914634	54	37	41	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40469	10.1371/journal.pone.0040469	http://dx.doi.org/10.1371/journal.pone.0040469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792341	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700053
J	Hammerschmidt, A; Chatterji, B; Zeiser, J; Schroder, A; Genieser, HG; Pich, A; Kaever, V; Schwede, F; Wolter, S; Seifert, R				Hammerschmidt, Andreas; Chatterji, Bijon; Zeiser, Johannes; Schroeder, Anke; Genieser, Hans-Gottfried; Pich, Andreas; Kaever, Volkhard; Schwede, Frank; Wolter, Sabine; Seifert, Roland			Binding of Regulatory Subunits of Cyclic AMP-Dependent Protein Kinase to Cyclic CMP Agarose	PLOS ONE			English	Article							CYTIDINE 3',5'-MONOPHOSPHATE CCMP; MAMMALIAN-TISSUES; CYCLASE ACTIVITY; CAMP; CGMP; 5'-MONOPHOSPHATE; NUCLEOTIDES; ACTIVATION; MECHANISM; SYSTEM	The bacterial adenylyl cyclase toxins CyaA from Bordetella pertussis and edema factor from Bacillus anthracis as well as soluble guanylyl cyclase alpha(1)beta(1) synthesize the cyclic pyrimidine nucleotide cCMP. These data raise the question to which effector proteins cCMP binds. Recently, we reported that cCMP activates the regulatory subunits RI alpha and RII alpha of cAMP-dependent protein kinase. In this study, we used two cCMP agarose matrices as novel tools in combination with immunoblotting and mass spectrometry to identify cCMP-binding proteins. In agreement with our functional data, RI alpha and RII alpha were identified as cCMP-binding proteins. These data corroborate the notion that cAMP-dependent protein kinase may serve as a cCMP target.	[Hammerschmidt, Andreas; Kaever, Volkhard; Wolter, Sabine; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany; [Chatterji, Bijon; Zeiser, Johannes; Schroeder, Anke; Pich, Andreas] Hannover Med Sch, Inst Toxicol, D-3000 Hannover, Germany; [Genieser, Hans-Gottfried; Schwede, Frank] Biolog Life Sci Inst, Bremen, Germany	Hannover Medical School; Hannover Medical School	Hammerschmidt, A (corresponding author), Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany.	seifert.roland@mh-hannover.de	Kaever, Volkhard/G-3280-2013; Seifert, Roland/G-3189-2013	Zeiser, Johannes/0000-0001-5518-2137; Genieser, Hans-Gottfried/0000-0002-4904-5790	Hannover Biomedical Research School; Deutsche Forschungsgemeinschaft [Se 529/5-2]	Hannover Biomedical Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Hannover Biomedical Research School to A. H. and Deutsche Forschungsgemeinschaft grant Se 529/5-2 to R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TR, 1982, MOL CELL ENDOCRINOL, V28, P373, DOI 10.1016/0303-7207(82)90134-4; Bertinetti Daniela, 2009, BMC Chem Biol, V9, P3, DOI 10.1186/1472-6769-9-3; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; BLOCH A, 1974, BIOCHEM BIOPH RES CO, V59, P955, DOI 10.1016/S0006-291X(74)80072-0; Burhenne H, 2011, N-S ARCH PHARMACOL S, V38, pP096; CECH SY, 1977, SCIENCE, V198, P1063, DOI 10.1126/science.22127; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; CORRIE JET, 1992, PROTEIN EXPRES PURIF, V3, P417, DOI 10.1016/S1046-5928(05)80044-0; Desch M, 2010, FEBS LETT, V584, P3979, DOI 10.1016/j.febslet.2010.07.059; GAION RM, 1979, BIOCHEM BIOPH RES CO, V86, P105, DOI 10.1016/0006-291X(79)90387-5; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; Hanke SE, 2011, NEW BIOTECHNOL, V28, P294, DOI 10.1016/j.nbt.2010.12.001; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KUO JF, 1978, J BIOL CHEM, V253, P2518; RALPH P, 1975, NATURE, V257, P393, DOI 10.1038/257393a0; Reinecke D, 2011, FEBS LETT, V585, P3259, DOI 10.1016/j.febslet.2011.09.004; Sager G, 2009, MINI-REV MED CHEM, V9, P1009, DOI 10.2174/138955709788681654; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SCOFIELD RE, 1977, ANAL BIOCHEM, V77, P152, DOI 10.1016/0003-2697(77)90300-1; Taylor SS, 2004, BIOCHIM BIOPHYS ACTA, V697, P259; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093	25	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39848	10.1371/journal.pone.0039848	http://dx.doi.org/10.1371/journal.pone.0039848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808067	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700019
J	Pless-Petig, G; Singer, BB; Rauen, U				Pless-Petig, Gesine; Singer, Bernhard B.; Rauen, Ursula			Cold Storage of Rat Hepatocyte Suspensions for One Week in a Customized Cold Storage Solution - Preservation of Cell Attachment and Metabolism	PLOS ONE			English	Article							LIVER ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; HYPOTHERMIC PRESERVATION; CHELATABLE IRON; CULTURED-HEPATOCYTES; ORGAN PRESERVATION; HYPOXIC INJURY; GLYCINE; MEDIA; GLUTATHIONE	Background & Aims: Primary hepatocytes are of great importance for basic research as well as cell transplantation. However, their stability, especially in suspension, is very low. This feature severely compromises storage and shipment. Based on previous studies with adherent cells, we here assessed cold storage injury in rat hepatocyte suspensions and aimed to find a cold storage solution that preserves viability, attachment ability and functionality of these cells. Methods: Rat hepatocyte suspensions were stored in cell culture medium, organ preservation solutions and modified TiProtec solutions at 4 degrees C for one week. Viability and cell volume were determined by flow cytometry. Thereafter, cells were seeded and density and metabolic capacity (reductive metabolism, forskolin-induced glucose release, urea production) of adherent cells were assessed. Results: Cold storage injury in hepatocyte suspensions became evident as cell death occurring during cold storage or rewarming or as loss of attachment ability. Cell death during cold storage was not dependent on cell swelling and was almost completely inhibited in the presence of glycine and L-alanine. Cell attachment could be greatly improved by use of chloride-poor solutions and addition of iron chelators. Using a chloride-poor, potassium-rich storage solution containing glycine, alanine and iron chelators, cultures with 75% of the density of control cultures and with practically normal cell metabolism could be obtained after one week of cold storage. Conclusion: In the solution presented here, cold storage injury of hepatocyte suspensions, differing from that of adherent hepatocytes, was effectively inhibited. The components which acted on the different injurious processes were identified.	[Pless-Petig, Gesine; Rauen, Ursula] Univ Klinikum Essen, Inst Physiol Chem, Essen, Germany; [Singer, Bernhard B.] Univ Klinikum Essen, Inst Anat, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Pless-Petig, G (corresponding author), Univ Klinikum Essen, Inst Physiol Chem, Essen, Germany.	ursula.rauen@uni-duisburg-essen.de	Pless-Petig, Gesine/F-3639-2010; Rauen, Ursula/N-2137-2014; Singer, Bernhard B./AAP-9999-2020	Pless-Petig, Gesine/0000-0001-8843-6607; 	Deutsche Forschungsgemeinschaft [RA 960/1-3]; Franz Kohler Chemie GmbH, Bensheim, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Franz Kohler Chemie GmbH, Bensheim, Germany	This study was supported by the Deutsche Forschungsgemeinschaft (RA 960/1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; U. Rauen obtained consulting fees from Dr. Franz Kohler Chemie GmbH, Bensheim, Germany. Dr. F. Kohler Chemie GmbH holds a patent on a preservation solution, covering most of the modified solutions used in this study; U. Rauen is one of the inventors mentioned in the patent. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.	Bakala A, 2007, POL J VET SCI, V10, P11; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; BRECHT M, 1994, AMINO ACIDS, V6, P25, DOI 10.1007/BF00808120; Carini R, 1997, HEPATOLOGY, V26, P107, DOI 10.1002/hep.510260114; DEGROOT H, 1991, BIOL CHEM H-S, V372, P35, DOI 10.1515/bchm3.1991.372.1.35; Frank A, 2000, J HEPATOL, V32, P58, DOI 10.1016/S0168-8278(00)80190-7; Fuckert O, 2000, TRANSPLANTATION, V70, P723, DOI 10.1097/00007890-200009150-00003; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Huang H, 2002, AM J TRANSPLANT, V2, P631, DOI 10.1034/j.1600-6143.2002.20708.x; Inuo H, 2007, J HEPATO-BILIARY-PAN, V14, P509, DOI 10.1007/s00534-007-1214-9; Gomez-Lechon MJ, 2008, CELL TRANSPLANT, V17, P887, DOI 10.3727/096368908786576534; Kerkweg U, 2003, TRANSPLANTATION, V76, P501, DOI 10.1097/01.TP.0000069830.78758.1C; Kerkweg U, 2002, HEPATOLOGY, V35, P560, DOI 10.1053/jhep.2002.31869; Mamprin ME, 2008, CRYOLETTERS, V29, P121; MARSH DC, 1990, CRYOBIOLOGY, V27, P1, DOI 10.1016/0011-2240(90)90047-8; MARSH DC, 1991, HEPATOLOGY, V13, P500, DOI 10.1016/0270-9139(91)90304-E; Ostrowska A, 2009, ARCH TOXICOL, V83, P493, DOI 10.1007/s00204-009-0419-x; Pahernik SA, 1996, CRYOBIOLOGY, V33, P552, DOI 10.1006/cryo.1996.0059; Pless G, 2012, CELL TRANSPLANT, V21, P23, DOI 10.3727/096368911X580509; Rauen U, 2007, CELL MOL LIFE SCI, V64, P192, DOI 10.1007/s00018-006-6456-1; Rauen U, 2000, FASEB J, V14, P1953, DOI 10.1096/fj.00-0071com; Rauen U, 2004, J INVEST MED, V52, P299, DOI 10.1136/jim-52-05-29; Rauen U, 2003, FREE RADICAL BIO MED, V35, P1664, DOI 10.1016/j.freeradbiomed.2003.09.018; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Rauen U, 2007, CRYOBIOLOGY, V54, P77, DOI 10.1016/j.cryobiol.2006.11.008; RODRIGUEZ JV, 1995, CELL TRANSPLANT, V4, P245, DOI 10.1016/0963-6897(95)90036-5; ROSSER BG, 1995, GASTROENTEROLOGY, V108, P252, DOI 10.1016/0016-5085(95)90032-2; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Vairetti M, 2001, FREE RADICAL BIO MED, V31, P954, DOI 10.1016/S0891-5849(01)00670-0; Wille T, 2008, J VASC SURG, V47, P422, DOI 10.1016/j.jvs.2007.09.048	30	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40444	10.1371/journal.pone.0040444	http://dx.doi.org/10.1371/journal.pone.0040444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792326	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700050
J	Thomas, A; Lee, PJ; Dalton, JE; Nomie, KJ; Stoica, L; Costa-Mattioli, M; Chang, P; Nuzhdin, S; Arbeitman, MN; Dierick, HA				Thomas, Amanda; Lee, Pei-Jung; Dalton, Justin E.; Nomie, Krystle J.; Stoica, Loredana; Costa-Mattioli, Mauro; Chang, Peter; Nuzhdin, Sergey; Arbeitman, Michelle N.; Dierick, Herman A.			A Versatile Method for Cell-Specific Profiling of Translated mRNAs in Drosophila	PLOS ONE			English	Article							COMPLEX TISSUES; MELANOGASTER; SYSTEM; INVERTEBRATES; TRANSCRIPTOME; MAINTENANCE; EXPRESSION; PHENOTYPES; GROWTH; GENES	In Drosophila melanogaster few methods exist to perform rapid cell-type or tissue-specific expression profiling. A translating ribosome affinity purification (TRAP) method to profile actively translated mRNAs has been developed for use in a number of multicellular organisms although it has only been implemented to examine limited sets of cell-or tissue-types in these organisms. We have adapted the TRAP method for use in the versatile GAL4/UAS system of Drosophila allowing profiling of almost any tissue/cell-type with a single genetic cross. We created transgenic strains expressing a GFP-tagged ribosomal protein, RpL10A, under the control of the UAS promoter to perform cell-type specific translatome profiling. The GFP::RpL10A fusion protein incorporates efficiently into ribosomes and polysomes. Polysome affinity purification strongly enriches mRNAs from expected genes in the targeted tissues with sufficient sensitivity to analyze expression in small cell populations. This method can be used to determine the unique translatome profiles in different cell-types under varied physiological, pharmacological and pathological conditions.	[Thomas, Amanda; Lee, Pei-Jung; Nomie, Krystle J.; Dierick, Herman A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dalton, Justin E.; Arbeitman, Michelle N.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Stoica, Loredana; Costa-Mattioli, Mauro; Dierick, Herman A.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Stoica, Loredana; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Costa-Mattioli, Mauro; Dierick, Herman A.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Chang, Peter; Nuzhdin, Sergey] Univ So Calif, Dept Biol Sci, Sect Mol & Computat Biol, Los Angeles, CA 90089 USA; [Dierick, Herman A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; State University System of Florida; Florida State University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Southern California; Baylor College of Medicine	Thomas, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	michelle.arbeitman@med.fsu.edu; dierick@bcm.edu		Thomas-Wilson, Amanda/0000-0001-5875-8349; Arbeitman, Michelle/0000-0002-2437-4352	National Science Foundation [IOS-1119473]; National Institutes of Health [R01GM073039]; Naman Family Fund for Junior Faculty at BCM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073039] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Naman Family Fund for Junior Faculty at BCM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Science Foundation (IOS-1119473), National Institutes of Health (R01GM073039) and The Naman Family Fund for Junior Faculty at BCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2004, DEVELOPMENT, V131, P2007, DOI 10.1242/dev.01077; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; Halbeisen RE, 2009, METHODS, V48, P306, DOI 10.1016/j.ymeth.2009.04.003; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Jiang ZH, 2005, OBES RES, V13, P1898, DOI 10.1038/oby.2005.233; Jones WD, 2009, BMB REP, V42, P705, DOI 10.5483/BMBRep.2009.42.11.705; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Masly JP, 2011, GENETICS, V189, P357, DOI 10.1534/genetics.111.130815; Miller MR, 2009, NAT METHODS, V6, P439, DOI [10.1038/nmeth.1329, 10.1038/NMETH.1329]; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064	30	74	74	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40276	10.1371/journal.pone.0040276	http://dx.doi.org/10.1371/journal.pone.0040276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792260	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800060
J	Buggert, M; Norstrom, MM; Czarnecki, C; Tupin, E; Luo, M; Gyllensten, K; Sonnerborg, A; Lundegaard, C; Lund, O; Nielsen, M; Karlsson, AC				Buggert, Marcus; Norstrom, Melissa M.; Czarnecki, Chris; Tupin, Emmanuel; Luo, Ma; Gyllensten, Katarina; Sonnerborg, Anders; Lundegaard, Claus; Lund, Ole; Nielsen, Morten; Karlsson, Annika C.			Characterization of HIV-Specific CD4+T Cell Responses against Peptides Selected with Broad Population and Pathogen Coverage	PLOS ONE			English	Article							CD8(+) T-CELLS; EXON-2 DNA; EPITOPES; GAG; INFECTION; REPLICATION; VACCINATION; IMMUNITY; MEMORY	CD4+ T cells orchestrate immunity against viral infections, but their importance in HIV infection remains controversial. Nevertheless, comprehensive studies have associated increase in breadth and functional characteristics of HIV-specific CD4+ T cells with decreased viral load. A major challenge for the identification of HIV-specific CD4+ T cells targeting broadly reactive epitopes in populations with diverse ethnic background stems from the vast genomic variation of HIV and the diversity of the host cellular immune system. Here, we describe a novel epitope selection strategy, PopCover, that aims to resolve this challenge, and identify a set of potential HLA class II-restricted HIV epitopes that in concert will provide optimal viral and host coverage. Using this selection strategy, we identified 64 putative epitopes (peptides) located in the Gag, Nef, Env, Pol and Tat protein regions of HIV. In total, 73% of the predicted peptides were found to induce HIV-specific CD4+ T cell responses. The Gag and Nef peptides induced most responses. The vast majority of the peptides (93%) had predicted restriction to the patient's HLA alleles. Interestingly, the viral load in viremic patients was inversely correlated to the number of targeted Gag peptides. In addition, the predicted Gag peptides were found to induce broader polyfunctional CD4+ T cell responses compared to the commonly used Gag-p55 peptide pool. These results demonstrate the power of the PopCover method for the identification of broadly recognized HLA class II-restricted epitopes. All together, selection strategies, such as PopCover, might with success be used for the evaluation of antigen-specific CD4+ T cell responses and design of future vaccines.	[Buggert, Marcus; Norstrom, Melissa M.; Sonnerborg, Anders; Karlsson, Annika C.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Czarnecki, Chris; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Tupin, Emmanuel] Swedish Inst Infect Dis Control, Dept Virol, Stockholm, Sweden; [Luo, Ma] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Gyllensten, Katarina] Stockholm S Gen Hosp Sodersjukhuset, Gay Mens Hlth Clin, Stockholm, Sweden; [Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Div Infect Dis, Stockholm, Sweden; [Lundegaard, Claus; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Karolinska Institutet; Public Health Agency of Canada; Swedish Institute for Infectious Disease Control; University of Manitoba; Karolinska Institutet; Technical University of Denmark	Buggert, M (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	mniel@cbs.dtu.dk	Karlsson, Annika/R-2255-2016; Sönnerborg, Anders/W-2011-2019; Lund, Ole/F-4437-2014; Nielsen, Morten/E-7754-2011; Buggert, Marcus/F-4663-2018; Nielsen, Morten/AAL-8700-2020	Karlsson, Annika/0000-0002-2028-8393; Sönnerborg, Anders/0000-0001-8928-3374; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Buggert, Marcus/0000-0003-0633-1719; Nielsen, Morten/0000-0001-7885-4311	Swedish Agency for International Development Cooperation-SIDA [2005-001756]; Swedish Research Council [K2010-56X-20345-04-3]; Karolinska Institutet; Ake Wibergs Foundation [40418186]; Swedish Physicians Against AIDS Research Foundation [FO2010-0019]; Swedish Society of Medicine [SLS-101021]; Clas Groschinskys Memorial fund [M10 33]	Swedish Agency for International Development Cooperation-SIDA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Ake Wibergs Foundation; Swedish Physicians Against AIDS Research Foundation; Swedish Society of Medicine; Clas Groschinskys Memorial fund	This work was supported by grants from the Swedish Agency for International Development Cooperation-SIDA (2005-001756), the Swedish Research Council (K2010-56X-20345-04-3), Karolinska Institutet, Ake Wibergs Foundation (40418186), the Swedish Physicians Against AIDS Research Foundation (FO2010-0019), the Swedish Society of Medicine (SLS-101021) and the Clas Groschinskys Memorial fund (M10 33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; FRANKE EK, 1994, J VIROL, V68, P5300, DOI 10.1128/JVI.68.8.5300-5305.1994; Gloster SE, 2004, AIDS, V18, P749, DOI 10.1097/00002030-200403260-00005; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lindkvist Annica, 2009, AIDS Res Ther, V6, P15, DOI 10.1186/1742-6405-6-15; Luo M, 1999, TISSUE ANTIGENS, V54, P69, DOI 10.1034/j.1399-0039.1999.540108.x; Luo M, 2001, HUM IMMUNOL, V62, P1294, DOI 10.1016/S0198-8859(01)00339-1; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Owen RE, 2007, J IMMUNOL METHODS, V326, P93, DOI 10.1016/j.jim.2007.07.012; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Prendergast A, 2011, AIDS, V25, P1329, DOI 10.1097/QAD.0b013e3283478575; Ramduth D, 2005, J INFECT DIS, V192, P1588, DOI 10.1086/496894; Ramduth D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005013; Ranasinghe S, 2011, J VIROL; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Riou C, 2012, J IMMUNOLOGY; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toussaint NC, 2009, NUCLEIC ACIDS RES, V37, pW617, DOI 10.1093/nar/gkp293; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19	38	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39874	10.1371/journal.pone.0039874	http://dx.doi.org/10.1371/journal.pone.0039874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792193	Green Published, gold			2022-12-27	WOS:000306436300012
J	Upadhyayula, SM; Mutheneni, SR; Kadiri, MR; Kumaraswamy, S; Nelaturu, SCB				Upadhyayula, Suryanaryana Murty; Mutheneni, Srinivasa Rao; Kadiri, Madhusudhan Rao; Kumaraswamy, Sriram; Nelaturu, Sarat Chandra Babu			Data Base Management System for Lymphatic Filariasis - A Neglected Tropical Disease	PLOS ONE			English	Article								Background: Researchers working in the area of Public Health are being confronted with large volumes of data on various aspects of entomology and epidemiology. To obtain the relevant information out of these data requires particular database management system. In this paper, we have described about the usages of our developed database on lymphatic filariasis. Methods: This database application is developed using Model View Controller (MVC) architecture, with MySQL as database and a web based interface. We have collected and incorporated the data on filariasis in the database from Karimnagar, Chittoor, East and West Godavari districts of Andhra Pradesh, India. Conclusion: The importance of this database is to store the collected data, retrieve the information and produce various combinational reports on filarial aspects which in turn will help the public health officials to understand the burden of disease in a particular locality. This information is likely to have an imperative role on decision making for effective control of filarial disease and integrated vector management operations.	[Upadhyayula, Suryanaryana Murty; Mutheneni, Srinivasa Rao; Kadiri, Madhusudhan Rao; Kumaraswamy, Sriram] CSIR Indian Inst Chem Technol, Div Biol, Hyderabad, Andhra Pradesh, India; [Nelaturu, Sarat Chandra Babu] Ctr Dev Adv Comp, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Centre for Development of Advanced Computing (C-DAC)	Upadhyayula, SM (corresponding author), CSIR Indian Inst Chem Technol, Div Biol, Hyderabad, Andhra Pradesh, India.	murty_usn@yahoo.com	Mutheneni, Srinivasa Rao/AAI-2262-2020	Mutheneni, Srinivasa Rao/0000-0003-3263-3905	Ministry of Communication and Information Technology (MC&IT), Govt. of India	Ministry of Communication and Information Technology (MC&IT), Govt. of India	The authors are thankful to Ministry of Communication and Information Technology (MC&IT), Govt. of India for sponsoring the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-86; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P221; Biswas G., 1996, REVISED STRATEGY CON; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; MARINEZ YN, 1984, STAT MED, V3, P101, DOI 10.1002/sim.4780030204; MCFADDEN ET, 1995, CONTROL CLIN TRIALS, V16, pS30; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; Roberts RJ, 2000, STAT MED, V19, P1645; Seim A R, 1999, Rev Soc Bras Med Trop, V32, P325, DOI 10.1590/S0037-86821999000300022; Upadhayula SM, 2010, ASIAN PAC J TROP MED, V3, P647, DOI 10.1016/S1995-7645(10)60156-3; vanEs GA, 1996, NETH J MED, V48, P38, DOI 10.1016/0300-2977(95)00036-4	12	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39970	10.1371/journal.pone.0039970	http://dx.doi.org/10.1371/journal.pone.0039970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792200	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300015
J	Haslinger, R; Pipa, G; Lima, B; Singer, W; Brown, EN; Neuenschwander, S				Haslinger, Robert; Pipa, Gordon; Lima, Bruss; Singer, Wolf; Brown, Emery N.; Neuenschwander, Sergio			Context Matters: The Illusive Simplicity of Macaque V1 Receptive Fields	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; GAMMA-BAND SYNCHRONIZATION; TIME-RESCALING THEOREM; NATURAL SCENES; RESPONSE VARIABILITY; NEURONAL CIRCUITS; CORTICAL-NEURONS; SPIKING ACTIVITY; CELL PROPERTIES; STRIATE CORTEX	Even in V1, where neurons have well characterized classical receptive fields (CRFs), it has been difficult to deduce which features of natural scenes stimuli they actually respond to. Forward models based upon CRF stimuli have had limited success in predicting the response of V1 neurons to natural scenes. As natural scenes exhibit complex spatial and temporal correlations, this could be due to surround effects that modulate the sensitivity of the CRF. Here, instead of attempting a forward model, we quantify the importance of the natural scenes surround for awake macaque monkeys by modeling it non-parametrically. We also quantify the influence of two forms of trial to trial variability. The first is related to the neuron's own spike history. The second is related to ongoing mean field population activity reflected by the local field potential (LFP). We find that the surround produces strong temporal modulations in the firing rate that can be both suppressive and facilitative. Further, the LFP is found to induce a precise timing in spikes, which tend to be temporally localized on sharp LFP transients in the gamma frequency range. Using the pseudo R 2 as a measure of model fit, we find that during natural scene viewing the CRF dominates, accounting for 60% of the fit, but that taken collectively the surround, spike history and LFP are almost as important, accounting for 40%. However, overall only a small proportion of V1 spiking statistics could be explained (R-2 similar to 5%), even when the full stimulus, spike history and LFP were taken into account. This suggests that under natural scene conditions, the dominant influence on V1 neurons is not the stimulus, nor the mean field dynamics of the LFP, but the complex, incoherent dynamics of the network in which neurons are embedded.	[Haslinger, Robert] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Haslinger, Robert; Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Pipa, Gordon] Univ Osnabruck, Dept Neuroinformat, Osnabruck, Germany; [Pipa, Gordon; Lima, Bruss; Singer, Wolf; Neuenschwander, Sergio] Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany; [Pipa, Gordon] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Neuenschwander, Sergio] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University Osnabruck; Max Planck Society; Harvard University; Massachusetts General Hospital; Universidade Federal do Rio Grande do Norte	Haslinger, R (corresponding author), Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	robhh@nmr.mgh.harvard.edu	Singer, Wolf/D-6874-2012; Pipa, Gordon/M-1813-2014; Lima, Bruss/I-9164-2016	Pipa, Gordon/0000-0002-3416-2652; Lima, Bruss/0000-0001-6865-2900; NEUENSCHWANDER, Sergio/0000-0001-7493-121X	National Institutes of Health [K25 NS052422-02, DP1 ODOO3646]; European Union [FP6-2005-NEST-Path-043309]; EC Project Phocus [240763]; Max Planck Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS052422] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); EC Project Phocus; Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants K25 NS052422-02 (RH), and DP1 ODOO3646 (EB), as well as European Union Grant FP6-2005-NEST-Path-043309 (GP), EC Project Phocus Grant 240763 (GP) and the Max Planck Society (GP, BL, WS, SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison P. S., 2002, ILLUSTRATED WAVELET; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, J COMP NEUROL, V498, P330, DOI 10.1002/cne.21060; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berens P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.002.2008; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Chen G, 2005, J PHYSIOL-LONDON, V564, P233, DOI 10.1113/jphysiol.2004.080051; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Chisum HJ, 2004, NEURAL NETWORKS, V17, P681, DOI 10.1016/j.neunet.2004.05.002; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; El Boustani S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000519; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Freeman RD, 2001, PROG BRAIN RES, V134, P157; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; GILBERT CD, 1993, CEREB CORTEX, V3, P373, DOI 10.1093/cercor/3.5.373; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Guo K, 2005, EUR J NEUROSCI, V21, P536, DOI 10.1111/j.1460-9568.2005.03858.x; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Haslinger R, 2010, NEURAL COMPUT, V22, P2477, DOI 10.1162/NECO_a_00015; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kording KP, 2004, J NEUROPHYSIOL, V91, P206, DOI 10.1152/jn.00149.2003; KULIKOWSKI JJ, 1981, EXP BRAIN RES, V44, P371; Lee J, 2010, J NEUROPHYSIOL, V104, P2556, DOI 10.1152/jn.01040.2009; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Liu YJ, 2011, J NEUROPHYSIOL, V105, P1306, DOI 10.1152/jn.00692.2010; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; McCullagh P, 1989, GEN LINEAR MODELS; Mittlbock M, 1996, STAT MED, V15, P1987, DOI 10.1002/(SICI)1097-0258(19961015)15:19<1987::AID-SIM318>3.3.CO;2-0; Mittlbock M, 2001, J CLIN EPIDEMIOL, V54, P99, DOI 10.1016/S0895-4356(00)00292-4; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Muller JR, 2003, J NEUROPHYSIOL, V90, P822, DOI 10.1152/jn.00005.2003; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Szentagothai J, 1978, P R SOC LOND B, V201; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zipser K, 1996, J NEUROSCI, V16, P7376	95	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39699	10.1371/journal.pone.0039699	http://dx.doi.org/10.1371/journal.pone.0039699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802940	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900014
J	Soares, MC; Bshary, R; Cardoso, SC; Cote, IM; Oliveira, RF				Soares, Marta C.; Bshary, Redouan; Cardoso, Sonia C.; Cote, Isabelle M.; Oliveira, Rui F.			Face Your Fears: Cleaning Gobies Inspect Predators despite Being Stressed by Them	PLOS ONE			English	Article							THALASSOMA-BIFASCIATUM; ARGININE VASOTOCIN; GOBIOSOMA-EVELYNAE; BEHAVIOR; FISH; RISK; REPRODUCTION; PREFERENCES; AGGRESSION; DAMSELFISH	Social stressors typically elicit two distinct behavioural responses in vertebrates: an active response (i.e., "fight or flight") or behavioural inhibition (i.e., freezing). Here, we report an interesting exception to this dichotomy in a Caribbean cleaner fish, which interacts with a wide variety of reef fish clients, including predatory species. Cleaning gobies appraise predatory clients as potential threat and become stressed in their presence, as evidenced by their higher cortisol levels when exposed to predatory rather than to non-predatory clients. Nevertheless, cleaning gobies neither flee nor freeze in response to dangerous clients but instead approach predators faster (both in captivity and in the wild), and interact longer with these clients than with non-predatory clients (in the wild). We hypothesise that cleaners interrupt the potentially harmful physiological consequences elicited by predatory clients by becoming increasingly proactive and by reducing the time elapsed between client approach and the start of the interaction process. The activation of a stress response may therefore also be responsible for the longer cleaning service provided by these cleaners to predatory clients in the wild. Future experimental studies may reveal similar patterns in other social vertebrate species when, for instance, individuals approach an opponent for reconciliation after a conflict.	[Soares, Marta C.; Cardoso, Sonia C.; Oliveira, Rui F.] ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal; [Soares, Marta C.; Bshary, Redouan] Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; [Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Oliveira, Rui F.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	Instituto Superior Psicologia Aplicada (ISPA); University of Neuchatel; Simon Fraser University; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Soares, MC (corresponding author), ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal.	msoares@ispa.pt	Soares, Marta C/J-4448-2013; Oliveira, Rui/A-3581-2013; Cote, Isabelle/ABD-5898-2021; Soares, Marta/GSM-7143-2022; Soares, Marta/J-4448-2013	Soares, Marta C/0000-0002-5213-2377; Oliveira, Rui/0000-0003-1528-618X; Soares, Marta/0000-0002-5213-2377; Cardoso, Sonia/0000-0002-5985-7792; Soares, Marta/0000-0001-5304-3424; Bshary, Redouan/0000-0001-7198-8472	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/MAR/105276/2008]; Natural Science and Engineering Research Council of Canada; Swiss Science Foundation	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Swiss Science Foundation(Swiss National Science Foundation (SNSF))	MSC, SCC and RFO are supported by the Fundacao para a Ciencia e Tecnologia (Portugal; grant: PTDC/MAR/105276/2008). IMC is supported by the Natural Science and Engineering Research Council of Canada. RB is supported by the Swiss Science Foundation. All fieldwork expenses were financed by the Swiss Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2005, MONOGRAPHS BEHAV ECO; Aureli F., 2000, NATURAL CONFLICT RES; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bshary R, 2002, ECOL LETT, V5, P130, DOI 10.1046/j.1461-0248.2002.00295.x; Bshary R, 2011, ETHOLOGY, V117, P246, DOI 10.1111/j.1439-0310.2010.01872.x; Bshary Redouan, 2008, P563; Bshary Redouan, 2001, P146, DOI 10.1017/CBO9780511752421.010; Chapuis L, 2009, ANIM BEHAV, V78, P455, DOI 10.1016/j.anbehav.2009.06.001; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; DARCY GH, 1974, COPEIA, P375; De Boer SF, 2003, EUR J PHARMACOL, V463, P145, DOI 10.1016/S0014-2999(03)01278-0; Delisle H F, 1969, THESIS U PUERTO RICO; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; Francini RB, 2000, J FISH BIOL, V56, P802, DOI 10.1111/j.1095-8649.2000.tb00873.x; Galhardo Leonor, 2009, ARBS Annual Review of Biomedical Sciences, V11, P1; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; JOHNSON WS, 1988, ENVIRON BIOL FISH, V23, P225, DOI 10.1007/BF00004913; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; POTTS GW, 1973, ANIM BEHAV, V21, P250, DOI 10.1016/S0003-3472(73)80068-5; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Santangelo N, 2006, P ROY SOC B-BIOL SCI, V273, P3085, DOI 10.1098/rspb.2006.3683; Santangelo N, 2010, BRAIN BEHAV EVOLUT, V75, P282, DOI 10.1159/000316867; Sazima I, 1998, B MAR SCI, V63, P605; Scott AP, 2007, GEN COMP ENDOCR, V153, P392, DOI 10.1016/j.ygcen.2006.11.006; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Soares MC, 2008, ETHOLOGY, V114, P209, DOI 10.1111/j.1439-0310.2007.01471.x; Soares MC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1015, DOI 10.1007/s00265-006-0334-6; Soares MC, 2010, ETHOLOGY, V116, P1244, DOI 10.1111/j.1439-0310.2010.01838.x; Soares MC, 2012, PLOS ONE IN PRESS; Wicksten MK, 1998, J NAT HIST, V32, P13, DOI 10.1080/00222939800770021; WINBERG S, 1993, NEUROREPORT, V4, P399, DOI 10.1097/00001756-199304000-00014	39	24	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39781	10.1371/journal.pone.0039781	http://dx.doi.org/10.1371/journal.pone.0039781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22802925	Green Published, gold, Green Submitted			2022-12-27	WOS:000305825800069
J	Caunt, CJ; Perett, RM; Fowkes, RC; McArdle, CA				Caunt, Christopher J.; Perett, Rebecca M.; Fowkes, Robert C.; McArdle, Craig A.			Mechanisms of GnRH-Induced Extracellular Signal-Regulated Kinase Nuclear Localization	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; ACTIVATED PROTEIN-KINASE; DUAL-SPECIFICITY PHOSPHATASES; DYNAMIN-DEPENDENT INTERNALIZATION; C-TERMINAL TAIL; MAP KINASE; SPATIOTEMPORAL REGULATION; FEEDBACK PHOSPHORYLATION; RECOMBINANT ADENOVIRUS; PITUITARY-CELLS	Gonadotropin-releasing hormone receptors (GnRHR) mediate activation and nuclear translocation of the extracellular signal regulated kinases 1 and 2 (ERK) by phosphorylation on the TEY motif. This is necessary for GnRH to initiate transcriptional programmes controlling fertility, but mechanisms that govern ERK targeting are unclear. Using automated microscopy to explore ERK regulation in single cells, we find that GnRHR activation induces marked redistribution of ERK to the nucleus and that this effect can be uncoupled from the level of TEY phosphorylation of ERK. Thus, 5 min stimulation with 100 nM GnRH increased phospho-ERK levels (from 89 +/- 34 to 555 +/- 45 arbitrary fluorescence units) and increased the nuclear: cytoplasmic (N:C) ERK ratio (from 1.36 +/- 0.06 to 2.16 +/- 0.05) in the whole cell population, but it also significantly increased N: C ERK in cells binned according to phospho-ERK levels. This phosphorylation unattributable component of the ERK translocation response occurs at a broad range of GnRHR expression levels, in the presence of tyrosine phosphatase and protein synthesis inhibitors, and in ERK mutants unable to undergo catalytic activation. It also occurred in mutants incapable of binding the DEF (docking site for ERK, F/Y-X-F/Y-P) domains found in many ERK binding partners. It was however, reduced by MEK or PKC inhibition and by mutations preventing TEY phosphorylation or that abrogate ERK binding to D (docking) domain partners. We therefore show that TEY phosphorylation of ERK is necessary, but not sufficient for the full nuclear localization response. We further show that this "phosphorylation unattributable'' component of GnRH-mediated ERK nuclear translocation requires both PKC activity and association with partner proteins via the D-domain.	[Caunt, Christopher J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Perett, Rebecca M.; McArdle, Craig A.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Fowkes, Robert C.] Univ London Royal Vet Coll, Endocrine Signaling Grp, London, England	University of Bath; University of Bristol; University of London; University of London Royal Veterinary College	Caunt, CJ (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	craig.mcardle@bristol.ac.uk	McArdle, Craig/AAQ-5660-2021; Fowkes, Robert/AAI-4756-2020; Fowkes, Robert/HHT-0664-2022	McArdle, Craig/0000-0003-4836-5351; Fowkes, Robert/0000-0002-2222-2056; 	Wellcome Trust [084588]; Medical Research Council [G0901763]; Royal Society [2010/R2]; MRC [G0901763] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Wellcome Trust (084588), Medical Research Council (G0901763) and the Royal Society (2010/R2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Alarid ET, 1996, DEVELOPMENT, V122, P3319; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Armstrong SP, 2010, J BIOL CHEM, V285, P24360, DOI 10.1074/jbc.M110.115964; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Bliss SP, 2009, MOL ENDOCRINOL, V23, P1092, DOI 10.1210/me.2009-0030; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Caunt CJ, 2010, J CELL SCI, V123, P4310, DOI 10.1242/jcs.076349; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Choi SG, 2011, MOL ENDOCRINOL, V25, P1027, DOI 10.1210/me.2010-0387; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; CLAYTON RN, 1981, ENDOCR REV, V2, P186, DOI 10.1210/edrv-2-2-186; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Hislop JN, 2001, J BIOL CHEM, V276, P39685, DOI 10.1074/jbc.M104542200; Hislop JN, 2000, ENDOCRINOLOGY, V141, P4564, DOI 10.1210/en.141.12.4564; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Plotnikov A, 2011, MOL CELL BIOL; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Ruf F, 2006, J BIOL CHEM, V281, P30967, DOI 10.1074/jbc.M606486200; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Volmat V, 2001, J CELL SCI, V114, P3433; Vomastek T, 2008, MOL CELL BIOL, V28, P6954, DOI 10.1128/MCB.00925-08; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	56	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40077	10.1371/journal.pone.0040077	http://dx.doi.org/10.1371/journal.pone.0040077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808094	Green Submitted, gold, Green Published			2022-12-27	WOS:000306366400013
J	Duwal, S; Schutte, C; von Kleist, M				Duwal, Sulav; Schuette, Christof; von Kleist, Max			Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; DISOPROXIL FUMARATE; POPULATION PHARMACOKINETICS; POSTEXPOSURE PROPHYLAXIS; HEALTHY-VOLUNTEERS; SIMULATION-MODEL; VIRAL DYNAMICS; STEADY-STATE; IN-VIVO	Antiviral pre-exposure prophylaxis (PrEP) through daily drug administration can protect healthy individuals from HIV-1 infection. While PrEP was recently approved by the FDA, the potential long-term consequences of PrEP implementation remain entirely unclear. The aim of this study is to predict the efficacy of different prophylactic strategies with the pro-drug tenofovir-disoproxil-fumarate (TDF) and to assess the sensitivity towards timing-and mode of TDF administration (daily-vs. single dose), adherence and the number of transmitted viruses. We developed a pharmacokinetic model for TDF and its active anabolite tenofovir-diphosphate (TFV-DP) and validated it with data from 4 different trials, including 4 distinct dosing regimes. Pharmacokinetics were coupled to an HIV model and viral decay following TDF mono-therapy was predicted, consistent with available data. Subsequently, a stochastic approach was used to estimate the % infections prevented by (i) daily TDF-based PrEP, (ii) one week TDF started either shortly before, or -after viral exposure and (iii) a single dose oral TDF before viral challenge (sd-PrEP). Analytical solutions were derived to assess the relation between intracellular TFV-DP concentrations and prophylactic efficacy. The predicted efficacy of TDF was limited by a slow accumulation of active compound (TFV-DP) and variable TFV-DP half-life and decreased with increasing numbers of transmitted viruses. Once daily TDF-based PrEP yielded <= 80% protection, if at least 40% of pills were taken. Sd-PrEP with 300 mg or 600 mg TDF could prevent <= 50% infections, when given at least before virus exposure. The efficacy dropped to <= 10%, when given 1 h before 24 h exposure. Efficacy could not be increased with increasing dosage or prolonged administration. Post-exposure prophylaxis poorly prevented infection. The use of drugs that accumulate more rapidly, or local application of tenofovir gel may overcome the need for drug administration long before virus exposure.	[Duwal, Sulav; Schuette, Christof; von Kleist, Max] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany	Free University of Berlin	Duwal, S (corresponding author), Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany.	vkleist@zedat.fu-berlin.de	von Kleist, Max/K-3023-2016	von Kleist, Max/0000-0001-6587-6394; Duwal, Sulav/0000-0002-8772-6706	DFG research center MATHEON	DFG research center MATHEON(German Research Foundation (DFG))	SD and MvK acknowledge funding from the DFG research center MATHEON provided through project A21 "Modeling, Simulation and Therapy Optimization for Infectious Diseases." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; [Anonymous], 2011, AIDS PATIENT CARE ST, V25, P383; Baggaley RF, 2010, AIDS, V24, P2418, DOI 10.1097/QAD.0b013e32833dbdfd; Baheti G, 2011, ANTIMICROB AGENTS CH; Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; Benaboud S, 2012, ANTIMICROB AGENTS CH, V56, P857, DOI 10.1128/AAC.05244-11; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Blum MR, 2007, J CLIN PHARMACOL, V47, P751, DOI 10.1177/0091270007300951; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bonate PL, 2006, PHARMACOKINETIC PHAR; Bouazza N, 2011, JAIDS-J ACQ IMM DEF, V58, P283, DOI 10.1097/QAI.0b013e3182302ea8; Centers for Disease Control and Prevention (CDC), 2011, CDC TRIAL ANOTH MAJ; CHAPMAN EH, 1981, J CLIN PATHOL, V34, P1083, DOI 10.1136/jcp.34.10.1083; Chapman TM, 2003, DRUGS, V63, P1597, DOI 10.2165/00003495-200363150-00006; Chittick GE, 2006, ANTIMICROB AGENTS CH, V50, P1304, DOI 10.1128/AAC.50.4.1304-1310.2006; Cohen J, 2012, SCIENCE, V336, P792, DOI 10.1126/science.336.6083.792; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Donnell D, 2012, 19 C RETR OP INF MAR; Droste JAH, 2005, ANTIMICROB AGENTS CH, V49, P680, DOI 10.1128/AAC.49.2.680-684.2005; Durand-Gasselin L, 2007, ANTIMICROB AGENTS CH, V51, P2105, DOI 10.1128/AAC.00831-06; Emau Peter, 2006, AIDS Res Ther, V3, P29, DOI 10.1186/1742-6405-3-29; Frank M, 2011, ANTIMICROB AGENTS CH, V55, P5529, DOI 10.1128/AAC.00741-11; Gagnieu MC, 2008, J CLIN PHARMACOL, V48, P1282, DOI 10.1177/0091270008322908; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Garcia-Lerma JG, 2011, J VIROL, V85, P6610, DOI 10.1128/JVI.00311-11; Garcia-Lerma JG, 2010, TRENDS PHARMACOL SCI, V31, P74, DOI 10.1016/j.tips.2009.10.009; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; Hayden EC, 2011, NATURE, V476, P260, DOI 10.1038/476260a; Hirt D, 2011, ANTIMICROB AGENTS CH, V55, P2961, DOI 10.1128/AAC.01377-10; Hurwitz Selwyn J., 2007, Antiviral Chemistry & Chemotherapy, V18, P329; Hurwitz SJ, 2008, ANTIMICROB AGENTS CH, V52, P4241, DOI 10.1128/AAC.00054-08; Jullien V, 2005, ANTIMICROB AGENTS CH, V49, P3361, DOI 10.1128/AAC.49.8.3361-3366.2005; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Katz DF, 2011, DRUG DELIV TRANSL RE, V1, P256, DOI 10.1007/s13346-011-0029-z; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Lifson JD, 2003, J MED PRIMATOL, V32, P201, DOI 10.1034/j.1600-0684.2003.00026.x; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Mayer KH, 2012, J ACQUIR IMMUNE DEFI; Morrow Gavin, 2008, Curr Infect Dis Rep, V10, P133, DOI 10.1007/s11908-008-0024-9; Naesens L, 1996, ANTIMICROB AGENTS CH, V40, P22, DOI 10.1128/AAC.40.1.22; *NIH, CURR HIV TREATM GUID; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Peter K, 1998, PHARMACEUT RES, V15, P819, DOI 10.1023/A:1011956011207; Piliero PJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS2, DOI 10.1097/01.qai.0000137001.40505.56; Pruvost A, 2005, ANTIMICROB AGENTS CH, V49, P1907, DOI 10.1128/AAC.49.5.1907-1914.2005; Pruvost A, 2009, ANTIMICROB AGENTS CH, V53, P1937, DOI 10.1128/AAC.01064-08; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Sedaghat AR, 2009, ANTIVIR THER, V14, P263; Sharma PL, 2004, CURR TOP MED CHEM, V4, P895, DOI 10.2174/1568026043388484; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Tan WY, 1998, MATH BIOSCI, V147, P173, DOI 10.1016/S0025-5564(97)00094-1; Tosini W, 2010, AIDS, V24, P2375, DOI 10.1097/QAD.0b013e32833dfad1; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Tuckwell HC, 2008, MATH BIOSCI, V214, P81, DOI 10.1016/j.mbs.2008.03.005; University of Washington, 2011, PIV STUD FINDS HIV M; Van Damme L, 2012, 19 C RETR OP INF MAR; von Kleist M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002359; von Kleist M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018204; von Kleist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000720; von Kleist M, 2009, EUR J PHARM SCI, V36, P532, DOI 10.1016/j.ejps.2008.12.010; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Winston A, 2005, HIV MED, V6, P191, DOI 10.1111/j.1468-1293.2005.00288.x; Wu L, 2008, CURR OPIN HIV AIDS, V3, P534, DOI 10.1097/COH.0b013e32830634c6; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	76	43	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40382	10.1371/journal.pone.0040382	http://dx.doi.org/10.1371/journal.pone.0040382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808148	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400049
J	Lim, DKY; Garg, S; Timmins, M; Zhang, ESB; Thomas-Hall, SR; Schuhmann, H; Li, Y; Schenk, PM				Lim, David K. Y.; Garg, Sourabh; Timmins, Matthew; Zhang, Eugene S. B.; Thomas-Hall, Skye R.; Schuhmann, Holger; Li, Yan; Schenk, Peer M.			Isolation and Evaluation of Oil-Producing Microalgae from Subtropical Coastal and Brackish Waters	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LIPID-ACCUMULATION; CELL-GROWTH; NANNOCHLOROPSIS-OCULATA; CHLORELLA-VULGARIS; BIODIESEL; TEMPERATURE; SALINITY; BIOFUELS; TRIACYLGLYCEROLS	Microalgae have been widely reported as a promising source of biofuels, mainly based on their high areal productivity of biomass and lipids as triacylglycerides and the possibility for cultivation on non-arable land. The isolation and selection of suitable strains that are robust and display high growth and lipid accumulation rates is an important prerequisite for their successful cultivation as a bioenergy source, a process that can be compared to the initial selection and domestication of agricultural crops. We developed standard protocols for the isolation and cultivation for a range of marine and brackish microalgae. By comparing growth rates and lipid productivity, we assessed the potential of subtropical coastal and brackish microalgae for the production of biodiesel and other oil-based bioproducts. This study identified Nannochloropsis sp., Dunaniella salina and new isolates of Chlorella sp. and Tetraselmis sp. as suitable candidates for a multiple-product algae crop. We conclude that subtropical coastal microalgae display a variety of fatty acid profiles that offer a wide scope for several oil-based bioproducts, including biodiesel and omega-3 fatty acids. A biorefinery approach for microalgae would make economical production more feasible but challenges remain for efficient harvesting and extraction processes for some species.	[Lim, David K. Y.; Garg, Sourabh; Timmins, Matthew; Zhang, Eugene S. B.; Thomas-Hall, Skye R.; Schuhmann, Holger; Li, Yan; Schenk, Peer M.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Timmins, Matthew] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Ctr Metabol, Sch Chem & Biochem, Nedlands, WA 6009, Australia	University of Queensland; University of Western Australia	Lim, DKY (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	p.schenk@uq.edu.au	Schenk, Peer/B-7879-2016; Li, Yan/A-5532-2008	Schenk, Peer/0000-0003-4878-3799; Li, Yan/0000-0002-9102-0917; Thomas-Hall, Skye/0000-0002-4208-5992; Li, Yan/0000-0002-9742-0081	Australian Research Council [LP0883380, LP0990558]; Pacific Seeds; Advanta India; North Queensland & Pacific Biodiesel; Queensland Sea Scallops Trading	Australian Research Council(Australian Research Council); Pacific Seeds; Advanta India; North Queensland & Pacific Biodiesel; Queensland Sea Scallops Trading	The authors wish to thank the Australian Research Council (LP0883380, LP0990558), Pacific Seeds, Advanta India, North Queensland & Pacific Biodiesel and Queensland Sea Scallops Trading for financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rezq TS, 1999, HYDROBIOLOGIA, V403, P97, DOI 10.1023/A:1003725626504; Ahmad AL, 2011, RENEW SUST ENERG REV, V15, P584, DOI 10.1016/j.rser.2010.09.018; Alonzo F, 1999, MAR CHEM, V67, P289, DOI 10.1016/S0304-4203(99)00075-4; Amaro HM, 2011, APPL ENERG, V88, P3402, DOI 10.1016/j.apenergy.2010.12.014; Araujo GS, 2011, BIORESOURCE TECHNOL, V102, P5248, DOI 10.1016/j.biortech.2011.01.089; Araujo SD, 2005, AQUACULTURE, V246, P405, DOI 10.1016/j.aquaculture.2005.02.051; Borowitzka M.A., 1988, P257; Bridgewater A, 2004, MOL GLOBAL PHOTOSYNT; Cavalli RO, 1999, AQUACULTURE, V179, P387, DOI 10.1016/S0044-8486(99)00173-8; Chen CY, 2010, BIOTECHNOL PROGR, V26, P679, DOI 10.1002/btpr.381; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Chiu SY, 2009, BIORESOURCE TECHNOL, V100, P833, DOI 10.1016/j.biortech.2008.06.061; Cho SH, 2007, FISHERIES SCI, V73, P1050, DOI 10.1111/j.1444-2906.2007.01435.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; de la Pena MR, 2005, AQUAC RES, V36, P1500, DOI 10.1111/j.1365-2109.2005.01371.x; Demirbas A, 2009, ENERG SOURCE PART B, V4, P310, DOI 10.1080/15567240701621166; Demirbas A, 2011, ENERG CONVERS MANAGE, V52, P163, DOI 10.1016/j.enconman.2010.06.055; Doroudi MS, 1999, AQUACULT INT, V7, P179, DOI 10.1023/A:1009207810808; DUNSTAN GA, 1993, J APPL PHYCOL, V5, P71, DOI 10.1007/BF02182424; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Emata AC, 2003, FISH PHYSIOL BIOCHEM, V28, P489, DOI 10.1023/B:FISH.0000030637.26086.ab; EMDADI D, 1989, MAR CHEM, V26, P215, DOI 10.1016/0304-4203(89)90004-2; Gong YM, 2011, BIOTECHNOL LETT, V33, P1269, DOI 10.1007/s10529-011-0574-z; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P269, DOI 10.1007/s10295-008-0495-6; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hu HH, 2003, BIOTECHNOL LETT, V25, P421, DOI 10.1023/A:1022489108980; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huerlimann R, 2010, BIOTECHNOL BIOENG, V107, P245, DOI 10.1002/bit.22809; Hur Byung-Ki, 2007, Korean Society for Biotechnology and Bioengineering Journal, V22, P37; Illman AM, 2000, ENZYME MICROB TECH, V27, P631, DOI 10.1016/S0141-0229(00)00266-0; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kliphuis AMJ, 2010, BIOTECHNOL PROGR, V26, P687, DOI 10.1002/btpr.379; Knothe G, 2005, FUEL PROCESS TECHNOL, V86, P1059, DOI 10.1016/j.fuproc.2004.11.002; Knothe G, 2005, BIODIESEL HDB, DOI [10.1201/9781003040262, DOI 10.1201/9781003040262]; Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef700639e; Lee SJ, 2011, BIOTECHNOL BIOPROC E, V16, P561, DOI 10.1007/s12257-010-0360-0; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Lorenz M., 2005, ALGAL CULTURING TECH, P145, DOI DOI 10.1016/B978-012088426-1/50011-1; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; MIYAMOTO K, 1988, BIOTECHNOL LETT, V10, P703, DOI 10.1007/BF01025286; Okauchi M, 1997, HYDROBIOLOGIA, V358, P217, DOI 10.1023/A:1003157419675; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; Patil V, 2007, AQUACULT INT, V15, P1, DOI 10.1007/s10499-006-9060-3; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Rocha JMS, 2003, BIOMOL ENG, V20, P237, DOI 10.1016/S1389-0344(03)00061-3; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; ROESSLER PG, 1990, J PHYCOL, V26, P393, DOI 10.1111/j.0022-3646.1990.00393.x; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; SHAMSUDIN L, 1992, J APPL PHYCOL, V4, P371, DOI 10.1007/BF02185795; Wang B, 2008, APPL MICROBIOL BIOT, V79, P707, DOI 10.1007/s00253-008-1518-y; Weyer KM, 2010, BIOENERG RES, V3, P204, DOI 10.1007/s12155-009-9046-x; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Malcata FX, 2011, TRENDS BIOTECHNOL, V29, P542, DOI 10.1016/j.tibtech.2011.05.005; ZEILER KG, 1995, ENERG CONVERS MANAGE, V36, P707, DOI 10.1016/0196-8904(95)00103-K	61	123	123	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40751	10.1371/journal.pone.0040751	http://dx.doi.org/10.1371/journal.pone.0040751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792403	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000306362400099
J	Meier, BP; D'Agostino, PR; Elliot, AJ; Maier, MA; Wilkowski, BM				Meier, Brian P.; D'Agostino, Paul R.; Elliot, Andrew J.; Maier, Markus A.; Wilkowski, Benjamin M.			Color in Context: Psychological Context Moderates the Influence of Red on Approach- and Avoidance-Motivated Behavior	PLOS ONE			English	Article							PERFORMANCE; ATTRACTION; EVOLUTION; WOMEN; SKIN	Background: A basic premise of the recently proffered color-in-context model is that the influence of color on psychological functioning varies as a function of the psychological context in which color is perceived. Some research has examined the appetitive and aversive implications of viewing the color red in romance-and achievement-relevant contexts, respectively, but in all existing empirical work approach and avoidance behavior has been studied in separate tasks and separate experiments. Research is needed to directly test whether red influences the same behavior differently depending entirely on psychological context. Methodology/Principal Findings: The present experiment was designed to put this premise to direct test in romance-and achievement-relevant contexts within the same experimental paradigm involving walking behavior. Our results revealed that exposure to red (but not blue) indeed has differential implications for walking behavior as a function of the context in which the color is perceived. Red increased the speed with which participants walked to an ostensible interview about dating (a romance-relevant context), but decreased the speed with which they walked to an ostensible interview about intelligence (an achievement-relevant context). Conclusions/Significance: These results are the first direct evidence that the influence of red on psychological functioning in humans varies by psychological context. Our findings contribute to both the literature on color psychology and the broader, emerging literature on the influence of context on basic psychological processes.	[Meier, Brian P.; D'Agostino, Paul R.] Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA; [Elliot, Andrew J.] Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY USA; [Maier, Markus A.] Univ Munich, Dept Psychol, Munich, Germany; [Wilkowski, Benjamin M.] Univ Wyoming, Dept Psychol, Laramie, WY 82071 USA	Gettysburg College; University of Rochester; University of Munich; University of Wyoming	Meier, BP (corresponding author), Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA.	bmeier@gettysburg.edu	Elliot, Andrew J/D-1546-2013		Gettysburg College	Gettysburg College	Funding was provided via a Gettysburg College Research and Professional Development Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Andersson Malte, 1994; Aslam M. M., 2006, J MARK COMMUN, V12, P15, DOI DOI 10.1080/13527260500247827; Barrett L. F., 2010, MIND CONTEXT, P1; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Bergman TJ, 2009, INT J PRIMATOL, V30, P791, DOI 10.1007/s10764-009-9374-x; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Braun C, 2001, BEAUTYCHECK UNPUB; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Deschner T, 2004, HORM BEHAV, V46, P204, DOI 10.1016/j.yhbeh.2004.03.013; DIXSON AF, 1983, ADV STUD BEHAV, V13, P63, DOI 10.1016/S0065-3454(08)60286-7; Drummond PD, 1997, PERS INDIV DIFFER, V23, P575, DOI 10.1016/S0191-8869(97)00077-9; Elliot AJ, 2011, RED ENHANCES W UNPUB; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2007, CURR DIR PSYCHOL SCI, V16, P250, DOI 10.1111/j.1467-8721.2007.00514.x; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Elliot AJ, 2006, MOTIV EMOTION, V30, P111, DOI 10.1007/s11031-006-9028-7; Elliot AJ, 2012, ADV EXP SOC PSYCHOL, V45, P61, DOI 10.1016/B978-0-12-394286-9.00002-0; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; Fehrman K. R., 2004, COLOR SECRET INFLUEN, V2nd; Ferguson MJ, 2007, IMPLICIT MEASURES AT; Fetterman AK, 2011, SOC PSYCHOL PERS SCI, V2, P311, DOI 10.1177/1948550610390051; Gerald Melissa S., 2003, Special Topics in Primatology, V3, P141; Gerald MS, 2009, BEHAV PROCESS, V80, P7, DOI 10.1016/j.beproc.2008.08.001; Gnambs T, 2010, COMPUT HUM BEHAV, V26, P1625, DOI 10.1016/j.chb.2010.06.010; Gueguen N, 2012, J SOC PSYCHOL, V152, P261, DOI 10.1080/00224545.2011.605398; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Knight C, 1995, CAMB ARCHAEOL J, V5, P75, DOI [10.1017/S0959774300001190, DOI 10.1017/S0959774300001190]; Lewin K., 1935, DYNAMIC THEORY PERS; Maier MA, 2008, PERS SOC PSYCHOL B, V34, P1530, DOI 10.1177/0146167208323104; Mehta R, 2009, SCIENCE, V323, P1226, DOI 10.1126/science.1169144; Pazda AD, 2012, J EXP SOC PSYCHOL, V48, P787, DOI 10.1016/j.jesp.2011.12.009; Pryke SR, 2002, BEHAV ECOL, V13, P622, DOI 10.1093/beheco/13.5.622; Roberts SC, 2010, EVOL PSYCHOL-US, V8, P350, DOI 10.1177/147470491000800304; Rozin P., 2015, EVOLUTIONARY PSYCHOL; Rutchick AM, 2010, EUR J SOC PSYCHOL, V40, P704, DOI 10.1002/ejsp.753; Saad G., 2011, CONSUMING INSTINCT W; Schwarz N, 2007, SOC COGNITION, V25, P638, DOI 10.1521/soco.2007.25.5.638; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Shevell SK, 2008, ANNU REV PSYCHOL, V59, P143, DOI 10.1146/annurev.psych.59.103006.093619; Tanaka A, 2011, SOC BEHAV PERSONAL, V39, P287, DOI 10.2224/sbp.2011.39.2.287; Ural SE, 2010, COLOR RES APPL, V35, P343, DOI 10.1002/col.20583; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264; Wittenbrink B, 2010, J PERS SOC PSYCHOL, p[216, 43]	45	71	72	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40333	10.1371/journal.pone.0040333	http://dx.doi.org/10.1371/journal.pone.0040333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22808136	Green Published, gold			2022-12-27	WOS:000306362400041
J	Pleurdeau, D; Imalwa, E; Detroit, F; Lesur, J; Veldman, A; Bahain, JJ; Marais, E				Pleurdeau, David; Imalwa, Emma; Detroit, Florent; Lesur, Josephine; Veldman, Anzel; Bahain, Jean-Jacques; Marais, Eugene			"Of Sheep and Men": Earliest Direct Evidence of Caprine Domestication in Southern Africa at Leopard Cave (Erongo, Namibia)	PLOS ONE			English	Article							MODERN HUMAN-BEHAVIOR; MIDDLE-STONE-AGE; BLOMBOS CAVE; C.2000 BP; ROCK ART; PASTORALISM; CHRONOLOGY; ORIGINS; CAPE; ARCHAEOLOGY	The origins of herding practices in southern Africa remain controversial. The first appearance of domesticated caprines in the subcontinent is thought to be c. 2000 years BP; however, the origin of this cultural development is still widely debated. Recent genetic analyses support the long-standing hypothesis of herder migration from the north, while other researchers have argued for a cultural diffusion hypothesis where the spread of herding practices took place without necessarily implicating simultaneous and large population movements. Here we document the Later Stone Age (LSA) site of Leopard Cave (Erongo, Namibia), which contains confirmed caprine remains, from which we infer that domesticates were present in the southern African region as early as the end of the first millennium BC. These remains predate the first evidence of domesticates previously recorded for the subcontinent. This discovery sheds new light on the emergence of herding practices in southern Africa, and also on the possible southward routes used by caprines along the western Atlantic coast.	[Pleurdeau, David; Detroit, Florent; Bahain, Jean-Jacques] Museum Natl Hist Nat, CNRS, Dept Prehist, UMR 7194, Paris, France; [Imalwa, Emma; Veldman, Anzel; Marais, Eugene] Natl Museum Namibia, Windhoek, Namibia; [Lesur, Josephine] Museum Natl Hist Nat, CNRS, Dept Ecol & Gest Biodiversite, UMR 7209, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Pleurdeau, D (corresponding author), Museum Natl Hist Nat, CNRS, Dept Prehist, UMR 7194, Paris, France.	dpleurd@mnhn.fr	Détroit, Florent/AFU-6586-2022; Bahain, Jean-Jacques/AAB-8910-2019; Détroit, Florent/G-1022-2010	Détroit, Florent/0000-0001-5208-6203; Détroit, Florent/0000-0001-5208-6203; Bahain, Jean-Jacques/0000-0002-1446-5568	Museum National d'Histoire Naturelle (BQR program); Museum National d'Histoire Naturelle (ATM program); French Ministry of Foreign Affairs; Labex BCDiv (Biological and Cultural Diversities) program	Museum National d'Histoire Naturelle (BQR program); Museum National d'Histoire Naturelle (ATM program); French Ministry of Foreign Affairs; Labex BCDiv (Biological and Cultural Diversities) program	This work was supported by the Museum National d'Histoire Naturelle (BQR and ATM programs), the French Ministry of Foreign Affairs (Corus 2 program), and the Labex BCDiv (Biological and Cultural Diversities) program. We also benefited from the kind support and assistance of the National Museum of Namibia and the Embassy of France in Namibia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht Martin, 2001, Cimbebasia, V17, P1; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Badenhorst S., 2003, Annals of the Transvaal Museum, V40, P91; Badenhorst S., 2006, AFR ARCHAEOL REV, V23, P45, DOI [10.1007/s10437-006-9007-0, DOI 10.1007/S10437-006-9007-0]; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bousman C.B., 1998, AFR ARCHAEOL REV, V15, P133; Brink J.S., 1999, Archaeozoologia, V10, P11; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Clark JD., 1977, PALEORIENT, V3, P127, DOI [10.3406/paleo.1975.4193, DOI 10.3406/PALEO.1975.4193]; COOKE CK, 1965, AFRICA, V35, P263, DOI 10.2307/1157174; Deacon H. J., 1978, S AFRICAN ARCHAEOLOG, V33, P39, DOI DOI 10.2307/3888251; Denbow J, 1990, AFR ARCHAEOL REV, V8, P139, DOI DOI 10.1007/BF01116874; Eastwood E., 2005, S AFRICAN ARCHAEOLOG, V9, P63; Ehret C, 1982, FIRST SPREAD FOOD PR, P158; Ehret C, 2008, SOUTH AFR HUMANIT, V20, P7; Ehret Christopher, 2001, AFRICAN CLASSICAL AG; Elphick R., 1977, KRAAL CASTLE KHOIKHO; Elphick R, 1985, KHOIKHOI FOUNDING WH; Fauvelle-Aymar FX, 2008, SOUTH AFR HUMANIT, V20, P1; Gentry A.W., 1978, P540; Gifford-Gonzalez D., 2000, AFR ARCHAEOL REV; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Guldemann T, 2008, SOUTH AFR HUMANIT, V20, P93; Haacke WHG, 2008, SOUTH AFR HUMANIT, V20, P163; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Henn BM, 2008, P NATL ACAD SCI USA, V105, P10693, DOI 10.1073/pnas.0801184105; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henshilwood C, 1996, ANTIQUITY, V70, P945, DOI 10.1017/S0003598X00084210; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Horsburgh KA, 2010, J ARCHAEOL SCI, V37, P2906, DOI 10.1016/j.jas.2010.06.035; Huffman TN., 2005, SO AFRICAN FIELD ARC, V17, P57; Inskeep RR, 1987, BRIT ARCHAOLOGICAL R; Jacobson L., 1987, S AFR ARCHAEOL BULL, P55; Jacobson L., 1987, S AFR ARCHAEOLOGICAL, V42, P174, DOI [10.2307/3888746, DOI 10.2307/3888746]; JERARDINO A, 1995, HOLOCENE, V5, P361, DOI 10.1177/095968369500500313; Kandel AW, 2005, J ARCHAEOL SCI, V32, P1711, DOI 10.1016/j.jas.2005.05.010; Kinahan J., 2011, HIST NAMIBIA BEGINNI, P15; Kinahan J, 1995, S AFRICAN ARCHAEOLOG, V50, P176, DOI DOI 10.2307/3889067; Kinahan J, 1991, PASTORAL NOMADS CENT; Kinahan J., 1996, S AFR ARCHAEOL BULL, V51, P106, DOI [10.2307/3888846, DOI 10.2307/3888846]; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Miller R, 2008, GEOLOGY NAMIBIA; Mitchell P, 2005, J AFR HIST, V46, P209, DOI 10.1017/S0021853705000770; Mitchell P, 2008, FARMING, V2; Mitchell P, 2010, J ANTHROPOL SCI, V88, P73; Morris AG, 2003, S AFR ARCHAEOL BULL, V58, P85, DOI 10.2307/3889305; Orton J, 2008, J ARCHAEOL SCI, V35, P1765, DOI 10.1016/j.jas.2007.11.014; PRUMMEL W, 1986, J ARCHAEOL SCI, V13, P567, DOI 10.1016/0305-4403(86)90041-5; Richter J, 1991, STUDIEN URGESCHICHTE, V3; Robbins LH, 2008, J AFR ARCHAEOL, V6, P131, DOI 10.3213/1612-1651-10106; Robbins LH, 2005, CURR ANTHROPOL, V46, P671, DOI 10.1086/432748; Sadr K, 2003, J AFR HIST, V44, P195, DOI 10.1017/S0021853702008393; Sadr K, 2003, S AFR ARCHAEOL BULL, V58, P27, DOI 10.2307/3889154; Sadr K, 1998, AFR ARCHAEOL REV, V15, P101, DOI [10.1023/A:1022158701778, DOI 10.1023/A:1022158701778]; Sadr K, 2008, SOUTH AFR HUMANIT, V20, P179; Sadr K, 2008, J AFR ARCHAEOL, V6, P103, DOI 10.3213/1612-1651-10105; SANDELOWSKY B H, 1977, Madoqua, V10, P221; Sandelowsky B.H., 1979, S AFRICAN ARCHAEOLOG, V34, P50, DOI DOI 10.2307/3888170; Sandelowsky B. H, 1974, GOODWIN 2, V2, P65; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; SCHWEITZER F R, 1979, Annals of the South African Museum, V78, P101; SEALY J, 1994, ANTIQUITY, V68, P58, DOI 10.1017/S0003598X00046196; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shaw PA, 2003, QUATERN INT, V111, P23, DOI 10.1016/S1040-6182(03)00012-0; Shi N, 2001, EARTH PLANET SC LETT, V187, P311, DOI 10.1016/S0012-821X(01)00267-9; Smith A.B., 1995, S AFRICAN ARCHAEOLOG, V50, P3, DOI [10.2307/3889270, DOI 10.2307/3889270]; Smith A.B., 2006, BAR INT SERIES, V1537; Smith A.B., 1991, S AFRICAN ARCHAEOLOG, V46, P71, DOI [10.2307/3889087, DOI 10.2307/3889087]; Smith A. B, 2008, ANIMALS PEOPLE ARCHA, P94; SMITH AB, 1992, ANNU REV ANTHROPOL, V21, P125; Smith AB, 1996, S AFRICAN ARCHAEOLOG, V51, P36, DOI DOI 10.2307/3888932; Smith BW, 2004, CURR ANTHROPOL, V45, P499, DOI 10.1086/422081; Stow G. W., 1905, NATIVE RACES S AFRIC; Stynder DD, 2007, AM J PHYS ANTHROPOL, V134, P489, DOI 10.1002/ajpa.20696; Tapela M, 2001, J AFR STUD, V15, P60; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Vogel J, 1997, S AFR J SCI, V93, P246; Vogelsang R., 2011, MOPANE TREE HOLOCENE; Vossen Rainer, 1997, KHOE SPRACHEN BEITRA; Wadley L, 1979, CIMBEBASIA, V3, P2; Walker N. J., 1983, S AFRICAN ARCHAEOLOG, V38, P88, DOI DOI 10.2307/3888641; Webley L, 2007, J ARID ENVIRON, V70, P629, DOI 10.1016/j.jaridenv.2006.03.009; Wendt WE, 1972, CIMBEBASIA B, V2, P1	85	69	71	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40340	10.1371/journal.pone.0040340	http://dx.doi.org/10.1371/journal.pone.0040340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22808138	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400042
J	Takahashi, T; Muro, S; Tanabe, N; Terada, K; Kiyokawa, H; Sato, S; Hoshino, Y; Ogawa, E; Uno, K; Naruishi, K; Takashiba, S; Mishima, M				Takahashi, Tamaki; Muro, Shigeo; Tanabe, Naoya; Terada, Kunihiko; Kiyokawa, Hirofumi; Sato, Susumu; Hoshino, Yuma; Ogawa, Emiko; Uno, Kazuko; Naruishi, Koji; Takashiba, Shogo; Mishima, Michiaki			Relationship between Periodontitis-Related Antibody and Frequent Exacerbations in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							DENTAL HYGIENE EDUCATION; CORONARY-HEART-DISEASE; PORPHYROMONAS-GINGIVALIS; COPD EXACERBATIONS; NURSING-HOME; INFLAMMATORY MARKERS; RISK; PATHOGENS; SYMPTOMS; BACTERIA	Background: To identify patients with chronic obstructive pulmonary disease (COPD) who are susceptible to frequent exacerbations is important. Although periodontitis aggravated by poor oral hygiene might increase the risk of lower respiratory tract infection, the relationship between periodontitis and COPD exacerbations remains unknown. This prospective cohort study investigates the relationship between periodontitis-related antibody and exacerbation frequency over a one-year period. Methods: We assessed an IgG antibody titer against Porphyromonas gingivalis, which is a major pathogen of periodontitis, and then prospectively followed up 93 individuals over one year to detect exacerbations. Results: The numbers of exacerbations and the rate of individuals with frequent exacerbations (at least two per year) were significantly lower in patients with higher IgG titer than those with normal IgG titer (0.8 vs. 1.2 per year, p = 0.045 and 14.3 vs. 38.6%, p = 0.009, respectively). Multivariate logistic regression analysis showed that being normal-IgG titer for periodontitis-related antibody significantly increased the risk of frequent exacerbations (relative risk, 5.27, 95% confidence interval, 1.30-25.7; p = 0.019) after adjusting for other possible confounders, such as a history of exacerbations in the past year, disease severity, COPD medication and smoking status. Conclusions: Normal-IgG titer for periodontitis-related antibody can be an independent predictor of frequent exacerbations. Measuring periodontitis-related antibody titers might be useful to identify patients with susceptibility to frequent exacerbations so that an aggressive prevention strategy can be designed.	[Takahashi, Tamaki; Muro, Shigeo; Tanabe, Naoya; Terada, Kunihiko; Kiyokawa, Hirofumi; Sato, Susumu; Hoshino, Yuma; Mishima, Michiaki] Kyoto Univ, Dept Resp Med, Kyoto, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Shiga, Japan; [Uno, Kazuko] Louis Pasteur Ctr Med Res, Kyoto, Japan; [Naruishi, Koji] Iwate Med Univ, Div Endodontol, Dept Conservat Dent & Oral Rehabil, Morioka, Iwate, Japan; [Takashiba, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathophysiol Periodontal Sci, Okayama 7008530, Japan	Kyoto University; Shiga University of Medical Science; Iwate Medical University; Okayama University	Takahashi, T (corresponding author), Kyoto Univ, Dept Resp Med, Kyoto, Japan.	smuro@kuhp.kyoto-u.ac.jp	Sato, Susumu/R-8976-2019; Takashiba, Shogo/C-9830-2010	Takashiba, Shogo/0000-0002-4712-6829	Ministry of Health, Labour and Welfare, Japan [16390234, 21590964]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grants-in-Aid for scientific research (B) (No. 16390234) and (C) (No. 21590964) and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bascones-Martinez A, 2011, MED ORAL PATOL ORAL, V16, pE722, DOI 10.4317/medoral.17032; BASKAR P, 1990, J IMMUNOL, V144, P2321; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; Bohnstedt S, 2010, J DENT RES, V89, P938, DOI 10.1177/0022034510370817; Brook I, 2003, CHEST, V124, P832, DOI 10.1378/chest.124.3.832; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deo Vikas, 2009, Indian J Dent Res, V20, P466, DOI 10.4103/0970-9290.59456; Drinka P, 2010, J AM MED DIR ASSOC, V11, P70, DOI 10.1016/j.jamda.2009.03.020; Garcia-Aymerich J, 2003, THORAX, V58, P100, DOI 10.1136/thorax.58.2.100; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kullberg E, 2010, J ADV NURS, V66, P1273, DOI 10.1111/j.1365-2648.2010.05298.x; Lamster IB, 1998, J CLIN PERIODONTOL, V25, P510, DOI 10.1111/j.1600-051X.1998.tb02480.x; Leuckfeld I, 2008, RESP MED, V102, P488, DOI 10.1016/j.rmed.2007.12.001; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; Miravitlles M, 2000, RESPIRATION, V67, P495, DOI 10.1159/000067462; Murayama Y, 1988, Adv Dent Res, V2, P339; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; Pussinen PJ, 2004, EUR J CARDIOV PREV R, V11, P408, DOI 10.1097/00149831-200410000-00008; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Pussinen PJ, 2003, ARTERIOSCL THROM VAS, V23, P1250, DOI 10.1161/01.ATV.0000072969.71452.87; Renvert S, 2003, ORAL HLTH PREV DE S1, V1, P358; Renvert Stefan, 2003, Oral Health Prev Dent, V1 Suppl 1, P341; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sims TJ, 2001, ORAL MICROBIOL IMMUN, V16, P193, DOI 10.1034/j.1399-302X.2001.160401.x; Sjogren P, 2010, J ADV NURS, V66, P345, DOI 10.1111/j.1365-2648.2009.05181.x; Soler N, 1998, AM J RESP CRIT CARE, V157, P1498, DOI 10.1164/ajrccm.157.5.9711044; Stoller JK, 2002, NEW ENGL J MED, V346, P988, DOI 10.1056/NEJMcp012477; Sugi N, 2011, J CLIN LAB ANAL, V25, P25, DOI 10.1002/jcla.20381; Surendar J, 2011, DIABETES TECHNOL THE, V13, P477, DOI 10.1089/dia.2010.0178; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Terada K, 2008, THORAX, V63, P951, DOI 10.1136/thx.2007.092858; Terada K, 2010, CHEST, V137, P326, DOI 10.1378/chest.09-0482; Yamazaki K, 2007, CLIN EXP IMMUNOL, V149, P445, DOI 10.1111/j.1365-2249.2007.03450.x; Zhang M, 2010, EUR J CLIN MICROBIOL, V29, P1487, DOI 10.1007/s10096-010-1027-7	42	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40570	10.1371/journal.pone.0040570	http://dx.doi.org/10.1371/journal.pone.0040570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792372	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400071
J	Amos, N; Butler, J; Lee, B; Shachar, MH; Hu, B; Tian, Y; Hong, JM; Garcia, D; Ikkawi, RM; Haddon, RC; Litvinov, D; Khizroev, S				Amos, Nissim; Butler, John; Lee, Beomseop; Shachar, Meir H.; Hu, Bing; Tian, Yuan; Hong, Jeongmin; Garcia, Davil; Ikkawi, Rabee M.; Haddon, Robert C.; Litvinov, Dmitri; Khizroev, Sakhrat			Multilevel-3D Bit Patterned Magnetic Media with 8 Signal Levels Per Nanocolumn	PLOS ONE			English	Article							FILMS	This letter presents an experimental study that shows that a 3rd physical dimension may be used to further increase information packing density in magnetic storage devices. We demonstrate the feasibility of at least quadrupling the magnetic states of magnetic-based data storage devices by recording and reading information from nanopillars with three magnetically-decoupled layers. Magneto-optical Kerr effect microscopy and magnetic force microscopy analysis show that both continuous (thin film) and patterned triple-stack magnetic media can generate eight magnetically-stable states. This is in comparison to only two states in conventional magnetic recording. Our work further reveals that ferromagnetic interaction between magnetic layers can be reduced by combining Co/Pt and Co/Pd multilayers media. Finally, we are showing for the first time an MFM image of multilevel-3D bit patterned media with 8 discrete signal levels.	[Amos, Nissim; Butler, John; Lee, Beomseop; Shachar, Meir H.; Tian, Yuan; Ikkawi, Rabee M.; Khizroev, Sakhrat] Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA; [Hu, Bing] Univ Calif Riverside, Dept Comp Sci & Engn, Riverside, CA 92521 USA; [Hong, Jeongmin; Khizroev, Sakhrat] Florida Int Univ, Dept Elect Engn, Miami, FL 33199 USA; [Garcia, Davil] Univ Calif Riverside, Dept Mat Sci & Engn, Riverside, CA 92521 USA; [Haddon, Robert C.] Univ Calif Riverside, Ctr Nanoscale Sci & Engn, Riverside, CA 92521 USA; [Litvinov, Dmitri] Univ Houston, Ctr Nanomagnet Syst, Houston, TX USA	University of California System; University of California Riverside; University of California System; University of California Riverside; State University System of Florida; Florida International University; University of California System; University of California Riverside; University of California System; University of California Riverside; University of Houston System; University of Houston	Amos, N (corresponding author), Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA.	Nissim.Amos@ee.ucr.edu	Haddon, Robert C/A-2528-2008; Hu, Bing/M-3186-2014	Haddon, Robert C/0000-0002-7903-5139; Hu, Bing/0000-0003-1284-6153; Shachar, Meir/0000-0001-7635-070X	National Science Foundation (NSF) [005084-002, 0824019]; DARPA/Defense Microelectronics Activity (DMEA) [H94003-09-2-0904]	National Science Foundation (NSF)(National Science Foundation (NSF)); DARPA/Defense Microelectronics Activity (DMEA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the National Science Foundation (NSF) under contracts 005084-002 and 0824019 and DARPA/Defense Microelectronics Activity (DMEA) under agreement number H94003-09-2-0904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2005, J APPL PHYS, V97, DOI 10.1063/1.1904705; Albrecht M., 2005, U.S. patent 6,865,044, Patent No. [6865044, 6,865,044]; Alexander YD, 2010, US Patent, Patent No. 7974031; Baltz V, 2007, EUR PHYS J-APPL PHYS, V39, P33, DOI 10.1051/epjap:2007107; Baltz V, 2005, J MAGN MAGN MATER, V290, P1286, DOI 10.1016/j.jmmm.2004.11.449; Bertero GA, 2003, IEEE T MAGN, V39, P651, DOI 10.1109/TMAG.2003.808987; Bing H, 2011, J APPL PHYS, V109; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Cui SQ, 2009, PROCEEDINGS OF THE 2009 PACIFIC-ASIA CONFERENCE ON CIRCUITS, COMMUNICATIONS AND SYSTEM, P536, DOI 10.1109/PACCS.2009.76; Grobis MK, 2011, IEEE T MAGN, V47, P6, DOI 10.1109/TMAG.2010.2076798; Hu H, 2006, OPT MATER, V28, P904, DOI 10.1016/j.optmat.2005.08.009; Jubert PO, 2010, IEEE T MAGN, V46, P4059, DOI 10.1109/TMAG.2010.2083678; Mehmet FE, 2011, US Patent, Patent No. 7982994; Nils JG, 2009, J APPL PHYS, V105; Piramanayagam SN, 2007, J APPL PHYS, V102, DOI 10.1063/1.2750414; Richter HJ, 2002, IEEE T MAGN, V38, P260, DOI 10.1109/20.990117; Sakhrat K, 2006, J APPL PHYS, V100; Seigler MA, 2008, IEEE T MAGN, V44, P119, DOI 10.1109/TMAG.2007.911029; Shah P, 2007, IEEE T MAGN, V43, P2280, DOI 10.1109/TMAG.2007.894010; Shaojing L, 2009, J APPL PHYS, V105; Speetzen N, 2005, J MAGN MAGN MATER, V287, P181, DOI 10.1016/j.jmmm.2004.10.030; Terris BD, 2009, J MAGN MAGN MATER, V321, P512, DOI 10.1016/j.jmmm.2008.05.046; Tetsunori K, 2008, J APPL PHYS, V103; Weller D, 2000, ANNU REV MATER SCI, V30, P611, DOI 10.1146/annurev.matsci.30.1.611; Winkler G, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152293; Yuan ZM, 2001, J MAGN MAGN MATER, V235, P481, DOI 10.1016/S0304-8853(01)00412-7; Zhang L, 2010, J MAGN MAGN MATER, V322, P2658, DOI 10.1016/j.jmmm.2010.04.003	27	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40134	10.1371/journal.pone.0040134	http://dx.doi.org/10.1371/journal.pone.0040134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808105	Green Submitted, Green Published, gold			2022-12-27	WOS:000306355500026
J	Giaime, E; Yamaguchi, H; Gautier, CA; Kitada, T; Shen, J				Giaime, Emilie; Yamaguchi, Hiroo; Gautier, Clement A.; Kitada, Tohru; Shen, Jie			Loss of DJ-1 Does Not Affect Mitochondrial Respiration but Increases ROS Production and Mitochondrial Permeability Transition Pore Opening	PLOS ONE			English	Article							DISEASE-ASSOCIATED PROTEIN; PARKINSONS-DISEASE; CELL-DEATH; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; DROSOPHILA DJ-1; IN-VIVO; MUTATIONS; DEGENERATION; PINK1	Background: Loss of function mutations in the DJ-1 gene have been linked to recessively inherited forms of Parkinsonism. Mitochondrial dysfunction and increased oxidative stress are thought to be key events in the pathogenesis of Parkinson's disease. Although it has been reported that DJ-1 serves as scavenger for reactive oxidative species (ROS) by oxidation on its cysteine residues, how loss of DJ-1 affects mitochondrial function is less clear. Methodology/Principal Findings: Using primary mouse embryonic fibroblasts (MEFs) or brains from DJ-1-/- mice, we found that loss of DJ-1 does not affect mitochondrial respiration. Specifically, endogenous respiratory activity as well as basal and maximal respiration are normal in intact DJ-1-/- MEFs, and substrate-specific state 3 and state 4 mitochondrial respiration are also unaffected in permeabilized DJ-1-/- MEFs and in isolated mitochondria from the cerebral cortex of DJ-1-/- mice at 3 months or 2 years of age. Expression levels and activities of all individual complexes composing the electron transport system are unchanged, but ATP production is reduced in DJ-1-/- MEFs. Mitochondrial transmembrane potential is decreased in the absence of DJ-1. Furthermore, mitochondrial permeability transition pore opening is increased, whereas mitochondrial calcium levels are unchanged in DJ-1-/- cells. Consistent with earlier reports, production of reactive oxygen species (ROS) is increased, though levels of antioxidative enzymes are unaltered. Interestingly, the decreased mitochondrial transmembrane potential and the increased mitochondrial permeability transition pore opening in DJ-1-/- MEFs can be restored by antioxidant treatment, whereas oxidative stress inducers have the opposite effects on mitochondrial transmembrane potential and mitochondrial permeability transition pore opening. Conclusions/Significance: Our study shows that loss of DJ-1 does not affect mitochondrial respiration or mitochondrial calcium levels but increases ROS production, leading to elevated mitochondrial permeability transition pore opening and reduced mitochondrial transmembrane potential.	[Giaime, Emilie; Yamaguchi, Hiroo; Gautier, Clement A.; Kitada, Tohru; Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Giaime, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Shen, Jie/GXH-9449-2022		National Institutes of Health [R01NS052745, R01NS041779]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041779, R01NS052745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (R01NS052745 and R01NS041779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo T, 2011, NEUROBIOL DIS, V41, P111, DOI 10.1016/j.nbd.2010.08.027; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braeckman BP, 1999, CURR BIOL, V9, P493, DOI 10.1016/S0960-9822(99)80216-4; BUCANA C, 1986, J HISTOCHEM CYTOCHEM, V34, P1109, DOI 10.1177/34.9.2426339; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; FARKAS DL, 1989, BIOPHYS J, V56, P1053, DOI 10.1016/S0006-3495(89)82754-7; Frezza Christian, 2007, Methods Mol Biol, V372, P405, DOI 10.1007/978-1-59745-365-3_29; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2012, MOL NEURODE IN PRESS; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Haugland RP, 1992, HDB FLUORESCENT PROB, P390; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Larsen NJ, 2011, NEUROSCIENCE, V196, P251, DOI 10.1016/j.neuroscience.2011.08.016; LUNDIN A, 1975, ANAL BIOCHEM, V66, P47, DOI 10.1016/0003-2697(75)90723-X; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Matsuura K, 1996, BRAIN RES, V733, P101, DOI 10.1016/S0006-8993(96)00686-5; McElroy W D, 1983, J Appl Biochem, V5, P197; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Odagiri K, 2009, J MOL CELL CARDIOL, V46, P989, DOI 10.1016/j.yjmcc.2008.12.022; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Schuh RA, 2011, J NEUROSCI RES, V89, P1979, DOI 10.1002/jnr.22650; Seaton TA, 1998, BRAIN RES, V809, P12, DOI 10.1016/S0006-8993(98)00790-2; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Wagenfeld A, 1998, BIOCHEM BIOPH RES CO, V251, P545, DOI 10.1006/bbrc.1998.9512; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhong N, 2008, HUM MOL GENET, V17, P3357, DOI 10.1093/hmg/ddn230; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	65	72	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40501	10.1371/journal.pone.0040501	http://dx.doi.org/10.1371/journal.pone.0040501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792356	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700057
J	Wolf, W; Kilic, A; Schrul, B; Lorenz, H; Schwappach, B; Seedorf, M				Wolf, Wendelin; Kilic, Annett; Schrul, Bianca; Lorenz, Holger; Schwappach, Blanche; Seedorf, Matthias			Yeast Ist2 Recruits the Endoplasmic Reticulum to the Plasma Membrane and Creates a Ribosome-Free Membrane Microcompartment	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; H+-ATPASE; CATION-TRANSPORT; PROTEIN; MUTATIONS; CALCIUM; HOMEOSTASIS; DOMAINS; PATHWAY; BINDING	The endoplasmic reticulum (ER) forms contacts with the plasma membrane. These contacts are known to function in non-vesicular lipid transport and signaling. Ist2 resides in specific domains of the ER in Saccharomyces cerevisiae where it binds phosphoinositide lipids at the cytosolic face of the plasma membrane. Here, we report that Ist2 recruits domains of the yeast ER to the plasma membrane. Ist2 determines the amount of cortical ER present and the distance between the ER and the plasma membrane. Deletion of IST2 resulted in an increased distance between ER and plasma membrane and allowed access of ribosomes to the space between the two membranes. Cells that overexpress Ist2 showed an association of the nucleus with the plasma membrane. The morphology of the ER and yeast growth were sensitive to the abundance of Ist2. Moreover, Ist2-dependent effects on cytosolic pH and genetic interactions link Ist2 to the activity of the H+ pump Pma1 in the plasma membrane during cellular adaptation to the growth phase of the culture. Consistently we found a partial colocalization of Ist2-containing cortical ER and Pma1-containing domains of the plasma membrane. Hence Ist2 may be critically positioned in domains that couple functions of the ER and the plasma membrane.	[Wolf, Wendelin; Kilic, Annett; Lorenz, Holger; Seedorf, Matthias] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany; [Schrul, Bianca; Schwappach, Blanche] Univ Med Gottingen, Dept Biochem 1, Gottingen, Germany; [Schrul, Bianca; Schwappach, Blanche] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Gottingen; Max Planck Society	Wolf, W (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany.	m.seedorf@zmbh.uni-heidelberg.de		Schwappach, Blanche/0000-0003-0225-6432	Deutsche Forschungsgemeinschaft [SE 811/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SE 811/5-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Brachmann CB, 1998, YEAST, V14, P115; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; Ercan E, 2009, TRAFFIC, V10, P1802, DOI 10.1111/j.1600-0854.2009.00995.x; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Franz A, 2007, FEBS LETT, V581, P401, DOI 10.1016/j.febslet.2006.12.048; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Getty AL, 2011, CELL MOL LIFE SCI, V68, P453, DOI 10.1007/s00018-010-0468-6; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Griffith J, 2008, TRAFFIC, V9, P1060, DOI 10.1111/j.1600-0854.2008.00753.x; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jennings ML, 2008, J GEN PHYSIOL, V131, P379, DOI 10.1085/jgp.200709905; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Juschke C, 2004, CURR BIOL, V14, P406, DOI 10.1016/j.cub.2004.02.034; Kama R, 2007, MOL CELL BIOL, V27, P605, DOI 10.1128/MCB.00699-06; Kim Y, 2005, EUKARYOT CELL, V4, P281, DOI 10.1128/EC.4.2.281-288.2005; KOLAROV J, 1988, J BIOL CHEM, V263, P10613; Lavieu G, 2010, P NATL ACAD SCI USA, V107, P6876, DOI 10.1073/pnas.1002536107; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; SIKORSKI RS, 1989, GENETICS, V122, P19; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stradalova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035132; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Withee JL, 1998, GENETICS, V149, P865; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002; ZIBIRRE R, 1986, J CELL PHYSIOL, V129, P85, DOI 10.1002/jcp.1041290113	60	60	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39703	10.1371/journal.pone.0039703	http://dx.doi.org/10.1371/journal.pone.0039703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808051	Green Published, gold			2022-12-27	WOS:000306354700017
J	Haneef, J; Parvathy, M; Thankayyan, RSK; Sithul, H; Sreeharshan, S				Haneef, Jazir; Parvathy, M.; Thankayyan, Santhosh Kumar R.; Sithul, Hima; Sreeharshan, Sreeja			Bax Translocation Mediated Mitochondrial Apoptosis and Caspase Dependent Photosensitizing Effect of Ficus religiosa on Cancer Cells	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; AQUEOUS EXTRACT; CLEAVAGE; ACTIVATION; PATHWAYS; THERAPY; STRESS; AGENTS; DEATH; CYCLE	The main aim of the present work was to investigate the potential effect of acetone extract of Ficus religosa leaf (FAE) in multiple apoptosis signalling in human breast cancer cells. FAE treatment significantly induced dose and time dependent, irreversible inhibition of breast cancer cell growth with moderate toxicity to normal breast epithelial cells. This observation was validated using Sulforhodamine B assay. Cell cycle analysis by Flow cytometry showed cell cycle arrest in G1 phase and induction of sub-G0 peak. FAE induced chromatin condensation and displayed an increase in apoptotic population in Annexin V-FITC/PI (Fluorescein isothiocyanate/Propidium iodide) double staining. FAE stimulated the loss of mitochondrial membrane potential in multiple breast cancer cell lines when compared to normal diploid cells. To understand the role of Bax in FAE induced apoptosis, we employed a sensitive cell based platform of MCF-7 cells expressing Bax-EGFP. Bax translocation to mitochondria was accompanied by the disruption of mitochondrial membrane potential and marked elevation in LEHDase activity (Caspase 9). Consistent with this data, FAE induced Caspase activation as evidenced by ratio change in FRET Caspase sensor expressing MCF-7 cell line and cleavage of prominent Caspases and PARP. Interestingly, FAE accelerated cell death in a mitochondrial dependent manner in continuous live cell imaging mode indicating its possible photosensitizing effect. Intracellular generation of reactive oxygen species (ROS) by FAE played a critical role in mediating apoptotic cell death and photosensitizing activity. FAE induced dose and time dependent inhibition of cancer cell growth which was associated with Bax translocation and mitochondria mediated apoptosis with the activation of Caspase 9 dependent Caspase cascade. FAE also possessed strong photosensitizing effect on cancer cell line that was mediated through rapid mitochondrial transmembrane potential loss and partial Caspase activation involving generation of intracellular ROS.	[Haneef, Jazir; Parvathy, M.; Thankayyan, Santhosh Kumar R.; Sithul, Hima; Sreeharshan, Sreeja] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Haneef, J (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram, Kerala, India.	trsanthosh@rgcb.res.in; sreejasreeharshan@yahoo.com			University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR), Government of India	University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from University Grants Commission (UGC) and Council of Scientific and Industrial Research (CSIR), Government of India, as Senior Research Fellowships to Dr. Haneef and Dr. Parvathy M respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aiyegoro OA, 2009, J MED PLANTS RES, V3, P1147; Aqil F, 2003, WORLD J MICROB BIOT, V19, P653, DOI 10.1023/A:1025128104056; Benjamin CW, 1998, MOL PHARMACOL, V53, P446, DOI 10.1124/mol.53.3.446; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Choi HY, 2009, J POLYM ENG, V29, P1, DOI 10.1515/POLYENG.2009.29.1-3.1; Choudhary G.P., 2006, PLANTA INDICA, V2, P17; Cisowska A, 2011, NAT PROD COMMUN, V6, P149; Denecker G, 2000, FEBS LETT, V465, P47, DOI 10.1016/S0014-5793(99)01702-0; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Grabley S, 2000, SPR DESKT EDIT CHEM, P3; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gulecha V, 2011, ASIAN PAC J TROP MED, V4, P526, DOI 10.1016/S1995-7645(11)60139-9; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Joseph J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020114; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Jung HW, 2008, PHYTOTHER RES, V22, P1064, DOI 10.1002/ptr.2442; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kirana H, 2009, INDIAN J EXP BIOL, V47, P822; Kwang SA, 2007, MOL PHARM, V71, P209; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lam M, 2001, J BIOL CHEM, V276, P47379, DOI 10.1074/jbc.M107678200; McDonald S, 2001, FOOD CHEM, V73, P73, DOI 10.1016/S0308-8146(00)00288-0; Meng JR, 2009, CANCER BIOL THER, V8, P2073, DOI 10.4161/cbt.8.21.9844; Naira N., 2009, INTERNET J ALTERN ME, V6, P2; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Panchal RG, 1998, BIOCHEM PHARMACOL, V55, P247, DOI 10.1016/S0006-2952(97)00240-2; Pandit R, 2010, J ETHNOPHARMACOL, V128, P462, DOI 10.1016/j.jep.2010.01.025; Ratnasooriya WD, 1998, MED SCI RES, V26, P817; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Seervi M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.90; Sheetal A, 2008, INDIAN J PHARM SCI, V70, P31; Shishodia S., 2006, ANTICANCER POTENTIAL; Shoeb M., 2006, BANGL J PHARMACOL, V1, P35, DOI [10.3329/bjp.v1i2.486, DOI 10.3329/BJP.V1I2.486]; Singh D, 2011, J ETHNOPHARMACOL, V134, P565, DOI 10.1016/j.jep.2011.01.046; Singh D, 2009, J ETHNOPHARMACOL, V123, P330, DOI 10.1016/j.jep.2009.02.042; Sirisha N., 2010, International Journal of PharmTech Research, V2, P2174; Sreelekshmi R., 2007, Natural Product Radiance, V6, P377; Taskeen A, 2009, NEW YORK SCI J, V2, P32; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; Trease G, 2002, PHARMACOGNOSY; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vinutha B, 2007, J ETHNOPHARMACOL, V109, P359, DOI 10.1016/j.jep.2006.06.014; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	51	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40055	10.1371/journal.pone.0040055	http://dx.doi.org/10.1371/journal.pone.0040055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792212	gold, Green Submitted, Green Published			2022-12-27	WOS:000306461800034
J	Krarup, NT; Grarup, N; Banasik, K; Friedrichsen, M; Faerch, K; Sandholt, CH; Jorgensen, T; Poulsen, P; Witte, DR; Vaag, A; Sorensen, T; Pedersen, O; Hansen, T				Krarup, Nikolaj Thure; Grarup, Niels; Banasik, Karina; Friedrichsen, Martin; Faerch, Kristine; Sandholt, Camilla Helene; Jorgensen, Torben; Poulsen, Pernille; Witte, Daniel Rinse; Vaag, Allan; Sorensen, Thorkild; Pedersen, Oluf; Hansen, Torben			The PNPLA3 rs738409 G-Allele Associates with Reduced Fasting Serum Triglyceride and Serum Cholesterol in Danes with Impaired Glucose Regulation	PLOS ONE			English	Article							BETA-CELL FUNCTION; ADIPONUTRIN GENE; INSULIN-SECRETION; HEPATIC STEATOSIS; LIVER; METABOLISM; PLASMA; EXPRESSION; IMPACT; RISK	Background and Aim: Non-alcoholic fatty liver disease (NAFLD) is a common condition, associated with hepatic insulin resistance and the metabolic syndrome including hyperglycaemia and dyslipidemia. We aimed at studying the potential impact of the NAFLD-associated PNPLA3 rs738409 G-allele on NAFLD-related metabolic traits in hyperglycaemic individuals. Methods: The rs738409 variant was genotyped in the population-based Inter99 cohort examined by an oral glucose-tolerance test, and a combined study-sample consisting of 192 twins (96 twin pairs) and a sub-set of the Inter99 population (n = 63) examined by a hyperinsulinemic euglycemic clamp (n(total) = 255). In Inter99, we analyzed associations of rs738409 with components of the WHO-defined metabolic syndrome (n = 5,847) and traits related to metabolic disease (n = 5,663). In the combined study sample we elucidated whether the rs738409 G-allele altered hepatic or peripheral insulin sensitivity. Study populations were divided into individuals with normal glucose-tolerance (NGT) and with impaired glucose regulation (IGR). Results: The case-control study showed no associations with components of the metabolic syndrome or the metabolic syndrome. Among 1,357 IGR individuals, the rs738409 G-allele associated with decreased fasting serum triglyceride levels (per allele effect(beta) = -9.9% [-14.4%; -4.0% (95% CI)], p = 5.1 x 10(-5)) and fasting total cholesterol (beta = -0.2 mmol/l [-0.3; -0.01 mmol/l(95% CI)], p = 1.5 x 10(-4)). Meta-analyses showed no impact on hepatic or peripheral insulin resistance in carriers of the rs738409 G-allele. Conclusion: Our findings suggest that the G-allele of PNPLA3 rs738409 associates with reduced fasting levels of cholesterol and triglyceride in individuals with IGR.	[Krarup, Nikolaj Thure; Grarup, Niels; Banasik, Karina; Sandholt, Camilla Helene; Sorensen, Thorkild; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Poulsen, Pernille] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; [Jorgensen, Torben] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Friedrichsen, Martin] Dept Exercise & Sports Sci, Copenhagen, Denmark; [Faerch, Kristine; Witte, Daniel Rinse; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Vaag, Allan] Rigshosp, Dept Diabet & Metab, DK-2100 Copenhagen, Denmark; [Sorensen, Thorkild] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk; Steno Diabetes Center; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; University of Southern Denmark	Krarup, NT (corresponding author), Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	nikolaj.krarup@sund.ku.dk	Pedersen, Oluf/AAG-8015-2020; Friedrichsen, Martin/A-3638-2015; Grarup, Niels/K-2807-2015; Banasik, Karina/G-1728-2013; Pedersen, Oluf/Z-1731-2019; Witte, Daniel/AAF-9535-2019; Banasik, Karina/S-3475-2019; Jørgensen, Torben/Z-1335-2018; Witte, Daniel R/C-1722-2008	Friedrichsen, Martin/0000-0003-3383-9593; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Witte, Daniel/0000-0002-0769-2922; Banasik, Karina/0000-0003-2489-2499; Witte, Daniel R/0000-0002-0769-2922; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831; Vaag, Allan Arthur/0000-0002-3690-2191; Faerch, Kristine/0000-0002-6127-0448; Krarup, Nikolaj Thure/0000-0001-6526-8663; Krarup, Nikolaj/0000-0002-1660-4832	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Health Research Council; European Commission [LSHM-CT-2005-018734]; Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences); Novo Nordisk; Novo Nordisk Foundation; Lundbeck A/S; Novo Nordisk A/S	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Health Research Council; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk(Novo Nordisk); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck A/S; Novo Nordisk A/S(Novo Nordisk)	The study was supported by grants from: the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP), the Danish Health Research Council, "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP, http://www.hepadip.org), which was supported by the European Commission as an integrated project under the 6th Framework Programme (LSHM-CT-2005-018734), the Danish Diabetes Association, the Danish Council for Independent Research (Medical Sciences) and Novo Nordisk. The NNF Center for Metabolic Research is funded by the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors NTK, KB, KF, CS, TH and OP hold stock in Novo Nordisk A/S. Author PP is employed by Novo Nordisk A/S. Authors TH and OP have received research grants and honoraria for speaking and participating at meetings from Lundbeck A/S and Novo Nordisk A/S. Author TIAS collaborates on various industrial obesity research as indicated on the website http://www.ipm.hosp.dk/Publications-site/tias/Disclosures.html. The study was supported by: Lundbeck A/S, Novo Nordisk A/S, and The NNF Center for Metabolic Research is funded by the Novo Nordisk Foundation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Dubuquoy C, 2011, J HEPATOL, V55, P145, DOI 10.1016/j.jhep.2010.10.024; Faerch K, 2008, DIABETOLOGIA, V51, P853, DOI 10.1007/s00125-008-0951-x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grunnet L, 2006, DIABETOLOGIA, V49, P343, DOI 10.1007/s00125-005-0080-8; He S, 2009, J BIOL CHEM; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; Huang Y, 2011, J BIOL CHEM     1224; JENSEN MD, 1995, J CLIN INVEST, V96, P2297, DOI 10.1172/JCI118285; Johansson LE, 2006, DIABETES, V55, P826, DOI 10.2337/diabetes.55.03.06.db05-1075; Johansson LE, 2008, EUR J ENDOCRINOL, V159, P577, DOI 10.1530/EJE-08-0426; Johansson LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005327; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Kollerits B, 2009, HUM MOL GENET, V18, P4669, DOI 10.1093/hmg/ddp424; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moldes M, 2006, EUR J ENDOCRINOL, V155, P461, DOI 10.1530/eje.1.02229; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Polson DA, 2003, BIOCHEM BIOPH RES CO, V301, P261, DOI 10.1016/S0006-291X(02)03027-9; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Poulsen P, 2002, DIABETOLOGIA, V45, P1649, DOI 10.1007/s00125-002-0983-6; Poulsen P, 2006, DIABETES, V55, P1819, DOI 10.2337/db05-1462; Richard J, 2011, EXPERT REV CARDIOVAS, V9, P321, DOI [10.1586/ERC.11.15, 10.1586/erc.11.15]; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Stancakova A, 2011, DIABETES, V60, P1608, DOI 10.2337/db10-1655; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zain SM, 2012, HUM GENET	35	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40376	10.1371/journal.pone.0040376	http://dx.doi.org/10.1371/journal.pone.0040376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792295	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300061
J	Sakhdari, A; Mujib, S; Vali, B; Yue, FY; MacParland, S; Clayton, K; Jones, RB; Liu, J; Lee, EY; Benko, E; Kovacs, C; Gommerman, J; Kaul, R; Ostrowski, MA				Sakhdari, Ali; Mujib, Shariq; Vali, Bahareh; Yue, Feng Yun; MacParland, Sonya; Clayton, Kiera; Jones, Richard Bradley; Liu, Jun; Lee, Erika Yue; Benko, Erika; Kovacs, Colin; Gommerman, Jennifer; Kaul, Rupert; Ostrowski, Mario A.			Tim-3 Negatively Regulates Cytotoxicity in Exhausted CD8(+) T Cells in HIV Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; NATURAL-KILLER-CELLS; MEDIATED CYTOTOXICITY; VIRUS-INFECTION; UP-REGULATION; DEPENDENT CYTOTOXICITY; PROLIFERATIVE CAPACITY; DISEASE PROGRESSION; GRANULE EXOCYTOSIS; IMPAIRED FUNCTION	Cytotoxic CD8(+) T cells (CTLs) contain virus infections through the release of granules containing both perforin and granzymes. T cell 'exhaustion' is a hallmark of chronic persistent viral infections including HIV. The inhibitory regulatory molecule, T cell Immunoglobulin and Mucin domain containing 3 (Tim-3) is induced on HIV-specific T cells in chronic progressive infection. These Tim-3 expressing T cells are dysfunctional in terms of their capacities to proliferate or to produce cytokines. In this study, we evaluated the effect of Tim-3 expression on the cytotoxic capabilities of CD8(+) T cells in the context of HIV infection. We investigated the cytotoxic capacity of Tim-3 expressing T cells by examining 1) the ability of Tim-3(+) CD8(+) T cells to make perforin and 2) the direct ability of Tim-3(+) CD8(+) T cells to kill autologous HIV infected CD4(+) target cells. Surprisingly, Tim-3(+) CD8(+) T cells maintain higher levels of perforin, which was mainly in a granule-associated (stored) conformation, as well as express high levels of T-bet. However, these cells were also defective in their ability to degranulate. Blocking the Tim-3 signalling pathway enhanced the cytotoxic capabilities of HIV specific CD8(+) T cells from chronic progressors by increasing; a) their degranulation capacity, b) their ability to release perforin, c) their ability to target activated granzyme B to HIV antigen expressing CD4(+) T cells and d) their ability to suppress HIV infection of CD4(+) T cells. In this latter effect, blocking the Tim-3 pathway enhances the cytotoxcity of CD8(+) T cells from chronic progressors to the level very close to that of T cells from viral controllers. Thus, the Tim-3 receptor, in addition to acting as a terminator for cytokine producing and proliferative functions of CTLs, can also down-regulate the CD8(+) T cell cytotoxic function through inhibition of degranulation and perforin and granzyme secretion.	[Sakhdari, Ali; Yue, Feng Yun; Clayton, Kiera; Jones, Richard Bradley; Liu, Jun; Lee, Erika Yue; Gommerman, Jennifer; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Mujib, Shariq; Vali, Bahareh; MacParland, Sonya; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Benko, Erika; Kovacs, Colin; Ostrowski, Mario A.] Maple Leaf Med Clin, Toronto, ON, Canada; [Ostrowski, Mario A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Sakhdari, A (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	ali.sakhdari@utoronto.ca	Sakhdari, Ali/AAD-9370-2019	Mujib, Shariq/0000-0002-6206-5622; MacParland, Sonya/0000-0002-8036-1425; Sakhdari, Ali/0000-0002-4610-7562; Kaul, Rupert/0000-0002-1586-4093; Gommerman, Jennifer/0000-0003-4576-6168	CIHR (Canadian Institutes of Health Research)	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	The funding source was CIHR (Canadian Institutes of Health Research) who provided funds for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, J ACQUIR IMMUNE DEFI; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Andersson J, 1999, AIDS, V13, P1295, DOI 10.1097/00002030-199907300-00005; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Barker E, 1997, J IMMUNOL, V159, P5123; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blackbourn DJ, 1996, P NATL ACAD SCI USA, V93, P13125, DOI 10.1073/pnas.93.23.13125; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Catalfamo M, 2003, CURR OPIN IMMUNOL, V15, P522, DOI 10.1016/S0952-7915(03)00114-6; Chun TW, 2001, P NATL ACAD SCI USA, V98, P253, DOI 10.1073/pnas.98.1.253; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Giorgi JV, 1999, IMMUNOL LETT, V66, P105, DOI 10.1016/S0165-2478(98)00170-9; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; HEINKELEIN M, 1995, J ACQ IMMUN DEF SYND, V10, P417, DOI 10.1097/00042560-199512000-00004; Heintel T, 2002, AIDS, V16, P1497, DOI 10.1097/00002030-200207260-00006; Hersperger AR, 2008, CYTOM PART A, V73A, P1050, DOI 10.1002/cyto.a.20596; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Hodgson PD, 1999, CLIN EXP IMMUNOL, V118, P63; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones N, 2006, AIDS RES HUM RETROV, V22, P1007, DOI 10.1089/aid.2006.22.1007; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2009, CELL MOL IMMUNOL, V6, P35, DOI 10.1038/cmi.2009.5; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KANE KP, 1993, J IMMUNOL, V150, P4788; Kuchroo VK, 2006, ADV IMMUNOL, V91, P227, DOI 10.1016/S0065-2776(06)91006-2; Lee SM, 2004, J MED GENET, V41, P137, DOI 10.1136/jmg.2003.011528; Liu HN, 2003, VIRAL IMMUNOL, V16, P381, DOI 10.1089/088282403322396172; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Makedonas G, 2009, J IMMUNOL, V182, P5560, DOI 10.4049/jimmunol.0803945; Meng YR, 2006, J IMMUNOL, V177, P1981, DOI 10.4049/jimmunol.177.3.1981; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Mujib S, 2012, J IMMUNOLOGY; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Pollack H, 1997, AIDS, V11, pF9, DOI 10.1097/00002030-199701000-00002; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sakuishi K, 2011, TRENDS IMMUNOL; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Shacklett BL, 2004, J IMMUNOL, V173, P641, DOI 10.4049/jimmunol.173.1.641; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; SHIVER JW, 1991, CELL, V64, P1175, DOI 10.1016/0092-8674(91)90272-Z; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Tayade C, 2005, J LEUKOCYTE BIOL, V78, P1347, DOI 10.1189/jlb.0305142; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594; Tsuchie H, 1997, INT J STD AIDS, V8, P307, DOI 10.1258/0956462971920145; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; YOUNG JDE, 1988, IMMUNOL REV, V103, P161, DOI 10.1111/j.1600-065X.1988.tb00755.x; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Zhu C, 2011, CURR TOP MICROBIOL, V350, P1, DOI 10.1007/82_2010_84	73	66	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40146	10.1371/journal.pone.0040146	http://dx.doi.org/10.1371/journal.pone.0040146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792231	Green Submitted, gold, Green Published			2022-12-27	WOS:000306436300031
J	Lenormand, M; Huet, S; Deffuant, G				Lenormand, Maxime; Huet, Sylvie; Deffuant, Guillaume			Deriving the Number of Jobs in Proximity Services from the Number of Inhabitants in French Rural Municipalities	PLOS ONE			English	Article								We use a minimum requirement approach to derive the number of jobs in proximity services per inhabitant in French rural municipalities. We first classify the municipalities according to their time distance in minutes by car to the municipality where the inhabitants go the most frequently to get services (called MFM). For each set corresponding to a range of time distance to MFM, we perform a quantile regression estimating the minimum number of service jobs per inhabitant that we interpret as an estimation of the number of proximity jobs per inhabitant. We observe that the minimum number of service jobs per inhabitant is smaller in small municipalities. Moreover, for municipalities of similar sizes, when the distance to the MFM increases, the number of jobs of proximity services per inhabitant increases.	[Lenormand, Maxime; Huet, Sylvie; Deffuant, Guillaume] Irstea, LISC, Clermont Ferrand, France	INRAE	Lenormand, M (corresponding author), Irstea, LISC, Clermont Ferrand, France.	maxime.lenormand@irstea.fr	Huet, Sylvie/AAV-5505-2020; Deffuant, Guillaume/GRF-3580-2022	Huet, Sylvie/0000-0003-2973-7738; Deffuant, Guillaume/0000-0001-6265-9300	European Union [ENV 2007-1, 212345]	European Union(European Commission)	This publication has been funded under the Prototypical policy impacts on multifunctional activities in rural municipalities collaborative project, European Union 7th Framework Programme (ENV 2007-1), contract no. 212345. https://prima.cemagref.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODSKY H, 1977, LAND ECON, V53, P445, DOI 10.2307/3145988; Brown DG, 2006, ECOL SOC, V11; Dissart JC, 2009, ADV MODERN TOURISM R; English DBK, 2000, SOC NATUR RESOUR, V13, P185, DOI 10.1080/089419200279054; Hubert J. P., 2009, GRANDES AGGLOMERATIO; Huet S, 2011, ESSA 2011 C SEPT 201, P22; Klosterman RE, 1990, COMMUNITY ANAL PLANN; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Leatherman J, 1997, EXTENSION REPORTS SE; MOORE CL, 1975, ECON GEOGR, V51, P350, DOI 10.2307/142919; Mordier B, 2010, SERVICES MARCHANDS P; PERSKY J, 1994, ECON GEOGR, V70, P129, DOI 10.2307/143651; Rutland T, 2007, LOCAL ECON, V22, P163, DOI 10.1080/02690940701416727; Ullman E, 1960, PAPERS P REGIONAL SC, V6, P192; Woller G, 2002, NONPROF VOLUNT SEC Q, V31, P419, DOI 10.1177/0899764002313006	15	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40001	10.1371/journal.pone.0040001	http://dx.doi.org/10.1371/journal.pone.0040001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	971EQ	22802948	Green Submitted, gold, Green Published			2022-12-27	WOS:000306186900022
J	Chen, WH; Zhou, W; Xia, T; Gu, X				Chen, Wenhai; Zhou, Wen; Xia, Tian; Gu, Xun			A Computational Analysis Framework for Molecular Cell Dynamics: Case-Study of Exocytosis	PLOS ONE			English	Article							SINGLE-MOLECULE; SYNAPTOTAGMIN; ACTIVATION; MECHANISMS; SNAREPINS; SENSOR	One difficulty in conducting biologically meaningful dynamic analysis at the systems biology level is that in vivo system regulation is complex. Meanwhile, many kinetic rates are unknown, making global system analysis intractable in practice. In this article, we demonstrate a computational pipeline to help solve this problem, using the exocytotic process as an example. Exocytosis is an essential process in all eukaryotic cells that allows communication in cells through vesicles that contain a wide range of intracellular molecules. During this process a set of proteins called SNAREs acts as an engine in this vesicle-membrane fusion, by forming four-helical bundle complex between (membrane) target-specific and vesicle-specific SNAREs. As expected, the regulatory network for exocytosis is very complex. Based on the current understanding of the protein-protein interaction network related to exocytosis, we mathematically formulated the whole system, by the ordinary differential equations (ODE). We then applied a mathematical approach (called inverse problem) to estimating the kinetic parameters in the fundamental subsystem (without regulation) from limited in vitro experimental data, which fit well with the reports by the conventional assay. These estimates allowed us to conduct an efficient stability analysis under a specified parameter space for the exocytotic process with or without regulation. Finally, we discuss the potential of this approach to explain experimental observations and to make testable hypotheses for further experimentation.	[Chen, Wenhai; Gu, Xun] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Chen, Wenhai; Gu, Xun] Fudan Univ, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China; [Zhou, Wen] Iowa State Univ, Dept Math, Ames, IA USA; [Xia, Tian] Iowa State Univ, Elect & Comp Engn Dept, Ames, IA USA; [Xia, Tian] Northwestern Univ, Clin & Translat Sci Inst, Biomed Informat Ctr, Chicago, IL 60611 USA; [Gu, Xun] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Fudan University; Fudan University; Iowa State University; Iowa State University; Northwestern University; Iowa State University	Chen, WH (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	tianxia@northwestern.edu; xgu@iastate.edu						Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; DeVries G., 2006, COURSE MATH BIOL QUA; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Keener J., 2001, MATH PHYSL; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lorenzi A, 2014, INTRO IDENTIFICATION, P83; Lu XB, 2005, J BIOL CHEM, V280, P30538, DOI 10.1074/jbc.M506862200; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Mezer A, 2004, J NEUROSCI, V24, P8838, DOI 10.1523/JNEUROSCI.2815-04.2004; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; Perko L, 2000, DIFFER EQUAT DYN SYS; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Vogel C. R., 2002, FRONT APPL MATH, DOI DOI 10.1137/1.9780898717570; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Xia T, 2012, BMC SYSTEMS IN PRESS	29	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38699	10.1371/journal.pone.0038699	http://dx.doi.org/10.1371/journal.pone.0038699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808014	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400005
J	Ikeda, Y; Tajima, S; Izawa-Ishizawa, Y; Kihira, Y; Ishizawa, K; Tomita, S; Tsuchiya, K; Tamaki, T				Ikeda, Yasumasa; Tajima, Soichiro; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Ishizawa, Keisuke; Tomita, Shuhei; Tsuchiya, Koichiro; Tamaki, Toshiaki			Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes	PLOS ONE			English	Article							IRON-METABOLISM; SERUM HEPCIDIN; MESSENGER-RNA; G-PROTEIN; RECEPTOR; MICE; CELLS; INFLAMMATION; ESTRADIOL; MECHANISM	Hepcidin, a liver-derived iron regulatory protein, plays a crucial role in iron metabolism. It is known that gender differences exist with respect to iron storage in the body; however, the effects of sex steroid hormones on iron metabolism are not completely understood. We focused on the effects of the female sex hormone estrogen on hepcidin expression. First, ovariectomized (OVX) and sham-operated mice were employed to investigate the effects of estrogen on hepcidin expression in an in vivo study. Hepcidin expression was decreased in the livers of OVX mice compared to the sham-operated mice. In OVX mice, bone morphologic protein-6 (BMP6), a regulator of hepcidin, was also found to be downregulated in the liver, whereas ferroportin (FPN), an iron export protein, was upregulated in the duodenum. Both serum and liver iron concentrations were elevated in OVX mice relative to their concentrations in sham-operated mice. In in vitro studies, 17 beta-estradiol (E-2) increased the mRNA expression of hepcidin in HepG2 cells in a concentration-dependent manner. E-2-induced hepatic hepcidin upregulation was not inhibited by ICI 182720, an inhibitor of the estrogen receptor; instead, hepcidin expression was increased by ICI 182720. E-2 and ICI 182720 exhibit agonist actions with G-protein coupled receptor 30 (GPR30), the 7-transmembrane estrogen receptor. G1, a GPR30 agonist, upregulated hepcidin expression, and GPR30 siRNA treatment abolished E-2-induced hepcidin expression. BMP6 expression induced by E-2 was abolished by GPR30 silencing. Finally, both E-2 and G1 supplementation restored reduced hepatic hepcidin and BMP6 expression and reversed the augmentation of duodenal FPN expression in the OVX mice. In contrast, serum hepcidin was elevated in OVX mice, which was reversed in these mice with E-2 and G1. Thus, estrogen is involved in hepcidin expression via a GPR30-BMP6-dependent mechanism, providing new insight into the role of estrogen in iron metabolism.	[Ikeda, Yasumasa; Tajima, Soichiro; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Tomita, Shuhei; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Dept Pharmacol, Inst Hlth Biosci, Tokushima 770, Japan; [Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Dept Med Pharmacol, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University; Tokushima University	Ikeda, Y (corresponding author), Univ Tokushima, Grad Sch, Dept Pharmacol, Inst Hlth Biosci, Tokushima 770, Japan.	yasuike@basic.med.tokushima-u.ac.jp		Ikeda, Yasumasa/0000-0003-4318-7349	Grants for the Regional Innovation Cluster Program; Houansha Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Tokushima Shinbun Foundation; Akaeda Foundation for Medical Research; Grants-in-Aid for Scientific Research [23790089, 24590381] Funding Source: KAKEN	Grants for the Regional Innovation Cluster Program; Houansha Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokushima Shinbun Foundation; Akaeda Foundation for Medical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants for the Regional Innovation Cluster Program and Houansha Foundation (to TT.), Grants-in-Aid for Young Scientist B, the Uehara Memorial Foundation, Takeda Science Foundation, Tokushima Shinbun Foundation, and Akaeda Foundation for Medical Research (to YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Cheng XL, 2006, LIFE SCI, V79, P1988, DOI 10.1016/j.lfs.2006.06.044; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Floreani A, 2011, CLIN CHEM LAB MED, V49, P197, DOI 10.1515/CCLM.2011.055; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Itkonen O, 2011, CLIN CHIM ACTA; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Kijima H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-167; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Krijt J, 2004, J HEPATOL, V40, P891, DOI 10.1016/j.jhep.2004.02.029; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Luque-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P846, DOI 10.1210/jc.2010-2211; Marino M, 2001, MOL CELL ENDOCRINOL, V182, P19, DOI 10.1016/S0303-7207(01)00556-1; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Milman N, 1996, INT J HEMATOL, V63, P103; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Solakidi S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P240; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Viatte L, 2005, BLOOD, V105, P4861, DOI 10.1182/blood-2004-12-4608; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205	35	81	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40465	10.1371/journal.pone.0040465	http://dx.doi.org/10.1371/journal.pone.0040465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792339	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400060
J	Lopez-Arbarello, A				Lopez-Arbarello, Adriana			Phylogenetic Interrelationships of Ginglymodian Fishes (Actinopterygii: Neopterygii)	PLOS ONE			English	Article							PECTORAL GIRDLE; SEMIONOTIFORM ACTINOPTERYGII; SWITZERLAND; EVOLUTION; REVISION; PROVINCE; GERMANY; PISCES; LEPISOSTEUS; HOMOLOGY	The Ginglymodi is one of the most common, though poorly understood groups of neopterygians, which includes gars, macrosemiiforms, and "semionotiforms." In particular, the phylogenetic relationships between the widely distributed "semionotiforms," and between them and other ginglymodians have been enigmatic. Here, the phylogenetic relationships between eight of the 11 "semionotiform" genera, five genera of living and fossil gars and three macrosemiid genera, are analysed through cladistic analysis, based on 90 morphological characters and 37 taxa, including 7 out-group taxa. The results of the analysis show that the Ginglymodi includes two main lineages: Lepisosteiformes and dagger Semionotiformes. The genera dagger Pliodetes, dagger Araripelepidotes, dagger Lepidotes, dagger Scheenstia, and dagger Isanichthys are lepisosteiforms, and not semionotiforms, as previously thought, and these taxa extend the stratigraphic range of the lineage leading to gars back up to the Early Jurassic. A monophyletic dagger Lepidotes is restricted to the Early Jurassic species, whereas the strongly tritoral species previously referred to dagger Lepidotes are referred to dagger Scheenstia. Other species previously referred to dagger Lepidotes represent other genera or new taxa. The macrosemiids are well nested within semionotiforms, together with dagger Semionotidae, here restricted to dagger Semionotus, and a new family including dagger Callipurbeckia n. gen. minor (previously referred to dagger Lepidotes), dagger Macrosemimimus, dagger Tlayuamichin, dagger Paralepidotus, and dagger Semiolepis. Due to the numerous taxonomic changes needed according to the phylogenetic analysis, this article also includes formal taxonomic definitions and diagnoses for all generic and higher taxa, which are new or modified. The study of Mesozoic ginglymodians led to confirm Patterson's observation that these fishes show morphological affinities with both halecomorphs and teleosts. Therefore, the compilation of large data sets including the Mesozoic ginglymodians and the re-evaluation of several hypotheses of homology are essential to test the hypotheses of the Halecostomi vs. the Holostei, which is one of the major topics in the evolution of Mesozoic vertebrates and the origin of modern fish faunas.	Bayer Staatssammlung Palaontol & Geol, Munich, Germany		Lopez-Arbarello, A (corresponding author), Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	a.Lopez-Arbarello@lrz.uni-muenchen.de	Lopez-Arbarello, Adriana/N-1834-2018	Lopez-Arbarello, Adriana/0000-0002-2924-3319	German Research Foundation [DFG LO1405/1, LO1405/3]; European Commission's Research Infrastructure Action [SYNTHESYS FR-TAF 2079]; Volkswagen Foundation	German Research Foundation(German Research Foundation (DFG)); European Commission's Research Infrastructure Action(European CommissionEuropean Commission Joint Research Centre); Volkswagen Foundation(Volkswagen)	This work has been supported by the German Research Foundation (http://www.dfg.de/) through the projects DFG LO1405/1 and LO1405/3, the European Commission's Research Infrastructure Action (http://www.synthesys.info/) through the grant SYNTHESYS FR-TAF 2079, and the Volkswagen Foundation (http://www.volkswagenstiftung.de/) through the project "Die Dynamik des Solnhofener Archipels". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassiz L., 1841, EDINBURGH NEW PHILOS, V30, P82; Agassiz L., 1832, NEUES JB MINERALOGIE, V3, P139; Allis E. P., 1889, J MORPHOL, V2, DOI 10.1002/jmor.1050020303; Allis E. P., 1898, J MORPHOL, V14, DOI [10.1002/jmor.1050140303, DOI 10.1002/JMOR.1050140303]; Allis EP., 1909, ZOOLOGICA, V57, P96; [Anonymous], 1833, RECHERCHES POISSONS; Arambourg C, 1958, TRAITE ZOOL, V13, P2173; ARRATIA G, 1991, J MORPHOL, V208, P1, DOI 10.1002/jmor.1052080102; Arratia G, 2001, J VERTEBR PALEONTOL, V21, P767, DOI 10.1671/0272-4634(2001)021[0767:TSGOTC]2.0.CO;2; Arratia G, 2007, J VERTEBR PALEONTOL, V27, P838, DOI 10.1671/0272-4634(2007)27[838:ANHFFT]2.0.CO;2; Arratia Gloria, 1999, P265; Arratia Gloria, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P135; Arratia Gloria, 2000, Estudios Oceanologicos, V19, P19; Arratia G, 2008, GEOL SOC SPEC PUBL, V295, P71, DOI 10.1144/SP295.6; Aumonier FJ, 1941, Q J MICROSC SCI, V83, P1; Bartram A. W. H., 1977, Bulletin Br. Mus. nat. Hist. (Geol.), V29, P137; Beltan L.L., 1972, Cienc Artes Barcelona, V41, P281; Berg L. S., 1940, Travaux de l'Institut de Zoologie Acad Sci Leningrad, V5, P87; Bjerring H.C., 1971, Acta Zoologica Stockholm, V52, P189; Bjerring H.C., 1972, Zoologica Scr, V(5), P193; Bjerring H. C., 1968, P341; Bjerring H. C., 1967, P223; Blainville H.de., 1818, NOUVEAU DICT HIST NA, V27, P310; BOCCHINO R A, 1973, Ameghiniana, V10, P254; Branco W., 1885, JB K ONIGLICH PREUSS, V1884, P181; Brito Paulo M., 1997, Geodiversitas, V19, P681; BRITO PM, 1988, GEOBIOS-LYON, V21, P819, DOI 10.1016/S0016-6995(88)80098-6; Brough J., 1939, TRIASSIC FISHES BESA; Bryant HN, 1997, CLADISTICS, V13, P337, DOI 10.1111/j.1096-0031.1997.tb00323.x; Cavin L, 2006, PALAEONTOLOGY, V49, P339, DOI 10.1111/j.1475-4983.2006.00539.x; Cavin L, 2001, B SOC GEOL FR, V172, P661, DOI 10.2113/172.5.661; Cavin L, 2010, NATURWISSENSCHAFTEN, V97, P1035, DOI 10.1007/s00114-010-0722-7; Chang M.M., 1977, MEM I VERT PALEONTOL, V12, P1; Coates MI, 1999, PHILOS T R SOC B, V354, P435, DOI 10.1098/rstb.1999.0396; Cope E.D., 1872, P AM SOC ADVANCEMENT, V20, P317; Cuvier G, 1825, RECHERCHES OSSEMENS, V3; Danil'chenko PG, 1964, OSNOVY PALEONTOLOGII, P378; Deecke W., 1889, PALAEONTOGRAPHICA, V35, P13; DEPINNA MCC, 1991, CLADISTICS, V7, P367; DEQUEIROZ K, 1990, SYST ZOOL, V39, P307, DOI 10.2307/2992353; Forey P. L., 2011, PALAEONTOL ELECTRON, V14, P1; Gallo Valeria, 2004, P253; Gardiner B. G., 1967, Bulletin of the British Museum (Natural History) Geology, V14, P143; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner BG, 2005, ZOOL J LINN SOC-LOND, V144, P511, DOI 10.1111/j.1096-3642.2005.00181.x; GARDINER BG, 1989, ZOOL J LINN SOC-LOND, V97, P135, DOI 10.1111/j.1096-3642.1989.tb00550.x; Gardiner Brian G., 1996, P117, DOI 10.1016/B978-012670950-6/50007-2; GARDINER BRIAN GEORGE, 1960, BULL BRIT MUS [NAT HIST] GEOL, V4, P239; Godefroit Pascal, 1994, Memoires pour Servir a l'Explication des Cartes Geologiques et Minieres de la Belgique, V39, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Gonzalez-Rodriguez K, 2004, J VERTEBR PALEONTOL, V24, P281, DOI 10.1671/1862; Gonzalez-Rodriguez Katia, 2004, P265; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande L, 2010, COPEIA, P1; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; HAMMARBERG FIGGE, 1937, ACTA ZOOLOGICA, V18, P209; Hay O. P., 1929, Vol I Carneg Inst Washington pub, V390, pUnpaginated; Hennig E., 1914, ARCH BIONTOLOGIE, V3, P293; Hilton Eric J., 2011, Fieldiana-Life and Earth Sciences, V3, P1; Hilton EJ, 2009, J SYST PALAEONTOL, V7, P427, DOI 10.1017/S1477201909002740; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Huxley TH., 1861, MEM GEOL SURV UK, V10, P1; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Jaekel O, 1929, MITTEILUNGEN MECKLEN, V3, P13; Jain S.L., 1985, Journal of the Palaeontological Society of India, V30, P18; Jain S.L., 1983, Journal of the Palaeontological Society of India, V28, P7; JAIN SOHAN LALL, 1963, PROC ZOOL SOC LONDON, V141, P119; JOLLIE M, 1986, CAN J ZOOL, V64, P365, DOI 10.1139/z86-058; JOLLIE M, 1984, COPEIA, P476, DOI 10.2307/1445204; JOLLIE M, 1975, J MORPHOL, V147, P61, DOI 10.1002/jmor.1051470106; Kriwet Juergen, 2005, Zitteliana Reihe A, V45, P135; L?pez-Arbarello A., 2008, REV ASOC GEOL ARGENT, V63, P586; Lacepede B. G. E., 1803, HIST NATURELLE POISS, V5; Lambers P.H, 1994, GEOBIOS, V27, P91, DOI 10.1016/S0016-6995(94)80024-3; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; LEHMAN JEAN-PIERRE, 1952, K SVENSKA VETENSKAPS AKAD HANDL, V2, P1; Lehman JP, 1966, ORIGINE VERTEBRES LE, VIV, P1; Lombardo C, 2001, RIV ITAL PALEONTOL S, V107, P345, DOI 10.13130/2039-4942/5439; Lombardo C., 2008, MESOZOIC FISHES, P129; Lopez-Arbarello A, 2008, PALAEONTOLOGY, V51, P1025, DOI 10.1111/j.1475-4983.2008.00806.x; Lopez-Arbarello A, 2008, PALAEONTOL Z, V82, P40; Lopez-Arbarello A, 2007, J VERTEBR PALEONTOL, V27, P811, DOI 10.1671/0272-4634(2007)27[811:SNSFTL]2.0.CO;2; Lopez-Arbarello A, 2006, J VERTEBR PALEONTOL, V26, p91A; Lopez-Arbarello A, 2011, ZOOTAXA, P1; Lopez-Arbarello A, 2011, J SYST PALAEONTOL, V9, P197, DOI 10.1080/14772019.2010.493751; Lopez-Arbarello Adriana, 2011, Zootaxa, V2749, P25; Lopez-Arbarello Adriana, 2004, P597; Lopez-Arbarello A, 2010, PALAEONTOLOGY, V53, P249, DOI 10.1111/j.1475-4983.2010.00931.x; Maddison W., 2018, MESQUITE MODULAR SYS; MADDISON WP, 1984, SYST ZOOL, V33, P83, DOI 10.2307/2413134; Maisch Michael W., 2004, Palaeontologische Zeitschrift, V78, P161; Maisey JG, 1991, SANTANA FOSSILS ILLU; Malzahn E., 1963, Geologisches Jahrbuch, V80, P539; McAllister D.E., 1968, B NATL MUSEUM CANADA, V221, P1; MCCUNE AR, 1986, PALAEONTOLOGY, V29, P213; Micklich N., 2001, KAUPIA, V11, P73; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Newberry J., 1888, US GEOLOGICAL SURVEY, V14, P1; NIELSEN E, 1942, MEDDELELSER GRONLAND, V138, P1; NIELSEN EIGIL, 1949, MEDDEL GRONLAND, V146, P1; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; NORMARK BB, 1991, MOL BIOL EVOL, V8, P819; Nybelin O., 1966, Bulletin of the British Museum (Natural History) Geology, V11, P351; Olsen P.E., 1991, Journal of Vertebrate Paleontology, V11, P269; Olsen PE., 1984, J VERTEBR PALEONTOL, V4, P481, DOI [10.1080/02724634.1984.10012024, DOI 10.1080/02724634.1984.10012024]; Owen R., 1860, PALAEONTOLOGY SYSTEM; PATTERSON C, 1982, AM ZOOL, V22, P241; Patterson C., 1973, Zoological J Linn Soc, V53, P233; PATTERSON C, 1975, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V88, P156; Patterson C, 1977, PROBLEMS VERTEBRATE, P1; Pehrson Torsten, 1940, ACTA ZOOL [STOCKHOLM], V21, P1; Piveteau J, 1935, ANN PALEONTOL, V23, P81; Poplin Cecile, 2004, P165; Quenstedt FA, 1847, UBER LEPIDOTUS LIAS; Rafinesque, 1820, W REV MISCELLANEOUS, V3, P165; Regan CT, 1923, P ZOOL SOC LOND, V1923, P445; Saint-Seine P.de., 1949, Nouvelles Archives du Museum d'Histoire Naturelle de Lyon Fasc, V2, P1; Sanford CPJ., 2000, THESES ZOOL, V33, P264; Santos R.daS., 1990, ANAIS ACAD BRASILEIR, V63, P239; Sauvage H.E., 1893, B SOC GEOLOGIQUE NOR, V14, P3; SCHAEFFER BOBB, 1950, AMER MUS NOVITATES, V1457, P1; Schroder KM, 2012, J VERTEBR PALEONTOL, V32, P512, DOI 10.1080/02724634.2012.649626; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; Stensio E., 1921, TRIASSIC FISHES SPTI; STENSIo ERIE A., 1932, MEDDELEL OM GRONLAND, V83, P1; Stolley E., 1920, Palaeontographica Stuttgart, V63; Su Dezao, 1996, Vertebrata Palasiatica, V34, P91; SU DZ, 1981, VERTEBRAT PALASIATIC, V19, P107; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Teixeira C., 1947, Broteria Lisbon, V16, P53; Thies D, 1996, J VERTEBR PALEONTOL, V16, P369, DOI 10.1080/02724634.1996.10011326; Thies D., 1989, Journal of Vertebrate Paleontology, V9, P18; Thies Detlev, 2008, Geologica et Palaeontologica, V42, P23; Thiolliere V., 1858, B SOC GEOLOGIQUE FRA, V2, P782; Tintori A, 2007, RIV ITAL PALEONTOL S, V113, P369, DOI 10.13130/2039-4942/5881; Tintori Andrea, 1996, P167; Wagner A, 1863, ABHANDLUNGEN KONIGLI, VIII, P138; Wei F., 1976, VERTEBRAT PALASIATIC, V14, P154; Wen W, 2012, ACTA PALAEONTOL POL, V57, P149, DOI 10.4202/app.2010.0089; Wenz S, 2003, GEODIVERSITAS, V25, P481; WENZ S, 1992, CR ACAD SCI II, V314, P1519; Wenz S, 1968, CAHIERS PALEONTOLOGI, P1; Wenz S., 1999, MESOZOIC FISHES, P107; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; Wiley E.O., 1976, Miscellaneous Publs Mus nat Hist Univ Kans, VNo. 64, P1; Woodward, 1916, PALAEONTOGR SOC, V2, P49; Woodward A.S., 1895, MEMOIRS GEOLOGICAL S, V9, P1; Woodward A.S., 1888, Q J GEOL SOC LOND, V44, P138; Woodward AS, 1897, P YORKS GEOL SOC, V13, P325; WOODWARD AS, 1890, MEMOIRS GEOLOGICAL S, V4, P1, DOI DOI 10.1080/00222939008694061; Xu GH, 2011, ZOOL J LINN SOC-LOND, V161, P595, DOI 10.1111/j.1096-3642.2010.00645.x; Zambelli R., 1987, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V10, P1; [No title captured]; [No title captured]	156	103	108	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39370	10.1371/journal.pone.0039370	http://dx.doi.org/10.1371/journal.pone.0039370			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808031	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400010
J	Reilly, D				Reilly, David			Gender, Culture, and Sex-Typed Cognitive Abilities	PLOS ONE			English	Article							SOCIAL-PSYCHOLOGY VIEW; SPATIAL ABILITY; COLLEGE SOPHOMORES; TEST-SCORES; MATHEMATICS; SCIENCE; SIMILARITIES; METAANALYSIS; STEREOTYPES; DIVERSITY	Although gender differences in cognitive abilities are frequently reported, the magnitude of these differences and whether they hold practical significance in the educational outcomes of boys and girls is highly debated. Furthermore, when gender gaps in reading, mathematics and science literacy are reported they are often attributed to innate, biological differences rather than social and cultural factors. Cross-cultural evidence may contribute to this debate, and this study reports national gender differences in reading, mathematics and science literacy from 65 nations participating in the 2009 round of the Programme for International Student Assessment (PISA). Consistently across all nations, girls outperform boys in reading literacy, d = -.44. Boys outperform girls in mathematics in the USA, d=.22 and across OECD nations, d=.13. For science literacy, while the USA showed the largest gender difference across all OECD nations, d=.14, gender differences across OECD nations were non-significant, and a small female advantage was found for non-OECD nations, d = -.09. Across all three domains, these differences were more pronounced at both tails of the distribution for low-and high-achievers. Considerable cross-cultural variability was also observed, and national gender differences were correlated with gender equity measures, economic prosperity, and Hofstede's cultural dimension of power distance. Educational and societal implications of such gender gaps are addressed, as well as the mechanisms by which gender differences in cognitive abilities are culturally mediated.	Griffith Univ, Sch Appl Psychol, Southport, Qld 4215, Australia	Griffith University	Reilly, D (corresponding author), Griffith Univ, Sch Appl Psychol, Southport, Qld 4215, Australia.	davidreilly.com@gmail.com	Reilly, David/Q-2466-2019	Reilly, David/0000-0003-1227-9806	Griffith University	Griffith University(Griffith University)	This research was supported in part by a Griffith University Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2011, SOC SCI RES, V40, P107, DOI 10.1016/j.ssresearch.2010.06.007; BAKER DP, 1993, SOCIOL EDUC, V66, P91, DOI 10.2307/2112795; BENBOW CP, 1988, BEHAV BRAIN SCI, V11, P169, DOI 10.1017/S0140525X00049244; Best DL, 1997, HDB CROSS CULTURAL P, V3, P163; Borenstein M, 1999, COMP META ANAL COMP; Borenstein M., 2009, INTRO METAANALYSIS; Caplan PJ, 1997, GENDER DIFFERENCES H, P52, DOI DOI 10.1093/ACPROF:OSO/9780195112917.003.0003; Carroll JB, 1997, CONT INTELLECTUAL AS, P69; CASEY MB, 1995, DEV PSYCHOL, V31, P697, DOI 10.1037/0012-1649.31.4.697; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dijkstra AG, 2000, FEM ECON, V6, P41; DWYER CA, 1973, REV EDUC RES, V43, P455, DOI 10.2307/1170076; Eagly A. H., 2004, PRAEGER GUIDE PSYCHO, P183; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Eagly AH, 2000, DEVELOPMENTAL SOCIAL PSYCHOLOGY OF GENDER, P123; EAGLY AH, 1995, AM PSYCHOL, V50, P145, DOI 10.1037/0003-066X.50.3.145; Eagly AH, 1997, AM PSYCHOL, V52, P1380, DOI 10.1037/0003-066X.52.12.1380.b; Eagly AH, 1987, SEX DIFFERNECES SOCI; ECCLES J, 1993, CHILD DEV, V64, P830, DOI 10.1111/j.1467-8624.1993.tb02946.x; Eccles J.S., 1985, GENDER INFLUENCES CL, P79, DOI DOI 10.1016/B978-0-12-752075-9.50010-6; ECCLES JS, 1990, J SOC ISSUES, V46, P183, DOI 10.1111/j.1540-4560.1990.tb01929.x; ECCLES JS, 1987, PSYCHOL WOMEN QUART, V11, P135, DOI 10.1111/j.1471-6402.1987.tb00781.x; Else-Quest NM, 2010, PSYCHOL BULL, V136, P103, DOI 10.1037/a0018053; Favreau OE, 1997, FEM PSYCHOL, V7, P63, DOI 10.1177/0959353597071010; Field AP, 2001, PSYCHOL METHODS, V6, P161, DOI 10.1037//1082-989X.6.2.161; Frome PM, 1998, J PERS SOC PSYCHOL, V74, P435, DOI 10.1037/0022-3514.74.2.435; Furnham A, 2004, AUST J PSYCHOL, V56, P10, DOI 10.1080/00049530410001688074; Furnham A, 2002, J GENET PSYCHOL, V163, P24, DOI 10.1080/00221320209597966; Furnham A, 2002, INTELLIGENCE, V30, P101, DOI 10.1016/S0160-2896(01)00080-0; Gallagher A.M., 2005, GENDER DIFFERENCES M; Gardner H., 1993, MULTIPLE INTELLIGENC; Gardner Howard, 1983, FRAMES MIND THEORY M; Geary DC, 2000, J EXP CHILD PSYCHOL, V77, P337, DOI 10.1006/jecp.2000.2594; Guiso L, 2008, SCIENCE, V320, P1164, DOI 10.1126/science.1154094; Halpern D. F., 2007, WHY ARENT MORE WOMEN, P121, DOI [10.1037/11546-010, DOI 10.1037/11546-010]; Halpern DF, 2000, EDUC PSYCHOL REV, V12, P229, DOI 10.1023/A:1009027516424; Halpern DF, 2000, SEX DIFFERNECES COGN; Halpern DF, 2011, SEX DIFFERNECES COGN; Halpern DF, 2011, SCIENCE, V333, P1706, DOI 10.1126/science.1205031; Halpern DF, 2011, SEX ROLES, V64, P336, DOI 10.1007/s11199-010-9891-2; Hanson SL, 1996, GENDER SOC, V10, P271, DOI 10.1177/089124396010003005; Hawke JL, 2009, DYSLEXIA, V15, P239, DOI 10.1002/dys.389; Hedges LV, 2008, CHILD DEV PERSPECT, V2, P167, DOI 10.1111/j.1750-8606.2008.00060.x; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Henry PJ, 2008, PSYCHOL INQ, V19, P49, DOI 10.1080/10478400802049936; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd, DOI DOI 10.1016/S0005-7967(02)00184-5; Horn J. L., 1994, ENCY HUMAN INTELLIGE, P443; Hyde J., 2007, HDB ACHIEVING GENDER, P19; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Hyde JS, 2009, P NATL ACAD SCI USA, V106, P8801, DOI 10.1073/pnas.0901265106; Hyde JS, 2007, CURR DIR PSYCHOL SCI, V16, P259, DOI 10.1111/j.1467-8721.2007.00516.x; HYDE JS, 1990, PSYCHOL BULL, V107, P139, DOI 10.1037/0033-2909.107.2.139; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; HYDE JS, 1990, PSYCHOL WOMEN QUART, V14, P299, DOI 10.1111/j.1471-6402.1990.tb00022.x; Jensen AR, 1998, FACTOR SCI MENTAL AB; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Lippa RA, 2010, ARCH SEX BEHAV, V39, P990, DOI 10.1007/s10508-008-9460-8; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; Nash SC., 1979, SEX RELATED DIFFEREN, P263; National Science Foundation: Division of science resources statistics, 2011, WOM MIN PERS DIS SCI; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Neisser U., 1967, COGNITIVE PSYCHOL; Newcombe NS, 2009, AM PSYCHOL, V64, P538, DOI 10.1037/a0014813; Nosek BA, 2002, J PERS SOC PSYCHOL, V83, P44, DOI 10.1037//0022-3514.83.1.44; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Nuttall R.L., 2005, GENDER DIFFERENCES M, P121; OECD, 2010, PISA 2012 RES WHAT S, VI; OECD, 2010, PISA 2009 RES LEARN, VV; Reilly D, 2012, SEX ROLES, V67, P247, DOI 10.1007/s11199-012-0134-6; Riegle-Crumb C., 2005, SOCIAL ORG SCH, P227; ROSENTHAL R, 1982, J EDUC PSYCHOL, V74, P708, DOI 10.1037/0022-0663.74.5.708; ROSENTHAL R, 1982, J EDUC PSYCHOL, V74, P166, DOI 10.1037/0022-0663.74.2.166; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; SEARS DO, 1986, J PERS SOC PSYCHOL, V51, P515, DOI 10.1037/0022-3514.51.3.515; SHAYWITZ SE, 1992, NEW ENGL J MED, V326, P145, DOI 10.1056/NEJM199201163260301; Hyde JS, 2006, SCIENCE, V314, P599, DOI 10.1126/science.1132154; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Sternberg RJ, 1994, ENCY HUMAN INTELLIGE; Triandis HC, 2004, ACAD MANAGE EXEC, V18, P88, DOI 10.5465/AME.2004.12689599; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Wai J, 2009, J EDUC PSYCHOL, V101, P817, DOI 10.1037/a0016127; Williams J.E., 1990, MEASURING SEX STEREO, VVol. 6; World Economic Forum, 2009, GLOB GEND GAP REP 20	85	100	102	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39904	10.1371/journal.pone.0039904	http://dx.doi.org/10.1371/journal.pone.0039904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973JD	22808072	Green Published, gold			2022-12-27	WOS:000306355500016
J	Wu, YR; Tan, LC; Fu, XL; Chen, CM; Au, WL; Chen, L; Chen, YC; Prakash, KM; Zheng, YF; Lee-Chen, GJ; Zhao, Y; Zeng, JS; Tan, EK; Pei, Z				Wu, Yih Ru; Tan, Louis C.; Fu, Xiaoli; Chen, Chiung Mei; Au, Wing Lok; Chen, Ling; Chen, Yi Chun; Prakash, Kumar M.; Zheng, Yifan; Lee-Chen, Guey-Jen; Zhao, Yi; Zeng, Jin-Sheng; Tan, Eng King; Pei, Zhong			LRRK2 A419V Is Not Associated with Parkinson's Disease in Different Chinese Populations	PLOS ONE			English	Article							MUTATIONS; VARIANTS; RISK	It has been suggested that a common LRRK2 polymorphic variant (A419V (rs34594498 C > T)) may be a risk factor among Asians (especially in Taiwan). In this study, we examined this variant in a larger and independent Taiwan cohort. We found the frequency of the variant (A419V) to be very rare in our Taiwan PD and controls (?0.6%). Further studies were conducted in two other Chinese populations (Singapore and China), comprising of a total of 3004 subjects including 1517 PD patients and 1487 control subjects. However, our multi-center Chinese study revealed that the frequency of the variant was rare (?0.4%) and was not associated with risk of PD, suggesting that the variant is not a major risk factor for PD among Chinese, at least in our study population.	[Wu, Yih Ru; Chen, Chiung Mei; Chen, Yi Chun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Linkou, Taiwan; [Tan, Louis C.; Au, Wing Lok; Prakash, Kumar M.; Zhao, Yi; Tan, Eng King] Singapore Gen Hosp, Natl Inst Neurosci, Singapore 0316, Singapore; [Fu, Xiaoli; Chen, Ling; Zheng, Yifan; Zeng, Jin-Sheng; Pei, Zhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Lee-Chen, Guey-Jen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Tan, Eng King] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	Chang Gung Memorial Hospital; Chang Gung University; National Neuroscience Institute (NNI); Singapore General Hospital; Sun Yat Sen University; National Taiwan Normal University; National University of Singapore	Wu, YR (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Linkou, Taiwan.	yihruwu@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		National Science Council, Executive Yuan [NSC98-2628-B-182A-001-MY3]; National Medical Research Council; Duke-NUS Graduate Medical School; Singapore Millennium Foundation; National Basic Research Program of China (973 Program) [2011CB510000]; Guangdong Science and Technology Foundation [2010B050700018]	National Science Council, Executive Yuan(Ministry of Science and Technology, Taiwan); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Duke-NUS Graduate Medical School(National University of Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Guangdong Science and Technology Foundation	This work was supported by grant NSC98-2628-B-182A-001-MY3 from the National Science Council, Executive Yuan; grant from National Medical Research Council, Duke-NUS Graduate Medical School, Singapore Millennium Foundation; grants from the National Basic Research Program of China (973 Program) (No. 2011CB510000) and grants from the Guangdong Science and Technology Foundation (No. 2010B050700018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dean A G, 2010, OPENEPI OPEN SOURCE; Guedes LC, 2010, PARKINSONISM RELAT D, V16, P237, DOI 10.1016/j.parkreldis.2009.11.004; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ross OA, 2008, ANN NEUROL, V64, P88, DOI 10.1002/ana.21405; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Tan EK, 2009, AM J MED GENET B, V150B, P1022, DOI 10.1002/ajmg.b.30923; Tan EK, 2010, HUM MUTAT, V31, P561, DOI 10.1002/humu.21225; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	9	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e36123	10.1371/journal.pone.0036123	http://dx.doi.org/10.1371/journal.pone.0036123			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22807999	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500001
J	Liu, YS; Feng, YP; Xie, JX; Luo, ZJ; Shen, CH; Niu, F; Zou, J; Tang, SF; Hao, J; Xu, JX; Xiao, LP; Xu, XM; Zhu, H				Liu, Yan-Sheng; Feng, Ya-Ping; Xie, Jia-Xin; Luo, Zhuo-Jing; Shen, Cai-Hong; Niu, Fang; Zou, Jian; Tang, Shao-Feng; Hao, Jiang; Xu, Jia-Xiang; Xiao, Li-Ping; Xu, Xiao-Ming; Zhu, Hui			A Novel First Aid Stretcher for Immobilization and Transportation of Spine Injured Patients	PLOS ONE			English	Article							LIFE-SUPPORT; BOARD; TRAUMA	Effective immobilization and transportation are vital to the life-saving acute medical care needed when treating critically injured people. However, the most common types of stretchers used today are wrought with problems that can lead to further medical complications, difficulty in employment and rescue, and ineffective transitions to hospital treatment. Here we report a novel first aid stretcher called the "emergency carpet'', which solves these problems with a unique design for spine injured patients. Polyurethane composite material, obtained by a novel process of manually mixing isocyanate and additives, can be poured into a specially designed fabric bag and allowed to harden to form a rigid human-shaped stretcher. The effectiveness of the emergency carpet was examined in the pre-hospital management of victims with spinal fractures. Additionally, it was tested on flat ground and complex terrain as well as in the sea and air. We demonstrated that the emergency carpet can be assembled and solidified on the scene in 5 minutes, providing effective immobilization to the entire injured body. With the protection of the emergency carpet, none of the 20 patients, who were finally confirmed to have spinal column fracture or dislocation, had any neurological deterioration during transportation. Furthermore, the carpet can be handled and transported by multiple means under differing conditions, without compromising immobilization. Finally, the emergency carpet allows the critically injured patient to receive multiple examinations such as X-ray, CT, and MRI without being removed from the carpet. Our results demonstrate that the emergency carpet has ideal capabilities for immobilization, extrication, and transportation of the spine injured patients. Compared with other stretchers, it allows for better mobility, effective immobilization, remarkable conformity to the body, and various means for transportation. The emergency carpet is promising for its intrinsic advantages in the pre-hospital management of accident victims.	[Liu, Yan-Sheng; Feng, Ya-Ping; Xie, Jia-Xin; Shen, Cai-Hong; Niu, Fang; Tang, Shao-Feng; Zhu, Hui] Kunming Gen Hosp Peoples Liberat Army, Peoples Liberat Army Clin Ctr Spinal Cord Injury, Kunming, Peoples R China; [Luo, Zhuo-Jing] Fourth Mil Med Univ, Affiliated Hosp 1, Dept Orthopaed, Xian 710032, Peoples R China; [Zou, Jian] Nanjing Med Univ, Wuxi Affiliated Hosp 1, Dept Clin Lab Sci, Wuxi, Peoples R China; [Hao, Jiang] Kunming Gen Hosp Peoples Liberat Army, Emergency Dept, Kunming, Peoples R China; [Xu, Jia-Xiang; Xiao, Li-Ping] Yunnan Emergency Ctr, Kunming, Peoples R China; [Xu, Xiao-Ming] Indiana Univ, Sch Med, Dept Neurol Surg, Stark Neurosci Res Inst,Spinal Cord & Brain Injur, Indianapolis, IN USA	Air Force Military Medical University; Nanjing Medical University; Indiana University System; Indiana University-Purdue University Indianapolis	Liu, YS (corresponding author), Kunming Gen Hosp Peoples Liberat Army, Peoples Liberat Army Clin Ctr Spinal Cord Injury, Kunming, Peoples R China.	xu26@iupui.edu; kmzhuhui@sina.com		Xu, Xiao-ming/0000-0002-7229-0081				CHAN D, 1994, ANN EMERG MED, V23, P48, DOI 10.1016/S0196-0644(94)70007-9; CORDELL WH, 1995, ANN EMERG MED, V26, P31, DOI 10.1016/S0196-0644(95)70234-2; Fromm R E Jr, 1992, J Intensive Care Med, V7, P223; Johnson DR, 1996, AM J EMERG MED, V14, P369, DOI 10.1016/S0735-6757(96)90051-0; Johnson K, 2002, CRIT CARE, V6, P439, DOI 10.1186/cc1538; Kwan I, 2005, PREHOSP DISASTER MED, V20, P47, DOI 10.1017/S1049023X00002144; Lovell M E, 1993, J R Army Med Corps, V139, P98; LOVELL ME, 1994, INJURY, V25, P179, DOI 10.1016/0020-1383(94)90158-9; Luscombe MD, 2003, EMERG MED J, V20, P476, DOI 10.1136/emj.20.5.476; Main PW, 1996, J ACCID EMERG MED, V13, P34; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Velmahos GC, 2004, J AM COLL SURGEONS, V199, P62, DOI 10.1016/j.jamcollsurg.2004.02.022; Wang HE, 2009, QUAL SAF HEALTH CARE, V18, P213, DOI 10.1136/qshc.2007.024562	13	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39544	10.1371/journal.pone.0039544	http://dx.doi.org/10.1371/journal.pone.0039544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792181	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700012
J	Ma, JZ; Amos, CI				Ma, Jianzhong; Amos, Christopher I.			Principal Components Analysis of Population Admixture	PLOS ONE			English	Article							GENOME-WIDE PATTERNS; SUBSTRUCTURE	With the availability of high-density genotype information, principal components analysis (PCA) is now routinely used to detect and quantify the genetic structure of populations in both population genetics and genetic epidemiology. An important issue is how to make appropriate and correct inferences about population relationships from the results of PCA, especially when admixed individuals are included in the analysis. We extend our recently developed theoretical formulation of PCA to allow for admixed populations. Because the sampled individuals are treated as features, our generalized formulation of PCA directly relates the pattern of the scatter plot of the top eigenvectors to the admixture proportions and parameters reflecting the population relationships, and thus can provide valuable guidance on how to properly interpret the results of PCA in practice. Using our formulation, we theoretically justify the diagnostic of two-way admixture. More importantly, our theoretical investigations based on the proposed formulation yield a diagnostic of multi-way admixture. For instance, we found that admixed individuals with three parental populations are distributed inside the triangle formed by their parental populations and divide the triangle into three smaller triangles whose areas have the same proportions in the big triangle as the corresponding admixture proportions. We tested and illustrated these findings using simulated data and data from HapMap III and the Human Genome Diversity Project.	[Ma, Jianzhong; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Ma, JZ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	jzma@mdanderson.org			National Institutes of Health [R01CA134682, R01AR057120]; NATIONAL CANCER INSTITUTE [R01CA134682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants R01CA134682 and R01AR057120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; ELSTON RC, 1971, ANN HUM GENET, V35, P9, DOI 10.1111/j.1469-1809.1956.tb01373.x; Ma JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012510; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Pugach I, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r19; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	15	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40115	10.1371/journal.pone.0040115	http://dx.doi.org/10.1371/journal.pone.0040115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808102	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700027
J	Mollah, ZU; Graham, KL; Krishnamurthy, B; Trivedi, P; Brodnicki, TC; Trapani, JA; Kay, TW; Thomas, HE				Mollah, Zia U.; Graham, Kate L.; Krishnamurthy, Balasubramanian; Trivedi, Prerak; Brodnicki, Thomas C.; Trapani, Joseph A.; Kay, Thomas W.; Thomas, Helen E.			Granzyme B Is Dispensable in the Development of Diabetes in Non-Obese Diabetic Mice	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CYTOCHROME-C RELEASE; CD8 T-CELL; DEFICIENT MICE; NOD MICE; CASPASE ACTIVATION; INDUCED APOPTOSIS; MOUSE GRANZYME; PERFORIN; DEATH	Pancreatic beta cell destruction in type 1 diabetes is mediated by cytotoxic CD8(+) T lymphoctyes (CTL). Granzyme B is an effector molecule used by CTL to kill target cells. We previously showed that granzyme B-deficient allogeneic CTL inefficiently killed pancreatic islets in vitro. We generated granzyme B-deficient non-obese diabetic (NOD) mice to test whether granzyme B is an important effector molecule in spontaneous type 1 diabetes. Granzyme B-deficient islet antigen-specific CD8+ T cells had impaired homing into islets of young mice. Insulitis was reduced in granzyme B-deficient mice at 70 days of age (insulitis score 0.043 +/- 0.019 in granzyme B-deficient versus 0.139 +/- 0.034 in wild-type NOD mice p<0.05), but was similar to wild-type at 100 and 150 days of age. We observed a reduced frequency of CD3(+)CD8(+) T cells in the islets and peripheral lymphoid tissues of granzyme B-deficient mice (p<0.005 and p<0.0001 respectively), but there was no difference in cell proportions in the thymus. Antigen-specific CTL developed normally in granzyme B-deficient mice, and were able to kill NOD islet target cells as efficiently as wild-type CTL in vitro. The incidence of spontaneous diabetes in granzyme B-deficient mice was the same as wild-type NOD mice. We observed a delayed onset of diabetes in granzyme B-deficient CD8-dependent NOD8.3 mice (median onset 102.5 days in granzyme B-deficient versus 57.50 days in wild-type NOD8.3 mice), which may be due to the delayed onset of insulitis or inefficient priming at an earlier age in this accelerated model of diabetes. Our data indicate that granzyme B is dispensable for beta cell destruction in type 1 diabetes, but is required for efficient early activation of CTL.	[Mollah, Zia U.; Graham, Kate L.; Krishnamurthy, Balasubramanian; Trivedi, Prerak; Brodnicki, Thomas C.; Kay, Thomas W.; Thomas, Helen E.] St Vincents Inst, Fitzroy, Vic, Australia; [Trivedi, Prerak; Brodnicki, Thomas C.; Kay, Thomas W.; Thomas, Helen E.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Trapani, Joseph A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center	Mollah, ZU (corresponding author), St Vincents Inst, Fitzroy, Vic, Australia.	hthomas@svi.edu.au		Trapani, Joseph/0000-0003-0983-1532; Brodnicki, Thomas/0000-0003-2294-315X	National Health and Medical Research Council of Australia (NHMRC): NHMRC/JDRF special program grant in type 1 diabetes [APP466658]; NHMRC Career Development Fellowship [APP620232]; NHMRC [APP502605]; Juvenile Diabetes Research Foundation (JDRF): JDRF Postdoctoral Fellowship [4-2006-1025]; JDRF Postdoctoral Fellowship [4-2006-1025]; JDRF Career Development Award; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC): NHMRC/JDRF special program grant in type 1 diabetes(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation (JDRF): JDRF Postdoctoral Fellowship; JDRF Postdoctoral Fellowship(Juvenile Diabetes Research Foundation); JDRF Career Development Award(Juvenile Diabetes Research Foundation); Victorian Government's Operational Infrastructure Support Program	This work was funded by National Health and Medical Research Council of Australia (NHMRC) (http://www.nhmrc.gov.au/): NHMRC/JDRF special program grant in type 1 diabetes APP466658; NHMRC project grant APP502605; NHMRC Career Development Fellowship (HT) APP620232; Juvenile Diabetes Research Foundation (JDRF) http://www.jdrf.org/): JDRF Postdoctoral Fellowship (ZM) 4-2006-1025; JDRF Postdoctoral Fellowship (KG) 4-2006-1025; JDRF Career Development Award (BK); The Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/BUSVIC/STANDARD/PC_60698.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Amrani A, 1999, J CLIN INVEST, V103, P1201, DOI 10.1172/JCI6266; Angstetra E, 2009, IMMUNOL CELL BIOL, V87, P178, DOI 10.1038/icb.2008.81; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Darwiche R, 2003, J IMMUNOL, V170, P6292, DOI 10.4049/jimmunol.170.12.6292; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Dudek NL, 2006, DIABETES, V55, P2412, DOI 10.2337/db06-0109; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Estella E, 2006, DIABETES, V55, P2212, DOI 10.2337/db06-0129; Graham KL, 2011, AM J PATHOL, V178, P2716, DOI 10.1016/j.ajpath.2011.02.015; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Kagi D, 1997, J EXP MED, V186, P989, DOI 10.1084/jem.186.7.989; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Leiter EH, 2009, DIABETES, V58, P1700, DOI 10.2337/db09-0120; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Nakayama M, 2007, J CLIN INVEST, V117, P1835, DOI 10.1172/JCI31368; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; SUMIDA T, 1994, INT IMMUNOL, V6, P1445, DOI 10.1093/intimm/6.9.1445; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Sutton VR, 2006, TRANSPLANTATION, V81, P146, DOI 10.1097/01.tp.0000191939.68451.d9; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Toso C, 2009, TRANSPLANTATION, V88, P1286, DOI 10.1097/TP.0b013e3181bc06b0; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Zajac AJ, 2003, VIROLOGY, V305, P1, DOI 10.1006/viro.2002.1754	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40357	10.1371/journal.pone.0040357	http://dx.doi.org/10.1371/journal.pone.0040357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792290	Green Published, gold			2022-12-27	WOS:000306354700038
J	Pulman, KGT; Somerville, EM; Clifton, PG				Pulman, Kim G. T.; Somerville, Elizabeth M.; Clifton, Peter G.			Intra-Accumbens Baclofen, But Not Muscimol, Increases Second Order Instrumental Responding for Food Reward in Rats	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; GABA(A) RECEPTOR; NEURONAL POPULATIONS; INCENTIVE SALIENCE; FOS-LIKE; ACTIVATION; MOTIVATION; BEHAVIOR; AMYGDALA; IMMUNOREACTIVITY	Stimulation of either GABA(A) or GABA(B) receptors within the nucleus accumbens shell strongly enhances food intake in rats. However the effects of subtype-selective stimulation of GABA receptors on instrumental responses for food reward are less well characterized. Here we contrast the effects of the GABA(A) receptor agonist muscimol and GABA(B) receptor agonist baclofen on instrumental responding for food using a second order reinforcement schedule. Bilateral intra-accumbens administration of baclofen (220-440 pmol) stimulated responding but a higher dose (660 pmol) induced stereotyped oral behaviour that interfered with responding. Baclofen (220-660 pmol) also stimulated intake of freely available chow. Muscimol (220-660 pmol) was without effect on responding for food on this schedule but did stimulate intake of freely available chow. Unilateral administration of either baclofen or muscimol (220 pmol) induced similar patterns of c-fos immunoreactivity in several hypothalamic sites but differed in its induction in the central nucleus of the amygdala. We conclude that stimulation of GABA(A) or GABA(B) receptors in the nucleus accumbens shell of rats produces clearly distinguishable effects on operant responding for food.	[Pulman, Kim G. T.; Clifton, Peter G.] Univ Sussex, Sch Psychol, Brighton, Sussex, England; [Somerville, Elizabeth M.] Univ Sussex, Sch Life Sci, Brighton, Sussex, England	University of Sussex; University of Sussex	Pulman, KGT (corresponding author), Univ Sussex, Sch Psychol, Brighton, Sussex, England.	pete@sussex.ac.uk		Clifton, Pete/0000-0003-1230-133X	Biotechnology and Biological Sciences Research Council (UK); British Association of Psychopharmacology	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Association of Psychopharmacology	KGT Pulman was supported by a Biotechnology and Biological Sciences Research Council (UK) Studentship and a British Association of Psychopharmacology Award for in-vivo science. The funders also jointly provided the financial resources to carry out these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheid GF, 2003, ANN NY ACAD SCI, V985, P185; Baldo BA, 2004, EUR J NEUROSCI, V19, P376, DOI 10.1111/j.1460-9568.2004.03093.x; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Basso AM, 1999, BEHAV NEUROSCI, V113, P324, DOI 10.1037/0735-7044.113.2.324; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; BERRIDGE KC, 1991, BEHAV NEUROSCI, V105, P3, DOI 10.1037/0735-7044.105.1.3; BERRIDGE KC, 1989, Q J EXP PSYCHOL-B, V41, P121; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Cardinal RN, 2006, NEURAL NETWORKS, V19, P1277, DOI 10.1016/j.neunet.2006.03.004; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Duva MA, 2005, NEUROSCI RES, V52, P95, DOI 10.1016/j.neures.2005.02.001; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; Faure A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011223; Finch DM, 1996, HIPPOCAMPUS, V6, P495; Galvan A, 2006, NEUROSCIENCE, V143, P351, DOI 10.1016/j.neuroscience.2006.09.019; Hanlon EC, 2004, PSYCHOPHARMACOLOGY, V172, P241, DOI 10.1007/s00213-003-1654-0; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Holland PC, 2008, J EXP PSYCHOL-ANIM B, V34, P119, DOI 10.1037/0097-7403.34.1.119; Kalinichev M, 2000, J COMP NEUROL, V416, P45, DOI 10.1002/(SICI)1096-9861(20000103)416:1<45::AID-CNE5>3.0.CO;2-K; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; KROGSGAARDLARSEN P, 1978, J NEUROCHEM, V30, P1377, DOI 10.1111/j.1471-4159.1978.tb10469.x; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; Meredith GE, 1999, ANN NY ACAD SCI, V877, P140, DOI 10.1111/j.1749-6632.1999.tb09266.x; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Mulder AB, 1998, J NEUROSCI, V18, P5095; Ng TKY, 2001, J COMP NEUROL, V433, P458, DOI 10.1002/cne.1153; Nie H, 2011, P NATL ACAD SCI USA, V108, P4459, DOI 10.1073/pnas.1016156108; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Peyron C, 1998, J NEUROSCI, V18, P9996; Pulman KGT, 2010, PHARMACOL BIOCHEM BE, V97, P156, DOI 10.1016/j.pbb.2010.05.028; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Smith KS, 2011, P NATL ACAD SCI USA, V108, pE255, DOI 10.1073/pnas.1101920108; Somerville EM, 1996, DRUG RECEPTOR SUBTYP, P367; Stanley BG, 1996, AM J PHYSIOL-REG I, V270, pR443, DOI 10.1152/ajpregu.1996.270.2.R443; STANLEY BG, 1993, BRAIN RES, V604, P304; Stratford TR, 2012, PHARMACOL BIOCHEM BE, V101, P499, DOI 10.1016/j.pbb.2012.02.010; Stratford TR, 1999, J NEUROSCI, V19, P11040, DOI 10.1523/JNEUROSCI.19-24-11040.1999; Stratford TR, 2005, BRAIN RES, V1048, P241, DOI 10.1016/j.brainres.2005.05.002; Stratford TR, 1997, J NEUROSCI, V17, P4434; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Taha SA, 2005, J NEUROSCI, V25, P1193, DOI 10.1523/JNEUROSCI.3975-04.2005; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Thornton-Jones ZD, 2005, PSYCHOPHARMACOLOGY, V179, P452, DOI 10.1007/s00213-004-2047-8; Touzani K, 1996, NEUROREPORT, V7, P517, DOI 10.1097/00001756-199601310-00034; Usuda I, 1998, BRAIN RES, V797, P73, DOI 10.1016/S0006-8993(98)00359-X; VALENSTEIN ES, 1970, PSYCHOL REV, V77, P16, DOI 10.1037/h0028581; Waldvogel HJ, 1997, NEUROSCIENCE, V80, P775, DOI 10.1016/S0306-4522(97)00056-0; Ward BO, 2000, PHYSIOL BEHAV, V68, P463, DOI 10.1016/S0031-9384(99)00197-3; Wirtshafter D, 2010, PHARMACOL BIOCHEM BE, V96, P342, DOI 10.1016/j.pbb.2010.06.004; Zhang M, 2003, BEHAV NEUROSCI, V117, P202, DOI 10.1037/0735-7044.117.2.202	60	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40057	10.1371/journal.pone.0040057	http://dx.doi.org/10.1371/journal.pone.0040057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808090	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000306354700024
J	Smith, BC; McAndrew, T; Chen, ZG; Harari, A; Barris, DM; Viswanathan, S; Rodriguez, AC; Castle, P; Herrero, R; Schiffman, M; Burk, RD				Smith, Benjamin C.; McAndrew, Thomas; Chen, Zigui; Harari, Ariana; Barris, David M.; Viswanathan, Shankar; Cecilia Rodriguez, Ana; Castle, Phillip; Herrero, Rolando; Schiffman, Mark; Burk, Robert D.			The Cervical Microbiome over 7 Years and a Comparison of Methodologies for Its Characterization	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; BACTERIAL-VAGINOSIS; VAGINAL MICROBIOME; COMMUNITIES; NEOPLASIA; WOMEN; ASSOCIATIONS; SEQUENCES	Background: The rapidly expanding field of microbiome studies offers investigators a large choice of methods for each step in the process of determining the microorganisms in a sample. The human cervicovaginal microbiome affects female reproductive health, susceptibility to and natural history of many sexually transmitted infections, including human papillomavirus (HPV). At present, long-term behavior of the cervical microbiome in early sexual life is poorly understood. Methods: The V6 and V6-V9 regions of the 16S ribosomal RNA gene were amplified from DNA isolated from exfoliated cervical cells. Specimens from 10 women participating in the Natural History Study of HPV in Guanacaste, Costa Rica were sampled successively over a period of 5-7 years. We sequenced amplicons using 3 different platforms (Sanger, Roche 454, and Illumina HiSeq 2000) and analyzed sequences using pipelines based on 3 different classification algorithms (usearch, RDP Classifier, and pplacer). Results: Usearch and pplacer provided consistent microbiome classifications for all sequencing methods, whereas RDP Classifier deviated significantly when characterizing Illumina reads. Comparing across sequencing platforms indicated 7%-41% of the reads were reclassified, while comparing across software pipelines reclassified up to 32% of the reads. Variability in classification was shown not to be due to a difference in read lengths. Six cervical microbiome community types were observed and are characterized by a predominance of either G. vaginalis or Lactobacillus spp. Over the 5-7 year period, subjects displayed fluctuation between community types. A PERMANOVA analysis on pairwise Kantorovich-Rubinstein distances between the microbiota of all samples yielded an F-test ratio of 2.86 (p<0.01), indicating a significant difference comparing within and between subjects' microbiota. Conclusions: Amplification and sequencing methods affected the characterization of the microbiome more than classification algorithms. Pplacer and usearch performed consistently with all sequencing methods. The analyses identified 6 community types consistent with those previously reported. The long-term behavior of the cervical microbiome indicated that fluctuations were subject dependent.	[Smith, Benjamin C.; Chen, Zigui; Barris, David M.; Burk, Robert D.] Yeshiva Univ, Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [McAndrew, Thomas; Harari, Ariana; Burk, Robert D.] Yeshiva Univ, Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY USA; [Chen, Zigui; Burk, Robert D.] Yeshiva Univ, Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA; [Viswanathan, Shankar; Burk, Robert D.] Yeshiva Univ, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Cecilia Rodriguez, Ana; Herrero, Rolando] Fdn INCIENSA, Proyecto Epidemiol Guanacaste, San Jose, Costa Rica; [Castle, Phillip] Amer Soc Clin Pathol ASCP Inst, Washington, DC USA; [Schiffman, Mark] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, BC (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA.	robert.burk@einstein.yu.edu	Castle, Philip/AAP-6395-2020; Rodríguez, Ana/GQR-0554-2022; Viswanathan, Shankar/AAX-5281-2020; Chen, Zigui/E-8490-2017; Schiffman, Mark/B-9766-2015	Castle, Philip/0000-0003-1082-6554; Chen, Zigui/0000-0002-8577-1298; Viswanathan, Shankar/0000-0003-3349-9090; Barris, David/0000-0001-8656-1666	National Cancer Institute [CA78527]; Einstein-Montefiore Center for AIDS; NIH [AI-51519]; Einstein Cancer Research Center from the National Cancer Institute [P30CA013330]; NATIONAL CANCER INSTITUTE [R01CA078527, P30CA013330, U01CA078527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein-Montefiore Center for AIDS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein Cancer Research Center from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Cancer Institute (CA78527) (RDB), the Einstein-Montefiore Center for AIDS funded by the NIH (AI-51519) and the Einstein Cancer Research Center (P30CA013330) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarke MA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-33; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Fettweis JM, 2012, CHEM BIODIVERS, V9, P965, DOI 10.1002/cbdv.201100359; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Matsen FA, 2011, ARXIV11075095V1QBIOP; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Nealson KH, 2007, ISME J, V1, P185, DOI 10.1038/ismej.2007.43; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rodriguez AC, 2007, SEX TRANSM DIS, V34, P494, DOI 10.1097/01.olq.0000251241.03088.a0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Witkin SS, 2012, SCI TRANSL MED, V4; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou X, 2010, INFECT DIS OBSTET GY, V2010; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	37	81	85	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40425	10.1371/journal.pone.0040425	http://dx.doi.org/10.1371/journal.pone.0040425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792313	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700046
J	Wang, Z; Wang, L; Yin, ZY; Xia, CY				Wang, Zhen; Wang, Lin; Yin, Zu-Yu; Xia, Cheng-Yi			Inferring Reputation Promotes the Evolution of Cooperation in Spatial Social Dilemma Games	PLOS ONE			English	Article							TIT-FOR-TAT; PRISONERS-DILEMMA; INDIRECT RECIPROCITY; WIN-STAY; STRATEGY; LOSE; EMERGENCE; RESONANCE; DYNAMICS; MOBILITY	In realistic world individuals with high reputation are more likely to influence the collective behaviors. Due to the cost and error of information dissemination, however, it is unreasonable to assign each individual with a complete cognitive power, which means that not everyone can accurately realize others' reputation situation. Here we introduce the mechanism of inferring reputation into the selection of potential strategy sources to explore the evolution of cooperation. Before the game each player is assigned with a randomly distributed parameter p denoting his ability to infer the reputation of others. The parameter p of each individual is kept constant during the game. The value of p indicates that the neighbor possessing highest reputation is chosen with the probability p and randomly choosing an opponent is left with the probability 1-p. We find that this novel mechanism can be seen as an universally applicable promoter of cooperation, which works on various interaction networks and in different types of evolutionary game. Of particular interest is the fact that, in the early stages of evolutionary process, cooperators with high reputation who are easily regarded as the potential strategy donors can quickly lead to the formation of extremely robust clusters of cooperators that are impervious to defector attacks. These clusters eventually help cooperators reach their undisputed dominance, which transcends what can be warranted by the spatial reciprocity alone. Moreover, we provide complete phase diagrams to depict the impact of uncertainty in strategy adoptions and conclude that the effective interaction topology structure may be altered under such a mechanism. When the estimation of reputation is extended, we also show that the moderate value of evaluation factor enables cooperation to thrive best. We thus present a viable method of understanding the ubiquitous cooperative behaviors in nature and hope that it will inspire further studies to resolve social dilemmas.	[Wang, Zhen; Xia, Cheng-Yi] Tianjin Univ Technol, Minist Educ, Key Lab Comp Vis & Syst, Tianjin, Peoples R China; [Wang, Zhen; Xia, Cheng-Yi] Tianjin Univ Technol, Tianjin Key Lab Intelligence Comp & Novel Softwar, Tianjin, Peoples R China; [Wang, Zhen; Yin, Zu-Yu] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Lin] Fudan Univ, Dept Elect Engn, Adapt Networks & Control Lab, Shanghai 200433, Peoples R China	Tianjin University of Technology; Tianjin University of Technology; Nankai University; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University; Fudan University	Wang, Z (corresponding author), Tianjin Univ Technol, Minist Educ, Key Lab Comp Vis & Syst, Tianjin, Peoples R China.	fdlwang@gmail.com; xialooking@163.com	Wang, Lin/B-4145-2013; Xia, Chengyi/A-2752-2012; Wang, Zhen/H-5017-2011	Wang, Lin/0000-0002-5371-2138; Xia, Chengyi/0000-0003-2686-5072; Wang, Zhen/0000-0002-8182-2852	National Natural Science Foundation of China [60904063]; Tianjin Municipal Natural Science Foundation of China [11JCYBJC06600]; Center for Asia Studies of Nankai University [2010-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation of China; Center for Asia Studies of Nankai University	CYX acknowledges the support from the National Natural Science Foundation of China (Grant No. 60904063) and the Tianjin Municipal Natural Science Foundation of China (Grant No. 11JCYBJC06600). ZW acknowledges the support from the Center for Asia Studies of Nankai University (Grant No. 2010-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SK, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011125; Binmore K. G., 1994, GAME THEORY SOCIAL C; Cao XB, 2010, PHYSICA A, V389, P1273, DOI 10.1016/j.physa.2009.11.044; Colman AM, 2013, GAME THEORY ITS APPL; Darwin Charles, 1876, ORIGIN SPECIES; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Du WB, 2008, PHYSICA A, V387, P3796, DOI 10.1016/j.physa.2008.02.036; Du WB, 2009, INT J MOD PHYS C, V20, P701, DOI 10.1142/S0129183109013923; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Floria LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026106; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Jimenez R, 2008, J THEOR BIOL, V250, P475, DOI 10.1016/j.jtbi.2007.10.010; Jin Q, 2012, CHAOS SOLITON FRACT, V45, P395, DOI 10.1016/j.chaos.2012.01.004; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M., 2011, PHYS REV E, V84; Perc M., 2011, PHYS REV E, V85; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/183; Perc M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.052102; Perc M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123027; Perc M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037102; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/267; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Semmann D, 2004, BEHAV ECOL SOCIOBIOL, V56, P248, DOI 10.1007/s00265-004-0782-9; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2009, EUR PHYS J B, V67, P337, DOI 10.1140/epjb/e2008-00470-8; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Tanimoto J, 2007, BIOSYSTEMS, V90, P856, DOI 10.1016/j.biosystems.2007.05.002; Tanimoto J, 2007, J THEOR BIOL, V247, P756, DOI 10.1016/j.jtbi.2007.03.033; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041130; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Vainstein MH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051905; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001917; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu Z.-X., 2009, PHYS REV E, V80; Xu ZJ, 2010, J THEOR BIOL, V264, P19, DOI 10.1016/j.jtbi.2010.01.025; Xu ZJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061104; Yamauchi A, 2011, BIOSYSTEMS, V103, P85, DOI 10.1016/j.biosystems.2010.10.006; Zhang J, 2011, PHYSICA A, V390, P2251, DOI 10.1016/j.physa.2011.02.036	84	163	163	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40218	10.1371/journal.pone.0040218	http://dx.doi.org/10.1371/journal.pone.0040218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808120	Green Submitted, gold, Green Published			2022-12-27	WOS:000306354700030
J	Behrens, M; Born, S; Redel, U; Voigt, N; Schuh, V; Raguse, JD; Meyerhof, W				Behrens, Maik; Born, Stephan; Redel, Ulrike; Voigt, Nadine; Schuh, Vanessa; Raguse, Jan-Dirk; Meyerhof, Wolfgang			Immunohistochemical Detection of TAS2R38 Protein in Human Taste Cells	PLOS ONE			English	Article							BITTER TASTE; SWEET TASTE; RECEPTOR GENE; TRANSDUCTION; EXPRESSION; FAMILY; GUSTDUCIN; TASTANTS	The sense of taste plays an important role in the evaluation of the nutrient composition of consumed food. Bitter taste in particular is believed to serve a warning function against the ingestion of poisonous substances. In the past years enormous progress was made in the characterization of bitter taste receptors, including their gene expression patterns, pharmacological features and presumed physiological roles in gustatory as well as in non-gustatory tissues. However, due to a lack in TAS2R-specifc antibodies the localization of receptor proteins within gustatory tissues has never been analyzed. In the present study we have screened a panel of commercially available antisera raised against human bitter taste receptors by immunocytochemical experiments. One of these antisera was found to be highly specific for the human bitter taste receptor TAS2R38. We further demonstrate that this antibody is able to detect heterologously expressed TAS2R38 protein on Western blots. The antiserum is, however, not able to interfere significantly with TAS2R38 function in cell based calcium imaging analyses. Most importantly, we were able to demonstrate the presence of TAS2R38 protein in human gustatory papillae. Using double immunofluorescence we show that TAS2R38-positive cells form a subpopulation of PLCbeta2 expressing cells. On a subcellular level the localization of this bitter taste receptor is neither restricted to the cell surface nor particularly enriched at the level of the microvilli protruding into the pore region of the taste buds, but rather evenly distributed over the entire cell body.	[Behrens, Maik; Born, Stephan; Redel, Ulrike; Voigt, Nadine; Schuh, Vanessa; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany; [Raguse, Jan-Dirk] Campus Virchow Hosp, Charite, Clin & Polyclin Oral & Maxillofacial Surg, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Behrens, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Arthur Scheunert Allee 114-116, Nuthetal, Germany.	behrens@dife.de	Behrens, Maik/B-6753-2016	Behrens, Maik/0000-0003-2082-8860; Born, Stephan/0000-0001-6841-1410	German Research Foundation [Me 1024/3-2]	German Research Foundation(German Research Foundation (DFG))	The work was supported by a grant from the German Research Foundation (Me 1024/3-2, www.dfg.de) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Gimelbrant AA, 1999, J NEUROCHEM, V72, P2301, DOI 10.1046/j.1471-4159.1999.0722301.x; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kuhn C, 2010, CHEM SENSES, V35, P395, DOI 10.1093/chemse/bjq027; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nehring RB, 2000, J PHYSIOL-PARIS, V94, P185, DOI 10.1016/S0928-4257(00)00203-5; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ogura T, 1997, J NEUROSCI, V17, P3580; Peri I, 2000, AM J PHYSIOL-CELL PH, V278, pC17, DOI 10.1152/ajpcell.2000.278.1.C17; Reichling C, 2008, J NEUROCHEM, V106, P1138, DOI 10.1111/j.1471-4159.2008.05453.x; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zubare-Samuelov M, 2005, AM J PHYSIOL-CELL PH, V289, pC483, DOI 10.1152/ajpcell.00547.2004	40	32	33	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40304	10.1371/journal.pone.0040304	http://dx.doi.org/10.1371/journal.pone.0040304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792271	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800066
J	Coggon, D; Ntani, G; Palmer, KT; Felli, VE; Harari, R; Barrero, LH; Felknor, SA; Gimeno, D; Cattrell, A; Serra, C; Bonzini, M; Solidaki, E; Merisalu, E; Habib, RR; Sadeghian, F; Kadir, M; Warnakulasuriya, SSP; Matsudaira, K; Nyantumbu, B; Sim, MR; Harcombe, H; Cox, K; Marziale, MH; Sarquis, LM; Harari, F; Freire, R; Harari, N; Monroy, MV; Quintana, LA; Rojas, M; Vega, EJS; Harris, EC; Vargas-Prada, S; Martinez, JM; Delclos, G; Benavides, FG; Carugno, M; Ferrario, MM; Pesatori, AC; Chatzi, L; Bitsios, P; Kogevinas, M; Oha, K; Sirk, T; Sadeghian, A; Peiris-John, RJ; Sathiakumar, N; Wickremasinghe, AR; Yoshimura, N; Kielkowski, D; Kelsall, HL; Hoe, VCW; Urquhart, DM; Derett, S; McBride, D; Gray, A				Coggon, David; Ntani, Georgia; Palmer, Keith T.; Felli, Vanda E.; Harari, Raul; Barrero, Lope H.; Felknor, Sarah A.; Gimeno, David; Cattrell, Anna; Serra, Consol; Bonzini, Matteo; Solidaki, Eleni; Merisalu, Eda; Habib, Rima R.; Sadeghian, Farideh; Kadir, Masood; Warnakulasuriya, Sudath S. P.; Matsudaira, Ko; Nyantumbu, Busisiwe; Sim, Malcolm R.; Harcombe, Helen; Cox, Ken; Marziale, Maria H.; Sarquis, Leila M.; Harari, Florencia; Freire, Rocio; Harari, Natalia; Monroy, Magda V.; Quintana, Leonardo A.; Rojas, Marianela; Vega, Eduardo J. Salazar; Harris, E. Clare; Vargas-Prada, Sergio; Martinez, J. Miguel; Delclos, George; Benavides, Fernando G.; Carugno, Michele; Ferrario, Marco M.; Pesatori, Angela C.; Chatzi, Leda; Bitsios, Panos; Kogevinas, Manolis; Oha, Kristel; Sirk, Tuuli; Sadeghian, Ali; Peiris-John, Roshini J.; Sathiakumar, Nalini; Wickremasinghe, A. Rajitha; Yoshimura, Noriko; Kielkowski, Danuta; Kelsall, Helen L.; Hoe, Victor C. W.; Urquhart, Donna M.; Derett, Sarah; McBride, David; Gray, Andrew			The CUPID (Cultural and Psychosocial Influences on Disability) Study: Methods of Data Collection and Characteristics of Study Sample	PLOS ONE			English	Article							NEW-ZEALAND NURSES; LOW-BACK-PAIN; RISK-FACTORS; MUSCULOSKELETAL DISORDERS; WORK-RELATEDNESS; POSTAL WORKERS; NECK PAIN; PREVALENCE; QUESTIONNAIRE; SYMPTOMS	Background: The CUPID (Cultural and Psychosocial Influences on Disability) study was established to explore the hypothesis that common musculoskeletal disorders (MSDs) and associated disability are importantly influenced by culturally determined health beliefs and expectations. This paper describes the methods of data collection and various characteristics of the study sample. Methods/Principal Findings: A standardised questionnaire covering musculoskeletal symptoms, disability and potential risk factors, was used to collect information from 47 samples of nurses, office workers, and other (mostly manual) workers in 18 countries from six continents. In addition, local investigators provided data on economic aspects of employment for each occupational group. Participation exceeded 80% in 33 of the 47 occupational groups, and after pre-specified exclusions, analysis was based on 12,426 subjects (92 to 1018 per occupational group). As expected, there was high usage of computer keyboards by office workers, while nurses had the highest prevalence of heavy manual lifting in all but one country. There was substantial heterogeneity between occupational groups in economic and psychosocial aspects of work; three-to fivefold variation in awareness of someone outside work with musculoskeletal pain; and more than ten-fold variation in the prevalence of adverse health beliefs about back and arm pain, and in awareness of terms such as "repetitive strain injury" (RSI). Conclusions/Significance: The large differences in psychosocial risk factors (including knowledge and beliefs about MSDs) between occupational groups should allow the study hypothesis to be addressed effectively.	[Coggon, David; Ntani, Georgia; Palmer, Keith T.; Cox, Ken; Harris, E. Clare] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Felli, Vanda E.] Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil; [Harari, Raul; Harari, Florencia; Freire, Rocio; Harari, Natalia] Corp Desarrollo Prod & Medio Ambiente Laboral, IFA Inst Dev Prod & Work Environm, Quito, Ecuador; [Barrero, Lope H.; Monroy, Magda V.; Quintana, Leonardo A.] Pontificia Univ Javeriana, Sch Engn, Bogota, Colombia; [Felknor, Sarah A.; Gimeno, David; Vega, Eduardo J. Salazar; Delclos, George] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, SW Ctr Occupat & Environm Hlth, Houston, TX USA; [Felknor, Sarah A.] NIOSH, Ctr Dis Control & Prevent, Atlanta, GA USA; [Cattrell, Anna] Kings Coll London, MRC, Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Serra, Consol; Vargas-Prada, Sergio; Martinez, J. Miguel; Delclos, George; Benavides, Fernando G.] Pompeu Fabra Univ, Ctr Res Occupat Hlth CiSAL, Barcelona, Spain; [Serra, Consol; Martinez, J. Miguel; Delclos, George; Benavides, Fernando G.] Carlos III Hlth Inst, Biomed Res Networking Ctr Epidemiol & Publ Hlth, Granada, Spain; [Serra, Consol] Parc Salut MAR, Dept Occupat Hlth, Barcelona, Spain; [Bonzini, Matteo; Ferrario, Marco M.] Univ Insubria, Epidemiol & Prevent Med Res Ctr, Varese, Italy; [Solidaki, Eleni; Chatzi, Leda] Univ Crete, Sch Med, Dept Social Med, Iraklion, Greece; [Merisalu, Eda] Univ Tartu, Dept Publ Hlth, EE-50090 Tartu, Estonia; [Habib, Rima R.] Amer Univ Beirut, Fac Hlth Sci, Dept Environm Hlth, Beirut, Lebanon; [Sadeghian, Farideh] Shahroud Univ Med Sci, Fac Hlth, Dept Occupat Hlth, Shahroud, Iran; [Kadir, Masood] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Warnakulasuriya, Sudath S. P.] Univ Sri Jayewardenepura, Fac Med Sci, Dept Med Educ & Hlth Sci, Nugegoda, Sri Lanka; [Matsudaira, Ko] Kanto Rosai Hosp, Clin Res Ctr Occupat Musculoskeletal Disorders, Kawasaki, Kanagawa, Japan; [Nyantumbu, Busisiwe; Kielkowski, Danuta] Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Johannesburg, South Africa; [Nyantumbu, Busisiwe; Kielkowski, Danuta] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Sim, Malcolm R.; Kelsall, Helen L.; Hoe, Victor C. W.; Urquhart, Donna M.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Harcombe, Helen; McBride, David; Gray, Andrew] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Marziale, Maria H.] Univ Sao Paulo, Sch Nursing Ribeirao Preto, Sao Paulo, Brazil; [Sarquis, Leila M.] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil; [Rojas, Marianela] Natl Univ Costa Rica, Inst Studies Toxic Subst IRET, Heredia, Costa Rica; [Carugno, Michele; Pesatori, Angela C.] Univ Milan, Dept Occupat & Environm Hlth, Milan, Italy; [Pesatori, Angela C.] Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy; [Bitsios, Panos] Univ Crete, Sch Med, Dept Psychiat, Iraklion, Greece; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis] IMIM Hosp Mar, Res Inst, Barcelona, Spain; [Kogevinas, Manolis] Consorcio Invest Biomed Epidemiol & Salud Publ CI, Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Oha, Kristel] N Estonia Med Ctr, Tallinn, Estonia; [Sirk, Tuuli] Polva Hosp, Polva, Estonia; [Sadeghian, Ali] Klinikum Leverkusen, Leverkusen, Germany; [Peiris-John, Roshini J.] Univ Sri Jayewardenepura, Fac Med Sci, Dept Physiol, Nugegoda, Sri Lanka; [Peiris-John, Roshini J.] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand; [Sathiakumar, Nalini] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Wickremasinghe, A. Rajitha] Univ Kelaniya, Fac Med, Kelaniya, Sri Lanka; [Yoshimura, Noriko] Univ Tokyo, Dept Joint Dis Res, Tokyo, Japan; [Hoe, Victor C. W.] Univ Malaya, Fac Med, Ctr Occupat & Environm Hlth, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Hoe, Victor C. W.] Univ Otago, Injury Prevent Res Unit, Dept Prevent & Social Med, Dunedin, New Zealand	University of Southampton; Universidade de Sao Paulo; Pontificia Universidad Javeriana; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of London; King's College London; Pompeu Fabra University; University of Insubria; University of Crete; University of Tartu; American University of Beirut; Shahroud University Medical Sciences; Aga Khan University; University Sri Jayewardenepura; National Health Laboratory Service; University of Witwatersrand; Monash University; University of Otago; Universidade de Sao Paulo; Universidade Federal do Parana; Universidad Nacional Costa Rica; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Crete; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens; University Sri Jayewardenepura; University of Auckland; University of Alabama System; University of Alabama Birmingham; University Kelaniya; University of Tokyo; Universiti Malaya; University of Otago	Coggon, D (corresponding author), Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England.		McBride, David I/F-9664-2010; harari, florencia/O-3786-2014; Harari, Florencia/AAQ-2003-2020; Martínez, José Miguel/AAU-3228-2021; Benavides, Fernando G./A-5137-2008; Felli, Vanda Elisa Andres/H-5942-2012; Carugno, Michele/AAA-6958-2019; Ferrario, Marco M./ABH-2115-2021; Hoe, VICTOR CW/B-5190-2010; Maria Helena Palucci Marziale, M.H.P. Marziale/I-6409-2012; Bonzini, Matteo/K-7540-2016; sadeghian, farideh/N-2607-2019; Vargas-Prada, S/I-3065-2014; Serra, C/E-6879-2014; Harari, Raúl/E-1241-2015; Kogevinas, Manolis/C-3918-2017; Sim, Malcolm/I-2761-2014; Gray, Andrew Robert/L-9161-2015; pesatori, angela/K-5742-2016	McBride, David I/0000-0001-5531-7687; harari, florencia/0000-0002-0362-579X; Martínez, José Miguel/0000-0002-9633-1204; Benavides, Fernando G./0000-0003-0747-2660; Felli, Vanda Elisa Andres/0000-0001-7250-4353; Hoe, VICTOR CW/0000-0002-8073-157X; Maria Helena Palucci Marziale, M.H.P. Marziale/0000-0003-2790-3333; Bonzini, Matteo/0000-0002-6405-7554; Vargas-Prada, S/0000-0002-0713-5392; Serra, C/0000-0001-8337-8356; Harari, Raúl/0000-0002-1829-5316; Kogevinas, Manolis/0000-0002-9605-0461; Gray, Andrew Robert/0000-0003-4299-2194; Monroy Silva, Magda Viviana/0000-0002-6185-5999; Ferrario, Marco M/0000-0003-2741-7124; Sadeghian, Farideh/0000-0001-7173-6451; Gimeno, David/0000-0003-2502-0465; Carugno, Michele/0000-0001-5212-2489; Kelsall, Helen/0000-0003-0664-3376; Barrero, Lope/0000-0003-1503-0264; Peiris-John, Roshini/0000-0001-7812-2268; Quintana, Leonardo/0000-0001-5625-0111; Sim, Malcolm/0000-0003-4739-2817; pesatori, angela/0000-0002-0261-3252	UK Medical Research Council; Colombia: United States National Institutes of Health (NIH) [5D43 TW00 0644-13, 0005919H]; NIH [5D43 TW00 0644-15, 0005919J]; National Institutes of Health and the Fogarty International Center (NIH-FIC) [5 D43 TWO5750]; NHMRC by the Ministry of Higher Education in Malaysia; VCWH by the Ministry of Higher Education in Malaysia; FOGARTY INTERNATIONAL CENTER [D43TW005750, D43TW000644] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A620_1018, MC_U147585823] Funding Source: researchfish; MRC [MC_UP_A620_1018, MC_U147585823] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Colombia: United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and the Fogarty International Center (NIH-FIC); NHMRC by the Ministry of Higher Education in Malaysia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); VCWH by the Ministry of Higher Education in Malaysia; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the central coordination of the CUPID study was provided by the UK Medical Research Council (www.mrc.ac.uk). In addition, support for data collection in individual countries was obtained from the following sources: Brazil: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Ecuador: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Colombia: United States National Institutes of Health (NIH) (www.grants.nih.gov) Grant 5D43 TW00 0644-13, sub-award 0005919H; NIH Grant 5D43 TW00 0644-15, sub-award 0005919J; and Pontificia Universidad Javeriana (www.javeriana.edu.co). Costa Rica: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Nicaragua: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). UK: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Spain: Spanish Health Research Fund (www.imia.medinfo.org) (FIS 070422), and Epidemiology and Public Health CIBER. Carlos III Institute of Health. Ministry of Science and Innovation. Italy: Department of Experimental Medicine, University of Insubria (www.unisubria.eu), Varese, Italy. Greece: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Estonia: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Lebanon: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Iran: Deputy for Training and Research, Shahroud University of Medical Sciences (www.shmu.ac.ir). Pakistan: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Sri Lanka: International Training and Research in Environmental and Occupational Health (ITREOH) Program of the University of Alabama at Birmingham (Grant number 5 D43 TWO5750 from the National Institutes of Health and the Fogarty International Center (NIH-FIC)) (www.fic.nih.gov/Programs/Pages/environmental-occupational-health.aspx). Japan: University of Tokyo (www.u-tokyo.ac.up/en/. South Africa: Colt Foundation (www.coltfoundation.org.uk) (CF/03/05). Australia: Monash University Strategic Grant Scheme and Monash University Near Miss Grant for NHMRC projects in 2008 (www.monash.edu.au). HLK and DMU were supported by Fellowships from NHMRC, and VCWH by the Ministry of Higher Education in Malaysia. New Zealand: Health Research Council of New Zealand (International Investment Opportunity Fund Grant) (www.hrc.govt.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Clinical Standards Advisory Group, 1994, EP REV EP COST BACK; Coggon D, 2005, OCCUP ENVIRON MED, V62, P281, DOI 10.1136/oem.2004.017335; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Ferrari AL, 2010, REV LAT-AM ENFERM, V18, P1092, DOI 10.1590/S0104-11692010000600008; GUN RT, 1990, MED J AUSTRALIA, V153, P376, DOI 10.5694/j.1326-5377.1990.tb125492.x; Harcombe H, 2010, INJURY PREV, V16, P96, DOI 10.1136/ip.2009.021766; Harcombe H, 2009, AUST NZ J PUBL HEAL, V33, P437, DOI 10.1111/j.1753-6405.2009.00425.x; Hoe VCW, 2012, OCCUP ENVIRON MED, V69, P198, DOI 10.1136/oemed-2011-100302; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Lotters F, 2003, SCAND J WORK ENV HEA, V29, P431; Macfarlane GJ, 2009, ANN RHEUM DIS, V68, P885, DOI 10.1136/ard.2008.090829; Macfarlane GJ, 2000, BRIT MED J, V321, P676, DOI 10.1136/bmj.321.7262.676; Madan I, 2008, INT J EPIDEMIOL, V37, P1181, DOI 10.1093/ije/dyn085; Matsudaira K, 2011, OCCUP ENVIRON MED, V68, P191, DOI 10.1136/oem.2009.053645; Palmer KT, 2008, PAIN, V136, P30, DOI 10.1016/j.pain.2007.06.011; Palmer KT, 2007, SCAND J WORK ENV HEA, V33, P165, DOI 10.5271/sjweh.1134; Palmer KT, 2007, OCCUP MED-OXFORD, V57, P67, DOI 10.1093/occmed/kql127; Palmer KT, 2011, BEST PRACT RES CL RH, V25, P15, DOI 10.1016/j.berh.2011.01.014; Palmer KT, 2000, BRIT MED J, V320, P1577, DOI 10.1136/bmj.320.7249.1577; Palmer KT, 2005, OCCUP MED-OXFORD, V55, P612, DOI 10.1093/occmed/kqi142; Palmer KT, 2001, SCAND J WORK ENV HEA, V27, P49, DOI 10.5271/sjweh.586; Ramond A, 2011, FAM PRACT, V28, P12, DOI 10.1093/fampra/cmq072; Solidaki E, 2010, SCAND J WORK ENV HEA, V36, P54, DOI 10.5271/sjweh.2884; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Warnakulusariya S, OCCUPATIONA IN PRESS	28	49	52	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39820	10.1371/journal.pone.0039820	http://dx.doi.org/10.1371/journal.pone.0039820			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792189	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306461800020
J	Flanagan, K; Fitzgerald, K; Baker, J; Regnstrom, K; Gardai, S; Bard, F; Mocci, S; Seto, P; You, M; Larochelle, C; Prat, A; Chow, S; Li, L; Vandevert, C; Zago, W; Lorenzana, C; Nishioka, C; Hoffman, J; Botelho, R; Willits, C; Tanaka, K; Johnston, J; Yednock, T				Flanagan, Ken; Fitzgerald, Kent; Baker, Jeanne; Regnstrom, Karin; Gardai, Shyra; Bard, Frederique; Mocci, Simonetta; Seto, Pui; You, Monica; Larochelle, Catherine; Prat, Alexandre; Chow, Samuel; Li, Lauri; Vandevert, Chris; Zago, Wagner; Lorenzana, Carlos; Nishioka, Christopher; Hoffman, Jennifer; Botelho, Raquel; Willits, Christopher; Tanaka, Kevin; Johnston, Jennifer; Yednock, Ted			Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; ADHESION MOLECULE; MULTIPLE-SCLEROSIS; MEMORY CELLS; IN-VITRO; EXPRESSION; RECEPTOR; LYMPHOCYTES; MIGRATION	TH17 cells enter tissues to facilitate pathogenic autoimmune responses, including multiple sclerosis (MS). However, the adhesion molecules involved in the unique migratory capacity of TH17 cells, into both inflamed and uninflamed tissues remain unclear. Herein, we characterize MCAM (CD146) as an adhesion molecule that defines human TH17 cells in the circulation; following in vitro restimulation of human memory T cells, nearly all of the capacity to secrete IL-17 is contained within the population of cells expressing MCAM. Furthermore, we identify the MCAM ligand as laminin 411, an isoform of laminin expressed within the vascular endothelial basement membranes under inflammatory as well as homeotstatic conditions. Purified MCAM-Fc binds to laminin 411 with an affinity of 27 nM, and recognizes vascular basement membranes in mouse and human tissue. MCAM-Fc binding was undetectable in tissue from mice with targeted deletion of laminin 411, indicating that laminin 411 is a major tissue ligand for MCAM. An anti-MCAM monoclonal antibody, selected for inhibition of laminin binding, as well as soluble MCAM-Fc, inhibited T cell adhesion to laminin 411 in vitro. When administered in vivo, the antibody reduced TH17 cell infiltration into the CNS and ameliorated disease in an animal model of MS. Our data suggest that MCAM and laminin 411 interact to facilitate TH17 cell entry into tissues and promote inflammation.	[Flanagan, Ken; Fitzgerald, Kent; Baker, Jeanne; Regnstrom, Karin; Gardai, Shyra; Bard, Frederique; Mocci, Simonetta; Seto, Pui; You, Monica; Chow, Samuel; Li, Lauri; Vandevert, Chris; Zago, Wagner; Lorenzana, Carlos; Nishioka, Christopher; Hoffman, Jennifer; Botelho, Raquel; Willits, Christopher; Tanaka, Kevin; Johnston, Jennifer; Yednock, Ted] Elan Pharmaceut, San Francisco, CA USA; [Larochelle, Catherine; Prat, Alexandre] Univ Montreal, CRCHUM, Ctr Excellence Neur, Neuroimmunol Res Lab, Montreal, PQ, Canada	Universite de Montreal	Flanagan, K (corresponding author), Elan Pharmaceut, San Francisco, CA USA.	kenneth.flanagan@elan.com		Johnston, Jennifer/0000-0002-4867-9230	Elan Pharmaceuticals	Elan Pharmaceuticals	Funding for all experiments was provided by Elan Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors are paid employees of Elan Pharmaceuticals, who funded this study: Ken Flanagan, Kent Fitzgerald, Jeanne Baker, Karin Regnstrom, Shyra Gardai, Frederique Bard, Simonetta Mocci, Pui Seto, Monica You, Samuel Chow, Lauri Li, Chris Vandevert, Wagner Zago, Carlos Lorenzana, Christopher Nishioka, Jennifer Hoffman, Raquel Botelho, Christopher Willits, Kevin Tanaka, Jennifer Johnston, and Ted Yednock. Elan Pharmaceuticals has an interest in exploring the biology herein for development of a therapeutic antibody. There are no patents, other products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2008, INT IMMUNOL, V20, P1361, DOI 10.1093/intimm/dxn106; Annunziato F, 2009, BLOOD, V114, P2213, DOI 10.1182/blood-2009-03-209189; Annunziato F, 2009, EUR J IMMUNOL, V39, P637, DOI 10.1002/eji.200839050; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Chen HB, 2001, ANTICANCER RES, V21, P505; CROFT M, 1994, J IMMUNOL, V152, P2675; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dagur PK, 2011, J AUTOIMMUN, V37, P319, DOI 10.1016/j.jaut.2011.09.003; Despoix N, 2008, EUR J IMMUNOL, V38, P2855, DOI 10.1002/eji.200838469; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Elshal MF, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-29; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnson JP, 1997, INT J CANCER, V73, P769; Kenne E, 2010, J LEUKOCYTE BIOL, V88, P523, DOI 10.1189/jlb.0110043; Kim Chang H., 2009, Inflammation & Allergy Drug Targets, V8, P221; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li J, 2007, J NEUROIMMUNOL, V192, P57, DOI 10.1016/j.jneuroim.2007.09.004; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Longbrake EE, 2009, EXPERT REV NEUROTHER, V9, P319, DOI 10.1586/14737175.9.3.319; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Mokkapati S, 2011, J BIOL CHEM, V286, P1911, DOI 10.1074/jbc.M110.149864; Pickl WF, 1997, J IMMUNOL, V158, P2107; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schlagbauer-Wadl H, 1999, INT J CANCER, V81, P951, DOI 10.1002/(SICI)1097-0215(19990611)81:6<951::AID-IJC18>3.0.CO;2-V; Shih IM, 1997, CANCER RES, V57, P3835; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Staquicini FI, 2008, CANCER RES, V68, P8419, DOI 10.1158/0008-5472.CAN-08-1242; TAIRA E, 1994, NEURON, V12, P861, DOI 10.1016/0896-6273(94)90338-7; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; Wondimu Z, 2006, MATRIX BIOL, V25, P89, DOI 10.1016/j.matbio.2005.10.001; Wu C, 2009, NAT MED, V15, P519, DOI 10.1038/nm.1957; Xie SH, 1997, CANCER RES, V57, P2295; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001	52	88	97	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40443	10.1371/journal.pone.0040443	http://dx.doi.org/10.1371/journal.pone.0040443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792325	gold, Green Submitted, Green Published			2022-12-27	WOS:000306461800086
J	Kim, SJ; Koo, HM; Lim, BJ; Oh, HJ; Yoo, DE; Shin, DH; Lee, MJ; Doh, FM; Park, JT; Yoo, TH; Kang, SW; Choi, KH; Jeong, HJ; Han, SH				Kim, Seung Jun; Koo, Hyang Mo; Lim, Beom Jin; Oh, Hyung Jung; Yoo, Dong Eun; Shin, Dong Ho; Lee, Mi Jung; Doh, Fa Mee; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Jeong, Hyeon Joo; Han, Seung Hyeok			Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; COMPLEMENT ACTIVATION; GLOMERULAR DEPOSITION; ANOREXIA-NERVOSA; SYSTEMIC-LUPUS; SERUM IGA; DISEASE; GLOMERULONEPHRITIS; ERYTHEMATOSUS; INFLAMMATION	Background and Aims: Mesangial C3 deposition is frequently observed in patients with IgA nephropathy (IgAN). However, the role of complement in the pathogenesis or progression of IgAN is uncertain. In this observational cohort study, we aimed to identify the clinical implications of circulating C3 levels and mesangial C3 deposition and to investigate their utility as predictors of renal outcomes in patients with IgAN. Methods: A total of 343 patients with biopsy-proven IgAN were enrolled between January 2000 and December 2008. Decreased serum C3 level (hypoC3) was defined as C3 <90 mg/dl. The study endpoint was end-stage renal disease (ESRD) and a doubling of the baseline serum creatinine (D-SCr). Results: Of the patients, there were 66 patients (19.2%) with hypoC3. During a mean follow-up of 53.7 months, ESRD occurred in 5 patients (7.6%) with hypoC3 compared with 9 patients (3.2%) with normal C3 levels (P=0.11). However, 12 patients (18.2%) with hypoC3 reached D-SCr compared with 17 patients (6.1%) with normal C3 levels [Hazard ratio (HR), 3.59; 95% confidence interval (CI), 1.33-10.36; P=0.018]. In a multivariable model in which serum C3 levels were treated as a continuous variable, hypoC3 significantly predicted renal outcome of D-SCr (per 1 mg/dl increase of C3; HR, 0.95; 95% CI, 0.92-0.99; P=0.011). The risk of reaching renal outcome was significantly higher in patients with mesangial C3 deposition 2+ to 3+ than in patients without deposition (HR 9.37; 95% CI, 1.10-80.26; P=0.04). Conclusions: This study showed that hypoC3 and mesangial C3 deposition were independent risk factors for progression, suggesting that complement activation may play a pathogenic role in patients with IgAN.	[Kim, Seung Jun; Koo, Hyang Mo; Oh, Hyung Jung; Yoo, Dong Eun; Shin, Dong Ho; Lee, Mi Jung; Doh, Fa Mee; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Seung Hyeok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lim, Beom Jin] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kang, Shin-Wook; Jeong, Hyeon Joo] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Kim, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	hansh@yuhs.ac	Kim, Seung Jun/N-5248-2019; Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Kim, Seung Jun/0000-0002-6913-6358; Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Lee, Mi Jung/0000-0001-8888-029X; Yoo, Tae-Hyun/0000-0002-9183-4507; Jeong, Hyeon Joo/0000-0002-9695-1227; Kang, Shin-Wook/0000-0002-5677-4756; Lim, Beom Jin/0000-0003-2856-0133; Choi, Kyu Hun/0000-0003-0095-9011; Park, Jung Tak/0000-0002-2325-8982; doh, fa mee/0000-0002-4780-6728	Brain Korea 21 Project for Medical Science, Yonsei University; National Research Foundation of Korea (NRF) grant; Korean government (MEST) [2011-0030711]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0030711), and by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammitzboll CG, 2011, RHEUMATOL INT; Birmingham DJ, 2010, LUPUS, V19, P1272, DOI 10.1177/0961203310371154; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chan Loretta Y Y, 2004, Clin Exp Nephrol, V8, P297; Cook HT, 2006, NAT CLIN PRACT RHEUM, V2, P330, DOI 10.1038/ncprheum0191; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; DAMICO G, 1987, SEMIN NEPHROL, V7, P355; DAMICO G, 1987, Q J MED, V64, P709; El Karoui K, 2012, J AM SOC NEPHROL, V23, P137, DOI 10.1681/ASN.2010111130; Endo M, 1998, NEPHROL DIAL TRANSPL, V13, P1984, DOI 10.1093/ndt/13.8.1984; Espinosa M, 2009, NEPHROL DIAL TRANSPL, V24, P886, DOI 10.1093/ndt/gfn563; FEEHALLY J, 1986, KIDNEY INT, V30, P924, DOI 10.1038/ki.1986.274; Flierl MA, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-16; Floege J, 2000, J AM SOC NEPHROL, V11, P2395, DOI 10.1681/ASN.V11122395; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt/gfg207; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Giannakakis K, 2011, CLIN REV ALLERG IMMU, V40, P170, DOI 10.1007/s12016-010-8207-1; Hernandez-Mijares A, 2007, INT J OBESITY, V31, P927, DOI 10.1038/sj.ijo.0803543; HIEMSTRA PS, 1987, EUR J IMMUNOL, V17, P321, DOI 10.1002/eji.1830170304; Janssen U, 2000, AM J KIDNEY DIS, V35, P21, DOI 10.1016/S0272-6386(00)70296-4; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Komatsu H, 2004, INTERNAL MED, V43, P1023, DOI 10.2169/internalmedicine.43.1023; Kusaba G, 2012, MED MOL MORPHOL, V45, P29, DOI 10.1007/s00795-011-0538-3; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Myllymaki JM, 2007, KIDNEY INT, V71, P343, DOI 10.1038/sj.ki.5002046; Nakagawa H, 2000, AM J NEPHROL, V20, P122, DOI 10.1159/000013568; Nasr SH, 2011, NEPHRON CLIN PRACT, V119, pC18, DOI 10.1159/000324180; Ohsawa I, 2010, J CLIN LAB ANAL, V24, P113, DOI 10.1002/jcla.20372; Oortwijn BD, 2008, SEMIN NEPHROL, V28, P58, DOI 10.1016/j.semnephrol.2007.10.007; PALMBLAD J, 1979, ACTA PAEDIATR SCAND, V68, P617, DOI 10.1111/j.1651-2227.1979.tb05067.x; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Roufosse CA, 2009, CURR OPIN NEPHROL HY, V18, P212, DOI 10.1097/MNH.0b013e328329605c; SIGAL LH, 1989, AM J DIS CHILD, V143, P1391; STAD RK, 1993, CLIN EXP IMMUNOL, V92, P514; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Tomino Y, 2000, J CLIN LAB ANAL, V14, P220, DOI 10.1002/1098-2825(2000)14:5<220::AID-JCLA4>3.3.CO;2-U; Tsokos GC, 2004, ARTHRITIS RHEUM-US, V50, P3404, DOI 10.1002/art.20602; van der Boog PJM, 2004, NEPHROL DIAL TRANSPL, V19, P2487, DOI 10.1093/ndt/gfh394; Walsh M, 2010, CLIN J AM SOC NEPHRO, V5, P425, DOI 10.2215/CJN.06530909; WYATT RJ, 1987, KIDNEY INT, V31, P1019, DOI 10.1038/ki.1987.101; Zwirner J, 1997, KIDNEY INT, V51, P1257, DOI 10.1038/ki.1997.171	43	78	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40495	10.1371/journal.pone.0040495	http://dx.doi.org/10.1371/journal.pone.0040495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792353	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800097
J	Davis, IW; Benninger, C; Benfey, PN; Elich, T				Davis, Ian W.; Benninger, Christopher; Benfey, Philip N.; Elich, Tedd			POWRS: Position-Sensitive Motif Discovery	PLOS ONE			English	Article							REGULATE GENE-EXPRESSION; TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; BINDING SITES; CORE PROMOTER; CIS-ELEMENTS; IDENTIFICATION; SEQUENCES; PROFILES; MAP	Transcription factors and the short, often degenerate DNA sequences they recognize are central regulators of gene expression, but their regulatory code is challenging to dissect experimentally. Thus, computational approaches have long been used to identify putative regulatory elements from the patterns in promoter sequences. Here we present a new algorithm "POWRS" (POsition-sensitive WoRd Set) for identifying regulatory sequence motifs, specifically developed to address two common shortcomings of existing algorithms. First, POWRS uses the position-specific enrichment of regulatory elements near transcription start sites to significantly increase sensitivity, while providing new information about the preferred localization of those elements. Second, POWRS forgoes position weight matrices for a discrete motif representation that appears more resistant to over-generalization. We apply this algorithm to discover sequences related to constitutive, high-level gene expression in the model plant Arabidopsis thaliana, and then experimentally validate the importance of those elements by systematically mutating two endogenous promoters and measuring the effect on gene expression levels. This provides a foundation for future efforts to rationally engineer gene expression in plants, a problem of great importance in developing biotech crop varieties. Availability: BSD-licensed Python code at http://grassrootsbio.com/papers/powrs/.	[Davis, Ian W.; Benninger, Christopher; Benfey, Philip N.; Elich, Tedd] GrassRoots Biotechnol, Durham, NC USA; [Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC USA; [Benfey, Philip N.] Duke Univ, Ctr Syst Biol, Durham, NC USA	Duke University; Duke University	Davis, IW (corresponding author), GrassRoots Biotechnol, Durham, NC USA.	ian.davis@grassrootsbio.com			National Science Foundation [0957836]; Div Of Industrial Innovation & Partnersh [0957836] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by the National Science Foundation (0957836). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Florquin K, 2005, NUCLEIC ACIDS RES, V33, P4255, DOI 10.1093/nar/gki737; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huggins P, 2011, BIOINFORMATICS, V27, P2361, DOI 10.1093/bioinformatics/btr412; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Keilwagen J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001070; Kim NK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-262; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Ma X, 2012, NUCL ACIDS RES; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Narang V, 2010, BIOINFORMATICS, V26, P1152, DOI 10.1093/bioinformatics/btq106; Narlikar L, 2006, BIOINFORMATICS, V22, pE384, DOI 10.1093/bioinformatics/btl251; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sun HQ, 2011, BIOINFORMATICS, V27, P2641, DOI 10.1093/bioinformatics/btr459; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Tharakaraman K, 2005, BIOINFORMATICS, V21, pI440, DOI 10.1093/bioinformatics/bti1028; Tremousaygue D, 2003, PLANT J, V33, P957, DOI 10.1046/j.1365-313X.2003.01682.x; Troukhan M, 2009, OMICS, V13, P139, DOI 10.1089/omi.2008.0034; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yan R, 2011, BIOINFORMATICS, V27, P2054, DOI 10.1093/bioinformatics/btr353; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Yokoyama KD, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp423	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40373	10.1371/journal.pone.0040373	http://dx.doi.org/10.1371/journal.pone.0040373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792292	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300059
J	Li, JZ; Gui, DY; Feng, CL; Wang, WZ; Du, BQ; Gan, T; Luo, YJ				Li, Jin-Zhen; Gui, Dan-Yang; Feng, Chun-Liang; Wang, Wen-Zhong; Du, Bo-Qi; Gan, Tian; Luo, Yue-Jia			Victims' Time Discounting 2.5 Years after the Wenchuan Earthquake: An ERP Study	PLOS ONE			English	Article							DECISION-MAKING; INTERTEMPORAL CHOICE; SELF-CONTROL; COGNITIVE CONTROL; BRAIN; REWARDS; PROBABILITY; RISK; RESOLUTION; INHIBITION	Background: Time discounting refers to the fact that the subjective value of a reward decreases as the delay until its occurrence increases. The present study investigated how time discounting has been affected in survivors of the magnitude-8.0 Wenchuan earthquake that occurred in China in 2008. Methodology: Nineteen earthquake survivors and 22 controls, all school teachers, participated in the study. Event-related brain potentials (ERPs) for time discounting tasks involving gains and losses were acquired in both the victims and controls. Findings: The behavioral data replicated our previous findings that delayed gains were discounted more steeply after a disaster. ERP results revealed that the P200 and P300 amplitudes were increased in earthquake survivors. There was a significant group (earthquake vs. non-earthquake) 6 task (gain vs. loss) interaction for the N300 amplitude, with a marginally significantly reduced N300 for gain tasks in the experimental group, which may suggest a deficiency in inhibitory control for gains among victims. Conclusions: The results suggest that post-disaster decisions might involve more emotional (System 1) and less rational thinking (System 2) in terms of a dual-process model of decision making. The implications for post-disaster intervention and management are also discussed.	[Li, Jin-Zhen; Gui, Dan-Yang; Feng, Chun-Liang; Du, Bo-Qi; Gan, Tian; Luo, Yue-Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wang, Wen-Zhong] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS	Li, JZ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	luoyj@bnu.edu.cn	Gan, Tian/AAV-7161-2021	Gui, Danyang/0000-0002-7940-1397	National Natural Science of China [91132704, 30930031]; Ministry of Sci & Tech (973 Program) [2011CB711000]; National Key Technologies R D Program [2009BAI77B01]; China Postdoctoral Science Foundation [20100480224]; Global Research Initiative Program, National Institutes of Health (NIH), USA [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Ministry of Sci & Tech (973 Program); National Key Technologies R D Program(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Global Research Initiative Program, National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the National Natural Science of China (91132704, 30930031), Ministry of Sci & Tech (973 Program, 2011CB711000), National Key Technologies R & D Program (2009BAI77B01), China Postdoctoral Science Foundation (No. 20100480224) and Global Research Initiative Program, National Institutes of Health (NIH), USA (1R01TW007897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Bal A, 2008, CHILD ADOL MENT H-UK, V13, P134, DOI 10.1111/j.1475-3588.2007.00469.x; Bechara A, 2002, BRAIN, V125, P1673, DOI 10.1093/brain/awf169; BENZION U, 1989, MANAGE SCI, V35, P270, DOI 10.1287/mnsc.35.3.270; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bland SH, 2005, J NERV MENT DIS, V193, P420, DOI 10.1097/01.nmd.0000165297.49452.41; Boettiger CA, 2007, J NEUROSCI, V27, P14383, DOI 10.1523/JNEUROSCI.2551-07.2007; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; Dearstyne B, 2007, GOV INFORM Q, V24, P29, DOI 10.1016/j.giq.2006.03.004; Estle SJ, 2007, PSYCHOL SCI, V18, P58, DOI 10.1111/j.1467-9280.2007.01849.x; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JSBT, 1996, BRIT J PSYCHOL, V87, P223, DOI 10.1111/j.2044-8295.1996.tb02587.x; Fehr E, 2002, NATURE, V415, P269, DOI 10.1038/415269a; Ferreira MB, 2006, J PERS SOC PSYCHOL, V91, P797, DOI 10.1037/0022-3514.91.5.797; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frank MJ, 2009, CURR DIR PSYCHOL SCI, V18, P73, DOI 10.1111/j.1467-8721.2009.01612.x; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Ganderton PT, 2000, J RISK UNCERTAINTY, V20, P271, DOI 10.1023/A:1007871514658; Ganzel BL, 2008, NEUROIMAGE, V40, P788, DOI 10.1016/j.neuroimage.2007.12.010; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; Glimcher PW, 2007, AM ECON REV, V97, P142, DOI 10.1257/aer.97.2.142; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Green L, 2004, J EXP ANAL BEHAV, V81, P39, DOI 10.1901/jeab.2004.81-39; GREEN L, 1993, BEHAV PHILOS, V21, P37; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201; Hardman D, 2009, JUDGM DECIS MAK, P106; Havenaar JM, 2003, SOC SCI MED, V56, P569, DOI 10.1016/S0277-9536(02)00062-X; Kahneman D., 2011, THINKING FAST SLOW; Karakaya Isil, 2004, Turk Psikiyatri Derg, V15, P257; Li JZ, 2011, J APPL SOC PSYCHOL, V41, P2739, DOI 10.1111/j.1559-1816.2011.00847.x; Li JZ, 2011, APPL COGNITIVE PSYCH, V25, P104, DOI 10.1002/acp.1648; Li S, 2010, RISK ANAL, V30, P699, DOI 10.1111/j.1539-6924.2010.01371.x; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; LOGUE AW, 1988, BEHAV BRAIN SCI, V11, P665, DOI 10.1017/S0140525X00053978; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Ma QG, 2008, NEUROSCI LETT, V431, P57, DOI 10.1016/j.neulet.2007.11.022; MacKeigan L D, 1993, Pharmacoeconomics, V3, P374, DOI 10.2165/00019053-199303050-00005; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MISCHEL W, 1967, J PERS SOC PSYCHOL, V5, P24, DOI 10.1037/h0024180; Murphy JG, 2001, PSYCHOL REC, V51, P571; Myers DG, 2001, OBSERVER, V14, P3; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Ohmura Y, 2006, EXP CLIN PSYCHOPHARM, V14, P318, DOI 10.1037/1064-1297.14.3.318; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Pavel, 2011, J COMP RES ANTHR SOC, V2, P117; Payne J.W., 2008, BLACKWELL HDB JUDGME, P110, DOI [10.1002/9780470752937.ch6, DOI 10.1002/9780470752937.CH6]; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Polezzi D, 2010, NEUROIMAGE, V49, P1886, DOI 10.1016/j.neuroimage.2009.08.068; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Read D., 2004, BLACKWELL HDB JUDGME, P424, DOI DOI 10.1002/9780470752937.CH21; REBER AS, 1992, PHILOS PSYCHOL, V5, P33, DOI 10.1080/09515089208573042; Rigoni D, 2010, BRAIN RES BULL, V81, P445, DOI 10.1016/j.brainresbull.2009.12.003; Sacco K, 2003, APPL COGNITIVE PSYCH, V17, P1113, DOI 10.1002/acp.989; Schoenfelder TE, 2003, J VOCAT BEHAV, V62, P43, DOI 10.1016/S0001-8791(02)00032-5; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SHELLEY MK, 1994, ORGAN BEHAV HUM DEC, V59, P124, DOI 10.1006/obhd.1994.1053; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; STEVENSON MK, 1986, J EXP PSYCHOL GEN, V115, P131, DOI 10.1037/0096-3445.115.2.131; Tamura H, 2000, EUR J OPER RES, V122, P461, DOI 10.1016/S0377-2217(99)00247-7; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Xu LJ, 2009, BRAIN RES, V1261, P65, DOI 10.1016/j.brainres.2008.12.061; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	74	23	25	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40316	10.1371/journal.pone.0040316	http://dx.doi.org/10.1371/journal.pone.0040316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974LI	22792277	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300052
J	Oda, Y; Onitsuka, T; Tsuchimoto, R; Hirano, S; Oribe, N; Ueno, T; Hirano, Y; Nakamura, I; Miura, T; Kanba, S				Oda, Yuko; Onitsuka, Toshiaki; Tsuchimoto, Rikako; Hirano, Shogo; Oribe, Naoya; Ueno, Takefumi; Hirano, Yoji; Nakamura, Itta; Miura, Tomofumi; Kanba, Shigenobu			Gamma Band Neural Synchronization Deficits for Auditory Steady State Responses in Bipolar Disorder Patients	PLOS ONE			English	Article							CORTEX IN-VITRO; RATING-SCALE; SODIUM VALPROATE; PLASMA GABA; SCHIZOPHRENIA; OSCILLATIONS; DEPRESSION; NETWORKS; INTERNEURONS; STIMULATION	Periodic auditory click stimulation has been reported to elicit an auditory steady state response (ASSR). The ASSR has been suggested to reflect the efficiency of gamma-amino butyric acid (GABA) inhibitory interneuronal activity. Although a potential role for GABAergic dysfunction has been previously proposed, the role of neural synchronization in the ASSR in people with bipolar disorder (BD) has received little attention. In the current study, we investigated ASSRs to 20 Hz, 30 Hz, 40 Hz and 80 Hz click trains in BD patients. A total of 14 (4 males) BD patients and 25 (10 males) healthy controls participated in this study. ASSRs were obtained using whole-head 306-channel magnetoencephalography to calculate, ASSR power values and phase locking factors (PLF). BD patients exhibited significantly reduced mean ASSR power and PLF values bilaterally at frequencies of 30, 40, and 80 Hz (p<0.05 for these frequencies). At 20 Hz, bipolar patients showed no significant reduction in mean ASSR power and PLF values. There was a significant negative correlation between 80 Hz-ASSR-power values obtained from the right hemisphere and scores on the Hamilton Depression Rating Scale (rho = -0.86, p=0.0003). The current study showed reduced low and high gamma band ASSR power and PLF bilaterally with no significant beta band ASSR reduction in BD patients. BD patients are characterized by deficits in gamma band oscillations, which may be associated with GABA inhibitory interneuronal activity dysfunction.	[Oda, Yuko; Onitsuka, Toshiaki; Tsuchimoto, Rikako; Hirano, Shogo; Oribe, Naoya; Ueno, Takefumi; Hirano, Yoji; Nakamura, Itta; Miura, Tomofumi; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan; [Oribe, Naoya; Hirano, Yoji] Boston VA Healthcare Syst, Dept Psychiat, Lab Neurosci, Clin Neurosci Div,Brockton Div, Brockton, MA USA; [Oribe, Naoya; Hirano, Yoji] Harvard Univ, Sch Med, Brockton, MA 02401 USA	Kyushu University; Harvard University	Oda, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan.	skanba@npsych.med.kyushu-u.ac.jp	Hirano, Yoji/AAR-5658-2021	Hirano, Yoji/0000-0001-6847-9677	Ministry of Education, Culture, Sports, Science and Technology, Japan [B22390226, C23591712]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan [H23 kokoro-ippan-002]; Mitsubishi Pharma Research Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Pharma Research Foundation	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan [B22390226 to SK, C23591712 to TO]; a grant by Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science to SK and TO; a grant from Ministry of Health, Labour and Welfare, Japan (H23 kokoro-ippan-002 to SK); and a Research Grant from Mitsubishi Pharma Research Foundation to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernasconi R, 1982, EXCERPTA MED, V26, P183; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Clark L, 2005, BIOL PSYCHIAT, V57, P183, DOI 10.1016/j.biopsych.2004.11.007; Cunningham MO, 2000, NEUROPHARMACOLOGY, V39, P2139, DOI 10.1016/S0028-3908(00)00051-4; Cunningham MO, 2004, J PHYSIOL-LONDON, V559, P347, DOI 10.1113/jphysiol.2004.068973; EMRICH HM, 1980, ARCH PSYCHIAT NERVEN, V229, P1, DOI 10.1007/BF00343800; Furukawa TA, 2007, J CLIN PSYCHOPHARM, V27, P531, DOI 10.1097/JCP.0b013e31814f30b1; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Hamm JP, 2011, BIOL PSYCHIAT, V69, P989, DOI 10.1016/j.biopsych.2010.11.021; Hassel B, 2001, EPILEPSY RES, V43, P153, DOI 10.1016/S0920-1211(00)00196-0; Kaiser J, 2004, NEUROIMAGE, V23, P551, DOI 10.1016/j.neuroimage.2004.06.033; Konradi C, 2011, ARCH GEN PSYCHIAT, V68, P340, DOI 10.1001/archgenpsychiatry.2010.175; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; LOSCHER W, 1989, BRAIN RES, V501, P198, DOI 10.1016/0006-8993(89)91044-5; LOSCHER W, 1981, LIFE SCI, V28, P2383, DOI 10.1016/0024-3205(81)90504-X; LOSCHER W, 1980, EPILEPSIA, V21, P611, DOI 10.1111/j.1528-1157.1980.tb04314.x; Maharajh K., 2007, INT CONG SERI, V1300, P707, DOI [10.1016/j.ics.2006.12.073, DOI 10.1016/J.ICS.2006.12.073]; O'Donnell BF, 2004, NEUROREPORT, V15, P1369, DOI 10.1097/01.wnr.0000127348.64681.b2; Oke OO, 2010, EUR J NEUROSCI, V31, P1435, DOI 10.1111/j.1460-9568.2010.07171.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Rass O, 2010, BIPOLAR DISORD, V12, P793, DOI 10.1111/j.1399-5618.2010.00871.x; Reite M, 2009, BIPOLAR DISORD, V11, P371, DOI 10.1111/j.1399-5618.2009.00701.x; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Shiah IS, 2000, INT CLIN PSYCHOPHARM, V15, P221, DOI 10.1097/00004850-200015040-00005; Sohal VS, 2012, BIOL PSYCHIAT, V71, P1039, DOI 10.1016/j.biopsych.2012.01.024; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Spencer KM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-85; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Tsuchimoto R, 2011, SCHIZOPHR RES, V133, P99, DOI 10.1016/j.schres.2011.07.020; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wang AY, 2011, ACTA NEUROPATHOL, V122, P615, DOI 10.1007/s00401-011-0881-4; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	41	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39955	10.1371/journal.pone.0039955	http://dx.doi.org/10.1371/journal.pone.0039955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792199	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300014
J	Rapacciuolo, G; Roy, DB; Gillings, S; Fox, R; Walker, K; Purvis, A				Rapacciuolo, Giovanni; Roy, David B.; Gillings, Simon; Fox, Richard; Walker, Kevin; Purvis, Andy			Climatic Associations of British Species Distributions Show Good Transferability in Time but Low Predictive Accuracy for Range Change	PLOS ONE			English	Article							LAND-COVER DATA; DISTRIBUTION MODELS; ENVELOPE MODELS; EXTINCTION RISK; GLOBAL CHANGE; HABITAT; NICHE; BUTTERFLIES; IMPACTS; PLANTS	Conservation planners often wish to predict how species distributions will change in response to environmental changes. Species distribution models (SDMs) are the primary tool for making such predictions. Many methods are widely used; however, they all make simplifying assumptions, and predictions can therefore be subject to high uncertainty. With global change well underway, field records of observed range shifts are increasingly being used for testing SDM transferability. We used an unprecedented distribution dataset documenting recent range changes of British vascular plants, birds, and butterflies to test whether correlative SDMs based on climate change provide useful approximations of potential distribution shifts. We modelled past species distributions from climate using nine single techniques and a consensus approach, and projected the geographical extent of these models to a more recent time period based on climate change; we then compared model predictions with recent observed distributions in order to estimate the temporal transferability and prediction accuracy of our models. We also evaluated the relative effect of methodological and taxonomic variation on the performance of SDMs. Models showed good transferability in time when assessed using widespread metrics of accuracy. However, models had low accuracy to predict where occupancy status changed between time periods, especially for declining species. Model performance varied greatly among species within major taxa, but there was also considerable variation among modelling frameworks. Past climatic associations of British species distributions retain a high explanatory power when transferred to recent time - due to their accuracy to predict large areas retained by species - but fail to capture relevant predictors of change. We strongly emphasize the need for caution when using SDMs to predict shifts in species distributions: high explanatory power on temporally-independent records - as assessed using widespread metrics - need not indicate a model's ability to predict the future.	[Rapacciuolo, Giovanni; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Div Ecol & Evolut, Ascot, Berks, England; [Rapacciuolo, Giovanni; Roy, David B.] Ctr Ecol & Hydrol, Biol Records Ctr, Wallingford, Oxon, England; [Rapacciuolo, Giovanni; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London, England; [Gillings, Simon] British Trust Ornithol, Thetford, Norfolk, England; [Fox, Richard] Butterfly Conservat, Wareham, Dorset, England; [Walker, Kevin] Bot Soc British Isles, Harrogate, N Yorkshire, England	Imperial College London; UK Centre for Ecology & Hydrology (UKCEH); Imperial College London; British Trust for Ornithology	Rapacciuolo, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Ecol & Evolut, Ascot, Berks, England.	giovanni.rapacciuolo05@imperial.ac.uk	Roy, David/A-6619-2009; Purvis, Andy/A-7529-2008; Gillings, Simon/I-2727-2015	Roy, David/0000-0002-5147-0331; Purvis, Andy/0000-0002-8609-6204; Rapacciuolo, Giovanni/0000-0003-1494-9017; Fox, Richard/0000-0001-6992-3522; Gillings, Simon/0000-0002-9794-2357	Biotechnology and Biological Sciences Research Council (BBSRC); NERC (Natural Environment Research Council) (through the Centre for Ecology Hydrology); Joint Nature Conservation Committee (JNCC); Natural Environment Research Council [CEH010021] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC (Natural Environment Research Council) (through the Centre for Ecology Hydrology)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Joint Nature Conservation Committee (JNCC); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Biotechnology and Biological Sciences Research Council (BBSRC), http://www.bbsrc.ac.uk/; Old Mutual plc, http://www.oldmutual.com/; NERC (Natural Environment Research Council) (through the Centre for Ecology & Hydrology), http://www.ceh.ac.uk/; and Joint Nature Conservation Committee (JNCC), http://jncc.defra.gov.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Asher J, 2001, MILLENNIUM ATLAS BUT; Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x; Barbosa AM, 2009, ECOL MODEL, V220, P747, DOI 10.1016/j.ecolmodel.2008.12.004; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Fuller RM, 2002, CARTOGR J, V39, P15; Gibbons D. W., 1993, NEW ATLAS BREEDING B; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanspach J, 2010, PERSPECT PLANT ECOL, V12, P219, DOI 10.1016/j.ppees.2010.04.002; Heath J., 1984, ATLAS BUTTERFLIES BR; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hof AR, 2012, DIVERSITY D IN PRESS; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kharouba HM, 2009, ECOLOGY, V90, P2213, DOI 10.1890/08-1304.1; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Perring F.H., 1962, ATLAS BRIT FLORA; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; Preston C, 2002, NEW ATLAS BRIT IRISH; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Sharrock J.T.R., 1976, ATLAS BREEDING BIRDS; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Stankowski PA, 2011, ECOL MODEL, V222, P567, DOI 10.1016/j.ecolmodel.2010.10.018; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syphard AD, 2010, J VEG SCI, V21, P177, DOI 10.1111/j.1654-1103.2009.01133.x; Telfer MG, 2002, BIOL CONSERV, V107, P99, DOI 10.1016/S0006-3207(02)00050-2; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; UNEPWCMC, 2011, UK NAT EC ASS SYNTH; Vanreusel W, 2007, CONSERV BIOL, V21, P201, DOI 10.1111/j.1523-1739.2006.00577.x; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	80	61	61	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40212	10.1371/journal.pone.0040212	http://dx.doi.org/10.1371/journal.pone.0040212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792243	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300036
J	Elashoff, MR; Nuttall, R; Beineke, P; Doctolero, MH; Dickson, M; Johnson, AM; Daniels, SE; Rosenberg, S; Wingrove, JA				Elashoff, Michael R.; Nuttall, Rachel; Beineke, Philip; Doctolero, Michael H.; Dickson, Mark; Johnson, Andrea M.; Daniels, Susan E.; Rosenberg, Steven; Wingrove, James A.			Identification of Factors Contributing to Variability in a Blood-Based Gene Expression Test	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; NONDIABETIC PATIENTS; MESSENGER-RNA; SIGNATURES; CELLS; INTERFERON; VALIDATION; CANCER; LUPUS	Background: Corus CAD is a clinically validated test based on age, sex, and expression levels of 23 genes in whole blood that provides a score (1-40 points) proportional to the likelihood of obstructive coronary disease. Clinical laboratory process variability was examined using whole blood controls across a 24 month period: Intra-batch variability was assessed using sample replicates; inter-batch variability examined as a function of laboratory personnel, equipment, and reagent lots. Methods/Results: To assess intra-batch variability, five batches of 132 whole blood controls were processed; inter-batch variability was estimated using 895 whole blood control samples. ANOVA was used to examine inter-batch variability at 4 process steps: RNA extraction, cDNA synthesis, cDNA addition to assay plates, and qRT-PCR. Operator, machine, and reagent lots were assessed as variables for all stages if possible, for a total of 11 variables. Intra-and inter-batch variations were estimated to be 0.092 and 0.059 Cp units respectively (SD); total laboratory variation was estimated to be 0.11 Cp units (SD). In a regression model including all 11 laboratory variables, assay plate lot and cDNA kit lot contributed the most to variability (p = 0.045; 0.009 respectively). Overall, reagent lots for RNA extraction, cDNA synthesis, and qRT-PCR contributed the most to inter-batch variance (52.3%), followed by operators and machines (18.9% and 9.2% respectively), leaving 19.6% of the variance unexplained. Conclusion: Intra-batch variability inherent to the PCR process contributed the most to the overall variability in the study while reagent lot showed the largest contribution to inter-batch variability.	[Elashoff, Michael R.; Nuttall, Rachel; Beineke, Philip; Doctolero, Michael H.; Dickson, Mark; Johnson, Andrea M.; Daniels, Susan E.; Rosenberg, Steven; Wingrove, James A.] CardioDx Inc, Palo Alto, CA 94303 USA		Elashoff, MR (corresponding author), CardioDx Inc, Palo Alto, CA 94303 USA.	jwingrove@cardiodx.com						Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cronin M, 2007, CLIN CHEM, V53, P1084, DOI 10.1373/clinchem.2006.076497; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Dumeaux V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000873; Elashoff MR, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-26; Goodison S, 2010, BIOANALYSIS, V2, P855, DOI 10.4155/BIO.10.35; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Lampe JW, 2004, CANCER EPIDEM BIOMAR, V13, P445; Llaverias G, 2008, PHARMACOGENOMICS, V9, P1035, DOI 10.2217/14622416.9.8.1035; McPhail S, 2005, DRUG DISCOV TODAY, V10, P1485, DOI 10.1016/S1359-6446(05)03644-5; Nakamura S, 2010, BIOCHEM BIOPH RES CO, V391, P846, DOI 10.1016/j.bbrc.2009.11.150; Park MY, 2007, BIOSTATISTICS, V8, P212, DOI 10.1093/biostatistics/kxl002; Rosenberg S, 2010, ANN INTERN MED, V153, P425, DOI 10.7326/0003-4819-153-7-201010050-00005; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730	18	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40068	10.1371/journal.pone.0040068	http://dx.doi.org/10.1371/journal.pone.0040068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802952	gold, Green Published, Green Submitted			2022-12-27	WOS:000306186900026
J	Kim, JR; Nandy, A; Maji, AK; Addy, M; Dondorp, AM; Day, NPJ; Pukrittayakamee, S; White, NJ; Imwong, M				Kim, Jung-Ryong; Nandy, Amitabha; Maji, Ardhendu Kumar; Addy, Manjulika; Dondorp, Arjen M.; Day, Nicholas P. J.; Pukrittayakamee, Sasithon; White, Nicholas J.; Imwong, Mallika			Genotyping of Plasmodium vivax Reveals Both Short and Long Latency Relapse Patterns in Kolkata	PLOS ONE			English	Article								Background: The Plasmodium vivax that was once prevalent in temperate climatic zones typically had an interval between primary infection and first relapse of 7-10 months, whereas in tropical areas P. vivax infections relapse frequently at intervals of 3-6 weeks. Defining the epidemiology of these two phenotypes from temporal patterns of illness in endemic areas is difficult or impossible, particularly if they overlap. Methods: A prospective open label comparison of chloroquine (CQ) alone versus CQ plus unobserved primaquine for either 5 days or 14 days was conducted in patients presenting with acute vivax malaria in Kolkata. Patients were followed for 15 months and primary and recurrent infections were genotyped using three polymorphic antigen and up to 8 microsatellite markers. Results: 151 patients were enrolled of whom 47 (31%) had subsequent recurrent infections. Recurrence proportions were similar in the three treatment groups. Parasite genotyping revealed discrete temporal patterns of recurrence allowing differentiation of probable relapse from newly acquired infections. This suggested that 32 of the 47 recurrences were probable relapses of which 22 (69%) were genetically homologous. The majority (81%) of probable relapses occurred within three months (16 homologous, 10 heterologous) and six genetically homologous relapses (19%) were of the long latency (8-10 month interval) phenotype. Conclusions: With long follow-up to assess temporal patterns of vivax malaria recurrence, genotyping of P. vivax can be used to assess relapse rates. A 14 day unobserved course of primaquine did not prevent relapse. Genotyping indicates that long latency P. vivax is prevalent in West Bengal, and that the first relapses after long latent periods are genetically homologous.	[Kim, Jung-Ryong; Pukrittayakamee, Sasithon; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Nandy, Amitabha; Addy, Manjulika] Ctr Trop Med & Parasitol, Kolkata, W Bengal, India; [Maji, Ardhendu Kumar] Calcutta Sch Trop Med, Dept Microbiol, Kolkata, India; [Dondorp, Arjen M.; Day, Nicholas P. J.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand; [Dondorp, Arjen M.; Day, Nicholas P. J.; White, Nicholas J.] Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Imwong, Mallika] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand	Mahidol University; Calcutta School of Tropical Medicine (CSTM); Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol University; Mahidol University	Kim, JR (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.	noi@tropmedres.ac	White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Imwong, Mallika/ABE-6493-2020	White, Nick/0000-0002-1897-1978; 	Wellcome Trust of Great Britain; National Science and Technology Development Agency; office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Wellcome Trust Intermediate Fellow [080867/Z/06/Z]	Wellcome Trust of Great Britain(Wellcome Trust); National Science and Technology Development Agency; office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Wellcome Trust Intermediate Fellow(Wellcome Trust)	This study was part of the Wellcome Trust-Mahidol University, Oxford Tropical Medicine Research Programme funded by the Wellcome Trust of Great Britain. MI is supported by the National Science and Technology Development Agency, the office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, and Wellcome Trust Intermediate Fellow [grant 080867/Z/06/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak T, 1998, AM J TROP MED HYG, V59, P175, DOI 10.4269/ajtmh.1998.59.175; Adak T, 2001, CLIN DIAGN LAB IMMUN, V8, P891, DOI 10.1128/CDLI.8.5.891-894.2001; Baird JK, 2011, ANTIMICROB AGENTS CH, V55, P1827, DOI 10.1128/AAC.01296-10; Chen NH, 2007, J INFECT DIS, V195, P934, DOI 10.1086/512242; Dua VK, 1996, TROP MED INT HEALTH, V1, P816; Gogtay N J, 2000, J Assoc Physicians India, V48, P1085; Gogtay NJ, 1999, ANN TROP MED PARASIT, V93, P809, DOI 10.1080/00034989957790; Imwong M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-20; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806; JAMES S. P., 1931, TRANS ROY SOC TROP MED AND HYG, V24, P477, DOI 10.1016/S0035-9203(31)90068-0; Kim, 2006, MALARIA J, V5, p71e; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Nandy A, 2003, ANN TROP MED PARASIT, V97, P215, DOI 10.1179/000349803235001868; SINHA S, 1989, Indian Journal of Malariology, V26, P83; Srivastava H. C., 1996, Indian Journal of Malariology, V33, P173; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Yorke W., 1924, Transactions of the Royal Society of Tropical Medicine London, V18, P13, DOI 10.1016/S0035-9203(24)90664-X; YORKE W., 1925, Transactions of the Royal Society of Tropical Medicine and Hygiene, V19, P108, DOI 10.1016/S0035-9203(26)80002-1	19	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39645	10.1371/journal.pone.0039645	http://dx.doi.org/10.1371/journal.pone.0039645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808048	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700010
J	Hou, ZJ; Hu, ZH; Blackwell, DJ; Miller, TD; Thomas, DD; Robia, SL				Hou, Zhanjia; Hu, Zhihong; Blackwell, Daniel J.; Miller, Tyler D.; Thomas, David D.; Robia, Seth L.			2-Color Calcium Pump Reveals Closure of the Cytoplasmic Headpiece with Calcium Binding	PLOS ONE			English	Article							PHOSPHOLAMBAN MUTANTS COMPETE; RESONANCE ENERGY-TRANSFER; SARCOPLASMIC-RETICULUM; LIVING CELLS; CA2+ TRANSPORT; WILD-TYPE; ATPASE; MECHANISM; NUCLEOTIDE; PHOSPHORYLATION	The sarco(endo) plasmic reticulum calcium ATPase (SERCA) undergoes conformational changes while transporting calcium, but the details of the domain motions are still unclear. The objective of the present study was to measure distances between the cytoplasmic domains of SERCA2a in order to reveal the magnitude and direction of conformational changes. Using fluorescence microscopy of live cells, we measured intramolecular fluorescence resonance energy transfer (FRET) from a donor fluorescent protein fused to the SERCA N-terminus to an acceptor fluorescent protein fused to either the N-, P-, or transmembrane domain. The "2-color" SERCA constructs were catalytically active as indicated by ATPase activity in vitro and Ca uptake in live cells. All constructs exhibited dynamic FRET changes in response to the pump ligands calcium and thapsigargin (Tg). These FRET changes were quantified as an index of SERCA conformational changes. Intramolecular FRET decreased with Tg for the two N-domain fusion sites (at residue 509 or 576), while the P-(residue 661) and TM-domain (C-terminus) fusions showed increased FRET with Tg. The magnitude of the Tg-dependent conformational change was not decreased by coexpression of phospholamban (PLB), nor did PLB slow the kinetics of Tg binding. FRET in ionophore-permeabilized cells was lower in EGTA than in saturating calcium for all constructs, indicating a decrease in domain separation distance with the structural transition from E2 (Ca-free) to E1 (Ca-bound). The data suggest closure of the cytoplasmic headpiece with Ca-binding. The present results provide insight into the structural dynamics of the Ca-ATPase. In addition, the 2-color SERCA constructs developed for this study may be useful for evaluating candidate small molecule regulators of Ca uptake activity.	[Hou, Zhanjia; Hu, Zhihong; Blackwell, Daniel J.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL USA; [Miller, Tyler D.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	Loyola University Chicago; University of Minnesota System; University of Minnesota Twin Cities	Hou, ZJ (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL USA.	srobia@lumc.edu		Thomas, David D./0000-0002-8822-2040	National Institutes of Health [HL106189, GM27906, P30 AR05722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a gift from the McCormick Foundation to Loyola University Chicago; National Institutes of Health grant HL106189 (to SLR); and GM27906 and P30 AR05722 (to DDT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablorh NA, 2012, ANAL BIOCH; Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Brini M, 2000, EMBO J, V19, P4926, DOI 10.1093/emboj/19.18.4926; Chen B, 2008, BIOCHEMISTRY-US, V47, P12448, DOI 10.1021/bi8014289; Chen BW, 2004, BIOCHEMISTRY-US, V43, P4366, DOI 10.1021/bi0356350; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; Gruber SJ, 2012, BIOCHEM BIOPH RES CO, V420, P236, DOI 10.1016/j.bbrc.2012.02.125; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kremers GJ, 2009, LAB TECH BIOCHEM MOL, V33, P171, DOI 10.1016/S0075-7535(08)00005-3; Liu YY, 2009, J MOL BIOL, V391, P858, DOI 10.1016/j.jmb.2009.06.044; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mahaney JE, 2008, BIOCHEMISTRY-US, V47, P13711, DOI 10.1021/bi801024a; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Rocheleau JV, 2003, BIOPHYS J, V84, P4078, DOI 10.1016/S0006-3495(03)75133-9; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Satoh K, 2011, J BIOL CHEM, V286, P20591, DOI 10.1074/jbc.M110.204685; Shannon TR, 1997, BIOPHYS J, V73, P1524, DOI 10.1016/S0006-3495(97)78184-0; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Yokokawa M, 2011, FEBS J, V278, P3025, DOI 10.1111/j.1742-4658.2011.08222.x; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	36	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40369	10.1371/journal.pone.0040369	http://dx.doi.org/10.1371/journal.pone.0040369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808146	Green Published, gold			2022-12-27	WOS:000306362400047
J	Macfadyen, S; Kriticos, DJ				Macfadyen, Sarina; Kriticos, Darren J.			Modelling the Geographical Range of a Species with Variable Life-History	PLOS ONE			English	Article							CHERRY-OAT APHID; PADI L HEMIPTERA; CEREAL APHIDS; NATIONAL-PARK; PREDICTION; SURVIVAL; CLIMATE; DISTRIBUTIONS; TEMPERATURE; COEXISTENCE	We show how a climatic niche model can be used to describe the potential geographic distribution of a pest species with variable life-history, and illustrate how to estimate biogeographic pest threats that vary across space. The models were used to explore factors that affect pest risk (irrigation and presences of host plant). A combination of current distribution records and published experimental data were used to construct separate models for the asexual and sexual lineages of Rhopalosiphum padi (Linnaeus) (Hemiptera: Aphididae). The two models were combined with knowledge of host plant presence to classify the global pest risk posed by R. padi. Whilst R. padi has a relatively limited area in which sexual lineages can persist year round, a much larger area is suitable for transient sexual and asexual lineages to exist. The greatest risk of establishment of persistent sexual and asexual populations is in areas with warm temperate climates. At the global scale the models show very little difference in risk patterns between natural rainfall and irrigation scenarios, but in Australia, the amount of land suitable for persistent asexual and transient sexual populations decreases (by 20%) if drought stress is no longer alleviated by irrigation. This approach proved useful for modelling the potential distribution of a species that has a variable life-history. We were able to use the model outputs to examine factors such as irrigation practices and host plant presence that altered the nature (transient or permanent) and extent of pest risk. The composite niche maps indicate pest risk in terms that are useful to both biosecurity agencies and pest managers.	[Macfadyen, Sarina; Kriticos, Darren J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Macfadyen, S (corresponding author), CSIRO Ecosyst Sci, Canberra, ACT, Australia.	Sarina.Macfadyen@csiro.au	Macfadyen, Sarina/C-1511-2008; Kriticos, Darren J/A-4170-2008	Macfadyen, Sarina/0000-0003-3553-4910; Kriticos, Darren J/0000-0003-2599-8105	Grains Research and Development Corporation (GRDC)	Grains Research and Development Corporation (GRDC)(Grains R&D Corp)	S.M.'s research is part of the National Invertebrate Pest Initiative (NIPI) and funded by the Grains Research and Development Corporation (GRDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman R.L., 2021, APHIDS WORLDS PLANTS; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Carter Nick, 1994, P129; DEBARRO PJ, 1992, ENTOMOL EXP APPL, V65, P205, DOI 10.1007/BF02343853; DEBARRO PJ, 1993, AUST J ZOOL, V41, P123, DOI 10.1071/ZO9930123; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fabre F, 2006, ECOL MODEL, V193, P457, DOI 10.1016/j.ecolmodel.2005.08.021; FAO, 2006, INT STAND PHYT MEAS; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Foster GN, 2004, PEST MANAG SCI, V60, P113, DOI 10.1002/ps.796; Gilabert A, 2009, MOL ECOL, V18, P3050, DOI 10.1111/j.1365-294X.2009.04250.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halkett F, 2006, J EVOLUTION BIOL, V19, P809, DOI 10.1111/j.1420-9101.2005.01055.x; Halkett F, 2005, MOL ECOL, V14, P325, DOI 10.1111/j.1365-294X.2004.02358.x; Harrington R, 2004, SCI UPDATE, P45; Harrington R, 2003, TURNING HEAT PESTS D, P1195; Hartley S, 2010, ECOGRAPHY, V33, P83, DOI 10.1111/j.1600-0587.2009.06037.x; Honek A, 2006, B ENTOMOL RES, V96, P269, DOI 10.1079/BER2006427; HUGHES R. D., 1964, AUSTRALIAN J ZOOL, V12, P174, DOI 10.1071/ZO9640174; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; LEATHER SR, 1989, B ENTOMOL RES, V79, P345, DOI 10.1017/S0007485300018344; LEATHER SR, 1981, ENTOMOL EXP APPL, V30, P197, DOI 10.1007/BF00300888; Lees AD, 1966, ADV INSECT PHYSL, V3, P207, DOI [DOI 10.1016/S0065-2806(08)60188-5, 10.1016/S0065-2806(08)60188-5]; Lushai G, 1996, ENTOMOL EXP APPL, V81, P113, DOI 10.1007/BF00187845; Maywald G., 2007, DYMEX MODEL BUILDER; Milne WM, 1999, AUST J EXP AGR, V39, P171, DOI 10.1071/EA98074; MURRAY MD, 1987, AUST J ZOOL, V35, P575, DOI 10.1071/ZO9870575; Parry HR, 2006, ECOL MODEL, V199, P451, DOI 10.1016/j.ecolmodel.2006.01.006; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Pinol J, 2009, ECOL MODEL, V220, P2469, DOI 10.1016/j.ecolmodel.2009.06.031; Richards WR, 1960, CAN ENTOMOL S, V13, P5; Rispe C, 1998, J THEOR BIOL, V195, P97, DOI 10.1006/jtbi.1998.0784; ROGERSON JP, 1947, B ENTOMOL RES, V38, P157, DOI 10.1017/S0007485300030261; Sandstrom JP, 2000, J INSECT BEHAV, V13, P815, DOI 10.1023/A:1007806416332; SHELFORD VE, 1963, ECOLOGY N AM; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; STRATHDEE AT, 1995, J INSECT PHYSIOL, V41, P653, DOI 10.1016/0022-1910(95)00029-T; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Thackray DJ, 2009, PLANT PATHOL, V58, P186, DOI 10.1111/j.1365-3059.2008.01950.x; Torikura H., 1991, Annual Report of the Society of Plant Protection of North Japan, P114; Underwood EC, 2004, DIVERS DISTRIB, V10, P447, DOI 10.1111/j.1366-9516.2004.00093.x; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Vitou Janine, 2009, Redia, V92, P237; Voegtlin D.J., 1998, P309; WARD SA, 1984, OECOLOGIA, V62, P230, DOI 10.1007/BF00379018; Watt MS, 2009, FOREST ECOL MANAG, V257, P1505, DOI 10.1016/j.foreco.2008.12.026; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; WILLIAMS JD, 1985, AUST VET J, V62, P367, DOI 10.1111/j.1751-0813.1985.tb14210.x; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805; Yonow T, 2004, ECOL MODEL, V173, P9, DOI 10.1016/S0304-3800(03)00306-5; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x; [No title captured]	57	34	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40313	10.1371/journal.pone.0040313	http://dx.doi.org/10.1371/journal.pone.0040313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808133	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400040
J	Stordal, B; Hamon, M; McEneaney, V; Roche, S; Gillet, JP; O'Leary, JJ; Gottesman, M; Clynes, M				Stordal, Britta; Hamon, Marion; McEneaney, Victoria; Roche, Sandra; Gillet, Jean-Pierre; O'Leary, John J.; Gottesman, Michael; Clynes, Martin			Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein	PLOS ONE			English	Article							ENERGY-DEPENDENT UPTAKE; MULTIDRUG-RESISTANCE; COLLATERAL SENSITIVITY; CROSS-RESISTANCE; MASS-SPECTROMETRY; INDUCED APOPTOSIS; DRUG-SENSITIVITY; IN-VITRO; EXPRESSION; GLUTATHIONE	The IGROVCDDP cisplatin-resistant ovarian cancer cell line is also resistant to paclitaxel and models the resistance phenotype of relapsed ovarian cancer patients after first-line platinum/taxane chemotherapy. A TaqMan low-density array (TLDA) was used to characterise the expression of 380 genes associated with chemotherapy resistance in IGROVCDDP cells. Paclitaxel resistance in IGROVCDDP is mediated by gene and protein overexpression of P-glycoprotein and the protein is functionally active. Cisplatin resistance was not reversed by elacridar, confirming that cisplatin is not a P-glycoprotein substrate. Cisplatin resistance in IGROVCDDP is multifactorial and is mediated in part by the glutathione pathway and decreased accumulation of drug. Total cellular glutathione was not increased. However, the enzyme activity of GSR and GGT1 were up-regulated. The cellular localisation of copper transporter CTR1 changed from membrane associated in IGROV-1 to cytoplasmic in IGROVCDDP. This may mediate the previously reported accumulation defect. There was decreased expression of the sodium potassium pump (ATP1A), MRP1 and FBP which all have been previously associated with platinum accumulation defects in platinum-resistant cell lines. Cellular localisation of MRP1 was also altered in IGROVCDDP shifting basolaterally, compared to IGROV-1. BRCA1 was also up-regulated at the gene and protein level. The overexpression of P-glycoprotein in a resistant model developed with cisplatin is unusual. This demonstrates that P-glycoprotein can be upregulated as a generalised stress response rather than as a specific response to a substrate. Mechanisms characterised in IGROVCDDP cells may be applicable to relapsed ovarian cancer patients treated with frontline platinum/taxane chemotherapy.	[Stordal, Britta; Hamon, Marion; Roche, Sandra; Clynes, Martin] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland; [Stordal, Britta; McEneaney, Victoria; O'Leary, John J.] St James Hosp, Dept Histopathol, Dublin 8, Ireland; [Stordal, Britta; McEneaney, Victoria; O'Leary, John J.] Trinity Coll Dublin, Dublin, Ireland; [Gillet, Jean-Pierre; Gottesman, Michael] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	Dublin City University; Trinity College Dublin; Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stordal, B (corresponding author), Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland.	stordalb@tcd.ie	gillet, jean-pierre/A-3714-2012; gillet, jean-pierre/A-1419-2017; Roche, Sandra/AAM-9800-2021	gillet, jean-pierre/0000-0003-2453-590X; Roche, Sandra/0000-0002-4363-4607; Stordal, Britta/0000-0002-7892-951X; O'Leary, John/0000-0001-7311-9326	Marie Curie International Incoming Fellowship from the European Union FP7 programme; Irish Cancer Society Postdoctoral Fellowship; Travel Fellowship from the European Association of Cancer Research; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research	Marie Curie International Incoming Fellowship from the European Union FP7 programme; Irish Cancer Society Postdoctoral Fellowship; Travel Fellowship from the European Association of Cancer Research; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by a Marie Curie International Incoming Fellowship from the European Union FP7 programme, and an Irish Cancer Society Postdoctoral Fellowship (BS). The collaboration between Britta Stordal and the National Cancer Institute was supported by a Travel Fellowship from the European Association of Cancer Research. This research was also supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (JPG, MG). The funders had no role in study design, data collection and a nalysis, decision to publish, or preparation of the manuscript.	Bates SE, 2004, J PHARMACOL EXP THER, V310, P836, DOI 10.1124/jpet.103.063149; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Callaghan R, 2008, J CLIN PHARMACOL, V48, P365, DOI 10.1177/0091270007311568; CHAUDHARY PM, 1993, J NATL CANCER I, V85, P632, DOI 10.1093/jnci/85.8.632; Cheng LH, 2010, GYNECOL ONCOL, V117, P159, DOI 10.1016/j.ygyno.2010.01.041; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; DeLoia JA, 2011, GYNECOLOGIC ONCOLOGY; DREW R, 1984, BIOCHEM PHARMACOL, V33, P2989, DOI 10.1016/0006-2952(84)90598-7; Gillett JP, 2011, MOL PHARMACEUT, V8, P2080, DOI 10.1021/mp200240a; Gottesman MM, 2009, CANC DRUG DISC DEV, P83, DOI 10.1007/978-1-60327-459-3_11; HAMAGUCHI K, 1993, CANCER RES, V53, P5225; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; HYAFIL F, 1993, CANCER RES, V53, P4595; Ihnat MA, 1997, CLIN CANCER RES, V3, P1339; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Kishimoto S, 2006, CANCER CHEMOTH PHARM, V57, P84, DOI 10.1007/s00280-005-0003-x; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; Le Moguen K, 2006, PROTEOMICS, V6, P5183, DOI 10.1002/pmic.200500925; Lee WK, 2011, TOXICOL SCI, V121, P343, DOI 10.1093/toxsci/kfr071; Lee YY, 2011, PROGNOSTIC VALUE COP, P135; Lewandowicz GM, 2002, CELLULAR GLUTATHIONE; Liang XJ, 2003, CANCER RES, V63, P5909; Locke VL, 1999, BRIT J HAEMATOL, V106, P86, DOI 10.1046/j.1365-2141.1999.01494.x; Ma JG, 1998, CANCER CHEMOTH PHARM, V41, P307, DOI 10.1007/s002800050744; Ma JG, 1998, CANCER CHEMOTH PHARM, V41, P186; MARTIN A, 1993, CYTOTECHNOLOGY, V11, P49, DOI 10.1007/BF00749057; Nakayama K, 2002, COPPER TRANSPORTING; O'Connor R, 2007, CANCER CHEMOTH PHARM, V59, P79, DOI 10.1007/s00280-006-0240-7; Ottone F, 1997, BRIT J CANCER, V76, P77, DOI 10.1038/bjc.1997.339; Parekh H, 1996, CANCER CHEMOTH PHARM, V37, P457, DOI 10.1007/s002800050412; Perego P, 1998, ANN ONCOL, V9, P423, DOI 10.1023/A:1008265012435; Pisano C, 2009, CANCER CHEMOTH PHARM, V64, P1021, DOI 10.1007/s00280-009-0958-0; Poulain L, 1998, INT J CANCER, V78, P454, DOI 10.1002/(SICI)1097-0215(19981109)78:4<454::AID-IJC11>3.0.CO;2-6; Quinn JE, 2003, CANCER RES, V63, P6221; Rahman Q, 1999, CRIT REV TOXICOL, V29, P543, DOI 10.1080/10408449991349276; RICHERT ND, 1988, BIOCHEMISTRY-US, V27, P7607, DOI 10.1021/bi00420a006; Rischin D, 2004, GYNECOL ONCOL, V93, P417, DOI 10.1016/j.ygyno.2004.01.037; Shen DW, 2000, J CELL PHYSIOL, V183, P108, DOI 10.1002/(SICI)1097-4652(200004)183:1<108::AID-JCP13>3.3.CO;2-W; Shen DW, 1998, CANCER RES, V58, P268; SILBER PM, 1986, ANAL BIOCHEM, V158, P68, DOI 10.1016/0003-2697(86)90590-7; Simon R, 2007, CANCER INFORM, V3, P11; Stewart JJ, 2006, MOL CELL PROTEOMICS, V5, P433, DOI 10.1074/mcp.M500140-MCP200; Stordal B, 2007, CANCER TREAT REV, V33, P688, DOI 10.1016/j.ctrv.2007.07.013; Stordal B, 2007, CANCER TREAT REV, V33, P347, DOI 10.1016/j.ctrv.2007.01.009; Stordal B, 2009, CURR CANCER DRUG TAR, V9, P354, DOI 10.2174/156800909788166592; Sun BY, 2007, MOL CELL PROTEOMICS, V6, P141, DOI 10.1074/mcp.T600046-MCP200; SUZUKAKE K, 1982, BIOCHEM PHARMACOL, V31, P121; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Wall R, 2007, TALANTA, V72, P145, DOI 10.1016/j.talanta.2006.10.010; Xu HD, 2005, BIOCHEM BIOPH RES CO, V328, P618, DOI 10.1016/j.bbrc.2005.01.015; Yang H, 2007, CANCER BIOL THER, V6, P942; YANG LY, 1993, INT J CANCER, V53, P478, DOI 10.1002/ijc.2910530321; Yang XW, 1995, ONCOL RES, V7, P619; Zhang XF, 2011, J SURG ONCOL, V104, P466, DOI 10.1002/jso.21958	57	75	77	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40717	10.1371/journal.pone.0040717	http://dx.doi.org/10.1371/journal.pone.0040717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792399	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306362400095
J	Beraneck, M; Bojados, M; Le Seac'h, A; Jamon, M; Vidal, PP				Beraneck, Mathieu; Bojados, Mickael; Le Seac'h, Anne; Jamon, Marc; Vidal, Pierre-Paul			Ontogeny of Mouse Vestibulo-Ocular Reflex Following Genetic or Environmental Alteration of Gravity Sensing	PLOS ONE			English	Article							VESTIBULAR SENSORY EPITHELIUM; OTOCONIA-DEFICIENT MICE; VERTICAL AXIS ROTATION; MACULO-OCULAR REFLEX; EYE-MOVEMENTS; MORPHOLOGICAL PROPERTIES; LINEAR ACCELERATION; SEMICIRCULAR CANALS; LOCOMOTOR CONTROL; CRITICAL PERIOD	The vestibular organs consist of complementary sensors: the semicircular canals detect rotations while the otoliths detect linear accelerations, including the constant pull of gravity. Several fundamental questions remain on how the vestibular system would develop and/or adapt to prolonged changes in gravity such as during long-term space journey. How do vestibular reflexes develop if the appropriate assembly of otoliths and semi-circular canals is perturbed? The aim of present work was to evaluate the role of gravity sensing during ontogeny of the vestibular system. In otoconia-deficient mice (ied), gravity cannot be sensed and therefore maculo-ocular reflexes (MOR) were absent. While canals-related reflexes were present, the ied deficit also led to the abnormal spatial tuning of the horizontal angular canal-related VOR. To identify putative otolith-related critical periods, normal C57Bl/6J mice were subjected to 2G hypergravity by chronic centrifugation during different periods of development or adulthood (Adult-HG) and compared to non-centrifuged (control) C57Bl/6J mice. Mice exposed to hypergravity during development had completely normal vestibulo-ocular reflexes 6 months after end of centrifugation. Adult-HG mice all displayed major abnormalities in maculo-ocular reflexe one month after return to normal gravity. During the next 5 months, adaptation to normal gravity occurred in half of the individuals. In summary, genetic suppression of gravity sensing indicated that otolith-related signals might be necessary to ensure proper functioning of canal-related vestibular reflexes. On the other hand, exposure to hypergravity during development was not sufficient to modify durably motor behaviour. Hence, 2G centrifugation during development revealed no otolith-specific critical period.	[Beraneck, Mathieu; Le Seac'h, Anne; Vidal, Pierre-Paul] Univ Paris 05, CNRS UMR 8194, Paris, France; [Bojados, Mickael; Jamon, Marc] Aix Marseille Univ, INSERM UMR 1106, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Beraneck, M (corresponding author), Univ Paris 05, CNRS UMR 8194, Sorbonne Paris Cite, Paris, France.	mathieu.beraneck@parisdescartes.fr		Beraneck, Mathieu/0000-0003-2722-0532	Centre National d'Etudes Spatiales; Agence Nationale de la Recherche [ANR-09-BLAN-0148]; CNRS PEPS; CNES; regional PACA; Neuro-IC programs	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS PEPS(Centre National de la Recherche Scientifique (CNRS)); CNES(Centre National D'etudes Spatiales); regional PACA; Neuro-IC programs	This work was funded by the Centre National d'Etudes Spatiales, the Agence Nationale de la Recherche (program ANR-09-BLAN-0148), CNRS PEPS and Neuro-IC programs. M. Bojados received fellowship from CNES and the regional PACA.	Alberts J R, 1985, Physiologist, V28, pS81; Andreescu CE, 2005, J NEUROPHYSIOL, V94, P3487, DOI 10.1152/jn.00147.2005; ANGELAKI DE, 1994, J NEUROPHYSIOL, V71, P1222, DOI 10.1152/jn.1994.71.3.1222; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Angelaki DE, 2009, ANN NY ACAD SCI, V1164, P19, DOI 10.1111/j.1749-6632.2009.03939.x; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Beraneck M, 2008, J NEUROPHYSIOL, V100, P945, DOI 10.1152/jn.90319.2008; Beraneck M, 2007, J NEUROPHYSIOL, V98, P1549, DOI 10.1152/jn.00590.2007; Bergstrom RA, 1998, GENETICS, V150, P815; Besson V, 2005, BIOL CELL, V97, P787, DOI 10.1042/BC20040525; Bojados M, 2011, EUROPEAN J IN PRESS; Bouet V, 2004, DEV BRAIN RES, V153, P69, DOI 10.1016/j.devbrainres.2004.03.022; Bouet V, 2004, BEHAV BRAIN RES, V150, P207, DOI 10.1016/S0166-4328(03)00258-4; Bouet V, 2003, BEHAV BRAIN RES, V139, P97, DOI 10.1016/S0166-4328(02)00085-2; Bruce LL, 2006, ADV SPACE RES, V38, P1041, DOI 10.1016/j.asr.2006.03.002; Bruce LL, 2003, ADV SPACE RES-SERIES, V32, P1533, DOI 10.1016/S0273-1177(03)90392-9; BUSH GA, 1993, J NEUROPHYSIOL, V69, P2039, DOI 10.1152/jn.1993.69.6.2039; Calabrese DR, 2006, JARO-J ASSOC RES OTO, V7, P151, DOI 10.1007/s10162-006-0031-1; Chabbert C, 2003, EUR J NEUROSCI, V17, P2497, DOI 10.1046/j.1460-9568.2003.02682.x; Clement G, 1998, BRAIN RES REV, V28, P161, DOI 10.1016/S0165-0173(98)00036-8; DEWAELE C, 1989, EXP BRAIN RES, V77, P166, DOI 10.1007/BF00250579; Eugene D, 2009, ANN NY ACAD SCI, V1164, P180, DOI 10.1111/j.1749-6632.2008.03727.x; Fritzsch B, 2003, ADV SPACE RES-SERIES, V32, P1495, DOI 10.1016/S0273-1177(03)90387-5; Gaboyard S, 2003, DEV BRAIN RES, V143, P15, DOI 10.1016/S0165-3806(03)00069-5; Geisler HC, 1996, BEHAV BRAIN RES, V80, P211, DOI 10.1016/0166-4328(96)00024-1; Geisler HC, 1998, J VESTIBUL RES-EQUIL, V8, P399, DOI 10.1016/S0957-4271(97)00100-6; Glover JC, 2003, J PHYSIOLOGY-PARIS, V97, P17, DOI 10.1016/j.jphysparis.2003.10.003; Green AM, 2003, J NEUROSCI, V23, P9265; HESS BJM, 1990, EUR J NEUROSCI, V2, P909, DOI 10.1111/j.1460-9568.1990.tb00003.x; Hoffman LF, 2006, HEARING RES, V222, P35, DOI 10.1016/j.heares.2006.05.013; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Jamon M, 2011, J INT SOC G IN PRESS; Jamon M, 2009, MICROGRAVITY SCI TEC, V21, P327, DOI 10.1007/s12217-008-9098-0; Jones SM, 2004, HEARING RES, V191, P34, DOI 10.1016/j.heares.2004.01.008; Jones TA, 2008, JARO-J ASSOC RES OTO, V9, P490, DOI 10.1007/s10162-008-0132-0; Jones TA, 1999, HEARING RES, V136, P75, DOI 10.1016/S0378-5955(99)00110-0; Kaufman G, 2005, J VESTIBUL RES-EQUIL, V15, P131; Lambert FM, 2008, J NEUROSCI, V28, P8086, DOI 10.1523/JNEUROSCI.1288-08.2008; Laurens J, 2011, EXP BRAIN RES, V210, P407, DOI 10.1007/s00221-011-2568-4; Maklad A, 2003, BRAIN RES BULL, V60, P497, DOI 10.1016/S0361-9230(03)00054-6; Maruta J, 2001, VISION RES, V41, P3255, DOI 10.1016/S0042-6989(01)00091-8; Moore ST, 2003, J VESTIBUL RES-EQUIL, V13, P377; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Nguon K, 2006, ADV SPACE RES, V38, P1138, DOI 10.1016/j.asr.2006.09.007; Nooij SAE, 2008, EXP BRAIN RES, V190, P165, DOI 10.1007/s00221-008-1460-3; Oman CM, 1996, J APPL PHYSIOL, V81, P69, DOI 10.1152/jappl.1996.81.1.69; Oommen BS, 2008, BRAIN RES, V1193, P57, DOI 10.1016/j.brainres.2007.11.053; Ornitz DM, 1998, HEARING RES, V122, P60, DOI 10.1016/S0378-5955(98)00080-X; Rohregger M, 2003, J NEUROPHYSIOL, V90, P3736, DOI 10.1152/jn.00561.2003; Ronca A E, 1997, J Gravit Physiol, V4, pP63; Ronca AE, 2000, J APPL PHYSIOL, V89, P2318, DOI 10.1152/jappl.2000.89.6.2318; Ronca AE, 2008, BEHAV NEUROSCI, V122, P224, DOI 10.1037/0735-7044.122.1.224; Serova L V, 1993, Physiologist, V36, pS31; Smith M, 2003, DEV BRAIN RES, V140, P133, DOI 10.1016/S0165-3806(02)00591-6; Sondag HNPM, 1997, BRAIN RES BULL, V43, P289, DOI 10.1016/S0361-9230(97)00008-7; Stahl JS, 2008, PROG BRAIN RES, V171, P503, DOI 10.1016/S0079-6123(08)00672-9; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; Straka H, 2002, J NEUROPHYSIOL, V88, P2287, DOI 10.1152/jn.00370.2002; Straka H, 2010, CURR OPIN NEUROBIOL, V20, P689, DOI 10.1016/j.conb.2010.06.003; Uchino Y, 2005, EXP BRAIN RES, V164, P271, DOI 10.1007/s00221-005-2341-7; Uno Y, 2002, J NEUROCHEM, V81, P1308, DOI 10.1046/j.1471-4159.2002.00933.x; van Alphen B, 2010, INVEST OPHTH VIS SCI, V51, P623, DOI 10.1167/iovs.09-4072; Vidal PP, 2004, J PHYSIOL-LONDON, V559, P625, DOI 10.1113/jphysiol.2004.063883; Walton KD, 2005, J PHYSIOL-LONDON, V565, P609, DOI 10.1113/jphysiol.2004.074393; Walton KD, 2005, J PHYSIOL-LONDON, V565, P593, DOI 10.1113/jphysiol.2004.074385; Wong AM, 1997, INTEGR PHYS BEH SCI, V32, P322, DOI 10.1007/BF02688630; Wubbels RJ, 2002, BRAIN RES BULL, V57, P677, DOI 10.1016/S0361-9230(01)00778-X; Wubbels RJ, 2002, BRAIN RES BULL, V58, P575, DOI 10.1016/S0361-9230(02)00828-6; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003; Yoder RM, 2009, J NEUROSCI, V29, P1061, DOI 10.1523/JNEUROSCI.1679-08.2009	71	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40414	10.1371/journal.pone.0040414	http://dx.doi.org/10.1371/journal.pone.0040414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808156	Green Submitted, Green Published, gold			2022-12-27	WOS:000306355500040
J	Santucci, D; Kawano, F; Ohira, T; Terada, M; Nakai, N; Francia, N; Alleva, E; Aloe, L; Ochiai, T; Cancedda, R; Goto, K; Ohira, Y				Santucci, Daniela; Kawano, Fuminori; Ohira, Takashi; Terada, Masahiro; Nakai, Naoya; Francia, Nadia; Alleva, Enrico; Aloe, Luigi; Ochiai, Toshimasa; Cancedda, Ranieri; Goto, Katsumasa; Ohira, Yoshinobu			Evaluation of Gene, Protein and Neurotrophin Expression in the Brain of Mice Exposed to Space Environment for 91 Days	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROTEOMIC ANALYSIS; TRANSGENIC MICE; BINDING-PROTEIN; HYPERGRAVITY; MICROGRAVITY; NGF; STRESS; ALPHA; RATS	Effects of 3-month exposure to microgravity environment on the expression of genes and proteins in mouse brain were studied. Moreover, responses of neurobiological parameters, nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF), were also evaluated in the cerebellum, hippocampus, cortex, and adrenal glands. Spaceflight-related changes in gene and protein expression were observed. Biological processes of the up-regulated genes were related to the immune response, metabolic process, and/or inflammatory response. Changes of cellular components involving in microsome and vesicular fraction were also noted. Molecular function categories were related to various enzyme activities. The biological processes in the down-regulated genes were related to various metabolic and catabolic processes. Cellular components were related to cytoplasm and mitochondrion. The down-regulated molecular functions were related to catalytic and oxidoreductase activities. Up-regulation of 28 proteins was seen following spaceflight vs. those in ground control. These proteins were related to mitochondrial metabolism, synthesis and hydrolysis of ATP, calcium/calmodulin metabolism, nervous system, and transport of proteins and/or amino acids. Down-regulated proteins were related to mitochondrial metabolism. Expression of NGF in hippocampus, cortex, and adrenal gland of wild type animal tended to decrease following spaceflight. As for pleiotrophin transgenic mice, spaceflight-related reduction of NGF occured only in adrenal gland. Consistent trends between various portions of brain and adrenal gland were not observed in the responses of BDNF to spaceflight. Although exposure to real microgravity influenced the expression of a number of genes and proteins in the brain that have been shown to be involved in a wide spectrum of biological function, it is still unclear how the functional properties of brain were influenced by 3-month exposure to microgravity.	[Santucci, Daniela; Francia, Nadia; Alleva, Enrico] Ist Super Sanita, Behav Neurosci Sect, Cellular Biol & Neurosci Dept, I-00161 Rome, Italy; [Kawano, Fuminori; Nakai, Naoya; Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Osaka, Japan; [Ohira, Takashi; Ohira, Yoshinobu] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Terada, Masahiro] Japan Aerosp Explorat Agcy, Ibaraki, Japan; [Aloe, Luigi] CNR, European Brain Res Inst, Inst Neurobiol & Mol Med, Rome, Italy; [Cancedda, Ranieri] Univ Genoa, DOBIG, Genoa, Italy; [Goto, Katsumasa] Toyohashi SOZO Univ, Grad Sch Hlth Sci, Aichi, Japan	Istituto Superiore di Sanita (ISS); Osaka University; Osaka University; Japan Aerospace Exploration Agency (JAXA); Consiglio Nazionale delle Ricerche (CNR); University of Genoa	Santucci, D (corresponding author), Ist Super Sanita, Behav Neurosci Sect, Cellular Biol & Neurosci Dept, Viale Regina Elena 299, I-00161 Rome, Italy.	ohira@space.hss.osaka-u.ac.jp	Goto, Katsumasa/T-6789-2019; Alleva, Enrico/B-1630-2013; Francia, Nadia/N-9174-2017	Goto, Katsumasa/0000-0001-5380-4561; Alleva, Enrico/0000-0002-9633-7657; Francia, Nadia/0000-0003-1888-2403	Italian Space Agency (ASI); Japan Society for the Promotion of Science [S-19100009]	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The central role of the Italian Space Agency (ASI) in planning, organizing logistics, and funding of the MDS mission as well as the tissue sharing program is gratefully acknowledged. The authors thank also NASA for logistic support in Cape Canaveral and Dryden bases. This study, in part, was supported by the Grant-in-Aid for Scientific Research (S-19100009, Y.O., http://www.jsps.go.jp/j-grantsinaid/index.html) from Japan Society for the Promotion of Science. The funders had no roles in study design, data collection and analyses, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALOE L, 1986, P NATL ACAD SCI USA, V83, P6184, DOI 10.1073/pnas.83.16.6184; Aloe L, 2002, PHARMACOL BIOCHEM BE, V73, P159, DOI 10.1016/S0091-3057(02)00757-8; Aloe L, 1999, BRAIN RES, V840, P125, DOI 10.1016/S0006-8993(99)01748-5; Aloe L, 2001, NEUROSCI LETT, V302, P29, DOI 10.1016/S0304-3940(01)01648-2; BRACCILAUDIERO L, 1993, NEUROREPORT, V4, P563, DOI 10.1097/00001756-199305000-00025; Cancedda Ranieri, 2002, J Gravit Physiol, V9, pP337; Cancedda R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032243; Cellerino A, 1998, J NEUROSCI, V18, P3351; Cirulli F, 2009, FRONT NEUROENDOCRIN, V30, P379, DOI 10.1016/j.yfrne.2009.05.002; DAmelio F, 1996, J NEUROSCI RES, V44, P532; Dapp C, 2004, PHYSIOL GENOMICS, V20, P97, DOI 10.1152/physiolgenomics.00100.2004; DeFelipe J, 2002, CEREB CORTEX, V12, P883, DOI 10.1093/cercor/12.8.883; Del Signore A, 2004, EUR J NEUROSCI, V19, P667, DOI 10.1111/j.0953-816X.2004.03171.x; Edgerton VR, 2001, J EXP BIOL, V204, P3217; Flamig G, 2001, NEUROENDOCRINOL LETT, V22, P461; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Francia N, 2004, PHYSIOL BEHAV, V83, P383, DOI 10.1016/j.physbeh.2004.08.011; Frigeri A, 2008, EXP BRAIN RES, V191, P289, DOI 10.1007/s00221-008-1523-5; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Ishihara A, 1997, NEUROSCIENCE, V81, P275, DOI 10.1016/S0306-4522(97)00097-3; Kawano F, 2004, AM J PHYSIOL-REG I, V287, pR76, DOI 10.1152/ajpregu.00694.2003; Kawano F, 2002, NEUROSCIENCE, V114, P1133, DOI 10.1016/S0306-4522(02)00304-4; Kawano F, 2010, J APPL PHYSIOL, V108, P676, DOI 10.1152/japplphysiol.00478.2009; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Leung T, 2002, FEBS LETT, V532, P445, DOI 10.1016/S0014-5793(02)03736-5; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Mandillo S, 2003, NEUROSCI LETT, V336, P147, DOI 10.1016/s0304-3940(02)01282-X; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Nomura S, 2012, NEUROSCI LETT, V509, P76, DOI 10.1016/j.neulet.2011.12.022; Ohira M, 2002, JPN J PHYSIOL, V52, P235, DOI 10.2170/jjphysiol.52.235; Ohira Y, 1999, J APPL PHYSIOL, V87, P1776, DOI 10.1152/jappl.1999.87.5.1776; Oke Y, 2012, JPN J AEROS IN PRESS; Ribotta MGY, 1998, DEV BRAIN RES, V111, P147; Sajdel-Sulkowska EM, 2009, CEREBELLUM, V8, P454, DOI 10.1007/s12311-009-0122-8; Sajdel-Sulkowska EM, 2005, NEUROREPORT, V16, P2037, DOI 10.1097/00001756-200512190-00014; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Santucci D, 2000, NEUROREPORT, V11, P3353, DOI 10.1097/00001756-200010200-00018; Sapolsky RM, 1999, EXP GERONTOL, V34, P721, DOI 10.1016/S0531-5565(99)00047-9; Sarkar P, 2006, J PROTEOME RES, V5, P548, DOI 10.1021/pr050274r; Sarkar P, 2008, NEUROCHEM RES, V33, P2335, DOI 10.1007/s11064-008-9738-1; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schmutz S, 2010, EXP PHYSIOL, V95, P723, DOI 10.1113/expphysiol.2009.051029; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; Temple MD, 2002, NEUROBIOL LEARN MEM, V78, P199, DOI 10.1006/nlme.2001.4049; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WESKAMP G, 1987, J NEUROCHEM, V48, P1779, DOI 10.1111/j.1471-4159.1987.tb05736.x; Wu D W, 2000, Space Med Med Eng (Beijing), V13, P244; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Yasuhara T, 2007, NEUROSCIENCE, V149, P182, DOI 10.1016/j.neuroscience.2007.07.045; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	54	40	44	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40112	10.1371/journal.pone.0040112	http://dx.doi.org/10.1371/journal.pone.0040112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808101	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700026
J	Sokalingam, S; Raghunathan, G; Soundrarajan, N; Lee, SG				Sokalingam, Sriram; Raghunathan, Govindan; Soundrarajan, Nagasundarapandian; Lee, Sun-Gu			A Study on the Effect of Surface Lysine to Arginine Mutagenesis on Protein Stability and Structure Using Green Fluorescent Protein	PLOS ONE			English	Article							SALT BRIDGES; ELECTROSTATIC INTERACTIONS; INDUSTRIAL ENZYMES; HYDROPHOBIC CORE; TRANSITION-STATE; MECHANISM; THERMOSTABILITY; THERMOTOLERANCE; BINDING; SDS	Two positively charged basic amino acids, arginine and lysine, are mostly exposed to protein surface, and play important roles in protein stability by forming electrostatic interactions. In particular, the guanidinium group of arginine allows interactions in three possible directions, which enables arginine to form a larger number of electrostatic interactions compared to lysine. The higher pKa of the basic residue in arginine may also generate more stable ionic interactions than lysine. This paper reports an investigation whether the advantageous properties of arginine over lysine can be utilized to enhance protein stability. A variant of green fluorescent protein (GFP) was created by mutating the maximum possible number of lysine residues on the surface to arginines while retaining the activity. When the stability of the variant was examined under a range of denaturing conditions, the variant was relatively more stable compared to control GFP in the presence of chemical denaturants such as urea, alkaline pH and ionic detergents, but the thermal stability of the protein was not changed. The modeled structure of the variant indicated putative new salt bridges and hydrogen bond interactions that help improve the rigidity of the protein against different chemical denaturants. Structural analyses of the electrostatic interactions also confirmed that the geometric properties of the guanidinium group in arginine had such effects. On the other hand, the altered electrostatic interactions induced by the mutagenesis of surface lysines to arginines adversely affected protein folding, which decreased the productivity of the functional form of the variant. These results suggest that the surface lysine mutagenesis to arginines can be considered one of the parameters in protein stability engineering.	[Sokalingam, Sriram; Raghunathan, Govindan; Soundrarajan, Nagasundarapandian; Lee, Sun-Gu] Pusan Natl Univ, Dept Chem Engn, Pusan, South Korea	Pusan National University	Sokalingam, S (corresponding author), Pusan Natl Univ, Dept Chem Engn, Pusan, South Korea.	sungulee@pusan.ac.kr	Raghunathan, Govindan/T-5299-2019	Raghunathan, Govindan/0000-0002-1456-0768; Soundrarajan, Nagasundarapandian/0000-0001-5239-7992	Basic Science Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2011-0021222]	Basic Science Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0021222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bhuyan AK, 2010, BIOPOLYMERS, V93, P186, DOI 10.1002/bip.21318; BORDERS CL, 1994, PROTEIN SCI, V3, P541; Boyle J., 2005, BIOCH MOL BIOL ED, V33, P74, DOI [10.1002/bmb.2005.494033010419, DOI 10.1002/BMB.2005.494033010419]; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Cormack P., 1996, GENE, V173, P33; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Gitlin I, 2006, J PHYS CHEM B, V110, P2372, DOI 10.1021/jp055699f; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang JR, 2008, HFSP J, V2, P378, DOI 10.2976/1.2976660; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11270, DOI 10.1021/bi00093a002; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; LATTMAN EE, 1993, P NATL ACAD SCI USA, V90, P439, DOI 10.1073/pnas.90.2.439; Makhatadze GI, 2004, J MOL BIOL, V336, P929, DOI 10.1016/j.jmb.2003.12.058; Marrs B, 1999, CURR OPIN MICROBIOL, V2, P241, DOI 10.1016/S1369-5274(99)80042-3; Matsutani M, 2011, BIOCHEM BIOPH RES CO, V409, P120, DOI 10.1016/j.bbrc.2011.04.126; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Nielsen MM, 2007, BIOPHYS J, V92, P3674, DOI 10.1529/biophysj.106.101238; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Otzen DE, 1999, PROTEIN SCI, V8, P1878, DOI 10.1110/ps.8.9.1878; Pavoor TV, 2009, P NATL ACAD SCI USA, V106, P11895, DOI 10.1073/pnas.0902828106; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Strub Caroline, 2004, BMC Biochemistry, V5, P9, DOI 10.1186/1471-2091-5-9; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Tigerstrom A, 2004, BIOCHEMISTRY-US, V43, P12563, DOI 10.1021/bi048926x; Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e; Turunen O, 2002, PROTEIN ENG, V15, P141, DOI 10.1093/protein/15.2.141; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yokota K, 2006, SCI TECHNOL ADV MAT, V7, P255, DOI 10.1016/j.stam.2006.03.003	41	143	150	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40410	10.1371/journal.pone.0040410	http://dx.doi.org/10.1371/journal.pone.0040410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792305	gold, Green Published, Green Submitted			2022-12-27	WOS:000306354700042
J	Barboza, FR; Gomez, J; Lercari, D; Defeo, O				Barboza, Francisco R.; Gomez, Julio; Lercari, Diego; Defeo, Omar			Disentangling Diversity Patterns in Sandy Beaches along Environmental Gradients	PLOS ONE			English	Article							CRAB EMERITA-BRASILIENSIS; DE-LA-PLATA; LIFE-HISTORY; RICHNESS PATTERNS; POPULATIONS; MACROFAUNA; MORPHODYNAMICS; SALINITY; MACROINFAUNA; ADAPTATIONS	Species richness in sandy beaches is strongly affected by concurrent variations in morphodynamics and salinity. However, as in other ecosystems, different groups of species may exhibit contrasting patterns in response to these environmental variables, which would be obscured if only aggregate richness is considered. Deconstructing biodiversity, i.e. considering richness patterns separately for different groups of species according to their taxonomic affiliation, dispersal mode or mobility, could provide a more complete understanding about factors that drive species richness patterns. This study analyzed macroscale variations in species richness at 16 Uruguayan sandy beaches with different morphodynamics, distributed along the estuarine gradient generated by the Rio de la Plata over a 2 year period. Species richness estimates were deconstructed to discriminate among taxonomic groups, supralittoral and intertidal forms, and groups with different feeding habits and development modes. Species richness was lowest at intermediate salinities, increasing towards oceanic and inner estuarine conditions, mainly following the patterns shown for intertidal forms. Moreover, there was a differential tolerance to salinity changes according to the habitat occupied and development mode, which determines the degree of sensitivity of faunal groups to osmotic stress. Generalized (additive and linear) mixed models showed a clear increase of species richness towards dissipative beaches. All taxonomic categories exhibited the same trend, even though responses to grain size and beach slope were less marked for crustaceans and insects than for molluscs or polychaetes. However, supralittoral crustaceans exhibited the opposite trend. Feeding groups decreased from dissipative to reflective systems, deposit feeders being virtually absent in the latter. This deconstructive approach highlights the relevance of life history strategies in structuring communities, highlighting the relative importance that salinity and morphodynamic gradients have on macroscale diversity patterns in sandy beaches.	[Barboza, Francisco R.; Gomez, Julio; Lercari, Diego; Defeo, Omar] Univ Republica, Fac Sci, Dept Ecol & Evolut, UNDECIMAR, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Barboza, FR (corresponding author), Univ Republica, Fac Sci, Dept Ecol & Evolut, UNDECIMAR, Montevideo, Uruguay.	odefeo@dinara.gub.uy	Lercari, Diego/AFZ-1141-2022	Lercari, Diego/0000-0001-7980-2193; Defeo, Omar/0000-0001-8318-528X; Barboza, Francisco Rafael/0000-0002-9100-2962	Fondo Clemente Estable [4034]; Agencia Nacional de Investigacion e Innovacion [INI-X-2010-2-3002]; Global Environmental Facility [GCP URU 030 GFF]; Programa de Desarrollo de las Ciencias Basicas; Pew Charitable Trusts	Fondo Clemente Estable; Agencia Nacional de Investigacion e Innovacion; Global Environmental Facility; Programa de Desarrollo de las Ciencias Basicas; Pew Charitable Trusts	Financial support provided from Fondo Clemente Estable (4034), Agencia Nacional de Investigacion e Innovacion (INI-X-2010-2-3002), Global Environmental Facility (GCP URU 030 GFF), Programa de Desarrollo de las Ciencias Basicas and The Pew Charitable Trusts is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attrill MJ, 2002, J ANIM ECOL, V71, P262, DOI 10.1046/j.1365-2656.2002.00593.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Blamires D, 2008, ACTA OECOL, V33, P97, DOI 10.1016/j.actao.2007.09.006; Brazeiro A, 1999, REV CHIL HIST NAT, V72, P93; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camus PA, 2002, REV CHIL HIST NAT, V75, P793; Cardoso RS, 2004, ESTUAR COAST SHELF S, V61, P559, DOI 10.1016/j.ecss.2004.06.021; Celentano E, 2010, MAR ECOL PROG SER, V398, P193, DOI 10.3354/meps08342; CHARMANTIER G, 1994, MAR ECOL PROG SER, V114, P93, DOI 10.3354/meps114093; Cisneros KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023724; Colombini I, 1996, REV CHIL HIST NAT, V69, P511; Contreras H, 2003, REV CHIL HIST NAT, V76, P543; DEFEO O, 1992, J COASTAL RES, V8, P830; Defeo O, 2003, J MAR BIOL ASSOC UK, V83, P331, DOI 10.1017/S0025315403007161h; Defeo O, 2001, MAR ECOL PROG SER, V212, P159, DOI 10.3354/meps212159; Defeo O, 1997, ESTUAR COAST SHELF S, V45, P453, DOI 10.1006/ecss.1996.0200; Defeo O, 2005, MAR ECOL PROG SER, V293, P143, DOI 10.3354/meps293143; DEFEO O, 1995, MAR ECOL PROG SER, V123, P73, DOI 10.3354/meps123073; Defeo O, 2011, MAR ECOL PROG SER, V433, P29, DOI 10.3354/meps09206; Defeo O, 2003, J COASTAL RES, P352; EMERY KO, 1961, LIMNOL OCEANOGR, V6, P90, DOI 10.4319/lo.1961.6.1.0090; ENDRASS U, 1976, MAR BIOL, V36, P47, DOI 10.1007/BF00388428; Fanini L, 2009, ECOL INDIC, V9, P167, DOI 10.1016/j.ecolind.2008.03.004; Folk R.L., 1974, PETROLOGY SEDIMENTAR; Gomez J, 1999, MAR ECOL PROG SER, V182, P209, DOI 10.3354/meps182209; Gomez J, 2012, ESTUAR COAST SHELF S, V98, P84, DOI 10.1016/j.ecss.2011.12.008; Guerrero RA, 1997, CONT SHELF RES, V17, P727, DOI 10.1016/S0278-4343(96)00061-1; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Herrick JE, 2002, SOIL SCI SOC AM J, V66, P1320, DOI 10.2136/sssaj2002.1320; Herrmann M, 2011, HELGOLAND MAR RES, V65, P285, DOI 10.1007/s10152-010-0222-3; JARAMILLO E, 1995, MAR ECOL PROG SER, V119, P311, DOI 10.3354/meps119311; KLAPOW LA, 1970, J ZOOL, V162, P359; Lercari D, 1999, ESTUAR COAST SHELF S, V49, P457, DOI 10.1006/ecss.1999.0521; Lercari D, 2006, ESTUAR COAST SHELF S, V68, P27, DOI 10.1016/j.ecss.2005.12.017; Lozoya JP, 2006, MAR FRESHWATER RES, V57, P421, DOI 10.1071/MF05067; Marquet PA, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P191; MCARDLE SB, 1992, J COASTAL RES, V8, P398; MCARDLE SB, 1991, MAR ECOL PROG SER, V76, P91, DOI 10.3354/meps076091; MCLACHLAN A, 1981, ESTUAR COAST SHELF S, V13, P11, DOI 10.1016/S0302-3524(81)80102-8; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; McLachlan A, 2006, ECOLOGY SANDY SHORES; McLachlan A., 1993, J COASTAL RES, V15, P27, DOI DOI 10.2307/25735721; McLachlan A, 2013, ENCY BIODIVERSITY, DOI [10.1016/B978-0-12-384720-1.00294-3, DOI 10.1016/B978-0-12-384720-1.00294-3]; McLachlan Anton, 2001, P741; Lozoya JP, 2010, ESTUAR COAST SHELF S, V87, P472, DOI 10.1016/j.ecss.2010.02.005; Remane A., 1934, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V37, P34; Rodil IF, 2004, ESTUAR COAST SHELF S, V61, P37, DOI 10.1016/j.ecss.2004.03.016; Schoeman DS, 2002, J EXP MAR BIOL ECOL, V276, P67, DOI 10.1016/S0022-0981(02)00239-3; Short AD, 1996, REV CHIL HIST NAT, V69, P589; Simionato CG, 2001, GEOPHYS RES LETT, V28, P2641, DOI 10.1029/2000GL012478; Taskey HJ, 1991, INMATURE INSECTS KEN, P708; Terribile LC, 2009, GLOBAL ECOL BIOGEOGR, V18, P123, DOI 10.1111/j.1466-8238.2008.00440.x; Veloso VG, 2001, J MAR BIOL ASSOC UK, V81, P369, DOI 10.1017/S0025315401003976; Wood S., 2011, R PACKAGE VERSION, V0, P1; Zuur Alain F., 2009, P1	55	36	36	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40468	10.1371/journal.pone.0040468	http://dx.doi.org/10.1371/journal.pone.0040468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792340	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800091
J	Cheng, HLM				Cheng, Hai-Ling Margaret			Effect of Hyperoxia and Hypercapnia on Tissue Oxygen and Perfusion Response in the Normal Liver and Kidney	PLOS ONE			English	Article							RENAL BLOOD-FLOW; CARBON-DIOXIDE; RELAXATION-TIMES; RAT MODEL; BOLD-MRI; INHALATION; TUMORS; HEMODYNAMICS; R-2-ASTERISK; VALIDATION	Objective: Inhalation of air with altered levels of oxygen and carbon dioxide to manipulate tissue oxygenation and perfusion has both therapeutic and diagnostic value. These physiological responses can be measured non-invasively with magnetic resonance (MR) relaxation times. However, interpreting MR measurements is not straight-forward in extra-cranial organs where gas challenge studies have only begun to emerge. Inconsistent results have been reported on MR, likely because different organs respond differently. The objective of this study was to elucidate organ-specific physiological responses to gas challenge underlying MR measurements by investigating oxygenation and perfusion changes in the normal liver and kidney cortex. Materials and Methods: Gas challenges (100% O-2, 10% CO2, and carbogen [90% O-2+10% CO2]) interleaved with room air was delivered to rabbits to investigate their effect on tissue oxygenation and perfusion. Real-time fiber-optic measurements of absolute oxygen and relative blood flow were made in the liver and kidney cortex. Results: Only the liver demonstrated a vasodilatory response to CO2. Perfusion changes to other gases were minimal in both organs. Tissue oxygenation measurements showed the liver responding only when CO2 was present and the kidney only when O-2 was present. Conclusion: This study reveals distinct physiological response mechanisms to gas challenge in the liver and kidney. The detailed characterization of organ-specific responses is critical to improving our understanding and interpretation of MR measurements in various body organs, and will help broaden the application of MR for non-invasive studies of gas challenges.	[Cheng, Hai-Ling Margaret] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Cheng, Hai-Ling Margaret] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Cheng, HLM (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	Hai-Ling.Cheng@sickkids.ca	Cheng, Hai-Ling Margaret/E-5551-2011	Cheng, Hai-Ling Margaret/0000-0002-0733-9512	Natural Sciences and Engineering Research Council of Canada [484801]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for the study was provided by the Natural Sciences and Engineering Research Council of Canada (grant no. 484801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi R, 2009, BRIT J CANCER, V100, P644, DOI 10.1038/sj.bjc.6604903; Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Baudelet C, 2004, MAGN RESON IMAGING, V22, P905, DOI 10.1016/j.mri.2004.02.005; Boss A, 2009, NMR BIOMED, V22, P638, DOI 10.1002/nbm.1378; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; DUTTON R, 1976, B EUR PHYSIOPATH RES, V12, P265; Edrei Y, 2011, NEOPLASIA, V13, P244, DOI 10.1593/neo.101354; Flemming B, 2000, J AM SOC NEPHROL, V11, P18, DOI 10.1681/ASN.V11118; Foadoddini M, 2011, EUR J CARDIO-THORAC, V39, P233, DOI 10.1016/j.ejcts.2010.05.036; FUJII H, 1985, JPN CIRC J, V49, P1185, DOI 10.1253/jcj.49.1185; Ganong WF, 1995, DYN BLOOD LYMPH FLOW, V30, P525; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Howe FA, 2001, NMR BIOMED, V14, P497, DOI 10.1002/nbm.716; HUGHES RL, 1979, PFLUG ARCH EUR J PHY, V381, P151, DOI 10.1007/BF00582346; Jones RA, 2002, MAGN RESON MED, V47, P728, DOI 10.1002/mrm.10127; Kaanders JHAM, 2002, LANCET ONCOL, V3, P728, DOI 10.1016/S1470-2045(02)00929-4; Lanzen JL, 1998, INT J RADIAT ONCOL, V42, P855, DOI 10.1016/S0360-3016(98)00312-5; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549, DOI 10.1152/ajpgi.1985.249.5.G549; Liu SY, 2011, MAGN RESON MED, V66, P1722, DOI 10.1002/mrm.22968; Lu J, 2009, NEUROIMAGE, V45, P1126, DOI 10.1016/j.neuroimage.2008.11.037; Mark CI, 2011, NEUROIMAGE, V54, P1102, DOI 10.1016/j.neuroimage.2010.08.070; Meier J, 2005, CLIN PHYSIOL FUNCT I, V25, P158, DOI 10.1111/j.1475-097X.2005.00603.x; MOSELEY ME, 1992, MAGNET RESON MED, V23, P21, DOI 10.1002/mrm.1910230104; Neeman M, 2001, MAGNET RESON MED, V45, P887, DOI 10.1002/mrm.1118; Noseworthy MD, 1999, JMRI-J MAGN RESON IM, V9, P814, DOI 10.1002/(SICI)1522-2586(199906)9:6<814::AID-JMRI8>3.0.CO;2-5; O'Connor JPB, 2007, MAGN RESON MED, V58, P490, DOI 10.1002/mrm.21357; O'Connor JPB, 2009, MAGN RESON MED, V61, P75, DOI 10.1002/mrm.21815; Peschke P, 2003, ADV EXP MED BIOL, V530, P19; Prisman E, 2008, J MAGN RESON IMAGING, V27, P185, DOI 10.1002/jmri.21102; Robinson SP, 2001, MAGN RESON IMAGING, V19, P161, DOI 10.1016/S0730-725X(01)00230-2; ROBINSON SP, 1995, INT J RADIAT ONCOL, V33, P855, DOI 10.1016/0360-3016(95)00072-1; Sharkey RA, 1998, EUR RESPIR J, V12, P653, DOI 10.1183/09031936.98.12030653; STONE JE, 1958, AM J PHYSIOL, V194, P115, DOI 10.1152/ajplegacy.1958.194.1.115; Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134; Thews O, 2002, RADIOTHER ONCOL, V62, P77, DOI 10.1016/S0167-8140(01)00401-7; Uematsu H, 2007, J COMPUT ASSIST TOMO, V31, P662, DOI 10.1097/rct.0b013e3180319114; Winter JD, 2011, ACAD RADIOL, V18, P1159, DOI 10.1016/j.acra.2011.04.016; Wise RG, 2007, J CEREBR BLOOD F MET, V27, P1521, DOI 10.1038/sj.jcbfm.9600465	40	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40485	10.1371/journal.pone.0040485	http://dx.doi.org/10.1371/journal.pone.0040485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792349	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800096
J	Enomoto, M; Kawazu, S; Kawai, S; Furuyama, W; Ikegami, T; Watanabe, J; Mikoshiba, K				Enomoto, Masahiro; Kawazu, Shin-ichiro; Kawai, Satoru; Furuyama, Wakako; Ikegami, Tohru; Watanabe, Jun-ichi; Mikoshiba, Katsuhiko			Blockage of Spontaneous Ca2+ Oscillation Causes Cell Death in Intraerythrocitic Plasmodium falciparum	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; MALARIA PARASITES; CONTINUOUS-CULTURE; TOXOPLASMA-GONDII; APICOMPLEXAN PARASITES; HOST-CELLS; INVASION; MELATONIN; ERYTHROCYTE	Malaria remains one of the world's most important infectious diseases and is responsible for enormous mortality and morbidity. Resistance to antimalarial drugs is a challenging problem in malaria control. Clinical malaria is associated with the proliferation and development of Plasmodium parasites in human erythrocytes. Especially, the development into the mature forms (trophozoite and schizont) of Plasmodium falciparum (P. falciparum) causes severe malaria symptoms due to a distinctive property, sequestration which is not shared by any other human malaria. Ca2+ is well known to be a highly versatile intracellular messenger that regulates many different cellular processes. Cytosolic Ca2+ increases evoked by extracellular stimuli are often observed in the form of oscillating Ca2+ spikes (Ca2+ oscillation) in eukaryotic cells. However, in lower eukaryotic and plant cells the physiological roles and the molecular mechanisms of Ca2+ oscillation are poorly understood. Here, we showed the observation of the inositol 1,4,5-trisphospate (IP3)-dependent spontaneous Ca2+ oscillation in P. falciparum without any exogenous extracellular stimulation by using live cell fluorescence Ca2+ imaging. Intraerythrocytic P. falciparum exhibited stage-specific Ca2+ oscillations in ring form and trophozoite stages which were blocked by IP3 receptor inhibitor, 2-aminoethyl diphenylborinate (2-APB). Analyses of parasitaemia and parasite size and electron micrograph of 2-APB-treated P. falciparum revealed that 2-APB severely obstructed the intraerythrocytic maturation, resulting in cell death of the parasites. Furthermore, we confirmed the similar lethal effect of 2-APB on the chloroquine-resistant strain of P. falciparum. To our best knowledge, we for the first time showed the existence of the spontaneous Ca2+ oscillation in Plasmodium species and clearly demonstrated that IP3-dependent spontaneous Ca2+ oscillation in P. falciparum is critical for the development of the blood stage of the parasites. Our results provide a novel concept that IP3/Ca2+ signaling pathway in the intraerythrocytic malaria parasites is a promising target for antimalarial drug development.	[Enomoto, Masahiro; Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Kawazu, Shin-ichiro; Furuyama, Wakako] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Kawai, Satoru] Dokkyo Med Univ, Lab Trop Med & Parasitol, Mibu, Tochigi, Japan; [Ikegami, Tohru; Watanabe, Jun-ichi] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Saitama, Japan	RIKEN; Obihiro University of Agriculture & Veterinary Medicine; Dokkyo Medical University; University of Tokyo; Japan Science & Technology Agency (JST)	Enomoto, M (corresponding author), Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON, Canada.	mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015; Enomoto, Masahiro/L-2209-2019	furuyama, wakako/0000-0001-7163-6960; Enomoto, Masahiro/0000-0002-9411-2999	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [2022007]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants to K.M. from the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology of Japan (2022007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2011, J BIOL CHEM, V286, P5905, DOI 10.1074/jbc.M110.188474; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Beraldo FH, 2007, J PINEAL RES, V43, P360, DOI 10.1111/j.1600-079X.2007.00486.x; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Biagini GA, 2003, J BIOL CHEM, V278, P27910, DOI 10.1074/jbc.M304193200; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL; Bilmen JG, 2002, CELL SIGNAL, V14, P955, DOI 10.1016/S0898-6568(02)00042-6; Bola B, 2009, BIOCHEM SOC T, V37, P961, DOI 10.1042/BST0370961; BROCKELMAN CR, 1982, J PROTOZOOL, V29, P454, DOI 10.1111/j.1550-7408.1982.tb05432.x; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Ch'ng JH, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.97; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Gratraud P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006889; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hotta CT, 2003, BRAZ J MED BIOL RES, V36, P1583, DOI 10.1590/S0100-879X2003001100016; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; Inselburg J, 1983, STAGE SPECIFIC INHIB; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; KAUSHAL DC, 1980, NATURE, V286, P490, DOI 10.1038/286490a0; Kawai S, 1996, AM J TROP MED HYG, V55, P223, DOI 10.4269/ajtmh.1996.55.223; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; MAENO Y, 1993, AM J TROP MED HYG, V49, P485, DOI 10.4269/ajtmh.1993.49.485; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Moreno SNJ, 2011, ESSAYS BIOCHEM, V51, P97, DOI [10.1042/BSE0510097, 10.1042/bse0510097]; Mouray E, 2007, BIOCHIMIE, V89, P337, DOI 10.1016/j.biochi.2006.11.001; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nagamune Kisaburo, 2008, V47, P70; Nagata T, 2004, MOL BIOL EVOL, V21, P1855, DOI 10.1093/molbev/msh197; Passos APD, 1997, BIOCHEM MOL BIOL INT, V42, P919; READ LK, 1991, J PARASITOL, V77, P346, DOI 10.2307/3283117; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Talman AM, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-24; TRAGER W, 1989, J PROTOZOOL, V36, P451; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Schalkwyk DA, 2010, BIOCHEM PHARMACOL, V79, P1291, DOI 10.1016/j.bcp.2009.12.025; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; WHO, 2011, WORLD MALARIA REPORT 2011, P1	55	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39499	10.1371/journal.pone.0039499	http://dx.doi.org/10.1371/journal.pone.0039499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792177	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800014
J	Heikkila, K; Nyberg, ST; Fransson, EI; Alfredsson, L; De Bacquer, D; Bjorner, JB; Bonenfant, S; Borritz, M; Burr, H; Clays, E; Casini, A; Dragano, N; Erbel, R; Geuskens, GA; Goldberg, M; Hooftman, WE; Houtman, IL; Joensuu, M; Jockel, KH; Kittel, F; Knutsson, A; Koskenvuo, M; Koskinen, A; Kouvonen, A; Leineweber, C; Lunau, T; Madsen, IEH; Hanson, LLM; Marmot, MG; Nielsen, ML; Nordin, M; Pentti, J; Salo, P; Rugulies, R; Steptoe, A; Siegrist, J; Suominen, S; Vahtera, J; Virtanen, M; Vaananen, A; Westerholm, P; Westerlund, H; Zins, M; Theorell, T; Hamer, M; Ferrie, JE; Singh-Manoux, A; Batty, GD; Kivimaki, M				Heikkila, Katriina; Nyberg, Solja T.; Fransson, Eleonor I.; Alfredsson, Lars; De Bacquer, Dirk; Bjorner, Jakob B.; Bonenfant, Sebastien; Borritz, Marianne; Burr, Hermann; Clays, Els; Casini, Annalisa; Dragano, Nico; Erbel, Raimund; Geuskens, Goedele A.; Goldberg, Marcel; Hooftman, Wendela E.; Houtman, Irene L.; Joensuu, Matti; Joeckel, Karl-Heinz; Kittel, France; Knutsson, Anders; Koskenvuo, Markku; Koskinen, Aki; Kouvonen, Anne; Leineweber, Constanze; Lunau, Thorsten; Madsen, Ida E. H.; Hanson, Linda L. Magnusson; Marmot, Michael G.; Nielsen, Martin L.; Nordin, Maria; Pentti, Jaana; Salo, Paula; Rugulies, Reiner; Steptoe, Andrew; Siegrist, Johannes; Suominen, Sakari; Vahtera, Jussi; Virtanen, Marianna; Vaananen, Ari; Westerholm, Peter; Westerlund, Hugo; Zins, Marie; Theorell, Tores; Hamer, Mark; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Kivimaki, Mika		IPD-Work Consortium	Job Strain and Alcohol Intake: A Collaborative Meta-Analysis of Individual-Participant Data from 140 000 Men and Women	PLOS ONE			English	Article							PATIENT DATA; WORK STRESS; HEALTH; RISK; CONSUMPTION; DRINKING; TRIALS	Background: The relationship between work-related stress and alcohol intake is uncertain. In order to add to the thus far inconsistent evidence from relatively small studies, we conducted individual-participant meta-analyses of the association between work-related stress (operationalised as self-reported job strain) and alcohol intake. Methodology and Principal Findings: We analysed cross-sectional data from 12 European studies (n = 142 140) and longitudinal data from four studies (n = 48 646). Job strain and alcohol intake were self-reported. Job strain was analysed as a binary variable (strain vs. no strain). Alcohol intake was harmonised into the following categories: none, moderate (women: 1-14, men: 1-21 drinks/week), intermediate (women: 15-20, men: 22-27 drinks/week) and heavy (women: > 20, men: > 27 drinks/week). Cross-sectional associations were modelled using logistic regression and the results pooled in random effects meta-analyses. Longitudinal associations were examined using mixed effects logistic and modified Poisson regression. Compared to moderate drinkers, non-drinkers and (random effects odds ratio (OR): 1.10, 95% CI: 1.05, 1.14) and heavy drinkers (OR: 1.12, 95% CI: 1.00, 1.26) had higher odds of job strain. Intermediate drinkers, on the other hand, had lower odds of job strain (OR: 0.92, 95% CI: 0.86, 0.99). We found no clear evidence for longitudinal associations between job strain and alcohol intake. Conclusions: Our findings suggest that compared to moderate drinkers, non-drinkers and heavy drinkers are more likely and intermediate drinkers less likely to report work-related stress.	[Heikkila, Katriina; Nyberg, Solja T.; Joensuu, Matti; Koskinen, Aki; Virtanen, Marianna; Vaananen, Ari; Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Fransson, Eleonor I.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [De Bacquer, Dirk; Clays, Els] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Bjorner, Jakob B.; Madsen, Ida E. H.; Rugulies, Reiner] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie; Singh-Manoux, Archana] Ctr Res Epidemiol & Populat Hlth, Inserm U1018, Villejuif, France; [Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie] Versailles St Quentin Univ, Versailles, France; [Borritz, Marianne] Bispebjerg Hosp, Dept Occupat Med, Copenhagen, Denmark; [Burr, Hermann] Ctr Maritime Hlth & Safety, Esbjerg, Denmark; [Casini, Annalisa; Kittel, France] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Dragano, Nico; Joeckel, Karl-Heinz; Lunau, Thorsten] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Erbel, Raimund] Univ Duisburg Essen, West German Heart Ctr Essen, Dept Cardiol, Essen, Germany; [Geuskens, Goedele A.; Hooftman, Wendela E.; Houtman, Irene L.] TNO, Hoofddorp, Netherlands; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Koskenvuo, Markku] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kouvonen, Anne] Wroclaw Fac, Warsaw Sch Social Sci & Humanities, Wroclaw, Poland; [Leineweber, Constanze; Hanson, Linda L. Magnusson; Westerlund, Hugo; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Marmot, Michael G.; Steptoe, Andrew; Westerlund, Hugo; Hamer, Mark; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Nielsen, Martin L.] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Nordin, Maria] Umea Univ, Dept Publ Hlth & Clin Med Occupat & Environm Med, Umea, Sweden; [Pentti, Jaana; Salo, Paula; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Siegrist, Johannes] Univ Dusseldorf, Dept Med Sociol, D-40225 Dusseldorf, Germany; [Suominen, Sakari] Folkhalsan Res Ctr, Helsinki, Finland; [Suominen, Sakari; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; [Westerholm, Peter] Uppsala Univ, Uppsala, Sweden; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England	Finnish Institute of Occupational Health; Karolinska Institutet; Jonkoping University; Ghent University; National Research Centre for the Working Environment; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Bispebjerg Hospital; Universite Libre de Bruxelles; University of Duisburg Essen; University of Duisburg Essen; Netherlands Organization Applied Science Research; Mid-Sweden University; University of Helsinki; SWPS University of Social Sciences & Humanities; Stockholm University; University of London; University College London; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Umea University; Finnish Institute of Occupational Health; University of Copenhagen; University of Copenhagen; Heinrich Heine University Dusseldorf; Folkhalsan Research Center; University of Turku; University of Turku; Uppsala University; University of Bristol	Heikkila, K (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	katriina.heikkila@ttl.fi	Westerlund, Hugo/A-3049-2012; Marmot, M G/Y-3920-2019; Leineweber, Constanze/G-7052-2012; Vahtera, Jussi/J-3271-2013; Steptoe, Andrew/Y-2440-2019; Leineweber, Constanze/Z-1330-2019; Goldberg, Marcel/I-7834-2012; Salo, Paula/D-6649-2013; Zins, Marie/AAX-6551-2021; Kivimaki, Mika/B-3607-2012; Hamer, Mark/AAJ-6814-2021; Ferrie, Jane/AAZ-2009-2020; Batty, GD/Y-4401-2018; Casini, Annalisa/ABG-2250-2020; Alfredsson, Lars/AAC-9007-2019; De Bacquer, Dirk/HGU-3191-2022; Hamer, Mark/C-1602-2008; Singh-Manoux, Archana/F-6804-2013; Hanson, Linda L Magnusson/D-2435-2017; Nielsen, Martin Lindhardt/E-3071-2012; Rugulies, Reiner/E-8140-2010; Siegrist, Johannes/AAL-6814-2021; Fransson, Eleonor I/J-7792-2013	Westerlund, Hugo/0000-0002-8806-5698; Marmot, M G/0000-0002-2431-6419; Leineweber, Constanze/0000-0001-8433-2405; Goldberg, Marcel/0000-0002-6161-5880; Salo, Paula/0000-0002-0812-277X; Kivimaki, Mika/0000-0002-4699-5627; Hamer, Mark/0000-0002-8726-7992; Batty, GD/0000-0003-1822-5753; Casini, Annalisa/0000-0002-3539-4500; Alfredsson, Lars/0000-0003-1688-6697; Hamer, Mark/0000-0002-8726-7992; Singh-Manoux, Archana/0000-0002-1244-5037; Hanson, Linda L Magnusson/0000-0002-2908-1903; Nielsen, Martin Lindhardt/0000-0002-1523-0453; Rugulies, Reiner/0000-0002-7752-131X; Siegrist, Johannes/0000-0002-7530-4178; Fransson, Eleonor I/0000-0001-9042-4832; De Bacquer, Dirk/0000-0002-3202-7238; Suominen, Sakari B./0000-0001-6648-603X; Madsen, Ida/0000-0003-3635-3900; Vahtera, Jussi/0000-0002-6036-061X; Clays, Els/0000-0002-1092-945X; Heikkila, Katriina/0000-0001-6269-6881; Theorell, Tores/0000-0003-1956-7931; Burr, Hermann/0000-0002-3864-6347; Kouvonen, Anne/0000-0001-6997-8312; Steptoe, Andrew/0000-0001-7808-4943	EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund, Denmark; Academy of Finland [132944]; BUPA Foundation [22094477]; Heinz Nixdorf Foundation, Germany; German Ministry of Education and Science (BMBF); German Research Foundation (DFG); German Social Accident Insurance (DGUV); Ministry of Social Affairs and Employment, The Netherlands; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G8802774, G19/35, G0902037] Funding Source: researchfish	EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund, Denmark; Academy of Finland(Academy of Finland); BUPA Foundation; Heinz Nixdorf Foundation, Germany; German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Social Accident Insurance (DGUV); Ministry of Social Affairs and Employment, The Netherlands(Netherlands Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The IPD-Work Consortium is supported by the EU New OSH ERA research programme (funded by the Finnish Work Environment Fund, Finland, the Swedish Research Council for Working Life and Social Research, Sweden, the German Social Accident Insurance, Germany, the Danish Work Environment Research Fund, Denmark), the Academy of Finland (grant #132944), and the BUPA Foundation (grant 22094477). The HNR was funded by the Heinz Nixdorf Foundation, Germany, German Ministry of Education and Science (BMBF) and the German Research Foundation (DFG). The German Social Accident Insurance (DGUV) supports analyses in the frame of the OSH ERA project. POLS was funded by the Ministry of Social Affairs and Employment, The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SUBST AB FACTS ALC; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Batty GD, 2009, J PUBLIC HEALTH-UK, V31, P360, DOI 10.1093/pubmed/fdp063; Blomeyer D, 2008, BIOL PSYCHIAT, V63, P146, DOI 10.1016/j.biopsych.2007.04.026; CONGER JJ, 1956, Q J STUD ALCOHOL, V17, P296; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Fransson EI, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-62; Frone MR, 1999, ALCOHOL RES HEALTH, V23, P284; Head J, 2004, OCCUP ENVIRON MED, V61, P219, DOI 10.1136/oem.2002.005256; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; International Center for Alcohol Policies, 2010, INT DRINK GUID; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Kouvonen A, 2005, J OCCUP ENVIRON MED, V47, P503, DOI 10.1097/01.jom.0000161734.81375.25; Lallukka T, 2008, SOC SCI MED, V66, P1681, DOI 10.1016/j.socscimed.2007.12.027; MCCRAE RR, 1990, STRESS MEDICINE, V6, P237, DOI 10.1002/smi.2460060309; National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV; Nyberg ST, 2011, J INTERN MED; Paterniti S, 2002, BRIT J PSYCHIAT, V181, P111; POHORECKY LA, 1991, ALCOHOL CLIN EXP RES, V15, P438, DOI 10.1111/j.1530-0277.1991.tb00543.x; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Riley RD, 2010, INT J EPIDEMIOL, V39, P1359, DOI 10.1093/ije/dyq129; Roche AM, 2008, ADDICTION, V103, P738, DOI 10.1111/j.1360-0443.2008.02154.x; Salo P, 2011, USING REPEATED MEASU; Siegrist J, 2006, SCAND J WORK ENV HEA, V32, P473, DOI 10.5271/sjweh.1052; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Simpura J, 2001, TRENDS DRINKING PATT; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Vinjar B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006687.pub2; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	38	72	74	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40101	10.1371/journal.pone.0040101	http://dx.doi.org/10.1371/journal.pone.0040101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792218	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306461800038
J	Marcelli, A; Abbruzzetti, S; Bustamante, JP; Feis, A; Bonamore, A; Boffi, A; Gellini, C; Salvi, PR; Estrin, DA; Bruno, S; Viappiani, C; Foggi, P				Marcelli, Agnese; Abbruzzetti, Stefania; Pablo Bustamante, Juan; Feis, Alessandro; Bonamore, Alessandra; Boffi, Alberto; Gellini, Cristina; Salvi, Pier Remigio; Estrin, Dario A.; Bruno, Stefano; Viappiani, Cristiano; Foggi, Paolo			Following Ligand Migration Pathways from Picoseconds to Milliseconds in Type II Truncated Hemoglobin from Thermobifida fusca	PLOS ONE			English	Article							TIME-RESOLVED THERMODYNAMICS; MYCOBACTERIUM-TUBERCULOSIS; HEME-PROTEINS; PHOTOACOUSTIC CALORIMETRY; VIBRATIONAL-RELAXATION; HORSE CARBOXYMYOGLOBIN; PHOTOINDUCED PROCESSES; STRUCTURAL DYNAMICS; ULTRAFAST DYNAMICS; BINDING-PROPERTIES	CO recombination kinetics has been investigated in the type II truncated hemoglobin from Thermobifida fusca (Tf-trHb) over more than 10 time decades (from 1 ps to similar to 100 ms) by combining femtosecond transient absorption, nanosecond laser flash photolysis and optoacoustic spectroscopy. Photolysis is followed by a rapid geminate recombination with a time constant of similar to 2 ns representing almost 60% of the overall reaction. An additional, small amplitude geminate recombination was identified at similar to 100 ns. Finally, CO pressure dependent measurements brought out the presence of two transient species in the second order rebinding phase, with time constants ranging from similar to 3 to similar to 100 ms. The available experimental evidence suggests that the two transients are due to the presence of two conformations which do not interconvert within the time frame of the experiment. Computational studies revealed that the plasticity of protein structure is able to define a branched pathway connecting the ligand binding site and the solvent. This allowed to build a kinetic model capable of describing the complete time course of the CO rebinding kinetics to Tf-trHb.	[Marcelli, Agnese; Foggi, Paolo] LENS, European Lab Nonlinear Spect, Florence, Italy; [Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dept Phys, I-43100 Parma, Italy; [Pablo Bustamante, Juan; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, INQUIMAE CONICET, Buenos Aires, DF, Argentina; [Feis, Alessandro; Gellini, Cristina; Salvi, Pier Remigio] Univ Florence, Dept Chem Ugo Schiff, Florence, Italy; [Bonamore, Alessandra; Boffi, Alberto] Univ Roma La Sapienza, Dept Biochem Sci, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Bruno, Stefano] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Foggi, Paolo] Univ Perugia, Dept Chem, I-06100 Perugia, Italy; [Foggi, Paolo] INO CNR, Florence, Italy	University of Parma; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Florence; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Parma; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR)	Marcelli, A (corresponding author), LENS, European Lab Nonlinear Spect, Florence, Italy.	marcelli@lens.unifi.it	Salvi, Pier Remigio/ABE-1408-2020; Foggi, Paolo/M-4596-2014; Bruno, Stefano/A-4582-2011; Viappiani, Cristiano/AAC-7579-2019; Feis, Alessandro/J-1724-2014; Bonamore, Alessandra/AAB-2587-2019; abbruzzetti, stefania/M-8640-2015; abbruzzetti, stefania/AAE-5518-2020; Foggi, Paolo/C-4532-2013; Estrin, Dario/AAY-7549-2020	Foggi, Paolo/0000-0002-2985-6721; Bruno, Stefano/0000-0002-7890-2472; Viappiani, Cristiano/0000-0001-7470-4770; Feis, Alessandro/0000-0003-3469-0647; Bonamore, Alessandra/0000-0002-3940-4657; abbruzzetti, stefania/0000-0001-7685-8554; abbruzzetti, stefania/0000-0001-7685-8554; Foggi, Paolo/0000-0002-2985-6721; Estrin, Dario/0000-0002-5006-7225; Bustamante, Juan/0000-0001-6546-2562	Regione Toscana under the project EPHODS	Regione Toscana under the project EPHODS	The authors acknowledge the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2008, 2008BFJ34R, Azioni Integrate Italia Spagna 2009, IT10L1M59M, and FIRB 2008 to Alessandra Bonamore), Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 2011-2013) and Istituto Pasteur Fondazione Cenci Bolognetti. One of the authors, A.M., wishes to acknowledge the grant financial support by Regione Toscana under the project EPHODS (POR FSE 2007-2013 obiettivo 2 Asse IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2005, J AM CHEM SOC, V127, P9865, DOI 10.1021/ja051702x; Abbruzzetti S, 2006, PHOTOCH PHOTOBIO SCI, V5, P1109, DOI 10.1039/b610236k; Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; Angeloni L, 2003, PHOTOCH PHOTOBIO SCI, V2, P730, DOI 10.1039/b301756g; ANSARI A, 1994, BIOCHEMISTRY-US, V33, P5128, DOI 10.1021/bi00183a017; Belogortseva N, 2007, J INORG BIOCHEM, V101, P977, DOI 10.1016/j.jinorgbio.2007.03.009; Benabbas A, 2010, J AM CHEM SOC, V132, P2811, DOI 10.1021/ja910005b; Bikiel DE, 2006, PHYS CHEM CHEM PHYS, V8, P5611, DOI 10.1039/b611741b; Boechi L, 2008, PROTEINS, V73, P372, DOI 10.1002/prot.22072; Boechi L, 2010, PROTEINS, V78, P962, DOI 10.1002/prot.22620; Bonamore A, 2005, FEBS J, V272, P4189, DOI 10.1111/j.1742-4658.2005.04831.x; BRASLAVSKY SE, 1992, CHEM REV, V92, P1381, DOI 10.1021/cr00014a007; Bruno S, 2007, J AM CHEM SOC, V129, P2880, DOI 10.1021/ja066638d; CALLIS JB, 1972, BIOCHIM BIOPHYS ACTA, V267, P348, DOI 10.1016/0005-2728(72)90122-3; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; Crespo A, 2005, J AM CHEM SOC, V127, P4433, DOI 10.1021/ja0450004; DIXON DW, 1985, J AM CHEM SOC, V107, P808, DOI 10.1021/ja00290a012; Droghetti E, 2010, BIOCHEMISTRY-US, V49, P10394, DOI 10.1021/bi101452k; Dunietz BD, 2003, J PHYS CHEM B, V107, P5623, DOI 10.1021/jp0226376; Feis A, 2001, J PHYS CHEM B, V105, P2638, DOI 10.1021/jp002639v; Feis A, 2008, BIOCHEMISTRY-US, V47, P902, DOI 10.1021/bi701297f; Foggi P, 2003, J PHYS CHEM A, V107, P1689, DOI 10.1021/jp021313e; Forti F, 2011, J COMPUT CHEM, V32, P2219, DOI 10.1002/jcc.21805; FRANZEN S, 1995, BIOCHEMISTRY-US, V34, P1224, DOI 10.1021/bi00004a016; Franzen S, 2001, BIOPHYS J, V80, P2372, DOI 10.1016/S0006-3495(01)76207-8; Frey AD, 2005, TRENDS BIOTECHNOL, V23, P69, DOI 10.1016/j.tibtech.2004.12.002; Gensch T, 2003, PHOTOCH PHOTOBIO SCI, V2, P699, DOI 10.1039/b303177b; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; GROGAN TG, 1994, J PHYS CHEM-US, V98, P13791, DOI 10.1021/j100102a053; Guallar V, 2009, J BIOL CHEM, V284, P3106, DOI 10.1074/jbc.M806183200; HAGEN SJ, 1995, SCIENCE, V269, P959, DOI 10.1126/science.7638618; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Ilari A, 2007, ARCH BIOCHEM BIOPHYS, V457, P85, DOI 10.1016/j.abb.2006.09.033; Jasaitis A, 2012, CHEM PHYS, V396, P10, DOI 10.1016/j.chemphys.2011.04.003; JONES CM, 1992, BIOCHEMISTRY-US, V31, P6692, DOI 10.1021/bi00144a008; Kholodenko Y, 2000, CHEM PHYS, V259, P71, DOI 10.1016/S0301-0104(00)00182-8; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Larsen RW, 2007, COORDIN CHEM REV, V251, P1101, DOI 10.1016/j.ccr.2006.08.018; Lim MH, 1997, J BIOL INORG CHEM, V2, P531, DOI 10.1007/s007750050167; Lim MH, 1996, J PHYS CHEM-US, V100, P12043, DOI 10.1021/jp9536458; Marcelli A, 2008, J PHYS CHEM A, V112, P1864, DOI 10.1021/jp710132s; Marti MA, 2008, METHOD ENZYMOL, V437, P477, DOI 10.1016/S0076-6879(07)37024-9; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; MARTIN JL, 1992, ANNU REV BIOPH BIOM, V21, P199, DOI 10.1146/annurev.bb.21.060192.001215; MARTIN JL, 1983, P NATL ACAD SCI-BIOL, V80, P173, DOI 10.1073/pnas.80.1.173; Miksovska J, 2003, J BIOL INORG CHEM, V8, P621, DOI 10.1007/s00775-003-0457-4; MILLER RJD, 1991, ANNU REV PHYS CHEM, V42, P581, DOI 10.1146/annurev.physchem.42.1.581; Mizutani Y, 1997, SCIENCE, V278, P443, DOI 10.1126/science.278.5337.443; Nicoletti FP, 2011, J AM CHEM SOC, V133, P20970, DOI 10.1021/ja209312k; Nicoletti FP, 2010, BIOCHEMISTRY-US, V49, P2269, DOI 10.1021/bi901671d; NORRIS CL, 1993, BIOPHYS J, V65, P1660, DOI 10.1016/S0006-3495(93)81223-2; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellet H, 2007, J BIOL CHEM, V282, P7491, DOI 10.1074/jbc.M609155200; PETERS KS, 1988, SCIENCE, V241, P1053, DOI 10.1126/science.3045967; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; PROJAHN HD, 1991, INORG CHEM, V30, P3288, DOI 10.1021/ic00017a014; RODRIGUEZ J, 1989, J AM CHEM SOC, V111, P6500, DOI 10.1021/ja00199a004; RODRIGUEZ J, 1991, J CHEM PHYS, V94, P6020, DOI 10.1063/1.460439; RUDZKI JE, 1985, J AM CHEM SOC, V107, P7849, DOI 10.1021/ja00312a007; Sakakura M, 2001, J AM CHEM SOC, V123, P4286, DOI 10.1021/ja9944655; Sakakura M, 2001, J PHYS CHEM B, V105, P10424, DOI 10.1021/jp0116252; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; SHANK CV, 1976, SCIENCE, V193, P50, DOI 10.1126/science.935853; Silkstone G, 2005, DALTON T, P3489, DOI 10.1039/b508183c; SMALL JR, 1992, BIOPHYS CHEM, V42, P29, DOI 10.1016/0301-4622(92)80005-P; Small JR, 1992, NUMERICAL COMPUTER M, V210; Sottini S, 2005, J PHYS CHEM B, V109, P19523, DOI 10.1021/jp0540981; Sottini S, 2005, J PHYS CHEM B, V109, P11411, DOI 10.1021/jp0514224; Steinbach PJ, 2002, J CHEM INF COMP SCI, V42, P1476, DOI 10.1021/ci025551i; Steinbach PJ, 2002, BIOPHYS J, V82, P2244, DOI 10.1016/S0006-3495(02)75570-7; Vetromile CM, 2011, BBA-PROTEINS PROTEOM, V1814, P1065, DOI 10.1016/j.bbapap.2011.01.009; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Vos MH, 1999, BBA-BIOENERGETICS, V1411, P1, DOI 10.1016/S0005-2728(99)00035-3; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n; Ye XO, 2003, J PHYS CHEM A, V107, P8156, DOI 10.1021/jp0276799	82	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39884	10.1371/journal.pone.0039884	http://dx.doi.org/10.1371/journal.pone.0039884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792194	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800024
J	Petrocelli, S; Tondo, ML; Daurelio, LD; Orellano, EG				Petrocelli, Silvana; Laura Tondo, Maria; Daurelio, Lucas D.; Orellano, Elena G.			Modifications of Xanthomonas axonopodis pv. citri Lipopolysaccharide Affect the Basal Response and the Virulence Process during Citrus Canker	PLOS ONE			English	Article							BIOFILM FORMATION; LIPID-A; NONHOST RESISTANCE; HOST-RANGE; O-ANTIGEN; PSEUDOMONAS-SOLANACEARUM; ARABIDOPSIS-THALIANA; EXPRESSION PATTERNS; INNATE IMMUNITY; BACTERIAL	Xanthomonas axonopodis pv. citri (Xac) is the phytopathogen responsible for citrus canker, one of the most devastating citrus diseases in the world. A broad range of pathogens is recognized by plants through so-called pathogen-associated molecular patterns (PAMPs), which are highly conserved fragments of pathogenic molecules. In plant pathogenic bacteria, lipopolisaccharyde (LPS) is considered a virulence factor and it is being recognized as a PAMP. The study of the participation of Xac LPS in citrus canker establishment could help to understand the molecular bases of this disease. In the present work we investigated the role of Xac LPS in bacterial virulence and in basal defense during the interaction with host and non host plants. We analyzed physiological features of Xac mutants in LPS biosynthesis genes (wzt and rfb303) and the effect of these mutations on the interaction with orange and tobacco plants. Xac mutants showed an increased sensitivity to external stresses and differences in bacterial motilities, in vivo and in vitro adhesion and biofilm formation. Changes in the expression levels of the LPS biosynthesis genes were observed in a medium that mimics the plant environment. Xacwzt exhibited reduced virulence in host plants compared to Xac wild-type and Xacrfb303. However, both mutant strains produced a lower increase in the expression levels of host plant defense-related genes respect to the parental strain. In addition, Xac LPS mutants were not able to generate HR during the incompatible interaction with tobacco plants. Our findings indicate that the structural modifications of Xac LPS impinge on other physiological attributes and lead to a reduction in bacterial virulence. On the other hand, Xac LPS has a role in the activation of basal defense in host and non host plants.	[Petrocelli, Silvana; Laura Tondo, Maria; Daurelio, Lucas D.; Orellano, Elena G.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut,Mol Biol Div, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Petrocelli, S (corresponding author), Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut,Mol Biol Div, Suipacha 531, RA-2000 Rosario, Argentina.	orellano@ibr.gov.ar	Daurelio, Lucas/AAT-6969-2020	Daurelio, Lucas Damian/0000-0002-1156-2266; Tondo, Maria Laura/0000-0002-0160-1882	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 01-12783]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 01-12783 to EGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EGO and LDD are staff members and SP and MLT are Fellows of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Atabek A, 2007, J BACTERIOL, V189, P8503, DOI 10.1128/JB.00769-07; Balsanelli E, 2010, ENVIRON MICROBIOL, V12, P2233, DOI 10.1111/j.1462-2920.2010.02187.x; Bishop RE, 2005, J ENDOTOXIN RES, V11, P174, DOI 10.1179/096805105X35242; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Braun SG, 2005, MOL PLANT MICROBE IN, V18, P674, DOI 10.1094/MPMI-18-0674; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Casabuono A, 2011, J BIOL CHEM, V286, P25628, DOI 10.1074/jbc.M110.186049; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daurelio Lucas D., 2009, P187; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; DOW JM, 1995, MOL PLANT MICROBE IN, V8, P768, DOI 10.1094/MPMI-8-0768; DRIGUES P, 1985, J BACTERIOL, V162, P504, DOI 10.1128/JB.162.2.504-509.1985; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Erbs G, 2012, MOL PLANT PATHOL, V13, P95, DOI 10.1111/j.1364-3703.2011.00730.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Gottwald TR, 2002, PHYTOPATHOLOGY, V92, P361, DOI 10.1094/PHYTO.2002.92.4.361; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; Huang TP, 2006, J BACTERIOL, V188, P3116, DOI 10.1128/JB.188.8.3116-3120.2006; Ingle RA, 2006, BIOESSAYS, V28, P880, DOI 10.1002/bies.20457; Jofre E, 2004, FEMS MICROBIOL LETT, V231, P267, DOI 10.1016/S0378-1097(04)00003-5; Jones AME, 2006, PROTEOMICS, V6, P4155, DOI 10.1002/pmic.200500172; Kannenberg EL, 2001, MOL MICROBIOL, V39, P379, DOI 10.1046/j.1365-2958.2001.02225.x; KAO CC, 1991, J BACTERIOL, V173, P7841, DOI 10.1128/jb.173.24.7841-7847.1991; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; KINGSLEY MT, 1993, J BACTERIOL, V175, P5839, DOI 10.1128/JB.175.18.5839-5850.1993; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; KOMEDA Y, 1977, J BACTERIOL, V129, P908, DOI 10.1128/JB.129.2.908-915.1977; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lerner A, 2009, MICROBIOL-SGM, V155, P791, DOI 10.1099/mic.0.021824-0; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Lindhout T, 2009, MICROBIOL-SGM, V155, P3449, DOI 10.1099/mic.0.030510-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marolda Cristina L., 2006, V347, P237; Molinaro A, 2009, EUR J ORG CHEM, V2009, P5887, DOI 10.1002/ejoc.200900682; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Newman MA, 2001, EUR J PLANT PATHOL, V107, P95, DOI 10.1023/A:1008738817551; Newman MA, 2000, MOL PLANT PATHOL, V1, P25, DOI 10.1046/j.1364-3703.2000.00004.x; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oh SK, 2006, PLANTA, V223, P1101, DOI 10.1007/s00425-006-0232-1; OJANEN T, 1993, APPL ENVIRON MICROB, V59, P4143, DOI 10.1128/AEM.59.12.4143-4151.1993; Patil PB, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-40; Patil PB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-243; Pimenta AD, 2003, MICROBES INFECT, V5, P1177, DOI 10.1016/j.micinf.2003.09.002; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHOONEJANS E, 1987, J BACTERIOL, V169, P4011, DOI 10.1128/jb.169.9.4011-4017.1987; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; Silipo A, 2005, GLYCOBIOLOGY, V15, P561, DOI 10.1093/glycob/cwi029; Silipo A, 2008, CHEMBIOCHEM, V9, P896, DOI 10.1002/cbic.200700693; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Titarenko E, 1997, J BACTERIOL, V179, P6699, DOI 10.1128/jb.179.21.6699-6704.1997; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vojnov AA, 1998, MICROBIOL-UK, V144, P1487, DOI 10.1099/00221287-144-6-1487; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; Wang JC, 2011, PHYSIOL MOL PLANT P, V75, P129, DOI 10.1016/j.pmpp.2010.09.003; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Williams V, 1996, APPL ENVIRON MICROB, V62, P100, DOI 10.1128/AEM.62.1.100-104.1996; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	85	38	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40051	10.1371/journal.pone.0040051	http://dx.doi.org/10.1371/journal.pone.0040051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792211	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800033
J	Sanderson, SD; Thoman, ML; Kis, K; Virts, EL; Herrera, EB; Widmann, S; Sepulveda, H; Phillips, JA				Sanderson, Sam D.; Thoman, Marilyn L.; Kis, Kornelia; Virts, Elizabeth L.; Herrera, Edgar B.; Widmann, Stephanie; Sepulveda, Homero; Phillips, Joy A.			Innate Immune Induction and Influenza Protection Elicited by a Response-Selective Agonist of Human C5a	PLOS ONE			English	Article							CONFORMATIONALLY BIASED AGONIST; BRONCHIAL EPITHELIAL-CELLS; BACILLE CALMETTE-GUERIN; MOLECULAR ADJUVANT; DENDRITIC CELLS; VIRUS INFECTION; ALVEOLAR MACROPHAGES; RESPIRATORY-TRACT; NEURAMINIDASE INHIBITORS; COMPLEMENT FRAGMENTS	The anaphylatoxin C5a is an especially potent mediator of both local and systemic inflammation. However, C5a also plays an essential role in mucosal host defense against bacterial, viral, and fungal infection. We have developed a response-selective agonist of human C5a, termed EP67, which retains the immunoenhancing activity of C5a at the expense of its inflammatory, anaphylagenic properties. EP67 insufflation results in the rapid induction of pulmonary cytokines and chemokines. This is followed by an influx of innate immune effector cells, including neutrophils, NK cells, and dendritic cells. EP67 exhibits both prophylactic and therapeutic protection when tested in a murine model of influenza A infection. Mice treated with EP67 within a twenty-four hour window of non-lethal infection were significantly protected from influenza-induced weight loss. Furthermore, EP67 delivered twenty-four hours after lethal infection completely blocked influenza-induced mortality (0% vs. 100% survival). Since protection based on innate immune induction is not restricted to any specific pathogen, EP67 may well prove equally efficacious against a wide variety of possible viral, bacterial, and fungal pathogens. Such a strategy could be used to stop the worldwide spread of emergent respiratory diseases, including but not limited to novel strains of influenza.	[Sanderson, Sam D.] Univ Nebraska Med Ctr, Sch Allied Hlth Profess, Omaha, NE USA; [Thoman, Marilyn L.; Virts, Elizabeth L.; Phillips, Joy A.] Sidney Kimmel Canc Ctr, San Diego, CA USA; [Thoman, Marilyn L.; Kis, Kornelia; Virts, Elizabeth L.; Herrera, Edgar B.; Phillips, Joy A.] San Diego State Univ, Biosci Ctr, San Diego, CA 92182 USA; [Widmann, Stephanie; Sepulveda, Homero] BD Biosci, San Diego, CA USA	University of Nebraska System; University of Nebraska Medical Center; California State University System; San Diego State University	Sanderson, SD (corresponding author), Univ Nebraska Med Ctr, Sch Allied Hlth Profess, Omaha, NE USA.	jphillips@sciences.sdsu.edu			National Institute of Allergy and Infectious Diseases [AI065712]; National Institute of General Medical Studies, National Institutes of Health [GM095884]; National Institute for Aging, National Institutes of Health [AG0278077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095884] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Studies, National Institutes of Health; National Institute for Aging, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supporting grants to Dr. Phillips were AI065712 from the National Institute of Allergy and Infectious Diseases and GM095884 from the National Institute of General Medical Studies, National Institutes of Health. Dr. Thoman is supported by AG0278077 from the National Institute for Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKOVIC ES, 1987, ANTIVIR RES, V8, P151, DOI 10.1016/0166-3542(87)90068-4; BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Buchner RR, 1997, J IMMUNOL, V158, P1670; Buchweitz John P, 2007, Toxicol Pathol, V35, P424, DOI 10.1080/01926230701302558; CHELEN CJ, 1995, J CLIN INVEST, V95, P1415, DOI 10.1172/JCI117796; Cottey R, 2001, CURR PROTOC IMMUNOL, V42; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; DeForge LE, 2007, J IMMUNOL METHODS, V320, P58, DOI 10.1016/j.jim.2006.12.001; Democratis J, 2006, J ANTIMICROB CHEMOTH, V58, P911, DOI 10.1093/jac/dkl376; Diaz-Mitoma F, 2004, J CLIN VIROL, V31, P100, DOI 10.1016/j.jcv.2004.04.006; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Duryee MJ, 2009, VACCINE, V27, P2981, DOI 10.1016/j.vaccine.2009.02.105; Ernst D, 2003, APPL HDB; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Finch AM, 1997, J MED CHEM, V40, P877, DOI 10.1021/jm960727r; Floreani AA, 1998, J IMMUNOL, V160, P5073; FUJISAWA H, 1987, J GEN VIROL, V68, P425, DOI 10.1099/0022-1317-68-2-425; GLASGOW LA, 1977, J INFECT DIS, V135, P763, DOI 10.1093/infdis/135.5.763; GOODMAN MG, 1982, J IMMUNOL, V129, P70; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hegde GV, 2008, INT IMMUNOPHARMACOL, V8, P819, DOI 10.1016/j.intimp.2008.01.031; HICKS JT, 1978, J IMMUNOL, V121, P1437; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Hugli T E, 1978, Adv Immunol, V26, P1, DOI 10.1016/S0065-2776(08)60228-X; HUGLI TE, 1987, AM REV RESPIR DIS, V135, pS9; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Karachunski PI, 2000, J IMMUNOL, V164, P5236, DOI 10.4049/jimmunol.164.10.5236; Kim AHJ, 2004, J IMMUNOL, V173, P2524, DOI 10.4049/jimmunol.173.4.2524; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3; MONTZ H, 1990, CELL IMMUNOL, V127, P337, DOI 10.1016/0008-8749(90)90137-G; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Morgan EL, 2010, VACCINE, V28, P8275, DOI 10.1016/j.vaccine.2010.10.008; Morgan EL, 2009, VACCINE, V28, P463, DOI 10.1016/j.vaccine.2009.10.029; MORGAN EL, 1983, J IMMUNOL, V130, P1257; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moulton RA, 2007, J LEUKOCYTE BIOL, V82, P956, DOI 10.1189/jlb.0206119; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Phillips JA, 2009, BIOCONJUGATE CHEM, V20, P1950, DOI 10.1021/bc9002794; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Sanderson SD, 2003, INT IMMUNOPHARMACOL, V3, P137, DOI 10.1016/S1567-5769(02)00260-6; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; SCHOLTISSEK C, 1991, ARCH VIROL, V119, P111, DOI 10.1007/BF01314327; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Sheen TR, 2011, VACCINE, V30, P9, DOI 10.1016/j.vaccine.2011.10.054; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SPENCER JC, 1977, J INFECT DIS, V136, P171, DOI 10.1093/infdis/136.2.171; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Suresh M, 2003, J IMMUNOL, V170, P788, DOI 10.4049/jimmunol.170.2.788; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Taylor SM, 2001, CURR MED CHEM, V8, P675, DOI 10.2174/0929867013373156; Tempero RM, 1997, J IMMUNOL, V158, P1377; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Ulrich JT, 2000, J IMMUNOL, V164, P5492, DOI 10.4049/jimmunol.164.10.5492; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Vogen SM, 2001, INT IMMUNOPHARMACOL, V1, P2151, DOI 10.1016/S1567-5769(01)00141-2; Vogen SM, 1999, J PEPT RES, V54, P74, DOI 10.1034/j.1399-3011.1999.00087.x; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; Wang K, 2012, COCHRANE DB SYST REV, V1	70	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40303	10.1371/journal.pone.0040303	http://dx.doi.org/10.1371/journal.pone.0040303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792270	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800065
J	Tcatchoff, L; Andersson, S; Utskarpen, A; Klokk, TI; Skanland, SS; Pust, S; Gerke, V; Sandvig, K				Tcatchoff, Lionel; Andersson, Sofia; Utskarpen, Audrun; Klokk, Tove Irene; Skanland, Sigrid S.; Pust, Sascha; Gerke, Volker; Sandvig, Kirsten			Annexin A1 and A2: Roles in Retrograde Trafficking of Shiga Toxin	PLOS ONE			English	Article							TO-GOLGI TRANSPORT; KINASE-C-DELTA; PHOSPHOLIPASE A(2); EARLY ENDOSOMES; CYTOSOLIC PHOSPHOLIPASE-A2; RECEPTOR; COMPLEX; RETROMER; CLATHRIN; LOCALIZATION	Annexins constitute a family of calcium and membrane binding proteins. As annexin A1 and A2 have previously been linked to various membrane trafficking events, we initiated this study to investigate the role of these annexins in the uptake and intracellular transport of the bacterial Shiga toxin (Stx) and the plant toxin ricin. Once endocytosed, both toxins are retrogradely transported from endosomes to the Golgi apparatus and the endoplasmic reticulum before being targeted to the cytosol where they inhibit protein synthesis. This study was performed to obtain new information both about toxin transport and the function of annexin A1 and annexin A2. Our data show that depletion of annexin A1 or A2 alters the retrograde transport of Stx but not ricin, without affecting toxin binding or internalization. Knockdown of annexin A1 increases Golgi transport of Stx, whereas knockdown of annexin A2 slightly decreases the same transport step. Interestingly, annexin A1 was found in proximity to cytoplasmic phospholipase A2 (cPLA(2)), and the basal as well as the increased Golgi transport of Stx upon annexin A1 knockdown is dependent on cPLA(2) activity. In conclusion, annexin A1 and A2 have different roles in Stx transport to the trans-Golgi network. The most prominent role is played by annexin A1 which normally works as a negative regulator of retrograde transport from the endosomes to the Golgi network, most likely by complex formation and inhibition of cPLA(2).	[Tcatchoff, Lionel; Andersson, Sofia; Utskarpen, Audrun; Klokk, Tove Irene; Skanland, Sigrid S.; Pust, Sascha; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Ctr Canc Biomed,Dept Biochem, Oslo, Norway; [Utskarpen, Audrun; Skanland, Sigrid S.; Sandvig, Kirsten] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Gerke, Volker] Univ Munster, Inst Med Chem, Ctr Mol Biol Inflammat, Munster, Germany	University of Oslo; University of Oslo; University of Munster	Tcatchoff, L (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Ctr Canc Biomed,Dept Biochem, Oslo, Norway.	ksandvig@radium.uio.no	Utskarpen, Audrun/GRS-0436-2022; Skånland, Sigrid S/AAW-4817-2021; Pust, Sascha/M-3201-2013	Pust, Sascha/0000-0002-0178-2206; Skanland, Sigrid S./0000-0003-1630-356X	Norwegian Cancer Society; Norwegian Research Council for Science and the Humanities; Norwegian Research Council - Functional Genomics (NFR-FUGE); German Research Council (DFG) [SFB 629]	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council for Science and the Humanities; Norwegian Research Council - Functional Genomics (NFR-FUGE); German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Norwegian Cancer Society, the Norwegian Research Council for Science and the Humanities, the Norwegian Research Council - Functional Genomics (NFR-FUGE), and the German Research Council to VG (DFG, SFB 629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Creutz CE, 2005, BIOCHEMISTRY-US, V44, P13795, DOI 10.1021/bi051160w; Croxtall JD, 2003, BIOCHEM J, V371, P927, DOI 10.1042/BJ20021856; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; Doody AM, 2009, BIOCHEM BIOPH RES CO, V388, P695, DOI 10.1016/j.bbrc.2009.08.067; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Dyve AB, 2009, BIOCHEM BIOPH RES CO, V390, P109, DOI 10.1016/j.bbrc.2009.09.076; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Engedal N, 2011, MICROB BIOTECHNOL, V4, P32, DOI 10.1111/j.1751-7915.2010.00180.x; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Futter CE, 2007, TRAFFIC, V8, P951, DOI 10.1111/j.1600-0854.2007.00590.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Herbert SP, 2007, J BIOL CHEM, V282, P34468, DOI 10.1074/jbc.M701541200; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kim SW, 2001, FEBS LETT, V489, P243, DOI 10.1016/S0014-5793(00)02326-7; Klinger SC, 2011, J CELL SCI, V124, P1095, DOI 10.1242/jcs.072538; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; LEE RWH, 1983, J BIOL CHEM, V258, P1326; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Moes M, 2010, CELL MOL LIFE SCI, V67, P1547, DOI 10.1007/s00018-010-0267-0; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Popoff V, 2009, TRAFFIC, V10, P1868, DOI 10.1111/j.1600-0854.2009.00993.x; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Reverter M, 2011, MOL BIOL CELL, V22, P4108, DOI 10.1091/mbc.E11-04-0332; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Sakaguchi M, 2007, J BIOL CHEM, V282, P35679, DOI 10.1074/jbc.M707538200; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Skanland SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005935; Skanland SS, 2009, CELL MICROBIOL, V11, P796, DOI 10.1111/j.1462-5822.2009.01292.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spooner RA, 2008, BIOCHEM J, V414, P471, DOI 10.1042/BJ20080149; THIEL C, 1992, J CELL SCI, V103, P733; Tian W, 2008, J BIOL CHEM, V283, P3960, DOI 10.1074/jbc.M707345200; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Turpin E, 1998, BBA-MOL CELL RES, V1402, P115, DOI 10.1016/S0167-4889(97)00151-1; Utskarpen A, 2006, TRAFFIC, V7, P663, DOI 10.1111/j.1600-0854.2006.00418.x; Utskarpen A, 2007, BIOCHEM BIOPH RES CO, V358, P566, DOI 10.1016/j.bbrc.2007.04.159; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387; Zobiack N, 2001, FEBS LETT, V500, P137, DOI 10.1016/S0014-5793(01)02604-7	72	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40429	10.1371/journal.pone.0040429	http://dx.doi.org/10.1371/journal.pone.0040429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792315	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800083
J	Wang, C; Chen, HF; Hao, QN; Sha, AH; Shan, ZH; Chen, LM; Zhou, R; Zhi, HJ; Zhou, XA				Wang, Cheng; Chen, HaiFeng; Hao, QingNan; Sha, AiHua; Shan, ZhiHui; Chen, LiMiao; Zhou, Rong; Zhi, HaiJian; Zhou, XinAn			Transcript Profile of the Response of Two Soybean Genotypes to Potassium Deficiency	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN-KINASE; K+ CHANNEL; MOLECULAR-MECHANISMS; SALT-STRESS; ARABIDOPSIS; METABOLISM; PLANTS; ACID; TRANSPORTERS	The macronutrient potassium (K) is essential to plant growth and development. Crop yield potential is often affected by lack of soluble K. The molecular regulation mechanism of physiological and biochemical responses to K starvation in soybean roots and shoots is not fully understood. In the present study, two soybean varieties were subjected to low-K stress conditions: a low-K-tolerant variety (You06-71) and a low-K-sensitive variety (HengChun04-11). Eight libraries were generated for analysis: 2 genotypes x2 tissues (roots and shoots) x2 time periods [short term (0.5 to 12 h) and long term (3 to 12 d)]. RNA derived from the roots and shoots of these two varieties across two periods (short term and long term) were sequenced and the transcriptomes were compared using high-throughput tag-sequencing. To this end, a large number of clean tags (tags used for analysis after removal of dirty tags) corresponding to distinct tags (all types of clean tags) were identified in eight libraries (L1, You06-71-root short term; L2, HengChun04-11-root short term; L3, You06-71-shoot short term; L4, HengChun04-11-shoot short term; L5, You06-71-root long term; L6, HengChun04-11-root long term; L7, You06-71-shoot long term; L8, HengChun04-11-shoot long term). All clean tags were mapped to the available soybean (Glycine max) transcript database (http://www.soybase.org). Many genes showed substantial differences in expression across the libraries. In total, 5,440 transcripts involved in 118 KEGG pathways were either up- or down-regulated. Fifteen genes were randomly selected and their expression levels were confirmed using quantitative RT-PCR. Our results provide preliminary information on the molecular mechanism of potassium absorption and transport under low-K stress conditions in different soybean tissues.	[Wang, Cheng; Zhi, HaiJian] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [Wang, Cheng; Chen, HaiFeng; Hao, QingNan; Sha, AiHua; Shan, ZhiHui; Chen, LiMiao; Zhou, Rong; Zhou, XinAn] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crop Biol, Wuhan, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wang, C (corresponding author), Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China.	zhj@njau.edu.cn; zhouocri@sina.com			National Transgenic Project [2011ZX08004-005]; Modern Agricultural Technology System [CARS-040PS08]; Crop Germplasms Resource Protection Project [NB07-2130315-06, NB08-2130315-(25-31)06]	National Transgenic Project; Modern Agricultural Technology System; Crop Germplasms Resource Protection Project	The authors are grateful for financial support by special funds from the major issue of National Transgenic Project (2011ZX08004-005), the Modern Agricultural Technology System (CARS-040PS08) and grants from the Crop Germplasms Resource Protection Project (NB07-2130315-06, NB08-2130315-(25-31)06). The funders had no role in study design, data collection and analysis, preparation of the manuscript and decision to publish were determined by the author.	Abbasi F, 2004, PLANT MOL BIOL, V55, P541, DOI 10.1007/s11103-004-1178-y; Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Adams F., 1974, The Plant Root and its Environment. Proceedings held at Virginia Polytechnic and State University, 1971. E.W.Carson (Editor), P441; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Assmann SM, 2003, TRENDS PLANT SCI, V8, P151, DOI 10.1016/S1360-1385(03)00052-9; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Becker D, 2003, FEBS LETT, V554, P119, DOI 10.1016/S0014-5793(03)01118-9; Benjamini Y, 2001, ANN STAT, V29, P1165; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Berger H, 2006, MOL MICROBIOL, V59, P433, DOI 10.1111/j.1365-2958.2005.04957.x; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Britto DT, 2008, PHYSIOL PLANTARUM, V133, P637, DOI 10.1111/j.1399-3054.2008.01067.x; Bryan J, 1999, BBA-BIOMEMBRANES, V1461, P285, DOI 10.1016/S0005-2736(99)00164-9; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YF, 2008, J INTEGR PLANT BIOL, V50, P835, DOI 10.1111/j.1744-7909.2008.00707.x; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Cullum R, 2011, RESPIROLOGY, V16, P210, DOI 10.1111/j.1440-1843.2010.01899.x; Deeken R, 2002, PLANTA, V216, P334, DOI 10.1007/s00425-002-0895-1; Duby G, 2008, PLANT J, V53, P115, DOI 10.1111/j.1365-313X.2007.03324.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; Gupta M, 2008, MOL GENET GENOMICS, V280, P437, DOI 10.1007/s00438-008-0377-7; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Jung JY, 2009, PLANT CELL, V21, P607, DOI 10.1105/tpc.108.063099; Jungk A, 1997, ADV AGRON, V61, P53, DOI 10.1016/S0065-2113(08)60662-8; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanneganti Vydehi, 2008, Physiology and Molecular Biology of Plants, V14, P109, DOI 10.1007/s12298-008-0010-6; Karam BS, 2002, CURR OPIN PLANT BIOL, V5, P430; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; Libault M, 2010, PLANT PHYSIOL, V152, P541, DOI 10.1104/pp.109.148379; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; Ma LG, 2005, PLANT PHYSIOL, V138, P80, DOI 10.1104/pp.104.054783; Marrush M, 1998, J AM SOC HORTIC SCI, V123, P925, DOI 10.21273/JASHS.123.5.925; Maser P, 2002, PLANT SOIL, V247, P43, DOI 10.1023/A:1021159130729; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; NAKAMURA RL, 1995, PLANT PHYSIOL, V109, P371, DOI 10.1104/pp.109.2.371; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pyo YJ, 2010, PLANT PHYSIOL, V153, P863, DOI 10.1104/pp.110.154369; Rapala-Kozik M, 2008, J EXP BOT, V59, P4133, DOI 10.1093/jxb/ern253; Ricarda D, 2001, J NEUROSCI, V21, P2058; Riechmann JL, 1998, BIOL CHEM, V379, P633; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Saijo Y, 2001, PLANT CELL PHYSIOL, V42, P1228, DOI 10.1093/pcp/pce158; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sudha G, 2002, PLANT CELL TISS ORG, V71, P181, DOI 10.1023/A:1020336626361; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Sutter JU, 2007, CURR BIOL, V17, P1396, DOI 10.1016/j.cub.2007.07.020; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tisdale S. L., 1993, SOIL FERTILITY FERTI, P109; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wang Y, 2010, CELL RES, V20, P826, DOI 10.1038/cr.2010.74; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Watanabe S, 2010, FEBS LETT, V584, P1181, DOI 10.1016/j.febslet.2010.02.023; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zhang GP, 1999, NUTR CYCL AGROECOSYS, V54, P41; Zhao J, 2008, PLANT PHYSIOL, V148, P796, DOI 10.1104/pp.108.124248	93	28	32	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39856	10.1371/journal.pone.0039856	http://dx.doi.org/10.1371/journal.pone.0039856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792192	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300011
J	Lu, JP; Huang, YQ; Wang, YX; Li, Y; Zhang, YJ; Wu, JJ; Zhao, FF; Meng, SJ; Yu, XW; Ma, QW; Song, MS; Chang, NB; Bittles, AH; Wang, W				Lu, Jiapeng; Huang, Yuqing; Wang, Youxin; Li, Yan; Zhang, Yujun; Wu, Jingjing; Zhao, Feifei; Meng, Shijiao; Yu, Xinwei; Ma, Qingwei; Song, Manshu; Chang, Naibai; Bittles, Alan H.; Wang, Wei			Profiling Plasma Peptides for the Identification of Potential Ageing Biomarkers in Chinese Han Adults	PLOS ONE			English	Article							OLDER PERSONS; SERUM-ALBUMIN; HUMAN LONGEVITY; RISK-FACTORS; AGE; FIBRINOGEN; MORTALITY; ASSOCIATION; POPULATION; PROTEIN	Advancing age is associated with cardiovascular disease, diabetes mellitus and cancer, and shows significant inter-individual variability. To identify ageing-related biomarkers we performed a proteomic analysis on 1890 Chinese Han individuals, 1136 males and 754 females, aged 18 to 82 years, using weak cation exchange magnetic bead based MALDI-TOF-MS analysis. The study identified 44 peptides which varied in concentration in different age groups. In particular, apolipoprotein A-I (ApoA1) concentration gradually increased between 18 to 50 years of age, the levels of fibrinogen alpha (FGA) decreased over the same age span, while albumin (ALB) was significantly degraded in middle-aged individuals. In addition, the plasma peptide profiles of FGA and four other unidentified proteins were found to be gender-dependent. Plasma proteins such as FGA, ALB and ApoA1 are significantly correlated with age in the Chinese Han population and could be employed as indicative ageing-related biomarkers.	[Lu, Jiapeng; Wang, Youxin; Wu, Jingjing; Zhao, Feifei; Meng, Shijiao; Yu, Xinwei; Song, Manshu; Wang, Wei] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Huang, Yuqing] Beijing Haidian Hosp, Dept Chest Surg, Beijing, Peoples R China; [Wang, Wei] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Bittles, Alan H.; Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Bittles, Alan H.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Li, Yan; Zhang, Yujun; Ma, Qingwei] Bioyong Technol Inc, Beijing, Peoples R China; [Chang, Naibai] Beijing Hosp, Dept Hematol, Beijing, Peoples R China; [Lu, Jiapeng; Wang, Youxin; Wu, Jingjing; Zhao, Feifei; Meng, Shijiao; Yu, Xinwei; Song, Manshu; Wang, Wei] Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Edith Cowan University; Murdoch University; Beijing Hospital	Lu, JP (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China.	songms@ccmu.edu.cn; wei6014@yahoo.com; wei.wang@ecu.edu.au	liu, li/HGC-0900-2022	Wang, Youxin/0000-0002-6574-6706; Huang, Yuqing/0000-0002-3182-1798; wang, wei/0000-0002-1430-1360; Song, Manshu/0000-0003-1433-7192; Bittles, Alan/0000-0002-8176-2730	National Science Technology Major Special Project on Major New Drug Innovation [2010ZX09401]; National "Twelfth Five-Year" Plan for Science and Technology Support [2012BAI37B03]; Major State Basic Research Program-973 of China [2011CB503806]; National Natural Science Foundation of China [30901238, 31070727, 81001281]	National Science Technology Major Special Project on Major New Drug Innovation; National "Twelfth Five-Year" Plan for Science and Technology Support; Major State Basic Research Program-973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by National Science Technology Major Special Project on Major New Drug Innovation (2010ZX09401) http://www.nmp.gov.cn/, National "Twelfth Five-Year" Plan for Science and Technology Support (2012BAI37B03) http://kjzc.jhgl.org/, Major State Basic Research Program-973 of China (No. 2011CB503806) http://program.most.gov.cn/, National Natural Science Foundation of China (30901238, 31070727 and 81001281) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred S, 2004, CLIN BIOCHEM, V37, P943, DOI 10.1016/j.clinbiochem.2004.09.002; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; BANERJEE AK, 1992, THROMB HAEMOSTASIS, V68, P261; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Bittles AH, 2005, HUMAN CLOCKS BIOCULT, P41; Bittles AH, 2008, OLD AGE PSYCHIAT, P3; Byerley LO, 2010, AGE, V32, P497, DOI 10.1007/s11357-010-9146-8; Capri M, 2006, ANN NY ACAD SCI, V1067, P252, DOI 10.1196/annals.1354.033; Choudhury A, 2004, BRIT J CANCER, V90, P657, DOI 10.1038/sj.bjc.6601604; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; FOLSOM AR, 1995, EUR HEART J, V16, P21, DOI 10.1093/eurheartj/16.suppl_A.21; Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Ishikawa S, 1997, THROMB HAEMOSTASIS, V77, P890; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; KLONOFFCOHEN H, 1992, J CLIN EPIDEMIOL, V45, P207, DOI 10.1016/0895-4356(92)90080-7; Ko GTC, 1997, ATHEROSCLEROSIS, V131, P211, DOI 10.1016/S0021-9150(97)06109-1; Kronenberg F, 2008, EXP GERONTOL, V43, P39, DOI 10.1016/j.exger.2007.09.005; Liu CB, 2011, INT J MED SCI, V8, P39, DOI 10.7150/ijms.8.39; LOWE GDO, 1995, EUR HEART J, V16, P2, DOI 10.1093/eurheartj/16.suppl_A.2; Lu JP, 2011, J PROTEOME RES, V10, P4959, DOI 10.1021/pr2004067; Miura Y, 2011, EXP GERONTOL, V46, P81, DOI 10.1016/j.exger.2010.10.002; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Reuben DB, 2002, J AM GERIATR SOC, V50, P638, DOI 10.1046/j.1532-5415.2002.50157.x; SALIVE ME, 1992, J CLIN EPIDEMIOL, V45, P213, DOI 10.1016/0895-4356(92)90081-W; Sebastiani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008210; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; Shah GN, 1995, BBA-LIPID LIPID MET, V1259, P277, DOI 10.1016/0005-2760(95)00174-3; Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014; Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008; Stessman J, 2005, MECH AGEING DEV, V126, P333, DOI 10.1016/j.mad.2004.08.025; Thomas NE, 2005, AM J HUM BIOL, V17, P809, DOI 10.1002/ajhb.20447; Troen BR, 2003, MT SINAI J MED, V70, P3; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Villanueva J, 2006, NAT PROTOC, V1, P880, DOI 10.1038/nprot.2006.128; Visser M, 2005, AM J CLIN NUTR, V82, P531; Wu S, 2011, INT J CLIN ONCOL; Zhang Xinyi, 2004, J Biomol Tech, V15, P167; ZHOU ZJ, 2004, LING NAN XIN XUE GUA, V10, P10	44	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39726	10.1371/journal.pone.0039726	http://dx.doi.org/10.1371/journal.pone.0039726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802942	Green Published, gold			2022-12-27	WOS:000306186900016
J	Simpson, PD; Moysi, E; Wicks, K; Sudan, K; Rowland-Jones, SL; McMichael, AJ; Knight, J; Gillespie, GM				Simpson, Peter D.; Moysi, Eirini; Wicks, Kate; Sudan, Kritika; Rowland-Jones, Sarah L.; McMichael, Andrew J.; Knight, Julian; Gillespie, Geraldine M.			Functional Differences Exist between TNF alpha Promoters Encoding the Common-237G SNP and the Rarer HLA-B*5701-Linked A Variant	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN-IMMUNODEFICIENCY-VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; SINGLE-NUCLEOTIDE POLYMORPHISMS; GENE-EXPRESSION; BINDING; REGION; HIV-1; HLA; IDENTIFICATION	A large body of functional and epidemiological evidence have previously illustrated the impact of specific MHC class I subtypes on clinical outcome during HIV-1 infection, and these observations have recently been re-iterated in genome wide association studies (GWAS). Yet because of the complexities surrounding GWAS-based approaches and the lack of knowledge relating to the identity of rarer single nucleotide polymorphism (SNP) variants, it has proved difficult to discover independent causal variants associated with favourable immune control. This is especially true of the candidate variants within the HLA region where many of the recently proposed disease influencing SNPs appear to reflect linkage with 'protective' MHC class I alleles. Yet causal MHC-linked SNPs may exist but remain overlooked owing to the complexities associated with their identification. Here we focus on the ancestral TNFa promoter 2237A variant (rs361525), shown historically to be in complete linkage disequilibrium with the 'protective' HLA-B*5701 allele. Many of the ancestral SNPs within the extended TNF alpha promoter have been associated with both autoimmune conditions and disease outcomes, however, the direct role of these variants on TNFa expression remains controversial. Yet, because of the important role played by TNF alpha in HIV-1 infection, and given the proximity of the -237 SNP to the core promoter, its location within a putative repressor region previously characterized in mice, and its disruption of a methylation-susceptible CpG dinucleotide motif, we chose to carefully evaluate its impact on TNF alpha production. Using a variety of approaches we now demonstrate that carriage of the A SNP is associated with lower TNF alpha production, via a mechanism not readily explained by promoter methylation nor the binding of transcription factors or repressors. We propose that the 2237A variant could represent a minor causal SNP that additionally contributes to the HLA-B*5701-mediated 'protective' effect during HIV-1 infection.	[Simpson, Peter D.; Moysi, Eirini; Sudan, Kritika; Rowland-Jones, Sarah L.; McMichael, Andrew J.; Gillespie, Geraldine M.] Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Wicks, Kate; Knight, Julian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Simpson, PD (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	peter.simpson@ndm.ox.ac.uk; geraldine.gillespie@imm.ox.ac.uk	Knight, Julian Charles/W-2399-2019; Sudan, Kritika/AAW-9282-2021	Knight, Julian Charles/0000-0002-0377-5536; Wicks, Kate/0000-0002-7724-9678; Moysi, Eirini/0000-0002-2070-2902	Medical Research Council; University of Oxford; MRC [G0501011] Funding Source: UKRI; Medical Research Council [G1000800f, G0501011] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Medical Research Council and the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM LJ, 1993, CLIN EXP IMMUNOL, V92, P14; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Amiot F, 1997, EUR J IMMUNOL, V27, P1035, DOI 10.1002/eji.1830270434; Baena A, 2002, GENES IMMUN, V3, P482, DOI 10.1038/sj.gene.6363898; Baena A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000621; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brinkman BMN, 1997, J INFECT DIS, V175, P188, DOI 10.1093/infdis/175.1.188; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Coolen MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025590; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fellay J, 2009, ANTIVIR THER, V14, P731, DOI 10.3851/IMP1253; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; FONG CLW, 1994, NUCLEIC ACIDS RES, V22, P1108, DOI 10.1093/nar/22.6.1108; Gallagher G, 1997, IMMUNOGENETICS, V45, P188, DOI 10.1007/s002510050188; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Hohjoh H, 2001, GENES IMMUN, V2, P105, DOI 10.1038/sj.gene.6363721; JONGENEEL CV, 1991, P NATL ACAD SCI USA, V88, P9717, DOI 10.1073/pnas.88.21.9717; Juffermans NP, 2000, BLOOD, V96, P2649; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kroeger KR, 1996, BIOCHEM MOL BIOL INT, V40, P43; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; POCIOT F, 1995, SCAND J IMMUNOL, V42, P501, DOI 10.1111/j.1365-3083.1995.tb03686.x; Qidwai T, 2011, SCAND J IMMUNOL, V74, P522, DOI 10.1111/j.1365-3083.2011.02602.x; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Shifera AS, 2010, ANAL BIOCHEM, V396, P167, DOI 10.1016/j.ab.2009.09.043; Shifera AS, 2009, ARCH BIOCHEM BIOPHYS, V490, P145, DOI 10.1016/j.abb.2009.08.013; Soga Y, 2003, J CLIN PERIODONTOL, V30, P524, DOI 10.1034/j.1600-051X.2003.00287.x; Stamou P, 2010, CURR DIR AUTOIMMUN, V11, P61, DOI 10.1159/000289197; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; VYAKARNAM A, 1990, AIDS, V4, P21, DOI 10.1097/00002030-199001000-00003; Warnecke PM, 1997, NUCLEIC ACIDS RES, V25, P4422, DOI 10.1093/nar/25.21.4422; Wicks K, 2011, GENES IMMUN, V12, P126, DOI 10.1038/gene.2010.62; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	43	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40100	10.1371/journal.pone.0040100	http://dx.doi.org/10.1371/journal.pone.0040100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808100	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700021
J	Sinicropi, D; Qu, K; Collin, F; Crager, M; Liu, ML; Pelham, RJ; Pho, M; Dei Rossi, A; Jeong, J; Scott, A; Ambannavar, R; Zheng, C; Mena, R; Esteban, J; Stephans, J; Morlan, J; Baker, J				Sinicropi, Dominick; Qu, Kunbin; Collin, Francois; Crager, Michael; Liu, Mei-Lan; Pelham, Robert J.; Pho, Mylan; Dei Rossi, Andrew; Jeong, Jennie; Scott, Aaron; Ambannavar, Ranjana; Zheng, Christina; Mena, Raul; Esteban, Jose; Stephans, James; Morlan, John; Baker, Joffre			Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; GENE-EXPRESSION PROFILES; NONCODING RNAS; CLINICAL-IMPLICATIONS; CHROMATIN; REGRESSION; TAMOXIFEN; CHEMOTHERAPY; METAANALYSIS; ANNOTATION	RNA biomarkers discovered by RT-PCR-based gene expression profiling of archival formalin-fixed paraffin-embedded (FFPE) tissue form the basis for widely used clinical diagnostic tests; however, RT-PCR is practically constrained in the number of transcripts that can be interrogated. We have developed and optimized RNA-Seq library chemistry as well as bioinformatics and biostatistical methods for whole transcriptome profiling from FFPE tissue. The chemistry accommodates low RNA inputs and sample multiplexing. These methods both enable rediscovery of RNA biomarkers for disease recurrence risk that were previously identified by RT-PCR analysis of a cohort of 136 patients, and also identify a high percentage of recurrence risk markers that were previously discovered using DNA microarrays in a separate cohort of patients, evidence that this RNA-Seq technology has sufficient precision and sensitivity for biomarker discovery. More than two thousand RNAs are strongly associated with breast cancer recurrence risk in the 136 patient cohort (FDR <10%). Many of these are intronic RNAs for which corresponding exons are not also associated with disease recurrence. A number of the RNAs associated with recurrence risk belong to novel RNA networks. It will be important to test the validity of these novel associations in whole transcriptome RNA-Seq screens of other breast cancer cohorts.	[Sinicropi, Dominick; Qu, Kunbin; Collin, Francois; Crager, Michael; Liu, Mei-Lan; Pelham, Robert J.; Pho, Mylan; Dei Rossi, Andrew; Jeong, Jennie; Scott, Aaron; Ambannavar, Ranjana; Zheng, Christina; Stephans, James; Morlan, John; Baker, Joffre] Genom Hlth Inc, Redwood City, CA USA; [Mena, Raul; Esteban, Jose] Providence St Joseph Med Ctr, Burbank, CA USA	Genomic Health	Sinicropi, D (corresponding author), Genom Hlth Inc, Redwood City, CA USA.	jbaker@genomichealth.com		Crager, Michael/0000-0002-3594-6299				Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Au KF, 2010, NUCLEIC ACIDS RES, V38, P4570, DOI 10.1093/nar/gkq211; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BLOCK GE, 1978, ANN SURG, V188, P372, DOI 10.1097/00000658-197809000-00012; Buchard A, 2007, J MOL DIAGN, V9, P612, DOI 10.2353/jmoldx.2007.070030; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chudova D, 2010, J CLIN ENDOCR METAB, V95, P5296, DOI 10.1210/jc.2010-1087; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; COX DR, 1972, J R STAT SOC B, V34, P187; Crager MR, 2010, STAT MED, V29, P33, DOI 10.1002/sim.3789; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esteban JM, 2003, P AM ASS CANC RES; Fisher B, 2004, LANCET, V364, P858, DOI 10.1016/S0140-6736(04)16981-X; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kiefer MHK, 2006, MULTIPLE GSTM GENE F; Kim C, 2011, J CLIN ONCOLOGY; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Mehra MR, 2007, J HEART LUNG TRANSPL, V26, P1255, DOI 10.1016/j.healun.2007.09.009; Mehra MR, 2008, J HEART LUNG TRANSPL, V27, P297, DOI 10.1016/j.healun.2007.11.578; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Samson K, 2011, ONCOLOGY TIMES, V33, P10; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Weigelt B, 2011, NAT REV CLIN ONCOL; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhang H, 1999, INT J CANCER, V84, P135, DOI 10.1002/(SICI)1097-0215(19990420)84:2<135::AID-IJC7>3.0.CO;2-C	56	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40092	10.1371/journal.pone.0040092	http://dx.doi.org/10.1371/journal.pone.0040092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808097	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700020
J	Yu, J; Xing, XB; Zeng, LY; Sun, JH; Li, W; Sun, H; He, Y; Li, J; Zhang, GQ; Wang, C; Li, YX; Xie, L				Yu, Jian; Xing, Xiaobin; Zeng, Lingyao; Sun, Jiehuan; Li, Wei; Sun, Han; He, Ying; Li, Jing; Zhang, Guoqing; Wang, Chuan; Li, Yixue; Xie, Lu			SyStemCell: A Database Populated with Multiple Levels of Experimental Data from Stem Cell Differentiation Research	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; GENE-EXPRESSION; HISTONE H3; TRANSCRIPTIONAL NETWORK; MOUSE; 5-HYDROXYMETHYLCYTOSINE; PLURIPOTENCY; METHYLATION; MICRORNAS; REVEALS	Elucidation of the mechanisms of stem cell differentiation is of great scientific interest. Increasing evidence suggests that stem cell differentiation involves changes at multiple levels of biological regulation, which together orchestrate the complex differentiation process; many related studies have been performed to investigate the various levels of regulation. The resulting valuable data, however, remain scattered. Most of the current stem cell-relevant databases focus on a single level of regulation (mRNA expression) from limited stem cell types; thus, a unifying resource would be of great value to compile the multiple levels of research data available. Here we present a database for this purpose, SyStemCell, deposited with multi-level experimental data from stem cell research. The database currently covers seven levels of stem cell differentiation-associated regulatory mechanisms, including DNA CpG 5-hydroxymethylcytosine/methylation, histone modification, transcript products, microRNA-based regulation, protein products, phosphorylation proteins and transcription factor regulation, all of which have been curated from 285 peer-reviewed publications selected from PubMed. The database contains 43,434 genes, recorded as 942,221 gene entries, for four organisms (Homo sapiens, Mus musculus, Rattus norvegicus, and Macaca mulatta) and various stem cell sources (e.g., embryonic stem cells, neural stem cells and induced pluripotent stem cells). Data in SyStemCell can be queried by Entrez gene ID, symbol, alias, or browsed by specific stem cell type at each level of genetic regulation. An online analysis tool is integrated to assist researchers to mine potential relationships among different regulations, and the potential usage of the database is demonstrated by three case studies. SyStemCell is the first database to bridge multi-level experimental information of stem cell studies, which can become an important reference resource for stem cell researchers. The database is available at http://lifecenter.sgst.cn/SyStemCell/.	[Yu, Jian; Xing, Xiaobin; Zeng, Lingyao; Sun, Jiehuan; Li, Wei; Sun, Han; He, Ying; Li, Jing; Zhang, Guoqing; Wang, Chuan; Li, Yixue; Xie, Lu] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Xing, Xiaobin; Sun, Han; He, Ying; Li, Yixue] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Sun, Jiehuan; Li, Wei; Li, Jing] Huazhong Sci & Technol Univ, Wuhan, Hubei, Peoples R China; [Zeng, Lingyao] Tongji Univ, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong University of Science & Technology; Tongji University	Yu, J (corresponding author), Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China.	yxli@sibs.ac.cn; xielu@scbit.org	zhang, guoqing/GXG-4800-2022	Zhang, Guoqing/0000-0001-8827-7546	National Key Basic Research Program [2010CB912702]; State Key Basic Research Program [2011CB910204]; Key Infectious Disease Project [2012ZX10002012-014]; National Natural Science Foundation of China [31070752]; National Key Technology RD Program [2008BAI64B01]; National Scientific-Basic Special Fund [2009FY120100]	National Key Basic Research Program(National Basic Research Program of China); State Key Basic Research Program; Key Infectious Disease Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); National Scientific-Basic Special Fund	Funding for open access charge: National Key Basic Research Program (2010CB912702); State Key Basic Research Program (2011CB910204); Key Infectious Disease Project (2012ZX10002012-014); National Natural Science Foundation of China (31070752); National Key Technology R&D Program (2008BAI64B01); National Scientific-Basic Special Fund (2009FY120100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arda HE, 2010, BRIEF FUNCT GENOMICS, V9, P4, DOI 10.1093/bfgp/elp049; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen H, 2009, NEUROL RES; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hatano A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar046; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2010, NUCLEIC ACIDS RES, V38, pD658, DOI 10.1093/nar/gkp933; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Miranda-Saavedra D, 2009, NUCLEIC ACIDS RES, V37, pD873, DOI 10.1093/nar/gkn854; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Oh IH, 2011, STEM CELLS; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pascal Laura E, 2007, BMC Urol, V7, P19, DOI 10.1186/1471-2490-7-19; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; SCACCHI R, 1991, ELECTROPHORESIS, V12, P667, DOI 10.1002/elps.1150120912; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smale ST, 2010, CURR OPIN GENET DEV, V20, P519, DOI 10.1016/j.gde.2010.06.010; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XY, 2010, INTEGR BIOL-UK, V2, P510, DOI 10.1039/c0ib00068j; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	60	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e35230	10.1371/journal.pone.0035230	http://dx.doi.org/10.1371/journal.pone.0035230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22807998	Green Submitted, gold, Green Published			2022-12-27	WOS:000306406700002
J	Ferreira, A; Santiago, FM; Silva, MV; Ferreira, FB; Macedo, AG; Mota, CM; Faria, MS; Silva, HH; Silva, DAO; Cunha, JP; Mineo, JR; Mineo, TWP				Ferreira Junior, Alvaro; Santiago, Fernanda M.; Silva, Murilo V.; Ferreira, Flavia B.; Macedo Junior, Arlindo G.; Mota, Caroline M.; Faria, Matheus S.; Silva, Hercilio H.; Silva, Deise A. O.; Cunha-Junior, Jair P.; Mineo, Jose R.; Mineo, Tiago W. P.			Production, Characterization and Applications for Toxoplasma gondii-Specific Polyclonal Chicken Egg Yolk Immunoglobulins	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; IGY-ANTIBODIES; NANOCRYSTAL DETECTION; INVASION; IMMUNITY; CELLS; IMMUNIZATION; QUANTITATION; TACHYZOITES; REINFECTION	Background: Toxoplasma gondii may cause abortions, ocular and neurological disorders in warm-blood hosts. Immunized mammals are a wide source of hyperimmune sera used in different approaches, including diagnosis and the study of host-parasite interactions. Unfortunately, mammalian antibodies present limitations for its production, such as the necessity for animal bleeding, low yield, interference with rheumatoid factor, complement activation and affinity to Fc mammalian receptors. IgY antibodies avoid those limitations; therefore they could be an alternative to be applied in T. gondii model. Methodology/Principal Findings: In this study we immunized hens with soluble tachyzoite antigens of T. gondii (STAg) and purified egg yolk antibodies (IgY) by an inexpensive and simple method, with high yield and purity degree. IgY anti-STAg antibodies presented high avidity and were able to recognize a broad range of parasite antigens, although some marked differences were observed in reactivity profile between antibodies produced in immunized hens and mice. Interestingly, IgY antibodies against Neospora caninum and Eimeria spp. did not react to STAg. We also show that IgY antibodies were suitable to detect T. gondii forms in paraffin-embedded sections and culture cell monolayers. Conclusions/Significance: Due to its cost-effectiveness, high production yield and varied range of possible applications, polyclonal IgY antibodies are useful tools for studies involving T. gondii.	[Ferreira Junior, Alvaro; Santiago, Fernanda M.; Silva, Murilo V.; Ferreira, Flavia B.; Macedo Junior, Arlindo G.; Mota, Caroline M.; Faria, Matheus S.; Silva, Hercilio H.; Silva, Deise A. O.; Cunha-Junior, Jair P.; Mineo, Jose R.; Mineo, Tiago W. P.] Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunoparasitol, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia	Ferreira, A (corresponding author), Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunoparasitol, Uberlandia, MG, Brazil.	tiagomineo@icbim.ufu.br	Mineo, Jose R/B-4151-2009; Mineo, Tiago W. P./B-4153-2009; Mota, Caroline/AAT-6995-2021; Ataee, Ramezan/M-2604-2017; Junior, Alvaro/AAH-3754-2019	Mineo, Jose R/0000-0002-9010-7228; Mineo, Tiago W. P./0000-0002-2339-2743; Pereira da Cunha Junior, Jair/0000-0001-6182-4298; Silva, Murilo/0000-0002-3397-0113; Santiago, Fernanda Maria/0000-0002-6204-0863	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 578763/2008-7, 303448/2010-5]; Fundacao de Amparo a Pesquisa de Minas Gerais [Fapemig PPM V F0323]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES AUX-PE-Parasitologia-1348-2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the following Brazilian research funding agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 578763/2008-7 and 303448/2010-5), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES AUX-PE-Parasitologia-1348-2011) and Fundacao de Amparo a Pesquisa de Minas Gerais (Fapemig PPM V F0323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita E.M., 1993, J IMMUNOL METHODS, V164, P141; Bauerle T, 2006, INT J ONCOL, V28, P573; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Brunda G, 2006, TOXICON, V48, P183, DOI 10.1016/j.toxicon.2006.04.011; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Cenci-Goga BT, 2011, FOODBORNE PATHOG DIS, V8, P751, DOI 10.1089/fpd.2010.0795; Chiliza TE, 2008, HYBRIDOMA, V27, P413, DOI 10.1089/hyb.2008.0051; Cunha JP, 2010, IMMUNOBIOLOGY, V215, P26, DOI 10.1016/j.imbio.2009.01.008; da Silva WD, 2010, VET IMMUNOL IMMUNOP, V135, P173, DOI 10.1016/j.vetimm.2009.12.011; de Paula VS, 2011, J VIROL METHODS, V171, P102, DOI 10.1016/j.jviromet.2010.10.008; Dubey JP, 2010, ZOONOSES PUBLIC HLTH, V57, P60, DOI 10.1111/j.1863-2378.2009.01274.x; Dzitko K, 2006, EXP PARASITOL, V112, P134, DOI 10.1016/j.exppara.2005.09.010; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Fu YF, 2011, INFECT IMMUN, V79, P512, DOI 10.1128/IAI.00969-10; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Gregg B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022936; Greunke K, 2008, CLIN BIOCHEM, V41, P1237, DOI 10.1016/j.clinbiochem.2008.07.004; HASSL A, 1987, ZBL BAKT-INT J MED M, V267, P247; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Innes EA, 2009, PARASITOLOGY, V136, P1887, DOI 10.1017/S0031182009991636; Lee SH, 2009, POULTRY SCI, V88, P562, DOI 10.3382/ps.2008-00340; Lourenco EV, 2006, MICROBES INFECT, V8, P1244, DOI 10.1016/j.micinf.2005.11.013; Marcolino PT, 2000, CLIN DIAGN LAB IMMUN, V7, P384, DOI 10.1128/CDLI.7.3.384-389.2000; Nguyen HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010152; Pauly D, 2009, POULTRY SCI, V88, P281, DOI 10.3382/ps.2008-00323; Pei JW, 2005, DEV COMP IMMUNOL, V29, P153, DOI 10.1016/j.dci.2004.06.009; Pfrepper KI, 2005, CLIN DIAGN LAB IMMUN, V12, P977, DOI 10.1128/CDLI.12.8.977-982.2005; Qu JX, 2011, PROTEIN EXPRES PURIF, V75, P225, DOI 10.1016/j.pep.2010.10.003; Ruan GP, 2005, PROTEIN EXPRES PURIF, V44, P45, DOI 10.1016/j.pep.2005.03.013; Schade R, 2001, SPRING LAB MAN, P218; Schade R, 2005, ATLA, V33, P1; Schade Rudiger, 1996, ALTEX, V13, P5; Schwarzkopf C, 2001, SPRING LAB MAN, P25; Silva DAO, 2002, VET PARASITOL, V107, P181, DOI 10.1016/S0304-4017(02)00132-2; Silva DAO, 2007, VET PARASITOL, V143, P234, DOI 10.1016/j.vetpar.2006.08.028; Silva NM, 2002, MICROBES INFECT, V4, P261, DOI 10.1016/S1286-4579(02)01537-X; Sohn CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018383; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; Villavedra M, 2001, INT J PARASITOL, V31, P21, DOI 10.1016/S0020-7519(00)00152-1; Wang YH, 2011, PARASITOL INT, V60, P105, DOI 10.1016/j.parint.2010.11.002; Xiao Y, 2010, BIOMARK MED, V4, P227, DOI [10.2217/bmm.10.7, 10.2217/BMM.10.7]; Xiao Y, 2008, INT J CANCER, V122, P2178, DOI 10.1002/ijc.23320; 2001, J AM VET MED ASS, V218, P669	47	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40391	10.1371/journal.pone.0040391	http://dx.doi.org/10.1371/journal.pone.0040391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808150	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400020
J	Arnold, EA; Hazelton, P; Lane, T; Christopoulos, KA; Galindo, GR; Steward, WT; Morin, SF				Arnold, Emily A.; Hazelton, Patrick; Lane, Tim; Christopoulos, Katerina A.; Galindo, Gabriel R.; Steward, Wayne T.; Morin, Stephen F.			A Qualitative Study of Provider Thoughts on Implementing Pre-Exposure Prophylaxis (PrEP) in Clinical Settings to Prevent HIV Infection	PLOS ONE			English	Article							UNITED-STATES; RISK; TRIALS; IMPACT	Background: A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabrine (TDF-FTC) can reduce HIV acquisition among men who have sex with men (MSM) and transgender (TG) women by 44%, and up to 90% if taken daily. We explored how medical and service providers understand research results and plan to develop clinical protocols to prescribe, support and monitor adherence for patients on PrEP in the United States. Methods: Using referrals from our community collaborators and snowball sampling, we recruited 22 healthcare providers in San Francisco, Oakland, and Los Angeles for in-depth interviews from May-December 2011. The providers included primary care physicians seeing high numbers of MSM and TG women, HIV specialists, community health clinic providers, and public health officials. We analyzed interviews thematically to produce recommendations for setting policy around implementing PrEP. Interview topics included: assessing clinician impressions of PrEP and CDC guidance, considerations of cost, office capacity, dosing schedules, and following patients over time. Results: Little or no demand for PrEP from patients was reported at the time of the interviews. Providers did not agree on the most appropriate patients for PrEP and believed that current models of care, which do not involve routine frequent office visits, were not well suited for prescribing PrEP. Providers detailed the need to build capacity and were concerned about monitoring side effects and adherence. PrEP was seen as potentially having impact on the epidemic but providers also noted that community education campaigns needed to be tailored to effectively reach specific vulnerable populations. Conclusions: While PrEP may be a novel and clinically compelling prevention intervention for MSM and TG women, it raises a number of important implementation challenges that would need to be addressed. Nonetheless, most providers expressed optimism that they eventually could prescribe and monitor PrEP in their practice.	[Arnold, Emily A.; Hazelton, Patrick; Lane, Tim; Galindo, Gabriel R.; Steward, Wayne T.; Morin, Stephen F.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Christopoulos, Katerina A.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Arnold, EA (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	Emily.Arnold@ucsf.edu			California HIV/AIDS Research Program [RP08-SF-603]; Evelyn and Walter Haas, Jr. Fund [P0043126]; UCSF/Gladstone Institute of Virology and Immunology Center for AIDS Research [P30 AI027763]; Center for AIDS Prevention Studies [NIMH 2P30MH-062246]; Traineeship in AIDS Prevention Studies [NIMH T32 MH019105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092220, T32MH019105, P30MH062246] Funding Source: NIH RePORTER	California HIV/AIDS Research Program; Evelyn and Walter Haas, Jr. Fund; UCSF/Gladstone Institute of Virology and Immunology Center for AIDS Research; Center for AIDS Prevention Studies; Traineeship in AIDS Prevention Studies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant to the UCSF AIDS Policy Research Center by the California HIV/AIDS Research Program (RP08-SF-603), the Evelyn and Walter Haas, Jr. Fund (P0043126), and special initiative funding from the UCSF/Gladstone Institute of Virology and Immunology Center for AIDS Research (P30 AI027763). Additional support was provided by the Center for AIDS Prevention Studies (NIMH 2P30MH-062246) and from the Traineeship in AIDS Prevention Studies (NIMH T32 MH019105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten J, 2012, ARV PREP HIV 1 PREV; Buchbinder SP, 2011, AIDS BEHAV, V15, pS72, DOI 10.1007/s10461-011-9894-1; Cahill S, 2012, PREEXPOSURE PROPHYLA; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Flash C, 2012, CURR INFECT DIS REP; Forsyth AD, 2012, CURR OPIN HIV AIDS, V7, P111, DOI 10.1097/COH.0b013e32834fcff6; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Grady D, 2012, FDA ADVISORY PANEL B; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grant RM, 2010, CLIN INFECT DIS, V50, pS96, DOI 10.1086/651479; Hazelton P., 2011, FINANCING DELIVERY M; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Kelesidis Theodoros, 2011, Curr HIV/AIDS Rep, V8, P94, DOI 10.1007/s11904-011-0078-4; Leibowitz AA, 2011, AM J PUBLIC HEALTH, V101, P982, DOI 10.2105/AJPH.2010.300066; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Michael NL, 2010, NEW ENGL J MED, V363, P2663, DOI 10.1056/NEJMe1012929; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; MSN Money, 2012, US FDA GRANTS PRIOR; Muhr T., 1997, ATLAS TI 5 KNOWLEDGE; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pazella E, 2011, COMMENTS ED PAZELLA; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Thigpen MC, 2012, IAS C HIV PATH TREAT; Underhill Kristen, 2010, Curr HIV/AIDS Rep, V7, P210, DOI 10.1007/s11904-010-0062-4; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272	30	111	111	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40603	10.1371/journal.pone.0040603	http://dx.doi.org/10.1371/journal.pone.0040603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792384	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400081
J	Brugnara, L; Vinaixa, M; Murillo, S; Samino, S; Rodriguez, MA; Beltran, A; Lerin, C; Davison, G; Correig, X; Novials, A				Brugnara, Laura; Vinaixa, Maria; Murillo, Serafin; Samino, Sara; Angel Rodriguez, Miguel; Beltran, Antoni; Lerin, Carles; Davison, Gareth; Correig, Xavier; Novials, Anna			Metabolomics Approach for Analyzing the Effects of Exercise in Subjects with Type 1 Diabetes Mellitus	PLOS ONE			English	Article							ADIPOSE-TISSUE LIPOLYSIS; INTERMEDIATE POOL SIZE; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; ADOLESCENTS; GLUCOSE; METABOLISM; CAPACITY; SUPPRESSION	The beneficial effects of exercise in patients with type 1 diabetes (T1D) are not fully proven, given that it may occasionally induce acute metabolic disturbances. Indeed, the metabolic disturbances associated with sustained exercise may lead to worsening control unless great care is taken to adjust carbohydrate intake and insulin dosage. In this work, pre- and post-exercise metabolites were analyzed using a H-1-NMR and GC-MS untargeted metabolomics approach assayed in serum. We studied ten men with T1D and eleven controls matched for age, body mass index, body fat composition, and cardiorespiratory capacity, participated in the study. The participants performed 30 minutes of exercise on a cycle-ergometer at 80% VO(2)max. In response to exercise, both groups had increased concentrations of gluconeogenic precursors (alanine and lactate) and tricarboxylic acid cycle intermediates (citrate, malate, fumarate and succinate). The T1D group, however, showed attenuation in the response of these metabolites to exercise. Conversely to T1D, the control group also presented increases in a-ketoglutarate, alpha-ketoisocaproic acid, and lipolysis products (glycerol and oleic and linoleic acids), as well as a reduction in branched chain amino acids (valine and leucine) determinations. The T1D patients presented a blunted metabolic response to acute exercise as compared to controls. This attenuated response may interfere in the healthy performance or fitness of T1D patients, something that further studies should elucidate.	[Brugnara, Laura; Murillo, Serafin; Lerin, Carles; Novials, Anna] Hosp Clin Barcelona, Dept Endocrinol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Vinaixa, Maria; Samino, Sara; Angel Rodriguez, Miguel; Beltran, Antoni; Correig, Xavier] Univ Rovira & Virgili, Tarragona, Spain; [Samino, Sara; Beltran, Antoni; Correig, Xavier] Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain; [Davison, Gareth] Univ Ulster, Sport & Exercise Sci Res Inst, Newtownabbey, North Ireland; [Brugnara, Laura; Vinaixa, Maria; Murillo, Serafin; Angel Rodriguez, Miguel; Lerin, Carles; Correig, Xavier; Novials, Anna] Spanish Biomed Res Ctr Diabet & Assoc Metab Disor, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Ulster University	Brugnara, L (corresponding author), Hosp Clin Barcelona, Dept Endocrinol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	anovials@clinic.ub.es	Vinaixa, Maria/AAB-1176-2020; Lerin, Carles/AAP-9916-2020; Correig, Xavier/K-9836-2014; Vinaixa, Maria/L-7236-2014	Vinaixa, Maria/0000-0001-9804-0171; Lerin, Carles/0000-0003-0950-4363; Correig, Xavier/0000-0002-6902-3054; Vinaixa, Maria/0000-0001-9804-0171; Samino, Sara/0000-0001-8371-679X; Novials, Anna/0000-0003-0465-2949; Rodriguez-Gomez, Miguel Angel/0000-0001-9568-9821	CIBERDEM - Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); METADIAB (Metabolism and Diabetes Project)	CIBERDEM - Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); METADIAB (Metabolism and Diabetes Project)	This work was supported by CIBERDEM - Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); METADIAB (Metabolism and Diabetes Project) 12-12-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MJ, 2009, MAGN RESON MED, V61, P525, DOI 10.1002/mrm.21808; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Bergman BC, 2012, J CLIN ENDOCR METAB, V97, P1663, DOI 10.1210/jc.2011-3172; Biolo G, 1999, DIABETES, V48, P949, DOI 10.2337/diabetes.48.5.949; Bowtell JL, 2007, SPORTS MED, V37, P1071, DOI 10.2165/00007256-200737120-00005; Chatzinikolaou A, 2008, DIABETES CARE, V31, P1397, DOI 10.2337/dc08-0072; Davison GW, 2002, FREE RADICAL BIO MED, V33, P1543, DOI 10.1016/S0891-5849(02)01090-0; DEVLIN JT, 1994, DIABETOLOGIA, V37, P358, DOI 10.1007/BF00408471; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Divertie GD, 1997, AM J PHYSIOL-ENDOC M, V272, pE1130, DOI 10.1152/ajpendo.1997.272.6.E1130; Enea C, 2010, ANAL BIOANAL CHEM, V396, P1167, DOI 10.1007/s00216-009-3289-4; Farhy LS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00040; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; GELFAND RA, 1987, J CLIN INVEST, V80, P1, DOI 10.1172/JCI113033; Gibala MJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE235; Gusso S, 2008, DIABETOLOGIA, V51, P1317, DOI 10.1007/s00125-008-1012-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HENRIKSSON J, 1991, J EXP BIOL, V160, P149; Item F, 2011, AM J PHYSIOL-REG I, V301, pR60, DOI 10.1152/ajpregu.00747.2010; Jacob S, 1999, DIABETOLOGIA, V42, P1171, DOI 10.1007/s001250051288; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Komatsu WR, 2005, PEDIATR DIABETES, V6, P145, DOI 10.1111/j.1399-543X.2005.00120.x; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Leon AS, 2000, METABOLISM, V49, P513, DOI 10.1016/S0026-0495(00)80018-9; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Levin K, 2001, DIABETOLOGIA, V44, P824; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Lindon J. C., 2007, HDB METABONOMICS MET; Makinen VP, 2006, MAGN RESON MATER PHY, V19, P281, DOI 10.1007/s10334-006-0054-y; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Palazoglu M., 2009, AGIL APPL NOTE, V2009, P5990; Palmieri V, 2008, INT J CARDIOL, V127, P390, DOI 10.1016/j.ijcard.2007.04.035; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; Perseghin G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1174, DOI 10.1152/ajpendo.00279.2003; SAHLIN K, 1990, ACTA PHYSIOL SCAND, V138, P259, DOI 10.1111/j.1748-1716.1990.tb08845.x; Schauer IE, 2011, DIABETES, V60, P306, DOI 10.2337/db10-0328; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stumvoll M, 2000, J CLIN ENDOCR METAB, V85, P3740, DOI 10.1210/jc.85.10.3740; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Valerio G, 2007, NUTR METAB CARDIOVAS, V17, P376, DOI 10.1016/j.numecd.2005.10.012; Vervoort G, 1999, HYPERTENSION, V34, P1080, DOI 10.1161/01.HYP.34.5.1080; YKIJARVINEN H, 1987, J CLIN INVEST, V80, P95, DOI 10.1172/JCI113069; YKIJARVINEN H, 1987, DIABETES, V36, P892, DOI 10.2337/diabetes.36.8.892; Zhang SC, 2009, ANAL CHEM, V81, P6080, DOI 10.1021/ac900424c	50	53	57	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40600	10.1371/journal.pone.0040600	http://dx.doi.org/10.1371/journal.pone.0040600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792382	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400079
J	Richt, JA; Rockx, B; Ma, WJ; Feldmann, F; Safronetz, D; Marzi, A; Kobasa, D; Strong, JE; Kercher, L; Long, D; Gardner, D; Brining, D; Feldmann, H				Richt, Juergen A.; Rockx, Barry; Ma, Wenjun; Feldmann, Friederike; Safronetz, David; Marzi, Andrea; Kobasa, Darwyn; Strong, James E.; Kercher, Lisa; Long, Dan; Gardner, Don; Brining, Douglas; Feldmann, Heinz			Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques	PLOS ONE			English	Article							H1N1 INFLUENZA; INFECTION; ORIGIN; TRANSMISSION; HEMAGGLUTININ; PATHOLOGY; RESPONSES; IMMUNE; PIGS; IL-6	The triple reassortant H2N3 virus isolated from diseased pigs in the United States in 2006 is pathogenic for certain mammals without prior adaptation and transmits among swine and ferrets. Adaptation, in the H2 hemagglutinin derived from an avian virus, includes the ability to bind to the mammalian receptor, a significant prerequisite for infection of mammals, in particular humans, which poses a big concern for public health. Here we investigated the pathogenic potential of swine H2N3 in Cynomolgus macaques, a surrogate model for human influenza infection. In contrast to human H2N2 virus, which served as a control and largely caused mild pneumonia similar to seasonal influenza A viruses, the swine H2N3 virus was more pathogenic causing severe pneumonia in nonhuman primates. Both viruses replicated in the entire respiratory tract, but only swine H2N3 could be isolated from lung tissue on day 6 post infection. All animals cleared the infection whereas swine H2N3 infected macaques still presented with pathologic changes indicative of chronic pneumonia at day 14 post infection. Swine H2N3 virus was also detected to significantly higher titers in nasal and oral swabs indicating the potential for animal-to-animal transmission. Plasma levels of IL-6, IL-8, MCP-1 and IFN gamma were significantly increased in swine H2N3 compared to human H2N2 infected animals supporting the previously published notion of increased IL-6 levels being a potential marker for severe influenza infections. In conclusion, the swine H2N3 virus represents a threat to humans with the potential for causing a larger outbreak in a non-immune or partially immune population. Furthermore, surveillance efforts in farmed pig populations need to become an integral part of any epidemic and pandemic influenza preparedness.	[Richt, Juergen A.; Ma, Wenjun] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Rockx, Barry; Safronetz, David; Marzi, Andrea; Feldmann, Heinz] Publ Hlth Agcy Canada, Virol Lab, Winnipeg, MB, Canada; [Feldmann, Friederike] Publ Hlth Agcy Canada, Off Operat Management, Winnipeg, MB, Canada; [Kobasa, Darwyn; Strong, James E.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Kercher, Lisa; Long, Dan; Gardner, Don; Brining, Douglas] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT USA; [Kobasa, Darwyn; Strong, James E.; Feldmann, Heinz] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Strong, James E.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada	Kansas State University; Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Manitoba; University of Manitoba	Richt, JA (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	jricht@vet.k-state.edu; feldmannh@niaid.nih.gov	Marzi, Andrea/AAF-4617-2020; Richt, Juergen/AAL-3632-2020	Marzi, Andrea/0000-0003-0186-9587; 	National Institutes of Health; Centers of Excellence for Influenza Research and Surveillance (CEIRS) of National Institute of Allergy and Infectious Disease, National Institutes of Health [HHSN266200700005C]; Kansas Bioscience Authority; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001168, ZIAAI001088, ZIGAI001048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers of Excellence for Influenza Research and Surveillance (CEIRS) of National Institute of Allergy and Infectious Disease, National Institutes of Health; Kansas Bioscience Authority; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was financially supported by the Intramural Research Program of the National Institutes of Health and by the Centers of Excellence for Influenza Research and Surveillance (CEIRS) program of the National Institute of Allergy and Infectious Disease, National Institutes of Health, under contract number HHSN266200700005C and by the Kansas Bioscience Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Beaudoin A, 2010, INFLUENZA OTHER RESP, V4, P163, DOI 10.1111/j.1750-2659.2009.00127.x; Brining DL, 2010, COMPARATIVE MED, V60, P389; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Kuiken T, 2003, VET PATHOL, V40, P304, DOI 10.1354/vp.40-3-304; Lee VJ, 2007, EMERG INFECT DIS, V13, P1052, DOI 10.3201/eid1307.061313; Liu JH, 2004, VIRUS GENES, V29, P81, DOI 10.1023/B:VIRU.0000032791.26573.f1; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Nakajima N, 2010, JPN J INFECT DIS, V63, P67; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; SCHOLTISSEK C, 1994, EUR J EPIDEMIOL, V10, P455, DOI 10.1007/BF01719674; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weingartl HM, 2009, J VIROL, V83, P4287, DOI 10.1128/JVI.02399-08; Wright P. F, 2001, ORTHOMYXOVIRUSES, P1533	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39990	10.1371/journal.pone.0039990	http://dx.doi.org/10.1371/journal.pone.0039990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808082	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400028
J	Liu, JX; Xu, Y; Zheng, CH; Wang, Y; Yang, JY				Liu, Jin-Xing; Xu, Yong; Zheng, Chun-Hou; Wang, Yi; Yang, Jing-Yu			Characteristic Gene Selection via Weighting Principal Components by Singular Values	PLOS ONE			English	Article							MICROARRAY TECHNOLOGY; STRESS RESPONSES; DNA MICROARRAY; EXPRESSION; MATRIX; IDENTIFICATION; APPROXIMATION; ONTOLOGY; DROUGHT; COLD	Conventional gene selection methods based on principal component analysis (PCA) use only the first principal component (PC) of PCA or sparse PCA to select characteristic genes. These methods indeed assume that the first PC plays a dominant role in gene selection. However, in a number of cases this assumption is not satisfied, so the conventional PCA-based methods usually provide poor selection results. In order to improve the performance of the PCA-based gene selection method, we put forward the gene selection method via weighting PCs by singular values (WPCS). Because different PCs have different importance, the singular values are exploited as the weights to represent the influence on gene selection of different PCs. The ROC curves and AUC statistics on artificial data show that our method outperforms the state-of-the-art methods. Moreover, experimental results on real gene expression data sets show that our method can extract more characteristic genes in response to abiotic stresses than conventional gene selection methods.	[Liu, Jin-Xing; Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China; [Wang, Yi] Harbin Inst Technol, Sch Mech Engn & Automat, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Zheng, Chun-Hou] Anhui Univ, Coll Elect Engn & Automat, Hefei, Anhui, Peoples R China; [Yang, Jing-Yu] Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Liu, Jin-Xing] Qufu Normal Univ, Coll Informat & Commun Technol, Rizhao, Shandong, Peoples R China; [Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Key Lab Network Oriented Intelligent Computat, Shenzhen, Guangdong, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen; Harbin Institute of Technology; University Town of Shenzhen; Anhui University; Nanjing University of Science & Technology; Qufu Normal University; Harbin Institute of Technology; University Town of Shenzhen	Liu, JX (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China.	laterfall2@yahoo.com.cn	Liu, Jin-Xing/AAU-7257-2020		National Natural Science Foundation of China [90820306]; Program for New Century Excellent Talents in University [NCET-08-0156]; NSFC [61071179]; Provincial natural science research program of higher education institutions of Anhui province [KJ2012A005]; China Postdoctoral Science Foundation [2012M510148]; Foundation of Qufu Normal University [XJ200947]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NSFC(National Natural Science Foundation of China (NSFC)); Provincial natural science research program of higher education institutions of Anhui province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Qufu Normal University	This work was supported by fund for Key Research Project of National Natural Science Foundation of China under grant No. 90820306; Program for New Century Excellent Talents in University (No. NCET-08-0156), NSFC under grant No. 61071179; Provincial natural science research program of higher education institutions of Anhui province, No. KJ2012A005; China Postdoctoral Science Foundation Funded Project, No. 2012M510148; The Foundation of Qufu Normal University under grant, No. XJ200947. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blevins T, 2010, METHODS MOL BIOL, V631, P87, DOI 10.1007/978-1-60761-646-7_9; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; De Haan JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-158; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Josefsen K, 2011, METHODS MOL BIOL, V703, P87, DOI 10.1007/978-1-59745-248-9_7; Journee M, 2010, J MACH LEARN RES, V11, P517; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Lai ZH, 2011, NEUROCOMPUTING, V74, P629, DOI 10.1016/j.neucom.2010.09.010; Liu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002689; Liu J.X., 2012, COMPUT BIOL MED, DOI [10.1016/j.compbiomed.2012.1002.1002, DOI 10.1016/J.COMPBIOMED.2012.1002.1002]; Liu JX, 2011, LASSO LOGISTIC REGRE, p463~466; Luss R, 2010, OPTIM ENG, V11, P145, DOI 10.1007/s11081-008-9057-z; Ma S, 2009, BIOINFORMATICS, V25, P882, DOI 10.1093/bioinformatics/btp085; Maan NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012782; Musumarra G, 2004, J CHEMOMETR, V18, P125, DOI 10.1002/cem.846; Park MS, 2009, PATTERN RECOGN, V42, P2353, DOI 10.1016/j.patcog.2009.04.011; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sampson DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024973; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang H, 2003, PATTERN RECOGN, V36, P563, DOI 10.1016/S0031-3203(02)00048-1; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	34	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38873	10.1371/journal.pone.0038873	http://dx.doi.org/10.1371/journal.pone.0038873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808018	Green Published, gold			2022-12-27	WOS:000306355500005
J	Madan, RP; Carpenter, C; Fiedler, T; Kalyoussef, S; McAndrew, TC; Viswanathan, S; Kim, M; Keller, MJ; Fredricks, DN; Herold, BC				Madan, Rebecca Pellett; Carpenter, Colleen; Fiedler, Tina; Kalyoussef, Sabah; McAndrew, Thomas C.; Viswanathan, Shankar; Kim, Mimi; Keller, Marla J.; Fredricks, David N.; Herold, Betsy C.			Altered Biomarkers of Mucosal Immunity and Reduced Vaginal Lactobacillus Concentrations in Sexually Active Female Adolescents	PLOS ONE			English	Article							SIMPLEX-VIRUS INFECTION; DISEASES TREATMENT GUIDELINES; HUMAN-IMMUNODEFICIENCY-VIRUS; BACTERIAL VAGINOSIS; GENITAL-TRACT; CHLAMYDIA-TRACHOMATIS; PROTECTIVE IMMUNITY; HUMAN LACTOFERRIN; QUANTITATIVE PCR; HIV ACQUISITION	Background: Genital secretions collected from adult women exhibit in vitro activity against herpes simplex virus (HSV) and coli (E. coli), but prior studies have not investigated this endogenous antimicrobial activity or its mediators in adolescent females. Methodology/Principal Findings: Anti-HSV and anti-E.coli activity were quantified from cervicovaginal lavage (CVL) specimens collected from 20 sexually active adolescent females (15-18 years). Soluble immune mediators that may influence this activity were measured in CVL, and concentrations of Lactobacillus jensenii and crispatus were quantified by PCR from vaginal swabs. Results for adolescents were compared to those obtained from 54 healthy, premenopausal adult women. Relative to specimens collected from adults, CVL collected from adolescent subjects had significantly reduced activity against E. coli and diminished concentrations of protein, IgG, and IgA but significantly increased anti-HSV activity and concentrations of interleukin (IL)-1 alpha, IL-6 and IL-1 receptor antagonist. Vaginal swabs collected from adolescent subjects had comparable concentrations of L. crispatus but significantly reduced concentrations of L. jensenii, relative to adult swabs. Conclusions/Significance: Biomarkers of genital mucosal innate immunity may differ substantially between sexually active adolescents and adult women. These findings warrant further study and may have significant implications for prevention of sexually transmitted infections in adolescent females.	[Madan, Rebecca Pellett; Carpenter, Colleen; Kalyoussef, Sabah; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Viswanathan, Shankar; Kim, Mimi] Albert Einstein Coll Med, Dept Epidemiol, New York, NY USA; [Viswanathan, Shankar; Kim, Mimi] Albert Einstein Coll Med, Dept Populat Hlth, New York, NY USA; [Keller, Marla J.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [McAndrew, Thomas C.; Keller, Marla J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Obstet & Gynecol, New York, NY USA; [McAndrew, Thomas C.; Keller, Marla J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Womens Hlth, New York, NY USA; [Fiedler, Tina; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Fred Hutchinson Cancer Center	Madan, RP (corresponding author), Albert Einstein Coll Med, Dept Pediat, New York, NY USA.	rebecca.madan@einstein.yu.edu	Viswanathan, Shankar/AAX-5281-2020	Viswanathan, Shankar/0000-0003-3349-9090; Herold, Betsy/0000-0001-9974-0786	National Institute of Allergy and Infectious Diseases [K23AI089271]; National Center for Research Resources, a component of the National Institutes of Health [UL1 RR025750, KL2 RR025748, TL1 RR025748]; United States Public Health Service [AI065309, AI061628]; Infectious Disease Society of America Young Investigator Award; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025748, UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065309, K23AI089271, R01AI061628] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Infectious Disease Society of America Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Award Number K23AI089271 from the National Institute of Allergy and Infectious Diseases; Clinical and Translational Science Award Grant UL1 RR025750 and KL2 RR025748 and TL1 RR025748 from the National Center for Research Resources, a component of the National Institutes of Health; United States Public Health Service Grants AI065309 (to BCH) and AI061628 (to DNF), and the Infectious Disease Society of America Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Cole AM, 2006, CURR TOP MICROBIOL, V306, P199; Crernel M, 2006, VACCINE, V24, P5744, DOI 10.1016/j.vaccine.2006.04.044; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; Draper DL, 2000, AM J OBSTET GYNECOL, V183, P1243, DOI 10.1067/mob.2000.107383; Feierman J, 2002, TEENAGERS HLTH CARE; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2011, ANAEROBE, V17, P191, DOI 10.1016/j.anaerobe.2011.01.001; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Geisler WM, 2011, CLIN INFECT DIS, V53, pS92, DOI 10.1093/cid/cir698; Graver MA, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-8; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Hwang LY, 2011, J REPROD IMMUNOL, V88, P66, DOI 10.1016/j.jri.2010.07.008; Jaspan HB, 2011, J INFECT DIS, V204, P1550, DOI 10.1093/infdis/jir591; John M, 2005, J INFECT DIS, V192, P1731, DOI 10.1086/497168; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; Lee-Huang S, 2005, BIOCHEMISTRY-US, V44, P4648, DOI 10.1021/bi0477081; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; MANSFIELD MJ, 1984, J REPROD MED, V29, P399; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; Marrazzo JM, 2011, ANAEROBE, V17, P186, DOI 10.1016/j.anaerobe.2011.03.016; Marrazzo JM, 2006, J INFECT DIS, V193, P1475, DOI 10.1086/503783; Matu MN, 2010, ANAEROBE, V16, P210, DOI 10.1016/j.anaerobe.2009.11.002; MCCOMB DE, 1979, J INFECT DIS, V139, P628, DOI 10.1093/infdis/139.6.628; Mitchell CM, 2008, AIDS RES HUM RETROV, V24, P667, DOI [10.1089/aid.2007.0268, 10.1089/aid.2008.0268]; MOSS GB, 1991, J INFECT DIS, V164, P588, DOI 10.1093/infdis/164.3.588; Rank RG, 2010, J INFECT DIS, V201, pS168, DOI 10.1086/652399; Rebbapragada A, 2008, JAIDS-J ACQ IMM DEF, V49, P520, DOI 10.1097/QAI.0b013e318189a7ca; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Saidi H, 2006, J IMMUNOL, V177, P5540, DOI 10.4049/jimmunol.177.8.5540; Shrier LA, 2003, J ADOLESCENT HEALTH, V32, P183, DOI 10.1016/S1054-139X(02)00536-0; Shust GF, 2010, AM J REPROD IMMUNOL, V63, P110, DOI 10.1111/j.1600-0897.2009.00768.x; TUFFREY M, 1990, J EXP PATHOL, V71, P403; Valimaa H, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-53; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; WOLNERHANSSEN P, 1991, SEX TRANSM DIS, V18, P21, DOI 10.1097/00007435-199101000-00005; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls, 1986, J ADOLESC HLTH CARE, V7, P229	44	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40415	10.1371/journal.pone.0040415	http://dx.doi.org/10.1371/journal.pone.0040415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808157	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500041
J	Derrible, S				Derrible, Sybil			Network Centrality of Metro Systems	PLOS ONE			English	Article							TRANSPORT; GROWTH; SUBWAY	Whilst being hailed as the remedy to the world's ills, cities will need to adapt in the 21st century. In particular, the role of public transport is likely to increase significantly, and new methods and technics to better plan transit systems are in dire need. This paper examines one fundamental aspect of transit: network centrality. By applying the notion of betweenness centrality to 28 worldwide metro systems, the main goal of this paper is to study the emergence of global trends in the evolution of centrality with network size and examine several individual systems in more detail. Betweenness was notably found to consistently become more evenly distributed with size (i.e. no "winner takes all") unlike other complex network properties. Two distinct regimes were also observed that are representative of their structure. Moreover, the share of betweenness was found to decrease in a power law with size (with exponent 1 for the average node), but the share of most central nodes decreases much slower than least central nodes (0.87 vs. 2.48). Finally the betweenness of individual stations in several systems were examined, which can be useful to locate stations where passengers can be redistributed to relieve pressure from overcrowded stations. Overall, this study offers significant insights that can help planners in their task to design the systems of tomorrow, and similar undertakings can easily be imagined to other urban infrastructure systems (e.g., electricity grid, water/wastewater system, etc.) to develop more sustainable cities.	Singapore MIT Alliance Res & Technol, Future Urban Mobil Interdisciplinary Grp, Singapore, Singapore	Singapore-MIT Alliance for Research & Technology Centre (SMART)	Derrible, S (corresponding author), Singapore MIT Alliance Res & Technol, Future Urban Mobil Interdisciplinary Grp, Singapore, Singapore.	derrible@mit.edu		Derrible, Sybil/0000-0002-2939-6016				[Anonymous], 2011, NATL GEOGRAPHIC MAGA; APTA, 2011, POT IMP GAS PRIC INC; Banavar JR, 2000, PHYS REV LETT, V84, P4745, DOI 10.1103/PhysRevLett.84.4745; Barthelemy M, 2004, EUR PHYS J B, V38, P163, DOI 10.1140/epjb/e2004-00111-4; Batty M., 2005, CITIES COMPLEXITY UN; Bavelas A., 1950, J ACOUST SOC AM, V22, P725, DOI [10.1121/1.1906679, DOI 10.1121/1.1906679]; Bavelas A, 1948, APPL ANTHROPOL, V7, P16, DOI [DOI 10.17730/HUMO.7.3.F4033344851GL053, 10.17730/humo.7.3.f4033344851gl053]; Berche B, 2009, EUR PHYS J B, V71, P125, DOI 10.1140/epjb/e2009-00291-3; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bilbao-Ubillos J, 2008, TRANSPORT RES A-POL, V42, P1098, DOI 10.1016/j.tra.2008.03.015; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Curtis C, 2011, TRANSPORT REV, V31, P179, DOI 10.1080/01441647.2010.525330; Danila B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.046114; Derrible S., 2010, THESIS U TORONTO TOR; Derrible S, 2011, TRANSPORT REV, V31, P495, DOI 10.1080/01441647.2010.543709; Derrible S, 2010, TRANSP RES RECORD, P43, DOI 10.3141/2146-06; Derrible S, 2010, PHYSICA A, V389, P3678, DOI 10.1016/j.physa.2010.04.008; Derrible S, 2010, TRANSPORTATION, V37, P275, DOI 10.1007/s11116-009-9227-7; Derrible S, 2009, TRANSPORT RES REC, P17, DOI 10.3141/2112-03; Dickens M, 2011, 2011 PUBLIC TRANSPOR; Forkenbrock DJ., 2001, GUIDEBOOK ASSESSING; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Glaeser EL, 2010, J REGIONAL SCI, V50, P221, DOI 10.1111/j.1467-9787.2009.00635.x; Glaeser EL, 2011, TRIUMPH CITY OUR GRE; Kennedy C., 2011, EVOLUTION GREAT WORL; Kuhnert C, 2006, PHYSICA A, V363, P96, DOI 10.1016/j.physa.2006.01.058; Laird JJ, 2005, TRANSP POLICY, V12, P537, DOI 10.1016/j.tranpol.2005.07.003; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; LEAVITT HJ, 1951, J ABNORM SOC PSYCH, V46, P38, DOI 10.1037/h0057189; Levinson D, 2006, TRANSPORT SCI, V40, P179, DOI 10.1287/trsc.1050.0132; Levinson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029721; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Northridge ME, 2011, J URBAN HEALTH, V88, P582, DOI 10.1007/s11524-011-9558-5; Oosterhaven J, 2003, TRANSPORT PROJECTS P; Ovenden M., 2007, TRANSIT MAPS WORLD; Pandit A., 2011, POW SYST C EXP PSCE, P1, DOI [10.1109/PSCE.2011.5772587, DOI 10.1109/PSCE.2011.5772587]; Parthasarathi P, 2012, ENVIRON PLANN B, V39, P137, DOI 10.1068/b36139; Porta S, 2009, ENVIRON PLANN B, V36, P450, DOI 10.1068/b34098; Roth C, 2012, J R SOC INTERFACE, V9, P2540, DOI 10.1098/rsif.2012.0259; Samaniego H., 2008, J TRANSP LAND USE, V1, P21, DOI [DOI 10.5198/JTLU.V1I1.29, 10.5198/jtlu.v1i1.29]; Sienkiewicz J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046127; Smith M., 2010, NODEXL FREE OPEN NET; Strogatz SH, 2009, NY TIMES; Taylor BW, 2007, INTRO MANAGEMENT SCI; TCRP, 1999, US PUBL TRANSP RED E; TED, 2012, TED PRIZ WISH BIG EN; TEODOROVIC D., 1986, TRANSPORTATION NETWO; von Ferber C, 2007, PHYSICA A, V380, P585, DOI 10.1016/j.physa.2007.02.101; von Ferber C, 2009, EUR PHYS J B, V68, P261, DOI 10.1140/epjb/e2009-00090-x; Vuchic V.R., 1999, TRANSPORTATION LIVAB; Wang FH, 2011, J TRANSP GEOGR, V19, P285, DOI 10.1016/j.jtrangeo.2010.01.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xie F, 2007, GEOGR ANAL, V39, P336, DOI 10.1111/j.1538-4632.2007.00707.x; Xie F, 2009, NETW SPAT ECON, V9, P291, DOI 10.1007/s11067-007-9037-4	56	95	97	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40575	10.1371/journal.pone.0040575	http://dx.doi.org/10.1371/journal.pone.0040575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792373	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800108
J	Sustar, V; Zelko, J; Lopalco, P; Lobasso, S; Ota, A; Ulrih, NP; Corcelli, A; Kralj-iglic, V				Sustar, Vid; Zelko, Jasna; Lopalco, Patrizia; Lobasso, Simona; Ota, Ajda; Ulrih, Natasa Poklar; Corcelli, Angela; Kralj-iglic, Veronika			Morphology, Biophysical Properties and Protein-Mediated Fusion of Archaeosomes	PLOS ONE			English	Article							GIANT PHOSPHOLIPID-VESICLES; LIPID-MEMBRANES; BENDING ELASTICITY; PHASE-TRANSITION; FLUID MEMBRANES; POLAR LIPIDS; CURVATURE; BETA(2)-GLYCOPROTEIN-I; STABILITY; LIPOSOMES	As variance from standard phospholipids of eubacteria and eukaryotes, archaebacterial diether phospholipids contain branched alcohol chains (phytanol) linked to glycerol exclusively with ether bonds. Giant vesicles (GVs) constituted of different species of archaebacterial diether phospholipids and glycolipids (archaeosomes) were prepared by electroformation and observed under a phase contrast and/or fluorescence microscope. Archaebacterial lipids and different mixtures of archaebacterial and standard lipids formed GVs which were analysed for size, yield and ability to adhere to each other due to the mediating effects of certain plasma proteins. GVs constituted of different proportions of archaeal or standard phosphatidylcholine were compared. In nonarchaebacterial GVs ( in form of multilamellar lipid vesicles, MLVs) the main transition was detected at T-m=34.2 degrees C with an enthalpy of Delta H=0.68 kcal/mol, whereas in archaebacterial GVs (MLVs) we did not observe the main phase transition in the range between 10 and 70 degrees C. GVs constituted of archaebacterial lipids were subject to attractive interaction mediated by beta 2 glycoprotein I and by heparin. The adhesion constant of beta 2 glycoprotein I - mediated adhesion determined from adhesion angle between adhered GVs was in the range of 10(-8) J/m(2). In the course of protein mediated adhesion, lateral segregation of the membrane components and presence of thin tubular membranous structures were observed. The ability of archaebacterial diether lipids to combine with standard lipids in bilayers and their compatibility with adhesion-mediating molecules offer further evidence that archaebacterial lipids are appropriate for the design of drug carriers.	[Sustar, Vid; Zelko, Jasna] Univ Ljubljana, Fac Med, Chair Orthopaed, Lab Clin Biophys, Ljubljana, Slovenia; [Lopalco, Patrizia; Lobasso, Simona; Corcelli, Angela] Univ Bari Aldo Moro, Dept Med Biochem Biol & Phys, Bari, Italy; [Ota, Ajda; Ulrih, Natasa Poklar] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Ljubljana, Slovenia; [Corcelli, Angela] IPCF CNR, Bari, Italy; [Kralj-iglic, Veronika] Univ Ljubljana, Fac Hlth Sci, Biomed Res Grp, Ljubljana, Slovenia	University of Ljubljana; Universita degli Studi di Bari Aldo Moro; University of Ljubljana; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); University of Ljubljana	Sustar, V (corresponding author), Univ Ljubljana, Fac Med, Chair Orthopaed, Lab Clin Biophys, Ljubljana, Slovenia.	veronika.kralj-iglic@fe.uni-lj.si	Ulrih, Natasa Poklar/B-2015-2008; LOBASSO, SIMONA/AAN-9109-2020	LOBASSO, SIMONA/0000-0003-3566-4547; Lopalco, Patrizia/0000-0003-3475-7485; Kralj-Iglic, Veronika/0000-0002-7496-2005; Ota, Ajda/0000-0001-6309-6669; Corcelli, Angela/0000-0001-9658-8520; Poklar Ulrih, Natasa/0000-0002-2731-9973	Italian Defense Ministry [9199, 2005]; Regione Puglia of Italy [15]; ARRS [P2-0232, J3-2120, J2-9219]	Italian Defense Ministry; Regione Puglia of Italy; ARRS(Slovenian Research Agency - Slovenia)	This work has been supported by the Italian Defense Ministry (contract 9199, 2005, http://www.difesa.it/default.htm) and Regione Puglia of Italy (Grant code 15, sens&MicroLab, http://www.regione.puglia.it/), and ARRS grants P2-0232, J3-2120 and J2-9219, http://www.arrs.gov.si/sl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2000, FRONT BIOSCI, V5, pD813; Alessandrini A, 2009, J PHYS CHEM B, V113, P3437, DOI 10.1021/jp809705d; Ambroic A, 2006, AUTOIMMUN REV, V6, P10, DOI 10.1016/j.autrev.2006.03.001; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Bagatolli L, 2000, BIOPHYS J, V79, P416, DOI 10.1016/S0006-3495(00)76303-X; Bagatolli LA, 2000, CHEM PHYS LIPIDS, V105, P135, DOI 10.1016/S0009-3084(00)00118-3; Bagatolli LA, 2010, PROG LIPID RES, V49, P378, DOI 10.1016/j.plipres.2010.05.001; Besnard M, 1997, J BIOL CHEM, V272, P992, DOI 10.1074/jbc.272.2.992; Bohinc K, 2004, EUROPHYS LETT, V68, P494, DOI 10.1209/epl/i2004-10250-2; BRIGHTON TA, 1994, BAILLIERE CLIN HAEM, V7, P541, DOI 10.1016/S0950-3536(05)80098-8; CAVAGNETTO F, 1992, BIOCHIM BIOPHYS ACTA, V1106, P273, DOI 10.1016/0005-2736(92)90006-8; Corcelli A, 2006, METHOD MICROBIOL, V35, P585, DOI 10.1016/S0580-9517(08)70028-X; DEULING HJ, 1976, J PHYS-PARIS, V37, P1335, DOI 10.1051/jphys:0197600370110133500; DUWE HP, 1990, PHYSICA A, V163, P410, DOI 10.1016/0378-4371(90)90349-W; ELFERINK MGL, 1993, EUR J BIOCHEM, V214, P917, DOI 10.1111/j.1432-1033.1993.tb17995.x; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; FAUCON JF, 1989, J PHYS-PARIS, V50, P2389, DOI 10.1051/jphys:0198900500170238900; Fosnaric M, 2005, J CHEM INF MODEL, V45, P1652, DOI 10.1021/ci050171t; Gambacorta A, 1985, WORLD J MICROB BIOT, V11, P115; Gamsjaeger R, 2005, BIOCHEM J, V389, P665, DOI 10.1042/BJ20050156; Genova J, 2009, J OPTOELECTRON ADV M, V11, P1222; Gmajner D, 2011, CHEM PHYS LIPIDS, V164, P236, DOI 10.1016/j.chemphyslip.2011.01.005; Gram GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006950; Hamdan R, 2007, BIOCHEMISTRY-US, V46, P10612, DOI 10.1021/bi700621j; Hammel M, 2001, BIOCHEMISTRY-US, V40, P14173, DOI 10.1021/bi0114372; Iglic A, 2010, BIOELECTROCHEMISTRY, V79, P223, DOI 10.1016/j.bioelechem.2010.05.003; Israelachvili J., 1997, INTERMOLECULAR SURFA; Julicher F, 1996, PHYS REV E, V53, P2670, DOI 10.1103/PhysRevE.53.2670; Kamath AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005771; KAS J, 1991, BIOPHYS J, V60, P825, DOI 10.1016/S0006-3495(91)82117-8; Kate M., 1993, BIOCH ARCHAEA ARCHAE, V26, P261, DOI DOI 10.1016/S0167-7306(08)60258-6; KATES M, 1968, CAN J BIOCHEM CELL B, V46, P971, DOI 10.1139/o68-145; KATES M, 1973, J LIPID RES, V14, P438; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Kralj-Iglic V, 1999, EUR PHYS J B, V10, P5, DOI 10.1007/s100510050822; Kralj-Iglic V, 2001, COLLOID SURFACE A, V181, P315, DOI 10.1016/S0927-7757(00)00802-5; Lamblet M, 2008, EUR PHYS J E, V26, P205, DOI 10.1140/epje/i2007-10317-x; Lobasso S, 2003, J LIPID RES, V44, P2120, DOI 10.1194/jlr.M300212-JLR200; Lobasso S, 2009, CHEM PHYS LIPIDS, V157, P12, DOI 10.1016/j.chemphyslip.2008.09.002; Lopalco P, 2004, J LIPID RES, V45, P194, DOI 10.1194/jlr.M300329-JLR200; Maaty WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006964; Mares T, 2012, SCI WORLD J, DOI 10.1100/2012/146804; Mathai JC, 2001, J BIOL CHEM, V276, P27266, DOI 10.1074/jbc.M103265200; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; May S, 2008, J PHYS CHEM B, V112, P1685, DOI 10.1021/jp073355e; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; Patel GB, 2000, INT J PHARM, V194, P39, DOI 10.1016/S0378-5173(99)00331-2; Patel GB, 1999, CRIT REV BIOTECHNOL, V19, P317, DOI 10.1080/0738-859991229170; Pavliv JI, 2010, CR ACAD BULG SCI, V63, P497; Peterlin P, 2008, COLLOID SURFACE B, V64, P77, DOI 10.1016/j.colsurfb.2008.01.004; POLZ E, 1979, BIOCHEM BIOPH RES CO, V90, P1305, DOI 10.1016/0006-291X(79)91178-1; Rappolt M., 2008, STRUCTURE DYNAMICS M, P45; Rappolt M, 2008, CHEM PHYS LIPIDS, V154, P46, DOI 10.1016/j.chemphyslip.2008.02.006; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; SEIFERT U, 1990, PHYS REV A, V42, P4768, DOI 10.1103/PhysRevA.42.4768; Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488; SONG JB, 1993, BIOPHYS J, V64, P1967, DOI 10.1016/S0006-3495(93)81566-2; Sprott GD, 2008, GLYCOBIOLOGY, V18, P559, DOI 10.1093/glycob/cwn038; Sprott GD, 2009, GLYCOBIOLOGY, V19, P267, DOI 10.1093/glycob/cwn129; Sprott GD, 1997, FEMS MICROBIOL LETT, V154, P17, DOI 10.1016/S0378-1097(97)00294-2; Sustar V, 2009, BLOOD CELL MOL DIS, V42, P223, DOI 10.1016/j.bcmd.2009.01.012; Tomsie N, 2005, J CHEM INF MODEL, V45, P1676, DOI 10.1021/ci050188b; Ulrih NP, 2009, APPL MICROBIOL BIOT, V84, P249, DOI 10.1007/s00253-009-2102-9; Urbanija J, 2008, EUR BIOPHYS J BIOPHY, V37, P1085, DOI 10.1007/s00249-007-0252-1; Urbanija J, 2007, CHEM PHYS LIPIDS, V150, P49, DOI 10.1016/j.chemphyslip.2007.06.216; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Vitkova V, 2003, J MATER SCI-MATER EL, V14, P819, DOI 10.1023/A:1026129910215; Yaghmur A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000479; ZILKER A, 1987, J PHYS-PARIS, V48, P2139, DOI 10.1051/jphys:0198700480120213900; ZILKER A, 1992, PHYS REV A, V46, P7998, DOI 10.1103/PhysRevA.46.7998	70	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39401	10.1371/journal.pone.0039401	http://dx.doi.org/10.1371/journal.pone.0039401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792173	Green Submitted, gold, Green Published			2022-12-27	WOS:000306461800011
J	Boulanger, A; Farge, M; Ramanoudjame, C; Wharton, K; Dura, JM				Boulanger, Ana; Farge, Morgane; Ramanoudjame, Christophe; Wharton, Kristi; Dura, Jean-Maurice			Drosophila Motor Neuron Retraction during Metamorphosis Is Mediated by Inputs from TGF-beta/BMP Signaling and Orphan Nuclear Receptors	PLOS ONE			English	Article							B ECDYSONE RECEPTOR; SYNAPTIC GROWTH; CELL-MIGRATION; II RECEPTOR; STABILIZATION; EXPRESSION; SYSTEM; AXONS; GENE; DEGENERATION	Larval motor neurons remodel during Drosophila neuro-muscular junction dismantling at metamorphosis. In this study, we describe the motor neuron retraction as opposed to degeneration based on the early disappearance of beta-Spectrin and the continuing presence of Tubulin. By blocking cell dynamics with a dominant-negative form of Dynamin, we show that phagocytes have a key role in this process. Importantly, we show the presence of peripheral glial cells close to the neuromuscular junction that retracts before the motor neuron. We show also that in muscle, expression of EcR-B1 encoding the steroid hormone receptor required for postsynaptic dismantling, is under the control of the ftz-f1/Hr39 orphan nuclear receptor pathway but not the TGF-beta signaling pathway. In the motor neuron, activation of EcR-B1 expression by the two parallel pathways (TGF-beta signaling and nuclear receptor) triggers axon retraction. We propose that a signal from a TGF-beta family ligand is produced by the dismantling muscle (postsynapse compartment) and received by the motor neuron (presynaptic compartment) resulting in motor neuron retraction. The requirement of the two pathways in the motor neuron provides a molecular explanation for the instructive role of the postsynapse degradation on motor neuron retraction. This mechanism insures the temporality of the two processes and prevents motor neuron pruning before postsynaptic degradation.	[Boulanger, Ana; Farge, Morgane; Ramanoudjame, Christophe; Wharton, Kristi; Dura, Jean-Maurice] Inst Human Genet, CNRS UPR1142, Dept Genet & Dev, Montpellier, France; [Wharton, Kristi] Brown Univ, Div Biol & Med, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Brown University	Boulanger, A (corresponding author), Inst Human Genet, CNRS UPR1142, Dept Genet & Dev, Montpellier, France.	ana.boulanger@igh.cnrs.fr; jmdura@igh.cnrs.fr			Centre National de la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer [3744]; Association Francaise contre les Myopathies [MNM1 2007]; Agence Nationale de la Recherche [ANR-07-NEURO-034-01]; AFM; ANR; National Institutes of Health [GM068118]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM068118, R01GM068118] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); AFM(Association Francaise contre les Myopathies); ANR(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Association pour la Recherche sur le Cancer (no 3744), the Association Francaise contre les Myopathies (MNM1 2007) and the Agence Nationale de la Recherche (ANR-07-NEURO-034-01). AB was supported by a postdoctoral fellowship from AFM and from ANR. MF was supported by ANR. CR was supported by AFM. Additional support was provided by National Institutes of Health GM068118 to KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Awasaki T, 2011, NAT NEUROSCI, V14, P6, DOI 10.1038/nn0111-6; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Boulanger A, 2011, NAT NEUROSCI, V14, P37, DOI 10.1038/nn.2700; BROADIE KS, 1991, DEVELOPMENT, V113, P103; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Fernandes JJ, 1999, INT REV NEUROBIOL, V43, P221, DOI 10.1016/S0074-7742(08)60547-4; Fortier TA, 2003, DEV BIOL, V257, P153, DOI 10.1016/S0012-1606(03)00036-8; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Garbe DS, 2007, DEVELOPMENT, V134, P273, DOI 10.1242/dev.02653; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Hebbar S, 2010, DEV BIOL, V340, P344, DOI 10.1016/j.ydbio.2010.01.005; Kamiya Y, 2008, FEBS LETT, V582, P2496, DOI 10.1016/j.febslet.2008.05.052; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Liu ZW, 2010, J NEUROSCI, V30, P11624, DOI 10.1523/JNEUROSCI.0410-10.2010; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Paladi M, 2004, J CELL SCI, V117, P6313, DOI 10.1242/jcs.01552; Parker L, 2006, DEVELOPMENT, V133, P4981, DOI 10.1242/dev.02673; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116; Ranjan R, 1998, J NEUROSCI, V18, P956; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	46	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40255	10.1371/journal.pone.0040255	http://dx.doi.org/10.1371/journal.pone.0040255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792255	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300041
J	Ferrer, IR; Wagener, ME; Song, MQ; Ford, ML				Ferrer, Ivana R.; Wagener, Maylene E.; Song, Mingqing; Ford, Mandy L.			CD154 Blockade Alters Innate Immune Cell Recruitment and Programs Alloreactive CD8(+) T Cells into KLRG-1 high Short-Lived Effector T Cells\	PLOS ONE			English	Article							DONOR-SPECIFIC TRANSFUSION; CARDIAC ALLOGRAFT-REJECTION; CD40 LIGAND; TRANSPLANTATION TOLERANCE; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; NONHUMAN-PRIMATES; ACUTE INFECTION; EXPRESSION; SKIN	CD154/CD40 blockade combined with donor specific transfusion remains one of the most effective therapies in prolonging allograft survival. Despite this, the mechanisms by which these pathways synergize to prevent rejection are not completely understood. Utilizing a BALB/c (H2-K-d) to B6 (H2-K-b) fully allogeneic skin transplant model system, we performed a detailed longitudinal analysis of the kinetics and magnitude of CD8(+) T cell expansion and differentiation in the presence of CD154/CD40 pathway blockade. Results demonstrated that treatment with anti-CD154 vs. DST had distinct and opposing effects on activated CD44(high) CD62L(low) CD8(+) T cells in skin graft recipients. Specifically, CD154 blockade delayed alloreactive CD8(+) T cell responses, while DST accelerated them. DST inhibited the differentiation of alloreactive CD8(+) T cells into multi-cytokine producing effectors, while CD40/CD154 blockade led to the diminution of the KLRG-1(low) long-lived memory precursor population compared with either untreated or DST treated animals. Moreover, only CD154 blockade effectively inhibited CXCL1 expression and neutrophil recruitment into the graft. When combined, anti-CD154 and DST acted synergistically to profoundly diminish the absolute number of IFN-gamma producing alloreactive CD8(+) T cells, and intra-graft expression of inflammatory chemokines. These findings demonstrate that the previously described ability of anti-CD154 and DST to result in alloreactive T cell deletion involves both delayed kinetics of T cell expansion and differentiation and inhibited development of KLRG-1(low) memory precursor cells.	[Ferrer, Ivana R.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA; Emory Univ, Dept Surg, Atlanta, GA 30322 USA	Emory University; Emory University	Ferrer, IR (corresponding author), Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA.	mandy.ford@emory.edu			National Institutes of Health [AI073707, AI079409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI079409, R01AI073707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI073707 and AI079409 to Mandy L. Ford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badell IR, 2012, AM J TRANSPLANT, V12, P126, DOI 10.1111/j.1600-6143.2011.03736.x; El-Sawy T, 2005, CIRCULATION, V112, P320, DOI 10.1161/CIRCULATIONAHA.104.516708; Floyd TL, 2011, J IMMUNOL, V186, P2033, DOI 10.4049/jimmunol.1003015; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hancock WW, 1996, P NATL ACAD SCI USA, V93, P13967, DOI 10.1073/pnas.93.24.13967; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Kondo T, 1996, TRANSPLANTATION, V61, P1750, DOI 10.1097/00007890-199606270-00015; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633; Margenthaler JA, 2003, TRANSPLANTATION, V75, P2119, DOI 10.1097/01.TP.0000069043.57679.85; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Pearl JP, 2007, TRANSPLANTATION, V83, P1219, DOI 10.1097/01.tp.0000259929.04596.d5; Pearson T, 2003, DIABETES, V52, P321, DOI 10.2337/diabetes.52.2.321; Phillips NE, 2003, J IMMUNOL, V170, P3015, DOI 10.4049/jimmunol.170.6.3015; Pluvinet R, 2004, BLOOD, V104, P3642, DOI 10.1182/blood-2004-03-0817; Preston EH, 2005, AM J TRANSPLANT, V5, P1032, DOI 10.1111/j.1600-6143.2005.00796.x; Quezada SA, 2003, BLOOD, V102, P1920, DOI 10.1182/blood-2003-02-0586; Ripoll E, 2011, GENE THER, V18, P945, DOI 10.1038/gt.2011.39; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shen X, 2010, AM J TRANSPLANT, V10, P1729, DOI 10.1111/j.1600-6143.2010.03205.x; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; van Maurik A, 2004, J IMMUNOL, V172, P2163, DOI 10.4049/jimmunol.172.4.2163; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhang T, 2011, AM J TRANSPLANT, V11, P1599, DOI 10.1111/j.1600-6143.2011.03624.x; Zheng XX, 1999, J IMMUNOL, V162, P4983	31	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40559	10.1371/journal.pone.0040559	http://dx.doi.org/10.1371/journal.pone.0040559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792369	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300072
J	Gaykalova, D; Vatapalli, R; Glazer, CA; Bhan, S; Shao, CB; Sidransky, D; Ha, PK; Califano, JA				Gaykalova, Daria; Vatapalli, Rajita; Glazer, Chad A.; Bhan, Sheetal; Shao, Chunbo; Sidransky, David; Ha, Patrick K.; Califano, Joseph A.			Dose-Dependent Activation of Putative Oncogene SBSN by BORIS	PLOS ONE			English	Article							CANCER-TESTIS GENE; TRANSCRIPTION FACTOR BORIS; LUNG-CANCER; CHROMOSOMAL-ABERRATIONS; HISTONE H3; LYSINE 9; EXPRESSION; CTCF; METHYLATION; CELLS	Testis-specific transcription factor BORIS (Brother of the Regulator of Imprinted Sites), a paralog and proposed functional antagonist of the widely expressed CTCF, is abnormally expressed in multiple tumor types and has been implicated in the epigenetic activation of cancer-testis antigens (CTAs). We have reported previously that suprabasin (SBSN), whose expression is restricted to the epidermis, is epigenetically derepressed in lung cancer. In this work, we establish that SBSN is a novel non-CTA target of BORIS epigenetic regulation. With the use of a doxycycline-inducible BORIS expressing vector, we demonstrate that relative BORIS dosage is critical for SBSN activation. At lower concentrations, BORIS induces demethylation of the SBSN CpG island and disruption and activation of chromatin around the SBSN transcription start site (TSS), resulting in a 35-fold increase in SBSN expression in the H358 human lung cancer cell line. Interestingly, increasing BORIS concentrations leads to a subsequent reduction in SBSN expression via chromatin repression. In a similar manner, increase in BORIS concentrations leads to eventual decrease of cell growth and colony formation. This is the first report demonstrating that different amount of BORIS defines its varied effects on the expression of a target gene via chromatin structure reorganization.	[Gaykalova, Daria; Vatapalli, Rajita; Glazer, Chad A.; Bhan, Sheetal; Shao, Chunbo; Sidransky, David; Ha, Patrick K.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Sidransky, David; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Sidransky, David; Ha, Patrick K.; Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Gaykalova, D (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu	Vatapalli, Rajita/AAN-1397-2021		National Cancer Institute Specialized Program of Research Excellence [5P50CA096784-05]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Dr. Califano and Dr. Gaykalova are supported by a National Cancer Institute Specialized Program of Research Excellence (5P50CA096784-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bazzi H, 2007, DEV DYNAM, V236, P961, DOI 10.1002/dvdy.21099; Bhan S, 2011, CLIN CANCER RES, V17, P4267, DOI 10.1158/1078-0432.CCR-11-0653; Buffart TE, 2009, VIRCHOWS ARCH, V455, P213, DOI 10.1007/s00428-009-0814-y; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Cuffel C, 2011, INT J CANCER, V128, P2625, DOI 10.1002/ijc.25607; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; Fiorentino FP, 2012, J CELL PHYSIOL, V227, P479, DOI 10.1002/jcp.22780; Fiorentino FP, 2011, MOL CANCER RES, V9, P225, DOI 10.1158/1541-7786.MCR-10-0493; Formolo CA, 2011, J PROTEOME RES, V10, P3149, DOI 10.1021/pr200210w; Gaykalova Daria A., 2009, V523, P109, DOI 10.1007/978-1-59745-190-1_8; Glazer CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008189; Hines WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009738; Hoffmann MJ, 2006, BIOCHEM PHARMACOL, V72, P1577, DOI 10.1016/j.bcp.2006.06.020; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kang Y, 2007, ONCOGENE, V26, P4394, DOI 10.1038/sj.onc.1210218; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Kosaka-Suzuki N, 2011, J BIOL CHEM, V286, P27378, DOI 10.1074/jbc.M111.243576; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Loukinov D, 2006, J CELL BIOCHEM, V98, P1037, DOI 10.1002/jcb.20953; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Mkrtichyan M, 2008, GENE THER, V15, P61, DOI 10.1038/sj.gt.3303044; Mkrtichyan M, 2011, CELL IMMUNOL, V270, P188, DOI 10.1016/j.cellimm.2011.05.007; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Park GT, 2002, J BIOL CHEM, V277, P45195, DOI 10.1074/jbc.M205380200; Park SY, 2004, CANCER GENET CYTOGEN, V152, P153, DOI 10.1016/j.cancergencyto.2003.10.016; Pugacheva EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013872; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Renaud S, 2011, NUCLEIC ACIDS RES, V39, P862, DOI 10.1093/nar/gkq827; Risinger JI, 2007, CLIN CANCER RES, V13, P1713, DOI 10.1158/1078-0432.CCR-05-2569; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Woloszynska-Read Anna, 2010, Cancer Immun, V10, P6; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Xu JH, 2010, BREAST CANCER RES TR, V120, P593, DOI 10.1007/s10549-009-0422-1	48	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40389	10.1371/journal.pone.0040389	http://dx.doi.org/10.1371/journal.pone.0040389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792300	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300062
J	Hu, HM; Zhang, SB; Lei, XH; Deng, ZL; Guo, WX; Qiu, ZF; Liu, S; Wang, XY; Zhang, H; Duan, EK				Hu, Hui-min; Zhang, Shou-bing; Lei, Xiao-hua; Deng, Zhi-li; Guo, Wei-xiang; Qiu, Zhi-fang; Liu, Shuang; Wang, Xin-yue; Zhang, He; Duan, En-kui			Estrogen Leads to Reversible Hair Cycle Retardation through Inducing Premature Catagen and Maintaining Telogen	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; STEM-CELLS; RECEPTOR-ALPHA; FOLLICLE; GROWTH; KERATINOCYTES; ENRICHMENT; INDUCTION; APOPTOSIS; INVIVO	Estrogen dysregulation causes hair disorder. Clinical observations have demonstrated that estrogen raises the telogen/anagen ratio and inhibits hair shaft elongation of female scalp hair follicles. In spite of these clinical insights, the properties of estrogen on hair follicles are poorly dissected. In the present study, we show that estrogen induced apoptosis of precortex cells and caused premature catagen by up-regulation of TGF beta 2. Immediately after the premature catagen, the expression of anagen chalone BMP4 increased. The up-regulation of BMP4 may further function to prevent anagen transition and maintain telogen. Interestingly, the hair follicle stem cell niche was not destructed during these drastic structural changes caused by estrogen. Additionally, dermal papilla cells, the estrogen target cells in hair follicles, kept their signature gene expressions as well as their hair inductive potential after estrogen treatment. Retention of the characteristics of both hair follicle stem cells and dermal papilla cells determined the reversibility of the hair cycle suppression. These results indicated that estrogen causes reversible hair cycle retardation by inducing premature catagen and maintaining telogen.	[Hu, Hui-min; Zhang, Shou-bing; Lei, Xiao-hua; Deng, Zhi-li; Guo, Wei-xiang; Qiu, Zhi-fang; Liu, Shuang; Wang, Xin-yue; Duan, En-kui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Hu, Hui-min; Zhang, Shou-bing; Deng, Zhi-li; Guo, Wei-xiang; Qiu, Zhi-fang; Liu, Shuang; Wang, Xin-yue] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhang, He] WN Agri Forestry Univ, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, HM (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	duane@ioz.ac.cn	Lei, Xiaohua/J-7020-2019; Qiu, Zhifang/P-8313-2014	Lei, Xiaohua/0000-0001-8095-9008; Qiu, Zhifang/0000-0001-9196-032X	Strategic Priority Research Program of the Chinese academy of Sciences [XDA 01010202]; National Basic Research Program of China Grant [2011CB710905]; National Natural Science Foundation of China Grants [30971671]	Strategic Priority Research Program of the Chinese academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese academy of Sciences [grant number XDA 01010202], National Basic Research Program of China Grant [grant number 2011CB710905] and National Natural Science Foundation of China Grants [grant number 30971671]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Chanda S, 2000, AM J PHYSIOL-ENDOC M, V278, pE202, DOI 10.1152/ajpendo.2000.278.2.E202; Conrad F, 2004, J INVEST DERMATOL, V122, P840, DOI 10.1111/j.0022-202X.2004.22344.x; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dawson HL, 1933, AM J ANAT, V53, P89, DOI 10.1002/aja.1000530104; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gharzi A, 2003, EXP DERMATOL, V12, P126, DOI 10.1034/j.1600-0625.2003.00106.x; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; JAHODA CAB, 1991, J CELL SCI, V99, P627; JAHODA CAB, 1984, J EMBRYOL EXP MORPH, V79, P211; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Kaufman KD, 2002, MOL CELL ENDOCRINOL, V198, P89, DOI 10.1016/S0303-7207(02)00372-6; Kim JY, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-2; KONDO S, 1990, ARCH DERMATOL RES, V282, P442, DOI 10.1007/BF00402619; Lin KK, 2004, P NATL ACAD SCI USA, V101, P15955, DOI 10.1073/pnas.0407114101; Lindner G, 1997, AM J PATHOL, V151, P1601; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; MONTAGNA W, 1962, STRUCTURE FUNCTION S; Moverare S, 2002, J INVEST DERMATOL, V119, P1053, DOI 10.1046/j.1523-1747.2002.00637.x; Nelson L.D., 2003, J INVEST DERMATOL, V121, p821a; Oh HS, 1996, P NATL ACAD SCI USA, V93, P12525, DOI 10.1073/pnas.93.22.12525; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Soma T, 1998, J INVEST DERMATOL, V111, P948, DOI 10.1046/j.1523-1747.1998.00408.x; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; WHITING DA, 1993, J AM ACAD DERMATOL, V28, P755, DOI 10.1016/0190-9622(93)70106-4; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544	41	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40124	10.1371/journal.pone.0040124	http://dx.doi.org/10.1371/journal.pone.0040124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792225	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300026
J	McHugh, BJ; Murdoch, A; Haslett, C; Sethi, T				McHugh, Brian J.; Murdoch, Amanda; Haslett, Christopher; Sethi, Tariq			Loss of the Integrin-Activating Transmembrane Protein Fam38A (Piezo1) Promotes a Switch to a Reduced Integrin-Dependent Mode of Cell Migration	PLOS ONE			English	Article							LUNG-CANCER; R-RAS; INVASION; MECHANISMS	Lung cancer is one of the most common fatal diseases in the developed world. The disease is rarely cured by currently available therapies, with an overall survival rate of similar to 10%. Characterizing novel proteins that offer crucial insights into the processes of lung tumour invasion and metastasis may therefore provide much-needed prognostic markers, and influence therapeutic strategies. Aberrant function of the integrin family of heterodimeric cell surface receptors is a common theme in cancer - investigation into novel integrin activity regulators may offer crucial insights into the processes of tumour invasion and metastasis and may reveal insights into potential therapeutic targets. We previously described that depletion of the novel multi-transmembrane domain protein Fam38A, located at the endoplasmic reticulum (ER), inactivates endogenous beta1 integrin affinity, reducing cell adhesion. We now show that depletion of Fam38A, also now known as Piezo1, causes anchorage independence and a switch to a reduced integrin-dependent mode of cell migration/invasion, a novel phenotype for this integrin-regulating protein. Normal lung epithelial cells show increased rates of migration by 2D time-lapse microscopy and increased capacity to invade into matrigel, despite having decreased integrin affinity. We confirm greatly depleted Fam38A expression in small cell lung cancer (SCLC) lines where a form of reduced integrin-dependent migration, i.e. amoeboid migration, is a known phenotype. We propose that loss of Fam38A expression may cause increased cell migration and metastasis in lung tumours.	[McHugh, Brian J.; Murdoch, Amanda; Haslett, Christopher] Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Sethi, Tariq] Kings Coll London, Dept Resp Med, London WC2R 2LS, England; [Sethi, Tariq] Kings Coll London, Dept Allergy, London WC2R 2LS, England	University of Edinburgh; University of London; King's College London; University of London; King's College London	McHugh, BJ (corresponding author), Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	Brian.McHugh@ed.ac.uk		McHugh, Brian/0000-0003-4747-0643	Chief Scientist Office of the Scottish Executive [CZB/4/691]; Medical Research Council [G0901697] Funding Source: researchfish; MRC [G0901697] Funding Source: UKRI	Chief Scientist Office of the Scottish Executive; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Chief Scientist Office of the Scottish Executive (http://www.cso.scot.nhs.uk/), grant number CZB/4/691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; COZENS AL, 1992, P NATL ACAD SCI USA, V89, P5171, DOI 10.1073/pnas.89.11.5171; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Girard L, 2000, CANCER RES, V60, P4894; Gregor A, 2001, THORAX, V56, P212, DOI 10.1136/thorax.56.3.212; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Levi F, 2004, INT J CANCER, V110, P155, DOI 10.1002/ijc.20097; McHugh B, 2004, J CELL BIOL, V167, P673, DOI 10.1083/jcb.200405155; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Mori Y, 1999, BRIT J CANCER, V80, P556, DOI 10.1038/sj.bjc.6690391; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Takeuchi T, 2006, PATHOL INT, V56, P434, DOI 10.1111/j.1440-1827.2006.01985.x; TSUDA H, 1994, CANCER RES, V54, P513	24	97	100	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40346	10.1371/journal.pone.0040346	http://dx.doi.org/10.1371/journal.pone.0040346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792288	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300058
J	Bonisch, U; Bohme, A; Kohajda, T; Mogel, I; Schutze, N; von Bergen, M; Simon, JC; Lehmann, I; Polte, T				Boenisch, Ulrike; Boehme, Alexander; Kohajda, Tibor; Moegel, Iljana; Schuetze, Nicole; von Bergen, Martin; Simon, Jan C.; Lehmann, Irina; Polte, Tobias			Volatile Organic Compounds Enhance Allergic Airway Inflammation in an Experimental Mouse Model	PLOS ONE			English	Article							NF-KAPPA-B; INDOOR RENOVATION ACTIVITIES; LUNG EPITHELIAL-CELLS; OXIDATIVE STRESS; ASTHMA; EXPOSURE; ASSOCIATION; CHILDREN; EMISSIONS; SCHOOLCHILDREN	Background: Epidemiological studies suggest an association between exposure to volatile organic compounds (VOCs) and adverse allergic and respiratory symptoms. However, whether VOCs exhibit a causal role as adjuvants in asthma development remains unclear. Methods: To investigate the effect of VOC exposure on the development of allergic airway inflammation Balb/c mice were exposed to VOCs emitted by new polyvinylchloride (PVC) flooring, sensitized with ovalbumin (OVA) and characterized in acute and chronic murine asthma models. Furthermore, prevalent evaporated VOCs were analyzed and mice were exposed to selected single VOCs. Results: Exposure of mice to PVC flooring increased eosinophilic lung inflammation and OVA-specific IgE serum levels compared to un-exposed control mice. The increased inflammation was associated with elevated levels of Th2-cytokines. Long-term exposure to PVC flooring exacerbated chronic airway inflammation. VOCs with the highest concentrations emitted by new PVC flooring were N-methyl-2-pyrrolidone (NMP) and 2,2,4-trimethyl-1,3-pentanediol diisobutyrate (TXIB). Exposure to NMP or TXIB also increased the allergic immune response in OVA-sensitized mice. In vitro or in vivo exposure to NMP or TXIB reduced IL-12 production in maturing dendritic cells (DCs) and enhanced airway inflammation after adoptive DC transfer into Balb/c mice. At higher concentrations both VOCs induced oxidative stress demonstrated by increased isoprostane and glutathione-S-transferase-pi1 protein levels in the lung of non-sensitized mice. Treatment of PVC flooring-exposed mice with N-acetylcysteine prevented the VOC-induced increase of airway inflammation. Conclusions: Our results demonstrate that exposure to VOCs may increase the allergic immune response by interfering with DC function and by inducing oxidative stress and has therefore to be considerate as risk factor for the development of allergic diseases.	[Boenisch, Ulrike; Boehme, Alexander; Moegel, Iljana; Schuetze, Nicole; Lehmann, Irina; Polte, Tobias] UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany; [Boenisch, Ulrike; Schuetze, Nicole; Simon, Jan C.; Polte, Tobias] Univ Leipzig, Dept Dermatol Venerol & Allergol, Leipzig Univ Med Ctr, Leipzig, Germany; [Kohajda, Tibor; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Metabol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Bonisch, U (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany.	tobias.polte@ufz.de	von Bergen, Martin/D-7960-2011	von Bergen, Martin/0000-0003-2732-2977; Lehmann, Irina/0000-0001-8875-5587	Helmholtz Association [VG-NG-337]	Helmholtz Association(Helmholtz Association)	The study was supported by the Helmholtz Association grant VG-NG-337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini F, 2009, AM J RESP CRIT CARE, V179, P984, DOI 10.1164/rccm.200807-1061OC; ANUNDI H, 1993, INT ARCH OCC ENV HEA, V65, P247, DOI 10.1007/BF00381198; Beaulieu HJ., 1991, APPL OCCUP ENVIRON H, V6, P874; Bowler RP, 2002, J ALLERGY CLIN IMMUN, V110, P349, DOI 10.1067/mai.2002.126780; Chan RCF, 2006, J ALLERGY CLIN IMMUN, V118, P455, DOI 10.1016/j.jaci.2006.06.006; Chen CM, 2007, NUTRITION, V23, P589, DOI 10.1016/j.nut.2007.05.004; Choi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013423; Cooke T. F., 1991, Reviews on Environmental Health, V9, P137; De Jong WH, 2009, TOXICOLOGY, V261, P103, DOI 10.1016/j.tox.2009.04.057; Diez U, 2000, INT J HYG ENVIR HEAL, V203, P23, DOI 10.1078/S1438-4639(04)70004-8; Dong GH, 2008, INT J ENVIRON HEAL R, V18, P267, DOI 10.1080/09603120701842864; Emenius G, 2004, INDOOR AIR, V14, P34, DOI 10.1046/j.1600-0668.2003.00207.x; Fei MJ, 2011, P NATL ACAD SCI USA, V108, P5360, DOI 10.1073/pnas.1015476108; Feltens R, 2010, TOXICOL APPL PHARM, V242, P100, DOI 10.1016/j.taap.2009.09.020; Fischader G, 2008, TOXICOL IN VITRO, V22, P359, DOI 10.1016/j.tiv.2007.09.015; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gu YH, 2008, HUM EXP TOXICOL, V27, P37, DOI 10.1177/0960327108088973; Hanninen M, 2005, U ALBERTA HLTH SCI J, V2, P11; Heinrich J, 2011, INT J HYG ENVIR HEAL, V214, P3, DOI 10.1016/j.ijheh.2010.08.009; Herbarth O, 2006, INT J HYG ENVIR HEAL, V209, P241, DOI 10.1016/j.ijheh.2006.01.003; Herberth G, 2009, PEDIAT ALLERG IMM-UK, V20, P563, DOI 10.1111/j.1399-3038.2008.00819.x; Huang RP, 1996, J CELL BIOL, V133, P211, DOI 10.1083/jcb.133.1.211; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Jarnstrom H, 2008, ENVIRON INT, V34, P420, DOI 10.1016/j.envint.2007.09.011; Jouyban A, 2010, J PHARM PHARM SCI, V13, P524, DOI 10.18433/J3P306; Kato T, 2006, EUR J IMMUNOL, V36, P1199, DOI 10.1002/eji.200535140; Larsson M, 2010, INDOOR AIR, V20, P494, DOI 10.1111/j.1600-0668.2010.00671.x; Leech JA, 2002, J EXPO ANAL ENV EPID, V12, P427, DOI 10.1038/sj.jea.7500244; Lehmann I, 2001, INT J HYG ENVIR HEAL, V204, P211, DOI 10.1078/1438-4639-00100; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; Metiainen P., 2002, 9 INT C IND QUAL CLI, V2, P108; Morbt N, 2011, J PROTEOME RES, V10, P363, DOI 10.1021/pr1005718; Morbt N, 2009, PROTEOMICS, V9, P4920, DOI 10.1002/pmic.200800836; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nielsen GD, 2007, INDOOR AIR, V17, P236, DOI 10.1111/j.1600-0668.2006.00468.x; Pearce N, 2006, INT J TUBERC LUNG D, V10, P125; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; Polte T, 2009, EUR J IMMUNOL, V39, P1736, DOI 10.1002/eji.200839004; Roder-Stolinski C, 2008, INHAL TOXICOL, V20, P813, DOI [10.1080/08958370802020810, 10.1080/08958370802020810 ]; Roder-Stolinski C, 2008, TOXICOL APPL PHARM, V231, P241, DOI 10.1016/j.taap.2008.04.010; Rumchev K, 2004, THORAX, V59, P746, DOI 10.1136/thx.2003.013680; Schutze N, 2010, AM J RESP CRIT CARE, V181, P1188, DOI 10.1164/rccm.200909-1350OC; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Smedje G, 1997, CLIN EXP ALLERGY, V27, P1270, DOI 10.1111/j.1365-2222.1997.tb01171.x; Solomon GM, 1996, J OCCUP ENVIRON MED, V38, P705, DOI 10.1097/00043764-199607000-00014; Sweet David G, 2002, Paediatr Respir Rev, V3, P140, DOI 10.1016/S1526-0550(02)00010-0; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Walters DM, 2001, AM J RESP CRIT CARE, V164, P1438, DOI 10.1164/ajrccm.164.8.2007121; Wieslander G, 1997, INT ARCH OCC ENV HEA, V69, P115; Wieslander G, 1997, ANN OCCUP HYG, V41, P155, DOI 10.1016/S0003-4878(96)00039-7; Wilke O, 2004, INDOOR AIR, V14, P98, DOI 10.1111/j.1600-0668.2004.00314.x; Yang G, 2004, J CLIN INVEST, V114, P669, DOI 10.1172/JCI200419300	54	50	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39817	10.1371/journal.pone.0039817	http://dx.doi.org/10.1371/journal.pone.0039817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802943	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900017
J	van der Weerd, NC; Grooteman, MPC; Bots, ML; van den Dorpel, MA; den Hoedt, CH; Mazairac, AHA; Nube, MJ; Penne, EL; Gaillard, CA; Wetzels, JFM; Wiegerinck, ET; Swinkels, DW; Blankestijn, PJ; ter Wee, PM				van der Weerd, Neelke C.; Grooteman, Muriel P. C.; Bots, Michiel L.; van den Dorpel, Marinus A.; den Hoedt, Claire H.; Mazairac, Albert H. A.; Nube, Menso J.; Penne, E. Lars; Gaillard, Carlo A.; Wetzels, Jack F. M.; Wiegerinck, Erwin T.; Swinkels, Dorine W.; Blankestijn, Peter J.; ter Wee, Piet M.		CONTRAST Investigators	Hepcidin-25 in Chronic Hemodialysis Patients Is Related to Residual Kidney Function and Not to Treatment with Erythropoiesis Stimulating Agents	PLOS ONE			English	Article							SERUM HEPCIDIN; IRON STATUS; ONLINE HEMODIAFILTRATION; ALL-CAUSE; PROHEPCIDIN; FERRITIN; THERAPY; DETERMINANTS; EXPRESSION; RESISTANCE	Hepcidin-25, the bioactive form of hepcidin, is a key regulator of iron homeostasis as it induces internalization and degradation of ferroportin, a cellular iron exporter on enterocytes, macrophages and hepatocytes. Hepcidin levels are increased in chronic hemodialysis (HD) patients, but as of yet, limited information on factors associated with hepcidin-25 in these patients is available. In the current cross-sectional study, potential patient-, laboratory-and treatment-related determinants of serum hepcidin-20 and -25, were assessed in a large cohort of stable, prevalent HD patients. Baseline data from 405 patients (62% male; age 63.7 +/- 13.9 [mean SD]) enrolled in the CONvective TRAnsport STudy (CONTRAST; NCT00205556) were studied. Predialysis hepcidin concentrations were measured centrally with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Patient-, laboratory-and treatment related characteristics were entered in a backward multivariable linear regression model. Hepcidin-25 levels were independently and positively associated with ferritin (p<0.001), hsCRP (p<0.001) and the presence of diabetes (p = 0.02) and inversely with the estimated glomerular filtration rate (p = 0.01), absolute reticulocyte count (p = 0.02) and soluble transferrin receptor (p<0.001). Men had lower hepcidin-25 levels as compared to women (p = 0.03). Hepcidin-25 was not associated with the maintenance dose of erythropoiesis stimulating agents (ESA) or iron therapy. In conclusion, in the currently studied cohort of chronic HD patients, hepcidin-25 was a marker for iron stores and erythropoiesis and was associated with inflammation. Furthermore, hepcidin-25 levels were influenced by residual kidney function. Hepcidin-25 did not reflect ESA or iron dose in chronic stable HD patients on maintenance therapy. These results suggest that hepcidin is involved in the pathophysiological pathway of renal anemia and iron availability in these patients, but challenges its function as a clinical parameter for ESA resistance.	[van der Weerd, Neelke C.; Grooteman, Muriel P. C.; Nube, Menso J.; Penne, E. Lars; Gaillard, Carlo A.; ter Wee, Piet M.] Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [van der Weerd, Neelke C.] Univ Amsterdam, Acad Med Ctr, Dept Nephrol, NL-1105 AZ Amsterdam, Netherlands; [Grooteman, Muriel P. C.; Nube, Menso J.; ter Wee, Piet M.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res VU Med Ctr ICaR VU, Amsterdam, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van den Dorpel, Marinus A.; den Hoedt, Claire H.] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands; [den Hoedt, Claire H.; Mazairac, Albert H. A.; Penne, E. Lars; Blankestijn, Peter J.] Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands; [Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [Wiegerinck, Erwin T.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, NL-6525 ED Nijmegen, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Maasstad Hospital; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen	van der Weerd, NC (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands.	n.c.vanderweerd@amc.uva.nl	van Hamersvelt, H.W./L-4348-2015; Gaillard, Carlo/AAC-6729-2022; Gaillard, Carlo/D-1514-2013; Wetzels, Jack F.M./A-1720-2014; Grooteman, Muriel/AAA-2602-2019; Swinkels, Dorine W./H-8098-2014	Gaillard, Carlo/0000-0002-8964-0236; Gaillard, Carlo/0000-0002-8964-0236; Wetzels, Jack F.M./0000-0002-0650-6921; Swinkels, Dorine W./0000-0002-1040-9446; Grooteman, Muriel/0000-0001-5447-2546; van Buren, Marjolijn/0000-0002-1822-6863; Penne, Erik/0000-0002-6018-4679; boer, walther/0000-0001-5048-2755	Dutch Kidney Foundation (Nierstichting Nederland) [C02.2019]; Fresenius Medical Care (The Netherlands); Gambro Lundia AB (Sweden); Dr. E.E. Twiss Fund, Roche Netherlands; International Society of Nephrology/Baxter Extramural Grant Program; Dutch Organization for Health Research and Development (ZonMW) [17088.2802]; Fresenius Medical Care; Roche Netherlands; Baxter Netherlands; Amgen BV Netherlands	Dutch Kidney Foundation (Nierstichting Nederland); Fresenius Medical Care (The Netherlands)(Netherlands Government); Gambro Lundia AB (Sweden); Dr. E.E. Twiss Fund, Roche Netherlands; International Society of Nephrology/Baxter Extramural Grant Program; Dutch Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Fresenius Medical Care; Roche Netherlands; Baxter Netherlands; Amgen BV Netherlands(Amgen)	The Dutch CONvective TRAnsport STudy is financially supported by a grant from the Dutch Kidney Foundation (Nierstichting Nederland, grant C02.2019) and unrestricted grants from Fresenius Medical Care (The Netherlands) and Gambro Lundia AB (Sweden). Additional support for CONTRAST was received from the Dr. E.E. Twiss Fund, Roche Netherlands; the International Society of Nephrology/Baxter Extramural Grant Program; the Dutch Organization for Health Research and Development (ZonMW, grant 17088.2802); and for this particular study from Amgen BV Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DWS is a co-founder and Medical Director of the "Hepcidinanalysis.com" initiative, which aims to serve the scientific and medical community with high-quality hepcidin-25 measurements (www.hepcidinanalysis.com). The other authors have declared that no competing interests exist. Furthermore, the main study was supported by funding from several commercial sources (Fresenius Medical Care, Gambro Lundia AB (Sweden), Roche Netherlands, Baxter Netherlands and Amgen BV Netherlands). This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2001, Am J Kidney Dis, V37, pS182; Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Babitt JL, 2010, AM J KIDNEY DIS, V55, P726, DOI 10.1053/j.ajkd.2009.12.030; Campostrini N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/329646; Chiang WC, 2002, CLIN NEPHROL, V58, P363; Costa E, 2009, ACTA HAEMATOL-BASEL, V122, P226, DOI 10.1159/000253590; Coyne DW, 2011, KIDNEY INT, V80, P240, DOI 10.1038/ki.2011.141; Ford BA, 2010, KIDNEY INT, V78, P769, DOI 10.1038/ki.2010.254; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Gambino R, 1997, CLIN CHEM, V43, P2408; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Jiang F, 2011, DIABETES RES CLIN PR, V93, P43, DOI 10.1016/j.diabres.2011.03.028; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Kuragano T, 2010, AM J NEPHROL, V31, P534, DOI 10.1159/000312381; Levin A, 2007, AM J KIDNEY DIS, V50, P471; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Macdougall IC, 2010, CLIN J AM SOC NEPHRO, V5, P1681, DOI 10.2215/CJN.05990809; Malyszko J, 2009, RENAL FAILURE, V31, P876, DOI 10.3109/08860220903216071; Malyszko J, 2009, KIDNEY BLOOD PRESS R, V32, P235, DOI 10.1159/000235747; Penne EL, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-8; Peters HPE, 2010, NEPHROL DIAL TRANSPL, V25, P848, DOI 10.1093/ndt/gfp546; Singh AK, 2007, KIDNEY INT, V71, P1163, DOI 10.1038/sj.ki.5002223; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Swinkels DW, 2008, NEPHROL DIAL TRANSPL, V23, P250, DOI 10.1093/ndt/gfn267; Tarng DC, 2002, NEPHROL DIAL TRANSPL, V17, P1063, DOI 10.1093/ndt/17.6.1063; Tessitore N, 2010, NEPHROL DIAL TRANSPL, V25, P3996, DOI 10.1093/ndt/gfq321; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Uehata T, 2012, NEPHROL DIAL TRANSPL, V27, P1076, DOI 10.1093/ndt/gfr431; van der Putten K, 2010, EUR J HEART FAIL, V12, P943, DOI 10.1093/eurjhf/hfq099; Weiss G, 2009, EUR J CLIN INVEST, V39, P883, DOI 10.1111/j.1365-2362.2009.02182.x; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506; Zaritsky J, 2010, CLIN J AM SOC NEPHRO, V5, P1010, DOI 10.2215/CJN.08161109; Zaritsky J, 2009, CLIN J AM SOC NEPHRO, V4, P1051, DOI 10.2215/CJN.05931108; Zaritsky JJ, 2009, KIDNEY INT, V76, P912, DOI 10.1038/ki.2009.272	40	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39783	10.1371/journal.pone.0039783	http://dx.doi.org/10.1371/journal.pone.0039783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808058	Green Published, Green Submitted, gold			2022-12-27	WOS:000306406700013
J	Loiselle, AE; Frisch, BJ; Wolenski, M; Jacobson, JA; Calvi, LM; Schwarz, EM; Awad, HA; O'Keefe, RJ				Loiselle, Alayna E.; Frisch, Benjamin J.; Wolenski, Matthew; Jacobson, Justin A.; Calvi, Laura M.; Schwarz, Edward M.; Awad, Hani A.; O'Keefe, Regis J.			Bone Marrow-Derived Matrix Metalloproteinase-9 Is Associated with Fibrous Adhesion Formation after Murine Flexor Tendon Injury	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SIGNALING PATHWAY; RAT-BRAIN; TNF-ALPHA; MMP-9; INDUCTION; CELLS; REPAIR; INFLAMMATION; FIBROBLASTS	The pathogenesis of adhesions following primary tendon repair is poorly understood, but is thought to involve dysregulation of matrix metalloproteinases (Mmps). We have previously demonstrated that Mmp9 gene expression is increased during the inflammatory phase following murine flexor digitorum (FDL) tendon repair in association with increased adhesions. To further investigate the role of Mmp9, the cellular, molecular, and biomechanical features of healing were examined in WT and Mmp9(-/-) mice using the FDL tendon repair model. Adhesions persisted in WT, but were reduced in Mmp9(-/-) mice by 21 days without any decrease in strength. Deletion of Mmp9 resulted in accelerated expression of neotendon associated genes, Gdf5 and Smad8, and delayed expression of collagen I and collagen III. Furthermore, WT bone marrow cells (GFP(+)) migrated specifically to the tendon repair site. Transplanting myeloablated Mmp9(-/-) mice with WT marrow cells resulted in greater adhesions than observed in Mmp9(-/-) mice and similar to those seen in WT mice. These studies show that Mmp9 is primarily derived from bone marrow cells that migrate to the repair site, and mediates adhesion formation in injured tendons. Mmp9 is a potential target to limit adhesion formation in tendon healing.	[Loiselle, Alayna E.; Wolenski, Matthew; Jacobson, Justin A.; Schwarz, Edward M.; Awad, Hani A.; O'Keefe, Regis J.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14627 USA; [Frisch, Benjamin J.; Calvi, Laura M.] Univ Rochester, Sch Med & Dent, Dept Med, Div Endocrine, Rochester, NY 14642 USA; [Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Loiselle, AE (corresponding author), Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14627 USA.	regis_okeefe@urmc.rochester.edu	Awad, Hani A/G-6976-2014; Mostafa, Taymour/H-6834-2019; Calvi, Laura/P-6988-2019	Awad, Hani A/0000-0003-2197-2610; Mostafa, Taymour/0000-0003-3627-0662; Calvi, Laura/0000-0001-6969-239X; Frisch, Benjamin/0000-0003-0048-8491	National Institutes of Health from NIAMS [AR056696]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056696] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was partially supported by National Institutes of Health grant number AR056696 from NIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Beredjiklian PK, 2003, J BONE JOINT SURG AM, V85A, P539, DOI 10.2106/00004623-200303000-00025; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Corbel M, 2002, CELL BIOL TOXICOL, V18, P51, DOI 10.1023/A:1014471213371; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823; GELBERMAN RH, 1986, J HAND SURG-AM, V11A, P106, DOI 10.1016/S0363-5023(86)80115-0; GELBERMAN RH, 1982, J HAND SURG-AM, V7, P170, DOI 10.1016/S0363-5023(82)80083-X; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531; Heissig B, 2010, HISTOL HISTOPATHOL, V25, P765, DOI 10.14670/HH-25.765; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Ingraham CA, 2011, J BIOL CHEM; Jozsa L.G., 1997, HUMAN TENDONS ANATOM; Kajikawa Y, 2007, J CELL PHYSIOL, V210, P684, DOI 10.1002/jcp.20876; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Karousou E, 2008, CLIN ORTHOP RELAT R, V466, P1577, DOI 10.1007/s11999-008-0255-y; Katzel EB, 2011, J ORTHOP RES, V29, P684, DOI 10.1002/jor.21235; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; KULICK MI, 1986, J HAND SURG-AM, V11A, P110, DOI 10.1016/S0363-5023(86)80116-2; Lim DH, 2006, AM J PHYSIOL-LUNG C, V291, pL265, DOI 10.1152/ajplung.00305.2005; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Mukherjee R, 2010, FASEB J, V24, P3819, DOI 10.1096/fj.10-155531; Muroski ME, 2008, CURR PHARM BIOTECHNO, V9, P34; Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40; Nee L, 2007, NEPHRON EXP NEPHROL, V107, pE73, DOI 10.1159/000108645; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Scabilloni JF, 2005, AM J PHYSIOL-LUNG C, V288, pL709, DOI 10.1152/ajplung.00034.2004; Shahab-Osterloh S, 2010, STEM CELLS, V28, P1590, DOI 10.1002/stem.487; Sharma P, 2005, SURG-J R COLL SURG E, V3, P309, DOI 10.1016/S1479-666X(05)80109-X; Strickland, 1995, J Am Acad Orthop Surg, V3, P44; Strickland JW, 2000, J HAND SURG-AM, V25A, P214; Tan RJ, 2006, AM J RESP CELL MOL, V35, P289, DOI 10.1165/rcmb.2005-0471OC; Turner NA, 2007, J MOL CELL CARDIOL, V43, P168, DOI 10.1016/j.yjmcc.2007.05.006; Virchenko O, 2004, AM J SPORT MED, V32, P1743, DOI 10.1177/0363546504263403; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Wang L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-14; Wang LY, 2010, J TOXICOL ENV HEAL A, V73, P410, DOI 10.1080/15287390903486550; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Woo SLY, 2000, ANNU REV BIOMED ENG, V2, P83, DOI 10.1146/annurev.bioeng.2.1.83; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Xia L, 2011, RHEUMATOLOGY INT; Zhou J, 2010, J EXP MED, V207, P1951, DOI 10.1084/jem.20100098	50	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40602	10.1371/journal.pone.0040602	http://dx.doi.org/10.1371/journal.pone.0040602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792383	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400080
J	Mika, A; Reynolds, SL; Mohlin, FC; Willis, C; Swe, PM; Pickering, DA; Halilovic, V; Wijeyewickrema, LC; Pike, RN; Blom, AM; Kemp, DJ; Fischer, K				Mika, Angela; Reynolds, Simone L.; Mohlin, Frida C.; Willis, Charlene; Swe, Pearl M.; Pickering, Darren A.; Halilovic, Vanja; Wijeyewickrema, Lakshmi C.; Pike, Robert N.; Blom, Anna M.; Kemp, David J.; Fischer, Katja			Novel Scabies Mite Serpins Inhibit the Three Pathways of the Human Complement System	PLOS ONE			English	Article							TICK HAEMAPHYSALIS-LONGICORNIS; SERINE-PROTEASE PARALOGUES; IXODES-RICINUS TICKS; SALIVARY-GLANDS; SOFT TICK; SARCOPTES-SCABIEI; ANTICOMPLEMENT PROTEINS; TRANSCRIPTOME ANALYSIS; ORNITHODOROS-MOUBATA; ACARI IXODIDAE	Scabies is a parasitic infestation of the skin by the mite Sarcoptes scabiei that causes significant morbidity worldwide, in particular within socially disadvantaged populations. In order to identify mechanisms that enable the scabies mite to evade human immune defenses, we have studied molecules associated with proteolytic systems in the mite, including two novel scabies mite serine protease inhibitors (SMSs) of the serpin superfamily. Immunohistochemical studies revealed that within mite-infected human skin SMSB4 (54 kDa) and SMSB3 (47 kDa) were both localized in the mite gut and feces. Recombinant purified SMSB3 and SMSB4 did not inhibit mite serine and cysteine proteases, but did inhibit mammalian serine proteases, such as chymotrypsin, albeit inefficiently. Detailed functional analysis revealed that both serpins interfered with all three pathways of the human complement system at different stages of their activation. SMSB4 inhibited mostly the initial and progressing steps of the cascades, while SMSB3 showed the strongest effects at the C9 level in the terminal pathway. Additive effects of both serpins were shown at the C9 level in the lectin pathway. Both SMSs were able to interfere with complement factors without protease function. A range of binding assays showed direct binding between SMSB4 and seven complement proteins (C1, properdin, MBL, C4, C3, C6 and C8), while significant binding of SMSB3 occurred exclusively to complement factors without protease function (C4, C3, C8). Direct binding was observed between SMSB4 and the complement proteases C1s and C1r. However no complex formation was observed between either mite serpin and the complement serine proteases C1r, C1s, MASP-1, MASP-2 and MASP-3. No catalytic inhibition by either serpin was observed for any of these enzymes. In summary, the SMSs were acting at several levels mediating overall inhibition of the complement system and thus we propose that they may protect scabies mites from complement-mediated gut damage.	[Mika, Angela; Reynolds, Simone L.; Willis, Charlene; Swe, Pearl M.; Pickering, Darren A.; Halilovic, Vanja; Kemp, David J.; Fischer, Katja] Queensland Inst Med Res, Dept Biol, Program Infect Dis, Brisbane, Qld 4006, Australia; [Reynolds, Simone L.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Mohlin, Frida C.; Blom, Anna M.] Lund Univ, Dept Lab Med, Malmo, Sweden; [Wijeyewickrema, Lakshmi C.; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Lund University; Monash University	Mika, A (corresponding author), Queensland Inst Med Res, Dept Biol, Program Infect Dis, Brisbane, Qld 4006, Australia.	Katja.Fischer@qimr.edu.au	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022; Fischer, Katja/H-4989-2014; Wijeyewickrema, Lakshmi/A-9676-2015; Willis, Charlene/U-1344-2017	Blom, Anna/0000-0002-1348-1734; Fischer, Katja/0000-0003-3408-3337; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; , Simone/0000-0002-4902-2003; Pike, Robert/0000-0002-2083-0269	Australian National Health and Medical Research Council [496600, 613626]; Swedish Research Council [K2009-68X-14928-06-3]; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Inga-Britt and Arne Lundberg Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg Foundation	This work was supported by the Australian National Health and Medical Research Council (http://www.nhmrc.gov.au/), Program Grant 496600, Project Grant 613626 and a fellowship to DJK. AB would like to acknowledge the financial support of the Swedish Research Council (K2009-68X-14928-06-3), the Swedish Foundation for Strategic Research and the Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; ALBERTI S, 1993, INFECT IMMUN, V61, P852; Aljamali MN, 2009, INSECT MOL BIOL, V18, P129, DOI 10.1111/j.1365-2583.2009.00863.x; Australian Government NHMRC, 2004, ACC BLOCK OV EM DEP, P1; Batista IFC, 2008, TOXICON, V51, P823, DOI 10.1016/j.toxicon.2007.12.011; Beckham SA, 2009, J BIOL CHEM, V284, P34413, DOI 10.1074/jbc.M109.061911; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOK I, 1995, J CLIN MICROBIOL, V33, P2139, DOI 10.1128/JCM.33.8.2139-2140.1995; Chalaire KC, 2011, J EXP BIOL, V214, P665, DOI 10.1242/jeb.052076; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Chmelar J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-233; Clucas DB, 2008, B WORLD HEALTH ORGAN, V86, P275, DOI 10.2471/BLT.07.043034; Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400; CROSSLEY LG, 1980, BIOCHEM J, V191, P173, DOI 10.1042/bj1910173; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Fischer K, 2003, AM J TROP MED HYG, V68, P61, DOI 10.4269/ajtmh.2003.68.1.0680061; Fischer K, 2009, J MOL BIOL, V390, P635, DOI 10.1016/j.jmb.2009.04.082; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; Francischetti IMB, 2008, INSECT BIOCHEM MOLEC, V38, P1, DOI 10.1016/j.ibmb.2007.09.009; Francischetti IMB, 2011, J PROTEOMICS, V74, P2892, DOI 10.1016/j.jprot.2011.07.015; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Francischetti IMB, 2008, J PROTEOMICS, V71, P493, DOI 10.1016/j.jprot.2008.07.006; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Hengge UR, 2006, LANCET INFECT DIS, V6, P769, DOI 10.1016/S1473-3099(06)70654-5; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Higgins WJ, 2010, J BIOL CHEM, V285, P3722, DOI 10.1074/jbc.M109.037358; Holt DC, 2003, J INVEST DERMATOL, V121, P1419, DOI 10.1046/j.1523-1747.2003.12621.x; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Kerr FK, 2008, MOL IMMUNOL, V45, P670, DOI 10.1016/j.molimm.2007.07.008; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LAWRENCE DA, 1994, J BIOL CHEM, V269, P27657; Lawrie CH, 2005, MOL IMMUNOL, V42, P31, DOI 10.1016/j.molimm.2004.07.001; Levi A, 2011, LASER MED SCI, V26, P291, DOI 10.1007/s10103-011-0894-1; Manderson GA, 2009, MOL IMMUNOL, V46, P3388, DOI 10.1016/j.molimm.2009.07.011; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; Mika A, 2011, PLOS NEGL T IN PRESS; Mika A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001331; Mounsey KE, 2008, FUTURE MICROBIOL, V3, P57, DOI 10.2217/17460913.3.1.57; Mulenga A, 2003, INSECT BIOCHEM MOLEC, V33, P267, DOI 10.1016/S0965-1748(02)00240-0; Mulenga A, 2001, J VET MED SCI, V63, P1063, DOI 10.1292/jvms.63.1063; Mulenga A, 2001, INSECT BIOCHEM MOLEC, V31, P817, DOI 10.1016/S0965-1748(00)00187-9; Mulenga A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-217; Nene V, 2004, INSECT BIOCHEM MOLEC, V34, P1117, DOI 10.1016/j.ibmb.2004.07.002; Nene V, 2002, INT J PARASITOL, V32, P1447, DOI 10.1016/S0020-7519(02)00159-5; Nicholson William L., 2009, P493; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Parola P, 2006, CLIN DERMATOL, V24, P191, DOI 10.1016/j.clindermatol.2005.11.007; Rapp CM, 2006, J MED ENTOMOL, V43, P539, DOI 10.1603/0022-2585(2006)43[539:POHIIT]2.0.CO;2; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Schroeder H, 2009, DEV COMP IMMUNOL, V33, P5, DOI 10.1016/j.dci.2008.07.010; Schroeder H, 2007, MICROBES INFECT, V9, P247, DOI 10.1016/j.micinf.2006.10.020; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; Skelly PJ, 2004, TRENDS PARASITOL, V20, P370, DOI 10.1016/j.pt.2004.05.007; Steen NA, 2006, TOXICON, V47, P1, DOI 10.1016/j.toxicon.2005.09.010; STEWART GA, 1992, IMMUNOLOGY, V75, P29; Sugino M, 2003, VACCINE, V21, P2844, DOI 10.1016/S0264-410X(03)00167-1; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x; Tyson KR, 2008, J IMMUNOL, V180, P3964, DOI 10.4049/jimmunol.180.6.3964; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Willis C, 2006, AM J TROP MED HYG, V75, P683, DOI 10.4269/ajtmh.2006.75.683; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149	79	52	52	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40489	10.1371/journal.pone.0040489	http://dx.doi.org/10.1371/journal.pone.0040489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792350	Green Published, gold, Green Submitted			2022-12-27	WOS:000306362400062
J	Schlievert, PM; Peterson, ML				Schlievert, Patrick M.; Peterson, Marnie L.			Glycerol Monolaurate Antibacterial Activity in Broth and Biofilm Cultures	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; STAPHYLOCOCCUS-AUREUS; SIGNAL-TRANSDUCTION; ENVELOPED VIRUSES; FATTY-ACIDS; IN-VITRO; MONOGLYCERIDES; INACTIVATION; ENTEROTOXIN; EXPRESSION	Background: Glycerol monolaurate (GML) is an antimicrobial agent that has potent activity against gram-positive bacteria. This study examines GML antibacterial activity in comparison to lauric acid, in broth cultures compared to biofilm cultures, and against a wide range of gram-positive, gram-negative, and non-gram staining bacteria. Methodology/Principal Findings: GML is >= 200 times more effective than lauric acid in bactericidal activity, defined as a >= 3 log reduction in colony-forming units (CFU)/ml, against Staphylococcus aureus and Streptococcus pyogenes in broth cultures. Both molecules inhibit superantigen production by these organisms at concentrations that are not bactericidal. GML prevents biofilm formation by Staphylococcus aureus and Haemophilus influenzae, as representative gram-positive and gram-negative organisms, tested in 96 well microtiter plates, and simultaneously is bactericidal for both organisms in mature biofilms. GML is bactericidal for a wide range of potential bacterial pathogens, except for Pseudomonas aeruginosa and Enterobacteriaceae. In the presence of acidic pH and the cation chelator ethylene diamine tetraacetic acid, GML has greatly enhanced bactericidal activity for Pseudomonas aeruginosa and Enterobacteriaceae. Solubilization of GML in a nonaqueous delivery vehicle (related to K-Y Warming (R)) enhances its bactericidal activity against S. aureus. Both R and S, and 1 and 2 position lauric acid derivatives of GML exhibit bactericidal activity. Despite year-long passage of Staphylococcus aureus on sub-growth inhibitory concentrations of GML (0.5 x minimum bactericidal concentration), resistance to GML did not develop. Conclusions/Significance: GML may be useful as a broad-spectrum human or animal topical microbicide and may be useful as an environmental surface microbicide for management of bacterial infections and contamination.	[Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Peterson, Marnie L.] Univ Minnesota, Minneapolis, MN USA	University of Iowa; University of Minnesota System; University of Minnesota Twin Cities	Schlievert, PM (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	patrick-schlievert@uiowa.edu		Schlievert, Patrick/0000-0001-8314-9369	National Institutes of Health [R01 AI074283, R01 AI73366, U54 AI57153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073366, R01AI074283, U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI074283, R01 AI73366, and U54 AI57153. PMS is a member of the Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGDOLL MS, 1981, LANCET, V1, P1017; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Ganzle MG, 2003, APPL ENVIRON MICROB, V69, P1305, DOI 10.1128/AEM.69.2.1305-1307.2003; Giantonio BJ, 1997, J CLIN ONCOL, V15, P1994, DOI 10.1200/JCO.1997.15.5.1994; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; KABARA JJ, 1980, J SOC COSMET CHEM, V31, P1; KABARA JJ, 1981, J FOOD PROTECT, V44, P633, DOI 10.4315/0362-028X-44.8.633; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lin YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007499; Lowery CA, 2009, J AM CHEM SOC, V131, P14473, DOI 10.1021/ja9056079; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; NAUCIEL C, 1969, EUR J BIOCHEM, V11, P160, DOI 10.1111/j.1432-1033.1969.tb00754.x; Pechous R, 2004, ANTIMICROB AGENTS CH, V48, P3057, DOI 10.1128/AAC.48.8.3057-3063.2004; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; REISER RF, 1987, J CLIN MICROBIOL, V25, P1450, DOI 10.1128/JCM.25.8.1450-1452.1987; Ruzin A, 2000, J BACTERIOL, V182, P2668, DOI 10.1128/JB.182.9.2668-2671.2000; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Schlievert PM, 2010, CLIN VACCINE IMMUNOL, V17, P722, DOI 10.1128/CVI.00483-09; SCHLIEVERT PM, 1984, J INFECT DIS, V149, P471, DOI 10.1093/infdis/149.3.471; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Strandberg KL, 2009, CLIN INFECT DIS, V49, P1711, DOI 10.1086/644614; THORMAR H, 1987, ANTIMICROB AGENTS CH, V31, P27, DOI 10.1128/AAC.31.1.27; THORMAR H, 1994, ANN NY ACAD SCI, V724, P465, DOI 10.1111/j.1749-6632.1994.tb38948.x; Vetter SM, 2005, ANTIMICROB AGENTS CH, V49, P1302, DOI 10.1128/AAC.49.4.1302-1305.2005; ZABRISKIE JB, 1964, J EXP MED, V119, P761, DOI 10.1084/jem.119.5.761	33	106	118	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40350	10.1371/journal.pone.0040350	http://dx.doi.org/10.1371/journal.pone.0040350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808139	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400043
J	Ganjalikhany, MR; Ranjbar, B; Taghavi, AH; Moghadam, TT				Ganjalikhany, Mohamad Reza; Ranjbar, Bijan; Taghavi, Amir Hossein; Moghadam, Tahereh Tohidi			Functional Motions of Candida antarctica Lipase B: A Survey through Open-Close Conformations	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; MOLECULAR-DYNAMICS; PSYCHROPHILIC ENZYMES; MESOPHILIC TRYPSINS; COLD; FLEXIBILITY; ADAPTATION; ACTIVATION; PLASTICITY; INSIGHTS	Candida antarctica lipase B (CALB) belongs to psychrophilic lipases which hydrolyze carboxyl ester bonds at low temperatures. There have been some features reported about cold-activity of the enzyme through experimental methods, whereas there is no detailed information on its mechanism of action at molecular level. Herein, a comparative molecular dynamics simulation and essential dynamics analysis have been carried out at three temperatures (5, 35 and 50 degrees C) to trace the dominant factors in the psychrophilic properties of CALB under cold condition. The results clearly describe the effect of temperature on CALB with meaningful differences in the flexibility of the lid region (alpha 5 helix), covering residues 141-147. Open-closed conformations have been obtained from different sets of long-term simulations (60 ns) at 5 degrees C gave two reproducible distinct forms of CALB. The starting open conformation became closed immediately at 35 and 50 degrees C during 60 ns of simulation, while a sequential open-closed form was observed at 5 degrees C. These structural alterations were resulted from alpha 5 helical movements, where the closed conformation of active site cleft was formed by displacement of both helix and its side chains. Analysis of normal mode showed concerted motions that are involved in the movement of both alpha 5 and alpha 10 helices. It is suggested that the functional motions needed for lypolytic activity of CALB is constructed from short-range movement of alpha 5, accompanied by long-range movement of the domains connected to the lid region.	[Ganjalikhany, Mohamad Reza; Ranjbar, Bijan; Taghavi, Amir Hossein] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran; [Moghadam, Tahereh Tohidi] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran	Tarbiat Modares University; Tarbiat Modares University	Ganjalikhany, MR (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran.	ranjbarb@modares.ac.ir	Ganjalikhany, Mohamad Reza/AAB-7845-2021	Ganjalikhany, Mohamad Reza/0000-0002-6865-0814	research council of Trabiat Modares University	research council of Trabiat Modares University	This research has been financially supported by the research council of Trabiat Modares University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpigny JL, 1997, J MOL CATAL B-ENZYM, V3, P29, DOI 10.1016/S1381-1177(96)00041-0; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Barbe S, 2009, PROTEINS, V77, P509, DOI 10.1002/prot.22462; Bordes F, 2010, BIOPHYS J, V99, P2225, DOI 10.1016/j.bpj.2010.07.040; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cherukuvada SL, 2005, PLOS COMPUT BIOL, V1, P182, DOI 10.1371/journal.pcbi.0010028; Cui Q, 2004, J MOL BIOL, V340, P345, DOI 10.1016/j.jmb.2004.04.044; De Diego T, 2005, BIOMACROMOLECULES, V6, P1457, DOI 10.1021/bm049259q; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller G, 1997, COMP BIOCHEM PHYS A, V118, P495, DOI 10.1016/S0300-9629(97)00011-X; Ferrario V, 2011, ADV SYNTH CATAL, V353, P2466, DOI 10.1002/adsc.201100397; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Georlette D, 2003, J BIOL CHEM, V278, P37015, DOI 10.1074/jbc.M305142200; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gianese G, 2002, PROTEINS, V47, P236, DOI 10.1002/prot.10084; Gonzalez-Navarro H, 2001, BIOCHEMISTRY-US, V40, P3174, DOI 10.1021/bi002202d; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8; Gutierrez-Ayesta C, 2007, ENZYME MICROB TECH, V41, P35, DOI 10.1016/j.enzmictec.2006.11.018; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Joseph B, 2007, BIOTECHNOL MOL BIOL, V2, P039; Joseph B, 2008, BIOTECHNOL ADV, V26, P457, DOI 10.1016/j.biotechadv.2008.05.003; Keskin O, 2002, BIOCHEMISTRY-US, V41, P491, DOI 10.1021/bi011393x; Kong YF, 2003, J MOL BIOL, V330, P129, DOI 10.1016/S0022-2836(03)00555-2; Leiros HKS, 2000, EUR J BIOCHEM, V267, P1039; Li WC, 2009, J MOL CATAL B-ENZYM, V57, P299, DOI 10.1016/j.molcatb.2008.10.009; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Narinx E, 1997, PROTEIN ENG, V10, P1271, DOI 10.1093/protein/10.11.1271; Papaleo E, 2008, FEBS LETT, V582, P1008, DOI 10.1016/j.febslet.2008.02.048; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Ramakrishnan K.S., 2008, INT J INTEGR BIOL, V2, P204; Raza S, 2001, PROTEIN SCI, V10, P329, DOI 10.1110/ps.33901; Rehm S, 2010, PROTEIN SCI, V19, P2122, DOI 10.1002/pro.493; Roy D, 2007, J BIOMOL STRUCT DYN, V24, P463, DOI 10.1080/07391102.2007.10507134; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Skjot M, 2009, CHEMBIOCHEM, V10, P520, DOI 10.1002/cbic.200800668; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svendsen A, 2000, BBA-PROTEIN STRUCT M, V1543, P223, DOI 10.1016/S0167-4838(00)00239-9; Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100; Trodler P, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-9; Trodler P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-38; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Uppenberg J, 1995, BIOCHEMISTRY-US, V34, P16838, DOI 10.1021/bi00051a035; Valadie H, 2003, J MOL BIOL, V332, P657, DOI 10.1016/S0022-2836(03)00851-9; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zecchinon L, 2001, EXTREMOPHILES, V5, P313, DOI 10.1007/s007920100207	55	36	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40327	10.1371/journal.pone.0040327	http://dx.doi.org/10.1371/journal.pone.0040327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808134	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500037
J	Wang, B; Tan, YX; Jia, J; Digre, A; Zhang, X; Vlodavsky, I; Li, JP				Wang, Bo; Tan, Ying-xia; Jia, Juan; Digre, Andreas; Zhang, Xiao; Vlodavsky, Israel; Li, Jin-ping			Accelerated Resolution of AA Amyloid in Heparanase Knockout Mice Is Associated with Matrix Metalloproteases	PLOS ONE			English	Article							UP-REGULATION; PROTEIN; MATRIX-METALLOPROTEINASE-9; SULFATE	AA-amyloidosis is a disease characterized by abnormal deposition of serum A amyloid (SAA) peptide along with other components in various organs. The disease is a complication of inflammatory conditions that cause persistent high levels of the acute phase reactant SAA in plasma. In experimental animal models, the deposited amyloid is resolved when the inflammation is stopped, suggesting that there is an efficient clearance mechanism for the amyloid. As heparan sulfate (HS) is one of the major components in the amyloid, its metabolism is expected to affect the pathology of AA amyloidosis. In this study, we investigated the effect of heparanase, a HS degradation enzyme, in resolution of the AA amyloid. The transgenic mice deficient in heparanase (Hpa-KO) produced a similar level of SAA in plasma as the wildtype control (Ctr) mice upon induction by injection of AEF (amyloid enhancing factor) and inflammatory stimuli. The induction resulted in formation of SAA amyloid 7-days post treatment in the spleen that displayed a comparable degree of amyloid load in both groups. The amyloid became significantly less in the Hpa-KO spleen than in the Ctr spleen 10-days post treatment, and was completely resolved in the Hpa-KO spleen on day 21 post induction, while a substantial amount was still detected in the Ctr spleen. The rapid clearance of the amyloid in the Hpa-KO mice can be ascribed to upregulated matrix metalloproteases (MMPs) that are believed to contribute to degradation of the protein components in the AA amyloid. The results indicate that both heparanase and MMPs play important parts in the pathological process of AA amyloidosis.	[Wang, Bo; Tan, Ying-xia; Jia, Juan; Digre, Andreas; Li, Jin-ping] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Zhang, Xiao] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Uppsala University; Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Wang, B (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	jin-pingli@imbim.uu.se			Swedish Science Council [K2009-67X-21128-01-3]; Swedish Cancer Foundation [090717]; Polysackaridforskning Foundation (Uppsala)	Swedish Science Council; Swedish Cancer Foundation; Polysackaridforskning Foundation (Uppsala)	This study is supported by the Swedish Science Council (K2009-67X-21128-01-3), Swedish Cancer Foundation (090717) and Polysackaridforskning Foundation (Uppsala). The funders had no role in data collection and analysis or preparation of the manuscript but they did have a role in design of the project and final decision to publish.	Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; AXELRAD MA, 1982, LAB INVEST, V47, P139; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Kisilevsky Robert, 2004, V299, P237; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Migita K, 1998, LAB INVEST, V78, P535; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sousa MM, 2004, FASEB J, V18, P124, DOI 10.1096/fj.04-2022fje; Stix B, 2001, AM J PATHOL, V159, P561, DOI 10.1016/S0002-9440(10)61727-0; Westermark GT, 2009, FEBS LETT, V583, P2685, DOI 10.1016/j.febslet.2009.04.026; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zitka O, 2010, CURR MED CHEM, V17, P3751, DOI 10.2174/092986710793213724	16	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39899	10.1371/journal.pone.0039899	http://dx.doi.org/10.1371/journal.pone.0039899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808071	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500015
J	Li, J; Sun, YA; Ye, JH				Li, Jing; Sun, Yanan; Ye, Jiang-Hong			Electroacupuncture Decreases Excessive Alcohol Consumption Involving Reduction of FosB/Delta FosB Levels in Reward-Related Brain Regions	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; RANDOMIZED-CONTROLLED-TRIAL; RECEPTOR AGONIST U50,488H; VOLUNTARY ETHANOL INTAKE; MESSENGER-RNA CONTENT; DELTA-FOSB; COGNITIVE DYSFUNCTION; PREFRONTAL CORTEX; DRUG-ADDICTION; GABAERGIC TAIL	New therapies are needed for alcohol abuse, a major public health problem in the U.S. and worldwide. There are only three FDA-approved drugs for treatment of alcohol abuse (naltrexone, acamprosate and disulfuram). On average these drugs yield only moderate success in reducing long-term alcohol consumption. Electroacupuncture has been shown to alleviate various drugs of abuse, including alcohol. Although previous studies have shown that electroacupuncture reduced alcohol consumption, the underlying mechanisms have not been fully elucidated. Delta FosB and FosB are members of the Fos family of transcription factors implicated in neural plasticity in drug addiction; a connection between electroacupuncture's treatment of alcohol abuse and the Fos family has not been established. In this study, we trained rats to drink large quantities of ethanol in a modified intermittent access two-bottle choice drinking procedure. When rats achieved a stable baseline of ethanol consumption, electroacupuncture (100 Hz or 2 Hz, 30 min each day) was administered at Zusanli (ST36) for 6 consecutive days. The level of FosB/Delta FosB in reward-related brain regions was assessed by immunohistochemistry. We found that the intake of and preference for ethanol in rats under 100 Hz, but not 2 Hz electroacupuncture regiment were sharply reduced. The reduction was maintained for at least 72 hours after the termination of electroacupuncture treatment. Conversely, 100 Hz electroacupuncture did not alter the intake of and preference for the natural rewarding agent sucrose. Additionally, FosB/Delta FosB levels in the prefrontal cortex, striatal region and the posterior region of ventral tegmental area were increased following excessive ethanol consumption, but were reduced after six-day 100 Hz electroacupuncture. Thus, this study demonstrates that six-day 100 Hz electroacupuncture treatment effectively reduces ethanol consumption and preference in rats that chronically drink excessive amount of ethanol. This effect of electroacupuncture may be mediated by down-regulation of FosB/Delta FosB in reward-related brain regions.	[Li, Jing; Ye, Jiang-Hong] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol Pharmacol & Physiol, Newark, NJ 07103 USA; [Sun, Yanan] Beijing Univ Chinese Med, Dong Zhi Men Hosp, Dept Neurol, Key Lab Internal Chinese Med,Minist Educ, Beijing, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Beijing University of Chinese Medicine	Li, J (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol Pharmacol & Physiol, 185 S Orange Ave, Newark, NJ 07103 USA.	ye@umdnj.edu			National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism [AA016964, AA016618]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016964, R21AA016618] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism [Grants AA016964 and AA016618]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Chen G, 2011, ALCOHOL CLIN EXP RES, V35, P1739, DOI 10.1111/j.1530-0277.2011.01520.x; Cui CL, 2008, NEUROCHEM RES, V33, P2013, DOI 10.1007/s11064-008-9784-8; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fadda P, 1999, ALCOHOL CLIN EXP RES, V23, P1296, DOI 10.1097/00000374-199908000-00002; Ford CP, 2007, J NEUROPHYSIOL, V97, P883, DOI 10.1152/jn.00963.2006; Han Jisheng, 2011, Front Med, V5, P141, DOI 10.1007/s11684-011-0136-8; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jindal V, 2008, J PEDIAT HEMATOL ONC, V30, P431, DOI 10.1097/MPH.0b013e318165b2cc; Karst M, 2002, ADDICT BIOL, V7, P415, DOI 10.1080/1355621021000006017; Kaufling J, 2010, BRIT J PHARMACOL, V161, P1677, DOI 10.1111/j.1476-5381.2010.00984.x; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kim YH, 2005, J ADDICT DIS, V24, P115, DOI 10.1300/J069v24n04_09; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kunz S, 2007, ALCOHOL CLIN EXP RES, V31, P436, DOI 10.1111/j.1530-0277.2006.00333.x; Li J, 2010, ALCOHOL CLIN EXP RES, V34; Li J, 2012, J PHARMACOL EXP THER, V341, P196, DOI 10.1124/jpet.111.190058; Li J, 2011, BRAIN RES BULL, V86, P428, DOI 10.1016/j.brainresbull.2011.08.013; Li J, 2011, ADDICT BIOL, V16, P600, DOI 10.1111/j.1369-1600.2011.00344.x; Lindholm S, 2001, BEHAV BRAIN RES, V120, P137, DOI 10.1016/S0166-4328(00)00368-5; Logrip ML, 2008, FASEB J, V22, P2393, DOI 10.1096/fj.07-099135; Logrip ML, 2009, ALCOHOL, V43, P359, DOI 10.1016/j.alcohol.2009.05.001; LU GW, 1983, AM J PHYSIOL, V245, pR606, DOI 10.1152/ajpregu.1983.245.4.R606; Mann K, 2004, ALCOHOL CLIN EXP RES, V28, P51, DOI 10.1097/01.ALC.0000108656.81563.05; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Marinelli PW, 2000, LIFE SCI, V66, P1915, DOI 10.1016/S0024-3205(00)00517-8; Meyers Robert J, 2003, Recent Dev Alcohol, V16, P183; Mitchell JM, 2005, PSYCHOPHARMACOLOGY, V182, P384, DOI 10.1007/s00213-005-0067-7; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nielsen CK, 2008, BIOL PSYCHIAT, V64, P974, DOI 10.1016/j.biopsych.2008.07.018; Overstreet DH, 2008, NEUROCHEM RES, V33, P2166, DOI 10.1007/s11064-008-9791-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; POKLIS A, 1982, CLIN CHEM, V28, P2125; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Shi XD, 2004, MOL BRAIN RES, V130, P124, DOI 10.1016/j.molbrainres.2004.07.016; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Stux G., 1987, ACUPUNCTURE TXB ATLA, V1st ed; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wang GB, 2011, PEPTIDES, V32, P713, DOI 10.1016/j.peptides.2010.12.006; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Winkler A, 1998, NEUROREPORT, V9, P1459, DOI 10.1097/00001756-199805110-00039; Winstanley CA, 2007, J NEUROSCI, V27, P10497, DOI 10.1523/JNEUROSCI.2566-07.2007; Winstanley CA, 2009, PHARMACOL BIOCHEM BE, V93, P278, DOI 10.1016/j.pbb.2008.12.007; Wu LZ, 1999, BRAIN RES, V851, P290, DOI 10.1016/S0006-8993(99)02069-7; Xuei X, 2006, MOL PSYCHIATR, V11, P1016, DOI 10.1038/sj.mp.4001882; Yang CH, 2002, PHARMACOL BIOCHEM BE, V72, P847, DOI 10.1016/S0091-3057(02)00769-4; Yang CH, 2010, ALCOHOL CLIN EXP RES, V34, P2137, DOI 10.1111/j.1530-0277.2010.01310.x; Yoon SS, 2012, PSYCHOPHARMACOLOGY B; Yoshimoto K, 2001, ALCOHOL CLIN EXP RES, V25, p63S; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zhao RJ, 2006, NEUROSCI LETT, V395, P28, DOI 10.1016/j.neulet.2005.10.043	58	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40347	10.1371/journal.pone.0040347	http://dx.doi.org/10.1371/journal.pone.0040347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792289	gold, Green Published, Green Submitted			2022-12-27	WOS:000306354700037
J	Pulgarin-R, PC; Burg, TM				Pulgarin-R, Paulo C.; Burg, Theresa M.			Genetic Signals of Demographic Expansion in Downy Woodpecker (Picoides pubescens) after the Last North American Glacial Maximum	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; PHYLOGEOGRAPHIC STRUCTURE; CONTRASTING PATTERNS; ICE AGES; DIVERGENCE; FLOW; MICROSATELLITES; COALESCENT; SPECIATION	The glacial cycles of the Pleistocene have been recognized as important, large-scale historical processes that strongly influenced the demographic patterns and genetic structure of many species. Here we present evidence of a postglacial expansion for the Downy Woodpecker (Picoides pubescens), a common member of the forest bird communities in North America with a continental distribution. DNA sequences from the mitochondrial tRNA-Lys, and ATPase 6 and 8 genes, and microsatellite data from seven variable loci were combined with a species distribution model (SDM) to infer possible historical scenarios for this species after the last glacial maximum. Analyses of Downy Woodpeckers from 23 geographic areas suggested little differentiation, shallow genealogical relationships, and limited population structure across the species' range. Microsatellites, which have higher resolution and are able to detect recent differences, revealed two geographic groups where populations along the eastern edge of the Rocky Mountains (Montana, Utah, Colorado, and southern Alberta) were genetically isolated from the rest of the sampled populations. Mitochondrial DNA, an important marker to detect historical patterns, recovered only one group. However, populations in Idaho and southeast BC contained high haplotype diversity and, in general were characterized by the absence of the most common mtDNA haplotype. The SDM suggested several areas in the southern US as containing suitable Downy Woodpecker habitat during the LGM. The lack of considerable geographic structure and the starburst haplotype network, combined with several population genetic tests, suggest a scenario of demographic expansion during the last part of Pleistocene and early Holocene.	[Pulgarin-R, Paulo C.; Burg, Theresa M.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Pulgarin-R, PC (corresponding author), Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia.	pc.pulgarin51@uniandes.edu.co			NSERC; Alberta Innovates Tech Futures-New Scholars Award	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Tech Futures-New Scholars Award	Funding was provided by NSERC Discovery Grant (http://www.nserc-crsng.gc.ca/), and Alberta Innovates Tech Futures-New Scholars Award (http://www.albertatechfutures.ca/), both to Theresa M. Burg. There is no specific grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; BALL RM, 1988, P NATL ACAD SCI USA, V85, P1558, DOI 10.1073/pnas.85.5.1558; BALL RM, 1992, AUK, V109, P626; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barrowclough GF, 2004, MOL ECOL, V13, P1911, DOI 10.1111/j.1365-294X.2004.02215.x; Beadell JS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000636; Belkhir K, 1996, GENETIX V4 02 LOGICI; Brito PH, 2007, MOL ECOL, V16, P3423, DOI 10.1111/j.1365-294X.2007.03401.x; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; BROWNING MR, 1995, J FIELD ORNITHOL, V66, P12; Browning RM, 1997, ERA AR PHILLIPS FEST, P25; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Burg TM, 2006, MOL ECOL, V15, P2409, DOI 10.1111/j.1365-294X.2006.02957.x; Burg TM, 2005, MOL ECOL, V14, P3745, DOI 10.1111/j.1365-294X.2005.02710.x; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Carstens BC, 2005, MOL ECOL, V14, P255, DOI 10.1111/j.1365-294X.2004.02404.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drovetski SV, 2004, P ROY SOC B-BIOL SCI, V271, P545, DOI 10.1098/rspb.2003.2638; Edwards SV, 2000, EVOLUTION, V54, P1839; Ellegren H, 1999, HEREDITAS, V130, P291, DOI 10.1111/j.1601-5223.1999.00291.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Graham BA, 2012, J AVIAN BIOL, V43, P198, DOI 10.1111/j.1600-048X.2012.05604.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jackson J. A, 2002, BIRDS N AM; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Johnson JA, 2003, MOL ECOL, V12, P3335, DOI 10.1046/j.1365-294X.2003.02013.x; KIMURA M, 1964, GENETICS, V49, P561; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Klicka J, 1999, P ROY SOC B-BIOL SCI, V266, P695, DOI 10.1098/rspb.1999.0691; Knopp T, 2009, HEREDITY, V102, P174, DOI 10.1038/hdy.2008.91; Larsson LC, 2009, CONSERV GENET, V10, P1255, DOI 10.1007/s10592-008-9693-z; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Manthey JD, 2011, MOL PHYLOGENET EVOL, V58, P502, DOI 10.1016/j.ympev.2010.12.003; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Nei M., 1987, MOL EVOLUTIONARY GEN; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Ouellet H.R, 1977, THESIS MCGILL U; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pereira SL, 2008, GENET MOL BIOL, V31, P964, DOI 10.1590/S1415-47572008005000021; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIELOU EC, 1991, ICE AGE RETURN LIFE; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Runck AM, 2005, MOL ECOL, V14, P1445, DOI 10.1111/j.1365-294X.2005.02501.x; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; Scribner KT, 2003, AUK, V120, P889, DOI 10.1642/0004-8038(2003)120[0889:POCGBC]2.0.CO;2; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; SLATKIN M, 1991, GENETICS, V129, P555; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Stenzler LM, 2009, CONDOR, V111, P470, DOI 10.1525/cond.2009.080052; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Swenson NG, 2004, EVOLUTION, V58, P2391; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valimaki K, 2008, MOL ECOL RESOUR, V8, P1152, DOI 10.1111/j.1755-0998.2008.02209.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila M, 2008, MOL ECOL RESOUR, V8, P415, DOI 10.1111/j.1471-8286.2007.01976.x; Walstrom VW, 2012, MOL ECOL, V21, P907, DOI 10.1111/j.1365-294X.2011.05384.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Zink Robert M., 1997, P301, DOI 10.1016/B978-012498315-1/50017-0	83	32	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40412	10.1371/journal.pone.0040412	http://dx.doi.org/10.1371/journal.pone.0040412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792306	Green Submitted, gold, Green Published			2022-12-27	WOS:000306354700043
J	Hamad, EA; Zhu, WZ; Chan, TO; Myers, V; Gao, E; Li, X; Zhang, J; Song, JL; Zhang, XQ; Cheung, JY; Koch, W; Feldman, AM				Hamad, Eman A.; Zhu, Weizhong; Chan, Tung O.; Myers, Valerie; Gao, Erhe; Li, Xue; Zhang, Jin; Song, Jianliang; Zhang, Xue-Qian; Cheung, Joseph Y.; Koch, Walter; Feldman, Arthur M.			Cardioprotection of Controlled and Cardiac-Specific Over-Expression of A(2A)-Adenosine Receptor in the Pressure Overload	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTOR; HEART-FAILURE; RESTRICTED OVEREXPRESSION; CARDIOMYOCYTE HYPERTROPHY; CONTRACTILE PERFORMANCE; A(1)-ADENOSINE RECEPTOR; MYOCARDIAL-INFARCTION; VENTRICULAR MYOCYTES; REPERFUSION INJURY; IN-VITRO	Adenosine binds to three G protein-coupled receptors (R) located on the cardiomyocyte (A(1)-R, A(2A)-R and A(3)-R) and provides cardiac protection during both ischemic and load-induced stress. While the role of adenosine receptor-subtypes has been well defined in the setting of ischemia-reperfusion, far less is known regarding their roles in protecting the heart during other forms of cardiac stress. Because of its ability to increase cardiac contractility and heart rate, we hypothesized that enhanced signaling through A(2A)-R would protect the heart during the stress of transverse aortic constriction (TAC). Using a cardiac-specific and inducible promoter, we selectively over-expressed A(2A)-R in FVB mice. Echocardiograms were obtained at baseline, 2, 4, 8, 12, 14 weeks and hearts were harvested at 14 weeks, when WT mice developed a significant decrease in cardiac function, an increase in end systolic and diastolic dimensions, a higher heart weight to body weight ratio (HW/BW), and marked fibrosis when compared with sham-operated WT. More importantly, these changes were significantly attenuated by over expression of the A(2A)-R. Furthermore, WT mice also demonstrated marked increases in the hypertrophic genes beta-myosin heavy chain (beta-MHC), and atrial natriuretic factor (ANF) - changes that are mediated by activation of the transcription factor GATA-4. Levels of the mRNAs encoding beta-MHC, ANP, and GATA-4 were significantly lower in myocardium from A(2A)-R TG mice after TAC when compared with WT and sham-operated controls. In addition, three inflammatory factors genes encoding cysteine dioxygenase, complement component 3, and serine peptidase inhibitor, member 3N, were enhanced in WT TAC mice, but their expression was suppressed in A(2A)-R TG mice. A(2A)-R over-expression is protective against pressure-induced heart failure secondary to TAC. These cardioprotective effects are associated with attenuation of GATA-4 expression and inflammatory factors. The A(2A)-R may provide a novel new target for pharmacologic therapy in patients with cardiovascular disease.	[Hamad, Eman A.; Zhu, Weizhong; Myers, Valerie; Gao, Erhe; Song, Jianliang; Zhang, Xue-Qian; Cheung, Joseph Y.; Koch, Walter; Feldman, Arthur M.] Temple Univ, Sch Med, Cardiovasc Res Ctr, Dept Physiol, Philadelphia, PA 19122 USA; [Hamad, Eman A.; Chan, Tung O.; Li, Xue; Zhang, Jin] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University	Hamad, EA (corresponding author), Temple Univ, Sch Med, Cardiovasc Res Ctr, Dept Physiol, Philadelphia, PA 19122 USA.	Weizhong.Zhu@Temple.edu; Arthur.Feldman@Temple.edu		hamad, abdullah/0000-0003-4677-7686; Chan, Tung/0000-0001-6574-9555	NIH [R37 HL061690, R01 HL56205, P01 HL091799]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL061690, P01HL091799, R01HL056205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported in part by NIH grants R37 HL061690 and R01 HL56205 (WJK), P01 HL091799 (WJK and AMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan TO, 2008, CTS-CLIN TRANSL SCI, V1, P126, DOI 10.1111/j.1752-8062.2008.00027.x; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chung ES, 1998, J HYPERTENS, V16, P1813, DOI 10.1097/00004872-199816120-00015; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Diedrichs H, 2004, EUR J HEART FAIL, V6, P3, DOI 10.1016/j.ejheart.2003.07.007; Dobson JG, 1997, CARDIOVASC RES, V34, P337, DOI 10.1016/S0008-6363(97)00023-0; DORN GW, 1994, AM J PHYSIOL, V267, pH400, DOI 10.1152/ajpheart.1994.267.1.H400; Dubey RK, 1997, CIRCULATION, V96, P2656, DOI 10.1161/01.CIR.96.8.2656; Fiser SM, 2002, J THORAC CARDIOV SUR, V124, P973, DOI 10.1067/mtc.2002.124886; Funakoshi H, 2007, CIRCULATION, V115, P2307, DOI 10.1161/CIRCULATIONAHA.107.694596; Funakoshi H, 2006, CIRCULATION, V114, P2240, DOI 10.1161/CIRCULATIONAHA.106.620211; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Gan XHT, 2005, J PHARMACOL EXP THER, V312, P27, DOI 10.1124/jpet.104.073122; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; GROSSMAN W, 1974, CIRC RES, V35, P793, DOI 10.1161/01.RES.35.5.793; Hall JL, 2004, PHYSIOL GENOMICS, V17, P283, DOI 10.1152/physiolgenomics.00004.2004; Hamad EA, 2010, AM J PHYSIOL-HEART C, V298, pH1738, DOI 10.1152/ajpheart.00688.2009; Harada K, 1999, CIRCULATION, V100, P2093, DOI 10.1161/01.CIR.100.20.2093; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Headrick JP, 2003, AM J PHYSIOL-HEART C, V285, pH1797, DOI 10.1152/ajpheart.00407.2003; Headrick JP, 2003, J PHYSIOL-LONDON, V549, P823, DOI 10.1113/jphysiol.2003.041541; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; HOLUBARSCH C, 1985, BASIC RES CARDIOL, V80, P582, DOI 10.1007/BF01907857; HOLUBARSCH C, 1985, CIRC RES, V56, P78, DOI 10.1161/01.RES.56.1.78; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Impellizzeri D, 2011, EUR J PHARMACOL, V668, P305, DOI 10.1016/j.ejphar.2011.06.049; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liao YL, 2003, CIRC RES, V93, P759, DOI 10.1161/01.RES.0000094744.88220.62; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZB, 2008, CIRCULATION, V118, P1713, DOI 10.1161/CIRCULATIONAHA.108.788307; McPherson JA, 2001, ARTERIOSCL THROM VAS, V21, P791, DOI 10.1161/01.ATV.21.5.791; Modesti PA, 2002, J MOL CELL CARDIOL, V34, P1491, DOI 10.1006/jmcc.2002.2095; Morimoto T, 2001, J BIOL CHEM, V276, P34983, DOI 10.1074/jbc.M005498200; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; Nagai T, 2011, HYPERTENSION, V57, P208, DOI 10.1161/HYPERTENSIONAHA.110.158915; Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404, DOI 10.1152/ajprenal.1999.277.3.F404; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676; Safran N, 2001, MOL CELL BIOCHEM, V217, P143, DOI 10.1023/A:1007209321969; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Todd J, 1996, ANN THORAC SURG, V62, P1364, DOI 10.1016/0003-4975(96)00495-X; Vinten-Johansen J, 1999, ANN THORAC SURG, V68, P1942, DOI 10.1016/S0003-4975(99)01018-8; Wagner DR, 1998, CIRCULATION, V97, P521; Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5; Xu X, 2008, HYPERTENSION, V51, P1557, DOI 10.1161/HYPERTENSIONAHA.108.110833; Yan XH, 2008, AM J PHYSIOL-HEART C, V294, pH1274, DOI 10.1152/ajpheart.00174.2006; Yang DC, 2010, MOL MED REP, V3, P497, DOI 10.3892/mmr_00000287	54	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39919	10.1371/journal.pone.0039919	http://dx.doi.org/10.1371/journal.pone.0039919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792196	gold, Green Submitted, Green Published			2022-12-27	WOS:000306461800025
J	Lapchak, PH; Ioannou, A; Rani, P; Lieberman, LA; Yoshiya, K; Kannan, L; Lucca, JJD; Kowalska, MA; Tsokos, GC				Lapchak, Peter H.; Ioannou, Antonis; Rani, Poonam; Lieberman, Linda A.; Yoshiya, Kazuhisa; Kannan, Lakshmi; Lucca, Jurandir J. Dalle; Kowalska, M. Anna; Tsokos, George C.			The Role of Platelet Factor 4 in Local and Remote Tissue Damage in a Mouse Model of Mesenteric Ischemia/Reperfusion Injury	PLOS ONE			English	Article							CXC-CHEMOKINE PLATELET-FACTOR-4; INFLAMMATORY-BOWEL-DISEASE; HUMAN PLATELET FACTOR-4; ISCHEMIA-REPERFUSION; HUMAN MONOCYTES; FACTOR-IV; MICE; CELLS; ATHEROSCLEROSIS; DIFFERENTIATION	The robust inflammatory response that occurs during ischemia reperfusion (IR) injury recruits factors from both the innate and adaptive immune systems. However the contribution of platelets and their products such as Platelet Factor 4 (PF4; CXCL4), during the pathogenesis of IR injury has not been thoroughly investigated. We show that a deficiency in PF4 protects mice from local and remote tissue damage after 30 minutes of mesenteric ischemia and 3 hours of reperfusion in PF4-/- mice compared to control B6 mice. This protection was independent from Ig or complement deposition in the tissues. However, neutrophil and monocyte infiltration were decreased in the lungs of PF4-/- mice compared with B6 control mice. Platelet-depleted B6 mice transfused with platelets from PF4-/- mice displayed reduced tissue damage compared with controls. In contrast, transfusion of B6 platelets into platelet depleted PF4-/- mice reconstituted damage in both intestine and lung tissues. We also show that PF4 may modulate the release of IgA. Interestingly, we show that PF4 expression on intestinal epithelial cells is increased after IR at both the mRNA and protein levels. In conclusion, these findings demonstrate that may PF4 represent an important mediator of local and remote tissue damage.	[Lapchak, Peter H.; Ioannou, Antonis; Rani, Poonam; Lieberman, Linda A.; Yoshiya, Kazuhisa; Kannan, Lakshmi; Tsokos, George C.] Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA; [Lapchak, Peter H.; Ioannou, Antonis; Rani, Poonam; Lieberman, Linda A.; Yoshiya, Kazuhisa; Kannan, Lakshmi; Tsokos, George C.] Harvard Univ, Sch Med, Boston, MA USA; [Kowalska, M. Anna] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Lucca, Jurandir J. Dalle] USA, Inst Surg Res, San Antonio, TX USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lapchak, PH (corresponding author), Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA.	aioannou@bicmc.harvard.edu; gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Lapchak, Peter H./B-3559-2009	tsokos, george C/0000-0001-9589-2360; Ioannou, Antonis/0000-0003-0064-5004; Lapchak, Peter/0000-0001-8597-088X	Medical Research and Material Command of the Department of the Army [W81XWH-09-1-0530, W81XWH-09-1-0536]	Medical Research and Material Command of the Department of the Army	The research presented herein was supported by Grant numbers W81XWH-09-1-0530 and W81XWH-09-1-0536 from Medical Research and Material Command of the Department of the Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin WM, 2010, CURR OPIN ORGAN TRAN; BEBAWY ST, 1986, J LEUKOCYTE BIOL, V39, P423, DOI 10.1002/jlb.39.4.423; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Chen J, 2009, J AUTOIMMUN, V32, P195, DOI 10.1016/j.jaut.2009.02.021; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Collins CE, 1997, ALIMENT PHARM THER, V11, P237, DOI 10.1046/j.1365-2036.1997.153328000.x; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Eslin DE, 2004, BLOOD, V104, P3173, DOI 10.1182/blood-2003-11-3994; Ferroni Patrizia, 2003, Current Vascular Pharmacology, V1, P157, DOI 10.2174/1570161033476772; Fricke I, 2004, FASEB J, V18, P1588, DOI 10.1096/fj.03-1435fje; Fujimi S, 2006, BLOOD, V107, P4399, DOI 10.1182/blood-2005-09-3776; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Gushiken FC, 2009, J THROMB HAEMOST, V7, P865, DOI 10.1111/j.1538-7836.2009.03334.x; Han ZC, 1997, BLOOD, V89, P2328, DOI 10.1182/blood.V89.7.2328; HERMODSON M, 1977, J BIOL CHEM, V252, P6276; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Ioannou A, 2011, CLIN IMMUNOL, V141, P3, DOI 10.1016/j.clim.2011.07.001; Johansson C, 2005, CLIN EXP IMMUNOL, V141, P279, DOI 10.1111/j.1365-2249.2005.02843.x; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Lapchak PH, 2012, AM J PHYSIOL-GASTR L, V302, pG888, DOI 10.1152/ajpgi.00499.2011; Lasagni L, 2007, BLOOD, V109, P4127, DOI 10.1182/blood-2006-10-052035; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Matthijsen RA, 2007, AM J PATHOL, V171, P1743, DOI 10.2353/ajpath.2007.070184; Padilla ND, 2007, SURGERY, V142, P722, DOI 10.1016/j.surg.2007.05.015; Pervushina O, 2004, J IMMUNOL, V173, P2060, DOI 10.4049/jimmunol.173.3.2060; Petersen F, 1996, J IMMUNOL, V156, P1954; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Schmitt-Sody M, 2007, SCAND J RHEUMATOL, V36, P311, DOI 10.1080/03009740701218741; Shenkman B, 2004, J THROMB HAEMOST, V2, P154, DOI 10.1111/j.1538-7836.2004.00527.x; Snoeck V, 2006, VET RES, V37, P455, DOI 10.1051/vetres:2006010; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; WALZ DA, 1977, THROMB RES, V11, P893, DOI 10.1016/0049-3848(77)90117-7; WATSON JB, 1994, J CLIN INVEST, V94, P261, DOI 10.1172/JCI117316; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Xia CQ, 2003, INT IMMUNOL, V15, P1007, DOI 10.1093/intimm/dxg100; Yoshida H, 2009, INFLAMM BOWEL DIS, V15, P1245, DOI 10.1002/ibd.20896; Yoshiya K, 2011, AM J PHYSIOL-GASTR L, V301, pG1020, DOI 10.1152/ajpgi.00239.2011; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2007, MOL IMMUNOL, V44, P103, DOI 10.1016/j.molimm.2006.06.022	51	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39934	10.1371/journal.pone.0039934	http://dx.doi.org/10.1371/journal.pone.0039934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792197	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800026
J	Chatterjee, A; Ghosh, SK; Adak, A; Singh, AK; Devara, PCS; Raha, S				Chatterjee, Abhijit; Ghosh, Sanjay K.; Adak, Anandamay; Singh, Ajay K.; Devara, Panuganti C. S.; Raha, Sibaji			Effect of Dust and Anthropogenic Aerosols on Columnar Aerosol Optical Properties over Darjeeling (2200 m asl), Eastern Himalayas, India	PLOS ONE			English	Article							VARIABILITY; ATHENS	Background: The loading of atmospheric particulate matter (aerosol) in the eastern Himalaya is mainly regulated by the locally generated anthropogenic aerosols from the biomass burning and by the aerosols transported from the distance sources. These different types of aerosol loading not only affect the aerosol chemistry but also produce consequent signature on the radiative properties of aerosol. Methodology/Principal Findings: An extensive study has been made to study the seasonal variations in aerosol components of fine and coarse mode aerosols and black carbon along with the simultaneous measurements of aerosol optical depth on clear sky days over Darjeeling, a high altitude station (2200 masl) at eastern Himalayas during the year 2008. We observed a heavy loading of fine mode dust component (Ca2+) during pre-monsoon (Apr - May) which was higher by 162% than its annual mean whereas during winter (Dec - Feb), the loading of anthropogenic aerosol components mainly from biomass burning (fine mode SO42- and black carbon) were higher (76% for black carbon and 96% for fine mode SO42-) from their annual means. These high increases in dust aerosols during pre-monsoon and anthropogenic aerosols during winter enhanced the aerosol optical depth by 25 and 40%, respectively. We observed that for every 1% increase in anthropogenic aerosols, AOD increased by 0.55% during winter whereas for every 1% increase in dust aerosols, AOD increased by 0.46% during pre-monsoon. Conclusion/Significance: The natural dust transport process (during pre-monsoon) plays as important a role in the radiation effects as the anthropogenic biomass burning (during winter) and their differential effects (rate of increase of the AOD with that of the aerosol concentration) are also very similar. This should be taken into account in proper modeling of the atmospheric environment over eastern Himalayas.	[Chatterjee, Abhijit; Adak, Anandamay; Raha, Sibaji] Bose Inst, Environm Sci Sect, Kolkata, India; [Chatterjee, Abhijit; Ghosh, Sanjay K.; Singh, Ajay K.; Raha, Sibaji] Bose Inst, Ctr Astroparticle Phys & Space Sci, Darjeeling, India; [Chatterjee, Abhijit; Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Ctr Astroparticle Phys & Space Sci, Kolkata, India; [Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Dept Phys, Kolkata, India; [Devara, Panuganti C. S.] Indian Inst Trop Meteorol, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM)	Chatterjee, A (corresponding author), Bose Inst, Environm Sci Sect, Kolkata, India.	sibajiraha@bic.boseinst.ernet.in	Singh, Ajay/AAF-4414-2020		Science and Engineering Research Council, Department of Science and Technology, Government of India under the Intensification of Research in High Priority Areas (IRHPA) scheme [IR/S2/PF-01/2003]	Science and Engineering Research Council, Department of Science and Technology, Government of India under the Intensification of Research in High Priority Areas (IRHPA) scheme	This study was supported through a grant (No. IR/S2/PF-01/2003) of the Science and Engineering Research Council, Department of Science and Technology, Government of India under the Intensification of Research in High Priority Areas (IRHPA) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu SS, 2007, ANN GEOPHYS, V25, P2209; Beegum SN, 2009, J ATMOS SOL-TERR PHY, V71, P1846, DOI 10.1016/j.jastp.2009.07.004; Carrico CM, 2003, ATMOS ENVIRON, V37, P2811, DOI 10.1016/S1352-2310(03)00197-3; Chatterjee A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011122; Decesari S, 2009, ATMOS CHEM PHYS DISC, V9, P25487, DOI DOI 10.5194/ACPD-9-25487-2009; Eck TF, 1999, J GEOPHYS RES-ATMOS, V104, P31333, DOI 10.1029/1999JD900923; Gautam R, 2011, ATMOS CHEM PHYS, V11, P12841, DOI 10.5194/acp-11-12841-2011; Gautam R, 2009, ANN GEOPHYS-GERMANY, V27, P3691, DOI 10.5194/angeo-27-3691-2009; Gautam R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037641; Habib G, 2006, ATMOS ENVIRON, V40, P1909, DOI 10.1016/j.atmosenv.2005.07.077; Hess M, 1998, B AM METEOROL SOC, V79, P831, DOI 10.1175/1520-0477(1998)079<0831:OPOAAC>2.0.CO;2; Kaskaoutis DG, 2006, J ATMOS SOL-TERR PHY, V68, P2147, DOI 10.1016/j.jastp.2006.07.008; Kaskaoutis DG, 2006, ATMOS RES, V79, P67, DOI 10.1016/j.atmosres.2005.05.001; LI Y, 1993, REMOTE SENS ENVIRON, V44, P81, DOI 10.1016/0034-4257(93)90104-6; MAYEWSKI PA, 1979, ARCTIC ALPINE RES, V11, P267, DOI 10.2307/1550417; Momin GA, 1999, CURR SCI INDIA, V76, P985; Moorthy KK, 2007, ANN GEOPHYS-GERMANY, V25, P2293; O'Neill NT, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000877; Singh RP, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004966; Thompson LG, 2000, SCIENCE, V289, P1916, DOI 10.1126/science.289.5486.1916	20	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40286	10.1371/journal.pone.0040286	http://dx.doi.org/10.1371/journal.pone.0040286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792264	Green Published, gold			2022-12-27	WOS:000306436300047
J	Desai, T; Shariff, A; Shariff, A; Kats, M; Fang, XM; Christiano, C; Ferris, M				Desai, Tejas; Shariff, Afreen; Shariff, Aabid; Kats, Mark; Fang, Xiangming; Christiano, Cynthia; Ferris, Maria			Tweeting the Meeting: An In-Depth Analysis of Twitter Activity at Kidney Week 2011	PLOS ONE			English	Article							INFORMATION	In recent years, the American Society of Nephrology (ASN) has increased its efforts to use its annual conference to inform and educate the public about kidney disease. Social media, including Twitter, has been one method used by the Society to accomplish this goal. Twitter is a popular microblogging service that serves as a potent tool for disseminating information. It allows for short messages (140 characters) to be composed by any author and distributes those messages globally and quickly. The dissemination of information is necessary if Twitter is to be considered a tool that can increase public awareness of kidney disease. We hypothesized that content, citation, and sentiment analyses of tweets generated from Kidney Week 2011 would reveal a large number of educational tweets that were disseminated to the public. An ideal tweet for accomplishing this goal would include three key features: 1) informative content, 2) internal citations, and 3) positive sentiment score. Informative content was found in 29% of messages, greater than that found in a similarly sized medical conference (2011 ADA Conference, 16%). Informative tweets were more likely to be internally, rather than externally, cited (38% versus 22%, p < 0.0001), thereby amplifying the original information to an even larger audience. Informative tweets had more negative sentiment scores than uninformative tweets (means -0.162 versus 0.199 respectively, p < 0.0001), therefore amplifying a tweet whose content had a negative tone. Our investigation highlights significant areas of promise and improvement in using Twitter to disseminate medical information in nephrology from a scientific conference. This goal is pertinent to many nephrology-focused conferences that wish to increase public awareness of kidney disease.	[Desai, Tejas; Christiano, Cynthia] E Carolina Univ, Div Nephrol & Hypertens, Greenville, NC 27858 USA; [Shariff, Afreen] E Carolina Univ, Dept Internal Med, Greenville, NC USA; [Shariff, Aabid] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Kats, Mark] NE Georgia Diagnost Clin, Dept Nephrol, Gainesville, GA USA; [Fang, Xiangming] E Carolina Univ, Dept Biostat, Greenville, NC USA; [Ferris, Maria] Univ N Carolina, Div Nephrol & Hypertens, Chapel Hill, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Carnegie Mellon University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill	Desai, T (corresponding author), E Carolina Univ, Div Nephrol & Hypertens, Greenville, NC 27858 USA.	desait@ecu.edu	Maria, Ferris E/A-5143-2012	Maria, Ferris E/0000-0003-1694-886X; Christiano, Cynthia/0000-0002-0547-8359				[Anonymous], 2007, 7 THINGS YOU SHOULD; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Chartier K, 2011, RENAL BUSINESS TODAY, P4; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249; Dann S, 2010, 1 MONDAY, V15, P1, DOI DOI 10.5210/FM.V15I12.2745; Ebner M, 2009, EUR C TECHN ENH LEAR; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Letierce J, 2010, P WEB SCI C 2010; Lotan G, 2011, INT J COMMUN-US, V5, P1375; Nielsen F. A., 2011, MSM, V718, P93, DOI DOI 10.1016/J.KN0SYS.2015.06.015; Parry M, 2011, HARVARD RES ACCUSED; Saraykar T, 2011, AM DIAB ASS ANN SCI; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Shinen B, 2009, TWITTERLOGICAL MISUN; Sparks MA, 2011, AM J KIDNEY DIS, V58, P512, DOI 10.1053/j.ajkd.2011.06.009; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Weller K., 2011, CEUR WORKSHOP P, P1; Weller K, 2011, P WEB SCI C; Zimmer M, 2010, ETHICS INF TECHNOL, V12, P313, DOI 10.1007/s10676-010-9227-5	22	79	80	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40253	10.1371/journal.pone.0040253	http://dx.doi.org/10.1371/journal.pone.0040253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792254	Green Published, gold			2022-12-27	WOS:000306436300040
J	Munk, M; Memon, AA; Goetze, JP; Nielsen, LB; Nexo, E; Sorensen, BS				Munk, Mathias; Memon, Ashfaque Ahmed; Goetze, Jens Peter; Nielsen, Lars Bo; Nexo, Ebba; Sorensen, Boe Sandahl			Hypoxia Changes the Expression of the Epidermal Growth Factor (EGF) System in Human Hearts and Cultured Cardiomyocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; MYOCARDIAL-INFARCTION; BREAST-CANCER; CELL-DEATH; NEUREGULIN; ERBB2; AKT; PROLIFERATION; CHEMOTHERAPY; TRASTUZUMAB	Background: The epidermal growth factor (EGF) receptors HER2 and HER4 and the ligands HB-EGF and NRG1 are crucial for heart development. The purpose of our study was to investigate the role of the complete EGF system in relation to hypoxia of the heart. Methodology/Principal Findings: We examined the mRNA expression by real time PCR of the 4 receptors and 12 ligands from the EGF-system in paired normoxic and hypoxic biopsies isolated from human hearts during coronary artery bypass operation. Compared to normoxic biopsies, hypoxic samples showed down-regulation of HER2 (P = 0.0005) and NRG1 (both alpha (P = 0.02) and beta (P = 0.03) isoforms). In contrast, HB-EGF (P = 0.0008), NRG2 beta (P = 0.01) and EGFR (P = 0.02) were up-regulated. As HER2 is essential for heart development and we find its expression reduced under hypoxia we investigated the effect of HER2 inhibition in hypoxic HL-1 cardiomyocytes by treatment with trastuzumab (20 nM). This resulted in inhibition of cardiomyocyte proliferation, but interestingly only in hypoxic cells. Co-treatment of HL-1 cells with HB-EGF (10 nM) but not with NRG-1 (5 ng/ml) rescued the cardiomyocytes from HER2 inhibition. HL-1 cardiomyocytes exposed to hypoxia revealed nuclear translocation of activated MAPK and the activity of this downstream signaling molecule was decreased by HER2 inhibition (20 nM trastuzumab), and re-established by HB-EGF (10 nM). Conclusions/Significance: Hypoxia in the human heart alters the expression of the EGF system. Mimicking the HER2 down-regulation seen in the human heart in cultured cardiomyocytes inhibited their proliferation under hypoxic conditions. Interestingly, HB-EGF is induced in the hypoxic human hearts, and rescues hypoxic cardiomyocytes from the effect of HER2 inhibition in the in vitro model. The results have implications for future treatment strategies of patients with ischemic heart disease.	[Munk, Mathias; Memon, Ashfaque Ahmed; Nexo, Ebba; Sorensen, Boe Sandahl] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Goetze, Jens Peter; Nielsen, Lars Bo] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen	Munk, M (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	boesoere@rm.dk		Memon, Ashfaque/0000-0002-1081-3553; Nexo, Ebba/0000-0001-9406-9081; Sorensen, Boe/0000-0002-9472-8099; Goetze, Jens Peter/0000-0001-6356-3829	Danish Cancer Society	Danish Cancer Society(Danish Cancer Society)	This work was funded by the Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2001, BIOCHEM J, V358, P481, DOI 10.1042/0264-6021:3580481; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; FAVARA BE, 1972, AM J CARDIOL, V30, P423, DOI 10.1016/0002-9149(72)90576-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Iwabu A, 2002, BASIC RES CARDIOL, V97, P214, DOI 10.1007/s003950200014; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jiang ZJ, 2002, BIOCHEM BIOPH RES CO, V294, P726, DOI 10.1016/S0006-291X(02)00540-5; Ky B, 2009, CIRCULATION, V120, P310, DOI 10.1161/CIRCULATIONAHA.109.856310; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Nielsen LB, 2002, ARTERIOSCL THROM VAS, V22, P1489, DOI 10.1161/01.ATV.0000030199.06252.26; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schooler K, 2000, ANAL BIOCHEM, V277, P135, DOI 10.1006/abio.1999.4387; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Suter TM, 2007, J CLIN ONCOL, V25, P3859, DOI 10.1200/JCO.2006.09.1611; Tanaka N, 2002, BIOCHEM BIOPH RES CO, V297, P375, DOI 10.1016/S0006-291X(02)02197-6; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250; Ushikoshi H, 2005, LAB INVEST, V85, P862, DOI 10.1038/labinvest.3700282; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	34	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40243	10.1371/journal.pone.0040243	http://dx.doi.org/10.1371/journal.pone.0040243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792252	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300039
J	Bron, PA; Wels, M; Bongers, RS; van Bokhorst-van de Veen, H; Wiersma, A; Overmars, L; Marco, ML; Kleerebezem, M				Bron, Peter A.; Wels, Michiel; Bongers, Roger S.; van Bokhorst-van de Veen, Hermien; Wiersma, Anne; Overmars, Lex; Marco, Maria L.; Kleerebezem, Michiel			Transcriptomes Reveal Genetic Signatures Underlying Physiological Variations Imposed by Different Fermentation Conditions in Lactobacillus plantarum	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; LACTIC-ACID BACTERIA; RIBONUCLEOTIDE REDUCTASE; LACTOCOCCUS-LACTIS; STATIONARY-PHASE; GROWTH; DIVERSITY; PATHWAYS; FLAVOR; IDENTIFICATION	Lactic acid bacteria (LAB) are utilized widely for the fermentation of foods. In the current post-genomic era, tools have been developed that explore genetic diversity among LAB strains aiming to link these variations to differential phenotypes observed in the strains investigated. However, these genotype-phenotype matching approaches fail to assess the role of conserved genes in the determination of physiological characteristics of cultures by environmental conditions. This manuscript describes a complementary approach in which Lactobacillus plantarum WCFS1 was fermented under a variety of conditions that differ in temperature, pH, as well as NaCl, amino acid, and O-2 levels. Samples derived from these fermentations were analyzed by full-genome transcriptomics, paralleled by the assessment of physiological characteristics, e. g., maximum growth rate, yield, and organic acid profiles. A data-storage and -mining suite designated FermDB was constructed and exploited to identify correlations between fermentation conditions and industrially relevant physiological characteristics of L. plantarum, as well as the associated transcriptome signatures. Finally, integration of the specific fermentation variables with the transcriptomes enabled the reconstruction of the gene-regulatory networks involved. The fermentation-genomics platform presented here is a valuable complementary approach to earlier described genotype-phenotype matching strategies which allows the identification of transcriptome signatures underlying physiological variations imposed by different fermentation conditions.	[Bron, Peter A.; Wels, Michiel; Bongers, Roger S.; van Bokhorst-van de Veen, Hermien; Wiersma, Anne; Overmars, Lex; Marco, Maria L.; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [Bron, Peter A.; Wels, Michiel; Bongers, Roger S.; van Bokhorst-van de Veen, Hermien; Wiersma, Anne; Overmars, Lex; Marco, Maria L.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Wels, Michiel; Overmars, Lex] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [van Bokhorst-van de Veen, Hermien; Kleerebezem, Michiel] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands	Top Institute Food & Nutrition; NIZO Food Research; Radboud University Nijmegen; Wageningen University & Research	Bron, PA (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	Michiel.Kleerebezem@nizo.nl	Marco, Maria/H-2322-2014; van Bokhorst-van de Veen, Hermien/K-2111-2013; Kleerebezem, Michiel/AAT-2078-2021	van Bokhorst-van de Veen, Hermien/0000-0003-4159-5955; Kleerebezem, Michiel/0000-0001-8552-2235	Kluyver Centre for Genomics of Industrial Fermentation of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Kluyver Centre for Genomics of Industrial Fermentation of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	PAB is partially funded by the research program of the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann H, 2009, APPL ENVIRON MICROB, V75, P5687, DOI 10.1128/AEM.00919-09; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bron Peter A, 2011, Bioeng Bugs, V2, P80, DOI 10.4161/bbug.2.2.13910; Brooijmans Rob, 2009, F1000 Biol Rep, V1, P34, DOI 10.3410/B1-34; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Corcoran BM, 2008, CURR PHARM DESIGN, V14, P1382, DOI 10.2174/138161208784480225; Derzelle S, 2003, APPL ENVIRON MICROB, V69, P4285, DOI 10.1128/AEM.69.7.4285-4290.2003; Dudley EG, 2005, J APPL MICROBIOL, V98, P14, DOI 10.1111/j.1365-2672.2004.02440.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fonseca F, 2006, APPL ENVIRON MICROB, V72, P6474, DOI 10.1128/AEM.00998-06; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Guinane CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018740; Hols P, 1999, J BACTERIOL, V181, P5521, DOI 10.1128/JB.181.17.5521-5526.1999; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Lacroix C, 2007, CURR OPIN BIOTECH, V18, P176, DOI 10.1016/j.copbio.2007.02.002; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V66, P209, DOI 10.1016/0378-1097(90)90284-W; Liu M, 2008, APPL ENVIRON MICROB, V74, P4590, DOI 10.1128/AEM.00150-08; Liu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-36; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; McLeod A, 2008, SYST APPL MICROBIOL, V31, P393, DOI 10.1016/j.syapm.2008.06.002; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; MURPHY MG, 1985, ARCH MICROBIOL, V141, P75, DOI 10.1007/BF00446743; Pieterse B, 2006, J MICROBIOL METH, V64, P207, DOI 10.1016/j.mimet.2005.04.035; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; REICHARD P, 1993, J BIOL CHEM, V268, P8383; Rolain T, 2012, J BACTERIOL IN PRESS; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Smit BA, 2009, APPL MICROBIOL BIOT, V81, P987, DOI 10.1007/s00253-008-1758-x; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; STARRENBURG MJC, 1991, APPL ENVIRON MICROB, V57, P3535, DOI 10.1128/AEM.57.12.3535-3540.1991; Stevens MJA, 2008, APPL ENVIRON MICROB, V74, P4776, DOI 10.1128/AEM.00136-08; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Vrancken G, 2011, APPL ENVIRON MICROB, V77, P3406, DOI 10.1128/AEM.02668-10; Wang YY, 2011, J BACTERIOL, V193, P313, DOI 10.1128/JB.01159-10; Weckx S, 2010, APPL ENVIRON MICROB, V76, P5402, DOI 10.1128/AEM.00570-10; Wels M, 2011, MICROB BIOTECHNOL, V4, P333, DOI 10.1111/j.1751-7915.2010.00217.x; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang ZY, 2009, J BACTERIOL, V191, P5020, DOI 10.1128/JB.00587-09; Zotta T, 2012, INT J FOOD MICROBIOL, V155, P51, DOI 10.1016/j.ijfoodmicro.2012.01.017	54	42	42	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38720	10.1371/journal.pone.0038720	http://dx.doi.org/10.1371/journal.pone.0038720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802930	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900004
J	Singh, S; Dev, A; Verma, R; Pradeep, A; Sathyanarayana, P; Green, JM; Narayanan, A; Wojchowski, DM				Singh, Seema; Dev, Arvind; Verma, Rakesh; Pradeep, Anamika; Sathyanarayana, Pradeep; Green, Jennifer M.; Narayanan, Aishwarya; Wojchowski, Don M.			Defining an EPOR- Regulated Transcriptome for Primary Progenitors, including Tnfr-sf13c as a Novel Mediator of EPO- Dependent Erythroblast Formation	PLOS ONE			English	Article							ERYTHROPOIETIN RECEPTOR; BAFF-R; CELLS; APOPTOSIS; IDENTIFICATION; PROLIFERATION; MODULATION; INHIBITION; SUPPRESSOR; EXPRESSION	Certain concepts concerning EPO/EPOR action modes have been challenged by in vivo studies: Bcl-x levels are elevated in maturing erythroblasts, but not in their progenitors; truncated EPOR alleles that lack a major p85/PI3K recruitment site nonetheless promote polycythemia; and Erk1 disruption unexpectedly bolsters erythropoiesis. To discover novel EPO/EPOR action routes, global transcriptome analyses presently are applied to interrogate EPO/EPOR effects on primary bone marrow-derived CFUe-like progenitors. Overall, 160 EPO/EPOR target transcripts were significantly modulated 2-to 21.8-fold. A unique set of EPO-regulated survival factors included Lyl1, Gas5, Pim3, Pim1, Bim, Trib3 and Serpina 3g. EPO/EPOR-modulated cell cycle mediators included Cdc25a, Btg3, Cyclin-d2, p27-kip1, Cyclin-g2 and CyclinB1-IP-1. EPO regulation of signal transduction factors was also interestingly complex. For example, not only Socs3 plus Socs2 but also Spred2, Spred1 and Eaf1 were EPO-induced as negative-feedback components. Socs2, plus five additional targets, further proved to comprise new EPOR/Jak2/Stat5 response genes (which are important for erythropoiesis during anemia). Among receptors, an atypical TNF-receptor Tnfr-sf13c was up-modulated >5-fold by EPO. Functionally, Tnfr-sf13c ligation proved to both promote proerythroblast survival, and substantially enhance erythroblast formation. The EPOR therefore engages a sophisticated set of transcriptome response circuits, with Tnfr-sf13c deployed as one novel positive regulator of proerythroblast formation.	[Singh, Seema; Dev, Arvind; Verma, Rakesh; Pradeep, Anamika; Sathyanarayana, Pradeep; Wojchowski, Don M.] Maine Med Ctr, Res Inst, Ctr Excellence Stem Cell Biol & Regenerat Med, Scarborough, ME USA; [Green, Jennifer M.] Affymax Inc, Palo Alto, CA USA; [Narayanan, Aishwarya] Strand Life Sci, Bangalore, Karnataka, India	Maine Medical Center	Singh, S (corresponding author), Maine Med Ctr, Res Inst, Ctr Excellence Stem Cell Biol & Regenerat Med, Scarborough, ME USA.	wojchd@mmc.org			National Institutes of Health [NIH R01 DK089439, NIH R01 HL44491]; NIH/NCRR [P20 RR18789]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants NIH R01 DK089439 and NIH R01 HL44491 (principal investigator, Dr. Wojchowski). Core facility contributions (Flow Cytometry and Progenitor Cell Analysis, and Bioinformatics) were supported in part via NIH/NCRR P20 RR18789 (Dr. Wojchowski, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2005, BBA-MOL BASIS DIS, V1740, P17, DOI 10.1016/j.bbadis.2005.03.003; Barlow JL, 2010, CELL CYCLE, V9, P4286, DOI 10.4161/cc.9.21.13742; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Chung B, 2010, FASEB J, V24, P2093, DOI 10.1096/fj.09-152561; Dev A, 2010, BLOOD, V116, P5334, DOI 10.1182/blood-2009-12-258947; Dicato M, 2010, CURR OPIN ONCOL, V22, P307, DOI 10.1097/CCO.0b013e32833aa9de; Doherty L, 2010, AM J HUM GENET, V86, P222, DOI 10.1016/j.ajhg.2009.12.015; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Huddleston H, 2003, BLOOD, V102, P142, DOI 10.1182/blood-2002-10-3245; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Klingmuller U, 1997, P NATL ACAD SCI USA, V94, P3016, DOI 10.1073/pnas.94.7.3016; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Krapf R, 2009, CLIN J AM SOC NEPHRO, V4, P470, DOI 10.2215/CJN.05040908; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Lombardero M, 2011, PATHOBIOLOGY, V78, P41, DOI 10.1159/000322975; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Mihalci SA, 2010, J IMMUNOL, V185, P1045, DOI 10.4049/jimmunol.1001120; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Mourtada-Maarabouni M, 2010, MOL PHARMACOL, V78, P19, DOI 10.1124/mol.110.064055; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Niu J, 2010, LEUK RES; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Ponassi R, 2008, CELL CYCLE, V7, P3211, DOI 10.4161/cc.7.20.6830; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Rauch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005456; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; Sathyanarayana P, 2007, BLOOD, V110, P509, DOI 10.1182/blood-2006-11-056465; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Suenobu S, 2002, BIOCHEM BIOPH RES CO, V293, P1124, DOI 10.1016/S0006-291X(02)00330-3; Tai YT, 2006, CANCER RES, V66, P6675, DOI 10.1158/0008-5472.CAN-06-0190; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Wan ZH, 2010, J CLIN INVEST, V120, P3530, DOI 10.1172/JCI41805; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Wojchowski DM, 2010, CURR OPIN HEMATOL, V17, P169, DOI 10.1097/MOH.0b013e328338008b; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zadjali F, 2011, J BIOL CHEM, V286, P480, DOI 10.1074/jbc.M110.173526; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	53	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e38530	10.1371/journal.pone.0038530	http://dx.doi.org/10.1371/journal.pone.0038530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808010	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700004
J	Bernier, LP; Blais, D; Boue-Grabot, E; Seguela, P				Bernier, Louis-Philippe; Blais, Dominique; Boue-Grabot, Eric; Seguela, Philippe			A Dual Polybasic Motif Determines Phosphoinositide Binding and Regulation in the P2X Channel Family	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CRYSTAL-STRUCTURE; ION-CHANNEL; K+ CHANNELS; RECEPTOR; PIP2; MODULATION; DESENSITIZATION; IDENTIFICATION; ACTIVATION	Phosphoinositides modulate the function of several ion channels, including most ATP-gated P2X receptor channels in neurons and glia, but little is known about the underlying molecular mechanism. We identified a phosphoinositide-binding motif formed of two clusters of positively charged amino acids located on the P2X cytosolic C-terminal domain, proximal to the second transmembrane domain. For all known P2X subtypes, the specific arrangement of basic residues in these semi-conserved clusters determines their sensitivity to membrane phospholipids. Neutralization of these positive charges disrupts the functional properties of the prototypical phosphoinositide-binding P2X4 subtype, mimicking wortmannin-induced phosphoinositide depletion, whereas adding basic residues at homologous positions to the natively insensitive P2X5 subtype establishes de novo phosphoinositide-mediated regulation. Moreover, biochemical evidence of in vitro P2X subunit-phospholipid interaction and functional intracellular phosphoinositide-binding assays demonstrate that the dual polybasic cluster is necessary and sufficient for regulation of P2X signaling by phospholipids.	[Bernier, Louis-Philippe; Blais, Dominique; Seguela, Philippe] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 2B4, Canada; [Boue-Grabot, Eric] Univ Bordeaux Segalen, Inst Malad Neurodegenerat, CNRS, UMR 5293, Bordeaux, France	McGill University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bernier, LP (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 2B4, Canada.	philippe.seguela@mcgill.ca	Boué-Grabot, Eric/AAQ-2061-2020	Boué-Grabot, Eric/0000-0003-2187-9037; Bernier, Louis-Philippe/0000-0001-5063-2338	CIHR; NSERC; CNRS	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CNRS(Centre National de la Recherche Scientifique (CNRS))	Supported by CIHR and NSERC operating grants (PS) and CNRS (EBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ase AR, 2010, J NEUROCHEM, V113, P1676, DOI 10.1111/j.1471-4159.2010.06734.x; Bernier LP, 2008, MOL PHARMACOL, V74, P785, DOI 10.1124/mol.108.047019; Bernier LP, 2008, J NEUROSCI, V28, P12938, DOI 10.1523/JNEUROSCI.3038-08.2008; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Collo G, 1996, J NEUROSCI, V16, P2495; D'Arco M, 2009, J BIOL CHEM, V284, P21393, DOI 10.1074/jbc.M109.023051; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Koshimizu T, 2002, J BIOL CHEM, V277, P46891, DOI 10.1074/jbc.M205274200; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; Mo G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-47; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Ruppelt A, 2001, J NEUROCHEM, V77, P1256, DOI 10.1046/j.1471-4159.2001.00348.x; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Toulme E, 2007, J NEUROCHEM, V102, P1357, DOI 10.1111/j.1471-4159.2007.04640.x; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Zhao Q, 2007, CHANNELS, V1, P46	33	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40595	10.1371/journal.pone.0040595	http://dx.doi.org/10.1371/journal.pone.0040595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792379	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400077
J	Bracciali, C; Campobello, D; Giacoma, C; Sara, G				Bracciali, Claudia; Campobello, Daniela; Giacoma, Cristina; Sara, Gianluca			Effects of Nautical Traffic and Noise on Foraging Patterns of Mediterranean Damselfish (Chromis chromis)	PLOS ONE			English	Article							FREQUENCY ACTIVE SONAR; HUMAN-GENERATED SOUND; ANTHROPOGENIC NOISE; FISH; BEHAVIOR; HEARING; AVOIDANCE; RESPONSES; NITROGEN; PREDATOR	Chromis chromis is a key species in the Mediterranean marine coastal ecosystems where, in summer, recreational boating and its associated noise overlap. Anthropogenic noise could induce behavioural modifications in marine organisms, thereby affecting population dynamics. In the case of an important species for the ecosystem like C. chromis, this could rebound on the community structure. Here, we measured nautical traffic during the summer of 2007 in a Southern Mediterranean Marine Protected Area (MPA) and simultaneously the feeding behaviour of C. chromis was video-recorded, within both the no-take A-zone and the B-zone where recreational use is allowed. Feeding frequencies, escape reaction and school density were analysed. C. chromis specimens were also collected from 2007 to 2008 to evaluate their physiological state using the Body Condition Index as a proxy of feeding efficiency. The MPA was more exploited by nautical tourism during holidays than on weekdays, particularly in the middle of the day. Greater traffic volume corresponded with lower feeding frequencies. The escape reaction was longer in duration (>1 min) when boat passed nearby, while moored boats did not induce an escape response. We found no differences in density between schools in the A-and B-zones and worse body conditions among those individuals inhabiting the B-zone in one area only. Overall, our findings revealed a significant modification of the daily foraging habits of C. chromis due to boat noise, which was slightly buffered by no-take zones established within the MPA.	[Bracciali, Claudia; Sara, Gianluca] Univ Palermo, Dipartimento Sci Terra & Mare, Palermo, Italy; [Bracciali, Claudia; Giacoma, Cristina] Univ Turin, Dipartimento Sci Vita & Biol Sistemi Life Sci & S, Turin, Italy; [Campobello, Daniela] Univ Palermo, Dept Environm Biol & Biodivers, Palermo, Italy	University of Palermo; University of Turin; University of Palermo	Bracciali, C (corresponding author), Univ Palermo, Dipartimento Sci Terra & Mare, Palermo, Italy.	daniela.campobello@unipa.it	Sara, Gianluca/AAG-7215-2020	Sara, Gianluca/0000-0002-7658-5274; GIACOMA, Cristina/0000-0002-8429-7723; Campobello, Daniela/0000-0003-4094-9395	DINAUTIS project by Italian Government	DINAUTIS project by Italian Government	Funds were provided by DINAUTIS project by the Environmental Minister of Italian Government (no numbers apply). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Amoser S, 2005, J EXP BIOL, V208, P3533, DOI 10.1242/jeb.01809; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Blumstein D.T., 2007, QUANTIFYING BEHAV JW, P211; BODDEKE R, 1963, NATURE, V197, P714, DOI 10.1038/197714b0; Buscaino G, 2010, MAR ENVIRON RES, V69, P136, DOI 10.1016/j.marenvres.2009.09.004; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; CHAPIN FS, 1992, TRENDS ECOL EVOL, V7, P107, DOI 10.1016/0169-5347(92)90141-W; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Davey AJH, 2007, FRESHWATER BIOL, V52, P1719, DOI 10.1111/j.1365-2427.2007.01800.x; De Robertis A, 2010, ICES J MAR SCI, V67, P985, DOI 10.1093/icesjms/fsp299; DULCIC J, 1995, FISH RES, V22, P255, DOI 10.1016/0165-7836(94)00318-Q; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Fasola M, 1997, MAR ECOL-P S Z N I, V18, P51, DOI 10.1111/j.1439-0485.1997.tb00426.x; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; Frid A, 2002, CONSERV ECOL, V6; Fuiman L. A., 1999, Journal of Fish Biology, V55, P215, DOI 10.1111/j.1095-8649.1999.tb01057.x; Gaucher L, 2012, J MORPHOL, V273, P49, DOI 10.1002/jmor.11005; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Halvorsen MB, 2012, J ACOUST SOC AM, V131, P599, DOI 10.1121/1.3664082; Handegard NO, 2003, AQUAT LIVING RESOUR, V16, P265, DOI 10.1016/S0990-7440(03)00020-2; Haviland-Howell G, 2007, J ACOUST SOC AM, V122, P151, DOI 10.1121/1.2717766; Holling C. S., 1959, Canadian Entomologist, V91, P385; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kastelein RA, 2008, MAR ENVIRON RES, V65, P369, DOI 10.1016/j.marenvres.2008.01.001; KENCHINGTON R, 1993, OCEAN COAST MANAGE, V21, P109, DOI 10.1016/0964-5691(93)90022-Q; Koen-Alonso Mariano, 2007, P1; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE, V3rd, P491, DOI [10.1017/CBO9780511805400, DOI 10.1017/CBO9780511805400]; KROHN MM, 1994, CAN J FISH AQUAT SCI, V51, P1119, DOI 10.1139/f94-111; La Manna G, 2010, CIENC MAR, V36, P71, DOI 10.7773/cm.v36i1.1457; Laland KN, 1999, ANIM BEHAV, V57, P331, DOI 10.1006/anbe.1998.0967; Lang B, 2011, J ANIM ECOL IN PRESS; Lehner PN, 1996, HDB ETHOLOGICAL METH, P672; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Magoulick DD, 2003, FRESHWATER BIOL, V48, P1186, DOI 10.1046/j.1365-2427.2003.01089.x; Miksis-Olds JL, 2011, MAR MAMMAL SCI, V27, P130, DOI 10.1111/j.1748-7692.2010.00381.x; Mussi M, 2005, J EXP BIOL, V208, P3037, DOI 10.1242/jeb.01750; MYRBERG AA, 1986, ANIM BEHAV, V34, P913, DOI 10.1016/S0003-3472(86)80077-X; Nash RDM, 2006, FISHERIES, V31, P236; Ona E, 2007, J ACOUST SOC AM, V121, pEL145, DOI 10.1121/1.2710741; Papale E, 2012, J MAR BIOL ASSOC UK, V92, P1877, DOI 10.1017/S002531541100083X; Picciulin Marta, 2002, Bioacoustics, V12, P236; Pinnegar JK, 2006, MAR BIOL, V148, P1089, DOI 10.1007/s00227-005-0141-z; Pinnegar JK, 2007, J EXP MAR BIOL ECOL, V352, P378, DOI 10.1016/j.jembe.2007.08.016; Pitcher TJ, 1993, BEHAV TELEOST FISHES, P439; Popper AN, 2003, FISHERIES, V28, P24, DOI 10.1577/1548-8446(2003)28[24:EOASOF]2.0.CO;2; Popper AN, 2004, ICES J MAR SCI, V61, P1057, DOI 10.1016/j.icesjms.2004.06.005; Popper AN, 2007, J ACOUST SOC AM, V122, P623, DOI 10.1121/1.2735115; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Purser J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017478; Ruiz JM, 2010, MAR ENVIRON RES, V69, P118, DOI 10.1016/j.marenvres.2009.09.002; Sand O, 2000, ENVIRON BIOL FISH, V57, P327, DOI 10.1023/A:1007575426155; Sara G, 2007, MAR ECOL PROG SER, V331, P243, DOI 10.3354/meps331243; Sara G, 2011, MAR ENVIRON RES, V71, P317, DOI 10.1016/j.marenvres.2011.02.007; SCHOENER TW, 1986, AM ZOOL, V26, P81; Simpson SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016625; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Thetmeyer H, 1997, J EXP MAR BIOL ECOL, V218, P187, DOI 10.1016/S0022-0981(97)00073-7; THETMEYER H, 1995, MAR ECOL PROG SER, V126, P1, DOI 10.3354/meps126001; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; Tyack PL, 2009, PHYS TODAY, V62, P39, DOI 10.1063/1.3265235; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Vabo R, 2002, FISH RES, V58, P59, DOI 10.1016/S0165-7836(01)00360-5; van Deurs M, 2011, MAR BIOL, V158, P1781, DOI 10.1007/s00227-011-1691-x; Wardle CS, 2001, CONT SHELF RES, V21, P1005, DOI 10.1016/S0278-4343(00)00122-9; Widmer WM, 2004, LANDSCAPE URBAN PLAN, V66, P173, DOI 10.1016/S0169-2046(03)00099-9; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562; Zar J.H., 1996, BIOSTAT ANAL; Zelick Randy, 1999, Springer Handbook of Auditory Research, V11, P363; ZUPO V., 2010, NATURAL SCI, V2, P1274, DOI DOI 10.4236/NS.2010.211154	73	51	51	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40582	10.1371/journal.pone.0040582	http://dx.doi.org/10.1371/journal.pone.0040582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792375	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400073
J	McCartney, G; Shipley, M; Hart, C; Davey-Smith, G; Kivimaki, M; Walsh, D; Watt, GC; Batty, GD				McCartney, Gerry; Shipley, Martin; Hart, Carole; Davey-Smith, George; Kivimaeki, Mika; Walsh, David; Watt, Graham C.; Batty, G. David			Why Do Males in Scotland Die Younger than Those in England? Evidence from Three Prospective Cohort Studies	PLOS ONE			English	Article							CORONARY HEART-DISEASE; MORTALITY; DEPRIVATION; INEQUALITIES; RENFREW; MEN	Background: To examine explanations for the higher rates of male mortality in two Scottish cohorts compared with a cohort in south-east England for which similar data were collected. Methodology/Principal Findings: We compared three cohort studies which recruited participants in the late 1960s and early 1970s. A total of 13,884 men aged 45-64 years at recruitment in the Whitehall occupational cohort (south-east England), 3,956 men in the Collaborative occupational cohort and 6,813 men in the Renfrew & Paisley population-based study (both central Scotland) were included in analyses of all-cause and cause-specific mortality. All-cause mortality was 25% (age-adjusted hazard ratio 1.25, 95% confidence interval (CI) 1.21 to 1.30) and 41% (hazard ratio 1.41 (95% CI 1.36 to 1.45) higher in the Collaborative and Renfrew & Paisley cohorts respectively compared to the Whitehall cohort. The higher mortality rates were substantially attenuated by social class (to 8% and 17% higher respectively), and were effectively eliminated upon the further addition of the other baseline risk factors, such as smoking habit, lung function and pre-existing self-reported morbidity. Despite this, coronary heart disease mortality remained 11% and 16% higher, stroke mortality 45% and 37% higher, mortality from accidents and suicide 51% and 70% higher, and alcohol-related mortality 46% and 73% higher in the Collaborative and Renfrew & Paisley cohorts respectively compared with the Whitehall cohort in the fully adjusted model. Conclusions/Significance: The higher all-cause, respiratory, and lung cancer male mortality in the Scottish cohorts was almost entirely explained by social class differences and higher prevalence of known risk factors, but reasons for the excess mortality from stroke, alcohol-related causes, accidents and suicide remained unknown.	[McCartney, Gerry] NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow, Lanark, Scotland; [Shipley, Martin; Kivimaeki, Mika; Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England; [Watt, Graham C.] Univ Glasgow, Inst Hlth & Wellbeing, Sect Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [Davey-Smith, George] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Walsh, David] Glasgow Ctr Populat Hlth, Glasgow, Lanark, Scotland; [Batty, G. David] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of London; University College London; University of Glasgow; University of Bristol; University of Edinburgh	McCartney, G (corresponding author), NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow, Lanark, Scotland.	gmccartney@nhs.net	Davey Smith, George/A-7407-2013; Kivimaki, Mika/B-3607-2012; Batty, GD/Y-4401-2018	Davey Smith, George/0000-0002-1407-8314; Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753; Walsh, David/0000-0002-3390-5039; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; McCartney, Gerry/0000-0001-6341-3521	British Heart Foundation; NHS Health Scotland; Medical Research Council, UK; United States National Institutes of Health [R01HL036310, R01AG034454]; Academy of Finland; BUPA Foundation Specialist Research Grant, United Kingdom; Department for Health and Social Security of the UK Government; Tobacco Research Council; Scottish Home and Health Department; Renfrewshire King Edward Memorial Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G8802774, G0902037, G19/35, G0100222] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); NHS Health Scotland; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); BUPA Foundation Specialist Research Grant, United Kingdom; Department for Health and Social Security of the UK Government; Tobacco Research Council; Scottish Home and Health Department; Renfrewshire King Edward Memorial Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	No specific funding was obtained for the analyses in this paper, although MS is supported by the British Heart Foundation, CH by NHS Health Scotland and MK by the Medical Research Council, UK. The United States National Institutes of Health (R01HL036310; R01AG034454), the Academy of Finland, and a BUPA Foundation Specialist Research Grant, United Kingdom. The original Whitehall study was funded by the then Department for Health and Social Security of the UK Government and the Tobacco Research Council. The Collaborative study was originally funded by the Scottish Home and Health Department and the Renfrew & Paisley study was supported by the Renfrewshire King Edward Memorial Trust and the Scottish Home and Health Department. The employing institutions and funders played no part in the study design, collection, analysis or interpretation of data, the writing of the report or in the decision to submit the article for publication.	[Anonymous], 1965, LANCET, V1, P775; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Dorling D., 2010, INJUSTICE WHY SOCIAL; Dorling D., 2007, POVERTY WEALTH PLACE; General Register Office, 1966, CLASS OCC 1966, P1; Hanlon P, 2005, J PUBLIC HEALTH, V27, P199, DOI 10.1093/pubmed/fdi002; Hart CL, 2005, INT J EPIDEMIOL, V34, P28, DOI 10.1093/ije/dyh348; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; Kivimaki M, 2008, OBESITY, V16, P1926, DOI 10.1038/oby.2008.322; Leon D. A., 2003, UNDERSTANDING HLTH S; LEON DA, 1995, J EPIDEMIOL COMMUN H, V49, P5, DOI 10.1136/jech.49.1.5; Leyland AH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-172; McCartney G, 2011, EXPLAINING SCOTLANDS; McCartney G, 2011, EUROPEAN J PUBLIC HL, P1, DOI [10.1093/eurpub/ckr1136, DOI 10.1093/EURPUB/CKR1136]; McCarttney G, 2012, PUBLIC HLTH IN PRESS; McLoone P, 2003, EUR J PUBLIC HEALTH, V13, P230, DOI 10.1093/eurpub/13.3.230; Menvielle G, 2010, INT J CANCER, V126, P1928, DOI 10.1002/ijc.24924; Mitchell R, 2005, J EPIDEMIOL COMMUN H, V59, P565, DOI 10.1136/jech.2004.029850; Morris RW, 2001, HEART, V86, P277, DOI 10.1136/heart.86.3.277; Norman P, 2011, SOC SCI MED, V73, P1; Reid D, 1974, LANCET, Vi; ROSE G, 1986, BRIT MED J, V293, P306, DOI 10.1136/bmj.293.6542.306; Rose G, 1968, CARDIOVASCULAR SURVE; Rose G, 1982, CARDIOVASCULAR SURVE; Shaw M, 2005, BMJ-BRIT MED J, V330, P1016, DOI 10.1136/bmj.330.7498.1016; Smith G.D., 1999, CRIT PUBLIC HEALTH, V9, P151; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Walsh D, 2010, PUBLIC HEALTH, V124, P487, DOI 10.1016/j.puhe.2010.02.006; Walsh D, 2010, EUR J PUBLIC HEALTH, V20, P58, DOI 10.1093/eurpub/ckp063; Whyte B., 2007, SCOTTISH MORTALITY E	31	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38860	10.1371/journal.pone.0038860	http://dx.doi.org/10.1371/journal.pone.0038860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22808017	gold, Green Published, Green Accepted			2022-12-27	WOS:000306362400007
J	Huang, X; Kushekhar, K; Nolte, I; Kooistra, W; Visser, L; Bouwman, I; Kouprie, N; Veenstra, R; van Imhoff, G; Olver, B; Houlston, RS; Poppema, S; Diepstra, A; Hepkema, B; van den Berg, A				Huang, Xin; Kushekhar, Kushi; Nolte, Ilja; Kooistra, Wierd; Visser, Lydia; Bouwman, Ilby; Kouprie, Niels; Veenstra, Rianne; van Imhoff, Gustaaf; Olver, Bianca; Houlston, Richard S.; Poppema, Sibrand; Diepstra, Arjan; Hepkema, Bouke; van den Berg, Anke			HLA Associations in Classical Hodgkin Lymphoma: EBV Status Matters	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; GENOME-WIDE ASSOCIATION; CLASS-I; NASOPHARYNGEAL CARCINOMA; ALLELES; DISEASE; PROTEIN; SUSCEPTIBILITY; EPITOPE; TOOL	The pathogenesis of classical Hodgkin lymphoma (cHL) involves environmental and genetic factors. To explore the role of the human leukocyte antigen (HLA) genes, we performed a case-control genotyping study in 338 Dutch cHL patients using a PCR-based sequence-specific oligonucleotide probe (SSOP) hybridization approach. The allele frequencies were compared to HLA typings of more than 6,000 controls. The age of the cHL patients varied between 13 and 81 years with a median of 35 years. Nodular sclerosis subtype was the most common subtype (87%) and EBV was detected in 25% of the cHL patients. HLA-B5 was significantly increased and HLA-DR7 significantly decreased in the total cHL patient population as compared to controls. Two class II associations were observed to be specific for the EBV- cHL population with an increase of HLA-DR2 and HLA-DR5. Allele frequencies of HLA-A1, HLA-B37 and HLA-DR10 were significantly increased in the EBV+ cHL population; these alleles are in strong linkage disequilibrium and form a common haplotype in Caucasians. The allele frequency of HLA-A2 was significantly decreased in the EBV+ cHL population. Analysis of haplotypes with a frequency of >1% revealed a significant increase of HLA-A2-B7-DR2 in EBV- cHL as compared to controls. SSOP association analysis revealed significant differences between EBV+ and EBV- cHL patients for 19 probes that discriminate between HLA-A*01 and HLA-A*02. In conclusion, the HLA-A1 and HLA-A2 antigens and not specific single nucleotide variants shared by multiple alleles are responsible for the association with EBV+ cHL. Furthermore several new protective and predisposing HLA class I and II associations for the EBV+, the EBV- and the entire cHL population were identified.	[Huang, Xin; Kushekhar, Kushi; Kooistra, Wierd; Visser, Lydia; Veenstra, Rianne; Poppema, Sibrand; Diepstra, Arjan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Huang, Xin] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Nolte, Ilja] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Groningen, Netherlands; [van Imhoff, Gustaaf] Univ Groningen, Dept Hematol, Univ Med Ctr Groningen, Groningen, Netherlands; [Bouwman, Ilby; Kouprie, Niels; Hepkema, Bouke] Univ Groningen, Dept Lab Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Olver, Bianca; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England	University of Groningen; Peking University; University of Groningen; University of Groningen; University of Groningen; University of London; Institute of Cancer Research - UK	Huang, X (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.van.den.berg01@umcg.nl	van den Berg, Anke/H-1718-2011; Poppema, Sibrand/D-1204-2012	van den Berg, Anke/0000-0002-8894-2638; Kushekhar, Kushi/0000-0003-2380-6309; Diepstra, Arjan/0000-0001-9239-1050; Houlston, Richard/0000-0002-5268-0242	Bernoulli Bursary, University Medical Center Groningen; Dutch Cancer Society [KWF: RUG 20094313]	Bernoulli Bursary, University Medical Center Groningen; Dutch Cancer Society(KWF Kankerbestrijding)	This work is supported by a Bernoulli Bursary, University Medical Center Groningen and by a grant from the Dutch Cancer Society (KWF: RUG 20094313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell MJ, 2009, J VIROL, V83, P2783, DOI 10.1128/JVI.01724-08; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Burt RD, 1996, CANCER EPIDEM BIOMAR, V5, P879; Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Cartwright RA, 2004, HEMATOL ONCOL, V22, P11, DOI 10.1002/hon.723; Depil S, 2004, ANN BIOL CLIN-PARIS, V62, P639; Diepstra A, 2005, EUR J HAEMATOL, V75, P34, DOI 10.1111/j.1600-0609.2005.00452.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Ghodke Y, 2005, EUR J EPIDEMIOL, V20, P475, DOI 10.1007/s10654-005-5081-x; HAFEZ MM, 1985, INT J CANCER, V36, P19, DOI 10.1002/ijc.2910360104; Hansen J A, 1977, Prog Clin Biol Res, V16, P217; Harty LC, 2002, BLOOD, V99, P690, DOI 10.1182/blood.V99.2.690; Helmberg W, 1998, TISSUE ANTIGENS, V51, P587, DOI 10.1111/j.1399-0039.1998.tb03000.x; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Hjalgrim H, 2010, P NATL ACAD SCI USA, V107, P6400, DOI 10.1073/pnas.0915054107; HORS J, 1983, IMMUNOL REV, V70, P167, DOI 10.1111/j.1600-065X.1983.tb00714.x; Huang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031865; Kruger S, 2003, J IMMUNOTHER, V26, P212, DOI 10.1097/00002371-200305000-00005; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Landgren O, 2007, HEMATOL ONCOL CLIN N, V21, P825, DOI 10.1016/j.hoc.2007.07.001; Lee SP, 1997, J IMMUNOL, V158, P3325; Marescotti D, 2010, IMMUNOLOGY, V129, P386, DOI 10.1111/j.1365-2567.2009.03190.x; Marshall WH, 1997, INT J CANCER, V19, P450; MURRAY RJ, 1988, J VIROL, V62, P3747, DOI 10.1128/JVI.62.10.3747-3755.1988; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Niens M, 2006, CANCER EPIDEM BIOMAR, V15, P2280, DOI 10.1158/1055-9965.EPI-06-0476; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROBERTSON SJ, 1987, CANCER, V59, P1314, DOI 10.1002/1097-0142(19870401)59:7<1314::AID-CNCR2820590714>3.0.CO;2-V; Schipper RF, 1996, TISSUE ANTIGENS, V48, P562, DOI 10.1111/j.1399-0039.1996.tb02670.x; Sonmez M, 2010, INTERNAL MED, V49, P607, DOI 10.2169/internalmedicine.49.2873; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Voo KS, 2004, J EXP MED, V199, P459, DOI 10.1084/jem.20031219	36	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39986	10.1371/journal.pone.0039986	http://dx.doi.org/10.1371/journal.pone.0039986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808081	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500019
J	Mullen, GP; Grundahl, KM; Gu, MY; Watanabe, S; Hobson, RJ; Crowell, JA; McManus, JR; Mathews, EA; Jorgensen, EM; Rand, JB				Mullen, Gregory P.; Grundahl, Kiely M.; Gu, Mingyu; Watanabe, Shigeki; Hobson, Robert J.; Crowell, John A.; McManus, John R.; Mathews, Eleanor A.; Jorgensen, Erik M.; Rand, James B.			UNC-41/Stonin Functions with AP2 to Recycle Synaptic Vesicles in Caenorhabditis elegans	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; C-ELEGANS; DROSOPHILA-MELANOGASTER; ADAPTER COMPLEX; SORTING ADAPTER; MOLECULAR-BASIS; GENE ENCODES; STONED LOCUS; PROTEIN; SYNAPTOTAGMIN	The recycling of synaptic vesicles requires the recovery of vesicle proteins and membrane. Members of the stonin protein family (Drosophila Stoned B, mammalian stonin 2) have been shown to link the synaptic vesicle protein synaptotagmin to the endocytic machinery. Here we characterize the unc-41 gene, which encodes the stonin ortholog in the nematode Caenorhabditis elegans. Transgenic expression of Drosophila stonedB rescues unc-41 mutant phenotypes, demonstrating that UNC-41 is a bona fide member of the stonin family. In unc-41 mutants, synaptotagmin is present in axons, but is mislocalized and diffuse. In contrast, UNC-41 is localized normally in synaptotagmin mutants, demonstrating a unidirectional relationship for localization. The phenotype of snt-1 unc-41 double mutants is stronger than snt-1 mutants, suggesting that UNC-41 may have additional, synaptotagmin-independent functions. We also show that unc-41 mutants have defects in synaptic vesicle membrane endocytosis, including a similar to 50% reduction of vesicles in both acetylcholine and GABA motor neurons. These endocytic defects are similar to those observed in apm-2 mutants, which lack the mu 2 subunit of the AP2 adaptor complex. However, no further reduction in synaptic vesicles was observed in unc-41 apm-2 double mutants, suggesting that UNC-41 acts in the same endocytic pathway as mu 2 adaptin.	[Mullen, Gregory P.; Grundahl, Kiely M.; Crowell, John A.; McManus, John R.; Mathews, Eleanor A.; Rand, James B.] Oklahoma Med Res Fdn, Genet Models Dis Res Program, Oklahoma City, OK 73104 USA; [Gu, Mingyu; Watanabe, Shigeki; Hobson, Robert J.; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Gu, Mingyu; Watanabe, Shigeki; Hobson, Robert J.; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA	Oklahoma Medical Research Foundation; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Mullen, GP (corresponding author), Oklahoma Med Res Fdn, Genet Models Dis Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	James-Rand@omrf.org		Watanabe, Shigeki/0000-0001-7580-8141; Mullen, Gregory/0000-0003-1090-6861	Oklahoma Medical Research Foundation; NIH [NS033187, GM059642, NS034307]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307, R01NS033187, R37NS034307] Funding Source: NIH RePORTER	Oklahoma Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by institutional funding from the Oklahoma Medical Research Foundation to J.B.R., and by NIH grants NS033187 and GM059642 to J.B.R., and NS034307 to E.M.J. Some nematode strains were provided by the Caenorhabditis Genetics Center, which was funded by the NIH National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao H, 2005, J NEUROPHYSIOL, V94, P1888, DOI 10.1152/jn.00080.2005; BRENNER S, 1974, GENETICS, V77, P71; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Estes PS, 2003, GENETICS, V165, P185; Fergestad T, 2001, J NEUROSCI, V21, P1218; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; Gu MY, 2008, J CELL BIOL, V183, P881, DOI 10.1083/jcb.200806088; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HARADA S, 1994, J NEUROCHEM, V63, P439; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Jung N, 2007, J CELL BIOL, V179, P1497, DOI 10.1083/jcb.200708107; Kamikura DM, 2003, GENE DEV, V17, P2798, DOI 10.1101/gad.1136103; Kelly LE, 2005, BIOCHEM J, V388, P195, DOI 10.1042/BJ20041797; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; LIU Q, 1995, BIOTECHNIQUES, V18, P470; Maritzen T, 2010, TRAFFIC, V11, P8, DOI 10.1111/j.1600-0854.2009.00971.x; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mathews EA, 2007, MOL CELL NEUROSCI, V34, P642, DOI 10.1016/j.mcn.2007.01.009; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; MOERMAN DG, 1986, P NATL ACAD SCI USA, V83, P2579, DOI 10.1073/pnas.83.8.2579; Mohrmann R, 2008, NEUROSCIENCE, V153, P1048, DOI 10.1016/j.neuroscience.2008.02.060; Mullen GP, 2006, MOL BIOL CELL, V17, P3021, DOI 10.1091/mbc.E06-02-0155; NGUYEN M, 1995, GENETICS, V140, P527; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; PETROVICH TZ, 1993, GENETICS, V133, P955; Phillips AM, 2010, TRAFFIC, V11, P16, DOI 10.1111/j.1600-0854.2009.00999.x; Phillips AM, 2000, J NEUROSCI, V20, P8254, DOI 10.1523/JNEUROSCI.20-22-08254.2000; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; RAND JB, 1985, PSYCHOPHARMACOL BULL, V21, P623; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Schuske K, 2007, NAT NEUROSCI, V10, P846, DOI 10.1038/nn1920; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	55	22	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40095	10.1371/journal.pone.0040095	http://dx.doi.org/10.1371/journal.pone.0040095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808098	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500024
J	Stunkel, W; Pan, H; Chew, SB; Tng, E; Tan, JH; Chen, L; Joseph, R; Cheong, CY; Ong, ML; Lee, YS; Chong, YS; Saw, SM; Meaney, MJ; Kwek, K; Sheppard, AM; Gluckman, PD; Holbrook, JD				Stuenkel, Walter; Pan, Hong; Chew, Siew Boom; Tng, Emilia; Tan, Jun Hao; Chen, Li; Joseph, Roy; Cheong, Clara Y.; Ong, Mei-Lyn; Lee, Yung Seng; Chong, Yap-Seng; Saw, Seang Mei; Meaney, Michael J.; Kwek, Kenneth; Sheppard, Allan M.; Gluckman, Peter D.; Holbrook, Joanna D.		GUSTO Study Grp	Transcriptome Changes Affecting Hedgehog and Cytokine Signalling in the Umbilical Cord: Implications for Disease Risk	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; INTRAUTERINE GROWTH RESTRICTION; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DNA METHYLATION PATTERNS; PRETERM BIRTH; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; YOUNG-ADULTS	Background: Babies born at lower gestational ages or smaller birthweights have a greater risk of poorer health in later life. Both the causes of these sub-optimal birth outcomes and the mechanism by which the effects are transmitted over decades are the subject of extensive study. We investigated whether a transcriptomic signature of either birthweight or gestational age could be detected in umbilical cord RNA. Methods: The gene expression patterns of 32 umbilical cords from Singaporean babies of Chinese ethnicity across a range of birthweights (1698-4151 g) and gestational ages (35-41 weeks) were determined. We confirmed the differential expression pattern by gestational age for 12 genes in a series of 127 umbilical cords of Chinese, Malay and Indian ethnicity. Results: We found that the transcriptome is substantially influenced by gestational age; but less so by birthweight. We show that some of the expression changes dependent on gestational age are enriched in signal transduction pathways, such as Hedgehog and in genes with roles in cytokine signalling and angiogenesis. We show that some of the gene expression changes we report are reflected in the epigenome. Conclusions: We studied the umbilical cord which is peripheral to disease susceptible tissues. The results suggest that soma-wide transcriptome changes, preserved at the epigenetic level, may be a mechanism whereby birth outcomes are linked to the risk of adult metabolic and arthritic disease and suggest that greater attention be given to the association between premature birth and later disease risk.	[Stuenkel, Walter; Pan, Hong; Chew, Siew Boom; Tng, Emilia; Tan, Jun Hao; Chen, Li; Joseph, Roy; Cheong, Clara Y.; Ong, Mei-Lyn; Lee, Yung Seng; Meaney, Michael J.; Gluckman, Peter D.; Holbrook, Joanna D.] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Lee, Yung Seng; Chong, Yap-Seng; Saw, Seang Mei] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Sheppard, Allan M.; Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; University of Auckland	Stunkel, W (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.	Walter_Stunkel@sics.a-star.edu.sg; joanna_holbrook@sics.a-star.edu.sg	Hanson, Mark/AAE-8236-2019; Lee, Yung Seng/F-2169-2014; Inskip, Hazel/L-5467-2018; Venkatesh, Sudhakar/T-9385-2019	Hanson, Mark/0000-0002-6907-613X; Lee, Yung Seng/0000-0002-1253-0557; Godfrey, Keith/0000-0002-4643-0618; Shek, Lynette/0000-0001-9064-8983; TINT, Mya Thway/0000-0002-9548-7186; Inskip, Hazel/0000-0001-8897-1749; Kapur, Jeevesh/0000-0002-5696-0233; Ferguson-Smith, Anne/0000-0002-7608-5894; Chong, Yap Seng/0000-0002-7232-8473; Venkatesh, Sudhakar/0000-0002-7514-1030; Holbrook, Joanna/0000-0003-1791-6894; Yap, Fabian/0000-0003-1083-7958	Singapore National Medical Research council; Agency for Science Technology and Research; MRC [MC_UP_A620_1017] Funding Source: UKRI; Medical Research Council [MC_UP_A620_1017] Funding Source: researchfish	Singapore National Medical Research council(National Medical Research Council, Singapore); Agency for Science Technology and Research(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The GUSTO Cohort is supported by a Translational Clinical Research Flagship programme grant from the Singapore National Medical Research council. http://www.nmrc.gov.sg/content/nmrc_internet/home/our_research/tcr_flagship_programme.html. SICS Investigators are supported in part through Agency for Science Technology and Research funding. http://www.a-star.edu.sg/AboutASTAR/Overview/tabid/140/Default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2012, CHEM BIODIV IN PRESS; Alfaidy N, 2003, J CLIN ENDOCR METAB, V88, P5033, DOI 10.1210/jc.2002-021915; Alisi A, 2011, ANN MED; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Arroyo JA, 2008, SEMIN PERINATOL, V32, P172, DOI 10.1053/j.semperi.2008.02.006; Baird J, 2011, OSTEOPOROSIS INT, V22, P1323, DOI 10.1007/s00198-010-1344-9; Belkacemi L, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-105; Bell PA, 2011, LOSS MATRILIN DOES N; Benameur T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012688; Borish L, 2011, CURR ALLERGY ASTHM R, V11, P7, DOI 10.1007/s11882-010-0153-8; Breukhoven PE, 2011, EUR J ENDOCRINOL, V164, P133, DOI 10.1530/EJE-10-0573; Briana DD, 2011, INTRAUTERINE GROWTH; Briana DD, 2008, BONE, V42, P307, DOI 10.1016/j.bone.2007.10.002; Broekman BFP, 2009, PEDIATRICS, V123, pE1011, DOI 10.1542/peds.2008-3344; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; Cohen J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r210; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Deckelbaum RA, 2002, J CELL SCI, V115, P3015; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Dennison EM, 2001, PAEDIATR PERINAT EP, V15, P211, DOI 10.1046/j.1365-3016.2001.00350.x; Duran-Gonzalez J, 2011, ARCH MED RES, V42, P523, DOI 10.1016/j.arcmed.2011.10.010; Fan JB, 2011, RHEUMATOL INT, V31, P629, DOI 10.1007/s00296-009-1341-5; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Gluckman PD, 2005, BIOL NEONATE, V87, P127, DOI 10.1159/000082311; Gluckman PD, 2010, GENOME MED, V2, DOI 10.1186/gm135; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Hofman Paul L., 2006, Metabolic Syndrome and Related Disorders, V4, P101, DOI 10.1089/met.2006.4.101; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Holroyd C, 2012, OSTEOPOROSIS INT, V23, P401, DOI 10.1007/s00198-011-1671-5; Honma T, 2011, BIOGERONTOLOGY; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Hoyo C, 2011, EPIGENETICS, V6; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Kajantie E, 2002, CLIN ENDOCRINOL, V57, P635, DOI 10.1046/j.1365-2265.2002.01659.x; Kajantie E, 2010, DIABETES CARE, V33, P2623, DOI 10.2337/dc10-0912; Kanaka-Gantenbein C, 2010, ANN NY ACAD SCI, V1205, P99, DOI 10.1111/j.1749-6632.2010.05683.x; Kistner A, 2002, PEDIATR RES, V51, P675, DOI 10.1203/01.PDR.0000017482.64723.C4; Komai-Koma M, 2011, J IMMUNOL, V186, P2584, DOI 10.4049/jimmunol.1002103; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Krukier II, 2003, B EXP BIOL MED+, V136, P369, DOI 10.1023/B:BEBM.0000010954.15992.68; Leach L, 2011, MICROCIRCULATION, V18, P253, DOI 10.1111/j.1549-8719.2011.00097.x; Lewis RM, 2012, BONE, V50, P337, DOI 10.1016/j.bone.2011.11.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehata Y, 2010, FREE RADICAL RES, V44, P913, DOI 10.3109/10715762.2010.490836; Mason E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014479; Mauro A, 2011, FOLIA HISTOCHEM CYTO, V49, P211, DOI 10.5603/FHC.2011.0029; McTernan CL, 2001, J CLIN ENDOCR METAB, V86, P4979, DOI 10.1210/jc.86.10.4979; Moon SS, 2011, ENDOCR J, V58, P949, DOI 10.1507/endocrj.EJ11-0035; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; Nanetti L, 2008, BJOG-INT J OBSTET GY, V115, P14, DOI 10.1111/j.1471-0528.2007.01567.x; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Picard C, 2007, CLIN ORTHOP RELAT R, P59, DOI 10.1097/BLO0b013e3180d09d9c; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Qiu AQ, 2012, NEUROIMAGE, V59, P1065, DOI 10.1016/j.neuroimage.2011.09.032; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Relton CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031821; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Schroeder JW, 2011, EPIGENETICS-US, V6, P1498, DOI 10.4161/epi.6.12.18296; Scott MN, 2011, J DEV BEHAV PEDIAT; Sebert S, 2011, AM J CLIN NUTR; Skilton MR, 2011, ARTERIOSCL THROM VAS, V31, P2975, DOI 10.1161/ATVBAHA.111.234757; Soh SE, 2012, COHORT PROFILE UNPUB; Sohi G, 2011, SEMIN REPROD MED, V29, P246, DOI 10.1055/s-0031-1275523; Takahashi M, 2007, BIOCHEM BIOPH RES CO, V364, P1037, DOI 10.1016/j.bbrc.2007.10.120; Tanegashima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010321; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Tu XL, 2012, DEV BIOL, V362, P76, DOI 10.1016/j.ydbio.2011.11.013; van der Kaay DCM, 2009, GROWTH HORM IGF RES, V19, P198, DOI 10.1016/j.ghir.2008.08.010; Wang K, 2011, J ENDOCRINOL; Wirbelauer J, 2011, EUR J OBSTET GYN R B, V155, P31, DOI 10.1016/j.ejogrb.2010.11.013; Zhang ZL, 2012, J BONE MINER METAB, V30, P69, DOI 10.1007/s00774-011-0284-6; Zuckerman-Levin N, 2011, PEDIATR RES, V70, P208, DOI 10.1203/PDR.0b013e3182226a0c	82	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39744	10.1371/journal.pone.0039744	http://dx.doi.org/10.1371/journal.pone.0039744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808055	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000306355500013
J	Dechet, AM; Parsons, M; Rambaran, M; Mohamed-Rambaran, P; Florendo-Cumbermack, A; Persaud, S; Baboolal, S; Ari, MD; Shadomy, SV; Zaki, SR; Paddock, CD; Clark, TA; Harris, L; Lyon, D; Mintz, ED				Dechet, Amy M.; Parsons, Michele; Rambaran, Madan; Mohamed-Rambaran, Pheona; Florendo-Cumbermack, Anita; Persaud, Shamdeo; Baboolal, Shirematee; Ari, Mary D.; Shadomy, Sean V.; Zaki, Sherif R.; Paddock, Christopher D.; Clark, Thomas A.; Harris, Lazenia; Lyon, Douglas; Mintz, Eric D.			Leptospirosis Outbreak following Severe Flooding: A Rapid Assessment and Mass Prophylaxis Campaign; Guyana, January-February 2005	PLOS ONE			English	Article							PULMONARY HEMORRHAGE; NICARAGUA; DIAGNOSIS; EPIDEMIC; DENGUE; TRIAL	Background: Leptospirosis is a zoonosis usually transmitted through contact with water or soil contaminated with urine from infected animals. Severe flooding can put individuals at greater risk for contracting leptospirosis in endemic areas. Rapid testing for the disease and large-scale interventions are necessary to identify and control infection. We describe a leptospirosis outbreak following severe flooding and a mass chemoprophylaxis campaign in Guyana. Methodology/Principal Findings: From January-March 2005, we collected data on suspected leptospirosis hospitalizations and deaths. Laboratory testing included anti-leptospiral dot enzyme immunoassay (DST), immunohistochemistry (IHC) staining, and microscopic agglutination testing (MAT). DST testing was conducted for 105 (44%) of 236 patients; 52 (50%) tested positive. Four (57%) paired serum samples tested by MAT were confirmed leptospirosis. Of 34 total deaths attributed to leptospirosis, postmortem samples from 10 (83%) of 12 patients were positive by IHC. Of 201 patients interviewed, 89% reported direct contact with flood waters. A 3-week doxycycline chemoprophylaxis campaign reached over 280,000 people. Conclusions: A confirmed leptospirosis outbreak in Guyana occurred after severe flooding, resulting in a massive chemoprophylaxis campaign to try to limit morbidity and mortality.	[Dechet, Amy M.; Parsons, Michele; Ari, Mary D.; Shadomy, Sean V.; Zaki, Sherif R.; Paddock, Christopher D.; Clark, Thomas A.; Harris, Lazenia; Mintz, Eric D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Dechet, Amy M.] Portland Providence Med Ctr, Portland, OR USA; [Rambaran, Madan; Mohamed-Rambaran, Pheona; Florendo-Cumbermack, Anita] Georgetown Publ Hosp Corp, Georgetown, Guyana; [Persaud, Shamdeo] Minist Hlth, Georgetown, Guyana; [Baboolal, Shirematee] Caribbean Epidemiol Ctr, Port Of Spain, Trinidad Tobago; [Lyon, Douglas] Ctr Dis Control & Prevent, Georgetown, Guyana; [Lyon, Douglas] La Clin Carino, Hood River, OR USA	Centers for Disease Control & Prevention - USA	Dechet, AM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	adechet@gmail.com	Shadomy, Sean/ABA-1234-2020					Alexander AD, 1986, MANUAL CLIN LAB IMMU, P435; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 2006, CARIBBEAN NET NEWS; Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brett-Major DM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007342.pub2; CDC, 1995, MMWR-MORBID MORTAL W, V44, P841; Center CE, 2008, MORB REV COMM DIS CA; Chawla V, 2004, J Assoc Physicians India, V52, P619; COLE JR, 1973, APPL MICROBIOL, V25, P976, DOI 10.1128/AEM.25.6.976-980.1973; Drazen JM, 2005, NEW ENGL J MED, V352, P827, DOI 10.1056/NEJMe058031; Galloway RL, 2009, EPIDEMIOL INFECT, V137, P1323, DOI 10.1017/S0950268808001751; Gaynor K, 2007, AM J TROP MED HYG, V76, P882, DOI 10.4269/ajtmh.2007.76.882; Genrich GL, 2007, AM J TROP MED HYG, V76, P251, DOI 10.4269/ajtmh.2007.76.251; Gonsalez Claudio R., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P59, DOI 10.1590/S0036-46651998000100012; Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2003, MANUAL CLIN MICROBIO; Liverpool J, 2008, ANN TROP MED PARASIT, V102, P239, DOI 10.1179/136485908X278784; MOTIE A, 1986, TROP ANIM HEALTH PRO, V18, P113, DOI 10.1007/BF02359724; MYERS DM, 1985, TROP ANIM HEALTH PRO, V17, P239, DOI 10.1007/BF02356985; Pradutkanchana Jintana, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P175; Saenz R, 1995, Prehosp Disaster Med, V10, P154; Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; Sehgal SC, 2000, INT J ANTIMICROB AG, V13, P249, DOI 10.1016/S0924-8579(99)00134-X; Silverman MS, 2004, ANN TROP MED PARASIT, V98, P851, DOI 10.1179/000349804X3216; Sun AH, 2011, BIOMED ENVIRON SCI, V24, P291, DOI 10.3967/0895-3988.2011.03.013; TAKAFUJI ET, 1984, NEW ENGL J MED, V310, P497, DOI 10.1056/NEJM198402233100805; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; White F, 1994, Bull Pan Am Health Organ, V28, P73; Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8	35	40	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39672	10.1371/journal.pone.0039672	http://dx.doi.org/10.1371/journal.pone.0039672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808049	gold, Green Published, Green Submitted			2022-12-27	WOS:000306354700016
J	Jiang, F; Yang, ML; Guo, W; Wang, XH; Kang, L				Jiang, Feng; Yang, Meiling; Guo, Wei; Wang, Xianhui; Kang, Le			Large-Scale Transcriptome Analysis of Retroelements in the Migratory Locust, Locusta migratoria	PLOS ONE			English	Article							NON-LTR RETROTRANSPOSONS; TRANSPOSABLE ELEMENTS; RNA-SEQ; GENE-EXPRESSION; PHASE-CHANGES; WEB SERVER; GENOME; EVOLUTION; FAMILIES; CLASSIFICATION	Background: Retroelements can successfully colonize eukaryotic genome through RNA-mediated transposition, and are considered to be some of the major mediators of genome size. The migratory locust Locusta migratoria is an insect with a large genome size, and its genome is probably subject to the proliferation of retroelements. An analysis of deep-sequencing transcriptome data will elucidate the structure, diversity and expression characteristics of retroelements. Results: We performed a de novo assembly from deep sequencing RNA-seq data and identified 105 retroelements in the locust transcriptome. Phylogenetic analysis of reverse transcriptase sequences revealed 1 copia, 1 BEL, 8 gypsy and 23 non-long terminal repeat (LTR) retroelements in the locust transcriptome. A novel approach was developed to identify full-length LTR retroelements. A total of 5 full-length LTR retroelements and 2 full-length non-LTR retroelements that contained complete structures for retrotransposition were identified. Structural analysis indicated that all these retroelements may have been activated or deprived of retrotransposition activities very recently. Expression profiling analysis revealed that the retroelements exhibited a unique expression pattern at the egg stage and showed differential expression profiles between the solitarious and gregarious phases at the fifth instar and adult stage. Conclusion: We hereby present the first de novo transcriptome analysis of retroelements in a species whose genome is not available. This work contributes to a comprehensive understanding of the landscape of retroelements in the locust transcriptome. More importantly, the results reveal that non-LTR retroelements are abundant and diverse in the locust transcriptome.	[Jiang, Feng; Yang, Meiling; Guo, Wei; Wang, Xianhui; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Yang, Meiling] Shanxi Univ, Coll Life Sci & Technol, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Shanxi University	Jiang, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	lkang@ioz.ac.cn	Kang, Le/ABD-1116-2022; Guo, Wei/A-7089-2008; Jiang, Feng/AHC-5102-2022	Kang, Le/0000-0003-4262-2329; Guo, Wei/0000-0001-9081-9754; Jiang, Feng/0000-0002-7407-7604	National Major Special Science and Technology Project [2009ZX08009-099B]; National Natural Science Foundation of China [30970407, 31100925]; Doctoral Program of Higher Education of China [20101401120008]	National Major Special Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Major Special Science and Technology Project (2009ZX08009-099B), National Natural Science Foundation of China (No. 30970407), National Natural Science Foundation of China (Grant No. 31100925) and Doctoral Program of Higher Education of China (20101401120008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipova I, 2005, BIOESSAYS, V27, P76, DOI 10.1002/bies.20159; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Biedler J, 2003, MOL BIOL EVOL, V20, P1811, DOI 10.1093/molbev/msg189; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blumenstiel JP, 2011, TRENDS GENET, V27, P23, DOI 10.1016/j.tig.2010.10.003; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Capy P, 2005, CYTOGENET GENOME RES, V110, P457, DOI 10.1159/000084978; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clegg MT, 2000, P NATL ACAD SCI USA, V97, P7016, DOI 10.1073/pnas.97.13.7016; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Dufresne F, 2011, CHROMOSOME RES, P1; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eickbush TH, 2002, CURR OPIN GENET DEV, V12, P669, DOI 10.1016/S0959-437X(02)00359-3; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Faunes F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022569; Fernandez-Medina RD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-260; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Guo BC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-396; Guo W, 2010, J INSECT PHYSIOL, V56, P943, DOI 10.1016/j.jinsphys.2010.05.007; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Han JS, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-15; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hawkins JS, 2009, P NATL ACAD SCI USA, V106, P17811, DOI 10.1073/pnas.0904339106; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kapitonov VV, 2009, GENE, V448, P207, DOI 10.1016/j.gene.2009.07.019; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kojima KK, 2011, MOL BIOL EVOL, V28, P17, DOI 10.1093/molbev/msq220; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Malik HS, 1998, MOL BIOL EVOL, V15, P1123, DOI 10.1093/oxfordjournals.molbev.a026020; Mansour A, 2007, J CELL MOL BIOL, V6, P99; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Minervini CF, 2009, GENE, V440, P42, DOI 10.1016/j.gene.2009.03.021; Moczek AP, 2010, PHILOS T R SOC B, V365, P593, DOI 10.1098/rstb.2009.0263; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Novick PA, 2009, MOL BIOL EVOL, V26, P1811, DOI 10.1093/molbev/msp090; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; PARKHURST SM, 1987, EMBO J, V6, P419, DOI 10.1002/j.1460-2075.1987.tb04771.x; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Pons J, 2005, MOL BIOL EVOL, V22, P991, DOI 10.1093/molbev/msi085; Raghavan N, 2007, INT J PARASITOL, V37, P1307, DOI 10.1016/j.ijpara.2007.04.002; Rho MN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-425; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028167; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schon I, 2006, GENE, V371, P296, DOI 10.1016/j.gene.2005.12.007; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sela N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r59; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Tomilin NV, 2008, BIOESSAYS, V30, P338, DOI 10.1002/bies.20741; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; Wang SZ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r61; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Xu AG, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000843; Zhao FQ, 2009, GENOME RES, V19, P1384, DOI 10.1101/gr.091363.109	77	25	30	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40532	10.1371/journal.pone.0040532	http://dx.doi.org/10.1371/journal.pone.0040532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792363	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800104
J	Nolan, MS; Podoll, AS; Hause, AM; Akers, KM; Finkel, KW; Murray, KO				Nolan, Melissa S.; Podoll, Amber S.; Hause, Anne M.; Akers, Katherine M.; Finkel, Kevin W.; Murray, Kristy O.			Prevalence of Chronic Kidney Disease and Progression of Disease Over Time among Patients Enrolled in the Houston West Nile Virus Cohort	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; GLOMERULAR-FILTRATION-RATE; INFECTION; URINE; PERSISTENCE; BIOMARKER; EQUATION; INJURY; NGAL	Introduction: In experimental models of West Nile virus (WNV) infection, animals develop chronic kidney infection with histopathological changes in the kidney up to 8-months post-infection. However, the long term pathologic effects of acute infection in humans are largely unknown. The purpose of this study was to assess renal outcomes following WNV infection, specifically the development of chronic kidney disease (CKD). Methods: In a cohort of 139 study participants with a previous diagnosis of WNV infection, we investigated the prevalence of CKD using the Kidney Disease Outcomes Quality Initiative (KDOQI) criteria based on the Modification of Diet in Renal Disease (MDRD) formula and urinary abnormalities, and assessed various risk factors and biomarkers. Results: Study participants were primarily male (60%) and non-Hispanic white (86%) with a mean age of 57 years. Most (83%) were four to nine years post-infection at the time of this study. Based on the KDOQI definition, 40% of participants had evidence of CKD, with 10% having Stage III or greater and 30% having Stage I-II. By urinary dipstick testing, 26% of patients had proteinuria and 23% had hematuria. Plasma NGAL levels were elevated in 14% of participants while MCP-1 levels were increased in 12%. Over 1.5 years, the average change in eGFR was -3.71 mL/min/1.73 m(2). Only a history of Neuroinvasive WNV disease was independently associated with CKD following multivariate analysis. Discussion: We found a high prevalence of CKD after long term follow-up in a cohort of participants previously infected with WNV. The majority of those with CKD are in Stage I-II indicating early stages of renal disease. Traditional risk factors were not associated with the presence of CKD in this population. Therefore, clinicians should regularly evaluate all patients with a history of WNV for evidence of CKD.	[Nolan, Melissa S.; Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Podoll, Amber S.; Akers, Katherine M.; Finkel, Kevin W.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Houston, TX USA; [Hause, Anne M.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Nolan, MS (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	KMurray@bcm.edu			Gillson Longenbaugh Foundation; NIH/NIAID [5R01AI091816-01, K23AI057341, N01 AI 50027-03, U19AI089992-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050027, R01AI091816, K23AI057341, U19AI089992] Funding Source: NIH RePORTER	Gillson Longenbaugh Foundation; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was generously funded by the Gillson Longenbaugh Foundation and the NIH/NIAID (5R01AI091816-01, K23AI057341, N01 AI 50027-03, and U19AI089992-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemtam N, 2012, NEPHROL DIAL TRANSPL, V27, P1847, DOI 10.1093/ndt/gfr561; [Anonymous], 2002, KDOQI CLIN PRACT GUI; [Anonymous], 2010, DIR SERV; Baty SA, 2012, J INFECT DIS, V205, P1476, DOI 10.1093/infdis/jis221; Clark WF, 2011, J AM SOC NEPHROL, V22, P1729, DOI 10.1681/ASN.2010111217; Damman K, 2008, EUR J HEART FAIL, V10, P997, DOI 10.1016/j.ejheart.2008.07.001; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Haase-Fielitz A, 2009, NEPHROL DIAL TRANSPL, V24, P3349, DOI 10.1093/ndt/gfp234; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lindsey NP, 2012, VECTOR-BORNE ZOONOT, V12, P230, DOI 10.1089/vbz.2011.0721; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339; Murray KO, CLIN VACCINE I UNPUB; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Murray KO, 2008, VECTOR-BORNE ZOONOT, V8, P167, DOI 10.1089/vbz.2007.0109; Papa A, 2011, J MED VIROL, V83, P1857, DOI 10.1002/jmv.22190; Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238; Zhang XL, 2012, KIDNEY INT, V81, P401, DOI 10.1038/ki.2011.354	21	60	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40374	10.1371/journal.pone.0040374	http://dx.doi.org/10.1371/journal.pone.0040374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792293	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800073
J	Wong, IPL; Driessler, F; Khor, EC; Shi, YC; Hormer, B; Nguyen, AD; Enriquez, RF; Eisman, JA; Sainsbury, A; Herzog, H; Baldock, PA				Wong, Iris P. L.; Driessler, Frank; Khor, Ee Cheng; Shi, Yan-Chuan; Hoermer, Birgit; Nguyen, Amy D.; Enriquez, Ronaldo F.; Eisman, John A.; Sainsbury, Amanda; Herzog, Herbert; Baldock, Paul A.			Peptide YY Regulates Bone Remodeling in Mice: A Link between Gut and Skeletal Biology	PLOS ONE			English	Article							MINERAL DENSITY; BARIATRIC SURGERY; NEUROPEPTIDE-Y; WEIGHT-LOSS; RECEPTORS; MASS; APPETITE; ESTROGEN; WOMEN; LEADS	Background & Aims: Gastrointestinal peptides are increasingly being linked to processes controlling the maintenance of bone mass. Peptide YY (PYY), a gut-derived satiety peptide of the neuropeptide Y family, is upregulated in some states that also display low bone mass. Importantly, PYY has high affinity for Y-receptors, particularly Y1R and Y2R, which are known to regulate bone mass. Anorexic conditions and bariatric surgery for obesity influence circulating levels of PYY and have a negative impact on bone mass, but the precise mechanism behind this is unclear. We thus examined whether alterations in PYY expression affect bone mass. Methods: Bone microstructure and cellular activity were analyzed in germline PYY knockout and conditional adult-onset PYY over-expressing mice at lumbar and femoral sites using histomorphometry and micro-computed tomography. Results: PYY displayed a negative relationship with osteoblast activity. Male and female PYY knockout mice showed enhanced osteoblast activity, with greater cancellous bone mass. Conversely, PYY over-expression lowered osteoblast activity in vivo, via a direct Y1 receptor mediated mechanism involving MAPK stimulation evident in vitro. In contrast to PYY knockout mice, PYY over expression also altered bone resorption, as indicated by greater osteoclast surface, despite the lack of Y-receptor expression in osteoclastic cells. While evident in both sexes, cellular changes were generally more pronounced in females. Conclusions: These data demonstrate that the gut peptide PYY is critical for the control of bone remodeling. This regulatory axis from the intestine to bone has the potential to contribute to the marked bone loss observed in situations of extreme weight loss and higher circulating PYY levels, such as anorexia and bariatric obesity surgery, and may be important in the maintenance of bone mass in the general population.	[Wong, Iris P. L.; Driessler, Frank; Khor, Ee Cheng; Shi, Yan-Chuan; Nguyen, Amy D.; Enriquez, Ronaldo F.; Sainsbury, Amanda; Herzog, Herbert; Baldock, Paul A.] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia; [Eisman, John A.; Herzog, Herbert; Baldock, Paul A.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Wong, IPL (corresponding author), Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia.	p.baldock@garvan.org.au	Eisman, John A/C-2886-2014; Shi, Yanchuan/H-5608-2012; Baldock, Paul/B-3840-2012; Salis, Amanda/A-3187-2011; Herzog, Herbert/B-8294-2008; Nguyen, Amy D/K-2588-2019	Shi, Yanchuan/0000-0002-8368-6735; Salis, Amanda/0000-0001-9176-1574; Nguyen, Amy D/0000-0003-4603-564X; , Herbert/0000-0002-1713-1029	National Health and Medical Research Council [427632]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Study funded by (in part) National Health and Medical Research Council grant 427632. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Bose M, 2010, OBESITY, V18, P1085, DOI 10.1038/oby.2009.473; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Ding KH, 2008, J BONE MINER RES, V23, P536, DOI 10.1359/JBMR.071202; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Fleischer J, 2008, J CLIN ENDOCR METAB, V93, P3735, DOI 10.1210/jc.2008-0481; Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hegde SS, 1995, J PHARMACOL EXP THER, V275, P1261; Henriksen DB, 2009, BONE; Igwe JC, 2009, J CELL BIOCHEM, V108, P621, DOI 10.1002/jcb.22294; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61; Lee NJ, 2010, BONE; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Misra M, 2006, J CLIN ENDOCR METAB, V91, P1027, DOI 10.1210/jc.2005-1878; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Pournaras DJ, 2010, OBES SURG, V20, P56, DOI 10.1007/s11695-009-9989-1; Rapuri PB, 2004, J CLIN ENDOCR METAB, V89, P4954, DOI 10.1210/jc.2004-0434; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Russell M, 2009, BONE, V45, P104, DOI 10.1016/j.bone.2009.03.668; Scheid JL, 2011, BONE, V49, P194, DOI 10.1016/j.bone.2011.04.011; Shi YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011361; Shi YC, 2012, NEUROPEPTID IN PRESS; Tsai WS, 2007, ARCH PEDIAT ADOL MED, V161, P217, DOI 10.1001/archpedi.161.3.217; Utz AL, 2008, BONE, V43, P135, DOI 10.1016/j.bone.2008.03.007; Valderas JP, 2010, J CLIN ENDOCR METAB, V95, P1069, DOI 10.1210/jc.2009-0983; Viegas M, 2010, ARQ BRAS ENDOCRINOL, V54, P158, DOI 10.1590/S0004-27302010000200011; von Mach MA, 2004, METABOLISM, V53, P918, DOI 10.1016/j.metabol.2004.01.015; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Wong IPL, 2010, CURR OPIN ENDOCRINOL, V17, P44, DOI 10.1097/MED.0b013e3283344a05; Wortley KE, 2007, GASTROENTEROLOGY, V133, P1534, DOI 10.1053/j.gastro.2007.08.024; Wucher H, 2008, OBES SURG, V18, P58, DOI 10.1007/s11695-007-9258-0; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yuzuriha H, 2007, FASEB J, V21, P2108, DOI 10.1096/fj.06-7621com	42	57	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40038	10.1371/journal.pone.0040038	http://dx.doi.org/10.1371/journal.pone.0040038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792209	Green Submitted, gold, Green Published			2022-12-27	WOS:000306461800032
J	Etxebeste, O; Herrero-Garcia, E; Cortese, MS; Garzia, A; Oiartzabal-Arano, E; de los Rios, V; Ugalde, U; Espeso, EA				Etxebeste, Oier; Herrero-Garcia, Erika; Cortese, Marc S.; Garzia, Aitor; Oiartzabal-Arano, Elixabet; de los Rios, Vivian; Ugalde, Unai; Espeso, Eduardo A.			GmcA Is a Putative Glucose-Methanol-Choline Oxidoreductase Required for the Induction of Asexual Development in Aspergillus nidulans	PLOS ONE			English	Article							DROSOPHILA-NINAG OXIDOREDUCTASE; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTORS; PROTEIN; FLBB; ESTABLISHMENT; DEGRADATION; MAINTENANCE; SPORULATION; EXPRESSION	Aspergillus nidulans asexual differentiation is induced by Upstream Developmental Activators (UDAs) that include the bZIP-type Transcription Factor (TF) FlbB. A 2D-PAGE/MS-MS-coupled screen for proteins differentially expressed in the presence and absence of FlbB identified 18 candidates. Most candidates belong to GO term classes involved in osmotic and/or oxidative stress response. Among these, we focused on GmcA, a putative glucose-methanol-choline oxidoreductase which is upregulated in a Delta flbB background. GmcA is not required for growth since no differences were detected in the radial extension upon deletion of gmcA. However, its activity is required to induce conidiation under specific culture conditions. A Delta gmcA strain conidiates profusely under acid conditions but displays a characteristic fluffy aconidial phenotype in alkaline medium. The absence of asexual development in a Delta gmcA strain can be suppressed, on one hand, using high concentrations of non-fermentable carbon sources like glycerol, and on the other hand, when the cMyb-type UDA TF flbD is overexpressed. Overall, the results obtained in this work support a role for GmcA at early stages of conidiophore initiation.	[Etxebeste, Oier; Cortese, Marc S.; Garzia, Aitor; Oiartzabal-Arano, Elixabet; Ugalde, Unai] Univ Basque Country Manuel de Lardizabal, Fac Chem, Dept Appl Chem, San Sebastian, Spain; [Herrero-Garcia, Erika; de los Rios, Vivian; Espeso, Eduardo A.] Ctr Invest Biol CSIC, Dept Med Celular & Mol, Madrid, Spain; [Cortese, Marc S.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Basque Foundation for Science	Etxebeste, O (corresponding author), Univ Basque Country Manuel de Lardizabal, Fac Chem, Dept Appl Chem, San Sebastian, Spain.	oier.echeveste@ehu.es	Espeso, Eduardo A/AAC-7238-2022; Espeso, Eduardo A/C-5259-2011; Etxebeste, Oier/H-8064-2019; Cortese, Marc/G-4026-2010	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Etxebeste, Oier/0000-0002-9786-6091; Garzia, Aitor/0000-0002-6270-1369; Cortese, Marc/0000-0002-5903-0525	Basque Government [SA-2010/00105, IT393-10]; Ministerio de Ciencia e Innovacion [BFU2010-17528, BFU2009-08701]; University of The Basque Country [BFU2010-17528]; Basque Government	Basque Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); University of The Basque Country; Basque Government(Basque Government)	This work has been supported by the Basque Government (SA-2010/00105 and IT393-10) and Ministerio de Ciencia e Innovacion (BFU2010-17528) to U.U. and to E.A.E. through grant BFU2009-08701. O.E was a contract researcher of The University of The Basque Country and is now associated to grant BFU2010-17528. E.H.-G. and A.G. held a predoctoral fellowship from the Basque Government, and M.S.C. was a contract researcher of the Ikerbasque program of the Basque Government (www.ikerbasque.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2010, MOL BIOL CELL, V21, P2756, DOI 10.1091/mbc.E10-02-0119; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Ahmad ST, 2006, J BIOL CHEM, V281, P9205, DOI 10.1074/jbc.M510293200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atoui A, 2010, FUNGAL GENET BIOL, V47, P962, DOI 10.1016/j.fgb.2010.08.007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; CASTRILLO JI, 1995, YEAST, V11, P1353, DOI 10.1002/yea.320111404; Cortese MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017505; De Loof Arnold, 2006, Insect Science, V13, P325, DOI 10.1111/j.1744-7917.2006.00101.x; Dinan L, 2001, PHYTOCHEMISTRY, V57, P325, DOI 10.1016/S0031-9422(01)00078-4; Durbin R., 1998, BIOL SEQUENCE ANAL P; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Etxebeste O, 2008, EUKARYOT CELL, V7, P38, DOI 10.1128/EC.00207-07; Etxebeste O, 2010, CURR PROTEIN PEPT SC, V11, P704, DOI 10.2174/138920310794557682; Etxebeste O, 2010, TRENDS MICROBIOL, V18, P569, DOI 10.1016/j.tim.2010.09.007; Etxebeste O, 2009, MOL MICROBIOL, V73, P775, DOI 10.1111/j.1365-2958.2009.06804.x; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Ferreira P, 2009, J BIOL CHEM, V284, P24840, DOI 10.1074/jbc.M109.011593; Garzia A, 2010, MOL MICROBIOL, V75, P1314, DOI 10.1111/j.1365-2958.2010.07063.x; Garzia A, 2009, MOL MICROBIOL, V71, P172, DOI 10.1111/j.1365-2958.2008.06520.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris SD, 2009, MOL MICROBIOL, V73, P733, DOI 10.1111/j.1365-2958.2009.06803.x; Herrero-Garcia E, 2011, FUNGAL BIOL-UK, V115, P393, DOI 10.1016/j.funbio.2011.02.005; Hervas-Aguilar A, 2010, EUKARYOT CELL, V9, P1504, DOI 10.1128/EC.00119-10; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; KAFER E, 1965, GENETICS, V52, P217; Kniemeyer O, 2011, PROTEOMICS, V11, P3232, DOI 10.1002/pmic.201100087; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; Lee AG, 1996, RHODOPSIN G PROTEIN; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Lo HC, 2012, J AM CHEM SOC, V134, P4709, DOI 10.1021/ja209809t; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Pontecorvo G, 1994, ASPERGILLUS 50 YEARS, P23; Pusztahelyi T, 2011, FUNGAL GENET BIOL, V48, P92, DOI 10.1016/j.fgb.2010.08.006; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Ruger-Herreros C, 2011, GENETICS, V188, P809, DOI 10.1534/genetics.111.130096; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; Seki T, 1998, EUR J BIOCHEM, V257, P522, DOI 10.1046/j.1432-1327.1998.2570522.x; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SKROMNE I, 1995, MICROBIOL-SGM, V141, P21, DOI 10.1099/00221287-141-1-21; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Soid-Raggi G, 2006, MOL MICROBIOL, V59, P854, DOI 10.1111/j.1365-2958.2005.04996.x; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Takeuchi H, 2005, BIOCHEM J, V389, P637, DOI 10.1042/BJ20050498; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; WIESER J, 1994, CURR GENET, V27, P62, DOI 10.1007/BF00326580; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zamocky M, 2004, GENE, V338, P1, DOI 10.1016/j.gene.2004.04.025	65	18	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40292	10.1371/journal.pone.0040292	http://dx.doi.org/10.1371/journal.pone.0040292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792266	Green Published, gold			2022-12-27	WOS:000306436300049
J	Ikenaga, N; Ohuchida, K; Mizumoto, K; Akagawa, S; Fujiwara, K; Eguchi, D; Kozono, S; Ohtsuka, T; Takahata, S; Tanaka, M				Ikenaga, Naoki; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Akagawa, Shin; Fujiwara, Kenji; Eguchi, Daiki; Kozono, Shingo; Ohtsuka, Takao; Takahata, Shunichi; Tanaka, Masao			Pancreatic Cancer Cells Enhance the Ability of Collagen Internalization during Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CATHEPSIN-B; RECEPTOR ENDO180; PROMOTES; UPARAP/ENDO-180; IDENTIFICATION; INVASIVENESS; DEGRADATION; INTEGRINS	Background: Extracellular matrix (ECM) remodeling is predominantly mediated by fibroblasts using intracellular and extracellular pathways. Although it is well known that extracellular degradation of the ECM by proteases derived from cancer cells facilitates cellular invasion, the intracellular degradation of ECM components by cancer cells has not been clarified. The aim of this study was to characterize collagen internalization, which is the initial step of the intracellular degradation pathway in pancreatic cancer cells, in light of epithelial-mesenchymal transition (EMT). Methodology/Principal Findings: We analyzed the function of collagen internalization in two pancreatic cancer cell lines, SUIT-2 and KP-2, and pancreatic stellate cells (PSCs) using Oregon Green 488-gelatin. PSCs had a strong ability for collagen uptake, and the pancreatic cancer cells also internalized collagen although less efficiently. The collagen internalization abilities of SUIT-2 and KP-2 cells were promoted by EMT induced by human recombinant transforming growth factor beta 1 (P<0.05). Expression of Endo180, a collagen uptake receptor, was high in mesenchymal pancreatic cancer cell lines, as determined by EMT marker expression (P<0.01). Quantitative RT-PCR and western blot analyses showed that Endo180 expression was also increased by EMT induction in SUIT-2 and KP-2 cells. Endo180 knockdown by RNA interference attenuated the collagen uptake (P<0.01) and invasive abilities (P<0.05) of SUIT-2 and KP-2 cells. Conclusions/Significance: Pancreatic cancer cells are capable of collagen internalization, which is enhanced by EMT. This ECM clearance system may be a novel mechanism for cellular invasion and a potential therapeutic target in pancreatic cancer.	[Ikenaga, Naoki; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Akagawa, Shin; Fujiwara, Kenji; Eguchi, Daiki; Kozono, Shingo; Ohtsuka, Takao; Takahata, Shunichi; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Ikenaga, Naoki] Japan Soc Promot Sci, Tokyo, Japan; [Ohuchida, Kenoki] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka 812, Japan; [Mizumoto, Kazuhiro] Kyushu Univ Hosp, Ctr Canc, Fukuoka 812, Japan	Kyushu University; Japan Society for the Promotion of Science; Kyushu University; Kyushu University	Ikenaga, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan.	kenoki@surg1.med.kyushu-u.ac.jp; mizumoto@surg1.med.kyushu-u.ac.jp	Fujiwara, Kenji/AAI-8431-2021	Fujiwara, Kenji/0000-0001-5900-9382; Ohuchida, Kenoki/0000-0003-4792-1168	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Fukuoka Foundation for Sound Health; Grants-in-Aid for Scientific Research [24390318] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Uehara Memorial Foundation and the Fukuoka Foundation for Sound Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ikenaga N, 2011, GASTROENTEROLOGY, V139; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Menke A, 2001, CANCER RES, V61, P3508; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Niedergethmann M, 2004, PANCREAS, V29, P204, DOI 10.1097/00006676-200410000-00005; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Quintanilla-Dieck MJ, 2008, J INVEST DERMATOL, V128, P2281, DOI 10.1038/jid.2008.63; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sameni Mansoureh, 2003, Mol Imaging, V2, P159, DOI 10.1162/153535003322556903; Segal G, 2001, J CELL SCI, V114, P119; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Szpaderska AM, 2004, ANTICANCER RES, V24, P3887; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496	40	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40434	10.1371/journal.pone.0040434	http://dx.doi.org/10.1371/journal.pone.0040434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792318	gold, Green Submitted, Green Published			2022-12-27	WOS:000306436300066
J	Ortuno-Pineda, C; Galindo-Rosales, JM; Calderon-Salinas, JV; Villegas-Sepulveda, N; Saucedo-Cardenas, O; De Nova-Ocampo, M; Valdes, J				Ortuno-Pineda, Carlos; Manuel Galindo-Rosales, Jose; Victor Calderon-Salinas, Jose; Villegas-Sepulveda, Nicolas; Saucedo-Cardenas, Odila; De Nova-Ocampo, Monica; Valdes, Jesus			Binding of hnRNP H and U2AF65 to Respective G-codes and a Poly-Uridine Tract Collaborate in the N50-5 ' ss Selection of the REST N Exon in H69 Cells	PLOS ONE			English	Article							PRE-MESSENGER-RNA; 5' SPLICE SITES; LUNG-CANCER; U1 SNRNP; POLYPYRIMIDINE-TRACT; TARGET GENES; RICH MOTIFS; REPRESSOR; RECOGNITION; PROTEINS	The splicing of the N exon in the pre-mRNA coding for the RE1-silencing transcription factor (REST) results in a truncated protein that modifies the expression pattern of some of its target genes. A weak 3'ss, three alternative 5'ss (N4-, N50-, and N62-5'ss) and a variety of putative target sites for splicing regulatory proteins are found around the N exon; two GGGG codes (G2-G3) and a poly-Uridine tract (N-PU) are found in front of the N50-5'ss. In this work we analyzed some of the regulatory factors and elements involved in the preferred selection of the N50-5'ss (N50 activation) in the small cell lung cancer cell line H69. Wild type and mutant N exon/beta-globin minigenes recapitulated N50 exon splicing in H69 cells, and showed that the N-PU and the G2-G3 elements are required for N50 exon splicing. Biochemical and knockdown experiments identified these elements as U2AF65 and hnRNP H targets, respectively, and that they are also required for N50 exon activation. Compared to normal MRC5 cells, and in keeping with N50 exon activation, U2AF65, hnRNP H and other splicing factors were highly expressed in H69 cells. CLIP experiments revealed that hnRNP H RNA-binding occurs first and is a prerequisite for U2AF65 RNA binding, and EMSA and CLIP experiments suggest that U2AF65-RNA recognition displaces hnRNP H and helps to recruit other splicing factors (at least U1 70K) to the N50-5'ss. Our results evidenced novel hnRNP H and U2AF65 functions: respectively, U2AF65-recruiting to a 5'ss in humans and the hnRNP H-displacing function from two juxtaposed GGGG codes.	[Ortuno-Pineda, Carlos; Manuel Galindo-Rosales, Jose; Victor Calderon-Salinas, Jose; Valdes, Jesus] Ctr Invest & Estudios Avanzados IPN, Dept Bioquim, Mexico City, DF, Mexico; [Saucedo-Cardenas, Odila] Univ Autonoma Nuevo Leon, Fac Med, Dept Histol, Monterrey, NL, Mexico; [Saucedo-Cardenas, Odila] Inst Mexicano Seguro Social, Ctr Invest Biomed NE, Div Genet, Monterrey, NL, Mexico; [De Nova-Ocampo, Monica] Escuela Nacl Med & Homeopatia IPN, Programa Inst Biomed Mol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Autonoma de Nuevo Leon; Instituto Mexicano del Seguro Social	Ortuno-Pineda, C (corresponding author), Ctr Invest & Estudios Avanzados IPN, Dept Bioquim, Mexico City, DF, Mexico.	jvaldes@cinvestav.mx		Villegas-Sepulveda, Nicolas/0000-0001-9489-2545; De Nova Ocampo, Monica/0000-0002-0750-7977	CONACyT [49355-M, 127557-M]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported with funds from CONACyT (Grants Nos. 49355-M and 127557-M, and a Postgraduate Scholarship to COP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznarez I, 2008, GENOME RES, V18, P1247, DOI 10.1101/gr.073155.107; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Boehr DD, 2012, BIOESSAYS; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Chou MY, 1999, MOL CELL BIOL, V19, P69; Coulson JM, 1999, CANCER RES, V59, P5123; Coulson JM, 2000, CANCER RES, V60, P1840; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Forch P, 2003, BIOCHEM J, V372, P235, DOI 10.1042/BJ20021202; Grabowski PJ, 2004, BIOCHEM SOC T, V32, P924, DOI 10.1042/BST0320924; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; Immaneni A, 2000, NUCLEIC ACIDS RES, V28, P3403, DOI 10.1093/nar/28.17.3403; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kirschbaum-Slager Natanja, 2004, Genet Mol Res, V3, P512; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Magin A, 2002, NEUROCHEM INT, V40, P195, DOI 10.1016/S0197-0186(01)00091-2; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Scheer JM, 2001, ANAL BIOCHEM, V298, P130, DOI 10.1006/abio.2001.5384; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Talukdar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027869; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40315	10.1371/journal.pone.0040315	http://dx.doi.org/10.1371/journal.pone.0040315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792276	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306436300051
J	Ditmer, MA; Stapleton, SP				Ditmer, Mark Allan; Stapleton, Seth Patrick			Factors Affecting Hatch Success of Hawksbill Sea Turtles on Long Island, Antigua, West Indies	PLOS ONE			English	Article							NEST-SITE SELECTION; ERETMOCHELYS-IMBRICATA; CARETTA-CARETTA; CLIMATE-CHANGE; LEATHERBACK; SAND; MORTALITY; PREFERENCES; TEMPERATURE; RECRUITMENT	Current understanding of the factors influencing hawksbill sea turtle (Eretmochelys imbricata) hatch success is disparate and based on relatively short-term studies or limited sample sizes. Because global populations of hawksbills are heavily depleted, evaluating the parameters that impact hatch success is important to their conservation and recovery. Here, we use data collected by the Jumby Bay Hawksbill Project (JBHP) to investigate hatch success. The JBHP implements saturation tagging protocols to study a hawksbill rookery in Antigua, West Indies. Habitat data, which reflect the varied nesting beaches, are collected at egg deposition, and nest contents are exhumed and categorized post-emergence. We analyzed hatch success using mixed-model analyses with explanatory and predictive datasets. We incorporated a random effect for turtle identity and evaluated environmental, temporal and individual-based reproductive variables. Hatch success averaged 78.6% (SD: 21.2%) during the study period. Highly supported models included multiple covariates, including distance to vegetation, deposition date, individual intra-seasonal nest number, clutch size, organic content, and sand grain size. Nests located in open sand were predicted to produce 10.4 more viable hatchlings per clutch than nests located >1.5 m into vegetation. For an individual first nesting in early July, the fourth nest of the season yielded 13.2 more viable hatchlings than the initial clutch. Generalized beach section and inter-annual variation were also supported in our explanatory dataset, suggesting that gaps remain in our understanding of hatch success. Our findings illustrate that evaluating hatch success is a complex process, involving multiple environmental and individual variables. Although distance to vegetation and hatch success were inversely related, vegetation is an important component of hawksbill nesting habitat, and a more complete assessment of the impacts of specific vegetation types on hatch success and hatchling sex ratios is needed. Future research should explore the roles of sand structure, nest moisture, and local weather conditions.	[Ditmer, Mark Allan; Stapleton, Seth Patrick] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Stapleton, Seth Patrick] Jumby Bay Hawksbill Project, St Johns, Bonaire, Netherlands	University of Minnesota System; University of Minnesota Twin Cities	Ditmer, MA (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	ditme004@umn.edu			Jumby Bay Island Company (JBIC)	Jumby Bay Island Company (JBIC)	All funding for the years of our study was provided by the Jumby Bay Island Company (JBIC - http://www.jumbybayisland.com/home.html). The Jumby Bay Hawksbill Project (JBHP) is a member of the Wider Caribbean Sea Turtle Conservation Network (WIDECAST). WIDECAST manages JBIC's annual contribution supporting the JBHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RA, 1981, COPEIA, P757; Barton BT, 2008, BIOL CONSERV, V141, P2139, DOI 10.1016/j.biocon.2008.06.013; BJORNDAL KA, 1985, COPEIA, P736, DOI 10.2307/1444767; Bourgeois S, 2009, BIOL CONSERV, V142, P85, DOI 10.1016/j.biocon.2008.09.028; Broderick AC, 2001, P ROY SOC B-BIOL SCI, V268, P1481, DOI 10.1098/rspb.2001.1695; Burnham KP., 2002, MODEL SELECTION MULT, P496; Chouinard MP, 2007, AUK, V124, P1305, DOI 10.1642/0004-8038(2007)124[1305:SAHUOM]2.0.CO;2; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Dobbs Kirstin A., 1999, Chelonian Conservation and Biology, V3, P344; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Eckert K., 2006, 2 WIDECAST, P40; Ficetola GF, 2007, ORYX, V41, P402, DOI 10.1017/S0030605307000543; Fish MR, 2005, CONSERV BIOL, V19, P482, DOI 10.1111/j.1523-1739.2005.00146.x; Glen F, 2004, GLOBAL CHANGE BIOL, V10, P2036, DOI 10.1111/j.1529-8817.2003.00865.x; Hamann M, 2003, CRC MAR BIOL SER, P135; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hays GC, 2001, OIKOS, V93, P87, DOI 10.1034/j.1600-0706.2001.930109.x; Hitchins PM, 2004, J ZOOL, V264, P383, DOI 10.1017/s0952836904005904; HORROCKS JA, 1991, MAR ECOL PROG SER, V69, P1, DOI 10.3354/meps069001; Kamel SJ, 2005, ANIM BEHAV, V70, P819, DOI 10.1016/j.anbehav.2005.01.006; Kamel SJ, 2006, ECOLOGY, V87, P2947, DOI 10.1890/0012-9658(2006)87[2947:IMOINS]2.0.CO;2; Kamel SJ, 2006, ECOL APPL, V16, P923, DOI 10.1890/1051-0761(2006)016[0923:DROSRD]2.0.CO;2; KRAEMER JE, 1980, HERPETOLOGICA, V36, P72; Levasseur K, 2011, MONITORING ERETMOCHE, P38; Marcovaldi MA, 1997, CAN J ZOOL, V75, P755, DOI 10.1139/z97-097; Marcovaldi Maria Angela, 2007, Endangered Species Research, V3, P133, DOI 10.3354/esr003133; Marcovaldi Maria Angela, 1999, Chelonian Conservation and Biology, V3, P301; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Mazaris AD, 2009, AMPHIBIA-REPTILIA, V30, P221, DOI 10.1163/156853809788201180; Mazerolle M.J., 2009, AICCMODAVG MODEL SEL; MCGINLEY MA, 1989, EVOL ECOL, V3, P150, DOI 10.1007/BF02270917; Meylan Anne B., 1999, Chelonian Conservation and Biology, V3, P200; Miller Jeffrey D., 1999, P124; Miller Jeffrey D., 1997, P51; MORTIMER J. A., 1982, BIOL CONSERVATION SE, P45; MORTIMER JA, 1990, COPEIA, P802, DOI 10.2307/1446446; Mortimer JA, 2008, IUCN 2010 IUCN RED L; Pike DA, 2006, J HERPETOL, V40, P91, DOI 10.1670/100-05N.1; Pike DA, 2008, ENVIRON MANAGE, V41, P461, DOI 10.1007/s00267-006-0434-0; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; Richardson James I., 1999, Chelonian Conservation and Biology, V3, P244; Stapleton SP, 2010, P 28 ANN S SEA TURTL, P189; Tomillo PS, 2009, MAR BIOL, V156, P2021, DOI 10.1007/s00227-009-1234-x; Wallace BP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P423, DOI 10.1086/420951; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; West B, 2007, LINEAR MIXED MODELS, P376; WHITMORE CP, 1985, BIOL CONSERV, V34, P251, DOI 10.1016/0006-3207(85)90095-3; Wood DW, 2000, COPEIA, P119; WOOD VE, 1986, BIOL CONSERV, V37, P321, DOI 10.1016/0006-3207(86)90076-5; Zuur Alain F., 2009, P1	53	32	36	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38472	10.1371/journal.pone.0038472	http://dx.doi.org/10.1371/journal.pone.0038472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802928	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900002
J	Wang, XF; Liu, F; Zhou, S; Xu, ZP; Hoellwarth, J; Chen, XJ; He, L; Zhang, RB; Liu, F; Wang, J; Su, C				Wang, Xuefeng; Liu, Fan; Zhou, Sha; Xu, Zhipeng; Hoellwarth, Jason; Chen, Xiaojun; He, Lei; Zhang, Rongbo; Liu, Feng; Wang, Jun; Su, Chuan			Partial Regulatory T Cell Depletion Prior to Schistosomiasis Vaccination Does Not Enhance the Protection	PLOS ONE			English	Article							MEDIATED ANTITUMOR IMMUNITY; DNA VACCINE; IN-VIVO; JAPONICUM; RESPONSES; IL-10; INFECTION; MELANOMA; IMMUNOTHERAPY; CHEMOTHERAPY	CD4(+)CD25(+) regulatory T cells (Tregs) do not only influence self-antigen specific immune responses, but also dampen the protective effect induced by a number of vaccines. The impact of CD4(+)CD25(+) Tregs on vaccines against schistosomiasis, a neglected tropical disease that is a major public health concern, however, has not been examined. In this study, a DNA vaccine encoding a 26 kDa glutathione S-transferase of Schistosoma japonicum (pVAX1-Sj26GST) was constructed and its potential effects were evaluated by depleting CD25(+) cells prior to pVAX1-Sj26GST immunization. This work shows that removal of CD25(+) cells prior to immunization with the pVAX1-Sj26GST schistosomiasis DNA vaccine significantly increases the proliferation of splenocytes and IgG levels. However, CD25(+) cell-depleted mice immunized with pVAX1-Sj26GST show no improved protection against S. japonicum. Furthermore, depletion of CD25(+) cells causes an increase in both proinflammatory cytokines (e. g. IFN-gamma, GM-CSF and IL-4) and an anti-inflammatory cytokine (e. g. IL-10), with CD4(+)CD25(-) T cells being one of the major sources of both IFN-gamma and IL-10. These findings indicate that partial CD25(+) cell depletion fails to enhance the effectiveness of the schistosome vaccine, possibly due to IL-10 production by CD4(+)CD25(-) T cells, or other cell types, after CD25(+) cell depletion during vaccination.	[Wang, Xuefeng; Zhang, Rongbo; Wang, Jun] Anhui Univ Sci & Technol, Sch Med, Dept Pathogen Biol & Immunol, Huainan, Anhui, Peoples R China; [Liu, Fan] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Zhou, Sha; Xu, Zhipeng; Chen, Xiaojun; He, Lei; Liu, Feng; Su, Chuan] Nanjing Med Univ, Jiangsu Key Lab Pathogen Biol, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China; [Hoellwarth, Jason] Univ So Calif, Keck Sch Med, Dept Educ Affairs, Los Angeles, CA 90033 USA	Anhui University of Science & Technology; Xiamen University; Nanjing Medical University; University of Southern California	Wang, XF (corresponding author), Anhui Univ Sci & Technol, Sch Med, Dept Pathogen Biol & Immunol, Huainan, Anhui, Peoples R China.	wangxxff1023@yahoo.com.cn	Chen, Xiaojun/P-8288-2017; He, Lei/L-4726-2019; Chen, Xiaojun/AAD-9401-2022; xu, zhipeng/M-7708-2019	Chen, Xiaojun/0000-0002-3698-2814; Chen, Xiaojun/0000-0002-3698-2814; xu, zhipeng/0000-0002-8853-5303; He, Lei/0000-0002-3821-2047	National Natural Science Foundation of China [30801046]; Anhui Academic and Technical Reserve Candidate Leaders; Anhui University of Science and Technology [2010YB004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Academic and Technical Reserve Candidate Leaders; Anhui University of Science and Technology	This work was supported by grant from the National Natural Science Foundation of China (No. 30801046), the grant from the Anhui Academic and Technical Reserve Candidate Leaders, and the grant 2010YB004 from Anhui University of Science and Technology to Xuefeng Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2009, PARASITOL RES, V104, P955, DOI 10.1007/s00436-009-1371-7; Aloysius MM, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-18; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bergquist NR, 2005, TRENDS PARASITOL, V21, P112, DOI 10.1016/j.pt.2005.01.001; Bhowmick S, 2009, INFECT IMMUN, V77, P1514, DOI 10.1128/IAI.01739-07; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Cabrera G, 2011, MEDICINA-BUENOS AIRE, V71, P243; Capron A, 2005, TRENDS PARASITOL, V21, P143, DOI 10.1016/j.pt.2005.01.003; Cardoso LS, 2010, CLIN EXP IMMUNOL, V160, P266, DOI 10.1111/j.1365-2249.2009.04084.x; Chuang CM, 2009, VACCINE, V27, P684, DOI 10.1016/j.vaccine.2008.11.042; Cools N, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89195; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Fujio K, 2010, ADV IMMUNOL, V105, P99, DOI 10.1016/S0065-2776(10)05004-2; Furuichi Y, 2005, WORLD J GASTROENTERO, V11, P3772, DOI 10.3748/wjg.v11.i24.3772; Hong H, 2010, CLIN EXP IMMUNOL, V159, P93, DOI 10.1111/j.1365-2249.2009.04018.x; HOON DSB, 1990, CANCER RES, V50, P5358; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jing WQ, 2011, BLOOD, V117, P6952, DOI 10.1182/blood-2010-12-326108; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kim B, 2008, VACCINE, V26, P5601, DOI 10.1016/j.vaccine.2008.07.099; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; Layland LE, 2010, J IMMUNOL, V184, P713, DOI 10.4049/jimmunol.0901435; Li MJ, 2011, EXP PARASITOL, V128, P427, DOI 10.1016/j.exppara.2011.05.012; Li YS, 1999, ACTA TROP, V73, P79, DOI 10.1016/S0001-706X(99)00019-4; Liu XS, 2009, J IMMUNOL, V183, P51, DOI 10.4049/jimmunol.0802047; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Maizels RM, 2011, ADV IMMUNOL, V112, P73, DOI 10.1016/B978-0-12-387827-4.00003-6; Matsushita N, 2008, J IMMUNOL METHODS, V333, P167, DOI 10.1016/j.jim.2008.01.012; McAleer JP, 2010, TRENDS IMMUNOL, V31, P429, DOI 10.1016/j.it.2010.08.005; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; McManus DP, 2005, PARASITE IMMUNOL, V27, P297, DOI 10.1111/j.1365-3024.2005.00784.x; Mikkelsen SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017183; Onizuka S, 1999, CANCER RES, V59, P3128; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; Tabbara KS, 2005, INFECT IMMUN, V73, P4714, DOI 10.1128/IAI.73.8.4714-4722.2005; Taylor MD, 2005, J IMMUNOL, V174, P4924, DOI 10.4049/jimmunol.174.8.4924; TIU WU, 1988, PARASITE IMMUNOL, V10, P693, DOI 10.1111/j.1365-3024.1988.tb00255.x; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; Toossi Z, 2011, CLIN EXP IMMUNOL, V163, P333, DOI 10.1111/j.1365-2249.2010.04269.x; Tuettenberg Andrea, 2007, J Dtsch Dermatol Ges, V5, P190, DOI 10.1111/j.1610-0387.2007.06179.x; Turner JD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001269; Tuve S, 2007, CANCER RES, V67, P5929, DOI 10.1158/0008-5472.CAN-06-4296; van der Vlugt LEPM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030883; Wang XF, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-109; Wang XF, 2009, EUR J IMMUNOL, V39, P3052, DOI 10.1002/eji.200939335; Wei F, 2008, VACCINE, V26, P4145, DOI 10.1016/j.vaccine.2008.05.034; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Zhang L, 2008, MICROBES INFECT, V10, P251, DOI 10.1016/j.micinf.2007.11.009	60	4	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40359	10.1371/journal.pone.0040359	http://dx.doi.org/10.1371/journal.pone.0040359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802961	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900035
J	Desjardins, JK; Hofmann, HA; Fernald, RD				Desjardins, Julie K.; Hofmann, Hans A.; Fernald, Russell D.			Social Context Influences Aggressive and Courtship Behavior in a Cichlid Fish	PLOS ONE			English	Article							HAPLOCHROMIS-BURTONI; DECEIVE COMPETITORS; FIGHTING FISH; DOMINANCE; EVOLUTION; AUDIENCE; STRATEGY; RANK	Social interactions require knowledge of the environment and status of others, which can be acquired indirectly by observing the behavior of others. When being observed, animals can also alter their signals based on who is watching. Here we observed how male cichlid fish (Astatotilapia burtoni) behave when being watched in two different contexts. In the first, we show that aggressive and courtship behaviors displayed by subordinate males depends critically on whether dominant males can see them, and in the second, we manipulated who was watching aggressive interactions and showed that dominant males will change their behavior depending on audience composition. In both cases, when a more dominant individual is out of view and the audience consists of more subordinate individuals, those males signal key social information to females by displaying courtship and dominant behaviors. In contrast, when a dominant male is present, males cease both aggression and courtship. These data suggest that males are keenly aware of their social environment and modulate their aggressive and courtship behaviors strategically for reproductive and social advantage.	[Desjardins, Julie K.; Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Inst Cellular & Mol Biol, Sect Integrat Biol, Austin, TX 78712 USA	Stanford University; University of Texas System; University of Texas Austin	Desjardins, JK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	desjarjk@stanford.edu	Hofmann, Hans A/E-4538-2016	Hofmann, Hans A/0000-0002-3335-330X	NSERC; National Science Foundation (NSF) [IOS-0923588]; Deutsche Forschungsgemeinschaft; NSF [IOS-0923588, IOS-0843712]; National Institutes of Health (NIH) [NS034950]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034950, R37NS034950, R01NS034950] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation (NSF)(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JKD was supported by an NSERC Post Doctoral Fellowship and National Science Foundation (NSF) IOS-0923588, HAH by a Deutsche Forschungsgemeinschaft postdoctoral fellowship and NSF IOS-0843712, and RDF by National Institutes of Health (NIH) NS034950 and NSF IOS-0923588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOULTON MJ, 1990, CHILD DEV, V61, P221; Chance MRA, 1976, SOCIAL STRUCTURE ATT; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; Drea CM, 1999, P NATL ACAD SCI USA, V96, P12965, DOI 10.1073/pnas.96.22.12965; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; Fernald RD, 2003, INTEGR COMP BIOL, V43, P771, DOI 10.1093/icb/43.6.771; Getty T, 1997, TRENDS ECOL EVOL, V12, P159, DOI 10.1016/S0169-5347(97)89783-2; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Kustan JM, 2011, P ROY SOC B IN PRESS; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Maynard-Smith J, 1988, J THEOR BIOL, V177, P305; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; Mitchell RW, 1986, DECEPTION PERSPECTIV; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; PARKER GA, 1981, ANIM BEHAV, V29, P221, DOI 10.1016/S0003-3472(81)80170-4; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Peake TM, 2006, ANIM BEHAV, V72, P1013, DOI 10.1016/j.anbehav.2006.01.029; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Plath M, 2008, CURR BIOL, V18, P1138, DOI 10.1016/j.cub.2008.06.067; Plath M, 2008, BEHAVIOUR, V145, P931, DOI 10.1163/156853908784089225; Plath M, 2010, ACTA ETHOL, V13, P49, DOI 10.1007/s10211-010-0074-5; Plath Martin, 2008, Communicative & Integrative Biology, V1, P199; Raihani NJ, 2011, P ROY SOC B IN PRESS; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1994, ANN NY ACAD SCI, V746, P294; Summers CH, 2005, J COMP PHYSIOL A, V191, P241, DOI 10.1007/s00359-004-0554-z; VAUGHN BE, 1981, DEV PSYCHOL, V17, P275, DOI 10.1037/0012-1649.17.3.275; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682; Whiten A., 1985, MACHIAVELLIAN INTELL; Whyte William Foote, 1993, STREET CORNER SOC; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	39	77	77	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e32781	10.1371/journal.pone.0032781	http://dx.doi.org/10.1371/journal.pone.0032781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22807996	Green Published, gold, Green Submitted			2022-12-27	WOS:000306366400001
J	Garvey, LJ; Pavese, N; Ramlackhansingh, A; Thomson, E; Allsop, JM; Politis, M; Kulasegaram, R; Main, J; Brooks, DJ; Taylor-Robinson, SD; Winston, A				Garvey, Lucy J.; Pavese, Nicola; Ramlackhansingh, Anil; Thomson, Emma; Allsop, Joanna M.; Politis, Marios; Kulasegaram, Ranjababu; Main, Janice; Brooks, David J.; Taylor-Robinson, Simon D.; Winston, Alan			Acute HCV/HIV Coinfection Is Associated with Cognitive Dysfunction and Cerebral Metabolite Disturbance, but Not Increased Microglial Cell Activation	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; CENTRAL-NERVOUS-SYSTEM; AIDS DEMENTIA COMPLEX; HIV-POSITIVE PATIENTS; BENZODIAZEPINE-RECEPTOR; BINDING-SITES; BRAIN; INFECTION; PET; IMPAIRMENT	Background: Microglial cell activation and cerebral function impairment are described in both chronic hepatitis C viral (HCV) and Human-Immune-Deficiency viral (HIV) infections. The aim of this study was to investigate the effect of acute HCV infection upon cerebral function and microglial cell activation in HIV-infected individuals. Methods: A case-control study was conducted. Subjects with acute HCV and chronic HIV coinfection (aHCV) were compared to matched controls with chronic HIV monoinfection (HIVmono). aHCV was defined as a new positive plasma HCV RNA within 12 months of a negative RNA test. Subjects underwent neuro-cognitive testing (NCT), cerebral proton magnetic resonance spectroscopy (H-1-MRS) and positron emission tomography (PET) using a C-11-radiolabeled ligand (PK11195), which is highly specific for translocator protein 18 kDA receptors on activated microglial cells. Differences between cases and controls were assessed using linear regression modelling. Results: Twenty-four aHCV cases completed NCT and H-1-MRS, 8 underwent PET. Of 57 HIVmono controls completing NCT, 12 underwent H-1-MRS and 8 PET. Subjects with aHCV demonstrated on NCT, significantly poorer executive function (mean (SD) error rate 26.50(17.87) versus 19.09(8.12), p = 0.001) and on H-1-MRS increased myo-inositol/ creatine ratios (mI/Cr, a marker of cerebral inflammation) in the basal ganglia (ratio of 0.71(0.22) versus 0.55(0.23), p = 0.03), compared to subjects with HIVmono. On PET imaging, no difference in C-11-PK11195 binding potential (BP) was observed between study groups (p > 0.10 all cerebral locations), however lower BPs were associated with combination antiretroviral therapy (cART) use in the parietal (p = 0.01) and frontal (p = 0.03) cerebral locations. Discussion: Poorer cognitive performance and disturbance of cerebral metabolites are observed in subjects with aHC, V compared to subjects with HIVmono. Higher C-11-PK11195 BP was not observed in subjects with aHCV, but was observed in subjects not on cART.	[Garvey, Lucy J.; Thomson, Emma; Main, Janice; Taylor-Robinson, Simon D.; Winston, Alan] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Garvey, Lucy J.; Thomson, Emma; Main, Janice; Winston, Alan] Imperial Coll Healthcare NHS Trust, Dept HIV & GU Med, London, England; [Pavese, Nicola; Ramlackhansingh, Anil; Politis, Marios; Brooks, David J.] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Neurosci Sect, London, England; [Allsop, Joanna M.] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Imaging Sci Dept, London, England; [Kulasegaram, Ranjababu] Guys & St Thomas NHS Fdn Trust, Dept HIV & GU Med, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust	Garvey, LJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.	lucy.garvey@nhs.net	Politis, Marios/GYQ-9446-2022; Winston, Alan/AGZ-3015-2022; Thomson, Emma C/M-8690-2017	Winston, Alan/0000-0002-5847-8416; Thomson, Emma C/0000-0003-1482-0889; Brooks, David/0000-0003-2602-2518; Pavese, Nicola/0000-0002-6801-6194	NIHR Biomedical Facility at Imperial College London; Wellcome Trust; United Kingdom National Institute for Health Research (NIHR); British Medical Research Council; European Union; MRC [G1100810, MC_U120036861] Funding Source: UKRI; Medical Research Council [G1100810, MC_U120036861] Funding Source: researchfish	NIHR Biomedical Facility at Imperial College London; Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The NIHR Biomedical Facility at Imperial College London funded infrastructure support. SDT-R holds grants from the Wellcome Trust, the United Kingdom National Institute for Health Research (NIHR), the British Medical Research Council and the European Union (Framework 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Brown AK, 2007, J NUCL MED, V48, P2072, DOI 10.2967/jnumed.107.044842; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; Cagnin A, 2006, GUT, V55, P547, DOI 10.1136/gut.2005.075051; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Christensen JD, 1996, MAGNET RESON MED, V35, P658, DOI 10.1002/mrm.1910350506; Cysique LAJ, 2006, ARCH CLIN NEUROPSYCH, V21, P185, DOI 10.1016/j.acn.2005.07.011; Endres CJ, 2009, J NUCL MED, V50, P1276, DOI 10.2967/jnumed.109.062265; Forton DA, 2005, AIDS, V19, pS53, DOI 10.1097/01.aids.0000192071.72948.77; Forton DM, 2008, J HEPATOL, V49, P316, DOI 10.1016/j.jhep.2008.03.022; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688; Forton DM, 2001, LANCET, V358, P38, DOI 10.1016/S0140-6736(00)05270-3; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ghosn J, 2004, HIV MED, V5, P303, DOI 10.1111/j.1468-1293.2004.00225.x; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grover VPB, 2012, J VIRAL HEPATITIS, V19, pE89, DOI 10.1111/j.1365-2893.2011.01510.x; Hammoud DA, 2005, J NEUROVIROL, V11, P346, DOI 10.1080/13550280500187351; Haussinger D, 2000, J HEPATOL, V32, P1035, DOI 10.1016/S0168-8278(00)80110-5; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Kim SJ, 2008, J NUCL MED, V49, P39, DOI 10.2967/jnumed.107.045724; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Laskus T, 2002, J VIROL, V76, P10064, DOI 10.1128/JVI.76.19.10064-10068.2002; Letendre SL, 2005, AIDS, V19, pS72, DOI 10.1097/01.aids.0000192073.18691.ff; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; Morgello S, 2005, AIDS, V19, pS116, DOI 10.1097/01.aids.0000192079.49185.f9; Murray J, 2008, J NEUROVIROL, V14, P17, DOI 10.1080/13550280701708427; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Richardson JL, 2005, AIDS, V19, P1659, DOI 10.1097/01.aids.0000186824.53359.62; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rojas S, 2007, J CEREBR BLOOD F MET, V27, P1975, DOI 10.1038/sj.jcbfm.9600500; Ryan EL, 2004, NEUROLOGY, V62, P957, DOI 10.1212/01.WNL.0000115177.74976.6C; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Tozzi V, 2005, AIDS RES HUM RETROV, V21, P706, DOI 10.1089/aid.2005.21.706; Tracey I, 1996, NEUROLOGY, V46, P783, DOI 10.1212/WNL.46.3.783; Turkheimer FE, 2007, J NUCL MED, V48, P158; Venneti S, 2008, J NEUROPATH EXP NEUR, V67, P1001, DOI 10.1097/NEN.0b013e318188b204; Vogel M, 2010, ANTIVIR THER, V15, P267, DOI 10.3851/IMP1501; Weissenborn K, 2004, J HEPATOL, V41, P845, DOI 10.1016/j.jhep.2004.07.022; Wiley CA, 2006, J NEUROVIROL, V12, P262, DOI 10.1080/13550280600873868; Winston A, 2010, J VIRAL HEPATITIS, V17, P419, DOI 10.1111/j.1365-2893.2009.01198.x; Winston A, 2010, CLIN INFECT DIS, V50, P920, DOI 10.1086/650743	44	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e38980	10.1371/journal.pone.0038980	http://dx.doi.org/10.1371/journal.pone.0038980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808022	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400006
J	Deckers, IAG; McLean, S; Linssen, S; Mommers, M; van Schayck, CP; Sheikh, A				Deckers, Ivette A. G.; McLean, Susannah; Linssen, Sanne; Mommers, Monique; van Schayck, C. P.; Sheikh, Aziz			Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990-2010: A Systematic Review of Epidemiological Studies	PLOS ONE			English	Review							ISAAC PHASE-I; CHILDHOOD ALLERGIC DISEASES; INCREASING PREVALENCE; CHANGING PREVALENCE; SCHOOL-CHILDREN; TAIWANESE ADOLESCENTS; RESPIRATORY SYMPTOMS; ASTHMA; SCHOOLCHILDREN; RHINITIS	The prevalence of atopic eczema has been found to have increased greatly in some parts of the world. Building on a systematic review of global disease trends in asthma, our objective was to study trends in incidence and prevalence of atopic eczema. Disease trends are important for health service planning and for generating hypotheses regarding the aetiology of chronic disorders. We conducted a systematic search for high quality reports of cohort, repeated cross-sectional and routine healthcare database-based studies in seven electronic databases. Studies were required to report on at least two measures of the incidence and/or prevalence of atopic eczema between 1990 and 2010 and needed to use comparable methods at all assessment points. We retrieved 2,464 citations, from which we included 69 reports. Assessing global trends was complicated by the use of a range of outcome measures across studies and possible changes in diagnostic criteria over time. Notwithstanding these difficulties, there was evidence suggesting that the prevalence of atopic eczema was increasing in Africa, eastern Asia, western Europe and parts of northern Europe (i.e. the UK). No clear trends were identified in other regions. There was inadequate study coverage worldwide, particularly for repeated measures of atopic eczema incidence. Further epidemiological work is needed to investigate trends in what is now one of the most common long-term disorders globally. A range of relevant measures of incidence and prevalence, careful use of definitions and description of diagnostic criteria, improved study design, more comprehensive reporting and appropriate interpretation of these data are all essential to ensure that this important field of epidemiological enquiry progresses in a scientifically robust manner.	[Deckers, Ivette A. G.; McLean, Susannah; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland; [Deckers, Ivette A. G.; Linssen, Sanne; Mommers, Monique; Sheikh, Aziz] Maastricht Univ, Med Ctr, Dept Epidemiol, CAPHRI, Maastricht, Netherlands; [van Schayck, C. P.] Maastricht Univ, Med Ctr, Dept Gen Practice, CAPHRI, Maastricht, Netherlands	University of Edinburgh; Maastricht University; Maastricht University	Deckers, IAG (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland.	Ivette.deckers@maastrichtuniversity.nl	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Mclean, Susannah/0000-0001-8238-5167				Abramidze T, 2006, Georgian Med News, P80; Abramidze T, 2007, Georgian Med News, P38; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Anderson HR, 2004, BRIT MED J, V328, P1052, DOI 10.1136/bmj.38057.583727.47; Annesi-Maesano I, 2009, ALLERGY, V64, P798, DOI 10.1111/j.1398-9995.2008.01886.x; Annus T, 2005, PEDIAT ALLERG IMM-UK, V16, P315, DOI 10.1111/j.1399-3038.2005.00276.x; [Anonymous], 2004, CURR PEDIAT RES; Anthracopoulos MB, 2009, PEDIAT ALLERG IMM-UK, V20, P180, DOI 10.1111/j.1399-3038.2008.00752.x; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Barraza-Villarreal A, 2007, ALLERGY ASTHMA PROC, V28, P368, DOI 10.2500/aap.2007.28.2998; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bjerg A, 2010, ALLERGY, V65, P48, DOI 10.1111/j.1398-9995.2009.02105.x; Borges WG, 2008, REV BRAS ALERG IMUNO, V31, P146; Bouayad Z, 2006, INT J TUBERC LUNG D, V10, P371; Brozek G, 2004, PEDIATR POL, V79, P385; Camelo-Nunes Inês C, 2004, J. Pediatr. (Rio J.), V80, P60, DOI 10.1590/S0021-75572004000100012; Cork Michael J, 2009, Br J Nurs, V18, P876; Cork MJ, 2009, BR J NURS, V18, P876; Cork MJ, 2009, BR J NURS, V18, P874; Demir AU, 2010, J ASTHMA, V47, P1128, DOI 10.3109/02770903.2010.517336; Devenny A, 2004, BMJ-BRIT MED J, V329, P489, DOI 10.1136/bmj.38139.666447.F7; Dorner T, 2007, WIEN MED WOCHENSCHR, V157, P235, DOI 10.1007/s10354-007-0419-5; Ellsasser G, 2002, MONATSSCHR KINDERH, V150, P839, DOI 10.1007/s00112-001-0344-4; Esamai F, 2002, East Afr Med J, V79, P514; Falade AG, 2009, J NATL MED ASSOC, V101, P414, DOI 10.1016/S0027-9684(15)30925-1; Flohr C, 2009, BRIT J DERMATOL, V161, P846, DOI 10.1111/j.1365-2133.2009.09261.x; Galassi C, 2006, PEDIATRICS, V117, P34, DOI 10.1542/peds.2004-2709; Galassi C, 2010, EVALUATION HLTH INFO; Grize L, 2006, ALLERGY, V61, P556, DOI 10.1111/j.1398-9995.2006.01030.x; Gupta R, 2007, THORAX, V62, P91, DOI 10.1136/thx.2004.038844; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Haidinger G, 2008, ALLERGOLOGIE, V31, P17; Harangi F, 2007, J EUR ACAD DERMATOL, V21, P964, DOI 10.1111/j.1468-3083.2007.02157.x; Heinrich J, 2002, EUR RESPIR J, V19, P1040, DOI 10.1183/09031936.02.00261802; ISAAC Steering Committee, 2011, ISAAC STOR; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Kalyoncu AF, 1999, PEDIATR ALLERGY IMMU, V10, P261, DOI 10.1034/j.1399-3038.1999.00031.x; Kramer U, 2010, CLIN EXP ALLERGY, V40, P289, DOI 10.1111/j.1365-2222.2009.03435.x; Kudzyte J, 2008, MEDICINA-LITHUANIA, V44, P944, DOI 10.3390/medicina44120118; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kusunoki Takashi, 2009, Allergology International, V58, P543, DOI 10.2332/allergolint.09-OA-0085; Kwong GNM, 2001, THORAX, V56, P312, DOI 10.1136/thorax.56.4.312; Latvala J, 2005, BMJ-BRIT MED J, V330, P1186, DOI 10.1136/bmj.38448.603924.AE; Lee SL, 2004, PEDIAT ALLERG IMM-UK, V15, P72, DOI 10.1046/j.0905-6157.2003.00109.x; Lee YL, 2007, CLIN EXP ALLERGY, V37, P543, DOI 10.1111/j.1365-2222.2007.02690.x; Lee YL, 2005, PEDIAT ALLERG IMM-UK, V16, P157, DOI 10.1111/j.1399-3038.2005.00211.x; Liao MF, 2009, J ASTHMA, V46, P541, DOI 10.1080/02770900902795546; Liao PF, 2009, PEDIATR NEONATOL, V50, P18, DOI 10.1016/S1875-9572(09)60025-5; Liberati A., 2009, J CLIN EPIDEMIOL, V62, pE1, DOI [DOI 10.1016/J.JCLINEPI.2009.06.006, 10.1016/j.jclinepi.2009.06.006]; Maziak W, 2003, ALLERGY, V58, P572, DOI 10.1034/j.1398-9995.2003.00161.x; McNeill G, 2009, PAEDIATR PERINAT EP, V23, P506, DOI 10.1111/j.1365-3016.2009.01057.x; Mommers M, 2005, Prim Care Respir J, V14, P31, DOI 10.1016/j.pcrj.2004.03.008; Montefort S, 2009, PEDIAT ALLERG IMM-UK, V20, P67, DOI 10.1111/j.1399-3038.2008.00746.x; Nishima Sankei, 2009, Allergology International, V58, P37, DOI 10.2332/allergolint.O-08-550; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Oh JW, 2004, J KOREAN MED SCI, V19, P716, DOI 10.3346/jkms.2004.19.5.716; Olesen AB, 2005, ACTA DERM-VENEREOL, V85, P244, DOI 10.1080/00015550510026343; Osman M, 2007, PEDIATR PULM, V42, P60, DOI 10.1002/ppul.20545; Owayed A, 2008, MED PRIN PRACT, V17, P284, DOI 10.1159/000129607; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Ponsonby AL, 2008, INT J EPIDEMIOL, V37, P559, DOI 10.1093/ije/dyn029; Public Health Resource Unit, 2018, CRIT SKILLS APPR PRO; Punekar YS, 2009, CLIN EXP ALLERGY, P1; Quah BS, 2005, RESPIROLOGY, V10, P244, DOI 10.1111/j.1440-1843.2005.00645.x; Riedi CA, 2005, J INVEST ALLERG CLIN, V15, P183; Riikjarv MA, 2000, EUR RESPIR J, V16, P86, DOI 10.1034/j.1399-3003.2000.16a15.x; Robertson CF, 2004, MED J AUSTRALIA, V180, P273, DOI 10.5694/j.1326-5377.2004.tb05924.x; Ronmark E, 2009, J ALLERGY CLIN IMMUN, V124, P357, DOI 10.1016/j.jaci.2009.05.011; Romano-Zelekha O, 2007, J ASTHMA, V44, P365, DOI 10.1080/02770900701363983; Rosado-Pinto J, 2006, REV FR ALLERGOL, V46, P305, DOI 10.1016/j.allerg.2006.01.011; Saeki H, 2009, J DERMATOL, V36, P512, DOI 10.1111/j.1346-8138.2009.00687.x; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schafer T, 2000, BRIT J DERMATOL, V143, P992, DOI 10.1046/j.1365-2133.2000.03832.x; Schernhammer ES, 2008, PEDIAT ALLERG IMM-UK, V19, P125, DOI 10.1111/j.1399-3038.2007.00597.x; Selnes A, 2005, ALLERGY, V60, P894, DOI 10.1111/j.1398-9995.2005.00797.x; Shamssain M, 2007, PEDIAT ALLERG IMM-UK, V18, P149, DOI 10.1111/j.1399-3038.2006.00498.x; Simpson CR, 2009, J ROY SOC MED, V102, P108, DOI 10.1258/jrsm.2009.080211; Sole D, 2007, J TROP PEDIATRICS, V53, P13, DOI 10.1093/tropej/fml044; Teeratakulpisarn J, 2004, ASIAN PAC J ALLERGY, V22, P175; Toelle BG, 2004, BRIT MED J, V328, P386, DOI 10.1136/bmj.328.7436.386; Trakultivakorn M, 2007, J ASTHMA, V44, P609, DOI 10.1080/02770900701540119; United Nations, 2010, COMP MACR GEOGR CONT; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Vellinga A, 2005, ACTA CLIN BELG, V60, P219, DOI 10.1179/acb.2005.038; Wang Hong-yu, 2006, Zhonghua Yi Xue Za Zhi, V86, P1014; Wang XS, 2004, ARCH DIS CHILD, V89, P423, DOI 10.1136/adc.2003.031112; Warner JO, 1999, THORAX, V54, pS46, DOI 10.1136/thx.54.2008.S46; Weber AS, 2010, PEDIAT ALLERG IMM-UK, V21, P1028, DOI 10.1111/j.1399-3038.2010.01030.x; Williams H, 2008, J ALLERGY CLIN IMMUN, V121, P947, DOI 10.1016/j.jaci.2007.11.004; Yan DC, 2005, ANN ALLERG ASTHMA IM, V95, P579, DOI 10.1016/S1081-1206(10)61022-8; Yura A, 2001, BRIT J DERMATOL, V145, P966, DOI 10.1046/j.1365-2133.2001.04506.x; Zar HJ, 2007, PEDIAT ALLERG IMM-UK, V18, P560, DOI 10.1111/j.1399-3038.2007.00554.x; 최현성, 2005, [Korean Journal of Dermatology, 대한피부과학회지], V43, P606	93	320	338	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39803	10.1371/journal.pone.0039803	http://dx.doi.org/10.1371/journal.pone.0039803			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808063	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400020
J	Visovatti, SH; Hyman, MC; Bouis, D; Neubig, R; McLaughlin, VV; Pinsky, DJ				Visovatti, Scott H.; Hyman, Matthew C.; Bouis, Diane; Neubig, Richard; McLaughlin, Vallerie V.; Pinsky, David J.			Increased CD39 Nucleotidase Activity on Microparticles from Patients with Idiopathic Pulmonary Arterial Hypertension	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ATP-DIPHOSPHOHYDROLASE; ADENOSINE-DIPHOSPHATE; EXTRACELLULAR ATP; NITRIC-OXIDE; ECTO-ATPASE; IN-VITRO; ACTIVATION; INHIBITION; RECEPTORS	Background: Idiopathic pulmonary arterial hypertension (IPAH) is a devastating disease characterized by increased pulmonary vascular resistance, smooth muscle and endothelial cell proliferation, perivascular inflammatory infiltrates, and in situ thrombosis. Circulating intravascular ATP, ADP, AMP and adenosine activate purinergic cell signaling pathways and appear to induce many of the same pathologic processes that underlie IPAH. Extracellular dephosphorylation of ATP to ADP and AMP occurs primarily via CD39 (ENTPD1), an ectonucleotidase found on the surface of leukocytes, platelets, and endothelial cells [1]. Microparticles are micron-sized phospholipid vesicles formed from the membranes of platelets and endothelial cells. Objectives: Studies here examine whether CD39 is an important microparticle surface nucleotidase, and whether patients with IPAH have altered microparticle-bound CD39 activity that may contribute to the pathophysiology of the disease. Methodology/ Principal Findings: Kinetic parameters, inhibitor blocking experiments, and immunogold labeling with electron microscopy support the role of CD39 as a major nucleotidase on the surface of microparticles. Comparison of microparticle surface CD39 expression and nucleotidase activity in 10 patients with advanced IPAH and 10 healthy controls using flow cytometry and thin layer chromatograph demonstrate the following: 1) circulating platelet (CD39(+) CD31(+) CD42b(+)) and endothelial (CD39(+) CD31(+) CD42b(+)) microparticle subpopulations in patients with IPAH show increased CD39 expression; 2) microparticle ATPase and ADPase activity in patients with IPAH is increased. Conclusions/ Significance: We demonstrate for the first time increased CD39 expression and function on circulating microparticles in patients with IPAH. Further research is needed to elucidate whether these findings identify an important trigger for the development of the disease, or reflect a physiologic response to IPAH.	[Visovatti, Scott H.; Bouis, Diane; McLaughlin, Vallerie V.; Pinsky, David J.] Univ Michigan, Dept Med, Div Cardiol, Ann Arbor, MI 48109 USA; [Hyman, Matthew C.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Neubig, Richard] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Michigan System; University of Michigan	Visovatti, SH (corresponding author), Univ Michigan, Dept Med, Div Cardiol, Ann Arbor, MI 48109 USA.	shv@med.umich.edu		Hyman, Matthew/0000-0002-4050-6925; Neubig, Richard/0000-0003-0501-0008	Pulmonary Hypertension Breakthrough Initiative; NIH [P01HL089407-04, R01HL086676-05, R01HL085149-04, T32HL007853-14]; Taubman Medical Research Institute of the University of Michigan; Cardiovascular Medical Research and Education Fund (CMREF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853, R01HL086676, R01HL085149, P01HL089407] Funding Source: NIH RePORTER	Pulmonary Hypertension Breakthrough Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taubman Medical Research Institute of the University of Michigan; Cardiovascular Medical Research and Education Fund (CMREF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Pulmonary Hypertension Breakthrough Initiative (DJP), and NIH grants P01HL089407-04 (DJP), R01HL086676-05 (DJP), R01HL085149-04 (DJP), T32HL007853-14 (SHV. and DJP), and the Taubman Medical Research Institute of the University of Michigan. Funding for the PHBI is provided by the Cardiovascular Medical Research and Education Fund (CMREF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile N, 2008, AM J RESP CRIT CARE, V177, P1268, DOI 10.1164/rccm.200710-1458OC; Baj-Krzyworzeka M, 2002, EXP HEMATOL, V30, P450, DOI 10.1016/S0301-472X(02)00791-9; Bakouboula B, 2008, AM J RESP CRIT CARE, V177, P536, DOI 10.1164/rccm.200706-840OC; Banz Y, 2008, BRIT J HAEMATOL, V142, P627, DOI 10.1111/j.1365-2141.2008.07230.x; Berchtold S, 1999, FEBS LETT, V458, P424, DOI 10.1016/S0014-5793(99)01197-7; Blaustein MP, 1998, CLIN EXP HYPERTENS, V20, P691, DOI 10.3109/10641969809053247; BOEYNAEMS JM, 1983, BIOCHEM BIOPH RES CO, V112, P290, DOI 10.1016/0006-291X(83)91829-6; BOGLE RG, 1991, BIOCHEM BIOPH RES CO, V180, P926, DOI 10.1016/S0006-291X(05)81154-4; BROOK MM, 1994, CIRCULATION, V90, P1287, DOI 10.1161/01.CIR.90.3.1287; BULLOUGH DA, 1994, J CLIN INVEST, V94, P1524, DOI 10.1172/JCI117493; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; CRACK BE, 1995, BRIT J PHARMACOL, V114, P475, DOI 10.1111/j.1476-5381.1995.tb13251.x; CRONSTEIN BN, 1983, J EXP MED, V158, P1160, DOI 10.1084/jem.158.4.1160; CROWLEY ST, 1994, CIRCULATION, V90, P1908, DOI 10.1161/01.CIR.90.4.1908; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dawicki DD, 1997, AM J PHYSIOL-LUNG C, V273, pL485, DOI 10.1152/ajplung.1997.273.2.L485; Distler JHW, 2005, ARTHRITIS RHEUM, V52, P3337, DOI 10.1002/art.21350; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Dubey RK, 1998, HYPERTENSION, V31, P516, DOI 10.1161/01.HYP.31.1.516; Edmunds NJ, 2003, J VASC RES, V40, P68, DOI 10.1159/000068941; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; Goepfert C, 2000, MOL MED, V6, P591, DOI 10.1007/BF03401797; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kiffer-Moreira T, 2010, FEMS YEAST RES, V10, P735, DOI 10.1111/j.1567-1364.2010.00641.x; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Marcus AJ, 2003, J THROMB HAEMOST, V1, P2497, DOI 10.1111/j.1538-7836.2003.00479.x; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; MCAUSLAN BR, 1983, MICROVASC RES, V26, P323, DOI 10.1016/0026-2862(83)90080-8; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; MeyerFernandes JR, 1997, ARCH BIOCHEM BIOPHYS, V341, P40, DOI 10.1006/abbi.1997.9933; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Wall MJ, 2008, NEUROPHARMACOLOGY, V55, P1251, DOI 10.1016/j.neuropharm.2008.08.005; Yegutkin GG, 2003, FASEB J, V17, P1328, DOI 10.1096/fj.02-1136fje; Zebisch M, 2007, BIOCHEMISTRY-US, V46, P11945, DOI 10.1021/bi701103y; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	41	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40829	10.1371/journal.pone.0040829	http://dx.doi.org/10.1371/journal.pone.0040829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792409	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400103
J	Hale, JS; Li, MZ; Sinyuk, M; Jahnen-Dechent, W; Lathia, JD; Silverstein, RL				Hale, James Scott; Li, Meizhang; Sinyuk, Maksim; Jahnen-Dechent, Willi; Lathia, Justin Durla; Silverstein, Roy Lee			Context Dependent Role of the CD36-Thrombospondin - Histidine-Rich Glycoprotein Axis in Tumor Angiogenesis and Growth	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; PLASMA-PROTEIN; BINDING-SITE; STEM-CELLS; IN-VIVO; THROMBOSPONDIN-1; CD36; EXPRESSION; CANCER; DOMAIN	The angiogenic switch is a promising therapeutic target in cancer. Work by our laboratory and others has described an important endogenous anti-angiogenic pathway mediated by interactions of CD36, a receptor on microvascular endothelial cells, with proteins containing thrombospondin (TSP) type I repeat domains (TSR). Recent studies revealed that circulating Histidine Rich Glycoprotein (HRG) inhibits the anti-angiogenic potential of the CD36-TSR pathway by functioning as a decoy receptor that binds and sequesters TSR proteins. As tumors of different origin display variable expression profiles of numerous targets, we hypothesized that the TSP-CD36-HRG axis regulates vascularization and growth in the tumor microenvironment in a context, or tumor type, dependent manner. Growth of Lewis Lung Carcinoma (LL2) and B16F1 Melanoma tumor cell implants in syngeneic wild type (WT), hrg, or cd36 null mice were used as a model to interrogate this signaling axis. LL2 tumor volumes were greater in cd36 null mice and smaller in hrg null mice compared to WT. Immunofluorescent staining showed increased vascularity in cd36 null vs. WT and WT vs. hrg null mice. No differences in tumor growth or vascularity were observed with B16F1 implants, consistent with lack of expression of TSP-1 in B16F1 cells. When TSR expression was induced in B16F1 cells by cDNA transfection, tumor growth and vascularity were similar to that seen with LL2 cells. These data show a role for CD36-mediated anti-angiogenic activity in the tumor microenvironment when TSR proteins are available and demonstrate that HRG modulates this activity. Further, they suggest a mechanism by which tumor microenvironments may regulate sensitivity to TSR containing proteins.	[Hale, James Scott; Silverstein, Roy Lee] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Hale, James Scott; Li, Meizhang; Sinyuk, Maksim; Lathia, Justin Durla; Silverstein, Roy Lee] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Hale, James Scott; Li, Meizhang; Sinyuk, Maksim; Lathia, Justin Durla; Silverstein, Roy Lee] Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Jahnen-Dechent, Willi] Rhein Westfal Tech Hsch Aachen Univ Hosp, Helmholtz Inst Biomed Engn, Aachen, Germany; [Silverstein, Roy Lee] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA	University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; Medical College of Wisconsin	Hale, JS (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.	rsilverstein@mcw.edu	Lathia, Justin/AHB-8296-2022; Jahnen-Dechent, Willi/A-7608-2011	Jahnen-Dechent, Willi/0000-0003-1315-4407	National Institutes of Health (NIH) [R01 HL085718]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01 HL085718 to Roy Silverstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANG NS, 1992, IMMUNOLOGY, V77, P532; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Crombie R, 1998, J EXP MED, V187, P25, DOI 10.1084/jem.187.1.25; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Dixelius J, 2006, CANCER RES, V66, P2089, DOI 10.1158/0008-5472.CAN-05-2217; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Garside SA, 2010, ENDOCRINOLOGY, V151, P5905, DOI 10.1210/en.2010-0283; Gutierrez LS, 2003, CARCINOGENESIS, V24, P199, DOI 10.1093/carcin/24.2.199; Hoekstra R, 2005, J CLIN ONCOL, V23, P5188, DOI 10.1200/JCO.2005.05.013; Hulett MD, 2000, IMMUNOL CELL BIOL, V78, P280, DOI 10.1046/j.1440-1711.2000.00940.x; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Juarez JC, 2002, CANCER RES, V62, P5344; Karathanasis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005843; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Klenotic PA, 2010, AM J PATHOL, V176, P2039, DOI 10.2353/ajpath.2010.090782; Kodama J, 2001, CLIN CANCER RES, V7, P2826; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; LEUNG L, 1993, J LAB CLIN MED, V121, P630; LEUNG LLK, 1986, J CLIN INVEST, V77, P1305, DOI 10.1172/JCI112435; LEUNG LLK, 1983, BLOOD, V62, P1016; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Markovic SN, 2007, AM J CLIN ONCOL-CANC, V30, P303, DOI 10.1097/01.coc.0000256104.80089.35; MORGAN WT, 1978, BIOCHIM BIOPHYS ACTA, V535, P319, DOI 10.1016/0005-2795(78)90098-3; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nijziel MR, 2006, NETH J MED, V64, P403; Nussenbaum F, 2010, J ONCOL, V2010, DOI 10.1155/2010/132641; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; PEARCE SFA, 1995, J BIOL CHEM, V270, P2981, DOI 10.1074/jbc.270.7.2981; Rege TA, 2009, J CELL PHYSIOL, V218, P94, DOI 10.1002/jcp.21570; Ren B, 2011, BLOOD, V117, P6036, DOI 10.1182/blood-2010-12-326017; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Rowe DH, 2000, J PEDIATR SURG, V35, P30, DOI 10.1016/S0022-3468(00)80008-1; SHATSKY M, 1989, J BIOL CHEM, V264, P8254; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Simantov R, 2001, J CLIN INVEST, V107, P45, DOI 10.1172/JCI9061; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246; Tsuchida-Straeten N, 2005, J THROMB HAEMOST, V3, P865, DOI 10.1111/j.1538-7836.2005.01238.x; Tugues S, 2012, CANCER RES, V72, P1953, DOI 10.1158/0008-5472.CAN-11-2194; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; Yang QW, 2003, CANCER RES, V63, P6299	45	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40033	10.1371/journal.pone.0040033	http://dx.doi.org/10.1371/journal.pone.0040033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808089	Green Submitted, Green Published, gold			2022-12-27	WOS:000306355500023
J	Jonker, RM; Zhang, Q; Van Hooft, P; Loonen, MJJE; Van der Jeugd, HP; Crooijmans, RPMA; Groenen, MAM; Prins, HHT; Kraus, RHS				Jonker, Rudy M.; Zhang, Qiong; Van Hooft, Pim; Loonen, Maarten J. J. E.; Van der Jeugd, Henk P.; Crooijmans, Richard P. M. A.; Groenen, Martien A. M.; Prins, Herbert H. T.; Kraus, Robert H. S.			The Development of a Genome Wide SNP Set for the Barnacle Goose Branta leucopsis	PLOS ONE			English	Article							BREEDING RANGE EXPANSION; MIGRATION; MARKERS; GEESE; RELATEDNESS; POPULATIONS; DIVERGENCE; SPREAD; BASE	Migratory birds are of particular interest for population genetics because of the high connectivity between habitats and populations. A high degree of connectivity requires using many genetic markers to achieve the required statistical power, and a genome wide SNP set can fit this purpose. Here we present the development of a genome wide SNP set for the Barnacle Goose Branta leucopsis, a model species for the study of bird migration. We used the genome of a different waterfowl species, Mallard Anas platyrhynchos, as a reference to align Barnacle Goose second generation sequence reads from an RRL library and detected 2188 SNPs genome wide. Furthermore, we used chimeric flanking sequences, merged from both Mallard and Barnacle Goose DNA sequence information, to create primers for validation by genotyping. Validation with a 384 SNP genotyping set resulted in 374 (97%) successfully typed SNPs in the assay, of which 358 (96%) were polymorphic. Additionally, we validated our SNPs on relatively old (30 years) museum samples, which resulted in a success rate of at least 80%. This shows that museum samples could be used in standard SNP genotyping assays. Our study also shows that the genome of a related species can be used as reference to detect genome wide SNPs in birds, because genomes of birds are highly conserved. This is illustrated by the use of chimeric flanking sequences, which showed that the incorporation of flanking nucleotides from Mallard into Barnacle Goose sequences lead to equal genotyping performance when compared to flanking sequences solely composed of Barnacle Goose sequence.	[Jonker, Rudy M.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Jonker, Rudy M.; Zhang, Qiong; Van Hooft, Pim; Prins, Herbert H. T.; Kraus, Robert H. S.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Zhang, Qiong] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Loonen, Maarten J. J. E.] Univ Groningen, Arctic Ctr, Groningen, Netherlands; [Van der Jeugd, Henk P.] Netherlands Inst Ecol, Dutch Ctr Avian Migrat & Demog, Wageningen, Netherlands; [Crooijmans, Richard P. M. A.; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Kraus, Robert H. S.] Senckenberg Res Inst, Conservat Genet Grp, Gelnhausen, Germany; [Kraus, Robert H. S.] Nat Hist Museum, Gelnhausen, Germany	University of Bielefeld; Wageningen University & Research; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Senckenberg Gesellschaft fur Naturforschung (SGN)	Jonker, RM (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	mrjonker@gmail.com	van der Jeugd, Henk/S-3159-2019; Vet, Louise E.M./B-1342-2009; van der Jeugd, Henk P/F-4891-2010; Jonker, Rudy/I-3979-2012; Groenen, Martien/D-8408-2012; Crooijmans, Richard PMA/E-2492-2012; Kraus, Robert/F-1188-2011; KNAW, NIOO-KNAW/A-4320-2012	van der Jeugd, Henk/0000-0002-5332-9526; Vet, Louise E.M./0000-0002-2287-1128; van der Jeugd, Henk P/0000-0002-5332-9526; Groenen, Martien/0000-0003-0484-4545; Kraus, Robert/0000-0002-8743-7082; Prins, Herbert/0000-0003-1131-5107; Loonen, Maarten J.J.E./0000-0002-3426-4595; KNAW, NIOO-KNAW/0000-0002-3835-159X	Dutch Faunafund; Royal Netherlands Shooting Association; Leibniz Association [SAW-2011-SGN-3]; Netherlands Organization for Scientific Research (NWO)	Dutch Faunafund; Royal Netherlands Shooting Association; Leibniz Association; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding was provided by Dutch Faunafund and Royal Netherlands Shooting Association. RHSK was also funded by grant SAW-2011-SGN-3 from the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to Bert Dibbits, who was of invaluable assistance in the lab. Martin Elferink assisted in the assignment of flanking sequences. Blood samples were collected as part of project BIRDHEALTH, funded by the Netherlands Organization for Scientific Research (NWO) on the occasion of the International Polar Year, Jouke Prop, Helmut Kruckenberg, Alexander Kondratyev and several students assisted in sample collection. We thank Kees Roselaar for access to the museum samples from the Zoological Museum Amsterdam. We thank Ning Li and Yinhua Huang and the Beijing Genomics Institute for providing the Mallard genome data.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderholm S, 2009, ANIM BEHAV, V78, P167, DOI 10.1016/j.anbehav.2009.04.011; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Eichhorn G, 2009, J ANIM ECOL, V78, P63, DOI 10.1111/j.1365-2656.2008.01485.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FILCHAGOV AV, 1992, POLAR RES, V11, P41, DOI 10.1111/j.1751-8369.1992.tb00411.x; FORSLUND P, 1991, ARDEA, V79, P342; Fowler AC, 2005, ANIM BEHAV, V69, P973, DOI 10.1016/j.anbehav.2004.07.014; Fowler AC, 2004, CONDOR, V106, P600, DOI 10.1650/7446; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Harrison XA, 2010, CONSERV GENET, P1; Harrison XA, 2010, MOL ECOL, V19, P5484, DOI 10.1111/j.1365-294X.2010.04852.x; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Jonker RM, 2011, BEHAV ECOL, V22, P326, DOI 10.1093/beheco/arq208; Jonker RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011369; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Kraus RHS, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-45; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; LARSSON K, 1988, ORNIS SCAND, V19, P182, DOI 10.2307/3676556; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Madsen J., 1999, GOOSE POPULATIONS W; Meininger Peter L., 1994, Limosa, V67, P1; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morin PA, 2007, MOL ECOL NOTES, V7, P937, DOI 10.1111/j.1471-8286.2007.01804.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; R Core Team, 2020, R LANG ENV STAT COMP; Shetty S, 1999, CHROMOSOME RES, V7, P289, DOI 10.1023/A:1009278914829; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Solexa I, 2006, BIOTECHNIQUES PROTOC, P29; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; van der Jeugd HP, 2006, ARDEA, V94, P421; van der Jeugd HP, 2003, POLAR BIOL, V26, P700, DOI 10.1007/s00300-003-0535-7; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wink M, 2006, J ORNITHOL, V147, P234, DOI 10.1007/s10336-006-0065-5	37	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38412	10.1371/journal.pone.0038412	http://dx.doi.org/10.1371/journal.pone.0038412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808008	gold, Green Published			2022-12-27	WOS:000306355500003
J	Thingnes, J; Lavelle, TJ; Hovig, E; Omholt, SW				Thingnes, Josef; Lavelle, Timothy J.; Hovig, Eivind; Omholt, Stig W.			Understanding the Melanocyte Distribution in Human Epidermis: An Agent-Based Computational Model Approach	PLOS ONE			English	Article							ETHNIC VARIATION; HUMAN SKIN; KERATINOCYTE; DENSITY; RULES; CELLS; FETAL	The strikingly even color of human skin is maintained by the uniform distribution of melanocytes among keratinocytes in the basal layer of the human epidermis. In this work, we investigated three possible hypotheses on the mechanism by which the melanocytes and keratinocytes organize themselves to generate this pattern. We let the melanocyte migration be aided by (1) negative chemotaxis due to a substance produced by the melanocytes themselves, or (2) positive chemotaxis due to a substance produced by keratinocytes lacking direct physical contact with a melanocyte, or (3) positive chemotaxis due to a substance produced by keratinocytes in a distance-to-melanocytes dependent manner. The three hypotheses were implemented in an agent-based computational model of cellular interactions in the basal layer of the human epidermis. We found that they generate mutually exclusive predictions that can be tested by existing experimental protocols. This model forms a basis for further understanding of the communication between melanocytes and other skin cells in skin homeostasis.	[Thingnes, Josef; Omholt, Stig W.] Norwegian Univ Life Sci, Dept Math Sci & Technol, Ctr Integrat Genet CIGENE, As, Norway; [Lavelle, Timothy J.; Hovig, Eivind] Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Hovig, Eivind] Univ Oslo, Inst Informat, Fac Math & Nat Sci, Oslo, Norway; [Hovig, Eivind] Norwegian Radium Hosp, Inst Med Informat, Oslo, Norway; [Omholt, Stig W.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway	Norwegian University of Life Sciences; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Life Sciences	Thingnes, J (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, Ctr Integrat Genet CIGENE, As, Norway.	joseft@ifi.uio.no	Hovig, Eivind/H-2474-2011; Thingnes, Josef/I-9329-2018	Hovig, Eivind/0000-0002-9103-1077; 	National Programme for Research in Functional Genomics (FUGE) in the Research Council of Norway	National Programme for Research in Functional Genomics (FUGE) in the Research Council of Norway(Research Council of Norway)	This study was supported by The National Programme for Research in Functional Genomics (FUGE) in the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008511; Alaluf S, 2003, PIGM CELL RES, V16, P35, DOI 10.1034/j.1600-0749.2003.00005.x; Alaluf S, 2002, PIGM CELL RES, V15, P112, DOI 10.1034/j.1600-0749.2002.1o071.x; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Burns TF, 2004, ROOKS TSB DERMATOLOG; Chung H, 2011, J BIOL CHEM, V286, P13438, DOI 10.1074/jbc.M110.166751; FITZPATRICK T B, 1963, Dermatol Wochenschr, V147, P481; Fitzpatrick TB, 1987, DERMATOLOGY GEN MED; Hachiya A, 2005, J INVEST DERMATOL, V125, P364, DOI 10.1111/j.0022-202X.2005.23832.x; Hearing VJ, 2007, PIGM CELL RES, V20, P334, DOI 10.1111/j.1600-0749.2007.pcr402.x; HOLBROOK KA, 1989, ANAT EMBRYOL, V180, P443, DOI 10.1007/BF00305119; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Jorizzo JL, 2008, DERMATOLOGY; LEPOOLE IC, 1994, PIGM CELL RES, V7, P33; Madden K, 2011, J AM ACAD DERMATOL, V64, P548, DOI 10.1016/j.jaad.2010.05.021; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; ROSDAHL I, 1983, J INVEST DERMATOL, V81, P278, DOI 10.1111/1523-1747.ep12518318; SCOTT GA, 1991, J INVEST DERMATOL, V97, P776, DOI 10.1111/1523-1747.ep12486726; Seiberg M, 2001, PIGM CELL RES, V14, P236, DOI 10.1034/j.1600-0749.2001.140402.x; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Smallwood R, 2011, UNDERSTANDING THE DYNAMICS OF BIOLOGICAL SYSTEMS: LESSONS LEARNED FROM INTEGRATIVE SYSTEMS BIOLOGY, P175, DOI 10.1007/978-1-4419-7964-3_9; Sun T, 2007, J R SOC INTERFACE, V4, P1077, DOI 10.1098/rsif.2007.0227; Sun T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002129; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Walker DC, 2010, J THEOR BIOL, V262, P425, DOI 10.1016/j.jtbi.2009.10.002; Walker D, 2006, J THEOR BIOL, V242, P774, DOI 10.1016/j.jtbi.2006.04.020; Walker D, 2006, TISSUE ENG, V12, P2301, DOI 10.1089/ten.2006.12.2301; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Whiteman DC, 1999, ARCH DERMATOL RES, V291, P511, DOI 10.1007/s004030050446	35	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40377	10.1371/journal.pone.0040377	http://dx.doi.org/10.1371/journal.pone.0040377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792296	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700040
J	Hocher, B; Armbruster, FP; Stoeva, S; Reichetzeder, C; Gron, HJ; Lieker, I; Khadzhynov, D; Slowinski, T; Roth, HJ				Hocher, Berthold; Armbruster, Franz Paul; Stoeva, Stanka; Reichetzeder, Christoph; Groen, Hans Juergen; Lieker, Ina; Khadzhynov, Dmytro; Slowinski, Torsten; Roth, Heinz Juergen			Measuring Parathyroid Hormone (PTH) in Patients with Oxidative Stress - Do We Need a Fourth Generation Parathyroid Hormone Assay?	PLOS ONE			English	Article							SECONDARY HYPERPARATHYROIDISM; INTRAVENOUS CALCITRIOL; HEMODIALYSIS-PATIENTS; RENAL OSTEODYSTROPHY; CALCIUM; UREMIA; IMMUNOASSAY; SECRETION; RESIDUES; RATS	Oxidation of PTH at methionine residues results in loss of biological activity. PTH may be oxidized in patients with renal disease. The aim of this study was to develop an assay considering oxidation of PTH. Oxidized hPTH was analyzed by high resolution nano-liquid chromatography coupled to ESI-FTT tandem mass spectrometry (nanoLC-ESI-FT-MS/MS) directly and after proteolytic cleavage. The oxidized hPTH(1-84) sample shows TIC-peaks at 18-20 min and several mass peaks due to mass shifts caused by oxidations. No significant signal for oxidized hPTH(1-84) species after removal of oxidized PTH molecules by a specific column with monoclonal antibodies (MAB) raised against the oxidized hPTH was detectable. By using this column in samples from 18 patients on dialysis we could demonstrate that measured PTH concentrations were substantially lower when considering oxidized forms of PTH. The relationship between PTH concentrations determined directly and those concentrations measured after removal of the oxidized PTH forms varies substantially. In some patients only 7% of traditionally measured PTH was free of oxidation, whereas in other patients 34% of the traditionally measured PTH was real intact PTH. In conclusion, a huge but not constant proportion of PTH molecules are oxidized in patients requiring dialysis. Since oxidized PTH is biologically inactive, the currently used methods to detect PTH in daily clinical practice may not adequately reflect PTH-related bone and cardiovascular abnormalities in patients on dialysis.	[Hocher, Berthold; Reichetzeder, Christoph] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Armbruster, Franz Paul; Stoeva, Stanka; Groen, Hans Juergen] Immundiagnostik AG, Bensheim, Germany; [Lieker, Ina; Khadzhynov, Dmytro; Slowinski, Torsten] Charite Mitte, Dept Nephrol, Berlin, Germany; [Roth, Heinz Juergen] Limbach Lab, Dept Endocrinol Oncol, Heidelberg, Germany	University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.	hocher@uni-potsdam.de	Armbruster, Franz Paul/D-7383-2014; Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Khadzhynov, Dmytro/0000-0001-5462-5776				BERSON SA, 1963, P NATL ACAD SCI USA, V49, P613, DOI 10.1073/pnas.49.5.613; BLIND E, 1987, CLIN CHEM, V33, P1376; Blind E, 2008, CLIN LAB, V54, P439; Brossard JH, 2000, CLIN CHEM, V46, P697; Chaykovska L, 2011, CLIN LAB, V57, P455; FELSENFELD AJ, 1991, NEPHROL DIAL TRANSPL, V6, P244, DOI 10.1093/ndt/6.4.244; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; GALCERAN T, 1984, ENDOCRINOLOGY, V115, P2375, DOI 10.1210/endo-115-6-2375; Garrett G, 2012, CLIN J AM SOC NEPHRO; Garrett G, 2012, ANN CLIN BIOCHEM, V49, P4, DOI 10.1258/acb.2011.011254; HORIUCHI N, 1988, J BONE MINER RES, V3, P353, DOI 10.1002/jbmr.5650030316; KEUTMANN HT, 1978, BIOCHEMISTRY-US, V17, P5723, DOI 10.1021/bi00619a019; Kumar V, 2010, CLIN CHEM, V56, P306, DOI 10.1373/clinchem.2009.134643; Lepage R, 1998, CLIN CHEM, V44, P805; Lopez MF, 2010, CLIN CHEM, V56, P281, DOI 10.1373/clinchem.2009.137323; MALBERTI F, 1992, NEPHROL DIAL TRANSPL, V7, P822; MESSA P, 1994, KIDNEY INT, V46, P1713, DOI 10.1038/ki.1994.473; ORIORDAN JL, 1974, J ENDOCRINOL, V63, P117, DOI 10.1677/joe.0.0630117; QUARLES LD, 1992, J CLIN ENDOCR METAB, V75, P145, DOI 10.1210/jc.75.1.145; RAMIREZ JA, 1993, J CLIN ENDOCR METAB, V76, P1489, DOI 10.1210/jc.76.6.1489; RODRIGUEZ M, 1991, J AM SOC NEPHROL, V2, P1014; SANCHEZ CP, 1995, KIDNEY INT, V48, P838, DOI 10.1038/ki.1995.359; Slatopolsky E, 2000, KIDNEY INT, V58, P753, DOI 10.1046/j.1523-1755.2000.00222.x; TAMPE J, 1992, J IMMUNOASSAY, V13, P1, DOI 10.1080/15321819208019821; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; ZULL JE, 1990, J BIOL CHEM, V265, P5671	27	56	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40242	10.1371/journal.pone.0040242	http://dx.doi.org/10.1371/journal.pone.0040242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792251	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800056
J	Linde, N; Gutschalk, CM; Hoffmann, C; Yilmaz, D; Mueller, MM				Linde, Nina; Gutschalk, Claudia M.; Hoffmann, Claudia; Yilmaz, Dilan; Mueller, Margareta M.			Integrating Macrophages into Organotypic Co-Cultures: A 3D In Vitro Model to Study Tumor-Associated Macrophages	PLOS ONE			English	Article							BASEMENT-MEMBRANE FORMATION; COLONY-STIMULATING FACTOR; SQUAMOUS-CELL CARCINOMAS; INTERFERON-GAMMA; PROGRESSION; SKIN; CULTURE; GROWTH; CANCER; DIFFERENTIATION	Tumor progression is controlled by signals from cellular and extra-cellular microenvironment including stromal cells and the extracellular matrix. Consequently, three-dimensional in vitro tumor models are essential to study the interaction of tumor cells with their microenvironment appropriately in a biologically relevant manner. We have previously used organotypic co-cultures to analyze the malignant growth of human squamous cell carcinoma (SCC) cell lines on a stromal equivalent in vitro. In this model, SCC cell lines are grown on a collagen-I gel containing fibroblasts. Since macrophages play a critical role in the progression of many tumor types, we now have expanded this model by integrating macrophages into the collagen gel of these organotypic tumor co-cultures. This model was established as a murine and a human system of skin SCCs. The effect of macrophages on tumor progression depends on their polarization. We demonstrate that macrophage polarization in organotypic co-cultures can be modulated towards and M1 or an M2 phenotype by adding recombinant IFN-gamma and LPS or IL-4 respectively to the growth medium. IL-4 stimulation of macrophage-containing cultures resulted in enhanced tumor cell invasion evidenced by degradation of the basement membrane, enhanced collagenolytic activity and increased MMP-2 and MMP-9. Interestingly, extended co-culture with tumor cells for three weeks resulted in spontaneous M2 polarization of macrophages without IL-4 treatment. Thus, we demonstrate that macrophages can be successfully integrated into organotypic co-cultures of murine or human skin SCCs and that this model can be exploited to analyze macrophage activation towards a tumor supporting phenotype.	[Linde, Nina; Gutschalk, Claudia M.; Yilmaz, Dilan; Mueller, Margareta M.] German Canc Res Ctr, Grp Tumor & Microenvironm, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Linde, N (corresponding author), German Canc Res Ctr, Grp Tumor & Microenvironm, Heidelberg, Germany.	muem@hs-furtwangen.de			Deutsche Forschungsgemeinschaft: DFG [SPP1190, MU1830/3-1]; DFG grant [GU791/2-1]	Deutsche Forschungsgemeinschaft: DFG(German Research Foundation (DFG)); DFG grant(German Research Foundation (DFG))	This work was financed by grants from the Deutsche Forschungsgemeinschaft: DFG grant SPP1190, project MU1830/3-1 and DFG grant GU791/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Barron L, 2011, AM J PHYSIOL-GASTR L, V300, pG723, DOI 10.1152/ajpgi.00414.2010; Bechetoille N, 2011, EXP DERMATOL, V20, P1035, DOI 10.1111/j.1600-0625.2011.01383.x; Brana C, 1999, J NEUROSCI METH, V90, P7, DOI 10.1016/S0165-0270(99)00045-X; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Fernandez-Bueno I, 2008, MOL VIS, V14, P2148; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; FUSENIG NE, 1983, J INVEST DERMATOL, V81, pS168, DOI 10.1111/1523-1747.ep12541032; Gawa K, 2006, J IMMUNOL, V177, P6787, DOI 10.4049/jimmunol.177.10.6787; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; HORNUNG J, 1987, J CANCER RES CLIN, V113, P325, DOI 10.1007/BF00397716; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KUEBLER JP, 1987, INVEST NEW DRUG, V5, P21; Lederle W, 2011, INT J CANCER, V128, P2803, DOI 10.1002/ijc.25621; Lederle W, 2010, AM J PATHOL, V176, P981, DOI 10.2353/ajpath.2010.080998; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Mueller MM, 1999, INT J CANCER, V83, P780, DOI 10.1002/(SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.3.CO;2-3; Obermueller E, 2004, CANCER RES, V64, P7801, DOI 10.1158/0008-5472.CAN-03-3301; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Stacey A, 1997, Methods Mol Biol, V75, P305; Stark Hans-Jurgen, 2004, Biol Proced Online, V6, P55, DOI 10.1251/bpo72; Stark JJ, 2006, J INVEST DERM SYMP P, V11, P93, DOI 10.1038/sj.jidsymp.5650015; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; YIP I, 1995, J CLIN ENDOCR METAB, V80, P1664, DOI 10.1210/jc.80.5.1664	42	71	71	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40058	10.1371/journal.pone.0040058	http://dx.doi.org/10.1371/journal.pone.0040058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792213	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800035
J	Luo, YQ; Kong, QK; Yang, J; Mitra, A; Golden, G; Wanda, SY; Roland, KL; Jensen, RV; Ernst, PB; Curtiss, R				Luo, Yingqin; Kong, Qingke; Yang, Jiseon; Mitra, Arindam; Golden, Greg; Wanda, Soo-Young; Roland, Kenneth L.; Jensen, Roderick V.; Ernst, Peter B.; Curtiss, Roy, III			Comparative Genome Analysis of the High Pathogenicity Salmonella Typhimurium Strain UK-1	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PROVIDES ACQUIRED-RESISTANCE; IMMUNE-RESPONSES; III SECRETION; DNA REPEATS; VIRULENCE; IDENTIFICATION; SEQUENCE; VACCINE; CRISPR	Salmonella enterica serovar Typhimurium, a gram-negative facultative rod-shaped bacterium causing salmonellosis and foodborne disease, is one of the most common isolated Salmonella serovars in both developed and developing nations. Several S. Typhimurium genomes have been completed and many more genome-sequencing projects are underway. Comparative genome analysis of the multiple strains leads to a better understanding of the evolution of S. Typhimurium and its pathogenesis. S. Typhimurium strain UK-1 (belongs to phage type 1) is highly virulent when orally administered to mice and chickens and efficiently colonizes lymphoid tissues of these species. These characteristics make this strain a good choice for use in vaccine development. In fact, UK-1 has been used as the parent strain for a number of nonrecombinant and recombinant vaccine strains, including several commercial vaccines for poultry. In this study, we conducted a thorough comparative genome analysis of the UK-1 strain with other S. Typhimurium strains and examined the phenotypic impact of several genomic differences. Whole genomic comparison highlights an extremely close relationship between the UK-1 strain and other S. Typhimurium strains; however, many interesting genetic and genomic variations specific to UK-1 were explored. In particular, the deletion of a UK-1-specific gene that is highly similar to the gene encoding the T3SS effector protein NleC exhibited a significant decrease in oral virulence in BALB/c mice. The complete genetic complements in UK-1, especially those elements that contribute to virulence or aid in determining the diversity within bacterial species, provide key information in evaluating the functional characterization of important genetic determinants and for development of vaccines.	[Luo, Yingqin; Kong, Qingke; Yang, Jiseon; Mitra, Arindam; Golden, Greg; Wanda, Soo-Young; Roland, Kenneth L.; Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Luo, Yingqin] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ USA; [Jensen, Roderick V.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Ernst, Peter B.] Univ Virginia, Div Gastroenterol & Hepatol, Dept Med, Charlottesville, VA USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Virginia Polytechnic Institute & State University; University of Virginia	Luo, YQ (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	rcurtiss@asu.edu	Mitra, Arindam/A-1379-2013; Kong, Qingke/K-3384-2019	Mitra, Arindam/0000-0002-1591-6164; Ernst, Peter/0000-0001-7777-1813; Yang, Jiseon/0000-0002-5393-7062	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI060557, AI08600, AI070491]; Bill and Melinda Gates Foundation [37863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070491, U01AI060557, R01AI060557] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants AI060557, AI08600 and AI070491, and the Bill and Melinda Gates Foundation grant 37863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrow PA, 2001, VACCINE, V19, P3432, DOI 10.1016/S0264-410X(01)00065-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Cady KC, 2011, MICROBIOL-SGM, V157, P430, DOI 10.1099/mic.0.045732-0; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chan K, 2005, INFECT IMMUN, V73, P5438, DOI 10.1128/IAI.73.9.5438-5449.2005; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Covone MG, 1998, INFECT IMMUN, V66, P224, DOI 10.1128/IAI.66.1.224-231.1998; CURTISS R, 1991, COLONIZATION CONTROL, P169; Curtiss R, 2009, INFECT IMMUN, V77, P1071, DOI 10.1128/IAI.00693-08; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Garcia-Quintanilla M, 2011, PLASMID, V65, P169, DOI 10.1016/j.plasmid.2010.12.001; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gotoh O, 2008, NUCLEIC ACIDS RES, V36, P2630, DOI 10.1093/nar/gkn105; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Gunn BM, 2010, CLIN VACCINE IMMUNOL, V17, P354, DOI 10.1128/CVI.00412-09; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; HASSAN J O, 1990, Research in Microbiology, V141, P839, DOI 10.1016/0923-2508(90)90119-B; Hassan JO, 1996, INFECT IMMUN, V64, P938, DOI 10.1128/IAI.64.3.938-944.1996; HASSAN JO, 1994, INFECT IMMUN, V62, P5519, DOI 10.1128/IAI.62.12.5519-5527.1994; HASSAN JO, 1993, AVIAN DIS, V37, P19, DOI 10.2307/1591452; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Izumiya H, 2011, ANTIMICROB AGENTS CH, V55, P623, DOI 10.1128/AAC.01215-10; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Kong QK, 2011, J IMMUNOL, V187, P412, DOI 10.4049/jimmunol.1100339; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANGE R, 1994, MOL MICROBIOL, V13, P733, DOI 10.1111/j.1365-2958.1994.tb00466.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Luo YQ, 2011, J BACTERIOL, V193, P4035, DOI 10.1128/JB.05224-11; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; McVey DS, 2002, VACCINE, V20, P1618, DOI 10.1016/S0264-410X(01)00516-3; Mohler VL, 2008, VACCINE, V26, P1751, DOI 10.1016/j.vaccine.2008.01.018; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; NEI M, 1986, MOL BIOL EVOL, V3, P418; Porter SB, 1997, AVIAN DIS, V41, P45, DOI 10.2307/1592442; PORTER SB, 1993, AVIAN DIS, V37, P265, DOI 10.2307/1591648; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Roland KL, 2005, CURR OPIN MOL THER, V7, P62; ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0; Rotger R, 1999, Int Microbiol, V2, P177; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Sheoran AS, 2001, VACCINE, V19, P3591, DOI 10.1016/S0264-410X(01)00072-X; Shi HY, 2010, CLIN VACCINE IMMUNOL, V17, P363, DOI 10.1128/CVI.00413-09; SKURNIK M, 1989, MOL MICROBIOL, V3, P517, DOI 10.1111/j.1365-2958.1989.tb00198.x; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAKAYANAGI Y, 1994, MOL GEN GENET, V243, P525, DOI 10.1007/BF00284200; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Tsolis RM, 2008, NAT REV MICROBIOL, V6, P883, DOI 10.1038/nrmicro2012; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Varma JK, 2005, EMERG INFECT DIS, V11, P943; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Zhang X, 1999, MICROB PATHOGENESIS, V26, P121, DOI 10.1006/mpat.1998.0245	98	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40645	10.1371/journal.pone.0040645	http://dx.doi.org/10.1371/journal.pone.0040645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792393	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800114
J	Trierweiler, C; Blum, HE; Hasselblatt, P				Trierweiler, Claudia; Blum, Hubert E.; Hasselblatt, Peter			The Transcription Factor c-Jun Protects against Liver Damage following Activated beta-Catenin Signaling	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEPATOCYTE PROLIFERATION; TUMOR-DEVELOPMENT; MYC DELETION; MOUSE-LIVER; APC; MICE; GROWTH; TUMORIGENESIS; REGENERATION	Background: The Wnt/beta-Catenin signaling pathway is central for liver functions and frequently deregulated in hepatocellular carcinoma (HCC). Analysis of the early phenotypes and molecular events following beta-Catenin activation is therefore essential for better understanding HCC pathogenesis. The AP-1 transcription factor c-Jun is a putative beta-Catenin target gene and promotes hepatocyte survival, proliferation, and liver tumorigenesis, suggesting that c-Jun may be a key target of beta-Catenin signaling in the liver. Methodology/Principal Findings: To address this issue, the immediate hepatic phenotypes following deletion of the tumor suppressor Apc and subsequent beta-Catenin activation were analyzed in mice. The contribution of c-Jun to these phenotypes was dissected in double mutant animals lacking both, Apc and c-Jun. beta-Catenin was rapidly activated in virtually all Apc mutant hepatocytes while c-Jun was induced only after several days, suggesting that its expression was rather a secondary event following Apc deletion in the liver. Loss of Apc resulted in increased hepatocyte proliferation, hepatomegaly, deregulated protein metabolism, and premature death. Interestingly, additional deletion of c-Jun did not affect hepatocyte proliferation but resulted in increased liver damage and mortality. This phenotype correlated with impaired expression of hepatoprotective genes such as Birc5, Egfr Igf1 and subsequently deregulated Akt signaling. Conclusions/Significance: These data indicate that c-Jun is not a primary target of beta-Catenin signaling in the liver, but rather protects against liver damage, which in turn may promote liver tumorigenesis.	[Trierweiler, Claudia; Blum, Hubert E.; Hasselblatt, Peter] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany; [Trierweiler, Claudia] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Trierweiler, C (corresponding author), Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany.	Peter.Hasselblatt@uniklinik-freiburg.de	Hasselblatt, Peter/AAF-3681-2021		German Research Foundation (DFG) [Ha4314/2-1, Ha4314/2-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG, www.dfg.de) grants Ha4314/2-1 and Ha4314/2-2 to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Augello C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-125; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Burke ZD, 2009, GASTROENTEROLOGY, V136, P2316, DOI 10.1053/j.gastro.2009.02.063; Cadoret A, 2001, CANCER RES, V61, P3245; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Decaens T, 2008, HEPATOLOGY, V47, P247, DOI 10.1002/hep.21952; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Fuest M, 2012, HEPATOLOGY, V55, P408, DOI 10.1002/hep.24699; Hasselblatt P, 2008, ONCOGENE, V27, P6102, DOI 10.1038/onc.2008.211; Hasselblatt P, 2007, P NATL ACAD SCI USA, V104, P17105, DOI 10.1073/pnas.0706272104; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Katiyar S, 2010, MOL BIOL CELL, V21, P4264, DOI 10.1091/mbc.E10-08-0705; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Qian J, 2008, GASTROENTEROLOGY, V135, P152, DOI 10.1053/j.gastro.2008.03.074; Reed KR, 2008, P NATL ACAD SCI USA, V105, P18919, DOI 10.1073/pnas.0805778105; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Torre C, 2011, J HEPATOL, V55, P86, DOI 10.1016/j.jhep.2010.10.021; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40638	10.1371/journal.pone.0040638	http://dx.doi.org/10.1371/journal.pone.0040638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792392	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800113
J	Veniant, MM; Hale, C; Helmering, J; Chen, MM; Stanislaus, S; Busby, J; Vonderfecht, S; Xu, J; Lloyd, DJ				Veniant, Murielle M.; Hale, Clarence; Helmering, Joan; Chen, Michelle M.; Stanislaus, Shanaka; Busby, Jim; Vonderfecht, Steven; Xu, Jing; Lloyd, David J.			FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice	PLOS ONE			English	Article							GROWTH-FACTOR 21; INSULIN SENSITIVITY; BETA-KLOTHO; DIABETES-MELLITUS; MOUSE MODELS; PPAR-ALPHA; RESISTANCE; TISSUE; OBESITY; FGF-21	Fibroblast growth factor 21 (FGF21) is a potent metabolic regulator, and pharmacological administration elicits glucose and lipid lowering responses in mammals. To delineate if adipose tissue is the predominant organ responsible for anti-diabetic effects of FGF21, we treated mice with reduced body fat (lipodystrophy mice with adipose specific expression of active sterol regulatory element binding protein 1c; Tg) with recombinant murine FGF21 (rmuFGF21). Unlike wildtype (WT) mice, Tg mice were refractory to the beneficial effects of rmuFGF21 on body weight, adipose mass, plasma insulin and glucose tolerance. To determine if adipose mass was critical for these effects, we transplanted WT white adipose tissue (WAT) into Tg mice and treated the mice with rmuFGF21. After transplantation, FGF21 responsiveness was completely restored in WAT transplanted Tg mice compared to sham Tg mice. Further, leptin treatment alone was sufficient to restore the anti-diabetic effects of rmuFGF21 in Tg mice. Molecular analyses of Tg mice revealed normal adipose expression of Fgfr1, Klb and an 8-fold over-expression of Fgf21. Impaired FGF21-induced signaling indicated that residual adipose tissue of Tg mice was resistant to FGF21, whilst normal FGF21 signaling was observed in Tg livers. Together these data suggest that adipose tissue is required for the triglyceride and glucose, but not the cholesterol lowering efficacy of FGF21, and that leptin and FGF21 exert additive anti-diabetic effects in Tg mice.	[Veniant, Murielle M.; Hale, Clarence; Helmering, Joan; Chen, Michelle M.; Stanislaus, Shanaka; Busby, Jim; Xu, Jing; Lloyd, David J.] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA; [Vonderfecht, Steven] Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Veniant, MM (corresponding author), Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA.	dlloyd@amgen.com		Lloyd, David/0000-0001-5924-0672	Amgen Inc.	Amgen Inc.(Amgen)	Amgen Inc. funded the study. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Amgen Inc. gave permission to publish.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Colombo C, 2003, J BIOL CHEM, V278, P3992, DOI 10.1074/jbc.M207665200; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Feng GS, 2006, EXPERT OPIN THER TAR, V10, P135, DOI 10.1517/14728222.10.1.135; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Gupte J, 2011, J MOL BIOL, V408, P491, DOI 10.1016/j.jmb.2011.03.003; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hale C, 2012, ENDOCRINOLOGY, V153, P69, DOI 10.1210/en.2010-1262; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	28	112	113	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40164	10.1371/journal.pone.0040164	http://dx.doi.org/10.1371/journal.pone.0040164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792234	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800045
J	Adhikari, A; Gupta, G; Majumder, S; Banerjee, S; Bhattacharjee, S; Bhattacharya, P; Kumari, S; Haldar, S; Majumdar, SB; Saha, B; Majumdar, S				Adhikari, Anupam; Gupta, Gaurav; Majumder, Saikat; Banerjee, Sayantan; Bhattacharjee, Surajit; Bhattacharya, Parna; Kumari, Sangeeta; Haldar, Subhadra; Majumdar, Suchandra Bhattacharyya; Saha, Bhaskar; Majumdar, Subrata			Mycobacterium indicus pranii (Mw) Re-Establishes Host Protective Immune Response in Leishmania donovani Infected Macrophages: Critical Role of IL-12	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; NF-KAPPA-B; AMPHOTERICIN-B; MICE; ACTIVATION; TUBERCULOSIS; INVOLVEMENT; TOXICITY; SYNTHASE; LEPROSY	Leishmania donovani, a protozoan parasite, causes a strong immunosuppression in a susceptible host and inflicts the fatal disease visceral leishmaniasis. Relatively high toxicity, low therapeutic index, and failure in reinstating host-protective anti-leishmanial immune responses have made anti-leishmanial drugs patient non-compliant and an immuno-modulatory treatment a necessity. Therefore, we have tested the anti-leishmanial efficacy of a combination of a novel immunomodulator, Mycobacterium indicus pranii (Mw), and an anti-leishmanial drug, Amphotericin B (AmpB). We observe that Mw alone or with a suboptimal dose of AmpB offers significant protection against L. donovani infection by activating the macrophages. Our experiments examining the anti-leishmanial activity of Mw alone or with AmpB also indicate a p38MAPK and ERK-1/2 regulated pro-inflammatory responses. The Mw-AmpB combination induced nitric oxide production, restored Th1 response, and significantly reduced parasite burden in wild type macrophages but not in IL-12-deficient macrophages indicating a pivotal role for IL-12 in the induction of host-protection by Mw and AmpB treatments. In addition, we observed that Mw alone or in combination with suboptimal dose of AmpB render protection against L. donovani infection in susceptible BALB/c mice. However, these treatments failed to render protection in IL-12-deficient mice in vivo which added further support that IL-12 played a central role in this chemo immunotherapeutic approach. Thus, we demonstrate a novel chemo-immunotherapeutic approach-Mw and AmpB crosstalk eliminating the parasite-induced immunosuppression and inducing collateral host-protective effects.	[Adhikari, Anupam; Gupta, Gaurav; Majumder, Saikat; Banerjee, Sayantan; Bhattacharjee, Surajit; Bhattacharya, Parna; Majumdar, Suchandra Bhattacharyya; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Kumari, Sangeeta; Haldar, Subhadra; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Adhikari, A (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@bic.boseinst.ernet.in	Bhattacharjee, Surajit/B-5979-2012; Majumder, Saikat/ABC-2194-2020; BANERJEE, SAYANTAN/AAD-8420-2019; Gupta, Gaurav/F-7519-2012	Bhattacharjee, Surajit/0000-0001-9233-4777; Majumder, Saikat/0000-0002-6591-9515; Gupta, Gaurav/0000-0003-4533-6272	Department of Biotechnology, Government of India, New Delhi; Bose Institute; National Centre for Cell science; council of Scientific and Industrial Research, Government of India, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Bose Institute(Department of Science & Technology (India)); National Centre for Cell science; council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The Department of Biotechnology, Government of India, New Delhi provided the financial assistance to this work. Intramural funding has been provided by the Bose Institute (S.M., Corresponding Author) and National Centre for Cell science (B.S). The council of Scientific and Industrial Research, Government of India, New Delhi provided fellowships to A.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Arning M, 1995, MYCOSES, V38, P459, DOI 10.1111/j.1439-0507.1995.tb00020.x; AZUMA I, 1968, J BACTERIOL, V96, P1885, DOI 10.1128/JB.96.5.1885-1887.1968; BERMAN JD, 1992, ANTIMICROB AGENTS CH, V36, P1978, DOI 10.1128/AAC.36.9.1978; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; CHAKKALATH HR, 1994, J IMMUNOL, V153, P4378; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; DAVIDSON RN, 1991, LANCET, V337, P1061, DOI 10.1016/0140-6736(91)91708-3; Dey R, 2007, SCAND J IMMUNOL, V66, P671, DOI 10.1111/j.1365-3083.2007.02025.x; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Little J. R., 1987, Clinical Immunology Newsletter, V8, P183, DOI 10.1016/0197-1859(87)90048-3; LITTLE JR, 1978, IMMUNOCHEMISTRY, V15, P219, DOI 10.1016/0161-5890(78)90058-5; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Matsuo K, 2006, MICROBIOL IMMUNOL, V50, P337, DOI 10.1111/j.1348-0421.2006.tb03792.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murray  H W, 2000, Int J Infect Dis, V4, P158, DOI 10.1016/S1201-9712(00)90078-X; REDDI PP, 1994, INT J LEPROSY, V62, P229; Rodrigues V, 1998, INFECT IMMUN, V66, P1233, DOI 10.1128/IAI.66.3.1233-1236.1998; SARTHOU P, 1986, J IMMUNOL, V137, P2156; Satoskar AR, 2000, EUR J IMMUNOL, V30, P834, DOI 10.1002/1521-4141(200003)30:3&lt;834::AID-IMMU834&gt;3.0.CO;2-9; SCHRECK R, 1994, METHOD ENZYMOL, V234, P151; SINGH IG, 1992, INFECT IMMUN, V60, P257, DOI 10.1128/IAI.60.1.257-263.1992; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; Taylor AP, 1997, J EXP MED, V185, P1231, DOI 10.1084/jem.185.7.1231; ZAHEER SA, 1993, J INFECT DIS, V167, P401, DOI 10.1093/infdis/167.2.401	30	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40265	10.1371/journal.pone.0040265	http://dx.doi.org/10.1371/journal.pone.0040265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792256	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300042
J	Harihar, A; Pandav, B				Harihar, Abishek; Pandav, Bivash			Influence of Connectivity, Wild Prey and Disturbance on Occupancy of Tigers in the Human-Dominated Western Terai Arc Landscape	PLOS ONE			English	Article							LEOPARD PANTHERA-PARDUS; EXTINCTION; TIGRIS; FRAMEWORK; ABUNDANCE; RECOVERY; DECLINE	Occupying only 7% of their historical range and confined to forested habitats interspersed in a matrix of human dominated landscapes, tigers (Panthera tigris) typify the problems faced by most large carnivores worldwide. With heads of governments of tiger range countries pledging to reverse the extinction process and setting a goal of doubling wild tiger numbers by 2022, achieving this target would require identifying existing breeding cores, potential breeding habitats and opportunities for dispersal. The Terai Arc Landscape (TAL) represents one region which has recently witnessed recovery of tiger populations following conservation efforts. In this study, we develop a spatially explicit tiger occupancy model with survey data from 2009-10 based on a priori knowledge of tiger biology and specific issues plaguing the western TAL (6,979 km 2), which occurs in two disjunct units (Tiger Habitat Blocks; THBs). Although the overall occupancy of tigers was 0.588 (SE 0.071), our results clearly indicate that loss in functionality of a regional corridor has resulted in tigers now occupying 17.58% of the available habitat in THB I in comparison to 88.5% in THB II. The current patterns of occupancy were best explained by models incorporating the interactive effect of habitat blocks (AIC w=0.883) on wild prey availability (AIC w=0.742) and anthropogenic disturbances (AIC w=0.143). Our analysis has helped identify areas of high tiger occupancy both within and outside existing protected areas, which highlights the need for a unified control of the landscape under a single conservation unit with the primary focus of managing tigers and associated wildlife. Finally, in the light of global conservation targets and recent legislations in India, our study assumes significance as we identify opportunities to secure (e.g. THB II) and increase (e.g. THB I) tiger populations in the landscape.	[Harihar, Abishek] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Harihar, Abishek; Pandav, Bivash] Wildlife Inst India, Dehra Dun, India	University of Kent; Wildlife Institute of India	Harihar, A (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	harihar.abishek@gmail.com	Harihar, Abishek/AAY-5092-2020	Harihar, Abishek/0000-0002-2446-6345	Kathryn Fuller Science for Nature Fellowships, WWF; Kaplan Graduate Awards, Panthera	Kathryn Fuller Science for Nature Fellowships, WWF; Kaplan Graduate Awards, Panthera	The work was supported in part by grants from the Kathryn Fuller Science for Nature Fellowships, WWF and Kaplan Graduate Awards, Panthera (to AH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asia Ministerial Conference on Tiger Conservation, 2010, 1 AS MIN C TIG CONS; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Bose J, 2011, INTERIM RELIEF SCHEM; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Champion HG, 1968, FOREST TYPE INDIA; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dinerstein E, 2006, SETTING PRIORITIES C; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Donovan T.M., 2007, EXERCISES OCCUPANCY; Fisher DO, 2003, P ROY SOC B-BIOL SCI, V270, P1801, DOI 10.1098/rspb.2003.2447; Goodrich JM, 2010, INTEGR ZOOL, V5, P300, DOI 10.1111/j.1749-4877.2010.00218.x; Government of India, 2011, CENS IND PROV POP TO; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Harihar A, 2009, ORYX, V43, P35, DOI 10.1017/S0030605307072043; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Harihar A, 2009, EUR J WILDLIFE RES, V55, P97, DOI 10.1007/s10344-008-0219-2; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines JE., 2006, PRESENCESOFTWARE EST; Jhala Y. V., 2011, STATUS TIGERS COPRED; Jhala Y, 2011, J APPL ECOL, V48, P14, DOI 10.1111/j.1365-2664.2010.01901.x; Johnsingh A., 2004, RR04001 WILDL I IND; Kanagaraj R, 2011, ECOGRAPHY, V34, P970, DOI 10.1111/j.1600-0587.2010.06482.x; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2005, CONSERV BIOL SER, V9, P373; Karanth KU, 2000, J ZOOL, V250, P255; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; Rhodes J, 2011, ECOGRAPHY, V34, P141, DOI 10.1111/j.1600-0587.2010.05908.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sanderson E., 2006, SETTING PRIORITIES C; Seidensticker J., 2010, BIOL CONSERVATION WI; Seidensticker J, 2010, INTEGR ZOOL, V5, P285, DOI 10.1111/j.1749-4877.2010.00214.x; SMITH JLD, 1989, ANIM BEHAV, V37, P1; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Stokes EJ, 2010, INTEGR ZOOL, V5, P363, DOI 10.1111/j.1749-4877.2010.00223.x; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Sunquist M. E., 1981, SOCIAL ORG TIGERS PA; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; Wikramanayake E, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P163, DOI 10.1016/B978-0-8155-1570-8.00010-4	52	67	67	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40105	10.1371/journal.pone.0040105	http://dx.doi.org/10.1371/journal.pone.0040105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792220	gold, Green Submitted, Green Published			2022-12-27	WOS:000306436300024
J	Jarviluoma, A; Strandin, T; Lulf, S; Bouchet, J; Makela, AR; Geyer, M; Benichou, S; Saksela, K				Jarviluoma, Annika; Strandin, Tomas; Luelf, Sebastian; Bouchet, Jerome; Makela, Anna R.; Geyer, Matthias; Benichou, Serge; Saksela, Kalle			High-Affinity Target Binding Engineered via Fusion of a Single-Domain Antibody Fragment with a Ligand-Tailored SH3 Domain	PLOS ONE			English	Article							HIV-1 NEF; ESCHERICHIA-COLI; VARIABLE DOMAINS; ANTIGEN-BINDING; PROTEIN; THERAPEUTICS; FAMILY; MULTIVALENT; STABILITY; EVOLUTION	Monoclonal and recombinant antibodies are ubiquitous tools in diagnostics, therapeutics, and biotechnology. However, their biochemical properties lack optimal robustness, their bacterial production is not easy, and possibilities to create multifunctional fusion proteins based on them are limited. Moreover, the binding affinities of antibodies towards their antigens are suboptimal for many applications where they are commonly used. To address these issues we have made use of the concept of creating high binding affinity based on multivalent target recognition via exploiting some of the best features of immunoglobulins (Ig) and non-Ig-derived ligand-binding domains. We have constructed a small protein, named Neffin, comprised of a 118 aa llama Ig heavy chain variable domain fragment (VHH) fused to a ligand-tailored 57 aa SH3 domain. Neffin could be readily produced in large amounts (>18 mg/L) in the cytoplasm of E. coli, and bound with a subpicomolar affinity (K-d 0.54 pM) to its target, the HIV-1 Nef protein. When expressed in human cells Neffin could potently inhibit Nef function. Similar VHH-SH3 fusion proteins could be targeted against many other proteins of interest and could have widespread use in diverse medical and biotechnology applications where biochemical robustness and strong binding affinity are required.	[Jarviluoma, Annika; Strandin, Tomas; Saksela, Kalle] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Luelf, Sebastian; Geyer, Matthias] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44139 Dortmund, Germany; [Bouchet, Jerome; Benichou, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France; [Bouchet, Jerome; Benichou, Serge] INSERM, U1016, Paris, France; [Makela, Anna R.] NEXT Biomed Technol NBT Oy, Helsinki, Finland; [Saksela, Kalle] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland	University of Helsinki; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Helsinki; Helsinki University Central Hospital	Jarviluoma, A (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	kalle.saksela@helsinki.fi	Strandin, Tomas/K-5322-2019; bouchet, jerome/I-7716-2019	Strandin, Tomas/0000-0002-2454-7479; bouchet, jerome/0000-0002-6611-4380; Geyer, Matthias/0000-0002-7718-5002; Saksela, Kalle/0000-0003-0827-122X; Benichou, Serge/0000-0003-3602-3530	Academy of Finland [127197]; Helsinki University Central Hospital Research Council [TYH2008307]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Council; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by grants to KS from the Academy of Finland (127197), Helsinki University Central Hospital Research Council (TYH2008307), and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Bouchet J, 2011, BLOOD; Breuer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020033; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gmeiner WH, 2001, CELL BIOCHEM BIOPHYS, V35, P127, DOI 10.1385/CBB:35:2:127; Grabulovski D, 2007, J BIOL CHEM, V282, P3196, DOI 10.1074/jbc.M609211200; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Hiipakka M, 2002, J GEN VIROL, V83, P3147, DOI 10.1099/0022-1317-83-12-3147; Hiipakka M, 2001, VIROLOGY, V286, P152, DOI 10.1006/viro.2001.0973; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; Hiipakka M, 2007, FEBS LETT, V581, P1735, DOI 10.1016/j.febslet.2007.03.044; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Honegger A., 2008, V181, P47; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Huang L, 2010, EXPERT REV MOL DIAGN, V10, P777, DOI 10.1586/ERM.10.62; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Koide A, 2007, METH MOL B, V352, P95; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Martineau P, 1999, J MOL BIOL, V292, P921, DOI 10.1006/jmbi.1999.3105; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Neri D, 1996, TRENDS BIOTECHNOL, V14, P465, DOI 10.1016/S0167-7799(96)10067-6; NERI D, 1995, J MOL BIOL, V246, P367, DOI 10.1006/jmbi.1994.0091; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Schuck P, 2010, METHODS MOL BIOL, V627, P15, DOI 10.1007/978-1-60761-670-2_2; Scolnik PA, 2009, MABS-AUSTIN, V1, P179, DOI 10.4161/mabs.1.2.7736; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Verheesen P, 2003, BBA-GEN SUBJECTS, V1624, P21, DOI 10.1016/j.bbagen.2003.09.006; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7	48	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40331	10.1371/journal.pone.0040331	http://dx.doi.org/10.1371/journal.pone.0040331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792285	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300056
J	Kouba, T; Danyi, I; Gunisova, S; Munzarova, V; Vlckova, V; Cuchalova, L; Neueder, A; Milkereit, P; Valasek, LS				Kouba, Tomas; Danyi, Istvan; Gunisova, Stanislava; Munzarova, Vanda; Vlckova, Vladislava; Cuchalova, Lucie; Neueder, Andreas; Milkereit, Philipp; Valasek, Leos Shivaya			Small Ribosomal Protein RPS0 Stimulates Translation Initiation by Mediating 40S-Binding of eIF3 via Its Direct Contact with the eIF3a/TIF32 Subunit	PLOS ONE			English	Article							RNA RECOGNITION MOTIF; P40/LAMININ RECEPTOR PRECURSOR; MULTIFACTOR COMPLEX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MESSENGER-RNAS; GCN4; REINITIATION; RESUMPTION; MATURATION	The ribosome translates information encoded by mRNAs into proteins in all living cells. In eukaryotes, its small subunit together with a number of eukaryotic initiation factors (eIFs) is responsible for locating the mRNA's translational start to properly decode the genetic message that it carries. This multistep process requires timely and spatially coordinated placement of eIFs on the ribosomal surface. In our long-standing pursuit to map the 40S-binding site of one of the functionally most complex eIFs, yeast multisubunit eIF3, we identified several interactions that placed its major body to the head, beak and shoulder regions of the solvent-exposed side of the 40S subunit. Among them is the interaction between the N-terminal domain (NTD) of the a/TIF32 subunit of eIF3 and the small ribosomal protein RPS0A, residing near the mRNA exit channel. Previously, we demonstrated that the N-terminal truncation of 200 residues in tif32-Delta 8 significantly reduced association of eIF3 and other eIFs with 40S ribosomes in vivo and severely impaired translation reinitiation that eIF3 ensures. Here we show that not the first but the next 200 residues of a/TIF32 specifically interact with RPS0A via its extreme C-terminal tail (CTT). Detailed analysis of the RPS0A conditional depletion mutant revealed a marked drop in the polysome to monosome ratio suggesting that the initiation rates of cells grown under non-permissive conditions were significantly impaired. Indeed, amounts of eIF3 and other eIFs associated with 40S subunits in the pre-initiation complexes in the RPS0A-depleted cells were found reduced; consistently, to the similar extent as in the tif32-Delta 8 cells. Similar but less pronounced effects were also observed with the viable CTT-less mutant of RPS0A. Together we conclude that the interaction between the flexible RPS0A-CTT and the residues 200-400 of the a/TIF32-NTD significantly stimulates attachment of eIF3 and its associated eIFs to small ribosomal subunits in vivo.	[Kouba, Tomas; Danyi, Istvan; Gunisova, Stanislava; Munzarova, Vanda; Vlckova, Vladislava; Cuchalova, Lucie; Valasek, Leos Shivaya] Inst Microbiol ASCR, Lab Regulat Gene Express, Vvi, Prague, Czech Republic; [Neueder, Andreas; Milkereit, Philipp] Univ Regensburg, Inst Biochem Genet & Mikrobiol, Regensburg, Germany	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Regensburg	Kouba, T (corresponding author), Inst Microbiol ASCR, Lab Regulat Gene Express, Vvi, Prague, Czech Republic.	valasekl@biomed.cas.cz	Cuchalova, Lucie/H-4650-2014; Gunišová, Stanislava/I-1765-2014; Valášek, Leoš Shivaya/I-5743-2014; Neueder, Andreas/K-4319-2015; Hronová, Vladislava/J-9860-2014	Valášek, Leoš Shivaya/0000-0001-8123-8667; Neueder, Andreas/0000-0002-2389-5236; Hronová, Vladislava/0000-0001-6447-019X; Kouba, Tomas/0000-0001-8173-6930	Wellcome Trusts [076456/Z/05/Z, 090812/Z/09/Z]; Czech Science Foundation [P305-11-0172]	Wellcome Trusts(Wellcome Trust); Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by The Wellcome Trusts Grants 076456/Z/05/Z and 090812/Z/09/Z, and the Czech Science Foundation P305-11-0172 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Ford CL, 1999, CANCER RES, V59, P704; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Lumsden T, 2010, NUCLEIC ACIDS RES, V38, P1261, DOI 10.1093/nar/gkp1113; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; Munzarova V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002137; Nemoto N, 2010, J BIOL CHEM IN PRESS; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Nielsen KH, 2007, METHOD ENZYMOL, V431, P15, DOI 10.1016/S0076-6879(07)31002-1; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sokabe M, 2012, NUCLEIC ACIDS RES, V40, P905, DOI 10.1093/nar/gkr772; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; Valasek LS, 2012, CURR PROTEI IN PRESS; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102	40	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40464	10.1371/journal.pone.0040464	http://dx.doi.org/10.1371/journal.pone.0040464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792338	Green Submitted, gold, Green Published			2022-12-27	WOS:000306436300068
J	Wang, AL; Xu, YQ; Ma, CQ; Gao, C; Li, LX; Wang, Y; Tao, F; Xu, P				Wang, Ailong; Xu, Youqiang; Ma, Cuiqing; Gao, Chao; Li, Lixiang; Wang, Yu; Tao, Fei; Xu, Ping			Efficient 2,3-Butanediol Production from Cassava Powder by a Crop-Biomass-Utilizer, Enterobacter cloacae subsp dissolvens SDM	PLOS ONE			English	Article							L-LACTIC ACID; FERMENTATION; ROOTS; BATCH	Background: 2,3-Butanediol (BD) is considered as one of the key platform chemicals used in a variety of industrial applications. It is crucial to find an efficient sugar-utilizing strain and feasible carbon source for the economical production of BD. Methodology/Principal Findings: Efficient BD production by a newly isolated Enterobacter cloacae subsp. dissolvens SDM was studied using crop-biomass cassava powder as substrate. The culture conditions and fermentation medium for BD production were optimized. Under the optimal conditions, 78.3 g l(-1) of BD was produced after 24 h in simultaneous saccharification and fermentation (SSF), with a yield of 0.42 g BD g(-1) cassava powder and a specific productivity of 3.3 g l(-1) h(-1). A higher BD concentration (93.9 g l(-1)) was produced after 47 h in fed-batch SSF. Conclusions/Significance: The results suggest that strain SDM is a good candidate for the BD production, and cassava powder could be used as an alternative substrate for the efficient production of BD.	[Wang, Ailong; Xu, Youqiang; Ma, Cuiqing; Gao, Chao; Li, Lixiang; Wang, Yu; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Tao, Fei; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University	Wang, AL (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn	Tao, Fei/E-5891-2010	Tao, Fei/0000-0002-5997-8770; Ma, Cuiqing/0000-0002-7468-1027; Gao, Chao/0000-0002-5205-0670; Wang, Yu/0000-0002-0957-9245	Chinese National Programs for High Technology Research and Development [2011AA02A207]; Chinese National Natural Science Foundation [30770064]	Chinese National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National Programs for High Technology Research and Development (2011AA02A207) and the Chinese National Natural Science Foundation (No. 30770064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; Cheng KK, 2010, PROCESS BIOCHEM, V45, P613, DOI 10.1016/j.procbio.2009.12.009; Choi GW, 2009, J CHEM TECHNOL BIOT, V84, P547, DOI 10.1002/jctb.2077; Djazuli M, 1999, FOOD CHEM, V65, P523, DOI 10.1016/S0308-8146(98)00218-0; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; Ghofar A, 2005, J BIOSCI BIOENG, V100, P606, DOI 10.1263/jbb.100.606; Gu Y, 2009, J IND MICROBIOL BIOT, V36, P1225, DOI 10.1007/s10295-009-0604-1; Jansen N B, 1983, Adv Biochem Eng Biotechnol, V27, P85; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; Ji XJ, 2011, APPL MICROBIOL BIOT, V89, P1119, DOI 10.1007/s00253-010-2940-5; Ji XJ, 2010, APPL MICROBIOL BIOT, V85, P1751, DOI 10.1007/s00253-009-2222-2; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P5214, DOI 10.1016/j.biortech.2009.05.036; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P3410, DOI 10.1016/j.biortech.2009.02.031; Kostinek M, 2007, INT J FOOD MICROBIOL, V114, P342, DOI 10.1016/j.ijfoodmicro.2006.09.029; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Nie ZK, 2011, APPL BIOCHEM BIOTECH, V163, P946, DOI 10.1007/s12010-010-9098-6; Nitayavardhana S, 2010, BIORESOURCE TECHNOL, V101, P2741, DOI 10.1016/j.biortech.2009.10.075; Papong S, 2010, BIORESOURCE TECHNOL, V101, pS112, DOI 10.1016/j.biortech.2009.09.006; Petrov K, 2010, APPL MICROBIOL BIOT, V87, P943, DOI 10.1007/s00253-010-2545-z; Qin JY, 2006, CHINESE J CHEM ENG, V14, P132, DOI 10.1016/S1004-9541(06)60050-5; Roble ND, 2003, BIOTECHNOL LETT, V25, P1093, DOI 10.1023/A:1024192131343; Saha BC, 1999, APPL MICROBIOL BIOT, V52, P321, DOI 10.1007/s002530051526; Sun LH, 2009, APPL MICROBIOL BIOT, V82, P847, DOI 10.1007/s00253-008-1823-5; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; Thang VH, 2010, APPL BIOCHEM BIOTECH, V161, P157, DOI 10.1007/s12010-009-8770-1; Wang AL, 2010, APPL MICROBIOL BIOT, V87, P965, DOI 10.1007/s00253-010-2557-8; Wang LM, 2010, BIORESOURCE TECHNOL, V101, P7895, DOI 10.1016/j.biortech.2010.05.018; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Xu YQ, 2012, J BACTERIOL, V194, P897, DOI 10.1128/JB.06495-11; Zeng AP, 2011, CURR OPIN BIOTECH, V22, P749, DOI 10.1016/j.copbio.2011.05.005; Zhang LY, 2010, J IND MICROBIOL BIOT, V37, P857, DOI 10.1007/s10295-010-0733-6	31	42	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40442	10.1371/journal.pone.0040442	http://dx.doi.org/10.1371/journal.pone.0040442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792324	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300067
J	Weinberg, SH; Tung, L				Weinberg, Seth H.; Tung, Leslie			Oscillation in Cycle Length Induces Transient Discordant and Steady-State Concordant Alternans in the Heart	PLOS ONE			English	Article							MONOMORPHIC VENTRICULAR-TACHYCARDIA; SMALL-SIGNAL AMPLIFICATION; MECHANISM; INITIATION	Alternans is a beat-to-beat alternation of the cardiac action potential duration (APD) or intracellular calcium (Ca-i) transient. In cardiac tissue, alternans can be spatially concordant or discordant, of which the latter has been shown to increase dispersion of repolarization and promote a substrate for initiation of ventricular fibrillation. Alternans has been studied almost exclusively under constant cycle length pacing conditions. However, heart rate varies greatly on a beat-by-beat basis in normal and pathological conditions. The purpose of this study was to determine if applying a repetitive but non-constant pacing pattern, specifically cycle length oscillation (CLO), promotes or suppresses a proarrhythmic substrate. We performed computational simulations and optical mapping experiments to investigate the potential consequences of CLO. In a single cell computational model, CLO induced APD and Ca-i alternans, which became "phase-matched" with the applied oscillation. As a consequence of the phase-matching, in one-dimensional cable simulations, neonatal rat ventricular myocyte monolayers, and isolated adult guinea pig hearts CLO could transiently induce spatial and electromechanical discordant alternans followed by a steady-state of concordance. Our results demonstrated that under certain conditions, CLO can initiate ventricular fibrillation in the isolated hearts. On the other hand, CLO can also exert an antiarrhythmic effect by converting an existing state of discordant alternans to concordant alternans.	[Weinberg, Seth H.; Tung, Leslie] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Weinberg, SH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	sweinbe9@jhmi.edu; ltung@jhu.edu		Weinberg, Seth/0000-0003-1170-0419	National Institutes of Health [R01 HL066239, S10 RR025544]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025544] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by National Institutes of Health grants R01 HL066239 (LT) and S10 RR025544 (LT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistrup GL, 2009, CIRCULATION RES; Berger CM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058101; BINKLEY PF, 1995, ANN INTERN MED, V122, P115, DOI 10.7326/0003-4819-122-2-199501150-00007; Christini DJ, 2001, P NATL ACAD SCI USA, V98, P5827, DOI 10.1073/pnas.091553398; Gelzer ARM, 2008, CIRCULATION, V118, P1123, DOI 10.1161/CIRCULATIONAHA.107.738013; Gratadour P, 2008, INT J CARDIOL, V127, pE138, DOI 10.1016/j.ijcard.2007.04.138; Hall GM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.198102; Heldstab J, 1983, Z PHYS B, P141; Huikuri HV, 1996, CIRCULATION, V93, P1836, DOI 10.1161/01.CIR.93.10.1836; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Otani NF, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021910; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Qu ZL, 2000, CIRCULATION, V102, P1664, DOI 10.1161/01.CIR.102.14.1664; ROELKE M, 1994, J AM COLL CARDIOL, V23, P117, DOI 10.1016/0735-1097(94)90509-6; RUBENSTEIN DS, 1995, CIRCULATION, V91, P201, DOI 10.1161/01.CIR.91.1.201; Saeed M, 2000, AM J CARDIOL, V85, P580, DOI 10.1016/S0002-9149(99)00815-2; Shiferaw Y, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021903; Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249; Tandri H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002445; Tung L, 2006, J ELECTROCARDIOL, V39, pS2, DOI 10.1016/j.jelectrocard.2006.04.010; Watanabe MA, 2001, J CARDIOVASC ELECTR, V12, P196, DOI 10.1046/j.1540-8167.2001.00196.x; Weinberg S, 2008, BIOPHYS J, V95, P1138, DOI 10.1529/biophysj.107.128207; Weinberg S, 2010, METHODS MOL BIOL, V660, P215, DOI 10.1007/978-1-60761-705-1_14; Weinberg S, 2010, AM J PHYSIOL-HEART C, V298, pH1727, DOI 10.1152/ajpheart.01036.2009; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; WIESENFELD K, 1986, PHYS REV A, V33, P629, DOI 10.1103/PhysRevA.33.629; Wu RZ, 2006, J CARDIOVASC ELECTR, V17, P87, DOI 10.1111/j.1540-8167.2005.00319.x; Zhao XP, 2007, NONLINEAR DYNAM, V48, P381, DOI 10.1007/s11071-006-9092-2; Zhao X, 2008, J COMPUT NONLIN DYN, V3, DOI 10.1115/1.2960467	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40477	10.1371/journal.pone.0040477	http://dx.doi.org/10.1371/journal.pone.0040477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792346	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300069
J	Yu, HP; Zhao, H; Wang, LE; Liu, ZS; Li, DH; Wei, QY				Yu, Hongping; Zhao, Hui; Wang, Li-E; Liu, Zhensheng; Li, Donghui; Wei, Qingyi			Correlation between Base-Excision Repair Gene Polymorphisms and Levels of In-Vitro BPDE-Induced DNA Adducts in Cultured Peripheral Blood Lymphocytes	PLOS ONE			English	Article							LUNG-CANCER RISK; POLYCYCLIC AROMATIC-HYDROCARBONS; SQUAMOUS-CELL CARCINOMA; DIOL EPOXIDE; BREAST-CANCER; ESCHERICHIA-COLI; REDOX REGULATION; NUCLEOTIDE; APE1; BENZO<A>PYRENE	In vitro benzo[a]pyrene diol epoxide (BPDE)-induced DNA adducts in cultured peripheral lymphocytes have been shown to be a phenotypic biomarker of individual's DNA repair phenotype that is associated with cancer risk. In this study, we explored associations between genotypes of base-excision repair genes (PARP1 Val762Ala, APEX1 Asp148Glu, and XRCC1 Arg399Gln) and in vitro BPDE-induced DNA adducts in cultured peripheral blood lymphocytes in 706 cancer-free non-Hispanic white subjects. We found that levels of BPDE-induced DNA adducts were significantly higher in ever smokers than in never smokers and that individuals with the Glu variant genotypes (i.e., Asp/Glu and Glu/Glu) exhibited lower levels of BPDE-induced DNA adducts than did individuals with the common Asp/Asp homozygous genotype (median RAL levels: 32.0 for Asp/Asp, 27.0 for Asp/Glu, and 17.0 for Glu/Glu, respectively; P-trend = 0.030). Further stratified analysis showed that compared with individuals with the common APEX1-148 homozygous Asp/Asp genotype, individuals with the APEX1-148Asp/Glu genotype or the Glu/Glu genotype had a lower risk of having higher-level adducts (adjusted OR = 0.60, 95% CI: 0.36-0.98 and adjusted OR = 0.47, 95% CI: 0.26-0.86, respectively; P-trend = 0.012) among smokers. Such an effect was not observed in non-smokers. However, there was no significant interaction between the APEX1 Asp148Glu polymorphism and smoking exposure in this study population (P = 0.512). Additional genotype-phenotype analysis found that the APEX1-148Glu allele had significantly increased expression of APEX1 mRNA in 270 Epstein-Barr virus-transformed lymphoblastoid cell lines, which is likely associated with more active repair activity. Our findings suggest that the functional APEX1-148Glu allele is associated with reduced risk of having high levels of BPDE-induced DNA adducts mediated with high levels of mRNA expression.	[Yu, Hongping] Guiling Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guilin, Peoples R China; [Yu, Hongping; Zhao, Hui; Wang, Li-E; Liu, Zhensheng; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yu, HP (corresponding author), Guiling Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guilin, Peoples R China.	yuhongping@hotmail.com; qwei@mdanderson.org	Zhao, Hui/AAS-7145-2020		National Institutes of Health [R01 ES-11740, R01 CA-131274, P30 CA-16672]; National Natural Science Foundation of China [30660162]; Natural Science Foundation of Guangxi [0719006]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA131274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (R01 ES-11740 and R01 CA-131274 to Dr. Wei, and P30 CA-16672 to The University of Texas M.D. Anderson Cancer Center), the National Natural Science Foundation of China (30660162), and the Natural Science Foundation of Guangxi (0719006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Alexandrov K, 2010, TOXICOL LETT, V198, P63, DOI 10.1016/j.toxlet.2010.04.009; Ali MF, 2008, ONCOL REP, V19, P1033; Baute J, 2008, CRIT REV BIOCHEM MOL, V43, P239, DOI 10.1080/10409230802309905 ; Benhamou S, 2000, MUTAT RES-REV MUTAT, V462, P149, DOI 10.1016/S1383-5742(00)00032-6; BLAKEY DH, 1990, MUTAT RES, V236, P35, DOI 10.1016/0921-8777(90)90030-9; Bonn D, 1998, LANCET, V351, P42, DOI 10.1016/S0140-6736(05)78079-X; Braithwaite E, 1998, CARCINOGENESIS, V19, P1239, DOI 10.1093/carcin/19.7.1239; Canbay E, 2010, ANTICANCER RES, V30, P1359; Casale GP, 2001, CHEM RES TOXICOL, V14, P192, DOI 10.1021/tx000012y; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; DAY RS, 1978, MUTAT RES, V50, P383, DOI 10.1016/0027-5107(78)90043-X; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Deng Q, 2011, MED ONCOL; DEVANESAN PD, 1992, CHEM RES TOXICOL, V5, P302, DOI 10.1021/tx00026a024; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fritz G, 2000, INT J BIOCHEM CELL B, V32, P925, DOI 10.1016/S1357-2725(00)00045-5; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HALL J, 1994, INT J CANCER, V58, P179, DOI 10.1002/ijc.2910580206; HELZLSOUER KJ, 1995, INT J CANCER, V64, P14, DOI 10.1002/ijc.2910640105; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Houtgraaf JH, 2006, CARDIOVASC REVASCULA, V7, P165, DOI 10.1016/j.carrev.2006.02.002; JEFFREY AM, 1979, SCIENCE, V206, P1309, DOI 10.1126/science.316186; Jin XM, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-38; Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014; KING HWS, 1979, CHEM-BIOL INTERACT, V24, P345, DOI 10.1016/0009-2797(79)90082-6; Li CY, 2006, CARCINOGENESIS, V27, P1894, DOI 10.1093/carcin/bgl042; Li DH, 2001, INT J CANCER, V93, P436, DOI 10.1002/ijc.1347.abs; Li DH, 2007, CANCER RES, V67, P5628, DOI 10.1158/0008-5472.CAN-07-0983; Li HH, 2009, BREAST, V18, P183, DOI 10.1016/j.breast.2009.03.008; Li Z, 2011, ARCH MED RES, V42, P226, DOI 10.1016/j.arcmed.2011.04.005; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; Lo YL, 2009, CANCER EPIDEM BIOMAR, V18, P223, DOI 10.1158/1055-9965.EPI-08-0749; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; Manvilla BA, 2010, BIOMOL NMR ASSIGN, V4, P5, DOI 10.1007/s12104-009-9196-y; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; Nemec AA, 2010, SEMIN CANCER BIOL, V20, P320, DOI 10.1016/j.semcancer.2010.10.010; O'Brien TJ, 2005, MOL CELL BIOCHEM, V279, P85, DOI 10.1007/s11010-005-8225-0; OSBORNE M, 1985, CHEM-BIOL INTERACT, V53, P183, DOI 10.1016/S0009-2797(85)80095-8; OSBORNE MR, 1981, CARCINOGENESIS, V2, P553, DOI 10.1093/carcin/2.6.553; PELTONEN K, 1995, J OCCUP ENVIRON MED, V37, P52, DOI 10.1097/00043764-199501000-00008; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Shekari M, 2008, CANCER BIOMARK, V4, P63, DOI 10.3233/CBM-2008-4202; STIERUM RH, 1994, CARCINOGENESIS, V15, P745, DOI 10.1093/carcin/15.4.745; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; STRAUB KM, 1977, P NATL ACAD SCI USA, V74, P5285, DOI 10.1073/pnas.74.12.5285; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Tudek B, 2007, MOL ASPECTS MED, V28, P258, DOI 10.1016/j.mam.2007.05.003; VANHOUTEN B, 1986, CARCINOGENESIS, V7, P83, DOI 10.1093/carcin/7.1.83; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; Wang ML, 2010, DNA CELL BIOL, V29, P303, DOI 10.1089/dna.2009.0969; WEI QY, 1994, AM J EPIDEMIOL, V140, P598, DOI 10.1093/oxfordjournals.aje.a117297; Wei QY, 1997, CANCER METAST REV, V16, P295, DOI 10.1023/A:1005852211430; Wei QY, 1996, CANCER RES, V56, P4103; Wei QY, 2000, J NATL CANCER I, V92, P1764; WEI QY, 1993, P NATL ACAD SCI USA, V90, P1614, DOI 10.1073/pnas.90.4.1614; WEINSTEIN IB, 1976, SCIENCE, V193, P592, DOI 10.1126/science.959820; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Yosunkaya E, 2010, BRIT J NEUROSURG, V24, P561, DOI 10.3109/02688697.2010.489655; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653; Zhao H, 2008, CARCINOGENESIS, V29, P1560, DOI 10.1093/carcin/bgn089; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	65	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40131	10.1371/journal.pone.0040131	http://dx.doi.org/10.1371/journal.pone.0040131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792228	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300029
J	Amigo-Correig, M; Barcelo-Batllori, S; Soria, G; Krezymon, A; Benani, A; Penicaud, L; Tudela, R; Planas, AM; Fernandez, E; Carmona, MD; Gomis, R				Amigo-Correig, Marta; Barcelo-Batllori, Silvia; Soria, Guadalupe; Krezymon, Alice; Benani, Alexandre; Penicaud, Luc; Tudela, Raul; Maria Planas, Anna; Fernandez, Eduardo; del Carmen Carmona, Maria; Gomis, Ramon			Anti-Obesity Sodium Tungstate Treatment Triggers Axonal and Glial Plasticity in Hypothalamic Feeding Centers	PLOS ONE			English	Article							RESPONSE MEDIATOR PROTEIN-2; WATER DIFFUSION; AGENT TUNGSTATE; ARCUATE NUCLEUS; NERVOUS-SYSTEM; ADIPOSE-TISSUE; FOOD-INTAKE; PHOSPHORYLATION; CRMP-2; RATS	Objective: This study aims at exploring the effects of sodium tungstate treatment on hypothalamic plasticity, which is known to have an important role in the control of energy metabolism. Methods: Adult lean and high-fat diet-induced obese mice were orally treated with sodium tungstate. Arcuate and paraventricular nuclei and lateral hypothalamus were separated and subjected to proteomic analysis by DIGE and mass spectrometry. Immunohistochemistry and in vivo magnetic resonance imaging were also performed. Results: Sodium tungstate treatment reduced body weight gain, food intake, and blood glucose and triglyceride levels. These effects were associated with transcriptional and functional changes in the hypothalamus. Proteomic analysis revealed that sodium tungstate modified the expression levels of proteins involved in cell morphology, axonal growth, and tissue remodeling, such as actin, CRMP2 and neurofilaments, and of proteins related to energy metabolism. Moreover, immunohistochemistry studies confirmed results for some targets and further revealed tungstate-dependent regulation of SNAP25 and HPC-1 proteins, suggesting an effect on synaptogenesis as well. Functional test for cell activity based on c-fos-positive cell counting also suggested that sodium tungstate modified hypothalamic basal activity. Finally, in vivo magnetic resonance imaging showed that tungstate treatment can affect neuronal organization in the hypothalamus. Conclusions: Altogether, these results suggest that sodium tungstate regulates proteins involved in axonal and glial plasticity. The fact that sodium tungstate could modulate hypothalamic plasticity and networks in adulthood makes it a possible and interesting therapeutic strategy not only for obesity management, but also for other neurodegenerative illnesses like Alzheimer's disease.	[Amigo-Correig, Marta; Barcelo-Batllori, Silvia; del Carmen Carmona, Maria; Gomis, Ramon] Hosp Clin Barcelona, Diabet & Obes Lab, Inst Invest Biomed August Pi & Sunyer, Endocrinol & Nutr Unit, Barcelona, Spain; [Amigo-Correig, Marta; Barcelo-Batllori, Silvia; del Carmen Carmona, Maria; Gomis, Ramon] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Tudela, Raul] Univ Barcelona, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Grp Biomed Imaging, Barcelona, Spain; [Soria, Guadalupe; Maria Planas, Anna] Inst Invest Biomed August Pi & Sunyer, CSIC, Inst Invest Biomed Barcelona, Dept Brain Ischemia & Neurodegenerat, Barcelona, Spain; [Soria, Guadalupe; Tudela, Raul; Maria Planas, Anna] Inst Invest Biomed August Pi & Sunyer, Expt MRI Unit 7T, Barcelona, Spain; [Krezymon, Alice; Benani, Alexandre; Penicaud, Luc] Univ Bourgogne, INRA 1324, UMR CNRS 6265, Taste & Food Sci Ctr, Dijon, France; [Fernandez, Eduardo] Miguel Hernandez Univ, Bioengn Inst, Elche, Spain; [Fernandez, Eduardo] Miguel Hernandez Univ, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Elche, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad Miguel Hernandez de Elche	Amigo-Correig, M (corresponding author), Hosp Clin Barcelona, Diabet & Obes Lab, Inst Invest Biomed August Pi & Sunyer, Endocrinol & Nutr Unit, Barcelona, Spain.	CARMONA@clinic.ub.es; RGOMIS@clinic.ub.es	Tudela, Raúl/K-8261-2017; Soria, Guadalupe/AAG-4658-2021; Soria, Guadalupe/GXH-4792-2022; Planas, Anna M/J-5991-2014; Fernandez, Eduardo/S-8206-2016; Benani, Alexandre/F-4002-2012	Tudela, Raúl/0000-0001-5134-4784; Soria, Guadalupe/0000-0002-8344-0479; Planas, Anna M/0000-0002-6147-1880; Fernandez, Eduardo/0000-0002-7052-6011; Carmona Orozco, Mamen/0000-0001-5911-6938; Benani, Alexandre/0000-0003-2046-0162; Barcelo-Batllori, Silvia/0000-0002-5352-9747	Spanish Ministry of Education of Science [SAF 2006-07382, BES-2007-17284]; Carlos III Health Institute (ISCIII) [CP07/00152]	Spanish Ministry of Education of Science(Spanish Government); Carlos III Health Institute (ISCIII)(Instituto de Salud Carlos III)	This work was supported by project no SAF 2006-07382 and grant no BES-2007-17284, both awarded by the Spanish Ministry of Education of Science, and by project noCP07/00152, financed by the Carlos III Health Institute (ISCIII). Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas is an initiative of ISCIII (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo-Correig M, 2011, DIABETES OBES METAB, V13, P235, DOI 10.1111/j.1463-1326.2010.01339.x; Amigo-Correig M, DIABETES OB IN PRESS; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Banas SM, 2009, CELL MOL NEUROBIOL, V29, P157, DOI 10.1007/s10571-008-9307-9; BARBERA A, 1994, J BIOL CHEM, V269, P20047; Barbera AGR, 2001, DIABETOLOGIA, V44; Barcelo-Batllori S, 2005, PROTEOMICS, V5, P4927, DOI 10.1002/pmic.200500050; Barcelo-Batllori S, 2002, PROTEOMICS, V2, P551, DOI 10.1002/1615-9861(200205)2:5<551::AID-PROT551>3.0.CO;2-O; Barcelo-Batllori S, 2008, MOL CELL PROTEOMICS, V7, P378, DOI 10.1074/mcp.M700198-MCP200; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Becskei C, 2009, NEUROENDOCRINOLOGY, V90, P371, DOI 10.1159/000251723; Bernabeu A, 2009, NEUROIMAGE, V47, P1172, DOI 10.1016/j.neuroimage.2009.04.080; Bouret S, 2004, SCIENCE, V304, P63; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; Canals I, 2009, ENDOCRINOLOGY, V150, P642, DOI 10.1210/en.2008-0881; Carmona MC, 2009, INT J OBES; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Claret M, 2005, ENDOCRINOLOGY, V146, P4362, DOI 10.1210/en.2005-0385; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Evans J, 2002, J NEUROPHYSIOL, V87, P1076, DOI 10.1152/jn.00088.2001; Felley-Bosco E, 1999, ELECTROPHORESIS, V20, P3508, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3508::AID-ELPS3508>3.0.CO;2-7; Fontan-Lozano A, 2008, MOL NEUROBIOL, V38, P167, DOI 10.1007/s12035-008-8040-1; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gomez-Ramos A, 2006, J NEUROSCI RES, V83, P264, DOI 10.1002/jnr.20726; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; HARRIS RBS, 1986, J NUTR, V116, P2536, DOI 10.1093/jn/116.12.2536; Hasan KM, 2006, MAGN RESON MED, V56, P130, DOI 10.1002/mrm.20935; Horvath TL, 2004, NEUROSCIENTIST, V10, P235, DOI 10.1177/1073858403262151; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kanninen K, 2004, NEUROSCI LETT, V367, P235, DOI 10.1016/j.neulet.2004.06.013; Kletzin A, 1996, FEMS MICROBIOL REV, V18, P5, DOI 10.1016/0168-6445(95)00025-9; Lazar M, 2005, MAGN RESON MED, V54, P860, DOI 10.1002/mrm.20653; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Morisaki S, 2011, J MAGN RESON IMAGING, V33, P535, DOI 10.1002/jmri.22442; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mungarndee SS, 2008, AM J PHYSIOL-REG I, V295, pR751, DOI 10.1152/ajpregu.90344.2008; Munoz MC, 2001, DIABETES, V50, P131, DOI 10.2337/diabetes.50.1.131; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Piquer S, 2007, BIOCHEM BIOPH RES CO, V358, P385, DOI 10.1016/j.bbrc.2007.04.143; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Stankiewiez PaG MJ, 1988, BIOCHEMISTRY-US, V27, P206; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; Tobin JE, 2011, J NEUROPATH EXP NEUR, V70, P157, DOI 10.1097/NEN.0b013e31820937e4; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Veeranna GJ, 2000, MOL BRAIN RES, V76, P229, DOI 10.1016/S0169-328X(00)00003-6; Verty ANA, 2010, ENDOCRINOLOGY, V151, P4236, DOI 10.1210/en.2009-1235; Vianna CR, 2011, ENDOCRINOLOGY, V152, P11, DOI 10.1210/en.2010-0778; Yamashita N, 2012, J NEUROSCI, V32, P1360, DOI 10.1523/JNEUROSCI.5563-11.2012; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zheng HY, 2008, PHYSIOLOGY, V23, P75, DOI 10.1152/physiol.00047.2007	61	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39087	10.1371/journal.pone.0039087	http://dx.doi.org/10.1371/journal.pone.0039087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802935	Green Published, gold			2022-12-27	WOS:000306186900009
J	Miller, AK; Britten, RD; Nielsen, PMF				Miller, Andrew K.; Britten, Randall D.; Nielsen, Poul M. F.			Declarative Representation of Uncertainty in Mathematical Models	PLOS ONE			English	Article							CELLML	An important aspect of multi-scale modelling is the ability to represent mathematical models in forms that can be exchanged between modellers and tools. While the development of languages like CellML and SBML have provided standardised declarative exchange formats for mathematical models, independent of the algorithm to be applied to the model, to date these standards have not provided a clear mechanism for describing parameter uncertainty. Parameter uncertainty is an inherent feature of many real systems. This uncertainty can result from a number of situations, such as: when measurements include inherent error; when parameters have unknown values and so are replaced by a probability distribution by the modeller; when a model is of an individual from a population, and parameters have unknown values for the individual, but the distribution for the population is known. We present and demonstrate an approach by which uncertainty can be described declaratively in CellML models, by utilising the extension mechanisms provided in CellML. Parameter uncertainty can be described declaratively in terms of either a univariate continuous probability density function or multiple realisations of one variable or several (typically non-independent) variables. We additionally present an extension to SED-ML (the Simulation Experiment Description Markup Language) to describe sampling sensitivity analysis simulation experiments. We demonstrate the usability of the approach by encoding a sample model in the uncertainty markup language, and by developing a software implementation of the uncertainty specification (including the SED-ML extension for sampling sensitivty analyses) in an existing CellML software library, the CellML API implementation. We used the software implementation to run sampling sensitivity analyses over the model to demonstrate that it is possible to run useful simulations on models with uncertainty encoded in this form.	[Miller, Andrew K.; Britten, Randall D.; Nielsen, Poul M. F.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Nielsen, Poul M. F.] Univ Auckland, Dept Engn Sci, Fac Engn, Auckland, New Zealand	University of Auckland; University of Auckland	Miller, AK (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand.	ak.miller@auckland.ac.nz			Virtual Physiological Human Share project under European Framework 7	Virtual Physiological Human Share project under European Framework 7	This work was funded by the Virtual Physiological Human Share project (http://www.vph-share.eu), under European Framework 7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS JH, 1982, COMMUN ACM, V25, P47, DOI 10.1145/358315.358390; Apt K, 2003, LECT N BIOINFORMAT; Carlisle D., 2000, SIGSAM Bulletin, V34, P6, DOI 10.1145/362001.362011; Devroye L., 1986, NONUNIFORM RANDOM VA, V4; Gilks W.R., 1994, LANGUAGE PROGRAM COM, P169; Hedley WJ, 2001, PHILOS T ROY SOC A, V359, P1073, DOI 10.1098/rsta.2001.0817; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Josey A, 2004, 10031 IEEE OP GROUP, P20; Kinderman A, 1976, J AM STAT ASSOC, P893; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Lloyd CM, 2004, PROG BIOPHYS MOL BIO, V85, P433, DOI 10.1016/j.pbiomolbio.2004.01.004; Lourakis M, 2008, LEVMAR LEVENBERG MAR; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Miller AK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-178; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Thomas A, 1992, BAYESIAN STATISTICS, P837; Von Neumann J., 1951, APPL MATH SER, V12, P36	19	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39721	10.1371/journal.pone.0039721	http://dx.doi.org/10.1371/journal.pone.0039721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802941	gold, Green Submitted, Green Published			2022-12-27	WOS:000306186900015
J	Akiyama, Y; Hoshino, T; Iwabuchi, K; Morishima, K				Akiyama, Yoshitake; Hoshino, Takayuki; Iwabuchi, Kikuo; Morishima, Keisuke			Room Temperature Operable Autonomously Moving Bio-Microrobot Powered by Insect Dorsal Vessel Tissue	PLOS ONE			English	Article							CULTURED CARDIOMYOCYTES; LONG-TERM; FABRICATION; STIMULATION	Living muscle tissues and cells have been attracting attention as potential actuator candidates. In particular, insect dorsal vessel tissue (DVT) seems to be well suited for a bio-actuator since it is capable of contracting autonomously and the tissue itself and its cells are more environmentally robust under culturing conditions compared with mammalian tissues and cells. Here we demonstrate an autonomously moving polypod microrobot (PMR) powered by DVT excised from an inchworm. We fabricated a prototype of the PMR by assembling a whole DVT onto an inverted two-row micropillar array. The prototype moved autonomously at a velocity of 3.5610(-2) mu m/s, and the contracting force of the whole DVT was calculated as 20 mu N. Based on the results obtained by the prototype, we then designed and fabricated an actual PMR. We were able to increase the velocity significantly for the actual PMR which could move autonomously at a velocity of 3.5 mu m/s. These results indicate that insect DVT has sufficient potential as the driving force for a bio-microrobot that can be utilized in microspaces.	[Akiyama, Yoshitake; Hoshino, Takayuki; Morishima, Keisuke] Osaka Univ, Dept Mech Engn, Suita, Osaka, Japan; [Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Dept Appl Mol Biol & Biochem, Fuchu, Tokyo, Japan; [Akiyama, Yoshitake; Hoshino, Takayuki; Morishima, Keisuke] Tokyo Univ Agr & Technol, Dept Bioapplicat & Syst Engn, Tokyo, Japan	Osaka University; Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology	Akiyama, Y (corresponding author), Osaka Univ, Dept Mech Engn, Suita, Osaka, Japan.	morishima@mech.eng.osaka-u.ac.jp	Iwabuchi, Kikuo/I-7530-2012; Morishima, Keisuke/AAZ-8751-2021; Hoshino, Takayuki/O-6226-2015; Morishima, Keisuke/L-2873-2016	Morishima, Keisuke/0000-0003-1146-3900; Hoshino, Takayuki/0000-0003-4376-7853; Morishima, Keisuke/0000-0003-1146-3900	Ministry of Education, Culture, Sports, Science and Technology in Japan [20034017, 21676002, 21111503, 21225007]; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Moritani Scholarship Foundation; TORAY Science Foundation; CASIO Science Promotion Foundation	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Moritani Scholarship Foundation; TORAY Science Foundation(Toray Industries, Inc.); CASIO Science Promotion Foundation	The present work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan Nos. 20034017, 21676002, 21111503, and 21225007, the Industrial Technology Research Grant Program (2006) from the New Energy and Industrial Technology Development Organization (NEDO) of Japan, The Moritani Scholarship Foundation, TORAY Science Foundation and CASIO Science Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Yoshitake, 2010, Journal of Biomechanical Science and Engineering, V5, P236, DOI 10.1299/jbse.5.236; Akiyama Y, 2008, P 12 INT C MIN SYST, P1669; Akiyama Y, 2008, J BIOTECHNOL, V133, P261, DOI 10.1016/j.jbiotec.2007.08.042; Akiyama Yoshitake, 2006, Conf Proc IEEE Eng Med Biol Soc, VSuppl, P6565; Akiyama Y, 2010, IN VITRO CELL DEV-AN, V46, P411, DOI 10.1007/s11626-009-9268-4; Akiyama Y, 2008, P IEEE RAS-EMBS INT, P501, DOI 10.1109/BIOROB.2008.4762909; Akiyama Y, 2009, LAB CHIP, V9, P140, DOI 10.1039/b809299k; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Horiguchi H, 2009, IEEE T NANOBIOSCI, V8, P349, DOI 10.1109/TNB.2009.2035282; Hunter I.W., 1992, IEEE SOL STAT SENS A, P178, DOI DOI 10.1109/SOLSEN.1992.228297; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; Ishisaka T., 2007, TRANSDUCERS '07 & Eurosensors XXI. 2007 14th International Conference on Solid-State Sensors, Actuators and Microsystems, P903, DOI 10.1109/SENSOR.2007.4300277; Kim DH, 2006, SENSOR ACTUAT B-CHEM, V117, P391, DOI 10.1016/j.snb.2005.11.051; Kim J, 2007, LAB CHIP, V7, P1504, DOI 10.1039/b705367c; Madden JD, 2007, SCIENCE, V318, P1094, DOI 10.1126/science.1146351; Mitsuhashi J, 2002, SPRING LAB MAN; Morishima K, 2006, SENSOR ACTUAT B-CHEM, V119, P345, DOI 10.1016/j.snb.2005.11.063; Park JY, 2007, LAB CHIP, V7, P1367, DOI 10.1039/b703900j; Shimizu K, 2010, INT C P MIN SYST CHE, P1229; Suzumura K, 2011, PROC IEEE MICR ELECT, P149, DOI 10.1109/MEMSYS.2011.5734383; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tanaka Y, 2006, LAB CHIP, V6, P362, DOI 10.1039/b515149j; Tanaka Y, 2006, LAB CHIP, V6, P230, DOI 10.1039/b512099c; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Yamasaki K, 2009, J ARTIF ORGANS, V12, P131, DOI 10.1007/s10047-009-0457-4	27	44	44	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38274	10.1371/journal.pone.0038274	http://dx.doi.org/10.1371/journal.pone.0038274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808004	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400001
J	Dutton, PJ; Warrander, LK; Roberts, SA; Bernatavicius, G; Byrd, LM; Gaze, D; Kroll, J; Jones, RL; Sibley, CP; Froen, JF; Heazell, AEP				Dutton, Philip J.; Warrander, Lynne K.; Roberts, Stephen A.; Bernatavicius, Giovanna; Byrd, Louise M.; Gaze, David; Kroll, Josh; Jones, Rebecca L.; Sibley, Colin P.; Froen, J. Frederik; Heazell, Alexander E. P.			Predictors of Poor Perinatal Outcome following Maternal Perception of Reduced Fetal Movements - A Prospective Cohort Study	PLOS ONE			English	Article							LATE STILLBIRTH; WOMEN; MANAGEMENT	Background: Maternal perception of reduced fetal movement (RFM) is associated with increased risk of stillbirth and fetal growth restriction (FGR). RFM is thought to represent fetal compensation to conserve energy due to insufficient oxygen and nutrient transfer resulting from placental insufficiency. Objective: To identify predictors of poor perinatal outcome after maternal perception of reduced fetal movements (RFM). Design: Prospective cohort study. Methods: 305 women presenting with RFM after 28 weeks of gestation were recruited. Demographic factors and clinical history were recorded and ultrasound performed to assess fetal biometry, liquor volume and umbilical artery Doppler. A maternal serum sample was obtained for measurement of placentally-derived or modified proteins including: alpha fetoprotein (AFP), human chorionic gonadotrophin (hCG), human placental lactogen (hPL), ischaemia-modified albumin (IMA), pregnancy associated plasma protein A (PAPP-A) and progesterone. Factors related to poor perinatal outcome were determined by logistic regression. Results: 22.1% of pregnancies ended in a poor perinatal outcome after RFM. The most common complication was small-for-gestational age infants. Pregnancy outcome after maternal perception of RFM was related to amount of fetal activity while being monitored, abnormal fetal heart rate trace, diastolic blood pressure, estimated fetal weight, liquor volume, serum hCG and hPL. Following multiple logistic regression abnormal fetal heart rate trace (Odds ratio 7.08, 95% Confidence Interval 1.31-38.18), (OR) diastolic blood pressure (OR 1.04 (95% CI 1.01-1.09), estimated fetal weight centile (OR 0.95, 95% CI 0.94-0.97) and log maternal serum hPL (OR 0.13, 95% CI 0.02-0.99) were independently related to pregnancy outcome. hPL was related to placental mass. Conclusion: Poor perinatal outcome after maternal perception of RFM is closely related to factors which are connected to placental dysfunction. Novel tests of placental function and associated fetal response may provide improved means to detect fetuses at greatest risk of poor perinatal outcome after RFM.	[Dutton, Philip J.; Warrander, Lynne K.; Kroll, Josh; Jones, Rebecca L.; Sibley, Colin P.; Heazell, Alexander E. P.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Bernatavicius, Giovanna; Byrd, Louise M.; Heazell, Alexander E. P.] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Dept Obstet, Manchester, Lancs, England; [Gaze, David] St George Hosp, Sch Med, Dept Chem Pathol, London, England; [Froen, J. Frederik] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway	University of Manchester; University of Manchester; St Georges University London; Norwegian Institute of Public Health (NIPH)	Dutton, PJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.	alexander.heazell@manchester.ac.uk	Jones, Rebecca/E-4481-2011; Gaze, David C./AAP-6453-2020	Jones, Rebecca/0000-0002-8871-0589; Gaze, David/0000-0002-0544-2356; Heazell, Alexander/0000-0002-4303-7845; Roberts, Steve/0000-0002-7477-7731; Warrander, Lynne/0000-0001-9529-8935; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Manchester Wellcome Trust Clinical Research Facility; Greater Manchester Clinical Local Research Network; Wolfson foundation; National Institutes for Health Research; National Institute for Health Research [CL-2009-06-002] Funding Source: researchfish	Manchester Wellcome Trust Clinical Research Facility(Wellcome Trust); Greater Manchester Clinical Local Research Network; Wolfson foundation; National Institutes for Health Research(National Health Research Institutes - Taiwan); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Manchester Wellcome Trust Clinical Research Facility and the Greater Manchester Clinical Local Research Network. It was underpinned by the National Institutes of Health Research Manchester Biomedical Research Centre. LW was supported by a studentship from the Wolfson foundation. AH is funded by a Clinical Lectureship from the National Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Benton SJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.019; CARL J, 1991, PLACENTA, V12, P289, DOI 10.1016/0143-4004(91)90011-4; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Daly N, 2011, EUR J OBSTET GYN R B, V159, P57, DOI 10.1016/j.ejogrb.2011.07.002; Flenady V, 2009, AUST NZ J OBSTET GYN, V49, P358, DOI 10.1111/j.1479-828X.2009.01026.x; Froen JF, 2008, SEMIN PERINATOL, V32, P307, DOI 10.1053/j.semperi.2008.04.015; Froen JF, 2008, SEMIN PERINATOL, V32, P243, DOI 10.1053/j.semperi.2008.04.004; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Heazell AEP, 2008, J OBSTET GYNAECOL, V28, P147, DOI 10.1080/01443610801912618; Heazell A E P, 2005, J Obstet Gynaecol, V25, P648; Heazell AE, 2012, REPROD SCI IN PRESS; Heazell AEP, 2008, ACTA OBSTET GYN SCAN, V87, P331, DOI 10.1080/00016340801902034; Maulik D, 2006, CLIN OBSTET GYNECOL, V49, P228, DOI 10.1097/00003081-200606000-00006; MINORS DS, 1979, BRIT J OBSTET GYNAEC, V86, P717, DOI 10.1111/j.1471-0528.1979.tb11273.x; O'Sullivan O, 2009, J OBSTET GYNAECOL, V29, P705, DOI 10.3109/01443610903229598; Pattison N., 2000, COCHRANE DB SYST REV; SADOVSKY E, 1973, OBSTET GYNECOL, V41, P845; Sergent F, 2005, Gynecol Obstet Fertil, V33, P861, DOI 10.1016/j.gyobfe.2005.07.041; Sinha D, 2007, J OBSTET GYNAECOL, V27, P41, DOI 10.1080/01443610601016909; Sinha MK, 2004, EMERG MED J, V21, P29, DOI 10.1136/emj.2003.006007; Smith GCS, 2010, 20 SCI ADV COMM ROYA; Stacey T, 2011, BIRTH-ISS PERINAT C, V38, P311, DOI 10.1111/j.1523-536X.2011.00490.x; TUFFNELL DJ, 1991, EUR J OBSTET GYN R B, V39, P165, DOI 10.1016/0028-2243(91)90052-M; Tveit JVH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-49; Tveit JVH, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-32; Unterscheider J, 2009, OBSTET GYNAECOL, V11, P245, DOI 10.1576/toag.11.4.245.27527; Warrander LK, 2011, ARCH DIS CHILD-FETAL, V96, pFa56; Warrander LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034851	30	76	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39784	10.1371/journal.pone.0039784	http://dx.doi.org/10.1371/journal.pone.0039784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808059	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400018
J	Llupia, A; Garcia-Basteiro, AL; Mena, G; Rios, J; Puig, J; Bayas, JM; Trilla, A				Llupia, Anna; Garcia-Basteiro, Alberto L.; Mena, Guillermo; Rios, Jose; Puig, Joaquim; Bayas, Jose M.; Trilla, Antoni			Vaccination Behaviour Influences Self-Report of Influenza Vaccination Status: A Cross-Sectional Study among Health Care Workers	PLOS ONE			English	Article							ELDERLY OUTPATIENTS; COVERAGE; VALIDATION; PROGRAM; QUESTIONNAIRE; PERSONNEL; ACCURACY; VALIDITY	Background: Published influenza vaccination coverage in health care workers (HCW) are calculated using two sources: self-report and vaccination records. The objective of this study was to determine whether self-report is a good proxy for recorded vaccination in HCW, as the degree of the relationship is not known, and whether vaccine behaviour influences self-reporting. Methods: A cross-sectional study was conducted using a self-administered survey during September 2010. Considering the vaccination record as the gold standard of vaccination, the properties of self-report as a proxy of the record (sensitivity, specificity, positive predictive value, negative predictive value) were calculated. Concordance between the vaccination campaigns studied (2007-2010) was made using the Kappa index, and discordance was analyzed using McNemar's test. Results: 248 HCW responded. The 95% confidence intervals of coverage according to the vaccination record and to self-report overlapped, except for 2007, and the Kappa index showed a substantial concordance, except for 2007. McNemar's test suggested that differences between discordant cases were not due to chance and it was found that the proportion of unvaccinated discordant cases was higher than that of vaccinated discordant cases. Conclusions: In our study population, self-reported influenza vaccination coverage in HCW in the previous two years is a good proxy of the vaccination record. However, vaccination behaviour influences the self-report and explains a trend to overestimate coverage in self-reporting compared to the vaccination record. The sources of coverage should be taken into account whenever comparisons are made.	[Llupia, Anna; Garcia-Basteiro, Alberto L.; Mena, Guillermo; Bayas, Jose M.; Trilla, Antoni] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Prevent Med & Epidemiol Unit, Barcelona, Catalonia, Spain; [Rios, Jose] Hosp Clin Barcelona, Clin Pharmacol Serv, Barcelona, Catalonia, Spain; [Rios, Jose] Univ Autonoma Barcelona, Biostat Unit, E-08193 Barcelona, Catalonia, Spain; [Puig, Joaquim] Univ Politecn Cataluna, Dept Appl Math 1, Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Universitat Politecnica de Catalunya	Llupia, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Prevent Med & Epidemiol Unit, Barcelona, Catalonia, Spain.	annallupia@gmail.com	Ríos, José/AAZ-2341-2020; Trilla, Antoni/G-2446-2018; Puig, Joaquim/G-1573-2015; Llupià, Anna/AAD-2093-2021	Ríos, José/0000-0002-0716-8784; Puig, Joaquim/0000-0003-0600-1023; Llupia, Anna/0000-0001-8284-7560; MENA PINILLA, GUILLERMO/0000-0003-0147-6302	Solvay-Abbott Influenza Research Grant; GlaxoSmithKline; Sanofi Pasteur MSD;  [MTM2009-06973]	Solvay-Abbott Influenza Research Grant; GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur MSD; 	This study was funded by the Solvay-Abbott Influenza Research Grant 2010. J Puig is funded by MTM2009-06973. The investigators were contracted by their institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JMB has received fees for lectures, advice and participation in working groups funded by the pharmaceutical industry. He has participated as principal investigator in clinical trials of vaccines (influenza vaccines, and others) promoted by GlaxoSmithKline and Sanofi Pasteur MSD. All other authors declare they have no competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrews RM, 2005, VACCINE, V23, P2756, DOI 10.1016/j.vaccine.2004.11.039; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Bertin M, 2007, AM J INFECT CONTROL, V35, P33, DOI 10.1016/j.ajic.2006.10.005; Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y; Bryant KA, 2004, INFECT CONT HOSP EP, V25, P912, DOI 10.1086/502319; de Juanes JR, 2007, VACCINE, V25, P201, DOI 10.1016/j.vaccine.2005.10.057; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Greene SK, 2009, AM J PREV MED, V37, P552, DOI 10.1016/j.amepre.2009.08.022; HUTCHISON BG, 1989, CAN J PUBLIC HEALTH, V80, P271; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Llupia A, 2010, AM J INFECT CONTROL, V38, P476, DOI 10.1016/j.ajic.2010.01.013; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mangtani P, 2007, EPIDEMIOL INFECT, V135, P139, DOI 10.1017/S0950268806006479; National Health and Medical Research Council (Australia), 1997, AUSTR IMM HDB; NICHOL KL, 1991, AM J PREV MED, V7, P199, DOI 10.1016/S0749-3797(18)30913-9; Russell ML, 2003, AM J INFECT CONTROL, V31, P457, DOI 10.1016/S0196-6553(03)00085-3; Salisbury D, 2006, IMMUNISATION INFECT, V3rd; Sartor C, 2004, INFECT CONT HOSP EP, V25, P918, DOI 10.1086/502320; Skull SA, 2007, VACCINE, V25, P4775, DOI 10.1016/j.vaccine.2007.04.015; Sy LS, 2010, VACCINE, V28, P5254, DOI 10.1016/j.vaccine.2010.05.061; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Walker FJ, 2006, INFECT CONT HOSP EP, V27, P257, DOI 10.1086/501538; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4	24	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39496	10.1371/journal.pone.0039496	http://dx.doi.org/10.1371/journal.pone.0039496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808039	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400011
J	Dups, J; Middleton, D; Yamada, M; Monaghan, P; Long, F; Robinson, R; Marsh, GA; Wang, LF				Dups, Johanna; Middleton, Deborah; Yamada, Manabu; Monaghan, Paul; Long, Fenella; Robinson, Rachel; Marsh, Glenn A.; Wang, Lin-Fa			A New Model for Hendra Virus Encephalitis in the Mouse	PLOS ONE			English	Article							NIPAH-VIRUS; EQUINE MORBILLIVIRUS; HAMSTER MODEL; INFECTION; HORSES; NEURONS; HUMANS; SYSTEM; HOST; CATS	Hendra virus (HeV) infection in humans is characterized by an influenza like illness, which may progress to pneumonia or encephalitis and lead to death. The pathogenesis of HeV infection is poorly understood, and the lack of a mouse model has limited the opportunities for pathogenetic research. In this project we reassessed the role of mice as an animal model for HeV infection and found that mice are susceptible to HeV infection after intranasal exposure, with aged mice reliably developing encephalitic disease. We propose an anterograde route of neuroinvasion to the brain, possibly along olfactory nerves. This is supported by evidence for the development of encephalitis in the absence of viremia and the sequential distribution of viral antigen along pathways of olfaction in the brain of intranasally challenged animals. In our studies mice developed transient lower respiratory tract infection without progressing to viremia and systemic vasculitis that is common to other animal models. These studies report a new animal model of HeV encephalitis that will allow more detailed studies of the neuropathogenesis of HeV infection, particularly the mode of viral spread and possible sequestration within the central nervous system; investigation of mechanisms that moderate the development of viremia and systemic disease; and inform the development of improved treatment options for human patients.	[Dups, Johanna; Middleton, Deborah; Yamada, Manabu; Monaghan, Paul; Long, Fenella; Robinson, Rachel; Marsh, Glenn A.; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dups, J (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia.	glenn.marsh@csiro.au; linfa.wang@csiro.au	Monaghan, Paul/H-1973-2013; Marsh, Glenn A/A-5418-2013; wang, lin/GSE-3040-2022	Marsh, Glenn A/0000-0002-3469-1837; Tripp, Ralph/0000-0002-2924-9956	CSIRO Office of the Chief Executive	CSIRO Office of the Chief Executive(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This study is supported in part by an Australian Postgraduate Award (JD) and a CEO Science Leader Award (LFW) from the CSIRO Office of the Chief Executive. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, HENDRA VIRUS EQUINE; [Anonymous], 2011, HENDRA VIRUS EQUINE; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bossart KN, 2008, VIROLOGY, V372, P357, DOI 10.1016/j.virol.2007.11.011; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Drescher U, 2002, CURR OPIN GENET DEV, V12, P397, DOI 10.1016/S0959-437X(02)00316-7; Feldman KS, 2009, J VIROL METHODS, V161, P52, DOI 10.1016/j.jviromet.2009.05.014; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Greer C. A., SENSES COMPREHENSIVE; Guillaume V, 2009, VIROLOGY, V387, P459, DOI 10.1016/j.virol.2009.03.001; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hooper PT, 1997, VET PATHOL, V34, P323, DOI 10.1177/030098589703400408; Lawrence DMP, 2000, J VIROL, V74, P1908, DOI 10.1128/JVI.74.4.1908-1918.2000; Li MY, 2010, VET RES, V41, DOI 10.1051/vetres/2010005; Marsh GA, 2011, EMERG INFECT DIS, V17, P2232, DOI 10.3201/eid1712.111162; Matsuda K, 2005, J GEN VIROL, V86, P1131, DOI 10.1099/vir.0.80704-0; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Monaghan P, 2001, J MICROSC-OXFORD, V203, P223, DOI 10.1046/j.1365-2818.2001.00888.x; MORI I, 1995, J GEN VIROL, V76, P1251, DOI 10.1099/0022-1317-76-5-1251; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Nakka P, 2011, CLIN RADIOL; Nolte J, 2009, HUMAN BRAIN ELECT RE; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; PRICE RW, 1981, INFECT IMMUN, V34, P571, DOI 10.1128/IAI.34.2.571-580.1981; Roberts A, 2005, J VIROL, V79, P5833, DOI 10.1128/JVI.79.9.5833-5838.2005; Rockx B, 2010, J VIROL, V84, P9831, DOI 10.1128/JVI.01163-10; Rudd PA, 2006, J VIROL, V80, P9361, DOI 10.1128/JVI.01034-06; Schaefer ML, 2002, J COMP NEUROL, V444, P221, DOI 10.1002/cne.10143; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Shipley MT, 1996, J NEUROBIOL, V30, P123; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; Tan CT, 2002, ANN NEUROL, V51, P703, DOI 10.1002/ana.10212; Virtue ER, 2011, J VIROL, V85, P4031, DOI 10.1128/JVI.02412-10; Weingartl H, 2005, J VIROL, V79, P7528, DOI 10.1128/JVI.79.12.7528-7534.2005; Westbury HA, 1996, AUST VET J, V74, P132, DOI 10.1111/j.1751-0813.1996.tb14813.x; WESTBURY HA, 1995, AUST VET J, V72, P278, DOI 10.1111/j.1751-0813.1995.tb03549.x; Williamson MM, 2001, J COMP PATHOL, V124, P273, DOI 10.1053/jcpa.2001.0464; Wilson DA, 2008, SENSES COMPREHENSIVE, P687; Wong KT, 2009, NEUROPATH APPL NEURO, V35, P296, DOI 10.1111/j.1365-2990.2008.00991.x; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9	45	40	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40308	10.1371/journal.pone.0040308	http://dx.doi.org/10.1371/journal.pone.0040308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808132	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500036
J	Kelly, JD; Dudderidge, TJ; Wollenschlaeger, A; Okoturo, O; Burling, K; Tulloch, F; Halsall, I; Prevost, T; Prevost, AT; Vasconcelos, JC; Robson, W; Leung, HY; Vasdev, N; Pickard, RS; Williams, GH; Stoeber, K				Kelly, John D.; Dudderidge, Tim J.; Wollenschlaeger, Alex; Okoturo, Odu; Burling, Keith; Tulloch, Fiona; Halsall, Ian; Prevost, Teresa; Prevost, Andrew Toby; Vasconcelos, Joana C.; Robson, Wendy; Leung, Hing Y.; Vasdev, Nikhil; Pickard, Robert S.; Williams, Gareth H.; Stoeber, Kai			Bladder Cancer Diagnosis and Identification of Clinically Significant Disease by Combined Urinary Detection of Mcm5 and Nuclear Matrix Protein 22	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; MINICHROMOSOME MAINTENANCE PROTEIN-2; PHOTODYNAMIC DIAGNOSIS; 5-AMINOLEVULINIC ACID; UROTHELIAL CANCER; DNA-REPLICATION; FOLLOW-UP; EXPRESSION; MARKERS; NMP22	Background: Urinary biomarkers for bladder cancer detection are constrained by inadequate sensitivity or specificity. Here we evaluate the diagnostic accuracy of Mcm5, a novel cell cycle biomarker of aberrant growth, alone and in combination with NMP22. Methods: 1677 consecutive patients under investigation for urinary tract malignancy were recruited to a prospective blinded observational study. All patients underwent ultrasound, intravenous urography, cystoscopy, urine culture and cytologic analysis. An immunofluorometric assay was used to measure Mcm5 levels in urine cell sediments. NMP22 urinary levels were determined with the FDA-approved NMP22 (R) Test Kit. Results: Genito-urinary tract cancers were identified in 210/1564 (13%) patients with an Mcm5 result and in 195/1396 (14%) patients with an NMP22 result. At the assay cut-point where sensitivity and specificity were equal, the Mcm5 test detected primary and recurrent bladder cancers with 69% sensitivity (95% confidence interval = 62-75%) and 93% negative predictive value (95% CI = 92-95%). The area under the receiver operating characteristic curve for Mcm5 was 0.75 (95% CI = 0.71-0.79) and 0.72 (95% CI = 0.67-0.77) for NMP22. Importantly, Mcm5 combined with NMP22 identified 95% (79/83; 95% CI = 88-99%) of potentially life threatening diagnoses (i.e. grade 3 or carcinoma in situ or stage >= pT1) with high specificity (72%, 95% CI = 69-74%). Conclusions: The Mcm5 immunoassay is a non-invasive test for identifying patients with urothelial cancers with similar accuracy to the FDA-approved NMP22 ELISA Test Kit. The combination of Mcm5 plus NMP22 improves the detection of UCC and identifies 95% of clinically significant disease. Trials of a commercially developed Mcm5 assay suitable for an end-user laboratory alongside NMP22 are required to assess their potential clinical utility in improving diagnostic and surveillance care pathways.	[Kelly, John D.; Dudderidge, Tim J.; Williams, Gareth H.; Stoeber, Kai] UCL, Dept Pathol, London, England; [Kelly, John D.; Dudderidge, Tim J.; Williams, Gareth H.; Stoeber, Kai] UCL, Inst Canc, London, England; [Dudderidge, Tim J.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Wollenschlaeger, Alex; Williams, Gareth H.; Stoeber, Kai] UCL, Wolfson Inst Biomed Res, London, England; [Okoturo, Odu] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Burling, Keith; Tulloch, Fiona; Halsall, Ian] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; [Prevost, Teresa; Vasconcelos, Joana C.] Univ Cambridge, Inst Publ Hlth, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge, England; [Prevost, Andrew Toby] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Robson, Wendy; Vasdev, Nikhil; Pickard, Robert S.] Freeman Rd Hosp, Dept Urol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Leung, Hing Y.] Univ Glasgow, Beatson Inst Canc Res, Glasgow, Lanark, Scotland	University of London; University College London; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; University College London; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; King's College London; Newcastle Freeman Hospital; Newcastle University - UK; Beatson Institute; University of Glasgow	Kelly, JD (corresponding author), UCL, Dept Pathol, London, England.	gareth.williams@ucl.ac.uk	Vasdev, Nikhil/AAG-3878-2020; Dudderidge, Tim/AAO-1430-2020	Vasdev, Nikhil/0000-0002-3966-5734; Prevost, A. Toby/0000-0003-1723-0796; Dudderidge, Tim/0000-0001-6373-3613; Leung, Hing Y./0000-0002-3933-3975	Cancer Research UK [C428/A3441]; Cancer Research UK [15151] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (grant number C428/A3441 to KS and GHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almallah YZ, 2000, UROLOGY, V56, P37, DOI 10.1016/S0090-4295(00)00555-0; American Cancer Society, 2012, CANC FACTS FIG 2012; Ayaru L, 2008, BRIT J CANCER, V98, P1548, DOI 10.1038/sj.bjc.6604342; Babjuk M, 2012, GUIDELINES NONMUSCLE; Barkley LR, 2007, EXP CELL RES, V313, P3789, DOI 10.1016/j.yexcr.2007.07.004; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Burger M, 2007, BRIT J CANCER, V96, P1711, DOI 10.1038/sj.bjc.6603784; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; Eward KL, 2004, J CELL SCI, V117, P5875, DOI 10.1242/jcs.01503; Gakis G, 2010, CURR OPIN UROL, V20, P388, DOI 10.1097/MOU.0b013e32833cc9f4; Gaston KE, 2010, METHODS MOL BIOL, V641, P303, DOI 10.1007/978-1-60761-711-2_17; Going JJ, 2002, GUT, V50, P373, DOI 10.1136/gut.50.3.373; Grossman HB, 2006, JAMA-J AM MED ASSOC, V295, P299, DOI 10.1001/jama.295.3.299; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Korkolopoulou P, 2005, HUM PATHOL, V36, P899, DOI 10.1016/j.humpath.2005.06.008; Kriegmair M, 1996, J UROLOGY, V155, P105, DOI 10.1016/S0022-5347(01)66559-5; Kruger S, 2003, EUR UROL, V43, P138, DOI 10.1016/S0302-2838(02)00580-8; Ku JH, 2012, BJU INT, V110, P630, DOI 10.1111/j.1464-410X.2011.10884.x; Lotan Y, 2008, BJU INT, V101, P1362, DOI 10.1111/j.1464-410X.2008.07473.x; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Mostofi FK, 1973, HISTOLOGICAL TYPING; Mowatt G, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14040; Ponsky LE, 2001, J UROLOGY, V166, P75, DOI 10.1016/S0022-5347(05)66080-6; Redorta JP, 2011, NEPHROUROL MON, V3, P182; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Saad A, 2002, BJU INT, V89, P369, DOI 10.1046/j.1464-4096.2001.01699.x; Sanchez-Carbayo M, 1999, BJU INT, V84, P706; Schneeweiss S, 1999, J UROLOGY, V161, P1116, DOI 10.1016/S0022-5347(01)61605-7; Shariat SF, 2006, J UROLOGY, V176, P919, DOI 10.1016/j.juro.2006.04.017; Shelfo SW, 1997, WORLD J UROL, V15, P107, DOI 10.1007/BF02201981; SHULTZ EK, 1995, CLIN CHEM, V41, P1248; Stoeber K, 2002, J NATL CANCER I, V94, P1071; UICC International Union Against Cancer, 2009, TNM CLASS MAL TUM; Wang G, 2012, CLIN GENITOURIN CANC, V10, P106, DOI 10.1016/j.clgc.2012.01.001; Williams GH, 2007, CURR OPIN CELL BIOL, V19, P672, DOI 10.1016/j.ceb.2007.10.005; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Zaak D, 2001, UROLOGY, V57, P690, DOI 10.1016/S0090-4295(00)01053-0; Zippe C, 1999, J UROLOGY, V161, P62, DOI 10.1016/S0022-5347(01)62063-9	38	31	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40305	10.1371/journal.pone.0040305	http://dx.doi.org/10.1371/journal.pone.0040305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792272	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700033
J	Nakajima, Y; Yamada, M; Taguchi, R; Shibusawa, N; Ozawa, A; Tomaru, T; Hashimoto, K; Saito, T; Tsuchiya, T; Okada, S; Satoh, T; Mori, M				Nakajima, Yasuyo; Yamada, Masanobu; Taguchi, Ryo; Shibusawa, Nobuyuki; Ozawa, Atsushi; Tomaru, Takuya; Hashimoto, Koshi; Saito, Tsugumichi; Tsuchiya, Takafumi; Okada, Shuichi; Satoh, Tetsurou; Mori, Masatomo			NR4A1 (Nur77) Mediates Thyrotropin-Releasing Hormone-Induced Stimulation of Transcription of the Thyrotropin beta Gene: Analysis of TRH Knockout Mice	PLOS ONE			English	Article							NUCLEAR RECEPTOR NUR77; THYROID-HORMONE; GLUCOCORTICOID-RECEPTOR; TERTIARY HYPOTHYROIDISM; SUBUNIT GENE; TUMOR-CELLS; PITUITARY; EXPRESSION; KINASE; GROWTH	Thyrotropin-releasing hormone (TRH) is a major stimulator of thyrotropin-stimulating hormone (TSH) synthesis in the anterior pituitary, though precisely how TRH stimulates the TSH beta gene remains unclear. Analysis of TRH-deficient mice differing in thyroid hormone status demonstrated that TRH was critical for the basal activity and responsiveness to thyroid hormone of the TSH beta gene. cDNA microarray and K-means cluster analyses with pituitaries from wild-type mice, TRH-deficient mice and TRH-deficient mice with thyroid hormone replacement revealed that the largest and most consistent decrease in expression in the absence of TRH and on supplementation with thyroid hormone was shown by the TSH beta gene, and the NR4A1 gene belonged to the same cluster as and showed a similar expression profile to the TSH beta gene. Immunohistochemical analysis demonstrated that NR4A1 was expressed not only in ACTH-and FSH-producing cells but also in thyrotrophs and the expression was remarkably reduced in TRH-deficient pituitary. Furthermore, experiments in vitro demonstrated that incubation with TRH in GH4C1 cells increased the endogenous NR4A1 mRNA level by approximately 50-fold within one hour, and this stimulation was inhibited by inhibitors for PKC and ERK1/2. Western blot analysis confirmed that TRH increased NR4A1 expression within 2 h. A series of deletions of the promoter demonstrated that the region between bp -138 and +37 of the TSH beta gene was responsible for the TRH-induced stimulation, and Chip analysis revealed that NR4A1 was recruited to this region. Conversely, knockdown of NR4A1 by siRNA led to a significant reduction in TRH-induced TSH beta promoter activity. Furthermore, TRH stimulated NR4A1 promoter activity through the TRH receptor. These findings demonstrated that 1) TRH is a highly specific regulator of the TSH beta gene, and 2) TRH mediated induction of the TSH beta gene, at least in part by sequential stimulation of the NR4A1-TSH beta genes through a PKC and ERK1/2 pathway.	[Nakajima, Yasuyo; Yamada, Masanobu; Taguchi, Ryo; Shibusawa, Nobuyuki; Ozawa, Atsushi; Tomaru, Takuya; Hashimoto, Koshi; Saito, Tsugumichi; Tsuchiya, Takafumi; Okada, Shuichi; Satoh, Tetsurou; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan	Gunma University	Nakajima, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan.	myamada@gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X	Health and Labor Sciences Research Grants; Research on Measures for Intractable Disease Hyptahalamo-Pituitary Dysfunction Research Group; Japan Society for the Promotion of Science	Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Research on Measures for Intractable Disease Hyptahalamo-Pituitary Dysfunction Research Group(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by grant from Health and Labor Sciences Research Grants, Research on Measures for Intractable Disease Hyptahalamo-Pituitary Dysfunction Research Group (MM), and Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (MY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; Bassett MH, 2004, ENDOCR RES, V30, P567, DOI 10.1081/ERC-200043715; BOLER J, 1969, BIOCHEM BIOPH RES CO, V37, P705, DOI 10.1016/0006-291X(69)90868-7; BURGUS R, 1969, CR ACAD SCI D NAT, V268, P2116; CARR FE, 1993, ENDOCRINOLOGY, V133, P1700, DOI 10.1210/en.133.4.1700; CARR FE, 1989, MOL ENDOCRINOL, V3, P717, DOI 10.1210/mend-3-4-717; Charles MA, 2006, MOL ENDOCRINOL, V20, P1366, DOI 10.1210/me.2005-0378; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Cohen LE, 2002, ENDOCR REV, V23, P431, DOI 10.1210/er.2001-0030; CRAWFORD PA, 1995, MOL CELL BIOL, V15, P4331; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Fernandez PM, 2000, ENDOCRINOLOGY, V141, P2392, DOI 10.1210/en.141.7.2392; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; GERSHENGORN MC, 1989, ANN NY ACAD SCI, V553, P191; GORDON DF, 1993, MOL CELL ENDOCRINOL, V96, P75, DOI 10.1016/0303-7207(93)90097-4; Gordon DF, 2002, MOL CELL ENDOCRINOL, V196, P53, DOI 10.1016/S0303-7207(02)00223-X; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; GUMBINER B, 1982, CELL, V28, P51, DOI 10.1016/0092-8674(82)90374-9; Hashimoto K, 2000, J BIOL CHEM, V275, P33365, DOI 10.1074/jbc.M006819200; Hashimoto K, 2005, MOL CELL ENDOCRINOL, V229, P11, DOI 10.1016/j.mce.2004.10.005; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; Inaoka Y, 2008, MOL REPROD DEV, V75, P931, DOI 10.1002/mrd.20788; Ishii S, 2004, MOL ENDOCRINOL, V18, P1708, DOI 10.1210/me.2004-0067; JACKSON IMD, 1982, NEW ENGL J MED, V306, P145, DOI 10.1056/NEJM198201213060305; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Kakar SS, 2003, GENE, V308, P67, DOI 10.1016/S0378-1119(03)00446-3; KANDA Y, 1994, BIOCHEM BIOPH RES CO, V199, P1447, DOI 10.1006/bbrc.1994.1393; Kashiwabara Y, 2009, J MOL ENDOCRINOL, V42, P225, DOI 10.1677/JME-08-0099; Kelly SN, 2005, J ENDOCRINOL, V186, P33, DOI 10.1677/joe.1.06005; KILEY SC, 1991, J BIOL CHEM, V266, P23761; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Lavoie PL, 2008, MOL ENDOCRINOL, V22, P1647, DOI 10.1210/me.2007-0567; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Maira M, 1999, MOL CELL BIOL, V19, P7549; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Manna PR, 2009, ENDOCRINOLOGY, V150, P3308, DOI 10.1210/en.2008-1668; Martin LJ, 2008, MOL ENDOCRINOL, V22, P2021, DOI 10.1210/me.2007-0370; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MORI M, 1988, NEUROENDOCRINOLOGY, V48, P153, DOI 10.1159/000125003; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nakajima Y, 2010, THYROID, V20, P917, DOI 10.1089/thy.2009.0389; Nikrodhanond AA, 2006, J BIOL CHEM, V281, P5000, DOI 10.1074/jbc.M511530200; Ohba K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018667; OHMICHI M, 1994, J BIOL CHEM, V269, P3783; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Santelli G, 1999, AM J PATHOL, V155, P799, DOI 10.1016/S0002-9440(10)65178-4; Satoh T, 1996, J BIOL CHEM, V271, P27919, DOI 10.1074/jbc.271.44.27919; Satoh T, 1999, ENDOCRINOLOGY, V140, P5004, DOI 10.1210/en.140.11.5004; Shibusawa N, 2003, J CLIN INVEST, V112, P588, DOI 10.1172/JCI200318377; Shibusawa N, 2000, MOL ENDOCRINOL, V14, P137, DOI 10.1210/me.14.1.137; SHUPNIK MA, 1989, ENDOCR REV, V10, P459, DOI 10.1210/edrv-10-4-459; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; STEINFELDER HJ, 1992, P NATL ACAD SCI USA, V89, P5942, DOI 10.1073/pnas.89.13.5942; Stocco CO, 2002, J BIOL CHEM, V277, P3293, DOI 10.1074/jbc.M110936200; Stocco CO, 2000, J BIOL CHEM, V275, P37202, DOI 10.1074/jbc.M006016200; Sun Y, 2003, J MOL ENDOCRINOL, V30, P87, DOI 10.1677/jme.0.0300087; Tagami T, 1997, MOL CELL BIOL, V17, P2642, DOI 10.1128/MCB.17.5.2642; Takano T, 2002, JPN J CLIN ONCOL, V32, P229, DOI 10.1093/jjco/hyf054; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; TATSUMI K, 1992, NAT GENET, V1, P56, DOI 10.1038/ng0492-56; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Umezawa R, 2009, ENDOCRINOLOGY; Wansa KDSA, 2005, J MOL ENDOCRINOL, V34, P835, DOI 10.1677/jme.1.01739; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Yamada M, 1997, P NATL ACAD SCI USA, V94, P10862, DOI 10.1073/pnas.94.20.10862; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848	80	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40437	10.1371/journal.pone.0040437	http://dx.doi.org/10.1371/journal.pone.0040437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792320	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700048
J	Empey, KM; Orend, JG; Peebles, RS; Egana, L; Norris, KA; Oury, TD; Kolls, JK				Empey, Kerry M.; Orend, Jacob G.; Peebles, R. Stokes, Jr.; Egana, Loreto; Norris, Karen A.; Oury, Tim D.; Kolls, Jay K.			Stimulation of Immature Lung Macrophages with Intranasal Interferon Gamma in a Novel Neonatal Mouse Model of Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							HUMAN ALVEOLAR MACROPHAGES; CD8 T-CELLS; FUNCTIONAL PLASTICITY; VIRAL LOAD; RSV; BRONCHIOLITIS; ACTIVATION; RESPONSES; DISEASE; PATHOGENESIS	Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and viral death in infants. Reduced CD8 T-cells and negligible interferon gamma (IFN gamma) in the airway are associated with severe infant RSV disease, yet there is an abundance of alveolar macrophages (AM) and neutrophils. However, it is unclear, based on our current understanding of macrophage functional heterogeneity, if immature AM improve viral clearance or contribute to inflammation and airway obstruction in the IFN gamma-deficient neonatal lung environment. The aim of the current study was to define the age-dependent AM phenotype during neonatal RSV infection and investigate their differentiation to classically activated macrophages (CAM) using i.n. IFN gamma in the context of improving viral clearance. Neonatal and adult BALB/cJ mice were infected with 1x10(6) plaque forming units (PFU)/gram (g) RSV line 19 and their AM responses compared. Adult mice showed a rapid and robust CAM response, indicated by increases in major histocompatibility complex class II (MHC II), CD86, CCR7, and a reduction in mannose receptor (MR). Neonatal mice showed a delayed and reduced CAM response, likely due to undetectable IFN gamma production. Intranasal (i.n.) treatment with recombinant mouse IFN gamma (rIFN gamma) increased the expression of CAM markers on neonatal AM, reduced viral lung titers, and improved weight gain compared to untreated controls with no detectable increase in CD4 or CD8 T-cell infiltration. In vitro infection of J774A. 1 macrophages with RSV induced an alternatively activated macrophage (AAM) phenotype however, when macrophages were first primed with IFN gamma, a CAM phenotype was induced and RSV spread to adjacent Hep-2 cells was reduced. These studies demonstrate that the neonatal AM response to RSV infection is abundant and immature, but can be exogenously stimulated to express the antimicrobial phenotype, CAM, with i.n. rIFN gamma.	[Empey, Kerry M.; Orend, Jacob G.; Egana, Loreto] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Kolls, Jay K.] Childrens Hosp Pittsburgh, Dept Pediat, Richard King Mellon Fdn Inst Pediat Res, Pittsburgh, PA 15213 USA; [Norris, Karen A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Peebles, R. Stokes, Jr.] Vanderbilt Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Empey, KM (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA.	kme33@pitt.edu; jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304	National Institutes of Health [KL2 RR024154, KL2TR000146]; Central Research Development Fund from the University of Pittsburgh Research Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062052, R37HL079142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Research Development Fund from the University of Pittsburgh Research Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The project described was supported by the National Institutes of Health through Grant Numbers KL2 RR024154 and KL2TR000146, Central Research Development Fund from the University of Pittsburgh Research Council, and resources provided by the University Of Pittsburgh School Of Pharmacy, Pittsburgh, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Benoit A, 2006, CLIN EXP IMMUNOL, V145, P147, DOI 10.1111/j.1365-2249.2006.03114.x; CIRINO NM, 1993, J GEN VIROL, V74, P1527, DOI 10.1099/0022-1317-74-8-1527; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Empey KM, 2007, INFECT IMMUN, V75, P3382, DOI 10.1128/IAI.00174-07; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GORDON S, IMMUNITY, V32, P593; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harker JA, 2010, J VIROL, V84, P5294, DOI 10.1128/JVI.02503-09; Hashimoto K, 2004, J VIROL, V78, P10303, DOI 10.1128/JVI.78.19.10303-10309.2004; Heidema J, 2004, J GEN VIROL, V85, P2365, DOI 10.1099/vir.0.80131-0; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Kaiko GE, 2010, J IMMUNOL, V185, P4681, DOI 10.4049/jimmunol.1001758; Lanson NA, 2003, CANCER RES, V63, P7936; Larranaga CL, 2009, PEDIAT INFECT DIS J; Lee YM, 2008, AM J RESP CRIT CARE, V177, P208, DOI 10.1164/rccm.200612-1890OC; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lukacs NW, 2006, AM J PATHOL, V169, P977, DOI 10.2353/ajpath.2006.051055; MIDULLA F, 1989, AM REV RESPIR DIS, V140, P771, DOI 10.1164/ajrccm/140.3.771; MOKOENA T, 1985, J CLIN INVEST, V75, P624, DOI 10.1172/JCI111740; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; PANUSKA JR, 1995, J CLIN INVEST, V96, P2445, DOI 10.1172/JCI118302; PANUSKA JR, 1990, J CLIN INVEST, V86, P113, DOI 10.1172/JCI114672; PANUSKA JR, 1992, AM REV RESPIR DIS, V145, P934, DOI 10.1164/ajrccm/145.4_Pt_1.934; Qureshi MH, 2001, J IMMUNOL, V166, P5704, DOI 10.4049/jimmunol.166.9.5704; Reed JL, 2008, J INFECT DIS, V198, P1783, DOI 10.1086/593173; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Stout RD, 2005, IMMUNOL REV, V205, P60, DOI 10.1111/j.0105-2896.2005.00260.x; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; WOODSIDE KH, 1983, J APPL PHYSIOL, V54, P94, DOI 10.1152/jappl.1983.54.1.94; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107	42	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40499	10.1371/journal.pone.0040499	http://dx.doi.org/10.1371/journal.pone.0040499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792355	Green Published, gold, Green Accepted			2022-12-27	WOS:000306461800099
J	Helmstadter, M; Luthy, K; Godel, M; Simons, M; Ashish; Nihalani, D; Rensing, SA; Fischbach, KF; Huber, TB				Helmstaedter, Martin; Luethy, Kevin; Goedel, Markus; Simons, Matias; Ashish; Nihalani, Deepak; Rensing, Stefan A.; Fischbach, Karl-Friedrich; Huber, Tobias B.			Functional Study of Mammalian Neph Proteins in Drosophila melanogaster	PLOS ONE			English	Article							IRREC-RST PROTEIN; SLIT DIAPHRAGM; AXONAL PROJECTIONS; ROLLING PEBBLES; MYOBLAST FUSION; CELL; ADHESION; GENE; MORPHOGENESIS; RECOGNITION	Neph molecules are highly conserved immunoglobulin superfamily proteins (IgSF) which are essential for multiple morphogenetic processes, including glomerular development in mammals and neuronal as well as nephrocyte development in D. melanogaster. While D. melanogaster expresses two Neph-like proteins (Kirre and IrreC/Rst), three Neph proteins (Neph1-3) are expressed in the mammalian system. However, although these molecules are highly abundant, their molecular functions are still poorly understood. Here we report on a fly system in which we overexpress and replace endogenous Neph homologs with mammalian Neph1-3 proteins to identify functional Neph protein networks required for neuronal and nephrocyte development. Misexpression of Neph1, but neither Neph2 nor Neph3, phenocopies the overexpression of endogenous Neph molecules suggesting a functional diversity of mammalian Neph family proteins. Moreover, structure-function analysis identified a conserved and specific Neph1 protein motif that appears to be required for the functional replacement of Kirre. Hereby, we establish D. melanogaster as a genetic system to specifically model molecular Neph1 functions in vivo and identify a conserved amino acid motif linking Neph1 to Drosophila Kirre function.	[Helmstaedter, Martin; Goedel, Markus; Simons, Matias; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Helmstaedter, Martin; Luethy, Kevin; Rensing, Stefan A.; Fischbach, Karl-Friedrich] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Rensing, Stefan A.; Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Simons, Matias; Rensing, Stefan A.] Univ Freiburg, Ctr Syst Biol, D-79106 Freiburg, Germany; [Ashish] CSIR Inst Microbial Technol, Chandigarh, India; [Nihalani, Deepak] Univ Penn, Philadelphia, PA 19104 USA	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Pennsylvania	Helmstadter, M (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	kff@uni-freiburg.de; tobias.huber@uniklinik-freiburg.de	nihalani, deepak/AAK-9453-2020; Simons, Matias/I-2038-2017	Simons, Matias/0000-0003-3959-6350; Luthy, Kevin/0000-0002-4510-3826; Huber, Tobias B./0000-0001-7175-5062	Bundesministerium fur Bildung und Forschung Gerontosys II - NephAge [031 5896A]; DFG and Else Kroner Foundation [Fef2 406614]; MS (BMBF Gerontosys II - NephAge) [031 5896A]; Excellence Initiative of the German Federal and State Governments [EXC 294]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956] Funding Source: NIH RePORTER	Bundesministerium fur Bildung und Forschung Gerontosys II - NephAge; DFG and Else Kroner Foundation; MS (BMBF Gerontosys II - NephAge); Excellence Initiative of the German Federal and State Governments; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grants to TBH (Fef2 406614; Bundesministerium fur Bildung und Forschung Gerontosys II - NephAge [031 5896A]; DFG and Else Kroner Foundation), to KFF (Fef2 406614) and MS (BMBF Gerontosys II - NephAge [031 5896A]), as well as by the Excellence Initiative of the German Federal and State Governments (TBH; EXC 294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulchand S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009374; Cagan RL, 2011, CURR OPIN NEPHROL HY, V20, P409, DOI 10.1097/MNH.0b013e328347ae02; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Kreiskother N, 2006, J MUSCLE RES CELL M, V27, P93, DOI 10.1007/s10974-006-9060-y; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Mallik L, 2012, J BIOL CHEM, V287, P9441, DOI 10.1074/jbc.M111.284927; Neumann-Haefelin E, 2010, HUM MOL GENET, V19, P2347, DOI 10.1093/hmg/ddq108; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Reiter C, 1996, DEVELOPMENT, V122, P1931; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Simons M, 2009, CURR OPIN NEPHROL HY, V18, P324, DOI 10.1097/MNH.0b013e32832e316d; Simons M, 2009, KIDNEY INT, V75, P455, DOI 10.1038/ki.2008.653; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Sugie A, 2010, DEVELOPMENT, V137, P3303, DOI 10.1242/dev.047332; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Wanner N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023598; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	40	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40300	10.1371/journal.pone.0040300	http://dx.doi.org/10.1371/journal.pone.0040300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792268	Green Submitted, gold, Green Published			2022-12-27	WOS:000306461800064
J	Henrick, BM; Nag, K; Yao, XD; Drannik, AG; Aldrovandi, GM; Rosenthal, KL				Henrick, Bethany M.; Nag, Kakon; Yao, Xiao-Dan; Drannik, Anna G.; Aldrovandi, Grace M.; Rosenthal, Kenneth L.			Milk Matters: Soluble Toll-Like Receptor 2 (sTLR2) in Breast Milk Significantly Inhibits HIV-1 Infection and Inflammation	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; CHILD TRANSMISSION; TLR2 ACTIVATION; RECOGNITION; TOLL-LIKE-RECEPTOR-2; RESPONSES; PROTEIN; EXPRESSION; PATHWAYS; SALIVA	The majority of infants who breastfeed from their HIV-positive mothers remain uninfected despite constant and repeated exposure to virus over weeks to years. This phenomenon is not fully understood but has been closely linked to innate factors in breast milk (BM). Most recently we have focused on one such innate factor, soluble Toll-like receptor 2 (sTLR2) for its significant contribution as an inhibitor of inflammation triggered by bacterial and viral antigens. We hypothesized that sTLR2 in BM inhibits immune activation/inflammation and HIV-1 infection. sTLR2 protein profiles were analyzed in HIV-uninfected BM and showed dramatic variability in expression concentration and predominant sTLR2 forms between women. sTLR2 immunodepleted BM, versus mock-depleted BM, incubated with Pam(3)CSK(4) lead to significant increases in IL-8 production in a TLR2-dependant fashion in U937, HEK293-TLR2, and Caco-2. Importantly, TLR2-specific polyclonal and monoclonal antibody addition to BM prior to cell-free R5 HIV-1 addition led to significantly (P < 0.01, P < 0.001, respectively) increased HIV-1 infection in TZM-bl reporter cells. To confirm these findings, sTLR2-depletion in BM led to significantly (P < 0.001) increased HIV-1 infection in TZM-bl cells. Notably, immunodepletion does not allow for the complete removal of sTLR2 from BM, thus functional testing shown here may underestimate the total effect elicited by sTLR2 against HIV-1 and synthetic bacterial ligand. This study provides evidence for the first time that sTLR2 in BM may provide a dual protective role for infants breastfeeding from their HIV-infected mothers by; (1) immunomodulating pro-inflammatory responses to bacterial ligands, and (2) directly inhibiting cell-free HIV-1 infection. Thus, sTLR2 in BM may be critical to infant health and prove beneficial in decreasing vertical HIV-1 transmission to infants.	[Henrick, Bethany M.; Nag, Kakon; Yao, Xiao-Dan; Drannik, Anna G.; Rosenthal, Kenneth L.] McMaster Univ, McMaster Immunol Res Ctr, Michael G DeGroote Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Aldrovandi, Grace M.] Childrens Hosp Los Angeles, Saban Res Inst, Dept Pediat, Los Angeles, CA 90027 USA; [Aldrovandi, Grace M.] Childrens Hosp Los Angeles, Saban Res Inst, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA	McMaster University; Children's Hospital Los Angeles; Children's Hospital Los Angeles	Henrick, BM (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Michael G DeGroote Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada.	rosenthl@mcmaster.ca	Henrick, Bethany/P-7388-2016	Henrick, Bethany/0000-0003-1883-6749	Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC); Antibody Immune Monitoring Consortium (CA-VIMC); National Institute of Child Health and Human Development [RO1 HD 39611, RO1 HD 40777]; Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040777, R01HD039611] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC); Antibody Immune Monitoring Consortium (CA-VIMC); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) and Antibody Immune Monitoring Consortium (CA-VIMC) as well as grants from the National Institute of Child Health and Human Development (RO1 HD 39611, RO1 HD 40777). Bethany M. Henrick and Anna G. Drannik were supported by Studentship Awards and Kenneth L. Rosenthal by a Career Scientist Award from the Ontario HIV Treatment Network (OHTN). Kakon Nag was supported by a Postdoctoral Award from the Canadian Institutes of Health Research (CIHR). Grace M. Aldrovandi is an Elizabeth Glaser Pediatric AIDS Foundation Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2011, LIFE SCI, V88, P980, DOI 10.1016/j.lfs.2010.09.023; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BEAUDRY M, 1995, J PEDIATR-US, V126, P191, DOI 10.1016/S0022-3476(95)70544-9; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; Coutsoudis A, 2002, AIDS, V16, P498, DOI 10.1097/00002030-200202150-00028; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Dulay AT, 2009, J IMMUNOL, V182, P7244, DOI 10.4049/jimmunol.0803517; Greene CM, 2004, INFECT IMMUN, V72, P3684, DOI 10.1128/IAI.72.6.3684-3687.2004; Grulee CG, 1935, JAMA-J AM MED ASSOC, P1; Heggelund L, 2004, AIDS, V18, P2437; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jain S, 2011, MUCOSAL IMMUNOL, V4, P539, DOI 10.1038/mi.2011.21; Kataoka H, 2006, CELL MICROBIOL, V8, P1199, DOI 10.1111/j.1462-5822.2006.00702.x; Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kramer MS, 2010, EARLY HUM DEV, V86, P729, DOI 10.1016/j.earlhumdev.2010.08.005; Kuhn L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001363; Kuroishi T, 2007, MOL IMMUNOL, V44, P1969, DOI 10.1016/j.molimm.2006.09.028; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; LeBouder E, 2006, J IMMUNOL, V176, P3742, DOI 10.4049/jimmunol.176.6.3742; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lyimo MA, 2009, JAIDS-J ACQ IMM DEF, V51, P117, DOI 10.1097/QAI.0b013e3181a3908d; Matala E, 2001, AIDS RES HUM RETROV, V17, P1725, DOI 10.1089/08892220152741423; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Michaud F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013742; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Padua E, 2009, AIDS RES HUM RETROV, V25, P1171, DOI 10.1089/aid.2009.0103; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; Plummer FA, 1998, AIDS RES HUM RETROV, V14, pS5; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P3546, DOI 10.1128/AAC.49.8.3546-3549.2005; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Salvatori F, 2001, AIDS RES HUM RETROV, V17, P925, DOI 10.1089/088922201750290041; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Verhasselt V, 2010, CURR OPIN IMMUNOL, V22, P623, DOI 10.1016/j.coi.2010.08.008; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Yoshimura A, 1999, J IMMUNOL, V163, P1	51	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40138	10.1371/journal.pone.0040138	http://dx.doi.org/10.1371/journal.pone.0040138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792230	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800043
J	Kingsbury, JM; Heitman, J; Pinnell, SR				Kingsbury, Joanne M.; Heitman, Joseph; Pinnell, Sheldon R.			Calcofluor White Combination Antifungal Treatments for Trichophyton rubrum and Candida albicans	PLOS ONE			English	Article							IN-VITRO; SACCHAROMYCES-CEREVISIAE; NIKKOMYCIN-Z; CONGO RED; RYLUX BSU; TESTING SUSCEPTIBILITIES; ASPERGILLUS-FUMIGATUS; SPORE GERMINATION; CLSI M38-A; CELL-WALLS	Superficial mycoses caused by dermatophyte fungi are among the most common infections worldwide, yet treatment is restricted by limited effective drugs available, drug toxicity, and emergence of drug resistance. The stilbene fluorescent brightener calcofluor white (CFW) inhibits fungi by binding chitin in the cell wall, disrupting cell wall integrity, and thus entails a different mechanism of inhibition than currently available antifungal drugs. To identify novel therapeutic options for the treatment of skin infections, we compared the sensitivity of representative strains of the dermatophyte Trichophyton rubrum and Candida albicans to CFW and a panel of fluorescent brighteners and phytoalexin compounds. We identified the structurally related stilbene fluorescent brighteners 71, 85, 113 and 134 as fungicidal to both T. rubrum and C. albicans to a similar degree as CFW, and the stilbene phytoalexins pinosylvan monomethyl ether and pterostilbene inhibited to a lesser degree, allowing us to develop a structure-activity relationship for fungal inhibition. Given the abilities of CFW to absorb UV365 (nm) and bind specifically to fungal cell walls, we tested whether CFW combined with UV365 nm irradiation would be synergistic to fungi and provide a novel photodynamic treatment option. However, while both treatments individually were cytocidal, UV365 nm irradiation reduced sensitivity to CFW, which we attribute to CFW photoinactivation. We also tested combination treatments of CFW with other fungal inhibitors and identified synergistic interactions between CFW and some ergosterol biosynthesis inhibitors in C. albicans. Therefore, our studies identify novel fungal inhibitors and drug interactions, offering promise for combination topical treatment regimes for superficial mycoses.	[Kingsbury, Joanne M.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Pinnell, Sheldon R.] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC USA; [Pinnell, Sheldon R.] Skin Sci Inst Inc, Durham, NC USA	Duke University; Duke University	Kingsbury, JM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	jokingsb@duke.edu	Heitman, Joseph/ABC-6006-2021	Kingsbury, Joanne/0000-0002-5939-7255	National Institutes of Health National Institute of Allergy and Infectious Diseases [R01 AI50438-08]; Small Business Innovation Research [2R44 AR0496086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050438] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Small Business Innovation Research(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health National Institute of Allergy and Infectious Diseases R01 AI50438-08 awarded to JH, and Small Business Innovation Research 2R44 AR0496086 awarded to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALY R, 1994, J AM ACAD DERMATOL, V31, pS21, DOI 10.1016/S0190-9622(08)81262-5; Andrade AC, 2000, MICROBIOL-SGM, V146, P1987, DOI 10.1099/00221287-146-8-1987; Anliker R, 1975, FLUORESCENT WHITENIN; ASM, 2012, ANTIMICROBIAL AGENTS, pi; BARTNICKIGARCIA S, 1994, ARCH BIOCHEM BIOPHYS, V310, P6, DOI 10.1006/abbi.1994.1133; Benedict FG, 1919, P NATL ACAD SCI USA, V5, P218, DOI 10.1073/pnas.5.6.218; Blankenship Jill R, 2003, Curr Opin Investig Drugs, V4, P192; Brasch J, 2003, MYCOSES, V46, P120, DOI 10.1046/j.1439-0507.2003.00857.x; Canton E, 2009, EXPERT REV ANTI-INFE, V7, P107, DOI 10.1586/14787210.7.1.107; Chalupova V, 2002, FOLIA MICROBIOL, V47, P152, DOI 10.1007/BF02817673; CLSI, 2008, M38A2 CLSI; CLSI, 2008, M27A3 CLSI; Dannaoui E, 2009, ANTIMICROB AGENTS CH, V53, P3549, DOI 10.1128/AAC.00184-09; DARKEN MA, 1963, APPL MICROBIOL, V11, P154, DOI 10.1128/AEM.11.2.154-156.1963; Djeridane A, 2006, MYCOSES, V49, P190, DOI 10.1111/j.1439-0507.2006.01230.x; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Espinel-Ingroff A, 2005, J CLIN MICROBIOL, V43, P3884, DOI 10.1128/JCM.43.8.3884-3889.2005; FINLAY AY, 1994, BRIT J DERMATOL, V130, P1, DOI 10.1111/j.1365-2133.1994.tb06082.x; Garcia-Rodriguez LJ, 2000, J BACTERIOL, V182, P2428, DOI 10.1128/JB.182.9.2428-2437.2000; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Ghannoum MA, 2006, J CLIN MICROBIOL, V44, P4353, DOI 10.1128/JCM.00688-06; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gupta AK, 1998, DRUGS, V55, P645, DOI 10.2165/00003495-199855050-00004; Gupta AK, 1998, LANCET, V351, P541, DOI 10.1016/S0140-6736(05)78552-4; Gupta AK, 1998, CUTIS, V62, P189; Haneke E, 1999, INT J DERMATOL, V38, P7, DOI 10.1046/j.1365-4362.1999.00015.x; HAPLOVA J, 1994, ARCH MICROBIOL, V161, P340, DOI 10.1007/BF00303590; HECTOR RF, 1992, ANTIMICROB AGENTS CH, V36, P1284, DOI 10.1128/AAC.36.6.1284; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HEJTMANEK M, 1990, FOLIA MICROBIOL, V35, P437, DOI 10.1007/BF02821413; Idnurm A, 2010, FUNGAL GENET BIOL, V47, P881, DOI 10.1016/j.fgb.2010.04.009; Jorgensen KB, 2010, MOLECULES, V15, P4334, DOI 10.3390/molecules15064334; Jun JH, 2007, J MICROBIOL BIOTECHN, V17, P1324; Jung HJ, 2005, ARCH PHARM RES, V28, P557, DOI 10.1007/BF02977758; KEPLINGER ML, 1974, TOXICOL APPL PHARM, V27, P494, DOI 10.1016/0041-008X(74)90029-5; Kim DH, 2004, BIOTECHNOL BIOENG, V87, P849, DOI 10.1002/bit.20189; Lee SK, 2005, FITOTERAPIA, V76, P258, DOI 10.1016/j.fitote.2004.12.004; Li RK, 1999, ANTIMICROB AGENTS CH, V43, P1401, DOI 10.1128/AAC.43.6.1401; Likhtenshtein G., 2009, STILBENES APPL CHEM; MAEDA H, 1967, J BIOCHEM-TOKYO, V62, P276, DOI 10.1093/oxfordjournals.jbchem.a128660; MARINES HM, 1987, OPHTHALMOLOGY, V94, P23, DOI 10.1016/S0161-6420(87)33516-X; Martinez-Rossi NM, 2008, MYCOPATHOLOGIA, V166, P369, DOI 10.1007/s11046-008-9110-7; MILEWSKI S, 1991, J GEN MICROBIOL, V137, P2155, DOI 10.1099/00221287-137-9-2155; MONHEIT JE, 1984, ARCH PATHOL LAB MED, V108, P616; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Nweze EI, 2010, J CLIN MICROBIOL, V48, P3750, DOI 10.1128/JCM.01357-10; Olesen BW, 1982, BRUEL KJAER TECHNICA, P1; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Onyewu Chiatogu, 2007, Anti-Infective Agents in Medicinal Chemistry, V6, P3; Ozkutuk A, 2007, MYCOSES, V50, P125, DOI 10.1111/j.1439-0507.2006.01333.x; Pan ZQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-7; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Pezet R, 1995, HDB PHYTOALEXIN META; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P1274, DOI 10.1128/JCM.02437-10; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P845, DOI 10.1128/JCM.02441-10; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P630, DOI 10.1128/JCM.02161-10; PFALLER MA, 1990, DIAGN MICR INFEC DIS, V13, P31, DOI 10.1016/0732-8893(90)90050-6; Raclavsky V, 1999, FOLIA MICROBIOL, V44, P663, DOI 10.1007/BF02825658; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; RUCHEL R, 1993, MYCOSES, V36, P239, DOI 10.1111/j.1439-0507.1993.tb00757.x; Sadeghi G, 2009, J DERMATOL TREAT, V20, P120, DOI 10.1080/09546630802449070; Santos DA, 2006, J CLIN MICROBIOL, V44, P98, DOI 10.1128/JCM.44.1.98-101.2006; Schmidt CL, 1999, YEAST, V15, P1503, DOI 10.1002/(SICI)1097-0061(199910)15:14<1503::AID-YEA481>3.3.CO;2-N; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Seppanen SK, 2004, PLANT CELL REP, V22, P584, DOI 10.1007/s00299-003-0728-0; Singh J, 2007, MED MYCOL, V45, P595, DOI 10.1080/13693780701549364; Siqueira ER, 2008, REV INST MED TROP SP, V50, P1, DOI 10.1590/S0036-46652008000100001; Smijs TGM, 2011, PHOTOCHEM PHOTOBIOL, V87, P2, DOI 10.1111/j.1751-1097.2010.00848.x; Smijs TGM, 2009, PHOTOCHEM PHOTOBIOL, V85, P733, DOI 10.1111/j.1751-1097.2008.00468.x; SURARIT R, 1987, J MED VET MYCOL, V25, P403; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Weber K, 2011, MYCOSES, V54, P30, DOI 10.1111/j.1439-0507.2009.01763.x; WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240, DOI 10.1128/CMR.8.2.240; Welsh O, 2010, CLIN DERMATOL, V28, P151, DOI 10.1016/j.clindermatol.2009.12.006; Zhang J, 2010, CHINESE MED J-PEKING, V123, P1909, DOI 10.3760/cma.j.issn.0366-6999.2010.14.015	75	33	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39405	10.1371/journal.pone.0039405	http://dx.doi.org/10.1371/journal.pone.0039405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792174	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800012
J	Shelton, DN; Fornalik, H; Neff, T; Park, SY; Bender, D; DeGeest, K; Liu, XM; Xie, WL; Meyerholz, DK; Engelhardt, JF; Goodheart, MJ				Shelton, Dawne N.; Fornalik, Hubert; Neff, Traci; Park, Soo Yeun; Bender, David; DeGeest, Koen; Liu, Xiaoming; Xie, Weiliang; Meyerholz, David K.; Engelhardt, John F.; Goodheart, Michael J.			The Role of LEF1 in Endometrial Gland Formation and Carcinogenesis	PLOS ONE			English	Article							BETA-CATENIN EXPRESSION; METHYL-N-NITROSOUREA; EPITHELIAL-MESENCHYMAL INTERACTIONS; CYCLIN D1 GENE; OVARIAN CARCINOMAS; MATRIX METALLOPROTEINASE-7; MICROSATELLITE INSTABILITY; ESTROGEN-RECEPTOR; SIGNALING PATHWAY; MUTATIONS	Endometrial carcinoma is the most common gynecologic cancer, yet the mechanisms underlying this disease process are poorly understood. We hypothesized that Lef1 is required for endometrial gland formation within the uterus and is overexpressed in endometrial cancer. Using Lef1 knockout (KO) mice, we compared uterine gland development to wild-type (WT) controls, with respect to both morphology and expression of the Lef1 targets, cyclin D1 and MMP7. We characterized the dynamics of Lef1 protein expression during gland development and the mouse estrus cycle, by immunostaining and Western blot. Finally, we investigated the roles of cyclin D1 and MMP7 in gland and cancer formation in the mouse, and assessed the relevance of Lef1 to human cancer by comparing expression levels in cancerous and normal endometrial tissues. Lef1 upregulation in mouse endometrium correlates with the proliferative stages of the estrus cycle and gland development during the neonatal period. WT mice endometrial glands began to develop by day 5 and were easily identified by day 9, whereas Lef1 KO mice endometrial glands had not developed by day 9 although the endometrial lining was intact. We found that during gland development cyclin D1 is elevated and localized to the gland buds, and that this requires the presence of Lef1. We also noted that Lef1 protein was expressed at higher levels in endometrial cancers within mice and humans when compared to normal endometrium. Our loss-of-function data indicate that Lef1 is required for the formation of endometrial glands in the mouse uterus. Lef1 protein elevation corresponds to gland formation during development, and varies cyclically with the mouse estrus cycle, in parallel with gland regeneration. Finally, Lef1 is overexpressed in human and mouse endometrial tumors, consistent with it playing a role in gland proliferation.	[Shelton, Dawne N.; Fornalik, Hubert; Neff, Traci; Park, Soo Yeun; Bender, David; DeGeest, Koen; Goodheart, Michael J.] Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Liu, Xiaoming; Xie, Weiliang; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Meyerholz, David K.] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Shelton, DN (corresponding author), Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.	michael-goodheart@uiowa.edu	Meyerholz, David/J-8131-2019; xie, weiliang/E-6551-2013	Meyerholz, David/0000-0003-1552-3253; Bender, David/0000-0002-9192-510X; LIU, XIAOMING/0000-0002-3902-9105; Goodheart, Michael/0000-0003-3498-8945; Engelhardt, John/0000-0003-2389-9277; xie, weiliang/0000-0002-4887-3711	Reproductive Scientist Development Program National Institutes of Health [5K12HD00849]; American Board of Obstetrics and Gynecology, National Cancer Institute [P30CA086862]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047967, P30DK054759] Funding Source: NIH RePORTER	Reproductive Scientist Development Program National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Board of Obstetrics and Gynecology, National Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant support to MJG: Reproductive Scientist Development Program National Institutes of Health grant 5K12HD00849 and The American Board of Obstetrics and Gynecology, National Cancer Institute P30CA086862. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Bircan S, 2005, PATHOL ONCOL RES, V11, P32, DOI 10.1007/BF03032403; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; BRODY JR, 1989, AM J ANAT, V186, P1, DOI 10.1002/aja.1001860102; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; Duan DS, 1999, DEVELOPMENT, V126, P4441; EVANS GS, 1990, CELL TISSUE KINET, V23, P619, DOI 10.1111/j.1365-2184.1990.tb01350.x; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Fukuchi T, 1998, CANCER RES, V58, P3526; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; Hai B, 2010, STEM CELLS DEV, V19, P1793, DOI 10.1089/scd.2009.0499; Horree N, 2008, J CLIN PATHOL, V61, P36, DOI 10.1136/jcp.2006.043794; Horst D, 2009, EUR J CANCER, V45, P2034, DOI 10.1016/j.ejca.2009.04.004; Horst D, 2009, CANCER, V115, P2063, DOI 10.1002/cncr.24254; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jesse S, 2010, INT J CANCER, V126, P1109, DOI 10.1002/ijc.24802; Jung HC, 2005, LIFE SCI, V77, P1249, DOI 10.1016/j.lfs.2005.02.009; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Konopka B, 2007, J CANCER RES CLIN, V133, P361, DOI 10.1007/s00432-006-0179-4; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kriegl L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-123; Machin P, 2002, HUM PATHOL, V33, P206, DOI 10.1053/hupa.2002.30723; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, DEVELOPMENT, V125, P3201; Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Moreno-Bueno G, 2001, DIAGN MOL PATHOL, V10, P116, DOI 10.1097/00019606-200106000-00008; Nei H, 1999, MOL CARCINOGEN, V25, P207, DOI 10.1002/(SICI)1098-2744(199907)25:3<207::AID-MC7>3.3.CO;2-W; Nikaido T, 1996, CANCER, V78, P1248, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1248::AID-CNCR12>3.3.CO;2-U; NIWA K, 1991, JPN J CANCER RES, V82, P1391, DOI 10.1111/j.1349-7006.1991.tb01811.x; Niwa K, 1996, CANCER LETT, V104, P115, DOI 10.1016/0304-3835(96)04240-1; NIWA K, 1993, JPN J CANCER RES, V84, P951, DOI 10.1111/j.1349-7006.1993.tb00183.x; Putti R, 1979, Basic Appl Histochem, V23, P25; Ray S, 2008, MOL ENDOCRINOL, V22, P1125, DOI 10.1210/me.2007-0445; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1997, CANCER RES, V57, P4624; Saegusa M, 2001, J PATHOL, V194, P59, DOI 10.1002/path.856; Saegusa M, 2001, BRIT J CANCER, V84, P209, DOI 10.1054/bjoc.2000.1581; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Spencer TE, 2006, MOL B INT U, P186; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; WHITTEN WK, 1968, SCIENCE, V161, P584, DOI 10.1126/science.161.3841.584; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Yi YC, 2010, CLIN CHEM LAB MED, V48, P337, DOI 10.1515/CCLM.2010.082; Zaino RJ, 2011, BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT, SIXTH EDITION, P105, DOI 10.1007/978-1-4419-0489-8_3; Zysow BR, 1997, ARTERIOSCL THROM VAS, V17, P1741, DOI 10.1161/01.ATV.17.9.1741	53	30	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40312	10.1371/journal.pone.0040312	http://dx.doi.org/10.1371/journal.pone.0040312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792274	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800068
J	Lunova, M; Zizer, E; Kucukoglu, O; Schwarz, C; Dillmann, WH; Wagner, M; Strnad, P				Lunova, Mariia; Zizer, Eugen; Kucukoglu, Ozlem; Schwarz, Carolin; Dillmann, Wolfgang H.; Wagner, Martin; Strnad, Pavel			Hsp72 Overexpression Accelerates the Recovery from Caerulein-Induced Pancreatitis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TRYPSINOGEN ACTIVATION; MOLECULAR CHAPERONES; THERAPEUTIC TOOLS; EXOCRINE PANCREAS; STRESS; PROTECTION; DISEASES; INJURY; EXPRESSION	Background and Aims: Heat shock protein (Hsp) 72 is a molecular chaperone which is upregulated in response to a variety of stress situations and has a general cytoprotective function. Increased Hsp72 levels were implicated in protection from acute pancreatitis; a hypothesis which was not tested in a transgenic mouse model yet. Methods: To analyze the role of Hsp72 during acute pancreatitis, well-characterized transgenic animals overexpressing rat Hsp72 (Hsp72 mice) under the control of the beta-actin promoter were subjected to caerulein- and L-arginine-induced acute pancreatitis. The severity of experimental pancreatitis was determined via serum lipase levels, morphometric evaluation and quantification of pancreatic edema/inflammation. Results: Hsp72 mice displayed similar to 100-times Hsp72 overexpression, but no changes in the remaining chaperones. Robust Hsp72 signal was observed in pancreatic acini, but not in islets or ductal cells. In both models, elevated Hsp72 did not protect from development of acute pancreatitis and the pancreatitis-associated lung injury, but accelerated recovery from caerulein- induced tissue injury (lower lipase levels, edema, inflammation and necrosis 36 h after caerulein administration). The observed protective function of Hsp72 in caerulein- induced pancreatitis is likely due to an attenuated NF-kappa B signalling. Conclusions: Hsp72 overexpression accelerates the recovery from acute pancreatitis and may represent a potential treatment strategy.	[Lunova, Mariia; Zizer, Eugen; Kucukoglu, Ozlem; Schwarz, Carolin; Wagner, Martin; Strnad, Pavel] Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany; [Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, San Diego, CA 92103 USA	Ulm University; University of California System; University of California San Diego	Lunova, M (corresponding author), Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany.	Mariia.Lunova@uniklinik-ulm.de; Pavel.Strnad@uniklinik-ulm.de	Kucukoglu, Ozlem/J-4713-2019; Lunova, Mariia/G-8447-2014	Kucukoglu, Ozlem/0000-0002-4217-9075; Lunova, Mariia/0000-0002-5795-7781	Emmy Noether program of the German Research Foundation [STR 1095/2-1]	Emmy Noether program of the German Research Foundation(German Research Foundation (DFG))	This work was supported by the Emmy Noether program of the German Research Foundation STR 1095/2-1 (P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MB, 2011, BIOMED PHARMACOTHER, V65, P239, DOI 10.1016/j.biopha.2011.04.025; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Bhagat L, 2002, GASTROENTEROLOGY, V122, P156, DOI 10.1053/gast.2002.30314; Bhagat L, 2000, J CLIN INVEST, V106, P81, DOI 10.1172/JCI8706; Chan YC, 2007, PANCREAS, V34, P1, DOI 10.1097/01.mpa.0000246658.38375.04; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Czako L, 2009, PANCREATOLOGY, V9, P351, DOI 10.1159/000181169; Dudeja V, 2009, GUT, V58, P1000, DOI 10.1136/gut.2007.140194; Feng JY, 2010, J DIGEST DIS, V11, P277, DOI 10.1111/j.1751-2980.2010.00450.x; Fetaud-Lapierre V, 2010, J PROTEOME RES, V9, P5929, DOI 10.1021/pr100695d; Gao HK, 2005, WORLD J GASTROENTERO, V11, P661, DOI 10.3748/wjg.v11.i5.661; Gupta KWB, 2010, ANN INTERN MED; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hegyi P, 2011, GUT, V60, P544, DOI 10.1136/gut.2010.218461; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Oruc N, 2004, PANCREAS, V28, pE1, DOI 10.1097/00006676-200401000-00020; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Rakonczay Z, 2003, J CELL PHYSIOL, V195, P383, DOI 10.1002/jcp.10268; Saluja A, 2008, J GASTROEN HEPATOL, V23, pS42, DOI 10.1111/j.1440-1746.2007.05272.x; SCHMIDT J, 1992, INT J PANCREATOL, V12, P41; Vege SS, 2007, GI EPIDEMIOLOGY, P221, DOI 10.1002/9780470692189.ch30; Wagner ACC, 1996, GASTROENTEROLOGY, V111, P1333, DOI 10.1053/gast.1996.v111.pm8898648; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Zhong BH, 2007, MOL BIOL CELL, V18, P4969, DOI 10.1091/mbc.E07-02-0180	29	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39972	10.1371/journal.pone.0039972	http://dx.doi.org/10.1371/journal.pone.0039972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792201	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300016
J	Vargas, S; Schuster, A; Sacher, K; Buttner, G; Schatzle, S; Lauchli, B; Hall, K; Hooper, JNA; Erpenbeck, D; Worheide, G				Vargas, Sergio; Schuster, Astrid; Sacher, Katharina; Buettner, Gabrielle; Schaetzle, Simone; Laeuchli, Benjamin; Hall, Kathryn; Hooper, John N. A.; Erpenbeck, Dirk; Woerheide, Gert			Barcoding Sponges: An Overview Based on Comprehensive Sampling	PLOS ONE			English	Article							DNA ISOLATION; DEMOSPONGIAE; PORIFERA; PHYLOGENIES; BACTERIA; PROTOCOL	Background: Phylum Porifera includes,8,500 valid species distributed world-wide in aquatic ecosystems ranging from ephemeral fresh-water bodies to coastal environments and the deep-sea. The taxonomy and systematics of sponges is complicated, and morphological identification can be both time consuming and erroneous due to phenotypic convergence and secondary losses, etc. DNA barcoding can provide sponge biologists with a simple and rapid method for the identification of samples of unknown taxonomic membership. The Sponge Barcoding Project (www.spongebarcoding.org), the first initiative to barcode a non-bilaterian metazoan phylum, aims to provide a comprehensive DNA barcode database for Phylum Porifera. Methodology/Principal Findings: similar to 7,400 sponge specimens have been extracted, and amplification of the standard COI barcoding fragment has been attempted for approximately 3,300 museum samples with similar to 25% mean amplification success. Based on this comprehensive sampling, we present the first report on the workflow and progress of the sponge barcoding project, and discuss some common pitfalls inherent to the barcoding of sponges. Conclusion: A DNA-barcoding workflow capable of processing potentially large sponge collections has been developed and is routinely used for the Sponge Barcoding Project with success. Sponge specific problems such as the frequent co-amplification of non-target organisms have been detected and potential solutions are currently under development. The initial success of this innovative project have already demonstrated considerable refinement of sponge systematics, evaluating morphometric character importance, geographic phenotypic variability, and the utility of the standard barcoding fragment for Porifera (despite its conserved evolution within this basal metazoan phylum).	[Vargas, Sergio; Schuster, Astrid; Sacher, Katharina; Buettner, Gabrielle; Schaetzle, Simone; Laeuchli, Benjamin; Erpenbeck, Dirk; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Hall, Kathryn; Hooper, John N. A.] Queensland Museum, Brisbane, Qld, Australia; [Hooper, John N. A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Erpenbeck, Dirk; Woerheide, Gert] GeoBioctr LMU, Munich, Germany; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, Munich, Germany	University of Munich; Queensland Museum; Griffith University; University of Munich	Vargas, S (corresponding author), Univ Munich, Dept Earth & Environm Sci, Munich, Germany.	woerheide@lmu.de	Vargas, Sergio/A-5678-2011; Hall, Kathryn/A-2402-2009; Wörheide, Gert/C-1080-2008; Hall, Kathryn/GVS-0464-2022	Vargas, Sergio/0000-0001-8704-1339; Hall, Kathryn/0000-0002-8785-4513; Wörheide, Gert/0000-0002-6380-7421; Schuster, Astrid/0000-0001-8978-3256; Hooper, John/0000-0003-1722-5954; Erpenbeck, Dirk/0000-0003-2716-1085	Alfred P. Sloan Foundation; GeoBio-CenterLMU; German Science Foundation (DFG) [Wo896/9-1, Wo896/9-2]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); GeoBio-CenterLMU; German Science Foundation (DFG)(German Research Foundation (DFG))	The Sponge Barcoding Project thanks the Marine Barcoding of Life Initiative (MarBol), funded by the Alfred P. Sloan Foundation and the GeoBio-CenterLMU, for financing the subsampling and extraction of 17,000 sponge specimens within the custodianship of the Queensland Museum, Brisbane, Australia, and the Taxonomic Research Informatics Network (TRIN) and Atlas of Living Australia (ALA) project for supporting the development of the morphometric database/wiki that provides complementary taxonomic verification for these sequence data. The authors also acknowledge funding of the German Science Foundation (DFG), through grants Wo896/9-1,2 to G. Worheide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Boom R, 1999, J CLIN MICROBIOL, V37, P615, DOI 10.1128/JCM.37.3.615-619.1999; Cardenas P, 2009, ZOOTAXA, P1; Chelossi E, 2004, J EXP MAR BIOL ECOL, V309, P21, DOI 10.1016/j.jembe.2004.03.006; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Erpenbeck D, 2006, MOL PHYLOGENET EVOL, V38, P293, DOI 10.1016/j.ympev.2005.11.001; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erpenbeck D, 2012, ORG DIVERS EVOL, P1; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1; Erpenbeck D, 2007, MAR BIOTECHNOL, V9, P2, DOI 10.1007/s10126-005-6109-7; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gatti S, 2002, BERICHTE POLAR MEERE, V434, P1, DOI DOI 10.2312/BZPM_0434_2002; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Sambrook E., 1989, MOL CLONING; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Siddall ME, 2009, SYST BIOL, V58, P445, DOI 10.1093/sysbio/syp033; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; van Soest RWM, 2012, WORLD PORIFERA DATAB; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Worheide G, 2008, PORIFERA RES BIODIVE, P123; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1	32	50	53	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39345	10.1371/journal.pone.0039345	http://dx.doi.org/10.1371/journal.pone.0039345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802937	Green Published, Green Submitted, gold			2022-12-27	WOS:000306186900011
J	Lange, CM; Bibert, S; Kutalik, Z; Burgisser, P; Cerny, A; Dufour, JF; Geier, A; Gerlach, TJ; Heim, MH; Malinverni, R; Negro, F; Regenass, S; Badenhoop, K; Bojunga, J; Sarrazin, C; Zeuzem, S; Muller, T; Berg, T; Bochud, PY; Moradpour, D				Lange, Christian M.; Bibert, Stephanie; Kutalik, Zoltan; Burgisser, Philippe; Cerny, Andreas; Dufour, Jean-Francois; Geier, Andreas; Gerlach, Tilman J.; Heim, Markus H.; Malinverni, Raffaele; Negro, Francesco; Regenass, Stephan; Badenhoop, Klaus; Bojunga, Joerg; Sarrazin, Christoph; Zeuzem, Stefan; Mueller, Tobias; Berg, Thomas; Bochud, Pierre-Yves; Moradpour, Darius		Swiss Hepatitis C Cohort Study Grp	A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C	PLOS ONE			English	Article							SEVERE FIBROSIS; TELAPREVIR; DISEASE; ASSOCIATION; BOCEPREVIR; CYP27B1; COHORT; HIV	Background: To perform a comprehensive study on the relationship between vitamin D metabolism and the response to interferon-a-based therapy of chronic hepatitis C. Methodology/Principal Findings: Associations between a functionally relevant polymorphism in the gene encoding the vitamin D 1 alpha-hydroxylase (CYP27B1-1260 rs10877012) and the response to treatment with pegylated interferon-alpha (PEG-IFN-alpha) and ribavirin were determined in 701 patients with chronic hepatitis C. In addition, associations between serum concentrations of 25-hydroxyvitamin D-3 (25[OH]D-3) and treatment outcome were analysed. CYP27B1-1260 rs10877012 was found to be an independent predictor of sustained virologic response (SVR) in patients with poor-response IL28B genotypes (15% difference in SVR for rs10877012 genotype AA vs. CC, p = 0.02, OR = 1.52, 95% CI = 1.061-2.188), but not in patients with favourable IL28B genotype. Patients with chronic hepatitis C showed a high prevalence of vitamin D insufficiency (25[OH]D-3<20 ng/mL) during all seasons, but 25(OH)D-3 serum levels were not associated with treatment outcome. Conclusions/Significance: Our study suggests a role of bioactive vitamin D (1,25[OH](2)D-3, calcitriol) in the response to treatment of chronic hepatitis C. However, serum concentration of the calcitriol precursor 25(OH)D-3 is not a suitable predictor of treatment outcome.	[Lange, Christian M.; Burgisser, Philippe; Moradpour, Darius] Univ Lausanne, Ctr Hosp Univ Vaudois, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Lange, Christian M.; Badenhoop, Klaus; Bojunga, Joerg; Sarrazin, Christoph; Zeuzem, Stefan] Klinikum JW Goethe Univ Frankfurt, Med Klin 1, Frankfurt, Germany; [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne, Ctr Hosp Univ Vaudois, Div Infect Dis, Lausanne, Switzerland; [Kutalik, Zoltan] Univ Lausanne, Ctr Hosp Univ Vaudois, Div Med Genet, Lausanne, Switzerland; [Cerny, Andreas] Osped Moncucco, Liver Unit, Lugano, Switzerland; [Dufour, Jean-Francois] Univ Bern, Inselspital, Univ Clin Visceral Surg & Med, CH-3010 Bern, Switzerland; [Geier, Andreas; Regenass, Stephan] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Gerlach, Tilman J.] Kantonsspital St Gallen, Div Gastroenterol, St Gallen, Switzerland; [Heim, Markus H.] Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland; [Malinverni, Raffaele] Hop Neuchatelois, Neuchatel, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Mueller, Tobias] Charite Campus Virchow Klinikum, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany; [Berg, Thomas] Univ Klinikum Leipzig, Sekt Hepatol, Klin Gastroenterol & Rheumatol, Leipzig, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Basel; University of Geneva; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Lange, CM (corresponding author), Univ Lausanne, Ctr Hosp Univ Vaudois, Div Gastroenterol & Hepatol, Lausanne, Switzerland.	Christian.Lange@chuv.ch; Darius.Moradpour@chuv.ch	Heim, Markus/A-7526-2008; Negro, Francesco/E-2183-2012; Bochud, Pierre-Yves/ABE-5979-2020; Dufour, Jean Francois Jacques/AAL-9866-2020; Kutalik, Zoltan/HHZ-5697-2022; Zeuzem, Stefan/AAE-7435-2019; Moradpour, Darius/G-7918-2017	Heim, Markus/0000-0002-7523-4894; Dufour, Jean Francois Jacques/0000-0002-8062-1346; Kutalik, Zoltan/0000-0001-8285-7523; Bibert, Stephanie/0000-0001-5170-7506; Bochud, Pierre-Yves/0000-0002-2208-4757; Mueller, Tobias/0000-0003-3426-5421; Berg, Thomas/0000-0003-0003-6241; Moradpour, Darius/0000-0003-1977-6792	Swiss National Science Foundation [3100A0-122447, 32003B-127613, 3347C0-108782/1, 33CSC0-108782/2]; Leenaards Foundation; European Community [260844, 241447]; Santos-Suarez Foundation; Deutsche Forschungsgemeinschaft [LA 2806/1-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation; European Community(European Commission); Santos-Suarez Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Swiss National Science Foundation (3100A0-122447 to DM, 32003B-127613 to PYB as well as 3347C0-108782/1 and 33CSC0-108782/2 to SCCS), the Leenaards Foundation (to PYB), the European Community's FP7 (grant agreement 260844 to PYB; and grant agreement 241447 to KB), and the Santos-Suarez Foundation (to PYB). CML is the recipient of a Research Fellowship from the Deutsche Forschungsgemeinschaft (LA 2806/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bailey R, 2007, DIABETES, V56, P2616, DOI 10.2337/db07-0652; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; Bitetto D, 2011, HEPATOLOGY; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; BOUILLON R, 1984, J CLIN ENDOCR METAB, V59, P86, DOI 10.1210/jcem-59-1-86; Clark PJ, 2011, AM J GASTROENTEROL, V106, P38, DOI 10.1038/ajg.2010.370; Clifton-Bligh RJ, 2011, CALCIFIED TISSUE INT, V88, P109, DOI 10.1007/s00223-010-9434-4; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Dong LM, 2009, CANCER EPIDEM BIOMAR, V18, P2540, DOI 10.1158/1055-9965.EPI-09-0228; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hofer H, 2002, AM J GASTROENTEROL, V97, P2880, DOI 10.1111/j.1572-0241.2002.07056.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lange CM, 2010, ALIMENT PHARM THER, V32, P14, DOI 10.1111/j.1365-2036.2010.04317.x; Lange CM, 2012, HEPATOLOGY, V55, P1038, DOI 10.1002/hep.24787; Lange CM, 2011, J HEPATOL, V55, P322, DOI 10.1016/j.jhep.2010.10.037; Lange CM, 2010, EUR J GASTROEN HEPAT, V22, P1303, DOI 10.1097/MEG.0b013e32833de92c; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; Lange CM, 2011, J HEPATOL, V55, P962; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Milazzo L, 2011, CURR HIV RES, V9, P186, DOI 10.2174/157016211795945269; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prasad L, 2007, INT J EPIDEMIOL, V36, P731, DOI 10.1093/ije/dym096; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Reusch J, 2009, HORM METAB RES, V41, P402, DOI 10.1055/s-0028-1128131; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sundqvist E, 2010, EUR J HUM GENET, V18, P1349, DOI 10.1038/ejhg.2010.113; Terrier B, 2011, J HEPATOL, V55, P756, DOI 10.1016/j.jhep.2011.01.041; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	38	61	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40159	10.1371/journal.pone.0040159	http://dx.doi.org/10.1371/journal.pone.0040159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808108	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400015
J	Cotsaftis, O; Plett, D; Shirley, N; Tester, M; Hrmova, M				Cotsaftis, Olivier; Plett, Darren; Shirley, Neil; Tester, Mark; Hrmova, Maria			A Two-Staged Model of Na+ Exclusion in Rice Explained by 3D Modeling of HKT Transporters and Alternative Splicing	PLOS ONE			English	Article							SALINITY TOLERANCE; DURUM-WHEAT; STRUCTURE PREDICTION; SODIUM TRANSPORTER; PROTEIN-SEQUENCE; SALT TOLERANCE; GENE FAMILY; NAX2; ARABIDOPSIS; PROFILES	The HKT family of Na+ and Na+/K+ transporters is implicated in plant salinity tolerance. Amongst these transporters, the cereal HKT1;4 and HKT1;5 are responsible for Na+ exclusion from photosynthetic tissues, a key mechanism for plant salinity tolerance. It has been suggested that Na+ is retrieved from the xylem transpiration stream either in the root or the leaf sheath, protecting the leaf blades from excessive Na+ accumulation. However, direct evidence for this scenario is scarce. Comparative modeling and evaluation of rice (Oryza sativa) HKT-transporters based on the recent crystal structure of the bacterial TrkH K+ transporter allowed to reconcile transcriptomic and physiological data. For OsHKT1;5, both transcript abundance and protein structural features within the selectivity filter could control shoot Na+ accumulation in a range of rice varieties. For OsHKT1;4, alternative splicing of transcript and the anatomical complexity of the sheath needed to be taken into account. Thus, Na+ accumulation in a specific leaf blade seems to be regulated by abundance of a correctly spliced OsHKT1;4 transcript in a corresponding sheath. Overall, allelic variation of leaf blade Na+ accumulation can be explained by a complex interplay of gene transcription, alternative splicing and protein structure.	[Cotsaftis, Olivier; Plett, Darren; Shirley, Neil; Tester, Mark; Hrmova, Maria] Univ Adelaide, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia	University of Adelaide	Cotsaftis, O (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia.	oliv.cotsaftis@gmail.com	Tester, Mark/J-2368-2017; Hrmova, Maria/AAH-3951-2020	Tester, Mark/0000-0002-5085-8801; Plett, Darren/0000-0002-9551-8755; Hrmova, Maria/0000-0002-3545-0605; Shirley, Neil/0000-0001-8114-9891; Cotsaftis, Olivier/0000-0002-9635-326X	Australian Research Council	Australian Research Council(Australian Research Council)	This work was financed through two Australian Research Council (www.arc.gov.au) grants to M. T. and M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Cotsaftis O, 2011, MOL PLANT, V4, P25, DOI 10.1093/mp/ssq056; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Domene C, 2012, BIOCHEMISTRY-US, V51, P1559, DOI 10.1021/bi201586n; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gregorio GB, 2002, FIELD CROP RES, V76, P91, DOI 10.1016/S0378-4290(02)00031-X; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; James RA, 2011, J EXP BOT, V62, P2939, DOI 10.1093/jxb/err003; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Platten JD, 2006, TRENDS PLANT SCI, V11, P372, DOI 10.1016/j.tplants.2006.06.001; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012571; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zeng LH, 2005, PLANT SOIL, V268, P51, DOI 10.1007/s11104-004-0180-0	30	132	138	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39865	10.1371/journal.pone.0039865	http://dx.doi.org/10.1371/journal.pone.0039865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808069	Green Published, gold			2022-12-27	WOS:000306362400024
J	Farine, JP; Ferveur, JF; Everaerts, C				Farine, Jean-Pierre; Ferveur, Jean-Francois; Everaerts, Claude			Volatile Drosophila Cuticular Pheromones Are Affected by Social but Not Sexual Experience	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; CIS-VACCENYL ACETATE; COURTSHIP BEHAVIOR; MELANOGASTER MALES; MATING-BEHAVIOR; CHEMICAL COMMUNICATION; OLFACTORY NEURONS; RECEPTOR NEURONS; HYDROCARBONS; PERCEPTION	Recognition of conspecifics and mates is based on a variety of sensory cues that are specific to the species, sex and social status of each individual. The courtship and mating activity of Drosophila melanogaster flies is thought to depend on the olfactory perception of a male-specific volatile pheromone, cis-vaccenyl acetate (cVA), and the gustatory perception of cuticular hydrocarbons (CHs), some of which are sexually dimorphic. Using two complementary sampling methods (headspace Solid Phase Micro-Extraction [SPME] and solvent extraction) coupled with GC-MS analysis, we measured the dispersion of pheromonal CHs in the air and on the substrate around the fly. We also followed the variations in CHs that were induced by social and sexual interactions. We found that all CHs present on the fly body were deposited as a thin layer on the substrate, whereas only a few of these molecules were also detected in the air. Moreover, social experience during early adult development and in mature flies strongly affected male volatile CHs but not cVA, whereas sexual interaction only had a moderate influence on dispersed CHs. Our study suggests that, in addition to their role as contact cues, CHs can influence fly behavior at a distance and that volatile, deposited and body pheromonal CHs participate in a three-step recognition of the chemical identity and social status of insects.	[Farine, Jean-Pierre; Ferveur, Jean-Francois; Everaerts, Claude] Univ Bourgogne, Ctr Sci Gout & Alimentat, Unite Mixte Rech 2572, Ctr Natl Rech Sci,Unite Mixte Rech 1324,INRA, Dijon, France	CEA; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Farine, JP (corresponding author), Univ Bourgogne, Ctr Sci Gout & Alimentat, Unite Mixte Rech 2572, Ctr Natl Rech Sci,Unite Mixte Rech 1324,INRA, Dijon, France.	Claude.Everaerts@u-bourgogne.fr						Addinsoft, 1995, DAT AN STAT MICR EXC; Aitchison J., 1986, MONOGRAPHS STAT APPL, P416; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; BELL WJ, 1985, ANIM BEHAV, V33, P436, DOI 10.1016/S0003-3472(85)80068-3; Bland JM, 2001, J CHROMATOGR A, V932, P119, DOI 10.1016/S0021-9673(01)01239-0; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Chikos JS, 1994, J CHEM ENG DATA, V42, P190; Chow DM, 2009, FLY, V3, P50, DOI 10.4161/fly.3.1.7775; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Everaerts C, 2010, ANIM BEHAV, V79, P1135, DOI 10.1016/j.anbehav.2010.02.013; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FERVEUR JF, 1993, GENETICS, V133, P561; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Foley BR, 2011, HEREDITY, V106, P68, DOI 10.1038/hdy.2010.40; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Griffith LC, 2009, ANN NY ACAD SCI, V1170, P394, DOI 10.1111/j.1749-6632.2009.04367.x; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Hall JC, 2002, J NEUROGENET, V16, P135, DOI 10.1080/01677060215307; Hansson BS, 2010, CHEMOECOLOGY, V20, P51, DOI 10.1007/s00049-009-0033-7; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Inoshita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019770; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Lebreton S, 2012, J INSECT PHYSIOL, V58, P125, DOI 10.1016/j.jinsphys.2011.10.009; Lecomte C, 1998, J CHEM ECOL, V24, P655, DOI 10.1023/A:1022390102631; Levine J, 2011, SURF INTERFACE ANAL, V43, P317, DOI 10.1002/sia.3455; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Villaverde ML, 2009, COMP BIOCHEM PHYS B, V154, P381, DOI 10.1016/j.cbpb.2009.08.001; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Marcillac F, 2004, J EXP BIOL, V207, P3927, DOI 10.1242/jeb.01236; Mehren JE, 2007, CURR BIOL, V17, pR240, DOI 10.1016/j.cub.2007.02.014; Meissner GW, 2011, GENETICS, V189, P195, DOI 10.1534/genetics.111.129940; Metzger M, 2010, ANIM BEHAV, V79, P1307, DOI 10.1016/j.anbehav.2010.03.003; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; O'Dell KMC, 2003, BEHAV PROCESS, V64, P211, DOI 10.1016/S0376-6357(03)00136-0; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Rouault JD, 2004, GENETICA, V120, P195, DOI 10.1023/B:GENE.0000017641.75820.49; Rybak F, 2002, CAN J ZOOL, V80, P987, DOI 10.1139/Z02-082; Said I, 2005, J INSECT PHYSIOL, V51, P1384, DOI 10.1016/j.jinsphys.2005.09.001; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Scott D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023645; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Shelly TE, 2004, J INSECT BEHAV, V17, P709, DOI 10.1023/B:JOIR.0000042551.10590.d2; SHOREY HH, 1970, ANIM BEHAV, V18, P159, DOI 10.1016/0003-3472(70)90085-0; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Sturtevant A.H, 1915, ANIM BEHAV, V5, P351, DOI DOI 10.1037/H0074109; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; Svetec N, 2005, GENET RES, V85, P183, DOI 10.1017/S0016672305007536; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Symonds MRE, 2005, J EVOLUTION BIOL, V18, P1253, DOI 10.1111/j.1420-9101.2005.00971.x; Thio-Henestrosa S, 2005, MATH GEOL, V37, P773, DOI 10.1007/s11004-005-7379-3; Thomas ML, 2011, P ROY SOC B-BIOL SCI, V278, P3123, DOI 10.1098/rspb.2011.0159; TORTORICI C, 1986, ANIM BEHAV, V34, P1568, DOI 10.1016/S0003-3472(86)80228-7; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wicker-Thomas C, 2007, J INSECT PHYSIOL, V53, P1089, DOI 10.1016/j.jinsphys.2007.07.003; Widemo F, 2006, P ROY SOC B-BIOL SCI, V273, P713, DOI 10.1098/rspb.2005.3379; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, P391, DOI [DOI 10.1017/CBO9780511615061, 10.1017/CBO9780511615061]; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0; Zwarts L, 2011, P NATL ACAD SCI USA, V108, P17070, DOI 10.1073/pnas.1113877108	86	61	62	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40396	10.1371/journal.pone.0040396	http://dx.doi.org/10.1371/journal.pone.0040396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808151	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400050
J	Hingtgen, S; Kasmieh, R; Elbayly, E; Nesterenko, I; Figueiredo, JL; Dash, R; Sarkar, D; Hall, D; Kozakov, D; Vajda, S; Fisher, PB; Shah, K				Hingtgen, Shawn; Kasmieh, Randa; Elbayly, Elizabeth; Nesterenko, Irina; Figueiredo, Jose-Luiz; Dash, Rupesh; Sarkar, Devanand; Hall, David; Kozakov, Dima; Vajda, Sandor; Fisher, Paul B.; Shah, Khalid			A First-Generation Multi-Functional Cytokine for Simultaneous Optical Tracking and Tumor Therapy	PLOS ONE			English	Article							APOPTOSIS-INDUCING CYTOKINE; CANCER-SPECIFIC APOPTOSIS; NEURAL PROGENITOR CELLS; STEM-CELLS; IN-VIVO; GENE-THERAPY; MELANOMA DIFFERENTIATION; GROWTH SUPPRESSION; MALIGNANT GLIOMAS; LENTIVIRUS VECTOR	Creating new molecules that simultaneously enhance tumor cell killing and permit diagnostic tracking is vital to overcoming the limitations rendering current therapeutic regimens for terminal cancers ineffective. Accordingly, we investigated the efficacy of an innovative new multi-functional targeted anti-cancer molecule, SM7L, using models of the lethal brain tumor Glioblastoma multiforme (GBM). Designed using predictive computer modeling, SM7L incorporates the therapeutic activity of the promising anti-tumor cytokine MDA-7/IL-24, an enhanced secretory domain, and diagnostic domain for non-invasive tracking. In vitro assays revealed the diagnostic domain of SM7L produced robust photon emission, while the therapeutic domain showed marked anti-tumor efficacy and significant modulation of p38MAPK and ERK pathways. In vivo, the unique multi-functional nature of SM7L allowed simultaneous real-time monitoring of both SM7L delivery and anti-tumor efficacy. Utilizing engineered stem cells as novel delivery vehicles for SM7L therapy (SC-SM7L), we demonstrate that SC-SM7L significantly improved pharmacokinetics and attenuated progression of established peripheral and intracranial human GBM xenografts. Furthermore, SC-SM7L anti-tumor efficacy was augmented in vitro and in vivo by concurrent activation of caspase-mediated apoptosis induced by adjuvant SC-mediated S-TRAIL delivery. Collectively, these studies define a promising new approach to treating highly aggressive cancers, including GBM, using the optimized therapeutic molecule SM7L.	[Hingtgen, Shawn; Kasmieh, Randa; Elbayly, Elizabeth; Nesterenko, Irina; Figueiredo, Jose-Luiz; Shah, Khalid] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02115 USA; [Hingtgen, Shawn; Kasmieh, Randa; Elbayly, Elizabeth; Nesterenko, Irina; Figueiredo, Jose-Luiz; Shah, Khalid] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Dash, Rupesh; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, VCU Inst Mol Med, VCU Massey Canc Ctr,Sch Med, Richmond, VA USA; [Hall, David; Kozakov, Dima; Vajda, Sandor] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Virginia Commonwealth University; Boston University	Hingtgen, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02115 USA.	kshah@mgh.harvard.edu		Kozakov, Dima/0000-0003-0464-4500; dash, rupesh/0000-0001-5740-7053	American Brain Tumor Association; Alliance for Cancer Gene Therapy; American Cancer Society [R21 CA131980, 1R01CA138922-01A2, R01 CA097318, PO1 CA104177, R01 CA127641, R01 CA134721, GM061867]; Dana Foundation; James McDonnel Foundation; NATIONAL CANCER INSTITUTE [P01CA104177, R01CA138922, R01CA134721, R21CA131980, R01CA127641, R01CA097318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061867] Funding Source: NIH RePORTER	American Brain Tumor Association; Alliance for Cancer Gene Therapy; American Cancer Society(American Cancer Society); Dana Foundation; James McDonnel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Brain Tumor Association (K. S., S. H.), Alliance for Cancer Gene Therapy (K. S.), and American Cancer Society (K. S.), R21 CA131980 (K. S.), 1R01CA138922-01A2 (K. S.), R01 CA097318 (P. B. F.), PO1 CA104177 (P. B. F.), R01 CA127641 (P. B. F.), R01 CA134721 (P. B. F.), GM061867 (S. V.), the Dana Foundation (D. S.), and the James McDonnel Foundation (K. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; Dash R, 2010, CYTOKINE GROWTH FACT; Dent P, 2010, ANTI-CANCER DRUG, V21, P725, DOI 10.1097/CAD.0b013e32833cfbe1; Dickson PV, 2007, J PEDIATR SURG, V42, P48, DOI 10.1016/j.jpedsurg.2006.09.050; Eager R, 2008, EXPERT OPIN BIOL TH, V8, P1633, DOI [10.1517/14712598.8.10.1633, 10.1517/14712598.8.10.1633 ]; Emdad L, 2009, CANCER BIOL THER, V8, P402, DOI 10.4161/cbt.8.5.7581; Fisher PB, 2005, CANCER RES, V65, P10128, DOI 10.1158/0008-5472.CAN-05-3127; Germano IM, 2010, CANCER GENE THER, V17, P664, DOI 10.1038/cgt.2010.31; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; Hagemeyer CE, 2009, THROMB HAEMOSTASIS, V101, P1012, DOI 10.1160/TH08-12-0816; Hamed HA, 2010, MOL THER, V18, P1130, DOI 10.1038/mt.2010.29; Hingtgen S, 2008, MOL CANCER THER, V7, P3575, DOI 10.1158/1535-7163.MCT-08-0640; Hingtgen SD, 2010, STEM CELLS, V28, P832, DOI 10.1002/stem.313; Jabr-Milane LS, 2008, CANCER TREAT REV, V34, P592, DOI 10.1016/j.ctrv.2008.04.003; Jiang HP, 1995, ONCOGENE, V11, P2477; Kock N, 2007, NEOPLASIA, V9, P435, DOI 10.1593/neo.07223; Lamborn KR, 2008, NEURO-ONCOLOGY, V10, P162, DOI 10.1215/15228517-2007-062; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Saeki T, 2002, ONCOGENE, V21, P4558, DOI 10.1038/sj.onc.1205553; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Sauane M, 2004, ONCOGENE, V23, P7679, DOI 10.1038/sj.onc.1207958; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sauane M, 2008, P NATL ACAD SCI USA, V105, P9763, DOI 10.1073/pnas.0804089105; Sauvageot CME, 2009, NEURO-ONCOLOGY, V11, P109, DOI 10.1215/15228517-2008-060; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Shah K, 2004, CANCER RES, V64, P3236, DOI 10.1158/0008-5472.CAN-03-3516; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Su ZZ, 2003, ONCOGENE, V22, P1164, DOI 10.1038/sj.onc.1206062; Su ZZ, 2005, ONCOGENE, V24, P7552, DOI 10.1038/sj.onc.1208911; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Tang YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008526; Venisnik KM, 2007, MOL IMAGING BIOL, V9, P267, DOI 10.1007/s11307-007-0101-8; Wang CJ, 2010, ONCOL RES, V18, P561, DOI 10.3727/096504010X12767359113929; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Yacoub A, 2008, CANCER BIOL THER, V7, P917, DOI 10.4161/cbt.7.6.5928; Yacoub A, 2008, MOL CANCER THER, V7, P314, DOI 10.1158/1535-7163.MCT-07-2150; Zhao L, 2006, CANCER GENE THER, V13, P1011, DOI 10.1038/sj.cgt.7700969	44	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40234	10.1371/journal.pone.0040234	http://dx.doi.org/10.1371/journal.pone.0040234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808125	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400036
J	Berthier, S; Minh, VCN; Baillet, A; Hograindleur, MA; Paclet, MH; Polack, B; Morel, F				Berthier, Sylvie; Minh Vu Chuong Nguyen; Baillet, Athan; Hograindleur, Marc-Andre; Paclet, Marie-Helene; Polack, Benoit; Morel, Francoise			Molecular Interface of S100A8 with Cytochrome b(558) and NADPH Oxidase Activation	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; CHRONIC GRANULOMATOUS-DISEASE; III SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; ARACHIDONIC-ACID; POLYMORPHONUCLEAR NEUTROPHILS; CONFORMATIONAL-CHANGES; FLAVOCYTOCHROME B; NOX2 ACTIVITY; CELL-LINE	S100A8 and S100A9 are two calcium binding Myeloid Related Proteins, and important mediators of inflammatory diseases. They were recently introduced as partners for phagocyte NADPH oxidase regulation. However, the precise mechanism of their interaction remains elusive. We had for aim (i) to evaluate the impact of S100 proteins on NADPH oxidase activity; (ii) to characterize molecular interaction of either S100A8, S100A9, or S100A8/S100A9 heterocomplex with cytochrome b(558); and (iii) to determine the S100A8 consensus site involved in cytochrome b(558)/S100 interface. Recombinant full length or S100A9-A8 truncated chimera proteins and ExoS-S100 fusion proteins were expressed in E. coli and in P. aeruginosa respectively. Our results showed that S100A8 is the functional partner for NADPH oxidase activation contrary to S100A9, however, the loading with calcium and a combination with phosphorylated S100A9 are essential in vivo. Endogenous S100A9 and S100A8 colocalize in differentiated and PMA stimulated PLB985 cells, with Nox2/gp91(phox) and p22(phox). Recombinant S100A8, loaded with calcium and fused with the first 129 or 54 N-terminal amino acid residues of the P. aeruginosa ExoS toxin, induced a similar oxidase activation in vitro, to the one observed with S100A8 in the presence of S100A9 in vivo. This suggests that S100A8 is the essential component of the S100A9/S100A8 heterocomplex for oxidase activation. In this context, recombinant full-length rS100A9-A8 and rS100A9-A8 truncated 90 chimera proteins as opposed to rS100A9-A8 truncated 86 and rS100A9-A8 truncated 57 chimeras, activate the NADPH oxidase function of purified cytochrome b(558) suggesting that the C-terminal region of S100A8 is directly involved in the molecular interface with the hemoprotein. The data point to four strategic (HEES90)-H-87 amino acid residues of the S100A8 C-terminal sequence that are involved directly in the molecular interaction with cytochrome b(558) and then in the phagocyte NADPH oxidase activation.	[Berthier, Sylvie; Minh Vu Chuong Nguyen; Baillet, Athan; Hograindleur, Marc-Andre; Paclet, Marie-Helene; Morel, Francoise] Univ Grenoble 1, Grp Rech & Etud Processus Inflammatoire GREPI, Lab Aging Imaging Modeling AGIM, Format Rech Evolut FRE Ctr Natl Rech Sci CNRS 340, Grenoble, France; [Baillet, Athan] CHU Grenoble, Clin Rheumatol, F-38043 Grenoble, France; [Paclet, Marie-Helene] CHU Grenoble, Lab Enzymes & Prot, F-38043 Grenoble, France; [Paclet, Marie-Helene; Polack, Benoit] CHU Grenoble, Inst Biol & Pathol, F-38043 Grenoble, France; [Polack, Benoit] Univ Grenoble 1, UMR 5525, CNRS, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Berthier, S (corresponding author), Univ Grenoble 1, Grp Rech & Etud Processus Inflammatoire GREPI, Lab Aging Imaging Modeling AGIM, Format Rech Evolut FRE Ctr Natl Rech Sci CNRS 340, Grenoble, France.	mvchuong@yahoo.fr	Paclet, Marie-Hélène/AAS-5029-2020; Polack, Benoit/M-6337-2014		Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; UFR de Medecine, Universite Joseph Fourier, Grenoble; Region Rhone-Alpes, programme Emergence; ARCUS (Actions en Regions de Cooperation Universitaire et Scientifique) France/Chine; CGD (Chronic Granulomatous Disease) research Trust UK; Groupement des Entreprises Francaises dans la lutte contre le Cancer, delegation de Grenoble; Societe Francaise de Rhumatologie; Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble	Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; UFR de Medecine, Universite Joseph Fourier, Grenoble; Region Rhone-Alpes, programme Emergence(Region Auvergne-Rhone-Alpes); ARCUS (Actions en Regions de Cooperation Universitaire et Scientifique) France/Chine; CGD (Chronic Granulomatous Disease) research Trust UK; Groupement des Entreprises Francaises dans la lutte contre le Cancer, delegation de Grenoble; Societe Francaise de Rhumatologie; Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble	This study was supported by grants from the "Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris", the "UFR de Medecine, Universite Joseph Fourier, Grenoble", the "Region Rhone-Alpes, programme Emergence 2003 and ARCUS (Actions en Regions de Cooperation Universitaire et Scientifique) France/Chine 2007-2008", the CGD (Chronic Granulomatous Disease) research Trust 2006-2007, UK, the "Groupement des Entreprises Francaises dans la lutte contre le Cancer, delegation de Grenoble", the "Societe Francaise de Rhumatologie" and the "Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillet A, 2011, FASEB J, V25, P2333, DOI 10.1096/fj.10-173807; Baillet A, 2010, RHEUMATOLOGY, V49, P671, DOI 10.1093/rheumatology/kep452; Batot G, 1998, BBA-MOL BASIS DIS, V1406, P188, DOI 10.1016/S0925-4439(98)00004-0; BATOT G, 1995, EUR J BIOCHEM, V234, P208, DOI 10.1111/j.1432-1033.1995.208_c.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benedyk M, 2007, J INVEST DERMATOL, V127, P2001, DOI 10.1038/sj.jid.5700820; Berthier S, 2003, J BIOL CHEM, V278, P25499, DOI 10.1074/jbc.M209755200; Berthier Sylvie, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P282; Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Derouazi M, 2008, APPL ENVIRON MICROB, V74, P3601, DOI 10.1128/AEM.02576-07; Doussiere J, 1996, BIOCHEMISTRY-US, V35, P13400, DOI 10.1021/bi960916b; Doussiere J, 2002, EUR J BIOCHEM, V269, P3246, DOI 10.1046/j.1432-1033.2002.03002.x; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Foubert TR, 2002, BBA-BIOMEMBRANES, V1567, P221, DOI 10.1016/S0005-2736(02)00619-3; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; MOREL F, 1987, BIOCHEM BIOPH RES CO, V149, P46, DOI 10.1016/0006-291X(87)91603-2; Morel F, 2007, B ACAD NAT MED PARIS, V191, P377, DOI 10.1016/S0001-4079(19)33082-1; Nicolas E, 2011, LEUKEMIA, V25, P57, DOI 10.1038/leu.2010.251; Paclet MH, 2007, FASEB J, V21, P1244, DOI 10.1096/fj.06-6852com; Paclet MH, 2001, EUR J BIOCHEM, V268, P5197, DOI 10.1046/j.0014-2956.2001.02455.x; Paclet MH, 2000, BIOCHEMISTRY-US, V39, P9302, DOI 10.1021/bi000483j; Polack B, 2000, BIOCHEM BIOPH RES CO, V275, P854, DOI 10.1006/bbrc.2000.3399; Polack B, 2005, Patent No. [WO2005049644, 2005049644]; Quenee L, 2005, BIOTECHNIQUES, V38, P63, DOI 10.2144/05381ST01; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; ROTH J, 1993, BLOOD, V82, P1875; Rucks EA, 2005, INFECT IMMUN, V73, P638, DOI 10.1128/IAI.73.1.638-643.2005; Schenten V, 2011, J LEUKOCYTE BIOL, V89, P587, DOI 10.1189/jlb.0510304; Schenten V, 2010, BBA-MOL CELL RES, V1803, P840, DOI 10.1016/j.bbamcr.2010.02.006; Sopalla C, 2002, BIOL CHEM, V383, P1895, DOI 10.1515/BC.2002.213; Taylor RM, 2012, ARCH BIOCHEM BIOPHYS, V521, P24, DOI 10.1016/j.abb.2012.01.018; Tirone F, 2007, FEBS LETT, V581, P1202, DOI 10.1016/j.febslet.2007.02.047; Tirone F, 2010, BIOCHEMISTRY-US, V49, P761, DOI 10.1021/bi901846y; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUCKER KA, 1987, BLOOD, V70, P372; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Voss A, 2011, FEBS LETT, V585, P440, DOI 10.1016/j.febslet.2010.12.037; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23	49	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40277	10.1371/journal.pone.0040277	http://dx.doi.org/10.1371/journal.pone.0040277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808130	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500035
J	van Wel, JHP; Kuypers, KPC; Theunissen, EL; Bosker, WM; Bakker, K; Ramaekers, JG				van Wel, Janelle H. P.; Kuypers, Kim P. C.; Theunissen, Eef L.; Bosker, Wendy M.; Bakker, Katja; Ramaekers, Johannes G.			Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT2 and 5-HT1 Receptors	PLOS ONE			English	Article							ECSTASY MDMA; REFLECTION-IMPULSIVITY; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; INHIBITORY CONTROL; SEROTONIN; AMPHETAMINE; PERFORMANCE; POLYDRUG; COCAINE; MEMORY	MDMA induces positive mood and increases impulse control during intoxication, but only a few studies on the neuropharmacological mechanisms underlying these processes have been conducted. It was hypothesized that pretreatment with 5-HT1 and 5-HT2 receptor blockers would prevent MDMA effects on mood and impulsivity. Subjects (N = 17) participated in a double-blind, placebo controlled, within-subject design involving 6 experimental conditions consisting of pretreatment (T1) and treatment (T2). T1 preceded T2 by 30 minutes. T1-T2 combinations were: placebo-placebo, 20 mg pindolol-placebo, 50 mg ketanserin-placebo, placebo-75 mg MDMA, 20 mg pindolol-75 mg MDMA and 50 mg ketanserin-75 g MDMA. Subjects completed a Profile of Mood States (POMS) questionnaire and several impulsivity tasks (Stop signal task, Matching familiar figures task, Cue dependent reversal learning task) at 1.5 hrs post-treatment. MDMA alone increased both positive (vigor, arousal, friendliness, elation, positive mood) and negative affect (anxiety, confusion) as assessed by the POMS questionnaire. MDMA also increased stop reaction time in the Stop signal task and reaction time in the Matching familiar figures task. Pretreatment with ketanserin blocked MDMA effects on positive affect, but not negative affect. Ketanserin did not influence the effects of MDMA on impulsivity. Pindolol did not interact with MDMA on any of the measures. In conclusion, 5-HT2 receptors mediate positive moods induced by MDMA but not negative moods or impulsivity. 5-HT1 receptors do not appear to be involved in MDMA effects on mood and impulse control.	[van Wel, Janelle H. P.; Kuypers, Kim P. C.; Theunissen, Eef L.; Bosker, Wendy M.; Bakker, Katja; Ramaekers, Johannes G.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, Maastricht, Netherlands	Maastricht University	van Wel, JHP (corresponding author), Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, Maastricht, Netherlands.	Janelle.vanWel@maastrichtuniversity.nl	Kuypers, Kim/L-1206-2019	Kuypers, Kim/0000-0001-7634-3809	Netherlands Organisation for Scientific Research (NWO) [400-05-096]; Lundbeck; MSD; Pierre Fabre; Pfizer; European Committee	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Lundbeck(Lundbeck Corporation); MSD; Pierre Fabre; Pfizer(Pfizer); European Committee	This research was funded by the Netherlands Organisation for Scientific Research (NWO, http://www.nwo.nl/), grant number: 400-05-096, awarded to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that over the past 3 years they have also received funding for research not related to this paper. JR, ET and KK have received grants from numerous pharmaceutical industries (Lundbeck, MSD, Pierre Fabre, Pfizer) the European Committee, and the Netherlands Organisation for Scientific Research (NWO). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anastasio NC, 2011, BEHAV PHARMACOL, V22, P248, DOI 10.1097/FBP.0b013e328345f90d; Bedi G, 2010, BIOL PSYCHIAT; Bosker WM, 2010, PSYCHOPHARMACOLOGY, V209, P69, DOI 10.1007/s00213-009-1767-1; BROGDEN RN, 1990, DRUGS, V40, P903, DOI 10.2165/00003495-199040060-00010; Butler GKL, 2004, DRUG ALCOHOL DEPEN, V76, P55, DOI 10.1016/j.drugalcdep.2004.04.003; CAIRNS E, 1978, DEV PSYCHOL, V14, P555, DOI 10.1037/0012-1649.14.5.555; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Curran HV, 1997, ADDICTION, V92, P821, DOI 10.1111/j.1360-0443.1997.tb02951.x; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fillmore MT, 2006, ADDICTION, V101, P1323, DOI 10.1111/j.1360-0443.2006.01522.x; Fillmore MT, 2006, J PSYCHOPHARMACOL, V20, P24, DOI 10.1177/0269881105057000; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V67, P157, DOI 10.1016/S0376-8716(02)00062-5; Fitzgerald PJ, 2011, PSYCHOPHARMACOLOGY, V213, P171, DOI 10.1007/s00213-010-1856-1; Flory JD, 2004, PSYCHIAT RES, V129, P11, DOI 10.1016/j.psychres.2004.06.010; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gouzoulis-Mayfrank Euphrosyne, 2009, Dialogues Clin Neurosci, V11, P305; Hasler F, 2009, J PSYCHOPHARMACOL, V23, P923, DOI 10.1177/0269881108094650; KAGAN J, 1966, J ABNORM PSYCHOL, V71, P17, DOI 10.1037/h0022886; Kirby LG, 2011, NEUROPHARMACOLOGY; Kuypers KPC, 2007, PSYCHOPHARMACOLOGY, V192, P111, DOI 10.1007/s00213-006-0679-6; Kuypers KPC, 2006, PSYCHOPHARMACOLOGY, V187, P467, DOI 10.1007/s00213-006-0434-z; Kuypers KPC, 2007, PSYCHOPHARMACOLOGY, V189, P557, DOI 10.1007/s00213-006-0321-7; Kuypers KPC, 2005, J PSYCHOPHARMACOL, V19, P633, DOI 10.1177/0269881105056670; Liechti ME, 2000, NEUROPSYCHOPHARMACOL, V23, P396, DOI 10.1016/S0893-133X(00)00126-3; Liechti ME, 2000, NEUROPSYCHOPHARMACOL, V22, P513, DOI 10.1016/S0893-133X(99)00148-7; Liechti ME, 2001, HUM PSYCHOPHARM CLIN, V16, P589, DOI 10.1002/hup.348; Logan Gordon D., 1994, P189; MESSER SB, 1981, DEV PSYCHOL, V17, P848, DOI 10.1037/0012-1649.17.6.848; Morgan MJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1562, DOI 10.1038/sj.npp.1300953; Morgan MJ, 1998, NEUROPSYCHOPHARMACOL, V19, P252, DOI 10.1016/S0893-133X(98)00012-8; Parrott AC, 2008, NEUROPSYCHOBIOLOGY, V57, P165, DOI 10.1159/000147470; Parrott AC, 1998, PSYCHOPHARMACOLOGY, V139, P261, DOI 10.1007/s002130050714; Parrott AC, 1997, HUM PSYCHOPHARM CLIN, V12, P501, DOI 10.1002/(SICI)1099-1077(199709/10)12:5<501::AID-HUP913>3.0.CO;2-V; Parrott AC, 2012, BR J PHARM; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Perales JC, 2009, J CLIN EXP NEUROPSYC, V31, P927, DOI 10.1080/13803390902758793; Piechatzek M, 2009, HUM PSYCHOPHARM CLIN, V24, P650, DOI 10.1002/hup.1069; Quednow BB, 2007, PSYCHOPHARMACOLOGY, V189, P517, DOI 10.1007/s00213-005-0256-4; Rabiner EA, 2000, NUCL MED BIOL, V27, P509, DOI 10.1016/S0969-8051(00)00120-7; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P1048, DOI 10.1038/sj.npp.1300894; Ramaekers JG, 2009, NEUROPSYCHOPHARMACOL, V34, P1641, DOI 10.1038/npp.2008.219; Reneman L, 2002, NEUROPSYCHOPHARMACOL, V26, P387, DOI 10.1016/S0893-133X(01)00366-9; SALKIND NJ, 1977, HUM DEV, V20, P377, DOI 10.1159/000271569; SCHMIDT CJ, 1987, J PHARMACOL EXP THER, V240, P1; SCHREIBER R, 1993, PROG NEURO-PSYCHOPH, V17, P87, DOI 10.1016/0278-5846(93)90034-P; SHARPLEY AL, 1994, NEUROPHARMACOLOGY, V33, P467, DOI 10.1016/0028-3908(94)90077-9; Talpos JC, 2006, J PSYCHOPHARMACOL, V20, P47, DOI 10.1177/0269881105056639; Toker L, 2010, ISR J PSYCHIATR REL, V47, P46; van Wel JHP, 2011, NEUROPSYCHOPHARMACOL, V36, P1932, DOI 10.1038/npp.2011.80; Verheyden SL, 2002, PSYCHOPHARMACOLOGY, V161, P23, DOI 10.1007/s00213-001-0995-9; Vollenweider FX, 2006, INT J NEUROPSYCHOPH, V9, pS73; Vollenweider FX, 2002, J PSYCHOACTIVE DRUGS, V34, P171, DOI 10.1080/02791072.2002.10399951; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0	55	62	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40187	10.1371/journal.pone.0040187	http://dx.doi.org/10.1371/journal.pone.0040187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808116	gold, Green Published, Green Submitted			2022-12-27	WOS:000306355500030
J	Anderson, JL; Mari, AR; Braasch, I; Amores, A; Hohenlohe, P; Batzel, P; Postlethwait, JH				Anderson, Jennifer L.; Mari, Adriana Rodriguez; Braasch, Ingo; Amores, Angel; Hohenlohe, Paul; Batzel, Peter; Postlethwait, John H.			Multiple Sex-Associated Regions and a Putative Sex Chromosome in Zebrafish Revealed by RAD Mapping and Population Genomics	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; RIBOSOMAL-RNA GENES; GERM-CELLS; Y-CHROMOSOME; OOCYTE APOPTOSIS; LINKAGE ANALYSIS; DIFFERENTIATION; TEMPERATURE; EXPRESSION; MEDAKA	Within vertebrates, major sex determining genes can differ among taxa and even within species. In zebrafish (Danio rerio), neither heteromorphic sex chromosomes nor single sex determination genes of large effect, like Sry in mammals, have yet been identified. Furthermore, environmental factors can influence zebrafish sex determination. Although progress has been made in understanding zebrafish gonad differentiation (e.g. the influence of germ cells on gonad fate), the primary genetic basis of zebrafish sex determination remains poorly understood. To identify genetic loci associated with sex, we analyzed F2 offspring of reciprocal crosses between Oregon *AB and Nadia (NA) wild-type zebrafish stocks. Genome-wide linkage analysis, using more than 5,000 sequence-based polymorphic restriction site associated (RAD-tag) markers and population genomic analysis of more than 30,000 single nucleotide polymorphisms in our *ABxNA crosses revealed a sex-associated locus on the end of the long arm of chr-4 for both cross families, and an additional locus in the middle of chr-3 in one cross family. Additional sequencing showed that two SNPs in dmrt1 previously suggested to be functional candidates for sex determination in a cross of ABxIndia wild-type zebrafish, are not associated with sex in our AB fish. Our data show that sex determination in zebrafish is polygenic and that different genes may influence sex determination in different strains or that different genes become more important under different environmental conditions. The association of the end of chr-4 with sex is remarkable because, unique in the karyotype, this chromosome arm shares features with known sex chromosomes: it is highly heterochromatic, repetitive, late replicating, and has reduced recombination. Our results reveal that chr-4 has functional and structural properties expected of a sex chromosome.	[Anderson, Jennifer L.; Mari, Adriana Rodriguez; Braasch, Ingo; Amores, Angel; Batzel, Peter; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Hohenlohe, Paul] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	University of Oregon; Idaho; University of Idaho	Anderson, JL (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	jpostle@uoneuro.uoregon.edu	Hohenlohe, Paul/AAE-7744-2019; Anderson, Jennifer L/I-5435-2012; Braasch, Ingo/A-6948-2010	Hohenlohe, Paul/0000-0002-7616-0161; Anderson, Jennifer L/0000-0002-0713-6897; Braasch, Ingo/0000-0003-4766-611X; Amores, Angel/0000-0002-9307-3609	National Institutes of Health (NIH) grant [R01GM085318]; NIH grant [P01HD22486]; Alexander von Humboldt Foundation; Volkswagen Foundation; National Science Foundation, Office of Cyber Infrastructure [OCI-0960354]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085318] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Volkswagen Foundation(Volkswagen); National Science Foundation, Office of Cyber Infrastructure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by National Institutes of Health (NIH) grant R01GM085318 (to JHP), NIH grant P01HD22486 (to JHP), a Feodor-Lynen-Fellowship of the Alexander von Humboldt Foundation (to IB), and a grant from the Volkswagen Foundation (to IB). The research was also supported by a Major Research Instrumentation grant from the National Science Foundation, Office of Cyber Infrastructure, "MRI-R2: Acquisition of an Applied Computational Instrument for Scientific Synthesis (ACISS)", Grant #: OCI-0960354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abozaid H, 2012, SEX DEV, V6, P201, DOI 10.1159/000336297; Abozaid H, 2011, SEX DEV, V5, P259, DOI 10.1159/000330120; ALVAREZ MC, 1991, J FISH BIOL, V39, P817, DOI 10.1111/j.1095-8649.1991.tb04411.x; Amores A, 1999, METHOD CELL BIOL, V60, P323; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baroiller JF, 2001, EXS, V91, P177; Barske LA, 2008, CURR OPIN GENET DEV, V18, P499, DOI 10.1016/j.gde.2008.11.004; Baumgartner-Parzer SM, 2001, J CLIN ENDOCR METAB, V86, P4771, DOI 10.1210/jc.86.10.4771; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown KH, 2012, P NATL ACAD SCI USA, V109, P529, DOI 10.1073/pnas.1112163109; BULL JJ, 1979, SCIENCE, V206, P1186, DOI 10.1126/science.505003; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; CHAN STH, 1983, FISH PHYSIOL, V9, P171; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Craves JAM, 2008, ANNU REV GENET, V42, P565, DOI 10.1146/annurev.genet.42.110807.091714; Crews D, 2003, EVOL DEV, V5, P50, DOI 10.1046/j.1525-142X.2003.03008.x; CREWS D, 1989, GEN COMP ENDOCR, V76, P159, DOI 10.1016/0016-6480(89)90042-7; Daga RR, 1996, CHROMOSOME RES, V4, P29, DOI 10.1007/BF02254941; Davidson WS, 2009, SEX DEV, V3, P78, DOI 10.1159/000223073; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Drummond A., 2011, GENEIOUS V5 5; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Fan J, 2007, BIOCHEM BIOPH RES CO, V363, P757, DOI 10.1016/j.bbrc.2007.09.047; FERGUSON MWJ, 1982, NATURE, V296, P850, DOI 10.1038/296850a0; Freeman JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-195; Gornung E, 2000, CHROMOSOME RES, V8, P362, DOI 10.1023/A:1009252017097; Gornung E, 1997, CHROMOSOME RES, V5, P40, DOI 10.1023/A:1018441402370; Goudet J, 1996, GENETICS, V144, P1933; GRUMBACH MM, 1963, P NATL ACAD SCI USA, V49, P581, DOI 10.1073/pnas.49.5.581; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Herpin A, 2009, NUCLEIC ACIDS RES, V37, P1510, DOI 10.1093/nar/gkn1065; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Ings JS, 2006, MOL REPROD DEV, V73, P943, DOI 10.1002/mrd.20490; JOHNSON SL, 1995, GENETICS, V139, P1727; Johnson SL, 1996, GENETICS, V142, P1277; Kallman K.D., 1984, P95; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; KAUFFMAN EJ, 1995, GENOMICS, V30, P337, DOI 10.1006/geno.1995.9869; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Kondo M, 2004, CURR BIOL, V14, P1664, DOI 10.1016/j.cub.2004.09.026; Kondo M, 2006, GENOME RES, V16, P815, DOI 10.1101/gr.5016106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis ZR, 2008, J MORPHOL, V269, P909, DOI 10.1002/jmor.10608; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Loukovitis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016599; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Martinez P, 2009, GENETICS, V183, P1443, DOI 10.1534/genetics.109.107979; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mindnich R, 2004, MOL CELL ENDOCRINOL, V215, P19, DOI 10.1016/j.mce.2003.11.010; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Mohideen MAPK, 2000, GENOMICS, V67, P102, DOI 10.1006/geno.2000.6233; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nanda I, 2000, CHROMOSOMA, V109, P173, DOI 10.1007/s004120050425; NAYUDU PL, 1979, COPEIA, P225, DOI 10.2307/1443407; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Pelegri F, 1999, METHOD CELL BIOL, V60, P1; Phillips RB, 2006, CYTOGENET GENOME RES, V114, P155, DOI 10.1159/000093332; Pieau C, 1999, CELL MOL LIFE SCI, V55, P887, DOI 10.1007/s000180050342; PIJNACKER LP, 1995, GENOME, V38, P1052, DOI 10.1139/g95-140; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Poutanen M, 1995, J STEROID BIOCHEM, V55, P525, DOI 10.1016/0960-0760(95)00201-4; QUIRK JG, 1973, SCIENCE, V180, P963, DOI 10.1126/science.180.4089.963; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2011, METHOD CELL BIOL, V105, P461, DOI 10.1016/B978-0-12-381320-6.00020-5; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Rosler A, 1996, J CLIN ENDOCR METAB, V81, P1827, DOI 10.1210/jc.81.5.1827; Ross JA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000391; Sato T, 2005, ZOOL SCI, V22, P985, DOI 10.2108/zsj.22.985; SAWETAWAN C, 1994, MOL CELL ENDOCRINOL, V99, P161, DOI 10.1016/0303-7207(94)90004-3; Schultheis C, 2009, SEX DEV, V3, P68, DOI 10.1159/000223072; Ser JR, 2010, EVOLUTION, V64, P486, DOI 10.1111/j.1558-5646.2009.00871.x; Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579; Shive HR, 2010, P NATL ACAD SCI USA, V107, P19350, DOI 10.1073/pnas.1011630107; Siegfried KR, 2010, J FISH BIOL, V76, P1879, DOI 10.1111/j.1095-8649.2010.02594.x; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Singer A, 2002, GENETICS, V160, P649; Skakkebaek NE, 2006, INT J ANDROL, V29, P2, DOI 10.1111/j.1365-2605.2005.00573.x; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Sola L, 2001, GENETICA, V111, P397, DOI 10.1023/A:1013776323077; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Tani S, 2010, GENE, V449, P41, DOI 10.1016/j.gene.2009.09.005; Tong SK, 2010, DEV BIOL, V344, P849, DOI 10.1016/j.ydbio.2010.05.515; Traut W, 2001, CHROMOSOME RES, V9, P659, DOI 10.1023/A:1012956324417; Tripathi N, 2009, GENETICS, V182, P365, DOI 10.1534/genetics.108.098541; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; Uchida D, 2002, J EXP BIOL, V205, P711; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Wang XG, 2007, DEV DYNAM, V236, P1329, DOI 10.1002/dvdy.21129; Wang XG, 2007, J FISH BIOL, V70, P33, DOI 10.1111/j.1095-8649.2007.01363.x; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whiteley AR, 2011, MOL ECOL; Winge O, 1930, J GENET, V23, P69, DOI 10.1007/BF03052594; Yoshimoto S, 2011, FEBS J, V278, P1020, DOI 10.1111/j.1742-4658.2011.08031.x; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108	112	165	169	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40701	10.1371/journal.pone.0040701	http://dx.doi.org/10.1371/journal.pone.0040701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792396	gold, Green Published, Green Submitted			2022-12-27	WOS:000306354700064
J	Srivastava, SK; Gayathri, S; Manjasetty, BA; Gopal, B				Srivastava, Sandeep Kumar; Gayathri, Savitha; Manjasetty, Babu A.; Gopal, Balasubramanian			Analysis of Conformational Variation in Macromolecular Structural Models	PLOS ONE			English	Article							HUMAN-FACTOR-VIII; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; ANGSTROM RESOLUTION; SECONDARY STRUCTURE; MEMBRANE-BINDING; C2 DOMAIN; METHYLOPHILUS-METHYLOTROPHUS; 3-DIMENSIONAL STRUCTURE; ANABAENA-VARIABILIS	Experimental conditions or the presence of interacting components can lead to variations in the structural models of macromolecules. However, the role of these factors in conformational selection is often omitted by in silico methods to extract dynamic information from protein structural models. Structures of small peptides, considered building blocks for larger macromolecular structural models, can substantially differ in the context of a larger protein. This limitation is more evident in the case of modeling large multi-subunit macromolecular complexes using structures of the individual protein components. Here we report an analysis of variations in structural models of proteins with high sequence similarity. These models were analyzed for sequence features of the protein, the role of scaffolding segments including interacting proteins or affinity tags and the chemical components in the experimental conditions. Conformational features in these structural models could be rationalized by conformational selection events, perhaps induced by experimental conditions. This analysis was performed on a non-redundant dataset of protein structures from different SCOP classes. The sequence-conformation correlations that we note here suggest additional features that could be incorporated by in silico methods to extract dynamic information from protein structural models.	[Srivastava, Sandeep Kumar; Gayathri, Savitha; Gopal, Balasubramanian] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Manjasetty, Babu A.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France; [Manjasetty, Babu A.] UVHCI, Grenoble, France	Indian Institute of Science (IISC) - Bangalore; European Molecular Biology Laboratory (EMBL)	Srivastava, SK (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	sandeep@mbu.iisc.ernet.in; bgopal@mbu.iisc.ernet.in	Manjasetty, Babu A/F-8366-2013; Gopal, Balasubramanian/ABG-3754-2021; Gopal, Balasubramanian/K-4566-2012	Manjasetty, Babu A/0000-0002-8229-4748; SRIVASTAVA, SANDEEP/0000-0003-4484-0223	Wellcome Trust [078994] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agarwal R, 2009, NAT STRUCT MOL BIOL, V16, P789, DOI 10.1038/nsmb.1626; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audette GF, 2004, BIOCHEMISTRY-US, V43, P11427, DOI 10.1021/bi048957s; Baeten L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000083; Bau R, 1998, J BIOL INORG CHEM, V3, P484, DOI 10.1007/s007750050258; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Brennan L, 2001, J MOL BIOL, V308, P353, DOI 10.1006/jmbi.2001.4600; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Enguita FJ, 2006, J BIOL INORG CHEM, V11, P189, DOI 10.1007/s00775-005-0065-6; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Fleming PJ, 2000, J MOL BIOL, V299, P487, DOI 10.1006/jmbi.2000.3750; GILBERT GE, 1995, BIOCHEMISTRY-US, V34, P3022, DOI 10.1021/bi00009a033; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keizer DW, 2001, J BIOL CHEM, V276, P24186, DOI 10.1074/jbc.M100659200; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kumar V, 2009, INT J PHARMACEUT, V366, P38, DOI 10.1016/j.ijpharm.2008.08.037; Lin SY, 1999, GRAEF ARCH CLIN EXP, V237, P157, DOI 10.1007/s004170050211; Liu Z, 2010, J BIOL CHEM, V285, P8824, DOI 10.1074/jbc.M109.080168; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma LX, 2000, J AM CHEM SOC, V122, P9473, DOI 10.1021/ja001368z; Madan LL, 2008, PROTEIN EXPRES PURIF, V57, P234, DOI 10.1016/j.pep.2007.10.002; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mezei M, 1998, PROTEIN ENG, V11, P411, DOI 10.1093/protein/11.6.411; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0; Morimoto K, 2006, J BIOCHEM, V139, P1065, DOI 10.1093/jb/mvj106; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Otterbein LR, 2002, STRUCTURE, V10, P557, DOI 10.1016/S0969-2126(02)00740-2; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Plaxco KW, 1997, NATURE, V386, P657, DOI 10.1038/386657a0; Plaxco KW, 1997, NATURE, V386, P659; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Rother K, 2009, NUCLEIC ACIDS RES, V37, pD393, DOI 10.1093/nar/gkn769; Ruvinsky AM, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3498743; Sastry M, 1998, STRUCTURE, V6, P223, DOI 10.1016/S0969-2126(98)00023-9; Schellenberg MJ, 2010, J MOL BIOL, V402, P720, DOI 10.1016/j.jmb.2010.08.020; Schmidt L, 2006, ACTA CRYSTALLOGR D, V62, P1022, DOI 10.1107/S0907444906023638; Seidel RD, 2004, J BIOL CHEM, V279, P48307, DOI 10.1074/jbc.M402109200; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tanaka S, 2002, J CHEM PHYS, V117, P3504, DOI 10.1063/1.1477456; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	51	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39993	10.1371/journal.pone.0039993	http://dx.doi.org/10.1371/journal.pone.0039993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808083	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306354700022
J	Wang, LJ; Zuo, B; Xu, DQ; Ren, ZQ; Zhang, HP; Li, XW; Lei, MG; Xiong, YZ				Wang, Linjie; Zuo, Bo; Xu, Dequan; Ren, Zuqing; Zhang, Hongping; Li, Xuewei; Lei, Minggang; Xiong, Yuanzhu			Alternative Splicing of the Porcine Glycogen Synthase Kinase 3 beta (GSK-3 beta) Gene with Differential Expression Patterns and Regulatory Functions	PLOS ONE			English	Article							NF-KAPPA-B; BETA-CATENIN; SKELETAL-MUSCLE; SUBSTRATE-SPECIFICITY; QUIESCENT CELLS; PHOSPHORYLATION; INSULIN; GSK3; KINASE-3-BETA; BINDING	Background: Glycogen synthase kinase 3 (GSK3 alpha and GSK3 beta) are serine/threonine kinases involved in numerous cellular processes and diverse diseases including mood disorders, Alzheimer's disease, diabetes, and cancer. However, in pigs, the information on GSK3 is very limited. Identification and characterization of pig GSK3 are not only important for pig genetic improvement, but also contribute to the understanding and development of porcine models for human disease prevention and treatment. Methodology: Five different isoforms of GSK3 beta were identified in porcine different tissues, in which three isoforms are novel. These isoforms had differential expression patterns in the fetal and adult of the porcine different tissues. The mRNA expression level of GSK3 beta isoforms was differentially regulated during the course of the insulin treatment, suggesting that different GSK3 beta isoforms may have different roles in insulin signaling pathway. Moreover, GSK3 beta 5 had a different role on regulating the glycogen synthase activity, phosphorylation and the expression of porcine GYS1 and GYS2 gene compared to other GSK3 beta isoforms. Conclusions: We are the first to report five different isoforms of GSK3 beta identified from the porcine different tissues. Splice variants of GSK3 beta exhibit differential activity towards glycogen synthase. These results provide new insight into roles of the GSK3 beta on regulating glycogen metabolism.	[Wang, Linjie; Zhang, Hongping; Li, Xuewei] Sichuan Agr Univ, Inst Genet & Anim Breeding, Yaan, Sichuan, Peoples R China; [Zuo, Bo; Xu, Dequan; Ren, Zuqing; Lei, Minggang; Xiong, Yuanzhu] Huazhong Agr Univ, Minist Agr, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China; [Zuo, Bo; Xu, Dequan; Ren, Zuqing; Lei, Minggang; Xiong, Yuanzhu] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Sichuan Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Wang, LJ (corresponding author), Sichuan Agr Univ, Inst Genet & Anim Breeding, Yaan, Sichuan, Peoples R China.	wanglinjie@sicau.edu.cn; yuanzhu010@yahoo.com.cn			National Natural Science Foundation of China [31101699]; Key Project of National Basic Research and Developmental Plan of China [2006CB102102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of National Basic Research and Developmental Plan of China	This study was supported by the grants from National Natural Science Foundation of China (31101699) and the Key Project of National Basic Research and Developmental Plan (2006CB102102) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Castano Z, 2010, J NEUROCHEM, V113, P117, DOI 10.1111/j.1471-4159.2010.06581.x; Ciaraldi TP, 2010, MOL CELL ENDOCRINOL, V315, P153, DOI 10.1016/j.mce.2009.05.020; Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Goetschel F, 2008, EXP CELL RES, V314, P1351, DOI 10.1016/j.yexcr.2007.12.015; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; MacAulay K, 2005, J BIOL CHEM, V280, P9509, DOI 10.1074/jbc.M411648200; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Mukai F, 2002, J NEUROCHEM, V81, P1073, DOI 10.1046/j.1471-4159.2002.00918.x; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; RYLATT DB, 1980, EUR J BIOCHEM, V107, P529; Saeki K, 2011, BIOL PHARM BULL, V34, P146, DOI 10.1248/bpb.34.146; Schaffer B, 2003, GENE, V302, P73, DOI 10.1016/S0378-1119(02)01092-2; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tullai JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020150; Wang LJ, 2012, MOL CELL BIOCHEM, V360, P169, DOI 10.1007/s11010-011-1054-4; Wood-Kaczmar A, 2009, MOL CELL NEUROSCI, V42, P184, DOI 10.1016/j.mcn.2009.07.002; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40250	10.1371/journal.pone.0040250	http://dx.doi.org/10.1371/journal.pone.0040250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792253	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800057
J	Nicolaidou, V; Wong, MM; Redpath, AN; Ersek, A; Baban, DF; Williams, LM; Cope, AP; Horwood, NJ				Nicolaidou, Vicky; Wong, Mei Mei; Redpath, Andia N.; Ersek, Adel; Baban, Dilair F.; Williams, Lynn M.; Cope, Andrew P.; Horwood, Nicole J.			Monocytes Induce STAT3 Activation in Human Mesenchymal Stem Cells to Promote Osteoblast Formation	PLOS ONE			English	Article							MARROW STROMAL CELLS; SIGNAL-TRANSDUCTION PATHWAY; ONCOSTATIN-M; ALKALINE-PHOSPHATASE; PARATHYROID-HORMONE; BONE-FORMATION; IMMUNE-SYSTEM; JAK-STAT; DIFFERENTIATION; GROWTH	A major therapeutic challenge is how to replace bone once it is lost. Bone loss is a characteristic of chronic inflammatory and degenerative diseases such as rheumatoid arthritis and osteoporosis. Cells and cytokines of the immune system are known to regulate bone turnover by controlling the differentiation and activity of osteoclasts, the bone resorbing cells. However, less is known about the regulation of osteoblasts (OB), the bone forming cells. This study aimed to investigate whether immune cells also regulate OB differentiation. Using in vitro cell cultures of human bone marrow-derived mesenchymal stem cells (MSC), it was shown that monocytes/macrophages potently induced MSC differentiation into OBs. This was evident by increased alkaline phosphatase (ALP) after 7 days and the formation of mineralised bone nodules at 21 days. This monocyte-induced osteogenic effect was mediated by cell contact with MSCs leading to the production of soluble factor(s) by the monocytes. As a consequence of these interactions we observed a rapid activation of STAT3 in the MSCs. Gene profiling of STAT3 constitutively active (STAT3C) infected MSCs using Illumina whole human genome arrays showed that Runx2 and ALP were up-regulated whilst DKK1 was down-regulated in response to STAT3 signalling. STAT3C also led to the up-regulation of the oncostatin M (OSM) and LIF receptors. In the co-cultures, OSM that was produced by monocytes activated STAT3 in MSCs, and neutralising antibodies to OSM reduced ALP by 50%. These data indicate that OSM, in conjunction with other mediators, can drive MSC differentiation into OB. This study establishes a role for monocyte/macrophages as critical regulators of osteogenic differentiation via OSM production and the induction of STAT3 signalling in MSCs. Inducing the local activation of STAT3 in bone cells may be a valuable tool to increase bone formation in osteoporosis and arthritis, and in localised bone remodelling during fracture repair.	[Nicolaidou, Vicky; Wong, Mei Mei; Redpath, Andia N.; Ersek, Adel; Williams, Lynn M.; Horwood, Nicole J.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London, England; [Baban, Dilair F.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Cope, Andrew P.] Kings Coll Sch Med, Acad Dept Rheumatol, Div Immunol Infect & Inflammatory Dis, Ctr Mol & Cellular Biol Inflammat, London, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of London; King's College London	Nicolaidou, V (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London, England.	nicole.horwood@kennedy.ox.ac.uk	Nicolaidou, Vicky/AAX-4756-2021	Cope, Andrew/0000-0001-6735-5496; Redpath, Andia/0000-0002-3620-4983; Ersek, Adel/0000-0001-7963-2980; nicolaidou, vicky/0000-0003-1017-2677; Horwood, Nicole/0000-0002-6344-1677	Arthritis Research UK; MRC [G0900160, G0700128] Funding Source: UKRI; Medical Research Council [G0700128] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Arthritis Research UK (http://www.arthritisresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; ALLAN EH, 1991, J CELL PHYSIOL, V149, P34, DOI 10.1002/jcp.1041490106; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI 10.1359/JBMR.080324; Arthur A, 2011, BONE, V48, P533, DOI 10.1016/j.bone.2010.10.180; Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Batten P, 2006, TISSUE ENG, V12, P2263, DOI 10.1089/ten.2006.12.2263; Bellido T, 1996, J CLIN INVEST, V97, P431, DOI 10.1172/JCI118432; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CENTRELLA M, 1989, ENDOCRINOLOGY, V125, P13, DOI 10.1210/endo-125-1-13; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; de Hooge ASK, 2002, AM J PATHOL, V160, P1733, DOI 10.1016/S0002-9440(10)61120-0; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; Fujio Y, 2004, FEBS LETT, V573, P202, DOI 10.1016/j.febslet.2004.07.082; FUJITANI Y, 1994, BIOCHEM BIOPH RES CO, V202, P1181, DOI 10.1006/bbrc.1994.2053; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; GARGOSKY SE, 1990, J ENDOCRINOL, V127, P391, DOI 10.1677/joe.0.1270391; Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2; Ge C, 2011, J BONE MINER RES; GIMBLE JM, 1994, J CELL BIOCHEM, V54, P122, DOI 10.1002/jcb.240540113; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; Guihard P, 2012, STEM CELLS; Gur-Wahnon D, 2007, EXP HEMATOL, V35, P426, DOI 10.1016/j.exphem.2006.11.001; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; HENRICHSEN E, 1956, EXP CELL RES, V11, P115, DOI 10.1016/0014-4827(56)90196-3; Holder N, 1999, DEVELOPMENT, V126, P2033; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Horwood N, 2008, AUTOIMMUNITY, V41, P230, DOI 10.1080/08916930701694766; Huang HC, 2010, J BONE MINER RES, V25, P819, DOI 10.1359/jbmr.091019; IKEDA E, 1988, CALCIFIED TISSUE INT, V43, P162, DOI 10.1007/BF02571314; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Katoh M, 2007, INT J MOL MED, V19, P273; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kovacevic A, 2008, J CELL BIOCHEM, V103, P994, DOI 10.1002/jcb.21472; Levi B, 2010, PLAST RECONSTR SURG, V126, P41, DOI 10.1097/PRS.0b013e3181da8858; Levy JB, 1996, ENDOCRINOLOGY, V137, P1159, DOI 10.1210/en.137.4.1159; Levy O, 2010, INT J BIOCHEM CELL B, V42, P1823, DOI 10.1016/j.biocel.2010.07.017; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Malaval L, 2005, J CELL PHYSIOL, V204, P585, DOI 10.1002/jcp.20312; MALIK N, 1995, MOL CELL BIOL, V15, P2349; Mikami Y, 2010, J CELL PHYSIOL, V223, P123, DOI 10.1002/jcp.22017; MIYAHARA T, 1991, TOXICOL LETT, V57, P257, DOI 10.1016/0378-4274(91)90200-P; Morgan JM, 2011, J CELL BIOCHEM, V112, P3354, DOI 10.1002/jcb.23265; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; OHMORI Y, 1988, BIOCHIM BIOPHYS ACTA, V970, P22, DOI 10.1016/0167-4889(88)90218-2; OWEN M, 1988, CIBA F SYMP, V136, P42; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Rauner M, 2011, J BONE MINER RES; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Repovic P, 2002, J NEUROSCI, V22, P5334; RICKARD DJ, 1993, CALCIFIED TISSUE INT, V52, P227, DOI 10.1007/BF00298724; Rifas L, 2003, J CELL BIOCHEM, V88, P650, DOI 10.1002/jcb.10436; Rifas L, 2006, J CELL BIOCHEM, V98, P706, DOI 10.1002/jcb.20933; SCHMID C, 1984, FEBS LETT, V173, P48, DOI 10.1016/0014-5793(84)81015-7; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	99	165	172	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39871	10.1371/journal.pone.0039871	http://dx.doi.org/10.1371/journal.pone.0039871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802946	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000306186900020
J	Vashisht, R; Mondal, AK; Jain, A; Shah, A; Vishnoi, P; Priyadarshini, P; Bhattacharyya, K; Rohira, H; Bhat, AG; Passi, A; Mukherjee, K; Choudhary, KS; Kumar, V; Arora, A; Munusamy, P; Subramanian, A; Venkatachalam, A; Gayathri, S; Raj, S; Chitra, V; Verma, K; Zaheer, S; Balaganesh, J; Gurusamy, M; Razeeth, M; Raja, I; Thandapani, M; Mevada, V; Soni, R; Rana, S; Ramanna, GM; Raghavan, S; Subramanya, SN; Kholia, T; Patel, R; Bhavnani, V; Chiranjeevi, L; Sengupta, S; Singh, PK; Atray, N; Gandhi, S; Avasthi, TS; Nisthar, S; Anurag, M; Sharma, P; Hasija, Y; Dash, D; Sharma, A; Scaria, V; Thomas, Z; Chandra, N; Brahmachari, SK; Bhardwaj, A				Vashisht, Rohit; Mondal, Anupam Kumar; Jain, Akanksha; Shah, Anup; Vishnoi, Priti; Priyadarshini, Priyanka; Bhattacharyya, Kausik; Rohira, Harsha; Bhat, Ashwini G.; Passi, Anurag; Mukherjee, Keya; Choudhary, Kumari Sonal; Kumar, Vikas; Arora, Anshula; Munusamy, Prabhakaran; Subramanian, Ahalyaa; Venkatachalam, Aparna; Gayathri, S.; Raj, Sweety; Chitra, Vijaya; Verma, Kaveri; Zaheer, Salman; Balaganesh, J.; Gurusamy, Malarvizhi; Razeeth, Mohammed; Raja, Ilamathi; Thandapani, Madhumohan; Mevada, Vishal; Soni, Raviraj; Rana, Shruti; Ramanna, Girish Muthagadhalli; Raghavan, Swetha; Subramanya, Sunil N.; Kholia, Trupti; Patel, Rajesh; Bhavnani, Varsha; Chiranjeevi, Lakavath; Sengupta, Soumi; Singh, Pankaj Kumar; Atray, Naresh; Gandhi, Swati; Avasthi, Tiruvayipati Suma; Nisthar, Shefin; Anurag, Meenakshi; Sharma, Pratibha; Hasija, Yasha; Dash, Debasis; Sharma, Arun; Scaria, Vinod; Thomas, Zakir; Chandra, Nagasuma; Brahmachari, Samir K.; Bhardwaj, Anshu		OSDD Consortium	Crowd Sourcing a New Paradigm for Interactome Driven Drug Target Identification in Mycobacterium tuberculosis	PLOS ONE			English	Article							ANTI-SIGMA-FACTOR; BINDING-SITES; DATABASE; NETWORK; BIOLOGY; INHIBITOR; ALGORITHM; PROTEINS	A decade since the availability of Mycobacterium tuberculosis (Mtb) genome sequence, no promising drug has seen the light of the day. This not only indicates the challenges in discovering new drugs but also suggests a gap in our current understanding of Mtb biology. We attempt to bridge this gap by carrying out extensive re-annotation and constructing a systems level protein interaction map of Mtb with an objective of finding novel drug target candidates. Towards this, we synergized crowd sourcing and social networking methods through an initiative 'Connect to Decode' (C2D) to generate the first and largest manually curated interactome of Mtb termed '3interactome pathway' (IPW), encompassing a total of 1434 proteins connected through 2575 functional relationships. Interactions leading to gene regulation, signal transduction, metabolism, structural complex formation have been catalogued. In the process, we have functionally annotated 87% of the Mtb genome in context of gene products. We further combine IPW with STRING based network to report central proteins, which may be assessed as potential drug targets for development of drugs with least possible side effects. The fact that five of the 17 predicted drug targets are already experimentally validated either genetically or biochemically lends credence to our unique approach.	[Vashisht, Rohit; Mondal, Anupam Kumar; Shah, Anup; Vishnoi, Priti; Bhattacharyya, Kausik; Mukherjee, Keya; Choudhary, Kumari Sonal; Anurag, Meenakshi; Dash, Debasis; Scaria, Vinod; Brahmachari, Samir K.] CSIR, Inst Genom & Integrat Biol, Delhi, India; [Vashisht, Rohit; Bhat, Ashwini G.; Chandra, Nagasuma] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Rohira, Harsha; Arora, Anshula; Raj, Sweety] Univ Delhi, Acharya Narendra Dev Coll, Delhi 110007, India; [Kumar, Vikas] Goethe Univ Frankfurt, Frankfurt, Germany; [Munusamy, Prabhakaran] PSG Coll Technol, Coimbatore, Tamil Nadu, India; [Subramanian, Ahalyaa; Venkatachalam, Aparna] SASTRA Univ, Thanjavur, Tamilnadu, India; [Gayathri, S.] SDM Coll, Ujire, Karnataka, India; [Chitra, Vijaya] Sree Narayan Guru Coll, Coimbatore, Tamil Nadu, India; [Verma, Kaveri] Maharshi Dayanand Univ, Rohtak, Haryana, India; [Zaheer, Salman] Amity Univ, Amity Inst Biotechnol, Lucknow, Uttar Pradesh, India; [Balaganesh, J.] Bharathiar Univ, Coimbatore, Tamil Nadu, India; [Gurusamy, Malarvizhi; Razeeth, Mohammed; Raja, Ilamathi; Thandapani, Madhumohan] Bharathidasan Univ, Tiruchirappall, Tamil Nadu, India; [Mevada, Vishal; Soni, Raviraj; Rana, Shruti] Hem N Gujarat Univ, Patan, Gujarat, India; [Ramanna, Girish Muthagadhalli; Raghavan, Swetha; Subramanya, Sunil N.] Business Intelligence Technol India Pvt Ltd, Bangalore, Karnataka, India; [Kholia, Trupti] Saurashtra Univ, Christ Coll, Rajkot 360005, Gujarat, India; [Patel, Rajesh] Hemchandracharya N Gujarat Univ, Dept Life Sci, Patan, Gujarat, India; [Bhavnani, Varsha] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Chiranjeevi, Lakavath] CSIR, Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Sengupta, Soumi] Indian Stat Inst, Kolkata, W Bengal, India; [Singh, Pankaj Kumar] Maulana Azad Natl Inst Technol, Bhopal, Madhya Pradesh, India; [Atray, Naresh] Shri Ram Coll Pharm, Karnal, Haryana, India; [Gandhi, Swati] Maharaj Sayajirao Univ Baroda, Baroda, Gujarat, India; [Avasthi, Tiruvayipati Suma] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Nisthar, Shefin] Univ Kerala, Thiruvananthapuram 695034, Kerala, India; [Sharma, Pratibha] All India Inst Med Sci, New Delhi, India; [Hasija, Yasha] Delhi Technol Univ, Dept Biotechnol, Delhi, India; [Sharma, Arun] CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Avasthi, Tiruvayipati Suma] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Institute of Science (IISC) - Bangalore; University of Delhi; Goethe University Frankfurt; PSG College Technology; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Maharshi Dayanand University; Bharathiar University; Bharathidasan University; Hemchandracharya North Gujarat University; Saurashtra University; Hemchandracharya North Gujarat University; Savitribai Phule Pune University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Indian Statistical Institute; Indian Statistical Institute Kolkata; National Institute of Technology (NIT System); Maulana Azad National Institute of Technology Bhopal; Maharaja Sayajirao University Baroda; University of Hyderabad; University of Kerala; All India Institute of Medical Sciences (AIIMS) New Delhi; Delhi Technological University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Universiti Malaya	Vashisht, R (corresponding author), CSIR, Inst Genom & Integrat Biol, Delhi, India.	nchandra@biochem.iisc.ernet.in; skb@igib.res.in; anshu@csir.res.in	Mevada, Vishal/N-4048-2014; Patel, Rajesh/X-4517-2018; Vashisht, Rohit/K-6181-2019; Choudhary, Kumari Sonal/M-4517-2017; Basheera, Shefin/ABI-1878-2020; chitra, Vijaya/ABD-2593-2021; Scaria, Vinod/AAS-3151-2021; Scaria, Vinod/B-2819-2008; Patel, Rajesh/G-5669-2012; Kumari, Sonal/AAW-7588-2020; Passi, Anurag/AAN-5309-2021; Tiruvayipati, Suma/AAF-8331-2021; Shait Mohammed, Mohammed Razeeth/AAY-3154-2020; Dash, Debasis/F-3137-2012	Mevada, Vishal/0000-0003-0739-026X; Vashisht, Rohit/0000-0002-2938-7259; Choudhary, Kumari Sonal/0000-0001-9527-7958; Basheera, Shefin/0000-0002-4368-2764; Patel, Rajesh/0000-0002-4712-1921; Passi, Anurag/0000-0002-0448-794X; Tiruvayipati, Suma/0000-0003-0195-1097; S, Gayathri/0000-0002-2776-1307; Scaria, Vinod/0000-0001-7644-7181; Sharma, Arun/0000-0003-3854-7944; Raghavan, Swetha/0000-0001-6951-0592; S, Gayathri/0000-0003-2431-9553; Shah, Anup/0000-0002-3793-1998; bhardwaj, anshu/0000-0001-5830-2616; Mondal, Anupam/0000-0002-3572-6392; Janakiraman, Balaganesh/0000-0002-5893-8961; Dash, Debasis/0000-0002-5647-3785; Kumar, Vikas/0000-0002-5263-9303; Shait Mohammed, Mohammed Razeeth/0000-0002-4711-1483; Bhattacharyya, Kausik/0000-0002-4033-676X; Subramanian, Ahalyaa/0000-0001-9669-8260; Chandra, Nagasuma/0000-0002-9939-8439	Council of Scientific and Industrial Research, India [HCP0001]; Hewlett-Packard; Sun Microsystems	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Hewlett-Packard; Sun Microsystems	This work was supported by the Council of Scientific and Industrial Research, India, Funding (Grant No. HCP0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Vipin Singh, Assistant Professor, Amity University, Noida, for very constructive and detailed comments on the manuscript. We also thank Dr. TS Balganesh, CSIR, and Dr. Vani Brahmachari, ACBR, for fruitful discussions on the manuscript. We acknowledge India 800 foundation for support towards rewarding the best contributors with net books, Hewlett-Packard and Sun Microsystems for providing financial and logistics support for the on-site phase of C2D. We would also like to thank Mahanagar Telephone Nigam Limited, Delhi, India, for providing connectivity and the National Knowledge Network (NKN) for providing high-bandwidth support for C2D on-site phase activities. We also acknowledge School of Information Technology, Jawaharlal Nehru University, Delhi, India, for hosting the on-site phase and Dr. Andrew Michael Lynn and his group, School of Information Technology, Jawaharlal Nehru University, and Dr. S Ramachandran, CSIR-Institute of Genomics and Integrative Biology and his group, Delhi, for providing logistics support. We also thank Dr. GPS Raghava, CSIR-Institute of Microbial Technology, Chandigarh, for hosting the IPW web server. The authors thank all the OSDD members for their active participation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anurag M, 2009, MOL BIOSYST, V5, P1752, DOI [10.1039/b905518p, 10.1039/B905518p]; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bhardwaj A, 2011, TUBERCULOSIS, V91, P479, DOI 10.1016/j.tube.2011.06.004; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chandra N, 2011, TUBERCULOSIS, V91, P487, DOI 10.1016/j.tube.2011.02.008; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grigorov MG, 2005, DRUG DISCOV TODAY, V10, P365, DOI 10.1016/S1359-6446(05)03369-6; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hey A. J. G., 2009, 4 PARADIGM DATA INTE; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kalidas Y, 2008, J STRUCT BIOL, V161, P31, DOI 10.1016/j.jsb.2007.09.005; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitano H, 2011, NAT CHEM BIOL, V7, P323, DOI 10.1038/nchembio.574; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Munos B, 2010, CLIN PHARMACOL THER, V87, P534, DOI 10.1038/clpt.2010.26; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Prakash T, 2005, J MOL BIOL, V345, P937, DOI 10.1016/j.jmb.2004.11.008; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Raman Karthik, 2010, Autom Exp, V2, P2, DOI 10.1186/1759-4499-2-2; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Singh S, 2008, CELL, V133, P201, DOI 10.1016/j.cell.2008.04.003; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams Antony J, 2011, COLLABORATIVE TOOLS; World Health Organization, 2010, WHOHTMTB20107; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Yeturu K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-543	48	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39808	10.1371/journal.pone.0039808	http://dx.doi.org/10.1371/journal.pone.0039808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808064	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400021
J	Johnson, GL; Bibby, DF; Wong, S; Agrawal, SG; Bustin, SA				Johnson, Gemma L.; Bibby, David F.; Wong, Stephenie; Agrawal, Samir G.; Bustin, Stephen A.			A MIQE-Compliant Real-Time PCR Assay for Aspergillus Detection	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; BRONCHOALVEOLAR LAVAGE FLUID; SEQUENCE-BASED AMPLIFICATION; LINKED-IMMUNOSORBENT-ASSAY; FUNGAL-INFECTIONS; QUANTITATIVE PCR; GALACTOMANNAN ANTIGEN; DIAGNOSIS; DNA; FUMIGATUS	The polymerase chain reaction (PCR) is widely used as a diagnostic tool in clinical laboratories and is particularly effective for detecting and identifying infectious agents for which routine culture and microscopy methods are inadequate. Invasive fungal disease (IFD) is a major cause of morbidity and mortality in immunosuppressed patients, and optimal diagnostic criteria are contentious. Although PCR-based methods have long been used for the diagnosis of invasive aspergillosis (IA), variable performance in clinical practice has limited their value. This shortcoming is a consequence of differing sample selection, collection and preparation protocols coupled with a lack of standardisation of the PCR itself. Furthermore, it has become clear that the performance of PCR-based assays in general is compromised by the inadequacy of experimental controls, insufficient optimisation of assay performance as well as lack of transparency in reporting experimental details. The recently published "Minimum Information for the publication of real-time Quantitative PCR Experiments" (MIQE) guidelines provide a blueprint for good PCR assay design and unambiguous reporting of experimental detail and results. We report the first real-time quantitative PCR (qPCR) assay targeting Aspergillus species that has been designed, optimised and validated in strict compliance with the MIQE guidelines. The hydrolysis probe-based assay, designed to target the 18S rRNA DNA sequence of Aspergillus species, has an efficiency of 100% (range 95-107%), a dynamic range of at least six orders of magnitude and limits of quantification and detection of 6 and 0.6 Aspergillus fumigatus genomes, respectively. It does not amplify Candida, Scedosporium, Fusarium or Rhizopus species and its clinical sensitivity is demonstrated in histological material from proven IA cases, as well as concordant PCR and galactomannan data in matched broncho-alveolar lavage and blood samples. The robustness, specificity and sensitivity of this assay make it an ideal molecular diagnostic tool for clinical use.	[Johnson, Gemma L.; Agrawal, Samir G.; Bustin, Stephen A.] Queen Mary Univ, Blizard Inst Cell & Mol Sci, London, England; [Agrawal, Samir G.] St Bartholomews Hosp, Dept Haematooncol, London, England; [Bibby, David F.] Barts & London NHS Trust, Div Infect, London, England; [Wong, Stephenie] Queen Elizabeth Hosp, Kowloon, Hong Kong, Peoples R China	University of London; Queen Mary University London; University of London; Queen Mary University London; Barts Health NHS Trust	Johnson, GL (corresponding author), Queen Mary Univ, Blizard Inst Cell & Mol Sci, London, England.	gemma.johnson@bartshealth.nhs.uk	Bustin, Stephen/H-3086-2013; Bustin, Stephen/HHT-0617-2022	Bustin, Stephen/0000-0003-1870-6098; Bustin, Stephen/0000-0003-1870-6098; Bibby, David/0000-0002-8458-9662	Barts; London Charity Grant [463/1317]; Pfizer; Gilead; Schering-Plough; MSD; Bio Rad	Barts; London Charity Grant; Pfizer(Pfizer); Gilead(Gilead Sciences); Schering-Plough(Merck & CompanySchering Plough Corporation); MSD; Bio Rad	This work was supported by a Barts and the London Charity Grant (Grant Reference Number: 463/1317) and grants from Pfizer, Gilead, Schering-Plough and MSD. The salary of G. Johnson was entirely funded from the Barts and the London Charity Grant. All other companies funded non-salary costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S. Agrawal has received honoraria for consultancy work and lectures and unrestricted educational grants from Pfizer, Gilead, Schering-Plough, MSD and Bio Rad. G. Johnson has received funding from Pfizer for attendance at conferences. G. Johnson has received funding for non-salary study costs from Pfizer, Gilead, Schering-Plough and MSD. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Bu R, 2005, J MED MICROBIOL, V54, P243, DOI 10.1099/jmm.0.45856-0; Bustin SA, 2010, MOL DIAGNOSTICS INFE, P53; Bustin SA, 2004, A Z QUANTITATIVE PCR; Bustin SA, 2011, CLIN CHEM, V57, P919, DOI 10.1373/clinchem.2011.162958; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Challier S, 2004, J CLIN MICROBIOL, V42, P844, DOI 10.1128/JCM.42.2.844-846.2004; Costa C, 2002, J CLIN MICROBIOL, V40, P2224, DOI 10.1128/JCM.40.6.2224-2227.2002; De Pauw B, 2002, SWISS MED WEEKLY, V132, P303; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Duval SM, 2008, J INVASIVE FUNGAL IN, V2, P46; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Faber J, 2009, MYCOSES, V52, P228, DOI 10.1111/j.1439-0507.2008.01565.x; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Girmenia C, 2012, CLIN MICROBIOL INFEC, V18, P990, DOI 10.1111/j.1469-0691.2011.03685.x; Groll AH, 2002, SWISS MED WKLY, V132, P303; Halliday C, 2005, J CLIN MICROBIOL, V43, P5366, DOI 10.1128/JCM.43.10.5366-5368.2005; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Kami M, 2001, CLIN INFECT DIS, V33, P1504, DOI 10.1086/323337; Khot PD, 2009, EXPERT REV ANTI-INFE, V7, P1201, DOI [10.1586/eri.09.104, 10.1586/ERI.09.104]; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Loeffler J, 2000, J CLIN MICROBIOL, V38, P586, DOI 10.1128/JCM.38.2.586-590.2000; Loeffler J, 2000, J CLIN MICROBIOL, V38, P3830, DOI 10.1128/JCM.38.10.3830-3833.2000; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Nolan T, 2006, ANAL BIOCHEM, V351, P308, DOI 10.1016/j.ab.2006.01.051; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Perfect JR, 2001, CLIN INFECT DIS, V33, P1824, DOI 10.1086/323900; Perlin DS, 2009, MED MYCOL, V47, pS223, DOI 10.1080/13693780802126583; Pham AS, 2003, AM J CLIN PATHOL, V119, P38, DOI 10.1309/RQ05PP9NEG6DADXR; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Sanguinetti M, 2003, J CLIN MICROBIOL, V41, P3922, DOI 10.1128/JCM.41.8.3922-3925.2003; Subira M, 2002, HAEMATOLOGICA, V87, P528; Torres HA, 2003, DIAGN MICR INFEC DIS, V46, P25, DOI 10.1016/S0732-8893(03)00013-0; Tsitsikas DA, 2012, MED MYCOL, V50, P538, DOI 10.3109/13693786.2011.630040; White PL, 2006, MED MYCOL, V44, pS191, DOI 10.1080/13693780600898003; White PL, 2006, J MOL DIAGN, V8, P376, DOI 10.2353/jmoldx.2006.050120; White PL, 2010, J CLIN MICROBIOL, V48, P1231, DOI 10.1128/JCM.01767-09; Zhao YA, 2010, J CLIN MICROBIOL, V48, P1378, DOI 10.1128/JCM.02214-09; Zhao YA, 2009, J CLIN MICROBIOL, V47, P2067, DOI 10.1128/JCM.02230-08; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	44	47	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40022	10.1371/journal.pone.0040022	http://dx.doi.org/10.1371/journal.pone.0040022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808087	Green Published, gold			2022-12-27	WOS:000306355500022
J	Moreno-Rueda, G; Redondo, T; Trenzado, CE; Sanz, A; Zuniga, JM				Moreno-Rueda, Gregorio; Redondo, Tomas; Trenzado, Cristina E.; Sanz, Ana; Zuniga, Jesus M.			Oxidative Stress Mediates Physiological Costs of Begging in Magpie (Pica pica) Nestlings	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; IMMUNE-RESPONSE; LOCAL RECRUITMENT; GROWTH; NEED; BEHAVIOR; BIRDS; EVOLUTION; PREDATION	Background: Theoretical models predict that a cost is necessary to guarantee honesty in begging displays given by offspring to solicit food from their parents. There is evidence for begging costs in the form of a reduced growth rate and immunocompetence. Moreover, begging implies vigorous physical activity and attentiveness, which should increase metabolism and thus the releasing of pro-oxidant substances. Consequently, we predict that soliciting offspring incur a cost in terms of oxidative stress, and growth rate and immune response (processes that generate pro-oxidants substances) are reduced in order to maintain oxidative balance. Methodology/Principal Findings: We test whether magpie (Pica pica) nestlings incur a cost in terms of oxidative stress when experimentally forced to beg intensively, and whether oxidative balance is maintained by reducing growth rate and immune response. Our results show that begging provokes oxidative stress, and that nestlings begging for longer bouts reduce growth and immune response, thereby maintaining their oxidative status. Conclusions/Significance: These findings help explaining the physiological link between begging and its associated growth and immunocompetence costs, which seems to be mediated by oxidative stress. Our study is a unique example of the complex relationships between the intensity of a communicative display (begging), oxidative stress, and life-history traits directly linked to viability.	[Moreno-Rueda, Gregorio; Trenzado, Cristina E.; Sanz, Ana] Univ Granada, Dept Zool, Granada, Spain; [Redondo, Tomas] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Zuniga, Jesus M.] Univ Granada, Serv Prod & Experimentac Anim, Ctr Instrumentac Cient, Granada, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Granada	Moreno-Rueda, G (corresponding author), Univ Granada, Dept Zool, Granada, Spain.	gmr@ugr.es	Moreno-Rueda, Gregorio/K-7068-2014; Redondo, Tomás/K-8896-2014; Trenzado, Cristina E/L-8309-2014	Moreno-Rueda, Gregorio/0000-0002-6726-7215; Redondo, Tomás/0000-0002-0927-9111; Trenzado, Cristina E/0000-0003-4347-6108	Spanish Government (Ministerio de Ciencia y Tecnologia, "Juan de la Cierva" program); Consejo Superior de Investigaciones Cientificas (CSIC; Proyectos Intramurales Especiales)	Spanish Government (Ministerio de Ciencia y Tecnologia, "Juan de la Cierva" program); Consejo Superior de Investigaciones Cientificas (CSIC; Proyectos Intramurales Especiales)	GM-R was supported by the Spanish Government (Ministerio de Ciencia y Tecnologia, "Juan de la Cierva" program), and TR was supported by the Consejo Superior de Investigaciones Cientificas (CSIC; Proyectos Intramurales Especiales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CL, 1999, ANIM BEHAV, V57, P967, DOI 10.1006/anbe.1998.1060; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Budden AE, 2001, CURR ORNITHOL, V16, P83; Buege J A, 1978, Methods Enzymol, V52, P302; Chappell MA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P143, DOI 10.1007/0-306-47660-6_8; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; De Neve L, 2004, J AVIAN BIOL, V35, P237, DOI 10.1111/j.0908-8857.2004.03161.x; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GUNTURKUN O, 1989, PHARMACOL BIOCHEM BE, V32, P415, DOI 10.1016/0091-3057(89)90172-X; Haff TM, 2011, BIOL LETTERS, V7, P493, DOI 10.1098/rsbl.2010.1125; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Halliwell B., 2007, FREE RADICALS BIOL M; Helfenstein F, 2008, BEHAV ECOL, V19, P108, DOI 10.1093/beheco/arm103; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; HUSBY M, 1992, ORNIS SCAND, V23, P483, DOI 10.2307/3676680; Injidi MH, 1989, BR POULT SCI, V282, P139; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Leonard ML, 2003, BEHAV ECOL SOCIOBIOL, V54, P573, DOI 10.1007/s00265-003-0668-2; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Magrath RD, 2010, ADV STUD BEHAV, V41, P187, DOI 10.1016/S0065-3454(10)41006-2; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martin-Galvez D, 2011, J EXP BIOL, V214, P1463, DOI 10.1242/jeb.050153; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Mock D. W., 1997, EVOLUTION SIBLING RI; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Moreno J, 2005, J AVIAN BIOL, V36, P251, DOI 10.1111/j.0908-8857.2005.03413.x; Moreno-Rueda G, 2011, J EVOLUTION BIOL, V24, P1091, DOI 10.1111/j.1420-9101.2011.02242.x; Moreno-Rueda G, 2007, ARDEOLA, V54, P15; Moreno-Rueda G, 2007, J ETHOL, V25, P215, DOI 10.1007/s10164-006-0020-1; Moreno-Rueda G, 2010, P ROY SOC B-BIOL SCI, V277, P2083, DOI 10.1098/rspb.2010.0109; Navarro C, 2003, OIKOS, V101, P291, DOI 10.1034/j.1600-0706.2003.11663.x; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; Norte AC, 2008, ACTA ORNITHOL, V43, P65, DOI 10.3161/000164508X345347; Parker GA, 2002, ECOL LETT, V5, P206, DOI 10.1046/j.1461-0248.2002.00301.x; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Price K, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P21, DOI 10.1007/0-306-47660-6_2; R Development Core Team, 2012, R LANG ENV STAT COMP; REDONDO T, 1992, ETHOLOGY, V92, P193; Redondo T, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P389, DOI 10.1007/0-306-47660-6_20; Reynolds PS, 1996, AUK, V113, P189, DOI 10.2307/4088945; Rodriguez-Girones MA, 2001, BEHAV ECOL, V12, P269, DOI 10.1093/beheco/12.3.269; RodriguezGirones MA, 1996, P NATL ACAD SCI USA, V93, P14637, DOI 10.1073/pnas.93.25.14637; Roulin A, 2001, BEHAV ECOL, V12, P506, DOI 10.1093/beheco/12.4.506; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Sarkar D., 2019, NLME LINEAR NONLINEA; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Sies H., 1991, OXIDATIVE STRESS OXI; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; SOLER M, 1991, CONDOR, V93, P49, DOI 10.2307/1368605; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; Tella JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003295; TRIVERS RL, 1974, AM ZOOL, V14, P249; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Weathers Wesley W., 1996, P461; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zuur Alain F., 2009, P1	74	25	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40367	10.1371/journal.pone.0040367	http://dx.doi.org/10.1371/journal.pone.0040367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808144	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500038
J	Brecht, I; Weissbrich, B; Braun, J; Toyka, KV; Weishaupt, A; Buttmann, M				Brecht, Isabel; Weissbrich, Benedikt; Braun, Julia; Toyka, Klaus Viktor; Weishaupt, Andreas; Buttmann, Mathias			Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; DIFFERENTIAL-DIAGNOSIS; NERVOUS-SYSTEM; CRITERIA; SERUM; MS	Background: Oligoclonal bands (OCB) are detected in the cerebrospinal fluid (CSF) in more than 95% of patients with multiple sclerosis (MS) in the Western hemisphere. Here we evaluated the intrathecal, polyspecific antiviral immune response as a potential diagnostic CSF marker for OCB-negative MS patients. Methodology/Principal Findings: We tested 46 OCB-negative German patients with paraclinically well defined, definite MS. Sixteen OCB-negative patients with a clear diagnosis of other autoimmune CNS disorders and 37 neurological patients without evidence for autoimmune CNS inflammation served as control groups. Antibodies against measles, rubella, varicella zoster and herpes simplex virus in paired serum and CSF samples were determined by ELISA, and virus-specific immunoglobulin G antibody indices were calculated. An intrathecal antibody synthesis against at least one neurotropic virus was detected in 8 of 26 (31%) patients with relapsing-remitting MS, 8 of 12 (67%) with secondary progressive MS and 5 of 8 (63%) with primary progressive MS, in 3 of 16 (19%) CNS autoimmune and 3 of 37 (8%) non-autoimmune control patients. Antibody synthesis against two or more viruses was found in 11 of 46 (24%) MS patients but in neither of the two control groups. On average, MS patients with a positive antiviral immune response were older and had a longer disease duration than those without. Conclusion: Determination of the intrathecal, polyspecific antiviral immune response may allow to establish a CSF-supported diagnosis of MS in OCB-negative patients when two or more of the four virus antibody indices are elevated.	[Brecht, Isabel; Toyka, Klaus Viktor; Weishaupt, Andreas; Buttmann, Mathias] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Weissbrich, Benedikt; Braun, Julia] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Brecht, I (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	m.buttmann@uni-wuerzburg.de	Buttmann, Mathias/AAD-7488-2021; Buttmann, Mathias/R-7301-2019	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685	Merck Serono Germany; University of Wurzburg; Merck Serono; Abbott; Dade Behring; Siemens; Sanofi Aventis; Teva Pharmaceutical Industries Ltd.; DFG (German National Research Foundation); BMBF (German Federal Ministry of Education and Science); State of Bavaria Research Funds; University Research Funds; Gemeinnutzige Hertie Stiftung; German MS Society; Interdisciplinary Center for Clinical Research (IZKF) at the University of Wurzburg; Biogen Idec	Merck Serono Germany; University of Wurzburg; Merck Serono(Merck & Company); Abbott(Abbott Laboratories); Dade Behring; Siemens(Siemens AG); Sanofi Aventis(Sanofi-Aventis); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); DFG (German National Research Foundation)(German Research Foundation (DFG)); BMBF (German Federal Ministry of Education and Science)(Federal Ministry of Education & Research (BMBF)); State of Bavaria Research Funds; University Research Funds; Gemeinnutzige Hertie Stiftung; German MS Society; Interdisciplinary Center for Clinical Research (IZKF) at the University of Wurzburg; Biogen Idec(Biogen)	This work was supported by an educational grant from Merck Serono Germany (to M. B.) and the University Research Fund at the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by Merck Serono Germany. None of the authors nor Merck Serono has commercial interests related to the content of this manuscript. I. B. received a travel grant from Merck Serono. B. W. received research grants from Abbott, Dade Behring and Siemens, and lecture fees from Dade Behring. J.B. reports no disclosures. K. V. T. served on a scientific advisory board for Merck Serono; has received travel expenses and/or speaker honoraria from Lundbeck Inc. and Teva Pharmaceutical Industries Ltd., and for lectures or educational activities not funded by industry; serves on the editorial boards of Current Treatment Options in Neurology and Therapeutic Advances in Neurological Disorders; serves as a consultant to Teva Pharmaceutical Industries Ltd., and served as a consultant to Merck Serono and Ebewe Neuro Pharma GmbH; and received research support from Sanofi Aventis and Teva Pharmaceutical Industries Ltd., Merck Serono, the DFG (German National Research Foundation), the BMBF (German Federal Ministry of Education and Science), State of Bavaria Research Funds, University Research Funds, the Gemeinnutzige Hertie Stiftung, and the German MS Society Research Fund. A. W. received research grants from the Interdisciplinary Center for Clinical Research (IZKF) at the University of Wurzburg and from the Gemeinnutzige Hertie Stiftung. M. B. received a travel grant from Biogen Idec; travel grants, speaker's fees and a research grant from Merck Serono; served on an advisory board for Almirall Hermal GmbH; and received research grants from Sanofi Aventis and Teva Pharmaceutical Industries Ltd., Novartis, and the Interdisciplinary Center for Clinical Research (IZKF) at the University of Wurzburg. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bednarova J, 2005, ACTA NEUROL SCAND, V112, P97, DOI 10.1111/j.1600-0404.2005.00418.x; FELGENHAUER K, 1992, CLIN INVESTIGATOR, V70, P28, DOI 10.1007/BF00422934; Jarius S, 2008, J NEUROL NEUROSUR PS, V79, P1134, DOI 10.1136/jnnp.2007.133330; Jarius S, 2009, J NEUROL SCI, V280, P98, DOI 10.1016/j.jns.2008.08.002; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; PUCCIONISOHLER M, 1995, ARQ NEURO-PSIQUIAT, V53, P760, DOI 10.1590/S0004-282X1995000500008; REIBER H, 1995, CLIN CHEM, V41, P256; REIBER H, 1991, CLIN CHEM, V37, P1153; Reiber H, 1998, MULT SCLER, V4, P111, DOI 10.1177/135245859800400304; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Schubert J, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-12; SINDIC CJM, 1994, J NEUROIMMUNOL, V54, P75, DOI 10.1016/0165-5728(94)90233-X; Thompson A, 2004, MULT SCLER J, V10, pS2, DOI 10.1191/1352458504ms1024oa	16	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40431	10.1371/journal.pone.0040431	http://dx.doi.org/10.1371/journal.pone.0040431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792316	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700047
J	Lv, KZ; Liu, LQ; Wang, LB; Yu, JR; Liu, XJ; Cheng, YX; Dong, MJ; Teng, RY; Wu, LJ; Fu, PF; Deng, WG; Hu, WX; Teng, LS				Lv, Kezhen; Liu, Liqun; Wang, Linbo; Yu, Jiren; Liu, Xiaojiao; Cheng, Yongxia; Dong, Minjun; Teng, Rongyue; Wu, Linjiao; Fu, Peifen; Deng, Wuguo; Hu, Wenxian; Teng, Lisong			Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer Cells	PLOS ONE			English	Article							CHEMORESISTANCE; RAS	Resistance to chemotherapy is a major obstacle for the effective treatment of cancers. Lin28 has been shown to contribute to tumor relapse after chemotherapy; however, the relationship between Lin28 and chemoresistance remained unknown. In this study, we investigated the association of Lin28 with paclitaxel resistance and identified the underlying mechanisms of action of Lin28 in human breast cancer cell lines and tumor tissues. We found that the expression level of Lin28 was closely associated with the resistance to paclitaxel treatment. The T47D cancer cell line, which highly expresses Lin28, is more resistant to paclitaxel than the MCF7, Bcap-37 or SK-BR-3 cancer cell lines, which had low-level expression of Lin28. Knocking down of Lin28 in Lin28 high expression T47D cells increased the sensitivity to paclitaxel treatment, while stable expression of Lin28 in breast cancer cells effectively attenuated the sensitivity to paclitaxel treatment, resulting in a significant increase of IC50 values of paclitaxel. Transfection with Lin28 also significantly inhibited paclitaxel-induced apoptosis. We also found that Lin28 expression was dramatically increased in tumor tissues after neoadjuvant chemotherapy or in local relapse or metastatic breast cancer tissues. Moreover, further studies showed that p21, Rb and Let-7 miRNA were the molecular targets of Lin28. Overexpression of Lin28 in breast cancer cells considerably induced p21 and Rb expression and inhibited Let-7 miRNA levels. Our results indicate that Lin28 expression might be one mechanism underlying paclitaxel resistance in breast cancer, and Lin28 could be a potential target for overcoming paclitaxel resistance in breast cancer.	[Lv, Kezhen; Wang, Linbo; Yu, Jiren; Liu, Xiaojiao; Cheng, Yongxia; Dong, Minjun; Teng, Rongyue; Wu, Linjiao; Fu, Peifen; Teng, Lisong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastrointest Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Wenxian] Zhejiang Univ, Coll Med, Key Lab Biotherapy Zhejiang Prov, Dept Surg Oncol,Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Liqun] Sun Yat Sen Univ, Huangpu Hosp, Affiliated Hosp 1, Dept Gen Surg, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Wuguo] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China; [Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China	Zhejiang University; Zhejiang University; Sun Yat Sen University; Dalian Medical University; Sun Yat Sen University	Hu, WX (corresponding author), Zhejiang Univ, Coll Med, Key Lab Biotherapy Zhejiang Prov, Dept Surg Oncol,Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	dengwg@hotmail.com; hwx2206@hotmail.com; lsteng@zju.edu.cn	wang, lin/GSE-3040-2022	Dong, Minjun/0000-0001-6429-3891	Zhejiang National Science Funding [Y2090345]; Qianjiang Talents Program Funding [2010R10065]; National Natural Science Fundation of China [81000996/H1610]; Science Technology Funding [2009C33157]	Zhejiang National Science Funding; Qianjiang Talents Program Funding; National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Funding	This study was supported by grants from the Zhejiang National Science Funding (Y2090345), the Qianjiang Talents Program Funding (2010R10065), the National Natural Science Fundation of China (81000996/H1610), and the Science Technology Funding (2009C33157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi AS, 2007, CANCER RES, V67, P2766, DOI 10.1158/0008-5472.CAN-06-3648; Besancon R, 2009, CURR MED CHEM, V16, P394, DOI 10.2174/092986709787315531; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Boyerinas B, 2011, INT J CANC; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Feng B, 2011, CANCER; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Jin W, 2003, BRIT J CANCER, V89, P185, DOI 10.1038/sj.bjc.6601048; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Juan HC, 2011, APOPTOSIS, V16, P174, DOI 10.1007/s10495-010-0555-z; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Pallis AG, 2011, ANN ONCOL, V22; Pan L, 2011, MOL CELL BIOCHEM, V355, P257, DOI 10.1007/s11010-011-0862-x; Scata KA, 2007, ADV EXP MED BIOL, V608, P70; Seo JH, 2007, CANCER CHEMOTH PHARM, V59, P269, DOI 10.1007/s00280-006-0266-x; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388	19	52	57	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40008	10.1371/journal.pone.0040008	http://dx.doi.org/10.1371/journal.pone.0040008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808086	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700023
J	Terao, C; Ohmura, K; Ikari, K; Kochi, Y; Maruya, E; Katayama, M; Yurugi, K; Shimada, K; Murasawa, A; Honjo, S; Takasugi, K; Matsuo, K; Tajima, K; Suzuki, A; Yamamoto, K; Momohara, S; Yamanaka, H; Yamada, R; Saji, H; Matsuda, F; Mimori, T				Terao, Chikashi; Ohmura, Koichiro; Ikari, Katsunori; Kochi, Yuta; Maruya, Etsuko; Katayama, Masaki; Yurugi, Kimiko; Shimada, Kota; Murasawa, Akira; Honjo, Shigeru; Takasugi, Kiyoshi; Matsuo, Keitaro; Tajima, Kazuo; Suzuki, Akari; Yamamoto, Kazuhiko; Momohara, Shigeki; Yamanaka, Hisashi; Yamada, Ryo; Saji, Hiroo; Matsuda, Fumihiko; Mimori, Tsuneyo			ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; HLA-DRB1 SHARED EPITOPE; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; RISK LOCUS; SUSCEPTIBILITY; ASSOCIATION; ALLELES; POPULATION; METAANALYSIS	HLA-DRB1, especially the shared epitope (SE), is strongly associated with rheumatoid arthritis (RA). However, recent studies have shown that SE is at most weakly associated with RA without anti-citrullinated peptide/protein antibody (ACPA). We have recently reported that ACPA-negative RA is associated with specific HLA-DRB1 alleles and diplotypes. Here, we attempted to detect genetically different subsets of ACPA-negative RA by classifying ACPA-negative RA patients into two groups based on their positivity for rheumatoid factor (RF). HLA-DRB1 genotyping data for totally 954 ACPA-negative RA patients and 2,008 healthy individuals in two independent sets were used. HLA-DRB1 allele and diplotype frequencies were compared among the ACPA-negative RF-positive RA patients, ACPA-negative RF-negative RA patients, and controls in each set. Combined results were also analyzed. A similar analysis was performed in 685 ACPA-positive RA patients classified according to their RF positivity. As a result, HLA-DRB1*04:05 and *09:01 showed strong associations with ACPA-negative RF-positive RA in the combined analysis (p = 8.86 x 10(-6) and 0.0011, OR: 1.57 (1.28-1.91) and 1.37 (1.13-1.65), respectively). We also found that HLA-DR14 and the HLA-DR8 homozygote were associated with ACPA-negative RF-negative RA (p = 0.00022 and 0.00013, OR: 1.52 (1.21-1.89) and 3.08 (1.68-5.64), respectively). These association tendencies were found in each set. On the contrary, we could not detect any significant differences between ACPA-positive RA subsets. As a conclusion, ACPA-negative RA includes two genetically distinct subsets according to RF positivity in Japan, which display different associations with HLA-DRB1. ACPA-negative RF-positive RA is strongly associated with HLA-DRB1*04:05 and *09:01. ACPA-negative RF-negative RA is associated with DR14 and the HLA-DR8 homozygote.	[Terao, Chikashi; Ohmura, Koichiro; Katayama, Masaki; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Terao, Chikashi; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Ikari, Katsunori; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Kochi, Yuta; Suzuki, Akari] RIKEN, Lab Autoimmune Dis, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Maruya, Etsuko; Saji, Hiroo] HLA Lab, Kyoto, Japan; [Yurugi, Kimiko] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan; [Shimada, Kota] Natl Hosp Org, Sagamihara Natl Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Murasawa, Akira] Niigata Rheumat Ctr, Dept Rheumatol, Niigata, Japan; [Honjo, Shigeru] Saiseikai Takaoka Hosp, Rheumatoid Arthrit Ctr, Toyama, Japan; [Takasugi, Kiyoshi] Dohgo Spa Hosp, Dept Internal Med, Ctr Rheumat Dis, Matsuyama, Ehime, Japan; [Matsuo, Keitaro; Tajima, Kazuo] Aichi Canc Ctr Hosp & Res Inst, Nagoya, Aichi, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Matsuda, Fumihiko] Japan Sci & Technol Agcy, CREST Program, Kawaguchi, Saitama, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, INSERM, Unite U852, Kyoto, Japan	Kyoto University; Kyoto University; Tokyo Women's Medical University; RIKEN; Kyoto University; Aichi Cancer Center; University of Tokyo; Japan Science & Technology Agency (JST); Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	a0001101@kuhp.kyoto-u.ac.jp; ohmurako@kuhp.kyoto-u.ac.jp	Matsuo, Keitaro/H-6758-2019; Yamamoto, Kazuhiko/N-5096-2015; Suzuki, Akari/N-5389-2015	Matsuo, Keitaro/0000-0003-1761-6314; Yamada, Ryo/0000-0002-1587-630X	Kyoto University; Genetics and Allied research in Rheumatic diseases Networking (GARNET) consortium; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Rheumatism Foundation; Waksman Foundation; Mitsubishi Pharma Research Foundation; Grants-in-Aid for Scientific Research [24659274, 24390360] Funding Source: KAKEN	Kyoto University; Genetics and Allied research in Rheumatic diseases Networking (GARNET) consortium; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Rheumatism Foundation(Japan Rheumatism Foundation); Waksman Foundation; Mitsubishi Pharma Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank Dr. Naoichiro Yukawa, Dr. Hajime Yoshifuji, Dr. Daisuke Kawabata, Dr. Takaki Nojima, Dr. Takashi Usui, and Dr. Takao Fujii of Kyoto University for collecting the DNA samples. We would also like to thank Mr. Taishi Shigeki for developing the clinical database software used at Dohgo Spa hospital. We would like to thank Dr. Yasuo Miura and Dr. Taira Maekawa of Kyoto University for their support of HLA-DRB1 genotyping. Moreover, we wish to thank all of the doctors and medical staff who collected the samples. This study was performed with the support of the Genetics and Allied research in Rheumatic diseases Networking (GARNET) consortium.; This study was supported by Grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, as well as by research grants from the Japan Rheumatism Foundation, the Waksman Foundation, and the Mitsubishi Pharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Furuya T, 2007, CLIN EXP RHEUMATOL, V25, P219; Gorman JD, 2004, ARTHRITIS RHEUM-US, V50, P400, DOI 10.1002/art.20006; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kallberg H, 2011, ANN RHEUM DIS, V70, P508, DOI 10.1136/ard.2009.120899; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mackie SL, 2012, GENES IMMUN, V13, P120, DOI 10.1038/gene.2011.60; Matsuda Y, 2003, ARTHRIT RHEUM-ARTHR, V49, P784, DOI 10.1002/art.11465; Morgan AW, 2009, ARTHRITIS RHEUM-US, V60, P2565, DOI 10.1002/art.24752; Ohmura K, 2010, RHEUMATOLOGY, V49, P2298, DOI 10.1093/rheumatology/keq273; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Okada Y, 2010, ANN RHEUM DIS, V69, P1569, DOI 10.1136/ard.2009.118018; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Queiro-Silva R, 2004, SCAND J RHEUMATOL, V33, P318, DOI 10.1080/03009740410005953; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Terao C, 2012, ANN RHEUM DIS, V71, P1095, DOI 10.1136/annrheumdis-2011-200907; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Terao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020457; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302	43	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40067	10.1371/journal.pone.0040067	http://dx.doi.org/10.1371/journal.pone.0040067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792215	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800037
J	van Loon, JE; Sanders, YV; de Wee, EM; Kruip, MJHA; de Maat, MPM; Leebeek, FWG				van Loon, Janine E.; Sanders, Yvonne V.; de Wee, Eva M.; Kruip, Marieke J. H. A.; de Maat, Moniek P. M.; Leebeek, Frank W. G.			Effect of Genetic Variation in STXBP5 and STX2 on von Willebrand Factor and Bleeding Phenotype in Type 1 von Willebrand Disease Patients	PLOS ONE			English	Article							MCMDM-1VWD; DIAGNOSIS; GENOTYPE	Background: In type 1 von Willebrand Disease (VWD) patients, von Willebrand Factor (VWF) levels and bleeding symptoms are highly variable. Recently, the association between genetic variations in STXBP5 and STX2 with VWF levels has been discovered in the general population. We assessed the relationship between genetic variations in STXBP5 and STX2, VWF levels, and bleeding phenotype in type 1 VWD patients. Methods: In 158 patients diagnosed with type 1 VWD according to the current ISTH guidelines, we genotyped three tagging-SNPs in STXBP5 and STX2 and analyzed their relationship with VWF:Ag levels and the severity of the bleeding phenotype, as assessed by the Tosetto bleeding score. Results: In STX2, rs7978987 was significantly associated with VWF:Ag levels (beta-coefficient (beta) = -0.04 IU/mL per allele, [95%CI -0.07;-0.001], p = 0.04) and VWF:CB activity (beta = -0.12 IU/mL per allele, [95%CI -0.17;-0.06], p<0.0001). For rs1039084 in STXBP5 a similar trend with VWF:Ag levels was observed: (beta = -0.03 IU/mL per allele [95% CI -0.06;0.003], p = 0.07). In women, homozygous carriers of the minor alleles of both SNPs in STXBP5 had a significantly higher bleeding score than homozygous carriers of the major alleles. (Rs1039084 p = 0.01 and rs9399599 p = 0.02). Conclusions: Genetic variation in STX2 is associated with VWF: Ag levels in patients diagnosed with type 1 VWD. In addition, genetic variation in STXBP5 is associated with bleeding phenotype in female VWD patients. Our findings may partly explain the variable VWF levels and bleeding phenotype in type 1 VWD patients.	[van Loon, Janine E.; Sanders, Yvonne V.; de Wee, Eva M.; Kruip, Marieke J. H. A.; de Maat, Moniek P. M.; Leebeek, Frank W. G.] Erasmus MC, Dept Haematol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Loon, JE (corresponding author), Erasmus MC, Dept Haematol, Rotterdam, Netherlands.	f.leebeek@erasmusmc.nl		Sanders, Yvonne/0000-0002-3603-737X	CSL Behring Prof. Heimburger Award; Dutch Haemophilia Foundation	CSL Behring Prof. Heimburger Award; Dutch Haemophilia Foundation	This work was supported by the CSL Behring Prof. Heimburger Award 2011 and the Dutch Haemophilia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cumming A, 2006, THROMB HAEMOSTASIS, V96, P630, DOI 10.1160/TH06-07-0383; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Goodeve A, 2007, BLOOD, V109, P112, DOI 10.1182/blood-2006-05-020784; James PD, 2007, BLOOD, V109, P145, DOI 10.1182/blood-2006-05-021105; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; MACFARLANE DE, 1975, THROMB DIATH HAEMOST, V34, P306, DOI 10.1055/s-0038-1651343; Ruggeri ZM, 2000, J CLIN INVEST, V105, P699, DOI 10.1172/JCI9604; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler J Evan, 2009, Hematology Am Soc Hematol Educ Program, P106, DOI 10.1182/asheducation-2009.1.106; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tosetto A, 2007, J THROMB HAEMOST, V5, P715, DOI 10.1111/j.1538-7836.2007.02444.x; van Loon JE, 2010, CIRC-CARDIOVASC GENE, V3, P507, DOI 10.1161/CIRCGENETICS.110.957407; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200	14	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40624	10.1371/journal.pone.0040624	http://dx.doi.org/10.1371/journal.pone.0040624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792389	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800110
J	Hatfaludi, T; Al-Hasani, K; Gong, L; Boyce, JD; Ford, M; Wilkie, IW; Quinsey, N; Dunstone, MA; Hoke, DE; Adler, B				Hatfaludi, Tamas; Al-Hasani, Keith; Gong, Lan; Boyce, John D.; Ford, Mark; Wilkie, Ian W.; Quinsey, Noelene; Dunstone, Michelle A.; Hoke, David E.; Adler, Ben			Screening of 71 P-multocida Proteins for Protective Efficacy in a Fowl Cholera Infection Model and Characterization of the Protective Antigen PlpE	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; GROUP-B STREPTOCOCCUS; HAEMOLYTICA SEROTYPE-1; HEMORRHAGIC SEPTICEMIA; SUBCELLULAR-LOCALIZATION; VACCINE DEVELOPMENT; BINDING-PROTEINS; LIVE VACCINE; VIRULENCE; IDENTIFICATION	Background: There is a strong need for a recombinant subunit vaccine against fowl cholera. We used a reverse vaccinology approach to identify putative secreted or cell surface associated P. multocida proteins that may represent potential vaccine candidate antigens. Principal Findings: A high-throughput cloning and expression protocol was used to express and purify 71 recombinant proteins for vaccine trials. Of the 71 proteins tested, only one, PlpE in denatured insoluble form, protected chickens against fowl cholera challenge. PlpE also elicited comparable levels of protection in mice. PlpE was localized by immunofluorescence to the bacterial cell surface, consistent with its ability to elicit a protective immune response. To explore the role of PlpE during infection and immunity, a plpE mutant was generated. The plpE mutant strain retained full virulence for mice. Conclusion: These studies show that PlpE is a surface exposed protein and was the only protein of 71 tested that was able to elicit a protective immune response. However, PlpE is not an essential virulence factor. This is the first report of a denatured recombinant protein stimulating protection against fowl cholera.	[Al-Hasani, Keith; Gong, Lan; Boyce, John D.; Quinsey, Noelene; Adler, Ben] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Gen, Clayton, Vic, Australia; [Hatfaludi, Tamas; Gong, Lan; Quinsey, Noelene; Dunstone, Michelle A.; Hoke, David E.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Al-Hasani, Keith; Boyce, John D.; Dunstone, Michelle A.; Adler, Ben] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Ford, Mark] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Wilkie, Ian W.] Univ Queensland, Brisbane, Qld, Australia	Monash University; Monash University; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Hatfaludi, T (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Gen, Clayton, Vic, Australia.	tamas.hatfaludi@monash.edu	Gong, Lan/J-6368-2016; Boyce, John D/F-5058-2012; Gong, Lan/O-7886-2019; Dunstone, Michelle/I-2895-2014	Gong, Lan/0000-0003-3136-1565; Boyce, John D/0000-0002-8614-3074; Gong, Lan/0000-0003-3136-1565; Dunstone, Michelle/0000-0002-6026-648X; Hatfaludi, Tamas/0000-0001-6605-9556; Al-Hasani, Keith/0000-0001-6109-5603	Australian Research Council, Canberra, Australia	Australian Research Council, Canberra, Australia(Australian Research Council)	This research was supported by the Australian Research Council, Canberra, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 1996, J BIOTECHNOL, V44, P139, DOI 10.1016/0168-1656(95)00113-1; Al-Hasani K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-3; APVMA, 2011, PUBL CHEM REG INF SY; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boyce J, 2009, PATHOGENESIS BACTERI; BOYCE J, 2004, PATHOGENESIS BACTERI, P273, DOI DOI 10.1002/9780470344903.CH20; Boyce JD, 2006, PROTEOMICS, V6, P870, DOI 10.1002/pmic.200401342; Boyce JD, 2001, INFECT IMMUN, V69, P1943, DOI 10.1128/IAI.69.3.1943-1946.2001; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Cardenas M, 2001, VET MICROBIOL, V80, P53, DOI 10.1016/S0378-1135(00)00372-2; Carter G R, 1967, Adv Vet Sci, V11, P321; Confer AW, 2006, VACCINE, V24, P2248, DOI 10.1016/j.vaccine.2005.11.036; Confer AW, 2003, VACCINE, V21, P2821, DOI 10.1016/S0264-410X(03)00213-5; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Ge Y, 2007, INFECT IMMUN, V75, P3833, DOI 10.1128/IAI.00188-07; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hansson M, 2000, BIOTECHNOL APPL BIOC, V32, P95, DOI 10.1042/BA20000034; Harper M, 2004, INFECT IMMUN, V72, P3436, DOI 10.1128/IAI.72.6.3436-3443.2004; Harper M, 2007, INFECT IMMUN, V75, P3885, DOI 10.1128/IAI.00212-07; Hatfaludi T, 2008, ANTIMICROB AGENTS CH, V52, P4166, DOI 10.1128/AAC.00245-08; Hatfaludi T, 2010, VET MICROBIOL, V144, P1, DOI 10.1016/j.vetmic.2010.01.027; HEDDLESTON KL, 1972, AVIAN DIS, V16, P925, DOI 10.2307/1588773; HEDDLESTON KL, 1972, AVIAN DIS, V16, P578, DOI 10.2307/1588675; Hopkins BA, 1998, AVIAN DIS, V42, P265, DOI 10.2307/1592476; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kristensen K, 1996, PEDIATR INFECT DIS J, V15, P525, DOI 10.1097/00006454-199606000-00010; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lee J, 2007, J MICROBIOL, V45, P179; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Luo YG, 1997, J BACTERIOL, V179, P7856, DOI 10.1128/jb.179.24.7856-7864.1997; Magyar T, 2002, VACCINE, V20, P1797, DOI 10.1016/S0264-410X(02)00023-3; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; MAKELA PH, 1980, LANCET, V2, P547; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moore DD, 1995, GLOB MOB SURV; Movahedi A, 2008, VET MICROBIOL, V131, P1, DOI 10.1016/j.vetmic.2008.02.011; MYINT A, 1989, VET REC, V124, P508, DOI 10.1136/vr.124.19.508; MYINT A, 1987, VET REC, V120, P500, DOI 10.1136/vr.120.21.500; Nagy G, 2008, INT J MED MICROBIOL, V298, P379, DOI 10.1016/j.ijmm.2008.01.012; Pandher K, 1998, INFECT IMMUN, V66, P5613, DOI 10.1128/IAI.66.12.5613-5619.1998; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Scott PV, 1999, AVIAN DIS, V43, P83, DOI 10.2307/1592765; Seib KL, 2009, INFECT IMMUN, V77, P292, DOI 10.1128/IAI.01071-08; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Singh AP, 2010, J VET SCI, V11, P227, DOI 10.4142/jvs.2010.11.3.227; Sthitmatee N, 2008, VACCINE, V26, P2398, DOI 10.1016/j.vaccine.2008.02.051; Tatum FM, 2009, AVIAN DIS, V53, P169, DOI 10.1637/8471-092308-Reg.1; Van Overbeke I, 2001, J VET MED B, V48, P15, DOI 10.1046/j.1439-0450.2001.00419.x; Verma R, 1997, VACCINE, V15, P1254, DOI 10.1016/S0264-410X(97)00025-X; Wilkie IW, 2000, VET MICROBIOL, V72, P57, DOI 10.1016/S0378-1135(99)00187-X; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Wu JR, 2007, VACCINE, V25, P4140, DOI 10.1016/j.vaccine.2007.03.005	58	23	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39973	10.1371/journal.pone.0039973	http://dx.doi.org/10.1371/journal.pone.0039973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792202	Green Submitted, Green Published, gold			2022-12-27	WOS:000306436300017
J	Metgud, CS; Naik, VA; Mallapur, MD				Metgud, Chandra S.; Naik, Vijaya A.; Mallapur, Maheshwar D.			Factors Affecting Birth Weight of a Newborn - A Community Based Study in Rural Karnataka, India	PLOS ONE			English	Article								Background: Low birth weight ( LBW) is a major public health problem in many developing countries, especially so in India. Although we do not know all the causes of LBW, maternal and environmental factors appear to be significant risk factors in its occurrence. Objectives: To know the factors affecting the birth weight of a newborn and to estimate the prevalence of LBW. Methods: The present study was carried out amongst 1138 pregnant women and their newborns residing in area covered by Kinaye Primary Health Centre in rural Karnataka, India. The study was conducted from 1st June 2008 to 31st December 2009. Results: The mean birth weight of newborns was 2.6 kg with a range of 1.2 to 3.8 kg. The prevalence of LBW was 22.9%. Among the studied risk factors, 25 of them were significantly associated with the birth weight of a newborn on univariate logistic regression analysis. Maternal education [Odds Ratio ( OR) 3.2], exposure to passive smoking [OR 2.3], age at first pregnancy >= 25 years [OR 3.6], birth interval <2 years [OR 2.4], previous history of LBW baby [OR 3.3], weight gain <= 4 kg during pregnancy [OR 7.0], maternal weight at last week of gestation <= 45 kg [OR 2.3], pregnancy induced hypertension [OR 3.3], high risk pregnancy [OR 3.6] and late antenatal registration [OR 3.6] emerged as significant risk factors on multivariate analysis. Conclusion: The problem of LBW is multidimensional, and hence, we need an integrated approach incorporating medical, social, economical and educational measures to address this issue.	[Metgud, Chandra S.; Naik, Vijaya A.; Mallapur, Maheshwar D.] KLE Univ, Jawaharlal Nehru Med Coll, Dept Community Med, Belgaum, Karnataka, India	K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum	Metgud, CS (corresponding author), KLE Univ, Jawaharlal Nehru Med Coll, Dept Community Med, Belgaum, Karnataka, India.	docchandra2006@yahoo.com	Metgud, Chandra/Q-5927-2019	Metgud, Chandra/0000-0002-1265-228X				Acharya D, 2004, INDIAN J COMMUNITY M, V29; Biswas R, 2008, Indian J Public Health, V52, P65; Ghate MM, 2001, J OBSTET GYNAECOL IN, V51, P38; Idris MZ, 2000, INDIAN J COMMUNITY M, V25, P156; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Joshi HS., 2005, IND J COMMUN MED, V30; Kapoor S K, 2001, Indian Pediatr, V38, P271; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Nair N. Sreekumaran, 2000, Indian Journal of Pediatrics, V67, P9, DOI 10.1007/BF02802625; Negi KS, 2006, JK SCI, V8, P31; Park K, 2007, PARKS TXB PREVENTIVE, V17, P426; Radhakrishnan T, 2000, Indian Pediatr, V37, P872; Rao B. T., 2007, Indian Journal of Community Medicine, V32, P272; Sachar RK, 2000, INDIAN J COMMUNITY M, V25, P166; Sachdev H.P.S., 2001, INT J DIABETES DEV C, V21, P13; Suryakantha AH, 2009, COMMUNITY MED RECENT, V2, P659; The Consumer Price Index, 2009, CONSUMER PRICE INDEX	17	41	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40040	10.1371/journal.pone.0040040	http://dx.doi.org/10.1371/journal.pone.0040040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792210	gold, Green Published			2022-12-27	WOS:000306436300021
J	Gao, YX; Feng, J; Ma, KY; Zhou, Z; Zhu, Y; Xu, QB; Wang, X				Gao, Yanxiang; Feng, Juan; Ma, Kongyang; Zhou, Zhou; Zhu, Yi; Xu, Qingbo; Wang, Xian			8,9-Epoxyeicosatrienoic Acid Inhibits Antibody Production of B Lymphocytes in Mice	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; EPOXYGENASE-DERIVED EICOSANOIDS; PLASMA-CELL DIFFERENTIATION; EPOXYEICOSATRIENOIC ACIDS; ARACHIDONIC-ACID; HYPERPOLARIZING FACTORS; ENDOTHELIAL-CELLS; PROSTAGLANDIN E-2; IMMUNE-RESPONSES; GENE-EXPRESSION	Epoxyeicosatrienoic acids (EETs), synthesized from arachidonic acid by cytochrome P450 epoxygenases, are converted to dihydroxyeicosatrienoic acids by soluble epoxide hydrolase. EETs exert anti-inflammatory effects. However, the effect of EETs on humoral immunity is poorly understood. The present study is to investigate the potential role of EETs on B cell function and mechanisms. We examined the role of EETs on antibody production of splenic B cells from C57BL/6 and apolipoprotein E-deficient (ApoE-/-) mice by means of ELISA. Of the 4 EET regioisomers, 8,9-EET decreased basal and activation-induced B cell antibody secretion. As well, 8,9-EET significantly inhibited B-cell proliferation and survival, plasma cell differentiation and class-switch recombination. Western blot analysis revealed that lipopolysaccharide-induced nuclear translocation of NF-kappa B could be attenuated by 8,9-EET. Furthermore, germinal center formation was impaired by 8,9-EET in mice in vivo. 8,9-EET may inhibit B-cell function in vitro and in vivo, which suggests a new therapeutic strategy for diseases with excess B cell activation.	[Gao, Yanxiang; Feng, Juan; Ma, Kongyang; Zhou, Zhou; Zhu, Yi; Wang, Xian] Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Qingbo] Kings Coll London, BHF Ctr, Cardiovasc Div, London WC2R 2LS, England	Peking University; University of London; King's College London	Gao, YX (corresponding author), Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Beijing 100871, Peoples R China.	xwang@bjmu.edu.cn	gao, yi/HCI-8298-2022; Zhou, Zhou/R-7788-2016; Gao, Yu/HGE-1937-2022; Ma, Kongyang/AAW-9433-2020; Gao, Y./GWZ-3665-2022	Ma, Kongyang/0000-0002-9739-7686	National Basic Research Program of China [2010CB912504, 2011CB503904]; National Natural Science Foundation of China [81121061, 81000115]; Fund of the Chinese Ministry of Education [20100001120049]; Programme of Introducing Talents of Discipline to Universities [B07001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of the Chinese Ministry of Education(Ministry of Education, China); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (URL: www.973.gov.cn/AreaAppl.aspx) [2010CB912504 and 2011CB503904] to X. Wang, the National Natural Science Foundation of China (URL: www.nsfc.gov.cn/Portal0/default124.htm) [81121061 to X. Wang; 81000115 to J. Feng], Fund of the Chinese Ministry of Education (URL: www.cutech.edu.cn/cn/kyjj/A0103index_1.htm) [20100001120049] to J. Feng, and the Programme of Introducing Talents of Discipline to Universities (URL: www.cutech.edu.cn/cn/kyjj/A0103index_1.htm) [B07001] to X. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit C, 2001, AM J PHYSIOL-LUNG C, V280, pL965, DOI 10.1152/ajplung.2001.280.5.L965; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Cheng MK, 2004, BRIT J PHARMACOL, V141, P441, DOI 10.1038/sj.bjp.0705640; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; JUNIER MP, 1990, ENDOCRINOLOGY, V126, P1534, DOI 10.1210/endo-126-3-1534; KATOH T, 1991, AM J PHYSIOL, V261, pF578, DOI 10.1152/ajprenal.1991.261.4.F578; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Liu XH, 2006, AM J PHYSIOL-CELL PH, V290, pC873, DOI 10.1152/ajpcell.00229.2005; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Medhora M, 2003, AM J PHYSIOL-HEART C, V284, pH215, DOI 10.1152/ajpheart.01118.2001; Michaelis UR, 2005, ARTERIOSCL THROM VAS, V25, P321, DOI 10.1161/01.ATV.0000151648.58516.eb; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Okunishi K, 2004, J IMMUNOL, V173, P6393, DOI 10.4049/jimmunol.173.10.6393; OLIW EH, 1994, PROG LIPID RES, V33, P329, DOI 10.1016/0163-7827(94)90029-9; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Smith KR, 2005, P NATL ACAD SCI USA, V102, P2186, DOI 10.1073/pnas.0409591102; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Sun JX, 2002, CIRC RES, V90, P1020, DOI 10.1161/01.RES.0000017727.35930.33; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; Wray J, 2008, EXP PHYSIOL, V93, P148, DOI 10.1113/expphysiol.2007.038612; Zhang LN, 2009, ARTERIOSCL THROM VAS, V29, P1265, DOI 10.1161/ATVBAHA.109.186064; Zhu PM, 2005, J IMMUNOL, V175, P4981, DOI 10.4049/jimmunol.175.8.4981	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40258	10.1371/journal.pone.0040258	http://dx.doi.org/10.1371/journal.pone.0040258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802958	Green Published, gold, Green Submitted			2022-12-27	WOS:000306186900032
J	Light, GA; Swerdlow, NR; Rissling, AJ; Radant, A; Sugar, CA; Sprock, J; Pela, M; Geyer, MA; Braff, DL				Light, Gregory A.; Swerdlow, Neal R.; Rissling, Anthony J.; Radant, Allen; Sugar, Catherine A.; Sprock, Joyce; Pela, Marlena; Geyer, Mark A.; Braff, David L.			Characterization of Neurophysiologic and Neurocognitive Biomarkers for Use in Genomic and Clinical Outcome Studies of Schizophrenia	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; MISMATCH NEGATIVITY DEFICITS; CONSENSUS COGNITIVE BATTERY; PREPULSE INHIBITION; P50 SUPPRESSION; ANTIPSYCHOTIC MEDICATIONS; TREATING SCHIZOPHRENIA; 1ST-DEGREE RELATIVES; SKILLS ASSESSMENT; BIPOLAR DISORDER	Background: Endophenotypes are quantitative, laboratory-based measures representing intermediate links in the pathways between genetic variation and the clinical expression of a disorder. Ideal endophenotypes exhibit deficits in patients, are stable over time and across shifts in psychopathology, and are suitable for repeat testing. Unfortunately, many leading candidate endophenotypes in schizophrenia have not been fully characterized simultaneously in large cohorts of patients and controls across these properties. The objectives of this study were to characterize the extent to which widely-used neurophysiological and neurocognitive endophenotypes are: 1) associated with schizophrenia, 2) stable over time, independent of state-related changes, and 3) free of potential practice/maturation or differential attrition effects in schizophrenia patients (SZ) and nonpsychiatric comparison subjects (NCS). Stability of clinical and functional measures was also assessed. Methods: Participants (SZ n = 341; NCS n = 205) completed a battery of neurophysiological (MMN, P3a, P50 and N100 indices, PPI, startle habituation, antisaccade), neurocognitive (WRAT-3 Reading, LNS-forward, LNS-reorder, WCST-64, CVLT-II). In addition, patients were rated on clinical symptom severity as well as functional capacity and status measures (GAF, UPSA, SOF). 223 subjects (SZ n = 163; NCS n = 58) returned for retesting after 1 year. Results: Most neurophysiological and neurocognitive measures exhibited medium-to-large deficits in schizophrenia, moderate-to-substantial stability across the retest interval, and were independent of fluctuations in clinical status. Clinical symptoms and functional measures also exhibited substantial stability. A Longitudinal Endophenotype Ranking System (LERS) was created to rank neurophysiological and neurocognitive biomarkers according to their effect sizes across endophenotype criteria. Conclusions: The majority of neurophysiological and neurocognitive measures exhibited deficits in patients, stability over a 1-year interval and did not demonstrate practice or time effects supporting their use as endophenotypes in neural substrate and genomic studies. These measures hold promise for informing the "gene-to-phene gap" in schizophrenia research.	[Light, Gregory A.; Sprock, Joyce; Geyer, Mark A.; Braff, David L.] San Diego VA Hlth Care Syst, VISN Mental Illness Res Educ & Clin Ctr MIRECC 22, La Jolla, CA 92161 USA; [Light, Gregory A.; Swerdlow, Neal R.; Rissling, Anthony J.; Sprock, Joyce; Pela, Marlena; Geyer, Mark A.; Braff, David L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Radant, Allen] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sugar, Catherine A.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Sugar, Catherine A.] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Light, GA (corresponding author), San Diego VA Hlth Care Syst, VISN Mental Illness Res Educ & Clin Ctr MIRECC 22, La Jolla, CA 92161 USA.	glight@ucsd.edu	Swerdlow, Neal/AAU-4912-2020; Light, Gregory/AAA-5696-2020	Light, Gregory/0000-0003-4730-8646	National Institute of Mental Health [MH042228, MH079777, MH065571]; Department of Veteran Affairs (VISN 22 Mental Illness Research, Education, and Clinical Center); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065571, R01MH042228, R01MH079777, R37MH042228] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Veteran Affairs (VISN 22 Mental Illness Research, Education, and Clinical Center); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from National Institute of Mental Health (MH042228, MH079777, and MH065571) and supported by the Department of Veteran Affairs (VISN 22 Mental Illness Research, Education, and Clinical Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2007, SCHIZOPHRENIA BULL, V33, P665, DOI 10.1093/schbul/sbl075; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Adler LE, 2004, AM J PSYCHIAT, V161, P1822, DOI 10.1176/appi.ajp.161.10.1822; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Bearden CE, 2006, TRENDS GENET, V22, P306, DOI 10.1016/j.tig.2006.04.004; BOUTROS NN, 1991, PSYCHIAT RES, V39, P181, DOI 10.1016/0165-1781(91)90086-5; Braff DL, 2007, BIOL PSYCHIAT, V61, P1204, DOI 10.1016/j.biopsych.2006.08.015; Braff David L, 2005, Dialogues Clin Neurosci, V7, P125; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Braff DL, 2004, PSYCHOPHARMACOLOGY, V174, P75, DOI 10.1007/s00213-004-1848-0; Calkins ME, 2003, INT J PSYCHOPHYSIOL, V49, P139, DOI 10.1016/S0167-8760(03)00101-6; Cho RY, 2005, SCHIZOPHRENIA BULL, V31, P865, DOI 10.1093/schbul/sbi050; CLEMENTZ BA, 1994, PSYCHOPHYSIOLOGY, V31, P486, DOI 10.1111/j.1469-8986.1994.tb01052.x; Clementz BA, 1997, BIOL PSYCHIAT, V41, P1035, DOI 10.1016/S0006-3223(96)00208-9; First M.B., 2016, STRUCTURED CLIN INTE; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Glahn DC, 2007, AM J MED GENET B, V144B, P242, DOI 10.1002/ajmg.b.30446; Glahn DC, 2012, BIOL PSYCHIAT, V71, P6, DOI 10.1016/j.biopsych.2011.08.022; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 2004, SCHIZOPHR RES, V72, P1, DOI 10.1016/j.schres.2004.09.006; Green MF, 2008, AM J PSYCHIAT, V165, P221, DOI 10.1176/appi.ajp.2007.07010089; Green MF, 2009, SCHIZOPHRENIA BULL, V35, P163, DOI 10.1093/schbul/sbn156; Greenwood TA, 2011, AM J PSYCHIAT; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; Greenwood TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029630; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hall MH, 2009, PSYCHOL MED, V39, P1277, DOI 10.1017/S0033291709005261; Hall MH, 2006, BEHAV GENET, V36, P845, DOI 10.1007/s10519-006-9091-6; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; Hetrick WP, 1996, BIOL PSYCHIAT, V39, P51, DOI 10.1016/0006-3223(95)00067-4; Horan WP, 2008, SCHIZOPHR RES, V103, P218, DOI 10.1016/j.schres.2008.02.014; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Jahshan C, 2011, PSYCHOL MED, V41, P1; Jahshan C, 2010, NEUROPSYCHOLOGY, V24, P109, DOI 10.1037/a0016791; Kawakubo Y, 2007, PSYCHIAT RES, V152, P261, DOI 10.1016/j.psychres.2006.02.010; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Kurtz MM, 2005, SCHIZOPHR RES, V74, P15, DOI 10.1016/j.schres.2004.07.005; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Leifker FR, 2010, SCHIZOPHR RES, V119, P246, DOI 10.1016/j.schres.2010.03.021; Light G A, 1999, Curr Psychiatry Rep, V1, P31, DOI 10.1007/s11920-999-0008-y; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light GA, 2000, AM J PSYCHIAT, V157, P767, DOI 10.1176/appi.ajp.157.5.767; Light GA, 1999, BIOL PSYCHIAT, V46, P990, DOI 10.1016/S0006-3223(99)00034-7; Light GA, 2001, AM J PSYCHIAT, V158, P2066, DOI 10.1176/appi.ajp.158.12.2066; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Marder SR, 2004, SCHIZOPHR RES, V72, P5, DOI 10.1016/j.schres.2004.09.010; Mathalon DH, 2000, BIOL PSYCHIAT, V47, P434, DOI 10.1016/S0006-3223(99)00277-2; Mausbach BT, 2010, BIPOLAR DISORD, V12, P45, DOI 10.1111/j.1399-5618.2009.00787.x; Maxwell E, 1992, MANUAL FIGS; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Meincke U, 2004, PSYCHIAT RES, V126, P51, DOI 10.1016/j.psychres.2004.01.003; Nagamoto HT, 1996, BIOL PSYCHIAT, V40, P181, DOI 10.1016/0006-3223(95)00371-1; Olincy A, 2010, SCHIZOPHR RES; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870; Perry W, 2001, SCHIZOPHRENIA BULL, V27, P157, DOI 10.1093/oxfordjournals.schbul.a006854; Radant AD, 2007, SCHIZOPHR RES, V89, P320, DOI 10.1016/j.schres.2006.08.010; Rapaport MH, 1996, AM J GERIAT PSYCHIAT, V4, P218, DOI 10.1097/00019442-199622430-00005; Rentzsch J, 2008, INT J PSYCHOPHYSIOL, V67, P81, DOI 10.1016/j.ijpsycho.2007.10.006; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SMITH DA, 1994, PSYCHOPHYSIOLOGY, V31, P495, DOI 10.1111/j.1469-8986.1994.tb01053.x; Stone WS, IMPAIRED LEARN UNPUB; Swerdlow NR, 2009, NEUROPSYCHOPHARMACOL, V34, P1854, DOI 10.1038/npp.2009.7; Swerdlow NR, 2007, SCHIZOPHR RES, V92, P237, DOI 10.1016/j.schres.2007.01.012; Swerdlow NR, 2011, SCHIZOPHR RES, V130, P1, DOI 10.1016/j.schres.2011.05.004; SWERDLOW NR, 1994, ARCH GEN PSYCHIAT, V51, P139; SWERDLOW NR, 1993, BIOL PSYCHIAT, V34, P253, DOI 10.1016/0006-3223(93)90079-S; Thompson A, 2011, SCHIZOPHR RES, V126, P51, DOI 10.1016/j.schres.2010.09.024; Turetsky B, 1998, BIOL PSYCHIAT, V43, P31, DOI 10.1016/S0006-3223(97)00261-8; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Turetsky BI, 2008, BIOL PSYCHIAT, V64, P1051, DOI 10.1016/j.biopsych.2008.06.018; Twamley EW, 2008, AM J PSYCHIATR REHAB, V11, P144, DOI 10.1080/15487760801963678; Umbricht D, 2002, BIOL PSYCHIAT, V51, P400, DOI 10.1016/S0006-3223(01)01242-2; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Wynn JK, 2007, SCHIZOPHR RES, V95, P134, DOI 10.1016/j.schres.2007.05.039	84	131	133	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39434	10.1371/journal.pone.0039434	http://dx.doi.org/10.1371/journal.pone.0039434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802938	Green Submitted, Green Published, gold			2022-12-27	WOS:000306186900012
J	Schelkle, B; Faria, PJ; Johnson, MB; van Oosterhout, C; Cable, J				Schelkle, Bettina; Faria, Patricia J.; Johnson, Mireille B.; van Oosterhout, Cock; Cable, Joanne			Mixed Infections and Hybridisation in Monogenean Parasites	PLOS ONE			English	Article							GYRODACTYLID INFECTIONS; POECILIA-RETICULATA; SEXUAL REPRODUCTION; HOST SWITCH; EVOLUTION; FISH; STRAINS; PLATYHELMINTHES; POPULATIONS; SPECIATION	Theory predicts that sexual reproduction promotes disease invasion by increasing the evolutionary potential of the parasite, whereas asexual reproduction tends to enhance establishment success and population growth rate. Gyrodactylid monogeneans are ubiquitous ectoparasites of teleost fish, and the evolutionary success of the specious Gyrodactylus genus is thought to be partly due to their use of various modes of reproduction. Gyrodactylus turnbulli is a natural parasite of the guppy (Poecilia reticulata), a small, tropical fish used as a model for behavioural, ecological and evolutionary studies. Using experimental infections and a recently developed microsatellite marker, we conclusively show that monogenean parasites reproduce sexually. Conservatively, we estimate that sexual recombination occurs and that between 3.7-10.9% of the parasites in our experimental crosses are hybrid genotypes with ancestors from different laboratory strains of G. turnbulli. We also provide evidence of hybrid vigour and/ or inter-strain competition, which appeared to lead to a higher maximum parasite load in mixed infections. Finally, we demonstrate inbreeding avoidance for the first time in platyhelminths which may influence the distribution of parasites within a host and their subsequent exposure to the host's localized immune response. Combined reproductive modes and inbreeding avoidance may explain the extreme evolutionary diversification success of parasites such as Gyrodactylus, where host-parasite coevolution is punctuated by relatively frequent host switching.	[Schelkle, Bettina; Faria, Patricia J.; Johnson, Mireille B.; Cable, Joanne] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Cardiff University; University of East Anglia	Schelkle, B (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	cablej@cardiff.ac.uk	Schelkle, Bettina/D-9835-2013; Cable, Joanne/A-4360-2010	Cable, Joanne/0000-0002-8510-7055; van Oosterhout, Cock/0000-0002-5653-738X	European Community [MTKD-CT-2005-030018]; Biotechnology and Biological Sciences Research Council [BB/D526137/1]	European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a European Community Framework Programme 6 Marie Curie Host Fellowship for Transfer of Knowledge (MTKD-CT-2005-030018) to JC and a Biotechnology and Biological Sciences Research Council (BB/D526137/1) studentship to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2004, MOL ECOL, V13, P997, DOI 10.1111/j.1365-294X.2004.02145.x; Badaraco JL, 2008, EXP PARASITOL, V119, P453, DOI 10.1016/j.exppara.2008.02.004; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Bakke TA, 2002, INT J PARASITOL, V32, P281, DOI 10.1016/S0020-7519(01)00331-9; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Beukeboom LW, 2007, HEREDITY, V98, P123, DOI 10.1038/sj.hdy.6800926; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; BREMOND P, 1989, PARASITOL RES, V76, P138, DOI 10.1007/BF00930836; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Bukowski TC, 2002, CAN J ZOOL, V80, P193, DOI 10.1139/Z01-220; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2002, INT J PARASITOL, V32, P255, DOI 10.1016/S0020-7519(01)00330-7; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; COHEN J, 1977, REPRODUCTION; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Davies CM, 2002, PARASITOLOGY, V124, P31, DOI 10.1017/S0031182001008873; Detwiler JT, 2010, GENES-BASEL, V1, P102, DOI 10.3390/genes1010102; Faria PJ, 2011, CONSERV GENET RESOUR, V3, P177, DOI 10.1007/s12686-010-9317-z; FRANDSEN F, 1978, J HELMINTHOL, V52, P11, DOI 10.1017/S0022149X0000506X; HARRIS PD, 1989, PARASITOLOGY, V98, P245, DOI 10.1017/S0031182000062156; Harris PD, 2004, SYST PARASITOL, V59, P1, DOI 10.1023/B:SYPA.0000038447.52015.e4; Harris PD, 1998, INT J PARASITOL, V28, P1595, DOI 10.1016/S0020-7519(98)00086-1; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Hedrick PW, 2002, EVOLUTION, V56, P654; Karvonen A, 2007, PARASITOLOGY, V134, P1237, DOI 10.1017/S0031182007002636; King TA, 2007, INT J PARASITOL, V37, P663, DOI 10.1016/j.ijpara.2006.11.015; Kirkman T. W., 1996, STAT USE; Kirkpatrick M, 2000, AM NAT, V155, P154, DOI 10.1086/303312; Kuusela J, 2007, MOL ECOL, V16, P5234, DOI 10.1111/j.1365-294X.2007.03562.x; Laird AR, 2003, J CLIN MICROBIOL, V41, P4400, DOI 10.1128/JCM.41.9.4400-4403.2003; Lawrence E., 2005, HENDERSONS DICT BIOL; MacCarthy T, 2007, P NATL ACAD SCI USA, V104, P12801, DOI 10.1073/pnas.0705455104; MACDONALD S, 1975, Z PARASITENKD, V45, P323, DOI 10.1007/BF00329822; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; MUTANI A, 1985, ACTA TROP, V42, P319; NEI M, 1968, P NATL ACAD SCI USA, V60, P517, DOI 10.1073/pnas.60.2.517; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; OHTA T, 1974, GENET RES, V23, P191, DOI 10.1017/S0016672300014816; Peck JR, 2000, J EVOLUTION BIOL, V13, P63, DOI 10.1046/j.1420-9101.2000.00142.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; ROLLINSON D, 1990, ACTA TROP, V47, P101, DOI 10.1016/0001-706X(90)90072-8; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schelkle B, 2009, DIS AQUAT ORGAN, V86, P65, DOI 10.3354/dao02087; Schjorring S, 2007, EVOLUTION, V61, P423, DOI 10.1111/j.1558-5646.2007.00028.x; SCOTT ME, 1982, PARASITOLOGY, V85, P217, DOI 10.1017/S0031182000055207; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seridi N, 2008, MICROBES INFECT, V10, P1309, DOI 10.1016/j.micinf.2008.07.031; Smoot LM, 2002, INFECT IMMUN, V70, P2694, DOI 10.1128/IAI.70.5.2694-2699.2002; Steinauer ML, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000222; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Trouve S, 1998, PARASITOLOGY, V117, P133, DOI 10.1017/S0031182098002947; van Oosterhout C, 2008, INT J PARASITOL, V38, P541, DOI 10.1016/j.ijpara.2007.09.016; van Oosterhout C, 2007, INT J PARASITOL, V37, P805, DOI 10.1016/j.ijpara.2006.12.016; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Webster RG, 2001, SCIENCE, V293, P1773; Zietara MS, 2006, HEREDITAS, V143, P84; Zietara MS, 2002, EVOLUTION, V56, P2445, DOI 10.1111/j.0014-3820.2002.tb00170.x	65	28	28	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39506	10.1371/journal.pone.0039506	http://dx.doi.org/10.1371/journal.pone.0039506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808040	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000306362400012
J	Drayton, JM; Hall, MD; Hunt, J; Jennions, MD				Drayton, Jean M.; Hall, Matthew D.; Hunt, John; Jennions, Michael D.			Sexual Signaling and Immune Function in the Black Field Cricket Teleogryllus commodus	PLOS ONE			English	Article							COURTSHIP SONG; TRADE-OFFS; IMMUNOCOMPETENCE HANDICAP; GRYLLODES-SIGILLATUS; GRYLLUS-BIMACULATUS; REPRODUCTIVE EFFORT; NATURAL-POPULATION; MALE ADVERTISEMENT; GENETIC VARIANCE; WILD POPULATION	The immunocompetence handicap hypothesis predicts that male sexual trait expression should be positively correlated with immunocompetence. Here we investigate if immune function in the cricket, Teleogryllus commodus, is related to specific individual components of male sexual signals, as well as to certain multivariate combinations of these components that females most strongly prefer. Male T. commodus produce both advertisement and courtship calls prior to mating. We measured fine-scale structural parameters of both call types and also recorded nightly advertisement calling effort. We then measured two standard indices of immune function: lysozyme-like activity of the haemolymph and haemocyte counts. We found a weak, positive relationship between advertisement calling effort and lysozyme-like activity. There was, however, little evidence that individual structural call components or the net multivariate attractiveness of either call type signalled immune function. The relationships between immunity and sexual signaling did not differ between inbred and outbred males. Our data suggest that it is unlikely that females assess overall male immune function using male calls.	[Drayton, Jean M.; Jennions, Michael D.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Hall, Matthew D.] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Hunt, John] Univ Exeter Cornwall, Ctr Ecol & Conservat, Coll Life & Environm Sci, Penryn, England	Australian National University; University of Basel; University of Exeter	Drayton, JM (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	Jean.Drayton@anu.edu.au	Jennions, Michael D/C-7560-2009; Hall, Matthew D/A-2006-2009; Hunt, John/F-1279-2014	Jennions, Michael D/0000-0001-9221-2788; Hall, Matthew D/0000-0002-4738-203X; Hunt, John/0000-0002-4962-8750	Australian Research Council [DP0555943]; Natural Environment Research Council; Royal Society; Australian Postgraduate Award; Natural Environment Research Council [NE/G016399/1] Funding Source: researchfish; NERC [NE/G016399/1] Funding Source: UKRI	Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Australian Postgraduate Award(Australian Government); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Australian Research Council (DP0555943 to M.D.J.). J.H. was funded by the Natural Environment Research Council and a Royal Society Fellowship. J.M.D. was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Adamo SA, 2004, J INSECT PHYSIOL, V50, P209, DOI 10.1016/j.jinsphys.2003.11.011; Ahtiainen JJ, 2005, J EVOLUTION BIOL, V18, P985, DOI 10.1111/j.1420-9101.2005.00907.x; Ahtiainen JJ, 2004, BEHAV ECOL, V15, P602, DOI 10.1093/beheco/arh062; BENTLEY DR, 1972, ANIM BEHAV, V20, P478, DOI 10.1016/S0003-3472(72)80012-5; Bentsen CL, 2006, AM NAT, V167, pE102, DOI 10.1086/501376; Blows MW, 2007, J EVOLUTION BIOL, V20, P1, DOI 10.1111/j.1420-9101.2006.01164.x; Boonekamp JJ, 2008, BIOL LETTERS, V4, P741, DOI 10.1098/rsbl.2008.0347; Brooks R, 2005, EVOLUTION, V59, P871, DOI 10.1111/j.0014-3820.2005.tb01760.x; Bussiere LF, 2006, EVOLUTION, V60, P792, DOI 10.1554/05-378.1; Chenoweth SF, 2005, AM NAT, V165, P281, DOI 10.1086/427271; Contreras-Garduno J, 2006, J ETHOL, V24, P165, DOI 10.1007/s10164-005-0177-z; Drayton JM, 2007, J EVOLUTION BIOL, V20, P1138, DOI 10.1111/j.1420-9101.2006.01286.x; Drayton JM, 2011, J EVOLUTION BIOL, V24, P47, DOI 10.1111/j.1420-9101.2010.02135.x; Drayton JM, 2011, BEHAV ECOL, V22, P486, DOI 10.1093/beheco/arr005; Drayton JM, 2010, EVOLUTION, V64, P3069, DOI 10.1111/j.1558-5646.2010.01053.x; Feder D, 1997, J INSECT PHYSIOL, V43, P513, DOI 10.1016/S0022-1910(97)00010-3; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Freitak D, 2003, P ROY SOC B-BIOL SCI, V270, pS220, DOI 10.1098/rsbl.2003.0069; Gershman SN, 2010, J EVOLUTION BIOL, V23, P829, DOI 10.1111/j.1420-9101.2010.01951.x; Getty T, 2006, TRENDS ECOL EVOL, V21, P83, DOI 10.1016/j.tree.2005.10.016; Gonzalez-Santoyo I, 2010, BEHAVIOUR, V147, P1285, DOI 10.1163/000579510X516777; Gonzalez-Tokman DM, 2010, J ETHOL, V28, P29, DOI 10.1007/s10164-009-0151-2; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hall MD, 2008, EVOLUTION, V62, P2305, DOI 10.1111/j.1558-5646.2008.00436.x; Hall MD, 2010, MOL ECOL, V19, P610, DOI 10.1111/j.1365-294X.2009.04496.x; HILL K G, 1972, Australian Journal of Zoology, V20, P153, DOI 10.1071/ZO9720153; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; KAVANAGH MW, 1987, J EXP BIOL, V130, P107; Kelly NB, 2009, P ROY SOC B-BIOL SCI, V276, P3175, DOI 10.1098/rspb.2009.0599; Kerr AM, 2010, BEHAV ECOL, V21, P647, DOI 10.1093/beheco/arq035; Ketola T, 2009, EVOL ECOL RES, V11, P1131; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Kurtz J, 1999, P ROY SOC B-BIOL SCI, V266, P2515, DOI 10.1098/rspb.1999.0954; Kurtz J, 2000, DEV COMP IMMUNOL, V24, P1, DOI 10.1016/S0145-305X(99)00057-9; Kurtz J, 2007, ZOOLOGY, V110, P336, DOI 10.1016/j.zool.2007.07.001; Lawniczak MKN, 2007, TRENDS ECOL EVOL, V22, P48, DOI 10.1016/j.tree.2006.09.012; Luong LT, 2007, EVOLUTION, V61, P1391, DOI 10.1111/j.1558-5646.2007.00116.x; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Moreno-Garcia M, 2010, J MED ENTOMOL, V47, P111, DOI 10.1603/ME08267; Murai M, 2009, EVOLUTION, V63, P2363, DOI 10.1111/j.1558-5646.2009.00726.x; Pomfret JC, 2006, BEHAV ECOL, V17, P466, DOI 10.1093/beheco/arj050; PRESTWICH KN, 1981, J COMP PHYSIOL, V143, P199; Rantala MJ, 2003, BIOL J LINN SOC, V79, P503, DOI 10.1046/j.1095-8312.2003.00202.x; Rantala MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2453, DOI 10.1098/rspb.2000.1305; Rantala MJ, 2005, FUNCT ECOL, V19, P323, DOI 10.1111/j.1365-2435.2005.00979.x; Rantala MJ, 2002, P ROY SOC B-BIOL SCI, V269, P1681, DOI 10.1098/rspb.2002.2056; Rantala MJ, 2003, FUNCT ECOL, V17, P534, DOI 10.1046/j.1365-2435.2003.00764.x; Rantala MJ, 2004, BEHAV ECOL, V15, P187, DOI 10.1093/beheco/arg103; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Rolff J, 2001, CAN J ZOOL, V79, P2176, DOI 10.1139/cjz-79-12-2176; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Ryder JJ, 2000, P ROY SOC B-BIOL SCI, V267, P1171, DOI 10.1098/rspb.2000.1125; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Simmons LW, 2010, BEHAV ECOL, V21, P1330, DOI 10.1093/beheco/arq154; Simmons LW, 2005, ANIM BEHAV, V69, P1235, DOI 10.1016/j.anbehav.2004.09.011; Simmons LW, 2005, SCIENCE, V309, P2031, DOI 10.1126/science.1114500; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Tomkins JL, 2010, SCIENCE, V328, P892, DOI 10.1126/science.1188013; Tregenza T, 2006, ANIM BEHAV, V72, P809, DOI 10.1016/j.anbehav.2006.01.019; Westneat DF, 1998, P ROY SOC B-BIOL SCI, V265, P1065, DOI 10.1098/rspb.1998.0400; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zajitschek F, 2009, FUNCT ECOL, V23, P602, DOI 10.1111/j.1365-2435.2008.01520.x	70	6	6	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39631	10.1371/journal.pone.0039631	http://dx.doi.org/10.1371/journal.pone.0039631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808047	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700015
J	Khalife, N; Glover, V; Hartikainen, AL; Taanila, A; Ebeling, H; Jarvelin, MR; Rodriguez, A				Khalife, Natasha; Glover, Vivette; Hartikainen, Anna-Liisa; Taanila, Anja; Ebeling, Hanna; Jarvelin, Marjo-Riitta; Rodriguez, Alina			Placental Size Is Associated with Mental Health in Children and Adolescents	PLOS ONE			English	Article							HYPERACTIVITY SYMPTOMS; MIXED-HANDEDNESS; BIRTH-WEIGHT; PREGNANCY; DISEASE; STRESS; GROWTH; ORIGINS; NEURODEVELOPMENT; INATTENTION	Background: The role of the placenta in fetal programming has been recognized as a highly significant, yet often neglected area of study. We investigated placental size in relation to psychopathology, in particular attention deficit hyperactivity disorder (ADHD) symptoms, in children at 8 years of age, and later as adolescents at 16 years. Methodology/Principal Findings: Prospective data were obtained from The Northern Finland Birth Cohort (NFBC) 1986. Placental weight, surface area and birth weight were measured according to standard procedures, within 30 minutes after birth. ADHD symptoms, probable psychiatric disturbance, antisocial disorder and neurotic disorder were assessed at 8 years (n = 8101), and ADHD symptoms were assessed again at 16 years (n = 6607), by teachers and parents respectively. We used logistic regression analyses to investigate the association between placental size and mental health outcomes, and controlled for gestational age, birth weight, socio-demographic factors and medical factors, during gestation. There were significant positive associations between placental size (weight, surface area and placental-to-birth-weight ratio) and mental health problems in boys at 8 and 16 years of age. Increased placental weight was linked with overall probable psychiatric disturbance (at 8y, OR = 1.14 [95% CI = 1.04-1.25]), antisocial behavior (at 8 y, OR = 1.14 [95% CI = 1.03-1.27]) and ADHD symptoms (inattention-hyperactivity at 16y, OR = 1.19 [95% CI = 1.02-1.38]). No significant associations were detected among girls. Conclusions/Significance: Compensatory placental growth may occur in response to prenatal insults. Such overgrowth may affect fetal development, including brain development, and ultimately contribute to psychopathology.	[Khalife, Natasha; Jarvelin, Marjo-Riitta; Rodriguez, Alina] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Glover, Vivette] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Oulu, Finland; [Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Taanila, Anja] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Ebeling, Hanna] Oulu Univ Hosp, Clin Child Psychiat, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Med Res Council, Hlth Protect Agcy, Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Rodriguez, Alina] Mid Sweden Univ, Dept Social Sci Psychol, Ostersund, Sweden; [Rodriguez, Alina] Kings Coll London, Med Res Council, Social Genet Dev Psychiat Ctr, London WC2R 2LS, England	Imperial College London; Imperial College London; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Health Protection Agency; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Finland National Institute for Health & Welfare; University of Oulu; Mid-Sweden University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London	Khalife, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England.	a.rodriguez@imperial.ac.uk	Rodriguez, Alina/B-3541-2015; Glover, Vivette/M-2711-2016	Rodriguez, Alina/0000-0003-1209-8802; Glover, Vivette/0000-0001-6543-1651; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Academy of Finland [103451]; Sigrid Juselius Foundation, Finland; Thule Institute; University of Oulu, Finland; National Institute of Mental Health [MH63706]; EURO-BLCS; VINNMER [P32925-1]; Medical Research Council [G0801056B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation, Finland(Sigrid Juselius Foundation); Thule Institute; University of Oulu, Finland; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EURO-BLCS; VINNMER; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Academy of Finland (103451); Sigrid Juselius Foundation, Finland; Thule Institute; University of Oulu, Finland; the National Institute of Mental Health (MH63706); and EURO-BLCS. Dr Rodriguez received support from VINNMER (P32925-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Baptiste-Roberts Kesha, 2008, BMC Pregnancy Childbirth, V8, P44, DOI 10.1186/1471-2393-8-44; Barker DJP, 2010, J DEV ORIG HLTH DIS, V1, P360, DOI 10.1017/S2040174410000280; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; Clifton VL, 2005, CELL TISSUE RES, V322, P63, DOI 10.1007/s00441-005-1117-5; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; Glover V, 2004, EARLY HUM DEV, V79, P107, DOI 10.1016/j.earlhumdev.2004.04.012; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey K M, 2001, Public Health Nutr, V4, P611; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Hindmarsh PC, 2000, LANCET, V356, P719, DOI 10.1016/S0140-6736(00)02630-1; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017071; KRUGER H, 1970, AM J OBSTET GYNECOL, V106, P586; Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42; L'Abee C, 2011, J PERINAT MED, V39, P27, DOI 10.1515/jpm.2010.119; Lahti J, 2009, BRIT J PSYCHIAT, V195, P132, DOI 10.1192/bjp.bp.108.054387; Lewis R, 2006, REV GYNECOL PERINAT, V6, P70, DOI DOI 10.1016/J.RIGAPP.2005.12.001; Lumey LH, 1998, PLACENTA, V19, P105; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Obel C, 2003, DEV MED CHILD NEUROL, V45, P557; Pedersen JF, 1981, OBSTET GYNECOLOGICAL, V36, P305; Raatikainen K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-268; Rees S, 2004, NEUROSCI LETT, V361, P111, DOI 10.1016/j.neulet.2004.02.002; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Rodriguez A, 2009, J CHILD PSYCHOL PSYC, V50, P1073, DOI 10.1111/j.1469-7610.2009.02071.x; Rodriguez A, 2008, J CHILD PSYCHOL PSYC, V49, P967, DOI 10.1111/j.1469-7610.2008.01923.x; Rodriguez A, 2010, PEDIATRICS, V125, pE340, DOI 10.1542/peds.2009-1165; Rodriguez A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-327; Roseboom TJ, 2011, PLACENTA, V32, P395, DOI 10.1016/j.placenta.2011.03.001; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Smalley SL, 2007, J AM ACAD CHILD PSY, V46, P1575, DOI 10.1097/chi.0b013e3181573137; Swanson J, 2005, CATEGORICAL DIMENSIO; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tegethoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014478; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	48	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40534	10.1371/journal.pone.0040534	http://dx.doi.org/10.1371/journal.pone.0040534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792364	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000306354700058
J	Amigo, I; Traba, J; Satrustegui, J; del Arco, A				Amigo, Ignacio; Traba, Javier; Satrustegui, Jorgina; del Arco, Araceli			SCaMC-1Like a Member of the Mitochondrial Carrier (MC) Family Preferentially Expressed in Testis and Localized in Mitochondria and Chromatoid Body	PLOS ONE			English	Article							MALE GERM-CELLS; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; NUAGE FORMATION; CALCIUM; PROTEIN; ATP; SPERMATOGENESIS; IDENTIFICATION; BODIES	Mitochondrial carriers (MC) form a highly conserved family involved in solute transport across the inner mitochondrial membrane in eukaryotes. In mammals, ATP-Mg/Pi carriers, SCaMCs, form the most complex subgroup with four paralogs, SCaMC-1, - 2, - 3 and - 3L, and several splicing variants. Here, we report the tissue distribution and subcellular localization of a mammalian-specific SCaMC paralog, 4930443G12Rik/SCaMC-1Like (SCaMC-1L), which displays unanticipated new features. SCaMC-1L proteins show higher amino acid substitution rates than its closest paralog SCaMC-1. In mouse, SCaMC-1L expression is restricted to male germ cells and regulated during spermatogenesis but unexpectedly its localization is not limited to mitochondrial structures. In mature spermatids SCaMC-1L is detected in the mitochondrial sheath but in previous differentiation stages appears associated to cytosolic granules which colocalize with specific markers of the chromatoid body (CB) in post-meiotic round spermatids and inter-mitochondrial cement (IMC) in spermatocytes. The origin of this atypical distribution was further investigated by transient expression in cell lines. Similarly to male germ cells, in addition to mitochondrial and cytosolic distribution, a fraction of SCaMC-1L-expressing COS-7 cells display cytosolic SCaMC-1L-aggregates which exhibit aggresomal-like features as the CB. Our results indicate that different regions of SCaMC-1L hinder its import into mitochondria and this apparently favours the formation of cytosolic aggregates in COS-7 cells. This mechanism could be also operational in male germ cells and explain the incorporation of SCaMC-1L into germinal granules.	[Amigo, Ignacio; Traba, Javier; Satrustegui, Jorgina] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid, Spain; [Amigo, Ignacio; Traba, Javier; Satrustegui, Jorgina] Univ Autonoma Madrid, CIBER Enfermedades Raras CIBERER, Madrid, Spain; [del Arco, Araceli] Univ Castilla La Mancha, CRIB, Fac Ciencias Ambientales & Bioquim, Area Bioquim, Toledo, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de Castilla-La Mancha	Amigo, I (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid, Spain.	Araceli.Arco@uclm.es	Traba, Javier/AAA-9287-2020; Satrustegui, Jorgina/R-6732-2019; del Arco, Araceli/R-5653-2019	Traba, Javier/0000-0002-7855-3540; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667; del Arco, Araceli/0000-0002-6839-542X; Amigo, Ignacio/0000-0003-0527-5954	Instituto de Salud Carlos III (ISCIII) [PI080610]; Ministerio de Educacion y Ciencia [BFU2008-04084/BMC]; institutional grant from the Fundacion Ramon Areces; Ministerio de Educacion y Ciencia (MEC); Comunidad de Madrid	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Educacion y Ciencia(Spanish Government); institutional grant from the Fundacion Ramon Areces; Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) PI080610 (to AdA), Ministerio de Educacion y Ciencia, BFU2008-04084/BMC (to JS) and by an institutional grant from the Fundacion Ramon Areces to the CBMSO CSIC-UAM. The CIBER de Enfermedades Raras is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank I. Manso for help with animal handling. The expert technical advice of the Optical and Confocal Microscopy Unit of the Centro de Biologia Molecular is also acknowledged. I. Amigo is a recipient of a FPI predoctoral fellowship from Ministerio de Educacion y Ciencia (MEC), J. Traba is a recipient of a fellowship from the Comunidad de Madrid.	Aihara T, 2009, BIOL REPROD, V80, P762, DOI 10.1095/biolreprod.108.074013; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Bonilla E, 2008, MOL HUM REPROD, V14, P137, DOI 10.1093/molehr/gan002; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brower JV, 2009, REPRODUCTION, V138, P463, DOI 10.1530/REP-09-0201; Burch AD, 2004, J VIROL, V78, P7175, DOI 10.1128/JVI.78.13.7175-7185.2004; Cavero S, 2005, BIOCHEM J, V392, P537, DOI 10.1042/BJ20050806; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; del Arco A, 2005, BIOCHEM J, V389, P647, DOI 10.1042/BJ20050283; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; del Arco A, 2000, BIOCHEM J, V345, P725, DOI 10.1042/0264-6021:3450725; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Esaki M, 2003, NAT STRUCT BIOL, V10, P988, DOI 10.1038/nsb1008; Fawcett D. W, 1970, Biology Reprod., V2, P129, DOI 10.1095/biolreprod2.1.129; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Force A, 1999, GENETICS, V151, P1531; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Haraguchi CM, 2005, J HISTOCHEM CYTOCHEM, V53, P455, DOI 10.1369/jhc.4A6520.2005; Haraguchi CM, 2003, BIOL REPROD, V69, P885, DOI 10.1095/biolreprod.102.013524; HESS RA, 1993, BIOL REPROD, V48, P1299, DOI 10.1095/biolreprod48.6.1299; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Hughes J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-306; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lynch M, 2000, GENETICS, V154, P459; Mazurek MP, 2010, EMBO REP, V11, P431, DOI 10.1038/embor.2010.51; Mosevitsky MI, 2012, ACTA HISTOCHEM, V114, P237, DOI 10.1016/j.acthis.2011.06.009; Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Pan JY, 2005, DEVELOPMENT, V132, P4029, DOI 10.1242/dev.02003; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Roesch K, 2004, HUM MOL GENET, V13, P2101, DOI 10.1093/hmg/ddh217; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Seitz J, 1995, INT J ANDROL, V18, P7; Shang P, 2010, J CELL SCI, V123, P331, DOI 10.1242/jcs.059949; SODERSTROM KO, 1976, MOL CELL ENDOCRINOL, V5, P181, DOI 10.1016/0303-7207(76)90082-4; Sun Q, 2009, J CELL SCI, V122, P1563, DOI 10.1242/jcs.047738; Szklarczyk R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r135; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Traba J, 2008, MOL MICROBIOL, V69, P570, DOI 10.1111/j.1365-2958.2008.06300.x; Traba J, 2011, CELL MOL LIFE SCI, V68, P1183, DOI 10.1007/s00018-010-0612-3; Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokota S, 2008, ACTA HISTOCHEM CYTOC, V41, P65, DOI 10.1267/ahc.08010	70	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40470	10.1371/journal.pone.0040470	http://dx.doi.org/10.1371/journal.pone.0040470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792342	Green Published, gold, Green Accepted			2022-12-27	WOS:000306461800092
J	Hasan, S; Danishuddin, M; Adil, M; Singh, K; Verma, PK; Khan, AU				Hasan, Sadaf; Danishuddin, Mohd; Adil, Mohd; Singh, Kunal; Verma, Praveen K.; Khan, Asad U.			Efficacy of E. officinalis on the Cariogenic Properties of Streptococcus mutans: A Novel and Alternative Approach to Suppress Quorum-Sensing Mechanism	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; BIOFILM FORMATION; ACID PRODUCTION; ADHERENCE; CARIES; HYDROPHOBICITY; IDENTIFICATION; INHIBITION; PROTEINS; EXTRACTS	The present study was focused on evaluating the potential of Emblica officinalis against cariogenic properties of Streptococcus mutans, a causative microorganism for caries. The effect of crude extract and ethanolic fraction from Emblica officinalis fruit was analysed against S. mutans. The sub-MIC concentrations of crude and ethanolic fraction of E. officinalis were evaluated for its cariogenic properties such as acid production, biofilm formation, cell-surface hydrophobicity, glucan production, sucrose-dependent and independent adherence. Its effect on biofilm architecture was also investigated with the help of confocal and scanning electron microscopy (SEM). Moreover, expression of genes involved in biofilm formation was also studied by quantitative RT-PCR. This study showed 50% reduction in adherence at concentrations 156 mu g/and 312.5 mu g/ml of crude extract and ethanolic fraction respectively. However, the biofilm was reduced to 50% in the presence of crude extract (39.04 mu g/ml) and ethanolic fraction (78.08 mu g/ml). Furthermore, effective reduction was observed in the glucan synthesis and cell surface hydrophobicity. The qRT-PCR revealed significant suppression of the genes involved in its virulence. Confocal and scanning electron microscopy clearly depicted the obliteration of biofilm structure with reference to control. Hence, this study reveals the potential of E. officinalis fruit extracts as an alternative and complementary medicine for dental caries by inhibiting the virulence factors of Streptococcus mutans.	[Hasan, Sadaf; Danishuddin, Mohd; Adil, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India; [Singh, Kunal; Verma, Praveen K.] Natl Inst Plant Genome Res, New Delhi, India	Aligarh Muslim University; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Hasan, S (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	Singh, Kunal/AAS-1975-2021; Khan, Asad U/K-8157-2013; hasan, sadaf/J-4050-2019	Singh, Kunal/0000-0001-9375-1070; Khan, Asad U/0000-0001-9191-9423; 	(Interdisciplinary Biotechnology Unit) IBU; Aligarh Muslim University (AMU); Indian Council of Medical Research (ICMR) [531 59/6/2009/BMS/TRM]	(Interdisciplinary Biotechnology Unit) IBU; Aligarh Muslim University (AMU); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This study was supported by internal funds of (Interdisciplinary Biotechnology Unit) IBU, Aligarh Muslim University (AMU) and Indian Council of Medical Research (ICMR) grant no. 531 59/6/2009/BMS/TRM to AUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	CIARDI JE, 1981, J DENT RES, V60, P756, DOI 10.1177/00220345810600031701; Dmitriev A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020127; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; HAMADA S, 1978, INFECT IMMUN, V20, P592, DOI 10.1128/IAI.20.3.592-599.1978; HARDIE JM, 1992, BRIT DENT J, V172, P271, DOI 10.1038/sj.bdj.4807849; Hazra B, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-20; IIO M, 1984, AGR BIOL CHEM TOKYO, V48, P2143, DOI 10.1080/00021369.1984.10866463; Islam B, 2009, J APPL MICROBIOL, V106, P1682, DOI 10.1111/j.1365-2672.2008.04135.x; Islam B, 2008, J ANTIMICROB CHEMOTH, V62, P751, DOI 10.1093/jac/dkn253; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Khan R, 2010, J APPL MICROBIOL, V109, P2151, DOI 10.1111/j.1365-2672.2010.04847.x; Khan R, 2009, MOLECULES, V14, P586, DOI 10.3390/molecules14020586; Koo H, 2000, ARCH ORAL BIOL, V45, P141, DOI 10.1016/S0003-9969(99)00117-X; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; MARTIN MA, 1989, AM J INFECT CONTROL, V17, P130, DOI 10.1016/0196-6553(89)90199-5; Matsumoto M, 1999, CARIES RES, V33, P441, DOI 10.1159/000016549; MCBRIDE BC, 1984, INFECT IMMUN, V44, P68, DOI 10.1128/IAI.44.1.68-75.1984; Miller-Torbert TA, 2008, MICROB PATHOGENESIS, V45, P53, DOI 10.1016/j.micpath.2008.02.001; Nascimento MM, 2004, J BACTERIOL, V186, P6383, DOI 10.1128/JB.186.19.6383-6390.2004; Nostro A, 2004, LETT APPL MICROBIOL, V38, P423, DOI 10.1111/j.1472-765X.2004.01509.x; Pecharki D, 2005, ORAL MICROBIOL IMMUN, V20, P366, DOI 10.1111/j.1399-302X.2005.00244.x; Perianayagam JB, 2004, J ETHNOPHARMACOL, V95, P83, DOI 10.1016/j.jep.2004.06.020; Prabu GR, 2006, J APPL MICROBIOL, V101, P487, DOI 10.1111/j.1365-2672.2006.02912.x; Razak Fathilah Abdul, 2003, J Oral Sci, V45, P201; Ribeiro DA, 2004, J PERIODONTAL RES, V39, P358, DOI 10.1111/j.1600-0765.2004.00759.x; Senadheera D, 2008, ADV EXP MED BIOL, V631, P178, DOI 10.1007/978-0-387-78885-2_12; ULLMAN RF, 1988, HEART LUNG, V17, P209; VANDERHOEVEN JS, 1984, INFECT IMMUN, V45, P356, DOI 10.1128/IAI.45.2.356-359.1984; Wakabayashi H, 2010, BIOMETALS, V23, P419, DOI 10.1007/s10534-010-9304-6; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993	36	51	55	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40319	10.1371/journal.pone.0040319	http://dx.doi.org/10.1371/journal.pone.0040319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792279	Green Published, gold, Green Submitted			2022-12-27	WOS:000306436300054
J	Uto-Konomi, A; Miyauchi, K; Ozaki, N; Motomura, Y; Suzuki, Y; Yoshimura, A; Suzuki, S; Cua, D; Kubo, M				Uto-Konomi, Ayako; Miyauchi, Kosuke; Ozaki, Naoko; Motomura, Yasutaka; Suzuki, Yoshie; Yoshimura, Akihiko; Suzuki, Shinobu; Cua, Daniel; Kubo, Masato			Dysregulation of Suppressor of Cytokine Signaling 3 in Keratinocytes Causes Skin Inflammation Mediated by Interleukin-20 Receptor-Related Cytokines	PLOS ONE			English	Article							NF-KAPPA-B; PERMEABILITY BARRIER; PSORIASIS; STAT3; SOCS3; MICE; HOMEOSTASIS; ROLES; IL-20; GENE	Homeostatic regulation of epidermal keratinocytes is controlled by the local cytokine milieu. However, a role for suppressor of cytokine signaling (SOCS), a negative feedback regulator of cytokine networks, in skin homeostasis remains unclear. Keratinocyte specific deletion of Socs3 (Socs3 cKO) caused severe skin inflammation with hyper-production of IgE, epidermal hyperplasia, and S100A8/9 expression, although Socs1 deletion caused no inflammation. The inflamed skin showed constitutive STAT3 activation and up-regulation of IL-6 and IL-20 receptor (IL-20R) related cytokines, IL-19, IL-20 and IL-24. Disease development was rescued by deletion of the Il6 gene, but not by the deletion of Il23, Il4r, or Rag1 genes. The expression of IL-6 in Socs3 cKO keratinocytes increased expression of IL-20R-related cytokines that further facilitated STAT3 hyperactivation, epidermal hyperplasia and neutrophilia. These results demonstrate that skin homeostasis is strictly regulated by the IL-6-STAT3-SOCS3 axis. Moreover, the SOCS3-mediated negative feedback loop in keratinocytes has a critical mechanistic role in the prevention of skin inflammation caused by hyperactivation of STAT3.	[Uto-Konomi, Ayako; Miyauchi, Kosuke; Motomura, Yasutaka; Suzuki, Yoshie; Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan; [Uto-Konomi, Ayako; Ozaki, Naoko; Suzuki, Shinobu] Nippon Boehringer Ingelheim Co Ltd, Kobe Pharma Res Inst, Dept Mol & Cellular Biol, Kobe, Hyogo, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Cua, Daniel] Schering Plough Biopharma, Palo Alto, CA USA; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Noda, Chiba 278, Japan	RIKEN; Boehringer Ingelheim; Keio University; Merck & Company; Tokyo University of Science	Uto-Konomi, A (corresponding author), RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan.	raysolfc@rcai.riken.jp	Yoshimura, Akihiko/K-5515-2013; Kubo, Masato/A-5918-2016		Ministry of Education, Culture, Sports, Science, and Technology (Japan); National Institute of Biomedical Innovation (NIBIO)	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	This work was supported by a grant from Grant in Aid for Scientific Research (B) and Grant in Aid for Scientific Research on Priority Areas of the Ministry of Education, Culture, Sports, Science, and Technology (Japan) and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boniface K, 2005, EUR CYTOKINE NETW, V16, P309; Bostjancic E, 2008, ACTA DERMATOVEN ALP, V17, P95; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Hara K, 2008, INT J PHARM, V356, P267, DOI 10.1016/j.ijpharm.2007.12.041; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kingo K, 2004, GENES IMMUN, V5, P117, DOI 10.1038/sj.gene.6364046; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Leng RX, EXPERT OPIN THER TAR, V15, P119; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Mohrs M, 1999, J IMMUNOL, V162, P7302; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Park YM, 1999, J DERMATOL SCI, V22, P17, DOI 10.1016/S0923-1811(99)00038-9; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Stenderup K, 2007, ANN NY ACAD SCI, V1110, P368, DOI 10.1196/annals.1423.039; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Wang XP, 2004, J INVEST DERMATOL, V123, P124, DOI 10.1111/j.0022-202X.2004.22736.x; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhu BM, 2008, J INVEST DERMATOL, V128, P1821, DOI 10.1038/sj.jid.5701224	37	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40343	10.1371/journal.pone.0040343	http://dx.doi.org/10.1371/journal.pone.0040343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792286	Green Submitted, gold, Green Published			2022-12-27	WOS:000306436300057
J	Vullo, R; Marugan-Lobon, J; Kellner, AWA; Buscalioni, AD; Gomez, B; de la Fuente, M; Moratalla, JJ				Vullo, Romain; Marugan-Lobon, Jesus; Kellner, Alexander W. A.; Buscalioni, Angela D.; Gomez, Bernard; de la Fuente, Montserrat; Moratalla, Jose J.			A New Crested Pterosaur from the Early Cretaceous of Spain: The First European Tapejarid (Pterodactyloidea: Azhdarchoidea)	PLOS ONE			English	Article							LAS HOYAS; HUAXIAPTERUS PTEROSAURIA; DIVERSITY PATTERNS; EARLY ANGIOSPERMS; SAMPLING BIASES; IBERIAN RANGES; CHINA; EVOLUTION; PALEOECOLOGY; LAGERSTATTE	Background: The Tapejaridae is a group of unusual toothless pterosaurs characterized by bizarre cranial crests. From a paleoecological point of view, frugivorous feeding habits have often been suggested for one of its included clades, the Tapejarinae. So far, the presence of these intriguing flying reptiles has been unambiguously documented from Early Cretaceous sites in China and Brazil, where pterosaur fossils are less rare and fragmentary than in similarly-aged European strata. Methodology/Principal Findings: Europejara olcadesorum gen. et sp. nov. is diagnosed by a unique combination of characters including an unusual caudally recurved dentary crest. It represents the oldest known member of Tapejaridae and the oldest known toothless pterosaur. The new taxon documents the earliest stage of the acquisition of this anatomical feature during the evolutionary history of the Pterodactyloidea. This innovation may have been linked to the development of new feeding strategies. Conclusion/Significance: The discovery of Europejara in the Barremian of the Iberian Peninsula reveals an earlier and broader global distribution of tapejarids, suggesting a Eurasian origin of this group. It adds to the poorly known pterosaur fauna of the Las Hoyas locality and contributes to a better understanding of the paleoecology of this Konservat-Lagerstatte. Finally, the significance of a probable contribution of tapejarine tapejarids to the early angiosperm dispersal is discussed.	[Vullo, Romain] Univ Rennes 1, CNRS, UMR 6118, Lab Geosci Rennes, Rennes, France; [Vullo, Romain; Marugan-Lobon, Jesus; Buscalioni, Angela D.; de la Fuente, Montserrat] Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, Madrid, Spain; [Kellner, Alexander W. A.] Univ Fed Rio de Janeiro, Lab Systemat & Taphon Fossil Vertebrates, Dept Geol & Paleontol, Museu Nacl, Rio De Janeiro, Brazil; [Gomez, Bernard] Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon Terre Plantes Environm, F-69622 Villeurbanne, France; [Moratalla, Jose J.] Inst Geol & Min Espana, Museo Geominero, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Autonomous University of Madrid; Universidade Federal do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vullo, R (corresponding author), Univ Rennes 1, CNRS, UMR 6118, Lab Geosci Rennes, Rennes, France.	romain.vullo@gmail.com	Kellner, Alexander W/H-1023-2015; Marugán-Lobón, Jesús/AAA-7614-2019; Moratalla, Jose Joaquin/E-3995-2018; Buscalioni, Angela D./AAA-5874-2019; Gomez, Bernard/B-1394-2012; Kellner, Alexander/ABE-9591-2020	Kellner, Alexander W/0000-0001-7174-9447; Moratalla, Jose Joaquin/0000-0002-4949-7666; Gomez, Bernard/0000-0003-1691-0634; Kellner, Alexander/0000-0001-7174-9447	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.779/2008, E-26/111.273/2010]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307276/2009-0]; Spanish Ministerio de Ciencia e Innovacion [CGL2009-11838BTE]; Junta de Castilla-La Mancha	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla-La Mancha	AWAK acknowledges the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ nos. E-26/102.779/2008 and E-26/111.273/2010) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq no. 307276/2009-0) for supporting research on pterosaurs, including the examination of the Las Hoyas specimen. This study was supported by the Project CGL2009-11838BTE of the Spanish Ministerio de Ciencia e Innovacion and the Junta de Castilla-La Mancha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Archangelsky S, 2009, CRETACEOUS RES, V30, P1073, DOI 10.1016/j.cretres.2009.03.001; Barral A, 2009, MESOZOIC TERRESTRIAL, P125; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Buscalioni AD, 2008, CRETACEOUS RES, V29, P687, DOI 10.1016/j.cretres.2008.02.004; Buscalioni AD, 2010, J IBER GEOL, V36, P297, DOI 10.5209/rev_JIGE.2010.v36.n2.13; Buscalioni Angela D., 2006, P9; Butler RJ, 2009, J EVOLUTION BIOL, V22, P446, DOI 10.1111/j.1420-9101.2008.01680.x; Butler RJ, 2012, EVOLUTION, V66, P147, DOI 10.1111/j.1558-5646.2011.01415.x; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Coiffard C, 2007, ANN BOT-LONDON, V100, P545, DOI 10.1093/aob/mcm160; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Dyke GJ, 2009, J EVOLUTION BIOL, V22, P890, DOI 10.1111/j.1420-9101.2008.01682.x; Eck Kristina, 2011, Swiss Journal of Palaeontology, V130, P277, DOI 10.1007/s13358-011-0024-5; Elgin RA, 2012, HIST BIOL IN PRESS, V24; Eriksson O, 2000, INT J PLANT SCI, V161, P319, DOI 10.1086/314248; FLEMING TH, 1991, AM NAT, V138, P1058, DOI 10.1086/285269; Fregenal-Martinez M.A., 2000, AAPG STUDIES GEOLOGY, V46, P303; Frey Eberhard, 2003, Geological Society Special Publication, V217, P65, DOI 10.1144/GSL.SP.2003.217.01.06; Frey E, 2011, SWISS J GEOSCI, V104, pS35, DOI 10.1007/s00015-011-0073-1; Friis EM, 2010, REV PALAEOBOT PALYNO, V162, P341, DOI 10.1016/j.revpalbo.2009.11.009; Gomez B, 2001, PALAEOGEOGR PALAEOCL, V170, P133, DOI 10.1016/S0031-0182(01)00232-2; Heimhofer U, 2010, REV PALAEOBOT PALYNO, V161, P105, DOI 10.1016/j.revpalbo.2010.03.010; Ibrahim N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010875; Kellner A.W.A., 1989, Anais da Academia Brasileira de Ciencias, V61, P439; Kellner A, 2007, J VERTEBR PALEONTOL, V27, p98A; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2010, AN ACAD BRAS CIENC, V82, P1063, DOI 10.1590/S0001-37652010000400025; Kellner Alexander W.A., 2007, Boletim do Museu Nacional Nova Serie Geologia, V75, P1; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P453; Lu Junchang, 2005, Geological Review (Beijing), V51, P458; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P683; Mohr BAR, 2000, INT J PLANT SCI, V161, pS155, DOI 10.1086/317580; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Osi A, 2011, CRETACEOUS RES, V32, P456, DOI 10.1016/j.cretres.2011.01.011; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Prentice KC, 2011, J SYST PALAEONTOL, V9, P337, DOI 10.1080/14772019.2011.565081; SANZ JL, 1988, GEOBIOS-LYON, V21, P611, DOI 10.1016/S0016-6995(88)80072-X; Sanz JL, 2001, PALAEOBIOLOGY, VII, P356; Stecher R, 2008, SWISS J GEOSCI, V101, P185, DOI 10.1007/s00015-008-1252-6; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Sun G, 2002, REV PALAEOBOT PALYNO, V121, P91, DOI 10.1016/S0034-6667(02)00083-0; Sun Ge, 2008, Palaeoworld, V17, P166, DOI 10.1016/j.palwor.2008.10.002; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Vullo R, 2009, GEOL MAG, V146, P931, DOI 10.1017/S0016756809990525; Wang XL, 2006, GEOL J, V41, P405, DOI 10.1002/gj.1046; Wang XL, 2012, NATURWISSENSCHAFTEN, V99, P249, DOI 10.1007/s00114-012-0889-1; Wang XL, 2009, AN ACAD BRAS CIENC, V81, P793, DOI 10.1590/S0001-37652009000400016; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Webb Colin J., 1998, Plant Species Biology, V13, P57, DOI 10.1111/j.1442-1984.1998.tb00248.x; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379; Witton MP, 2009, CRETACEOUS RES, V30, P676, DOI 10.1016/j.cretres.2008.12.004; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zheng XT, 2011, P NATL ACAD SCI USA, V108, P15904, DOI 10.1073/pnas.1112694108; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	67	47	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38900	10.1371/journal.pone.0038900	http://dx.doi.org/10.1371/journal.pone.0038900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802931	gold, Green Published			2022-12-27	WOS:000306186900005
J	Gray, LW; Peng, FY; Molloy, SA; Pendyala, VS; Muchenditsi, A; Muzik, O; Lee, J; Kaplan, JH; Lutsenko, S				Gray, Lawrence W.; Peng, Fangyu; Molloy, Shannon A.; Pendyala, Venkata S.; Muchenditsi, Abigael; Muzik, Otto; Lee, Jaekwon; Kaplan, Jack H.; Lutsenko, Svetlana			Urinary Copper Elevation in a Mouse Model of Wilson's Disease Is a Regulated Process to Specifically Decrease the Hepatic Copper Load	PLOS ONE			English	Article							TRANSPORTING ATPASE; BIOLOGICAL SAMPLES; MAMMALIAN-CELLS; VIRAL-HEPATITIS; MENKES DISEASE; LIVER-DISEASE; GENE; HOMEOSTASIS; EXCRETION; ACCUMULATION	Body copper homeostasis is regulated by the liver, which removes excess copper via bile. In Wilson's disease (WD), this function is disrupted due to inactivation of the copper transporter ATP7B resulting in hepatic copper overload. High urinary copper is a diagnostic feature of WD linked to liver malfunction; the mechanism behind urinary copper elevation is not fully understood. Using Positron Emission Tomography-Computed Tomography (PET-CT) imaging of live Atp7b(-/-) mice at different stages of disease, a longitudinal metal analysis, and characterization of copper-binding molecules, we show that urinary copper elevation is a specific regulatory process mediated by distinct molecules. PET-CT and atomic absorption spectroscopy directly demonstrate an age-dependent decrease in the capacity of Atp7b(-/-) livers to accumulate copper, concomitant with an increase in urinary copper. This reciprocal relationship is specific for copper, indicating that cell necrosis is not the primary cause for the initial phase of metal elevation in the urine. Instead, the urinary copper increase is associated with the down-regulation of the copper-transporter Ctr1 in the liver and appearance of a 2 kDa Small Copper Carrier, SCC, in the urine. SCC is also elevated in the urine of the liver-specific Ctr1(-/-) knockouts, which have normal ATP7B function, suggesting that SCC is a normal metabolite carrying copper in the serum. In agreement with this hypothesis, partially purified SCC-Cu competes with free copper for uptake by Ctr1. Thus, hepatic down-regulation of Ctr1 allows switching to an SCC-mediated removal of copper via kidney when liver function is impaired. These results demonstrate that the body regulates copper export through more than one mechanism; better understanding of urinary copper excretion may contribute to an improved diagnosis and monitoring of WD.	[Gray, Lawrence W.; Pendyala, Venkata S.; Muchenditsi, Abigael; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Peng, Fangyu] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Molloy, Shannon A.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Muzik, Otto] Wayne State Univ, Sch Med, Carman & Ann Adams Dept Pediat, Detroit, MI USA; [Muzik, Otto] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68583 USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wayne State University; Wayne State University; University of Nebraska System; University of Nebraska Lincoln	Gray, LW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu	Peng, Fangyu/D-1079-2015	Peng, Fangyu/0000-0002-3142-3845; Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [5F31DK084730, 5R01DK079209, 5P01GM067166, S10-RR025512]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675, S10RR025512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK084730, R01DK079209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants 5F31DK084730 to LWG, 5R01DK079209 to JL, and 5P01GM067166 to SL and JHK. The mass-spectrometry work was done at the Metal Ion Core (Oregon Health and Science University), supported by NIH instrumentation grant S10-RR025512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2011, CLIN LAB, V57, P847; Afridi HI, 2009, BIOL TRACE ELEM RES, V129, P78, DOI 10.1007/s12011-008-8297-2; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Burkhead JL, 2011, BIOMETALS, V24, P455, DOI 10.1007/s10534-011-9430-9; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; ELMES ME, 1989, J PATHOL, V158, P131, DOI 10.1002/path.1711580208; FROMMER DJ, 1981, DIGESTION, V21, P169, DOI 10.1159/000198559; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Huster D, 2010, BEST PRACT RES CL GA, V24, P531, DOI 10.1016/j.bpg.2010.07.014; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; Linz R, 2008, AM J PHYSIOL-RENAL, V294, pF53, DOI 10.1152/ajprenal.00314.2007; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; MELICHAR B, 1994, J TRACE ELEM ELECT H, V8, P209; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Peng F., 2011, MOL IMAGING BIOL; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Pfeiffer Ronald F, 2011, Handb Clin Neurol, V100, P681, DOI 10.1016/B978-0-444-52014-2.00049-5; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Walshe JM, 2011, QJM-INT J MED, V104, P775, DOI 10.1093/qjmed/hcr073; WILKEN H, 1961, KLIN WOCHENSCHR, V39, P147, DOI 10.1007/BF01485365; Zischka H, 2011, J CLIN INVEST, V121, P1508, DOI 10.1172/JCI45401	33	51	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38327	10.1371/journal.pone.0038327	http://dx.doi.org/10.1371/journal.pone.0038327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22802922	Green Published, gold			2022-12-27	WOS:000305730900009
J	Sher, F; Boddeke, E; Olah, M; Copray, S				Sher, Falak; Boddeke, Erik; Olah, Marta; Copray, Sjef			Dynamic Changes in Ezh2 Gene Occupancy Underlie Its Involvement in Neural Stem Cell Self-Renewal and Differentiation towards Oligodendrocytes	PLOS ONE			English	Article							POLYCOMB SILENCING MECHANISMS; HISTONE METHYLTRANSFERASE; PRECURSOR CELLS; GROUP PROTEINS; TGF-BETA; FATE; EXPRESSION; METHYLATION; REGULATORS; ROLES	Background: The polycomb group protein Ezh2 is an epigenetic repressor of transcription originally found to prevent untimely differentiation of pluripotent embryonic stem cells. We previously demonstrated that Ezh2 is also expressed in multipotent neural stem cells (NSCs). We showed that Ezh2 expression is downregulated during NSC differentiation into astrocytes or neurons. However, high levels of Ezh2 remained present in differentiating oligodendrocytes until myelinating. This study aimed to elucidate the target genes of Ezh2 in NSCs and in premyelinating oligodendrocytes (pOLs). Methodology/Principal Findings: We performed chromatin immunoprecipitation followed by high-throughput sequencing to detect the target genes of Ezh2 in NSCs and pOLs. We found 1532 target genes of Ezh2 in NSCs. During NSC differentiation, the occupancy of these genes by Ezh2 was alleviated. However, when the NSCs differentiated into oligodendrocytes, 393 of these genes remained targets of Ezh2. Analysis of the target genes indicated that the repressive activity of Ezh2 in NSCs concerns genes involved in stem cell maintenance, in cell cycle control and in preventing neural differentiation. Among the genes in pOLs that were still repressed by Ezh2 were most prominently those associated with neuronal and astrocytic committed cell lineages. Suppression of Ezh2 activity in NSCs caused loss of stem cell characteristics, blocked their proliferation and ultimately induced apoptosis. Suppression of Ezh2 activity in pOLs resulted in derangement of the oligodendrocytic phenotype, due to re-expression of neuronal and astrocytic genes, and ultimately in apoptosis. Conclusions/Significance: Our data indicate that the epigenetic repressor Ezh2 in NSCs is crucial for proliferative activity and maintenance of neural stemness. During differentiation towards oligodendrocytes, Ezh2 repression continues particularly to suppress other neural fate choices. Ezh2 is completely downregulated during differentiation towards neurons and astrocytes allowing transcription of these differentiation programs. The specific fate choice towards astrocytes or neurons is apparently controlled by epigenetic regulators other than Ezh2.	[Sher, Falak; Boddeke, Erik; Olah, Marta; Copray, Sjef] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands	University of Groningen	Sher, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands.	j.c.v.m.copray@med.umcg.nl		Sher, Falak/0000-0002-4429-0084	Dutch Foundation MS Research [04-554MS]	Dutch Foundation MS Research	Funding provided by Dutch Foundation MS Research, 04-554MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner L, 2008, CELL TISSUE RES, V331, P225, DOI 10.1007/s00441-007-0466-7; Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chou RH, 2011, AM J TRANSL RES, V3, P243; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeWald LE, 2011, J NEUROSCI, V31, P3470, DOI 10.1523/JNEUROSCI.2768-10.2011; Erhardt S, 2003, DEV GENES EVOL, V213, P336, DOI 10.1007/s00427-003-0331-y; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Golestaneh N, 2005, ONCOGENE, V24, P5722, DOI 10.1038/sj.onc.1208925; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Namihira M, 2008, PHILOS T R SOC B, V363, P2099, DOI 10.1098/rstb.2008.2262; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2004, COLD SPRING HARB SYM, V69, P301, DOI 10.1101/sqb.2004.69.301; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sher F, 2011, CELL REPROGRAM, V13, P1, DOI 10.1089/cell.2010.0052; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	51	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40399	10.1371/journal.pone.0040399	http://dx.doi.org/10.1371/journal.pone.0040399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808153	Green Submitted, gold, Green Published			2022-12-27	WOS:000306366400021
J	Kueider, AM; Parisi, JM; Gross, AL; Rebok, GW				Kueider, Alexandra M.; Parisi, Jeanine M.; Gross, Alden L.; Rebok, George W.			Computerized Cognitive Training with Older Adults: A Systematic Review	PLOS ONE			English	Review							ATTENTIONAL CONTROL; MEMORY PERFORMANCE; PLASTICITY; SPEED; IMPAIRMENT; IMPACT; GAMES; ABILITIES; PROGRAM; TRIAL	A systematic review to examine the efficacy of computer-based cognitive interventions for cognitively healthy older adults was conducted. Studies were included if they met the following criteria: average sample age of at least 55 years at time of training; participants did not have Alzheimer's disease or mild cognitive impairment; and the study measured cognitive outcomes as a result of training. Theoretical articles, review articles, and book chapters that did not include original data were excluded. We identified 151 studies published between 1984 and 2011, of which 38 met inclusion criteria and were further classified into three groups by the type of computerized program used: classic cognitive training tasks, neuropsychological software, and video games. Reported pre-post training effect sizes for intervention groups ranged from 0.06 to 6.32 for classic cognitive training interventions, 0.19 to 7.14 for neuropsychological software interventions, and 0.09 to 1.70 for video game interventions. Most studies reported older adults did not need to be technologically savvy in order to successfully complete or benefit from training. Overall, findings are comparable or better than those from reviews of more traditional, paper-and-pencil cognitive training approaches suggesting that computerized training is an effective, less labor intensive alternative.	[Kueider, Alexandra M.; Parisi, Jeanine M.; Rebok, George W.] Johns Hopkins Univ, Dept Mental Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Gross, Alden L.] Harvard Univ, Sch Med, Hebrew SeniorLife, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Hebrew SeniorLife	Kueider, AM (corresponding author), Johns Hopkins Univ, Dept Mental Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	akueider@jhsph.edu		Kueider, Alexandra/0000-0001-7132-5003	National Institutes of Health (NIH)/National Institute on Aging (NIA) Age-related Cognitive Disorders Training Program fellowship [T32AG027668-05]; NIH Translational Research in Aging fellowship [T32AG023480-07]; NIA [P01AG031720]; NATIONAL INSTITUTE ON AGING [T32AG027668, P01AG031720, T32AG023480] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute on Aging (NIA) Age-related Cognitive Disorders Training Program fellowship; NIH Translational Research in Aging fellowship; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AMK was supported by a National Institutes of Health (NIH)/National Institute on Aging (NIA) Age-related Cognitive Disorders Training Program fellowship (T32AG027668-05, PI: Albert). ALG was supported by a NIH Translational Research in Aging fellowship (T32AG023480-07, PI: Lipsitz) and the NIA (P01AG031720, PI: Inouye). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2010, PSYCHOL AGING, V25, P753, DOI 10.1037/a0019277; [Anonymous], PHYS OCCUPATIONAL TH, DOI DOI 10.1080/J148V14N02_02; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barnes DE, 2009, ALZ DIS ASSOC DIS, V23, P205, DOI 10.1097/WAD.0b013e31819c6137; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Belchior PDC, 2008, PROQUEST INFORM LEAR; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Bherer L, 2005, PSYCHOL AGING, V20, P695, DOI 10.1037/0882-7974.20.4.695; Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; Blackford RC, 1990, GERIATRIC MEMORY TRA; Bottiroli S, 2009, AGING NEUROPSYCHOL C, V16, P401, DOI 10.1080/13825580802691763; BOTWINICK J, 1957, J GERONTOL, V12, P300, DOI 10.1093/geronj/12.3.300; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Cassavaugh ND, 2009, APPL ERGON, V40, P943, DOI 10.1016/j.apergo.2009.02.001; CLARK JE, 1987, J GERONTOL, V42, P82, DOI 10.1093/geronj/42.1.82; CZAJA SJ, 1993, PSYCHOL AGING, V8, P59, DOI 10.1037/0882-7974.8.1.59; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Drew B., 1986, COGNITIVE REHABILITA, V4, P26; Dunlosky J, 2003, PSYCHOL AGING, V18, P340, DOI 10.1037/0882-7974.18.2.340; DUSTMAN RE, 1992, J GERONTOL, V47, pP168, DOI 10.1093/geronj/47.3.P168; Eckroth-Bucher M, 2009, AM J ALZHEIMERS DIS, V24, P234, DOI 10.1177/1533317509332624; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Fernandez A., 2011, TRANSFORMING BRAIN H; FINKEL SI, 1989, EXP AGING RES, V15, P199; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; Gamberini L, 2006, PSYCHNOLOGY J, V4, P285; George DR, 2011, GERONTOLOGIST; Goldstein J, 1997, SOC BEHAV PERSONAL, V25, P345, DOI 10.2224/sbp.1997.25.4.345; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hart TA, 2008, BEHAV INFORM TECHNOL, V27, P191, DOI 10.1080/01449290600802031; Hinman, 2002, J GERIATR PHYS THER, V25, P10, DOI DOI 10.1519/00139143-200225030-00003; Hollis-Sawyer LA, 1999, EDUC GERONTOL, V25, P661, DOI 10.1080/036012799267521; Jamieson BA, 2000, J GERONTOL B-PSYCHOL, V55, pP343, DOI 10.1093/geronb/55.6.P343; Jennings JM, 2005, AGING NEUROPSYCHOL C, V12, P278, DOI 10.1080/138255890968312; Klusmann V, 2010, J GERONTOL A-BIOL, V65, P680, DOI 10.1093/gerona/glq053; Kramer A. F., 2008, HDB AGING COGNITION, V3, P189, DOI DOI 10.1080/01924780903295796; KRAMER AF, 1995, J EXP PSYCHOL-APPL, V1, P50, DOI 10.1037/1076-898X.1.1.50; Lajoie Y, 2004, AGING CLIN EXP RES, V16, P363; Lee B, 2011, COMPUT HUM BEHAV, V27, P1231, DOI 10.1016/j.chb.2011.01.003; Li SC, 2008, PSYCHOL AGING, V23, P731, DOI 10.1037/a0014343; Lustig C, 2008, PSYCHOL AGING, V23, P754, DOI 10.1037/a0014295; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Martin M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006220.pub2; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mozolic JL, 2011, NEUROBIOL AGING, V32, P655, DOI 10.1016/j.neurobiolaging.2009.04.013; Ownby RL, 2008, GERONTOLOGIST, V48, P170, DOI 10.1093/geront/48.2.170; Peretz C, 2011, NEUROEPIDEMIOLOGY, V36, P91, DOI 10.1159/000323950; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pew Internet and American Life Project, 2010, CHANG INT US AG 2000; Ralls RS, 1998, AGE COMPUTER TRAININ; Rasmusson DX, 1999, AGING NEUROPSYCHOL C, V6, P56, DOI 10.1076/anec.6.1.56.790; Rebok GW, 2007, J GERONTOL B-PSYCHOL, V62, P53, DOI 10.1093/geronb/62.special_issue_1.53; Rebok GW, 1996, APPL COGNITIVE PSYCH, V10, P211, DOI 10.1002/(SICI)1099-0720(199606)10:3<211::AID-ACP375>3.0.CO;2-C; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Saczynski JS, 2004, INT J COGN TECHNOL, V9, P25; Schmiedek F, 2010, GEROPSYCH, V23, P59, DOI 10.1024/1662-9647/a000013; Shapira N, 2007, AGING MENT HEALTH, V11, P477, DOI 10.1080/13607860601086546; Slegers K, 2009, SUCCESSFUL COGNITIVE, P41; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Thompson G, 2005, EDUC GERONTOL, V31, P603, DOI 10.1080/03601270591003364; Tierney MC, 1996, NEUROLOGY, V46, P149, DOI 10.1212/WNL.46.1.149; Torres A., 2008, ICDVRAT, V19, P191; U.S. Department of Commerce U.S. Census Bureau, 2011, STAT ABSTR US 2011; Vance D, 2007, REHABIL PSYCHOL, V52, P89, DOI 10.1037/0090-5550.52.1.89; VERHAEGHEN P, 1992, PSYCHOL AGING, V7, P242, DOI 10.1037/0882-7974.7.2.242; Wadley VG, 2006, ARCH PHYS MED REHAB, V87, P757, DOI 10.1016/j.apmr.2006.02.027; Weybright EH, 2010, THER RECREAT J, V44, P271; White H, 2002, AGING MENT HEALTH, V6, P213, DOI 10.1080/13607860220142422; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805	73	362	374	10	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40588	10.1371/journal.pone.0040588	http://dx.doi.org/10.1371/journal.pone.0040588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22792378	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400076
J	Ramegowda, V; Senthil-Kumar, M; Nataraja, KN; Reddy, MK; Mysore, KS; Udayakumar, M				Ramegowda, Venkategowda; Senthil-Kumar, Muthappa; Nataraja, Karaba N.; Reddy, Malireddy K.; Mysore, Kirankumar S.; Udayakumar, Makarla			Expression of a Finger Millet Transcription Factor, EcNAC1, in Tobacco Confers Abiotic Stress-Tolerance	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; COARCTATA ROXB. TATEOKA; DNA-BINDING SPECIFICITY; HALOPHYTIC WILD-RICE; DROUGHT TOLERANCE; LOW-TEMPERATURE; SALT TOLERANCE; FUNCTIONAL-ANALYSIS; FREEZING TOLERANCE; ORYZA-SATIVA	NAC (NAM, ATAF1-2, and CUC2) proteins constitute one of the largest families of plant-specific transcription factors and have been shown to be involved in diverse plant processes including plant growth, development, and stress-tolerance. In this study, a stress-responsive NAC gene, EcNAC1, was isolated from the subtracted stress cDNA library generated from a drought adapted crop, finger millet, and characterized for its role in stress-tolerance. The expression analysis showed that EcNAC1 was highly induced during water-deficit and salt stress. EcNAC1 shares high amino acid similarity with rice genes that have been phylogenetically classified into stress-related NAC genes. Our results demonstrated that tobacco transgenic plants expressing EcNAC1 exhibit tolerance to various abiotic stresses like simulated osmotic stress, by polyethylene glycol (PEG) and mannitol, and salinity stress. The transgenic plants also showed enhanced tolerance to methyl-viologen (MV) induced oxidative stress. Reduced levels of reactive oxygen species (ROS) and ROS-induced damage were noticed in pot grown transgenic lines under water-deficit and natural high light conditions. Root growth under stress and recovery growth after stress alleviation was more in transgenic plants. Many stress-responsive genes were found to be up-regulated in transgenic lines expressing EcNAC1. Our results suggest that EcNAC1 overexpression confers tolerance against abiotic stress in susceptible species, tobacco.	[Ramegowda, Venkategowda; Nataraja, Karaba N.; Udayakumar, Makarla] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Ramegowda, Venkategowda; Senthil-Kumar, Muthappa; Mysore, Kirankumar S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Reddy, Malireddy K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India	University of Agricultural Sciences Bangalore; Noble Research Institute; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Ramegowda, V (corresponding author), Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA.	udayakumar_m@yahoo.com	Senthil-Kumar, Muthappa/A-6699-2009; Mysore, Kirankumar/AAG-7112-2020	Senthil-Kumar, Muthappa/0000-0003-1502-1659; Mysore, Kirankumar/0000-0002-9805-5741; Nataraja, Karaba N./0000-0002-9766-3622	Department of Biotechnology [BT/PR/4946/Agr/16/421/2004]; Centre of excellence [BT/01/COE/05/03]; Government of India; Indian Council of Agricultural Research, India [10-(6)/2005 EPD]	Department of Biotechnology; Centre of excellence; Government of India; Indian Council of Agricultural Research, India(Indian Council of Agricultural Research (ICAR))	This work has been supported by grants from the Department of Biotechnology (Transcription factor project grant number F.No.BT/PR/4946/Agr/16/421/2004, Centre of excellence grant number F.No. BT/01/COE/05/03), Government of India and Indian Council of Agricultural Research (Niche area of excellence grant number F.No.10-(6)/2005 EP&D), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; Amtmann A, 2005, PLANT PHYSIOL, V138, P127, DOI 10.1104/pp.105.059972; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Cong L, 2008, BIOCHEM BIOPH RES CO, V371, P702, DOI 10.1016/j.bbrc.2008.04.126; COSIO C, 2004, PLANT PHYSIOL, V134, P1; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Dezar CA, 2005, TRANSGENIC RES, V14, P429, DOI 10.1007/s11248-005-5076-0; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Fujita M, 2007, BIOCHEM BIOPH RES CO, V364, P250, DOI 10.1016/j.bbrc.2007.09.124; Fujiwara M, 2006, PLANT PHYSIOL, V140, P734, DOI 10.1104/pp.105.068395; Ganguly M, 2011, PLANT CELL REP, V30, P1617, DOI 10.1007/s00299-011-1072-4; Gopalakrishna R, 2001, BIOCHEM BIOPH RES CO, V284, P574, DOI 10.1006/bbrc.2001.4992; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; HALLIWELL B, 1988, METHOD BIOCHEM ANAL, V33, P59; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Impa SM, 2005, CROP SCI, V45, P2517, DOI 10.2135/cropsci2005.0119; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kathuria H, 2009, PLANT BIOTECHNOL J, V7, P512, DOI 10.1111/j.1467-7652.2009.00420.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Majee M, 2004, J BIOL CHEM, V279, P28539, DOI 10.1074/jbc.M310138200; Mishra RN, 2005, ANAL BIOCHEM, V345, P149, DOI 10.1016/j.ab.2005.07.029; Miyazaki S, 1999, MOL GEN GENET, V261, P307, DOI 10.1007/s004380050971; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Mundree Sagadevan G., 2002, African Journal of Biotechnology, V1, P28; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nakashima K, 2011, BIOCH BIOPH IN PRESS; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nogueira FTS, 2005, PLANT SCI, V169, P93, DOI 10.1016/j.plantsci.2005.03.008; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Olsen AN, 2005, PLANT SCI, V169, P785, DOI 10.1016/j.plantsci.2005.05.035; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sarret G, 2002, PLANT PHYSIOL, V130, P1; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sengupta S, 2008, PLANT CELL ENVIRON, V31, P1442, DOI 10.1111/j.1365-3040.2008.01850.x; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sutherland MW, 1997, FREE RADICAL RES, V27, P283, DOI 10.3109/10715769709065766; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; UMA S, 1995, ANN BOT-LONDON, V76, P43, DOI 10.1006/anbo.1995.1076; Vera-Estrella R, 2005, PLANT PHYSIOL, V139, P1507, DOI 10.1104/pp.105.067850; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Waditee R, 2002, P NATL ACAD SCI USA, V99, P4109, DOI 10.1073/pnas.052576899; Weir I, 2004, DEVELOPMENT, V131, P915, DOI 10.1242/dev.00993; Whittaker A, 2001, J EXP BOT, V52, P961, DOI 10.1093/jexbot/52.358.961; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yokotani N, 2009, PLANTA, V229, P1065, DOI 10.1007/s00425-009-0895-5	77	44	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40397	10.1371/journal.pone.0040397	http://dx.doi.org/10.1371/journal.pone.0040397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808152	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400051
J	Twenge, JM; Campbell, WK; Gentile, B				Twenge, Jean M.; Campbell, W. Keith; Gentile, Brittany			Increases in Individualistic Words and Phrases in American Books, 1960-2008	PLOS ONE			English	Article							CULTURAL PRODUCTS; METAANALYSIS; COLLECTIVISM; PERSONALITY; TIME; SELF; HEAD	Cultural products such as song lyrics, television shows, and books reveal cultural differences, including cultural change over time. Two studies examine changes in the use of individualistic words (Study 1) and phrases (Study 2) in the Google Books Ngram corpus of millions of books in American English. Current samples from the general population generated and rated lists of individualistic words and phrases (e.g., "unique," "personalize," "self," "all about me," "I am special," "I'm the best"). Individualistic words and phrases increased in use between 1960 and 2008, even when controlling for changes in communal words and phrases. Language in American books has become increasingly focused on the self and uniqueness in the decades since 1960.	[Twenge, Jean M.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Campbell, W. Keith; Gentile, Brittany] Univ Georgia, Dept Psychol, Athens, GA 30602 USA	California State University System; San Diego State University; University System of Georgia; University of Georgia	Twenge, JM (corresponding author), San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA.	jtwenge@mail.sdsu.edu	Twenge, Jean M./ABD-6562-2021	Twenge, Jean M./0000-0002-6542-8281; Gentile, Brittany/0000-0002-6302-5593				Andre M, 2010, SCAND J PUBLIC HEALT, V38, P457, DOI 10.1177/1403494810371247; [Anonymous], 1981, NEW RULES SEARCHING; BAUMEISTER RF, 1987, J PERS SOC PSYCHOL, V52, P163, DOI 10.1037/0022-3514.52.1.163; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; DeWall CN, 2011, PSYCHOL AESTHET CREA, V5, P200, DOI 10.1037/a0023195; Friedan Betty, 1963, FEMININE MYSTIQUE; Fukuyama Francis, 1999, GREAT DISRUPTION HUM; Howe N., 2000, MILLENNIALS RISING N, V1st ed.; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; Koenig AM, 2011, PSYCHOL BULL, V137, P616, DOI 10.1037/a0023557; Konrath SH, 2011, PERS SOC PSYCHOL REV, V15, P180, DOI 10.1177/1088868310377395; Kroeber A. L., 1952, CULTURE CRITICAL REV; Lamoreaux M, 2012, J CROSS CULT PSYCHOL, V43, P299, DOI 10.1177/0022022110385234; Lindfors P, 2012, J ADOLESC IN PRESS; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Morling B, 2008, PERS SOC PSYCHOL REV, V12, P199, DOI 10.1177/1088868308318260; Myers David, 2000, AM PARADOX SPIRITUAL; Pennebaker, 2011, SECRET LIFE PRONOUNS, DOI 10.1387/gogoa.17916; SCHAIE K W, 1965, Psychol Bull, V64, P92, DOI 10.1037/h0022371; Schwartz SH, 2001, J CROSS CULT PSYCHOL, V32, P268, DOI 10.1177/0022022101032003002; SIMMONS DD, 1994, J SOC PSYCHOL, V134, P69, DOI 10.1080/00224545.1994.9710885; STEWART AJ, 1989, AM PSYCHOL, V44, P30, DOI 10.1037/0003-066X.44.1.30; Terracciano A, 2010, PERSPECT PSYCHOL SCI, V5, P93, DOI 10.1177/1745691609357017; Trzesniewski KH, 2010, PERSPECT PSYCHOL SCI, V5, P58, DOI 10.1177/1745691609356789; Twenge J. M., 2006, GENERATION ME WHY TO; Twenge JM, 2007, J RES PERS, V41, P171, DOI 10.1016/j.jrp.2006.03.006; Twenge JM, 2010, SOC PSYCHOL PERS SCI, V1, P99, DOI 10.1177/1948550609355719; TWENGE JEAN M., 2009, NARCISSISM EPIDEMIC; Twenge JM, 2012, SELF IDENTI IN PRESS; U. S. Census, 2004, STAT ABSTR US; Uhls YT, 2011, J PSYCHOSOCIAL RES, V5; Zou X, 2009, J PERS SOC PSYCHOL, V97, P579, DOI 10.1037/a0016399	33	91	95	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40181	10.1371/journal.pone.0040181	http://dx.doi.org/10.1371/journal.pone.0040181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973JD	22808113	Green Published, gold			2022-12-27	WOS:000306355500029
J	Luo, SQ; Hu, JP; Qu, Q; Li, J; Ren, W; Zhang, JM; Zhong, Y; Hu, WX				Luo, Sai-Qun; Hu, Jing-Ping; Qu, Qiang; Li, Jiang; Ren, Wei; Zhang, Jia-Ming; Zhong, Yan; Hu, Wei-Xin			The Effects of Promoter Methylation on Downregulation of DAZAP2 in Multiple Myeloma Cell Lines	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DEPENDENT KINASE INHIBITOR; MARROW STROMAL CELLS; NF-KAPPA-B; DNA METHYLATION; MYELOGENOUS LEUKEMIA; BONE-DISEASE; EXPRESSION; GENE; INTERLEUKIN-6	Our previous studies had shown that DAZAP2 was profoundly downregulated in bone marrow mononuclear cells from multiple myeloma patients. In this report, we analyzed epigenetic changes in multiple myeloma cell lines to understand the molecular mechanisms underlying the downregulation of DAZAP2. Four multiple myeloma cell lines, KM3, MM. 1S, OPM-2 and ARH-77, were studied. The results of methylation specific PCR (MSP) showed that the promoter of DAZAP2 was methylated for KM3, MM. 1S, OPM-2 and unmethylated for ARH-77. The DAZAP2 promoter region was amplified to obtain a series of different length sequences. All of the amplified sequences were inserted to luciferase reporter vector. The constructs were transfected into COS-7 cells and the luciferase activities were measured to search for the core region of DAZAP2 promoter. Two CpG islands were found in DAZAP2 promoter region. The results of luciferase assay showed that CpG island 1 displayed weak transcriptional activity, whereas CpG island 2 exhibited strong transcriptional activity (273 folds) compared to the control. The sequence that covered both CpG islands 1 and 2 showed higher activity (1,734 folds) compared to the control, suggesting that the two islands had synergistic effect on regulating DAZAP2 expression. We also found that M. Sss I methylase could inhibit the luciferase activity, whereas demethylation using 5-aza-29-deoxycytidine treatment rescued the expression of DAZAP2 for multiple myeloma cell lines. These data revealed that methylation of DAZAP2 promoter was involved in downregulation of DAZAP2 in multiple myeloma cells.	[Luo, Sai-Qun; Hu, Jing-Ping; Qu, Qiang; Li, Jiang; Ren, Wei; Zhang, Jia-Ming; Zhong, Yan; Hu, Wei-Xin] Cent S Univ, Xiangya Sch Med, Mol Biol Res Ctr, Changsha, Hunan, Peoples R China	Central South University	Hu, WX (corresponding author), Cent S Univ, Xiangya Sch Med, Mol Biol Res Ctr, Changsha, Hunan, Peoples R China.	weixinhu@yahoo.com.cn	Zhang, Jiaming/GSD-8224-2022	Hu, Jingping/0000-0001-5548-1241	National Natural Science Foundation of China [81071947, 30770906, 30270750, 39880021]; Science Foundation from Ministry of Education of China [200805330049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation from Ministry of Education of China	This work was supported with grants from the National Natural Science Foundation of China (no. 81071947, 30770906, 30270750 and 39880021) and the Science Foundation from Ministry of Education of China (no. 200805330049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Kenneth C, 2002, Hematology Am Soc Hematol Educ Program, P214; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Choi SH, 2011, NUCLEIC ACIDS RES, V39, P104, DOI 10.1093/nar/gkq774; Choi SJ, 2001, J CLIN INVEST, V108, P1833, DOI 10.1172/JCI13116; Corn PG, 1999, CANCER RES, V59, P3352; Dejeux E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-68; Dewan MZ, 2004, CANCER SCI, V95, P564, DOI 10.1111/j.1349-7006.2004.tb02487.x; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Galm O, 2005, ANN HEMATOL, V84, P39, DOI 10.1007/s00277-005-0005-0; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; Kocemba KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030359; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kulkarni MS, 2002, LEUKEMIA, V16, P127, DOI 10.1038/sj.leu.2402328; Link PA, 2008, CANCER RES, V68, P9358, DOI 10.1158/0008-5472.CAN-08-1860; Liu H, 2004, BLOOD, V104, P2505, DOI 10.1182/blood-2004-02-0483; Lukas J, 2009, NUCLEIC ACIDS RES, V37, P3007, DOI 10.1093/nar/gkp179; Mateos MV, 2002, BRIT J HAEMATOL, V118, P1034, DOI 10.1046/j.1365-2141.2002.03749.x; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Pei JH, 2011, TUMOR BIOL, V32, P1133, DOI 10.1007/s13277-011-0215-0; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Rasmussen T, 2005, BLOOD, V105, P317, DOI 10.1182/blood-2004-03-0833; Roche DD, 2009, DEV BIOL, V333, P26, DOI 10.1016/j.ydbio.2009.06.019; Roman-Gomez J, 2009, J CLIN ONCOL, V27, P1316, DOI 10.1200/JCO.2008.19.3441; Schmelz K, 2005, INT J CANCER, V114, P683, DOI 10.1002/ijc.20797; Shaughnessy J, 2000, BLOOD, V96, P1505, DOI 10.1182/blood.V96.4.1505.h8001505_1505_1511; Shi YW, 2007, CHINESE MED J-PEKING, V120, P1659, DOI 10.1097/00029330-200710010-00003; Shi Yiwu, 2004, Genomics Proteomics & Bioinformatics, V2, P47; Siu LLP, 2003, BRIT J HAEMATOL, V122, P70, DOI 10.1046/j.1365-2141.2003.04396.x; Sossey-Alaoui K, 2002, GENOMICS, V80, P5, DOI 10.1006/geno.2002.6792; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tsui SL, 2000, GENOMICS, V65, P266, DOI 10.1006/geno.2000.6169; Wang MC, 2006, CHINESE MED J-PEKING, V119, P1226, DOI 10.1097/00029330-200607020-00018; Wijermans PW, 2005, ANN HEMATOL, V84, P9, DOI 10.1007/s00277-005-0012-1; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	41	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40475	10.1371/journal.pone.0040475	http://dx.doi.org/10.1371/journal.pone.0040475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792345	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700055
J	Xu, Y; Wang, SH; Chao, HJ; Liu, SJ; Zhou, NY				Xu, Ying; Wang, Song-He; Chao, Hong-Jun; Liu, Shuang-Jiang; Zhou, Ning-Yi			Biochemical and Molecular Characterization of the Gentisate Transporter GenK in Corynebacterium glutamicum	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; PSEUDOMONAS-ALCALIGENES NCIMB-9867; SP STRAIN U2; LACTOSE PERMEASE; NAG GENES; DEGRADATION; PATHWAY; PROTEIN; PUTIDA; PCAK	Background: Gentisate (2,5-dihydroxybenzoate) is a key ring-cleavage substrate involved in various aromatic compounds degradation. Corynebacterium glutamicum ATCC13032 is capable of growing on gentisate and genK was proposed to encode a transporter involved in this utilization by its disruption in the restriction-deficient mutant RES167. Its biochemical characterization by uptake assay using [C-14]-labeled gentisate has not been previously reported. Methodology/Principal Findings: In this study, biochemical characterization of GenK by uptake assays with [C-14]-labeled substrates demonstrated that it specifically transported gentisate into the cells with V-max and K-m of 3.06 +/- 0.16 nmol/min/mg of dry weight and 10.71 +/- 0.11 mu M respectively, and no activity was detected for either benzoate or 3-hydoxybenzoate. When GenK was absent in strain RES167 Delta genK, it retained 85% of its original transport activity at pH 6.5 compared to that of strain RES167. However, it lost 79% and 88% activity at pH 7.5 and 8.0, respectively. A number of competing substrates, including 3-hydroxybenzoate, benzoate, protocatechuate and catechol, significantly inhibited gentisate uptake by more than 40%. Through site-directed mutagenesis, eight amino acid residues of GenK, Asp-54, Asp-57 and Arg-386 in the hydrophobic transmembrane regions and Arg-103, Trp-309, Asp-312, Arg-313 and Ile-317 in the hydrophilic cytoplasmic loops were shown to be important for gentisate transport. When conserved residues Asp-54 and Asp-57 respectively were changed to glutamate, both mutants retained approximately 50% activity and were able to partially complement the ability of strain RES167 Delta genK to grow on gentisate. Conclusions/Significance: Our results demonstrate that GenK is an active gentisate transporter in Corynebacterium glutamicum ATCC13032. The GenK-mediated gentisate transport was also shown to be a limiting step for the gentisate utilization by this strain. This enhances our understanding of gentisate transport in the microbial degradation of aromatic compounds.	[Xu, Ying; Wang, Song-He; Chao, Hong-Jun; Zhou, Ning-Yi] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China; [Liu, Shuang-Jiang] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Xu, Y (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China.	n.zhou@pentium.whiov.ac.cn	Chao, Hongjun/O-6252-2014; Liu, Shuang-Jiang/E-5756-2013; Chao, Hong-Jun/GPT-1718-2022	Chao, Hongjun/0000-0002-2481-8056; 	National Natural Science Foundation of China [30730002, 30900014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30730002 and 30900014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; Collier LS, 1997, J BACTERIOL, V179, P5943, DOI 10.1128/jb.179.18.5943-5946.1997; Ditty JL, 2002, J BACTERIOL, V184, P1444, DOI 10.1128/JB.184.5.1444-1448.2002; Ditty JL, 1999, J BACTERIOL, V181, P5068, DOI 10.1128/JB.181.16.5068-5074.1999; Gao XL, 2005, J BACTERIOL, V187, P7696, DOI 10.1128/JB.187.22.7696-7702.2005; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Jakoby M, 1999, BIOTECHNOL TECH, V13, P437, DOI 10.1023/A:1008968419217; Jeon CO, 2006, APPL ENVIRON MICROB, V72, P1086, DOI 10.1128/AEM.72.2.1086-1095.2006; JessenMarshall AE, 1997, J BACTERIOL, V179, P2616, DOI 10.1128/jb.179.8.2616-2622.1997; KASHKET ER, 1985, ANNU REV MICROBIOL, V39, P219, DOI 10.1146/annurev.mi.39.100185.001251; KONOPKA A, 1993, FEMS MICROBIOL LETT, V111, P93, DOI 10.1111/j.1574-6968.1993.tb06367.x; LACK L, 1959, BIOCHIM BIOPHYS ACTA, V34, P117, DOI 10.1016/0006-3002(59)90239-2; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Leveau JHJ, 1998, J BACTERIOL, V180, P2237, DOI 10.1128/JB.180.8.2237-2243.1998; Liu TT, 2011, APPL MICROBIOL BIOT, V90, P671, DOI 10.1007/s00253-010-3033-1; Nichols NN, 1997, J BACTERIOL, V179, P5056, DOI 10.1128/jb.179.16.5056-5061.1997; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Tauch A, 2002, CURR MICROBIOL, V45, P362, DOI 10.1007/s00284-002-3728-3; Wang SH, 2011, INT BIODETER BIODEGR, V65, P527, DOI 10.1016/j.ibiod.2011.02.004; Xu Y, 2006, BIOCHEM BIOPH RES CO, V346, P555, DOI 10.1016/j.bbrc.2006.05.143; Yeo CC, 2003, GENE, V312, P239, DOI 10.1016/S0378-1119(03)00619-X; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Youn JW, 2009, J BACTERIOL, V191, P5480, DOI 10.1128/JB.00640-09; Zhou NY, 2002, J BACTERIOL, V184, P1547, DOI 10.1128/JB.184.6.1547-1555.2002; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	31	76	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38701	10.1371/journal.pone.0038701	http://dx.doi.org/10.1371/journal.pone.0038701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808015	gold, Green Published, Green Submitted			2022-12-27	WOS:000306354700004
J	Adilakshmi, T; Sudol, I; Tapinos, N				Adilakshmi, Tadepalli; Sudol, Ida; Tapinos, Nikos			Combinatorial Action of miRNAs Regulates Transcriptional and Post-Transcriptional Gene Silencing following in vivo PNS Injury	PLOS ONE			English	Article							SCHWANN-CELLS; RNA CLEAVAGE; NERVE INJURY; MICRORNAS; MYELINATION; IDENTIFICATION; BIOGENESIS; ARGONAUTE2; SIGNALS; TARGETS	Injury response in the peripheral nervous system (PNS) is characterized by rapid alterations in the genetic program of Schwann cells. However, the epigenetic mechanisms modulating these changes remain elusive. Here we show that sciatic nerve injury in mice induces a cohort of 22 miRNAs, which coordinate Schwann cell differentiation and dedifferentiation through a combinatorial modulation of their positive and negative gene regulators. These miRNAs and their targeted mRNAs form functional complexes with the Argonaute-2 protein to mediate post-transcriptional gene silencing. MiR-138 and miR-709 show the highest affinity amongst the cohort, for binding and regulation of Egr2, Sox-2 and c-Jun expression following injury. Moreover, miR-709 participates in the formation of epigenetic silencing complexes with H3K27me3 and Argonaute-1 to induce transcriptional gene silencing of the Egr2 promoter. Collectively, we identified a discrete cohort of miRNAs as the central epigenetic regulators of the transition between differentiation and dedifferentiation during the acute phase of PNS injury.	[Adilakshmi, Tadepalli; Sudol, Ida; Tapinos, Nikos] Geisinger Med Clin, Weis Ctr Res, Mol Neurosci Lab, Danville, PA 17822 USA	Geisinger Medical Center	Adilakshmi, T (corresponding author), Geisinger Med Clin, Weis Ctr Res, Mol Neurosci Lab, 100 N Acad Ave, Danville, PA 17822 USA.	ntapinos1@geisinger.edu			Geisinger Clinic	Geisinger Clinic	The study was supported by internal funds from Geisinger Clinic to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Castanotto D, 2005, MOL THER, V12, P179, DOI 10.1016/j.ymthe.2005.03.003; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Ghislain J, 2002, DEVELOPMENT, V129, P155; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hannon GJ, 2006, COLD SPRING HARB SYM, V71, P551, DOI 10.1101/sqb.2006.71.064; Jang SW, 2010, J NEUROCHEM, V115, P1409, DOI 10.1111/j.1471-4159.2010.07045.x; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Muller HW, 1998, CURR OPIN NEUROL, V11, P557; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Radtke Christine, 2009, Eplasty, V9, pe47; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Yun B, 2010, J NEUROSCI, V30, P7722, DOI 10.1523/JNEUROSCI.0876-10.2010; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171	44	53	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39674	10.1371/journal.pone.0039674	http://dx.doi.org/10.1371/journal.pone.0039674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792185	Green Submitted, gold, Green Published			2022-12-27	WOS:000306461800016
J	Hall, ZJ; MacDougall-Shackleton, SA				Hall, Zachary J.; MacDougall-Shackleton, Scott A.			Influence of Testosterone Metabolites on Song-Control System Neuroplasticity during Photostimulation in Adult European Starlings (Sturnus vulgaris)	PLOS ONE			English	Article							HIGH VOCAL CENTER; CONTROL NUCLEI VOLUMES; SEASONAL-LIKE GROWTH; NEURONAL RECRUITMENT; ZEBRA FINCHES; ESTROGEN-RECEPTOR; CONTROL-CIRCUITS; FEMALE CANARIES; AVIAN BRAIN; ANDROGEN	The song-control system is a network of discrete nuclei in the songbird brain that controls the production and learning of birdsong and exhibits some of the best-studied neuroplasticity found in the adult brain. Photoperiodic growth of the song-control system during the breeding season is driven, at least in part, by the gonadal steroid testosterone. When acting on neural tissue, however, testosterone can be metabolized into 5 alpha-dihydrotestosterone (DHT) or 17 beta-estradiol (E2), which activate different hormonal signaling pathways. By treating adult starlings with both testosterone metabolites and metabolite antagonists, we attempted to isolate the effects of androgen and estrogen treatment on neuroplasticity during photostimulation in male and female European starlings (Sturnus vulgaris). Photostimulation resulted in a large HVC volume typical of the breeding season in all treatments independent of hormone treatment. E2 had additional effects on HVC growth by reducing neuron density and enhancing early survival of new neurons recruited to HVC in females but did not significantly affect HVC volume. Conversely, DHT reduced the migration of new neurons, assessed by the expression of doublecortin, to HVC. DHT also increased syrinx mass and maintained RA (robust nucleus of the arcopallium) cytoarchitecture in the presence of aromatase inhibitors. In addition, we document the first evidence of sex-specific neuroplastic responses of the song-control system to androgens and estrogens. These findings suggest that the contributions of DHT and E2 signaling in songbird neuroplasticity may be regulated by photoperiod and that future studies should account for species and sex differences in the brain.	[Hall, Zachary J.] Univ Western Ontario, Dept Biol, Adv Facil Avian Res, London, ON, Canada; [MacDougall-Shackleton, Scott A.] Univ Western Ontario, Dept Psychol, Adv Facil Avian Res, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Hall, ZJ (corresponding author), Univ St Andrews, St Marys Coll, Sch Psychol, St Andrews, Fife, Scotland.	zjh2@st-andrews.ac.uk	MacDougall-Shackleton, Scott A/C-6622-2008	MacDougall-Shackleton, Scott A/0000-0001-8518-765X	Natural Sciences and Engineering Research Council of Canada [217831]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by a grant from the Natural Sciences and Engineering Research Council of Canada (Grant # 217831; http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil P, 2003, BEHAV BRAIN RES, V143, P15, DOI 10.1016/S0166-4328(03)00006-8; Ball GF, 2004, ANN NY ACAD SCI, V1016, P586, DOI 10.1196/annals.1298.043; Ball GF, 1999, BRAIN BEHAV EVOLUT, V54, P28, DOI 10.1159/000006609; Balthazart J, 2008, EUR J NEUROSCI, V27, P801, DOI 10.1111/j.1460-9568.2008.06059.x; Bentley GE, 2003, GEN COMP ENDOCR, V134, P187, DOI 10.1016/S0016-6480(03)00261-2; Bernard DJ, 1997, GEN COMP ENDOCR, V105, P276, DOI 10.1006/gcen.1996.6829; Bernard DJ, 1997, BRAIN RES, V760, P163, DOI 10.1016/S0006-8993(97)00277-1; BERNARD DJ, 1995, J COMP NEUROL, V360, P726, DOI 10.1002/cne.903600415; Boseret G, 2007, J CHEM NEUROANAT, V33, P140, DOI 10.1016/j.jchemneu.2007.02.002; Brenowitz EA, 2002, P NATL ACAD SCI USA, V99, P12421, DOI 10.1073/pnas.192308799; Brenowitz EA, 2001, J NEUROSCI, V21, P2320, DOI 10.1523/JNEUROSCI.21-07-02320.2001; Chen TT, 2010, POULTRY SCI, V89, P558, DOI 10.3382/ps.2009-00429; DAWSON A, 1983, J ENDOCRINOL, V97, P253, DOI 10.1677/joe.0.0970253; DEVOOGD T, 1981, SCIENCE, V214, P202, DOI 10.1126/science.7280692; Fair J., 2010, ORNITHOLOGICAL COUNC; Fusani L, 2007, HORM BEHAV, V51, P62, DOI 10.1016/j.yhbeh.2006.08.005; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Grisham W, 2007, NEUROSCI LETT, V418, P92, DOI 10.1016/j.neulet.2007.03.002; Gulledge CC, 1997, J NEUROBIOL, V32, P391, DOI 10.1002/(SICI)1097-4695(199704)32:4<391::AID-NEU3>3.0.CO;2-1; Hall ZJ, 2010, BRAIN BEHAV EVOLUT, V76, P168, DOI 10.1159/000320971; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; Kafitz KW, 1999, GLIA, V27, P88; KIRN J, 1994, P NATL ACAD SCI USA, V91, P7844, DOI 10.1073/pnas.91.17.7844; KIRN JR, 1989, J NEUROSCI, V9, P3176; Kirn JR, 1999, J COMP NEUROL, V411, P487; London SE, 2009, FRONT NEUROENDOCRIN, V30, P302, DOI 10.1016/j.yfrne.2009.05.001; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; MacDougall-Shackleton SA, 2003, NEUROSCI LETT, V340, P165, DOI 10.1016/S0304-3940(03)00109-5; MacDougall-Shackleton SA, 2001, BRAIN BEHAV EVOLUT, V58, P38, DOI 10.1159/000047260; Meitzen J, 2007, J COMP PHYSIOL A, V193, P677, DOI 10.1007/s00359-007-0222-1; Metzdorf R, 1999, J COMP NEUROL, V407, P115; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; Newman AEM, 2009, EUR J NEUROSCI, V29, P1905, DOI 10.1111/j.1460-9568.2009.06748.x; NORDEEN EJ, 1988, J NEUROSCI, V8, P2869; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Pavlova DZ, 2007, BEHAVIOUR, V144, P663, DOI 10.1163/156853907781347835; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; RASIKA S, 1994, P NATL ACAD SCI USA, V91, P7854, DOI 10.1073/pnas.91.17.7854; Riebel K, 2003, ADV STUD BEHAV, V33, P49, DOI 10.1016/S0065-3454(03)33002-5; Riters LV, 2001, J NEUROENDOCRINOL, V13, P985, DOI 10.1046/j.1365-2826.2001.00723.x; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SCHLINGER BA, 1992, P NATL ACAD SCI USA, V89, P7650, DOI 10.1073/pnas.89.16.7650; Schlinger BA, 1997, J NEUROBIOL, V33, P619, DOI 10.1002/(SICI)1097-4695(19971105)33:5<619::AID-NEU9>3.0.CO;2-7; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Smith GT, 1997, J NEUROSCI, V17, P6001; Soma KK, 1999, GEN COMP ENDOCR, V115, P442, DOI 10.1006/gcen.1999.7334; Soma KK, 2004, J NEUROBIOL, V58, P413, DOI 10.1002/neu.10288; Stevenson TJ, 2008, GEN COMP ENDOCR, V156, P385, DOI 10.1016/j.ygcen.2008.01.015; Thompson CK, 2005, J COMP NEUROL, V481, P276, DOI 10.1002/cne.20381; Tramontin AD, 2003, J NEUROBIOL, V57, P130, DOI 10.1002/neu.10263; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Tramontin AD, 1998, J COMP NEUROL, V396, P186, DOI 10.1002/(SICI)1096-9861(19980629)396:2<186::AID-CNE4>3.0.CO;2-X; Vellema M, 2010, J COMP NEUROL, V518, P1442, DOI 10.1002/cne.22281; Wade J, 2000, J COMP NEUROL, V426, P154; Yamamura T, 2011, J NEUROSCI, V31, P9649, DOI 10.1523/JNEUROSCI.0088-11.2011	56	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40060	10.1371/journal.pone.0040060	http://dx.doi.org/10.1371/journal.pone.0040060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792214	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800036
J	Hammers, M; Richardson, DS; Burke, T; Komdeur, J				Hammers, Martijn; Richardson, David S.; Burke, Terry; Komdeur, Jan			Age-Dependent Terminal Declines in Reproductive Output in a Wild Bird	PLOS ONE			English	Article							SEYCHELLES WARBLER; TERRITORY QUALITY; SENESCENCE; PERFORMANCE; EVOLUTION; RATES; POPULATION; RESTRAINT; PATTERNS; SURVIVAL	In many iteroparous species individual fitness components, such as reproductive output, first increase with age and then decline during late-life. However, individuals differ greatly in reproductive lifespan, but reproductive declines may only occur in the period just before their death as a result of an age-independent decline in physiological condition. To fully understand reproductive senescence it is important to investigate to what extent declines in late-life reproduction can be explained by age, time until death, or both. However, the study of late-life fitness performance in natural populations is challenging as the exact birth and death dates of individuals are often not known, and most individuals succumb to extrinsic mortality before reaching old age. Here, we used an exceptional long-term longitudinal dataset of individuals from a natural, closed, and predator-free population of the Seychelles warbler (Acrocephalus sechellensis) to investigate reproductive output, both in relation to age and to the time until the death of an individual (reverse-age approach). We observed an initial age-dependent increase in reproductive output that was followed by a decline in old age. However, we found no significant decline in reproductive output in the years directly preceding death. Although post-peak reproductive output declined with age, this pattern differed between terminal and non-terminal reproductive attempts, and the age-dependence of the terminal breeding attempt explained much of the variation in age-specific reproductive output. In fact, terminal declines in reproductive output were steeper in very old individuals. These results indicate that not only age-dependent, but also age-independent factors, such as physiological condition, need to be considered to understand reproductive senescence in wild-living animals.	[Hammers, Martijn; Komdeur, Jan] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Hammers, Martijn; Richardson, David S.] Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; [Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Richardson, David S.] Nat Seychelles, Victoria, Mahe, Seychelles	University of Groningen; University of East Anglia; University of Sheffield	Hammers, M (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	martijnhammers@gmail.com	Komdeur, Jan/X-1261-2019; Burke, Terry/B-3196-2011; Richardson, David S/A-5082-2010	Komdeur, Jan/0000-0002-9241-0124; Burke, Terry/0000-0003-3848-1244; Richardson, David S/0000-0001-7226-9074	UK Natural Environment Research Council; The Netherlands Organisation for Scientific Research; NERC [NE/F02083X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F02083X/1, NE/B504106/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by grants from the UK Natural Environment Research Council and The Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, IME4 LINEAR MIXED EF; Bouwhuis S, 2009, P ROY SOC B-BIOL SCI, V276, P2769, DOI 10.1098/rspb.2009.0457; Bouwhuis S, 2010, J ANIM ECOL, V79, P1251, DOI 10.1111/j.1365-2656.2010.01730.x; Brouwer L, 2006, J ANIM ECOL, V75, P1321, DOI 10.1111/j.1365-2656.2006.01155.x; Brouwer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033167; Brouwer L, 2010, MOL ECOL, V19, P3444, DOI 10.1111/j.1365-294X.2010.04750.x; Brouwer L, 2009, ECOLOGY, V90, P729, DOI 10.1890/07-1437.1; Catry P, 2006, P ROY SOC B-BIOL SCI, V273, P1625, DOI 10.1098/rspb.2006.3482; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Coulson JC, 2001, J AVIAN BIOL, V32, P146, DOI 10.1034/j.1600-048X.2001.320207.x; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Dugdale HL, 2011, MOL ECOL, V20, P3261, DOI 10.1111/j.1365-294X.2011.05167.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Komdeur J, 2005, J ORNITHOL, V146, P305, DOI 10.1007/s10336-005-0008-6; Komdeur J, 2005, BIOL CONSERV, V124, P15, DOI 10.1016/j.biocon.2004.12.009; Komdeur J, 2004, IBIS, V146, P298, DOI 10.1046/j.1474-919X.2004.00255.x; KOMDEUR J, 1994, BEHAV ECOL SOCIOBIOL, V34, P175, DOI 10.1007/BF00167742; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Komdeur J, 1996, BEHAV ECOL, V7, P417, DOI 10.1093/beheco/7.4.417; Komdeur J, 1996, J BIOL RHYTHM, V11, P333, DOI 10.1177/074873049601100407; KOMDEUR J, 1995, ANIM BEHAV, V49, P695; Komdeur J., 1991, TRENDS ECOLOGY EVOLU, V7, P330; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Martin JGA, 2011, ECOL LETT, V14, P576, DOI 10.1111/j.1461-0248.2011.01621.x; McCleery RH, 2008, P R SOC B, V275, P963, DOI 10.1098/rspb.2007.1418; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Newton I, 1989, LIFETIME REPROD SUCC; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rattiste K, 2004, P ROY SOC B-BIOL SCI, V271, P2059, DOI 10.1098/rspb.2004.2832; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Richardson DS, 2007, EVOLUTION, V61, P2790, DOI 10.1111/j.1558-5646.2007.00222.x; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Stearns S.C., 1992, pi; Torres R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027245; van de Crommenacker J, 2011, J ANIM ECOL, V80, P668, DOI 10.1111/j.1365-2656.2010.01792.x; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	52	45	45	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40413	10.1371/journal.pone.0040413	http://dx.doi.org/10.1371/journal.pone.0040413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792307	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000306461800078
J	Pearce, MS; Mann, KD; Martin-Ruiz, C; Parker, L; White, M; von Zglinicki, T; Adams, J				Pearce, Mark S.; Mann, Kay D.; Martin-Ruiz, Carmen; Parker, Louise; White, Martin; von Zglinicki, Thomas; Adams, Jean			Childhood Growth, IQ and Education as Predictors of White Blood Cell Telomere Length at Age 49-51 Years: The Newcastle Thousand Families Study	PLOS ONE			English	Article							BIRTH-WEIGHT; DYSFUNCTION; ATTAINMENT	Background: Telomere length is emerging as a potential factor in the pathogenesis of cardiovascular disease. We investigated whether birth weight, infant growth, childhood cognition and adult height, as well as a range of lifestyle, socioeconomic and educational factors, were associated with white blood cell telomere length at age 49-51 years. Methods: The study included 318 members of the Newcastle Thousand Families Study, a prospectively followed birth cohort which includes all individuals born in Newcastle, England in May and June 1947, who attended for clinical examination at age 49-51 years, and had telomere length successfully measured using real-time PCR analyses of DNA extracted from peripheral blood mononuclear cells. Results: No association was found between birth weight and later telomere length. However, associations were seen with other factors from early life. Education level was the only predictor in males, while telomere length in females was associated with gestational age at birth, childhood growth and childhood IQ. Conclusions: While these findings may be due to chance, in particular where differing associations were seen between males and females, they do provide evidence of early life associations with telomere length much later in life. Our findings of sex differences in the education association may reflect the sex differences in achieved education levels in this generation where few women went to university regardless of their intelligence. Our findings do not support the concept of telomere length being on the pathway between very early growth and later disease risk.	[Pearce, Mark S.; Mann, Kay D.; White, Martin; Adams, Jean] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Martin-Ruiz, Carmen; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Parker, Louise] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Parker, Louise] Dalhousie Univ, Dept Paediat, Halifax, NS, Canada	Newcastle University - UK; Newcastle University - UK; Dalhousie University; Dalhousie University	Pearce, MS (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mark.pearce@ncl.ac.uk	Mann, Kay/T-4406-2019; Adams, Jean/G-2402-2010	Mann, Kay/0000-0003-0115-5293; Adams, Jean/0000-0002-5733-7830; Pearce, Mark/0000-0002-0583-3779; PARKER, LOUISE/0000-0002-5188-8113; Martin-Ruiz, Carmen/0000-0002-3361-6974; White, Martin/0000-0002-1861-6757; von Zglinicki, Thomas/0000-0002-5939-0248	Faculty of Public Health Medicine/BUPA research fellowship; Research into Aging programme grant; Fuse - the Centre for Translational Research in Public Health; UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute of Health Research; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI	Faculty of Public Health Medicine/BUPA research fellowship; Research into Aging programme grant; Fuse - the Centre for Translational Research in Public Health; UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was partly supported by funding from the Faculty of Public Health Medicine/BUPA research fellowship (2001-4) awarded to JA and by a Research into Aging programme grant awarded to TvZ. JA is funded in full and MW in part by Fuse - the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding for Fuse is provided by the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and National Institute of Health Research. The views expressed in this paper do not necessarily represent those of the funders or UKCRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2007, AGING CELL, V6, P125, DOI 10.1111/j.1474-9726.2006.00258.x; Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Davy P, 2009, PLACENTA, V30, P539, DOI 10.1016/j.placenta.2009.03.005; Devore EE, 2011, NEUROSCI LETT, V492, P15, DOI 10.1016/j.neulet.2011.01.041; Forrest LF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-895; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Friedrich U, 2001, PEDIATR RES, V49, P252, DOI 10.1203/00006450-200102000-00020; Fuster JJ, 2007, J HYPERTENS, V25, P2185, DOI 10.1097/HJH.0b013e3282ef6196; Fyhrquist F, 2011, J Hum Hypertens, V25, P711, DOI 10.1038/jhh.2011.57; Harris SE, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.013; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Mann KD, 2011, J HYPERTENS, V29, P1077, DOI 10.1097/HJH.0b013e328346d76c; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Mayer S, 2006, CYTOGENET GENOME RES, V112, P194, DOI 10.1159/000089870; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pearce MS, 2009, INT J EPIDEMIOL, V38, P932, DOI 10.1093/ije/dyn184; Raqib R, 2007, AM J CLIN NUTR, V85, P845, DOI 10.1093/ajcn/85.3.845; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Surtees PG, 2012, BRAIN BEHAV IMMUN, V26, P414, DOI 10.1016/j.bbi.2011.11.009; Thomas P, 2008, MECH AGEING DEV, V129, P183, DOI 10.1016/j.mad.2007.12.004; Valdes AM, 2010, NEUROBIOL AGING, V31, P986, DOI 10.1016/j.neurobiolaging.2008.07.012; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Bonsdorff MB, 2011, AM J EPIDEMIOL, V174, P1336, DOI 10.1093/aje/kwr270; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; World Health Organisation, 1990, ORG MON TRENDS DET 3; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012	36	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40116	10.1371/journal.pone.0040116	http://dx.doi.org/10.1371/journal.pone.0040116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792222	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800040
J	Wernike, K; Breithaupt, A; Keller, M; Hoffmann, B; Beer, M; Eschbaumer, M				Wernike, Kerstin; Breithaupt, Angele; Keller, Markus; Hoffmann, Bernd; Beer, Martin; Eschbaumer, Michael			Schmallenberg Virus Infection of Adult Type I Interferon Receptor Knock-Out Mice	PLOS ONE			English	Article							PROTECTION; DEFICIENT; CATTLE; LETHAL; CELLS	Schmallenberg virus (SBV), a novel orthobunyavirus, was discovered in Europe in late 2011. It causes mild and transient disease in adult ruminants, but fetal infection can lead to abortion or severe malformations. There is considerable demand for SBV research, but in vivo studies in large animals are complicated by their long gestation periods and the cost of high containment housing. The goal of this study was to investigate whether type I interferon receptor knock-out (IFNAR(-/-)) mice are a suitable small animal model for SBV. Twenty IFNAR(-/-) mice were inoculated with SBV, four were kept as controls. After inoculation, all were observed and weighed daily; two mice per day were sacrificed and blood, brain, lungs, liver, spleen, and intestine were harvested. All but one inoculated mouse lost weight, and two mice died spontaneously at the end of the first week, while another two had to be euthanized. Real-time RT-PCR detected large amounts of SBV RNA in all dead or sick mice; the controls were healthy and PCR-negative. IFNAR(-/-) mice are susceptible to SBV infection and can develop fatal disease, making them a handy and versatile tool for SBV vaccine research.	[Wernike, Kerstin; Hoffmann, Bernd; Beer, Martin; Eschbaumer, Michael] FLI, Inst Diagnost Virol, Greifswald, Germany; [Breithaupt, Angele] FLI, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Keller, Markus] FLI, Inst Novel & Emerging Infect Dis, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Wernike, K (corresponding author), FLI, Inst Diagnost Virol, Greifswald, Germany.	kerstin.wernike@fli.bund.de	Breithaupt, Angele/GON-7227-2022; Breithaupt, Angele/B-6155-2013	Breithaupt, Angele/0000-0002-6373-5923; Eschbaumer, Michael/0000-0002-1104-0695				Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; Bilk S, 2012, VET MICROBI IN PRESS; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; Eschbaumer M, 2012, VET MICROBIOL, V155, P417, DOI 10.1016/j.vetmic.2011.08.019; Franceschi V, 2011, VACCINE, V29, P3074, DOI 10.1016/j.vaccine.2011.01.075; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; KUROGI H, 1976, ARCH VIROL, V51, P67, DOI 10.1007/BF01317835; Lorenzo G, 2010, VACCINE, V28, P2937, DOI 10.1016/j.vaccine.2010.02.018; Ma GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034425; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Oem JK, 2012, VET MICROBI IN PRESS; Operschall E, 1999, J CLIN VIROL, V13, P17, DOI 10.1016/S1386-6532(99)00008-6; Schuh T, 1999, HUM GENE THER, V10, P1649, DOI 10.1089/10430349950017653; WECHSLER SJ, 1991, J INVERTEBR PATHOL, V57, P200, DOI 10.1016/0022-2011(91)90117-9	16	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40380	10.1371/journal.pone.0040380	http://dx.doi.org/10.1371/journal.pone.0040380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792298	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800074
J	Winter, JM; Tang, LH; Klimstra, DS; Brennan, MF; Brody, JR; Rocha, FG; Jia, XY; Qin, LX; D'Angelica, MI; DeMatteo, RP; Fong, Y; Jarnagin, WR; O'Reilly, EM; Allen, PJ				Winter, Jordan M.; Tang, Laura H.; Klimstra, David S.; Brennan, Murray F.; Brody, Jonathan R.; Rocha, Flavio G.; Jia, Xiaoyu; Qin, Li-Xuan; D'Angelica, Michael I.; DeMatteo, Ronald P.; Fong, Yuman; Jarnagin, William R.; O'Reilly, Eileen M.; Allen, Peter J.			A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DUCTAL ADENOCARCINOMA; INTRAEPITHELIAL NEOPLASIA; TRANSLATIONAL RESEARCH; ADJUVANT CHEMOTHERAPY; SINGLE-INSTITUTION; CARCINOMA-CELLS; GROWTH-FACTOR; EXPRESSION; RESECTION	Background: One-fifth of patients with seemingly 'curable' pancreatic ductal adenocarcinoma (PDA) experience an early recurrence and death, receiving no definable benefit from a major operation. Some patients with advanced stage tumors are deemed 'unresectable' by conventional staging criteria (e.g. liver metastasis), yet progress slowly. Effective biomarkers that stratify PDA based on biologic behavior are needed. To help researchers sort through the maze of biomarker data, a compendium of similar to 2500 published candidate biomarkers in PDA was compiled (PLoS Med, 2009. 6(4) p. e1000046). Methods and Findings: Building on this compendium, we constructed a survival tissue microarray (termed s-TMA) comprised of short-term (cancer-specific death < 12 months, n = 58) and long-term survivors (> 30 months, n = 79) who underwent resection for PDA (total, n = 137). The s-TMA functions as a biological filter to identify bona fide prognostic markers associated with survival group extremes (at least 18 months separate survival groups). Based on a stringent selection process, 13 putative PDA biomarkers were identified from the public biomarker repository. Candidates were tested against the s-TMA by immunohistochemistry to identify the best markers of tumor biology. In a multivariate model, MUC1 (odds ratio, OR = 28.95, 3+ vs. negative expression, p = 0.004) and MSLN (OR = 12.47, 3+ vs. negative expression, p = 0.01) were highly predictive of early cancer-specific death. By comparison, pathologic factors (size, lymph node metastases, resection margin status, and grade) had ORs below three, and none reached statistical significance. ROC curves were used to compare the four pathologic prognostic features (ROC area = 0.70) to three univariate molecular predictors (MUC1, MSLN, MUC2) of survival group (ROC area = 0.80, p = 0.07). Conclusions: MUC1 and MSLN were superior to pathologic features and other putative biomarkers as predicting survival group. Molecular assays comparing cancers from short and long survivors are an effective strategy to screen biomarkers and prioritize candidate cancer genes for diagnostic and therapeutic studies.	[Winter, Jordan M.; Brody, Jonathan R.] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA; [Tang, Laura H.; Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Brennan, Murray F.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Fong, Yuman] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Rocha, Flavio G.; Jarnagin, William R.] Virginia Mason Med Ctr, Dept Surg, Seattle, WA 98101 USA; [Jia, Xiaoyu; Qin, Li-Xuan; Allen, Peter J.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [O'Reilly, Eileen M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Jefferson University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Virginia Mason Medical Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Winter, JM (corresponding author), Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA.	allenp@mskcc.org	Rocha, Flavio/AAV-3411-2020	O'Reilly, Eileen M./0000-0002-8076-9199; Brennan, Murray/0000-0003-2358-4371	Marshall and Therese Sonenshine Foundation;  [U01 CA152653]; NATIONAL CANCER INSTITUTE [U01CA152653] Funding Source: NIH RePORTER	Marshall and Therese Sonenshine Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funds for the study were derived from U01 CA152653, PI Allen. In addition, funds were provided by the Marshall and Therese Sonenshine Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2003, AM J SURG PATHOL, V27, P571, DOI 10.1097/00000478-200305000-00002; Argani P, 2001, CLIN CANCER RES, V7, P3862; Arnaoutakis GJ, 2011, J GASTROINTEST SURG, V15, P1611, DOI 10.1007/s11605-011-1605-8; Barton JG, 2009, J GASTROINTEST SURG, V13, P2050, DOI 10.1007/s11605-009-0849-z; Ben QW, 2010, ANN SURG ONCOL, V17, P2213, DOI 10.1245/s10434-010-0955-x; Berger AC, 2008, J CLIN ONCOL, V26, P5918, DOI 10.1200/JCO.2008.18.6288; Boeck S, 2007, ONCOLOGY-BASEL, V72, P314, DOI 10.1159/000113054; Brennan MF, 2004, ANN SURG, V240, P293, DOI 10.1097/01.sla.0000133125.85489.07; Cantile M, 2009, INT J CANCER, V125, P1532, DOI 10.1002/ijc.24438; Cao DF, 2007, MODERN PATHOL, V20, P570, DOI 10.1038/modpathol.3800772; Cardillo TM, 2001, CLIN CANCER RES, V7, P3186; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen L, 1996, J CLIN INVEST, V98, P2539, DOI 10.1172/JCI119072; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chung GG, 2006, CANCER, V106, P1677, DOI 10.1002/cncr.21783; Coppola D, 2011, PANCREAS, V40, P433, DOI 10.1097/MPA.0b013e318205eb03; Einama T, 2011, PANCREAS, V40, P1276, DOI 10.1097/MPA.0b013e318221bed8; Feng Y, 2009, MOL CANCER THER, V8, P1113, DOI 10.1158/1535-7163.MCT-08-0945; Garcea G, 2008, J PANCREAS, V9, P99; Gray PJ, 2004, MOL CANCER THER, V3, P641; Gray RG, 2011, J CLIN ONCOL, V29, P4611, DOI 10.1200/JCO.2010.32.8732; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; Hinoda Y, 2003, J GASTROENTEROL, V38, P1162, DOI 10.1007/s00535-003-1224-6; Hollevoet K, 2012, J CLIN ONCOL, V30, P1541, DOI 10.1200/JCO.2011.39.6671; Huang JJ, 2000, ANN SURG, V231, P890, DOI 10.1097/00000658-200006000-00014; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Jain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023344; Jhala N, 2006, AM J CLIN PATHOL, V126, P572, DOI 10.1309/CEV30BE088CBDQD9; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; Karamitopoulou E, 2010, PATHOLOGY, V42, P229, DOI 10.3109/00313021003631379; Kondo N, 2010, ANN SURG ONCOL, V17, P2321, DOI 10.1245/s10434-010-1033-0; Kurihara T, 2000, J CLIN INVEST, V106, P763, DOI 10.1172/JCI9180; Leao IC, 2008, CTS-CLIN TRANSL SCI, V1, P228, DOI 10.1111/j.1752-8062.2008.00070.x; Levi E, 2004, J CLIN PATHOL, V57, P456, DOI 10.1136/jcp.2003.013292; Lisovsky M, 2010, HUM PATHOL, V41, P902, DOI 10.1016/j.humpath.2009.12.004; Marsh WL, 2009, APPL IMMUNOHISTO M M, V17, P216, DOI 10.1097/PAI.0b013e31818c1aa6; Matros E, 2006, CANCER-AM CANCER SOC, V106, P693, DOI 10.1002/cncr.21609; Morse DL, 2010, BIOCHEM PHARMACOL, V80, P748, DOI 10.1016/j.bcp.2010.05.018; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pham NA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-43; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Sharon E, 2011, CLIN CHEM LAB MED; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shi CJ, 2012, HUM PATHOL, V43, P1, DOI 10.1016/j.humpath.2011.04.003; Showalter SL, 2008, CANCER BIOL THER, V7, P1584, DOI 10.4161/cbt.7.10.6562; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Takikita M, 2009, CANCER RES, V69, P2950, DOI 10.1158/0008-5472.CAN-08-3879; Tanaka M, 2011, J HISTOCHEM CYTOCHEM, V59, P942, DOI 10.1369/0022155411420569; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Tsuruta Y, 2008, CLIN CANCER RES, V14, P3582, DOI 10.1158/1078-0432.CCR-07-5053; Wegener W, 2008, SAFETY EFFICACY STUD; Wen J, 2010, PANCREAS, V39, P622, DOI 10.1097/MPA.0b013e3181c75f5e; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Winter JM, 2006, CANCER BIOL THER, V5, P360, DOI 10.4161/cbt.5.4.2552; Winter JM, 2012, ANN SURG ONCOL, V19, P169, DOI 10.1245/s10434-011-1900-3; Yang Wen-bin, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2135; Yang Wen-bin, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1908; Yu Guan-Zhen, 2005, Ai Zheng, V24, P1398; Yu GZ, 2004, PANCREAS, V28, P421, DOI 10.1097/00006676-200405000-00011	67	30	37	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40157	10.1371/journal.pone.0040157	http://dx.doi.org/10.1371/journal.pone.0040157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792233	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800044
J	Wolf, J; Armstrong, B				Wolf, Jennyfer; Armstrong, Ben			The Association of Season and Temperature with Adverse Pregnancy Outcome in Two German States, a Time-Series Analysis	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; LOW-BIRTH-WEIGHT; DISSIPATION LIMIT THEORY; HEAT-SHOCK RESPONSE; OF-THE-LITERATURE; PRETERM BIRTH; GESTATION LENGTH; RESIDENTIAL-MOBILITY; OUTDOOR TEMPERATURE; INFECTIOUS-DISEASES	Background: A seasonality of low birth weight (LBW) and preterm birth (PTB) has been described for most regions and there is evidence that this pattern is caused by ambient outdoor temperature. However, the association as such, the direction of effect and the critical time of exposure remain controversial. Methods: Logistic, time-series regression was performed on nearly 300,000 births from two German states to study the association between season and daily mean temperature and changes in daily proportions of term LBW (tLBW) or PTB. Analyses were adjusted for time-varying factors. Temperature exposures were examined during different periods of pregnancy. Results: Weak evidence for an association between season of conception, season of birth or ambient outdoor temperature and tLBW or PTB was found. Results of analyses of temperature were not consistent between the two states. Different sources of bias which would have artificially led to stronger findings were detected and are described. Conclusions: No clear evidence for an association between season of conception, season of birth or temperature and tLBW or PTB was found. In the study of pregnancy outcome different sources of bias can be identified which can potentially explain heterogeneous findings of the past.	[Wolf, Jennyfer; Armstrong, Ben] London Sch Hyg & Trop Med, Dept Social & Environm Hlth, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Wolf, J (corresponding author), WHO, Dept Publ Hlth & Environm, CH-1211 Geneva, Switzerland.	jennyfer.wolf@googlemail.com		armstrong, benedict/0000-0003-4407-0409	German Academic Exchange Office (DAAD)	German Academic Exchange Office (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Jennyfer Wolf received a scholarship of the German Academic Exchange Office (DAAD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Andrews WW, 1995, INFECT AGENT DIS, V4, P196; ANIELLO C, 1995, COMPUT GEOSCI-UK, V21, P965, DOI 10.1016/0098-3004(95)00033-5; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; BANTJE H, 1987, SOC SCI MED, V24, P733, DOI 10.1016/0277-9536(87)90110-9; Basu R, 2010, AM J EPIDEMIOL, V172, P1108, DOI 10.1093/aje/kwq170; Bodnar LM, 2008, PAEDIATR PERINAT EP, V22, P538, DOI 10.1111/j.1365-3016.2008.00971.x; Carson C, 2006, AM J EPIDEMIOL, V164, P77, DOI 10.1093/aje/kwj147; Chodick G, 2007, ANN EPIDEMIOL, V17, P440, DOI 10.1016/j.annepidem.2006.10.013; Chodick G, 2009, HUM BIOL, V81, P463, DOI 10.3378/027.081.0405; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; COOPERSTOCK M, 1986, AM J EPIDEMIOL, V124, P234, DOI 10.1093/oxfordjournals.aje.a114381; Dadvand P, 2011, ENVIRON HEALTH PERSP, V119, P1449, DOI 10.1289/ehp.1003241; Darrow LA, 2009, EPIDEMIOLOGY, V20, P699, DOI 10.1097/EDE.0b013e3181a66e96; Darrow LA, 2009, EPIDEMIOLOGY, V20, P689, DOI 10.1097/EDE.0b013e3181a7128f; Deschenes O, 2009, AM ECON REV, V99, P211, DOI 10.1257/aer.99.2.211; Duncan TC, 2009, STAT METHODS ENV EPI, P158; Edwards MJ, 1998, CELL STRESS CHAPERON, V3, P213, DOI 10.1379/1466-1268(1998)003<0213:ATHSRH>2.3.CO;2; Edwards MJ, 1997, INT J DEV BIOL, V41, P345; Elter K, 2004, AUST NZ J OBSTET GYN, V44, P553, DOI 10.1111/j.1479-828X.2004.00314.x; Fellman J, 2000, HUM BIOL, V72, P851; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Flouris AD, 2009, AM J HUM BIOL, V21, P214, DOI 10.1002/ajhb.20818; Gouveia N, 2003, INT J EPIDEMIOL, V32, P390, DOI 10.1093/ije/dyg077; HOLMES JHG, 1986, TROP ANIM HEALTH PRO, V18, P185, DOI 10.1007/BF02359533; HOWELL CE, 1951, J ANIM SCI, V10, P789, DOI 10.2527/jas1951.104789x; KELLER CA, 1983, AM J EPIDEMIOL, V118, P689, DOI 10.1093/oxfordjournals.aje.a113679; KHOURY MJ, 1988, J CLIN EPIDEMIOL, V41, P15, DOI 10.1016/0895-4356(88)90004-2; Laaidi M, 2011, ENVIRON RISQUE SANTE, V10, P128, DOI 10.1684/ers.2011.0432; Lackland D T, 2003, J Clin Hypertens (Greenwich), V5, P133, DOI 10.1111/j.1524-6175.2003.01353.x; Lajinian S, 1997, AM J PUBLIC HEALTH, V87, P1205, DOI 10.2105/AJPH.87.7.1205; Lawlor DA, 2005, BJOG-INT J OBSTET GY, V112, P647, DOI 10.1111/j.1471-0528.2004.00488.x; Lee MC, 1998, FAM PRACT, V15, P336, DOI 10.1093/fampra/15.4.336; Lee SJ, 2006, BJOG-INT J OBSTET GY, V113, P1280, DOI 10.1111/j.1471-0528.2006.01055.x; Lee SJ, 2005, THESIS LONDON SCH HY; Lee SJ, 2008, ENVIRON RES, V106, P185, DOI 10.1016/j.envres.2007.10.003; Lisonkova S, 2010, J OBSTET GYNAECOL CA, V32, P541, DOI 10.1016/S1701-2163(16)34522-4; Madsen C, 2010, ENVIRON RES, V110, P363, DOI 10.1016/j.envres.2010.02.005; Magnus P, 2001, BRIT J OBSTET GYNAEC, V108, P1116, DOI 10.1111/j.1471-0528.2003.00273.x; MANGOLD WD, 1981, AM J PUBLIC HEALTH, V71, P601, DOI 10.2105/AJPH.71.6.601; MATSUDA S, 1993, HUM BIOL, V65, P481; MATSUDA S, 1995, HUM BIOL, V67, P641; MATSUDA S, 1992, INT J EPIDEMIOL, V21, P91, DOI 10.1093/ije/21.1.91; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McGrath JJ, 2005, ANN HUM BIOL, V32, P547, DOI 10.1080/03014460500154699; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; Murray LJ, 2000, OBSTET GYNECOL, V96, P689, DOI 10.1016/S0029-7844(00)01022-X; Porter KR, 1999, AM J PUBLIC HEALTH, V89, P1090, DOI 10.2105/AJPH.89.7.1090; Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134; RIOPELLE AJ, 1975, AM J CLIN NUTR, V28, P1170, DOI 10.1093/ajcn/28.10.1170; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Rousham EK, 1998, AUST NZ J PUBL HEAL, V22, P669, DOI 10.1111/j.1467-842X.1998.tb01467.x; Ruff CB, 1994, AM J PHYS ANTHROPOL, V37, P65, DOI DOI 10.1002/AJPA.1330370605; Scott IC, 2008, ANIM REPROD SCI, V109, P206, DOI 10.1016/j.anireprosci.2007.11.025; SELVIN S, 1971, BRIT J PREV SOC MED, V25, P12; Simons MJP, 2011, J EXP BIOL, V214, P38, DOI 10.1242/jeb.044230; Speakman JR, 2010, INTEGR COMP BIOL, V50, P793, DOI 10.1093/icb/icq049; Sram RJ, 2005, ENVIRON HEALTH PERSP, V113, P375, DOI 10.1289/ehp.6362; Strand LB, 2011, ENVIRON RES, V111, P451, DOI 10.1016/j.envres.2011.01.023; Strand LB, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-49; Tam WH, 2008, GYNECOL OBSTET INVES, V66, P22, DOI 10.1159/000114252; Thornton J G, 2001, Eur J Obstet Gynecol Reprod Biol, V95, P5, DOI 10.1016/S0301-2115(00)00381-X; Tustin K, 2004, DEV PSYCHOBIOL, V45, P221, DOI 10.1002/dev.20030; US EPA, 2006, HLTH CLIM CHANG HLTH; Wells JCK, 2002, AM J PHYS ANTHROPOL, V119, P276, DOI 10.1002/ajpa.10137; Wells JCK, 2002, J THEOR BIOL, V214, P413, DOI 10.1006/jtbi.2001.2465; Wier ML, 2007, PAEDIATR PERINAT EP, V21, P4, DOI 10.1111/j.1365-3016.2007.00856.x; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Wohlfahrt J, 1998, LANCET, V352, P1990, DOI 10.1016/S0140-6736(05)61336-0; World Health Organization, TOP 10 CAUS DEATH; Yackerson NS, 2007, CLIN EXP OBSTET GYN, V34, P27; Yamauchi F, 2010, EMPIRICAL STUDY GROW; YEATES N. T. M., 1956, AUSTRALIAN JOUR AGRIC RES, V7, P435, DOI 10.1071/AR9560435	73	47	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40228	10.1371/journal.pone.0040228	http://dx.doi.org/10.1371/journal.pone.0040228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792247	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000306461800052
J	Smith, LJ; Stapleton, MR; Buxton, RS; Green, J				Smith, Laura J.; Stapleton, Melanie R.; Buxton, Roger S.; Green, Jeffrey			Structure-Function Relationships of the Mycobacterium tuberculosis Transcription Factor WhiB1	PLOS ONE			English	Article							NITRIC-OXIDE; 4FE-4S CLUSTER; PROTEIN	Background: Members of the WhiB-like (Wbl) protein family possess iron-sulfur clusters and are implicated in the regulation of developmental processes in Actinomycetes. Mycobacterium tuberculosis possesses seven Wbl proteins. The [4Fe-4S] cluster of M. tuberculosis WhiB1 is relatively insensitive to O-2 but very sensitive to nitric oxide (NO). Nitric oxide nitrosylates the WhiB1 iron-sulfur cluster and promotes DNA-binding; the apo-forms of WhiB1 also bind DNA. However, the molecular requirements for iron-sulfur cluster acquisition and for DNA-binding by WhiB1 are poorly characterized. Methods and Findings: WhiB1 variants were created by site-directed mutagenesis and the abilities of the corresponding proteins to acquire an iron-sulfur cluster and/or bind to whiB1 promoter DNA were assessed. All four Cys residues (Cys9, 37, 40, and 46) in the N-terminal region of WhiB1 were required for incorporation of a [4Fe-4S] cluster, whereas a possible alternative cluster ligand Asp13 (by analogy with M. smegmatis WhiB2) was not. The C-terminal region of WhiB1 is predicted to house the DNA-binding domain of the protein consisting of a predicted beta-turn ((58)GVWGG(62)) followed by two amino acid motifs ((KRRN75)-K-72 and (78)TKAR(81)) that are conserved in WhiB1 proteins. Gly residues (Gly58, 61 and 62) in the b-turn and positively-charged residues (Lys72, Arg73, Arg74, Lys79 and Arg81) in the downstream conserved regions were required for binding of WhiB1 DNA. Conclusions: Site-directed mutagenesis of M. tuberculosis whiB1 and characterization of the corresponding proteins has been used to explore structure-function relationships of the NO-responsive transcription factor WhiB1. This showed that all four conserved Cys residues in the N-terminal region are required for incorporation of iron-sulfur clusters but not for DNA-binding. Analysis of variants with amino acid substitutions in the C-terminal region revealed the crucial roles played by a predicted b-turn and two conserved positively-charged motifs in facilitating DNA-binding, but not iron-sulfur cluster acquisition, by WhiB1.	[Smith, Laura J.; Stapleton, Melanie R.; Green, Jeffrey] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Buxton, Roger S.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	University of Sheffield; MRC National Institute for Medical Research	Smith, LJ (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	mbp08ljs@sheffield.ac.uk			Biotechnology and Biological Sciences Research Council UK;  [BB/G018960/1]; Biotechnology and Biological Sciences Research Council [BB/G018960/1] Funding Source: researchfish; Medical Research Council [MC_U117585867] Funding Source: researchfish; BBSRC [BB/G018960/1] Funding Source: UKRI; MRC [MC_U117585867] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Biotechnology and Biological Sciences Research Council UK studentship to LJS and Project Grant BB/G018960/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Erht S, 2009, CELL MICROBIOL, V11, P1170; Flynn JL, 1998, J IMMUNOL, V160, P1796; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Ragahund TR, 2006, J BACTERIOL, V188, P6966; Ralph AP, 2008, TRENDS MICROBIOL, V16, P336, DOI 10.1016/j.tim.2008.04.003; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Stapleton MR, 2012, TUBERCULOSIS EDINB, DOI [10.1016/j.tube2012.03.001, DOI 10.1016/J.TUBE2012.03.001]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; World Health Organisation, 2011, WHOHTMTB201116	15	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40407	10.1371/journal.pone.0040407	http://dx.doi.org/10.1371/journal.pone.0040407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792304	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000306436300064
J	Schon, I; Pinto, RL; Halse, S; Smith, AJ; Martens, K; Birky, CW				Schon, Isa; Pinto, Ricardo L.; Halse, Stuart; Smith, Alison J.; Martens, Koen; Birky, C. William, Jr.			Cryptic Species in Putative Ancient Asexual Darwinulids (Crustacea, Ostracoda)	PLOS ONE			English	Article							GLOBAL DIVERSITY; SEMITERRESTRIAL HABITATS; DNA TAXONOMY; GENUS; EVOLUTION; ORIBATIDA; ROTIFERA; ACARI; DIVERSIFICATION; DELIMITATION	Background: Fully asexually reproducing taxa lack outcrossing. Hence, the classic Biological Species Concept cannot be applied. Methodology/Principal Findings: We used DNA sequences from the mitochondrial COI gene and the nuclear ITS2 region to check species boundaries according to the evolutionary genetic (EG) species concept in five morphospecies in the putative ancient asexual ostracod genera, Penthesilenula and Darwinula, from different continents. We applied two methods for detecting cryptic species, namely the K/h method and the General Mixed Yule Coalescent model (GMYC). We could confirm the existence of species in all five darwinulid morphospecies and additional cryptic diversity in three morphospecies, namely in Penthesilenula brasiliensis, Darwinula stevensoni and in P. aotearoa. The number of cryptic species within one morphospecies varied between seven (P. brasiliensis), five to six (D. stevensoni) and two (P. aotearoa), respectively, depending on the method used. Cryptic species mainly followed continental distributions. We also found evidence for coexistence at the local scale for Brazilian cryptic species of P. brasiliensis and P. aotearoa. Our ITS2 data confirmed that species exist in darwinulids but detected far less EG species, namely two to three cryptic species in P. brasiliensis and no cryptic species at all in the other darwinulid morphospecies. Conclusions/Significance: Our results clearly demonstrate that both species and cryptic diversity can be recognized in putative ancient asexual ostracods using the EG species concept, and that COI data are more suitable than ITS2 for this purpose. The discovery of up to eight cryptic species within a single morphospecies will significantly increase estimates of biodiversity in this asexual ostracod group. Which factors, other than long-term geographic isolation, are important for speciation processes in these ancient asexuals remains to be investigated.	[Schon, Isa; Martens, Koen] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Schon, Isa] Univ Hasselt, Dept Biol, Diepenbeek, Belgium; [Pinto, Ricardo L.] Univ Brasilia, Inst Geosci, Brasilia, DF, Brazil; [Halse, Stuart] Bennelongia Pty Ltd, Wembley, WA, Australia; [Smith, Alison J.] Kent State Univ, Dept Geol, Kent, OH 44242 USA; [Martens, Koen] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Birky, C. William, Jr.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Royal Belgian Institute of Natural Sciences; Hasselt University; Universidade de Brasilia; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Ghent University; University of Arizona	Schon, I (corresponding author), Royal Belgian Inst Nat Sci, Brussels, Belgium.	isa.schoen@naturalsciences.be	Halse, Stuart/GXF-7832-2022; Martens, Koen RLM/A-8171-2010; Pinto, Ricardo/I-4814-2012	Pinto, Ricardo/0000-0002-4128-8405	FAPESP [Proc: 03/13510-5]; CAPES [Proc: BEX3406/04-0]; Belgian OSTC [MO/36/005, MO/36/015]; Flemish FWO [1.5.172.09N]; Department of Environment and Conservation (Western Australia)	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Belgian OSTC; Flemish FWO(FWO); Department of Environment and Conservation (Western Australia)	Fellowships to RP: FAPESP (Proc: 03/13510-5); CAPES (Proc: BEX3406/04-0). Research Founding to IS & KM: Belgian OSTC (MO/36/005 & MO/36/015). Research Founding to KM: Flemish FWO (krediet voor navorsers 1.5.172.09N). Scientific Stay of IS & KM: Department of Environment and Conservation (Western Australia). Visiting Fellowship to IS: Edit-Cowan-University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artheau M, 2007, INVERTEBR SYST, V21, P471, DOI 10.1071/IS05058; Barraclough TG, 2003, EVOLUTION, V57, P2166; Bell G, 1982, MASTERPIECE NATURE E; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Birky CW, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P201, DOI 10.1007/978-90-481-2770-2_10; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Bode SNS, 2010, MOL PHYLOGENET EVOL, V54, P542, DOI 10.1016/j.ympev.2009.08.022; Bromham L, 2000, J MOL EVOL, V50, P296, DOI 10.1007/s002399910034; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; COYNE JA, 1994, EVOLUTION, V48, P19, DOI 10.1111/j.1558-5646.1994.tb01290.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2008, J EVOLUTION BIOL, V21, P580, DOI 10.1111/j.1420-9101.2007.01472.x; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023969; Fontaneto D, 2011, HYDROBIOLOGIA, V662, P27, DOI 10.1007/s10750-010-0481-7; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Foottit R. G., 1997, V54, P291; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hay WW, 1999, GEOL S AM S, P1; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Heethoff M, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-2; Heethoff M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P241, DOI 10.1007/978-90-481-2770-2_12; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Martens K, 2003, P ROY SOC B-BIOL SCI, V270, P723, DOI 10.1098/rspb.2002.2270; Martens K, 2005, HYDROBIOLOGIA, V538, P153, DOI 10.1007/s10750-004-4945-5; Martens K, 2002, INVERTEBR SYST, V16, P195, DOI 10.1071/IT01022; Martens K, 1998, SEX AND PARTHENOGENESIS, P295; Martens K, 1998, SEX AND PARTHENOGENESIS, P197; Martens K, 2008, NATURE, V453, P587, DOI 10.1038/453587b; Martens K, 2008, HYDROBIOLOGIA, V595, P185, DOI 10.1007/s10750-007-9245-4; Martens K, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P187, DOI 10.1007/978-90-481-2770-2_9; Maynard Smith, 1998, EVOL GENET; MAYR E, 1970, P453; Molostovskaya II, 2000, HYDROBIOLOGIA, V419, P125, DOI 10.1023/A:1003982517547; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Neiman M, 2009, ANN NY ACAD SCI, V1168, P185, DOI 10.1111/j.1749-6632.2009.04572.x; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pinto RL, 2005, CRUSTACEANA, V78, P975, DOI 10.1163/156854005775197244; Pinto RL, 2005, ZOOL J LINN SOC-LOND, V145, P145, DOI 10.1111/j.1096-3642.2005.00185.x; Pinto RL, 2004, J NAT HIST, V38, P2567, DOI 10.1080/00222930310001647424; Pinto RL, 2003, ZOOL J LINN SOC-LOND, V139, P305, DOI 10.1046/j.1096-3642.2003.00070.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2018, R LANG ENV STAT COMP; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Rossetti G, 2011, BELG J ZOOL, V141, P55; Rossetti Giampaolo, 1998, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V68, P55; Rossetti Giampaolo, 1996, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V66, P73; Schatz H, 2008, HYDROBIOLOGIA, V595, P323, DOI 10.1007/s10750-007-9027-z; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P217, DOI 10.1007/978-90-481-2770-2_11; Schoen Isa, 2008, V3, P341, DOI 10.1007/7050_2007_032; Schon I, 2007, HYDROBIOLOGIA, V575, P33, DOI 10.1007/s10750-006-0276-z; Schon I, 1998, J NAT HIST, V32, P943, DOI 10.1080/00222939800770481; Schon I, 2003, BIOL J LINN SOC, V79, P93, DOI 10.1046/j.1095-8312.2003.00186.x; Schon I, 1998, P ROY SOC B-BIOL SCI, V265, P235, DOI 10.1098/rspb.1998.0287; Schon I, 2003, P ROY SOC B-BIOL SCI, V270, P827, DOI 10.1098/rspb.2002.2314; Schwander T, 2011, CURR BIOL, V21, P1129, DOI 10.1016/j.cub.2011.05.026; Schwander T, 2009, MOL ECOL, V18, P28, DOI 10.1111/j.1365-294X.2008.03992.x; Segers H, 2008, HYDROBIOLOGIA, V595, P49, DOI 10.1007/s10750-007-9003-7; Smith RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1569, DOI 10.1098/rspb.2005.3452; Subias L. S., 2004, Graellsia, V60, P3; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Van Doninck K, 2003, FRESHWATER BIOL, V48, P1285, DOI 10.1046/j.1365-2427.2003.01078.x; Van Doninck K, 2002, OECOLOGIA, V132, P205, DOI 10.1007/s00442-002-0939-z; Welch DBM, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P259, DOI 10.1007/978-90-481-2770-2_13; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	85	43	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39844	10.1371/journal.pone.0039844	http://dx.doi.org/10.1371/journal.pone.0039844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802945	gold, Green Submitted, Green Published			2022-12-27	WOS:000306186900019
J	Wang, H; Haeger, SM; Kloxin, AM; Leinwand, LA; Anseth, KS				Wang, Huan; Haeger, Sarah M.; Kloxin, April M.; Leinwand, Leslie A.; Anseth, Kristi S.			Redirecting Valvular Myofibroblasts into Dormant Fibroblasts through Light-mediated Reduction in Substrate Modulus	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; IDIOPATHIC PULMONARY-FIBROSIS; HEPATIC STELLATE CELLS; AORTIC-VALVE DISEASE; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; TRANSFORMING GROWTH-FACTOR-BETA-1; PHOTODEGRADABLE HYDROGELS; LUNG MYOFIBROBLASTS; GRANULATION-TISSUE	Fibroblasts residing in connective tissues throughout the body are responsible for extracellular matrix (ECM) homeostasis and repair. In response to tissue damage, they activate to become myofibroblasts, which have organized contractile cytoskeletons and produce a myriad of proteins for ECM remodeling. However, persistence of myofibroblasts can lead to fibrosis with excessive collagen deposition and tissue stiffening. Thus, understanding which signals regulate de-activation of myofibroblasts during normal tissue repair is critical. Substrate modulus has recently been shown to regulate fibrogenic properties, proliferation and apoptosis of fibroblasts isolated from different organs. However, few studies track the cellular responses of fibroblasts to dynamic changes in the microenvironmental modulus. Here, we utilized a light-responsive hydrogel system to probe the fate of valvular myofibroblasts when the Young's modulus of the substrate was reduced from similar to 32 kPa, mimicking pre-calcified diseased tissue, to similar to 7 kPa, mimicking healthy cardiac valve fibrosa. After softening the substrata, valvular myofibroblasts de-activated with decreases in alpha-smooth muscle actin (alpha-SMA) stress fibers and proliferation, indicating a dormant fibroblast state. Gene signatures of myofibroblasts (including alpha-SMA and connective tissue growth factor (CTGF)) were significantly down-regulated to fibroblast levels within 6 hours of in situ substrate elasticity reduction while a general fibroblast gene vimentin was not changed. Additionally, the de-activated fibroblasts were in a reversible state and could be re-activated to enter cell cycle by growth stimulation and to express fibrogenic genes, such as CTGF, collagen 1A1 and fibronectin 1, in response to TGF-beta 1. Our data suggest that lowering substrate modulus can serve as a cue to down-regulate the valvular myofibroblast phenotype resulting in a predominantly quiescent fibroblast population. These results provide insight in designing hydrogel substrates with physiologically relevant stiffness to dynamically redirect cell fate in vitro.	[Wang, Huan; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Haeger, Sarah M.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Kloxin, April M.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE USA; [Kloxin, April M.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE USA; [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Wang, Huan; Leinwand, Leslie A.; Anseth, Kristi S.] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Delaware; University of Delaware; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Wang, H (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	kristi.anseth@colorado.edu		LEINWAND, LESLIE/0000-0003-1470-4810; Wang, Huan/0000-0001-9048-2733; WANG, HUAN/0000-0002-3857-5737	National Institutes of Health (NIH) [R01 HL089260, NIH R01 HL50560]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089260, R01HL050560] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was funded by National Institutes of Health (NIH) R01 HL089260, NIH R01 HL50560 and Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031; Chakravarti S, 2004, INVEST OPHTH VIS SCI, V45, P3475, DOI 10.1167/iovs.04-0343; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Choi CK, 2010, TRENDS CELL BIOL, V20, P705, DOI 10.1016/j.tcb.2010.09.007; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dussaule JC, 2011, INT J EXP PATHOL, V92, P151, DOI 10.1111/j.1365-2613.2011.00760.x; Edep ME, 2000, CARDIOVASC PATHOL, V9, P281, DOI 10.1016/S1054-8807(00)00043-0; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Gaggini F, 2004, J COMB CHEM, V6, P805, DOI 10.1021/cc049963a; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Ingram JL, 2003, CHEST, V123, p422S, DOI 10.1378/chest.123.3_suppl.422S; Jester JV, 1996, CORNEA, V15, P505; JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1; Kabuyama Y, 2007, GENES CELLS, V12, P1235, DOI 10.1111/j.1365-2443.2007.01127.x; Kaden JJ, 2005, CARDIOVASC PATHOL, V14, P80, DOI 10.1016/j.carpath.2005.01.002; Kato R, 2001, EXP CELL RES, V265, P54, DOI 10.1006/excr.2001.5179; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139; Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Lin CC, 2010, J CONTROL RELEASE, V142, P384, DOI 10.1016/j.jconrel.2009.11.022; Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M; Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Pho M, 2008, AM J PHYSIOL-HEART C, V294, pH1767, DOI 10.1152/ajpheart.01305.2007; Quinlan AMT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023272; Raghavan S, 2010, LANGMUIR, V26, P17733, DOI 10.1021/la102955m; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D; Santiago JJ, 2010, DEV DYNAM, V239, P1573, DOI 10.1002/dvdy.22280; SAPPINO AP, 1990, LAB INVEST, V63, P144; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Wallach-Dayan SB, 2007, P NATL ACAD SCI USA, V104, P20460, DOI 10.1073/pnas.0705582104; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003; Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Zhang YH, 2011, MATRIX BIOL, V30, P135, DOI 10.1016/j.matbio.2010.10.008; Zhou XX, 2011, AM J RESP CELL MOL, V45, P1256, DOI 10.1165/rcmb.2011-0065OC	73	82	82	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39969	10.1371/journal.pone.0039969	http://dx.doi.org/10.1371/journal.pone.0039969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808079	gold, Green Published, Green Submitted			2022-12-27	WOS:000306406700017
J	Musante, L; Saraswat, M; Duriez, E; Byrne, B; Ravida, A; Domon, B; Holthofer, H				Musante, Luca; Saraswat, Mayank; Duriez, Elodie; Byrne, Barry; Ravida, Alessandra; Domon, Bruno; Holthofer, Harry			Biochemical and Physical Characterisation of Urinary Nanovesicles following CHAPS Treatment	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; EXOSOMES; SOLUBILIZATION; BIOMARKERS; CLONING; IDENTIFICATION; ENKEPHALINASE; BIOGENESIS; EXPRESSION; PROTEOMICS	Urinary exosomes represent a precious source of potential biomarkers for disease biology. Currently, the methods for vesicle isolation are severely restricted by the tendency of vesicle entrapment, e. g. by the abundant Tamm-Horsfall protein (THP) polymers. Treatment by reducing agents such as dithiothreitol (DTT) releases entrapped vesicles, thus increasing the final yield. However, this harsh treatment can cause remodelling of all those proteins which feature extra-vesicular domains stabilized by internal disulfide bridges and have detrimental effects on their biological activity. In order to optimize exosomal yield, we explore two vesicle treatment protocols-dithiothreitol (DTT) and 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic (CHAPS)-applied to the differential centrifugation protocol for exosomal vesicle isolation. The results show that CHAPS treatment does not affect vesicle morphology or exosomal marker distribution, thus eliminating most of THP interference. Moreover, the recovery and preservation of catalytic activity of two trans-membrane proteases, dipeptidyl peptidase IV and nephrilysin, was examined and found to be clearly superior after CHAPS treatment compared to DTT. Finally, proteomic profiling by mass spectrometry (MS) revealed that 76.2% of proteins recovered by CHAPS are common to those seen for DTT treatment, which illustrates underlining similarities between the two approaches. In conclusion, we provide a major improvement to currently-utilized urinary vesicle isolation strategies to allow recovery of urinary vesicles without the deleterious interference of abundant urinary proteins, while preserving typical protein folding and, consequently, the precious biological activity of urinary proteins which serve as valuable biomarkers.	[Musante, Luca; Saraswat, Mayank; Byrne, Barry; Ravida, Alessandra; Holthofer, Harry] Dublin City Univ, Ctr BioAnalyt Sci CBAS, Dublin 9, Ireland; [Duriez, Elodie; Domon, Bruno] CRP Sante, Luxembourg Clin Prote Ctr LCP, Strassen, Luxembourg	Dublin City University; Luxembourg Institute of Health	Musante, L (corresponding author), Dublin City Univ, Ctr BioAnalyt Sci CBAS, Dublin 9, Ireland.	harry.holthofer@dcu.ie	Saraswat, Mayank/F-2985-2015; Musante, Luca/F-5086-2017; Musante, Luca/A-8460-2015	Saraswat, Mayank/0000-0002-5021-8150; Musante, Luca/0000-0003-0845-275X; Musante, Luca/0000-0002-6225-8598; Duriez, Elodie/0000-0001-8780-3479; Ravida, Alessandra/0000-0001-8547-2039	Luxembourg Fonds National de la Recherche (FNR) (PEARL grant); Health Research Board (HRB) [HRA/09/62]	Luxembourg Fonds National de la Recherche (FNR) (PEARL grant)(Luxembourg National Research Fund); Health Research Board (HRB)	This work was funded by The Luxembourg Fonds National de la Recherche (FNR) (PEARL grant). We acknowledge the financial support of the Health Research Board (HRB), grant number HRA/09/62. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Ageberg M, 2003, CLIN LAB HAEMATOL, V25, P297, DOI 10.1046/j.1365-2257.2003.00541.x; Ahola H, 1999, AM J PATHOL, V155, P907, DOI 10.1016/S0002-9440(10)65190-5; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bajari TM, 2005, METHODS, V36, P109, DOI 10.1016/j.ymeth.2004.11.007; Busek P, 2004, INT J BIOCHEM CELL B, V36, P408, DOI 10.1016/S1357-2725(03)00262-0; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; ERDOS EG, 1989, FASEB J, V3, P145, DOI 10.1096/fasebj.3.2.2521610; FAIRLEY JK, 1983, BRIT MED J, V287, P1838, DOI 10.1136/bmj.287.6408.1838; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; FLORENTIN D, 1984, ANAL BIOCHEM, V141, P62, DOI 10.1016/0003-2697(84)90425-1; Garner AE, 2008, BIOPHYS J, V94, P1326, DOI 10.1529/biophysj.107.114108; Gonzales PA, 2010, METHODS MOL BIOL, V641, P89, DOI 10.1007/978-1-60761-711-2_6; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Hara M, 2010, HUM PATHOL, V41, P1265, DOI 10.1016/j.humpath.2010.02.004; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; HJELMELAND LM, 1980, P NATL ACAD SCI-BIOL, V77, P6368, DOI 10.1073/pnas.77.11.6368; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kentsis A, 2009, PROTEOM CLIN APPL, V3, P1052, DOI 10.1002/prca.200900008; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Kobayashi K, 2001, ARCH BIOCHEM BIOPHYS, V388, P113, DOI 10.1006/abbi.2000.2265; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; KUMAR S, 1985, HISTOCHEM J, V17, P1251, DOI 10.1007/BF01002506; LABETA MO, 1988, J IMMUNOL METHODS, V112, P133, DOI 10.1016/0022-1759(88)90043-9; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; LIU WJ, 1995, ENDOCRINOLOGY, V136, P779, DOI 10.1210/en.136.2.779; Marimuthu A, 2011, J PROTEOME RES, V10, P2734, DOI 10.1021/pr2003038; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; MCQUEEN EG, 1966, J CLIN PATHOL, V19, P392, DOI 10.1136/jcp.19.4.392; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Patari A, 2003, DIABETES, V52, P2969, DOI 10.2337/diabetes.52.12.2969; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; SHIMADA K, 1994, J BIOL CHEM, V269, P18275; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sustar V, 2011, INT J NANOMED, V6, P2737, DOI 10.2147/IJN.S24537; TAMM I, 1952, J EXP MED, V95, P71, DOI 10.1084/jem.95.1.71; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Watanabe T, 2005, CELL TISSUE RES, V321, P185, DOI 10.1007/s00441-005-1148-y; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Wenk R E, 1981, Pathobiol Annu, V11, P229; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206	59	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e37279	10.1371/journal.pone.0037279	http://dx.doi.org/10.1371/journal.pone.0037279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808001	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400002
J	Villers, A; Godaux, E; Ris, L				Villers, Agnes; Godaux, Emile; Ris, Laurence			Long-Lasting LTP Requires Neither Repeated Trains for Its Induction Nor Protein Synthesis for Its Development	PLOS ONE			English	Article							BETA-ADRENERGIC-RECEPTORS; KINASE M-ZETA; TERM POTENTIATION; LATE-PHASE; D-SERINE; SYNAPTIC PLASTICITY; AMPA RECEPTORS; HIPPOCAMPAL SLICES; CA1 REGION; REPEATED TETANIZATION	Current thinking about LTP triggered in the area CA1 of hippocampal slices is ruled by two "dogmas'': (1) A single train of high-frequency stimulation is sufficient to trigger short-lasting LTP (1 - 3 h), whereas multiple trains are required to induce long-lasting LTP (L-LTP, more than 4 h). (2) The development of the late phase of L-LTP requires the synthesis of new proteins. In this study, we found that a single high-frequency train could trigger an LTP lasting more than 8 h that was not affected by either anisomycin or cycloheximide (two inhibitors of protein synthesis). We ascertained that the induction of this L-LTP made use of the same mechanisms as those usually reported to be involved in LTP induction: it was dependent on NMDA receptors and on the activation of two "core'' kinases, CaMKII and PI3K. These findings call into question the two "dogmas'' about LTP.	[Villers, Agnes; Godaux, Emile; Ris, Laurence] Univ Mons, Dept Neurosci, B-7000 Mons, Belgium	University of Mons	Villers, A (corresponding author), Univ Mons, Dept Neurosci, B-7000 Mons, Belgium.	laurence.ris@umons.ac.be	VILLERS, Arnauld/K-6629-2016	VILLERS, Arnauld/0000-0002-6298-7758	Belgian Fund for Scientific Research (F.R.S-FNRS); Queen Elisabeth Fund for Medical Research	Belgian Fund for Scientific Research (F.R.S-FNRS)(Fonds de la Recherche Scientifique - FNRS); Queen Elisabeth Fund for Medical Research	The work was support by the Belgian Fund for Scientific Research (F.R.S-FNRS) and by the Queen Elisabeth Fund for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2009, NEUROSCI RES, V63, P59, DOI 10.1016/j.neures.2008.10.008; Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Appleby VJ, 2011, J NEUROCHEM, V116, P530, DOI 10.1111/j.1471-4159.2010.07133.x; Bagayogo IP, 2009, ASN NEURO, V1, DOI 10.1042/AN20090006; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bortolotto ZA, 1998, NEUROPHARMACOLOGY, V37, P535, DOI 10.1016/S0028-3908(98)00058-6; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; Bortolotto ZA, 2008, NEUROPHARMACOLOGY, V55, P454, DOI 10.1016/j.neuropharm.2008.06.020; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Capron B, 2006, LEARN MEMORY, V13, P271, DOI 10.1101/lm.135406; Chan CB, 2011, EMBO J, V30, P4274, DOI 10.1038/emboj.2011.281; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Connor SA, 2011, J PHYSIOL-LONDON, V589, P4321, DOI 10.1113/jphysiol.2011.209379; Damiani CL, 2007, J NEUROCHEM, V100, P720, DOI 10.1111/j.1471-4159.2006.04321.x; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fonseca R, 2012, EUR J NEUROSCI, V35, P195, DOI 10.1111/j.1460-9568.2011.07955.x; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; French PJ, 2001, EUR J NEUROSCI, V13, P968, DOI 10.1046/j.0953-816x.2001.01467.x; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gelinas JN, 2008, LEARN MEMORY, V15, P403, DOI 10.1101/lm.830008; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hernandez RV, 2005, BRAIN RES PROTOC, V15, P6, DOI 10.1016/j.brainresprot.2005.02.003; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 2005, LEARN MEMORY, V12, P587, DOI 10.1101/lm.98905; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; LIPTON P, 1977, J NEUROCHEM, V28, P1347, DOI 10.1111/j.1471-4159.1977.tb12330.x; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021568; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Navakkode S, 2010, LEARN MEMORY, V17, P605, DOI 10.1101/lm.1991910; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Pirttimaki TM, 2011, J NEUROSCI, V31, P7637, DOI 10.1523/JNEUROSCI.5783-10.2011; Raymond M, 2011, J NEUROSCI, V31, P17864, DOI 10.1523/JNEUROSCI.3179-11.2011; Redondo RL, 2010, FENS ABSTR, V4, P1613; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Ris L, 2007, LEARN MEMORY, V14, P185, DOI 10.1101/lm.451507; Ris L, 2009, NEUROREPORT, V20, P1572, DOI 10.1097/WNR.0b013e328332e021; Rudy JW, 2008, NEUROBIOL LEARN MEM, V89, P219, DOI 10.1016/j.nlm.2007.08.014; Rudy JW, 2006, LEARN MEMORY, V13, P1, DOI 10.1101/lm.157806; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sajikumar S, 2005, CURR OPIN NEUROBIOL, V15, P607, DOI 10.1016/j.conb.2005.08.009; Sajikumar S, 2008, LEARN MEMORY, V15, P46, DOI 10.1101/lm.816908; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sharma AV, 2012, J NEUROSCI, V32, P2377, DOI 10.1523/JNEUROSCI.3543-11.2012; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Squire LR., 1999, MEMORY MIND MOL; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tenorio G, 2010, LEARN MEMORY, V17, P627, DOI 10.1101/lm.1974510; Thalhammer A, 2006, EMBO J, V25, P5873, DOI 10.1038/sj.emboj.7601420; Vickers CA, 2005, J PHYSIOL-LONDON, V568, P803, DOI 10.1113/jphysiol.2005.092924; Villers A, 2010, NEUROREPORT, V21, P210, DOI 10.1097/WNR.0b013e328335c311; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Young JZ, 2006, EUR J NEUROSCI, V23, P1784, DOI 10.1111/j.1460-9568.2006.04707.x	80	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40823	10.1371/journal.pone.0040823	http://dx.doi.org/10.1371/journal.pone.0040823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792408	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400102
J	Zhang, H; Hu, XX; Wang, ZP; Zhang, YD; Wang, SZ; Wang, N; Ma, L; Leng, L; Wang, SW; Wang, QG; Wang, YX; Tang, ZQ; Li, N; Da, Y; Li, H				Zhang, Hui; Hu, Xiaoxiang; Wang, Zhipeng; Zhang, Yuandan; Wang, Shouzhi; Wang, Ning; Ma, Li; Leng, Li; Wang, Shengwen; Wang, Qigui; Wang, Yuxiang; Tang, Zhiquan; Li, Ning; Da, Yang; Li, Hui			Selection Signature Analysis Implicates the PC1/PCSK1 Region for Chicken Abdominal Fat Content	PLOS ONE			English	Article							QUANTITATIVE TRAITS; POSITIVE SELECTION; GENE POLYMORPHISM; GENOME; OBESITY; ASSOCIATION; LOCI; VARIANTS; SEQUENCE	We conducted a selection signature analysis using the chicken 60k SNP chip in two chicken lines that had been divergently selected for abdominal fat content (AFC) for 11 generations. The selection signature analysis used multiple signals of selection, including long-range allele frequency differences between the lean and fat lines, long-range heterozygosity changes, linkage disequilibrium, haplotype frequencies, and extended haplotype homozygosity. Multiple signals of selection identified ten signatures on chromosomes 1, 2, 4, 5, 11, 15, 20, 26 and Z. The 0.73 Mb PC1/PCSK1 region of the Z chromosome at 55.43-56.16 Mb was the most heavily selected region. This region had 26 SNP markers and seven genes, Mar-03, SLC12A2, FBN2, ERAP1, CAST, PC1/PCSK1 and ELL2, where PC1/PCSK1 are the chicken/human names for the same gene. The lean and fat lines had two main haplotypes with completely opposite SNP alleles for the 26 SNP markers and were virtually line-specific, and had a recombinant haplotype with nearly equal frequency (0.193 and 0.196) in both lines. Other haplotypes in this region had negligible frequencies. Nine other regions with selection signatures were PAH-IGF1, TRPC4, GJD4-CCNY, NDST4, NOVA1, GALNT9, the ESRP2-GALR1 region with five genes, the SYCP2-CADH4 with six genes, and the TULP1-KIF21B with 14 genes. Genome-wide association analysis showed that nearly all regions with evidence of selection signature had SNP effects with genome-wide significance (P<10(-6)) on abdominal fat weight and percentage. The results of this study provide specific gene targets for the control of chicken AFC and a potential model of AFC in human obesity.	[Zhang, Hui; Wang, Zhipeng; Wang, Shouzhi; Wang, Ning; Leng, Li; Wang, Qigui; Wang, Yuxiang; Tang, Zhiquan; Li, Hui] Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China; [Zhang, Hui; Wang, Zhipeng; Wang, Shouzhi; Wang, Ning; Leng, Li; Wang, Qigui; Wang, Yuxiang; Tang, Zhiquan; Li, Hui] NE Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhang, Yuandan] Univ New England, Anim Genet & Breeding Unit, Armidale, NSW, Australia; [Ma, Li; Wang, Shengwen; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China; China Agricultural University; University of New England; University of Minnesota System; University of Minnesota Twin Cities	Zhang, H (corresponding author), Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China.	yda@umn.edu; lihui@neau.edu.cn	ma, li/C-1585-2014; Ma, Li/B-1844-2010		China Agriculture Research System [CARS-42]; National 863 project of China [2010AA10A102]; National 973 Project of China [2009CB941604]	China Agriculture Research System; National 863 project of China; National 973 Project of China(National Basic Research Program of China)	This research was supported by China Agriculture Research System (No. CARS-42), National 863 project of China (No. 2010AA10A102) and National 973 Project of China (No. 2009CB941604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Chambers JR, 1990, POULTRY BREEDING GEN; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Choquet H, 2011, METHODS MOL BIOL, V768, P247, DOI 10.1007/978-1-61779-204-5_13; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Han DH, 2008, KOREAN J PHYSIOL PHA, V12, P125, DOI 10.4196/kjpp.2008.12.3.125; HAVENSTEIN GB, 1994, POULTRY SCI, V73, P1795, DOI 10.3382/ps.0731795; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Ikeobi CON, 2002, ANIM GENET, V33, P428, DOI 10.1046/j.1365-2052.2002.00911.x; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; Kessler AM, 2000, AN C APINCO CIENC TE; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mao YC, 2006, PHYSIOL GENOMICS, V28, P46, DOI 10.1152/physiolgenomics.00096.2006; Methot J, 2010, EXPERT REV CARDIOVAS, V8, P639, DOI 10.1586/ERC.10.38; Morgan Angharad R, 2011, BMC Res Notes, V4, P253, DOI 10.1186/1756-0500-4-253; Mutch DM, 2006, PLOS GENET, V2, P1956, DOI 10.1371/journal.pgen.0020188; Nones K, 2006, ANIM GENET, V37, P95, DOI 10.1111/j.1365-2052.2005.01387.x; Parikh RM, 2007, MED HYPOTHESES, V68, P1272, DOI 10.1016/j.mehy.2006.10.038; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2011, OBESITY, V19, P2436, DOI 10.1038/oby.2011.237; Zhou H, 2005, POULTRY SCI, V84, P212, DOI 10.1093/ps/84.2.212	31	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40736	10.1371/journal.pone.0040736	http://dx.doi.org/10.1371/journal.pone.0040736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792402	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400098
J	Guo, Y; Xu, WW; Song, J; Deng, W; Liu, DQ; Zhang, HT				Guo, Yan; Xu, Wen-Wen; Song, Jie; Deng, Wen; Liu, Di-Qiu; Zhang, Hua-Tang			Intracellular Overexpression of HIV-1 Nef Impairs Differentiation and Maturation of Monocytic Precursors towards Dendritic Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; EXPRESSION; ACTIVATION; INFECTION; REPLICATION; LYMPHOCYTES; MACROPHAGES; INDUCTION; PROTEIN	Nef functions as an immunosuppressive factor critical for HIV-1 replication, survival and development of AIDS following HIV-1 infection. What effects Nef exerts on differentiation and maturation of monocytes towards dendritic cells (DCs) remains greatly controversial. In this study, we used THP-1 (human monocytic leukemia cell line) as monocytic DC precursors to investigate how overexpression of HIV-1 Nef influences the processes of differentiation and maturation of dendritic cells. In striking contrast to negative controls, our results showed that morphological and phenotypical changes (CD11c, CD14, CD40, CD80, CD83, CD86, and HLA-DR) occurred on recombinant THP-1 expressing HIV-1 Nef (short for Nef) upon co-stimulation of GM-CSF/IL-4 or GM-CSF/IL-4/TNF-alpha/ionomycin. Moreover, CD4, CCR5, and CXCR4 were also down-regulated on Nef. It might be hypothesized that Nef prevents superinfection and signal transduction in HIV-1 infected monocytes. Collectively, our study demonstrates that long-lasting expression of Nef at high levels indeed retards differentiation and maturation of dendritic cells in terms of phenotype and morphology. We are hopeful that potentially, stable expression of intracellular Nef in vivo may function as a subtle mode to support long-lasting HIV-1 existence.	[Guo, Yan; Xu, Wen-Wen; Song, Jie; Deng, Wen; Liu, Di-Qiu; Zhang, Hua-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Guo, Yan; Xu, Wen-Wen; Song, Jie; Deng, Wen; Liu, Di-Qiu; Zhang, Hua-Tang] Kunming Inst Zool, Kunming, Peoples R China; [Xu, Wen-Wen; Song, Jie] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Guo, Y (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China.	liudiqiu@mail.kiz.ac.cn	Liu, Diqiu/AAY-4439-2020; Xu, Wenwen/AAD-9116-2019		Chinese Academy of 13 Sciences [A0820]; National Natural Science Foundation of China [31070817, 30771951]; Applied Fundamental Research Program of Yunnan Province [2008CC001, 2010CD101]	Chinese Academy of 13 Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Fundamental Research Program of Yunnan Province	This work was supported by the 100 Talents Programme of The Chinese Academy of 13 Sciences(No. A0820), the National Natural Science Foundation of China (General program, No. 31070817 and No. 30771951), and the Applied Fundamental Research Program of Yunnan Province (No.2008CC001 and No. 2010CD101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Breuer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020033; CARREER R, 1994, AIDS RES HUM RETROV, V10, P523, DOI 10.1089/aid.1994.10.523; Chen XC, 2006, CELL IMMUNOL, V243, P10, DOI 10.1016/j.cellimm.2006.11.001; Cho MH, 2010, INFECT IMMUN, V78, P387, DOI 10.1128/IAI.00956-09; Coquillard G, 2009, J INFECT DIS, V200, P947, DOI 10.1086/605476; Creery D, 2002, CLIN DIAGN LAB IMMUN, V9, P1212, DOI 10.1128/CDLI.9.6.1212-1221.2002; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; Foster JL, 2011, J NEUROIMMUNE PHARM, V6, P230, DOI 10.1007/s11481-011-9262-y; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Gray LR, 2011, J NEUROVIROL, V17, P82, DOI 10.1007/s13365-010-0001-6; Hayakawa E, 2012, J ATHEROSCLER THROMB, V19, P13, DOI 10.5551/jat.9472; Hiyoshi M, 2012, J CELL PHYSIOL, V227, P1090, DOI 10.1002/jcp.22825; Huang JH, 2011, J INFECT DIS, V204, P1557, DOI 10.1093/infdis/jir616; Lambrechts N, 2009, TOXICOL APPL PHARM, V236, P221, DOI 10.1016/j.taap.2009.01.026; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lehmann MH, 2006, EXP CELL RES, V312, P3659, DOI 10.1016/j.yexcr.2006.08.008; Leon B, 2005, MONOCYTE DERIVED DEN, P313; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Maess Marten B, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5612; Martinez-Pomar N, 2006, CLIN EXP IMMUNOL, V144, P233, DOI 10.1111/j.1365-2249.2006.03063.x; Messmer D, 2002, AIDS RES HUM RETROV, V18, P1043, DOI 10.1089/08892220260235407; Morgan CR, 2011, BIOCHEMISTRY-US, V50, P3394, DOI 10.1021/bi200197e; Niu LG, 2011, VACCINE, V29, P2110, DOI 10.1016/j.vaccine.2010.12.131; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369, DOI 10.1111/j.1365-2249.1994.tb05499.x; Ogasawara N, 2009, BIOCHEM BIOPH RES CO, V389, P543, DOI 10.1016/j.bbrc.2009.09.024; Olivetta E, 2006, EXP CELL RES, V312, P890, DOI 10.1016/j.yexcr.2005.12.003; Patham B, 2011, CURR MED CHEM, V18, P3987, DOI 10.2174/092986711796957194; Poudrier J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002154; Quaranta MG, 2006, FASEB J, V20, P2198, DOI 10.1096/fj.06-6260rev; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; Smed-Sorensen A, 2011, CURR OPIN HIV AIDS, V6, P405, DOI 10.1097/COH.0b013e328349b06b; Sowrirajan B, 2011, VIRUSES-BASEL, V3, P1091, DOI 10.3390/v3071091; Spivak AM, 2011, J VIROL, V85, P10399, DOI 10.1128/JVI.05409-11; Sugiyama R, 2011, FEBS LETT, V585, P3367, DOI 10.1016/j.febslet.2011.09.029; Takeuchi Satoshi, 2007, Allergol Int, V56, P215, DOI 10.2332/allergolint.R-07-149; Tangsinmankong N, 2000, CYTOKINE, V12, P1506, DOI 10.1006/cyto.2000.0741; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Tokarev Andrey, 2011, Cell Logist, V1, P90; van der Vlist M, 2011, CURR OPIN HIV AIDS, V6, P348, DOI 10.1097/COH.0b013e328349a2d1; Wang X, 2011, AM J PATHOL, V178, P41, DOI 10.1016/j.ajpath.2010.11.042	45	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40179	10.1371/journal.pone.0040179	http://dx.doi.org/10.1371/journal.pone.0040179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808111	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700029
J	Zhang, Y; Xu, JY; Wang, ZW; Zhang, XL; Liang, XM; Civelli, O				Zhang, Yan; Xu, Junyan; Wang, Zhiwei; Zhang, Xiuli; Liang, Xinmiao; Civelli, Olivier			BmK-YA, an Enkephalin-Like Peptide in Scorpion Venom	PLOS ONE			English	Article							BUTHUS-MARTENSII KARSCH; MOLECULAR CHARACTERIZATION; OPIOID RECEPTOR; 3-FINGER TOXIN; IDENTIFICATION; NEUROTOXINS; PROENKEPHALIN; ANTAGONIST; EXENDIN-4; CHANNELS	By screening extracts of venom from the Asian scorpion Buthus martensii Karsch (BmK) for their abilities to activate opioid receptors, we have identified BmK-YA, an amidated peptide containing an enkephalin-like sequence. BmK-YA is encoded by a precursor that displays a signal sequence and contains four copies of BmK-YA sequences and four of His(4)-BmK-YA, all flanked by single amino acid residues. BmK-YA and His(4)-BmK-YA are amidated and thus fulfill the characteristics expected of bioactive peptides. BmK-YA can activate mammalian opioid receptors with selectivity for the delta subtype while His(4)-BmK-YA is inactive at opioid receptors. The discovery of BmK-YA suggests that scorpion venom may represent a novel source of bioactive molecules targeting G protein-coupled receptors (GPCRs) and reveal additional insights on the evolution of the opioid precursors.	[Zhang, Yan; Wang, Zhiwei; Civelli, Olivier] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Xu, Junyan; Zhang, Xiuli; Liang, Xinmiao] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Civelli, Olivier] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Civelli, Olivier] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA	University of California System; University of California Irvine; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of California System; University of California Irvine; University of California System; University of California Irvine	Zhang, Y (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	liangxm@dicp.ac.cn; ocivelli@uci.edu	Civelli, Olivier/A-8392-2012		National Institute of Health [MH60231, DA024746]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Tourette Syndrome Association; National Natural Science Funds for Distinguished Young Scholar to Xinmiao Liang in China [20825518]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024746] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Tourette Syndrome Association; National Natural Science Funds for Distinguished Young Scholar to Xinmiao Liang in China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health (www.nih.gov/) Grants MH60231 and DA024746, an Established Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) and a Tourette Syndrome Association (www.tsa-usa.org/) award to Olivier Civelli. This work was also supported by National Natural Science Funds (http://www.nsfc.gov.cn) for Distinguished Young Scholar to Xinmiao Liang in China (20825518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal KM, 2003, CELL BIOCHEM BIOPHYS, V38, P215, DOI 10.1385/CBB:38:2:215; BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; Cao ZY, 2004, J PEPT RES, V64, P33, DOI 10.1111/j.1399-3011.2004.00164.x; CHANG C. C., 1963, ARCH INTERNATL PHARMACODYN THER, V144, P241; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; Ducancel F, 2005, CELL MOL LIFE SCI, V62, P2828, DOI 10.1007/s00018-005-5286-x; EGBERTSON MS, 1994, J MED CHEM, V37, P2537, DOI 10.1021/jm00042a007; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; ENG J, 1992, J BIOL CHEM, V267, P7402; ESNOUF MP, 1967, BRIT J HAEMATOL, V13, P581, DOI 10.1111/j.1365-2141.1967.tb00765.x; Fox JW, 2007, CURR PHARM DESIGN, V13, P2927, DOI 10.2174/138161207782023739; Gazarian KG, 2005, VACCINE, V23, P3357, DOI 10.1016/j.vaccine.2004.12.027; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Guan RJ, 2001, BBA-PROTEIN STRUCT M, V1549, P9, DOI 10.1016/S0167-4838(01)00241-2; Guan RJ, 2000, ACTA CRYSTALLOGR D, V56, P1012, DOI 10.1107/S0907444900006004; Guo ZM, 2007, CHEM COMMUN, P2491, DOI 10.1039/b701831b; Khalap A, 2005, ANN NY ACAD SCI, V1040, P22, DOI 10.1196/annals.1327.003; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Koivula K, 2010, TOXICON, V56, P440, DOI 10.1016/j.toxicon.2010.05.001; Lan ZD, 1999, TOXICON, V37, P815, DOI 10.1016/S0041-0101(98)00221-9; LEUNG MK, 1984, P NATL ACAD SCI-BIOL, V81, P955, DOI 10.1073/pnas.81.3.955; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Li F., 1997, CHIN J PHARM TOXIN, V11, P154; Liu DW, 2008, INT J PEPT RES THER, V14, P137, DOI 10.1007/s10989-008-9122-7; Liu YF, 2003, PROTEIN EXPRES PURIF, V27, P253, DOI 10.1016/S1046-5928(02)00609-5; Maiga A, 2012, TOXICON, V59, P487, DOI 10.1016/j.toxicon.2011.03.009; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; Quinton L, 2010, BRIT J PHARMACOL, V159, P316, DOI 10.1111/j.1476-5381.2009.00532.x; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; RomiLebrun R, 1997, EUR J BIOCHEM, V245, P457, DOI 10.1111/j.1432-1033.1997.00457.x; Rouget C, 2010, BRIT J PHARMACOL, V161, P1361, DOI 10.1111/j.1476-5381.2010.00966.x; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Salzet M, 1997, BRAIN RES, V768, P224, DOI 10.1016/S0006-8993(97)00646-X; SEIZINGER BR, 1985, NATURE, V313, P57, DOI 10.1038/313057a0; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Sharpe IA, 2003, J BIOL CHEM, V278, P34451, DOI 10.1074/jbc.M305410200; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; STEFANO GB, 1992, P NATL ACAD SCI USA, V89, P9316, DOI 10.1073/pnas.89.19.9316; Toombs CF, 2001, HAEMOSTASIS, V31, P141; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; VandeCraen M, 1997, EUR J IMMUNOL, V27, P1296, DOI 10.1002/eji.1830270535; Wang CY, 2000, BRAIN RES BULL, V53, P335, DOI 10.1016/S0361-9230(00)00355-5; WEBER E, 1983, P NATL ACAD SCI-BIOL, V80, P7362, DOI 10.1073/pnas.80.23.7362; WOLLEMANN M, 1990, J NEUROCHEM, V54, P1095, DOI 10.1111/j.1471-4159.1990.tb01934.x; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026; Zhang Y, 2011, NEUROCHEM RES, V36, P2104, DOI 10.1007/s11064-011-0534-y; Zhu MM, 2009, BRIT J PHARMACOL, V158, P1895, DOI 10.1111/j.1476-5381.2009.00471.x	49	12	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40417	10.1371/journal.pone.0040417	http://dx.doi.org/10.1371/journal.pone.0040417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792309	Green Published, gold			2022-12-27	WOS:000306354700045
J	Zhang, Y; Wang, LL; Wang, LL; Wu, N; Zhou, Z; Song, LS				Zhang, Ying; Wang, Leilei; Wang, Lingling; Wu, Ning; Zhou, Zhi; Song, Linsheng			An Integrin from Shrimp Litopenaeus vannamei Mediated Microbial Agglutination and Cell Proliferation	PLOS ONE			English	Article							BETA-INTEGRIN; CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; ALPHA-V-BETA-3; EXPRESSION; HEMOCYTES; SUBUNITS; WSSV	Background: Integrins are a family of adhesion receptors which regulate cell proliferation, differentiation, leukocyte migration, and complement receptor-dependent phagocytosis. In invertebrates, as a cell adhesion receptor, beta integrins play an important role for the balanced activation of immune defense responses especially during the encounter of infections. The present study attempts to characterize the immune functions of shrimp integrin (LvIntegrin) to have better understanding on the immune system and its regulation mechanisms in shrimps. Methodology: A shrimp integrin was identified from the Pacific white shrimp Litopenaeus vannamei (designated as LvIntegrin). Its full-length cDNA was of 2621 bp with an open reading frame (ORF) of 2439 bp encoding a polypeptide of 812 amino acids. The mRNA expression of LvIntegrin was significantly up-regulated at 3, 6 and 12 h after Listonella anguillarum challenge. The cDNA fragment encoding beta integrin domains (beta A and hybrid domain) of LvIntegrin was recombined and expressed in Escherichia coli BL21(DE3)-pLysS. The recombinant protein (rLvIntegrin) could significantly agglutinate the tested microbe including E. coli JM109, L. anguillarum, Micrococcus luteus and Candida dattiladattila in the presence of divalent cations. Moreover, when NIH3T3 cells were cultured with rLvIntegrin, the proliferation rate increased significantly in a dose-dependent manner. Conclusions: LvIntegrin, a shrimp beta integrin was identified from L. vannamei, shared several highly conserved features. LvIntegrin exhibited broad-spectrum agglutination activity towards both bacteria and fungi and could improve the proliferation of NIH3T3 cells, indicating that LvIntegrin is involved in the immune response against microbe challenge and regulation of cell proliferation as a cell adhesion receptor in shrimp.	[Zhang, Ying; Wang, Leilei; Wang, Lingling; Wu, Ning; Zhou, Zhi; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhang, Ying] Shandong Marine Fisheries Res Inst, Res Ctr Fishery Resources & Ecol, Yantai, Peoples R China; [Wang, Leilei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China (973 program) from the Chinese Ministry of Science and Technology [2012CB114405]; Shandong Provincial Natural Science Foundation [JQ201110, ZR2011CQ017]	National Basic Research Program of China (973 program) from the Chinese Ministry of Science and Technology(National Basic Research Program of China); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This research was supported by National Basic Research Program of China (973 program, No. 2012CB114405) from the Chinese Ministry of Science and Technology http://www.973.gov.cn/, and Grants (No. JQ201110 to L. Wang and No. ZR2011CQ017 to Y. Zhang) from Shandong Provincial Natural Science Foundation (http://www.sdnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Burke RD, 1999, INT REV CYTOL, V191, P257, DOI 10.1016/S0074-7696(08)60161-8; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; Dinkins MB, 2008, DEV DYNAM, V237, P3927, DOI 10.1002/dvdy.21802; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hu JA, 2010, J INSECT PHYSIOL, V56, P1846, DOI 10.1016/j.jinsphys.2010.08.001; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Levin DM, 2005, INSECT BIOCHEM MOLEC, V35, P369, DOI 10.1016/j.ibmb.2005.01.003; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Luo T, 2007, MOL IMMUNOL, V44, P1516, DOI 10.1016/j.molimm.2006.09.015; Lutz KL, 1997, CURR TOP PEPT PROT R, V2, P69; Marsden M, 1997, DEV BIOL, V181, P234, DOI 10.1006/dbio.1996.8451; Miyazawa S, 2004, IMMUNOGENETICS, V55, P836, DOI 10.1007/s00251-004-0651-8; Moita LF, 2006, INSECT BIOCHEM MOLEC, V36, P282, DOI 10.1016/j.ibmb.2006.01.004; O'Reilly AM, 2008, J CELL BIOL, V182, P801, DOI 10.1083/jcb.200710141; Okada Y, 2011, BIOCHEM PHARMACOL, V81, P866, DOI 10.1016/j.bcp.2011.01.010; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wang Z, 2007, BIOCHEM BIOPH RES CO, V357, P26, DOI 10.1016/j.bbrc.2007.03.094; WILCOX M, 1989, DEVELOPMENT, V107, P891; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang HJ, 2007, FISH SHELLFISH IMMUN, V22, P88, DOI 10.1016/j.fsi.2006.03.015; YEE GH, 1993, DEVELOPMENT, V118, P845; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P418, DOI 10.1016/j.dci.2009.11.012; Zhang Y, 2009, FISH SHELLFISH IMMUN, V26, P183, DOI 10.1016/j.fsi.2008.03.008; Zhuang S, 2008, DEV COMP IMMUNOL, V32, P365, DOI 10.1016/j.dci.2007.07.007	37	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40615	10.1371/journal.pone.0040615	http://dx.doi.org/10.1371/journal.pone.0040615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792387	gold, Green Published, Green Submitted			2022-12-27	WOS:000306354700061
J	Meng, Y; Sohar, I; Wang, LL; Sleat, DE; Lobel, P				Meng, Yu; Sohar, Istvan; Wang, Lingling; Sleat, David E.; Lobel, Peter			Systemic Administration of Tripeptidyl Peptidase I in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis: Effect of Glycan Modification	PLOS ONE			English	Article							ENZYME-REPLACEMENT-THERAPY; BLOOD-BRAIN-BARRIER; RECEPTOR-MEDIATED TRANSPORT; MANNOSE 6-PHOSPHATE; INTRACEREBROVENTRICULAR INFUSION; ACID SPHINGOMYELINASE; LYSOSOMAL DISEASES; STORAGE; VII; MICE	Late-infantile neuronal ceroid lipofuscinosis (LINCL) is a recessive genetic disease of childhood caused by deficiencies in the lysosomal protease tripeptidyl peptidase I (TPP1). Disease is characterized by progressive and extensive neuronal death. One hurdle towards development of enzyme replacement therapy is delivery of TPP1 to the brain. In this study, we evaluated the effect of modifying N-linked glycans on recombinant human TPP1 on its pharmacokinetic properties after administration via tail vein injection to a mouse model of LINCL. Unmodified TPP1 exhibited a dose-dependent serum half-life of 12 min (0.12 mg) to 45 min (2 mg). Deglycosylation or modification using sodium metaperiodate oxidation and reduction with sodium borohydride increased the circulatory half-life but did not improve targeting to the brain compared to unmodified TPP1. Analysis of liver, brain, spleen, kidney and lung demonstrated that for all preparations, >95% of the recovered activity was in the liver. Interestingly, administration of a single 2 mg dose (80 mg/kg) of unmodified TPP1 resulted in similar to 10% of wild-type activity in brain. This suggests that systemic administration of unmodified recombinant enzyme merits further exploration as a potential therapy for LINCL.	[Meng, Yu; Sohar, Istvan; Sleat, David E.; Lobel, Peter] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Wang, Lingling] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Vivarium, Piscataway, NJ 08854 USA; [Sleat, David E.; Lobel, Peter] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Meng, Y (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	lobel@cabm.rutgers.edu			National Institutes of Health Grant [NS037918]; Batten Disease Support & Research Association Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Batten Disease Support & Research Association Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS037918 (PL) and by a Batten Disease Support & Research Association Fellowship (YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair D, 2010, MOL GENET METAB, V99, P132, DOI 10.1016/j.ymgme.2009.10.002; Blanz J, 2008, HUM MOL GENET, V17, P3437, DOI 10.1093/hmg/ddn237; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Dickson P, 2007, MOL GENET METAB, V91, P61, DOI 10.1016/j.ymgme.2006.12.012; Dickson PI, 2010, MOL GENET METAB, V101, P115, DOI 10.1016/j.ymgme.2010.06.020; Dierenfeld AD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001380; Dodge JC, 2009, EXP NEUROL, V215, P349, DOI 10.1016/j.expneurol.2008.10.021; Elliger SS, 1999, GENE THER, V6, P1175, DOI 10.1038/sj.gt.3300931; Gliddon BL, 2004, PEDIATR RES, V56, P65, DOI 10.1203/01.PDR.0000129661.40499.12; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; Guhaniyogi J, 2009, J BIOL CHEM, V284, P3985, DOI 10.1074/jbc.M806943200; Kakkis E, 2004, MOL GENET METAB, V83, P163, DOI 10.1016/j.ymgme.2004.07.003; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; NAKAJIMA M, 1988, J CELL BIOCHEM, V36, P157, DOI 10.1002/jcb.240360207; Rozaklis T, 2011, EXP NEUROL, V230, P123, DOI 10.1016/j.expneurol.2011.04.004; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sleat DE, 2004, J NEUROSCI, V24, P9117, DOI 10.1523/JNEUROSCI.2729-04.2004; Sohar I, 2000, CLIN CHEM, V46, P1005; Tsuji D, 2011, ANN NEUROL, V69, P691, DOI 10.1002/ana.22262; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Urayama A, 2008, MOL THER, V16, P1261, DOI 10.1038/mt.2008.84; VALENZANO KJ, 1993, ANAL BIOCHEM, V209, P156, DOI 10.1006/abio.1993.1096; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Vogler C, 1999, PEDIATR RES, V45, P838, DOI 10.1203/00006450-199906000-00010; Vogler C, 2005, P NATL ACAD SCI USA, V102, P14777, DOI 10.1073/pnas.0506892102; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; Xu S, 2011, MOL THER, V19, P1842, DOI 10.1038/mt.2011.130; Ziegler RJ, 2011, EXP NEUROL, V231, P261, DOI 10.1016/j.expneurol.2011.06.019	33	28	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40509	10.1371/journal.pone.0040509	http://dx.doi.org/10.1371/journal.pone.0040509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792360	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800101
J	Sawall, Y; Richter, C; Ramette, A				Sawall, Yvonne; Richter, Claudio; Ramette, Alban			Effects of Eutrophication, Seasonality and Macrofouling on the Diversity of Bacterial Biofilms in Equatorial Coral Reefs	PLOS ONE			English	Article							LARVAL SETTLEMENT; MULTIVARIATE ANALYSES; MICROBIAL DIVERSITY; COMMUNITY; BIODIVERSITY; SEDIMENTS; DYNAMICS; ANTIBACTERIAL; METAMORPHOSIS; PRODUCTIVITY	Biofilms play an important role as a settlement cue for invertebrate larvae and significantly contribute to the nutrient turnover in aquatic ecosystems. Nevertheless, little is known about how biofilm community structure generally responds to environmental changes. This study aimed to identify patterns of bacterial dynamics in coral reef biofilms in response to associated macrofouling community structure, microhabitat (exposed vs. sheltered), seasonality, and eutrophication. Settlement tiles were deployed at four reefs along a cross-shelf eutrophication gradient and were exchanged every 4 months over 20 months. The fouling community composition on the tiles was recorded and the bacterial community structure was assessed with the community fingerprinting technique Automated Ribosomal Intergenic Spacer Analysis (ARISA). Bacterial operational taxonomic unit (OTU) number was higher on exposed tiles, where the fouling community was homogenous and algae-dominated, than in sheltered habitats, which were occupied by a variety of filter feeders. Furthermore, OTU number was also highest in eutrophied near-shore reefs, while seasonal variations in community structure were most pronounced in the oligotrophic mid-shelf reef. In contrast, the macrofouling community structure did not change significantly with seasons. Changes in bacterial community patterns were mostly affected by microhabitat, seasonal and anthropogenically derived changes in nutrient availability, and to a lesser extent by changes in the macrofouling community structure. Path analysis revealed a complex interplay of various environmental and biological factors explaining the spatial and temporal variations in bacterial biofilm communities under natural conditions.	[Sawall, Yvonne] Leibniz Ctr Trop Marine Ecol, Bremen, Germany; [Richter, Claudio] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Ramette, Alban] Max Planck Inst Marine Microbiol, HGF MPG Grp Deep Sea Ecol & Technol, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society	Sawall, Y (corresponding author), Helmholtz Ctr Ocean Res GEOMAR, Res Unit Benth Ecol, Kiel, Germany.	aramette@mpi-bremen.de	Richter, Claudio/AAT-1212-2020; Ramette, Alban/E-9197-2016	Richter, Claudio/0000-0002-8182-6896; Ramette, Alban/0000-0002-3437-4639	German Federal Ministry of Education and Research (BMBF) under a bilateral German-Indonesian project (SPICE) [03F0472A]; Bremen International Graduate School for Marine Sciences (GLOMAR); German Research Foundation (DFG); Max Planck Society	German Federal Ministry of Education and Research (BMBF) under a bilateral German-Indonesian project (SPICE)(Federal Ministry of Education & Research (BMBF)); Bremen International Graduate School for Marine Sciences (GLOMAR); German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This study was funded by the German Federal Ministry of Education and Research (BMBF) under a bilateral German-Indonesian project (SPICE, grant number 03F0472A). Further support was given by the Bremen International Graduate School for Marine Sciences (GLOMAR) funded by the German Research Foundation (DFG). AR was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2012, FEMS MICROBIOL ECOL, V80, P294, DOI 10.1111/j.1574-6941.2011.01289.x; Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; ALOGILY SM, 1977, NATURE, V265, P728, DOI 10.1038/265728a0; Armstrong E, 2001, HYDROBIOLOGIA, V461, P37, DOI 10.1023/A:1012756913566; Belliveau SA, 2002, MAR ECOL PROG SER, V232, P105, DOI 10.3354/meps232105; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; BOTO KG, 1978, ANAL CHEM, V50, P392, DOI 10.1021/ac50025a009; BUSS LW, 1981, J EXP MAR BIOL ECOL, V49, P151, DOI 10.1016/0022-0981(81)90067-8; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Claret C, 1998, AQUAT SCI, V60, P33, DOI 10.1007/s000270050025; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; DELGADO O, 1994, CORAL REEFS, V13, P151, DOI 10.1007/BF00301191; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025; English S, 1997, SURVEY MANUAL TROPIC, V2; Fairfull SJL, 1999, MAR FRESHWATER RES, V50, P235, DOI 10.1071/MF97267; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Gillan DC, 1998, APPL ENVIRON MICROB, V64, P3464; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hewson I, 2006, MICROB ECOL, V51, P147, DOI 10.1007/s00248-005-0144-9; Hewson I, 2006, MAR ECOL PROG SER, V306, P79, DOI 10.3354/meps306079; Hoeksema Bert W., 2007, V29, P117; HOEKSEMA BW, 1989, NETH J SEA RES, V23, P149, DOI 10.1016/0077-7579(89)90009-4; Huang YL, 2007, APPL ENVIRON MICROB, V73, P6284, DOI 10.1128/AEM.00578-07; Hung OS, 2005, MAR ECOL PROG SER, V304, P155, DOI 10.3354/meps304155; Jin T, 2005, MAR ECOL PROG SER, V297, P169, DOI 10.3354/meps297169; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kinkade C, 1997, DEEP-SEA RES PT I, V44, P581, DOI 10.1016/S0967-0637(97)00002-2; Lau SCK, 2005, AQUAT MICROB ECOL, V38, P41, DOI 10.3354/ame038041; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1998, NUMERICAL ECOLOGY, V2; Meyer-Reil LA, 2000, MAR POLLUT BULL, V41, P255, DOI 10.1016/S0025-326X(00)00114-4; MOLL H, 1983, THESIS LEIDEN U; Moss JA, 2006, APPL ENVIRON MICROB, V72, P5679, DOI 10.1128/AEM.02773-05; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nocker A, 2004, APPL ENVIRON MICROB, V70, P6834, DOI 10.1128/AEM.70.11.6834-6845.2004; Poltak SR, 2011, ISME J, V5, P369, DOI 10.1038/ismej.2010.136; Pringault O, 2008, MICROB ECOL, V55, P247, DOI 10.1007/s00248-007-9272-8; Qian PY, 2009, SPRINGER SER BIOFILM, V4, P315, DOI 10.1007/7142_2008_19; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Renema W, 2001, PALAEOGEOGR PALAEOCL, V175, P125, DOI 10.1016/S0031-0182(01)00389-3; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; Schottner S, 2011, ENVIRON MICROBIOL, V13, P1815, DOI 10.1111/j.1462-2920.2011.02494.x; SLATTERY M, 1995, J EXP MAR BIOL ECOL, V190, P61, DOI 10.1016/0022-0981(95)00032-M; Stirk WA, 2007, J APPL PHYCOL, V19, P271, DOI 10.1007/s10811-006-9134-7; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Uthicke S, 2007, ESTUAR COAST SHELF S, V72, P188, DOI 10.1016/j.ecss.2006.10.017; WALLS JT, 1993, J EXP MAR BIOL ECOL, V169, P1, DOI 10.1016/0022-0981(93)90039-Q; Webster NS, 2006, ENVIRON MICROBIOL, V8, P1177, DOI 10.1111/j.1462-2920.2006.01007.x; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wieczorek SK, 1998, BIOFOULING, V12, P81, DOI 10.1080/08927019809378348; [No title captured], DOI DOI 10.1023/A:1009971414055	63	36	38	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39951	10.1371/journal.pone.0039951	http://dx.doi.org/10.1371/journal.pone.0039951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792198	Green Published, gold, Green Accepted			2022-12-27	WOS:000306461800027
J	Pazos, MA; Kraus, TA; Munoz-Fontela, C; Moran, TM				Pazos, Michael A.; Kraus, Thomas A.; Munoz-Fontela, Cesar; Moran, Thomas M.			Estrogen Mediates Innate and Adaptive Immune Alterations to Influenza Infection in Pregnant Mice	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; COLLAGEN-INDUCED ARTHRITIS; CD8(+) T-CELLS; MULTIPLE-SCLEROSIS; VIRUS INFECTION; POSTPARTUM WOMEN; VIRAL-INFECTION; HORMONE ESTRIOL; PRETERM LABOR; CUTTING EDGE	Pregnancy is a leading risk factor for severe complications during an influenza virus infection. Women infected during their second and third trimesters are at increased risk for severe cardiopulmonary complications, premature delivery, and death. Here, we establish a murine model of aerosolized influenza infection during pregnancy. We find significantly altered innate antiviral responses in pregnant mice, including decreased levels of IFN-beta, IL-1 alpha, and IFN-gamma at early time points of infection. We also find reduced cytotoxic T cell activity and delayed viral clearance. We further demonstrate that pregnancy levels of the estrogen 17-beta-estradiol are able to induce key anti-inflammatory phenotypes in immune responses to the virus independently of other hormones or pregnancy-related stressors. We conclude that elevated estrogen levels result in an attenuated anti-viral immune response, and that pregnancy-associated morbidities occur in the context of this anti-inflammatory phenotype.	[Pazos, Michael A.; Kraus, Thomas A.; Moran, Thomas M.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Kraus, Thomas A.] Mt Sinai Sch Med, Dept Obstet Gynecol & Reprod Sci, New York, NY USA; [Munoz-Fontela, Cesar] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Heinrich Pette Institute	Pazos, MA (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	Thomas.Moran@mssm.edu		Munoz-Fontela, Cesar/0000-0002-7725-2586	National Institutes of Health (NIH) [RO1 AI41111, NO1 AI50028, U19 AI062623, F31 AI086197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI086197, R01AI041111, N01AI050028, U19AI062623] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The following National Institutes of Health (NIH) grants contributed to this work: RO1 AI41111, NO1 AI50028, U19 AI062623, F31 AI086197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Biswas Debajit K, 2005, Sci STKE, V2005, ppe27, DOI 10.1126/stke.2882005pe27; Blanchard-Rohner G, 2011, VACCINE, V29, P7542, DOI 10.1016/j.vaccine.2011.08.013; Borderia AV, 2008, J IMMUNOL, V181, P6872, DOI 10.4049/jimmunol.181.10.6872; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CASEY ML, 1989, J CLIN INVEST, V83, P430, DOI 10.1172/JCI113901; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Dulos J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3032; Elloso MM, 2005, J ENDOCRINOL, V185, P243, DOI 10.1677/joe.1.06063; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Escribese MM, 2008, BLOOD, V112, P4574, DOI 10.1182/blood-2008-04-148692; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; GELLIN BG, 1991, AM J EPIDEMIOL, V133, P392, DOI 10.1093/oxfordjournals.aje.a115893; Harger JH, 2002, J INFECT DIS, V185, P422, DOI 10.1086/338832; Harris J, 1919, JAMA; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hermesh T, 2010, CELL HOST MICROBE, V7, P343, DOI 10.1016/j.chom.2010.04.006; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jansson L, 2001, ARTHRITIS RHEUM, V44, P2168, DOI 10.1002/1529-0131(200109)44:9<2168::AID-ART370>3.0.CO;2-2; Jara LJ, 2011, CLIN REV ALLERG IMMU, V40, P50, DOI 10.1007/s12016-009-8185-3; Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim S, 1999, NEUROLOGY, V52, P1230, DOI 10.1212/WNL.52.6.1230; Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006; Klein Sabra L, 2010, Biol Sex Differ, V1, P5, DOI 10.1186/2042-6410-1-5; KLIPPLE GL, 1989, RHEUM DIS CLIN N AM, V15, P213; Kraus TA, 2010, AM J REPROD IMMUNOL, V64, P411, DOI 10.1111/j.1600-0897.2010.00889.x; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lopez CB, 2000, CELL IMMUNOL, V206, P107, DOI 10.1006/cimm.2000.1736; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Luft T, 1998, J IMMUNOL, V161, P1947; Marcelin G, 2011, J VIROL, V85, P11208, DOI 10.1128/JVI.00654-11; MATTSSON R, 1991, CLIN EXP IMMUNOL, V85, P41, DOI 10.1111/j.1365-2249.1991.tb05679.x; Mattsson R, 1998, AM J REPROD IMMUNOL, V40, P383, DOI 10.1111/j.1600-0897.1998.tb00422.x; McNeil SA, 2011, AM J OBSTET GYNECOL, V204, pS54, DOI 10.1016/j.ajog.2011.04.031; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Munoz-Fontela C, 2011, J IMMUNOL, V187, P6428, DOI 10.4049/jimmunol.1101459; Nesin M, 2000, AM J PERINAT, V17, P393, DOI 10.1055/s-2000-13457; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Robertson CA, 2004, EMERG INFECT DIS, V10, P345, DOI 10.3201/eid1002.030736; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Ruder C, 2009, J CLIN INVEST, V119, P2184, DOI 10.1172/JCI37760; SCHULMAN JL, 1963, J EXP MED, V118, P257, DOI 10.1084/jem.118.2.257; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; SIEM RA, 1960, J NEUROPATH EXP NEUR, V19, P125, DOI 10.1097/00005072-196001000-00013; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; STGEME JW, 1970, CALIF MED, V112, P25; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Svensson T, 2011, PHARMACOEPIDEM DR S, V20, P1030, DOI 10.1002/pds.2194; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Thomas IJ, 2007, J IMMUNOL, V179, P5936, DOI 10.4049/jimmunol.179.9.5936; Varner MW, 2011, OBSTET GYNECOL, V118, P593, DOI 10.1097/AOG.0b013e318229e484; WILLIAMS K, 1977, J HYG-CAMBRIDGE, V79, P249, DOI 10.1017/S0022172400053067; Wong SF, 2003, BJOG-INT J OBSTET GY, V110, P641, DOI 10.1046/j.1471-0528.2003.03008.x; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503	74	55	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40502	10.1371/journal.pone.0040502	http://dx.doi.org/10.1371/journal.pone.0040502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792357	Green Published, Green Submitted, gold			2022-12-27	WOS:000306436300070
J	Zou, HF; Li, RS; Jia, YM; Yang, XJ; Ni, YD; Cong, RH; Soloway, PD; Zhao, RQ				Zou, Huafeng; Li, Runsheng; Jia, Yimin; Yang, Xiaojing; Ni, Yingdong; Cong, Rihua; Soloway, Paul D.; Zhao, Ruqian			Breed-Dependent Transcriptional Regulation of 5 '-Untranslated GR (NR3C1) Exon 1 mRNA Variants in the Liver of Newborn Piglets	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR GENE; ELEMENT-BINDING PROTEIN; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; DIFFERENTIAL REGULATION; EPIGENETIC REGULATION; DNA METHYLATION; RESTRICTED DIET; EXPRESSION; PROMOTER; MULTIPLE	Glucocorticoids are vital for life and regulate an array of physiological functions by binding to the ubiquitously expressed glucocorticoid receptor (GR, also known as NR3C1). Previous studies demonstrate striking breed differences in plasma cortisol levels in pigs. However, investigation into the breed-dependent GR transcriptional regulation is hampered by lacking porcine GR promoter information. In this study, we sequenced 5.3 kb upstream of the translation start codon of the porcine GR gene, and identified seven alternative 59-untranslated exons 1-4, 1-5, 1-6, 1-7, 1-8, 1-9,10 and 1-11. Among all these mRNA variants, exons 1-4 and 1-5, as well as the total GR were expressed significantly (P<0.05) higher in the liver of newborn piglets of Large White (LW) compared with Erhualian, a Chinese indigenous breed. Overall level of CpG methylation in the region flanking exons 1-4 and 1-5 did not show breed difference. However, nuclear content of Sp1, p-CREB and GR in the liver was significantly (P<0.05) higher in LW piglets, associated with enhanced binding of p-CREB, and higher level of histone H3 acetylation in 1-4 and 1-5 promoters. In contrast, GR binding to promoters of exons 1-4 and 1-5 was significantly diminished in LW piglets, implicating the presence of negative GREs. These results indicate that the difference in the hepatic expression of GR transcript variants between two breeds of pigs is determined, at least partly, by the disparity in the binding of transcription factors and the enrichment of histone H3 acetylation to the promoters.	[Zou, Huafeng; Li, Runsheng; Jia, Yimin; Yang, Xiaojing; Ni, Yingdong; Cong, Rihua; Zhao, Ruqian] Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China; [Soloway, Paul D.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Cornell University	Zou, HF (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zhao.ruqian@gmail.com	Soloway, Paul/T-8243-2019; LI, Runsheng/AFR-9519-2022	LI, Runsheng/0000-0003-1563-1844; Soloway, Paul/0000-0003-1967-0437; Zou, Huafeng/0000-0002-6994-9586	National Basic Research Program of China [2012CB124703]; Major National Science & Technology Program [2009ZX08009-138B]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; Cornell University; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105243] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Major National Science & Technology Program; Special Fund for Agro-scientific Research in the Public Interest; Cornell University; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Basic Research Program of China (2012CB124703), the Major National Science & Technology Program (2009ZX08009-138B), the Special Fund for Agro-scientific Research in the Public Interest (201003011), the Jeffrey Sean Lehman Fund for Scholarly Exchange with China from Cornell University, and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt SR, 2010, PSYCHONEUROENDOCRINO, V35, P544, DOI 10.1016/j.psyneuen.2009.09.001; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; Boullion RD, 2003, COMPARATIVE MED, V53, P42; Breslin MB, 2001, MOL ENDOCRINOL, V15, P1381, DOI 10.1210/me.15.8.1381; Breslin MB, 1998, J STEROID BIOCHEM, V67, P369, DOI 10.1016/S0960-0760(98)00138-1; Brinks V, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08.008.2007, 10.3389/neuro.08/008.2007]; Cabral ALB, 2001, MOL CELL ENDOCRINOL, V175, P67, DOI 10.1016/S0303-7207(01)00396-3; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen FH, 1999, J CELL BIOCHEM, V74, P418, DOI 10.1002/(SICI)1097-4644(19990901)74:3<418::AID-JCB10>3.0.CO;2-6; Desautes C, 1999, DOMEST ANIM ENDOCRIN, V16, P193, DOI 10.1016/S0739-7240(99)00014-4; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Govindan MV, 2010, J BIOL CHEM, V285, P4489, DOI 10.1074/jbc.M109.072728; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Johren O, 2007, BRAIN RES, V1184, P160, DOI 10.1016/j.brainres.2007.09.036; Klemcke HG, 2003, BIOL REPROD, V69, P1945, DOI 10.1095/biolreprod.103.018150; Li LA, 2008, LIVEST SCI, V113, P169, DOI 10.1016/j.livsci.2007.03.008; Li X, 2009, MEAT SCI, V81, P218, DOI 10.1016/j.meatsci.2008.07.022; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Liu YJ, 2005, DIABETES, V54, P32, DOI 10.2337/diabetes.54.1.32; Marelli SP, 2010, ANIM BIOTECHNOL, V21, P140, DOI 10.1080/10495391003608621; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mostyn A, 2006, J ENDOCRINOL, V190, P631, DOI 10.1677/joe.1.06731; Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Penuelas I, 1998, J STEROID BIOCHEM, V67, P89, DOI 10.1016/S0960-0760(98)00097-1; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Russcher H, 2007, J MOL ENDOCRINOL, V38, P91, DOI 10.1677/jme.1.02117; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Suehiro T, 2004, MOL CELL ENDOCRINOL, V222, P33, DOI 10.1016/j.mce.2004.05.005; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Turner JD, 2006, BIOCHEM PHARMACOL, V72, P1529, DOI 10.1016/j.bcp.2006.07.005; Turner JD, 2010, BIOCHEM PHARMACOL, V80, P1860, DOI 10.1016/j.bcp.2010.06.037; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wei S, 2010, LIVEST SCI, V131, P240, DOI 10.1016/j.livsci.2010.04.007; Yau JLW, 2004, MOL BRAIN RES, V129, P189, DOI 10.1016/j.molbrainres.2004.06.033; Yuan LX, 2009, BRAIN RES, V1273, P18, DOI 10.1016/j.brainres.2009.03.052; ZONG J, 1990, MOL CELL BIOL, V10, P5580, DOI 10.1128/MCB.10.10.5580	44	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40432	10.1371/journal.pone.0040432	http://dx.doi.org/10.1371/journal.pone.0040432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792317	gold, Green Published, Green Submitted			2022-12-27	WOS:000306436300065
J	Ribeiro, FS; da Silva, ICD; Carneiro, VC; Belgrano, FD; Mohana-Borges, R; Rosa, ID; Benchimol, M; Souza, NRQ; Mesquita, RD; Sorgine, MHF; Gazos-Lopes, F; Vicentino, ARR; Wu, WJ; Maciel, RD; da Silva-Neto, MAC; Fantappie, MR				Ribeiro, Fabio Schneider; de Abreu da Silva, Isabel Caetano; Carneiro, Vitor Coutinho; Belgrano, Fabricio dos Santos; Mohana-Borges, Ronaldo; Rosa, Ivone de Andrade; Benchimol, Marlene; Quintino Souza, Nathalia Rocha; Mesquita, Rafael Dias; Ferreira Sorgine, Marcos Henrique; Gazos-Lopes, Felipe; Revoredo Vicentino, Amanda Roberta; Wu, Wenjie; Maciel, Renata de Moraes; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado			The Dengue Vector Aedes aegypti Contains a Functional High Mobility Group Box 1 (HMGB1) Protein with a Unique Regulatory C-Terminus	PLOS ONE			English	Article							DNA-BINDING PROPERTIES; ACIDIC TAIL; CHROMATIN PROTEIN; IN-VITRO; DSP1; DOMAINS; GENE; RECEPTORS; COMPLEXES; INTERACT	The mosquito Aedes aegypti can spread the dengue, chikungunya and yellow fever viruses. Thus, the search for key molecules involved in the mosquito survival represents today a promising vector control strategy. High Mobility Group Box (HMGB) proteins are essential nuclear factors that maintain the high-order structure of chromatin, keeping eukaryotic cells viable. Outside the nucleus, secreted HMGB proteins could alert the innate immune system to foreign antigens and trigger the initiation of host defenses. In this work, we cloned and functionally characterized the HMGB1 protein from Aedes aegypti (AaHMGB1). The AaHMGB1 protein typically consists of two HMG-box DNA binding domains and an acidic C-terminus. Interestingly, AaHMGB1 contains a unique alanine/glutamine-rich (AQ-rich) C-terminal region that seems to be exclusive of dipteran HMGB proteins. AaHMGB1 is localized to the cell nucleus, mainly associated with heterochromatin. Circular dichroism analyses of AaHMGB1 or the C-terminal truncated proteins revealed a-helical structures. We showed that AaHMGB1 can effectively bind and change the topology of DNA, and that the AQ-rich and the C-terminal acidic regions can modulate its ability to promote DNA supercoiling, as well as its preference to bind supercoiled DNA. AaHMGB1 is phosphorylated by PKA and PKC, but not by CK2. Importantly, phosphorylation of AaHMGB1 by PKA or PKC completely abolishes its DNA bending activity. Thus, our study shows that a functional HMGB1 protein occurs in Aedes aegypt and we provide the first description of a HMGB1 protein containing an AQ-rich regulatory C-terminus.	[Ribeiro, Fabio Schneider; de Abreu da Silva, Isabel Caetano; Carneiro, Vitor Coutinho; Gazos-Lopes, Felipe; Revoredo Vicentino, Amanda Roberta; Maciel, Renata de Moraes; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Belgrano, Fabricio dos Santos; Mohana-Borges, Ronaldo; Rosa, Ivone de Andrade] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Quintino Souza, Nathalia Rocha; Mesquita, Rafael Dias] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, Rio De Janeiro, Brazil; [Quintino Souza, Nathalia Rocha; Mesquita, Rafael Dias; Ferreira Sorgine, Marcos Henrique; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil; [Rosa, Ivone de Andrade; Benchimol, Marlene] Univ Santa Ursula, Rio De Janeiro, Brazil; [Wu, Wenjie] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Roswell Park Cancer Institute	Ribeiro, FS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.	fantappie@bioqmed.ufrj.br	Borges, Ronaldo S Mohana/C-5575-2013; Mesquita, Rafael Dias/AAH-4352-2022; Silva-Neto, Mario A C/C-1211-2013; Mesquita, Rafael Dias/AFP-3693-2022; de Moraes Maciel, Renata/E-1426-2014	Mesquita, Rafael Dias/0000-0002-2882-3362; Silva-Neto, Mario A C/0000-0003-2273-194X; Mesquita, Rafael Dias/0000-0002-2882-3362; Carneiro, Vitor/0000-0003-1518-7667; Belgrano, Fabricio/0000-0002-0411-7244	INCT-EM; CNPq; Faperj	INCT-EM; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by INCT-EM (http://www.inctem.bioqmed.ufrj.br/), CNPq (http://www.cnpq.br/), and Faperj (http://www.faperj.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar MM, 2008, EUKARYOT CELL, V7, P1565, DOI 10.1128/EC.00123-08; Aleporou-Marinou V, 2003, BIOCHEM GENET, V41, P291, DOI 10.1023/B:BIGI.0000006030.05308.04; de Oliveira FMB, 2006, GENE, V377, P33, DOI 10.1016/j.gene.2006.03.001; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Briquet S, 2006, EUKARYOT CELL, V5, P672, DOI 10.1128/EC.5.4.672-682.2006; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086; Chen YH, 2011, MOL IMMUNOL, V48, P793, DOI 10.1016/j.molimm.2010.11.020; da Silva ICD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023572; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hagedorn HH, 1989, PHYSL ROLES HEMOLYMP; Kiilerich B, 2008, GENE, V407, P86, DOI 10.1016/j.gene.2007.09.025; Kirov NC, 1996, EMBO J, V15, P7079, DOI 10.1002/j.1460-2075.1996.tb01099.x; Lamiable O, 2010, GENESIS, V48, P244, DOI 10.1002/dvg.20609; Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Martin D, 2003, J BIOCHEM, V134, P583, DOI 10.1093/jb/mvg177; Mosrin-Huaman C, 1998, DEV GENET, V23, P324; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; NER SS, 1993, NUCLEIC ACIDS RES, V21, P4369, DOI 10.1093/nar/21.18.4369; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Payet D, 1997, J MOL BIOL, V266, P66, DOI 10.1006/jmbi.1996.0782; Pfaffl MW, 2001, APMIS, V109, P345, DOI 10.1034/j.1600-0463.2001.090503.x; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; Retief J D, 2000, Methods Mol Biol, V132, P243; Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249; Salvaing J, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-9; Seabra-Junior E.S., 2011, FAT FUNCTIONAL ANAL; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x; Stros M, 1998, J BIOL CHEM, V273, P10355; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Thomsen MS, 2004, BIOCHEMISTRY-US, V43, P8029, DOI 10.1021/bi0499009; WAGNER CR, 1992, MOL CELL BIOL, V12, P1915, DOI 10.1128/MCB.12.5.1915; Wang SF, 1998, J BIOL CHEM, V273, P27531, DOI 10.1074/jbc.273.42.27531; WARD LD, 1985, METHOD ENZYMOL, V117, P400; WISNIEWSKI JR, 1992, J BIOL CHEM, V267, P17170; WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P10713; WISNIEWSKI JR, 1994, EUR J BIOCHEM, V225, P687, DOI 10.1111/j.1432-1033.1994.00687.x; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	55	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40192	10.1371/journal.pone.0040192	http://dx.doi.org/10.1371/journal.pone.0040192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802955	Green Submitted, gold, Green Published			2022-12-27	WOS:000306186900029
J	van Bokhorst-van de Veen, H; Lee, IC; Marco, ML; Wels, M; Bron, PA; Kleerebezem, M				van Bokhorst-van de Veen, Hermien; Lee, I-Chiao; Marco, Maria L.; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel			Modulation of Lactobacillus plantarum Gastrointestinal Robustness by Fermentation Conditions Enables Identification of Bacterial Robustness Markers	PLOS ONE			English	Article							STRESS-RESPONSE; IN-VITRO; GENETIC-CHARACTERIZATION; BILE-SALT; STRAINS; LACTOCOCCUS; SURVIVAL; REUTERI; GROWTH; WCFS1	Background: Lactic acid bacteria (LAB) are applied worldwide in the production of a variety of fermented food products. Additionally, specific Lactobacillus species are nowadays recognized for their health-promoting effects on the consumer. To optimally exert such beneficial effects, it is considered of great importance that these probiotic bacteria reach their target sites in the gut alive. Methodology/Principal Findings: In the accompanying manuscript by Bron et al. the probiotic model organism Lactobacillus plantarum WCFS1 was cultured under different fermentation conditions, which was complemented by the determination of the corresponding molecular responses by full-genome transcriptome analyses. Here, the gastrointestinal (GI) survival of the cultures produced was assessed in an in vitro assay. Variations in fermentation conditions led to dramatic differences in GI-tract survival (up to 7-log) and high robustness could be associated with low salt and low pH during the fermentations. Moreover, random forest correlation analyses allowed the identification of specific transcripts associated with robustness. Subsequently, the corresponding genes were targeted by genetic engineering, aiming to enhance robustness, which could be achieved for 3 of the genes that negatively correlated with robustness and where deletion derivatives displayed enhanced survival compared to the parental strain. Specifically, a role in GI-tract survival could be confirmed for the lp_1669-encoded AraC-family transcription regulator, involved in capsular polysaccharide remodeling, the penicillin-binding protein Pbp2A involved in peptidoglycan biosynthesis, and the Na+/H+ antiporter NapA3. Moreover, additional physiological analysis established a role for Pbp2A and NapA3 in bile salt and salt tolerance, respectively. Conclusion: Transcriptome trait matching enabled the identification of biomarkers for bacterial (gut-) robustness, which is important for our molecular understanding of GI-tract survival and could facilitate the design of culture conditions aimed to enhance probiotic culture robustness.	[van Bokhorst-van de Veen, Hermien; Lee, I-Chiao; Marco, Maria L.; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [van Bokhorst-van de Veen, Hermien; Lee, I-Chiao; Marco, Maria L.; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [van Bokhorst-van de Veen, Hermien; Kleerebezem, Michiel] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands; [Wels, Michiel] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Top Institute Food & Nutrition; NIZO Food Research; Wageningen University & Research; Radboud University Nijmegen	van Bokhorst-van de Veen, H (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	Michiel.Kleerebezem@nizo.nl	van Bokhorst-van de Veen, Hermien/K-2111-2013; Kleerebezem, Michiel/AAT-2078-2021; Marco, Maria/H-2322-2014	van Bokhorst-van de Veen, Hermien/0000-0003-4159-5955; Kleerebezem, Michiel/0000-0001-8552-2235				Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bron PA, 2006, J APPL MICROBIOL, V100, P728, DOI 10.1111/j.1365-2672.2006.02891.x; Bron PA, 2004, J BACTERIOL, V186, P7829, DOI 10.1128/JB.186.23.7829-7835.2004; Bron PA, 2011, FOOD MICROBIOL FOOD, P369, DOI 10.1007/978-0-387-92771-8_16; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Corcoran BM, 2008, CURR PHARM DESIGN, V14, P1382, DOI 10.2174/138161208784480225; Corcoran BM, 2004, J APPL MICROBIOL, V96, P1024, DOI 10.1111/j.1365-2672.2004.02219.x; Eijsink VGH, 1996, J BACTERIOL, V178, P2232, DOI 10.1128/jb.178.8.2232-2237.1996; FAO/WHO, 2001, EV HLTH NUTR PROP PO; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Georgieva RN, 2008, J BASIC MICROB, V48, P234, DOI 10.1002/jobm.200700355; Gobbetti M, 2010, CRIT REV FOOD SCI, V50, P716, DOI 10.1080/10408398.2010.499770; GOVERS MJAP, 1994, J LIPID RES, V35, P741; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Ingham CJ, 2008, APPL ENVIRON MICROB, V74, P7750, DOI 10.1128/AEM.00982-08; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kim WS, 2001, CURR MICROBIOL, V43, P346, DOI 10.1007/s002840010314; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Looijesteijn PJ, 1999, J BIOSCI BIOENG, V88, P178, DOI 10.1016/S1389-1723(99)80198-4; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; Marteau P, 1997, J DAIRY SCI, V80, P1031, DOI 10.3168/jds.S0022-0302(97)76027-2; Matto J, 2004, J APPL MICROBIOL, V97, P459, DOI 10.1111/j.1365-2672.2004.02340.x; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Pfeiler EA, 2007, J BACTERIOL, V189, P4624, DOI 10.1128/JB.00337-07; Prasad J, 2003, APPL ENVIRON MICROB, V69, P917, DOI 10.1128/AEM.69.2.917-925.2003; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Sorvig E, 2005, MICROBIOL-SGM, V151, P2439, DOI 10.1099/mic.0.28084-0; Succi M, 2005, FEMS MICROBIOL LETT, V244, P129, DOI 10.1016/j.femsle.2005.01.037; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; van Bokhorst-van de Veen H, 2011, APPL ENVIRON MICROB, V77, P5247, DOI 10.1128/AEM.00515-11; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Vesa T, 2000, ALIMENT PHARM THER, V14, P823; Wall T, 2007, APPL ENVIRON MICROB, V73, P3924, DOI 10.1128/AEM.01502-06; Watson D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-176; Weckx S, 2010, APPL ENVIRON MICROB, V76, P5402, DOI 10.1128/AEM.00570-10; Wegkamp A, 2008, MODULATION FOLATE PR; Wegkamp A, 2009, FEMS MICROBIOL LETT, V297, P261, DOI 10.1111/j.1574-6968.2009.01690.x; Wels M, 2006, NUCLEIC ACIDS RES, V34, P1947, DOI 10.1093/nar/gkl138; Whitehead K, 2008, APPL ENVIRON MICROB, V74, P1812, DOI 10.1128/AEM.02259-07; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173	55	50	51	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39053	10.1371/journal.pone.0039053	http://dx.doi.org/10.1371/journal.pone.0039053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802934	gold, Green Published			2022-12-27	WOS:000306186900008
J	Di Pasquale, G; Dicembrini, I; Raimondi, L; Pagano, C; Egan, JM; Cozzi, A; Cinci, L; Loreto, A; Manni, ME; Berretti, S; Morelli, A; Zheng, CY; Michael, DG; Maggi, M; Vettor, R; Chiorini, JA; Mannucci, E; Rotella, CM				Di Pasquale, Giovanni; Dicembrini, Ilaria; Raimondi, Laura; Pagano, Claudio; Egan, Josephine M.; Cozzi, Andrea; Cinci, Lorenzo; Loreto, Andrea; Manni, Maria E.; Berretti, Silvia; Morelli, Annamaria; Zheng, Changyu; Michael, Drew G.; Maggi, Mario; Vettor, Roberto; Chiorini, John A.; Mannucci, Edoardo; Rotella, Carlo M.			Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; LEBERS CONGENITAL AMAUROSIS; GLP-1 RECEPTOR AGONISTS; INSULIN SENSITIVITY; EXPRESSION; DELIVERY; VECTORS; RELEASE; MICE; HOMEOSTASIS	Exendin-4 (Ex-4) is a Glucagon-like peptide 1 (GLP-1) receptor agonist approved for the treatment of Type 2 Diabetes (T2DM), which requires daily subcutaneous administration. In T2DM patients, GLP-1 administration is reported to reduce glycaemia and HbA1c in association with a modest, but significant weight loss. The aim of present study was to characterize the site-specific profile and metabolic effects of Ex-4 levels expressed from salivary glands (SG) in vivo, following adenoassociated virus-mediated (AAV) gene therapy in two different animal models of obesity prone to impaired glucose tolerance and T2DM, specifically, Zucker fa/fa rats and high fed diet (HFD) mice. Following percutaneous injection of AAV5 into the salivary glands, biologically active Ex-4 was detected in the blood of both animal models and expression persisted in salivary gland ductal cell until the end of the study. In treated mice, Ex-4 levels averaged 138.9 +/- 42.3 pmol/L on week 6 and in treated rats, mean circulating Ex-4 levels were 238.2 +/- 72 pmol/L on week 4 and continued to increase through week 8. Expression of Ex-4 resulted in a significant decreased weight gain in both mice and rats, significant improvement in glycemic control and/or insulin sensitivity as well as visceral adipose tissue adipokine profile. In conclusion, these results suggest that sustained site-specific expression of Ex-4 following AAV5-mediated gene therapy is feasible and may be useful in the treatment of obesity as well as trigger improved metabolic profile.	[Di Pasquale, Giovanni; Zheng, Changyu; Michael, Drew G.; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Dicembrini, Ilaria; Rotella, Carlo M.] Univ Florence, Endocrinol Sect, Dept Clin Pathophysiol, Florence, Italy; [Raimondi, Laura; Cozzi, Andrea; Loreto, Andrea; Manni, Maria E.; Berretti, Silvia] Univ Florence, Dept Pharmacol, Florence, Italy; [Pagano, Claudio; Vettor, Roberto] Univ Padua, Dept Med & Surg Sci, Endocrine Metab Lab, Padua, Italy; [Egan, Josephine M.] Natl Inst Aging & Hlth, Diabet Sect, Baltimore, MD USA; [Cinci, Lorenzo] Univ Florence, Sect Histol, Dept Anat, Florence, Italy; [Morelli, Annamaria; Maggi, Mario] Univ Florence, Sexual Med & Androl Unit, Dept Clin Physiopathol, Florence, Italy; [Mannucci, Edoardo] Careggi Teaching Hosp, Diabet Agcy, Florence, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Florence; University of Florence; University of Padua; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Florence; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Di Pasquale, G (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA.	jchiorini@dir.nidcr.nih.gov; c.rotella@dfc.unifi.it	Maggi, Mario/AAB-8284-2019; Raimondi, laura/A-9280-2013; Pagano, Claudio/O-1873-2013; Morelli, Annamaria/AAS-4244-2020; Mannucci, Edoardo/K-6749-2016; VETTOR, ROBERTO/K-7121-2016	Mannucci, Edoardo/0000-0001-9759-9408; MAGGI, Mario/0000-0003-3267-4221; Cinci, Lorenzo/0000-0002-1799-4828; Morelli, Annamaria/0000-0001-8027-9870; Vettor, Roberto/0000-0003-0625-6667; Raimondi, Laura/0000-0002-8423-0860; PAGANO, CLAUDIO/0000-0002-4335-8411; Loreto, Andrea/0000-0001-6535-6436	Italian Ministry of Health, Regione Toscana Department of Health (Italy); intramural National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000214, ZIAAG000905] Funding Source: NIH RePORTER	Italian Ministry of Health, Regione Toscana Department of Health (Italy); intramural National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by Italian Ministry of Health, Regione Toscana Department of Health (Italy), and intramural National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen J, 2011, HUM GENE THER, V22, P84, DOI 10.1089/hum.2010.097; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BEUTLER AS, 1995, J NEUROCHEM, V64, P475; Breslin WL, 2010, LAB ANIM-UK, V44, P231, DOI 10.1258/la.2010.009114; Choi S, 2005, MOL THER, V12, P885, DOI 10.1016/j.ymthe.2005.03.039; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Di Pasquale G, 2005, MOL THER, V11, P849, DOI 10.1016/j.ymthe.2005.02.004; Diaz-Nido J, 2010, CURR OPIN INVEST DR, V11, P813; Dicembrini I, 2011, EXP DIABETES RES, DOI 10.1155/2011/898913; Doyle ME, 2001, ENDOCRINOLOGY, V142, P4462, DOI 10.1210/en.142.10.4462; Gribble FM, 2008, DIABETIC MED, V25, P889, DOI 10.1111/j.1464-5491.2008.02514.x; He X, 1998, GENE THER, V5, P537, DOI 10.1038/sj.gt.3300622; Katano H, 2006, GENE THER, V13, P594, DOI 10.1038/sj.gt.3302691; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Kumar M, 2007, GENE THER, V14, P162, DOI 10.1038/sj.gt.3302836; Kwon I, 2008, PHARM RES, V25, P489, DOI 10.1007/s11095-007-9431-0; Lee Y, 2008, J GENE MED, V10, P260, DOI 10.1002/jgm.1153; Lee YS, 2007, DIABETES, V56, P1671, DOI 10.2337/db06-1182; Liu R, 2010, BIOCHEM BIOPH RES CO, V403, P172, DOI 10.1016/j.bbrc.2010.10.131; Madsbad S, 2009, BEST PRACT RES CL EN, V23, P463, DOI 10.1016/j.beem.2009.03.008; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Mannucci E, 2000, DIABETIC MED, V17, P713, DOI 10.1046/j.1464-5491.2000.00367.x; Monami M, 2009, EUR J ENDOCRINOL, V160, P909, DOI 10.1530/EJE-09-0101; Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509; Neumiller JJ, 2009, J AM PHARM ASSOC, V49, pS16, DOI 10.1331/JAPhA.2009.09078; Niemeyer GP, 2009, BLOOD, V113, P797, DOI 10.1182/blood-2008-10-181479; Oana F, 2005, METABOLISM, V54, P995, DOI 10.1016/j.metabol.2005.02.016; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; Parker HE, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239940900132X; Rotella CM, 2005, J ENDOCRINOL INVEST, V28, P746, DOI 10.1007/BF03347560; Rowzee AM, 2011, EXP DIABETES RES, DOI 10.1155/2011/601047; Samani Y, 2011, BIOCH BIOPH IN PRESS; Samson SL, 2008, MOL THER, V16, P1805, DOI 10.1038/mt.2008.198; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Srivastava A, 2008, J CELL BIOCHEM, V105, P17, DOI 10.1002/jcb.21819; Stieger K, 2006, MOL THER, V13, P967, DOI 10.1016/j.ymthe.2005.12.001; Sumner-Jones SG, 2006, GENE THER, V13, P1703, DOI 10.1038/sj.gt.3302815; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Voutetakis A, 2005, J ENDOCRINOL, V185, P363, DOI 10.1677/joe.1.06171; Voutetakis A, 2010, ENDOCRINOLOGY, V151, P4566, DOI 10.1210/en.2010-0193; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zhao JP, 2011, J NUTR BIOCHEM, V22, P835, DOI 10.1016/j.jnutbio.2010.06.012	44	14	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40074	10.1371/journal.pone.0040074	http://dx.doi.org/10.1371/journal.pone.0040074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808093	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700019
J	Woolley, JF; Naughton, R; Stanicka, J; Gough, DR; Bhatt, L; Dickinson, BC; Chang, CJ; Cotter, TG				Woolley, John F.; Naughton, Ruth; Stanicka, Joanna; Gough, David R.; Bhatt, Lavinia; Dickinson, Bryan C.; Chang, Christopher J.; Cotter, Thomas G.			H2O2 Production Downstream of FLT3 Is Mediated by p22phox in the Endoplasmic Reticulum and Is Required for STAT5 Signalling	PLOS ONE			English	Article							IMAGING HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PLASMA-MEMBRANE; DNA-DAMAGE; ACTIVATION; NOX4; KINASE; DEGRADATION; EXPRESSION; MECHANISM	The internal tandem duplication (ITD) of the juxtamembrane region of the FLT3 receptor has been associated with increased reactive oxygen species (ROS) generation in acute myeloid leukemia (AML). How this elevated level of ROS contributes to the leukemic phenotype, however, remains poorly understood. In this work we show that ROS in the FLT3-ITD expressing AML cell line MV4-11 is reduced by treatment with PKC412, an inhibitor of FLT3, DPI, a flavoprotein inhibitor, and VAS2870, a Nox specific inhibitor, suggesting that ROS production is both FLT3 and NADPH oxidase dependent. The majority of these ROS co-localize to the endoplasmic reticulum (ER), as determined with the H2O2-specific aryl-boronate dye Peroxyorange 1, which also corresponds to co-localization of p22phox. Moreover, knocking down p22phox dramatically reduces H2O2 after 24 hours in the ER, without affecting mitochondrial ROS. Significantly, the FLT3 inhibitor PKC412 reduces H2O2 in FLT3-ITD expressing cell lines (MV4-11, MOLM-13) through reduction of p22phox over 24 hours. Reduced p22phox is achieved by proteasomal degradation and is prevented upon GSK3-b inhibition. Knockdown of p22phox resulted in reduced STAT5 signalling and reduced Pim-1 levels in the cells after 24 hours. Thus, we have shown that FLT3 driven H2O2 production in AML cells is mediated by p22phox and is critical for STAT5 signalling.	[Woolley, John F.; Naughton, Ruth; Stanicka, Joanna; Gough, David R.; Bhatt, Lavinia; Cotter, Thomas G.] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Tumour Biol Lab, Biosci Res Inst, Cork, Ireland; [Dickinson, Bryan C.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University College Cork; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Woolley, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Tumour Biol Lab, Biosci Res Inst, Cork, Ireland.	t.cotter@ucc.ie		Cotter, Thomas/0000-0003-4626-5613; Woolley, John/0000-0001-7885-8515	Children's Leukemia Research Project, Cancer Research Ireland and Science Foundation Ireland; National Institutes of Health [GM 79465, T32 GM066698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, T32GM066698] Funding Source: NIH RePORTER	Children's Leukemia Research Project, Cancer Research Ireland and Science Foundation Ireland(Science Foundation Ireland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Children's Leukemia Research Project, Cancer Research Ireland and Science Foundation Ireland (SFI). The authors thank the National Institutes of Health (GM 79465 to C.J.C.) for funding. C.J.C. is an Investigator with the Howard Hughes Medical Institute. B.C.D. was partially supported by a Chemical Biology Training Grant from the National Institutes of Health (T32 GM066698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira D, 2011, J BIOL CHEM, V286, P32313, DOI 10.1074/jbc.M111.249060; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Birkenkamp KU, 2001, LEUKEMIA, V15, P1923, DOI 10.1038/sj.leu.2402317; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Edderkaoui M, 2011, J BIOL CHEM, V286, P7779, DOI 10.1074/jbc.M110.200063; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Hole PS, 2011, BLOOD, V117, P5816, DOI 10.1182/blood-2011-01-326025; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Kayser S, 2009, BLOOD, V114, P2386, DOI 10.1182/blood-2009-03-209999; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Lee CF, 2010, CIRC RES, V106, P1489, DOI 10.1161/CIRCRESAHA.109.215392; Li J, 2007, J CLIN INVEST, V117, P3283, DOI 10.1172/JCI31772; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sattler M, 1999, BLOOD, V93, P2928; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Small D, 2008, SEMIN HEMATOL, V45, pS17, DOI 10.1053/j.seminhematol.2008.07.007; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454	53	43	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e34050	10.1371/journal.pone.0034050	http://dx.doi.org/10.1371/journal.pone.0034050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22807997	Green Published, gold, Green Submitted			2022-12-27	WOS:000306406700001
J	Otte, WM; Dijkhuizen, RM; van Meer, MPA; van der Hel, WS; Verlinde, SAMW; van Nieuwenhuizen, O; Viergever, MA; Stam, CJ; Braun, KPJ				Otte, Willem M.; Dijkhuizen, Rick M.; van Meer, Maurits P. A.; van der Hel, Wilhelmina S.; Verlinde, Suzanne A. M. W.; van Nieuwenhuizen, Onno; Viergever, Max A.; Stam, Cornelis J.; Braun, Kees P. J.			Characterization of Functional and Structural Integrity in Experimental Focal Epilepsy: Reduced Network Efficiency Coincides with White Matter Changes	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD NETWORKS; SUBJECT DIFFUSION DATA; TETANUS TOXIN; SPATIAL STATISTICS; STATUS EPILEPTICUS; VOXELWISE ANALYSIS; RAT MODEL; MRI DATA	Background: Although focal epilepsies are increasingly recognized to affect multiple and remote neural systems, the underlying spatiotemporal pattern and the relationships between recurrent spontaneous seizures, global functional connectivity, and structural integrity remain largely unknown. Methodology/Principal Findings: Here we utilized serial resting-state functional MRI, graph-theoretical analysis of complex brain networks and diffusion tensor imaging to characterize the evolution of global network topology, functional connectivity and structural changes in the interictal brain in relation to focal epilepsy in a rat model. Epileptic networks exhibited a more regular functional topology than controls, indicated by a significant increase in shortest path length and clustering coefficient. Interhemispheric functional connectivity in epileptic brains decreased, while intrahemispheric functional connectivity increased. Widespread reductions of fractional anisotropy were found in white matter regions not restricted to the vicinity of the epileptic focus, including the corpus callosum. Conclusions/Significance: Our longitudinal study on the pathogenesis of network dynamics in epileptic brains reveals that, despite the locality of the epileptogenic area, epileptic brains differ in their global network topology, connectivity and structural integrity from healthy brains.	[Otte, Willem M.; van Meer, Maurits P. A.; van der Hel, Wilhelmina S.; Verlinde, Suzanne A. M. W.; van Nieuwenhuizen, Onno; Braun, Kees P. J.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Otte, Willem M.; Dijkhuizen, Rick M.; van Meer, Maurits P. A.; Viergever, Max A.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Otte, WM (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	wim@invivonmr.uu.nl	Otte, Willem M/I-1228-2013; Otte, Willem M./J-6140-2019; Viergever, Max A/J-1215-2014	Otte, Willem M/0000-0003-1511-6834; Otte, Willem M./0000-0003-1511-6834; Stam, Cornelis/0000-0001-9163-7274; Dijkhuizen, Rick/0000-0002-4623-4078	Dutch National Epilepsy Fund (NEF) [08-10]; Utrecht University's High Potential program	Dutch National Epilepsy Fund (NEF); Utrecht University's High Potential program	This research was supported by the Dutch National Epilepsy Fund (NEF nr. 08-10) and Utrecht University's High Potential program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barkmeier DT, 2009, CLIN EEG NEUROSCI, V40, P234, DOI 10.1177/155005940904000405; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; BRENER K, 1991, EUR J NEUROSCI, V3, P47, DOI 10.1111/j.1460-9568.1991.tb00810.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; CENDES F, 1995, NEUROLOGY, V45, P2058, DOI 10.1212/WNL.45.11.2058; Chavez M, 2006, CHAOS, V16, DOI 10.1063/1.2180467; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Coan AC, 2009, NEUROLOGY, V73, P834, DOI 10.1212/WNL.0b013e3181b783dd; Duncan J, 2009, CURR OPIN NEUROL, V22, P179, DOI 10.1097/WCO.0b013e328328f260; Dupont S, 2000, BRAIN, V123, P1722, DOI 10.1093/brain/123.8.1722; Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3; Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; ITO BM, 1988, NEUROLOGY, V38, P924, DOI 10.1212/WNL.38.6.924; Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones R. H., 1993, LONGITUDINAL DATA SE; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Klein S, 2009, IEEE T MED IMAGING; Koepp MJ, 2005, LANCET NEUROL, V4, P42, DOI 10.1016/S1474-4422(04)00965-2; Kotloski R, 2002, PROG BRAIN RES, V135, P95; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; LOUIS ED, 1990, ELECTROEN CLIN NEURO, V75, P548, DOI 10.1016/0013-4694(90)90141-6; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Marsh ED, 2006, EPILEPSIA, V47, P1999, DOI 10.1111/j.1528-1167.2006.00894.x; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mirsattari SM, 2004, ARCH NEUROL-CHICAGO, V61, P1254, DOI 10.1001/archneur.61.8.1254; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; MORRELL F, 1989, J CLIN NEUROPHYSIOL, V6, P227, DOI 10.1097/00004691-198907000-00002; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nilsen KE, 2006, EPILEPSIA, V47, P1169, DOI 10.1111/j.1528-1167.2006.00540.x; Nilsen KE, 2005, EPILEPSIA, V46, P179, DOI 10.1111/j.0013-9580.2005.26004.x; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Otte WM, 2012, EPILEPSIA, P1; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Percha B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031909; Pinheiro J., 2007, R PACKAGE VERSION, V3, P57; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; RUBINOV M, 2009, NEUROIMAGE; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Siek J, 2002, BOOST GRAPH LIB USER, P112; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Stam CJ, 2012, CLIN NEUROPHYSIOL; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Sutula TP, 2003, CURR OPIN NEUROL, V16, P189, DOI 10.1097/00019052-200304000-00012; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Vaessen M.J., 2011, CEREB CORTEX; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Wang K, 2010, NMR BIOMED; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007	76	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39078	10.1371/journal.pone.0039078	http://dx.doi.org/10.1371/journal.pone.0039078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808026	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400008
J	Boyden, AW; Legge, KL; Waldschmidt, TJ				Boyden, Alexander W.; Legge, Kevin L.; Waldschmidt, Thomas J.			Pulmonary Infection with Influenza A Virus Induces Site-Specific Germinal Center and T Follicular Helper Cell Responses	PLOS ONE			English	Article							MEMORY B-CELLS; ANTIBODY-SECRETING CELLS; LYMPHOID-TISSUE; DENDRITIC CELLS; IMMUNE-RESPONSES; CUTTING EDGE; MICE; EXPRESSION; IL-21; LUNG	Protection from influenza A virus (IAV) challenge requires switched, high affinity Abs derived from long-lived memory B cells and plasma cells. These B cell subsets are generated in germinal centers (GCs), hallmark structures of T helper cell-driven B cell immunity. A full understanding of the GC reaction after respiratory IAV infection is lacking, as is the characterization of T follicular helper (T-FH) cells that support GCs. Here, GC B cell and T-FH cell responses were studied in mice following pulmonary challenge with IAV. Marked GC reactions were induced in draining lymph nodes (dLNs), lung, spleen and nasal-associated lymphoid tissue (NALT), although the magnitude and kinetics of the response was site-specific. Examination of switching within GCs demonstrated IgG2(+) cells to compose the largest fraction in dLNs, lung and spleen. IgA(+) GC B cells were infrequent in these sites, but composed a significant subset of the switched GC population in NALT. Further experiments demonstrated splenectomized mice to withstand a lethal recall challenge, suggesting the spleen to be unnecessary for long-term protection in spite of strong GC responses in this organ. Final studies showed that T-FH cell numbers were highest in dLNs and spleen, and peaked in all sites prior to the height of the GC reaction. T-FH cells purified from dLNs generated IL-21 and IFN gamma upon activation, although CD4(+)CXCR5(-) T effector cells produced higher levels of all cytokines. Collectively, these findings reveal respiratory IAV infection to induce strong T helper cell-driven B cell responses in various organs, with each site displaying unique attributes.	[Boyden, Alexander W.; Legge, Kevin L.; Waldschmidt, Thomas J.] Univ Iowa, Interdisciplinary Grad Program Immunol, Carver Coll Med, Iowa City, IA 52242 USA; [Boyden, Alexander W.; Legge, Kevin L.; Waldschmidt, Thomas J.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Legge, Kevin L.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Boyden, AW (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Carver Coll Med, Iowa City, IA 52242 USA.	thomas-waldschmidt@uiowa.edu		Waldschmidt, Thomas/0000-0001-6147-6991; Legge, Kevin/0000-0001-9800-6854; Boyden, Alexander/0000-0003-3440-7848	National Institutes of Health [R01AI071085, R01AA019438]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants R01AI071085 and R01AA019438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2011, IMMUNOLOGY, V133, P452, DOI 10.1111/j.1365-2567.2011.03456.x; Arulanandam BP, 2001, J IMMUNOL, V166, P226, DOI 10.4049/jimmunol.166.1.226; Asanuma H, 1998, VACCINE, V16, P1257, DOI 10.1016/S0264-410X(98)00048-6; Asanuma H, 1997, J IMMUNOL METHODS, V202, P123, DOI 10.1016/S0022-1759(96)00243-8; Baumgarth N, 2008, CURR TOP MICROBIOL, V319, P41; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Brydak LB, 2004, J CLIN IMMUNOL, V24, P225, DOI 10.1023/B:JOCI.0000025444.24160.d5; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chapman TJ, 2005, VIROLOGY, V340, P296, DOI 10.1016/j.virol.2005.06.023; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Elgueta R, 2010, IMMUNOL REV, V236, P139, DOI 10.1111/j.1600-065X.2010.00924.x; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; FAZEKAS G, 1994, EUR J IMMUNOL, V24, P3063, DOI 10.1002/eji.1830241222; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; HOCART MJ, 1989, J GEN VIROL, V70, P2439, DOI 10.1099/0022-1317-70-9-2439; HYLAND L, 1994, J VIROL, V68, P6083, DOI 10.1128/JVI.68.9.6083-6086.1994; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; JONES PD, 1987, CELL IMMUNOL, V109, P53, DOI 10.1016/0008-8749(87)90291-7; JONES PD, 1986, J VIROL, V60, P614, DOI 10.1128/JVI.60.2.614-619.1986; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kopf M, 2002, EUR J IMMUNOL, V32, P2229, DOI 10.1002/1521-4141(200208)32:8<2229::AID-IMMU2229>3.0.CO;2-T; Langley JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-219; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Liang B, 2001, J VIROL, V75, P5416, DOI 10.1128/JVI.75.11.5416-5420.2001; Linterman MA, 2010, PROG MOL BIOL TRANSL, V92, P207, DOI 10.1016/S1877-1173(10)92009-7; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lund FE, 2002, J IMMUNOL, V169, P5236, DOI 10.4049/jimmunol.169.9.5236; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Rangel-Moreno J, 2005, J IMMUNOL, V175, P4904, DOI 10.4049/jimmunol.175.8.4904; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sealy R, 2003, IMMUNOLOGY, V108, P431, DOI 10.1046/j.1365-2567.2003.01615.x; Shen CH, 2010, P NATL ACAD SCI USA, V107, P22587, DOI 10.1073/pnas.1016350108; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Skountzou I, 2010, J IMMUNOL, V185, P1642, DOI 10.4049/jimmunol.1000091; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Swain SL, 2004, VIRAL IMMUNOL, V17, P197, DOI 10.1089/0882824041310577; Tamura S, 1998, J GEN VIROL, V79, P291, DOI 10.1099/0022-1317-79-2-291; Topham DJ, 1997, J IMMUNOL, V159, P5197; Tripp RA, 1997, J IMMUNOL, V158, P3716; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Wolf AI, 2011, J CLIN INVEST, V121, P3954, DOI 10.1172/JCI57362; Wolniak KL, 2004, CRIT REV IMMUNOL, V24, P39, DOI 10.1615/CritRevImmunol.v24.20; Wolniak KL, 2006, J IMMUNOL, V177, P2072, DOI 10.4049/jimmunol.177.4.2072; Xiao YL, 2004, J IMMUNOL, V172, P7432, DOI 10.4049/jimmunol.172.12.7432; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yoo JK, 2010, J EXP MED, V207, P1435, DOI 10.1084/jem.20091373; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zeng JW, 2009, J IMMUNOL, V182, P4721, DOI 10.4049/jimmunol.0802833; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	81	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40733	10.1371/journal.pone.0040733	http://dx.doi.org/10.1371/journal.pone.0040733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792401	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400097
J	Glaab, E; Bacardit, J; Garibaldi, JM; Krasnogor, N				Glaab, Enrico; Bacardit, Jaume; Garibaldi, Jonathan M.; Krasnogor, Natalio			Using Rule-Based Machine Learning for Candidate Disease Gene Prioritization and Sample Classification of Cancer Gene Expression Data	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR EXPRESSION; NON-HODGKINS-LYMPHOMAS; PARTIAL LEAST-SQUARES; PROSTATE-CANCER; FEATURE-SELECTION; MICROARRAY DATA; BREAST-CANCER; OUTCOME PREDICTION; COA RACEMASE; HEPSIN	Microarray data analysis has been shown to provide an effective tool for studying cancer and genetic diseases. Although classical machine learning techniques have successfully been applied to find informative genes and to predict class labels for new samples, common restrictions of microarray analysis such as small sample sizes, a large attribute space and high noise levels still limit its scientific and clinical applications. Increasing the interpretability of prediction models while retaining a high accuracy would help to exploit the information content in microarray data more effectively. For this purpose, we evaluate our rule-based evolutionary machine learning systems, BioHEL and GAssist, on three public microarray cancer datasets, obtaining simple rule-based models for sample classification. A comparison with other benchmark microarray sample classifiers based on three diverse feature selection algorithms suggests that these evolutionary learning techniques can compete with state-of-the-art methods like support vector machines. The obtained models reach accuracies above 90% in two-level external cross-validation, with the added value of facilitating interpretation by using only combinations of simple if-then-else rules. As a further benefit, a literature mining analysis reveals that prioritizations of informative genes extracted from BioHEL's classification rule sets can outperform gene rankings obtained from a conventional ensemble feature selection in terms of the pointwise mutual information between relevant disease terms and the standardized names of top-ranked genes.	[Glaab, Enrico; Bacardit, Jaume; Krasnogor, Natalio] Univ Nottingham, Interdisciplinary Comp & Complex Syst ICOS Res Gr, Nottingham NG7 2RD, England; [Garibaldi, Jonathan M.] Univ Nottingham, Intelligent Modeling & Anal IMA Res Grp, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Glaab, E (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.	Natalio.Krasnogor@Nottingham.ac.uk	Bacardit, Jaume/F-9293-2014; Glaab, Enrico/A-9136-2012	Bacardit, Jaume/0000-0002-2692-7205; Glaab, Enrico/0000-0003-3977-7469; Garibaldi, Jonathan/0000-0002-9690-7074	Marie-Curie Early-Stage-Training programme [MEST-CT-2004-007597]; United Kingdom Engineering and Physical Sciences Research Council [EP/E017215/1, EP/H016597/1, EP/J004111/1]; Biotechnology and Biological Sciences Research Council [BB/F01855X/1]; Engineering and Physical Sciences Research Council [EP/E017215/1, EP/J004111/1, EP/H016597/1] Funding Source: researchfish; BBSRC [BB/F01855X/1] Funding Source: UKRI; EPSRC [EP/H016597/1, EP/J004111/1, EP/E017215/1] Funding Source: UKRI	Marie-Curie Early-Stage-Training programme(European Commission); United Kingdom Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge support by the Marie-Curie Early-Stage-Training programme (grant MEST-CT-2004-007597), by the United Kingdom Engineering and Physical Sciences Research Council (EP/E017215/1, EP/H016597/1 and EP/J004111/1) and the Biotechnology and Biological Sciences Research Council (BB/F01855X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuff HB, 2006, CANCER RES, V66, P7968, DOI 10.1158/0008-5472.CAN-05-4279; Aguilar-Ruiz JS, 2003, IEEE T SYST MAN CY B, V33, P324, DOI 10.1109/TSMCB.2002.805696; Alexe Gabriela, 2006, Breast Cancer Res, V8, pR41, DOI 10.1186/bcr1512; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bacardit J, 2008, LECT NOTES COMPUTER, V4998, P255; Bacardit J, 2004, THESIS RAMON LLULL U; Bacardit J, 2008, GECCO 08, P1421; Bacardit J., 2009, MEMET COMPUT, V1, P55, DOI DOI 10.1007/S12293-008-0005-4; Bacardit J, 2007, LECT NOTES ARTIF INT, V4399, P282, DOI 10.1007/978-3-540-71231-2_19; Bacardit J, 2007, LECT NOTES ARTIF INT, V4399, P59, DOI 10.1007/978-3-540-71231-2_5; Bacardit J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-6; Bassel GW, 2011, PLANT CELL, V23, P3101, DOI 10.1105/tpc.111.088153; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Bende RJ, 2007, LEUKEMIA, V21, P18, DOI 10.1038/sj.leu.2404426; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Blanco R, 2004, INT J PATTERN RECOGN, V18, P1373, DOI 10.1142/S0218001404003800; Boulesteix A.-L., 2004, STAT APPL GENET MOL, V3, P1075, DOI DOI 10.2202/1544-6115.1075; Boulesteix AL, 2008, BIOINFORMATICS, V24, P1698, DOI 10.1093/bioinformatics/btn262; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Bray GA, 2002, J NUTR, V132, p3451S, DOI 10.1093/jn/132.11.3451S; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calle M Luz, 2011, Brief Bioinform, V12, P86, DOI 10.1093/bib/bbq011; Chen ZX, 2003, J UROLOGY, V169, P1316, DOI 10.1097/01.ju.0000050648.40164.0d; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chu W, 2005, BIOINFORMATICS, V21, P3385, DOI 10.1093/bioinformatics/bti526; Conover W. J., 1971, PRACTICAL NONPARAMET; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dani C, 1997, J CELL SCI, V110, P1279; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch JM, 2003, BIOINFORMATICS, V19, P45, DOI 10.1093/bioinformatics/19.1.45; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; DiLella AG, 2001, J HISTOCHEM CYTOCHEM, V49, P669, DOI 10.1177/002215540104900517; Divina F, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P385; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Fano R M, 1961, AM J PHYS, V29, P793, DOI DOI 10.1119/1.1937609; FASOLA G, 1984, ACTA HAEMATOL-BASEL, V72, P231, DOI 10.1159/000206395; Ferdinandusse S, 2000, J LIPID RES, V41, P1890; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gerhold DL, 2002, NAT GENET, V32, P547, DOI 10.1038/ng1042; Gilbert R, 2000, P GEN EV COMP C GECC, P551; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Glaab E., 2010, LECT NOTES INFORM, V173, P123; Glaab E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-597; Glaab E, 2010, J STAT SOFTW, V36, P1; Glaab E, 2010, BIOINFORMATICS, V26, P1271, DOI 10.1093/bioinformatics/btq131; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Goh L., 2004, P 2 C AS PAC BIOINF, P161; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Ha CM, 2008, NEUROENDOCRINOLOGY, V88, P199, DOI 10.1159/000139579; Habashy HO, 2010, EJC SUPPL, V8, P91, DOI 10.1016/S1359-6349(10)70143-9; Habashy HO, 2011, BREAST CANCER RES TR, V128, P315, DOI 10.1007/s10549-010-1073-y; HABESHAW JA, 1983, LANCET, V1, P498; Hall M. A., 2000, P 17 INT C MACH LEAR; Hastie T., 1986, STAT SCI, V1, P297; Holland J.H., 2000, LNCS LNAI, V1813, P3, DOI [10.1007/3-540-45027-01, DOI 10.1007/3-540-45027-01]; Hu YJ, 2008, LECT NOTES COMPUT SC, V4985, P846; Jayasurya A, 2000, CANCER LETT, V155, P99, DOI 10.1016/S0304-3835(00)00414-6; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Kuefer R, 2002, AM J PATHOL, V161, P841, DOI 10.1016/S0002-9440(10)64244-7; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lecocke M, 2006, CANCER INFORM, V2, P313; Lee JY, 2003, GENOMICS, V82, P78, DOI 10.1016/S0888-7543(03)00098-3; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Li L., 2002, METHODS MICROARRAY D, P81, DOI [10.1007/978-1-4615-0873-1_7, DOI 10.1007/978-1-4615-0873-1_7]; Li W, 2001, METHODS MICROARRAY D, P137; Lin BY, 2008, CLIN CANCER RES, V14, P1397, DOI 10.1158/1078-0432.CCR-07-1535; Lin BY, 2003, GENOMICS, V82, P331, DOI 10.1016/S0888-7543(03)00151-4; Liu J, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2275, DOI 10.1109/ICMLC.2003.1259886; Luo J, 2001, CANCER RES, V61, P4683; Luo J, 2002, CANCER RES, V62, P2220; Ma PCH, 2006, IEEE T EVOLUT COMPUT, V10, P296, DOI 10.1109/TEVC.2005.859371; Magee JA, 2001, CANCER RES, V61, P5692; MEDEIROS LJ, 1988, CANCER, V61, P1844; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moore JH, 2002, GENET EPIDEMIOL, V23, P57, DOI 10.1002/gepi.1117; Mosca E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-76; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Nakashima M, 2008, ANTICANCER RES, V28, P609; Nicodemus KK, 2011, BRIEF BIOINFORM, V12, P369, DOI 10.1093/bib/bbr016; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Paul TK, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P453; PILERI S, 1984, BRIT J HAEMATOL, V58, P501, DOI 10.1111/j.1365-2141.1984.tb03997.x; Popovici V, 2011, BIOINFORMATICS, V27, P1729, DOI 10.1093/bioinformatics/btr233; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; RISSANEN J, 1983, ANN STAT, V11, P416, DOI 10.1214/aos/1176346150; Rivest R. L., 1987, Machine Learning, V2, P229, DOI 10.1007/BF00058680; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; Shen L, 2005, IEEE ACM T COMPUT BI, V2, P166, DOI 10.1109/TCBB.2005.22; Sheng WG, 2006, J HEURISTICS, V12, P447, DOI 10.1007/s10732-006-7284-z; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Srikantan V, 2002, CANCER RES, V62, P6812; Stephan C, 2004, J UROLOGY, V171, P187, DOI 10.1097/01.ju.0000101622.74236.94; Stojanov M, 2007, THESIS DTSCH KREBSF; Stout M, 2009, SOFT COMPUT, V13, P245, DOI 10.1007/s00500-008-0318-8; Stout M, 2008, BIOINFORMATICS, V24, P916, DOI 10.1093/bioinformatics/btn050; Sun YJ, 2007, BIOINFORMATICS, V23, P30, DOI 10.1093/bioinformatics/btl543; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Theocharis SE, 2004, HISTOPATHOLOGY, V45, P103, DOI 10.1111/j.1365-2559.2004.01922.x; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tokuda Y, 2003, BJU INT, V91, P716, DOI 10.1046/j.1464-410X.2003.04218.x; Toyota M, 1999, CANCER RES, V59, P4535; Tsuruoka Y, 2008, BIOINFORMATICS, V24, P2559, DOI 10.1093/bioinformatics/btn469; Vanpoucke G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r213; Vapnik V.N., 1974, THEORY PATTERN RECOG; Venturini G., 1993, Machine Learning: ECML-93. European Conference on Machine Learning Proceedings, P280; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Wold H., 1975, PERSPECTIVES PROBABI, V12, P117, DOI [10.1017/s0021900200047604, DOI 10.1017/S0021900200047604, 10.1017/S0021900200047604]; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wood IA, 2007, BIOINFORMATICS, V23, P1363, DOI 10.1093/bioinformatics/btm117; Zervakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-53; Zhang CL, 2006, IEEE ACM T COMPUT BI, V3, P312, DOI 10.1109/TCBB.2006.42; Zhang H, 2010, BREAST CANCER RES TR, V121, P41, DOI 10.1007/s10549-009-0450-x; Zhang SQ, 2011, BMC BIOINFORMATICS, V12, DOI [10.1186/1471-2105-12-238, 10.1186/1471-2105-12-450]	128	70	72	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39932	10.1371/journal.pone.0039932	http://dx.doi.org/10.1371/journal.pone.0039932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808075	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400027
J	Maezawa, S; Fukushima, R; Matsushita, T; Kato, T; Takagaki, Y; Nishiyama, Y; Ando, S; Matsumoto, T; Kouda, K; Hayano, T; Suzuki, M; Koiwai, K; Koiwai, O				Maezawa, So; Fukushima, Rie; Matsushita, Toyofumi; Kato, Tomoyoshi; Takagaki, Yoshiki; Nishiyama, Yoshihiro; Ando, Sachiko; Matsumoto, Takuro; Kouda, Kousuke; Hayano, Takahide; Suzuki, Masahiro; Koiwai, Kotaro; Koiwai, Osamu			Ubiquitylation of Terminal Deoxynucleotidyltransferase Inhibits Its Activity	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYMES; DNA-REPAIR; PHYSICAL INTERACTION; LIGASE COMPLEX; PROTEIN; PATHWAY; MONOUBIQUITINATION; IDENTIFICATION; GENE; E2	Terminal deoxynucleotidyltransferase (TdT), which template-independently synthesizes DNA during V(D)J recombination in lymphoid cells, is ubiquitylated by a BPOZ-2/Cul3 complex, as the ubiquitin ligase, and then degraded by the 26 S proteasome. We show here that TdT is ubiquitylated by the Cul3-based ubiquitylation system in vitro. Because TdT could also be ubiquitylated in the absence of Cul/BPOZ-2, we determined that it could also be directly ubiquitylated by the E2 proteins UbcH5a/b/c and UbcH6, E3-independently. Furthermore, the ubiquitylated TdT inhibited its nucleotidyltransferase activity.	[Maezawa, So; Fukushima, Rie; Matsushita, Toyofumi; Kato, Tomoyoshi; Takagaki, Yoshiki; Nishiyama, Yoshihiro; Ando, Sachiko; Matsumoto, Takuro; Kouda, Kousuke; Hayano, Takahide; Suzuki, Masahiro; Koiwai, Kotaro; Koiwai, Osamu] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan	Tokyo University of Science	Maezawa, S (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan.	maezws@rs.noda.tus.ac.jp		Koiwai, Kotaro/0000-0002-9684-3699				Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Bollum F J, 1974, Methods Enzymol, V29, P70; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hong S, 2008, BIOCHEM BIOPH RES CO, V371, P256, DOI 10.1016/j.bbrc.2008.04.066; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KOIWAI O, 1988, BIOCHEM BIOPH RES CO, V154, P91, DOI 10.1016/0006-291X(88)90654-7; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lucero P, 2000, J BACTERIOL, V182, P241, DOI 10.1128/JB.182.1.241-243.2000; Maezawa S, 2008, GENES CELLS, V13, P439, DOI 10.1111/j.1365-2443.2008.01179.x; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V372, P708, DOI 10.1016/j.bbrc.2008.05.113; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	41	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39511	10.1371/journal.pone.0039511	http://dx.doi.org/10.1371/journal.pone.0039511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808041	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400013
J	Zhu, F; Ma, XH; Qin, C; Tao, L; Liu, X; Shi, Z; Zhang, CL; Tan, CY; Chen, YZ; Jiang, YY				Zhu, Feng; Ma, Xiao Hua; Qin, Chu; Tao, Lin; Liu, Xin; Shi, Zhe; Zhang, Cun Long; Tan, Chun Yan; Chen, Yu Zong; Jiang, Yu Yang			Drug Discovery Prospect from Untapped Species: Indications from Approved Natural Product Drugs	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; TYROSINE KINASE; INHIBITORS; METABOLITES; STAUROSPORINE; ANTIBIOTICS; IMATINIB; DESIGN	Due to extensive bioprospecting efforts of the past and technology factors, there have been questions about drug discovery prospect from untapped species. We analyzed recent trends of approved drugs derived from previously untapped species, which show no sign of untapped drug-productive species being near extinction and suggest high probability of deriving new drugs from new species in existing drug-productive species families and clusters. Case histories of recently approved drugs reveal useful strategies for deriving new drugs from the scaffolds and pharmacophores of the natural product leads of these untapped species. New technologies such as cryptic gene-cluster exploration may generate novel natural products with highly anticipated potential impact on drug discovery.	[Zhu, Feng; Zhang, Cun Long; Tan, Chun Yan; Chen, Yu Zong; Jiang, Yu Yang] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China; [Zhu, Feng] Chongqing Univ, Innovat Drug Res Ctr, Chongqing 630044, Peoples R China; [Zhu, Feng] Chongqing Univ, Coll Chem & Chem Engn, Chongqing 630044, Peoples R China; [Zhu, Feng; Ma, Xiao Hua; Qin, Chu; Tao, Lin; Liu, Xin; Shi, Zhe; Chen, Yu Zong] Natl Univ Singapore, Dept Pharm, Bioinformat & Drug Design Grp, Singapore 117548, Singapore; [Zhu, Feng; Ma, Xiao Hua; Qin, Chu; Tao, Lin; Liu, Xin; Shi, Zhe; Chen, Yu Zong] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117548, Singapore; [Qin, Chu; Tao, Lin] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chongqing University; Chongqing University; National University of Singapore; National University of Singapore; National University of Singapore	Zhu, F (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China.	phacyz@nus.edu.sg; Jiangyy@sz.tsinghua.edu.cn	Zhu, Feng/F-1489-2011; Tan, Chunyan/F-2785-2012; MA, XIAO/HHN-5611-2022; ZHU, Feng/X-2659-2018; jiang, yu/HGU-0029-2022; Liu, Xin/U-5451-2019; ZHU, Feng/ABF-5843-2021	Tan, Chunyan/0000-0002-4263-2175; ZHU, Feng/0000-0001-8069-0053; Liu, Xin/0000-0002-6542-3181; ZHU, Feng/0000-0001-8069-0053; Chen, Yu Zong/0000-0002-5473-8022; Tao, Lin/0000-0001-7494-4758	National University of Singapore Research Scholarship; Ministry of Science and Technology; 863 Hi-Tech Program [2007AA02Z160]; Key Special Project Grant, China [2009ZX09501-004]	National University of Singapore Research Scholarship(National University of Singapore); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 863 Hi-Tech Program(National High Technology Research and Development Program of China); Key Special Project Grant, China	We acknowledge support from the National University of Singapore Research Scholarship, Ministry of Science and Technology, 863 Hi-Tech Program (2007AA02Z160), Key Special Project Grant 2009ZX09501-004, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1995, BIOORG MED CHEM LETT, V5, P853, DOI 10.1016/0960-894X(95)00127-F; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Chiang YM, 2011, CURR OPIN CHEM BIOL, V15, P137, DOI 10.1016/j.cbpa.2010.10.011; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; DANN JG, 1986, BIOCHEM BIOPH RES CO, V134, P71, DOI 10.1016/0006-291X(86)90528-0; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Furet P, 1995, J COMPUT AID MOL DES, V9, P465, DOI 10.1007/BF00124317; Gambacorti-Passerini C, 2008, LANCET ONCOL, V9, P600, DOI 10.1016/S1470-2045(08)70152-9; Harvey AL, 1999, TRENDS PHARMACOL SCI, V20, P196, DOI 10.1016/S0165-6147(99)01346-2; Hunt JT, 2009, MOL CANCER THER, V8, P275, DOI 10.1158/1535-7163.MCT-08-0999; Kingston DGI, 2009, J NAT PROD, V72, P507, DOI 10.1021/np800568j; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lydon NB, 2004, LEUKEMIA RES, V28, pS29, DOI 10.1016/j.leukres.2003.10.002; MCQUADE TJ, 1990, SCIENCE, V247, P454, DOI 10.1126/science.2405486; Nakano H, 2009, J ANTIBIOT, V62, P17, DOI 10.1038/ja.2008.4; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Piel J, 2011, ANNU REV MICROBIOL, V65, P431, DOI 10.1146/annurev-micro-090110-102805; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Pullen CB, 2003, PHYTOCHEMISTRY, V62, P377, DOI 10.1016/S0031-9422(02)00550-2; RALPH RK, 1972, BIOCHEM J, V130, P901, DOI 10.1042/bj1300901a; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; ROBERTS NA, 1990, SCIENCE, V248, P358, DOI 10.1126/science.2183354; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Traxler PM, 1996, J MED CHEM, V39, P2285, DOI 10.1021/jm960118j; Tulp M, 2005, TRENDS PHARMACOL SCI, V26, P175, DOI 10.1016/j.tips.2005.02.001; Tulp M, 2002, TRENDS PHARMACOL SCI, V23, P225, DOI 10.1016/S0165-6147(02)02007-2; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; WALL ME, 1995, CANCER RES, V55, P753; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Zhu F, 2011, P NATL ACAD SCI USA, V108, P12943, DOI 10.1073/pnas.1107336108	37	36	37	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39782	10.1371/journal.pone.0039782	http://dx.doi.org/10.1371/journal.pone.0039782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808057	gold, Green Published, Green Submitted			2022-12-27	WOS:000306362400017
J	Flanagan, TP; Letendre, K; Burnside, WR; Fricke, GM; Moses, ME				Flanagan, Tatiana P.; Letendre, Kenneth; Burnside, William R.; Fricke, G. Matthew; Moses, Melanie E.			Quantifying the Effect of Colony Size and Food Distribution on Harvester Ant Foraging	PLOS ONE			English	Article							POGONOMYRMEX-OCCIDENTALIS; FORMICA-RUFA; FIDELITY; BEHAVIOR; AVAILABILITY; ECOLOGY; HYMENOPTERA; RECRUITMENT; STRATEGIES; PATTERNS	Desert seed-harvester ants, genus Pogonomyrmex, are central place foragers that search for resources collectively. We quantify how seed harvesters exploit the spatial distribution of seeds to improve their rate of seed collection. We find that foraging rates are significantly influenced by the clumpiness of experimental seed baits. Colonies collected seeds from larger piles faster than randomly distributed seeds. We developed a method to compare foraging rates on clumped versus random seeds across three Pogonomyrmex species that differ substantially in forager population size. The increase in foraging rate when food was clumped in larger piles was indistinguishable across the three species, suggesting that species with larger colonies are no better than species with smaller colonies at collecting clumped seeds. These findings contradict the theoretical expectation that larger groups are more efficient at exploiting clumped resources, thus contributing to our understanding of the importance of the spatial distribution of food sources and colony size for communication and organization in social insects.	[Flanagan, Tatiana P.; Letendre, Kenneth; Burnside, William R.; Moses, Melanie E.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Flanagan, Tatiana P.; Letendre, Kenneth; Fricke, G. Matthew; Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Moses, Melanie E.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of New Mexico; University of New Mexico; The Santa Fe Institute	Flanagan, TP (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	tpaz@unm.edu		Fricke, George/0000-0002-4466-8649	Defense Advanced Research Projects Agency (DARPA) [P-1070-113237]; National Institutes of Health (NIH) [P20 RR-018754]; National Science Foundation Emerging Frontiers (NSF EF) [1038682]; Microsoft Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Emerging Frontiers (NSF EF); Microsoft Research(Microsoft); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors gratefully acknowledge support from Defense Advanced Research Projects Agency (DARPA) grant P-1070-113237, www.darpa.mil; National Institutes of Health (NIH) grant P20 RR-018754, www.nih.gov; National Science Foundation Emerging Frontiers (NSF EF) grant 1038682, www.nsf.gov; and a gift from Microsoft Research, research.microsoft.com; from Sandia National Laboratories LDRD 09-1292 to KL, www.sandia.gov; and from the Sevilleta LTER to WB and MEM, sev.lternet.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been funded in part by a gift from Microsoft Research (research.microsoft.com). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ABRAMSKY Z, 1983, OECOLOGIA, V57, P328, DOI 10.1007/BF00377176; Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; [Anonymous], PASW STAT REL 18 0 1; [Anonymous], 1971, INSECT SOC; ARON S, 1989, BIOL BEHAV, V14, P207; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; BERNSTEIN RA, 1975, ECOLOGY, V56, P213, DOI 10.2307/1935314; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Buchkremer EM, 2008, BEHAV ECOL, V19, P984, DOI 10.1093/beheco/arn057; CARACO T, 1975, AM NAT, V109, P343, DOI 10.1086/283001; Cole AC, 1968, POGONOMYMEX HARVESTE; CRIST TO, 1991, ENVIRON ENTOMOL, V20, P265, DOI 10.1093/ee/20.1.265; CRIST TO, 1992, ECOLOGY, V73, P1768, DOI 10.2307/1940028; DAVIDSON DW, 1977, ECOLOGY, V58, P725, DOI 10.2307/1936209; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Denny AJ, 2001, ANIM BEHAV, V62, P139, DOI 10.1006/anbe.2001.1718; Edelman A, 2010, THESIS U NEW MEXICO; FEWELL JH, 1990, OECOLOGIA, V82, P45, DOI 10.1007/BF00318532; FEWELL JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P401, DOI 10.1007/BF00294977; FRESNEAU D, 1985, INSECT SOC, V32, P109, DOI 10.1007/BF02224226; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; HILL K, 1987, ETHOL SOCIOBIOL, V8, P1, DOI 10.1016/0162-3095(87)90055-0; HOBBS RJ, 1985, OECOLOGIA, V67, P519, DOI 10.1007/BF00790023; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; HOLLDOBLER B, 1970, Psyche (Cambridge), V77, P385, DOI 10.1155/1970/38470; Hou C, 2010, P NATL ACAD SCI USA, V107, P3634, DOI 10.1073/pnas.0908071107; Johnson RA, 2000, SOCIOBIOLOGY, V36, P89; KUNIN WE, 1994, OECOLOGIA, V98, P328, DOI 10.1007/BF00324221; MEHLHOP P, 1983, ECOL ENTOMOL, V8, P69, DOI 10.1111/j.1365-2311.1983.tb00484.x; Moses ME, 2005, THESIS U NEW MEXICO; Mull JF, 1997, AM MIDL NAT, V138, P1, DOI 10.2307/2426649; Paz Flanagan Tatiana, 2011, 2011 IEEE SSCI Symposium on Artificial Life (ALIFE), P178, DOI 10.1109/ALIFE.2011.5954650; REICHMAN OJ, 1984, J BIOGEOGR, V11, P1, DOI 10.2307/2844771; ROSENGREN R, 1986, INSECT SOC, V33, P306, DOI 10.1007/BF02224248; RYER CH, 1995, ANIM BEHAV, V49, P411, DOI 10.1006/anbe.1995.0054; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; TAYLOR F, 1977, BEHAV ECOL SOCIOBIOL, V2, P147, DOI 10.1007/BF00361899; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; WHITFORD WG, 1975, ENVIRON ENTOMOL, V4, P689, DOI 10.1093/ee/4.5.689; WHITFORD WG, 1978, ECOLOGY, V59, P185, DOI 10.2307/1936647; Wilby A, 2000, OECOLOGIA, V125, P495, DOI 10.1007/s004420000478	45	25	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39427	10.1371/journal.pone.0039427	http://dx.doi.org/10.1371/journal.pone.0039427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808035	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500010
J	Meng, J; Cheng, XL; Liu, J; Zhang, WQ; Li, XJ; Kong, H; Xu, HY				Meng, Jie; Cheng, Xuelian; Liu, Jian; Zhang, Weiqi; Li, Xiaojin; Kong, Hua; Xu, Haiyan			Effects of Long and Short Carboxylated or Aminated Multiwalled Carbon Nanotubes on Blood Coagulation	PLOS ONE			English	Article							PROTEIN ADSORPTION; CALCIUM-ENTRY; IN-VITRO; PLATELET; COMPATIBILITY; SIRNA; CYTOTOXICITY; ACTIVATION; CELLS	In this work the effects of four different multiwalled carbon nanotubes (MWCNTs), including long carboxylated (L-COOH), short carboxylated (S-COOH), long aminated (L-NH2) and short aminated (S-NH2) ones, on the integrity of red blood cells, coagulation kinetics and activation of platelets were investigated with human whole blood. We found that the four MWCNTs induced different degrees of red blood cell damage as well as a mild level of platelet activation (10-25%). L-COOH and L-NH2 induced a higher level of platelet activation than S-COOH and S-NH2 respectively; meanwhile L-NH2 caused marked reductions in platelet viability. The presence of the four MWCNTs led to earlier fibrin formation, L-NH2 increased the clots hardness significantly, while L-COOH and S-NH2 made the clots become softer. It was concluded that the four MWCNTs affected blood coagulation process and the clots mechanical properties; they also altered the integrity of the red blood cells and the viability of the platelets, as well as induced platelets activation. The effects of MWCNTs depended on the size and chemistry of the nanotubes and the type of cells they contacted.	[Meng, Jie] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Meng, J (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	xuhy@pumc.edu.cn	Zhang, Weiqi/J-3974-2019	Zhang, Weiqi/0000-0003-4315-6809	National Key Program of China (973 program) [2011CB933504]; National Natural Science Foundation of China [81000665]; Beijing Municipal Natural Science Foundation [7092063]	National Key Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	The authors thank National Key Program of China (973 program 2011CB933504), National Natural Science Foundation of China (81000665) and Beijing Municipal Natural Science Foundation (7092063) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108; Bihari P, 2010, TOXICOLOGY, V269, P148, DOI 10.1016/j.tox.2009.08.011; Bomboi F, 2011, J COLLOID INTERF SCI, V355, P342, DOI 10.1016/j.jcis.2010.12.026; Burke AR, 2011, BIOMATERIALS, V32, P5970, DOI 10.1016/j.biomaterials.2011.04.059; Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615; Jia FM, 2009, J MATER CHEM, V19, P8950, DOI 10.1039/b916219d; Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k; Koh LB, 2008, J BIOMED MATER RES A, V86A, P394, DOI 10.1002/jbm.a.31605; Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003; Lacerda SHD, 2011, ACS NANO, V5, P5808, DOI 10.1021/nn2015369; Ladeira MS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385101; Ling WL, 2011, ACS NANO, V5, P730, DOI 10.1021/nn102400w; Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020; Meng J, 2005, J BIOMED MATER RES A, V74A, P208, DOI 10.1002/jbm.a.30315; Meng J, 2005, NANOMED-NANOTECHNOL, V1, P136, DOI 10.1016/j.nano.2005.03.003; Murugesan S, 2006, LANGMUIR, V22, P3461, DOI 10.1021/la0534468; Nemmar A, 2007, J THROMB HAEMOST, V5, P1217, DOI 10.1111/j.1538-7836.2007.02557.x; Radomski A, 2005, BRIT J PHARMACOL, V146, P882, DOI 10.1038/sj.bjp.0706386; Rossi NAA, 2009, BIOMATERIALS, V30, P638, DOI 10.1016/j.biomaterials.2008.09.057; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006; Semberova J, 2009, NANO LETT, V9, P3312, DOI 10.1021/nl901603k; Sobhani Z, 2011, INT J NANOMED, V6, P705, DOI 10.2147/IJN.S17336; Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095; Tang AM, 2011, CONTRAST MEDIA MOL I, V6, P93, DOI 10.1002/cmmi.410; Vinante M, 2009, J NANOSCI NANOTECHNO, V9, P3785, DOI 10.1166/jnn.2009.NS68; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wu W, 2011, METHODS MOL BIOL, V751, P565, DOI 10.1007/978-1-61779-151-2_35; Yang M, 2010, J NANOSCI NANOTECHNO, V10, P7550, DOI 10.1166/jnn.2010.2825; Zemp RJ, 2009, NAT NANOTECHNOL, V4, P798, DOI 10.1038/nnano.2009.367	30	41	42	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38995	10.1371/journal.pone.0038995	http://dx.doi.org/10.1371/journal.pone.0038995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808023	gold, Green Submitted, Green Published			2022-12-27	WOS:000306355500006
J	Ohkura, M; Sasaki, T; Kobayashi, C; Ikegaya, Y; Nakai, J				Ohkura, Masamichi; Sasaki, Takuya; Kobayashi, Chiaki; Ikegaya, Yuji; Nakai, Junichi			An Improved Genetically Encoded Red Fluorescent Ca2+ Indicator for Detecting Optically Evoked Action Potentials	PLOS ONE			English	Article							IN-VIVO; CALCIUM INDICATORS; SIGNALS; PROTEIN; RESOLUTION; ELEGANS; NEURONS; SENSOR; BRAIN	Genetically encoded Ca2+ indicators (GECIs) are powerful tools to image activities of defined cell populations. Here, we developed an improved red fluorescent GECI, termed R-CaMP1.07, by mutagenizing R-GECO1. In HeLa cell assays, R-CaMP1.07 exhibited a 1.5-2-fold greater fluorescence response compared to R-GECO1. In hippocampal pyramidal neurons, R-CaMP1.07 detected Ca2+ transients triggered by single action potentials (APs) with a probability of 95% and a signal-to-noise ratio >7 at a frame rate of 50 Hz. The amplitudes of Ca2+ transients linearly correlated with the number of APs. The expression of R-CaMP1.07 did not significantly alter the electrophysiological properties or synaptic activity patterns. The co-expression of R-CaMP1.07 and channelrhodpsin-2 (ChR2), a photosensitive cation channel, in pyramidal neurons demonstrated that R-CaMP1.07 was applicable for the monitoring of Ca2+ transients in response to optically evoked APs, because the excitation light for R-CaMP1.07 hardly activated ChR2. These technical advancements provide a novel strategy for monitoring and manipulating neuronal activity with single cell resolution.	[Ohkura, Masamichi; Sasaki, Takuya; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Kobayashi, Chiaki; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan	Saitama University; University of Tokyo	Ohkura, M (corresponding author), Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan.	mohkura@mail.saitama-u.ac.jp; jnakai@mail.saitama-u.ac.jp	Nakai, Junichi/GQZ-6415-2022; Sasaki, Takuya/J-3283-2015; Ohkura, Masamichi/J-6976-2012	Ohkura, Masamichi/0000-0002-3659-7780; Ikegaya, Yuji/0000-0003-2260-8191	Regional Innovation Cluster Program (City Area Type, Central Saitama Area); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22500285, 24111509, 10J05408, 21500379]	Regional Innovation Cluster Program (City Area Type, Central Saitama Area); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Regional Innovation Cluster Program (City Area Type, Central Saitama Area) and grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to M.O. (nos. 22500285 and 24111509), T. S. (no. 10J05408) and J.N. (no. 21500379). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Peled ES, 2011, NAT NEUROSCI, V14, P519, DOI 10.1038/nn.2767; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi N, 2011, CURR PROTOC NEUROSCI; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	33	91	94	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39933	10.1371/journal.pone.0039933	http://dx.doi.org/10.1371/journal.pone.0039933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808076	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500017
J	Short, MK; Hallett, JP; Tar, K; Dange, T; Schmidt, M; Moir, R; Willis, IM; Jubinsky, PT				Short, Mary K.; Hallett, Joshua P.; Tar, Krisztina; Dange, Thomas; Schmidt, Marion; Moir, Robyn; Willis, Ian M.; Jubinsky, Paul T.			The Yeast Magmas Ortholog Pam16 Has an Essential Function in Fermentative Growth That Involves Sphingolipid Metabolism	PLOS ONE			English	Article							PHOSPHOSPHINGOLIPID PHOSPHOLIPASE-C; PROTEIN IMPORT MOTOR; SACCHAROMYCES-CEREVISIAE; ACID SYNTHESIS; PRESEQUENCE TRANSLOCASE; CERAMIDE SYNTHESIS; J-DOMAIN; MITOCHONDRIA; GENE; CARDIOLIPIN	Magmas is a growth factor responsive gene encoding an essential mitochondrial protein in mammalian cells. Pam16, the Magmas ortholog in Saccharomyces cerevisiae, is a component of the presequence translocase-associated motor. A temperature-sensitive allele (pam16-I61N) was used to query an array of non-essential gene-deletion strains for synthetic genetic interactions. The pam16-I61N mutation at ambient temperature caused synthetic lethal or sick phenotypes with genes involved in lipid metabolism, perixosome synthesis, histone deacetylation and mitochondrial protein import. The gene deletion array was also screened for suppressors of the pam16-I61N growth defect to identify compensatory pathways. Five suppressor genes were identified (SUR4, ISC1, IPT1, SKN1, and FEN1) and all are involved in sphingolipid metabolism. pam16-I61N cells cultured in glucose at non-permissive temperatures resulted in rapid growth inhibition and G1 cell cycle arrest, but cell viability was maintained. Altered mitochondria morphology, reduced peroxisome induction in glycerol/ethanol and oleate, and changes in the levels of several sphingolipids including C18 alpha-hydroxy-phytoceramide, were also observed in the temperature sensitive strain. Deletion of SUR4, the strongest suppressor, reversed the temperature sensitive fermentative growth defect, the morphological changes and the elevated levels of C18 alpha-hydroxy phytoceramide in pam16-I61N. Deletion of the other four suppressor genes had similar effects on C18 alpha-hydroxy-phytoceramide levels and restored proliferation to the pam16-I61N strain. In addition, pam16-I61N inhibited respiratory growth, likely by reducing cardiolipin, which is essential for mitochondrial function. Our results suggest that the pleiotropic effects caused by impaired Pam16/Magmas function are mediated in part by changes in lipid metabolism.	[Short, Mary K.; Hallett, Joshua P.; Jubinsky, Paul T.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Tar, Krisztina; Dange, Thomas; Schmidt, Marion; Moir, Robyn; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Jubinsky, Paul T.] Yale Univ, Sch Med, Dept Pediat, Hematol Oncol Sect, New Haven, CT 06510 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yale University	Short, MK (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	ian.willis@einstein.yu.edu; paul.jubinsky@yale.edu		Willis, Ian/0000-0001-6599-2395	National Institutes of Health [NIH GM084228]; National Institute of General Medical Sciences [NIGMS GM085177]; James B. Ax Family Foundation; SAS Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085177, R01GM084228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); James B. Ax Family Foundation; SAS Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH GM084228)-MS, National Institute of General Medical Sciences (NIGMS GM085177)-IMW, James B. Ax Family Foundation, the SAS Foundation for Cancer Research, and support from Donna Alex and Mary and Robert Cancilla to PTJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Becker S, 2001, GENE, V262, P15, DOI 10.1016/S0378-1119(00)00548-5; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bleve G, 2011, BBA-BIOMEMBRANES, V1808, P733, DOI 10.1016/j.bbamem.2010.12.005; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Busti S, 2010, SENSORS-BASEL, V10, P6195, DOI 10.3390/s100606195; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; de Avalos SV, 2005, J BIOL CHEM, V280, P7170, DOI 10.1074/jbc.M411058200; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dickson RC, 2010, ADV EXP MED BIOL, V688, P217; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; Elsner S, 2009, INT J MOL SCI, V10, P2041, DOI 10.3390/ijms10052041; FOX TD, 1991, METHOD ENZYMOL, V194, P149; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Jubinsky PT, 2011, BIOORG MED CHEM LETT, V21, P3479, DOI 10.1016/j.bmcl.2011.03.050; Jubinsky PT, 2005, J MOL HISTOL, V36, P69, DOI 10.1007/s10735-004-3840-8; Jubinsky PT, 2003, J HISTOCHEM CYTOCHEM, V51, P585, DOI 10.1177/002215540305100504; Jubinsky PT, 2001, EXP HEMATOL, V29, P1392, DOI 10.1016/S0301-472X(01)00749-4; Kawano T, 2008, BIOL PHARM BULL, V31, P998, DOI 10.1248/bpb.31.998; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Kitagaki H, 2009, J BIOL CHEM, V284, P10818, DOI 10.1074/jbc.M805029200; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Mokranjac D, 2007, J BIOL CHEM, V282, P18037, DOI 10.1074/jbc.M701895200; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Pais JE, 2011, MOL BIOL CELL, V22, P4740, DOI 10.1091/mbc.E11-08-0715; Peng Jianbin, 2005, In Silico Biology, V5, P251; Perkins GA, 2001, EUR J CELL BIOL, V80, P139, DOI 10.1078/0171-9335-00149; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; PIPER PW, 1986, EUR J BIOCHEM, V161, P525, DOI 10.1111/j.1432-1033.1986.tb10474.x; Plesofsky NS, 2008, EUKARYOT CELL, V7, P2147, DOI 10.1128/EC.00147-08; Roy S, 2012, FASEB J; Saleem RA, 2010, MOL CELL PROTEOMICS, V9, P2076, DOI 10.1074/mcp.M000116-MCP201; Saleem RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011953; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Scatena R, 2012, ADV EXP MED BIOL, V942, P287, DOI 10.1007/978-94-007-2869-1_13; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Sertil O, 2007, MOL CELL BIOL, V27, P2037, DOI 10.1128/MCB.02297-06; Shechtman CF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215038; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Tagliati F, 2010, ENDOCRINOLOGY, V151, P4635, DOI 10.1210/en.2010-0441; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Thevissen K, 2005, FEBS LETT, V579, P1973, DOI 10.1016/j.febslet.2005.02.043; Thevissen K, 2010, FEMS MICROBIOL LETT, V303, P163, DOI 10.1111/j.1574-6968.2009.01869.x; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Laan M, 2005, MOL CELL BIOL, V25, P7449, DOI 10.1128/MCB.25.17.7449-7458.2005; Vizeacoumar FJ, 2004, MOL BIOL CELL, V15, P665, DOI 10.1091/mbc.E03-09-0681; Vizeacoumar FJ, 2003, J CELL BIOL, V161, P321, DOI 10.1083/jcb.200210130; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu BX, 2011, J BIOL CHEM, V286, P22362, DOI 10.1074/jbc.M110.156471; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	93	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39428	10.1371/journal.pone.0039428	http://dx.doi.org/10.1371/journal.pone.0039428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808036	gold, Green Submitted, Green Published			2022-12-27	WOS:000306355500011
J	Singh, S; Singh, J; Kumar, S; Gopinath, K; Balooni, V; Singh, N; Mani, K				Singh, Sarman; Singh, Jitendra; Kumar, Sandeep; Gopinath, Krishnamoorthy; Balooni, Veena; Singh, Niti; Mani, Kalaivani			Poor Performance of Serological Tests in the Diagnosis of Pulmonary Tuberculosis: Evidence from a Contact Tracing Field Study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNOLOGICAL DIAGNOSIS; ASSAY; SERODIAGNOSIS; ANTIGEN	Background: Delayed or missed diagnosis of TB continues to fuel the global TB epidemic, especially in resource limited settings. Use of serology for the diagnosis of tuberculosis, commonly used in India, is another factor. In the present study a commercially available serodiagnostic assay was assessed for its diagnostic value in combination with smear, culture and clinical manifestations. Methodology/Principal Findings: A total of 2300 subjects were recruited for the study, but 1041 subjects were excluded for various reasons. Thus 1259 subjects were included in the study of which 470 were pulmonary tuberculosis cases (440 of 470 were culture-positive) and 789 were their asymptomatic contacts. A house-to-house survey method was used. Blood samples were tested for IgM, IgA, and IgG antibodies using the Pathozyme Myco M (IgM), Myco A (IgA) and Myco G (IgG) enzyme immunoassay (EIA). Out of 470 PTB cases, BCG scar was positive in 82.34%. The Mantoux test and smear positivity rates in PTB cases were 94.3% (430/456), and 65.32% (307/470), respectively. Among the asymptomatic contacts, BCG scar was positive in 95.3% and Mantoux test was positive in 80.66% (442/548) contacts. No contact was found falsely smear positive. The sensitivity of IgM, IgA, and IgG EIA tests was 48.7%, 25.7% and 24.4%, respectively, while the specificity was 71.5%, 80.5%, 76.6%, respectively. Performance of EIAs was not affected by the previous BCG vaccination. However, prior BCG vaccination was statistically significantly (p = 0.005) associated with Mantoux test positivity in PTB cases but not in contacts (p = 0.127). The agreement between serology and Mantoux test was not significant. Conclusion: The commercial serological test evaluated showed poor sensitivity and specificity and suggests no utility for detection of pulmonary tuberculosis.	[Singh, Sarman; Singh, Jitendra; Kumar, Sandeep; Gopinath, Krishnamoorthy; Balooni, Veena] All India Inst Med Sci, Div Clin Microbiol, Dept Lab Med, New Delhi, India; [Singh, Niti] Lala Ram Sarup Inst TB & Resp Dis, New Delhi, India; [Mani, Kalaivani] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, S (corresponding author), All India Inst Med Sci, Div Clin Microbiol, Dept Lab Med, New Delhi, India.	sarman_singh@yahoo.com	Singh, Sarman/AAR-8914-2020; KUMAR, SANDEEP/GZA-7182-2022; Krishnamoorthy, Gopinath/K-3269-2012	Singh, Sarman/0000-0002-0749-9647; Krishnamoorthy, Gopinath/0000-0002-0617-6897	Indian Council of Medical Research, New Delhi (ICMR) [5/8/5/4/2005-ECD-I]	Indian Council of Medical Research, New Delhi (ICMR)(Indian Council of Medical Research (ICMR))	The study was supported by Indian Council of Medical Research, New Delhi (ICMR Sanction Order Number: 5/8/5/4/2005-ECD-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2007, SCAND J IMMUNOL, V66, P176, DOI 10.1111/j.1365-3083.2007.01978.x; Adjei AA, 2003, JPN J INFECT DIS, V56, P161; [Anonymous], 2011, COMM SER TESTS DIAGN; [Anonymous], 2011, GLOB TUB CONTR; Arloing S., 1898, C R ACAD SCI, V126, P1398; BOTHAMLEY GH, 1995, EUR RESPIR J, V8, pS676; Bukhary Zakeya Abdulbaqi, 2007, Ann Thorac Med, V2, P47, DOI 10.4103/1817-1737.32229; Butt Tariq, 2004, J Coll Physicians Surg Pak, V14, P105; Chan ED, 2000, TUBERCLE LUNG DIS, V80, P131, DOI 10.1054/tuld.2000.0243; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001074; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Gennaro ML, 2000, CLIN INFECT DIS, V30, pS243, DOI 10.1086/313868; Gopinath K, 2009, J APPL MICROBIOL, V107, P425, DOI 10.1111/j.1365-2672.2009.04218.x; Grenier J, 2012, EUR RESPIR J, V39, P502, DOI 10.1183/09031936.00070611; Imaz MS, 2004, J CLIN MICROBIOL, V42, P884, DOI 10.1128/JCM.42.2.884-887.2004; Julian E, 2000, INT J TUBERC LUNG D, V4, P1082; KENT TP, 1985, PUBLIC HLTH MYCOBACT; Laal S, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P71; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; NASSAU E, 1976, TUBERCLE, V57, P67, DOI 10.1016/0041-3879(76)90019-2; Oyewo TA, 1999, INT J TUBERC LUNG D, V3, P231; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; Silva VMC, 2003, INT J TUBERC LUNG D, V7, P478; SINGH M, 1992, GENE, V117, P53, DOI 10.1016/0378-1119(92)90489-C; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; Singh S, 2011, INDIAN J MED RES, V134, P384, DOI 10.4103/0971-5916.90980; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; VERBON A, 1993, AM REV RESPIR DIS, V148, P378, DOI 10.1164/ajrccm/148.2.378; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Wilkinson RJ, 1997, J CLIN MICROBIOL, V35, P553, DOI 10.1128/JCM.35.3.553-557.1997	36	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40213	10.1371/journal.pone.0040213	http://dx.doi.org/10.1371/journal.pone.0040213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808119	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500032
J	Cameron, DJ; Galvin, C; Alkam, T; Sidhu, H; Ellison, J; Luna, S; Ethell, DW				Cameron, D. Joshua; Galvin, Cooper; Alkam, Tursun; Sidhu, Harpreet; Ellison, John; Luna, Salvadore; Ethell, Douglas W.			Alzheimer's-Related Peptide Amyloid-beta Plays a Conserved Role in Angiogenesis	PLOS ONE			English	Article							GAMMA-SECRETASE; DISEASE; TRIALS; DIFFERENTIATION; PRESENILIN-1; PLAQUES; CELLS	Alzheimer's disease research has been at an impasse in recent years with lingering questions about the involvement of Amyloid-beta (A beta). Early versions of the amyloid hypothesis considered A beta something of an undesirable byproduct of APP processing that wreaks havoc on the human neocortex, yet evolutionary conservation - over three hundred million years - indicates this peptide plays an important biological role in survival and reproductive fitness. Here we describe how A beta regulates blood vessel branching in tissues as varied as human umbilical vein and zebrafish hindbrain. High physiological concentrations of A beta monomer induced angiogenesis by a conserved mechanism that blocks gamma-secretase processing of a Notch intermediate, NEXT, and reduces the expression of downstream Notch target genes. Our findings allude to an integration of signaling pathways that utilize gamma-secretase activity, which may have significant implications for our understanding of Alzheimer's pathogenesis vis-a-vis vascular changes that set the stage for ensuing neurodegeneration.	[Cameron, D. Joshua] Western Univ Hlth Sci, Coll Optometry, Pomona, CA USA; [Alkam, Tursun; Luna, Salvadore; Ethell, Douglas W.] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA; [Ethell, Douglas W.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences; Western University of Health Sciences	Cameron, DJ (corresponding author), Western Univ Hlth Sci, Coll Optometry, Pomona, CA USA.	dougeth64@gmail.com	Alkam, Tursun/AAG-5503-2019	Ethell, Douglas/0000-0002-9237-0265; Sidhu, Harpreet/0000-0001-8767-3897	Western University of Health Sciences College of Optometry; College of Biomedical Sciences; California Institute for Regenerative Medicine [RN1-00538]; 5-College Neuroscience Summer Fellowship through the Claremont Colleges	Western University of Health Sciences College of Optometry; College of Biomedical Sciences; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); 5-College Neuroscience Summer Fellowship through the Claremont Colleges	Funding provided by the Western University of Health Sciences College of Optometry to DJC, College of Biomedical Sciences to DWE, and a grant from the California Institute for Regenerative Medicine (RN1-00538) to DWE. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John Dowling for critical comments on the manuscript. CG received a 5-College Neuroscience Summer Fellowship through the Claremont Colleges.	Alzheimers Assoc, 2011, ALZHEIMERS DEMENT, V7, P208, DOI 10.1016/j.jalz.2011.02.004; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Carlson C, 2011, ALZHEIMERS DEMENT, V7, P396, DOI 10.1016/j.jalz.2011.05.2353; Cechetto David F, 2008, Expert Rev Neurother, V8, P743, DOI 10.1586/14737175.8.5.743; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Ethell DW, 2010, NEUROSCIENTIST, V16, P614, DOI 10.1177/1073858410366162; Ethell DW, 2002, CURR BIOL, V12, P1595, DOI 10.1016/S0960-9822(02)01140-5; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hayashi H, 2007, BIOCHEM BIOPH RES CO, V363, P584, DOI 10.1016/j.bbrc.2007.09.003; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Liao YF, 2007, MOL PHARMACOL, V71, P588, DOI 10.1124/mol.106.024299; Malinda KM, 1998, J IMMUNOL, V160, P1001; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Nagase H, 2011, CURR STEM CELL RES T, V6, P131, DOI 10.2174/157488811795495459; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Westerfield M, 2007, ZEBRAFISH BOOK; Wilcock DM, 2009, CNS NEUROL DISORD-DR, V8, P50, DOI 10.2174/187152709787601858; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	35	37	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39598	10.1371/journal.pone.0039598	http://dx.doi.org/10.1371/journal.pone.0039598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792182	Green Submitted, Green Published, gold			2022-12-27	WOS:000306354700013
J	de Timary, P; Cani, PD; Duchemin, J; Neyrinck, AM; Gihousse, D; Laterre, PF; Badaoui, A; Leclercq, S; Delzenne, NM; Starkel, P				de Timary, Philippe; Cani, Patrice D.; Duchemin, Julie; Neyrinck, Audrey M.; Gihousse, Dominique; Laterre, Pierre-Francois; Badaoui, Abdenor; Leclercq, Sophie; Delzenne, Nathalie M.; Starkel, Peter			The Loss of Metabolic Control on Alcohol Drinking in Heavy Drinking Alcohol-Dependent Subjects	PLOS ONE			English	Article							RESEARCH CLINICS PREVALENCE; NERVOUS-SYSTEM CONTROL; HABITUAL FOOD-INTAKE; GHRELIN LEVELS; BODY-WEIGHT; ENERGY-EXPENDITURE; NUTRIENT INTAKE; LEPTIN LEVELS; SERUM LEPTIN; CONSUMPTION	Background: Most physiological studies interested in alcohol-dependence examined ethanol as a pharmacological agent rather than a nutrient. We conducted two studies, which assessed the metabolic and endocrine factors involved in the regulation of alcohol and nutrient intake in alcohol-dependent (AD) subjects. We also examined the potential role of a disruption in energy balance in alcohol-dependence. Methods and Results: In Study-1, quantitative dietetic interviews of eating and drinking habits were conducted with 97 AD subjects. The population was split around a median alcohol intake value of 12.5 kcal/kg/day. The results showed that the "low alcohol'' drinking AD subjects had high Body Mass Index (BMI) and Fat Mass (FM) and alcohol intake was compensated for by a decrease in non-alcoholic intakes. "High alcohol'' drinking AD subjects, on the other hand, had low BMI and FM and the total caloric intakes were largely above norms. In Study-2, 24 AD inpatients were submitted to dietetic interviews, calorimetry and blood samplings for the measurement of biomarkers of the regulation of metabolism and satiety, on day 2, 5 and 16 of abstinence. These patients were compared with 20 controls matched for age and gender. We observed in AD patients an increase in cortisol, leptin and PYY plasma levels and a decrease in ghrelin, which might explain the observed decrease in non-alcoholic intakes. However, alcoholic and non-alcoholic intakes correlated positively with basal metabolism and negatively with leptin and leptin/BMI. Conclusion: For individuals consuming below 12.5 kcal/kg/day of alcohol, alcohol intake is compensated for by a decrease in non-alcoholic nutrient intakes, probably due to changes in metabolic and satiety factors. For individuals consuming above 12.5 kcal/kg/day of alcohol, alcohol accelerates metabolism and decreases fat mass and leptin levels, and the total caloric intake largely exceeds norms. A dual model for regulation of energy intake in AD subjects is proposed.	[de Timary, Philippe; Duchemin, Julie; Leclercq, Sophie] Catholic Univ Louvain, Dept Adult Psychiat, St Luc Acad Hosp, Brussels, Belgium; [de Timary, Philippe; Duchemin, Julie; Leclercq, Sophie] Catholic Univ Louvain, Psychol Dev CSDP Res Unit, Inst Neurosci, Brussels, Belgium; [de Timary, Philippe; Duchemin, Julie; Leclercq, Sophie] Catholic Univ Louvain, Inst Psychol, Brussels, Belgium; [Cani, Patrice D.; Neyrinck, Audrey M.; Leclercq, Sophie; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium; [Gihousse, Dominique] Catholic Univ Louvain, Dept Dietet, St Luc Acad Hosp, Brussels, Belgium; [Laterre, Pierre-Francois] Catholic Univ Louvain, Dept Anestesiol, St Luc Acad Hosp, Brussels, Belgium; [Laterre, Pierre-Francois; Badaoui, Abdenor; Starkel, Peter] Catholic Univ Louvain, Inst Clin Res, Brussels, Belgium; [Badaoui, Abdenor; Starkel, Peter] Catholic Univ Louvain, Dept Gastroenterol, St Luc Acad Hosp, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel	de Timary, P (corresponding author), Catholic Univ Louvain, Dept Adult Psychiat, St Luc Acad Hosp, Brussels, Belgium.	Philippe.detimary@uclouvain.be	D., Cani Patrice/M-8055-2016; Neyrinck, Audrey/AAE-7929-2019; Stärkel, Peter/AAC-6400-2019; Delzenne, Nathalie/AAC-4628-2019	D., Cani Patrice/0000-0003-2040-2448; Neyrinck, Audrey/0000-0002-9435-3338; Delzenne, Nathalie/0000-0003-2115-6082; Leclercq, Sophie/0000-0002-2894-5220	FNRS-FRS, FSR [3.4.585.07F]; Fonds Speciaux de Recherche pour l'Agriculture et l'Industrie; Fondation Saint-Luc	FNRS-FRS, FSR(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherche pour l'Agriculture et l'Industrie; Fondation Saint-Luc	This work was supported by grant 3.4.585.07F from FNRS-FRS, FSR 2004, by Fonds Speciaux de Recherche pour l'Agriculture et l'Industrie and a grant from Fondation Saint-Luc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 2000, AM J GASTROENTEROL, V95, P2323; Addolorato G, 1998, J INTERN MED, V244, P387; Addolorato G, 1998, AM J GASTROENTEROL, V93, P2476, DOI 10.1111/j.1572-0241.1998.00707.x; Addolorato G, 2006, ALCOHOL CLIN EXP RES, V30, P1933, DOI 10.1111/j.1530-0277.2006.00238.x; Ahima RS, 2008, J CLIN INVEST, V118, P2380, DOI 10.1172/JCI36284; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Badaoui A, 2008, EUR J CLIN INVEST, V38, P397, DOI 10.1111/j.1365-2362.2008.01947.x; BEBB HT, 1971, AM J CLIN NUTR, V24, P1042; Berneis K, 1997, METABOLISM, V46, P750, DOI 10.1016/S0026-0495(97)90118-9; BLOCK G, 1985, AM J EPIDEMIOL, V122, P27, DOI 10.1093/oxfordjournals.aje.a114084; BLOCK G, 1982, AM J EPIDEMIOL, V115, P492, DOI 10.1093/oxfordjournals.aje.a113331; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; CAMARGO CA, 1987, J AM COLL NUTR, V6, P271; de Castro JM, 2006, J NUTR, V136, P1382, DOI 10.1093/jn/136.5.1382; DENNIS BH, 1985, AM J CLIN NUTR, V41, P312, DOI 10.1093/ajcn/41.5.1103; FISHER M, 1985, AM J CLIN NUTR, V41, P623, DOI 10.1093/ajcn/41.3.623; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; GORDON T, 1986, ARCH INTERN MED, V146, P262, DOI 10.1001/archinte.146.2.262; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Goris AHC, 2001, BRIT J NUTR, V85, P629, DOI 10.1079/BJN2001322; GRUCHOW HW, 1985, AM J CLIN NUTR, V42, P289, DOI 10.1093/ajcn/42.2.289; Hillemacher T, 2007, PSYCHONEUROENDOCRINO, V32, P87, DOI 10.1016/j.psyneuen.2006.09.013; HILLERS VN, 1985, AM J CLIN NUTR, V41, P356, DOI 10.1093/ajcn/41.2.356; Horvath B, 2002, BIOCHEM PHARMACOL, V64, P369, DOI 10.1016/S0006-2952(02)01167-X; JACOBSEN BK, 1987, J CHRON DIS, V40, P795, DOI 10.1016/0021-9681(87)90131-7; Jahn H, 2001, ARCH GEN PSYCHIAT, V58, P509, DOI 10.1001/archpsyc.58.5.509; JONES BR, 1982, AM J CLIN NUTR, V35, P135, DOI 10.1093/ajcn/35.1.135; Kiefer F, 2001, BIOL PSYCHIAT, V49, P782, DOI 10.1016/S0006-3223(01)01081-2; Kim DJ, 2005, ALCOHOL ALCOHOLISM, V40, P76, DOI 10.1093/alcalc/agh108; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Kraus T, 2005, ALCOHOL CLIN EXP RES, V29, P2154, DOI 10.1097/01.alc.0000191753.82554.7e; Kraus T, 2004, ADDICT BIOL, V9, P213, DOI 10.1111/j.1369-1600.2004.tb00535.x; Lagiou P, 1999, ANN NUTR METAB, V43, P23, DOI 10.1159/000012763; Leggio L, 2008, ALCOHOL CLIN EXP RES, V32, P450, DOI 10.1111/j.1530-0277.2007.00589.x; LIEBER CS, 1973, RES COMMUN CHEM PATH, V6, P983; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; LIEBER CS, 1991, AM J CLIN NUTR, V54, P976, DOI 10.1093/ajcn/54.6.976; MAISTO SA, 1982, ADDICT BEHAV, V7, P33, DOI 10.1016/0306-4603(82)90022-3; Mantzoros CS, 1998, OBES RES, V6, P179, DOI 10.1002/j.1550-8528.1998.tb00335.x; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NACE EP, 1984, ANNU REV MED, V35, P293, DOI 10.1146/annurev.me.35.020184.001453; Nicolas JM, 2001, ALCOHOL CLIN EXP RES, V25, P83; PIROLA RC, 1972, PHARMACOLOGY, V7, P185, DOI 10.1159/000136288; Rosenbaum M, 2002, J CLIN ENDOCR METAB, V87, P2391, DOI 10.1210/jc.87.5.2391; Santolaria F, 2003, ALCOHOL ALCOHOLISM, V38, P60, DOI 10.1093/alcalc/agg015; Santolaria F, 2000, DRUG ALCOHOL DEPEN, V59, P295, DOI 10.1016/S0376-8716(99)00129-5; SCHATZKIN A, 1987, NEW ENGL J MED, V316, P1169, DOI 10.1056/NEJM198705073161901; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SEPPA K, 1992, ARCH INTERN MED, V152, P297, DOI 10.1001/archinte.152.2.297; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; WEATHERALL R, 1988, EUR J CLIN NUTR, V42, P221; WINDHAM CT, 1983, J AM DIET ASSOC, V82, P364; Windham CT, 1983, J AM DIET ASSOC, V82, P373; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmet P, 1998, NUTRITION, V14, P653	56	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38682	10.1371/journal.pone.0038682	http://dx.doi.org/10.1371/journal.pone.0038682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808013	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700003
J	Peters, HL; Pitt, JJ; Wood, LR; Hamilton, NJ; Sarsero, JP; Buck, NE				Peters, Heidi L.; Pitt, James J.; Wood, Leonie R.; Hamilton, Natasha J.; Sarsero, Joseph P.; Buck, Nicole E.			Mouse Models for Methylmalonic Aciduria	PLOS ONE			English	Article							COA MUTASE; PROPIONIC ACIDEMIA; IN-VITRO; METABOLISM; INTEGRATION; MANAGEMENT; DISORDERS; NUTRITION; GROWTH; ENZYME	Methylmalonic aciduria (MMA) is a disorder of organic acid metabolism resulting from a functional defect of methylmalonyl-CoA mutase (MCM). MMA is associated with significant morbidity and mortality, thus therapies are necessary to help improve quality of life and prevent renal and neurological complications. Transgenic mice carrying an intact human MCM locus have been produced. Four separate transgenic lines were established and characterised as carrying two, four, five or six copies of the transgene in a single integration site. Transgenic mice from the 2-copy line were crossed with heterozygous knockout MCM mice to generate mice hemizygous for the human transgene on a homozygous knockout background. Partial rescue of the uniform neonatal lethality seen in homozygous knockout mice was observed. These rescued mice were significantly smaller than control littermates (mice with mouse MCM gene). Biochemically, these partial rescue mice exhibited elevated methylmalonic acid levels in urine, plasma, kidney, liver and brain tissue. Acylcarnitine analysis of blood spots revealed elevated propionylcarnitine levels. Analysis of mRNA expression confirms the human transgene is expressed at higher levels than observed for the wild type, with highest expression in the kidney followed closely by brain and liver. Partial rescue mouse fibroblast cultures had only 20% of the wild type MCM enzyme activity. It is anticipated that this humanised partial rescue mouse model of MMA will enable evaluation of long-term pathophysiological effects of elevated methylmalonic acid levels and be a valuable model for the investigation of therapeutic strategies, such as cell transplantation.	[Peters, Heidi L.; Wood, Leonie R.; Hamilton, Natasha J.; Sarsero, Joseph P.; Buck, Nicole E.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Pitt, James J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, VCGS Pathol, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Peters, HL (corresponding author), Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia.	heidi.peters@mcri.edu.au	peters, heidi/GWD-0358-2022	Peters, Heidi/0000-0001-7189-5874	Murdoch Childrens Research Institute; National Health and Medical Research Council [491256]; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council clinical Career Development Award	Murdoch Childrens Research Institute; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council clinical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Murdoch Childrens Research Institute, National Health and Medical Research Council (#491256) and the Victorian Government's Operational Infrastructure Support Program. HP was the recipient of an National Health and Medical Research Council clinical Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Essa M, 1998, CLIN GENET, V54, P90; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Buck NE, 2009, MOL GENET METAB, V97, P244, DOI 10.1016/j.ymgme.2009.04.004; Chace DH, 2001, CLIN CHEM, V47, P2040; CHURCH JA, 1984, J INHERIT METAB DIS, V7, P12, DOI 10.1007/BF01805612; Corazza F, 1996, BIOL NEONATE, V70, P304; Feillet F, 2000, J PEDIATR-US, V136, P659, DOI 10.1067/mpd.2000.104290; Howden SE, 2008, GENE THER, V15, P1372, DOI 10.1038/gt.2008.84; Hu RM, 2009, J GENE MED, V11, P361, DOI 10.1002/jgm.1297; HYMAN SL, 1987, J PEDIATR-US, V111, P558, DOI 10.1016/S0022-3476(87)80121-X; INOUE S, 1981, PEDIATR RES, V15, P95, DOI 10.1203/00006450-198102000-00001; KAHLER SG, 1989, J PEDIATR-US, V115, P235, DOI 10.1016/S0022-3476(89)80071-X; KAHLER SG, 1994, J PEDIATR-US, V124, P239, DOI 10.1016/S0022-3476(94)70311-6; Le Saux A, 2010, TRANSGENIC RES, V19, P923, DOI 10.1007/s11248-010-9368-7; Leonard JV, 2003, EUR J PEDIATR, V162, pS21, DOI 10.1007/s00431-003-1345-1; LEONARD JV, 1995, J INHERIT METAB DIS, V18, P430, DOI 10.1007/BF00710054; LINDBLAD B, 1968, ACTA PAEDIATR SCAND, V57, P417, DOI 10.1111/j.1651-2227.1968.tb07314.x; Magera MJ, 2000, CLIN CHEM, V46, P1804; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; Nagy A., 2003, MANIPULATING MOUSE E; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; THREADGILL DW, 1990, CYTOGENET CELL GENET, V53, P112, DOI 10.1159/000132907; WILKEMEYER MF, 1993, BIOCHEM J, V296, P663, DOI 10.1042/bj2960663; WILKEMEYER MF, 1990, BIOCHEM J, V271, P449, DOI 10.1042/bj2710449; WILLARD HF, 1980, J CLIN INVEST, V65, P690, DOI 10.1172/JCI109715; WILLARD HF, 1976, HUM GENET, V34, P277, DOI 10.1007/BF00295291; Yannicelli S, 2003, MOL GENET METAB, V80, P181, DOI 10.1016/j.ymgme.2003.08.012	28	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40609	10.1371/journal.pone.0040609	http://dx.doi.org/10.1371/journal.pone.0040609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792386	gold, Green Published			2022-12-27	WOS:000306354700060
J	Trupp, M; Zhu, HJ; Wikoff, WR; Baillie, RA; Zeng, ZB; Karp, PD; Fiehn, O; Krauss, RM; Kaddurah-Daouk, R				Trupp, Miles; Zhu, Hongjie; Wikoff, William R.; Baillie, Rebecca A.; Zeng, Zhao-Bang; Karp, Peter D.; Fiehn, Oliver; Krauss, Ronald M.; Kaddurah-Daouk, Rima			Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment	PLOS ONE			English	Article							GLOBAL BIOCHEMICAL APPROACH; XANTHINE-OXIDASE; CHOLESTEROL; THERAPY; OUTPATIENTS; EXPRESSION; RECEPTOR; SAFETY; HEART; SERUM	Statins are widely prescribed for reducing LDL-cholesterol (C) and risk for cardiovascular disease (CVD), but there is considerable variation in therapeutic response. We used a gas chromatography-time-of-flight mass-spectrometry-based metabolomics platform to evaluate global effects of simvastatin on intermediary metabolism. Analyses were conducted in 148 participants in the Cholesterol and Pharmacogenetics study who were profiled pre and six weeks post treatment with 40 mg/day simvastatin: 100 randomly selected from the full range of the LDL-C response distribution and 24 each from the top and bottom 10% of this distribution ("good'' and "poor'' responders, respectively). The metabolic signature of drug exposure in the full range of responders included essential amino acids, lauric acid (p<0.0055, q<0.055), and alpha-tocopherol (p<0.0003, q<0.017). Using the HumanCyc database and pathway enrichment analysis, we observed that the metabolites of drug exposure were enriched for the pathway class amino acid degradation (p<0.0032). Metabolites whose change correlated with LDL-C lowering response to simvastatin in the full range responders included cystine, urea cycle intermediates, and the dibasic amino acids ornithine, citrulline and lysine. These dibasic amino acids share plasma membrane transporters with arginine, the rate-limiting substrate for nitric oxide synthase (NOS), a critical mediator of cardiovascular health. Baseline metabolic profiles of the good and poor responders were analyzed by orthogonal partial least square discriminant analysis so as to determine the metabolites that best separated the two response groups and could be predictive of LDL-C response. Among these were xanthine, 2-hydroxyvaleric acid, succinic acid, stearic acid, and fructose. Together, the findings from this study indicate that clusters of metabolites involved in multiple pathways not directly connected with cholesterol metabolism may play a role in modulating the response to simvastatin treatment.	[Trupp, Miles; Karp, Peter D.] SRI Int, Bioinformat Res Grp, Al Ctr, Menlo Pk, CA 94025 USA; [Zhu, Hongjie; Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Durham, NC USA; [Wikoff, William R.; Fiehn, Oliver] Univ Calif Davis, Genom Ctr, Davis, CA 95616 USA; [Baillie, Rebecca A.] Rosa & Co, Cupertino, CA USA; [Zeng, Zhao-Bang] NC State Univ, Bioinformat Res Ctr, Raleigh, NC USA; [Krauss, Ronald M.] Childrens Hosp Oakland Res Inst, Oakland, CA USA	SRI International; Duke University; University of California System; University of California Davis; University of North Carolina; North Carolina State University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Trupp, M (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	rkrauss@chori.org; kaddu001@mc.duke.edu	baillie, rebecca/AAQ-3400-2020; Karp, Peter/C-3514-2012	baillie, rebecca/0000-0003-3966-6320; Karp, Peter/0000-0002-5876-6418; Kaddurah-Daouk, Rima/0000-0003-1858-5732	National Institute of General Medical Sciences [R24, GM078233, U01 HL069757]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institute of General Medical Sciences grants R24, GM078233, "The Metabolomics Research Network for Drug Response Phenotype'' (RKD, RMK); and U01 HL069757, "Pharmacogenomics and Risk of Cardiovascular Disease'' (RMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aura AM, 2011, MOL BIOSYST, V7, P437, DOI 10.1039/c0mb00023j; Bai JPF, 2010, DRUG METAB PHARMACOK, V25, P62, DOI 10.2133/dmpk.25.62; Baigent C, 2005, AM J KIDNEY DIS, V45, P473, DOI 10.1053/j.ajkd.2004.11.015; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Dawson J, 2006, BR J CLIN PHARM; Devaraj S, 2001, J LIPID RES, V42, P521; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Human JA, 1997, CLIN CHIM ACTA, V263, P67, DOI 10.1016/S0009-8981(97)06557-1; Huskey J, 2009, ATHEROSCLEROSIS, V205, P202, DOI 10.1016/j.atherosclerosis.2008.11.010; Jasinska M, 2007, PHARMACOL REP, V59, P483; Ji Y, 2011, CLIN PHARMACOL THER, V89, P97, DOI 10.1038/clpt.2010.250; Kaddurah-Daouk R, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.22; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482; Kaddurah-Daouk R, 2010, METABOLOMICS, V6, P191, DOI 10.1007/s11306-010-0207-x; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Laferrere B, 2011, SCI TRANSL MED, V3, p80re82; Lee BE, 2009, J INVEST MED, V57, P902, DOI 10.2310/JIM.0b013e3181bca50c; Mangravite LM, 2008, CURR OPIN MOL THER, V10, P555; Namli S, 2007, RENAL FAILURE, V29, P55, DOI 10.1080/08860220601038892; Neunteufl T, 1998, J AM COLL CARDIOL, V32, P711, DOI 10.1016/S0735-1097(98)00295-2; Nicholson JK, 2011, PHARMACOGENOMICS, V12, P103, DOI 10.2217/PGS.10.157; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pal S, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-3; Piorunska-Stolzmann M, 2003, DRUG EXP CLIN RES, V29, P37; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, CIRC-CARDIOVASC QUAL, V2, P279, DOI 10.1161/CIRCOUTCOMES.109.868299; Rode S, 2008, BIOCHEM BIOPH RES CO, V369, P868, DOI 10.1016/j.bbrc.2008.02.132; Ryden M, 2010, NUTR METAB CARDIOVAS; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Schwartz IF, 2011, J VASC RES, V48, P252, DOI 10.1159/000320356; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019477; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vaquero MP, 2010, NUTR HOSP, V25, P193, DOI 10.3305/nh.2010.25.2.4405; Vasankari T, 2004, ANN MED, V36, P618, DOI 10.1080/07853890410018844; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yao JK, 2010, MOL PSYCHIATR, V15, P938, DOI 10.1038/mp.2009.33; Yao JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009508	46	68	73	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38386	10.1371/journal.pone.0038386	http://dx.doi.org/10.1371/journal.pone.0038386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808006	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700002
J	Comeau, AM; Tremblay, D; Moineau, S; Rattei, T; Kushkina, AI; Tovkach, FI; Krisch, HM; Ackermann, HW				Comeau, Andre M.; Tremblay, Denise; Moineau, Sylvain; Rattei, Thomas; Kushkina, Alla I.; Tovkach, Fedor I.; Krisch, Henry M.; Ackermann, Hans-Wolfgang			Phage Morphology Recapitulates Phylogeny: The Comparative Genomics of a New Group of Myoviruses	PLOS ONE			English	Article							VIBRIO-CHOLERAE; TEMPERATE BACTERIOPHAGES; SEQUENCE; DNA; CLASSIFICATION; PROTEOME	Among dsDNA tailed bacteriophages (Caudovirales), members of the Myoviridae family have the most sophisticated virion design that includes a complex contractile tail structure. The Myoviridae generally have larger genomes than the other phage families. Relatively few "dwarf'' myoviruses, those with a genome size of less than 50 kb such as those of the Mu group, have been analyzed in extenso. Here we report on the genome sequencing and morphological characterization of a new group of such phages that infect a diverse range of Proteobacteria, namely Aeromonas salmonicida phage 56, Vibrio cholerae phages 138 and CP-T1, Bdellovibrio phage phi 1422, and Pectobacterium carotovorum phage ZF40. This group of dwarf myoviruses shares an identical virion morphology, characterized by usually short contractile tails, and have genome sizes of approximately 45 kb. Although their genome sequences are variable in their lysogeny, replication, and host adaption modules, presumably reflecting differing lifestyles and hosts, their structural and morphogenesis modules have been evolutionarily constrained by their virion morphology. Comparative genomic analysis reveals that these phages, along with related prophage genomes, form a new coherent group within the Myoviridae. The results presented in this communication support the hypothesis that the diversity of phages may be more structured than generally believed and that the innumerable phages in the biosphere all belong to discrete lineages or families.	[Comeau, Andre M.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Comeau, Andre M.] Univ Laval, IBIS, Quebec City, PQ, Canada; [Tremblay, Denise; Moineau, Sylvain; Ackermann, Hans-Wolfgang] Univ Laval, Fac Med Dent, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale, Quebec City, PQ, Canada; [Moineau, Sylvain] Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada; [Rattei, Thomas] Univ Vienna, Dept Computat Syst Biol, Vienna, Austria; [Kushkina, Alla I.; Tovkach, Fedor I.] DK Zabolotny Inst Microbiol & Virol, Kiev, Ukraine; [Krisch, Henry M.] CNRS, Lab Microbiol & Genet Mol, Toulouse, France; [Krisch, Henry M.] Univ Toulouse Paul Sabatier, Lab Microbiol & Genet Mol, Toulouse, France; [Ackermann, Hans-Wolfgang] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University; University of Vienna; National Academy of Sciences Ukraine; Zabolotny Institute of Microbiology & Virology of NASU; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Laval University	Comeau, AM (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	andre.comeau@ibis.ulaval.ca	Rattei, Thomas/F-1366-2011; Kushkina, Alla/AAS-2804-2020; Moineau, Sylvain/N-3578-2013; Kushkina, Alla/AAC-2224-2020; Moineau, Sylvain/I-7231-2019	Rattei, Thomas/0000-0002-0592-7791; Kushkina, Alla/0000-0002-2206-7324; Moineau, Sylvain/0000-0002-2832-5101	Institute of Biological Sciences (INSB) of the Centre National de la Recherche Scientifique (CNRS); Kribu Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada (Major Resources Support Program)	Institute of Biological Sciences (INSB) of the Centre National de la Recherche Scientifique (CNRS); Kribu Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada (Major Resources Support Program)(Natural Sciences and Engineering Research Council of Canada (NSERC))	HMK's research was supported by intramural funding from the Institute of Biological Sciences (INSB) of the Centre National de la Recherche Scientifique (CNRS) and by supplementary funding from the Kribu Foundation. SM acknowledges funding from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Major Resources Support Program). SM holds a Tier 1 Canada Research Chair in Bacteriophages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Ackermann Hans-W, 2011, Bacteriophage, V1, P138; ACKERMANN HW, 1985, ANN INST PASTEUR VIR, V136E, P175, DOI 10.1016/S0769-2617(85)80044-7; ACKERMANN HW, 1983, ANN INST PASTEUR VIR, V134, P387, DOI 10.1016/S0769-2617(83)80011-2; ALTHAUSER M, 1972, J VIROL, V10, P516, DOI 10.1128/JVI.10.3.516-523.1972; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Chaconas G, 1999, BIOCHEM CELL BIOL, V77, P487, DOI 10.1139/bcb-77-6-487; CHATTERJ.SN, 1965, INDIAN J MED RES, V53, P934; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Comeau AM, 2007, VIROLOGY, V362, P384, DOI 10.1016/j.virol.2006.12.031; Deveau H, 2002, APPL ENVIRON MICROB, V68, P4364, DOI 10.1128/AEM.68.9.4364-4369.2002; Grigoriev PS, 2001, MOL MICROBIOL, V42, P355, DOI 10.1046/j.1365-2958.2001.02632.x; GUIDOLIN A, 1984, J VIROL, V51, P163, DOI 10.1128/JVI.51.1.163-169.1984; Hauser R, 2011, J BACTERIOL, V193, P3135, DOI 10.1128/JB.01481-10; Hardies SC, 2003, VIROLOGY, V310, P359, DOI 10.1016/S0042-6822(03)00172-7; Hidaka T, 1971, MEM FAC FISH KAGOSHI, V20, P141; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Leblanc C, 2009, ENV MICROBIOL REP, V1, P499, DOI 10.1111/j.1758-2229.2009.00055.x; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; OGG JE, 1981, INFECT IMMUN, V31, P737, DOI 10.1128/IAI.31.2.737-741.1981; OGG JE, 1978, INFECT IMMUN, V19, P231, DOI 10.1128/IAI.19.1.231-238.1978; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; POPOFF M, 1971, Annales de Recherches Veterinaires, V2, P33; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Resch G, 2004, J BACTERIOL, V186, P5523, DOI 10.1128/JB.186.16.5523-5528.2004; Sabri M, 2011, J BACTERIOL, V193, P551, DOI 10.1128/JB.01117-10; Schwudke D, 2008, J BACTERIOL, V190, P332, DOI 10.1128/JB.01402-07; Serwer P, 2004, VIROLOGY, V329, P412, DOI 10.1016/j.virol.2004.08.021; Shelton CB, 2000, J BACTERIOL, V182, P6130, DOI 10.1128/JB.182.21.6130-6136.2000; Shingler V, 2011, FEMS MICROBIOL REV, V35, P425, DOI 10.1111/j.1574-6976.2010.00255.x; Sullivan MB, 2008, ENVIRON MICROBIOL, V10, P2810, DOI 10.1111/j.1462-2920.2008.01702.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Tovkach F. I., 2002, Mikrobiologiya, V71, P75; VARON M, 1972, J VIROL, V9, P519, DOI 10.1128/JVI.9.3.519-525.1972; WILLI K, 1993, MED MICROBIOL LETT, V2, P419; Willi K, 1997, ORAL MICROBIOL IMMUN, V12, P40, DOI 10.1111/j.1399-302X.1997.tb00365.x	41	43	45	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40102	10.1371/journal.pone.0040102	http://dx.doi.org/10.1371/journal.pone.0040102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792219	Green Submitted, gold, Green Published			2022-12-27	WOS:000306461800039
J	Schabussova, I; Hufnagl, K; Tang, MLK; Hoflehner, E; Wagner, A; Loupal, G; Nutten, S; Zuercher, A; Mercenier, A; Wiedermann, U				Schabussova, Irma; Hufnagl, Karin; Tang, Mimi L. K.; Hoflehner, Elisabeth; Wagner, Angelika; Loupal, Gerhard; Nutten, Sophie; Zuercher, Adrian; Mercenier, Annick; Wiedermann, Ursula			Perinatal Maternal Administration of Lactobacillus paracasei NCC 2461 Prevents Allergic Inflammation in a Mouse Model of Birch Pollen Allergy	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GENE-ENVIRONMENT INTERACTIONS; REGULATORY T-CELLS; IMMUNE-RESPONSES; INTESTINAL MICROFLORA; AIRWAY INFLAMMATION; MURINE MODEL; BET V-1; ASTHMA; INFANTS	Background: The hygiene hypothesis implies that microbial agents including probiotic bacteria may modulate foetal/neonatal immune programming and hence offer effective strategies for primary allergy prevention; however their mechanisms of action are poorly understood. We investigated whether oral administration of Lactobacillus paracasei NCC 2461 to mothers during gestation/lactation can protect against airway inflammation in offspring in a mouse model of birch pollen allergy, and examined the immune mechanisms involved. Methods: BALB/c mice were treated daily with L. paracasei in drinking water or drinking water alone in the last week of gestation and during lactation. Their offspring were sensitized with recombinant Bet v 1, followed by aerosol challenge with birch pollen extract. Results: Maternal exposure to L. paracasei prevented the development of airway inflammation in offspring, as demonstrated by attenuation of eosinophil influx in the lungs; reduction of IL-5 levels in bronchoalveolar lavage, and in lung and mediastinal lymph node cell cultures; and reduced peribronchial inflammatory infiltrate and mucus hypersecretion. While allergen-specific IgE and IgG antibody levels remained unchanged by the treatment, IL-4 and IL-5 production in spleen cell cultures were significantly reduced upon allergen stimulation in offspring of L. paracasei treated mice. Offspring of L. paracasei supplemented mothers had significantly reduced Bet v 1-specific as well as Concanavalin A-induced responses in spleen and mesenteric lymph node cell cultures, suggesting the modulation of both antigen-specific and mitogen-induced immune responses in offspring. These effects were associated with increased Foxp3 mRNA expression in the lungs and increased TGF-beta in serum. Conclusion: Our data show that in a mouse model of birch pollen allergy, perinatal administration of L. paracasei NCC 2461 to pregnant/lactating mothers protects against the development of airway inflammation in offspring by activating regulatory pathways, likely through TLR2/4 signalling.	[Schabussova, Irma; Hufnagl, Karin; Hoflehner, Elisabeth; Wagner, Angelika; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Tang, Mimi L. K.] Univ Melbourne, Royal Childrens Hosp, Dept Allergy & Immunol, Melbourne, Vic, Australia; [Tang, Mimi L. K.] Murdoch Childrens Res Inst, Dept Allergy & Immune Disorders, Melbourne, Vic, Australia; [Tang, Mimi L. K.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Loupal, Gerhard] Univ Vet Med Vienna, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Nutten, Sophie; Mercenier, Annick] Nestle Res Ctr, Nutr & Hlth Dept, CH-1000 Lausanne, Switzerland; [Zuercher, Adrian] CSL Behring AG, Bern, Switzerland	Medical University of Vienna; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Veterinary Medicine Vienna; Nestle SA; CSL	Schabussova, I (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at	Tang, Mimi/ABD-8350-2020	Tang, Mimi/0000-0002-3839-5293; Schabussova, Irma/0000-0002-2109-2640; Wiedermann, Ursula/0000-0002-1302-3223; Wagner, Angelika/0000-0002-5447-9534	Nestle (Investor Initiated Study; "Prenatal- and perinatal interventions against allergic sensitization''); SFB grant ("Mucosal tolerance induction, a strategy for prevention and therapy of type I allergy,'' from the Austrian Science Fund [F0814]	Nestle (Investor Initiated Study; "Prenatal- and perinatal interventions against allergic sensitization''); SFB grant ("Mucosal tolerance induction, a strategy for prevention and therapy of type I allergy,'' from the Austrian Science Fund	This work was financially supported by Nestle (Investor Initiated Study; "Prenatal- and perinatal interventions against allergic sensitization'') and by a SFB grant ("Mucosal tolerance induction, a strategy for prevention and therapy of type I allergy,'' F0814) from the Austrian Science Fund. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Blumer N, 2007, CLIN EXP ALLERGY, V37, P348, DOI 10.1111/j.1365-2222.2007.02671.x; Bortolatto J, 2008, CLIN EXP ALLERGY, V38, P1668, DOI 10.1111/j.1365-2222.2008.03036.x; Brand S, 2011, J ALLERGY CLIN IMMUN, V128, P618, DOI 10.1016/j.jaci.2011.04.035; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Daniel C, 2006, ALLERGY, V61, P812, DOI 10.1111/j.1398-9995.2006.01071.x; de Roock S, 2010, CLIN EXP ALLERGY, V40, P103, DOI 10.1111/j.1365-2222.2009.03344.x; Dotterud CK, 2010, BRIT J DERMATOL, V163, P616, DOI 10.1111/j.1365-2133.2010.09889.x; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Latvala S, 2011, CLIN EXP IMMUNOL, V165, P94, DOI 10.1111/j.1365-2249.2011.04408.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martinez-Canavate A, 2009, PEDIAT ALLERG IMM-UK, V20, P592, DOI 10.1111/j.1399-3038.2008.00833.x; Matsuzaki T, 1998, J DAIRY SCI, V81, P48, DOI 10.3168/jds.S0022-0302(98)75549-3; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006474.pub2; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Renz H, 2011, ALLERGY, V66, P10, DOI 10.1111/j.1398-9995.2011.02622.x; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Repa A, 2003, VACCINE, V22, P87, DOI 10.1016/S0264-410X(03)00528-0; Savino F, 2004, ACTA PAEDIATR, V93, P825, DOI [10.1080/08035250410027625, 10.1111/j.1651-2227.2004.tb03025.x]; Savino F, 2011, ACTA PAEDIATR, V100, P75, DOI 10.1111/j.1651-2227.2010.01988.x; Schabussova I, 2011, VACCINE, V29, P1981, DOI 10.1016/j.vaccine.2010.12.101; Schaub B, 2009, J ALLERGY CLIN IMMUN, V123, p[774, e775]; Schwarzer M, 2011, ALLERGY, V66, P368, DOI 10.1111/j.1398-9995.2010.02488.x; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Suzuki S, 2007, CLIN EXP ALLERGY, V37, P506, DOI 10.1111/j.1365-2222.2007.02676.x; Tang MLK, 2010, CURR OPIN PEDIATR, V22, P626, DOI 10.1097/MOP.0b013e32833d9728; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Velasco G, 2005, AM J RESP CELL MOL, V32, P218, DOI 10.1165/rcmb.2003-0435OC; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; von der Weid T, 2001, CLIN DIAGN LAB IMMUN, V8, P695, DOI 10.1128/CDLI.8.4.695-701.2001; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x	39	31	35	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40271	10.1371/journal.pone.0040271	http://dx.doi.org/10.1371/journal.pone.0040271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792257	gold, Green Published			2022-12-27	WOS:000306461800058
J	Engrav, LH; Heimbach, DM; Rivara, FP; Kerr, KF; Osler, T; Pham, TN; Sharar, SR; Esselman, PC; Bulger, EM; Carrougher, GJ; Honari, S; Gibran, NS				Engrav, Loren H.; Heimbach, David M.; Rivara, Frederick P.; Kerr, Kathleen F.; Osler, Turner; Pham, Tam N.; Sharar, Sam R.; Esselman, Peter C.; Bulger, Eileen M.; Carrougher, Gretchen J.; Honari, Shari; Gibran, Nicole S.			Harborview Burns-1974 to 2009	PLOS ONE			English	Article							REGIONAL BURN CENTER; LAST 10 YEARS; FLUID CREEP; RETROSPECTIVE ANALYSIS; CHANGING PATTERN; INVITED CRITIQUE; PEDIATRIC BURNS; THERMAL-INJURY; UNITED-STATES; MORTALITY	Background: Burn demographics, prevention and care have changed considerably since the 1970s. The objectives were to 1) identify new and confirm previously described changes, 2) make comparisons to the American Burn Association National Burn Repository, 3) determine when the administration of fluids in excess of the Baxter formula began and to identify potential causes, and 4) model mortality over time, during a 36-year period (1974-2009) at the Harborview Burn Center in Seattle, WA, USA. Methods and Findings: 14,266 consecutive admissions were analyzed in five-year periods and many parameters compared to the National Burn Repository. Fluid resuscitation was compared in five-year periods from 1974 to 2009. Mortality was modeled with the rBaux model. Many changes are highlighted at the end of the manuscript including 1) the large increase in numbers of total and short-stay admissions, 2) the decline in numbers of large burn injuries, 3) that unadjusted case fatality declined to the mid-1980s but has changed little during the past two decades, 4) that race/ethnicity and payer status disparity exists, and 5) that the trajectory to death changed with fewer deaths occurring after seven days post-injury. Administration of fluids in excess of the Baxter formula during resuscitation of uncomplicated injuries was evident at least by the early 1990s and has continued to the present; the cause is likely multifactorial but pre-hospital fluids, prophylactic tracheal intubation and opioids may be involved. Conclusions: 1) The dramatic changes include the rise in short-stay admissions; as a result, the model of burn care practiced since the 1970s is still required but is no longer sufficient. 2) Fluid administration in excess of the Baxter formula with uncomplicated injuries began at least two decades ago. 3) Unadjusted case fatality declined to similar to 6% in the mid-1980s and changed little since then. The rBaux mortality model is quite accurate.	[Engrav, Loren H.; Carrougher, Gretchen J.] Univ Washington, Dept Surg, Div Plast Surg, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Kerr, Kathleen F.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Osler, Turner] Univ Vermont, Dept Surg, Div Trauma, Burlington, VT 05405 USA; [Sharar, Sam R.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Esselman, Peter C.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Engrav, LH (corresponding author), Univ Washington, Dept Surg, Div Plast Surg, Seattle, WA 98195 USA.	engrav@u.washington.edu	Kerr, Kathleen F./A-2893-2013	Kerr, Kathleen F./0000-0002-6438-9583	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education [H133A070047]; Northwest Burn Foundation, Seattle, WA	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education(US Department of Education); Northwest Burn Foundation, Seattle, WA	This work was funded in part by National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, #H133A070047 (http://www2.ed.gov/about/offices/list/osers/nidrr/index.html) and by Northwest Burn Foundation, Seattle, WA (http://www.nwburn.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja RB, 2009, BURNS, V35, P650, DOI 10.1016/j.burns.2009.01.008; Akerlund E, 2007, BURNS, V33, P31, DOI 10.1016/j.burns.2006.10.002; Aluarado R, 2009, BURNS, V35, P4, DOI 10.1016/j.burns.2008.03.008; Anlatici R, 2002, BURNS, V28, P231, DOI 10.1016/S0305-4179(01)00095-X; [Anonymous], 2007, J BURN CARE RES, V28, P134; [Anonymous], 2011, COMPR HOSP ABSTR REP; [Anonymous], NAT BURN REP REP DAT; Anwar U, 2007, J BURN CARE RES, V28, P299, DOI 10.1097/BCR.0B013E318031A106; Blaisdell LL, 2011, J BURN CARE RES; Blot S, 2009, BRIT J SURG, V96, P111, DOI 10.1002/bjs.6329; Blumetti J, 2008, J BURN CARE RES, V29, P180, DOI 10.1097/BCR.0b013e31815f5a62; Bowman SM, 2011, INJURY PREV, V17, P166, DOI 10.1136/ip.2009.023655; Brigham PA, 2008, J BURN CARE RES, V29, P248, DOI 10.1097/BCR.0b013e31815f366c; Brusselaers N, 2005, INTENS CARE MED, V31, P1648, DOI 10.1007/s00134-005-2819-6; Brusselaers N, 2009, BURNS, V35, P1009, DOI 10.1016/j.burns.2008.12.017; Cartotto R, 2010, J BURN CARE RES, V31, P551, DOI 10.1097/BCR.0b013e3181e4d732; Chung KK, 2010, J TRAUMA, V69, pS49, DOI 10.1097/TA.0b013e3181e425f1; Chung KK, 2009, J TRAUMA, V67, P231, DOI 10.1097/TA.0b013e3181ac68cf; Colohan SM, 2010, J BURN CARE RES, V31, P529, DOI 10.1097/BCR.0b013e3181e4d680; Davey RB, 1999, BURNS, V25, P62, DOI 10.1016/S0305-4179(98)00059-X; Dimick A R, 1993, J Burn Care Rehabil, V14, P284; Dorsey R, 2011, JAMA-J AM MED ASSOC, V306, P2378, DOI 10.1001/jama.2011.1789; Eastman AL, 2010, J BURN CARE RES, V31, P701, DOI 10.1097/BCR.0b013e3181eebe4f; Edelman LS, 2007, BURNS, V33, P958, DOI 10.1016/j.burns.2007.05.002; Enei SD, 2004, BURNS, V30, P348, DOI 10.1016/j.burns.2003.12.004; ERDMANN TC, 1991, PEDIATRICS, V88, P572; Forster NA, 2011, BURNS, V37, P958, DOI 10.1016/j.burns.2011.03.009; Galeiras R, 2009, BURNS, V35, P201, DOI 10.1016/j.burns.2008.07.019; Gamelli RL, 2006, J BURN CARE RES, V27, P1, DOI 10.1097/01.bcr.0000192268.98506.31; Garner WL, 2005, BURNS, V31, pS32, DOI 10.1016/j.burns.2004.10.002; Gomez M, 2008, J TRAUMA, V65, P636, DOI 10.1097/TA.0b013e3181840c6d; Gomez M, 2008, J BURN CARE RES, V29, P130, DOI [10.1097/BCR.0b013e31815f6efd, 1097/BCR.0b013e31815f6efd]; Han TH, 2005, BURNS, V31, P465, DOI 10.1016/j.burns.2004.11.014; Hartford CE, 2007, J BURN CARE RES, V28, P770, DOI 10.1097/BCR.0b013e318148cba7; Hemington-Gorse SJ, 2011, BURNS, V37, P981, DOI 10.1016/j.burns.2011.03.012; Franco MAH, 2006, BURNS, V32, P1044, DOI 10.1016/j.burns.2006.03.023; Imahara SD, 2006, J BURN CARE RES, V27, P270, DOI 10.1097/01.BCR.0000216532.71360.9B; Jaskille AD, 2009, CLIN PLAST SURG, V36, P701, DOI 10.1016/j.cps.2009.05.003; Jeng JC, 2008, J BURN CARE RES, V29, P572, DOI 10.1097/BCR.0b013e31817de28c; Johnson LS, 2011, J BURN CARE RES, V32, P13, DOI 10.1097/BCR.0b013e318204b3ab; Karr CJ, 2005, PUBLIC HEALTH REP, V120, P19, DOI 10.1177/003335490512000105; Kastenmeier A, 2010, J BURN CARE RES, V31, P130, DOI 10.1097/BCR.0b013e3181cb8ca2; Kemalyan N, 1996, BAXTER FORMULA 1995; Klein MB, 2006, BURNS, V32, P940, DOI 10.1016/j.burns.2006.04.001; Klein MB, 2007, J BURN CARE RES, V28, P49, DOI 10.1097/BCR.0B013E31802C894B; Lawrence A, 2010, J BURN CARE RES, V31, P40, DOI 10.1097/BCR.0b013e3181cb8c72; Lionelli GT, 2005, BURNS, V31, P958, DOI 10.1016/j.burns.2005.06.006; Lumenta DB, 2009, J BURN CARE RES, V30, P231, DOI 10.1097/BCR.0b013e318198a2d6; Macrino S, 2008, BURNS, V34, P509, DOI 10.1016/j.burns.2007.06.010; Mandelcorn E, 2003, BURNS, V29, P469, DOI 10.1016/S0305-4179(03)00063-9; McGwin G, 2003, J BURN CARE REHABIL, V24, P21, DOI 10.1097/00004630-200301000-00006; McGwin G, 2008, BURNS, V34, P320, DOI 10.1016/j.burns.2007.06.003; Mistry RM, 2010, BURNS, V36, P403, DOI 10.1016/j.burns.2009.05.021; Moreau AR, 2005, J TRAUMA, V58, P967, DOI 10.1097/01.TA.0000162729.24548.00; Muller MJ, 2001, BRIT J SURG, V88, P583, DOI 10.1046/j.1365-2168.2001.01726.x; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; Onarheim H, 2009, BURNS, V35, P1142, DOI 10.1016/j.burns.2009.06.191; Ong YS, 2006, BURNS, V32, P145, DOI 10.1016/j.burns.2005.09.005; Osler T, 2010, J TRAUMA, V68, P690, DOI 10.1097/TA.0b013e3181c453b3; Papp A, 2009, BURNS, V35, P565, DOI 10.1016/j.burns.2008.03.006; Park JO, 2009, BURNS, V35, P482, DOI 10.1016/j.burns.2008.10.007; Pavlovich AR, 2009, J BURN CARE RES, V30, P574, DOI 10.1097/BCR.0b013e3181abfad0; Peck M, 2010, J BURN CARE RES, V31, P918, DOI 10.1097/BCR.0b013e3181f93723; Peck MD, 2007, J BURN CARE RES, V28, P691, DOI 10.1097/BCR.0B013E318148C9F8; Pereira C, 2004, BURNS, V30, P761, DOI 10.1016/j.burns.2004.05.012; Pham TN, 2008, J BURN CARE RES, V29, P257, DOI 10.1097/BCR.0b013e31815f3876; Pham TN, 2009, J BURN CARE RES, V30, P301, DOI 10.1097/BCR.0b013e318198a241; Pham TN, 2009, J BURN CARE RES, V30, P30, DOI 10.1097/BCR.0b013e3181921efc; Pruitt BA, 2000, J TRAUMA, V49, P567, DOI 10.1097/00005373-200009000-00030; Rashid A, 2001, BURNS, V27, P723, DOI 10.1016/S0305-4179(01)00034-1; Richard RL, 2008, J BURN CARE RES, V29, P425, DOI 10.1097/BCR.0b013e318171081d; Rimmer RB, 2008, J BURN CARE RES, V29, P595, DOI 10.1097/BCR.0b013e31817db8a4; Rivara FP, 2001, ARCH PEDIAT ADOL MED, V155, P119, DOI 10.1001/archpedi.155.2.119; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Sagraves SG, 2007, J BURN CARE RES, V28, P111, DOI 10.1097/BCR.0B013E31802C893B; Salisbury R, 1992, J Burn Care Rehabil, V13, P495, DOI 10.1097/00004630-199209000-00001; SARMA BP, 1994, BURNS, V20, P253, DOI 10.1016/0305-4179(94)90194-5; Shakespeare PG, 2003, BURNS, V29, P105, DOI 10.1016/S0305-4179(02)00316-9; Spinks A, 2008, J BURN CARE RES, V29, P482, DOI 10.1097/BCR.0b013e3181776ed9; Sullivan SR, 2004, BURNS, V30, P583, DOI 10.1016/j.burns.2004.03.002; Tricklebank S, 2009, BURNS, V35, P757, DOI 10.1016/j.burns.2008.09.007; Turegun M, 1997, BURNS, V23, P584, DOI 10.1016/S0305-4179(97)00081-8; Van Niekerk A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-374; Ward CG, 2007, J BURN CARE RES, V28, P306, DOI 10.1097/BCR.0B013E318031AA6F; Warden GD, 2003, J BURN CARE REHABIL, V24, P173, DOI 10.1097/01.BCR.0000066784.94077.C6; Warden Glenn D., 1993, Journal of Burn Care and Rehabilitation, V14, P581, DOI 10.1097/00004630-199311000-00001; Wibbenmeyer L, 2010, J BURN CARE RES, V31, P48, DOI 10.1097/BCR.0b013e3181c7ed30; XIAO J, 1992, BURNS, V18, P228, DOI 10.1016/0305-4179(92)90075-6	88	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40086	10.1371/journal.pone.0040086	http://dx.doi.org/10.1371/journal.pone.0040086			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792216	gold, Green Submitted, Green Published			2022-12-27	WOS:000306436300022
J	De Serres, G; Gariepy, MC; Coleman, B; Rouleau, I; McNeil, S; Benoit, M; McGeer, A; Ambrose, A; Needham, J; Bergeron, C; Grenier, C; Sleigh, K; Kallos, A; Ouakki, M; Ouhoummane, N; Stiver, G; Valiquette, L; McCarthy, A; Bettinger, J				De Serres, Gaston; Gariepy, Marie-Claude; Coleman, Brenda; Rouleau, Isabelle; McNeil, Shelly; Benoit, Melanie; McGeer, Allison; Ambrose, Ardith; Needham, Judy; Bergeron, Chantal; Grenier, Cynthia; Sleigh, Kenna; Kallos, Arlene; Ouakki, Manale; Ouhoummane, Najwa; Stiver, Grant; Valiquette, Louis; McCarthy, Anne; Bettinger, Julie		PHAC-CIHR Influenza Res Network	Short and Long-Term Safety of the 2009 AS03-Adjuvanted Pandemic Vaccine	PLOS ONE			English	Article							EVENTS FOLLOWING IMMUNIZATION; TRIVALENT INFLUENZA VACCINE; OCULO-RESPIRATORY SYNDROME; ADVERSE EVENTS; A H1N1; SURVEILLANCE	Background: This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monovalent pandemic vaccine through an active web-based electronic surveillance. We compared its safety profile to that of the seasonal trivalent inactivated influenza vaccine (TIV) for 2010-2011. Methodology/Principal Findings: Health care workers (HCW) vaccinated in 2009 with the pandemic vaccine (Arepanrix (R) from GSK) or HCW vaccinated in 2010 with the 2010-2011 TIV were invited to participate in a web-based active surveillance of vaccine safety. They completed two surveys the day-8 survey covered the first 7 days post-vaccination and the day-29 survey covered events occurring 8 to 28 days after vaccination. Those who reported a problem were called by a nurse to obtain details. The main outcome was the occurrence of a new health problem or the worsening of an existing health condition that resulted in a medical consultation or work absenteeism. For the pandemic vaccine, a six-month follow-up for the occurrence of serious adverse events (SAE) was conducted. Among the 6242 HCW who received the pandemic vaccine, 440 (7%) reported 468 events compared to 328 of the 7645 HCW (4.3%) who reported 339 events after the seasonal vaccine. The 2009 pandemic vaccine was associated with significantly more local reactions than the 2010-2011 seasonal vaccine (1% vs. 0.03%, p < 0.001). Paresthesia was reported by 7 HCW (0.1%) after the pandemic vaccine but by none after the seasonal vaccine. For the pandemic vaccine, no clustering of SAE was found in the 6 month follow-up. Conclusion: The 2009 pandemic vaccine seems to have a good safety profile, similar to the 2010-2011 TIV, with the exception of local reactions. This surveillance was adequately powered to identify AE associated with an excess risk >= 1 per 1000 vaccinations but is insufficient to detect rare AE.	[De Serres, Gaston; Gariepy, Marie-Claude; Rouleau, Isabelle; Benoit, Melanie] Univ Laval, Ctr Rech CHUQ CHUL, Quebec City, PQ, Canada; [De Serres, Gaston; Ouakki, Manale; Ouhoummane, Najwa] INSPQ, Quebec City, PQ, Canada; [Coleman, Brenda; McGeer, Allison] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [McNeil, Shelly; Ambrose, Ardith] Canadian Ctr Vaccinol, Halifax, NS, Canada; [Needham, Judy; Kallos, Arlene; Bettinger, Julie] BC Childrens Hosp, Vaccine Evaluat Ctr, Vancouver, BC, Canada; [Needham, Judy; Sleigh, Kenna; Kallos, Arlene; Stiver, Grant; Bettinger, Julie] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Grenier, Cynthia; McCarthy, Anne] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada; [Grenier, Cynthia; Valiquette, Louis] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Coleman, Brenda; McGeer, Allison] Univ Toronto, Toronto, ON, Canada	Laval University; Institut national de sante publique du Quebec (INSPQ); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute; University of Sherbrooke; University of Toronto	De Serres, G (corresponding author), Univ Laval, Ctr Rech CHUQ CHUL, Quebec City, PQ, Canada.	gaston.deserres@ssss.gouv.qc.ca	McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; Coleman, Brenda L./0000-0002-7144-4827; McNeil, Shelly/0000-0001-5444-4166; Bettinger, Julie/0000-0002-2118-4174; McCarthy, Anne/0000-0001-7195-6366; Needham, Judy/0000-0002-6327-176X	Public Health Agency of Canada (PHAC)/Canada Institutes for Health Research (CIHR) Influenza Research network (PCIRN); GlaxoSmithKline (GSK) Canada; GSK; Sanofi Pasteur; Pfizer; Sanofi; Merck	Public Health Agency of Canada (PHAC)/Canada Institutes for Health Research (CIHR) Influenza Research network (PCIRN)(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline (GSK) Canada; GSK(GlaxoSmithKline); Sanofi Pasteur; Pfizer(Pfizer); Sanofi(Sanofi-Aventis); Merck(Merck & Company)	This study was funded by the Public Health Agency of Canada (PHAC)/Canada Institutes for Health Research (CIHR) Influenza Research network (PCIRN) and by GlaxoSmithKline (GSK) Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Gaston De Serres has received research grant from GSK, Sanofi Pasteur. Shelly McNeil has research grants from GSK, Pfizer, and Sanofi and participated in clinical trials for GSK, Sanofi, Pfizer, Merck, Novartis. She has received speaking fees/honoraria from Merck, GsK and Pfizer. Melanie Benoit owned Janssen-ortho stocks and/or stock options and was an employee of Janssenortho (Johnson and Johnson) until 2009. Louis Valiquette has served on advisory boards for Abbott and Wyeth, and has received compensation to conduct clinical trials involving antibacterials from Genzyme, Wyeth, Merck, Pfizer, BioCryst, and Optimer. The other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Armstrong PK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000016; Bias Harald, 2011, BMC Res Notes, V4, P297, DOI 10.1186/1756-0500-4-297; Blyth CC, 2011, VACCINE, V29, P5107, DOI 10.1016/j.vaccine.2011.05.054; Bonhoeffer J, 2002, VACCINE, V21, P298, DOI 10.1016/S0264-410X(02)00449-8; Boulianne N, 2001, Can Commun Dis Rep, V27, P85; Choe YJ, 2011, JPN J INFECT DIS, V64, P297; De Serres G, 2003, VACCINE, V21, P2354, DOI 10.1016/S0264-410X(03)00094-X; De Serres G, 2010, SHORT LONG TERM ACTI; Garcon N, 2012, EXPERT REV VACCINES, V11, P349, DOI [10.1586/erv.11.192, 10.1586/ERV.11.192]; GlaxoSmithKline Inc, 2010, AREPANRIX H1N1 AS03; Gold MS, 2010, MED J AUSTRALIA, V193, P492, DOI 10.5694/j.1326-5377.2010.tb04029.x; Groupe Central ESPRI, 2010, SURV MAN CLIN INH SU; Hardy S, 2010, 9 C CAN IMM CENTR C; Harmark L, 2011, VACCINE, V29, P1941, DOI 10.1016/j.vaccine.2010.12.123; Iskander John, 2005, Yale J Biol Med, V78, P265; Kiertiburanakul S, 2011, AM J INFECT CONTROL, V39, P525, DOI 10.1016/j.ajic.2010.09.011; Kraigher A, 2010, VACCINE, V28, P5467, DOI 10.1016/j.vaccine.2010.05.066; Lapphra K, 2010, VACCINE, V28, P6199, DOI 10.1016/j.vaccine.2010.07.019; Mayet A, 2011, VACCINE, V29, P2576, DOI 10.1016/j.vaccine.2011.01.056; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; Rouleau I, 2010, ANAPHYLAXIS ALLERGIC; Skowronski DM, 2003, CLIN INFECT DIS, V36, P705, DOI 10.1086/367667; Tavares F, 2011, VACCINE, V29, P6402, DOI 10.1016/j.vaccine.2011.04.026; Vogel FR, 2009, EXPERT REV VACCINES, V8, P483, DOI [10.1586/erv.09.5, 10.1586/ERV.09.5]; World Health Organization, 2010, PAND H1N1 2009 UPD 1	25	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38563	10.1371/journal.pone.0038563	http://dx.doi.org/10.1371/journal.pone.0038563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802929	Green Published, gold, Green Submitted			2022-12-27	WOS:000306186900003
J	Channappanavar, R; Twardy, BS; Suvas, S				Channappanavar, Rudragouda; Twardy, Brandon S.; Suvas, Susmit			Blocking of PDL-1 Interaction Enhances Primary and Secondary CD8 T Cell Response to Herpes Simplex Virus-1 Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; PD-1 EXPRESSION; LISTERIA-MONOCYTOGENES; TRIGEMINAL GANGLIA; PROGRAMMED DEATH-1; DENDRITIC CELLS; EXHAUSTION; BLOCKADE; LATENCY; B7-H1	The blocking of programmed death ligand-1 (PDL-1) has been shown to enhance virus-specific CD8 T cell function during chronic viral infections. Though, how PDL-1 blocking at the time of priming affects the quality of CD8 T cell response to acute infections is not well understood and remains controversial. This report demonstrates that the magnitude of the primary and secondary CD8 T cell responses to herpes simplex virus-1 (HSV-1) infection is subject to control by PDL-1. Our results showed that after footpad HSV-1 infection, PD-1 expression increases on immunodominant SSIEFARL peptide specific CD8 T cells. Additionally, post-infection, the level of PDL-1 expression also increases on CD11c+ dendritic cells. Intraperitoneal administration of anti-PDL-1 monoclonal antibody given one day prior to and three days after cutaneous HSV-1 infection, resulted in a marked increase in effector and memory CD8 T cell response to SSIEFARL peptide. This was shown by measuring the quantity and quality of SSIEFARL-specific CD8 T cells by making use of ex-vivo assays that determine antigen specific CD8 T cell function, such as intracellular cytokine assay, degranulation assay to measure cytotoxicity and viral clearance. Our results are discussed in terms of the beneficial effects of blocking PDL-1 interactions, while giving prophylactic vaccines, to generate a more effective CD8 T cell response to viral infection.	[Channappanavar, Rudragouda; Twardy, Brandon S.; Suvas, Susmit] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA	Oakland University	Channappanavar, R (corresponding author), Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA.	suvas@oakland.edu			American Federation for Aging Research (AFAR) Grant; National Eye Institute [R21EY020625]; Oakland University Research Excellence Fund (REF); NATIONAL EYE INSTITUTE [R21EY020625] Funding Source: NIH RePORTER	American Federation for Aging Research (AFAR) Grant; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oakland University Research Excellence Fund (REF); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by an American Federation for Aging Research (AFAR) Grant, National Eye Institute grant R21EY020625, and the Oakland University Research Excellence Fund (REF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; Allie SR, 2011, J IMMUNOL, V186, P6280, DOI 10.4049/jimmunol.1003870; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Bryant-Hudson KM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/924619; Chentoufi AA, 2011, J VIROL, V85, P9127, DOI 10.1128/JVI.00587-11; Chentoufi AA, 2012, VIRAL IMMUNOL, V25, P204, DOI 10.1089/vim.2011.0091; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Crawford A, 2009, CURR OPIN IMMUNOL, V21, P179, DOI 10.1016/j.coi.2009.01.010; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Hokey DA, 2008, EUR J IMMUNOL, V38, P1435, DOI 10.1002/eji.200737857; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jun H, 2005, FEBS LETT, V579, P6259, DOI 10.1016/j.febslet.2005.09.098; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lafon M, 2008, J IMMUNOL, V180, P7506, DOI 10.4049/jimmunol.180.11.7506; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Mott KR, 2009, J VIROL, V83, P2246, DOI 10.1128/JVI.02234-08; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; Seo SK, 2008, IMMUNOLOGY, V123, P90, DOI 10.1111/j.1365-2567.2007.02708.x; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Talay O, 2009, P NATL ACAD SCI USA, V106, P2741, DOI 10.1073/pnas.0813367106; Telcian AG, 2011, J INFECT DIS, V203, P85, DOI 10.1093/infdis/jiq020; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Zelinskyy G, 2011, J IMMUNOL, V187, P3730, DOI 10.4049/jimmunol.1101612	35	34	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39757	10.1371/journal.pone.0039757	http://dx.doi.org/10.1371/journal.pone.0039757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808056	Green Submitted, Green Published, gold			2022-12-27	WOS:000306366400011
J	Detorakis, GI; Rougier, NP				Detorakis, Georgios Is; Rougier, Nicolas P.			A Neural Field Model of the Somatosensory Cortex: Formation, Maintenance and Reorganization of Ordered Topographic Maps	PLOS ONE			English	Article							LATERAL CONNECTIVITY; RECEPTIVE-FIELDS; MOTOR CORTEX; CORTICAL MAP; PLASTICITY; ADULT; ORGANIZATION; MODULATION; NETWORKS; INHIBITION	We investigate the formation and maintenance of ordered topographic maps in the primary somatosensory cortex as well as the reorganization of representations after sensory deprivation or cortical lesion. We consider both the critical period (postnatal) where representations are shaped and the post-critical period where representations are maintained and possibly reorganized. We hypothesize that feed-forward thalamocortical connections are an adequate site of plasticity while cortico-cortical connections are believed to drive a competitive mechanism that is critical for learning. We model a small skin patch located on the distal phalangeal surface of a digit as a set of 256 Merkel ending complexes (MEC) that feed a computational model of the primary somatosensory cortex (area 3b). This model is a two-dimensional neural field where spatially localized solutions (a.k.a. bumps) drive cortical plasticity through a Hebbian-like learning rule. Simulations explain the initial formation of ordered representations following repetitive and random stimulations of the skin patch. Skin lesions as well as cortical lesions are also studied and results confirm the possibility to reorganize representations using the same learning rule and depending on the type of the lesion. For severe lesions, the model suggests that cortico-cortical connections may play an important role in complete recovery.	[Detorakis, Georgios Is; Rougier, Nicolas P.] Univ Nancy 2, Univ Nancy 1, Inst Natl Polytech Lorraine, INRIA,CNRS,UMR 7503, F-54001 Nancy, France	Centre National de la Recherche Scientifique (CNRS); Inria; Universite de Lorraine	Detorakis, GI (corresponding author), Univ Nancy 2, Univ Nancy 1, Inst Natl Polytech Lorraine, INRIA,CNRS,UMR 7503, F-54001 Nancy, France.	Nicolas.Rougier@inria.fr	Detorakis, Georgios/K-1297-2019	Detorakis, Georgios/0000-0001-5891-1702; Rougier, Nicolas P./0000-0002-6972-589X				Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Buxhoeveden DP, 2002, BRAIN, V125, P935, DOI 10.1093/brain/awf110; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196; Coombes S, 2005, BIOL CYBERN, V93, P91, DOI 10.1007/s00422-005-0574-y; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Edelman GM., 1978, MINDFUL BRAIN CORTIC; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Florence SL, 1997, SEMIN NEUROSCI, V9, P3, DOI 10.1006/smns.1997.0101; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; GOODWIN AW, 1995, J NEUROSCI, V15, P798; Hahnloser RHR, 2003, NEURAL COMPUT, V15, P621, DOI 10.1162/089976603321192103; Hamdy S, 2000, CLIN SCI, V99, P151, DOI 10.1042/CS19990300; Hickmott PW, 2002, J NEUROPHYSIOL, V88, P1288, DOI 10.1152/jn.00994.2001; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Hsiao SS, 2008, HUMAN HAPTIC PERCEPT, P103; Hutt A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.055701; Jones EG, 1997, P NATL ACAD SCI USA, V94, P11003, DOI 10.1073/pnas.94.20.11003; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Joublin F, 1996, BIOL CYBERN, V74, P275, DOI 10.1007/BF00652228; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; KISHIMOTO K, 1979, J MATH BIOL, V7, P303, DOI 10.1007/BF00275151; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Kolb Bryan, 2001, Neural Plasticity, V8, P1, DOI 10.1155/NP.2001.1; KRUBITZER LA, 1990, J NEUROSCI, V10, P952; Lemon RN, 2008, EXP PHYSIOL, V93, P798, DOI 10.1113/expphysiol.2007.039081; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; MERZENICH MM, 1982, TRENDS NEUROSCI, V5, P434, DOI 10.1016/0166-2236(82)90235-1; MOLL R, 1984, DIFFERENTIATION, V28, P136, DOI 10.1111/j.1432-0436.1984.tb00277.x; Mountcastle V.B., 1978, MINDFUL BRAIN CORTIC, P7; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Pare M, 2002, J COMP NEUROL, V445, P347, DOI 10.1002/cne.10196; PEARSON JC, 1987, J NEUROSCI, V7, P4209; Petersen CCH, 2003, PFLUG ARCH EUR J PHY, V447, P126, DOI 10.1007/s00424-003-1167-z; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rougier N, 2011, NEUROCOMPUTING, V74, P1840, DOI 10.1016/j.neucom.2010.06.034; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Schaefer M, 2005, NEUROIMAGE, V27, P130, DOI 10.1016/j.neuroimage.2005.04.005; Sober SJ, 1997, J NEUROPHYSIOL, V78, P3438, DOI 10.1152/jn.1997.78.6.3438; Steven MS, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1243; SUR M, 1985, BRAIN RES, V342, P391, DOI 10.1016/0006-8993(85)91144-8; Taylor JG, 1999, BIOL CYBERN, V80, P393, DOI 10.1007/s004220050534; Tremere L, 2001, J NEUROPHYSIOL, V86, P94, DOI 10.1152/jn.2001.86.1.94; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Werner H, 2001, BIOL CYBERN, V85, P211, DOI 10.1007/s004220000237; Xing J, 1996, J NEUROPHYSIOL, V75, P184, DOI 10.1152/jn.1996.75.1.184; Xing J, 1996, J NEUROPHYSIOL, V75, P217, DOI 10.1152/jn.1996.75.1.217; Xing J, 1996, J NEUROPHYSIOL, V75, P200, DOI 10.1152/jn.1996.75.1.200; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	67	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40257	10.1371/journal.pone.0040257	http://dx.doi.org/10.1371/journal.pone.0040257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808127	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400017
J	Bosse, JB; Bauerfeind, R; Popilka, L; Marcinowski, L; Taeglich, M; Jung, C; Striebinger, H; von Einem, J; Gaul, U; Walther, P; Koszinowski, UH; Ruzsics, Z				Bosse, Jens B.; Bauerfeind, Rudolf; Popilka, Leonhard; Marcinowski, Lisa; Taeglich, Martina; Jung, Christophe; Striebinger, Hannah; von Einem, Jens; Gaul, Ulrike; Walther, Paul; Koszinowski, Ulrich H.; Ruzsics, Zsolt			A Beta-Herpesvirus with Fluorescent Capsids to Study Transport in Living Cells	PLOS ONE			English	Article							SIMPLEX-VIRUS; HUMAN CYTOMEGALOVIRUS; VIRAL REPLICATION; ESCHERICHIA-COLI; NUCLEAR EGRESS; PROTEIN; TEGUMENT; VISUALIZATION; LOCALIZATION; GLYCOPROTEIN	Fluorescent tagging of viral particles by genetic means enables the study of virus dynamics in living cells. However, the study of beta-herpesvirus entry and morphogenesis by this method is currently limited. This is due to the lack of replication competent, capsid-tagged fluorescent viruses. Here, we report on viable recombinant MCMVs carrying ectopic insertions of the small capsid protein (SCP) fused to fluorescent proteins (FPs). The FPs were inserted into an internal position which allowed the production of viable, fluorescently labeled cytomegaloviruses, which replicated with wild type kinetics in cell culture. Fluorescent particles were readily detectable by several methods. Moreover, in a spread assay, labeled capsids accumulated around the nucleus of the newly infected cells without any detectable viral gene expression suggesting normal entry and particle trafficking. These recombinants were used to record particle dynamics by live-cell microscopy during MCMV egress with high spatial as well as temporal resolution. From the resulting tracks we obtained not only mean track velocities but also their mean square displacements and diffusion coefficients. With this key information, we were able to describe particle behavior at high detail and discriminate between particle tracks exhibiting directed movement and tracks in which particles exhibited free or anomalous diffusion.	[Bosse, Jens B.; Popilka, Leonhard; Marcinowski, Lisa; Striebinger, Hannah; Koszinowski, Ulrich H.; Ruzsics, Zsolt] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Bauerfeind, Rudolf] Hannover Med Sch, Dept Cell Biol, D-3000 Hannover, Germany; [von Einem, Jens] Univ Med Ctr Ulm, Inst Virol, Ulm, Germany; [Taeglich, Martina; Jung, Christophe; Gaul, Ulrike] Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany; [Walther, Paul] Univ Ulm, Cent Unit Electron Microscopy, Ulm, Germany	University of Munich; Hannover Medical School; Ulm University; University of Munich; Ulm University	Bosse, JB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ruzsics@lmb.uni-muenchen.de	Bosse, Jens Bernhard/D-7336-2011; Ruzsics, Zsolt/D-6284-2014; von Einem, Jens/ABB-4480-2021	Bosse, Jens Bernhard/0000-0001-7252-5541; von Einem, Jens/0000-0001-7508-4702	German Research Foundation; Bayerisch-FranzosischesHochschulzentrum/Centre de Cooperation Universitaire Franco-Bavarois (BFHZ-CCUFB) [FK20-10]; German National Academic Foundation (Studienstiftung des deutschenVolkes)	German Research Foundation(German Research Foundation (DFG)); Bayerisch-FranzosischesHochschulzentrum/Centre de Cooperation Universitaire Franco-Bavarois (BFHZ-CCUFB); German National Academic Foundation (Studienstiftung des deutschenVolkes)	This work was supported by the German Research Foundation as part of the "Schwerpunktprogramm 1175" (SPP1175) and the Bayerisch-FranzosischesHochschulzentrum/Centre de Cooperation Universitaire Franco-Bavarois (BFHZ-CCUFB) through the project FK20-10. JBB was supported by a PhD studentship from the German National Academic Foundation (Studienstiftung des deutschenVolkes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Antinone SE, 2006, J VIROL, V80, P11235, DOI 10.1128/JVI.01441-06; Bohannon KP, 2012, J GEN VIROL, V93, P124, DOI 10.1099/vir.0.036145-0; Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; Borst EM, 2001, J VIROL, V75, P1450, DOI 10.1128/JVI.75.3.1450-1458.2001; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Chaudhuri V, 2008, J VIROL, V82, P10231, DOI 10.1128/JVI.01890-07; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cockrell SK, 2011, J VIROL, V85, P4875, DOI 10.1128/JVI.00242-11; Conway JF, 2010, J MOL BIOL, V397, P575, DOI 10.1016/j.jmb.2010.01.043; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; Desai P, 1998, VIROLOGY, V247, P115, DOI 10.1006/viro.1998.9230; Desai P, 1998, J VIROLOGY; Dohner K, 2006, J VIROL, V80, P8211, DOI 10.1128/JVI.02528-05; Donnelly M, 2001, J VIROL, V75, P2575, DOI 10.1128/JVI.75.6.2575-2583.2001; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; Endress T, 2008, EUR BIOPHYS J BIOPHY, V37, P1291, DOI 10.1007/s00249-008-0322-z; Finke S, 2004, J VIROL, V78, P12333, DOI 10.1128/JVI.78.22.12333-12343.2004; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Frampton AR, 2010, VET MICROBIOL, V141, P12, DOI 10.1016/j.vetmic.2009.07.035; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Glotzer JB, 2001, J VIROL, V75, P2421, DOI 10.1128/JVI.75.5.2421-2434.2001; Hazelton PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/eid0903.020327; Henson BW, 2009, J VIROL, V83, P3877, DOI 10.1128/JVI.01733-08; Hutchinson I, 2002, J VIROL, V76, P10365, DOI 10.1128/JVI.76.20.10365-10373.2002; Kirstein J, 2005, J AM CHEM SOC, V130, P1638; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Krautwald M, 2008, J GEN VIROL, V89, P1346, DOI 10.1099/vir.0.83652-0; Lai LL, 2003, J VIROL, V77, P2730, DOI 10.1128/JVI.77.4.2730-2735.2003; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Maninger S, 2011, J VIROL, V85, P9254, DOI 10.1128/JVI.00443-11; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; Menard C, 2003, J VIROL, V77, P5557, DOI 10.1128/JVI.77.10.5557-5570.2003; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; NII S, 1968, J VIROL, V2, P517, DOI 10.1128/JVI.2.5.517-536.1968; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliveira SA, 2002, J VIROL, V76, P885, DOI 10.1128/JVI.76.2.885-894.2002; Perkins EM, 2008, J VIROL, V82, P7201, DOI 10.1128/JVI.00423-08; Potel C, 2002, J VIROL METHODS, V105, P13, DOI 10.1016/S0166-0934(02)00027-7; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Roberts KL, 2010, J VIROL, V84, P9889, DOI 10.1128/JVI.00732-10; Rupp B, 2005, J VIROL, V79, P486, DOI 10.1128/JVI.79.1.486-494.2005; Rupp B, 2007, J VIROL, V81, P5508, DOI 10.1128/JVI.02796-06; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schaffer P A, 1975, Curr Top Microbiol Immunol, V70, P51; Scrivano L, 2010, J VIROL, V84, P4469, DOI 10.1128/JVI.02441-09; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Sugimoto K, 2008, J VIROL, V82, P5198, DOI 10.1128/JVI.02681-07; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001	62	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40585	10.1371/journal.pone.0040585	http://dx.doi.org/10.1371/journal.pone.0040585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792376	Green Published, Green Submitted, gold			2022-12-27	WOS:000306362400074
J	Sinha, V; Ganguly, B; Bandyopadhyay, T				Sinha, Vivek; Ganguly, Bishwajit; Bandyopadhyay, Tusar			Energetics of Ortho-7 (Oxime Drug) Translocation through the Active-Site Gorge of Tabun Conjugated Acetylcholinesterase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY DIFFERENCES; MONTE-CARLO DATA; CONFIGURATIONAL ENTROPY; KINETIC-ANALYSIS; MEAN FORCE; BINDING; MACROMOLECULES; MECHANISM; EQUALITY	Oxime drugs translocate through the 20 angstrom active-site gorge of acetylcholinesterase in order to liberate the enzyme from organophosphorus compounds' (such as tabun) conjugation. Here we report bidirectional steered molecular dynamics simulations of oxime drug (Ortho-7) translocation through the gorge of tabun intoxicated enzyme, in which time dependent external forces accelerate the translocation event. The simulations reveal the participation of drug-enzyme hydrogen bonding, hydrophobic interactions and water bridges between them. Employing nonequilibrium theorems that recovers the free energy from irreversible work done, we reconstruct potential of mean force along the translocation pathway such that the desired quantity represents an unperturbed system. The potential locates the binding sites and barriers for the drug to translocate inside the gorge. Configurational entropic contribution of the protein-drug binding entity and the role of solvent translational mobility in the binding energetics is further assessed.	[Sinha, Vivek] Indian Inst Sci Educ & Res Kolkata, Mohanpur, Nadia, India; [Ganguly, Bishwajit] Cent Salt & Marine Chem Res Inst, Analyt Sci Discipline, Council Sci & Ind Res, Bhavnagar 364002, Gujarat, India; [Bandyopadhyay, Tusar] Bhabha Atom Res Ctr, Theoret Chem Sect, Chem Grp, Bombay 400085, Maharashtra, India	Indian Institute of Science Education & Research (IISER) - Kolkata; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Bhabha Atomic Research Center (BARC)	Sinha, V (corresponding author), Indian Inst Sci Educ & Res Kolkata, Mohanpur Campus, Mohanpur, Nadia, India.	btusar@barc.gov.in	sinha, vivek/ABH-1216-2020	sinha, vivek/0000-0002-6856-9469	Department of Atomic Energy-Board of Research in Nuclear Sciences (DAE-BRNS), Mumbai, India [2007/37/19/BRNS]; Homi Bhabha Centre for Science Education	Department of Atomic Energy-Board of Research in Nuclear Sciences (DAE-BRNS), Mumbai, India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); Homi Bhabha Centre for Science Education	Part of this work was financially supported by Department of Atomic Energy-Board of Research in Nuclear Sciences (DAE-BRNS), Mumbai, India (vide DAE-Sanction NO: 2007/37/19/BRNS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We sincerely thank Mr. Amit Das for several useful discussions. TB is grateful to Prof. R. Chelli for kindly providing one necessary software customized here to calculate free energy profiles. TB is also thankful to Prof. T. Mukherjee and S. K. Ghosh for their encouragement during the entire course of the work. BG acknowledges support from Dr. P. K. Ghosh. VS sincerely acknowledges Homi Bhabha Centre for Science Education for the support that he has received from NIUS program.	ADAMS PR, 1981, J MEMBRANE BIOL, V58, P161, DOI 10.1007/BF01870902; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Artursson E, 2009, TOXICOLOGY, V265, P108, DOI 10.1016/j.tox.2009.09.002; Aurbek N, 2010, CHEM-BIOL INTERACT, V187, P215, DOI 10.1016/j.cbi.2010.01.035; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Branduardi D, 2005, J AM CHEM SOC, V127, P9147, DOI 10.1021/ja0512780; Bui JM, 2003, BIOPHYS J, V85, P2267, DOI 10.1016/S0006-3495(03)74651-7; Casida JE, 2004, CHEM RES TOXICOL, V17, P983, DOI 10.1021/tx0499259; Chang CEA, 2007, P NATL ACAD SCI USA, V104, P1534, DOI 10.1073/pnas.0610494104; Chelli R, 2009, PHYS CHEM CHEM PHYS, V11, P1152, DOI 10.1039/b810914c; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ekstrom FJ, 2007, CLIN PHARMACOL THER, V82, P282, DOI 10.1038/sj.clpt.6100151; Ekstrom F, 2006, BIOCHEM PHARMACOL, V72, P597, DOI 10.1016/j.bcp.2006.05.027; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; Frisch M.J., 2016, GAUSSIAN16 REV B01; Grosman C, 2001, P NATL ACAD SCI USA, V98, P14102, DOI 10.1073/pnas.251402498; HALLAK M, 1989, NEUROPHARMACOLOGY, V28, P199, DOI 10.1016/0028-3908(89)90093-2; Heymann B, 2001, BIOPHYS J, V81, P1295, DOI 10.1016/S0006-3495(01)75787-6; Hummer G, 2005, ACCOUNTS CHEM RES, V38, P504, DOI 10.1021/ar040148d; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Kaur J, 2000, CURR MED CHEM, V7, P273, DOI 10.2174/0929867003375254; Kesharwani MK, 2010, ACTA PHARMACOL SIN, V31, P313, DOI 10.1038/aps.2009.193; Kosztin I, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166379; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lexa KW, 2011, J AM CHEM SOC, V133, P200, DOI 10.1021/ja1079332; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Minh DDL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.180602; Nicolini P, 2010, J PHYS CHEM B, V114, P9546, DOI 10.1021/jp102263y; Niu CY, 2005, J PHYS CHEM B, V109, P23730, DOI 10.1021/jp0552877; Pang YP, 2003, CHEM BIOL, V10, P491, DOI 10.1016/S1074-5521(03)00126-1; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tai K, 2001, BIOPHYS J, V81, P715, DOI 10.1016/S0006-3495(01)75736-0; Tarek M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138101; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Voet D, 2005, BIOCHEMISTRY; Ward JM, 2010, J AM CHEM SOC, V132, P11058, DOI 10.1021/ja910535j; Wiener Sage W, 2004, J Intensive Care Med, V19, P22, DOI 10.1177/0885066603258659; Worek F, 2007, BIOCHEM PHARMACOL, V73, P1807, DOI 10.1016/j.bcp.2007.02.008; Xu YC, 2003, J AM CHEM SOC, V125, P11340, DOI 10.1021/ja029775t	49	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40188	10.1371/journal.pone.0040188	http://dx.doi.org/10.1371/journal.pone.0040188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808117	Green Submitted, gold, Green Published			2022-12-27	WOS:000306362400034
J	Alevra, M; Schwartz, P; Schild, D				Alevra, Mihai; Schwartz, Peter; Schild, Detlev			Direct Measurement of Diffusion in Olfactory Cilia Using a Modified FRAP Approach	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; MOLECULAR-DIFFUSION; FROG; COEFFICIENT; NEURONS	The diffusion coefficient of fluorescein in detached cilia of Xenopus laevis olfactory receptor neurons was measured using spatially-resolved FRAP, where the dye along half of the ciliary length was photobleached and its spatiotemporal fluorescence redistribution recorded. Fitting a one-dimensional numerical simulation of diffusion and photobleaching for 35 cilia resulted in a mean value of the diffusion coefficient (1.20 +/- 0.23).10(-10)m(2)/s and thus a reduction by a factor of 3.4 compared to free diffusion in aqueous solution.	[Alevra, Mihai; Schild, Detlev] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany; [Alevra, Mihai; Schild, Detlev] German Res Fdn Res Ctr Mol Physiol Brain, Gottingen, Germany; [Schild, Detlev] German Res Fdn Cluster Excellence 171, Gottingen, Germany; [Schwartz, Peter] Univ Gottingen, Dept Anat & Embryol, Gottingen, Germany	University of Gottingen; University of Gottingen	Alevra, M (corresponding author), Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany.	malevra@gwdg.de	Alevra, Mihai/AAL-2679-2021	Alevra, Mihai/0000-0002-1384-0071	"Deutsche Forschungsgemeinschaft" Research Center Molecular Physiology of the Brain (CMPB); Cluster of Excellence 171	"Deutsche Forschungsgemeinschaft" Research Center Molecular Physiology of the Brain (CMPB); Cluster of Excellence 171	This work was supported by grants of the "Deutsche Forschungsgemeinschaft" Research Center Molecular Physiology of the Brain (CMPB, http://cmpb.de/) to DS and MA, and the Cluster of Excellence 171 (http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id=32501626) to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANHOLT RRH, 1986, J NEUROSCI, V6, P1962; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chen CH, 1999, BIOPHYS J, V76, P2861, DOI 10.1016/S0006-3495(99)77440-0; CHEN Z, 1986, J NEUROSCI, V6, P2146; Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gennerich A, 2000, BIOPHYS J, V79, P3294, DOI 10.1016/S0006-3495(00)76561-1; Gennerich A, 2002, BIOPHYS J, V83, P510, DOI 10.1016/S0006-3495(02)75187-4; Hansen A, 1998, J COMP NEUROL, V398, P273, DOI 10.1002/(SICI)1096-9861(19980824)398:2<273::AID-CNE8>3.0.CO;2-Y; Junek S, 2009, BIOPHYS J, V96, P3801, DOI 10.1016/j.bpj.2008.12.3962; Kim SA, 2010, J NEUROSCI, V30, P16409, DOI 10.1523/JNEUROSCI.3063-10.2010; KLEENE SJ, 1994, J EXP BIOL, V195, P307; Olveczky BP, 1998, BIOPHYS J, V74, P2722, DOI 10.1016/S0006-3495(98)77978-0; SONG LL, 1995, BIOPHYS J, V68, P2588, DOI 10.1016/S0006-3495(95)80442-X; Takao D, 2008, J EXP BIOL, V211, P3594, DOI 10.1242/jeb.021923; Takeuchi H, 2008, J NEUROSCI, V28, P766, DOI 10.1523/JNEUROSCI.3531-07.2008; Weickert J, 1998, IEEE T IMAGE PROCESS, V7, P398, DOI 10.1109/83.661190	17	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39628	10.1371/journal.pone.0039628	http://dx.doi.org/10.1371/journal.pone.0039628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808046	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500012
J	Dinardo, MM; Camerino, G; Mele, A; Latorre, R; Camerino, DC; Tricarico, D				Dinardo, Maria Maddalena; Camerino, Giulia; Mele, Antonietta; Latorre, Ramon; Camerino, Diana Conte; Tricarico, Domenico			Splicing of the rSlo Gene Affects the Molecular Composition and Drug Response of Ca2+-Activated K+ Channels in Skeletal Muscle	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; PROTEIN-KINASE-A; BK CHANNEL; BETA-1 SUBUNIT; RAT-BRAIN; CALCIUM; EXPRESSION; VARIANTS; SURFACE; SLO	The molecular composition and drug responses of calcium-activated K+ (BK) channels of skeletal muscle are unknown. Patch-clamp experiments combined with transcript scanning of the Kcnma1 gene encoding the alpha subunit of the BK channel were performed in rat slow-twitch soleus (Sol) and fast-twitch flexor digitorum brevis (FDB) skeletal muscles. Five splicing products of the Kcnma1 gene were isolated from Sol and FDB: the e17, e22, + 29 aa, Slo27 and Slo0 variants. RT-PCR analysis demonstrated that the expression of e22 and Slo0 were 80-90% higher in FDB than Sol, whereas the expression of Slo27 was 60% higher in Sol than FDB, and the + 29 aa variant was equally expressed in both muscle types. No beta 1-4 subunits were detected. In Sol, a large BK current with low Ca2+ sensitivity was recorded. The BK channel of Sol also showed a reduced response to BK channel openers, such as NS1619, acetazolamide and related drugs. In FDB, a reduced BK current with high Ca2+ sensitivity and an enhanced drug response was recorded. The total BK RNA content, which was 200% higher in Sol than in FDB, correlated with the BK currents in both muscles. Drug responses primarily correlated with e22 and Slo0 expression levels in FDB and to Slo27 expression in Sol muscle. In conclusion, phenotype-dependent BK channel biophysical and pharmacological properties correlated with the expression levels of the variants in muscles. These findings may be relevant to conditions affecting postural muscles, such as prolonged bed-rest, and to diseases affecting fast-twitch muscles, such as periodic paralysis. Down-regulation or up-regulation of the variants associated with pathological conditions may affect channel composition and drug responses.	[Dinardo, Maria Maddalena; Camerino, Giulia; Mele, Antonietta; Camerino, Diana Conte; Tricarico, Domenico] Univ Bari, Dept Pharmacobiol, Fac Pharm, Bari, Italy; [Latorre, Ramon] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso, Chile	Universita degli Studi di Bari Aldo Moro; Universidad de Valparaiso	Dinardo, MM (corresponding author), Univ Bari, Dept Pharmacobiol, Fac Pharm, Bari, Italy.	dtricarico@farmbiol.uniba.it	Camerino, Giulia Maria/I-6896-2013	Camerino, Giulia Maria/0000-0003-1410-6327; Conte, Diana/0000-0003-0162-9698	Telethon [GGP10101]; Fondecyt [1110430]; Centro Interdisciplinario de Neurociencia de Valparaiso is a Millennium Scientific Institute	Telethon(Fondazione Telethon); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centro Interdisciplinario de Neurociencia de Valparaiso is a Millennium Scientific Institute	This work was supported by Telethon GGP10101 (Pi of grant); grant Fondecyt 1110430 and the Centro Interdisciplinario de Neurociencia de Valparaiso is a Millennium Scientific Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Ahluwaila J, 2004, RETRACTION NATURE, V427, p[853, etraction]; BIELEFELDT K, 1994, J PHYSIOL-LONDON, V475, P241, DOI 10.1113/jphysiol.1994.sp020065; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Erxleben C, 2002, J BIOL CHEM, V277, P27045, DOI 10.1074/jbc.M203087200; Gribkoff VK, 2001, NEUROSCIENTIST, V7, P166, DOI 10.1177/107385840100700211; Ha TS, 2000, EUR J BIOCHEM, V267, P910, DOI 10.1046/j.1432-1327.2000.01076.x; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Jones EMC, 1998, P ROY SOC B-BIOL SCI, V265, P685, DOI 10.1098/rspb.1998.0348; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Lovell PV, 2001, J NEUROSCI, V21, P3429, DOI 10.1523/JNEUROSCI.21-10-03429.2001; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Matthews E, 2011, NEUROLOGY, V77, P1960, DOI 10.1212/WNL.0b013e31823a0cb6; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; PEREZ G, 1994, BIOPHYS J, V66, P1022, DOI 10.1016/S0006-3495(94)80883-5; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; REINHART PH, 1991, J NEUROSCI, V11, P1627; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Rogers KL, 2002, EUR J PHARM SCI, V15, P321, DOI 10.1016/S0928-0987(02)00012-X; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Shadfar S, 2011, NUTR CANCER, V63, P749, DOI 10.1080/01635581.2011.563032; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shipston MJ, 1996, J BIOL CHEM, V271, P9197, DOI 10.1074/jbc.271.16.9197; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; Tian LJ, 2001, J PHYSIOL-LONDON, V537, P57, DOI 10.1111/j.1469-7793.2001.0057k.x; Tricarico D, 2005, NEUROBIOL DIS, V20, P296, DOI 10.1016/j.nbd.2005.03.011; Tricarico D, 2004, FASEB J, V18, P760, DOI 10.1096/fj.03-0722fje; Tricarico D, 2000, ANN NEUROL, V48, P304, DOI 10.1002/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A; Tricarico D, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00008; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Van Goor F, 2001, J NEUROSCI, V21, P5902, DOI 10.1523/JNEUROSCI.21-16-05902.2001; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zhang YL, 2004, J BIOL CHEM, V279, P52324, DOI 10.1074/jbc.M408543200; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200	55	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40235	10.1371/journal.pone.0040235	http://dx.doi.org/10.1371/journal.pone.0040235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808126	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500034
J	Benito-Miguel, M; Garcia-Carmona, Y; Balsa, A; Bautista-Caro, MB; Arroyo-Villa, I; Cobo-Ibanez, T; Bonilla-Hernan, MG; de Ayala, CP; Sanchez-Mateos, P; Martin-Mola, E; Miranda-Carus, ME				Benito-Miguel, Marta; Garcia-Carmona, Yolanda; Balsa, Alejandro; Bautista-Caro, Maria-Belen; Arroyo-Villa, Irene; Cobo-Ibanez, Tatiana; Gema Bonilla-Hernan, Maria; Perez de Ayala, Carlos; Sanchez-Mateos, Paloma; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia			IL-15 Expression on RA Synovial Fibroblasts Promotes B Cell Survival	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; FOLLICULAR DENDRITIC CELLS; T-CELL; NECROSIS-FACTOR; BETA-CHAIN; SYNOVIOCYTES; PROLIFERATION; RECEPTOR; DISEASE; DIFFERENTIATION	Introduction: The purpose of this study was to examine the role of RA Synovial Fibroblast (RASFib) IL-15 expression on B cell survival. Methods: Magnetically sorted peripheral blood memory B cells from 15 healthy subjects were cocultured with RASFib. Results: RASFib constitutively expressed membrane IL-15. Survival of isolated B cells cultured for 6 days, below 5%, was extended in coculture with RASFib to 52+/28% (p<0.001). IL-15 neutralizing agents but not isotype controls, reduced this rate to 31+/26% (p<0.05). Interestingly, rhIL-15 had no effect on isolated B cells but significantly increased their survival in coculture with RASFib. In parallel, B cell IL-15R chains were upregulated in cocultures. BAFF and VCAM-1, that are expressed on RASFib, were tested as potential candidates involved in upregulating B cell IL-15R. Culture of B cells in the presence of rhBAFF or rhVCAM-1 resulted in significantly increased survival, together with upregulation of all three IL-15R chains; in parallel, rhIL-15 potentiated the anti-apoptotic effect of BAFF and VCAM-1. Both BAFF and VCAM-1 neutralizing agents downmodulated the effect of RASFib on B cell survival and IL-15R expression. In parallel, rhIL-15 had a lower effect on the survival of B cells cocultured with RASFib in the presence of BAFF or VCAM-1 neutralizing agents. Peripheral blood B cells from 15 early RA patients demonstrated an upregulated IL-15R and increased survival in cocultures. Conclusion: IL-15 expression on RASFib significantly contributes to the anti-apoptotic effect of RASFib on B cells. IL-15 action is facilitated by BAFF and VCAM-1 expressed on RASFib, through an upregulation of IL-15R chains.	[Benito-Miguel, Marta; Garcia-Carmona, Yolanda; Balsa, Alejandro; Bautista-Caro, Maria-Belen; Arroyo-Villa, Irene; Cobo-Ibanez, Tatiana; Gema Bonilla-Hernan, Maria; Perez de Ayala, Carlos; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain; [Sanchez-Mateos, Paloma] Hosp Gen Univ Gregorio Maranon, Lab Inmunooncol, Madrid, Spain	Hospital Universitario La Paz; General University Gregorio Maranon Hospital	Benito-Miguel, M (corresponding author), Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain.	mmiranda.hulp@salud.madrid.org	Miranda-Carus, Maria-Eugenia/S-7403-2019; Balsa, Alejandro/ABF-6456-2020; Benito Miguel, Marta/O-8776-2014; Sanchez-Mateos, Paloma/E-8931-2013; Clemente-Suarez, Vicente Javier/K-7980-2014	Benito Miguel, Marta/0000-0002-2023-1063; Garcia-Carmona, Yolanda/0000-0003-2562-4752; Sanchez-Mateos, Paloma/0000-0001-6589-4445; Clemente-Suarez, Vicente Javier/0000-0002-2397-2801	Roche Pharmaceuticals; Ministerio de Ciencia e Innovacion grant [SAF 2009-07100]; RETICS Program from "Instituto de Salud Carlos III" (ISCIII) [RD08/0075]	Roche Pharmaceuticals(Roche Holding); Ministerio de Ciencia e Innovacion grant(Spanish Government); RETICS Program from "Instituto de Salud Carlos III" (ISCIII)	This work was supported by an unrestricted research grant from Roche Pharmaceuticals,(www.roche.com) by Ministerio de Ciencia e Innovacion grant SAF 2009-07100, (www.micinn.es) and by RETICS Program, RD08/0075 (RIER) from "Instituto de Salud Carlos III" (ISCIII) (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh G, 2011, EUR J IMMUNOL, V41, P2113, DOI 10.1002/eji.201041194; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balsa A, 2004, J RHEUMATOL, V31, P40; Benito-Miguel M, 2009, J IMMUNOL, V183, P8268, DOI 10.4049/jimmunol.0900007; Briard D, 2002, J IMMUNOL, V168, P4326, DOI 10.4049/jimmunol.168.9.4326; Buckley CD, 2003, RHEUMATOLOGY, V42, P1433, DOI 10.1093/rheumatology/keg413; Burger JA, 2001, J CLIN INVEST, V107, P305, DOI 10.1172/JCI11092; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Catalan D, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2985; CHOMARAT P, 1993, ARTHRITIS RHEUM-US, V36, P234, DOI 10.1002/art.1780360215; Dorner T, 2003, CURR OPIN RHEUMATOL, V15, P246, DOI 10.1097/00002281-200305000-00011; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Edwards JCW, 1997, CLIN EXP IMMUNOL, V108, P407, DOI 10.1046/j.1365-2249.1997.4061306.x; Ernestam S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1871; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hase H, 2004, BLOOD, V103, P2257, DOI 10.1182/blood-2003-08-2694; Hayashida K, 2000, J IMMUNOL, V164, P1110, DOI 10.4049/jimmunol.164.2.1110; Hopken UE, 2010, J LEUKOCYTE BIOL, V87, P671, DOI 10.1189/jlb.0709505; Kim YS, 1998, J IMMUNOL, V160, P5742; Kurowska M, 2002, J IMMUNOL, V169, P1760, DOI 10.4049/jimmunol.169.4.1760; Li WX, 2005, INT IMMUNOL, V17, P429, DOI 10.1093/intimm/dxh223; Lindhout E, 1999, J IMMUNOL, V162, P5949; McInnes IB, 1998, IMMUNOL TODAY, V19, P75, DOI 10.1016/S0167-5699(97)01205-X; Miranda-Carus ME, 2004, J IMMUNOL, V173, P1463, DOI 10.4049/jimmunol.173.2.1463; Ohata J, 2005, J IMMUNOL, V174, P864, DOI 10.4049/jimmunol.174.2.864; Park CS, 2004, J IMMUNOL, V173, P6676, DOI 10.4049/jimmunol.173.11.6676; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Prokopec KE, 2010, CLIN IMMUNOL, V137, P322, DOI 10.1016/j.clim.2010.08.006; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Reparon-Schuijt CC, 2000, ARTHRITIS RHEUM, V43, P1115, DOI 10.1002/1529-0131(200005)43:5<1115::AID-ANR22>3.0.CO;2-A; Rochas C, 2009, ARTHRITIS RHEUM-US, V60, P1261, DOI 10.1002/art.24498; Saalbach A, 2000, J INVEST DERMATOL, V115, P882, DOI 10.1046/j.1523-1747.2000.00104.x; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weyand CM, 2003, CURR OPIN RHEUMATOL, V15, P259, DOI 10.1097/00002281-200305000-00013; ZVAIFLER NJ, 1974, ARTHRITIS RHEUM, V17, P297, DOI 10.1002/art.1780170315; ZVAIFLER NJ, 1994, SEMIN ARTHRITIS RHEU, V23, P11, DOI 10.1016/0049-0172(94)90080-9	42	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40620	10.1371/journal.pone.0040620	http://dx.doi.org/10.1371/journal.pone.0040620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792388	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700062
J	Ma, JZ; Amos, CI				Ma, Jianzhong; Amos, Christopher I.			Investigation of Inversion Polymorphisms in the Human Genome Using Principal Components Analysis	PLOS ONE			English	Article							STRUCTURAL VARIATION; DISEASE; IDENTIFICATION; RECOMBINATION; IMPACT; GENE	Despite the significant advances made over the last few years in mapping inversions with the advent of paired-end sequencing approaches, our understanding of the prevalence and spectrum of inversions in the human genome has lagged behind other types of structural variants, mainly due to the lack of a cost-efficient method applicable to large-scale samples. We propose a novel method based on principal components analysis (PCA) to characterize inversion polymorphisms using high-density SNP genotype data. Our method applies to non-recurrent inversions for which recombination between the inverted and non-inverted segments in inversion heterozygotes is suppressed due to the loss of unbalanced gametes. Inside such an inversion region, an effect similar to population substructure is thus created: two distinct "populations" of inversion homozygotes of different orientations and their 1:1 admixture, namely the inversion heterozygotes. This kind of substructure can be readily detected by performing PCA locally in the inversion regions. Using simulations, we demonstrated that the proposed method can be used to detect and genotype inversion polymorphisms using unphased genotype data. We applied our method to the phase III HapMap data and inferred the inversion genotypes of known inversion polymorphisms at 8p23.1 and 17q21.31. These inversion genotypes were validated by comparing with literature results and by checking Mendelian consistency using the family data whenever available. Based on the PCA-approach, we also performed a preliminary genome-wide scan for inversions using the HapMap data, which resulted in 2040 candidate inversions, 169 of which overlapped with previously reported inversions. Our method can be readily applied to the abundant SNP data, and is expected to play an important role in developing human genome maps of inversions and exploring associations between inversions and susceptibility of diseases.	[Ma, Jianzhong; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Ma, JZ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	jzma@mdanderson.org			National Institutes of Health [R01CA134682, R01AR057120]; NATIONAL CANCER INSTITUTE [R01CA134682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants R01CA134682 and R01AR057120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bansal V, 2007, GENOME RES, V17, P219, DOI 10.1101/gr.5774507; Bosch N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008269; Caceres A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-28; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Feuk L, 2010, GENOME MED, V2, DOI 10.1186/gm132; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Jaarola M, 1998, AM J HUM GENET, V63, P218, DOI 10.1086/301900; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Ma JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012510; Navarro A, 1997, GENETICS, V146, P695; Navarro A, 2005, NAT GENET, V37, P115, DOI 10.1038/ng0205-115; O'Reilly PF, 2010, BIOINFORMATICS, V26, P838, DOI 10.1093/bioinformatics/btq029; Osborne L, 2010, NAT GENET, V29, P321; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Salm A, 2012, GENOME RES IN PRESS, P23; Sindi SS, 2010, J COMPUT BIOL, V17, P517, DOI 10.1089/cmb.2009.0185; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sturtevant AH, 1921, P NATL ACAD SCI USA, V7, P235, DOI 10.1073/pnas.7.8.235; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	31	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40224	10.1371/journal.pone.0040224	http://dx.doi.org/10.1371/journal.pone.0040224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808122	Green Published, Green Submitted, gold			2022-12-27	WOS:000306354700031
J	Yang, WB; Liang, QL; Ye, ZJ; Niu, CM; Ma, WL; Xiong, XZ; Du, RH; Zhou, Q; Zhang, JC; Shi, HZ				Yang, Wei-Bing; Liang, Qiu-Li; Ye, Zhi-Jian; Niu, Chun-Mi; Ma, Wan-Li; Xiong, Xian-Zhi; Du, Rong-Hui; Zhou, Qiong; Zhang, Jian-Chu; Shi, Huan-Zhong			Cell Origins and Diagnostic Accuracy of Interleukin 27 in Pleural Effusions	PLOS ONE			English	Article							REGULATORY T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; TH17 CELLS; IL-27; RESPONSES; METAANALYSIS; INFECTION; CCL22; WSX-1	The objective of the present study was to investigate the presence of interleukin (IL)-27 in pleural effusions and to evaluate the diagnostic significance of pleural IL-27. The concentrations of IL-27 were determined in pleural fluids and sera from 68 patients with tuberculous pleural effusion, 63 malignant pleural effusion, 22 infectious pleural effusion, and 21 transudative pleural effusion. Flow cytometry was used to identify which pleural cell types expressed IL-27. It was found that the concentrations of pleural IL-27 in tuberculous group were significantly higher than those in malignant, infectious, and transudative groups, respectively. Pleural CD4(+) T cells, CD8(+) T cells, NK cells, NKT cells, B cells, monocytes, macrophages, and mesothelial cells might be the cell sources for IL-27. IL-27 levels could be used for diagnostic purpose for tuberculous pleural effusion, with the cut off value of 1,007 ng/L, IL-27 had a sensitivity of 92.7% and specificity of 99.1% for differential diagnosing tuberculous pleural effusion from non-tuberculous pleural effusions. Therefore, compared to non-tuberculous pleural effusions, IL-27 appeared to be increased in tuberculous pleural effusion. IL-27 in pleural fluid is a sensitive and specific biomarker for the differential diagnosing tuberculous pleural effusion from pleural effusions with the other causes.	[Yang, Wei-Bing; Ye, Zhi-Jian; Niu, Chun-Mi; Ma, Wan-Li; Xiong, Xian-Zhi; Zhou, Qiong; Zhang, Jian-Chu; Shi, Huan-Zhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Resp & Crit Care Med, Key Lab Pulm Dis,Hlth Minist,Union Hosp, Wuhan 430074, Peoples R China; [Liang, Qiu-Li] Guangxi Med Univ, Affiliated Hosp 1, Inst Resp Dis, Nanning, Peoples R China; [Du, Rong-Hui] Wuhan Inst TB Prevent & Control, Dept Internal Med, Wuhan, Peoples R China	Huazhong University of Science & Technology; Guangxi Medical University	Yang, WB (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Resp & Crit Care Med, Key Lab Pulm Dis,Hlth Minist,Union Hosp, Wuhan 430074, Peoples R China.	zsn0928@163.com; shihuanzhong@sina.com		Zhang, Jianchu/0000-0002-8731-6600	National Basic Research Program of China (973 Program) [National Basic Research Program of China (973 Program 2012CB518706]; National Science Fund for Distinguished Young Scholars of China [30925032]; 12th Five-Year National Science and Technology Program of Social Development, Ministry of Science and Technology, China [2012BAI05B02]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 12th Five-Year National Science and Technology Program of Social Development, Ministry of Science and Technology, China	This work was supported in part by a grant from National Basic Research Program of China (973 Program 2012CB518706); in part by a grant from National Science Fund for Distinguished Young Scholars (No. 30925032) of China; and in part by a grant from the 12th Five-Year National Science and Technology Program of Social Development, Ministry of Science and Technology, China (No. 2012BAI05B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONY VB, 1985, J CLIN INVEST, V76, P1514, DOI 10.1172/JCI112131; ANTONY VB, 1983, ACTA CYTOL, V27, P355; BARNES PF, 1989, J IMMUNOL, V142, P1114; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Hamm H, 1997, EUR RESPIR J, V10, P1150, DOI 10.1183/09031936.97.10051150; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; O'Dwyer MJ, 2008, INTENS CARE MED, V34, P683, DOI 10.1007/s00134-007-0968-5; Pearl JE, 2004, J IMMUNOL, V173, P7490, DOI 10.4049/jimmunol.173.12.7490; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Qin XJ, 2009, CLIN CANCER RES, V15, P2231, DOI 10.1158/1078-0432.CCR-08-2641; Robinson CM, 2008, J INFECT DIS, V198, P359, DOI 10.1086/589774; Sahn SA, 2008, TXB PLEURAL DIS, P209; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; Villena V, 2002, ARCH BRONCONEUMOL, V38, P21, DOI 10.1016/S0300-2896(02)75142-9; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Ye ZJ, 2011, CLIN VACCINE IMMUNOL, V18, P1608, DOI 10.1128/CVI.05214-11; Ye ZJ, 2010, J IMMUNOL, V185, P6348, DOI 10.4049/jimmunol.1001728; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445; Zhang JD, 2011, J IMMUNOL, V186, P5885, DOI 10.4049/jimmunol.1003447	30	43	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40450	10.1371/journal.pone.0040450	http://dx.doi.org/10.1371/journal.pone.0040450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792330	Green Published, gold, Green Submitted			2022-12-27	WOS:000306354700052
J	Alkhalaf, A; Kleefstra, N; Groenier, KH; Bilo, HJG; Gans, ROB; Heeringa, P; Scheijen, JL; Schalkwijk, CG; Navis, GJ; Bakker, SJL				Alkhalaf, Alaa; Kleefstra, Nanne; Groenier, Klaas H.; Bilo, Henk J. G.; Gans, Reinold O. B.; Heeringa, Peter; Scheijen, Jean L.; Schalkwijk, Casper G.; Navis, Gerjan J.; Bakker, Stephan J. L.			Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy	PLOS ONE			English	Article							HUMAN PLASMA-PROTEIN; HIGH-DOSE THIAMINE; VASCULAR-DISEASE; DOUBLE-BLIND; CELLS	Background: Formation of advanced glycation endproducts (AGEs), endothelial dysfunction, and low-grade inflammation are intermediate pathways of hyperglycemia-induced vascular complications. We investigated the effect of benfotiamine on markers of these pathways in patients with type 2 diabetes and nephropathy. Methods: Patients with type 2 diabetes and urinary albumin excretion in the high-normal and microalbuminuric range (15-300 mg/24h) were randomized to receive benfotiamine (n = 39) or placebo (n = 43). Plasma and urinary AGEs (N-epsilon-( carboxymethyl) lysine [CML], N-epsilon-(Carboxyethyl) lysine [CEL], and 5- hydro- 5- methylimidazolone [MG- H1]) and plasma markers of endothelial dysfunction (soluble vascular cell adhesion molecule-1 [sVCAM-1], soluble intercellular adhesion molecule- 1 [sICAM-1], soluble E-selectin) and low-grade inflammation (high-sensitivity C-reactive protein [hs-CRP], serum amyloid-A [SAA], myeloperoxidase [MPO]) were measured at baseline and after 6 and 12 weeks. Results: Compared to placebo, benfotiamine did not result in significant reductions in plasma or urinary AGEs or plasma markers of endothelial dysfunction and low-grade inflammation. Conclusions: Benfotiamine for 12 weeks did not significantly affect intermediate pathways of hyperglycemia-induced vascular complications.	[Alkhalaf, Alaa; Kleefstra, Nanne; Bilo, Henk J. G.; Gans, Reinold O. B.; Navis, Gerjan J.; Bakker, Stephan J. L.] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Alkhalaf, Alaa; Kleefstra, Nanne; Groenier, Klaas H.; Bilo, Henk J. G.] Isala Clin, Ctr Diabet, Zwolle, Netherlands; [Alkhalaf, Alaa; Bilo, Henk J. G.] Isala Clin, Dept Internal Med, Zwolle, Netherlands; [Kleefstra, Nanne] Langerhans Med Res Grp, Zwolle, Netherlands; [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Scheijen, Jean L.; Schalkwijk, Casper G.] Univ Hosp Maastricht, Dept Internal Med, Maastricht, Netherlands	University of Groningen; Isala Clinics; Isala Clinics; Langerhans Medical Research Group; University of Groningen; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC)	Alkhalaf, A (corresponding author), Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands.	a.alkhalaf@isala.nl	Heeringa, Peter/A-6008-2009; Bakker, Stephan J. L./J-4023-2015; Scheijen, Jean/AAY-3799-2020	Heeringa, Peter/0000-0001-8684-763X; Bakker, Stephan J. L./0000-0003-3356-6791; Scheijen, Jean/0000-0002-1268-2286; Schalkwijk, Casper G/0000-0003-0190-2690; Gans, Reinold/0000-0001-5481-2387; Kleefstra, Nanne/0000-0003-1473-8519	European Union; medical research foundation in Zwolle	European Union(European Commission); medical research foundation in Zwolle	This trial was partly funded by a grant from the European Union to PREDICTIONS (Prevention of Diabetes Complication) network and by the medical research foundation in Zwolle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf A, 2010, DIABETES CARE, V33, P1598, DOI 10.2337/dc09-2241; Ashokkumar B, 2006, AM J PHYSIOL-RENAL, V291, pF796, DOI 10.1152/ajprenal.00078.2006; Babaei-Jadidi R, 2003, DIABETES, V52, P2110, DOI 10.2337/diabetes.52.8.2110; Bukhari FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2137, DOI 10.1093/ndt/gfq675; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Karachalias N, 2010, DIABETOLOGIA, V53, P1506, DOI 10.1007/s00125-010-1722-z; Rabbani N, 2009, DIABETOLOGIA, V52, P208, DOI 10.1007/s00125-008-1224-4; Reidling JC, 2005, AM J PHYSIOL-GASTR L, V288, pG1127, DOI 10.1152/ajpgi.00539.2004; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Scheijen JLJM, 2009, J CHROMATOGR B, V877, P610, DOI 10.1016/j.jchromb.2009.01.022; Steffes MW, 1999, NEPHROL DIAL TRANSPL, V14, P19, DOI 10.1093/ndt/14.1.19; Stirban A, 2006, DIABETES CARE, V29, P2064, DOI 10.2337/dc06-0531; Teerlink T, 2004, CLIN CHEM, V50, P1222, DOI 10.1373/clinchem.2004.031286; Thornalley PJ, 2007, DIABETOLOGIA, V50, P2164, DOI 10.1007/s00125-007-0771-4; Winkler G, 1999, ARZNEIMITTEL-FORSCH, V49, P220; Xue MZ, 2008, DIABETES, V57, P2809, DOI 10.2337/db06-1003	16	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40427	10.1371/journal.pone.0040427	http://dx.doi.org/10.1371/journal.pone.0040427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792314	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800082
J	Chia, BS; Lanzas, F; Rifat, D; Herrera, A; Kim, EY; Sailer, C; Torres-Chavolla, E; Narayanaswamy, P; Einarsson, V; Bravo, J; Pascale, JM; Ioerger, TR; Sacchettini, JC; Karakousis, PC				Chia, Bing-Shao; Lanzas, Fedora; Rifat, Dalin; Herrera, Aubrey; Kim, Elizabeth Y.; Sailer, Christine; Torres-Chavolla, Edith; Narayanaswamy, Purvaja; Einarsson, Viktor; Bravo, Jaime; Pascale, Juan M.; Ioerger, Thomas R.; Sacchettini, James C.; Karakousis, Petros C.			Use of Multiplex Allele-Specific Polymerase Chain Reaction (MAS-PCR) to Detect Multidrug-Resistant Tuberculosis in Panama	PLOS ONE			English	Article							ARYLAMINE N-ACETYLTRANSFERASE; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; DRUG-RESISTANCE; RIFAMPIN-RESISTANT; RPOB MUTATIONS; GENE; KATG; PREVALENCE; STRAINS	The frequency of individual genetic mutations conferring drug resistance (DR) to Mycobacterium tuberculosis has not been studied previously in Central America, the place of origin of many immigrants to the United States. The current gold standard for detecting multidrug-resistant tuberculosis (MDR-TB) is phenotypic drug susceptibility testing (DST), which is resource-intensive and slow, leading to increased MDR-TB transmission in the community. We evaluated multiplex allele-specific polymerase chain reaction (MAS-PCR) as a rapid molecular tool to detect MDR-TB in Panama. Based on DST, 67 MDR-TB and 31 drug-sensitive clinical isolates were identified and cultured from an archived collection. Primers were designed to target five mutation hotspots that confer resistance to the first-line drugs isoniazid and rifampin, and MAS-PCR was performed. Whole-genome sequencing confirmed DR mutations identified by MAS-PCR, and provided frequencies of genetic mutations. DNA sequencing revealed 70.1% of MDR strains to have point mutations at codon 315 of the katG gene, 19.4% within mabA-inhA promoter, and 98.5% at three hotspots within rpoB. MAS-PCR detected each of these mutations, yielding 82.8% sensitivity and 100% specificity for isoniazid resistance, and 98.4% sensitivity and 100% specificity for rifampin resistance relative to DST. The frequency of individual DR mutations among MDR strains in Panama parallels that of other TB-endemic countries. The performance of MAS-PCR suggests that it may be a relatively inexpensive and technically feasible method for rapid detection of MDR-TB in developing countries.	[Chia, Bing-Shao; Rifat, Dalin; Herrera, Aubrey; Sailer, Christine; Torres-Chavolla, Edith; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lanzas, Fedora; Bravo, Jaime; Pascale, Juan M.] ICGES, Dept Genom & Prote, Panama City, Panama; [Kim, Elizabeth Y.; Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Narayanaswamy, Purvaja; Einarsson, Viktor; Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci, College Stn, TX 77843 USA; [Sacchettini, James C.] Texas A&M Univ, Dept Biochem Biophys, College Stn, TX USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Chia, BS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	petros@jhmi.edu	Chia, Bing Shao/GYJ-4068-2022; Karakousis, Petros Constantine/AAR-7899-2020	Chia, Bing Shao/0000-0003-0101-5805; Rifat, Dalin/0000-0002-8918-5173	Johns Hopkins Center for Global Health faculty pilot grant; NIH [AI083125, HL106786]	Johns Hopkins Center for Global Health faculty pilot grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Johns Hopkins Center for Global Health faculty pilot grant and NIH grants AI083125 and HL106786 to PCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev MV, 2007, J ANTIMICROB CHEMOTH, V59, P1057, DOI 10.1093/jac/dkm086; [Anonymous], 2008, TECHN P BACT DIAGN T; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Cavusoglu C, 2002, J CLIN MICROBIOL, V40, P4435, DOI 10.1128/JCM.40.12.4435-4438.2002; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; DeVito JA, 2003, ANTIMICROB AGENTS CH, V47, P188, DOI 10.1128/AAC.47.1.188-195.2003; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gegia M, 2008, ANTIMICROB AGENTS CH, V52, P725, DOI 10.1128/AAC.01124-07; Hofling CC, 2005, INT J TUBERC LUNG D, V9, P87; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Karakousis PC, 2009, INFECT DIS-SER, P271, DOI 10.1007/978-1-59745-180-2_24; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; O'Brien RJ, 2001, AM J RESP CRIT CARE, V163, P1055, DOI 10.1164/ajrccm.163.5.2007122; Pan American Health Organization, MAN BACT DIAGN TUB S; Park YK, 2005, J MICROBIOL METH, V63, P165, DOI 10.1016/j.mimet.2005.03.002; Payton M, 1999, J BACTERIOL, V181, P1343, DOI 10.1128/JB.181.4.1343-1347.1999; Qian LS, 2002, J CLIN MICROBIOL, V40, P1091, DOI 10.1128/JCM.40.3.1091-1094.2002; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2004, J MED MICROBIOL, V53, P107, DOI 10.1099/jmm.0.05343-0; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sandy J, 2002, J MOL BIOL, V318, P1071, DOI 10.1016/S0022-2836(02)00141-9; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; Tho DQ, 2008, INT J TUBERC LUNG D, V12, P1306; US Census Bureau, C2010BR04 US CENS BU; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; World Health Organisation, 2011, WHOHTMTB201116; Yang ZH, 2005, DIAGN MICR INFEC DIS, V53, P201, DOI 10.1016/j.diagmicrobio.2005.06.007; Yue J, 2003, J CLIN MICROBIOL, V41, P2209, DOI 10.1128/JCM.41.5.2209-2212.2003; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	34	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40456	10.1371/journal.pone.0040456	http://dx.doi.org/10.1371/journal.pone.0040456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792333	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800089
J	Markovic, D; Freyhof, J; Wolter, C				Markovic, Danijela; Freyhof, Joerg; Wolter, Christian			Where Are All the Fish: Potential of Biogeographical Maps to Project Current and Future Distribution Patterns of Freshwater Species	PLOS ONE			English	Article							CLIMATE-CHANGE; IMPACTS; TEMPERATURE; RESOLUTION; MODELS; SHIFTS; RANGE	The dendritic structure of river networks is commonly argued against use of species atlas data for modeling freshwater species distributions, but little has been done to test the potential of grid-based data in predictive species mapping. Using four different niche-based models and three different climate change projections for the middle of the 21st century merged pairwise as well as within a consensus modeling framework, we studied the variability in current and future distribution patterns of 38 freshwater fish species across Germany. We used grid-based (11 x 11 km) fish distribution maps and numerous climatic, topographic, hydromorphologic, and anthropogenic factors derived from environmental maps at a finer scale resolution (250 m-1 km). Apart from the explicit predictor selection, our modeling framework included uncertainty estimation for all phases of the modeling process. We found that the predictive performance of some niche-based models is excellent independent of the predictor data set used, emphasizing the importance of a well-grounded predictor selection process. Though important, climate was not a primary key factor for any of the studied fish species groups, in contrast to substrate preferences, hierarchical river structure, and topography. Generally, distribution ranges of cold-water and warm-water species are expected to change significantly in the future; however, the extent of changes is highly uncertain. Finally, we show that the mismatch between the current and future ranges of climatic variables of more than 90% is the most limiting factor regarding reliability of our future estimates. Our study highlighted the underestimated potential of grid cell information in biogeographical modeling of freshwater species and provides a comprehensive modeling framework for predictive mapping of species distributions and evaluation of the associated uncertainties.	[Markovic, Danijela; Freyhof, Joerg; Wolter, Christian] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Markovic, D (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany.	markovic@igb-berlin.de	Wolter, Christian/F-6210-2014	Wolter, Christian/0000-0002-2819-2900	European Commission BIOFRESH project - Biodiversity of Freshwater Ecosystems: Status, Trends, Pressures, and Conservation Priorities (7th FWP) [226874]	European Commission BIOFRESH project - Biodiversity of Freshwater Ecosystems: Status, Trends, Pressures, and Conservation Priorities (7th FWP)	Current research is funded by the European Commission BIOFRESH project - Biodiversity of Freshwater Ecosystems: Status, Trends, Pressures, and Conservation Priorities (7th FWP ref. 226874), http://www.freshwaterbiodiversity.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Bezdek J. C., 1981, Pattern recognition with fuzzy objective function algorithms; Borgstrom R, 2005, ECOL FRESHW FISH, V14, P375, DOI 10.1111/j.1600-0633.2005.00112.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Buisson L, 2008, ECOL FRESHW FISH, V17, P244, DOI 10.1111/j.1600-0633.2007.00276.x; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Buisson L, 2009, DIVERS DISTRIB, V15, P613, DOI 10.1111/j.1472-4642.2009.00565.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Daufresne M, 2004, GLOBAL CHANGE BIOL, V10, P124, DOI 10.1046/j.1529-8817.2003.00720.x; Daufresne M, 2007, GLOBAL CHANGE BIOL, V13, P2467, DOI 10.1111/j.1365-2486.2007.01449.x; de Jager AL, 2010, HYDROLOG SCI J, V55, P661, DOI 10.1080/02626667.2010.490786; Franklin J, 2009, MAPPING SPECIES DIST; Goldstein RM, 2004, T AM FISH SOC, V133, P971, DOI 10.1577/T03-080.1; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Lassalle G, 2009, FRESHWATER BIOL, V54, P587, DOI 10.1111/j.1365-2427.2008.02135.x; Lassalle G, 2008, BIOL CONSERV, V141, P1105, DOI 10.1016/j.biocon.2008.02.010; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Limburg KE, 2009, BIOSCIENCE, V59, P955, DOI 10.1525/bio.2009.59.11.7; Logez M, 2012, ECOL FRESHW FISH, V21, P266, DOI 10.1111/j.1600-0633.2011.00545.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Nelson KC, 2009, J APPL ECOL, V46, DOI 10.1111/j.1365-2664.2008.01599.x; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Pankhurst NW, 2010, J FISH BIOL, V76, P69, DOI 10.1111/j.1095-8649.2009.02484.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pottgiesser T, 2004, HDB LIMNOLOGIE, V19, p[; Rahel FJ, 2008, CONSERV BIOL, V22, P551, DOI 10.1111/j.1523-1739.2008.00953.x; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; TURC L., 1961, Annales Agronomiques, V12, P13; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wang LZ, 2006, AM FISH S S, V48, P1; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	47	40	40	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40530	10.1371/journal.pone.0040530	http://dx.doi.org/10.1371/journal.pone.0040530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792361	Green Published, Green Submitted, gold			2022-12-27	WOS:000306461800102
J	Seo, M; Oh, S				Seo, Minseok; Oh, Sejong			CBFS: High Performance Feature Selection Algorithm Based on Feature Clearness	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; CANCER; CLASSIFICATION	Background: The goal of feature selection is to select useful features and simultaneously exclude garbage features from a given dataset for classification purposes. This is expected to bring reduction of processing time and improvement of classification accuracy. Methodology: In this study, we devised a new feature selection algorithm (CBFS) based on clearness of features. Feature clearness expresses separability among classes in a feature. Highly clear features contribute towards obtaining high classification accuracy. CScore is a measure to score clearness of each feature and is based on clustered samples to centroid of classes in a feature. We also suggest combining CBFS and other algorithms to improve classification accuracy. Conclusions/Significance: From the experiment we confirm that CBFS is more excellent than up-to-date feature selection algorithms including FeaLect. CBFS can be applied to microarray gene selection, text categorization, and image classification.	[Seo, Minseok] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; Dankook Univ, WCU Res Ctr Nanobiomed Sci, Cheonan, South Korea	Dankook University; Dankook University	Seo, M (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.	sejongoh@dankook.ac.kr			World Class University (WCU) project of the Ministry of Education, Science & Technology (MEST) [R31-2008-000-10069-0]; Korea Science and Engineering Foundation (KOSEF)	World Class University (WCU) project of the Ministry of Education, Science & Technology (MEST); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	This study was supported by grant No. R31-2008-000-10069-0 from the World Class University (WCU) project of the Ministry of Education, Science & Technology (MEST) and the Korea Science and Engineering Foundation (KOSEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengio Y, 2004, J MACH LEARN RES, V5, P1089; BERRAR D. P., 2009, PRACTICAL APPROACH M; Blake CL, 1998, UCI REPOSITORY MACHI; Chang C.C., 2005, LIBSVM LIB SUPPORT V; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Ding C., 2003, P IEEE COMP SOC C BI, V523; Fawcett T., 2004, ROC GRAPHS NOTES PRA; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GORMAN RP, 1988, NEURAL NETWORKS, V1, P75, DOI 10.1016/0893-6080(88)90023-8; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Guyon I, 2007, PATTERN RECOGN LETT, V28, P1438, DOI 10.1016/j.patrec.2007.02.014; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Kononenko I, 1995, CISM COURSES LECT, V363; Liang JN, 2008, PATTERN RECOGN, V41, P1429, DOI 10.1016/j.patcog.2007.10.018; Notterman DA, 2001, CANCER RES, V61, P3124; Oh S, 2011, COMPUT BIOL MED, V41, P115, DOI 10.1016/j.compbiomed.2010.12.006; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Wainwright MJ, 2009, IEEE T INFORM THEORY, V55, P2183, DOI 10.1109/TIT.2009.2016018; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Winarko E, DATA MINING; Zare H., 2010, FEALECT FEATURE SELE	23	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40419	10.1371/journal.pone.0040419	http://dx.doi.org/10.1371/journal.pone.0040419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792310	gold, Green Published, Green Submitted			2022-12-27	WOS:000306461800079
J	Yan, P; Zhu, XZ; Li, HM; Shrubsole, MJ; Shi, HM; Zhang, MZ; Harris, RC; Hao, CM; Dai, Q				Yan, Ping; Zhu, Xiangzhu; Li, Haiming; Shrubsole, Martha J.; Shi, Haiming; Zhang, Ming-zhi; Harris, Raymond C., Jr.; Hao, Chuan-Ming; Dai, Qi			Association of High Blood Pressure with Renal Insufficiency: Role of Albuminuria, from NHANES, 1999-2006	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM CREATININE; NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; POSITION STATEMENT; HYPERTENSION; PROGRESSION; PROTEINURIA; PREVALENCE; MORTALITY	Background: The relationship between hypertension and kidney disease is complicated. Clinical trials found intense blood pressure control was not associated with alterations in glomerular filtration rate (GFR) in all patients but did slow the rate of GFR decline among those with a higher baseline proteinuria. However, the underlying mechanism has been unclear. Methods: We tested the hypothesis that the association between high blood pressure and renal function is modified by albuminuria status by conducting analyses in a cross-sectional study with 12,440 adult participants without known kidney diseases, diabetes or cardiovascular diseases, participating in the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Results: 1226 out of 12440 were found to have unknown high blood pressure and 4494 were found to have reduced renal function. Overall, a moderate association was found between high blood pressure and renal function insufficiency in all participants analyzed. However, among participants with albuminuria, the prevalence of moderate-severe renal insufficiency substantially and progressively increased from normal subjects to prehypertensive and undiagnosed hypertensive subjects (1.43%, 3.44%, 10.96%, respectively, P for trend <0.0001); on the other hand, the prevalence of undiagnosed hypertension was also significantly higher among subjects with moderate-severe renal insufficiency than those with mild renal insufficiency (35.54% Vs 19.09%, P value <0.05), supporting an association between hypertension and renal function damage. In contrast, no association between hypertension and renal insufficiency was observed among those without albuminuria in this population. Similar findings were observed when the CKD-EPI equation was used. Conclusions: The association between high blood pressure and reduced renal function could be dependent upon the albuminuria status. This finding may provide a possible explanation for results observed in clinical trials of intensive blood pressure control. Further studies are warranted to confirm our findings.	[Yan, Ping; Shi, Haiming] Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China; [Li, Haiming; Hao, Chuan-Ming] Fudan Univ, Huashan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Yan, Ping; Zhu, Xiangzhu; Shrubsole, Martha J.; Dai, Qi] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Zhang, Ming-zhi; Harris, Raymond C., Jr.; Hao, Chuan-Ming] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN USA	Fudan University; Fudan University; Vanderbilt University; Vanderbilt University	Yan, P (corresponding author), Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China.	qi.dai@vanderbilt.edu	Shrubsole, Martha J/K-5052-2015; Zhu, Xiangzhu/ABB-5787-2021; Zhu, Xiao-Shan/B-2179-2015	Shrubsole, Martha J/0000-0002-5591-7575; Zhu, Xiangzhu/0000-0002-4462-8815; Zhu, Xiao-Shan/0000-0003-1223-1415	International Society of Nephrology; Vanderbilt Epidemiology Center	International Society of Nephrology; Vanderbilt Epidemiology Center	This work is partially supported by the International Fellowship Program of the International Society of Nephrology (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Drs. Qi Dai and Xiangzhu Zhu's effort was supported by the Vanderbilt Epidemiology Center's development fund. No additional external funding received for this study.	[Anonymous], 2004, AM J KIDNEY DIS, V43, pS14, DOI 10.1053/j/ajkd.2004.03.004; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Barri Yousri M, 2006, Curr Cardiol Rep, V8, P411, DOI 10.1007/s11886-006-0098-7; Bidani AK, 2011, NAT REV NEPHROL, V7, P128, DOI 10.1038/nrneph.2010.168; CHAVERS BM, 1984, KIDNEY INT, V25, P576, DOI 10.1038/ki.1984.57; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Di Angelantonio Emanuele, 2010, BMJ, V341, pc4986, DOI 10.1136/bmj.c4986; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Gansevoort RT, 2010, CURR OPIN NEPHROL HY, V19, P308, DOI 10.1097/MNH.0b013e328337bbbe; Hamm LL, 2010, AM J MED SCI, V340, P30, DOI 10.1097/MAJ.0b013e3181e590f0; Islam TM, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-17; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; Kalaitzidis RG, 2010, KIDNEY INT, V77, P194, DOI 10.1038/ki.2009.439; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; National Center for Health Statistics. Centers for Disease Control and Prevention, CTR DIS CONTR PREV N; National Health and Nutrition Examination Survey, 2003, PHYS EX PROC MAN; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Population Division US Census Bureau, 2007, NCEST200601 US BUR C; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Sabanayagam C, 2011, ASIA-PAC J PUBLIC HE, V23, P936, DOI 10.1177/1010539510361637; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Segura J, 2011, ADV CHRONIC KIDNEY D, V18, P23, DOI 10.1053/j.ackd.2010.11.001; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Udani S, 2011, NAT REV NEPHROL, V7, P11, DOI 10.1038/nrneph.2010.154; Upadhyay A, 2011, ANN INTERN MED, V154, P541, DOI 10.7326/0003-4819-154-8-201104190-00335; Wang TJ, 2007, HYPERTENSION, V49, P432, DOI 10.1161/01.HYP.0000256956.61872.aa; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; You L, 2011, ENVIRON HEALTH PERSP, V119, P527, DOI 10.1289/ehp.1002572	46	81	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e37837	10.1371/journal.pone.0037837	http://dx.doi.org/10.1371/journal.pone.0037837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	23029464	gold, Green Published, Green Submitted			2022-12-27	WOS:000306186900001
J	Borges, JC; Seraphim, TV; Mokry, DZ; Almeida, FCL; Cyr, DM; Ramos, CHI				Borges, Julio C.; Seraphim, Thiago V.; Mokry, David Z.; Almeida, Fabio C. L.; Cyr, Douglas M.; Ramos, Carlos H. I.			Identification of Regions Involved in Substrate Binding and Dimer Stabilization within the Central Domains of Yeast Hsp40 Sis1	PLOS ONE			English	Article							MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; DNAK CHAPERONE; HSP70; PROTEIN; YDJ1; ULTRACENTRIFUGATION; SPECTROSCOPY; AGGREGATION; SPECIFICITY	Protein folding, refolding and degradation are essential for cellular life and are regulated by protein homeostatic processes such those that involve the molecular chaperone DnaK/Hsp70 and its co-chaperone DnaJ. Hsp70 action is initiated when proteins from the DnaJ family bind an unfolded protein for delivery purposes. In eukaryotes, the DnaJ family can be divided into two main groups, Type I and Type II, represented by yeast cytosolic Ydj1 and Sis1, respectively. Although sharing some unique features both members of the DnaJ family, Ydj1 and Sis1 are structurally and functionally distinct as deemed by previous studies, including the observation that their central domains carry the structural and functional information even in switched chimeras. In this study, we combined several biophysical tools for evaluating the stability of Sis1 and mutants that had the central domains (named Gly/Met rich domain and C-terminal Domain I) deleted or switched to those of Ydj1 to gain insight into the role of these regions in the structure and function of Sis1. The mutants retained some functions similar to full length wild-type Sis1, however they were defective in others. We found that: 1) Sis1 unfolds in at least two steps as follows: folded dimer to partially folded monomer and then to an unfolded monomer. 2) The Gly/Met rich domain had intrinsically disordered characteristics and its deletion had no effect on the conformational stability of the protein. 3) The deletion of the C-terminal Domain I perturbed the stability of the dimer. 4) Exchanging the central domains perturbed the conformational stability of the protein. Altogether, our results suggest the existence of two similar subdomains in the C-terminal domain of DnaJ that could be important for stabilizing each other in order to maintain a folded substrate-binding site as well as the dimeric state of the protein.	[Seraphim, Thiago V.; Mokry, David Z.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil; [Borges, Julio C.; Seraphim, Thiago V.] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil; [Seraphim, Thiago V.] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil; [Almeida, Fabio C. L.] Natl Ctr Nucl Magnet Resonance Macromol UFRJ, Inst Med Biochem, Rio De Janeiro, Brazil; [Almeida, Fabio C. L.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Cyr, Douglas M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of North Carolina; University of North Carolina Chapel Hill	Ramos, CHI (corresponding author), Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil.	cramos@iqm.unicamp.br	Ramos, CH/C-1571-2012; Almeida, Fabio/O-4989-2018; Borges, Julio C/C-6160-2008; Seraphim, Thiago V/J-9949-2013; Portes Santos, Claudia/D-5093-2009	Ramos, CH/0000-0002-7246-9081; Almeida, Fabio/0000-0001-6046-7006; Borges, Julio C/0000-0003-4856-748X; Santos, Helena/0000-0002-5240-5662; Monteiro-Neto, Cassiano/0000-0001-9342-8089; Cyr, Douglas/0000-0002-4928-3414; Vargas Seraphim, Thiago/0000-0002-8682-8962; Portes Santos, Claudia/0000-0001-5165-0853	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981, R01GM067785] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the agencies that funded this work through grants, namely, the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - www.fapesp.br) and Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq - www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges JC, 2011, CURR MED CHEM, V18, P1276; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; da Silva KP, 2011, PROTEIN PEPTIDE LETT, V18, P132; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Ramos CHI, 2005, PROTEIN PEPTIDE LETT, V12, P213, DOI 10.2174/0929866053587156; Ramos CHI, 1999, BIOCHEMISTRY-US, V38, P9783, DOI 10.1021/bi9828627; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40; Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]	31	41	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50927	10.1371/journal.pone.0050927	http://dx.doi.org/10.1371/journal.pone.0050927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	22792329	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200082
J	Sim, SC; Durstewitz, G; Plieske, J; Wieseke, R; Ganal, MW; Van Deynze, A; Hamilton, JP; Buell, CR; Causse, M; Wijeratne, S; Francis, DM				Sim, Sung-Chur; Durstewitz, Gregor; Plieske, Joerg; Wieseke, Ralf; Ganal, Martin W.; Van Deynze, Allen; Hamilton, John P.; Buell, C. Robin; Causse, Mathilde; Wijeratne, Saranga; Francis, David M.			Development of a Large SNP Genotyping Array and Generation of High-Density Genetic Maps in Tomato	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; LYCOPERSICON-PENNELLII; DISEASE RESISTANCE; CULTIVATED TOMATO; GENOMIC SELECTION; LINKAGE MAPS; DISCOVERY; MARKERS; POLYMORPHISM; LOCI	The concurrent development of high-throughput genotyping platforms and next generation sequencing (NGS) has increased the number and density of genetic markers, the efficiency of constructing detailed linkage maps, and our ability to overlay recombination and physical maps of the genome. We developed an array for tomato with 8,784 Single Nucleotide Polymorphisms (SNPs) mainly discovered based on NGS-derived transcriptome sequences. Of the SNPs, 7,720 (88%) passed manufacturing quality control and could be scored in tomato germplasm. The array was used to generate high-density linkage maps for three interspecific F-2 populations: EXPEN 2000 (Solanum lycopersicum LA0925 x S. pennellii LA0716, 79 individuals), EXPEN 2012 (S. lycopersicum Moneymaker x S. pennellii LA0716, 160 individuals), and EXPIM 2012 (S. lycopersicum Moneymaker x S. pimpinellifolium LA0121, 183 individuals). The EXPEN 2000-SNP and EXPEN 2012 maps consisted of 3,503 and 3,687 markers representing 1,076 and 1,229 unique map positions (genetic bins), respectively. The EXPEN 2000-SNP map had an average marker bin interval of 1.6 cM, while the EXPEN 2012 map had an average bin interval of 0.9 cM. The EXPIM 2012 map was constructed with 4,491 markers (1,358 bins) and an average bin interval of 0.8 cM. All three linkage maps revealed an uneven distribution of markers across the genome. The dense EXPEN 2012 and EXPIM 2012 maps showed high levels of colinearity across all 12 chromosomes, and also revealed evidence of small inversions between LA0716 and LA0121. Physical positions of 7,666 SNPs were identified relative to the tomato genome sequence. The genetic and physical positions were mostly consistent. Exceptions were observed for chromosomes 3, 10 and 12. Comparing genetic positions relative to physical positions revealed that genomic regions with high recombination rates were consistent with the known distribution of euchromatin across the 12 chromosomes, while very low recombination rates were observed in the heterochromatic regions.	[Sim, Sung-Chur; Francis, David M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Durstewitz, Gregor; Plieske, Joerg; Wieseke, Ralf; Ganal, Martin W.] TraitGenet GmbH, Gatersleben, Germany; [Van Deynze, Allen] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Causse, Mathilde] INRA, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France; [Wijeratne, Saranga] Ohio State Univ, Ohio Agr Res & Dev Ctr, Mol Cellular & Imagining Ctr, Wooster, OH 44691 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; Michigan State University; INRAE; University System of Ohio; Ohio State University	Sim, SC (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	francis.77@osu.edu	Panthee, Dilip/AAH-2974-2022; Francis, David/B-7262-2012; Panthee, Dilip/CAF-8991-2022; Wijeratne, Saranga/I-5341-2016; Causse, Mathilde/AAF-6555-2020; Panthee, Dilip/AFM-0574-2022; Hamilton, John P/G-1379-2016	Panthee, Dilip/0000-0002-8736-512X; Wijeratne, Saranga/0000-0002-9782-4406; Panthee, Dilip/0000-0002-8736-512X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Sim, Sung-Chur/0000-0001-7672-6260; Stoffel, Karl/0000-0003-4431-3626; Francis, David/0000-0003-2016-1357	United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA) [2008-55300-04757, 2009-85606-05673]; German Federal Ministry of Education and Research (BMBF) [0315639A]; Agropolis Fondation; French foundation for Agricultural Sciences and Sustainable Development	United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA)(United States Department of Agriculture (USDA)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Agropolis Fondation; French foundation for Agricultural Sciences and Sustainable Development	This work was supported by a grant from the United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA) (2008-55300-04757 and 2009-85606-05673). Work at TraitGenetics was supported by the German Federal Ministry of Education and Research (BMBF) through grant number 0315639A. INRA SNPs were obtained from the INRA AIP Bioresources and from the ARCAD sub-project "Comparative population genomics''. ARCAD (Agropolis Resource Center for Crop Conservation, Adaptation and Diversity) is funded (2009-2013) by the Agropolis Fondation, the French foundation for Agricultural Sciences and Sustainable Development (www.arcad-project.org and www.agropolis-fondation.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2010, CYTOGENET GENOME RES, V129, P24, DOI 10.1159/000313850; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bundock PC, 2009, PLANT BIOTECHNOL J, V7, P347, DOI 10.1111/j.1467-7652.2009.00401.x; CHETELAT RT, 1991, THEOR APPL GENET, V82, P704, DOI 10.1007/BF00227314; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; ESHED Y, 1995, GENETICS, V141, P1147; Frary A, 2005, THEOR APPL GENET, V111, P291, DOI 10.1007/s00122-005-2023-7; Frary A, 1996, MOL GEN GENET, V250, P295, DOI 10.1007/BF02174387; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Heffner EL, 2011, CROP SCI, V51, P2597, DOI 10.2135/cropsci2011.05.0253; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kabelka E, 2002, PHYTOPATHOLOGY, V92, P504, DOI 10.1094/PHYTO.2002.92.5.504; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Meuwissen THE, 2001, GENETICS, V157, P1819; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHERMAN JD, 1992, GENOME, V35, P354, DOI 10.1139/g92-054; Shirasawa K, 2010, DNA RES, V17, P381, DOI 10.1093/dnares/dsq024; Sim SC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-466; Stack SM, 2009, CYTOGENET GENOME RES, V124, P339, DOI 10.1159/000218137; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; TANKSLEY SD, 1992, GENETICS, V132, P1141; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; van der Knaap E, 2004, GENETICS, V168, P2127, DOI 10.1534/genetics.104.031013; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y	48	272	283	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40563	10.1371/journal.pone.0040563	http://dx.doi.org/10.1371/journal.pone.0040563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802968	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500057
J	Villani, A; Frigessi, A; Liljeros, F; Nordvik, MK; de Blasio, BF				Villani, Antonella; Frigessi, Arnoldo; Liljeros, Fredrik; Nordvik, Monica K.; de Blasio, Birgitte Freiesleben			A Characterization of Internet Dating Network Structures among Nordic Men Who Have Sex with Men	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; PARTNERS; ONLINE; RISK; PREFERENCES	Background: The Internet has become an important venue for seeking sexual partners and may facilitate transmission of sexually transmitted infections. Methods: We examined a 64-day data log of flirt messages expressing sexual interest among MSM within the Qruiser. com community. We used logistic regression to analyze characteristics of MSM sending and receiving flirt messages and negative binomial regression to examine individual activity and popularity. The structural properties, including the core structure of the flirt network, were analyzed. Results: The MSM population consisted of approximately 40% homosexuals and 37% bisexuals, while the remaining 23% included men who identified as heterosexual but searched for sex with men and "experimental". MSM were more likely to send flirt messages if they were homosexual and aged 40+ years; young people aged, 30 years were more likely to receive a flirt. Possession of a webcam was strongly associated with both sending flirt messages and being a flirt target. The distributions of flirts sent (max k(out) = 2162) and received (max k(in) = 84) were highly heterogeneous. Members in central cores were more likely homosexuals, singles, and aged 31-40 years. The probability of a matched flirt (flirt returned from target) increased from 1% in the outer core to 18% in the central core (core size = 4). Discussion: The flirt network showed high degree heterogeneity similar to the structural properties of real sexual contact networks with a single central core. Further studies are needed to explore use of webcam for Internet dating.	[Villani, Antonella] Univ Aquila, Dept Math, I-67100 Laquila, Italy; [Frigessi, Arnoldo; de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Liljeros, Fredrik; Nordvik, Monica K.] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Liljeros, Fredrik] Inst Future Studies, Stockholm, Sweden; [Nordvik, Monica K.] Mid Sweden Univ, Dept Social Work, Ostersund, Sweden; [de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway	University of L'Aquila; University of Oslo; Stockholm University; Institute for Futures Studies; Mid-Sweden University; Norwegian Institute of Public Health (NIPH)	Villani, A (corresponding author), Univ Aquila, Dept Math, I-67100 Laquila, Italy.	birgitte.deblasio@basalmed.uio.no	Liljeros, Fredrik G I/I-2667-2018	Liljeros, Fredrik G I/0000-0001-8642-6624; Frigessi, Arnoldo/0000-0001-7103-7589; Norkko, Joanna/0000-0001-9885-8408; Villnas, Anna/0000-0003-3077-929X	Norwegian Research Council [166056/V50]; Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	Norwegian Research Council(Research Council of NorwayEuropean Commission); Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	Birgitte Freiesleben de Blasio was supported by the Norwegian Research Council (Projects 166056/V50). Fredrik Liljeros was supported by Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no external funding sources for this study.	Al-Tayyib AA, 2009, SEX TRANSM INFECT, V85, P216, DOI 10.1136/sti.2008.032631; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Bull SS, 2000, SEX TRANSM DIS, V27, P545, DOI 10.1097/00007435-200010000-00008; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Daneback K, 2005, ARCH SEX BEHAV, V34, P321, DOI 10.1007/s10508-005-3120-z; Daneback K, 2007, CYBERPSYCHOL BEHAV, V10, P100, DOI 10.1089/cpb.2006.9986; de Nooy W, 2005, EXPLORATIVE SOCIAL N; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Fiore ART, 2004, THESIS MIT; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Gobrogge KL, 2007, ARCH SEX BEHAV, V36, P717, DOI 10.1007/s10508-007-9216-x; Kim AA, 2001, J ACQ IMMUN DEF SYND, V28, P89; Klausner JD, 2000, JAMA-J AM MED ASSOC, V284, P447, DOI 10.1001/jama.284.4.447; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mustanski BS, 2007, AIDS CARE, V19, P822, DOI 10.1080/09540120701237244; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ross MW, 2005, CYBERPSYCHOL BEHAV, V8, P131, DOI 10.1089/cpb.2005.8.131; Sautter JM, 2010, SOC SCI QUART, V91, P554, DOI 10.1111/j.1540-6237.2010.00707.x; Silverthorne ZA, 2000, ARCH SEX BEHAV, V29, P67, DOI 10.1023/A:1001886521449; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295	22	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39717	10.1371/journal.pone.0039717	http://dx.doi.org/10.1371/journal.pone.0039717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22808052	Green Submitted, Green Published, gold			2022-12-27	WOS:000306406700011
J	Lee, MS; Jung, JI; Kwon, SH; Lee, SM; Morita, K; Her, S				Lee, Mi-Sook; Jung, Jae-In; Kwon, Seung-Hae; Lee, Sang-Mok; Morita, Kyoji; Her, Song			TIMP-2 Fusion Protein with Human Serum Albumin Potentiates Anti-Angiogenesis-Mediated Inhibition of Tumor Growth by Suppressing MMP-2 Expression	PLOS ONE			English	Article							TISSUE INHIBITOR; IN-VIVO; MATRIX-METALLOPROTEINASE; CELL-PROLIFERATION; ESCHERICHIA-COLI; DOWN-REGULATION; APOPTOSIS; ACTIVATION; CANCER; THERAPY	TIMP-2 protein has been intensively studied as a promising anticancer candidate agent, but the in vivo mechanism underlying its anticancer effect has not been clearly elucidated by previous works. In this study, we investigated the mechanism underlying the anti-tumor effects of a TIMP-2 fusion protein conjugated with human serum albumin (HSA/TIMP-2). Systemic administration of HSA/TIMP-2 effectively inhibited tumor growth at a minimum effective dose of 60 mg/kg. The suppressive effect of HSA/TIMP-2 was accompanied by a marked reduction of in vivo vascularization. The anti-angiogenic activity of HSA/TIMP-2 was directly confirmed by CAM assays. In HSA/TIMP-2-treated tumor tissues, MMP-2 expression was profoundly decreased without a change in MT1-MMP expression of PECAM-1-positive cells. MMP-2 mRNA was also decreased by HSA/TIMP-2 treatment of human umbilical vein endothelial cells. Zymographic analysis showed that HSA/TIMP-2 substantially decreased extracellular pro-MMP-2 activity (94-99% reduction) and moderately decreased active MMP-2 activity (10-24% reduction), suggesting MT1-MMP-independent MMP-2 modulation. Furthermore, HSA/TIMP-2 had no effect on in vitro active MMP-2 activity and in vivo MMP-2 activity. These studies show that HSA/TIMP-2 potentiates anti-angiogenic activity by modulating MMP-2 expression, but not MMP-2 activity, to subsequently suppress tumor growth, suggesting an important role for MMP-2 expression rather than MMP-2 activity in anti-angiogenesis.	[Lee, Mi-Sook; Jung, Jae-In; Kwon, Seung-Hae; Her, Song] Korea Basic Sci Inst, Chuncheon Ctr, Div Bioimaging, Chunchon, South Korea; [Lee, Sang-Mok] BiocurePharm, Daejeon Bio Venture Town, Taejon, South Korea; [Morita, Kyoji] Shikoku Univ, Sch Hlth Sci, Dept Nursing, Neuropharmacol Lab, Tokushima, Japan	Korea Basic Science Institute (KBSI)	Lee, MS (corresponding author), Kyung Hee Univ, Coll Oriental Med, Dept Basic Oriental Med Sci, Seoul, South Korea.	swher@kbsi.re.kr		CORBETTA, MAURIZIO/0000-0001-8295-3304	Korea Basic Science Institute grant [T31901]	Korea Basic Science Institute grant	This study was supported by a Korea Basic Science Institute grant (T31901) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JS, 1992, J CLIN PATHOL, V45, P1116, DOI 10.1136/jcp.45.12.1116; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fassina G, 2000, CLIN EXP METASTAS, V18, P111, DOI 10.1023/A:1006797522521; Fernandez CA, 2010, J BIOL CHEM, V285, P41886, DOI 10.1074/jbc.M110.166439; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Hajitou A, 2001, CANCER RES, V61, P3450; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Imren S, 1996, CANCER RES, V56, P2891; Itoh T, 1998, CANCER RES, V58, P1048; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kang WK, 2007, PROTEIN EXPRES PURIF, V53, P331, DOI 10.1016/j.pep.2007.02.001; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kwon GT, 2011, J NUTR BIOCH; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee Mi-Sook, 2010, [Journal of Life Science, 생명과학회지], V20, P1738; Lee MS, 2011, J PHARM PHARM SCI, V14, P368, DOI 10.18433/J3H88D; Lee MS, 2010, BIOCHEM BIOPH RES CO, V394, P348, DOI 10.1016/j.bbrc.2010.03.009; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Li H, 2001, HUM GENE THER, V12, P515, DOI 10.1089/104303401300042429; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Morita K, 2009, J MOL NEUROSCI, V38, P31, DOI 10.1007/s12031-008-9156-5; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; NEGRO A, 1995, FEBS LETT, V360, P52, DOI 10.1016/0014-5793(95)00073-I; Nishida Y, 2008, CANCER RES, V68, P9096, DOI 10.1158/0008-5472.CAN-08-2522; Park JY, 2009, ANAL BIOCHEM, V394, P217, DOI 10.1016/j.ab.2009.07.040; Preaux AM, 2002, HEPATOLOGY, V36, P615, DOI 10.1053/jhep.2002.35279; Rho SB, 2007, J CELL BIOCHEM, V101, P57, DOI 10.1002/jcb.21127; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shapiro S, 2010, AM J PHYSIOL-CELL PH, V298, pC942, DOI 10.1152/ajpcell.00305.2009; Steinbrenner H, 2003, BIOCHEM BIOPH RES CO, V308, P486, DOI 10.1016/S0006-291X(03)01430-X; STETLERSTEVENSON WG, 1990, J BIOL CHEM, V265, P13933; Storgard Chris, 2004, V294, P123; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Sun Jun, 2009, J Mol Signal, V4, P4, DOI 10.1186/1750-2187-4-4; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617; VAUPEL P, 1989, CANCER RES, V49, P6449; Williamson RA, 2000, METH MOL B, V151, P257, DOI 10.1385/1-59259-046-2:257; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yi Y, 2005, CURR GENE THER, V5, P25, DOI 10.2174/1566523052997514	57	152	154	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35710	10.1371/journal.pone.0035710	http://dx.doi.org/10.1371/journal.pone.0035710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22792291	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200051
J	Li, ZH; Lu, CX; Peng, B; Zeng, H; Zhou, ZG; Wu, YM; Zhong, GM				Li, Zhihong; Lu, Chunxue; Peng, Bo; Zeng, Hao; Zhou, Zhiguan; Wu, Yimou; Zhong, Guangming			Induction of Protective Immunity against Chlamydia muridarum Intravaginal Infection with a Chlamydial Glycogen Phosphorylase	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CLASS-II COMPLEXES; TRACHOMATIS INFECTION; ACQUIRED-IMMUNITY; VACCINATION; INHIBITION; CELLS; MICE; IMMUNIZATION; HYDROSALPINX	We evaluated 7 C. muridarum ORFs for their ability to induce protection against chlamydial infection in a mouse intravaginal infection model. These antigens, although encoded in C. muridarum genome, are transcriptionally regulated by a cryptic plasmid that is known to contribute to C. muridarum pathogenesis. Of the 7 plasmid-regulated ORFs, the chlamydial glycogen phosphorylase or GlgP, when delivered into mice intramuscularly, induced the most pronounced protective immunity against C. muridarum intravaginal infection. The GlgP-immunized mice displayed a significant reduction in vaginal shedding of live organisms on day 14 after infection. The protection correlated well with a robust C. muridarum-specific antibody and a Th1-dominant T cell responses, which significantly reduced the severity but not overall incidence of hydrosalpinx. The GlgP-induced partial protection against upper genital tract pathology suggests that GlgP may be considered a component for a multi-subunit vaccine. These results have demonstrated that intramuscular immunization of mice with purified proteins can be used to identify vaccine antigens for preventing intravaginal infection with C. trachomatis in humans.	[Li, Zhihong; Lu, Chunxue; Peng, Bo; Zeng, Hao; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Li, Zhihong; Zhou, Zhiguan] Cent S Univ, Xiangya Hosp 2, Dept Surg, Changsha, Hunan, Peoples R China; [Lu, Chunxue; Peng, Bo; Wu, Yimou] Univ S China, Dept Pathol & Microbiol, Hengyang, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; Central South University; University of South China	Li, ZH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@uthscsa.edu			National Institutes of Health [R01AI64537]; Merck-UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck-UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number R01AI64537 and a Merck-UT sponsorship (2009-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; [Centers for Disease Control and Prevention C Services USDoHaH], 2009, SEX TRANSM DIS SURV; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; EISSENBERG LG, 1981, INFECT IMMUN, V32, P889, DOI 10.1128/IAI.32.2.889-896.1981; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; GRAYSTON JT, 1962, ANN NY ACAD SCI, V98, P352, DOI 10.1111/j.1749-6632.1962.tb30558.x; Greene W, 2004, INFECT IMMUN, V72, P451, DOI 10.1128/IAI.72.1.451-460.2004; Johnson N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002125.pub3; Karunakaran KP, 2008, J IMMUNOL, V180, P2459, DOI 10.4049/jimmunol.180.4.2459; Kinnunen AH, 2002, HUM REPROD, V17, P2073, DOI 10.1093/humrep/17.8.2073; Lei L, 2011, MICROB PATHOGENESIS, V51, P101, DOI 10.1016/j.micpath.2011.05.002; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Olivares-Zavaleta N, 2010, VACCINE, V28, P1454, DOI 10.1016/j.vaccine.2009.11.073; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Pal S, 2002, INFECT IMMUN, V70, P4812, DOI 10.1128/IAI.70.9.4812-4817.2002; Pal S, 1999, VACCINE, V17, P459, DOI 10.1016/S0264-410X(98)00219-9; Peterman TA, 2006, ANN INTERN MED, V145, P564, DOI 10.7326/0003-4819-145-8-200610170-00005; Qi ML, 2011, J BACTERIOL, V193, P2498, DOI 10.1128/JB.01301-10; Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98; Rodgers AK, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.005; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; SHERMAN KJ, 1990, SEX TRANSM DIS, V17, P115, DOI 10.1097/00007435-199007000-00001; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Strandell A, 2000, HUM REPROD UPDATE, V6, P387, DOI 10.1093/humupd/6.4.387; Strandell A, 1999, HUM REPROD, V14, P2762, DOI 10.1093/humrep/14.11.2762; Strandell A, 2004, J ASSIST REPROD GEN, V21, P241, DOI 10.1023/B:JARG.0000042009.93520.15; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Wang J, 2009, VACCINE, V27, P2967, DOI 10.1016/j.vaccine.2009.02.095; Xiao YM, 2005, J IMMUNOL, V174, P1701, DOI 10.4049/jimmunol.174.3.1701; Zhong G, 2011, CURR CHEM BIOL, V5, P9; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2009, TRENDS MICROBIOL, V17, P467, DOI 10.1016/j.tim.2009.07.007	41	133	150	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32997	10.1371/journal.pone.0032997	http://dx.doi.org/10.1371/journal.pone.0032997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22792223	Green Submitted, Green Published, gold			2022-12-27	WOS:000302381500072
J	Peng, XJ; Zhao, Y; Cao, JG; Zhang, W; Jiang, HY; Li, XY; Ma, Q; Zhu, SW; Cheng, BJ				Peng, Xiaojian; Zhao, Yang; Cao, Jiangang; Zhang, Wei; Jiang, Haiyang; Li, Xiaoyu; Ma, Qing; Zhu, Suwen; Cheng, Beijiu			CCCH-Type Zinc Finger Family in Maize: Genome-Wide Identification, Classification and Expression Profiling under Abscisic Acid and Drought Treatments	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA-BINDING PROTEINS; ANKYRIN REPEAT; MESSENGER-RNA; STRESS RESPONSES; GENE FAMILIES; ARABIDOPSIS; TOLERANCE; ELEMENTS; TRISTETRAPROLIN	Background: CCCH-type zinc finger proteins comprise a large protein family. Increasing evidence suggests that members of this family are RNA-binding proteins with regulatory functions in mRNA processing. Compared with those in animals, functions of CCCH-type zinc finger proteins involved in plant growth and development are poorly understood. Methodology/Principal Findings: Here, we performed a genome-wide survey of CCCH-type zinc finger genes in maize (Zea mays L.) by describing the gene structure, phylogenetic relationships and chromosomal location of each family member. Promoter sequences and expression profiles of putative stress-responsive members were also investigated. A total of 68 CCCH genes (ZmC3H1-68) were identified in maize and divided into seven groups by phylogenetic analysis. These 68 genes were found to be unevenly distributed on 10 chromosomes with 15 segmental duplication events, suggesting that segmental duplication played a major role in expansion of the maize CCCH family. The Ka/Ks ratios suggested that the duplicated genes of the CCCH family mainly experienced purifying selection with limited functional divergence after duplication events. Twelve maize CCCH genes grouped with other known stress-responsive genes from Arabidopsis were found to contain putative stress-responsive cis-elements in their promoter regions. Seven of these genes chosen for further quantitative real-time PCR analysis showed differential expression patterns among five representative maize tissues and over time in response to abscisic acid and drought treatments. Conclusions: The results presented in this study provide basic information on maize CCCH proteins and form the foundation for future functional studies of these proteins, especially for those members of which may play important roles in response to abiotic stresses.	[Peng, Xiaojian; Zhao, Yang; Cao, Jiangang; Zhang, Wei; Jiang, Haiyang; Li, Xiaoyu; Ma, Qing; Zhu, Suwen; Cheng, Beijiu] Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China	Anhui Agricultural University	Peng, XJ (corresponding author), Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China.	bjchengahau@163.com			National Natural Science Foundation of China [31071423, 11075001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Natural Science Foundation of China (No. 31071423 and 11075001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Bai CY, 1996, MOL CELL BIOL, V16, P6661; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kosarev P, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-4-research0016; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li ZS, 1998, PLANT CELL, V10, P383, DOI 10.1105/tpc.10.3.383; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; PLA M, 1993, PLANT MOL BIOL, V21, P259, DOI 10.1007/BF00019942; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Seong ES, 2007, J BIOCHEM MOL BIOL, V40, P952; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	55	133	150	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40120	10.1371/journal.pone.0040120	http://dx.doi.org/10.1371/journal.pone.0040120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792223	Green Submitted, Green Published, gold			2022-12-27	WOS:000306461800041
J	Xu, JY; Qi, X; Gong, JF; Yu, MY; Zhang, FX; Sha, HB; Gao, X				Xu, Jingyue; Qi, Xin; Gong, Jianfeng; Yu, Mingyan; Zhang, Fangxiong; Sha, Haibo; Gao, Xiang			Fstl1 Antagonizes BMP Signaling and Regulates Ureter Development	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; URINARY-TRACT DEVELOPMENT; SONIC-HEDGEHOG; CONGENITAL-ANOMALIES; MOUSE URETER; BRANCHING MORPHOGENESIS; PERISTALTIC MACHINERY; VESICOURETERAL REFLUX; KIDNEY DEVELOPMENT; EXPRESSION	Bone morphogenetic protein (BMP) signaling pathway plays important roles in urinary tract development although the detailed regulation of its activity in this process remains unclear. Here we report that follistatiri-like 1 (Fstl1), encoding a secreted extracellular glycoprotein, is expressed in developing ureter and antagonizes BMP signaling activity. Mouse embryos carrying disrupted Fstl1 gene displayed prominent hydroureter arising from proximal segment and tireterovesical junction defects. These defects were associated with significant reduction in ureteric epithelial cell proliferation at E15.5 and E16.5 as well as absence of subepithelial ureteral mesenchymal cells in the urinary tract at E16.5 and E18.5. At the molecular level, increased BMP signaling was found in Fstl1 deficient ureters, indicated by elevated pSmad1/5/8 activity. in vitro study also indicated that Fstl1 can directly bind to ALK6 which is specifically expressed in ureteric epithelial cells in developing ureter. Furthermore, Sonic hedgehog (SHH) signaling, which is crucial for differentiation of ureteral subepithelial cell proliferation, was also impaired in Fstl1(-/-) ureter. Altogether, our data suggest that Fstl1 is essential in maintaining normal ureter development by antagonizing BMP signaling.	[Xu, Jingyue; Qi, Xin; Gong, Jianfeng; Yu, Mingyan; Sha, Haibo; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China; [Zhang, Fangxiong] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Life Sci, Shanghai, Peoples R China	Nanjing University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xu, JY (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China.	gaoxiang@nju.edu.cn			MOST (The Ministry of Science and Technology) [2011CB944104, 2011BAI15B02, 2011ZX09307-302-02]; NSFC (The National Science Foundation of China) [30825024]	MOST (The Ministry of Science and Technology); NSFC (The National Science Foundation of China)	This work is supported in part by grants from MOST (The Ministry of Science and Technology) (2011CB944104, 2011BAI15B02, 2011ZX09307-302-02) and NSFC (The National Science Foundation of China) (30825024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Bellusci S, 1996, DEVELOPMENT, V122, P1693; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; BOBER E, 1994, DEVELOPMENT, V120, P603; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Bush KT, 2006, DEV BIOL, V298, P571, DOI 10.1016/j.ydbio.2006.07.006; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chia I, 2011, DEVELOPMENT, V138, P2089, DOI 10.1242/dev.056838; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; Ding J, 2009, ENDOCRINOLOGY, V150, P2136, DOI 10.1210/en.2008-1006; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Hoshino T, 2008, GENES CELLS, V13, P159, DOI 10.1111/j.1365-2443.2007.01158.x; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Liem KF, 2000, DEVELOPMENT, V127, P4855; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Mendelsohn C, 2004, J CLIN INVEST, V113, P957, DOI 10.1172/JCI21402; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Mitchell EKL, 2006, GENE EXPR PATTERNS, V6, P519, DOI 10.1016/j.modgep.2005.10.008; Miyazaki Y, 1998, J CLIN INVEST, V102, P1489, DOI 10.1172/JCI4401; Miyazaki Y, 2003, PEDIATR INT, V45, P598, DOI 10.1046/j.1442-200X.2003.01777.x; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Monsoro-Burq AH, 2001, MOL CELL, V7, P789, DOI 10.1016/S1097-2765(01)00223-4; Murawski IJ, 2007, AM J PHYSIOL-RENAL, V293, pF1736, DOI 10.1152/ajprenal.00221.2007; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Okabayashi K, 1999, BIOCHEM BIOPH RES CO, V254, P42, DOI 10.1006/bbrc.1998.9892; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Schedl A, 2000, CURR OPIN GENET DEV, V10, P543, DOI 10.1016/S0959-437X(00)00125-8; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Towers P, 1999, DEV BIOL, V214, P298, DOI 10.1006/dbio.1999.9421; Uetani N, 2009, CLIN GENET, V75, P307, DOI 10.1111/j.1399-0004.2009.01175.x; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Umezu T, 2010, P NATL ACAD SCI USA, V107, P4601, DOI 10.1073/pnas.0909501107; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689	58	56	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32554	10.1371/journal.pone.0032554	http://dx.doi.org/10.1371/journal.pone.0032554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22808012	Green Submitted, Green Published, gold			2022-12-27	WOS:000304780500008
J	Sim, SC; Van Deynze, A; Stoffel, K; Douches, DS; Zarka, D; Ganal, MW; Chetelat, RT; Hutton, SF; Scott, JW; Gardner, RG; Panthee, DR; Mutschler, M; Myers, JR; Francis, DM				Sim, Sung-Chur; Van Deynze, Allen; Stoffel, Kevin; Douches, David S.; Zarka, Daniel; Ganal, Martin W.; Chetelat, Roger T.; Hutton, Samuel F.; Scott, John W.; Gardner, Randolph G.; Panthee, Dilip R.; Mutschler, Martha; Myers, James R.; Francis, David M.			High-Density SNP Genotyping of Tomato (Solanum lycopersicum L.) Reveals Patterns of Genetic Variation Due to Breeding	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM ANALYSIS; LATE BLIGHT RESISTANCE; SELF-PRUNING GENE; MAP-BASED CLONING; DISEASE RESISTANCE; CULTIVATED TOMATO; PHYTOPHTHORA-INFESTANS; BACTERIAL SPOT; COMPLEX TRAITS	The effects of selection on genome variation were investigated and visualized in tomato using a high-density single nucleotide polymorphism (SNP) array. 7,720 SNPs were genotyped on a collection of 426 tomato accessions (410 inbreds and 16 hybrids) and over 97% of the markers were polymorphic in the entire collection. Principal component analysis (PCA) and pairwise estimates of F-st supported that the inbred accessions represented seven sub-populations including processing, large-fruited fresh market, large-fruited vintage, cultivated cherry, landrace, wild cherry, and S. pimpinellifolium. Further divisions were found within both the contemporary processing and fresh market sub-populations. These sub-populations showed higher levels of genetic diversity relative to the vintage sub-population. The array provided a large number of polymorphic SNP markers across each sub-population, ranging from 3,159 in the vintage accessions to 6,234 in the cultivated cherry accessions. Visualization of minor allele frequency revealed regions of the genome that distinguished three representative sub-populations of cultivated tomato (processing, fresh market, and vintage), particularly on chromosomes 2, 4, 5, 6, and 11. The PCA loadings and F-st outlier analysis between these three sub-populations identified a large number of candidate loci under positive selection on chromosomes 4, 5, and 11. The extent of linkage disequilibrium (LD) was examined within each chromosome for these sub-populations. LD decay varied between chromosomes and sub-populations, with large differences reflective of breeding history. For example, on chromosome 11, decay occurred over 0.8 cM for processing accessions and over 19.7 cM for fresh market accessions. The observed SNP variation and LD decay suggest that different patterns of genetic variation in cultivated tomato are due to introgression from wild species and selection for market specialization.	[Sim, Sung-Chur; Francis, David M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Van Deynze, Allen; Stoffel, Kevin] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Douches, David S.; Zarka, Daniel] Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA; [Ganal, Martin W.] TraitGenet GmbH, Gatersleben, Germany; [Chetelat, Roger T.] Univ Calif Davis, CM Rick Tomato Genet Resource Ctr, Davis, CA 95616 USA; [Hutton, Samuel F.; Scott, John W.] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL USA; [Gardner, Randolph G.; Panthee, Dilip R.] N Carolina State Univ, Mt Hort Crops Res & Extens Ctr, Dept Hort Sci, Mills River, NC USA; [Mutschler, Martha] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Myers, James R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; Michigan State University; University of California System; University of California Davis; State University System of Florida; University of Florida; University of North Carolina; North Carolina State University; Cornell University; Oregon State University	Francis, DM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	francis.77@osu.edu	Panthee, Dilip/AAH-2974-2022; Francis, David/B-7262-2012; Panthee, Dilip/CAF-8991-2022; Wijeratne, Saranga/I-5341-2016; Causse, Mathilde/AAF-6555-2020; Panthee, Dilip/AFM-0574-2022; Hamilton, John P/G-1379-2016	Panthee, Dilip/0000-0002-8736-512X; Wijeratne, Saranga/0000-0002-9782-4406; Panthee, Dilip/0000-0002-8736-512X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Sim, Sung-Chur/0000-0001-7672-6260; Stoffel, Karl/0000-0003-4431-3626; Francis, David/0000-0003-2016-1357	United States Department of Agriculture/National Institute of Food and Agriculture [2008-55300-04757, 2009-85606-05673]; German Federal Ministry of Education and Research (BMBF) [0315639A]	United States Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the United States Department of Agriculture/National Institute of Food and Agriculture (2008-55300-04757 and 2009-85606-05673). Work at TraitGenetics was supported by the German Federal Ministry of Education and Research (BMBF) through grant number 0315639A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LJ, 1934, OHIO AGR EXP STA B, V539; [Anonymous], MICROSATELLITE ANAL; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Barry CS, 2008, PLANT PHYSIOL, V147, P179, DOI 10.1104/pp.108.118430; Bates D., 1988, NONLINEAR REGRESSION; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BERRY SZ, 1991, HORTSCIENCE, V26, P1093, DOI 10.21273/HORTSCI.26.8.1093; BOHN G. W., 1939, SCIENCE, V89, P603, DOI 10.1126/science.89.2322.603; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Budiman MA, 2004, THEOR APPL GENET, V108, P190, DOI 10.1007/s00122-003-1429-3; Carmel-Goren L, 2003, PLANT MOL BIOL, V52, P1215, DOI 10.1023/B:PLAN.0000004333.96451.11; Chunwongse J, 2002, J HORTIC SCI BIOTECH, V77, P281, DOI 10.1080/14620316.2002.11511493; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; ESHED Y, 1995, GENETICS, V141, P1147; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; GARDNER RG, 1992, HORTSCIENCE, V27, P1233, DOI 10.21273/HORTSCI.27.11.1233; George WL, 1983, TOMATO PRODUCTION PR, P48; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham E. B., 2004, REP TOMATO GENET COO, V54, P22; Graham TO, 1959, TOM GEN COOP REP, V9, P37; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hemming MN, 2004, THEOR APPL GENET, V109, P409, DOI 10.1007/s00122-004-1646-4; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jimenez-Gomez JM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-85; Jones CM, 2007, AM J BOT, V94, P935, DOI 10.3732/ajb.94.6.935; Kabelka E, 2002, PHYTOPATHOLOGY, V92, P504, DOI 10.1094/PHYTO.2002.92.5.504; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kim MJ, 2005, J AM SOC HORTIC SCI, V130, P877, DOI 10.21273/JASHS.130.6.877; Labate JA, 2005, MOL BREEDING, V16, P343, DOI 10.1007/s11032-005-1911-5; Labate JA, 2010, HORTSCIENCE, V45, pS145; Labate JA, 2009, THEOR APPL GENET, V118, P1005, DOI 10.1007/s00122-008-0957-2; Lanfermeijer FC, 2003, PLANT MOL BIOL, V52, P1037, DOI 10.1023/A:1025434519282; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Merk HL, 2012, J AM SOC HORTIC SCI, V137, P427, DOI 10.21273/JASHS.137.6.427; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Moreau P, 1998, MOL PLANT MICROBE IN, V11, P259, DOI 10.1094/MPMI.1998.11.4.259; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; NEI M, 1974, GENETICS, V76, P379; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Park YH, 2004, GENOME, V47, P510, DOI 10.1139/G04-004; Pei CC, 2012, THEOR APPL GENET, V124, P533, DOI 10.1007/s00122-011-1726-1; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2016, R FDN STAT COMP; Ranc N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-130; RASMUSSEN W. D., 1968, Technology Cult., Chicago., V9, P531, DOI 10.2307/3101894; RAY J, 1992, PLANT MOL BIOL, V19, P401, DOI 10.1007/BF00023387; Rick C. M., 1976, Evolution of crop plants., P268; RICK CHARLES M., 1958, ECON BOT, V12, P346, DOI 10.1007/BF02860023; RICK CM, 1977, PLANT SYST EVOL, V127, P139, DOI 10.1007/BF00984147; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Robbins MD, 2010, HORTSCIENCE, V45, P1424, DOI 10.21273/HORTSCI.45.10.1424; Robbins MD, 2009, PHYTOPATHOLOGY, V99, P1037, DOI 10.1094/PHYTO-99-9-1037; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scott JW, 2008, HORTSCIENCE, V43, P2228, DOI 10.21273/HORTSCI.43.7.2228; Scott JW, 2004, J AM SOC HORTIC SCI, V129, P394, DOI 10.21273/JASHS.129.3.0394; Sim SC, 2011, HEREDITY, V106, P927, DOI 10.1038/hdy.2010.139; Sim SC, 2011, DOWNSTREAM ANAL SNPS; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Sim SC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-466; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Spassova MI, 2001, MOL BREEDING, V7, P151, DOI 10.1023/A:1011363119763; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stevens MA., 1986, TOMATO CROP SCI BASI, P35; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; United States Department of Agriculture States Relations Service Office of Experiment Stations, 1919, EXP STAT REC, V39; van Berloo R, 2008, THEOR APPL GENET, V117, P89, DOI 10.1007/s00122-008-0755-x; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; WATTS VM, 1947, P AM SOC HORTIC SCI, V49, P233; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMS CE, 1993, GENOME, V36, P619, DOI 10.1139/g93-083; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yang WC, 2005, PHYTOPATHOLOGY, V95, P519, DOI 10.1094/PHYTO-95-0519; Yang WC, 2004, MOL BREEDING, V14, P21, DOI 10.1023/B:MOLB.0000037992.03731.a5; Yuan DJ, 2008, SCI HORTIC-AMSTERDAM, V118, P20, DOI 10.1016/j.scienta.2008.05.011; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	102	272	283	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45520	10.1371/journal.pone.0045520	http://dx.doi.org/10.1371/journal.pone.0045520			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	22802968	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900068
J	Choi, YH; Jit, M; Flasche, S; Gay, N; Miller, E				Choi, Yoon Hong; Jit, Mark; Flasche, Stefan; Gay, Nigel; Miller, Elizabeth			Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales	PLOS ONE			English	Article							CONJUGATE VACCINE; SEROTYPE REPLACEMENT; CARRIAGE; IMPACT	Introduction: England and Wales recently replaced the 7-valent pneumococcal conjugate vaccine (PCV7) with its 13-valent equivalent (PCV13), partly based on projections from mathematical models of the long-term impact of such a switch compared to ceasing pneumococcal conjugate vaccination altogether. Methods: A compartmental deterministic model was used to estimate parameters governing transmission of infection and competition between different groups of pneumococcal serotypes prior to the introduction of PCV13. The best-fitting parameters were used in an individual based model to describe pneumococcal transmission dynamics and effects of various options for the vaccination programme change in England and Wales. A number of scenarios were conducted using (i) different assumptions about the number of invasive pneumococcal disease cases adjusted for the increasing trend in disease incidence prior to PCV7 introduction in England and Wales, and (ii) a range of values representing serotype replacement induced by vaccination of the additional six serotypes in PCV13. Results: Most of the scenarios considered suggest that ceasing pneumococcal conjugate vaccine use would cause an increase in invasive pneumococcal disease incidence, while replacing PCV7 with PCV13 would cause an overall decrease. However, the size of this reduction largely depends on the level of competition induced by the additional serotypes in PCV13. The model estimates that over 20 years of PCV13 vaccination, around 5000-62000 IPD cases could be prevented compared to stopping pneumococcal conjugate vaccination altogether. Conclusion: Despite inevitable uncertainty around serotype replacement effects following introduction of PCV13, the model suggests a reduction in overall invasive pneumococcal disease incidence in all cases. Our results provide useful evidence on the benefits of PCV13 to countries replacing or considering replacing PCV7 with PCV13, as well as data that can be used to evaluate the cost-effectiveness of such a switch.	[Choi, Yoon Hong; Jit, Mark; Flasche, Stefan; Miller, Elizabeth] Hlth Protect Agcy, Hlth Protect Serv Colindale, London, England; [Jit, Mark] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Flasche, Stefan] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Gay, Nigel] Fu Consulting, Hungerford, Berks, England	Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; University of Strathclyde	Choi, YH (corresponding author), Hlth Protect Agcy, Hlth Protect Serv Colindale, London, England.	yoon.choi@hpa.org.uk	Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Miller, Jason/0000-0002-6912-2925; Jit, Mark/0000-0001-6658-8255; Flasche, Stefan/0000-0002-5808-2606; Choi, Yongwook/0000-0003-4017-9669; Chan, Agnes/0000-0003-2373-9580	NHGRI NIH HHS [5R01HG004701-03, R01 HG004701] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Boccalini S, 2011, VACCINE, V29, P9521, DOI 10.1016/j.vaccine.2011.10.013; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; De Wals P, 2009, CLIN THER, V31, P2152, DOI 10.1016/j.clinthera.2009.10.014; Flasche S, 2011, EUROSURVEILLANCE, V16, P13; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Robberstad B, 2011, VACCINE, V29, P8564, DOI 10.1016/j.vaccine.2011.09.025; Strutton DR, 2012, J INFECTION, V64, P54, DOI 10.1016/j.jinf.2011.10.015; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	16	749	773	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39927	10.1371/journal.pone.0039927	http://dx.doi.org/10.1371/journal.pone.0039927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	23056405	Green Published, gold, Green Accepted			2022-12-27	WOS:000306406700015
J	Wang, DH; Hu, JR; Wang, LY; Hu, YJ; Tan, FQ; Zhou, H; Shao, JZ; Yang, WX				Wang, Da-Hui; Hu, Jian-Rao; Wang, Li-Ya; Hu, Yan-Jun; Tan, Fu-Qing; Zhou, Hong; Shao, Jian-Zhong; Yang, Wan-Xi			The Apoptotic Function Analysis of p53, Apaf1, Caspase3 and Caspase7 during the Spermatogenesis of the Chinese Fire-Bellied Newt Cynops orientalis	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; CADMIUM-INDUCED APOPTOSIS; FOLLICLE-STIMULATING-HORMONE; GLUCOSE-METABOLISM; OXIDATIVE STRESS; STRUCTURAL BASIS; DNA-DAMAGE; SPERMATOGONIAL APOPTOSIS; TESTOSTERONE WITHDRAWAL; SIGNALING PATHWAY	Background: Spontaneous and stress-induced germ cell apoptosis during spermatogenesis of multicellular organisms have been investigated broadly in mammals. Spermatogenetic process in urodele amphibians was essentially like that in mammals in spite of morphological differences; however, the mechanism of germ cell apoptosis in urodele amphibians remains unknown. The Chinese fire-belly newt, Cynops orientalis, was an excellent organism for studying germ cell apoptosis due to its sensitiveness to temperature, strong endurance of starvation, and sensitive skin to heavy metal exposure. Methodology/Principal Findings: TUNEL result showed that spontaneous germ cell apoptosis took place in normal newt, and severe stress-induced apoptosis occurred to spermatids and sperm in response to heat shock (40 degrees C 2 h), cold exposure(4 degrees C 12 h), cadmium exposure(Cd 36 h), and starvation stress. Quantitative reverse transcription polymerase chain reactions (qRT-PCR) showed that gene expression of Caspase3 or Caspase7 was obviously elevated after stress treatment. Apaf1 was not altered at its gene expression level, and p53 was significantly decreased after various stress treatment. Caspase assay demonstrated that Caspase-3, -8,-9 enzyme activities in newt testis were significantly elevated after heat shock (40 degrees C 2 h), cold exposure(4 degrees C 12 h), and cadmium exposure(Cd 36 h), while Caspase3 and Caspase8 activities were increased with Caspase9 significantly decreased after starvation treatment. Conclusions/Significance: Severe germ cell apoptosis triggered by heat shock, cold exposure, and cadmium exposure was Caspase3 dependent, which probably involved both extrinsic and intrinsic pathways. Apaf1 may be involved in this process without elevating its gene expression. But starvation-induced germ cell apoptosis was likely mainly through extrinsic pathway. p53 was probably not responsible for stress-induced germ cell apoptosis in newt testis. The intriguing high occurrence of spermatid and sperm apoptosis probably resulted from the sperm morphology and unique reproduction policy of Chinese fire-belly newt, Cynops orientalis.	[Wang, Da-Hui; Zhou, Hong; Shao, Jian-Zhong; Yang, Wan-Xi] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Jian-Rao] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Li-Ya; Hu, Yan-Jun] Zhejiang Univ, Womens Hosp, Sch Med, Dept Reprod Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Tan, Fu-Qing] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University; Zhejiang University; Zhejiang University	Wang, DH (corresponding author), Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	wang, dahui/0000-0001-6435-5132; Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [31072198, 81100393]; National Basic Research Program of China (973 Program) [2012CB967902]; Zhejiang Provincial Natural Science Foundation of China [Y2100296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by the following projects: National Natural Science Foundation of China (No. 31072198 and 81100393), the National Basic Research Program of China (973 Program, Grant number: No. 2012CB967902), Zhejiang Provincial Natural Science Foundation of China (No. Y2100296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE SI, 1994, INT J DEV BIOL, V38, P201; ALLAN DJ, 1992, CELL PROLIFERAT, V25, P241, DOI 10.1111/j.1365-2184.1992.tb01399.x; Allemand I, 1999, ONCOGENE, V18, P6521, DOI 10.1038/sj.onc.1203052; Allsopp TE, 2000, CELL DEATH DIFFER, V7, P984, DOI 10.1038/sj.cdd.4400733; BAKALKIN G, 1994, P NATL ACAD SCI USA, V91, P413, DOI 10.1073/pnas.91.1.413; BARTKE A, 1995, ENDOCRINOLOGY, V136, P3, DOI 10.1210/en.136.1.3; Bernal-Manas CM, 2005, ACTA HISTOCHEM, V107, P365, DOI 10.1016/j.acthis.2005.07.002; Beumer TL, 1997, MOL REPROD DEV, V47, P240, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;240::AID-MRD2&gt;3.0.CO;2-L; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; BILLIG H, 1995, ENDOCRINOLOGY, V136, P5, DOI 10.1210/en.136.1.5; Blanco-Rodriguez J, 2003, REPRODUCTION, V126, P661, DOI 10.1530/reprod/126.5.661; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHOWDHURY AK, 1964, AM J ANAT, V115, P509, DOI 10.1002/aja.1001150307; Ciesielska AS, 2000, TOXICOLOGY, V145, P171; Coureui M, 2006, CELL DEATH DIFFER, V13, P1927, DOI 10.1038/sj.cdd.4401887; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Embree-Ku M, 2002, BIOL REPROD, V66, P1456, DOI 10.1095/biolreprod66.5.1456; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Furuchi T, 1996, DEVELOPMENT, V122, P1703; Glander HJ, 2002, ANDROLOGIA, V34, P227, DOI 10.1046/j.1439-0272.2002.00501.x; Gordo S, 2008, P NATL ACAD SCI USA, V105, P16426, DOI 10.1073/pnas.0805658105; Gosden R, 1997, BRIT MED BULL, V53, P644; Hall JL, 2001, DIABETES, V50, P1171, DOI 10.2337/diabetes.50.5.1171; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Hasegawa M, 1998, RADIAT RES, V149, P263, DOI 10.2307/3579959; Hassoun EA, 1996, TOXICOLOGY, V112, P219, DOI 10.1016/0300-483X(96)03404-X; HECKERT L, 1993, RECENT PROG HORM RES, V48, P61; HENRIKSEN K, 1995, ENDOCRINOLOGY, V136, P3285, DOI 10.1210/en.136.8.3285; HEW KW, 1993, TOXICOL APPL PHARM, V121, P15, DOI 10.1006/taap.1993.1123; Hikim APS, 1997, BIOL REPROD, V57, P1193, DOI 10.1095/biolreprod57.5.1193; Hikim APS, 1999, REV REPROD, V4, P38; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; HIKIM APS, 1995, ENDOCRINOLOGY, V136, P2770, DOI 10.1210/en.136.6.2770; Hikim APS, 1998, J CLIN ENDOCR METAB, V83, P152; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; HUCKINS C, 1978, ANAT REC, V190, P905, DOI 10.1002/ar.1091900410; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Ji YL, 2010, REPROD TOXICOL, V29, P176, DOI 10.1016/j.reprotox.2009.10.014; Ji Zai-Si, 1994, Zygote, V2, P53; Jimi S, 2004, ANN NY ACAD SCI, V1011, P325, DOI 10.1196/annals.1293.032; Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kilic M, 2002, CELL DEATH DIFFER, V9, P125, DOI 10.1038/sj/cdd/4400968; Kim J, 2009, TOXICOL LETT, V188, P45, DOI 10.1016/j.toxlet.2009.03.006; Kim MS, 2000, TOXICOLOGY, V145, P27, DOI 10.1016/S0300-483X(99)00176-6; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; Lafuente A, 2004, TOXICOL LETT, V146, P175, DOI 10.1016/j.toxlet.2003.10.004; Lafuente A, 2003, BIOMETALS, V16, P243, DOI 10.1023/A:1020658128413; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LASKEY JW, 1991, TOXICOL APPL PHARM, V108, P296, DOI 10.1016/0041-008X(91)90119-Y; Lee J, 1999, ENDOCRINOLOGY, V140, P852, DOI 10.1210/en.140.2.852; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Li LH, 1996, J ANDROL, V17, P538; Li M, 2000, J BIOL CHEM, V275, P39702, DOI 10.1074/jbc.M007369200; Lia MY, 2011, FISH SHELLFISH IMMUN, V30, P910, DOI 10.1016/j.fsi.2011.01.018; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Liu J, 2001, LIFE SCI, V69, P1833, DOI 10.1016/S0024-3205(01)01267-X; LOCKSHIN RA, 1964, J INSECT PHYSIOL, V10, P643, DOI 10.1016/0022-1910(64)90034-4; Lomb DJ, 2009, MOL PHARMACOL, V75, P1198, DOI 10.1124/mol.108.053157; Lue Y, 1997, J ANDROL, V18, P166; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2000, ENDOCRINOLOGY, V141, P1414, DOI 10.1210/en.141.4.1414; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Matsui Y, 1998, APMIS, V106, P142, DOI 10.1111/j.1699-0463.1998.tb01329.x; McClure RF, 1999, J BIOL CHEM, V274, P7756, DOI 10.1074/jbc.274.12.7756; MIEUSSET R, 1995, INT J ANDROL, V18, P169, DOI 10.1111/j.1365-2605.1995.tb00408.x; Morissette MR, 2003, J MOL CELL CARDIOL, V35, P1217, DOI 10.1016/S0022-2828(03)00212-8; Nandi S, 1999, BIOL REPROD, V61, P70, DOI 10.1095/biolreprod61.1.70; Nowicki A, 1996, INT J CANCER, V65, P112, DOI 10.1002/(SICI)1097-0215(19960103)65:1<112::AID-IJC19>3.3.CO;2-R; OBEROSLER P, 1993, EMBO J, V12, P2389, DOI 10.1002/j.1460-2075.1993.tb05893.x; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; Ohta H, 2003, BIOL REPROD, V68, P2249, DOI 10.1095/biolreprod.102.014779; Ozawa N, 2002, J CLIN INVEST, V109, P457, DOI [10.1172/JCI0213190, 10.1172/JCI200213190]; Paasch U, 2003, J ANDROL, V24, P246; PACKER AI, 1995, MOL REPROD DEV, V42, P303, DOI 10.1002/mrd.1080420307; Pant N, 2003, REPROD TOXICOL, V17, P447, DOI 10.1016/S0890-6238(03)00036-4; Pareek TK, 2007, APOPTOSIS, V12, P1085, DOI 10.1007/s10495-006-0039-3; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; RAGAN HA, 1990, REV ENVIRON CONTAM T, V114, P1; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Richburg JH, 2000, TOXICOL LETT, V112, P79, DOI 10.1016/S0378-4274(99)00253-2; Ricote M, 2002, MOL REPROD DEV, V63, P202, DOI 10.1002/mrd.10167; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; ROBERTS KP, 1991, ANN NY ACAD SCI, V637, P90, DOI 10.1111/j.1749-6632.1991.tb27303.x; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.950; Said TM, 2004, HUM REPROD UPDATE, V10, P39, DOI 10.1093/humupd/dmh003; Salazar G, 2005, DEV DYNAM, V234, P114, DOI 10.1002/dvdy.20533; Schamberger CJ, 2005, EXP CELL RES, V302, P115, DOI 10.1016/j.yexcr.2004.08.026; Sen Gupta R, 2004, MOL CELL ENDOCRINOL, V221, P57, DOI 10.1016/j.mce.2004.03.012; Siu ER, 2009, TOXICOL APPL PHARM, V238, P240, DOI 10.1016/j.taap.2009.01.028; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; STOCCO DM, 1993, ENDOCRINOLOGY, V133, P2827, DOI 10.1210/en.133.6.2827; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Thangaraju M, 2000, J BIOL CHEM, V275, P33487, DOI 10.1074/jbc.M005824200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vera Y, 2004, BIOL REPROD, V70, P1534, DOI 10.1095/biolreprod.103.024661; Vera Y, 2006, MOL ENDOCRINOL, V20, P1597, DOI 10.1210/me.2005-0395; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Q, 2010, TOXICOL LETT, V199, P129, DOI 10.1016/j.toxlet.2010.08.014; Wang X, 2003, FERTIL STERIL, V80, P531, DOI 10.1016/S0015-0282(03)00756-8; Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984; Wolgemuth DJ, 2003, CYTOGENET GENOME RES, V103, P256, DOI 10.1159/000076811; Woolveridge L, 1999, BIOL REPROD, V60, P461, DOI 10.1095/biolreprod60.2.461; Wu XD, 2002, REPROD TOXICOL, V16, P379, DOI 10.1016/S0890-6238(02)00039-4; Xu CY, 1996, TOXICOLOGY, V107, P1, DOI 10.1016/0300-483X(95)03195-L; Xu GG, 2010, BIOL REPROD, V83, P979, DOI 10.1095/biolreprod.110.085415; Xu Jian, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P25; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yang JM, 2003, REPROD TOXICOL, V17, P553, DOI 10.1016/S0890-6238(03)00100-X; Yazawa T, 1999, GEN COMP ENDOCR, V113, P302, DOI 10.1006/gcen.1998.7207; Yazawa T, 2000, ENDOCRINOLOGY, V141, P2027, DOI 10.1210/en.141.6.2027; Yazawa T, 2003, MOL REPROD DEV, V66, P60, DOI 10.1002/mrd.10328; Yazawa T, 2001, GEN COMP ENDOCR, V122, P296, DOI 10.1006/gcen.2001.7631; Yazawa T, 2001, MOL REPROD DEV, V59, P209, DOI 10.1002/mrd.1024; Yin YZ, 1998, BIOL REPROD, V58, P492, DOI 10.1095/biolreprod58.2.492; Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074; Yin YZ, 2002, J ANDROL, V23, P64, DOI 10.1002/jand.2002.23.1.64; Young KA, 1999, ENDOCRINOLOGY, V140, P3133, DOI 10.1210/en.140.7.3133; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZH, 2003, CONTRACEPTION, V68, P297, DOI 10.1016/S0010-7824(03)00176-8; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zheng H, 1996, TOXICOL APPL PHARM, V136, P229, DOI 10.1006/taap.1996.0029; Zhou T, 1999, TOXICOLOGY, V142, P1, DOI 10.1016/S0300-483X(99)00115-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	147	117	120	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39920	10.1371/journal.pone.0039920	http://dx.doi.org/10.1371/journal.pone.0039920			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22808142	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100139
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
